PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Abe, E; Ikeda, K; Nutahara, E; Hayashi, M; Yamashita, A; Taguchi, R; Doi, K; Honda, D; Okino, N; Ito, M				Abe, Eriko; Ikeda, Kazutaka; Nutahara, Eri; Hayashi, Masahiro; Yamashita, Atsushi; Taguchi, Ryo; Doi, Kosaku; Honda, Daiske; Okino, Nozomu; Ito, Makoto			Novel Lysophospholipid Acyltransferase PLAT1 of Aurantiochytrium limacinum F26-b Responsible for Generation of Palmitate-Docosahexaenoate-Phosphatidylcholine and Phosphatidylethanolamine	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ACYL-COA; SCHIZOCHYTRIUM; METABOLISM; EXPRESSION; CLONING; FAMILY; CELLS; THRAUSTOCHYTRIDS; IDENTIFICATION	N-3 polyunsaturated fatty acids (PUFA), such as docosahexaenoic acid (DHA, 22:6n-3), have been reported to play roles in preventing cardiovascular diseases. The major source of DHA is fish oils but a recent increase in the global demand of DHA and decrease in fish stocks require a substitute. Thraustochytrids, unicellular marine protists belonging to the Chromista kingdom, can synthesize large amounts of DHA, and, thus, are expected to be an alternative to fish oils. DHA is found in the acyl chain(s) of phospholipids as well as triacylglycerols in thraustochytrids; however, how thraustochytrids incorporate DHA into phospholipids remains unknown. We report here a novel lysophospholipid acyltransferase (PLAT1), which is responsible for the generation of DHA-containing phosphatidylcholine and phosphatidylethanolamine in thraustochytrids. The PLAT1 gene, which was isolated from the genomic DNA of Aurantiochytrium limacinum F26-b, was expressed in Saccharomyces cerevisiae, and the FLAG-tagged recombinant enzyme was characterized after purification with anti-FLAG affinity gel. PLAT1 shows wide specificity for donor substrates as well as acceptor substrates in vitro, i.e, the enzyme can adopt lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylserine and lysophosphatidylinositol as acceptor substrates, and 15:0/16:0-CoA and DHA-CoA as donor substrates. In contrast to the in vitro experiment, only lysophosphatidylcholine acyltransferase and lysophosphatidylethanolamine acyltransferase activities were decreased in plat1-knockout mutants, resulting in a decrease of 16:0-DHA-phosphatidylcholine (PC) [PC(38:6)] and 16:0-DHA-phosphatidylethanolamine (PE) [PE(38:6)], which are two major DHA-containing phospholipids in A. limacinum F26-b. However, the amounts of other phospholipid species including DHA-DHA-PC [PC(44:12)] and DHA-DHA-PE [PE(44:12)] were almost the same in plat-knockout mutants and the wild-type. These results indicate that PLAT1 is the enzyme responsible for the generation of 16:0-DHA-PC and 16:0-DHA-PE in the thraustochytrid.	[Abe, Eriko; Nutahara, Eri; Okino, Nozomu; Ito, Makoto] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fukuoka 812, Japan; [Ikeda, Kazutaka] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Hayashi, Masahiro] Miyazaki Univ, Fac Agr, Miyazaki 88921, Japan; [Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Tokyo 173, Japan; [Taguchi, Ryo] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan; [Doi, Kosaku] Konan Univ, Grad Sch Nat Sci, Higashinada Ku, Kobe, Hyogo, Japan; [Doi, Kosaku; Honda, Daiske] Konan Univ, Inst Integrat Neurobiol, Higashinada Ku, Kobe, Hyogo, Japan; [Honda, Daiske] Konan Univ, Fac Sci & Engn, Higashinada Ku, Kobe, Hyogo, Japan; [Ito, Makoto] Kyushu Univ, Bioarchtechture Ctr, Fukuoka 812, Japan	Kyushu University; Keio University; University of Miyazaki; Teikyo University; Chubu University; Konan University; Konan University; Konan University; Kyushu University	Ito, M (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fukuoka 812, Japan.	makotoi@agr.kyushu-u.ac.jp	Ito, Makoto/Q-6164-2019; Okino, Nozomu/AAY-2635-2021	ito, Makoto/0000-0003-3159-7818; Yamashita, Atsushi/0000-0002-2544-2134; Honda, Daiske/0000-0002-3436-4561	Japanese Ministry of Education, Culture, Science and Technology [24380058]; Grants-in-Aid for Scientific Research [24619007] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Basic research B (24380058) from the Japanese Ministry of Education, Culture, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2006, J BIOCHEM, V140, P247, DOI 10.1093/jb/mvj145; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Crawford MA, 1997, AM J CLIN NUTR, V66, P1032, DOI 10.1093/ajcn/66.4.1032S; Giusto NM, 2000, PROG LIPID RES, V39, P315, DOI 10.1016/S0163-7827(00)00009-6; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Harris WS, 2013, POSTGRAD MED, V125, P100, DOI 10.3810/pgm.2013.11.2717; Hayashi M, 2007, BIOSCI BIOTECH BIOCH, V71, P222, DOI 10.1271/bbb.60308; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Honda D, 1998, MYCOL RES, V102, P439, DOI 10.1017/S0953756297005170; Ikeda K, 2011, ANAL BIOANAL CHEM, V400, P1853, DOI 10.1007/s00216-011-4703-2; Kobayashi T, 2011, APPL ENVIRON MICROB, V77, P3870, DOI 10.1128/AEM.02664-10; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Levy BD, 2010, PROSTAG LEUKOTR ESS, V82, P327, DOI 10.1016/j.plefa.2010.02.003; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Lu B, 2005, BIOCHEM J, V385, P469, DOI 10.1042/BJ20041348; Martins DA, 2013, MAR DRUGS, V11, P2259, DOI 10.3390/md11072259; Matsuda T, 2012, J LIPID RES, V53, P1210, DOI 10.1194/jlr.M024935; Miyamoto E, 2007, J NUTR SCI VITAMINOL, V53, P471, DOI 10.3177/jnsv.53.471; Nagano N, 2009, J OLEO SCI, V58, P623, DOI 10.5650/jos.58.623; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Ohara J, 2013, MAR BIOTECHNOL, V15, P476, DOI 10.1007/s10126-013-9496-1; Raghukumar S, 2008, MAR BIOTECHNOL, V10, P631, DOI 10.1007/s10126-008-9135-4; Rossmeisl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038834; Sakaguchi K, 2012, APPL ENVIRON MICROB, V78, P3193, DOI 10.1128/AEM.07129-11; SATOUCHI K, 1993, LIPIDS, V28, P837, DOI 10.1007/BF02536239; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, BIOCHEM BIOPH RES CO, V383, P320, DOI 10.1016/j.bbrc.2009.04.013; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uauy R, 2001, LIPIDS, V36, P885, DOI 10.1007/s11745-001-0798-1; von Schacky C, 2007, CARDIOVASC RES, V73, P310, DOI 10.1016/j.cardiores.2006.08.019; Yamashita A, 2007, BBA-MOL CELL BIOL L, V1771, P1202, DOI 10.1016/j.bbalip.2007.07.002; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yokoyama Rinka, 2007, Mycoscience, V48, P199, DOI 10.1007/s10267-006-0362-0	39	12	12	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102377	10.1371/journal.pone.0102377	http://dx.doi.org/10.1371/journal.pone.0102377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090090	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700006
J	Lin, M; Jiao, JW; Zhan, XH; Zhan, XF; Pan, MC; Wang, JL; Wang, CF; Zhong, TY; Zhang, Q; Yu, X; Wu, JR; Yang, HT; Lin, F; Tong, X; Yang, H; Zha, GC; Wang, Q; Zheng, L; Wen, YF; Yang, LY				Lin, Min; Jiao, Ji-Wei; Zhan, Xiu-Hui; Zhan, Xiao-Fen; Pan, Mei-Chen; Wang, Jun-Li; Wang, Chun-Fang; Zhong, Tian-Yu; Zhang, Qin; Yu, Xia; Wu, Jiao-Ren; Yang, Hui-Tian; Lin, Fen; Tong, Xin; Yang, Hui; Zha, Guang-Cai; Wang, Qian; Zheng, Lei; Wen, Ying-Fang; Yang, Li-Ye			High Resolution Melting Analysis: A Rapid Screening and Typing Tool for Common beta-Thalassemia Mutation in Chinese Population	PLOS ONE			English	Article							SYBR GREEN1; HEMOGLOBINOPATHIES; IDENTIFICATION; PCR; ALPHA; ASSAY	beta-thalassemia is a common inherited disorder worldwide including southern China, and at least 45 distinct beta-thalassemia mutations have been identified in China. High-resolution melting (HRM) assay was recently introduced as a rapid, inexpensive and effective method for genotyping. However, there was no systemic study on the diagnostic capability of HRM to identify beta-thalassemia. Here, we used an improved HRM method to screen and type 12 common beta-thalassemia mutations in Chinese, and the rapidity and reliability of this method was investigated. The whole PCR and HRM procedure could be completed in 40 min. The heterozygous mutations and 4 kinds of homozygous mutations could be readily differentiated from the melting curve except c.-78A>G heterozygote and c.-79A>G heterozygote. The diagnostic reliability of this HRM assay was evaluated on 756 pre-typed genomic DNA samples and 50 cases of blood spots on filter paper, which were collected from seven high prevalent provinces in southern China. If c.-78A>G heterozygote and c.-79A>G heterozygote were classified into the same group (c.-78&79 A>G heterozygote), the HRM method was in complete concordance with the reference method (reverse dot blot/DNA-sequencing). In a conclusion, the HRM method appears to be an accurate and sensitive method for the rapid screening and identification of beta-thalassemia mutations. In the future, we suggest this technology to be used in neonatal blood spot screening program. It could enlarge the coverage of beta-thalassemia screening program in China. At the same time, its value should be confirmed in prospectively clinical and epidemiological studies.	[Lin, Min; Zhan, Xiao-Fen; Wu, Jiao-Ren; Yang, Hui-Tian; Lin, Fen; Tong, Xin; Yang, Hui; Yang, Li-Ye] Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China; [Lin, Min; Pan, Mei-Chen] Shantou Univ, Coll Med, Affiliated Hosp 1, Med Lab, Shantou, Guangdong, Peoples R China; [Jiao, Ji-Wei; Zhan, Xiu-Hui; Zha, Guang-Cai] Hanshan Normal Univ, Dept Biol, Chaozhou, Guangdong, Peoples R China; [Wang, Jun-Li; Wang, Chun-Fang] Hosp Youjiang Med Univ Nationalities, Dept Lab Med, Baise, Guangxi Provinc, Peoples R China; [Zhong, Tian-Yu] Gannan Med Univ, Affiliated Hosp 1, Med Lab, Ganzhou, Jiangxi, Peoples R China; [Zhang, Qin] Peoples Hosp Yunan Prov, Lab Med Ctr, Kunming, Yunnan Province, Peoples R China; [Yu, Xia] Chengdu Womens & Childrens Cent Hosp, Dept Lab Med, Chengdu, Sichuan Provinc, Peoples R China; [Yang, Hui; Wang, Qian; Zheng, Lei] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China; [Wen, Ying-Fang] Meixian Peoples Hosp, Med Lab, Meizhou, Guangdong, Peoples R China	Southern Medical University - China; Shantou University; Hanshan Normal University; Youjiang Medical University for Nationalities; Gannan Medical University; Southern Medical University - China	Yang, LY (corresponding author), Southern Med Univ, Chaozhou Cent Hosp, Cent Lab, Chaozhou, Guangdong, Peoples R China.	yangleeyee@sina.com		Zhong, Tianyu/0000-0003-1934-0032	National Natural Science Foundation of China [81101329]; Social Development Program of Guangdong Province [2011B031800329]; Natural Science Foundation for Young Scientists of Jiangxi Province [20122BAB215006]; Foundation of the Health Department of Guangxi Province, China [2012713, Z2012085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development Program of Guangdong Province; Natural Science Foundation for Young Scientists of Jiangxi Province; Foundation of the Health Department of Guangxi Province, China	This work was partially supported by the National Natural Science Foundation of China (contract/grant number 81101329 to Min Lin), Social Development Program of Guangdong Province (contract/grant number 2011B031800329 to Min Lin), Natural Science Foundation for Young Scientists of Jiangxi Province (contract/grant number 20122BAB215006 to Tian-Yu Zhong) and Foundation of the Health Department of Guangxi Province, China (contract/grant number 2012713 and Z2012085 to Jun-Li Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borbely N, 2013, J CLIN PATHOL, V66, P29, DOI 10.1136/jclinpath-2012-200946; CHAN V, 1987, AM J HUM GENET, V41, P678; Chen GM, 2012, INT J PEDIATR OTORHI, V76, P1771, DOI 10.1016/j.ijporl.2012.08.021; Chen JT, 2013, J MOL DIAGN THER, V5, P225; Cui GL, 2013, GENE, V514, P125, DOI 10.1016/j.gene.2012.11.004; Er TK, 2012, CLIN CHIM ACTA, V413, P1781, DOI 10.1016/j.cca.2012.06.033; Feng Shan-wei, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P223, DOI 10.3760/cma.j.issn.1003-9406.2011.02.023; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; Galanello R, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-11; Gu Xue-fan, 2005, Zhonghua Er Ke Za Zhi, V43, P321; He XA, 2010, GENET TEST MOL BIOMA, V14, P851, DOI 10.1089/gtmb.2010.0048; Li DZ, 2009, PRENATAL DIAG, V29, P637, DOI 10.1002/pd.2251; Li Q, 2008, CLIN BIOCHEM, V41, P681, DOI 10.1016/j.clinbiochem.2008.02.008; Lin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055024; Lin M, 2012, BLOOD CELL MOL DIS, V48, P86, DOI 10.1016/j.bcmd.2011.12.001; Pornprasert S, 2008, EUR J HAEMATOL, V80, P510, DOI 10.1111/j.1600-0609.2008.01055.x; Pornprasert S, 2012, HEMOGLOBIN, V36, P491, DOI 10.3109/03630269.2012.709896; Pornprasert S, 2011, KOREAN J LAB MED, V31, P138, DOI 10.3343/kjlm.2011.31.3.138; Reichert VCD, 2008, ANN HEMATOL, V87, P381, DOI 10.1007/s00277-007-0418-z; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Shih HC, 2009, CLIN BIOCHEM, V42, P1667, DOI 10.1016/j.clinbiochem.2009.07.017; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Xiong F, 2010, CLIN GENET, V78, P139, DOI 10.1111/j.1399-0004.2010.01430.x; Xiong F, 2011, J MOL DIAGN, V13, P427, DOI 10.1016/j.jmoldx.2011.03.005; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456	25	8	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102243	10.1371/journal.pone.0102243	http://dx.doi.org/10.1371/journal.pone.0102243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089872	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700004
J	Martens, A; Rojas, SV; Baraki, H; Rathert, C; Schecker, N; Hernandez, SR; Schwanke, K; Zweigerdt, R; Martin, U; Saito, S; Haverich, A; Kutschka, I				Martens, Andreas; Rojas, Sebastian V.; Baraki, Hassina; Rathert, Christian; Schecker, Natalie; Hernandez, Sara Rojas; Schwanke, Kristin; Zweigerdt, Robert; Martin, Ulrich; Saito, Shunsuke; Haverich, Axel; Kutschka, Ingo			Macroscopic Fluorescence Imaging: A Novel Technique to Monitor Retention and Distribution of Injected Microspheres in an Experimental Model of Ischemic Heart Failure	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; EMBRYONIC STEM-CELLS; INTRAMYOCARDIAL INJECTION; CARDIAC REPAIR; DELIVERY	Background: The limited effectiveness of cardiac cell therapy has generated concern regarding its clinical relevance. Experimental studies show that cell retention and engraftment are low after injection into ischemic myocardium, which may restrict therapy effectiveness significantly. Surgical aspects and mechanical loss are suspected to be the main culprits behind this phenomenon. As current techniques of monitoring intramyocardial injections are complex and time-consuming, the aim of the study was to develop a fast and simple model to study cardiac retention and distribution following intramyocardial injections. For this purpose, our main hypothesis was that macroscopic fluorescence imaging could adequately serve as a detection method for intramyocardial injections. Methods and Results: A total of 20 mice underwent ligation of the left anterior descending artery (LAD) for myocardial infarction. Fluorescent microspheres with cellular dimensions were used as cell surrogates. Particles (5 x 10(5)) were injected into the infarcted area of explanted resting hearts (Ex vivo myocardial injetions EVMI, n = 10) and in vivo into beating hearts (In vivo myocardial injections IVMI, n = 10). Microsphere quantification was performed by fluorescence imaging of explanted organs. Measurements were repeated after a reduction to homogenate dilutions. Cardiac microsphere retention was 2.78 x 10(5) +/- 0.31 x 10(5) in the EVMI group. In the IVMI group, cardiac retention of microspheres was significantly lower (0.74 x 10(5) +/- 0.18 x 10(5); p<0.05). Direct fluorescence imaging revealed venous drainage through the coronary sinus, resulting in a microsphere accumulation in the left (0.90 x 10(5) +/- 0.20 x 10(5)) and the right (1.07 x 10(5) +/- 0.17 x 10(5)) lung. Processing to homogenates involved further particle loss (p<0.05) in both groups. Conclusions: We developed a fast and simple direct fluorescence imaging method for biodistribution analysis which enabled the quantification of fluorescent microspheres after intramyocardial delivery using macroscopic fluorescence imaging. This new technique showed massive early particle loss and venous drainage into the right atrium leading to substantial accumulation of graft particles in both lungs.	[Martens, Andreas; Rojas, Sebastian V.; Baraki, Hassina; Saito, Shunsuke; Haverich, Axel; Kutschka, Ingo] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany; [Martens, Andreas; Rojas, Sebastian V.; Rathert, Christian; Schecker, Natalie; Schwanke, Kristin; Zweigerdt, Robert; Martin, Ulrich; Haverich, Axel; Kutschka, Ingo] Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs, Hannover, Germany; [Hernandez, Sara Rojas] Hannover Med Sch, Dept Anaesthesiol & Intens Care Med, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Rojas, SV (corresponding author), Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany.	rojas.sebastian@mh-hannover.de	Martin, Ulrich/F-4888-2017; Haverich, Axel/AAC-7552-2022; Rojas, Sebastian V/AFR-1536-2022; Martens, Andreas/AAG-2746-2020	Martin, Ulrich/0000-0003-1058-4540; Rojas, Sebastian V/0000-0002-9505-1358; Martens, Andreas/0000-0002-7953-2645				Al Kindi A, 2008, FRONT BIOSCI-LANDMRK, V13, P2421, DOI 10.2741/2855; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Anderl JN, 2009, J BIOMED MATER RES A, V88A, P704, DOI 10.1002/jbm.a.31917; Azene N, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-7; Behfar A, 2013, CIRC-CARDIOVASC INTE, V6, P710, DOI 10.1161/CIRCINTERVENTIONS.112.000422; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bonios M, 2011, J NUCL CARDIOL, V18, P443, DOI 10.1007/s12350-011-9369-9; Clifford DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037373; Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011; Fu Yingli, 2011, Imaging Med, V3, P473; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Kutschka I, 2007, J HEART LUNG TRANSPL, V26, P273, DOI 10.1016/j.healun.2006.11.604; Kutschka I, 2006, CIRCULATION, V114, pI167, DOI 10.1161/CIRCULATIONAHA.105.001297; Kutschka I, 2006, CIRCULATION, V114, pI174, DOI 10.1161/CIRCULATIONAHA.105.001370; Lang C, 2013, EUR J NUCL MED MOL I, V40, P1730, DOI 10.1007/s00259-013-2480-1; Leri A, 2008, CURR PROB CARDIOLOGY, V33, P91, DOI 10.1016/j.cpcardiol.2007.11.002; Li SH, 2009, J THORAC CARDIOV SUR, V137, P1225, DOI 10.1016/j.jtcvs.2008.11.001; Li XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066688; Martens A, 2014, ARTIF ORGANS, V38, P978, DOI 10.1111/aor.12268; Martens A, 2011, CYTOTHERAPY, V13, P864, DOI 10.3109/14653249.2011.571247; Mauritz C, 2011, EUR HEART J, V32, P2634, DOI 10.1093/eurheartj/ehr166; Mignone JL, 2010, CIRC J, V74, P2517, DOI 10.1253/circj.CJ-10-0958; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Stamm C, 2012, LANCET, V379, P891, DOI 10.1016/S0140-6736(12)60385-7; Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034; Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Zweigerdt R, 2007, SEMIN CELL DEV BIOL, V18, P794, DOI 10.1016/j.semcdb.2007.09.014	30	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e101775	10.1371/journal.pone.0101775	http://dx.doi.org/10.1371/journal.pone.0101775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089764	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700003
J	Nuruddin, S; Syverstad, GHE; Lillehaug, S; Leergaard, TB; Nilsson, LNG; Ropstad, E; Krogenaes, A; Haraldsen, IRH; Torp, R				Nuruddin, Syed; Syverstad, Gry Helen Enger; Lillehaug, Sveinung; Leergaard, Trygve B.; Nilsson, Lars N. G.; Ropstad, Erik; Krogenaes, Anette; Haraldsen, Ira Ronit Hebold; Torp, Reidun			Elevated mRNA-Levels of Gonadotropin-Releasing Hormone and Its Receptor in Plaque-Bearing Alzheimer's Disease Transgenic Mice	PLOS ONE			English	Article							LUTEINIZING-HORMONE; COGNITIVE FUNCTION; BETA; MEN; EXPRESSION; REGULATOR; DEMENTIA; ACETATE; PROTEIN; BRAIN	Research on Alzheimer's disease (AD) has indicated an association between hormones of the hypothalamic-pituitary-gonadal (HPG) axis and cognitive senescence, indicating that post meno-/andropausal changes in HPG axis hormones are implicated in the neuropathology of AD. Studies of transgenic mice with AD pathologies have led to improved understanding of the pathophysiological processes underlying AD. The aims of this study were to explore whether mRNA-levels of gonadotropin-releasing hormone (Gnrh) and its receptor (Gnrhr) were changed in plaque-bearing Alzheimer's disease transgenic mice and to investigate whether these levels and amyloid plaque deposition were downregulated by treatment with a gonadotropin-releasing hormone analog (Gnrh-a; Leuprorelin acetate). The study was performed on mice carrying the Arctic and Swedish amyloid-b precursor protein (AbPP) mutations (tgArcSwe). At 12 months of age, female tgArcSwe mice showed a twofold higher level of Gnrh mRNA and more than 1.5 higher level of Gnrhr mRNA than age matched controls. Male tgArcSwe mice showed the same pattern of changes, albeit more pronounced. In both sexes, Gnrha treatment caused significant down-regulation of Gnrh and Gnrhr mRNA expression. Immunohistochemistry combined with quantitative image analysis revealed no significant changes in the plaque load after Gnrh-a treatment in hippocampus and thalamus. However, plaque load in the cerebral cortex of treated females tended to be lower than in female vehicle-treated mice. The present study points to the involvement of hormonal changes in AD mice models and demonstrates that these changes can be effectively counteracted by pharmacological treatment. Although known to increase in normal aging, our study shows that Gnrh/Gnrhr mRNA expression increases much more dramatically in tgArcSwe mice. Treatment with Leuprorelin acetate successfully abolished the transgene specific effects on Gnrh/Gnrhr mRNA expression. The present experimental approach should serve as a platform for further studies on the usefulness of Gnrh-a treatment in suppressing plaque development in AD.	[Nuruddin, Syed; Ropstad, Erik; Krogenaes, Anette] Norwegian Sch Vet Sci, Oslo, Norway; [Syverstad, Gry Helen Enger; Lillehaug, Sveinung; Leergaard, Trygve B.; Torp, Reidun] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway; [Haraldsen, Ira Ronit Hebold] Oslo Univ Hosp, Rikshosp, Div Surg & Clin Neurosci, Dept Neuropsychiat & Psychosomat Med, Oslo, Norway; [Nilsson, Lars N. G.] Univ Oslo, Dept Pharmacol, Oslo, Norway; [Nilsson, Lars N. G.] Oslo Univ Hosp, Oslo, Norway; [Nilsson, Lars N. G.] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden	Norwegian University of Life Sciences; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Uppsala University	Torp, R (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway.	torp@medisin.uio.no	Center, Norwegian Transgenic/T-2512-2018; Nuruddin, Syed/Q-2398-2018; Haraldsen, Ira Hebold/AAY-4300-2021	Nuruddin, Syed/0000-0002-6779-8315; Leergaard, Trygve B./0000-0001-5965-8470; nilsson, lars/0000-0002-8362-1042; Krogenaes, Anette/0000-0001-6280-5697	Letten Centre, IMB, UiO; Nasjonalforeningen for folkehelsen	Letten Centre, IMB, UiO; Nasjonalforeningen for folkehelsen	The authors would also like to thank Letten Centre, IMB, UiO for support to Reidun Torp, CIVITAN Norge Alzheimer foundation, and Nasjonalforeningen for folkehelsen for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADR M, 1988, PEPTIDES, V9, P441, DOI 10.1016/0196-9781(88)90283-5; Barron AM, 2006, ENDOCRINE, V29, P257, DOI 10.1385/ENDO:29:2:257; Bowen RL, 2001, JAMA-J AM MED ASSOC, V286, P790, DOI 10.1001/jama.286.7.790; Bowen RL, 2004, J BIOL CHEM, V279, P20539, DOI 10.1074/jbc.M311993200; Bryan KJ, 2010, J NEUROCHEM, V112, P870, DOI 10.1111/j.1471-4159.2009.06502.x; Casadesus G, 2006, BBA-MOL BASIS DIS, V1762, P447, DOI 10.1016/j.bbadis.2006.01.008; Cherrier MM, 2003, J UROLOGY, V170, P1808, DOI 10.1097/01.ju.0000091640.59812.83; D'Amico AV, 2010, ALZ DIS ASSOC DIS, V24, P85, DOI 10.1097/WAD.0b013e31819cb8f4; Ehlers K, 2013, GONADOTROPIN RELEASI; Evans NP, 2012, PSYCHONEUROENDOCRINO, V37, P1876, DOI 10.1016/j.psyneuen.2012.03.020; Francis PT, 2012, EXPERT REV NEUROTHER, V12, P1351, DOI [10.1586/ern.12.124, 10.1586/ERN.12.124]; Gault PM, 2003, J NEUROENDOCRINOL, V15, P831, DOI 10.1046/j.1365-2826.2003.01065.x; Green HJ, 2002, BJU INT, V90, P427, DOI 10.1046/j.1464-410X.2002.02917.x; Grigorova M, 2006, PSYCHONEUROENDOCRINO, V31, P935, DOI 10.1016/j.psyneuen.2006.05.004; He DQ, 1999, BRAIN RES, V820, P71, DOI 10.1016/S0006-8993(98)01358-4; Hogervorst E, 2004, EXP GERONTOL, V39, P1633, DOI 10.1016/j.exger.2004.06.019; Lillehaug S, 2014, NEUROBIOL AGING, V35, P556, DOI 10.1016/j.neurobiolaging.2013.09.013; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lu F, 1999, CHINESE J PHYSIOL, V42, P67; Marlatt MW, 2005, CURR MED CHEM, V12, P1137, DOI 10.2174/0929867053764644; Meethal SV, 2005, ENDOCRINE, V26, P317, DOI 10.1385/ENDO:26:3:317; Millar RP, 2005, ANIM REPROD SCI, V88, P5, DOI 10.1016/j.anireprosci.2005.05.032; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nelson CJ, 2008, CANCER, V113, P1097, DOI 10.1002/cncr.23658; Nogami H, 2007, J NEUROENDOCRINOL, V19, P583, DOI 10.1111/j.1365-2826.2007.01565.x; Nuruddin S, 2013, PSYCHONEURO IN PRESS; Nuruddin S, 2013, BEHAV BRAIN RES, V242, P9, DOI 10.1016/j.bbr.2012.12.027; Rodrigues MA, 2008, J ALZHEIMERS DIS, V13, P267; Schally AV, 2001, FRONT NEUROENDOCRIN, V22, P248, DOI 10.1006/frne.2001.0217; SEDGEWICK J, 2008, SCI IMAGING PHOTOSHO; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Sherwin BB, 2003, J MOL NEUROSCI, V20, P385, DOI 10.1385/JMN:20:3:385; Simpkins James W, 2009, Ther Adv Neurol Disord, V2, P31, DOI 10.1177/1756285608100427; Skinner DC, 2009, J NEUROENDOCRINOL, V21, P282, DOI 10.1111/j.1365-2826.2009.01842.x; Stevenson TJ, 2012, FRONT NEUROENDOCRIN, V33, P287, DOI 10.1016/j.yfrne.2012.09.001; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verdile G, 2014, MOL PSYCHIATR, V19, P69, DOI 10.1038/mp.2012.147; Verri M, 2012, INT J IMMUNOPATH PH, V25, P345, DOI 10.1177/039463201202500204; Wang LY, 2010, CNS NEUROL DISORD-DR, V9, P651, DOI 10.2174/187152710793361559; Wilson AC, 2006, J ENDOCRINOL, V191, P651, DOI 10.1677/joe.1.07047; Wimo A, 2007, ALZHEIMERS DEMENT, V3, P81, DOI 10.1016/j.jalz.2007.02.001; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Wojniusz S, 2011, HORM BEHAV, V59, P22, DOI 10.1016/j.yhbeh.2010.09.010; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143	45	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103607	10.1371/journal.pone.0103607	http://dx.doi.org/10.1371/journal.pone.0103607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089901	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700037
J	Sun, CS; Wang, CYH; Chen, BPW; He, RY; Liu, GCH; Wang, CH; Chen, WL; Chern, Y; Huang, JJT				Sun, Chia-Sui; Wang, Cindy Yu-Hsiang; Chen, Bryan Po-Wen; He, Ruei-Yu; Liu, Gerard Chun-Hao; Wang, Chih-Hsien; Chen, Wenlung; Chern, Yijuang; Huang, Joseph Jen-Tse			The Influence of Pathological Mutations and Proline Substitutions in TDP-43 Glycine-Rich Peptides on Its Amyloid Properties and Cellular Toxicity	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; BINDING PROTEIN 43; DNA-BINDING; ALZHEIMER-DISEASE; ION CHANNELS; AGGREGATION; ALS; INCLUSIONS; SCLEROSIS; NEURODEGENERATION	TAR DNA-binding protein (TDP-43) was identified as the major ubiquitinated component deposited in the inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) in 2006. Later on, numerous ALS-related mutations were found in either the glycine or glutamine/asparagine-rich region on the TDP-43 C-terminus, which hinted on the importance of mutations on the disease pathogenesis. However, how the structural conversion was influenced by the mutations and the biological significance of these peptides remains unclear. In this work, various peptides bearing pathogenic or de novo designed mutations were synthesized and displayed their ability to form twisted amyloid fibers, cause liposome leakage, and mediate cellular toxicity as confirmed by transmission electron microscopy (TEM), circular dichroism (CD), Thioflavin T (ThT) assay, Raman spectroscopy, calcein leakage assay, and cell viability assay. We have also shown that replacing glycines with prolines, known to obstruct beta-sheet formation, at the different positions in these peptides may influence the amyloidogenesis process and neurotoxicity. In these cases, GGG308PPP mutant was not able to form beta-amyloid, cause liposome leakage, nor jeopardized cell survival, which hinted on the importance of the glycines (308-310) during amyloidogenesis.	[Sun, Chia-Sui] Natl Yang Ming Univ, Taiwan Int Grad Program Mol Med, Taipei 112, Taiwan; [Sun, Chia-Sui] Acad Sinica, Taipei 115, Taiwan; [Sun, Chia-Sui; Wang, Cindy Yu-Hsiang; Chen, Bryan Po-Wen; He, Ruei-Yu; Liu, Gerard Chun-Hao; Huang, Joseph Jen-Tse] Acad Sinica, Inst Chem, Taipei, Taiwan; [Sun, Chia-Sui; Chern, Yijuang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Sun, Chia-Sui] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wang, Cindy Yu-Hsiang; Liu, Gerard Chun-Hao] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Wang, Chih-Hsien; Chen, Wenlung] Natl Chiayi Univ, Dept Appl Chem, Chiayi, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Chiayi University	Huang, JJT (corresponding author), Acad Sinica, Inst Chem, Taipei, Taiwan.	jthuang@gate.sinica.edu.tw	chern, yijuang/S-7013-2018; Huang, Joseph Jen-Tse/E-4918-2015	chern, yijuang/0000-0002-5842-5429; Huang, Joseph Jen-Tse/0000-0003-4847-7126	Academia Sinica; National Science Council, Taiwan [AS-100-TP2-B02, NSC 100-2113-M-001-013-MY2, NSC 102-2113-M-001-007]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica (http://www.sinica.edu.tw/index.shtml) and the National Science Council, Taiwan. (http://web1.most.gov.tw/) Grant number: AS-100-TP2-B02, NSC 100-2113-M-001-013-MY2, and NSC 102-2113-M-001-007. RYH was supported by the postdoctoral fellowship from Academia Sinica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Bigio EH, 2013, ACTA NEUROPATHOL, V125, P463, DOI 10.1007/s00401-013-1089-6; Blanch EW, 2000, J MOL BIOL, V301, P553, DOI 10.1006/jmbi.2000.3981; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Chang CK, 2012, BIOCHEM BIOPH RES CO, V425, P219, DOI 10.1016/j.bbrc.2012.07.071; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Gendron TF, 2013, J ALZHEIMERS DIS, V33, pS35, DOI 10.3233/JAD-2012-129036; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Janssens J, 2013, HUM MOL GENET, V22, pR77, DOI 10.1093/hmg/ddt349; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Jiang P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000357; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Liu GCH, 2013, CHEM COMMUN, V49, P11212, DOI 10.1039/c3cc46762g; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Malchiodi-Albedi Fiorella, 2011, Int J Alzheimers Dis, V2011, P906964, DOI 10.4061/2011/906964; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; Narayan P, 2013, J AM CHEM SOC, V135, P1491, DOI 10.1021/ja3103567; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Parker SJ, 2012, NEUROCHEM INT, V60, P415, DOI 10.1016/j.neuint.2012.01.019; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Poduslo JF, 1999, J NEUROBIOL, V39, P371, DOI 10.1002/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.3.CO;2-5; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Robinson JL, 2013, ACTA NEUROPATHOL, V125, P121, DOI 10.1007/s00401-012-1055-8; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Wang IF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1766; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wigley WC, 2002, NAT STRUCT BIOL, V9, P381, DOI 10.1038/nsb784; WOOD SJ, 1995, BIOCHEMISTRY-US, V34, P724, DOI 10.1021/bi00003a003; Xu YF, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-73; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	48	26	27	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103644	10.1371/journal.pone.0103644	http://dx.doi.org/10.1371/journal.pone.0103644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090004	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700038
J	Ettenauer, JD; Jurado, V; Pinar, G; Miller, AZ; Santner, M; Saiz-Jimenez, C; Sterflinger, K				Ettenauer, Joerg D.; Jurado, Valme; Pinar, Guadalupe; Miller, Ana Z.; Santner, Markus; Saiz-Jimenez, Cesareo; Sterflinger, Katja			Halophilic Microorganisms Are Responsible for the Rosy Discolouration of Saline Environments in Three Historical Buildings with Mural Paintings	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; ANCIENT WALL PAINTINGS; POLYMERASE-CHAIN-REACTION; SP NOV.; BACTERIAL COMMUNITIES; CULTURAL-HERITAGE; MOLECULAR METHODS; MICROBIAL-CELLS; SOLAR SALTERN	A number of mural paintings and building materials from monuments located in central and south Europe are characterized by the presence of an intriguing rosy discolouration phenomenon. Although some similarities were observed among the bacterial and archaeal microbiota detected in these monuments, their origin and nature is still unknown. In order to get a complete overview of this biodeterioration process, we investigated the microbial communities in saline environments causing the rosy discolouration of mural paintings in three Austrian historical buildings using a combination of culture-dependent and -independent techniques as well as microscopic techniques. The bacterial communities were dominated by halophilic members of Actinobacteria, mainly of the genus Rubrobacter. Representatives of the Archaea were also detected with the predominating genera Halobacterium, Halococcus and Halalkalicoccus. Furthermore, halophilic bacterial strains, mainly of the phylum Firmicutes, could be retrieved from two monuments using special culture media. Inoculation of building materials (limestone and gypsum plaster) with selected isolates reproduced the unaesthetic rosy effect and biodeterioration in the laboratory.	[Ettenauer, Joerg D.; Pinar, Guadalupe; Sterflinger, Katja] Univ Nat Resources & Life Sci, VIBT BOKU, Dept Biotechnol, Vienna, Austria; [Jurado, Valme; Miller, Ana Z.; Saiz-Jimenez, Cesareo] IRNAS CSIC, Inst Recursos Nat & Agrobiol, Seville, Spain; [Miller, Ana Z.] Univ Lisbon, Inst Super Tecn, CEPGIST CERENA, P-1699 Lisbon, Portugal; [Santner, Markus] Abt Konservierung & Restaurierung, Bundesdenkmalamt, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Universidade de Lisboa; Instituto Superior Tecnico	Ettenauer, JD (corresponding author), Univ Nat Resources & Life Sci, VIBT BOKU, Dept Biotechnol, Vienna, Austria.	joerg.ettenauer@boku.ac.at	Pinar, Guadalupe/I-8959-2016; JURADO, VALME/E-3468-2016; Miller, Ana Zélia/AAD-1117-2019; Miller, Ana Zélia/H-8140-2012; SAIZ-JIMENEZ, CESAREO/I-8885-2012	Pinar, Guadalupe/0000-0001-7881-8572; JURADO, VALME/0000-0003-0972-9909; Miller, Ana Zélia/0000-0002-0553-8470; Miller, Ana Zélia/0000-0002-0553-8470; SAIZ-JIMENEZ, CESAREO/0000-0003-0036-670X; Sterflinger, Katja/0000-0002-0296-6728	Ministry of Care of Monuments in Austria (Bundesdenkmalamt); University of Natural Resources and Life Sciences (Vienna); Spanish Ministry [2007-00058]	Ministry of Care of Monuments in Austria (Bundesdenkmalamt); University of Natural Resources and Life Sciences (Vienna); Spanish Ministry(Spanish Government)	JE, GP and KS were partly financially supported with funding provided from the Ministry of Care of Monuments in Austria (Bundesdenkmalamt). Further funding was provided by the University of Natural Resources and Life Sciences (Vienna). CSJ, VJ and AZM acknowledge support from project Consolider project from the Spanish Ministry (CSD) 2007-00058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarossi G., 1994, STUDI RICERCHE CONSE, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Balderrama-Subieta A, 2013, INT J SYST EVOL MICR, V63, P3319, DOI 10.1099/ijs.0.045401-0; Bastian F, 2010, MICROBIOL-SGM, V156, P644, DOI 10.1099/mic.0.036160-0; Bhattarai HD, 2006, HYDROBIOLOGIA, V568, P417, DOI 10.1007/s10750-006-0220-2; Blazquez F, 1997, EUR J MINERAL, V9, P889; Busse HJ, 1996, J BIOTECHNOL, V47, P3, DOI 10.1016/0168-1656(96)01379-X; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Decrouez D, 1992, CONS MON MED BAS P 2; Diaz-Herraiz M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01440; Ettenauer J, 2010, INT J ASTROBIOL, V9, P59, DOI 10.1017/S1473550409990383; Ettenauer JD, 2012, SCI TOTAL ENVIRON, V439, P44, DOI 10.1016/j.scitotenv.2012.09.005; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; Fernandes P, 2006, APPL MICROBIOL BIOT, V73, P291, DOI 10.1007/s00253-006-0599-8; GIOVANNONI JJ, 1991, NUCLEIC ACIDS RES, V19, P6553, DOI 10.1093/nar/19.23.6553; Goh F, 2006, INT J SYST EVOL MICR, V56, P1323, DOI 10.1099/ijs.0.64180-0; Gorbushina AA, 2007, ENVIRON MICROBIOL, V9, P1613, DOI 10.1111/j.1462-2920.2007.01301.x; GRIFFIN PS, 1991, INT BIODETERIOR, V28, P187, DOI 10.1016/0265-3036(91)90042-P; Gurtner C, 2000, INT BIODETER BIODEGR, V46, P229, DOI 10.1016/S0964-8305(00)00079-2; Gutierrez MC, 2010, INT J SYST EVOL MICR, V60, P1802, DOI 10.1099/ijs.0.015602-0; Head IM, 1998, MICROB ECOL, V35, P1, DOI 10.1007/s002489900056; Heyrman J, 2002, INT J SYST EVOL MICR, V52, P2049, DOI 10.1099/00207713-52-6-2049; Imperi F, 2007, ENVIRON MICROBIOL, V9, P2894, DOI 10.1111/j.1462-2920.2007.01393.x; Jung YT, 2009, INT J SYST EVOL MICR, V59, P2929, DOI 10.1099/ijs.0.009191-0; Jurado V, 2012, SYST APPL MICROBIOL, V35, P306, DOI 10.1016/j.syapm.2012.04.007; Kageyama A, 2007, J GEN APPL MICROBIOL, V53, P185, DOI 10.2323/jgam.53.185; Kamekura M, 2007, SALINE SYST, V3, P1; Krumbein W. E., 1988, Biodeterioration 7. Selected papers presented at the 7th International Biodeterioration Symposium, Cambridge, UK, September 1987., P78; Kuske CR, 1998, APPL ENVIRON MICROB, V64, P2463; Laiz L, 2003, ENVIRON MICROBIOL, V5, P72, DOI 10.1046/j.1462-2920.2003.00381.x; Laiz L, 2009, NATURWISSENSCHAFTEN, V96, P71, DOI 10.1007/s00114-008-0452-2; Laiz L, 2011, INT BIODETER BIODEGR, V65, P1100, DOI 10.1016/j.ibiod.2011.04.010; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Li WJ, 2004, INT J SYST EVOL MICR, V54, P837, DOI 10.1099/ijs.0.02935-0; Liu BB, 2013, ANTON LEEUW INT J G, V103, P1007, DOI 10.1007/s10482-013-9880-x; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Martin-Sanchez PM, 2012, ENVIRON SCI TECHNOL, V46, P3762, DOI 10.1021/es2040625; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NEEFS JM, 1990, NUCLEIC ACIDS RES, V18, P2237, DOI 10.1093/nar/18.suppl.2237; Ozcan B, 2006, MICROBIOLOGY+, V75, P739, DOI 10.1134/S002626170606018X; Pinar G, 2001, FEMS MICROBIOL ECOL, V37, P45, DOI 10.1016/S0168-6496(01)00144-1; Pinar G, 2001, METHOD ENZYMOL, V336, P356, DOI 10.1016/S0076-6879(01)36601-6; Pinar G, 2001, APPL ENVIRON MICROB, V67, P4891, DOI 10.1128/AEM.67.10.4891-4895.2001; Pinar G., 2009, BUILDING MAT PROPERT, P163; Pinar G, 2013, FEMS MICROBIOL ECOL, V86, P341, DOI 10.1111/1574-6941.12165; Pinar G, 2009, INT BIODETER BIODEGR, V63, P851, DOI 10.1016/j.ibiod.2009.02.004; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; REYSENBACH AL, 1992, APPL ENVIRON MICROB, V58, P3417, DOI 10.1128/AEM.58.10.3417-3418.1992; Ripka K, 2006, INT BIODETER BIODEGR, V58, P124, DOI 10.1016/j.ibiod.2006.05.004; Roh SW, 2010, J BACTERIOL, V192, P4528, DOI 10.1128/JB.00663-10; Rullkotter J, 1997, ABSTR PAP AM CHEM S, V213, P10; Saiz-Jimenez C, 2000, INT BIODETER BIODEGR, V46, P319, DOI 10.1016/S0964-8305(00)00104-9; SAIZJIMENEZ C, 1975, SOIL SCI SOC AM J, V39, P649, DOI 10.2136/sssaj1975.03615995003900040023x; Sambrook J., 2001, MOL CLONING LAB MANU; Schabereiter-Gurtner C, 2001, ARCH MICROBIOL, V176, P347, DOI 10.1007/s002030100333; Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V45, P77, DOI 10.1016/S0167-7012(01)00227-5; Schafer J, 2010, SYST APPL MICROBIOL, V33, P260, DOI 10.1016/j.syapm.2010.04.006; Sterflinger K, 2013, APPL MICROBIOL BIOT, V97, P9637, DOI 10.1007/s00253-013-5283-1; Teske A, 1996, APPL ENVIRON MICROB, V62, P1405, DOI 10.1128/AEM.62.4.1405-1415.1996; Tsiamis G, 2008, RES MICROBIOL, V159, P609, DOI 10.1016/j.resmic.2008.09.007; Yoon JH, 2010, INT J SYST EVOL MICR, V60, P754, DOI 10.1099/ijs.0.013136-0; Yu Y, 2005, ACTA OCEANOL SIN, V24, P135	64	37	38	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103844	10.1371/journal.pone.0103844	http://dx.doi.org/10.1371/journal.pone.0103844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084531	gold, Green Submitted, Green Published			2022-12-27	WOS:000339819800088
J	Giovagnetti, V; Flori, S; Tramontano, F; Lavaud, J; Brunet, C				Giovagnetti, Vasco; Flori, Serena; Tramontano, Ferdinando; Lavaud, Johann; Brunet, Christophe			The Velocity of Light Intensity Increase Modulates the Photoprotective Response in Coastal Diatoms	PLOS ONE			English	Article							PHAEODACTYLUM-TRICORNUTUM; DIADINOXANTHIN CYCLE; CHLOROPHYLL FLUORESCENCE; PHYTOPLANKTON GROWTH; VERTICAL VARIABILITY; PLANKTONIC DIATOMS; ENERGY-DISSIPATION; PHOTOSYNTHESIS; ACCLIMATION; MODEL	In aquatic ecosystems, the superimposition of mixing events to the light diel cycle exposes phytoplankton to changes in the velocity of light intensity increase, from diurnal variations to faster mixing-related ones. This is particularly true in coastal waters, where diatoms are dominant. This study aims to investigate if coastal diatoms differently activate the photoprotective responses, xanthophyll cycle (XC) and non-photochemical fluorescence quenching (NPQ), to cope with predictable light diel cycle and unpredictable mixing-related light variations. We compared the effect of two fast light intensity increases (simulating mixing events) with that of a slower increase (corresponding to the light diel cycle) on the modulation of XC and NPQ in the planktonic coastal diatom Pseudo-nitzschia multistriata. During each light treatment, the photon flux density (PFD) progressively increased from darkness to five peaks, ranging from 100 to 650 mu mol photons m(-2) s(-1). Our results show that the diel cycle-related PFD increase strongly activates XC through the enhancement of the carotenoid biosynthesis and induces a moderate and gradual NPQ formation over the light gradient. In contrast, during mixing-related PFD increases, XC is less activated, while higher NPQ rapidly develops at moderate PFD. We observe that together with the light intensity and its increase velocity, the saturation light for photosynthesis (Ek) is a key parameter in modulating photoprotection. We propose that the capacity to adequately regulate and actuate alternative photoprotective 'safety valves' in response to changing velocity of light intensity increase further enhances the photophysiological flexibility of diatoms. This might be an evolutionary outcome of diatom adaptation to turbulent marine ecosystems characterized by unpredictable mixing-related light changes over the light diel cycle.	[Giovagnetti, Vasco; Flori, Serena; Tramontano, Ferdinando; Brunet, Christophe] Stn Zool Anton Dohrn, Naples, Italy; [Lavaud, Johann] Univ La Rochelle, Unite Mixte Rech 7266, La Rochelle, France	Stazione Zoologica Anton Dohrn di Napoli; La Rochelle Universite	Brunet, C (corresponding author), Stn Zool Anton Dohrn, Naples, Italy.	christophe.brunet@szn.it	brunet, christophe/AAD-7817-2021; Flori, Serena/GPP-7017-2022; Lavaud, Johann/N-6185-2014	Flori, Serena/0000-0003-3407-2785; Lavaud, Johann/0000-0002-4704-2502; Giovagnetti, Vasco/0000-0002-3298-4310				Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Brunet C, 2003, J PLANKTON RES, V25, P1413, DOI 10.1093/plankt/fbg091; Brunet C, 2008, J PLANKTON RES, V30, P645, DOI 10.1093/plankt/fbn028; Brunet C, 2007, MAR ECOL PROG SER, V346, P15, DOI 10.3354/meps07017; Brunet C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087015; Brunet C, 2010, J PLANKTON RES, V32, P1609, DOI 10.1093/plankt/fbq104; Chukhutsina VU, 2014, BBA-BIOENERGETICS, V1837, P899, DOI 10.1016/j.bbabio.2014.02.021; Costa BS, 2013, J EXP BOT, V64, P483, DOI 10.1093/jxb/ers340; D'Alelio D, 2010, LIMNOL OCEANOGR, V55, P106, DOI 10.4319/lo.2010.55.1.0106; Dambek M, 2012, J EXP BOT, V63, P5607, DOI 10.1093/jxb/ers211; Dimier C, 2007, J PHYCOL, V43, P937, DOI 10.1111/j.1529-8817.2007.00381.x; Dimier C, 2009, PROTIST, V160, P397, DOI 10.1016/j.protis.2009.03.001; Dimier C, 2009, LIMNOL OCEANOGR, V54, P823, DOI 10.4319/lo.2009.54.3.0823; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Eisenstadt D, 2008, ENVIRON MICROBIOL, V10, P1997, DOI 10.1111/j.1462-2920.2008.01616.x; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Finazzi G, 2010, TRENDS PLANT SCI, V15, P565, DOI 10.1016/j.tplants.2010.07.004; Geider RJ, 2009, PLANT ECOL DIVERS, V2, P165, DOI 10.1080/17550870903300949; Geider RJ, 1997, MAR ECOL PROG SER, V148, P187, DOI 10.3354/meps148187; Giovagnetti V, 2012, EUR J PHYCOL, V47, P408, DOI 10.1080/09670262.2012.733030; Giovagnetti V, 2010, J PLANKTON RES, V32, P1501, DOI 10.1093/plankt/fbq074; Goss R, 2006, J PLANT PHYSIOL, V163, P1008, DOI 10.1016/j.jplph.2005.09.008; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Gundermann K, 2012, BBA-BIOENERGETICS, V1817, P1044, DOI 10.1016/j.bbabio.2012.03.008; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kooistra Wiebe H. C. F., 2007, P207; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Lavaud J, 2002, PHOTOSYNTH RES, V74, P51, DOI 10.1023/A:1020890625141; Lavaud J, 2014, ADV PHOTOSY IN PRESS; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Lavaud J, 2006, PLANT CELL PHYSIOL, V47, P1010, DOI 10.1093/pcp/pcj058; Lavaud J, 2013, BBA-BIOENERGETICS, V1827, P294, DOI 10.1016/j.bbabio.2012.11.012; Lavaud J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036806; Lawrenz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058137; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Lepetit B, 2012, PHOTOSYNTH RES, V111, P245, DOI 10.1007/s11120-011-9633-5; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lohr M, 2011, PHYTOPLANKTON PIGMEN, P113, DOI DOI 10.1017/CB09780511732263.006; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Miloslavina Y, 2009, BBA-BIOENERGETICS, V1787, P1189, DOI 10.1016/j.bbabio.2009.05.012; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; OWENS TG, 1986, PHOTOCHEM PHOTOBIOL, V43, P535, DOI 10.1111/j.1751-1097.1986.tb09532.x; Polimene L, 2014, J PLANKTON RES, V36, P214, DOI 10.1093/plankt/fbt086; Polimene L, 2012, J PLANKTON RES, V34, P196, DOI 10.1093/plankt/fbr102; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Schumann A, 2007, PHYCOLOGIA, V46, P113, DOI 10.2216/06-30.1; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Talmy D, 2013, LIMNOL OCEANOGR, V58, P1802, DOI 10.4319/lo.2013.58.5.1802; Tassan S, 1995, LIMNOL OCEANOGR, V40, P1358, DOI 10.4319/lo.1995.40.8.1358; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; van Leeuwe MA, 2005, MAR ECOL PROG SER, V288, P9, DOI 10.3354/meps288009; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Wu HY, 2012, PLANT PHYSIOL, V160, P464, DOI 10.1104/pp.112.203067	61	21	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103782	10.1371/journal.pone.0103782	http://dx.doi.org/10.1371/journal.pone.0103782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083713	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800079
J	Hatagishi, E; Okamoto, M; Ohmiya, S; Yano, H; Hori, T; Saito, W; Miki, H; Suzuki, Y; Saito, R; Yamamoto, T; Shoji, M; Morisaki, Y; Sakata, S; Nishimura, H				Hatagishi, Etsuko; Okamoto, Michiko; Ohmiya, Suguru; Yano, Hisakazu; Hori, Toru; Saito, Wakana; Miki, Hiroshi; Suzuki, Yasushi; Saito, Reiko; Yamamoto, Taro; Shoji, Makoto; Morisaki, Yoshihisa; Sakata, Soichiro; Nishimura, Hidekazu			Establishment and Clinical Applications of a Portable System for Capturing Influenza Viruses Released through Coughing	PLOS ONE			English	Article							AEROSOL TRANSMISSION; OUTBREAK	Coughing plays an important role in influenza transmission; however, there is insufficient information regarding the viral load in cough because of the lack of convenient and reliable collection methods. We developed a portable airborne particle-collection system to measure the viral load; it is equipped with an air sampler to draw air and pass it through a gelatin membrane filter connected to a cone-shaped, megaphone-like device to guide the cough airflow to the membrane. The membrane was dissolved in a medium, and the viral load was measured using quantitative real-time reverse transcriptase-polymerase chain reaction and a plaque assay. The approximate viral recovery rate of this system was 10% in simulation experiments to collect and quantify the viral particles aerosolized by a nebulizer. Using this system, cough samples were collected from 56 influenza A patients. The total viral detection rate was 41% (23/56), and the viral loads varied significantly (from <10, less than the detection limit, to 2240 viral gene copies/cough). Viable viruses were detected from 3 samples with <= 18 plaque forming units per cough sample. The virus detection rates were similar among different groups of patients infected with different viral subtypes and during different influenza seasons. Among patients who did not receive antiviral treatment, viruses were detected in one of six cases in the vaccinated group and four of six cases in the unvaccinated group. We found cases with high viral titers in throat swabs or oral secretions but very low or undetectable in coughs and vice versa suggesting other possible anatomical sites where the viruses might be mixed into the cough. Our system is easy to operate, appropriate for bedside use, and is useful for comparing the viral load in cough samples from influenza patients under various conditions and settings. However, further large-scale studies are warranted to validate our results.	[Hatagishi, Etsuko; Okamoto, Michiko; Ohmiya, Suguru; Yano, Hisakazu; Hori, Toru; Nishimura, Hidekazu] Sendai Med Ctr, Div Clin Res, Virus Res Ctr, Sendai, Miyagi, Japan; [Hatagishi, Etsuko; Yamamoto, Taro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Int Hlth, Nagasaki 852, Japan; [Saito, Wakana; Miki, Hiroshi] Sendai Med Ctr, Dept Resp Med, Sendai, Miyagi, Japan; [Suzuki, Yasushi; Saito, Reiko] Niigata Univ, Grad Sch Med & Dent Sci, Dept Infect Dis Control & Int Med, Div Publ Hlth, Niigata, Japan; [Yamamoto, Taro] Nagasaki Univ, Inst Trop Med, Dept Int Hlth, Nagasaki 852, Japan; [Shoji, Makoto] Shoji Clin, Sendai, Miyagi, Japan; [Morisaki, Yoshihisa] Japan Self Def Force Sendai Hosp, Sendai, Miyagi, Japan; [Sakata, Soichiro] Takasago Thermal Engn Co Ltd, Tokyo, Japan	Nagasaki University; Niigata University; Nagasaki University	Nishimura, H (corresponding author), Sendai Med Ctr, Div Clin Res, Virus Res Ctr, Sendai, Miyagi, Japan.	hide-nishimura@mte.biglobe.ne.jp	Okamoto, Michiko/AAE-4373-2019	Okamoto, Michiko/0000-0002-3505-5939	Sendai Medical Center	Sendai Medical Center	This work was supported by the annual budget for clinical research of Sendai Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Daum LT, 2007, INFLUENZA OTHER RESP, V1, P167, DOI 10.1111/j.1750-2659.2007.00024.x; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Fabian P, 2009, INDOOR AIR, V19, P433, DOI 10.1111/j.1600-0668.2009.00609.x; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Nishimura H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080244; NUMAZAKI Y, 1987, MICROBIOL IMMUNOL, V31, P1085, DOI 10.1111/j.1348-0421.1987.tb01340.x; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Tang JW, 2008, NEW ENGL J MED, V359, pE19, DOI 10.1056/NEJMicm072576; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Ujike M, 2010, EMERG INFECT DIS, V16, P926, DOI 10.3201/eid1606.091623; Verreault D, 2008, MICROBIOL MOL BIOL R, V72, P413, DOI 10.1128/MMBR.00002-08; Wang SX, 2006, EPIDEMIOL INFECT, V134, P786, DOI 10.1017/S095026880500556X; Weesendorp E, 2009, VET MICROBIOL, V135, P222, DOI 10.1016/j.vetmic.2008.09.073; Wong BCK, 2010, CLIN INFECT DIS, V51, P1176, DOI 10.1086/656743	22	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103560	10.1371/journal.pone.0103560	http://dx.doi.org/10.1371/journal.pone.0103560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083787	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800050
J	Sola, R; Valls, RM; Puzo, J; Calabuig, JR; Brea, A; Pedret, A; Morina, D; Villar, J; Millan, J; Anguera, A				Sola, Rosa; Valls, Rosa-M; Puzo, Jose; Calabuig, Jose-Ramon; Brea, Angel; Pedret, Anna; Morina, David; Villar, Jose; Millan, Jesus; Anguera, Anna			Effects of Poly-Bioactive Compounds on Lipid Profile and Body Weight in a Moderately Hypercholesterolemic Population with Low Cardiovascular Disease Risk: A Multicenter Randomized Trial	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; MYOCARDIAL-INFARCTION; MONASCUS-PURPUREUS; APOLIPOPROTEIN-B; HDL CHOLESTEROL; RICE; BERBERINE; POLICOSANOL; COMBINATION; EFFICACY	A dietary supplement (AP, Armolipid Plus) that combines red yeast rice extract, policosanol, berberine, folic acid, coenzyme Q10 and asthaxantine can have beneficial effects on cardiovascular disease (CVD) biomarkers. The aim of this study was to assess whether the intake of AP, in combination with dietary recommendations, reduces serum low density lipoprotein cholesterol (LDL-c) concentrations and other CVD biomarkers in patients with hypercholesterolemia. Eligible patients were recruited from the outpatient clinics of six Spanish hospitals Hospital Virgen del Rocio (Sevilla); Hospital San Jorge (Huesca); Hospital San Pedro (Logrono); Hospital Gregorio Maranon (Madrid), Hospital la Fe (Valencia) and Hospital Universitari Sant Joan (Reus) as recruiting and coordinating center. 102 participants (mean age +/- SD; 50.91 +/- 11.61; 32 men) with low CVD, with mild-to-moderately elevated LDL-c (between 3.35 mmol/L and 4.88 mmol/L) without hypolipemic therapy were randomized in a double-blind, parallel, controlled, multicenter trial commencing January 2012 and ending December 2012. Among the exclusion criteria were any concomitant chronic disease, triglycerides (TG) >3.97 mmol/L, pregnant or lactating, and history of CVD. At 12 weeks, compared to placebo, AP reduced LDL-c by -6.9%, apolipoprotein (Apo) B-100 by -6.6% and total cholesterol/HDL-c ratio by -5.5%, the ApoB/ApoA1 ratio by -8.6%, while increasing ApoA1 by +2.5% (p<0.05). AP consumption was associated with modest mean weight loss of -0.93 kg (95%CI: -1.74 to -0.12; P = 0.02) compared with control group while dietary composition remained unchanged in the AP group. The AP product was well tolerated. In conclusion, AP, combined with dietary recommendations, reduced LDL-c levels as well as total cholesterol/HDL-c and ApoB/ApoA1 ratios, while increasing Apo A1, all of which are improvements in CVD risk indicators. AP is a product which could benefit patients having moderate hyperlipidemia and excess body weight.	[Sola, Rosa; Valls, Rosa-M; Pedret, Anna] Univ Rovira & Virgili, Fac Med, Hosp Univ San Joan, IISPV,CIBERDEM,Serv Med Interna, E-43201 Reus, Spain; [Puzo, Jose] Hosp Univ San Jorge, Unidad Lipidos, Huesca, Spain; [Puzo, Jose] Hosp Univ San Jorge, Lab Bioquim, Huesca, Spain; [Calabuig, Jose-Ramon] Hosp Univ, Dept Med Interna, Valencia, Spain; [Calabuig, Jose-Ramon] Politecn La Fe, Dept Med Interna, Valencia, Spain; [Brea, Angel] Hosp Univ San Pedro, Serv Med Interna, Unidad Lipidos, Logrono, Spain; [Morina, David] Ctr Tecnol Nutr & Salut, Reus, Spain; [Villar, Jose] Hosp Univ Virgen Rocio, Unidad Hipertens & Lipdos, Seville, Spain; [Millan, Jesus] Univ Gregorio Maranon, Serv Med Interna, Madrid, Spain; [Anguera, Anna] Rottapharm SL, Dept Med, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Hospital Universidad San Jorge; Hospital Universidad San Jorge; University of Sevilla; Virgen del Rocio University Hospital; General University Gregorio Maranon Hospital	Sola, R (corresponding author), Univ Rovira & Virgili, Fac Med, Hosp Univ San Joan, IISPV,CIBERDEM,Serv Med Interna, C St Llorenc 21, E-43201 Reus, Spain.	rosa.sola@urv.cat	SOLÀ, Rosa/N-5919-2014; IBIS, HIPERCOLESTERO/P-3953-2015; Moriña, David/H-1712-2015; Moriña, David/AAX-8427-2021; Valls, Rosa M/AAB-1163-2019; Puzo, Jose/AAE-5827-2021	Moriña, David/0000-0001-5949-7443; Moriña, David/0000-0001-5949-7443; Valls, Rosa M/0000-0002-3351-0942; Puzo, Jose/0000-0002-1309-4363; SOLA, Rosa/0000-0002-8359-235X; Pedret, Anna/0000-0002-5327-932X	(Nutrition and Health Technology Centre; CTNS)-TECNIO, Reus (Spain) [CT09-1-0019]	(Nutrition and Health Technology Centre; CTNS)-TECNIO, Reus (Spain)	Rottaphram S.L. provided a grant to the Centre Tecnologic de Nutricio i Salut (Nutrition and Health Technology Centre; CTNS)-TECNIO CT09-1-0019), Reus (Spain). The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Logistic support, analysis and interpretation of the data were provided by CTNS; Hospital Universitari Sant Joan and Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, Reus (Spain).	Affuso F, 2012, WORLD J CARDIOL, V4, P77, DOI 10.4330/wjc.v4.i3.77; Berthold HK, 2006, JAMA-J AM MED ASSOC, V295, P2262, DOI 10.1001/jama.295.19.2262; Canetti M, 1995, INT J CLIN PHARM RES, V15, P159; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Chen JT, 2005, PHARMACOTHERAPY, V25, P171, DOI 10.1592/phco.25.2.171.56942; Cicero AFG, 2010, MEDITERR J NUTR META, V3, P239, DOI 10.1007/s12349-010-0028-5; Cicero AFG, 2005, COMPLEMENT THER MED, V13, P273, DOI 10.1016/j.ctim.2005.07.008; Cicero AEG, 2007, ARZNEIMITTELFORSCH, V57, P26; Cicero AFG, 2013, NUTR RES, V33, P622, DOI 10.1016/j.nutres.2013.05.015; Clarke R, 2005, AM J CLIN NUTR, V82, P806, DOI 10.1093/ajcn/82.4.806; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dulin MF, 2006, AM J CLIN NUTR, V84, P1543, DOI 10.1093/ajcn/84.6.1543; Engelfriet P, 2010, EUR J CARDIOV PREV R, V17, P50, DOI 10.1097/HJR.0b013e32832f3a76; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goff D. C., 2014, J AM COLL CARDIOL, V63, P25, DOI DOI 10.1161/01.CIR.0000437741.48606.98; Gouni-Berthold I, 2002, AM HEART J, V143, P356, DOI 10.1067/mhj.2002.119997; Guardamagna O, 2011, NUTR METAB CARDIOVAS, V21, P424, DOI 10.1016/j.numecd.2009.10.015; Harland JI, 2012, NUTR RES REV, V25, P249, DOI 10.1017/S0954422412000170; Hu YS, 2012, PHYTOMEDICINE, V19, P861, DOI 10.1016/j.phymed.2012.05.009; Izzo R, 2010, J HYPERTENS, V28, P1482, DOI 10.1097/HJH.0b013e3283395208; Kidd P, 2011, ALTERN MED REV, V16, P355; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li YG, 2004, J PHARMACEUT BIOMED, V35, P1101, DOI 10.1016/j.jpba.2004.04.004; Lu ZL, 2008, AM J CARDIOL, V101, P1689, DOI 10.1016/j.amjcard.2008.02.056; Marazzi G, 2011, ADV THER, V28, P1105, DOI 10.1007/s12325-011-0082-5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Needham M, 2014, NEUROMUSCULAR DISORD, V24, P4, DOI 10.1016/j.nmd.2013.09.011; Parish S, 2009, EUR HEART J, V30, P2137, DOI 10.1093/eurheartj/ehp221; Pisciotta L, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-123; Redberg RF, 2009, CIRCULATION, V120, P1296, DOI 10.1161/CIRCULATIONAHA.109.192617; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Sniderman AD, 2011, CIRC-CARDIOVASC QUAL, V4, P337, DOI 10.1161/CIRCOUTCOMES.110.959247; Stone NJ, 2013, J AM COLL CARDIOL S, DOI DOI 10.1016/J.JACC.2013.11.002.[; Trimarco B, 2011, MEDITERR J NUTR META, V4, P133, DOI 10.1007/s12349-010-0043-6; U.S. Food and Drug Administration (FDA), 2010, DIET SUPPL; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x; Wang TH, 2007, ADV FOOD NUTR RES, V53, P123, DOI 10.1016/S1043-4526(07)53004-4; Xie WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024520; Yang CW, 2012, COMPLEMENT THER MED, V20, P466, DOI 10.1016/j.ctim.2012.07.004	42	39	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e101978	10.1371/journal.pone.0101978	http://dx.doi.org/10.1371/journal.pone.0101978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084280	Green Published, gold			2022-12-27	WOS:000339819800006
J	Cristescu, ME; Demiri, B; Altshuler, I; Crease, TJ				Cristescu, Melania E.; Demiri, Bora; Altshuler, Ianina; Crease, Teresa J.			Gene Expression Variation in Duplicate Lactate dehydrogenase Genes: Do Ecological Species Show Distinct Responses?	PLOS ONE			English	Article							DAPHNIA-PULEX GROUP; CLONAL DIVERSITY; ENZYME GENOTYPE; B GENE; POPULATIONS; SPECIATION; EVOLUTION; HYPOXIA; PCR; REPRODUCTION	Lactate dehydrogenase (LDH) has been shown to play an important role in adaptation of several aquatic species to different habitats. The genomes of Daphnia pulex, a pond species, and Daphnia pulicaria, a lake inhabitant, encode two L-LDH enzymes, LDHA and LDHB. We estimated relative levels of Ldh gene expression in these two closely related species and their hybrids in four environmental settings, each characterized by one of two temperatures (10 degrees C or 20 degrees C), and one of two concentrations of dissolved oxygen (DO; 6.5-7 mg/l or 2-3 mg/l). We found that levels of LdhA expression were 4 to 48 times higher than LdhB expression (p<0.005) in all three groups (the two parental species and hybrids). Moreover, levels of LdhB expression differed significantly (p<0.05) between D. pulex and D. pulicaria, but neither species differed from the hybrid. Consistently higher expression of LdhA relative to LdhB in both species and the hybrid suggests that the two isozymes could be performing different functions. No significant differences in levels of gene expression were observed among the four combinations of temperature and dissolved oxygen (p>0.1). Given that Daphnia dwell in environments characterized by fluctuating conditions with long periods of low dissolved oxygen concentration, we suggest that these species could employ regulated metabolic depression to survive in such environments.	[Cristescu, Melania E.; Demiri, Bora] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Crease, Teresa J.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Cristescu, Melania E.; Altshuler, Ianina] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Windsor; University of Guelph; McGill University	Cristescu, ME (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada.	melania.cristescu@mcgill.ca	Crease, Teresa/E-2932-2015; Altshuler, Ianina/O-3206-2019	Crease, Teresa/0000-0001-8074-8024; Cristescu, Melania/0000-0002-0854-4040; Altshuler, Ianina/0000-0003-2235-1664	NSERC Canada; NSERC CREATE grant	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CREATE grant	This work was supported by NSERC Canada Discovery grants to TJC and MEC and by an NSERC CREATE grant to MEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colbourne John K., 1997, P163; CRAWFORD DL, 1992, MOL BIOL EVOL, V9, P806; Crease TJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-212; Crease TJ, 1997, HEREDITY, V79, P242; Cristescu ME, 2012, MOL ECOL, V21, P1411, DOI 10.1111/j.1365-294X.2011.05465.x; Cristescu ME, 2009, J MOL EVOL, V69, P276, DOI 10.1007/s00239-009-9274-x; Cristescu ME, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-268; Cristescu MEA, 2006, GENOMICS, V88, P415, DOI 10.1016/j.ygeno.2006.03.007; Dahlhoff EP, 2000, P NATL ACAD SCI USA, V97, P10056, DOI 10.1073/pnas.160277697; Dudycha JL, 2004, FRESHWATER BIOL, V49, P505, DOI 10.1111/j.1365-2427.2004.01201.x; Dudycha JL, 2003, OECOLOGIA, V135, P555, DOI 10.1007/s00442-003-1230-7; Dudycha JL, 1999, EVOLUTION, V53, P1744, DOI 10.1111/j.1558-5646.1999.tb04559.x; Eanes WF, 1999, ANNU REV ECOL SYST, V30, P301, DOI 10.1146/annurev.ecolsys.30.1.301; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; EVERSE J, 1973, ADV ENZYMOL RAMB, V37, P61; Gorr TA, 2004, INT CONGR SER, V1275, P55, DOI 10.1016/j.ics.2004.08.068; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; HEBERT PDN, 1989, EVOLUTION, V43, P1004, DOI 10.1111/j.1558-5646.1989.tb02546.x; HEBERT PDN, 1983, HEREDITY, V51, P353, DOI 10.1038/hdy.1983.40; Hebert PDN, 2001, HEREDITY, V87, P153, DOI 10.1046/j.1365-2540.2001.00885.x; Heier CR, 2009, LIMNOL OCEANOGR, V54, P492, DOI 10.4319/lo.2009.54.2.0492; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; INNES DJ, 1986, HEREDITY, V57, P345, DOI 10.1038/hdy.1986.134; Johns GC, 2004, MOL BIOL EVOL, V21, P314, DOI 10.1093/molbev/msh021; Karl I, 2009, ECOGRAPHY, V32, P488, DOI 10.1111/j.1600-0587.2008.05660.x; Lopez J.A., 2007, TOTAL RNA EXTRACTION; Lynch M, 2000, GENETICS, V154, P459; MARKERT CL, 1975, SCIENCE, V189, P102, DOI 10.1126/science.1138367; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Paul RJ, 1998, COMP BIOCHEM PHYS A, V120, P519, DOI 10.1016/S1095-6433(98)10062-4; Pfrender ME, 2000, MOL ECOL, V9, P1717, DOI 10.1046/j.1365-294x.2000.01062.x; POWERS DA, 1991, ANNU REV GENET, V25, P629; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rees BB, 2001, BIOL BULL, V200, P247, DOI 10.2307/1543505; Rossignol F, 2003, J CELL BIOCHEM, V89, P67, DOI 10.1002/jcb.10484; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schulte PM, 2000, P NATL ACAD SCI USA, V97, P6597, DOI 10.1073/pnas.97.12.6597; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Spanier KI, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-50; THRELKELD ST, 1979, ECOLOGY, V60, P165, DOI 10.2307/1936478; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; WRIGHT D, 1990, FRESHWATER BIOL, V24, P43, DOI 10.1111/j.1365-2427.1990.tb00306.x; Xu S, 2013, MOL ECOL, V22, P4549, DOI 10.1111/mec.12407	45	2	2	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103964	10.1371/journal.pone.0103964	http://dx.doi.org/10.1371/journal.pone.0103964			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080082	Green Submitted, gold, Green Published			2022-12-27	WOS:000339954800100
J	Van Biesen, W; van der Veer, SN; Murphey, M; Loblova, O; Davies, S				Van Biesen, Wim; van der Veer, Sabine N.; Murphey, Mark; Loblova, Olga; Davies, Simon			Patients' Perceptions of Information and Education for Renal Replacement Therapy: An Independent Survey by the European Kidney Patients' Federation on Information and Support on Renal Replacement Therapy	PLOS ONE			English	Article							SHARED DECISION-MAKING; DIALYSIS MODALITY SELECTION; PERITONEAL-DIALYSIS; REFERRAL PATTERN; DISEASE PATIENTS; ESRD PATIENTS; HEALTH-CARE; EXPERIENCE; INITIATION; CONTRAINDICATIONS	Background: Selection of an appropriate renal replacement modality is of utmost importance for patients with end stage renal disease. Previous studies showed provision of information to and free modality choice by patients to be suboptimal. Therefore, the European Kidney Patients' Federation (CEAPIR) explored European patients' perceptions regarding information, education and involvement on the modality selection process. Methods: CEAPIR developed a survey, which was disseminated by the national kidney patient organisations in Europe. Results: In total, 3867 patients from 36 countries completed the survey. Respondents were either on in-centre haemodialysis (53%) or had a functioning graft (38%) at the time of survey. The majority (78%) evaluated the general information about kidney disease and treatment as helpful, but 39% did not recall being told about alternative treatment options than their current one. Respondents were more often satisfied with information provided on in-centre haemodialysis (90%) and transplantation (87%) than with information provided on peritoneal dialysis (79%) or home haemodialysis (61%), and were more satisfied with information from health care professionals vs other sources such as social media. Most (75%) felt they had been involved in treatment selection, 29% perceived they had no free choice. Involvement in modality selection was associated with enhanced satisfaction with treatment (OR 3.13; 95% CI 2.72-3.60). Many respondents (64%) could not remember receiving education on how to manage their kidney disease in daily life. Perceptions on information seem to differ between countries. Conclusions: Kidney patients reported to be overall satisfied with the information they received on their disease and treatment, although information seemed mostly to have been focused on one modality. Patients involved in modality selection were more satisfied with their treatment. However, in the perception of the patients, the freedom to choose an alternative modality showed room for improvement.	[Van Biesen, Wim] Ghent Univ Hosp, Div Renal, Ghent, Belgium; [van der Veer, Sabine N.] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; [Murphey, Mark] Irish Kidney Assoc, Dublin, Ireland; [Loblova, Olga] A&R Edelman, London, England; [Loblova, Olga] Cent European Univ, Dept Publ Policy, Budapest, Hungary; [Davies, Simon] Univ Hosp North Staffordshire, Dept Nephrol, Stoke On Trent, Staffs, England	Ghent University; Ghent University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Central European University	Van Biesen, W (corresponding author), Ghent Univ Hosp, Div Renal, Ghent, Belgium.	wim.vanbiesen@ugent.be		Davies, Simon/0000-0001-5127-4755; van der Veer, Sabine/0000-0003-0929-436X; Loblova, Olga/0000-0003-2481-8440	Baxter Healthcare	Baxter Healthcare	Baxter Healthcare provided logistical and financial support for this initiative through an unrestricted scientific grant to CEAPIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameling JM, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-140; Caring for Australians with Renal Impairment (CARI), 2005, ACC ONT DIAL GUID; Chewning B, 2012, PATIENT EDUC COUNS, V86, P9, DOI 10.1016/j.pec.2011.02.004; Covic A, 2010, NEPHROL DIAL TRANSPL, V25, P1757, DOI 10.1093/ndt/gfq206; Crow R, 2002, Health Technol Assess, V6, P1; Curtin R B, 2001, Nephrol Nurs J, V28, P385; Curtin RB, 2001, NEPHROL NURS J, V28, P393; Fadem SZ, 2011, CLIN J AM SOC NEPHRO, V6, P605, DOI 10.2215/CJN.06970810; Finkelstein FO, 2008, KIDNEY INT, V74, P1178, DOI 10.1038/ki.2008.376; Flynn KE, 2006, SOC SCI MED, V63, P1158, DOI 10.1016/j.socscimed.2006.03.030; Hingwala J, 2013, NEPHROL DIAL TRANSPL, V28, P732, DOI 10.1093/ndt/gfs323; Jager KJ, 2004, AM J KIDNEY DIS, V43, P891, DOI 10.1053/j.ajkd.2003.12.051; Kurella Tamura M, 2013, KIDNEY INT; Lameire N, 1999, NEPHROL DIAL TRANSPL, V14, P16, DOI 10.1093/ndt/14.suppl_6.16; Lameire N, 2002, KIDNEY INT, V61, pS27, DOI 10.1046/j.1523-1755.61.s80.6.x; Lee A, 2008, NEPHROL DIAL TRANSPL, V23, P3953, DOI 10.1093/ndt/gfn365; Lobbedez T, 2008, NEPHROL DIAL TRANSPL, V23, P3290, DOI 10.1093/ndt/gfn213; Lobbedez T, 2013, NEPHROL DIAL TRANSPL, V28, P1276, DOI 10.1093/ndt/gft018; Mehrotra R, 2005, KIDNEY INT, V68, P378; Morton RL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c112; Morton RL, 2012, AM J KIDNEY DIS, V60, P102, DOI 10.1053/j.ajkd.2011.12.030; Moss AH, 2001, AM J KIDNEY DIS, V37, P1081; Muthalagappan S, 2013, NEPHROL DIAL TRANSPL, V28, P2717, DOI 10.1093/ndt/gft245; Oliver MJ, 2010, NEPHROL DIAL TRANSPL, V25, P2737, DOI 10.1093/ndt/gfq085; Povlsen JV, 2009, CONTRIB NEPHROL, V163, P261, DOI 10.1159/000223808; Song MK, 2013, NEPHROL DIAL TRANSPL, V28, P2815, DOI 10.1093/ndt/gft238; Stehman-Breen CO, 2000, KIDNEY INT, V57, P639, DOI 10.1046/j.1523-1755.2000.t01-1-00885.x; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Tennankore KK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-192; Van Biesen W, 1999, PERITON DIALYSIS INT, V19, pS273; Van Biesen W, 2013, NEPHROL DIAL TRANSPL, V28, P1980, DOI 10.1093/ndt/gft291; van der Veer SN, 2012, NEPHROL DIAL TRANSPL, V27, P4188, DOI 10.1093/ndt/gfs351; van der Veer SN, 2012, NEPHROL DIAL TRANSPL, V27, P3284, DOI 10.1093/ndt/gfs023; van der Weijden T, 2013, BMJ QUAL SAF, V22, P855, DOI 10.1136/bmjqs-2012-001502; Winterbottom A, 2007, NEPHROL DIAL TRANSPL, V22, P2291, DOI 10.1093/ndt/gfm095; Winterbottom AE, 2012, NEPHROL DIAL TRANSPL, V27, P325, DOI 10.1093/ndt/gfr266; Wright JA, 2011, AM J KIDNEY DIS, V57, P387, DOI 10.1053/j.ajkd.2010.09.018	38	52	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103914	10.1371/journal.pone.0103914	http://dx.doi.org/10.1371/journal.pone.0103914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079071	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800094
J	Goodreau, SM; Carnegie, NB; Vittinghoff, E; Lama, JR; Fuchs, JD; Sanchez, J; Buchbinder, SP				Goodreau, Steven M.; Carnegie, Nicole B.; Vittinghoff, Eric; Lama, Javier R.; Fuchs, Jonathan D.; Sanchez, Jorge; Buchbinder, Susan P.			Can Male Circumcision Have an Impact on the HIV Epidemic in Men Who Have Sex with Men?	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HOMOSEXUAL ROLE SEPARATION; RISK; ACQUISITION; PREVENTION; SURVEILLANCE; SPREAD; PERU	Background: Three trials have demonstrated the prophylactic effect of male circumcision (MC) for HIV acquisition among heterosexuals, and MC interventions are underway throughout sub-Saharan Africa. Similar efforts for men who have sex with men (MSM) are stymied by the potential for circumcised MSM to acquire HIV easily through receptive sex and transmit easily through insertive sex. Existing work suggests that MC for MSM should reach its maximum potential in settings where sexual role segregation is historically high and relatively stable across the lifecourse; HIV incidence among MSM is high; reported willingness for prophylactic circumcision is high; and pre-existing circumcision rates are low. We aim to identify the likely public health impact that MC interventions among MSM would have in one setting that fulfills these conditions-Peru-as a theoretical upper bound for their effectiveness among MSM generally. Methods and Findings: We use a dynamic, stochastic sexual network model based in exponential-family random graph modeling and parameterized from multiple behavioral surveys of Peruvian MSM. We consider three enrollment criteria (insertive during 100%, >80% or >60% of UAI) and two levels of uptake (25% and 50% of eligible men); we explore sexual role proportions from two studies and different frequencies of switching among role categories. Each scenario is simulated 10 times. We estimate that efficiency could reach one case averted per 6 circumcisions. However, the population-level impact of an optimistic MSM-MC intervention in this setting would likely be at most similar to 5-10% incidence and prevalence reductions over 25 years. Conclusions: Roll-out of MC for MSM in Peru would not result in a substantial reduction in new HIV infections, despite characteristics in this population that could maximize such effects. Additional studies are needed to confirm these results for other MSM populations, and providers may consider the individual health benefits of offering MC to their MSM patients.	[Goodreau, Steven M.] Univ Washington, Seattle, WA 98195 USA; [Carnegie, Nicole B.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Vittinghoff, Eric] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lama, Javier R.; Sanchez, Jorge] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Fuchs, Jonathan D.; Buchbinder, Susan P.] San Francisco Dept Publ Hlth, San Francisco, CA USA	University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; San Francisco Department of Public Health	Goodreau, SM (corresponding author), Univ Washington, Seattle, WA 98195 USA.	goodreau@uw.edu	Goodreau, Steven/P-2366-2017	Carnegie, Nicole/0000-0001-7664-6682; Goodreau, Steven/0000-0003-1009-5763	US National Institutes of Health [R01 AI083060, R01 HD068395, R01 AI52054]; US Naval Medical Research Unit 6 [62787A S17 H B0002]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068395, R24HD042828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069496, R37AI051164, UM1AI069496, R01AI083060, R01AI052054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Naval Medical Research Unit 6; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding came from the US National Institutes of Health (R01 AI083060, R01 HD068395, R01 AI52054) and by US Naval Medical Research Unit 6 (Work Unit Number 62787A S17 H B0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2009, J INFECT DIS, V200, P1803, DOI 10.1086/648472; Armbruster B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070043; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Caceres C F, 1999, Cult Health Sex, V1, P261, DOI 10.1080/136910599301012; Carrier J, 1995, OTROS INTIMACY HOMOS, Vxxii; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295; Goodreau SM, 2005, J INFECT DIS, V191, pS147, DOI 10.1086/425268; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guanira J, 2007, 4 INT AIDS SOC C HIV; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Instituto Nacional de Estadistica e Informatica, 2011, B ANAL DEM, V36; Krivitsky PN, 2011, STAT METHODOL, V8, P319, DOI 10.1016/j.stamet.2011.01.005; Krivitsky PN, 2010, ARXIV10111937V1; Lama JR, 2006, JAIDS-J ACQ IMM DEF, V42, P501, DOI 10.1097/01.qai.0000221677.29693.dd; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Lau JTF, 2011, AIDS CARE, V23, P1472, DOI 10.1080/09540121.2011.565018; Lau JTF, 2012, J SEX MED, V9, P1904, DOI 10.1111/j.1743-6109.2010.02050.x; Londish GJ, 2010, SEX HEALTH, V7, P463, DOI 10.1071/SH09080; McDaid LM, 2010, SEX TRANSM INFECT, V86, P404, DOI 10.1136/sti.2010.042895; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; Murray S. O., 1995, LATIN AM MALE HOMOSE; Peinado J, 2007, J SEX RES, V44, P233, DOI 10.1080/00224490701443676; Rogers JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061725; Sanchez J, 2011, AIDS, V25, P519, DOI 10.1097/QAD.0b013e328340fd81; Sanchez J, 2009, JAIDS-J ACQ IMM DEF, V51, pS47, DOI 10.1097/QAI.0b013e3181a2671d; Soto RJ, 2007, JAIDS-J ACQ IMM DEF, V46, P101; Templeton DJ, 2010, CURR OPIN INFECT DIS, V23, P45, DOI 10.1097/QCO.0b013e328334e54d; Thornton AC, 2011, SEX TRANSM DIS, V38, P928, DOI 10.1097/OLQ.0b013e318221562a; TRICHOPOULOS D, 1988, LANCET, V2, P965; VANDRUTEN H, 1992, J SEX RES, V29, P477, DOI 10.1080/00224499209551663; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Wei CY, 2011, SEX TRANSM DIS, V38, P353, DOI 10.1097/OLQ.0b013e3181fe6523; WHO UNAIDS, 2011, PROGR SCAL MAL CIRC; Wiysonge CS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007496.pub2	38	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102960	10.1371/journal.pone.0102960	http://dx.doi.org/10.1371/journal.pone.0102960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076493	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800021
J	Ojikutu, B; Higgins-Biddle, M; Greeson, D; Phelps, BR; Amzel, A; Okechukwu, E; Kolapo, U; Cabral, H; Cooper, E; Hirschhorn, LR				Ojikutu, Bisola; Higgins-Biddle, Molly; Greeson, Dana; Phelps, Benjamin R.; Amzel, Anouk; Okechukwu, Emeka; Kolapo, Usman; Cabral, Howard; Cooper, Ellen; Hirschhorn, Lisa R.			The Association between Quality of HIV Care, Loss to Follow-Up and Mortality in Pediatric and Adolescent Patients Receiving Antiretroviral Therapy in Nigeria	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1-INFECTED CHILDREN; TREATMENT OUTCOMES; CLINICAL CARE; HEALTH-CARE; SCALE-UP; OF-CARE; PROGRAM; IMPROVEMENT; INITIATION	Access to pediatric HIV treatment in resource-limited settings has risen significantly. However, little is known about the quality of care that pediatric or adolescent patients receive. The objective of this study is to explore quality of HIV care and treatment in Nigeria and to determine the association between quality of care, loss-to-follow-up and mortality. A retrospective cohort study was conducted including patients <= 18 years of age who initiated ART between November 2002 and December 2011 at 23 sites across 10 states. 1,516 patients were included. A quality score comprised of 6 process indicators was calculated for each patient. More than half of patients (55.5%) were found to have a high quality score, using the median score as the cut-off. Most patients were screened for tuberculosis at entry into care (81.3%), had adherence measurement and counseling at their last visit (88.7% and 89.7% respectively), and were prescribed co-trimoxazole at some point during enrollment in care (98.8%). Thirty-seven percent received a CD4 count in the six months prior to chart review. Mortality within 90 days of ART initiation was 1.9%. A total of 4.2% of patients died during the period of follow-up (mean: 27 months) with 19.0% lost to follow-up. In multivariate regression analyses, weight for age z-score (Adjusted Hazard Ratio (AHR): 0.90; 95% CI: 0.85, 0.95) and high quality indicator score (compared a low score, AHR: 0.43; 95% CI: 0.26, 0.73) had a protective effect on mortality. Patients with a high quality score were less likely to be lost to follow-up (Adjusted Odds Ratio (AOR): 0.42; 95% CI: 0.32, 0.56), compared to those with low score. These findings indicate that providing high quality care to children and adolescents living with HIV is important to improve outcomes, including lowering loss to follow-up and decreasing mortality in this age group.	[Ojikutu, Bisola; Higgins-Biddle, Molly] John Snow Inc, Boston, MA 02210 USA; [Ojikutu, Bisola] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Greeson, Dana] Columbia Univ, Dept Epidemiol, New York, NY USA; [Phelps, Benjamin R.; Amzel, Anouk] US Agcy Int Dev, Washington, DC 20523 USA; [Okechukwu, Emeka] US Agcy Int Dev, Abuja, Nigeria; [Kolapo, Usman] Indepth Precis, Abuja, Nigeria; [Cabral, Howard] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Cooper, Ellen] Boston Univ, Sch Med, Boston, MA 02118 USA; [Hirschhorn, Lisa R.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Columbia University; United States Agency for International Development (USAID); United States Agency for International Development (USAID); Boston University; Boston University; Harvard University; Harvard Medical School	Ojikutu, B (corresponding author), John Snow Inc, Boston, MA 02210 USA.	bojikutu@jsi.com	Okechukwu, Emeka Franklin/AAH-1130-2020	Hirschhorn, Lisa/0000-0002-4355-7437; Ojikutu, Bisola/0000-0001-7957-8881	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development [GHH-I-00-07-00059-00]	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development under the terms of contract no. GHH-I-00-07-00059-00. Bisola Ojikutu and Molly-Higgins Biddle are employed by John Snow Inc. Usman Kolapo is employed by Indepth Precision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EJ, 2012, JAIDS-J ACQ IMM DEF, V60, pS105, DOI 10.1097/QAI.0b013e31825cf4f5; Alemayehu YK, 2009, INT J QUAL HEALTH C, V21, P356, DOI 10.1093/intqhc/mzp030; Anigilaje EA, 2013, ISRN PEDIATR; Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Braitstein P, 2011, JAIDS-J ACQ IMM DEF, V57, pE40, DOI 10.1097/QAI.0b013e3182167f0d; Brennan AT, 2011, AIDS, V25, P2027, DOI 10.1097/QAD.0b013e32834b6480; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; BROOK RH, 1977, MED CARE, V15, P1; Bygrave H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052856; Campbell SM, 2000, SOC SCI MED, V51, P1611, DOI 10.1016/S0277-9536(00)00057-5; Ciampa PJ, 2012, JAIDS-J ACQ IMM DEF, V60, pE46, DOI 10.1097/QAI.0b013e31824c0267; Davies MA, 2013, PEDIAT INFECT DIS J; Doherty T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-406; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; DONABEDIAN A, 1988, INQUIRY-J HEALTH CAR, V25, P173; Ekouevi DK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-519; Emdin CA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18445; Evans D, 2013, AIDS RES HUM RETROV, V29, P892, DOI [10.1089/aid.2012.0215, 10.1089/AID.2012.0215]; Fayorsey RN, 2013, JAIDS-J ACQ IMM DEF, V62, pE124, DOI 10.1097/QAI.0b013e3182869558; Federal Ministry of Health of Nigeria, 2010, NAT GUID PED HIV AID; George E, 2007, J INFECT DIS, V195, P1411, DOI 10.1086/514823; Horberg M, 2011, AIDS PATIENT CARE ST, V25, P21, DOI 10.1089/apc.2010.0315; Kline MW, 2006, PEDIATRICS, V117, P1388, DOI 10.1542/peds.2005-1348; Lamb MR, 2014, AIDS, V28, P559, DOI 10.1097/QAD.0000000000000054; Leatherman S, 2010, INT J QUAL HEALTH C, V22, P237, DOI 10.1093/intqhc/mzq028; Leroy V, 2013, JAIDS-J ACQ IMM DEF, V62, P208, DOI 10.1097/QAI.0b013e31827b70bf; Lolekha R, 2010, JT COMM J QUAL PATIE, V36, P541, DOI 10.1016/S1553-7250(10)36082-X; Mainz J, 2003, INT J QUAL HEALTH C, V15, P523, DOI 10.1093/intqhc/mzg081; Marazzi MC, 2014, PEDIATR INFECT DIS J, V33, P295, DOI 10.1097/INF.0b013e3182a0994b; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Mukhtar-Yola Mariya, 2006, Afr J AIDS Res, V5, P141, DOI 10.2989/16085900609490374; Nyandiko W, 2013, JAIDS-J ACQ IMM DEF, V63, pE49, DOI 10.1097/QAI.0b013e31828e1e2c; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Sripipatana T, 2007, AM J OBSTET GYNECOL, V197, pS107, DOI 10.1016/j.ajog.2007.03.069; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Thanprasertsuk S, 2012, INT J QUAL HEALTH C, V24, P338, DOI 10.1093/intqhc/mzs008; The Institute of Medicine, 1998, CROSS QUAL CHASM IOM; UNAIDS, 2011, GLOB HIV AIDS RESP E; UNAIDS, COUNTR PROF NIG; Virga PH, 2012, INT J MED INFORM, V81, pE39, DOI 10.1016/j.ijmedinf.2012.06.006; Walker AS, 2012, CLIN INFECT DIS, V55, P1707, DOI 10.1093/cid/cis797; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; Were MC, 2013, PEDIATRICS, V131, pE789, DOI 10.1542/peds.2012-2072; World Health Organization, 2013, TREATM HIV CHILDR; World Health Organization, 2011, GUID INT CAS FIND PE; World Health Organization, 2010, ANT THER HIV INF INF; Zanoni BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022706; Zhao Y, 2013, CLIN INFECT DIS, V56, P735, DOI 10.1093/cid/cis941	50	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e100039	10.1371/journal.pone.0100039	http://dx.doi.org/10.1371/journal.pone.0100039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25075742	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800004
J	Yeom, HG; Kim, JS; Chung, CK				Yeom, Hong Gi; Kim, June Sic; Chung, Chun Kee			High-Accuracy Brain-Machine Interfaces Using Feedback Information	PLOS ONE			English	Article							PRIMATE MOTOR CORTEX; ARM MOVEMENTS; TETRAPLEGIA; SIGNALS; ENSEMBLES; DIRECTION; VELOCITY; HUMANS	Sensory feedback is very important for movement control. However, feedback information has not been directly used to update movement prediction model in the previous BMI studies, although the closed-loop BMI system provides the visual feedback to users. Here, we propose a BMI framework combining image processing as the feedback information with a novel prediction method. The feedback-prediction algorithm (FPA) generates feedback information from the positions of objects and modifies movement prediction according to the information. The FPA predicts a target among objects based on the movement direction predicted from the neural activity. After the target selection, the FPA modifies the predicted direction toward the target and modulates the magnitude of the predicted vector to easily reach the target. The FPA repeats the modification in every prediction time points. To evaluate the improvements of prediction accuracy provided by the feedback, we compared the prediction performances with feedback (FPA) and without feedback. We demonstrated that accuracy of movement prediction can be considerably improved by the FPA combining feedback information. The accuracy of the movement prediction was significantly improved for all subjects (P<0.001) and 32.1% of the mean error was reduced. The BMI performance will be improved by combining feedback information and it will promote the development of a practical BMI system.	[Yeom, Hong Gi; Chung, Chun Kee] Seoul Natl Univ, Interdisciplinary Program Neurosci, Seoul, South Korea; [Yeom, Hong Gi; Kim, June Sic; Chung, Chun Kee] Seoul Natl Univ Hosp, MEG Ctr, Seoul 110744, South Korea; [Kim, June Sic; Chung, Chun Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea; [Kim, June Sic] Seoul Natl Univ, Sensory Organ Res Inst, Seoul, South Korea; [Chung, Chun Kee] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JS (corresponding author), Seoul Natl Univ, Interdisciplinary Program Neurosci, Seoul, South Korea.	jskim@snuh.org	Chung, Chun Kee/J-5650-2012	Chung, Chun Kee/0000-0003-3485-2327; Yeom, Hong Gi/0000-0002-5323-413X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0011712]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0011712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradberry TJ, 2010, J NEUROSCI, V30, P3432, DOI 10.1523/JNEUROSCI.6107-09.2010; Bradberry TJ, 2009, NEUROIMAGE, V47, P1691, DOI 10.1016/j.neuroimage.2009.06.023; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Flint RD, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046006; Fraser GW, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055004; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; HARALICK RM, 1985, COMPUT VISION GRAPH, V29, P100, DOI 10.1016/S0734-189X(85)90153-7; Hauschild M, 2012, P NATL ACAD SCI USA, V109, P17075, DOI 10.1073/pnas.1215092109; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Judy JW, 2012, IEEE PULSE, V3, P57, DOI 10.1109/MPUL.2011.2181026; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Kim SP, 2011, IEEE T NEUR SYS REH, V19, P193, DOI 10.1109/TNSRE.2011.2107750; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; MacKenzie I. S., 2001, CHI 2001 Conference Proceedings. Conference on Human Factors in Computing Systems, P9, DOI 10.1145/365024.365028; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Shanechi MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059049; Thrun S., 2005, PROBABILISTIC ROBOTI; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wu W, 2004, IEEE T BIO-MED ENG, V51, P933, DOI 10.1109/TBME.2004.826666; Yeom HG, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026006	24	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103539	10.1371/journal.pone.0103539	http://dx.doi.org/10.1371/journal.pone.0103539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076487	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800061
J	Heggemann, F; Hamm, K; Brade, J; Streitner, F; Doesch, C; Papavassiliu, T; Borggrefe, M; Haghi, D				Heggemann, Felix; Hamm, Karsten; Brade, Joachim; Streitner, Florian; Doesch, Christina; Papavassiliu, Theano; Borggrefe, Martin; Haghi, Dariusch			Right Ventricular Function Quantification in Takotsubo Cardiomyopathy Using Two-Dimensional Strain Echocardiography	PLOS ONE			English	Article							APICAL BALLOONING SYNDROME; HEART-FAILURE; LONGITUDINAL STRAIN; PLEURAL EFFUSIONS; SPECKLE TRACKING; PROGNOSTIC VALUE; HYPERTENSION; INVOLVEMENT; DYSFUNCTION; ADULTS	Aims: This study sought to characterize global and regional right ventricular (RV) myocardial function in patients with Takotsubo cardiomyopathy (TC) using 2D strain imaging. Methods: We compared various parameters of RV and left ventricular (LV) systolic function between 2 groups of consecutive patients with TC at initial presentation and upon follow-up. Group 1 had RV involvement and group 2 did not have RV involvement. Results: At initial presentation, RV peak systolic longitudinal strain (RVPSS) and RV fractional area change (RVFAC) were significantly lower in group 1 (-13.2 +/- 8.6% vs. -21.8 +/- 5.4%, p = 0.001; 30.7 +/- 9.3% vs. 43.5 +/- 6.3%, p = 0.001) and improved significantly upon follow-up. Tricuspid annular plane systolic excursion (TAPSE) did not differ significantly at initial presentation between both groups (14.8 +/- 4.1 mm vs. 17.9 +/- 3.5 mm, p = 0.050). Differences in regional systolic RV strain were only observed in the mid and apical segments. LV ejection fraction (LVEF) and LV global strain were significantly lower in group 1 (36 +/- 8% vs. 46 +/- 10%, p = 0.006 and -5.5 +/- 4.8% vs. -10.2 > 6.2%, p = 0.040) at initial presentation. None of the parameters were significantly different between the 2 groups upon follow-up. A RVPSS cut-off value of >-19.1% had a sensitivity of 85% and a specificity of 71% to discriminate between the 2 groups. Conclusion: In TC, RVFAC, RVPSS, LVEF and LV global strain differed significantly between patients with and without RV dysfunction, whereas TAPSE did not. 2 D strain imaging was feasible for the assessment of RV dysfunction in TC and could discriminate between patients with and without RV involvement in a clinically meaningful way.	[Heggemann, Felix; Streitner, Florian; Doesch, Christina; Papavassiliu, Theano; Borggrefe, Martin; Haghi, Dariusch] Heidelberg Univ, Univ Med Ctr Mannheim, Med Dept 1, Mannheim, Germany; [Hamm, Karsten] Ctr Cardiovasc Med, Dept Cardiol, Bad Neustadt an der Saale, Germany; [Brade, Joachim] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Biometr & Stat, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Heggemann, F (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Med Dept 1, Mannheim, Germany.	felixheggemann@gmx.de		Hamm, Karsten/0000-0001-5808-5842				Aneq MA, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-37; Brixey AG, 2011, CURR OPIN PULM MED, V17, P226, DOI 10.1097/MCP.0b013e32834702fb; Brown SB, 2011, CHEST, V140, P27, DOI 10.1378/chest.10-1136; Burgdorf C, 2011, CLIN RES CARDIOL, V100, P617, DOI 10.1007/s00392-011-0293-4; Cameli M, 2012, TRANSPL P, V44, P2013, DOI 10.1016/j.transproceed.2012.06.018; Diller GP, 2012, AM HEART J, V163, P859, DOI 10.1016/j.ahj.2012.01.038; Dote K, 1991, J Cardiol, V21, P203; Elesber AA, 2006, J AM COLL CARDIOL, V47, P1082, DOI 10.1016/j.jacc.2005.12.004; Giusca S, 2010, HEART, V96, P281, DOI 10.1136/hrt.2009.171728; Guendouz S, 2012, CIRC J, V76, P127, DOI 10.1253/circj.CJ-11-0778; Haeck MLA, 2012, CIRC-CARDIOVASC IMAG, V5, P628, DOI 10.1161/CIRCIMAGING.111.971465; Haghi D, 2007, INT J CARDIOL, V120, P205, DOI 10.1016/j.ijcard.2006.09.019; Haghi D, 2006, EUR HEART J, V27, P2433, DOI 10.1093/eurheartj/ehl274; Hanekom L, 2007, EUR HEART J, V28, P1765, DOI 10.1093/eurheartj/ehm188; Heggemann F, 2009, EUR J ECHOCARDIOGR, V10, P760, DOI 10.1093/ejechocard/jep062; Jurcut R, 2010, EUR J ECHOCARDIOGR, V11, P81, DOI 10.1093/ejechocard/jep234; Kempny A, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-32; Kurisu S, 2005, INTERNAL MED, V44, P727, DOI 10.2169/internalmedicine.44.727; Mrdovic I, 2010, J AM COLL CARDIOL, V55, P1750, DOI 10.1016/j.jacc.2009.02.098; Natanzon A, 2009, AM J MED SCI, V338, P211, DOI 10.1097/MAJ.0b013e3181a3936f; Nishikawa S, 2004, CIRC J, V68, P1076, DOI 10.1253/circj.68.1076; Nyui N, 2000, JPN CIRC J, V64, P715, DOI 10.1253/jcj.64.715; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Stahli BE, 2011, EUR HEART J, V32, P1821, DOI 10.1093/eurheartj/ehr079; Ternacle J, 2013, J AM SOC ECHOCARDIOG, V26, P721, DOI 10.1016/j.echo.2013.03.021; Teske AJ, 2009, J AM SOC ECHOCARDIOG, V22, P920, DOI 10.1016/j.echo.2009.05.014; Teske PR, 2009, MOL ECOL RESOUR, V9, P1162, DOI 10.1111/j.1755-0998.2009.02595.x	27	21	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103717	10.1371/journal.pone.0103717	http://dx.doi.org/10.1371/journal.pone.0103717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089702	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700046
J	Hsia, RY; Antwi, YA; Weber, E; Nath, JB				Hsia, Renee Y.; Antwi, Yaa Akosa; Weber, Ellerie; Nath, Julia Brownell			A Cross-Sectional Analysis of Variation in Charges and Prices across California for Percutaneous Coronary Intervention	PLOS ONE			English	Article							HEALTH-CARE; TRANSPARENCY; COMPETITION; POOR	Background: Though past studies have shown wide variation in aggregate hospital price indices and specific procedures, few have documented or explained such variation for distinct and common episodes of care. Objectives: We sought to examine the variability in charges for percutaneous coronary intervention (PCI) with a drug-eluting stent and without major complications (MS-DRG-247), and determine whether hospital and market characteristics influenced these charges. Methods: We conducted a cross-sectional analysis of adults admitted to California hospitals in 2011 for MS-DRG-247 using patient discharge data from the California Office of Statewide Health Planning and Development. We used a two-part linear regression model to first estimate hospital-specific charges adjusted for patient characteristics, and then examine whether the between-hospital variation in those estimated charges was explained by hospital and market characteristics. Results: Adjusted charges for the average California patient admitted for uncomplicated PCI ranged from $22,047 to $165,386 (median: $88,350) depending on which hospital the patient visited. Hospitals in areas with the highest cost of living, those in rural areas, and those with more Medicare patients had higher charges, while government-owned hospitals charged less. Overall, our model explained 43% of the variation in adjusted charges. Estimated discounted prices paid by private insurers ranged from $3,421 to $80,903 (median: $28,571). Conclusions: Charges and estimated discounted prices vary widely between hospitals for the average California patient undergoing PCI without major complications, a common and relatively homogeneous episode of care. Though observable hospital characteristics account for some of this variation, the majority remains unexplained.	[Hsia, Renee Y.; Nath, Julia Brownell] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Antwi, Yaa Akosa] Indiana Univ Purdue Univ, Dept Econ, Indianapolis, IN 46202 USA; [Weber, Ellerie] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA	University of California System; University of California San Francisco; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Hsia, RY (corresponding author), Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA.	renee.hsia@emergency.ucsf.edu			National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI [KL2 TR000143]; Robert Wood Johnson Foundation Physician Faculty Scholars Program; UCSF Center for Healthcare Value grant	National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI; Robert Wood Johnson Foundation Physician Faculty Scholars Program(Robert Wood Johnson Foundation (RWJF)); UCSF Center for Healthcare Value grant	This work was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number KL2 TR000143 (RYH), the Robert Wood Johnson Foundation Physician Faculty Scholars Program (RYH), and a UCSF Center for Healthcare Value grant. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of any of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2012, INP QUAL IND TECHN S; Anderson GF, 2007, HEALTH AFFAIR, V26, P780, DOI 10.1377/hlthaff.26.3.780; [Anonymous], 2003, FED REGISTER, V110, P34494; [Anonymous], 2006, FED REGISTER, V160, P47870; [Anonymous], 2008, FED REGISTER, V84, P23542; California Office of Statewide Health Planning and Development (OSHPD), 2011, FIN HOSP ANN UT DAT; Capps C, 2004, HEALTH AFFAIR, V23, P175, DOI 10.1377/hlthaff.23.2.175; Capps Cory, 2010, ANTITRUST TREATMENT; Carter GM, 1993, HOSPITAL RELATIVE VA; Centers for Medicare and Medicaid Services, 2011, HIST IMP FIL; DeNavas-Walt C., 2012, INCOME POVERTY HLTH; Dobson A., 2005, STUDY HOSP CHARGE SE; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faddy M, 2009, VALUE HEALTH, V12, P309, DOI 10.1111/j.1524-4733.2008.00421.x; Farrell KS, 2010, J GEN INTERN MED, V25, P110, DOI 10.1007/s11606-009-1176-5; Gaynor M, 2003, RAND J ECON, V34, P764, DOI 10.2307/1593787; Ginsburg Paul B, 2005, Health Aff (Millwood), VSuppl Web Exclusives, pW5; Ginsburg PB., 2010, WIDE VARIATION HOSP; Government Accountability Office, 2011, GAO11791; Government Accountability Office (GAO), 2005, GAO05856; Health Resources and Services Administration, 2009, AR RES FIL; Healthcare Cost and Utilization Project, 2011, HCUP NET NAT REG EST; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; Hsia RY, 2012, ARCH INTERN MED, V172, P818, DOI 10.1001/archinternmed.2012.1173; Internal Revenue Service, 2006, IRS EX ORG TE GE HOS; Kaplan RS, 2011, HARVARD BUS REV, V89, P46; Keeler EB, 1999, J HEALTH ECON, V18, P69, DOI 10.1016/S0167-6296(98)00036-8; Kyle MK, 2007, HEALTH AFFAIR, V26, P1384, DOI 10.1377/hlthaff.26.5.1384; MELNICK GA, 1992, J HEALTH ECON, V11, P217, DOI 10.1016/0167-6296(92)90001-H; Melnick G, 2007, J HEALTH ECON, V26, P400, DOI 10.1016/j.jhealeco.2006.10.002; Melnick G, 2013, HEALTH AFFAIR, V32, P1101, DOI 10.1377/hlthaff.2012.0731; Milliman, 2007, COST EFF HOSP FAC CA; Program Medicare, 2012, FED REG, V77, P170; Reinhardt U, 2009, NY TIMES; Reinhardt UE, 2006, HEALTH AFFAIR, V25, P57, DOI 10.1377/hlthaff.25.1.57; Reinhardt UE, 2013, NY TIMES; Shwartz M, 1995, INQUIRY-J HEALTH CAR, V32, P476; U.S. Department of Justice and the Federal Trade Commission (U.S. DOJ/FTC, 2010, HORIZONTAL MERGER GU; Vashi AA, 2013, JAMA-J AM MED ASSOC, V309, P364, DOI 10.1001/jama.2012.216219; Wilensky GR, 2006, HEALTH AFFAIR, V25, P174, DOI 10.1377/hlthaff.25.1.174	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103829	10.1371/journal.pone.0103829	http://dx.doi.org/10.1371/journal.pone.0103829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25089905	Green Published, gold			2022-12-27	WOS:000339812700059
J	Jia, SX; Keilberg, D; Hot, E; Thanbichler, M; Sogaard-Andersen, L; Lenz, P				Jia, Shuxin; Keilberg, Daniela; Hot, Edina; Thanbichler, Martin; Sogaard-Andersen, Lotte; Lenz, Peter			Effect of the Min System on Timing of Cell Division in Escherichia coli	PLOS ONE			English	Article							TO-POLE OSCILLATION; CHROMOSOME-REPLICATION; FTSZ RING; TOPOLOGICAL REGULATION; ASSEMBLY DYNAMICS; BACILLUS-SUBTILIS; STOCHASTIC-MODEL; SEPTUM FORMATION; INHIBITOR MINC; RAPID POLE	In Escherichia coli the Min protein system plays an important role in positioning the division site. We show that this system also has an effect on timing of cell division. We do this in a quantitative way by measuring the cell division waiting time (defined as time difference between appearance of a division site and the division event) and the Z-ring existence time. Both quantities are found to be different in WT and cells without functional Min system. We develop a series of theoretical models whose predictions are compared with the experimental findings. Continuous improvement leads to a final model that is able to explain all relevant experimental observations. In particular, it shows that the chromosome segregation defect caused by the absence of Min proteins has an important influence on timing of cell division. Our results indicate that the Min system affects the septum formation rate. In the absence of the Min proteins this rate is reduced, leading to the observed strongly randomized cell division events and the longer division waiting times.	[Jia, Shuxin; Lenz, Peter] Univ Marburg, Dept Phys, D-35032 Marburg, Germany; [Jia, Shuxin; Keilberg, Daniela; Thanbichler, Martin; Sogaard-Andersen, Lotte; Lenz, Peter] Univ Marburg, LOEWE Ctr Synthet Microbiol, Marburg, Germany; [Keilberg, Daniela; Hot, Edina; Thanbichler, Martin; Sogaard-Andersen, Lotte] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Thanbichler, Martin] Univ Marburg, Dept Biol, Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Max Planck Society; Philipps University Marburg	Lenz, P (corresponding author), Univ Marburg, Dept Phys, D-35032 Marburg, Germany.	peter.lenz@Physik.Uni-Marburg.DE		Sogaard-Andersen, Lotte/0000-0002-0674-0013; Lenz, Peter/0000-0001-7705-3950	German Research Council within the framework of the Graduate School "Intra- and Intercellular Transport and Communication"; Max Planck Society; LOEWE Research Center for Synthetic Microbiology	German Research Council within the framework of the Graduate School "Intra- and Intercellular Transport and Communication"; Max Planck Society(Max Planck SocietyFoundation CELLEX); LOEWE Research Center for Synthetic Microbiology	This work was supported by the German Research Council within the framework of the Graduate School "Intra- and Intercellular Transport and Communication", the Max Planck Society, and the LOEWE Research Center for Synthetic Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLUND T, 1992, MOL MICROBIOL, V6, P2073, DOI 10.1111/j.1365-2958.1992.tb01380.x; Akerlund T, 2002, MICROBIOL-SGM, V148, P3213, DOI 10.1099/00221287-148-10-3213; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; BI E, 1990, J BACTERIOL, V172, P2765, DOI 10.1128/jb.172.5.2765-2768.1990; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Bonny M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003347; Boye E, 2003, EMBO REP, V4, P757, DOI 10.1038/sj.embor.embor895; Browning ST, 2004, BIOTECHNOL BIOENG, V88, P575, DOI 10.1002/bit.20223; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Creutziger M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/9/095016; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; Di Ventura B, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.44; Di Ventura B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.111; DONACHIE WD, 1968, NATURE, V219, P1077, DOI 10.1038/2191077a0; Donachie WD, 2003, CURR OPIN MICROBIOL, V6, P146, DOI 10.1016/S1369-5274(03)00026-2; Drew DA, 2005, P NATL ACAD SCI USA, V102, P6114, DOI 10.1073/pnas.0502037102; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Fischer-Friedrich E, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016009; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Fried L, 2012, J MICROBIOL METH, V91, P537, DOI 10.1016/j.mimet.2012.09.023; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Haeusser DP, 2008, CURR OPIN MICROBIOL, V11, P94, DOI 10.1016/j.mib.2008.02.008; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; HELMSTETTER CE, 1968, J MOL BIOL, V31, P507, DOI 10.1016/0022-2836(68)90424-5; Howard M, 2005, J CELL BIOL, V168, P533, DOI 10.1083/jcb.200411122; Howard M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278102; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Hu ZL, 2000, J BACTERIOL, V182, P3965, DOI 10.1128/JB.182.14.3965-3971.2000; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; JAFFE A, 1988, J BACTERIOL, V170, P3094, DOI 10.1128/jb.170.7.3094-3101.1988; Jenal U, 2009, RES MICROBIOL, V160, P687, DOI 10.1016/j.resmic.2009.09.006; Johnson JE, 2002, J BACTERIOL, V184, P2951, DOI 10.1128/JB.184.11.2951-2962.2002; Kerr RA, 2006, P NATL ACAD SCI USA, V103, P347, DOI 10.1073/pnas.0505825102; Koch AL, 2002, CRIT REV MICROBIOL, V28, P61, DOI 10.1080/1040-840291046696; Kruse K, 2002, BIOPHYS J, V82, P618, DOI 10.1016/S0006-3495(02)75426-X; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Laub MT, 2007, ANNU REV GENET, V41, P429, DOI 10.1146/annurev.genet.41.110306.130346; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Lenz P, 2011, NAT REV MICROBIOL, V9, P565, DOI 10.1038/nrmicro2612; Leonardy S, 2010, EMBO J, V29, P2276, DOI 10.1038/emboj.2010.114; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; Lutkenhaus J, 2002, CURR OPIN MICROBIOL, V5, P548, DOI 10.1016/S1369-5274(02)00376-4; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; MAHAFFY JM, 1989, J THEOR BIOL, V140, P453, DOI 10.1016/S0022-5193(89)80109-2; Mannik J, 2012, P NATL ACAD SCI USA, V109, P6957, DOI 10.1073/pnas.1120854109; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; McAdams HH, 2009, FEBS LETT, V583, P3984, DOI 10.1016/j.febslet.2009.09.030; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Migocki MD, 2002, EMBO REP, V3, P1163, DOI 10.1093/embo-reports/kvf233; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; MULDER E, 1990, MOL GEN GENET, V221, P87, DOI 10.1007/BF00280372; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; NORDSTROM K, 1991, MOL MICROBIOL, V5, P769, DOI 10.1111/j.1365-2958.1991.tb00747.x; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schofield WB, 2010, EMBO J, V29, P3068, DOI 10.1038/emboj.2010.207; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Sun Q, 1998, MOL MICROBIOL, V29, P491, DOI 10.1046/j.1365-2958.1998.00942.x; TEATHER RM, 1974, J BACTERIOL, V118, P407, DOI 10.1128/JB.118.2.407-413.1974; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; Tostevin F, 2006, PHYS BIOL, V3, P1, DOI 10.1088/1478-3975/3/1/001; VINELLA D, 1995, BIOESSAYS, V17, P527, DOI 10.1002/bies.950170609; Wery M, 2001, BIOCHIMIE, V83, P193, DOI 10.1016/S0300-9084(01)01254-8; WOLDRINGH CL, 1990, RES MICROBIOL, V141, P39, DOI 10.1016/0923-2508(90)90096-9; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	88	8	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103863	10.1371/journal.pone.0103863	http://dx.doi.org/10.1371/journal.pone.0103863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090009	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700060
J	Alam, M; Chen, X; Zhang, ZC; Li, Y; He, JF				Alam, Monzurul; Chen, Xi; Zhang, Zicong; Li, Yan; He, Jufang			A Brain-Machine-Muscle Interface for Restoring Hindlimb Locomotion after Complete Spinal Transection in Rats	PLOS ONE			English	Article							CORD-INJURY; MOTOR CORTEX; STIMULATION; NEURONS; REHABILITATION; TETRAPLEGIA; MOVEMENTS	A brain-machine interface (BMI) is a neuroprosthetic device that can restore motor function of individuals with paralysis. Although the feasibility of BMI control of upper-limb neuroprostheses has been demonstrated, a BMI for the restoration of lower-limb motor functions has not yet been developed. The objective of this study was to determine if gait-related information can be captured from neural activity recorded from the primary motor cortex of rats, and if this neural information can be used to stimulate paralysed hindlimb muscles after complete spinal cord transection. Neural activity was recorded from the hindlimb area of the primary motor cortex of six female Sprague Dawley rats during treadmill locomotion before and after mid-thoracic transection. Before spinal transection there was a strong association between neural activity and the step cycle. This association decreased after spinal transection. However, the locomotive state (standing vs. walking) could still be successfully decoded from neural recordings made after spinal transection. A novel BMI device was developed that processed this neural information in real-time and used it to control electrical stimulation of paralysed hindlimb muscles. This system was able to elicit hindlimb muscle contractions that mimicked forelimb stepping. We propose this lower-limb BMI as a future neuroprosthesis for human paraplegics.	[Alam, Monzurul; Chen, Xi; Zhang, Zicong; Li, Yan; He, Jufang] Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Chen, Xi; He, Jufang] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; City University of Hong Kong	Alam, M (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China.	malam@mednet.ucla.edu; jufanghe@cityu.edu.hk	Zhang, Zicong/V-7853-2019	Zhang, Zicong/0000-0002-6453-5528; Alam, Monzurul/0000-0003-0987-1999; HE, Jufang/0000-0002-4288-5957; CHEN, Xi/0000-0002-2144-6584	Hong Kong Research Grants Council [PolyU5614/10M]; Ministry of Science and Technology of China [2012CB966300]; Charlie Lee Charitable Foundation; Fong Shu Fook Tong Foundation; Fong's Family Foundation; P. K. Yu Foundation	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Charlie Lee Charitable Foundation; Fong Shu Fook Tong Foundation; Fong's Family Foundation; P. K. Yu Foundation	This work was supported by Hong Kong Research Grants Council (PolyU5614/10M) and Ministry of Science and Technology of China (2012CB966300), The Charlie Lee Charitable Foundation, Fong Shu Fook Tong Foundation, and Fong's Family Foundation. M Alam was supported by the P. K. Yu Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Alam M, 2013, CONVERGING CLIN ENG, P35; BELOOZEROVA IN, 1993, J PHYSIOL-LONDON, V461, P1; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; CROZIER KS, 1991, ARCH PHYS MED REHAB, V72, P119; Drew T, 1996, CAN J PHYSIOL PHARM, V74, P426, DOI 10.1139/cjpp-74-4-426; Drew T, 1991, Curr Opin Neurobiol, V1, P652, DOI 10.1016/S0959-4388(05)80044-3; Fitzsimmons NA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.003.2009; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Fouad K, 2004, PROG NEUROBIOL, V73, P107, DOI 10.1016/j.pneurobio.2004.04.003; Gerasimenko Yu P, 2003, Neurosci Behav Physiol, V33, P247, DOI 10.1023/A:1022199214515; Gerasimenko YP, 2007, J NEUROPHYSIOL, V98, P2525, DOI 10.1152/jn.00836.2007; Gibson S, 2008, IEEE ENG MED BIO, P5015, DOI 10.1109/IEMBS.2008.4650340; Giszter SF, 2010, ANN NY ACAD SCI, V1198, P279, DOI 10.1111/j.1749-6632.2010.05534.x; Gorska T, 1999, ACTA NEUROBIOL EXP, V59, P131; He JP, 2008, P IEEE, V96, P1152, DOI 10.1109/JPROC.2008.922593; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Ichiyama RM, 2005, NEUROSCI LETT, V383, P339, DOI 10.1016/j.neulet.2005.04.049; Jung W., 2005, OP AMP APPL HDB; Lebedev MA, 2011, CLINICS, V66, P25, DOI 10.1590/S1807-59322011001300004; Lebedev Mikhail A., 2008, P219; Luo Peng, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P1416; Manohar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052173; Marin Cristina, 2010, Front Neuroeng, V3, P8, DOI 10.3389/fneng.2010.00008; Moritz CT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025017; Motchenbacher CD, 1993, LOW NOISE ELECT SYST; Moxon KA, 2008, NEUROSCIENCE, V156, P1083, DOI 10.1016/j.neuroscience.2008.08.009; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Nicolelis M, 2007, METHODS NEURAL ENSEM, DOI DOI 10.1201/9781420006414; Orlovskii GN., 1999, NEURONAL CONTROL LOC; SCI-recovery, 2013, SPIN CORD INJ; Scott SH, 2008, NAT NEUROSCI, V11, P1245, DOI 10.1038/nn1108-1245; Song WG, 2009, IEEE T BIO-MED ENG, V56, P2712, DOI 10.1109/TBME.2009.2026284; Thakor NV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007303; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; VANHEUNINGEN R, 1984, MED BIOL ENG COMPUT, V22, P77, DOI 10.1007/BF02443749; Wahnoun R, 2006, J NEURAL ENG, V3, P162, DOI 10.1088/1741-2560/3/2/010; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; WATERS RL, 1991, PARAPLEGIA, V29, P573, DOI 10.1038/sc.1991.85; Wattanapanitch W, 2007, IEEE T BIOMED CIRC S, V1, P136, DOI 10.1109/TBCAS.2007.907868; Xiao-qin Liu, 2011, 2011 4th International Conference on Biomedical Engineering and Informatics, P854, DOI 10.1109/BMEI.2011.6098451; Zacksenhouse Miriam, 2008, P57; Zelenin PV, 2011, J NEUROSCI, V31, P4636, DOI 10.1523/JNEUROSCI.6511-10.2011	45	11	11	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103764	10.1371/journal.pone.0103764	http://dx.doi.org/10.1371/journal.pone.0103764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084446	gold, Green Published			2022-12-27	WOS:000339819800077
J	Bohner, G; Schluter, LE				Bohner, Gerd; Schlueter, Lena E.			A Room with a Viewpoint Revisited: Descriptive Norms and Hotel Guests' Towel Reuse Behavior	PLOS ONE			English	Article							SOCIAL NORMS; CONSENSUS	Field experiments on descriptive norms as a means to increase hotel guests' towel reuse [1] were replicated and extended. In two hotels in Germany (Study 1: N = 724; Study 2: N = 204), descriptive norm messages suggesting that 75% of guests had reused their towels, or a standard message appealing to environmental concerns, were placed in guests' bathrooms. Descriptive norm messages varied in terms of proximity of the reference group ("hotel guests'' vs. "guests in this room'') and temporal proximity (currently vs. two years previous). Reuse of towels was unobtrusively recorded. Results showed that reuse rates were high overall and that both standard and descriptive norm messages increased reuse rates compared to a no-message baseline. However, descriptive norm messages were not more effective than the standard message, and effects of proximity were inconsistent across studies. Discussion addresses cultural and conceptual issues in comparing the present findings with previous ones.	[Bohner, Gerd; Schlueter, Lena E.] Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany	University of Bielefeld	Bohner, G (corresponding author), Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany.	gerd.bohner@uni-bielefeld.de	Bohner, Gerd/B-2274-2008	Bohner, Gerd/0000-0002-0564-3625	Deutsche Forschungsgemeinschaft; Open Access Publication Funds of Bielefeld University Library	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University Library	The authors acknowledge support for the article processing charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto M, 2000, PERS SOC PSYCHOL B, V26, P891, DOI 10.1177/01461672002610001; BOHNER G, 1992, EUR J SOC PSYCHOL, V22, P511, DOI 10.1002/ejsp.2420220602; Bohner G., 1995, EUROPEAN REV SOCIAL, V6, P33, DOI [10.1080/14792779443000003, DOI 10.1080/14792779443000003]; Bohner G, 2010, PSYCHOL CRIME LAW, V16, P671, DOI 10.1080/1068316X.2010.492349; Bollinger B, 2012, MARKET SCI, V31, P900, DOI 10.1287/mksc.1120.0727; Brandt MJ, 2013, J PERS SOC PSYCHOL, V104, P765, DOI 10.1037/a0031751; Burger JM, 2009, AM PSYCHOL, V64, P1, DOI 10.1037/a0010932; CIALDINI RB, 1991, ADV EXP SOC PSYCHOL, V24, P201; Cohen J.E., 1988, STAT POWER ANAL BEHA; Darke PR, 1998, PERS SOC PSYCHOL B, V24, P1205, DOI 10.1177/01461672982411007; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Erb HP, 2006, BASIC APPL SOC PSYCH, V28, P221, DOI 10.1207/s15324834basp2803_2; Garcia SM, 2009, PSYCHOL SCI, V20, P871, DOI 10.1111/j.1467-9280.2009.02385.x; Gockeritz S, 2010, EUR J SOC PSYCHOL, V40, P514, DOI 10.1002/ejsp.643; Goldstein N. J., 2009, SOCIAL PSYCHOL CONSU, P273; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Grau I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086056; Heider, 1958, PSYCHOL INTERPERSONA; Makel MC, 2012, PERSPECT PSYCHOL SCI, V7, P537, DOI 10.1177/1745691612460688; McShane BB, 2012, J MARKETING RES, V49, P854, DOI 10.1509/jmr.11.0223; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; PETTY RE, 1981, J PERS SOC PSYCHOL, V41, P847, DOI 10.1037/0022-3514.41.5.847; Reese G, 2014, J SOC PSYCHOL, V154, P97, DOI 10.1080/00224545.2013.855623; Rosenthal E, 2009, WHAT MAKES EUROPE GR; ROSENTHAL R, 1990, AM PSYCHOL, V45, P775, DOI 10.1037/0003-066X.45.6.775; Schultz PW, 2008, SOC INFLUENCE, V3, P4, DOI 10.1080/15534510701755614; Sedikides C, 2003, J PERS SOC PSYCHOL, V84, P60, DOI 10.1037/0022-3514.84.1.60; Stroebe W, 2014, PERSPECT PSYCHOL SCI, V9, P59, DOI 10.1177/1745691613514450; Terry DJ, 1996, PERS SOC PSYCHOL B, V22, P776, DOI 10.1177/0146167296228002; The World Bank, 2014, CO2 EM METR TONS PER; Zell E, 2009, J PERS SOC PSYCHOL, V97, P467, DOI 10.1037/a0015453	31	55	56	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104086	10.1371/journal.pone.0104086	http://dx.doi.org/10.1371/journal.pone.0104086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4JL	25084348	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800126
J	Grorud-Colvert, K; Claudet, J; Tissot, BN; Caselle, JE; Carr, MH; Day, JC; Friedlander, AM; Lester, SE; De Loma, TL; Malone, D; Walsh, WJ				Grorud-Colvert, Kirsten; Claudet, Joachim; Tissot, Brian N.; Caselle, Jennifer E.; Carr, Mark H.; Day, Jon C.; Friedlander, Alan M.; Lester, Sarah E.; De Loma, Thierry Lison; Malone, Daniel; Walsh, William J.			Marine Protected Area Networks: Assessing Whether the Whole Is Greater than the Sum of Its Parts	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; RESERVE NETWORKS; HAWAIIAN-ISLANDS; REEF FISHES; POPULATIONS; CONNECTIVITY; SIZE; CONSERVATION; ABUNDANCE; DESIGN	Anthropogenic impacts are increasingly affecting the world's oceans. Networks of marine protected areas (MPAs) provide an option for increasing the ecological and economic benefits often provided by single MPAs. It is vital to empirically assess the effects of MPA networks and to prioritize the monitoring data necessary to explain those effects. We summarize the types of MPA networks based on their intended management outcomes and illustrate a framework for evaluating whether a connectivity network is providing an outcome greater than the sum of individual MPA effects. We use an analysis of an MPA network in Hawai'i to compare networked MPAs to non-networked MPAs to demonstrate results consistent with a network effect. We assert that planning processes for MPA networks should identify their intended outcomes while also employing coupled field monitoring-simulation modeling approaches, a powerful way to prioritize the most relevant monitoring data for empirically assessing MPA network performance.	[Grorud-Colvert, Kirsten] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Claudet, Joachim] Univ Perpignan, Natl Ctr Sci Res CNRS, F-66025 Perpignan, France; [Claudet, Joachim] Lab Excellence CORAIL, Perpignan, France; [Tissot, Brian N.] Humboldt State Univ, Marine Lab, Trinidad, CA USA; [Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Carr, Mark H.] Univ Calif Santa Cruz, Long Marine Lab, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Day, Jon C.] Great Barrier Reef Marine Pk Author, Townsville, Qld, Australia; [Friedlander, Alan M.] Univ Hawaii, Dept Biol, Honolulu, HI USA; [Lester, Sarah E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA USA; [De Loma, Thierry Lison] CRIOBE, Moorea, Iceland; [Malone, Daniel] Univ Calif Santa Cruz, Long Marine Lab, Inst Marine Sci, Santa Cruz, CA USA; [Walsh, William J.] Hawaii Div Aquat Resources, Kailua, HI USA	Oregon State University; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia; California State University System; California State Polytechnic University, Humboldt; University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz; University of Hawaii System; University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz	Grorud-Colvert, K (corresponding author), Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA.	grorudck@science.oregonstate.edu	Claudet, Joachim/C-6335-2008; Day, Jon C/H-3276-2016	Claudet, Joachim/0000-0001-6295-1061; Day, Jon C/0000-0003-3906-0759; Tissot, Brian/0000-0003-0398-2241	David and Lucille Packard Foundation; Gordon and Betty Moore Foundation; EU FP7 COCONET; biodivERsA BUFFER; Hawaii Coral Reef Initiative Research Program (HCRI-RP) under the National Oceanic and Atmospheric Administration (NOAA); Coral Reef Monitoring Grants under NOAA's Coral Reef Conservation Program	David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); EU FP7 COCONET; biodivERsA BUFFER; Hawaii Coral Reef Initiative Research Program (HCRI-RP) under the National Oceanic and Atmospheric Administration (NOAA); Coral Reef Monitoring Grants under NOAA's Coral Reef Conservation Program	Funding was provided by the David and Lucille Packard Foundation (http://www.packard.org/), Gordon and Betty Moore Foundation (http://www.moore.org/), EU FP7 COCONET (http://www.coconet-fp7.eu/), biodivERsA BUFFER (http://www.biodiversa.org/518), Hawaii Coral Reef Initiative Research Program (HCRI-RP, http://www.cop.noaa.gov/ecosystems/coralreefs/current/hcri-factsheet-cr.aspx) under the National Oceanic and Atmospheric Administration (NOAA), and Coral Reef Monitoring Grants under NOAA's Coral Reef Conservation Program (http://coralreef.noaa.gov/aboutcrcp/workwithus/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2006, AQUAT CONSERV, V16, P349, DOI 10.1002/aqc.730; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Browman HI, 2004, MAR ECOL PROG SER, V274, P271; Carr MH, 2011, FRONT ECOL ENVIRON, V9, P342, DOI 10.1890/090096; CDFG (California Department of Fish and Game), 2008, CAL MAR LIF PROT ACT; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Claudet J, 2004, AQUAT LIVING RESOUR, V17, P129, DOI 10.1051/alr:2004017; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Day J, 2002, WORLD C AQUATIC PROT, P401; Edgar GJ, 2004, ENVIRON CONSERV, V31, P212, DOI 10.1017/S0376892904001584; Fenberg PB, 2012, MAR POLICY, V36, P1012, DOI 10.1016/j.marpol.2012.02.021; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; GBRMPA, 2002, BIOPH OP PRINC REC S; Gleason M, 2013, OCEAN COAST MANAGE, V74, P90, DOI 10.1016/j.ocecoaman.2012.08.013; Grorud-Colvert K., 2011, MARINE PROTECTED ARE, P293; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; IUCN World Commission on Protected Areas, 2008, EST RES MAR PROT AR; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Joseph LN, 2009, ECOL APPL, V19, P631, DOI 10.1890/07-2107.1; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; McCook LJ, 2009, CORAL REEFS, V28, P353, DOI 10.1007/s00338-008-0463-7; McInerney CE, 2012, BIOL CONSERV, V152, P262, DOI 10.1016/j.biocon.2012.03.009; Miller I, 2012, MAR ENVIRON RES, V79, P167, DOI 10.1016/j.marenvres.2012.05.008; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Murray SN, 1999, FISHERIES, V24, P11, DOI 10.1577/1548-8446(1999)024&lt;0011:NRN&gt;2.0.CO;2; NRC, 2001, MAR PROT AR TOOLS SU; Parrish JD, 2000, INTERACTIONS NONINDI; Pelletier D, 2008, CAN J FISH AQUAT SCI, V65, P765, DOI 10.1139/F08-026; Pillay D, 2010, MAR ECOL PROG SER, V415, P35, DOI 10.3354/meps08733; Rassweiler A, 2012, P NATL ACAD SCI US; Russ GR, 1996, MAR ECOL PROG SER, V132, P1, DOI 10.3354/meps132001; Saarman E, 2013, OCEAN COAST MANAGE, V74, P45, DOI 10.1016/j.ocecoaman.2012.08.021; Schumacher BD, 2011, THESIS U HAWAII; Shanks AL, 2003, ECOL APPL, V13, pS159; Stevenson TC, 2013, MAR POLICY, V39, P215, DOI 10.1016/j.marpol.2012.11.003; Stevenson TC, 2011, ICES J MAR SCI, V68, P813, DOI 10.1093/icesjms/fsr020; SWEATMAN H, 2001, 5 AUSTR I MAR SCI; Tissot Brian N., 2004, Pacific Science, V58, P175, DOI 10.1353/psc.2004.0024; Tissot BN, 2009, COAST MANAGE, V37, P255, DOI 10.1080/08920750902851096; Walsh W, 2013, LONG TERM MONITORING; White C, 2008, ECOL LETT, V11, P370, DOI 10.1111/j.1461-0248.2007.01151.x; White JW, 2013, CONSERV LETT, V6, P180, DOI 10.1111/j.1755-263X.2012.00295.x; White JW, 2011, FRONT ECOL ENVIRON, V9, P390, DOI 10.1890/100138; White JW, 2010, MAR ECOL PROG SER, V398, P49, DOI 10.3354/meps08327; Williams ID, 2009, BIOL CONSERV, V142, P1066, DOI 10.1016/j.biocon.2008.12.029; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092	55	70	70	0	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e102298	10.1371/journal.pone.0102298	http://dx.doi.org/10.1371/journal.pone.0102298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084458	Green Published, gold			2022-12-27	WOS:000339819800008
J	Han, SL; Zhang, XP; Zou, LL; Lu, CH; Zhang, J; Li, J; Li, MQ				Han, Shilong; Zhang, Xiaoping; Zou, Liling; Lu, Chenhui; Zhang, Jun; Li, Jue; Li, Maoquan			Does Drug-Eluting Bead Transcatheter Arterial Chemoembolization Improve the Management of Patients with Hepatocellular Carcinoma? A Meta-Analysis	PLOS ONE			English	Article							PHASE-II TRIAL; TRANSARTERIAL CHEMOEMBOLIZATION; IN-VITRO; DC BEAD; DEB TACE; DOXORUBICIN; IRINOTECAN; SURVIVAL; LIVER; MICROSPHERES	Background: Drug eluting beads (DEB) are relatively new embolic agents that allow sustained release of chemotherapeutic agents in a localized fashion to the tumor. This technique is associated with reduced systemic side effects relative to systemic chemotherapy and an increase in the dose of antineoplastic agent delivered to the lesion. The meta-analysis was undertaken to assess the effectiveness of DEB-transcatheter arterial chemoembolization (TACE) in the management of hepatocellular cancer. Methods: We searched the Web of Science, PubMed, EBSCO, EMBASE, the Wiley Library and Google Scholar for studies on DEB-TACE in the management of hepatocellular cancer from 1979 to April 2013. The risk of bias was assessed using RevMan 5.1. Random and fixed-effects meta-analytical models were used where indicated, and between-study heterogeneity was assessed. Disease control, complications and severe complications were recorded. Results: Five studies met the selection criteria, three RCTs and two case-control studies, published from 2010 to 2012, included 217 patients in the DEB-TACE group and 237 in the conventional-TACE group. There was no significance over disease control (OR 2.27, 95% CI 0.78-6.63) with moderate between-study heterogeneity (chi(2) = 6.83, degrees of freedom [df] = 3; p<0.08; I-2 = 56%). Complications in both groups were assessed and no significant difference was observed (chi(2) = 6.34, degrees of freedom [df] = 4; p<0.18; I-2 = 37%). Severe complications were also assessed and no significant difference was observed (chi(2) = 6.47, degrees of freedom [df] = 4; p<0.17; I-2 = 38%). No publication bias relating to the above outcomes was detected by funnel plot. DEB-TACE benefited disease control without an increase in complications and severe complications.	[Han, Shilong; Zhang, Xiaoping; Lu, Chenhui; Li, Maoquan] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Intervent & Vasc Surg, Shanghai 200092, Peoples R China; [Zou, Liling; Zhang, Jun; Li, Jue] Tongji Univ, Sch Med, Heart Lung & Blood Vessel Ctr, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Li, J (corresponding author), Tongji Univ, Sch Med, Heart Lung & Blood Vessel Ctr, Shanghai 200092, Peoples R China.	Jueli@tongji.edu.cn; cjr.limaoquan@163.vip.com			National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAI15B06]	National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program)	This work was supported by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BAI15B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burrel M, 2012, J HEPATOL, V56, P1330, DOI 10.1016/j.jhep.2012.01.008; Camma C, 2002, RADIOLOGY, V224, P47, DOI 10.1148/radiol.2241011262; Cannon RM, 2012, ONKOLOGIE, V35, P184, DOI 10.1159/000337402; Chung WS, 2012, AM J ROENTGENOL, V199, P349, DOI 10.2214/AJR.11.7563; Clarke M, 2001, LANCET, V357, P1728, DOI 10.1016/S0140-6736(00)04934-5; Dhanasekaran R, 2010, HPB, V12, P174, DOI 10.1111/j.1477-2574.2009.00138.x; Doi SAR, 2011, CONTEMP CLIN TRIALS, V32, P288, DOI 10.1016/j.cct.2010.12.006; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Eyol E, 2008, CLIN EXP METASTAS, V25, P273, DOI 10.1007/s10585-008-9142-x; Alonso MGH, 2010, RADIOLOGIA-MADRID, V52, P425, DOI 10.1016/j.rx.2010.05.008; Grosso M, 2008, CARDIOVASC INTER RAD, V31, P1141, DOI 10.1007/s00270-008-9409-2; Gupta S, 2011, CARDIOVASC INTER RAD, V34, P1021, DOI 10.1007/s00270-011-0154-6; Han KH, 2011, ONCOLOGY-BASEL, V81, P158, DOI 10.1159/000333280; Hong K, 2006, CLIN CANCER RES, V12, P2563, DOI 10.1158/1078-0432.CCR-05-2225; Jordan O, 2010, J VASC INTERV RADIOL, V21, P1084, DOI 10.1016/j.jvir.2010.02.042; Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P335, DOI 10.1097/01.RVI.0000195323.46152.B3; Lewis AL, 2006, J VASC INTERV RADIOL, V17, P1335, DOI 10.1097/01.RVI.0000228416.21560.7F; Liu DM, 2012, CARDIOVASC INTER RAD, V35, P391, DOI 10.1007/s00270-011-0168-0; Maeda N, 2010, J VASC INTERV RADIOL, V21, P877, DOI 10.1016/j.jvir.2010.02.009; Malagari K, 2008, CARDIOVASC INTER RAD, V31, P269, DOI 10.1007/s00270-007-9226-z; Malagari K, 2012, CARDIOVASC INTER RAD, V35, P1119, DOI 10.1007/s00270-012-0394-0; Malagari K, 2011, CARDIOVASC INTER RAD, V34, P774, DOI 10.1007/s00270-010-0044-3; Malagari K, 2010, CARDIOVASC INTER RAD, V33, P541, DOI 10.1007/s00270-009-9750-0; Martin RCG, 2010, CARDIOVASC INTER RAD, V33, P960, DOI 10.1007/s00270-010-9937-4; Martin R, 2012, HEPATO-GASTROENTEROL, V59, P255, DOI 10.5754/hge10240; Moschouris H, 2010, CARDIOVASC INTER RAD, V33, P1022, DOI 10.1007/s00270-010-9800-7; Namur J, 2011, J HEPATOL, V55, P1332, DOI 10.1016/j.jhep.2011.03.024; Osuga K, 2012, INT J CLIN ONCOL, V17, P306, DOI 10.1007/s10147-012-0445-1; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; Pomoni M, 2012, HEPATO-GASTROENTEROL, V59, P820, DOI 10.5754/hge11347; Poon RTP, 2007, CLIN GASTROENTEROL H, V5, P1100, DOI 10.1016/j.cgh.2007.04.021; Prajapati HJ, 2013, ANN ONCOL, V24, P965, DOI 10.1093/annonc/mds605; Prajapati HJ, 2012, J VASC INTERV RADIOL, V23, P1286, DOI 10.1016/j.jvir.2012.07.003; Reyes DK, 2009, CANCER J, V15, P526, DOI 10.1097/PPO.0b013e3181c5214b; Sacco R, 2011, J VASC INTERV RADIOL, V22, P1545, DOI 10.1016/j.jvir.2011.07.002; Sadick M, 2010, ONKOLOGIE, V33, P31, DOI 10.1159/000264620; Seki A, 2012, CARDIOVASC INTER RAD, V35, P555, DOI 10.1007/s00270-011-0176-0; Seki A, 2011, CARDIOVASC INTER RAD, V34, P557, DOI 10.1007/s00270-010-9975-y; Skowasch M, 2012, EUR J RADIOL, V81, P3857, DOI 10.1016/j.ejrad.2012.07.002; Smith BW, 2009, J GASTROEN HEPATOL, V24, pA307; Song MJ, 2012, J HEPATOL, V57, P1244, DOI 10.1016/j.jhep.2012.07.017; Sottani C, 2012, ANTICANCER RES, V32, P1769; Syha R, 2012, EUR J GASTROEN HEPAT, V24, P1325, DOI 10.1097/MEG.0b013e32835724bc; Takayasu K, 2012, JPN J CLIN ONCOL, V42, P247, DOI 10.1093/jjco/hys020; Tam KY, 2011, EUR J PHARM SCI, V44, P1, DOI 10.1016/j.ejps.2011.06.013; Taylor RR, 2007, EUR J PHARM SCI, V30, P7, DOI 10.1016/j.ejps.2006.09.002; van Malenstein H, 2011, ONKOLOGIE, V34, P368, DOI 10.1159/000329602; Varela M, 2007, J HEPATOL, V46, P474, DOI 10.1016/j.jhep.2006.10.020; Vogl TJ, 2011, AM J ROENTGENOL, V197, pW562, DOI 10.2214/AJR.10.4379; Walzer N, 2008, CURR OPIN GASTROEN, V24, P312, DOI 10.1097/MOG.0b013e3282fafef3; Weng LH, 2011, INT J PHARMACEUT, V409, P185, DOI 10.1016/j.ijpharm.2011.02.058; Wiggermann P, 2011, MED SCI MONITOR, V17, pCR189, DOI 10.12659/MSM.881714	53	23	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e102686	10.1371/journal.pone.0102686	http://dx.doi.org/10.1371/journal.pone.0102686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083860	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800011
J	Kannangara, TS; Bostrom, CA; Ratzlaff, A; Thompson, L; Cater, RM; Gil-Mohapel, J; Christie, BR				Kannangara, Timal S.; Bostrom, Crystal A.; Ratzlaff, Andrea; Thompson, Lee; Cater, Robyn M.; Gil-Mohapel, Joana; Christie, Brian R.			Deletion of the NMDA Receptor GluN2A Subunit Significantly Decreases Dendritic Growth in Maturing Dentate Granule Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; POSTNATAL HIPPOCAMPAL NEUROGENESIS; ADULT HIPPOCAMPUS; SPINE DENSITY; RAT-BRAIN; IN-VITRO; FUNCTIONAL-PROPERTIES; DEPENDENT REGULATION; CELL-PROLIFERATION; EPSILON-1 SUBUNIT	It is known that NMDA receptors can modulate adult hippocampal neurogenesis, but the contribution of specific regulatory GluN2 subunits has been difficult to determine. Here we demonstrate that mice lacking GluN2A (formerly NR2A) do not show altered cell proliferation or neuronal differentiation, but present significant changes in neuronal morphology in dentate granule cells. Specifically, GluN2A deletion significantly decreased total dendritic length and dendritic complexity in DG neurons located in the inner granular zone. Furthermore, the absence of GluN2A also resulted in a localized increase in spine density in the middle molecular layer, a region innervated by the medial perforant path. Interestingly, alterations in dendritic morphology and spine density were never seen in dentate granule cells located in the outer granular zone, a region that has been hypothesized to contain older, more mature, neurons. These results indicate that although the GluN2A subunit is not critical for the cell proliferation and differentiation stages of the neurogenic process, it does appear to play a role in establishing synaptic and dendritic morphology in maturing dentate granule cells localized in the inner granular zone.	[Kannangara, Timal S.; Bostrom, Crystal A.; Ratzlaff, Andrea; Thompson, Lee; Cater, Robyn M.; Gil-Mohapel, Joana; Christie, Brian R.] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Bostrom, Crystal A.; Ratzlaff, Andrea; Thompson, Lee; Cater, Robyn M.; Christie, Brian R.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Christie, Brian R.] Univ Victoria, Grad Program Neurosci, Victoria, BC, Canada; [Kannangara, Timal S.; Christie, Brian R.] Univ British Columbia, Dept Cellular & Physiol Sci, Victoria, BC, Canada; [Kannangara, Timal S.; Christie, Brian R.] Univ British Columbia, Grad Program Neurosci, Victoria, BC, Canada; [Kannangara, Timal S.; Christie, Brian R.] Univ British Columbia, Brain Res Ctr, Victoria, BC, Canada	University of Victoria; University of Victoria; University of Victoria; University of British Columbia; University of British Columbia; University of British Columbia	Christie, BR (corresponding author), Univ Victoria, Div Med Sci, Victoria, BC, Canada.	brain64@uvic.ca	Christie, Brian Ross/AAF-3766-2019; Gil-Mohapel, Joana/AAP-8871-2021	Christie, Brian Ross/0000-0002-6830-0160; Gil-Mohapel, Joana/0000-0003-4982-1662; Kannangara, Timal/0000-0003-1893-7961	Canadian Institutes for Health Research (CIHR MOP) [125888]; Fragile-X Research Foundation of Canada	Canadian Institutes for Health Research (CIHR MOP)(Canadian Institutes of Health Research (CIHR)); Fragile-X Research Foundation of Canada	This work was supported by the Canadian Institutes for Health Research (CIHR MOP 125888) and Fragile-X Research Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAMHAM CR, 1991, BRAIN RES, V567, P42, DOI 10.1016/0006-8993(91)91433-2; BREWER GJ, 1989, NEUROSCI LETT, V99, P268, DOI 10.1016/0304-3940(89)90458-8; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C; Cameron HA, 1998, NEUROSCIENCE, V82, P349; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Chancey JH, 2013, J NEUROSCI, V33, P6614, DOI 10.1523/JNEUROSCI.0781-13.2013; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ewald RC, 2008, J NEUROSCI, V28, P850, DOI 10.1523/JNEUROSCI.5078-07.2008; Ewald RC, 2009, FRONT NEUROSCI, P1; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Gao C, 2011, J NEUROSCI, V31, P8533, DOI 10.1523/JNEUROSCI.1300-11.2011; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Gil-Mohapel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075125; Gould E, 1997, J NEUROSCI, V17, P2492; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Henle F, 2012, N-S ARCH PHARMACOL, V385, P171, DOI 10.1007/s00210-011-0701-3; Hu M, 2009, EUR J PHARMACOL, V622, P37, DOI 10.1016/j.ejphar.2009.09.031; Ino H, 2000, MOL BRAIN RES, V78, P163, DOI 10.1016/S0169-328X(00)00092-9; Jiang W, 2004, BRAIN RES, V1020, P154, DOI 10.1016/j.brainres.2004.06.028; Kannangara TS, 2011, NEUROBIOL AGING, V32, P2279, DOI 10.1016/j.neurobiolaging.2009.12.025; Kannangara TS, 2009, HIPPOCAMPUS, V19, P889, DOI 10.1002/hipo.20514; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; KEMPERMANN G, 2006, ADULT NEUROGENESIS S; Kitamura T, 2003, NEUROSCI RES, V47, P55, DOI 10.1016/S0168-0102(03)00171-8; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lee LJ, 2005, J NEUROSCI, V25, P2304, DOI 10.1523/JNEUROSCI.4902-04.2005; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Nacher J, 2007, NEUROSCIENCE, V144, P855, DOI 10.1016/j.neuroscience.2006.10.021; Nacher J, 2006, HIPPOCAMPUS, V16, P267, DOI 10.1002/hipo.20160; Nacher J, 2003, NEUROBIOL AGING, V24, P273, DOI 10.1016/S0197-4580(02)00096-9; Nacher J, 2001, EUR J NEUROSCI, V13, P512, DOI 10.1046/j.0953-816x.2000.01424.x; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petrus DS, 2009, EUR J NEUROSCI, V29, P244, DOI 10.1111/j.1460-9568.2008.06579.x; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Redila VA, 2006, NEUROSCIENCE, V137, P1299, DOI 10.1016/j.neuroscience.2005.10.050; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Schmidt-Salzmann C, 2014, J PHYSIOL-LONDON, V592, P125, DOI 10.1113/jphysiol.2013.267203; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sepulveda FJ, 2010, J NEUROPHYSIOL; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SHOLL D A, 1956, Prog Neurobiol, P324; Simpson JM, 2011, NEUROBIOL DIS, V41, P249, DOI 10.1016/j.nbd.2010.09.012; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Tovar KR, 1999, J NEUROSCI, V19, P4180; Townsend M, 2003, P NATL ACAD SCI USA, V100, P1340, DOI 10.1073/pnas.0335786100; Tronel S, 2010, P NATL ACAD SCI USA, V107, P7963, DOI 10.1073/pnas.0914613107; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Ven TJV, 2005, J NEUROSCI, V25, P9488, DOI 10.1523/JNEIROSCI.2450-05.2005; Vlachos A, 2013, NEUROBIOL DIS, V59, P267, DOI 10.1016/j.nbd.2013.07.018; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Wenzel A, 1997, J NEUROCHEM, V68, P469; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	83	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103155	10.1371/journal.pone.0103155	http://dx.doi.org/10.1371/journal.pone.0103155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083703	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800019
J	Lee, EY; Kim, SS; Lee, JS; Kim, IJ; Song, SH; Cha, SK; Park, KS; Kang, JS; Chung, CH				Lee, Eun Young; Kim, Sang Soo; Lee, Ji-Sung; Kim, In Joo; Song, Sang Heon; Cha, Seung-Kuy; Park, Kyu-Sang; Kang, Jeong Suk; Chung, Choon Hee			Soluble alpha-Klotho as a Novel Biomarker in the Early Stage of Nephropathy in Patients with Type 2 Diabetes	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TRPV5 CHANNEL; MICE; EXCRETION; URINARY; PROTEIN	Objective: Although alpha-klotho is known as an anti-aging, antioxidant, and cardio-renal protective protein, the clinical implications of soluble alpha-klotho levels in patients with diabetes have not been evaluated. Therefore, this study evaluated whether plasma and urinary alpha-klotho levels are associated with albuminuria in kidney disease in diabetes. Research Design and Methods: A total of 147 patients with type 2 diabetes and 25 healthy control subjects were enrolled. The plasma and urine concentrations of alpha-klotho were analyzed by enzyme-linked immunosorbent assay. Results: Plasma alpha-klotho (572.4 pg/mL [95% CI, 541.9-604.6 pg/mL] vs. 476.9 pg/mL [95% CI, 416.9-545.5 pg/mL]) and urinary alpha-klotho levels (59.8 pg/mg creatinine [95% CI, 43.6-82.0 pg/mg creatinine] vs. 21.0 pg/mg creatinine [95% CI, 9.7-45.6 pg/mg creatinine]) were significantly higher in diabetic patients than non-diabetic controls. Among diabetic patients, plasma alpha-klotho concentration was inversely associated with albuminuria stages (normoalbuminuria, 612.6 pg/mL [95% CI, 568.9-659.6 pg/mL], microalbuminuria, 551.8 pg/mL [95% CI, 500.5-608.3 pg/mL], and macroalbuminuria, 505.7 pg/mL [95% CI, 439.7-581.7 pg/mL] (p for trend = 0.0081), while urinary alpha-klotho levels were remained constantly high with increasing urinary albumin excretion. Conclusions: Soluble alpha-klotho levels in plasma and urine may be novel and useful early markers of diabetic renal injury.	[Lee, Eun Young; Kang, Jeong Suk] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea; [Kim, Sang Soo; Kim, In Joo; Song, Sang Heon] Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea; [Lee, Ji-Sung] Soonchunhyang Univ, Med Ctr, Biostat Consulting Unit, Seoul, South Korea; [Cha, Seung-Kuy; Park, Kyu-Sang] Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju, South Korea; [Chung, Choon Hee] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea	Soonchunhyang University; Pusan National University; Pusan National University Hospital; Soonchunhyang University; Yonsei University; Yonsei University	Lee, EY (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea.	eylee@sch.ac.kr	Park, Kyong Soo/C-2265-2008; Lee, Eun Young/Q-6592-2019	Park, Kyong Soo/0000-0003-3597-342X; Lee, Eun Young/0000-0002-4513-9888; Chung, Choon/0000-0003-1144-7206; Park, Kyu-Sang/0000-0003-0322-9807	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012R1A1A2044121]; Soonchunhyang University [20130626]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; Soonchunhyang University	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2012R1A1A2044121) and the Soonchunhyang University Research Fund (No. 20130626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetunji OR, 2009, DIABETES RES CLIN PR, V85, P179, DOI 10.1016/j.diabres.2009.04.028; Akimoto T, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-155; Asai O, 2012, KIDNEY INT, V81, P539, DOI 10.1038/ki.2011.423; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Devaraj S, 2012, AM J CLIN PATHOL, V137, P479, DOI 10.1309/AJCPGPMAF7SFRBO4; Hu MC, 2012, NEPHROL DIAL TRANSPL, V27, P2650, DOI 10.1093/ndt/gfs160; Hu MC, 2012, ADV EXP MED BIOL, V728, P126, DOI 10.1007/978-1-4614-0887-1_9; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2012, NAT REV NEPHROL, V8, P423, DOI 10.1038/nrneph.2012.92; Kacso IM, 2012, CLIN BIOCHEM, V45, P1415, DOI 10.1016/j.clinbiochem.2012.07.098; Karalliedde J, 2013, CLIN J AM SOC NEPHRO, V8, P1899, DOI 10.2215/CJN.02700313; Kempe DS, 2009, PFLUG ARCH EUR J PHY, V458, P503, DOI 10.1007/s00424-009-0636-4; Kim HR, 2013, AM J KIDNEY DIS, V61, P899, DOI 10.1053/j.ajkd.2013.01.024; Kuro-O M, 2012, CURR OPIN NEPHROL HY, V21, P362, DOI 10.1097/MNH.0b013e32835422ad; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lang F, 2012, TRANSFUS MED HEMOTH, V39, P308, DOI 10.1159/000342534; Lim SC, 2013, J RENIN ANGIOTENSIN; Lin Y, 2013, ENDOCRINOLOGY, V154, P3855, DOI 10.1210/en.2013-1053; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262	23	46	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e102984	10.1371/journal.pone.0102984	http://dx.doi.org/10.1371/journal.pone.0102984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084095	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800013
J	Skeldon, AC; Dijk, DJ; Derks, G				Skeldon, Anne C.; Dijk, Derk-Jan; Derks, Gianne			Mathematical Models for Sleep-Wake Dynamics: Comparison of the Two-Process Model and a Mutual Inhibition Neuronal Model	PLOS ONE			English	Article							BORDER-COLLISION BIFURCATIONS; QUANTITATIVE MODEL; DURATION; METAANALYSIS; FATIGUE	Sleep is essential for the maintenance of the brain and the body, yet many features of sleep are poorly understood and mathematical models are an important tool for probing proposed biological mechanisms. The most well-known mathematical model of sleep regulation, the two-process model, models the sleep-wake cycle by two oscillators: a circadian oscillator and a homeostatic oscillator. An alternative, more recent, model considers the mutual inhibition of sleep promoting neurons and the ascending arousal system regulated by homeostatic and circadian processes. Here we show there are fundamental similarities between these two models. The implications are illustrated with two important sleep-wake phenomena. Firstly, we show that in the two-process model, transitions between different numbers of daily sleep episodes can be classified as grazing bifurcations. This provides the theoretical underpinning for numerical results showing that the sleep patterns of many mammals can be explained by the mutual inhibition model. Secondly, we show that when sleep deprivation disrupts the sleep-wake cycle, ostensibly different measures of sleepiness in the two models are closely related. The demonstration of the mathematical similarities of the two models is valuable because not only does it allow some features of the two-process model to be interpreted physiologically but it also means that knowledge gained from study of the two-process model can be used to inform understanding of the behaviour of the mutual inhibition model. This is important because the mutual inhibition model and its extensions are increasingly being used as a tool to understand a diverse range of sleep-wake phenomena such as the design of optimal shift-patterns, yet the values it uses for parameters associated with the circadian and homeostatic processes are very different from those that have been experimentally measured in the context of the two-process model.	[Skeldon, Anne C.; Derks, Gianne] Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England; [Dijk, Derk-Jan] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	University of Surrey; University of Surrey	Skeldon, AC (corresponding author), Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England.	a.skeldon@surrey.ac.uk		Skeldon, Anne/0000-0001-6387-4766; Derks, Gianne/0000-0002-2437-1813	Engineering and Physical Sciences Research Council [EP/I000992/1]; Royal Society of Medicine; EPSRC [EP/I000992/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society of Medicine(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partially supported by the Engineering and Physical Sciences Research Council (grant number EP/I000992/1) www.epsrc.ac.uk and by the Royal Society of Medicine www.rsm.ac.uk (DJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; AKERSTEDT T, 2014, J SLEEP RES, V23, P240; Archer SN, 2014, P NATL ACAD SCI USA, V111, pE682, DOI 10.1073/pnas.1316335111; Avinash D., 2005, SLEEP WAKE RES NETHE, V16, P39; Avrutin V, 2006, NONLINEARITY, V19, P1875, DOI 10.1088/0951-7715/19/8/007; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; Behn CGD, 2012, SIAM J APPL DYN SYST, V11, P212, DOI 10.1137/110832823; Behn CGD, 2010, J NEUROPHYSIOL, V103, P1937, DOI 10.1152/jn.00795.2009; Booth V, 2014, MATH BIOSCI, V250, P54, DOI 10.1016/j.mbs.2014.01.012; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Coombes S, 2000, PHYS REV E, V62, P4057, DOI 10.1103/PhysRevE.62.4057; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Fulcher BD, 2010, J THEOR BIOL, V264, P407, DOI 10.1016/j.jtbi.2010.02.028; Fulcher BD, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051920; Hagenauer MH, 2013, HORM BEHAV, V64, P270, DOI 10.1016/j.yhbeh.2013.01.013; Jain P, 2003, INT J BIFURCAT CHAOS, V13, P3341, DOI 10.1142/S0218127403008533; Jenni OG, 2005, SLEEP, V28, P1446, DOI 10.1093/sleep/28.11.1446; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Kronholm E, 2011, J SLEEP RES, V20, P288, DOI 10.1111/j.1365-2869.2010.00899.x; LoFaro T, 1996, MATH COMPUT MODEL, V24, P27, DOI 10.1016/0895-7177(96)00105-7; LoFaro T, 1999, J MATH BIOL, V38, P479, DOI 10.1007/s002850050157; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; McCauley P, 2009, J THEOR BIOL, V256, P227, DOI 10.1016/j.jtbi.2008.09.012; Moller-Levet CS, 2013, P NATL ACCADEMY SCI; Moore-Ede MC., 1984, MATH MODELS CIRCADIA; Nakao M, 1997, METHOD INFORM MED, V36, P282; Nakao M, 1998, PSYCHIAT CLIN NEUROS, V52, P131, DOI 10.1111/j.1440-1819.1998.tb00990.x; Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x; NUSSE HE, 1992, PHYSICA D, V57, P39, DOI 10.1016/0167-2789(92)90087-4; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Phillips AJK, 2010, J BIOL RHYTHM, V25, P217, DOI 10.1177/0748730410369208; Phillips AJK, 2008, J THEOR BIOL, V255, P413, DOI 10.1016/j.jtbi.2008.08.022; Phillips AJK, 2011, J BIOL RHYTHM, V26, P441, DOI 10.1177/0748730411414163; Phillips AJK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000826; Postnova S, 2009, J BIOL RHYTHM, V24, P523, DOI 10.1177/0748730409346655; Puckeridge M, 2011, J THEOR BIOL, V273, P44, DOI 10.1016/j.jtbi.2010.12.018; Rempe MJ, 2010, J MATH BIOL, V60, P615, DOI 10.1007/s00285-009-0276-5; Tamakawa Y, 2006, J NEUROPHYSIOL, V95, P2055, DOI 10.1152/jn.00575.2005	43	36	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103877	10.1371/journal.pone.0103877	http://dx.doi.org/10.1371/journal.pone.0103877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084361	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800096
J	Sughrue, T; Brody, JP				Sughrue, Trevor; Brody, James P.			Breast Tumor Laterality in the United States Depends Upon the Country of Birth, but Not Race	PLOS ONE			English	Article							CANCER LATERALITY; AGE-PERIOD; MORTALITY; COHORT; RISK; ORIGINS; DISEASE; RATES; SIZE	More breast cancers are diagnosed in the left breast than the right. The ratio (l/r) is called the laterality ratio. We analyzed 1.2 million cases of breast cancer diagnosed in the US between 1973 and 2010 and recorded by the Surveillance, Epidemiology, and End Results (SEER) program. We found that the laterality ratio depends upon the country of birth, but not race of the patient. We identified five countries of birth that had p-values larger than 0.995, while we expected to see less than 1. Those born in Japan (l/r = 1.14, p = 0.997), the Ryukyu Islands (l/r = 2.6, p = 0.998), Laos (l/r = 1.62, p = 0.9999) and Algeria (l/r = 2.1 p = 0.9959) had significantly larger laterality ratios compared to the overall SEER population (l/r = 1.04). Those born in Poland (l/r = 0.92, p = 0.997) had a laterality ratio significantly less than expected. We compared the laterality ratio calculated for tumors occurring in each quadrant of the breast for two immigrant populations: those born in Japan and those born in Poland. We found the only significant difference was in the laterality ratio of the upper outer quadrant. Thus, the birthplace effect appears to only occur in the upper outer quadrant of the breast. Finally, we found a small, but statistically significant, increase in the breast cancer laterality ratio with age, and decrease with birth year and year of diagnosis.	[Sughrue, Trevor; Brody, James P.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine	Brody, JP (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA.	jpbrody@uci.edu		Brody, James/0000-0002-7995-5197	University of California	University of California(University of California System)	This study was funded solely by internal University of California funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSK T, 1947, BRIT J CANCER, V1, P345, DOI 10.1038/bjc.1947.31; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; EKBOM A, 1994, CANCER CAUSE CONTROL, V5, P510, DOI 10.1007/BF01831378; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Harding C, 2012, CANCER-AM CANCER SOC, V118, P1371, DOI 10.1002/cncr.26376; HARTVEIT F, 1983, CLIN ONCOL, V9, P135; Hilakivi-Clarke L, 2006, TRENDS ENDOCRIN MET, V17, P340, DOI 10.1016/j.tem.2006.09.002; Holford T R, 1992, Stat Methods Med Res, V1, P317, DOI 10.1177/096228029200100306; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; ING R, 1977, LANCET, V2, P124; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Lagiou P, 2008, PLOS MED, V5, P1306, DOI 10.1371/journal.pmed.0050194; LOUGHRY CW, 1989, ANN PLAS SURG, V22, P380, DOI 10.1097/00000637-198905000-00002; Michels KB, 1996, LANCET, V348, P1542, DOI 10.1016/S0140-6736(96)03102-9; National Cancer Institute, 2013, SURV EP END RES SEER; Perkins CI, 2004, CANCER CAUSE CONTROL, V15, P637, DOI 10.1023/B:CACO.0000036171.44162.5f; Roychoudhuri R, 2006, CANCER CAUSE CONTROL, V17, P655, DOI 10.1007/s10552-005-0615-9; RUTQVIST LE, 1990, BRIT J CANCER, V61, P866, DOI 10.1038/bjc.1990.193; Silva ID, 2008, PLOS MED, V5, P1372, DOI 10.1371/journal.pmed.0050193; Soto-Ortiz L, 2012, THEORY CANC AGE SPEC; TRICHOPOULOS D, 1992, EPIDEMIOLOGY, V3, P523, DOI 10.1097/00001648-199211000-00011; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; Trichopoulos D, 1990, Epidemiology, V1, P95; Tu YK, 2012, EPIDEMIOLOGY, V23, P583, DOI 10.1097/EDE.0b013e31824d57a9; Weiss HA, 1996, CANCER CAUSE CONTROL, V7, P539, DOI 10.1007/BF00051887	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103313	10.1371/journal.pone.0103313	http://dx.doi.org/10.1371/journal.pone.0103313			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083708	Green Published, gold			2022-12-27	WOS:000339819800029
J	Voros, A; Simm, R; Slamti, L; Mckay, MJ; Hegna, IK; Nielsen-LeRoux, C; Hassan, KA; Paulsen, IT; Lereclus, D; Okstad, OA; Molloy, MP; Kolsto, AB				Voros, Aniko; Simm, Roger; Slamti, Leyla; Mckay, Matthew J.; Hegna, Ida K.; Nielsen-LeRoux, Christina; Hassan, Karl A.; Paulsen, Ian T.; Lereclus, Didier; Okstad, Ole Andreas; Molloy, Mark P.; Kolsto, Anne-Brit			SecDF as Part of the Sec-Translocase Facilitates Efficient Secretion of Bacillus cereus Toxins and Cell Wall-Associated Proteins	PLOS ONE			English	Article							PLCR VIRULENCE REGULON; HEMOLYSIN BL; EFFLUX PUMP; COMPREHENSIVE ANALYSIS; MULTIDRUG-RESISTANCE; ENTEROTOXIN COMPLEX; GENE-EXPRESSION; EXPORT; THURINGIENSIS; SUBTILIS	The aim of this study was to explore the role of SecDF in protein secretion in Bacillus cereus ATCC 14579 by in-depth characterization of a markerless secDF knock out mutant. Deletion of secDF resulted in pleiotropic effects characterized by a moderately slower growth rate, aberrant cell morphology, enhanced susceptibility to xenobiotics, reduced virulence and motility. Most toxins, including food poisoning-associated enterotoxins Nhe, Hbl, and cytotoxin K, as well as phospholipase C were less abundant in the secretome of the Delta secDF mutant as determined by label-free mass spectrometry. Global transcriptome studies revealed profound transcriptional changes upon deletion of secDF indicating cell envelope stress. Interestingly, the addition of glucose enhanced the described phenotypes. This study shows that SecDF is an important part of the Sec-translocase mediating efficient secretion of virulence factors in the Gram-positive opportunistic pathogen B. cereus, and further supports the notion that B. cereus enterotoxins are secreted by the Sec-system.	[Voros, Aniko; Simm, Roger; Hegna, Ida K.; Okstad, Ole Andreas; Kolsto, Anne-Brit] Univ Oslo, Sch Pharm, Dept Pharma Biosci, Lab Microbial Dynam LaMDa, N-0514 Oslo, Norway; [Mckay, Matthew J.; Molloy, Mark P.] Macquarie Univ, APAF, Sydney, NSW 2109, Australia; [Slamti, Leyla; Lereclus, Didier] UMR1319 Micalis, INRA, Guyancourt, France; [Lereclus, Didier] UMR Micalis, AgroParistech, Jouy En Josas, France; [Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia	University of Oslo; Macquarie University; INRAE; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Macquarie University	Kolsto, AB (corresponding author), Univ Oslo, Sch Pharm, Dept Pharma Biosci, Lab Microbial Dynam LaMDa, N-0514 Oslo, Norway.	a.b.kolsto@farmasi.uio.no	Okstad, Ole Andreas/ABE-4202-2020; Nielsen-Leroux, Christina/GRS-3334-2022; Lereclus, Didier/AAD-8293-2019; Simm, Roger/AAN-8965-2020; Hassan, Karl/B-2802-2013; Paulsen, Ian/K-3832-2012	Simm, Roger/0000-0001-5187-2456; McKay, Matthew/0000-0002-3430-2467; Lereclus, Didier/0000-0001-9047-9104; Hassan, Karl/0000-0003-2031-9679; Paulsen, Ian/0000-0001-9015-9418; Molloy, Mark/0000-0003-4679-5868; Okstad, Ole Andreas/0000-0001-9351-8535	Norwegian Research Council (FUGE II); EU [IRSES-GA-2009_247634]	Norwegian Research Council (FUGE II); EU(European Commission)	The work was funded by The Norwegian Research Council (FUGE II) and EU grant IRSES-GA-2009_247634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebusuyi AA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-252; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Aubry A, 2012, INFECT IMMUN, V80, P3521, DOI 10.1128/IAI.00224-12; Bazzini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018902; BEECHER DJ, 1995, INFECT IMMUN, V63, P4423, DOI 10.1128/IAI.63.11.4423-4428.1995; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Bolhuis A, 1998, J BIOL CHEM, V273, P21217, DOI 10.1074/jbc.273.33.21217; Bouillaut L, 2005, APPL ENVIRON MICROB, V71, P8903, DOI 10.1128/AEM.71.12.8903-8910.2005; Burg-Golani T, 2013, J BACTERIOL, V195, P5262, DOI 10.1128/JB.00697-13; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Clair G, 2010, MOL CELL PROTEOMICS, V9, P1486, DOI 10.1074/mcp.M000027-MCP201; Daniels C, 2009, CLIN MICROBIOL INFEC, V15, P32, DOI 10.1111/j.1469-0691.2008.02693.x; DeLisa MP, 2004, J BACTERIOL, V186, P366, DOI 10.1128/JB.186.2.366-373.2004; Dietrich R, 1999, APPL ENVIRON MICROB, V65, P4470; Dietrich R, 2005, APPL ENVIRON MICROB, V71, P8214, DOI 10.1128/AEM.71.12.8214-8220.2005; Fagerlund A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-304; Fedhila S, 2010, J INVERTEBR PATHOL, V103, P24, DOI 10.1016/j.jip.2009.09.005; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; GARDEL C, 1987, J BACTERIOL, V169, P1286, DOI 10.1128/jb.169.3.1286-1290.1987; Ghelardi E, 2002, J BACTERIOL, V184, P6424, DOI 10.1128/JB.184.23.6424-6433.2002; Ghelardi E, 2007, APPL ENVIRON MICROB, V73, P4089, DOI 10.1128/AEM.02345-06; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Gohar M, 2005, PROTEOMICS, V5, P3696, DOI 10.1002/pmic.200401225; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Gominet M, 2001, MOL MICROBIOL, V40, P963, DOI 10.1046/j.1365-2958.2001.02440.x; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Grenha R, 2013, P NATL ACAD SCI USA, V110, P1047, DOI 10.1073/pnas.1213770110; Guillemet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055085; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Hansmeier N, 2006, PROTEOMICS, V6, P2465, DOI 10.1002/pmic.200500360; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; Hecker M, 1998, MOL MICROBIOL, V29, P1129, DOI 10.1046/j.1365-2958.1998.00977.x; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Ho TD, 2012, CURR OPIN MICROBIOL, V15, P182, DOI 10.1016/j.mib.2012.01.001; ISOBE M, 1995, BIOORG MED CHEM LETT, V5, P2855, DOI 10.1016/0960-894X(95)00503-L; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Kaakoush NO, 2013, HELICOBACTER, V18, P316, DOI 10.1111/hel.12045; Kaakoush NO, 2010, FEBS J, V277, P1606, DOI 10.1111/j.1742-4658.2010.07587.x; Kesel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053457; Kinsinger RF, 2003, J BACTERIOL, V185, P5627, DOI 10.1128/JB.185.18.5627-5631.2003; KLEEREBEZEM M, 1993, MOL MICROBIOL, V7, P947, DOI 10.1111/j.1365-2958.1993.tb01186.x; Knyazev DG, 2013, J BIOL CHEM, V288, P17941, DOI 10.1074/jbc.M113.477893; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; LAVALLIE ER, 1989, J BACTERIOL, V171, P3085, DOI 10.1128/jb.171.6.3085-3094.1989; Li H, 2011, MOL MICROBIOL, V80, P886, DOI 10.1111/j.1365-2958.2011.07557.x; Lippolis R, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-28; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; Lund T, 1996, FEMS MICROBIOL LETT, V141, P151, DOI 10.1016/0378-1097(96)00208-X; Mckay MJ, 2007, PROTEOM CLIN APPL, V1, P1570, DOI 10.1002/prca.200700305; Meneses N, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-51; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Milani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050323; Minagawa S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-70; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Nelson SS, 2006, J BACTERIOL, V188, P348, DOI 10.1128/JB.188.1.348-351.2006; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Niu C, 2005, J MICROBIOL METH, V62, P129, DOI 10.1016/j.mimet.2005.01.013; Nouwen N, 2005, J BACTERIOL, V187, P6852, DOI 10.1128/JB.187.19.6852-6855.2005; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Provenano M, 2007, ADV EXP MED BIOL, V593, P66; Quiblier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063513; Quiblier C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-72; Raddadi N, 2005, J APPL MICROBIOL, V99, P1070, DOI 10.1111/j.1365-2672.2005.02713.x; Ramarao N, 2012, JOVE-J VIS EXP, DOI 10.3791/4392; Ravagnani A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-39; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; Salvetti S, 2011, APPL ENV MICROBIOL; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Shah IM, 2010, MOL MICROBIOL, V75, P1232, DOI 10.1111/j.1365-2958.2010.07046.x; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; STARK MJR, 1987, GENE, V51, P255, DOI 10.1016/0378-1119(87)90314-3; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Thay B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054661; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; van der Voort M, 2009, J APPL MICROBIOL, V107, P795, DOI 10.1111/j.1365-2672.2009.04252.x; van Schaik W, 2004, J BACTERIOL, V186, P4100, DOI 10.1128/JB.186.13.4100-4109.2004; van Schaik W, 2004, J BACTERIOL, V186, P316, DOI 10.1128/JB.186.2.316-325.2004; van Schaik W, 2007, J BACTERIOL, V189, P4384, DOI 10.1128/JB.00313-07; Verheust C, 2005, J BACTERIOL, V187, P1966, DOI 10.1128/JB.187.6.1966-1973.2005; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Voros A, 2013, MICROBIOLOGY; Watt SA, 2005, PROTEOMICS, V5, P153, DOI 10.1002/pmic.200400905; Webber MA, 2001, ANTIMICROB AGENTS CH, V45, P1550, DOI 10.1128/AAC.45.5.1550-1552.2001; Wolf D, 2010, J BACTERIOL, V192, P4680, DOI 10.1128/JB.00543-10; Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	101	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103326	10.1371/journal.pone.0103326	http://dx.doi.org/10.1371/journal.pone.0103326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083861	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800031
J	Zhang, XT; Wang, Y; Hu, WJ; Li, DY; Zhou, ZM; Pan, DF; Wu, WL; Xu, TD				Zhang, Xiaotian; Wang, Yi; Hu, Wenjing; Li, Dongye; Zhou, Zhongmin; Pan, Defeng; Wu, Wanling; Xu, Tongda			Interleukin-1/Toll-Like Receptor-Induced Nuclear Factor Kappa B Signaling Participates in Intima Hyperplasia after Carotid Artery Balloon Injury in Goto-Kakizaki Rats: A Potential Target Therapy Pathway	PLOS ONE			English	Article							IN-STENT RESTENOSIS; DIABETES-MELLITUS; DOWN-REGULATION; BETA-CELL; CORONARY; ANGIOPLASTY; EXPRESSION; IMPLANTATION; GLUCOKINASE; ACTIVATION	The value of restenosis after percutaneous coronary intervention (PCI) is recognized worldwide, especially for diabetic patients. Interleukin-1/Toll-like receptor (IL-1/TLR) signaling is involved in innate and adaptive immune responses, but whether and how the IL-1/TLR-induced nuclear factor kappa B (NF kappa B) pathway plays key roles in intimal formation is unclear. The underlying mechanism of intima hyperplasia was investigated with a model of carotid balloon injury in Goto-Kakizaki (GK) and Wistar rats and with lipopolysaccharide-stimulated macrophages. Elastic-van Gieson staining showed the medial area peakedon Day 3 post-injury and decreased by Day 7 post-injury in both GK and Wistar rats. The N/M at Day 7 in GK rats was significantly higher than in Wistar rats (p<0.001). The percent of 5-ethynyl-29-deoxyuridine (EdU) staining-positive cells on Day 3 post-injury was greater than seen on Day 7 post-injury in GK and Wistar rats. The percent of EdU-positive cells on Days 3 and 7 post-injury in Wistar rats was less than that found in GK rats (p<0.01; p<0.05). NF kappa Bp65 immunostaining had increased by Day 7 post-injury. Agilent Whole Genome Oligo Microarray verified that the IL-1/TLR-induced NF kappa B pathway was activated by carotid balloon injury. TLR4, IL-1 receptor associated kinase, inhibitors a of NF kappa B, human antigen R, c-Myc (Proto-Oncogene Proteins), EGF-like module-containing mucin-like hormone receptor-like 1 and Interleukin-6 were up-regulated or down-regulated according to immunochemistry, quantitative real-time PCR, Western blotting and Enzyme linked immunosorbent assay. Overall, we conclude that the IL-1/TLR-induced NF kappa B pathway participates in the intimal hyperplasia after carotid injury in GK and Wistar rats and that GK rats respond more intensely to the inflammation than Wistar rats.	[Zhang, Xiaotian; Wang, Yi; Hu, Wenjing; Li, Dongye] Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China; [Zhou, Zhongmin] Northeast Ohio Med Univ, Aultman Hosp, Dept Internal Med, Canton, OH USA; [Zhou, Zhongmin] Northeast Ohio Med Univ, Canton Med Educ Fdn, Canton, OH USA; [Pan, Defeng; Wu, Wanling; Xu, Tongda] Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Northeast Ohio Medical University (NEOMED); Northeast Ohio Medical University (NEOMED); Xuzhou Medical University	Li, DY (corresponding author), Xuzhou Med Coll, Inst Cardiovasc Dis Res, Xuzhou, Jiangsu, Peoples R China.; Xu, TD (corresponding author), Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China.	dongyelichina@gmail.com; xtd3004@aliyun.com	李, 东/GYA-4703-2022; 李, 东野/AAY-6410-2020	Xu, Tongda/0000-0002-5594-3992	Academic Degrees Committee; Department of Education of Jiangsu province [CXLX11-0732]	Academic Degrees Committee; Department of Education of Jiangsu province	This work was supported by the Academic Degrees Committee and the Department of Education of Jiangsu province (grant number CXLX11-0732). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MR, 1999, CIRC RES, V85, P524, DOI 10.1161/01.RES.85.6.524; Bu DX, 2005, FASEB J, V19, P1293, DOI 10.1096/fj.04-2645fje; Christopher T, 2012, PLOS GENET, V8; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; Fraczek J, 2008, J BIOL CHEM, V283, P31697, DOI 10.1074/jbc.M804779200; Frese T, 2007, HORM METAB RES, V39, P567, DOI 10.1055/s-2007-984471; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Goto Y, 1988, Adv Exp Med Biol, V246, P29; Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6; Guo JS, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-150; Hatao F, 2004, J LEUKOCYTE BIOL, V76, P904, DOI 10.1189/jlb.0504277; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hurst RT, 2003, ANN INTERN MED, V139, P824, DOI 10.7326/0003-4819-139-10-200311180-00010; Jensen LO, 2008, EUR HEART J, V29, P2733, DOI 10.1093/eurheartj/ehn434; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kong JY, 2013, INFLAMM RES, V62, P173, DOI 10.1007/s00011-012-0568-x; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Landry DB, 1997, AM J PATHOL, V151, P1085; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Li Y, 2011, J MOL MED, V89, P545, DOI 10.1007/s00109-011-0729-3; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2630, DOI 10.1161/01.ATV.0000247259.01257.b3; Liu Xiaoshun, 2004, Expert Rev Cardiovasc Ther, V2, P653, DOI 10.1586/14779072.2.5.653; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Ma XD, 2010, INT J CLIN EXP MED, V3, P192; Majid Abdul, 2009, Acta Med Indones, V41, P41; Martin DM, 2011, MED ENG PHYS, V33, P148, DOI 10.1016/j.medengphy.2010.10.009; Marz W, 2004, CIRCULATION, V109, P2844, DOI 10.1161/01.CIR.0000129306.44085.C4; Murthy SN, 2010, DIABETES, V59, P3240, DOI 10.2337/db09-1761; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Ohtani K, 2004, GENE THER, V11, P1273, DOI 10.1038/sj.gt.3302288; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Ozer N, 2008, HEART VESSELS, V23, P75, DOI 10.1007/s00380-007-1020-y; Portha B, 2005, DIABETES-METAB RES, V21, P495, DOI 10.1002/dmrr.566; Rosano GMC, 2006, AM J CARDIOL, V98, p14J, DOI 10.1016/j.amjcard.2006.07.004; Schachinger V, 2006, CLIN RES CARDIOL, V95, P18, DOI 10.1007/s00392-006-1115-y; Schillinger M, 2001, J ENDOVASC THER, V8, P477, DOI 10.1583/1545-1550(2001)008<0477:RAPTAI>2.0.CO;2; Schillinger M, 2005, VASC HEALTH RISK MAN, V1, P73, DOI 10.2147/vhrm.1.1.73.58932; Soran O, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-012-0323-5; Stella, 2002, CELL, V109, P21; Suganamia Ta, 2007, BIOCHEM BIOPH RES CO, V354, P5; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; Yu CM, 2012, INT J CARDIOL; Zhang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012323; Zhou ZM, 2002, ATHEROSCLEROSIS, V161, P153, DOI 10.1016/S0021-9150(01)00640-2	47	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103794	10.1371/journal.pone.0103794	http://dx.doi.org/10.1371/journal.pone.0103794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083789	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800080
J	Corniani, N; Velini, ED; Silva, FML; Nanayakkara, NPD; Witschel, M; Dayan, FE				Corniani, Natalia; Velini, Edivaldo D.; Silva, Ferdinando M. L.; Nanayakkara, N. P. Dhammika; Witschel, Matthias; Dayan, Franck E.			Novel Bioassay for the Discovery of Inhibitors of the 2-C-Methyl-D-erythritol 4-Phosphate (MEP) and Terpenoid Pathways Leading to Carotenoid Biosynthesis	PLOS ONE			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE; MEVALONATE ISOPRENOID BIOSYNTHESIS; NONMEVALONATE PATHWAY; STATISTICAL PARAMETER; PHOSPHATE-PATHWAY; HIGHER-PLANTS; CLOMAZONE; HERBICIDES; ANTIMALARIAL; METABOLISM	The 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway leads to the synthesis of isopentenyl diphosphate in plastids. It is a major branch point providing precursors for the synthesis of carotenoids, tocopherols, plastoquinone and the phytyl chain of chlorophylls, as well as the hormones abscisic acid and gibberellins. Consequently, disruption of this pathway is harmful to plants. We developed an in vivo bioassay that can measure the carbon flow through the carotenoid pathway. Leaf cuttings are incubated in the presence of a phytoene desaturase inhibitor to induce phytoene accumulation. Any compound reducing the level of phytoene accumulation is likely to interfere with either one of the steps in the MEP pathway or the synthesis of geranylgeranyl diphosphate. This concept was tested with known inhibitors of steps of the MEP pathway. The specificity of this in vivo bioassay was also verified by testing representative herbicides known to target processes outside of the MEP and carotenoid pathways. This assay enables the rapid screen of new inhibitors of enzymes preceding the synthesis of phytoene, though there are some limitations related to the non-specific effect of some inhibitors on this assay.	[Corniani, Natalia; Velini, Edivaldo D.; Silva, Ferdinando M. L.] Sao Paulo State Univ, Fac Agron Sci, Botucatu, SP, Brazil; [Nanayakkara, N. P. Dhammika] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA; [Witschel, Matthias] BASF SE, GVA HC B009, Ludwigshafen, Germany; [Dayan, Franck E.] USDA ARS, Nat Prod Utilizat Res Unit, University, MS 38677 USA	Universidade Estadual Paulista; University of Mississippi; BASF; United States Department of Agriculture (USDA)	Dayan, FE (corresponding author), USDA ARS, Nat Prod Utilizat Res Unit, University, MS 38677 USA.	franck.dayan@ars.usda.gov	Dayan, Franck E/AAB-6565-2022; Dayan, Franck/A-7592-2009	Dayan, Franck E/0000-0001-6964-2499; Dayan, Franck/0000-0001-6964-2499; Corniani, Natalia/0000-0001-7342-5171	Brazilian Agency CAPES (Coordination for the Improvement of Higher Education Personnel) [BEX 0226/12-2]	Brazilian Agency CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Grant# BEX 0226/12-2 from the Brazilian Agency CAPES (Coordination for the Improvement of Higher Education Personnel) that supported the research of N. Corniani in a USDA laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RL, 1990, WEED TECHNOL, V4, P606, DOI 10.1017/S0890037X00026063; Baerg RJ, 1996, PESTIC BIOCHEM PHYS, V55, P10, DOI 10.1006/pest.1996.0030; BARTLEY GE, 1995, PLANT CELL, V7, P1027, DOI 10.1105/tpc.7.7.1027; Botella-Pavia P, 2004, PLANT J, V40, P188, DOI 10.1111/j.1365-313X.2004.02198.x; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; CHANG JH, 1987, ACS SYM SER, V355, P10; Chang WC, 2013, CURR OPIN CHEM BIOL, V17, P571, DOI 10.1016/j.cbpa.2013.06.020; Cordoba E, 2011, J EXP BOT, V62, P2023, DOI 10.1093/jxb/erq393; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; CROTEAU R, 1992, PLANT PHYSIOL, V98, P1515, DOI 10.1104/pp.98.4.1515; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Culpepper AS, 2001, WEED SCI, V49, P613, DOI 10.1614/0043-1745(2001)049[0613:EOIOCA]2.0.CO;2; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Dayan FE, 2003, ENCY AGROCHEMICALS, V2, P744; Dayan FE, 2014, WEED SCI, DOI [10.1614/WS-D-1613-00063.00061, DOI 10.1614/WS-D-1613-00063.00061]; Dayan FE, 2010, WEED SCI, V58, P340, DOI 10.1614/WS-09-092.1; De Mendiburu F., 2014, **DATA OBJECT**; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; DENO NC, 1947, J AM CHEM SOC, V69, P2233, DOI 10.1021/ja01201a505; Duke SO, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P23; DUKE SO, 1985, WEED SCI, V33, P786, DOI 10.1017/S0043174500083351; DUKE SO, 1991, WEED SCI, V39, P339, DOI 10.1017/S0043174500073033; Duke SO, 2012, PEST MANAG SCI, V68, P505, DOI 10.1002/ps.2333; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; ELNAGGAR SF, 1992, J AGR FOOD CHEM, V40, P880, DOI 10.1021/jf00017a036; Ershov YV, 2007, APPL BIOCHEM MICRO+, V43, P115, DOI 10.1134/S0003683807020019; Fellermeier M, 1999, TETRAHEDRON LETT, V40, P2743, DOI 10.1016/S0040-4039(99)00361-5; Fellermeier M, 2001, EUR J BIOCHEM, V268, P6302, DOI 10.1046/j.0014-2956.2001.02585.x; Ferhatoglu Y, 2006, PESTIC BIOCHEM PHYS, V85, P7, DOI 10.1016/j.pestbp.2005.10.002; Ferhatoglu Y, 2005, PESTIC BIOCHEM PHYS, V81, P59, DOI 10.1016/j.pestbp.2004.09.002; Ge X, 2012, PESTIC BIOCHEM PHYS, V104, P187, DOI 10.1016/j.pestbp.2012.07.009; Ge X, 2011, PEST MANAG SCI, V67, P1215, DOI 10.1002/ps.2169; Gong YF, 2006, PLANTA MED, V72, P329, DOI 10.1055/s-2005-916234; Hale I, 2012, MEDCHEMCOMM, V3, P418, DOI 10.1039/c2md00298a; Hayashi D, 2013, CHEM COMMUN, V49, P5535, DOI 10.1039/c3cc40758f; Hess FD, 2000, WEED SCI, V48, P160, DOI 10.1614/0043-1745(2000)048[0160:LDHAO]2.0.CO;2; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Koyama T., 1999, COMPREHENSIVE NATURA, V2, P69, DOI DOI 10.1016/B978-0-08-091283-7.00037-0; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lee DL, 1997, WEED SCI, V45, P601; Lichtenthaler HK, 2010, ADV PHOTOSYNTH RESP, V31, P95; Lichtenthaler HK, 2000, Z NATURFORSCH C, V55, P305; Lichtenthaler HK, 2000, BIOCHEM SOC T, V28, P785, DOI 10.1042/BST0280785; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lichtenthaler HK, 1997, FEBS LETT, V400, P271, DOI 10.1016/S0014-5793(96)01404-4; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Malkin R., 2000, BIOCH MOL BIOL PLANT, P568; Mueller C, 2000, BIOCHEM SOC T, V28, P792, DOI 10.1042/BST0280792; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Ritz C, 2005, J STAT SOFTW, V12, P1; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rohdich F, 2000, P NATL ACAD SCI USA, V97, P6451, DOI 10.1073/pnas.97.12.6451; Rohmer M, 1998, PROG DRUG RES, V50, P135; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Rohmer Michel, 2004, Curr Opin Investig Drugs, V5, P154; Sandmann G., 1989, Target sites of herbicide action., P25; Schuhr Christoph A., 2003, Phytochemistry Reviews, V2, P3, DOI 10.1023/B:PHYT.0000004180.25066.62; Schwender J, 1997, FEBS LETT, V414, P129, DOI 10.1016/S0014-5793(97)01002-8; SEEFELDT SS, 1995, WEED TECHNOL, V9, P218, DOI 10.1017/S0890037X00023253; Service RF, 2007, SCIENCE, V316, P1114, DOI 10.1126/science.316.5828.1114; Service RF, 2013, SCIENCE, V341, P1329, DOI 10.1126/science.341.6152.1329; Singh N, 2007, CURR PHARM DESIGN, V13, P1161, DOI 10.2174/138161207780618939; Sprecher SL, 1998, J AQUAT PLANT MANAGE, V36, P111; Sui YX, 2007, J BIOMOL SCREEN, V12, P229, DOI 10.1177/1087057106296498; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; WEIMER MR, 1991, WEED SCI, V39, P529, DOI 10.1017/S0043174500088317; WEIMER MR, 1992, PLANT PHYSIOL, V98, P427, DOI 10.1104/pp.98.2.427; Weinberg T, 2003, WEED SCI, V51, P663, DOI 10.1614/P2002-106; Withers ST, 2007, APPL MICROBIOL BIOT, V73, P980, DOI 10.1007/s00253-006-0593-1; Witschel M, 2013, PEST MANAG SCI, V69, P559, DOI 10.1002/ps.3479; Yasuor H, 2010, PLANT PHYSIOL, V153, P319, DOI 10.1104/pp.110.153296; Zamponi GW, 2003, J MED CHEM, V46, P87, DOI 10.1021/jm020354w; Zeidler J, 2000, BIOCHEM SOC T, V28, P796, DOI 10.1042/BST0280796; Zeidler J, 1998, Z NATURFORSCH C, V53, P980; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao LS, 2013, ANNU REV BIOCHEM, V82, P497, DOI 10.1146/annurev-biochem-052010-100934	77	10	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103704	10.1371/journal.pone.0103704	http://dx.doi.org/10.1371/journal.pone.0103704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077957	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800066
J	de Andrade, L; Lynch, C; Carvalho, E; Rodrigues, CG; Vissoci, JRN; Passos, GF; Pietrobon, R; Nihei, OK; Carvalho, MDD				de Andrade, Luciano; Lynch, Catherine; Carvalho, Elias; Rodrigues, Clarissa Garcia; Nickenig Vissoci, Joao Ricardo; Passos, Guttenberg Ferreira; Pietrobon, Ricardo; Nihei, Oscar Kenji; de Barros Carvalho, Maria Dalva			System Dynamics Modeling in the Evaluation of Delays of Care in ST-Segment Elevation Myocardial Infarction Patients within a Tiered Health System	PLOS ONE			English	Article							QUALITATIVE COMPARATIVE-ANALYSIS; DOOR-OUT TIME; INTERHOSPITAL TRANSFER; PRIMARY ANGIOPLASTY; REPERFUSION; CARDIOLOGISTS; ASSOCIATION; GUIDELINES; MANAGEMENT; MORTALITY	Background: Mortality rates amongst ST segment elevation myocardial infarction (STEMI) patients remain high, especially in developing countries. The aim of this study was to evaluate the factors related with delays in the treatment of STEMI patients to support a strategic plan toward structural and personnel modifications in a primary hospital aligning its process with international guidelines. Methods and Findings: The study was conducted in a primary hospital localized in Foz do Iguacu, Brazil. We utilized a qualitative and quantitative integrated analysis including on-site observations, interviews, medical records analysis, Qualitative Comparative Analysis (QCA) and System Dynamics Modeling (SD). Main cause of delays were categorized into three themes: a) professional, b) equipment and c) transportation logistics. QCA analysis confirmed four main stages of delay to STEMI patient's care in relation to the 'Door-in-Door-out' time at the primary hospital. These stages and their average delays in minutes were: a) First Medical Contact (From Door-In to the first contact with the nurse and/or physician): 7 minutes; b) Electrocardiogram acquisition and review by a physician: 28 minutes; c) ECG transmission and Percutaneous Coronary Intervention Center team feedback time: 76 minutes; and d) Patient's Transfer Waiting Time: 78 minutes. SD baseline model confirmed the system's behavior with all occurring delays and the need of improvements. Moreover, after model validation and sensitivity analysis, results suggested that an overall improvement of 40% to 50% in each of these identified stages would reduce the delay. Conclusions: This evaluation suggests that investment in health personnel training, diminution of bureaucracy, and management of guidelines might lead to important improvements decreasing the delay of STEMI patients' care. In addition, this work provides evidence that SD modeling may highlight areas where health system managers can implement and evaluate the necessary changes in order to improve the process of care.	[de Andrade, Luciano; de Barros Carvalho, Maria Dalva] Univ Estadual Maringa, Dept Hlth Sci, Maringa, Parana, Brazil; [Lynch, Catherine] Duke Univ, Duke Global Hlth Inst, Dept Surg, Div Emergency Med, Durham, NC USA; [Carvalho, Elias] Univ Estadual Maringa, Maringa, Parana, Brazil; [Carvalho, Elias] Pontificia Univ Catolica PUC PR, Knowledge Discovery & Machine Learning Grp, Grad Program Informat PPGIA, Curitiba, Parana, Brazil; [de Andrade, Luciano; Nihei, Oscar Kenji] State Univ West Parana, Dept Nursing, Foz Do Iguacu, Parana, Brazil; [Rodrigues, Clarissa Garcia] Fundacao Univ Cardiol, Inst Cardiol Rio Grande do Sul, Porto Alegre, RS, Brazil; [Nickenig Vissoci, Joao Ricardo] Fac Inga, Dept Med, Maringa, Parana, Brazil; [Passos, Guttenberg Ferreira] Univ Brasilia, Dept Informat, Brasilia, DF, Brazil; [Pietrobon, Ricardo] Duke Univ Hlth Syst, Dept Surg, Durham, NC USA	Universidade Estadual de Maringa; Duke University; Universidade Estadual de Maringa; Universidade Estadual do Oeste do Parana; Fundacao Universitaria de Cardiologia; Centro Universitario Inga (UNINGA); Universidade de Brasilia; Duke University	Carvalho, MDD (corresponding author), Univ Estadual Maringa, Dept Hlth Sci, Maringa, Parana, Brazil.	kiracarva@gmail.com	Carvalho, Maria Dalva/AAK-8411-2021; Carvalho, Elias/J-7086-2012	Carvalho, Maria Dalva/0000-0002-1377-3331; Carvalho, Elias/0000-0002-2638-7202; Staton, Catherine/0000-0002-6468-2894	Science Without Borders Program, Brazilian Government	Science Without Borders Program, Brazilian Government	LA and JRNV were funded by the Science Without Borders Program, Brazilian Government (http://www.cienciasemfronteiras.gov.br/web/csf-eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre FV, 2008, CIRCULATION, V117, P1145, DOI 10.1161/CIRCULATIONAHA.107.728519; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Bardin L., 1977, ANAL OF CONTENT, P70; Beltrame RL, 2006, FORMACAO MED DEBATE; Brazil. Ministry of Health, 2011, RED URG EM LINH CUID; Carneiro JKR, 2005, REV BRAS CARDIOL INV, V13, P32; Clemmensen P, 2005, J ELECTROCARDIOL, V38, P194, DOI 10.1016/j.jelectrocard.2005.06.035; Cronqvist L., 2009, CONFIGURATIONAL COMP; de Andrade L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059363; De Luca G, 2008, ANN EMERG MED, V52, P665, DOI 10.1016/j.annemergmed.2008.08.033; Dusa A, 2010, QUAL QUANT, V44, P99, DOI 10.1007/s11135-008-9183-x; Feitosa-Filho GS, 2012, REV BRAS CLIN MED, V10, P91; Fiss PC, 2007, ACAD MANAGE REV, V32, P1180, DOI 10.5465/AMR.2007.26586092; Forrester J.W., 1969, URBAN DYNAMICS; Franco B, 2008, REV LAT-AM ENFERM, V16, P414, DOI 10.1590/S0104-11692008000300013; Frigotto G, 1996, NEW CULTURAL MAPS NE; GASKELL G., 2002, PESQUISA QUALITATIVA; Giuliani E, 2010, J EVAL CLIN PRACT, V16, P1071, DOI 10.1111/j.1365-2753.2009.01254.x; Goldberg RJ, 2002, AM J CARDIOL, V89, P791, DOI 10.1016/S0002-9149(02)02186-0; Herrin J, 2011, ARCH INTERN MED, V171, P1879, DOI 10.1001/archinternmed.2011.481; Hines J., 2005, MOL STRUCTURE BUILDI; Hug S, 2013, POLIT ANAL, V21, P252, DOI 10.1093/pan/mps061; Hutchison AW, 2009, CIRC-CARDIOVASC INTE, V2, P528, DOI 10.1161/CIRCINTERVENTIONS.109.892372; Jollis JG, 2012, CIRC-CARDIOVASC QUAL, V5, P423, DOI 10.1161/CIRCOUTCOMES.111.964668; Khan SA, 2007, STUD HEALTH TECHNOL, V129, P247; Khraim FM, 2009, PATIENT EDUC COUNS, V75, P155, DOI 10.1016/j.pec.2008.09.019; Lacerda A, 2012, REV MED RES, V14, P193; Larson David M, 2008, Curr Cardiol Rep, V10, P415, DOI 10.1007/s11886-008-0065-6; Lassen JF, 2013, NAT REV CARDIOL, V10, P41, DOI 10.1038/nrcardio.2012.156; Lino MM, 2008, REV ESC ENFERM USP, V42, P771, DOI 10.1590/S0080-62342008000400022; Loch A, 2013, POSTGRAD MED J, V89, P335, DOI 10.1136/postgradmedj-2012-131174; Mahmoud KD, 2013, EUR HEART J-ACUTE CA, V2, P166, DOI 10.1177/2048872613481449; Marcolino MS, 2013, ARQ BRAS CARDIOL, V100, P307, DOI 10.5935/abc.20130054; Marx A., 2011, METHODOLOGICAL INNOV, V6, P103, DOI [10.4256/mio.2010.0037, DOI 10.4256/MIO.2010.0037]; Miedema MD, 2011, CIRCULATION, V124, P1636, DOI 10.1161/CIRCULATIONAHA.111.033118; Minayo M. S., 1996, PESQUISA SOCIAL TEOR; Nielsen PH, 2010, CIRCULATION, V121, P1484, DOI 10.1161/CIRCULATIONAHA.109.873224; NVivo, 2012, QUAL DAT AN SOFTW VE; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Oliva R, 2003, EUR J OPER RES, V151, P552, DOI 10.1016/S0377-2217(02)00622-7; Park YH, 2012, J KOREAN MED SCI, V27, P864, DOI 10.3346/jkms.2012.27.8.864; Peacock WF, 2008, TEX HEART I J, V35, P152; Ragin C. C, 2008, REDESIGNING SOCIAL I; Ragin C.C., 1987, COMPUT METHOD BIOMEC; Rathore SS, 2006, J AM COLL CARDIOL, V47, P1346, DOI 10.1016/j.jacc.2005.11.053; Rihoux B, 2006, INT SOCIOL, V21, P679, DOI 10.1177/0268580906067836; Saltelli A., 2000, WILEY SERIES PROBABI; Seegmuller EF, 2008, CIENC CULT, V39, P9; Sejersten M, 2008, AM J CARDIOL, V101, P941, DOI 10.1016/j.amjcard.2007.11.038; Silverman D., 2006, INTERPRETING QUALITA, V3a; Soares JD, 2009, ARQ BRAS CARDIOL, V92, P430; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Sterman J, 2004, DYNAMICA, V10, P51; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Thiem A, 2013, R J, V5, P87; Thilo C, 2013, CLIN RES CARDIOL, V102, P905, DOI 10.1007/s00392-013-0608-8; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; VANDENBELT M, 2004, MEDIATED MODELING SY; Ventana Systems Inc, 2011, VENS DSS; Victor Suma M, 2012, Indian Heart J, V64, P582, DOI 10.1016/j.ihj.2012.09.007; Wang TY, 2011, JAMA-J AM MED ASSOC, V305, P2540, DOI 10.1001/jama.2011.862; World Health Organization (WHO), 2013, TOP 10 CAUS DEATH	63	13	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103577	10.1371/journal.pone.0103577	http://dx.doi.org/10.1371/journal.pone.0103577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079362	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800056
J	Hickey, C; Chelazzi, L; Theeuwes, J				Hickey, Clayton; Chelazzi, Leonardo; Theeuwes, Jan			Reward-Priming of Location in Visual Search	PLOS ONE			English	Article							POP-OUT; SELECTIVE ATTENTION; NEURAL BASIS; CAPTURE; STIMULI; DOPAMINE; TARGET	Existing visual search research has demonstrated that the receipt of reward will be beneficial for subsequent perceptual and attentional processing of features that have characterized targets, but detrimental for processing of features that have characterized irrelevant distractors. Here we report a similar effect of reward on location. Observers completed a visual search task in which they selected a target, ignored a salient distractor, and received random-magnitude reward for correct performance. Results show that when target selection garnered rewarding outcome attention is subsequently a.) primed to return to the target location, and b.) biased away from the location that was occupied by the salient, task-irrelevant distractor. These results suggest that in addition to priming features, reward acts to guide visual search by priming contextual locations of visual stimuli.	[Hickey, Clayton; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Hickey, Clayton] Univ Trento, Ctr Mind Brain Sci CIMeC, Trento, Trento, Italy; [Chelazzi, Leonardo] Univ Verona, Dept Neurol & Visual Sci, I-37100 Verona, Italy; [Chelazzi, Leonardo] Italian Inst Neurosci, Verona, Italy	Vrije Universiteit Amsterdam; University of Trento; University of Verona	Hickey, C (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	clayton.hickey@unitn.it	Theeuwes, Jan/ABF-3771-2020; Hickey, Clayton/ABA-6126-2021; Chelazzi, Leonardo/B-6084-2011	Hickey, Clayton/0000-0002-4162-5643; Chelazzi, Leonardo/0000-0001-8566-0611; Theeuwes, Jan/0000-0002-5849-7721	Netherlands Organization for Scientific Research (NWO) VENI [016-125-283]; European Research Council (ERC) [2012-AdG-323413]; Fondazione Cariverona	Netherlands Organization for Scientific Research (NWO) VENI(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC)); Fondazione Cariverona(Fondazione Cariverona)	This work was made possible by a Netherlands Organization for Scientific Research (NWO) VENI grant (016-125-283) to CH and a European Research Council (ERC) advanced grant (2012-AdG-323413) to JT. LC is supported by Fondazione Cariverona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BA, 2012, VIS COGN, V20, P647, DOI 10.1080/13506285.2012.679711; Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Arsenault JT, 2013, NEURON, V77, P1174, DOI 10.1016/j.neuron.2013.01.008; Atas A, 2014, PSYCHOL SCI, V25, P113, DOI 10.1177/0956797613499591; Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Buschschulte A, 2014, J COGNITIVE NEUROSCI, V26, P1049, DOI 10.1162/jocn_a_00539; Camara E, 2013, EXP BRAIN RES, V230, P291, DOI 10.1007/s00221-013-3654-6; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; Chelazzi L, 2013, VISION RES, V85, P58, DOI 10.1016/j.visres.2012.12.005; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Della Libera C, 2006, PSYCHOL SCI, V17, P222; Della Libera C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019460; Della Libera C, 2009, PSYCHOL SCI, V20, P778, DOI 10.1111/j.1467-9280.2009.02360.x; Geyer T, 2007, J EXP PSYCHOL HUMAN, V33, P788, DOI 10.1037/0096-1523.33.4.788; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hickey C, 2013, VISION RES, V92, P67, DOI 10.1016/j.visres.2013.09.008; Hickey C, 2012, CURR BIOL, V22, pR219, DOI 10.1016/j.cub.2012.02.007; Hickey C, 2011, VIS COGN, V19, P117, DOI 10.1080/13506285.2010.503946; Hickey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014087; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Hickey C, 2010, EXP BRAIN RES, V201, P789, DOI 10.1007/s00221-009-2094-9; Hickey C, 2009, J COGNITIVE NEUROSCI, V21, P760, DOI 10.1162/jocn.2009.21039; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Kristjansson A, 2007, CEREB CORTEX, V17, P1612, DOI 10.1093/cercor/bhl072; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P1229, DOI 10.3758/APP.72.5.1229; Kumada T, 2002, PERCEPT PSYCHOPHYS, V64, P493, DOI 10.3758/BF03194720; Lee J, 2013, J NEUROSCI, V33, P10625, DOI 10.1523/JNEUROSCI.5575-12.2013; Maljkovic V, 1996, PERCEPT PSYCHOPHYS, V58, P977, DOI 10.3758/BF03206826; Mastropasqua T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053683; PARK JY, 1994, J EXP PSYCHOL HUMAN, V20, P613, DOI 10.1037/0096-1523.20.3.613; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Qi SQ, 2013, BRAIN RES, V1532, P32, DOI 10.1016/j.brainres.2013.07.044; RABBITT P, 1979, Q J EXP PSYCHOL, V31, P305, DOI 10.1080/14640747908400729; Raymond JE, 2009, PSYCHOL SCI, V20, P981, DOI 10.1111/j.1467-9280.2009.02391.x; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Rothkirch M, 2013, EXP BRAIN RES, V224, P35, DOI 10.1007/s00221-012-3284-4; Rutherford HJV, 2010, PSYCHON B REV, V17, P536, DOI 10.3758/PBR.17.4.536; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Shomstein S, 2013, PSYCHOL SCI, V24, P2369, DOI 10.1177/0956797613490743; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; TREISMAN A, 1992, AM PSYCHOL, V47, P862, DOI 10.1037/0003-066X.47.7.862; Wang LH, 2013, J VISION, V13, DOI 10.1167/13.3.5	49	42	44	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103372	10.1371/journal.pone.0103372	http://dx.doi.org/10.1371/journal.pone.0103372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6EF	25080218	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800041
J	Nilsson, MI; Macneil, LG; Kitaoka, Y; Alqarni, F; Suri, R; Akhtar, M; Haikalis, ME; Dhaliwal, P; Saeed, M; Tarnopolsky, MA				Nilsson, Mats I.; Macneil, Lauren G.; Kitaoka, Yu; Alqarni, Fatimah; Suri, Rahul; Akhtar, Mahmood; Haikalis, Maria E.; Dhaliwal, Pavneet; Saeed, Munim; Tarnopolsky, Mark A.			Redox State and Mitochondrial Respiratory Chain Function in Skeletal Muscle of LGMD2A Patients	PLOS ONE			English	Article							CALPAIN-3 GENE; OXIDATIVE STRESS; CAPN3 GENE; MUTATIONS; DIAGNOSIS; EXERCISE; FEATURES; 2A	Background: Calpain-3 deficiency causes oxidative and nitrosative stress-induced damage in skeletal muscle of LGMD2A patients, but mitochondrial respiratory chain function and anti-oxidant levels have not been systematically assessed in this clinical population previously. Methods: We identified 14 patients with phenotypes consistent with LGMD2A and performed CAPN3 gene sequencing, CAPN3 expression/autolysis measurements, and in silico predictions of pathogenicity. Oxidative damage, anti-oxidant capacity, and mitochondrial enzyme activities were determined in a subset of muscle biopsies. Results: Twenty-one disease-causing variants were detected along the entire CAPN3 gene, five of which were novel (c. 338 T>C, c.500 T>C, c.1525-1 G>T, c.2115+4 T>G, c.2366 T>A). Protein-and mRNA-based tests confirmed in silico predictions and the clinical diagnosis in 75% of patients. Reductions in antioxidant defense mechanisms (SOD-1 and NRF-2, but not SOD-2), coupled with increased lipid peroxidation and protein ubiquitination, were observed in calpain-3 deficient muscle, indicating a redox imbalance primarily affecting non-mitochondrial compartments. Although ATP synthase levels were significantly lower in LGMD2A patients, citrate synthase, cytochrome c oxidase, and complex I+III activities were not different from controls. Conclusions: Despite significant oxidative damage and redox imbalance in cytosolic/myofibrillar compartments, mitochondrial respiratory chain function is largely maintained in skeletal muscle of LGMD2A patients.	[Nilsson, Mats I.; Macneil, Lauren G.; Kitaoka, Yu; Alqarni, Fatimah; Suri, Rahul; Akhtar, Mahmood; Haikalis, Maria E.; Dhaliwal, Pavneet; Saeed, Munim; Tarnopolsky, Mark A.] McMaster Univ Hosp, Neuromuscular Clin, Dept Pediat & Med, Hamilton, ON, Canada	McMaster University	Tarnopolsky, MA (corresponding author), McMaster Univ Hosp, Neuromuscular Clin, Dept Pediat & Med, Hamilton, ON, Canada.	tarnopol@mcmaster.ca	Nilsson, Mats/AAG-2068-2021	Nilsson, Mats/0000-0001-5656-5578; Kitaoka, Yu/0000-0001-6932-2735	Jessica Heikoop and family; Jay's Drive Fore MD Golf Tournament	Jessica Heikoop and family; Jay's Drive Fore MD Golf Tournament	Work was supported with private donations from Jessica Heikoop and family and Jay's Drive Fore MD Golf Tournament. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini C.F.M., 2005, CALPAINOPATHY SEATTL; Ankala A, 2013, MUSCLE NERVE, V47, P931, DOI 10.1002/mus.23763; Beckmann JS, 1996, CURR OPIN NEUROL, V9, P389, DOI 10.1097/00019052-199610000-00013; Chae J, 2001, NEUROMUSCULAR DISORD, V11, P547, DOI 10.1016/S0960-8966(01)00197-3; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Duguez S, 2006, FEBS J, V273, P3427, DOI 10.1111/j.1742-4658.2006.05351.x; Fanin M, 2007, J MED GENET, V44, P38, DOI 10.1136/jmg.2006.044859; Fanin M, 2004, HUM MUTAT, V24, P52, DOI 10.1002/humu.20058; Fanin M, 2013, NEUROPATH APPL NEURO, V39, P762, DOI 10.1111/nan.12034; Fanin M, 2003, AM J PATHOL, V163, P1929, DOI 10.1016/S0002-9440(10)63551-1; Fanin M, 2009, EUR J HUM GENET, V17, P598, DOI 10.1038/ejhg.2008.193; Fardeau M, 1996, NEUROMUSCULAR DISORD, V6, P447, DOI 10.1016/S0960-8966(96)00387-2; Grover GJ, 2008, INT J BIOCHEM CELL B, V40, P2698, DOI 10.1016/j.biocel.2008.06.013; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Kawai H, 1998, MUSCLE NERVE, V21, P1493, DOI 10.1002/(SICI)1097-4598(199811)21:11<1493::AID-MUS19>3.0.CO;2-1; Kitaoka Y, 2013, MOL GENET METAB, V110, P297, DOI 10.1016/j.ymgme.2013.06.022; Kolski HK, 2008, NEUROPATHOLOGY, V28, P264, DOI 10.1111/j.1440-1789.2007.00871.x; Krahn M, 2006, CLIN GENET, V69, P444, DOI 10.1111/j.1399-0004.2006.00603.x; Kramerova I, 2012, HUM MOL GENET, V21, P3193, DOI 10.1093/hmg/dds144; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Kramerova I, 2009, HUM MOL GENET, V18, P3194, DOI 10.1093/hmg/ddp257; McKenzie S, 2000, AM J PHYSIOL-ENDOC M, V278, pE580, DOI 10.1152/ajpendo.2000.278.4.E580; Milic A, 2007, NEUROMUSCULAR DISORD, V17, P148, DOI 10.1016/j.nmd.2006.11.001; Murphy RM, 2006, AM J PHYSIOL-CELL PH, V290, pC116, DOI 10.1152/ajpcell.00291.2005; Murphy RM, 2007, J APPL PHYSIOL, V103, P926, DOI 10.1152/japplphysiol.01422.2006; Nilsson MI, 2014, GENE, V537, P41, DOI 10.1016/j.gene.2013.12.033; Nilsson MI, 2013, MUSCLE NERVE, V47, P740, DOI 10.1002/mus.23666; Nilsson MI, 2012, MOL GENET METAB, V107, P469, DOI 10.1016/j.ymgme.2012.09.010; Ojima K, 2012, J CLIN INVEST, V120, P2672; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Ojima K, 2011, J MOL BIOL, V407, P439, DOI 10.1016/j.jmb.2011.01.057; Ono Y, 2010, J BIOL CHEM, V285, P22984, DOI 10.1074/jbc.M110.126946; Piluso G, 2005, J MED GENET, V42, P686, DOI 10.1136/jmg.2004.028738; Rajakumar D, 2013, NEUROCHEM RES, P1; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Saenz A, 2005, BRAIN, V128, P732, DOI 10.1093/brain/awh408; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Todorova A, 2005, CLIN GENET, V67, P356, DOI 10.1111/j.1399-0004.2005.00398.x; Whitehead NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015354; Wu Y, 2011, MOL GENET METAB, V104, P587, DOI 10.1016/j.ymgme.2011.08.012	43	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102549	10.1371/journal.pone.0102549	http://dx.doi.org/10.1371/journal.pone.0102549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079074	gold, Green Submitted, Green Published			2022-12-27	WOS:000339954800014
J	Wiens, O; Xia, D; von Schubert, C; Wastling, JM; Dobbelaere, DAE; Heussler, VT; Woods, KL				Wiens, Olga; Xia, Dong; von Schubert, Conrad; Wastling, Jonathan M.; Dobbelaere, Dirk A. E.; Heussler, Volker T.; Woods, Kerry L.			Cell Cycle-Dependent Phosphorylation of Theileria annulata Schizont Surface Proteins	PLOS ONE			English	Article							NF-KAPPA-B; PARVA; SURVIVAL; PATHWAY; JUN; PROLIFERATION; ACTIVATION; INFECTION; KINASE; TOOLS	The invasion of Theileria sporozoites into bovine leukocytes is rapidly followed by the destruction of the surrounding host cell membrane, allowing the parasite to establish its niche within the host cell cytoplasm. Theileria infection induces host cell transformation, characterised by increased host cell proliferation and invasiveness, and the activation of anti-apoptotic genes. This process is strictly dependent on the presence of a viable parasite. Several host cell kinases, including PI3-K, JNK, CK2 and Src-family kinases, are constitutively activated in Theileria-infected cells and contribute to the transformed phenotype. Although a number of host cell molecules, including IkB kinase and polo-like kinase 1 (Plk1), are recruited to the schizont surface, very little is known about the schizont molecules involved in host-parasite interactions. In this study we used immunofluorescence to detect phosphorylated threonine (p-Thr), serine (p-Ser) and threonine-proline (p-Thr-Pro) epitopes on the schizont during host cell cycle progression, revealing extensive schizont phosphorylation during host cell interphase. Furthermore, we established a quick protocol to isolate schizonts from infected macrophages following synchronisation in S-phase or mitosis, and used mass spectrometry to detect phosphorylated schizont proteins. In total, 65 phosphorylated Theileria proteins were detected, 15 of which are potentially secreted or expressed on the surface of the schizont and thus may be targets for host cell kinases. In particular, we describe the cell cycle-dependent phosphorylation of two T. annulata surface proteins, TaSP and p104, both of which are highly phosphorylated during host cell S-phase. TaSP and p104 are involved in mediating interactions between the parasite and the host cell cytoskeleton, which is crucial for the persistence of the parasite within the dividing host cell and the maintenance of the transformed state.	[Wiens, Olga; von Schubert, Conrad; Dobbelaere, Dirk A. E.; Woods, Kerry L.] Univ Bern, Vetsuisse Fac, Div Mol Pathobiol, Bern, Switzerland; [Xia, Dong; Wastling, Jonathan M.] Univ Liverpool, Inst Infect & Global Hlth, Dept Infect Biol, Liverpool L69 3BX, Merseyside, England; [Xia, Dong; Wastling, Jonathan M.] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Wastling, Jonathan M.] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 3BX, Merseyside, England; [Heussler, Volker T.] Univ Bern, Inst Cell Biol, Bern, Switzerland	University of Bern; University of Liverpool; University of Liverpool; University of Liverpool; University of Bern	Woods, KL (corresponding author), Univ Bern, Vetsuisse Fac, Div Mol Pathobiol, Bern, Switzerland.	kerry.woods@vetsuisse.unibe.ch	Heussler, Volker/H-9322-2019	Heussler, Volker/0000-0001-8028-9825; Xia, Dong/0000-0003-4571-2776	Swiss National Science Foundation [SNF_31003A_130780]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (grant SNF_31003A_130780). http://www.snf.ch/en/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson R, 1997, PARASITOL TODAY, V13, P390, DOI 10.1016/S0169-4758(97)01127-7; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Aurrecoechea C, 2013, NUCLEIC ACIDS RES, V41, pD684, DOI 10.1093/nar/gks1113; Baumgartner M, 2000, CELL MICROBIOL, V2, P329, DOI 10.1046/j.1462-5822.2000.00062.x; Baumgartner M, 1999, MICROBES INFECT, V1, P1181, DOI 10.1016/S1286-4579(99)00244-0; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Botteron C, 1998, BIOCHEM BIOPH RES CO, V246, P418, DOI 10.1006/bbrc.1998.8635; Chaussepied M, 1998, MOL BIOCHEM PARASIT, V94, P215, DOI 10.1016/S0166-6851(98)00070-X; Chaussepied M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001197; Daubenberger C, 1997, MOL BIOCHEM PARASIT, V85, P265, DOI 10.1016/S0166-6851(97)02831-4; Dessauge F, 2005, PARASITOLOGY, V130, pS37, DOI 10.1017/S0031182005008140; Dessauge F, 2005, TRENDS PARASITOL, V21, P377, DOI 10.1016/j.pt.2005.06.003; Dessauge G, 2005, ONCOGENE, V24, P1075, DOI 10.1038/sj.onc.1208314; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dobbelaere D., 2009, INTRACELLULAR NICHES, P613, DOI [10.1002/9783527629176., DOI 10.1002/9783527629176]; DOBBELAERE DAE, 1988, P NATL ACAD SCI USA, V85, P4730, DOI 10.1073/pnas.85.13.4730; Dulla K, 2010, MOL CELL PROTEOMICS, V9, P1167, DOI 10.1074/mcp.M900335-MCP200; Galley Y, 1997, P NATL ACAD SCI USA, V94, P5119, DOI 10.1073/pnas.94.10.5119; Guergnon J, 2003, CELL MICROBIOL, V5, P709, DOI 10.1046/j.1462-5822.2003.00314.x; Guergnon J, 2006, APOPTOSIS, V11, P1263, DOI 10.1007/s10495-006-7702-6; Heussler VT, 2001, CELL MICROBIOL, V3, P537, DOI 10.1046/j.1462-5822.2001.00134.x; Heussler VT, 2002, SCIENCE, V298, P1033, DOI 10.1126/science.1075462; IRVIN AD, 1982, RES VET SCI, V33, P298, DOI 10.1016/S0034-5288(18)32305-1; IVANOV V, 1989, MOL CELL BIOL, V9, P4677, DOI 10.1128/MCB.9.11.4677; Jackson AP, 2014, NUCL ACIDS RES; Kinnaird JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066833; Kuhni-Boghenbor K, 2012, CELL MICROBIOL, V14, P1867, DOI 10.1111/cmi.12006; Kuenzi P, 2003, J IMMUNOL, V171, P1224, DOI 10.4049/jimmunol.171.3.1224; Lizundia R, 2006, CANCER RES, V66, P6105, DOI 10.1158/0008-5472.CAN-05-3861; Malik R, 2010, PROTEOMICS, V10, P1270, DOI 10.1002/pmic.200900365; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; OLEMOIYOI OK, 1993, EMBO J, V12, P1621, DOI 10.1002/j.1460-2075.1993.tb05807.x; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Seitzer U, 2007, PARASITOL RES, V101, pS217, DOI 10.1007/s00436-007-0685-6; Seitzer U, 2010, PARASITOL RES, V106, P1085, DOI 10.1007/s00436-010-1747-8; Shiels B, 2006, INT J PARASITOL, V36, P9, DOI 10.1016/j.ijpara.2005.09.002; SHIELS B, 1992, J CELL SCI, V101, P99; STABEL JR, 1995, VET IMMUNOL IMMUNOP, V45, P211, DOI 10.1016/0165-2427(94)05348-V; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; von Schubert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000499; Weir W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-42; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Witschi M, 2013, INT J PARASITOL, V43, P173, DOI 10.1016/j.ijpara.2012.10.017; Woods K., 2014, Protein phosphorylation in parasites: novel targets for antiparasitic intervention, P181; Woods KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003346	48	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103821	10.1371/journal.pone.0103821	http://dx.doi.org/10.1371/journal.pone.0103821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077614	Green Published, gold, Green Accepted			2022-12-27	WOS:000339954800084
J	Wood, KA; Stillman, RA; Daunt, F; O'Hare, MT				Wood, Kevin A.; Stillman, Richard A.; Daunt, Francis; O'Hare, Matthew T.			Can Sacrificial Feeding Areas Protect Aquatic Plants from Herbivore Grazing? Using Behavioural Ecology to Inform Wildlife Management	PLOS ONE			English	Article							WHITE-FRONTED GEESE; SWANS CYGNUS-OLOR; FOOD SUPPLEMENTATION; REDUCE PREDATION; STANDING CROP; DUCK NESTS; CONSERVATION; CONFLICT; IMPACT; PATTERNS	Effective wildlife management is needed for conservation, economic and human well-being objectives. However, traditional population control methods are frequently ineffective, unpopular with stakeholders, may affect non-target species, and can be both expensive and impractical to implement. New methods which address these issues and offer effective wildlife management are required. We used an individual-based model to predict the efficacy of a sacrificial feeding area in preventing grazing damage by mute swans (Cygnus olor) to adjacent river vegetation of high conservation and economic value. The accuracy of model predictions was assessed by a comparison with observed field data, whilst prediction robustness was evaluated using a sensitivity analysis. We used repeated simulations to evaluate how the efficacy of the sacrificial feeding area was regulated by (i) food quantity, (ii) food quality, and (iii) the functional response of the forager. Our model gave accurate predictions of aquatic plant biomass, carrying capacity, swan mortality, swan foraging effort, and river use. Our model predicted that increased sacrificial feeding area food quantity and quality would prevent the depletion of aquatic plant biomass by swans. When the functional response for vegetation in the sacrificial feeding area was increased, the food quantity and quality in the sacrificial feeding area required to protect adjacent aquatic plants were reduced. Our study demonstrates how the insights of behavioural ecology can be used to inform wildlife management. The principles that underpin our model predictions are likely to be valid across a range of different resource-consumer interactions, emphasising the generality of our approach to the evaluation of strategies for resolving wildlife management problems.	[Wood, Kevin A.; Daunt, Francis; O'Hare, Matthew T.] Ctr Ecol & Hydrol, Edinburgh, Midlothian, Scotland; [Wood, Kevin A.; Stillman, Richard A.] Bournemouth Univ, Fac Sci & Technol, Poole BH12 5BB, Dorset, England	UK Centre for Ecology & Hydrology (UKCEH); Bournemouth University	Wood, KA (corresponding author), Ctr Ecol & Hydrol, Edinburgh, Midlothian, Scotland.	kevinwoodecology@hotmail.co.uk	Wood, Kevin/C-7312-2012; O'Hare, Matthew T/F-3648-2011; Daunt, Francis/K-6688-2012	Wood, Kevin/0000-0001-9170-6129; Daunt, Francis/0000-0003-4638-3388	Centre for Ecology & Hydrology Algorithm (Natural Environment Research Council) [NEC3579]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Centre for Ecology & Hydrology Algorithm (Natural Environment Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded through a Centre for Ecology & Hydrology Algorithm (Grant Number NEC3579; Natural Environment Research Council, http://www.nerc.ac.uk/) studentship awarded to KW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2004, J APPL ECOL, V41, P675, DOI 10.1111/j.0021-8901.2004.00923.x; Amano T, 2007, J APPL ECOL, V44, P506, DOI 10.1111/j.1365-2664.2007.01314.x; Amano T, 2012, ECOL RES, V27, P495, DOI 10.1007/s11284-012-0928-6; Ankney CD, 1996, J WILDLIFE MANAGE, V60, P217, DOI 10.2307/3802219; BECH C, 1980, J COMP PHYSIOL, V136, P61, DOI 10.1007/BF00688623; BLOKPOEL H, 1989, WILDLIFE SOC B, V17, P435; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Brunckhorst H., 1996, OKOLOGIE ENERGETIK P; Bullock J. M., 2000, Grazing management: the principles and practice of grazing, for profit and environmental gain, within temperate grassland systems. Proceedings of the British Grassland Society Conference held at the Cairn Hotel, Harrogate, 29 February-2 March 2000., P17; Conover M., 2002, RESOLVING HUMAN WILD; Conover MR, 2005, WILDLIFE SOC B, V33, P1330, DOI 10.2193/0091-7648(2005)33[1330:EOSFTR]2.0.CO;2; Cooper SM, 2000, WILDLIFE SOC B, V28, P660; Decker DJ, 1997, WILDLIFE SOC B, V25, P788; Delany S, 2005, DUCKS GEESE SWANS, P231; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gayet G, 2011, AQUAT BOT, V95, P110, DOI 10.1016/j.aquabot.2011.04.003; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; GOSLING LM, 1989, BIOL J LINN SOC, V38, P39, DOI 10.1111/j.1095-8312.1989.tb01561.x; Greenwood RJ, 1998, WILDLIFE SOC B, V26, P219; GROSS JE, 1993, ECOLOGY, V74, P778, DOI 10.2307/1940805; Hairston N. G., 1989, ECOLOGICAL EXPT PURP; HANSEN LP, 1979, J MAMMAL, V60, P335, DOI 10.2307/1379805; Heydon MJ, 2010, WILDLIFE RES, V37, P731, DOI 10.1071/WR10006; Hodder KH, 1997, J APPL ECOL, V34, P547, DOI 10.2307/2404906; Jozkowicz Alicja, 1996, Acta Ornithologica (Warsaw), V31, P45; Kear J, 1988, MUTE SWAN; KERSTEN M, 1987, ARDEA, V75, P175; Lopez-Bao JV, 2010, ANIM CONSERV, V13, P35, DOI 10.1111/j.1469-1795.2009.00300.x; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; McKay HV, 2001, AGR ECOSYST ENVIRON, V84, P99, DOI 10.1016/S0167-8809(00)00207-3; McLane AJ, 2011, ECOL MODEL, V222, P1544, DOI 10.1016/j.ecolmodel.2011.01.020; Meissner Wlodzimierz, 2007, Ornis Svecica, V17, P148; Nolet BA, 2002, J ANIM ECOL, V71, P979, DOI 10.1046/j.1365-2656.2002.00662.x; Nolet BA, 2005, OIKOS, V111, P302, DOI 10.1111/j.0030-1299.2005.14043.x; O'Hare MT, 2007, FRESHWATER BIOL, V52, P2463, DOI 10.1111/j.1365-2427.2007.01841.x; Orr RJ, 1997, APPL ANIM BEHAV SCI, V52, P65, DOI 10.1016/S0168-1591(96)01120-3; OWEN M, 1990, IBIS, V132, P238, DOI 10.1111/j.1474-919X.1990.tb01042.x; Owen M., 1975, Wildfowl, V26, P31; OWEN M, 1977, Biological Conservation, V11, P209, DOI 10.1016/0006-3207(77)90005-2; PANDIT AK, 1984, J ENVIRON MANAGE, V18, P73; Percival SM, 1997, BIOL CONSERV, V82, P273, DOI 10.1016/S0006-3207(97)00041-4; Perry G, 1997, TRENDS ECOL EVOL, V18, P228; RATTRAY PV, 1974, NEW ZEAL J AGR RES, V17, P401, DOI 10.1080/00288233.1974.10421024; Redpath SM, 2001, J APPL ECOL, V38, P1157, DOI 10.1046/j.0021-8901.2001.00683.x; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; REES EC, 1990, J APPL ECOL, V27, P939, DOI 10.2307/2404388; Ringelman KM, 2014, ECOL MODEL, V272, P141, DOI 10.1016/j.ecolmodel.2013.09.028; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Sahlsten J, 2010, WILDLIFE BIOL, V16, P85, DOI 10.2981/08-085; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Spray C.J., 2002, Aspects of Applied Biology, V67, P67; Stephens D.W., 1986, pi; Stillman RA, 2008, ECOL MODEL, V216, P265, DOI 10.1016/j.ecolmodel.2008.04.014; Stillman RA, 2010, BIOL REV, V85, P413, DOI 10.1111/j.1469-185X.2009.00106.x; Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896; Takatsuki S, 2009, BIOL CONSERV, V142, P1922, DOI 10.1016/j.biocon.2009.02.011; Tatu KS, 2007, J WILDLIFE MANAGE, V71, P1431, DOI 10.2193/2006-130; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; van Eerden M. R., 1996, Gibier Faune Sauvage, V13, P681; VanVuren D, 1996, BIOL AGRIC HORTIC, V13, P39, DOI 10.1080/01448765.1996.9754765; VICKERY JA, 1994, J APPL ECOL, V31, P371, DOI 10.2307/2404551; Vickery JA, 1999, BIOL CONSERV, V89, P93, DOI 10.1016/S0006-3207(98)00134-7; Watola GV, 2003, J APPL ECOL, V40, P565, DOI 10.1046/j.1365-2664.2003.00811.x; Wood K.A, 2012, THESIS BOURNEMOUTH U; Wood Kevin A., 2014, British Wildlife, V25, P171; Wood KA, 2013, OIKOS, V122, P1720, DOI 10.1111/j.1600-0706.2013.00592.x; Wood KA, 2013, BIRD STUDY, V60, P229, DOI 10.1080/00063657.2013.776003; Wood KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056287; Wood KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049824; Wood KA, 2012, AQUAT BOT, V102, P28, DOI 10.1016/j.aquabot.2012.04.006; Wood Kevin A., 2012, P339; Wood KA, 2012, HYDROBIOLOGIA, V686, P157, DOI 10.1007/s10750-012-1007-2; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1	73	13	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e104034	10.1371/journal.pone.0104034	http://dx.doi.org/10.1371/journal.pone.0104034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077615	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000339954800104
J	Botman, D; Rottinger, E; Martindale, MQ; de Jong, J; Kaandorp, JA				Botman, Daniel; Roettinger, Eric; Martindale, Mark Q.; de Jong, Johann; Kaandorp, Jaap A.			A Computational Approach towards a Gene Regulatory Network for the Developing Nematostella vectensis Gut	PLOS ONE			English	Article							SEA-ANEMONE; POSITIONAL INFORMATION; EXPRESSION; CNIDARIAN; SPECIFICATION; SENSITIVITY; PATTERN; MODEL; AXIS	Background: The starlet sea anemone Nematostella vectensis is a diploblastic cnidarian that expresses a set of conserved genes for gut formation during its early development. During the last decade, the spatial distribution of many of these genes has been visualized with RNA hybridization or protein immunolocalization techniques. However, due to N. vectensis' curved and changing morphology, quantification of these spatial data is problematic. A method is developed for two-dimensional gene expression quantification, which enables a numerical analysis and dynamic modeling of these spatial patterns. Methods/Result: In this work, first standardized gene expression profiles are generated from publicly available N. vectensis embryo images that display mRNA and/or protein distributions. Then, genes expressed during gut formation are clustered based on their expression profiles, and further grouped based on temporal appearance of their gene products in embryonic development. Representative expression profiles are manually selected from these clusters, and used as input for a simulation-based optimization scheme. This scheme iteratively fits simulated profiles to the selected profiles, leading to an optimized estimation of the model parameters. Finally, a preliminary gene regulatory network is derived from the optimized model parameters. Outlook: While the focus of this study is N. vectensis, the approach outlined here is suitable for inferring gene regulatory networks in the embryonic development of any animal, thus allowing to comparatively study gene regulation of gut formation in silico across various species.	[Botman, Daniel; Kaandorp, Jaap A.] Univ Amsterdam, Amsterdam, Netherlands; [Roettinger, Eric] Univ Nice Sophia Antipolis, Inst Res Canc & Aging, Nice IRCAN, UMR 7284, F-06189 Nice, France; [Roettinger, Eric] CNRS, Inst Res Canc & Aging, Nice IRCAN, UMR 7284, F-06034 Nice, France; [Roettinger, Eric] Fac Med Nice, INSERM, Inst Res Canc & Aging, Nice IRCAN,U1081, F-06034 Nice, France; [Martindale, Mark Q.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA; [de Jong, Johann] Netherlands Canc Inst, Computat Canc Biol Grp, Div Mol Carcinogenesis, Amsterdam, Netherlands	University of Amsterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; State University System of Florida; University of Florida; Netherlands Cancer Institute	Kaandorp, JA (corresponding author), Univ Amsterdam, Amsterdam, Netherlands.	j.a.kaandorp@uva.nl	Röttinger, Eric/AAX-6277-2021	Rottinger, Eric/0000-0002-2938-6774; de Jong, Johann/0000-0002-2097-0915	Knowledge Based Bio-Economy (KBBE) EU grant [289434]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093116] Funding Source: NIH RePORTER	Knowledge Based Bio-Economy (KBBE) EU grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is part of the BioPreDyn project (www.biopredyn.eu). BioPreDyn is a Cooperation project of the Knowledge Based Bio-Economy (KBBE) EU grant, with the number 289434. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botman Daniel, 2012, BMC Res Notes, V5, P555, DOI 10.1186/1756-0500-5-555; Crombach A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046658; Crombach A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002589; Darling JA, 2005, BIOESSAYS, V27, P211, DOI 10.1002/bies.20181; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Egea JA, 2010, COMPUT OPER RES, V37, P315, DOI 10.1016/j.cor.2009.05.003; Egea JA, 2009, IND ENG CHEM RES, V48, P4388, DOI 10.1021/ie801717t; Fomekong-Nanfack Y, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-94; Fritzenwanker JH, 2007, DEV BIOL, V310, P264, DOI 10.1016/j.ydbio.2007.07.029; Fritzenwanker JH, 2004, DEV BIOL, V275, P389, DOI 10.1016/j.ydbio.2004.08.014; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2012, CURR OPIN GENET DEV, V22, P533, DOI 10.1016/j.gde.2012.10.005; Jaeger J, 2009, MOL BIOSYST, V5, P1549, DOI 10.1039/b904722k; Lee PN, 2007, DEV BIOL, V310, P169, DOI 10.1016/j.ydbio.2007.05.040; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Magie CR, 2007, DEV BIOL, V305, P483, DOI 10.1016/j.ydbio.2007.02.044; Maly T, 1996, APPL NUMER MATH, V20, P57, DOI 10.1016/0168-9274(95)00117-4; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Ormestad M, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-17; Pennisi E, 2005, SCIENCE, V309, P80, DOI 10.1126/science.309.5731.80; Peter IS, 2011, NATURE, V474, P635, DOI 10.1038/nature10100; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reeves GT, 2006, DEV CELL, V11, P289, DOI 10.1016/j.devcel.2006.08.006; Rottinger E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003164; Ryan JF, 2003, NUCLEIC ACIDS RES, V31, P159, DOI 10.1093/nar/gkg116; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	31	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103341	10.1371/journal.pone.0103341	http://dx.doi.org/10.1371/journal.pone.0103341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076223	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800039
J	Choi, DP; Oh, SM; Lee, JM; Cho, HM; Lee, WJ; Song, BM; Rhee, Y; Kim, HC				Choi, Dong Phil; Oh, Sun Min; Lee, Ju-Mi; Cho, Hye Min; Lee, Won Joon; Song, Bo-Mi; Rhee, Yumie; Kim, Hyeon Chang			Serum 25-Hydroxyvitamin D and Insulin Resistance in Apparently Healthy Adolescents	PLOS ONE			English	Article							VITAMIN-D INSUFFICIENCY; HYPOVITAMINOSIS-D; METABOLIC SYNDROME; OBESE CHILDREN; RISK; SENSITIVITY; ASSOCIATION; EXPRESSION; ETHNICITY; RECEPTOR	Purpose: Vitamin D deficiency is a common condition that is associated with diabetes and insulin resistance. However, the association between vitamin D and insulin resistance has not been fully studied, especially in the general adolescent population. Therefore, we assessed the association between serum 25-hydroxyvitamin D [25(OH)D] level and insulin resistance among apparently healthy Korean adolescents. Methods: A total of 260 (135 male and 125 female) adolescents in a rural high school were assessed for serum 25(OH)D, fasting plasma glucose, and insulin. All of the participants were aged 15 to 16 years old, and without known hypertension or diabetes. Serum 25(OH)D was analyzed both as a continuous and categorical variable in association with insulin resistance. Insulin resistance was estimated by homeostasis model assessment (HOMA-IR). Increased insulin resistance was operationally defined as a HOMA-IR value higher than the sex-specific 75th percentile. Results: In male adolescents, every 10 ng/ml decrease in 25(OH)D level was associated with a 0.25 unit increase in HOMA-IR (p = 0.003) after adjusting for age and BMI. Compared to those in the highest quartile, male adolescents in the lowest 25(OH)D quartile were at significantly higher risk for insulin resistance: unadjusted odds ratio 4.06 (95% CI, 1.26 to 13.07); age and BMI adjusted odds ratio 3.59 (95% CI, 1.03 to 12.57). However, 25(OH)D level, either in continuous or categorical measure, was not significantly associated with insulin resistance among female adolescents. Conclusions: This study suggests that serum 25(OH)D level may be inversely associated with insulin resistance in healthy male adolescents.	[Choi, Dong Phil; Song, Bo-Mi] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea; [Oh, Sun Min; Lee, Ju-Mi; Cho, Hye Min; Lee, Won Joon; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120749, South Korea; [Rhee, Yumie] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea; [Choi, Dong Phil; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120749, South Korea.	hckim@yuhs.ac	Rhee, Yumie/L-8020-2019; Kim, Hyeon Chang/F-8796-2019	Rhee, Yumie/0000-0003-4227-5638; Kim, Hyeon Chang/0000-0001-7867-1240	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) [2010-0007860]; Yonsei University College of Medicine [6-2010-0164]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST); Yonsei University College of Medicine(General Electric)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST) (No. 2010-0007860) and by a faculty research grant of Yonsei University College of Medicine for 2010 (6-2010-0164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemzadeh R, 2008, METABOLISM, V57, P183, DOI 10.1016/j.metabol.2007.08.023; Alvarez JA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/351385; [Anonymous], 2009, KOR NAT HLTH NUTR EX; Belenchia AM, 2013, AM J CLIN NUTR, V97, P774, DOI 10.3945/ajcn.112.050013; Bland R, 2004, J STEROID BIOCHEM, V89-90, P121, DOI 10.1016/j.jsbmb.2004.03.115; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Del Gobbo LC, 2011, J NUTR, V141, P290, DOI 10.3945/jn.110.129619; Erdonmez D, 2011, J CLIN RES PEDIATR E, V3, P198, DOI 10.4274/jcrpe.507; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Godsland IF, 2005, DIABETOLOGIA, V48, P2213, DOI 10.1007/s00125-005-1930-0; Grimnes G, 2010, DIABETIC MED, V27, P1107, DOI 10.1111/j.1464-5491.2010.03092.x; Gulseth HL, 2010, DIABETES CARE, V33, P923, DOI 10.2337/dc09-1692; Heaney RP, 2013, ADV NUTR, V4, P303, DOI 10.3945/an.113.003731; Hoffman RP, 2000, PEDIATR RES, V48, P384, DOI 10.1203/00006450-200009000-00022; Isaia G, 2001, DIABETES CARE, V24, P1496, DOI 10.2337/diacare.24.8.1496; JOHNSON JA, 1994, AM J PHYSIOL, V267, pE356, DOI 10.1152/ajpendo.1994.267.3.E356; Kayaniyil S, 2010, DIABETES CARE, V33, P1379, DOI 10.2337/dc09-2321; Kelishadi R, 2014, J PEDIAT-BRAZIL, V90, P28, DOI 10.1016/j.jped.2013.06.006; Kelly A, 2011, ARCH DIS CHILD, V96, P447, DOI 10.1136/adc.2010.187591; Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad; Lee M, 2003, NEW DIR CHILD ADOLES, V99, P9, DOI 10.1002/cd.63; Liu E, 2009, J NUTR, V139, P329, DOI 10.3945/jn.108.093831; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292; Moran A, 2008, CIRCULATION, V117, P2361, DOI 10.1161/CIRCULATIONAHA.107.704569; Muszkat P, 2010, ARQ BRAS ENDOCRINOL, V54, P110, DOI 10.1590/S0004-27302010000200005; Olson ML, 2012, J CLIN ENDOCR METAB, V97, P279, DOI 10.1210/jc.2011-1507; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; SIMPSON RU, 1985, J BIOL CHEM, V260, P8882; Zhao GX, 2010, DIABETES CARE, V33, P344, DOI 10.2337/dc09-0924; 이종국, 2008, Clinical and Experimental Pediatrics, V51, P33	32	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103108	10.1371/journal.pone.0103108	http://dx.doi.org/10.1371/journal.pone.0103108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072652	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600023
J	Das, JK; Felty, Q				Das, Jayanta K.; Felty, Quentin			PCB153-Induced Overexpression of ID3 Contributes to the Development of Microvascular Lesions	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; POLYCHLORINATED-BIPHENYLS; PULMONARY-HYPERTENSION; IN-VITRO; PLEXIFORM LESIONS; TYROSINE KINASE; PCB; CANCER	Microvascular lesions resulting from endothelial cell dysfunction are produced in the brain, lung, kidney, and retina of patients of complex chronic diseases. The environmental and molecular risk factors which may contribute in the development of microvascular damage are unclear. The mechanism(s) responsible for initiating microvascular damage remain poorly defined, although several inciting factors have been proposed, including environmental toxicants-induced oxidative stress. Enhanced neovascularization has been implicated in either the development or progression of proliferative vascular lesions. Here, we present evidence for how PCB-induced ROS may contribute to the development of a neovascular phenotype with the aim of elucidating the role of environmental toxicants in endothelial dysfunction with a specific focus on the inhibitor of differentiation protein ID3. We used a combination of phenotype and immunohistochemical analysis followed by validating with protein expression and post-translational modifications with Western Blot and MALDI-TOF/TOF analysis. We also looked for a correlation between ID3 expression in vascular tissue. Our results showed that PCB-induced ROS mediated a highly tube branched neovascular phenotype that also depended on ID3 and Pyk2; and PCB153 treatment increased the size of endothelial spheroids under conditions typically used for clonal selection of stem cell spheroids. High ID3 protein expression correlated with a greater degree of malignancy and oxidative DNA damage marker 8-OHdG in blood vessels from human subjects. PCB153 treatment increased both serine and tyrosine phosphorylation of endothelial ID3. Stable ID3 overexpression increased cell survival of human microvascular endothelial cell line hCMEC/D3. In summary, our data provide evidence that ID3 may play a critical role in regulating vascular endothelial cell survival and development of microvascular lesions induced by persistent environmental pollutants such as PCB153. Findings of this study are important because they provide a new paradigm by which PCBs may contribute to the growth of microvascular lesions.	[Das, Jayanta K.; Felty, Quentin] Florida Int Univ, Dept Environm & Occupat Hlth, Miami, FL 33199 USA	State University System of Florida; Florida International University	Felty, Q (corresponding author), Florida Int Univ, Dept Environm & Occupat Hlth, Miami, FL 33199 USA.	feltyq@fiu.edu	DAS, JAYANTA/E-2596-2015	DAS, JAYANTA/0000-0002-2840-1645; Felty, Quentin/0000-0002-7151-0441	National Institute of Health [1SC3GM084827-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM084827] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of Health 1SC3GM084827-01A1: QF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2013, COMPR PHYSIOL, V3, P1011, DOI 10.1002/cphy.c120024; Aird WC, 2005, J THROMB HAEMOST, V3, P1392, DOI 10.1111/j.1538-7836.2005.01328.x; Arzuaga X, 2007, CARDIOVASC TOXICOL, V7, P264, DOI 10.1007/s12012-007-9005-8; Benezra R, 2001, ONCOGENE, V20, P8334, DOI 10.1038/sj.onc.1205160; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Charlier CJ, 2004, CLIN CHIM ACTA, V347, P177, DOI 10.1016/j.cccn.2004.04.025; Cutchins A, 2012, ARTERIOSCL THROM VAS, V32, P317, DOI 10.1161/ATVBAHA.111.234856; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Eum SY, 2009, TOXICOL APPL PHARM, V240, P299, DOI 10.1016/j.taap.2009.07.022; Felty Q, 2008, ATHEROSCLEROSIS, V198, P12, DOI 10.1016/j.atherosclerosis.2007.12.048; Forrest S, 2004, ARTERIOSCL THROM VAS, V24, P2014, DOI 10.1161/01.ATV.0000143932.03151.ad; Forrest ST, 2004, CIRC RES, V95, P557, DOI 10.1161/01.RES.0000142735.67542.5a; Forrest ST, 2004, J BIOL CHEM, V279, P32897, DOI 10.1074/jbc.M404882200; Frank GD, 2000, BIOCHEM BIOPH RES CO, V270, P761, DOI 10.1006/bbrc.2000.2505; Friis T, 2006, APMIS, V114, P211, DOI 10.1111/j.1600-0463.2006.apm_189.x; Gautschi O, 2008, CANCER RES, V68, P2250, DOI 10.1158/0008-5472.CAN-07-6403; Ghosh S, 2007, INT J TOXICOL, V26, P203, DOI 10.1080/10915810701352648; Goncharov A, 2008, ENVIRON RES, V106, P226, DOI 10.1016/j.envres.2007.10.006; Gronning LM, 2006, AM J PHYSIOL-ENDOC M, V290, pE599, DOI 10.1152/ajpendo.00242.2005; Gustavsson P, 1997, AM J IND MED, V32, P234, DOI 10.1002/(SICI)1097-0274(199709)32:3<234::AID-AJIM8>3.3.CO;2-I; Hansen LG, 1998, ENVIRON HEALTH PERSP, V106, P171, DOI 10.2307/3433919; Hennig B, 2002, TOXICOL APPL PHARM, V181, P174, DOI 10.1006/taap.2002.9408; Hennig B, 2002, INT J HYG ENVIR HEAL, V205, P95, DOI 10.1078/1438-4639-00134; Inoue K, 2006, ENVIRON HEALTH PERSP, V114, P1179, DOI 10.1289/ehp.9032; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910; Lim EJ, 2007, AM J PHYSIOL-HEART C, V293, pH3340, DOI 10.1152/ajpheart.00921.2007; Matsumura ME, 2001, ARTERIOSCL THROM VAS, V21, P752, DOI 10.1161/01.ATV.21.5.752; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1010, DOI 10.1289/ehp.1002922; Nickenig G, 2002, FASEB J, V16, P1077, DOI 10.1096/fj.01-0570com; Noren K, 1999, ARCH ENVIRON CON TOX, V37, P408, DOI 10.1007/s002449900532; Norton JD, 2000, J CELL SCI, V113, P3897; Petrulis JR, 2000, J BIOCHEM MOL TOXIC, V14, P73, DOI 10.1002/(SICI)1099-0461(2000)14:2<73::AID-JBT2>3.0.CO;2-1; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramadass P, 2003, TOXICOL SCI, V76, P212, DOI 10.1093/toxsci/kfg227; Ritter R, 2011, ENVIRON HEALTH PERSP, V119, P225, DOI 10.1289/ehp.1002211; Rodriguez P, 2005, BIOTECHNOL LETT, V27, P1869, DOI 10.1007/s10529-005-3895-y; Rojiani AM, 1996, J NEUROSURG, V85, P1078, DOI 10.3171/jns.1996.85.6.1078; Sergeev AV, 2005, ENVIRON HEALTH PERSP, V113, P756, DOI 10.1289/ehp.7595; Soares Raquel, 2003, Angiogenesis, V6, P271, DOI 10.1023/B:AGEN.0000029413.32882.dd; TANABE S, 1988, ENVIRON POLLUT, V50, P5, DOI 10.1016/0269-7491(88)90183-2; Tanaka F, 2003, CANCER RES, V63, P6791; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Tokunaga Shoji, 2003, Fukuoka Acta Medica, V94, P110; Tuder RM, 2001, J PATHOL, V195, P367, DOI 10.1002/path.953; TUDER RM, 1994, AM J PATHOL, V144, P275; Uemura H, 2009, ENVIRON HEALTH PERSP, V117, P568, DOI 10.1289/ehp.0800012; Wahlang B, 2013, J NUTR BIOCHEM, V24, P1587, DOI 10.1016/j.jnutbio.2013.01.009; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wice BM, 2001, DIABETOLOGIA, V44, P453, DOI 10.1007/s001250051643; Zhang XM, 2007, J BIOL CHEM, V282, P33284, DOI 10.1074/jbc.M705089200; Zhao B, 2010, TOXICOL SCI, V117, P393, DOI 10.1093/toxsci/kfq217	52	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104159	10.1371/journal.pone.0104159	http://dx.doi.org/10.1371/journal.pone.0104159			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090023	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700104
J	Nelson, KB; Karver, J; Kullman, C; Graham, JP				Nelson, Kali B.; Karver, Jonathan; Kullman, Craig; Graham, Jay P.			User Perceptions of Shared Sanitation among Rural Households in Indonesia and Bangladesh	PLOS ONE			English	Article							LATRINES	Background: The practice of sharing sanitation facilities does not meet the current World Health Organization/UNICEF definition for what is considered improved sanitation. Recommendations have been made to categorize shared sanitation as improved sanitation if security, user access, and other conditions can be assured, yet limited data exist on user preferences with respect to shared facilities. Objective: This study analyzed user perceptions of shared sanitation facilities in rural households in East Java, Indonesia, and Bangladesh. Methods: Cross-sectional studies of 2,087 households in East Java and 3,000 households in Bangladesh were conducted using questionnaires and observational methods. Relative risks were calculated to analyze associations between sanitation access and user perceptions of satisfaction, cleanliness, and safety. Results: In East Java, 82.4% of households with private improved sanitation facilities reported feeling satisfied with their place of defecation compared to 68.3% of households with shared improved facilities [RR 1.19, 95% CI 1.09, 1.31]. In Bangladesh, 87.7% of households with private improved facilities reported feeling satisfied compared to 74.5% of households with shared improved facilities [RR 1.15, 95% CI 1.10, 1.20]. In East Java, 79.5% of households who reported a clean latrine also reported feeling satisfied with their place of defecation; only 38.9% of households who reported a dirty latrine also reported feeling satisfied [RR 1.74, 95% CI 1.45, 2.08]. Conclusion: Simple distinctions between improved and unimproved sanitation facilities tend to misrepresent the variability observed among households sharing sanitation facilities. Our results suggest that private improved sanitation is consistently preferred over any other sanitation option. An increased number of users appeared to negatively affect toilet cleanliness, and lower levels of cleanliness were associated with lower levels of satisfaction. However, when sanitation facilities were clean and shared by a limited number of households, users of shared facilities often reported feeling both satisfied and safe.	[Nelson, Kali B.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA; [Kullman, Craig] World Bank Water & Sanitat Program, Washington, DC USA; [Graham, Jay P.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Environm & Occupat Hlth, Washington, DC 20052 USA; [Graham, Jay P.] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Global Hlth, Washington, DC USA	George Washington University; The World Bank; George Washington University; George Washington University	Graham, JP (corresponding author), George Washington Univ, Milken Inst Sch Publ Hlth, Dept Environm & Occupat Hlth, Washington, DC 20052 USA.	jgraham@gwu.edu		Nelson, Kali/0000-0002-8099-2980				[Anonymous], WATERLINES; Biran A, 2011, TROP MED INT HEALTH, V16, P854, DOI 10.1111/j.1365-3156.2011.02764.x; Buttenheim AM, 2008, POPUL ENVIRON, V30, P26, DOI 10.1007/s11111-008-0074-9; de Souza K, 2010, COMMUNAL TOILETS URB; Fuller JA, 2014, AM J TROP MED HYG, V91, P173, DOI 10.4269/ajtmh.13-0503; General Economics Division Planning Commission Government of the People's Republic of Bangladesh (GED), 2012, MILL DEV GOALS BANGL; Gunther I, 2012, IS SHARED SANITATION; Jenkins MW, 2005, SOC SCI MED, V61, P2446, DOI 10.1016/j.socscimed.2005.04.036; Kapadia-Kundu N, 2006, PACHOD PAISA SCALE N; Kvarnstrom E, 2011, J WATER SANIT HYG DE, V1, P3, DOI 10.2166/washdev.2011.014; Mazeau A., 2010, ASSESSING PEOPLES VI; Mazeau A, 2014, WATER ENVIRON J, V28, P592, DOI 10.1111/wej.12075; Ministry of National Development Planning, 2010, REP ACH MILL DEV GOA; Montgomery MA, 2010, AM J TROP MED HYG, V82, P693, DOI 10.4269/ajtmh.2010.09-0540; Norman G, 2011, WATER SANITATION URB; Rodgers AF, 2007, TROP MED INT HEALTH, V12, P772, DOI 10.1111/j.1365-3156.2007.01848.x; Roma E, 2010, WATER SA, V36, P589; Tumwebaze IK, 2013, INT J ENVIRON HEAL R, V23, P191, DOI 10.1080/09603123.2012.713095; WHO UNICEF, 2014, EST US WAT SOURC SAN; WHO/UNICEF, 2012, PROP CONS DRINK WAT; WHO/UNICEF, 2010, IMPR UN WAT SAN FAC; WHO/UNICEF, 2010, JMP TECHN TASK FORC; WHO/UNICEF, 2008, PROGR DRINK WAT SAN; WHO-UNICEF, 2013, PROGR DRINK WAT SAN; Zheng Y, 2013, J WATER SANIT HYG DE, V3, P240, DOI 10.2166/washdev.2013.154	25	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103886	10.1371/journal.pone.0103886	http://dx.doi.org/10.1371/journal.pone.0103886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090096	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700061
J	Sun, CJ; Pan, YH; Wang, HB; Li, J; Nie, P; Wang, XM; Ma, H; Huo, FT				Sun, Chunjuan; Pan, Yinghua; Wang, Hongbo; Li, Jian; Nie, Pei; Wang, Ximing; Ma, Heng; Huo, Futao			Assessment of the Coronary Venous System Using 256-Slice Computed Tomography	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; MITRAL-VALVE ANNULUS; NONINVASIVE VISUALIZATION; ANATOMY; SINUS; VEINS; ANGIOGRAPHY	Purpose: To investigate the coronary venous system and its relation to adjacent structures using 256-slice computed tomography (CT). Materials and Methods: The study consisted of 102 patients who underwent coronary CT angiography (CTA) using 256-slice CT. For each patient, the coronary venous system and its relation to adjacent structures were evaluated. The appropriate locations and diameters of the posterior interventricular vein (PIV), posterior vein of the left ventricle (PVLV) and the left marginal vein (LMV) were detected. The paired student's t test was used to evaluate the difference between the diameter of the coronary sinus (CS) ostium in anteroposterior direction and that in superoinferior direction. Results: The CS, great cardiac vein (GCV), PIV, and anterior interventricular vein (AIV) were visualized in all cases. It was possible to evaluate at least one main vein with adequate caliber and regular course for cardiac resynchronization therapy (CRT) in 96.1% of these cases. The diameter of the CS ostium in superoinferior direction (11.7 +/- 2.1 mm) was larger than that in anteroposterior direction (9.0 +/- 2.0 mm) (t = 13.511, P < 0.05). For the majority of the cases, the CS-GCV was located above the level of the mitral valve annulus (MVA), while the left circumflex coronary artery (LCX) was coursed between the CS-GCV and the MVA. LMV had more intersection with the circumflex or circumflex marginal than PVLV. Conclusion: 256-slice CT provides superior noninvasive evaluation of the coronary venous system which has important clinical implications.	[Sun, Chunjuan; Nie, Pei; Wang, Ximing] Shandong Univ, Shandong Med Imaging Res Inst, Shandong Prov Key Lab Diag & Treatment Cardiocere, Jinan, Shandong, Peoples R China; [Sun, Chunjuan; Pan, Yinghua; Wang, Hongbo; Li, Jian; Ma, Heng; Huo, Futao] Yuhuangding Hosp, Dept Radiol, Yantai, Shandong, Peoples R China	Shandong University	Wang, XM (corresponding author), Shandong Univ, Shandong Med Imaging Res Inst, Shandong Prov Key Lab Diag & Treatment Cardiocere, Jinan, Shandong, Peoples R China.	wangximing369@126.com; mahengyhd@163.com			Shandong Province Natural Science Foundation [ZR2012HM013]; Yantai City Science and Technology Development Plan [2012090]	Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Yantai City Science and Technology Development Plan	Funding was received from the Shandong Province Natural Science Foundation (ZR2012HM013) and Yantai City Science and Technology Development Plan (2012090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbara S, 2005, AM J ROENTGENOL, V185, P1001, DOI 10.2214/AJR.04.1382; Arbelo E, 2008, REV ESP CARDIOL, V61, P936, DOI 10.1016/S1885-5857(08)60254-6; Blendea D, 2007, HEART RHYTHM, V4, P1155, DOI 10.1016/j.hrthm.2007.05.023; Chiribiri A, 2008, AM J CARDIOL, V101, P407, DOI 10.1016/j.amjcard.2007.08.049; Echeverri D, 2013, J INVASIVE CARDIOL, V25, P98; Genc B, 2013, DIAGN INTERV RADIOL, V19, P286, DOI 10.5152/dir.2013.012; Hasdemir C, 2007, ANATOL J CARDIOL, V7, P53; Hosch W, 2011, EUR J RADIOL, V80, P127, DOI 10.1016/j.ejrad.2010.07.011; Jongbloed MRM, 2005, J AM COLL CARDIOL, V45, P749, DOI 10.1016/j.jacc.2004.11.035; Klass O, 2010, EUR RADIOL, V20, P1124, DOI 10.1007/s00330-009-1652-7; Knackstedt C, 2008, INT J CARDIOVAS IMAG, V24, P783, DOI 10.1007/s10554-008-9333-1; Koos R, 2004, AM J CARDIOL, V94, P59, DOI 10.1016/j.amjcard.2004.03.031; Loukas M, 2009, CLIN ANAT, V22, P129, DOI 10.1002/ca.20745; Ma H, 2011, INT J CARDIOVAS IMAG, V27, P1003, DOI 10.1007/s10554-010-9757-2; Malago R, 2012, EUR J RADIOL, V81, P3262, DOI 10.1016/j.ejrad.2012.03.007; Mao SS, 2005, AM HEART J, V150, P315, DOI 10.1016/j.ahj.2004.09.050; Maselli D, 2006, CIRCULATION, V114, P377, DOI 10.1161/CIRCULATIONAHA.105.609883; Mlynarski R, 2011, CIRC J, V75, P613, DOI 10.1253/circj.CJ-10-0736; Muhlenbruch G, 2005, AM J ROENTGENOL, V185, P1252, DOI 10.2214/AJR.04.1231; Saremi F, 2012, RADIOGRAPHICS, V32, pE1, DOI 10.1148/rg.321115014; Tada H, 2005, CIRC J, V69, P165, DOI 10.1253/circj.69.165; Tops LF, 2007, CIRCULATION, V115, P1426, DOI 10.1161/CIRCULATIONAHA.106.677880; Van de Veire NR, 2008, AM J CARDIOL, V101, P1023, DOI 10.1016/j.amjcard.2007.11.052; Van de Veire NR, 2006, J AM COLL CARDIOL, V48, P1832, DOI 10.1016/j.jacc.2006.07.042; Vaseghi M, 2010, CIRC-ARRHYTHMIA ELEC, V3, P219, DOI 10.1161/CIRCEP.110.957332	25	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104246	10.1371/journal.pone.0104246	http://dx.doi.org/10.1371/journal.pone.0104246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089900	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700114
J	Wang, QS; Jan, E				Wang, Qing S.; Jan, Eric			Switch from Cap- to Factorless IRES-Dependent 0 and+1 Frame Translation during Cellular Stress and Dicistrovirus Infection	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; HOST PROTEIN-SYNTHESIS; METHIONINE-INDEPENDENT INITIATION; PARALYSIS VIRUS; MEDIATED TRANSLATION; OVERLAPPING GENE; C-VIRUS; RNA; ELEMENTS; SHUTOFF	Internal ribosome entry sites (IRES) are utilized by a subset of cellular and viral mRNAs to initiate translation during cellular stress and virus infection when canonical cap-dependent translation is compromised. The intergenic region (IGR) IRES of the Dicistroviridae uses a streamlined mechanism in which it can directly recruit the ribosome in the absence of initiation factors and initiates translation using a non-AUG codon. A subset of IGR IRESs including that from the honey bee viruses can also direct translation of an overlapping +1 frame gene. In this study, we systematically examined cellular conditions that lead to IGR IRES-mediated 0 and +1 frame translation in Drosophila S2 cells. Towards this, a novel bicistronic reporter that exploits the 2A ``stop-go'' peptide was developed to allow the detection of IRES-mediated translation in vivo. Both 0 and +1 frame translation by the IGR IRES are stimulated under a number of cellular stresses and in S2 cells infected by cricket paralysis virus, demonstrating a switch from cap-dependent to IRES-dependent translation. The regulation of the IGR IRES mechanism ensures that both 0 frame viral structural proteins and +1 frame ORFx protein are optimally expressed during virus infection.	[Wang, Qing S.; Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Jan, E (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	ej@mail.ubc.ca	Jan, Eric/O-1923-2019		Canadian Institute of Health Research [MOP-81244]; NSERC [RGPIN 341459-12]; Genome Canada	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada)	This study was supported in part by the Canadian Institute of Health Research (MOP-81244), an NSERC Discovery Grant (RGPIN 341459-12), and Genome Canada to E.J. E.J. is a Michael Smith Foundation for Health Research Scholar and a CIHR New Investigator Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bonning BC, 2010, ANNU REV ENTOMOL, V55, P129, DOI 10.1146/annurev-ento-112408-085457; Brakier-Gingras L, 2012, EXPERT OPIN THER TAR, V16, P249, DOI 10.1517/14728222.2012.665879; Brown JD, 2010, NUCLEIC ACIDS MOL BI, V24, P101, DOI 10.1007/978-0-387-89382-2_5; Carter JR, 2008, J GEN VIROL, V89, P3150, DOI 10.1099/vir.0.2008/003921-0; Cencic R, 2011, P NATL ACAD SCI USA, V108, P1046, DOI 10.1073/pnas.1011477108; Costantino DA, 2008, NAT STRUCT MOL BIOL, V15, P57, DOI 10.1038/nsmb1351; de Breyne S, 2009, P NATL ACAD SCI USA, V106, P9197, DOI 10.1073/pnas.0900153106; Deniz N, 2009, RNA, V15, P932, DOI 10.1261/rna.1315109; Doudna J.A., 2007, COLD SPRING HARB MON, V48, P129; Dulude D, 2006, VIROLOGY, V345, P127, DOI 10.1016/j.virol.2005.08.048; Elroy-Stein O., 2007, TRANSLATIONAL CONTRO, P155; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Feng PH, 2005, J VIROL, V79, P9651, DOI 10.1128/JVI.79.15.9651-9664.2005; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Firth AE, 2012, J GEN VIROL; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-193; Garrey JL, 2010, J VIROL, V84, P1124, DOI 10.1128/JVI.02006-09; Gonzalez M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00075; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; Hertz MI, 2011, NUCLEIC ACIDS RES, V39, P7276, DOI 10.1093/nar/gkr427; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Ivanov IP, 2000, EMBO J, V19, P1907, DOI 10.1093/emboj/19.8.1907; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; Jang CJ, 2010, RNA, V16, P1182, DOI 10.1261/rna.2044610; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; King HA, 2010, BIOCHEM SOC T, V38, P1581, DOI 10.1042/BST0381581; Koh CS, 2014, P NATL ACAD SCI US; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; KWONG AD, 1987, P NATL ACAD SCI USA, V84, P1926, DOI 10.1073/pnas.84.7.1926; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; MOORE NF, 1981, VIROLOGY, V112, P411, DOI 10.1016/0042-6822(81)90288-9; Nishiyama T, 2003, NUCLEIC ACIDS RES, V31, P2434, DOI 10.1093/nar/gkg336; OROSKAR AA, 1989, J VIROL, V63, P1897, DOI 10.1128/JVI.63.5.1897-1906.1989; Perez C, 2011, J VIROL, V85, P156, DOI 10.1128/JVI.01778-10; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pfingsten JS, 2007, J MOL BIOL, V370, P856, DOI 10.1016/j.jmb.2007.04.076; Plank TDM, 2012, WIRES RNA, V3, P195, DOI 10.1002/wrna.1105; Pringle FM, 1999, J GEN VIROL, V80, P1855, DOI 10.1099/0022-1317-80-7-1855; Ren Q, 2012, P NATL ACAD SCI USA, V109, pE630, DOI 10.1073/pnas.1111303109; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Sabath N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-144; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Shibuya N, 2003, J VIROL, V77, P12002, DOI 10.1128/JVI.77.22.12002-12010.2003; Telenti A, 2002, J VIROL, V76, P7868, DOI 10.1128/JVI.76.15.7868-7873.2002; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; Walsh D, 2005, J VIROL, V79, P8057, DOI 10.1128/JVI.79.13.8057-8064.2005; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wang QS, 2013, METHODS, V59, P167, DOI 10.1016/j.ymeth.2012.09.004; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000	59	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103601	10.1371/journal.pone.0103601	http://dx.doi.org/10.1371/journal.pone.0103601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089704	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700035
J	Dago, AE; Stepansky, A; Carlsson, A; Luttgen, M; Kendall, J; Baslan, T; Kolatkar, A; Wigler, M; Bethel, K; Gross, ME; Hicks, J; Kuhn, P				Dago, Angel E.; Stepansky, Asya; Carlsson, Anders; Luttgen, Madelyn; Kendall, Jude; Baslan, Timour; Kolatkar, Anand; Wigler, Michael; Bethel, Kelly; Gross, Mitchell E.; Hicks, James; Kuhn, Peter			Rapid Phenotypic and Genomic Change in Response to Therapeutic Pressure in Prostate Cancer Inferred by High Content Analysis of Single Circulating Tumor Cells	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; SURVIVAL; EVOLUTION; PROGRESSION	Timely characterization of a cancer's evolution is required to predict treatment efficacy and to detect resistance early. High content analysis of single Circulating Tumor Cells (CTCs) enables sequential characterization of genotypic, morphometric and protein expression alterations in real time over the course of cancer treatment. This concept was investigated in a patient with castrate-resistant prostate cancer progressing through both chemotherapy and targeted therapy. In this case study, we integrate across four timepoints 41 genome-wide copy number variation (CNV) profiles plus morphometric parameters and androgen receptor (AR) protein levels. Remarkably, little change was observed in response to standard chemotherapy, evidenced by the fact that a unique clone (A), exhibiting highly rearranged CNV profiles and AR+ phenotype was found circulating before and after treatment. However, clinical response and subsequent progression after targeted therapy was associated with the drastic depletion of clone A, followed by the sequential emergence of two distinct CTC sub-populations that differed in both AR genotype and expression phenotype. While AR-cells with flat or pseudo-diploid CNV profiles (clone B) were identified at the time of response, a new tumor lineage of AR+ cells (clone C) with CNV altered profiles was detected during relapse. We showed that clone C, despite phylogenetically related to clone A, possessed a unique set of somatic CNV alterations, including MYC amplification, an event linked to hormone escape. Interesting, we showed that both clones acquired AR gene amplification by deploying different evolutionary paths. Overall, these data demonstrate the timeframe of tumor evolution in response to therapy and provide a framework for the multi-scale analysis of fluid biopsies to quantify and monitor disease evolution in individual patients.	[Dago, Angel E.; Carlsson, Anders; Luttgen, Madelyn; Kolatkar, Anand; Bethel, Kelly] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Stepansky, Asya; Kendall, Jude; Baslan, Timour; Wigler, Michael; Hicks, James] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Stepansky, Asya; Kendall, Jude] Skyline Genom, Roslyn Hts, NY USA; [Baslan, Timour] SUNY Stony Brook, Dept Mol & Cellular Biol, Stony Brook, NY USA; [Bethel, Kelly] Scripps Clin, Dept Pathol, La Jolla, CA USA; [Gross, Mitchell E.] Univ So Calif, Keck Sch Med, Los Angeles, CA USA; [Kuhn, Peter] Univ So Calif, Dornsife Coll Letters Arts & Sci, Los Angeles, CA USA	Scripps Research Institute; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Scripps Research Institute; University of Southern California; University of Southern California	Hicks, J (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	hicks@cshl.edu; pkuhn@usc.edu		Bethel, Kelly/0000-0002-7005-8641; Gross, Mitchell/0000-0002-1691-921X; Wigler, Michael/0000-0003-4396-1971	National Cancer Institute [U54CA143906]; National Cancer Institute (NCI) [PA-12-149-]; Swedish Research Council [Dnr 2012-235]; Dr. Marilyn Simons for cancer research at CSHL; Breast Cancer Research Foundation; Skyline Genomics; NATIONAL CANCER INSTITUTE [P30CA045508, U54CA143907, U54CA143906] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Dr. Marilyn Simons for cancer research at CSHL; Breast Cancer Research Foundation; Skyline Genomics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Award Number U54CA143906 from the National Cancer Institute. A. E. Dago is a recipient of a PA-12-149- Research Supplements to Promote Diversity in Health-Related Research awarded by the National Cancer Institute (NCI). A. Carlsson is funded by the Swedish Research Council, Dnr 2012-235. JH, JK, TB and MW were supported by a special grant from Dr. Marilyn Simons for cancer research at CSHL, a Breast Cancer Research Foundation grant, and research support from Skyline Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Asya Stepansky of Skyline Genomics had a significant role in developing the protocol for isolating DNA from HD-CTC cells and performed the Illumina library preparations. Skyline Genomics financially supported the Illumina sequencing at the Cold Spring Harbor Genome facility as a demonstration of their capabilities as a future service provider. The company did not have a role in design of the experiments or interpretation of the data.	Almendro V, 2014, CANCER RES, V74, P1338, DOI 10.1158/0008-5472.CAN-13-2357-T; Attard G, 2011, CLIN CANCER RES, V17, P1649, DOI 10.1158/1078-0432.CCR-10-0567; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goatly A, 2008, MODERN PATHOL, V21, P902, DOI 10.1038/modpathol.2008.74; Halir R, 1998, WSCG '98, VOL 1, P125; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132; Koivisto P, 1997, CANCER RES, V57, P314; Lazar DC, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016002; Li B, 2013, CLIN CANC RES; Magbanua MJM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-78; Marrinucci D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016003; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Miyamoto DT, 2012, CANCER DISCOV, V2, P995, DOI 10.1158/2159-8290.CD-12-0222; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nair VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067733; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Team RC, 2012, R LANG ENV STAT COMP; Toivanen R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005688	35	110	114	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e101777	10.1371/journal.pone.0101777	http://dx.doi.org/10.1371/journal.pone.0101777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084170	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000339819800005
J	Ge, ZW; Yang, ZL; Pfister, DH; Carbone, M; Bau, T; Smith, ME				Ge, Zai-Wei; Yang, Zhu L.; Pfister, Donald H.; Carbone, Matteo; Bau, Tolgor; Smith, Matthew E.			Multigene Molecular Phylogeny and Biogeographic Diversification of the Earth Tongue Fungi in the Genera Cudonia and Spathularia (Rhytismatales, Ascomycota)	PLOS ONE			English	Article							TRUE MORELS MORCHELLA; HISTORICAL BIOGEOGRAPHY; RIBOSOMAL DNA; SPECIES RECOGNITION; DIVERGENCE TIMES; EVOLUTION; TREE; HEMISPHERE; DISPERSAL; REVEALS	The family Cudoniaceae (Rhytismatales, Ascomycota) was erected to accommodate the "earth tongue fungi" in the genera Cudonia and Spathularia. There have been no recent taxonomic studies of these genera, and the evolutionary relationships within and among these fungi are largely unknown. Here we explore the molecular phylogenetic relationships within Cudonia and Spathularia using maximum likelihood and Bayesian inference analyses based on 111 collections from across the Northern Hemisphere. Phylogenies based on the combined data from ITS, nrLSU, rpb2 and tef-1 alpha sequences support the monophyly of three main clades, the /flavida, /velutipes, and /cudonia clades. The genus Cudonia and the family Cudoniaceae are supported as monophyletic groups, while the genus Spathularia is not monophyletic. Although Cudoniaceae is monophyletic, our analyses agree with previous studies that this family is nested within the Rhytismataceae. Our phylogenetic analyses circumscribes 32 species-level clades, including the putative recognition of 23 undescribed phylogenetic species. Our molecular phylogeny also revealed an unexpectedly high species diversity of Cudonia and Spathularia in eastern Asia, with 16 (out of 21) species-level clades of Cudonia and 8 (out of 11) species-level clades of Spathularia. We estimate that the divergence time of the Cudoniaceae was in the Paleogene approximately 28 Million years ago (Mya) and that the ancestral area for this group of fungi was in Eastern Asia based on the current data. We hypothesize that the large-scale geological and climatic events in Oligocene (e. g. the global cooling and the uplift of the Tibetan plateau) may have triggered evolutionary radiations in this group of fungi in East Asia. This work provides a foundation for future studies on the phylogeny, diversity, and evolution of Cudonia and Spathularia and highlights the need for more molecular studies on collections from Europe and North America.	[Ge, Zai-Wei; Yang, Zhu L.] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Ge, Zai-Wei; Pfister, Donald H.] Harvard Univ, Harvard Univ Herbaria, Cambridge, MA 02138 USA; [Ge, Zai-Wei; Pfister, Donald H.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Ge, Zai-Wei; Smith, Matthew E.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Bau, Tolgor] Jilin Agr Univ, Inst Mycol, Changchun, Jilin, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Harvard University; Harvard University; State University System of Florida; University of Florida; Jilin Agricultural University	Ge, ZW (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China.	zaiweige@gmail.com; fungi@mail.kib.ac.cn	Smith, Matthew E/A-8115-2012; Smith, Matthew E./ABC-3015-2020	Smith, Matthew E/0000-0002-0878-0932; Smith, Matthew E./0000-0002-0878-0932	National Natural Science Foundation of China [31270074, U1302263]; Yunnan Provincial Government [U1302263]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-24]; Farlow Fellowships from the Friends of Farlow; CAS/SAFEA International Partnership Program for Creative Research Teams; U. S. National Science Foundation [DEB-0321846]; University of Florida's Institute for Food and Agricultural Sciences (IFAS)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Government; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Farlow Fellowships from the Friends of Farlow; CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); U. S. National Science Foundation(National Science Foundation (NSF)); University of Florida's Institute for Food and Agricultural Sciences (IFAS)	This study was supported by the National Natural Science Foundation of China (No. 31270074), the Joint Funds of the National Natural Science Foundation of China and Yunnan Provincial Government (No. U1302263), the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KSCX2-EW-J-24), and the Farlow Fellowships from the Friends of Farlow to Zai-Wei Ge. Field work was jointly supported by the CAS/SAFEA International Partnership Program for Creative Research Teams and the U. S. National Science Foundation (No. DEB-0321846 to D. E. Boufford), and the University of Florida's Institute for Food and Agricultural Sciences (IFAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; [Anonymous], 1973, FUNGI ADV TREATISE; AXELROD DI, 1983, ANN MO BOT GARD, V70, P629, DOI 10.2307/2398982; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bonito G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052765; Cai Q, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-143; Chung SL, 1998, NATURE, V394, P769, DOI 10.1038/29511; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Divakar PK, 2012, AM J BOT, V99, P2014, DOI 10.3732/ajb.1200258; Doring H, 1998, CRYPTOGAMIE BRYOL L, V19, P123; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Du XH, 2012, FUNGAL GENET BIOL, V49, P455, DOI 10.1016/j.fgb.2012.03.006; Duff GH, 1922, BOT GAZ, V74, P264, DOI 10.1086/333097; Dugan KA, 2002, J FORENSIC SCI, V47, P811; Dupont-Nivet G, 2007, NATURE, V445, P635, DOI 10.1038/nature05516; Durand E.J., 1921, MYCOLOGIA, V13, P184; Durand EJ., 1908, ANN MYCOL, V6, P387; Fang MY, 2005, FLORA CHINA, V14, P260; Feng B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037567; Fries EM, 1849, DISCOMYCETES, V346, P259; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GARGAS A, 1995, SCIENCE, V268, P1492, DOI 10.1126/science.7770775; Ge ZW, 2010, FUNGAL DIVERS, V45, P81, DOI 10.1007/s13225-010-0062-0; Ge ZW, 2008, FUNGAL DIVERS, V32, P59; Geml J, 2006, MOL ECOL, V15, P225, DOI 10.1111/j.1365-294X.2005.02799.x; Gernandt DS, 2001, MYCOLOGIA, V93, P915, DOI 10.2307/3761757; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanso M, 2012, FOREST PATHOL, V42, P124, DOI 10.1111/j.1439-0329.2011.00728.x; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hawksworth DL, 2005, FUNGAL COMMUNITY ITS, DOI DOI 10.1201/9781420027891.CH2; Hibbett DS, 1997, P NATL ACAD SCI USA, V94, P12002, DOI 10.1073/pnas.94.22.12002; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hintikka V., 1970, Metsatieteellisen tutkimuslaitoksen julkaisuja, V69, P68; Hosaka K, 2008, MYCOL RES, V112, P448, DOI 10.1016/j.mycres.2007.06.004; Hou CL, 2005, MYCOPATHOLOGIA, V159, P299, DOI 10.1007/s11046-004-5653-4; Imai S, 1955, SCI REPORTS YOKOHOMA; Imai S, 1941, J FAC AGR HOKKAIDO U, V45, P155; Jansen G, 2010, MOL PHYLOGENET EVOL, V56, P294, DOI 10.1016/j.ympev.2010.01.029; Jeandroz S, 2008, J BIOGEOGR, V35, P815, DOI 10.1111/j.1365-2699.2007.01851.x; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kirk P, 2001, BISBYS DICT FUNGI; Kirk PM., 2008, DICT FUNGI, V10th ed; Kraatz BP, 2010, GEOLOGY, V38, P111, DOI 10.1130/G30619.1; Landvik Sara, 1993, Systema Ascomycetum, V11, P107; Lantz H, 2011, MYCOLOGIA, V103, P57, DOI 10.3852/10-060; Leavitt SD, 2012, BIOL J LINN SOC, V107, P920, DOI 10.1111/j.1095-8312.2012.01978.x; Lin Y. G., 1994, Acta Mycologica Sinica, V13, P8; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lloyd CG, 1916, GEOGLOSSACEAE; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; MAASGEESTERANUS RA, 1972, P K NED AKAD C BIOL, V75, P243; MAINS EB, 1955, MYCOLOGIA, V47, P846, DOI 10.2307/3755508; Mains EB, 1940, AM J BOT, V27, P322, DOI 10.2307/2436703; MAINS EB, 1956, MYCOLOGIA, V48, P694, DOI 10.2307/3755379; Manos PS, 2001, INT J PLANT SCI, V162, pS77, DOI 10.1086/323280; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Matheny PB, 2009, J BIOGEOGR, V36, P577, DOI 10.1111/j.1365-2699.2008.02055.x; Moncalvo JM, 2008, MYCOL RES, V112, P425, DOI 10.1016/j.mycres.2007.12.001; MUELLER GM, 2004, BIODIVERSITY FUNGI I; Mueller GM, 2007, BIODIVERS CONSERV, V16, P1, DOI 10.1007/s10531-006-9117-7; Nannfeldt JA, 1942, ARK BOT A, V30A, P1; NYLANDER J.A.A., 2004, MRMODELTEST V2 3; O'Donnell K, 2011, FUNGAL GENET BIOL, V48, P252, DOI 10.1016/j.fgb.2010.09.006; Persoon CH, 1794, N MAG BOT IHREM GANZ, V1, P63; Platt JL, 2000, MYCOLOGIA, V92, P475, DOI 10.2307/3761506; Pringle A, 2009, MOL ECOL, V18, P817, DOI 10.1111/j.1365-294X.2008.04030.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rahm E, 1966, SCHWEIZ Z PILZK, V44, P165; Ran JH, 2006, MOL PHYLOGENET EVOL, V41, P405, DOI 10.1016/j.ympev.2006.05.039; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rehm H, 1904, HEDWIGIA, V44, P1; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Renner SS, 2005, TRENDS PLANT SCI, V10, P550, DOI 10.1016/j.tplants.2005.09.010; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Schoch CL, 2009, PERSOONIA, V22, P129, DOI 10.3767/003158509X461486; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Schumacher HCF, 1803, ENUMERATIO PLANTARUM, V2, P1; Sharma M, 1983, INDIA J CRAMMERS BIB, V91, P203; Skrede I, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-230; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; Sung GH, 2008, MOL PHYLOGENET EVOL, V49, P495, DOI 10.1016/j.ympev.2008.08.028; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Takamatsu S, 2006, MYCOL RES, V110, P1093, DOI 10.1016/j.mycres.2006.07.005; Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Tiffney BH, 2001, INT J PLANT SCI, V162, pS3, DOI 10.1086/323880; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang E, 2012, NAT GEOSCI, V5, P640, DOI [10.1038/ngeo1538, 10.1038/NGEO1538]; Wang Z, 2002, MYCOLOGIA, V94, P641, DOI 10.2307/3761715; Wang Z, 2006, MYCOLOGIA, V98, P1065, DOI 10.3852/mycologia.98.6.1065; Wang Z, 2006, MOL PHYLOGENET EVOL, V41, P295, DOI 10.1016/j.ympev.2006.05.031; Wang Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004246; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang Z.L., 2005, EVOL GENET, P35; Yang ZL, 2011, FUNGAL DIVERS, V50, P47, DOI 10.1007/s13225-011-0121-1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	106	19	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103457	10.1371/journal.pone.0103457	http://dx.doi.org/10.1371/journal.pone.0103457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084276	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800045
J	Saez-Laguna, E; Guevara, MA; Diaz, LM; Sanchez-Gomez, D; Collada, C; Aranda, I; Cervera, MT				Saez-Laguna, Enrique; Guevara, Maria-Angeles; Diaz, Luis-Manuel; Sanchez-Gomez, David; Collada, Carmen; Aranda, Ismael; Cervera, Maria-Teresa			Epigenetic Variability in the Genetically Uniform Forest Tree Species Pinus pinea L	PLOS ONE			English	Article							DNA METHYLATION POLYMORPHISM; CYTOSINE METHYLATION; CLIMATIC ADAPTATION; NATURAL VARIATION; POPULATIONS; DIVERGENCE; TRAITS; AFLP; TRANSCRIPTION; DEPAUPERATE	There is an increasing interest in understanding the role of epigenetic variability in forest species and how it may contribute to their rapid adaptation to changing environments. In this study we have conducted a genome-wide analysis of cytosine methylation pattern in Pinus pinea, a species characterized by very low levels of genetic variation and a remarkable degree of phenotypic plasticity. DNA methylation profiles of different vegetatively propagated trees from representative natural Spanish populations of P. pinea were analyzed with the Methylation Sensitive Amplified Polymorphism (MSAP) technique. A high degree of cytosine methylation was detected (64.36% of all scored DNA fragments). Furthermore, high levels of epigenetic variation were observed among the studied individuals. This high epigenetic variation found in P. pinea contrasted with the lack of genetic variation based on Amplified Fragment Length Polymorphism (AFLP) data. In this manner, variable epigenetic markers clearly discriminate individuals and differentiates two well represented populations while the lack of genetic variation revealed with the AFLP markers fail to differentiate at both, individual or population levels. In addition, the use of different replicated trees allowed identifying common polymorphic methylation sensitive MSAP markers among replicates of a given propagated tree. This set of MSAPs allowed discrimination of the 70% of the analyzed trees.	[Saez-Laguna, Enrique; Guevara, Maria-Angeles; Diaz, Luis-Manuel; Sanchez-Gomez, David; Aranda, Ismael; Cervera, Maria-Teresa] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Ctr Invest Forestal CIFOR, Dept Ecol & Genet, Madrid, Spain; [Saez-Laguna, Enrique; Guevara, Maria-Angeles; Diaz, Luis-Manuel; Collada, Carmen; Cervera, Maria-Teresa] UPM, Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Unidad Mixta Genom & Ecofisiol Forestal, Madrid, Spain; [Collada, Carmen] UPM, ETSIM, Dept Biotecnol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Cervera, MT (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Ctr Invest Forestal CIFOR, Dept Ecol & Genet, Madrid, Spain.	cervera@inia.es	Sanchez-Gomez, David/K-5653-2014; Collada, Carmen/H-1529-2015; Guevara, M Angeles/H-5858-2011; Cervera, M. Teresa/G-9181-2012; Aranda, Ismael/B-7050-2008	Sanchez-Gomez, David/0000-0002-0588-9713; Collada, Carmen/0000-0003-0236-1312; Guevara, M Angeles/0000-0001-7399-3136; Cervera, M. Teresa/0000-0001-6797-2347; Aranda, Ismael/0000-0001-9086-7940	EPINEA: Estudio de la variabilidad epigenetica de Pinus pinea y su papel para el control molecular de la repuestas adaptativa [SUM 2008-05]; PINCOxSEQ: Estudio multidisciplinar de la respuesta de Pinus pinaster a sequia bajo distintas concentraciones de CO2 atmosferico [AGL2012-35175]; ProCoGen: PROmoting a functional and COmparative understanding of the conifer GENome - implementing applied aspects for more productive and adapted forests [7FP-289841]; Predoctoral Fellowship ESL [BES-2010-039754]	EPINEA: Estudio de la variabilidad epigenetica de Pinus pinea y su papel para el control molecular de la repuestas adaptativa; PINCOxSEQ: Estudio multidisciplinar de la respuesta de Pinus pinaster a sequia bajo distintas concentraciones de CO2 atmosferico; ProCoGen: PROmoting a functional and COmparative understanding of the conifer GENome - implementing applied aspects for more productive and adapted forests; Predoctoral Fellowship ESL	This work was supported by the following: EPINEA: Estudio de la variabilidad epigenetica de Pinus pinea y su papel para el control molecular de la repuestas adaptativa (SUM 2008-05), www.inia.es; PINCOxSEQ: Estudio multidisciplinar de la respuesta de Pinus pinaster a sequia bajo distintas concentraciones de CO2 atmosferico (AGL2012-35175), www.mineco.gob.es; ProCoGen: PROmoting a functional and COmparative understanding of the conifer GENome - implementing applied aspects for more productive and adapted forests (7FP-289841), http://ec.europa.eu/research/fp7/; and Predoctoral Fellowship ESL (BES-2010-039754), www.mineco.gob.es. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Bucher E, 2012, CURR OPIN PLANT BIOL, V15, P503, DOI 10.1016/j.pbi.2012.08.006; BUTKUS V, 1987, NUCLEIC ACIDS RES, V15, P7091, DOI 10.1093/nar/15.17.7091; Carrasquinho I, 2013, TREE GENET GENOMES, V9, P855, DOI 10.1007/s11295-013-0603-2; Catalan G., 1997, REGIONES PROCEDENCIA; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Cervera MT, 1998, THEOR APPL GENET, V97, P51, DOI 10.1007/s001220050866; Cervera MT, 2000, CAN J FOREST RES, V30, P1608, DOI 10.1139/cjfr-30-10-1608; Chambel MR, 2007, ANN FOREST SCI, V64, P87, DOI 10.1051/forest:2006092; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fallour D, 1997, SILVAE GENET, V46, P201; FAO, 2020, GLOBAL FOREST RESOUR; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fraga MF, 2002, TREE PHYSIOL, V22, P813, DOI 10.1093/treephys/22.11.813; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gourcilleau D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009101; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Huang LC, 2012, PHYSIOL PLANTARUM, V145, P360, DOI 10.1111/j.1399-3054.2012.01606.x; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Johnsen O, 2005, PLANT CELL ENVIRON, V28, P1090, DOI 10.1111/j.1365-3040.2005.01356.x; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Keyte AL, 2006, J HERED, V97, P444, DOI 10.1093/jhered/esl023; Lafon-Placette C, 2013, NEW PHYTOL, V197, P416, DOI 10.1111/nph.12026; Latzel V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3875; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li A, 2011, PLANT MOL BIOL REP, V29, P784, DOI 10.1007/s11105-010-0280-3; Li YD, 2008, ECOL RES, V23, P927, DOI 10.1007/s11284-007-0459-8; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lisch D, 2011, CURR OPIN PLANT BIOL, V14, P156, DOI 10.1016/j.pbi.2011.01.003; Marfil CF, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-21; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Monteuuis O, 2008, TREES-STRUCT FUNCT, V22, P779, DOI 10.1007/s00468-008-0238-3; Mougel C, 2002, INT J SYST EVOL MICR, V52, P573, DOI 10.1099/00207713-52-2-573; Mutke S, 2005, SILVAE GENET, V54, P189, DOI 10.1515/sg-2005-0028; Mutke S., 2013, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P73; Mutke S., 2000, NUCIS Newsletter, P50; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Pinzauti F, 2012, AM J BOT, V99, pE362, DOI 10.3732/ajb.1200064; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Raj S, 2011, P NATL ACAD SCI USA, V108, P12521, DOI 10.1073/pnas.1103341108; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Richards CL, 2010, NEW PHYTOL, V187, P562, DOI 10.1111/j.1469-8137.2010.03369.x; Richards CL, 2010, BIOSCIENCE, V60, P232, DOI 10.1525/bio.2010.60.3.9; Richards CL, 2012, PLANT GENOME DIVERSI, V1; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards EJ, 2011, CURR OPIN PLANT BIOL, V14, P204, DOI 10.1016/j.pbi.2011.03.009; Rohde A, 2008, NEW PHYTOL, V177, P2, DOI 10.1111/j.1469-8137.2007.02319.x; Salmon A, 2008, PLANT SCI, V174, P61, DOI 10.1016/j.plantsci.2007.09.012; Sanchez-Gomez D, 2011, ENVIRON EXP BOT, V70, P104, DOI 10.1016/j.envexpbot.2010.08.007; SCHULMAN E, 1958, NATL GEOGR, V113, P355; Scoville AG, 2011, NEW PHYTOL, V191, P251, DOI 10.1111/j.1469-8137.2011.03656.x; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; *STATSOFT INC, 2004, STATISTICA DAT AN SO; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Vendramin GG, 2008, EVOLUTION, V62, P680, DOI 10.1111/j.1558-5646.2007.00294.x; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Verhoeven KJF, 2010, MOL ECOL, V19, P315, DOI 10.1111/j.1365-294X.2009.04460.x; Vining Kelly J, 2012, BMC Genomics, V13, P27, DOI 10.1186/1471-2164-13-27; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Yakovlev IA, 2014, TREE GENET GENOMES, V10, P355, DOI 10.1007/s11295-013-0691-z; Yakovlev IA, 2010, NEW PHYTOL, V187, P1154, DOI 10.1111/j.1469-8137.2010.03341.x; Zhang MS, 2010, J GENET GENOMICS, V37, P1, DOI 10.1016/S1673-8527(09)60020-5; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010; Zonneveld BJM, 2012, NORD J BOT, V30, P490, DOI 10.1111/j.1756-1051.2012.01516.x	79	56	58	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103145	10.1371/journal.pone.0103145	http://dx.doi.org/10.1371/journal.pone.0103145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084460	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000339819800017
J	Thompson, A; Devine, S; Kattan, M; Muir, A				Thompson, Alex; Devine, Scott; Kattan, Mike; Muir, Andrew			Prediction of Treatment Week Eight Response & Sustained Virologic Response in Patients Treated with Boceprevir Plus Peginterferon Alfa and Ribavirin	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ALPHA-2B/RIBAVIRIN P/RBV; SVR; RETREATMENT; TELAPREVIR; INFECTION; RATES	Aim: Sustained virologic response (SVR) can be attained with boceprevir plus peginterferon alfa and ribavirin (PR) in up to 68% of patients, and short duration therapy is possible if plasma HCV RNA levels are undetectable at treatment week 8 (TW8 response). We have developed predictive models for SVR, and TW8 response using data from boceprevir clinical trials. Methods: Regression models were built to predict TW8 response and SVR. Separate models were built for TW8 and SVR using baseline variables only, and compared to models with baseline variables plus HCV RNA change after 4 weeks of PR (TW4 delta). Predictive accuracy was assessed by c-statistics, calibration curves, and decision curve analyses. Nomograms were developed to create clinical decision support tools. Models were externally validated using independent data. Results: The models that included TW4 delta produced the best discrimination ability. The predictive factors for TW8 response (n = 856) were TW4 delta, race, platelet count and ALT. The predictive factors for SVR (n = 522) were TW4 delta, HCV-subtype, gender, BMI, RBV dose and platelet count. The discrimination abilities of these models were excellent (C-statistics = 0.88, 0.80 respectively). Baseline models for TW8 response (n = 444) and SVR (n = 197) had weaker discrimination ability (C-statistic = 0.76, 0.69). External validation confirmed the predictive accuracy of the week 4 models. Conclusions: Models incorporating baseline and treatment week 4 data provide excellent prediction of TW8 response and SVR, and support the clinical utility of the lead-in phase of PR. The nomograms are suitable for point-of-care use to inform individual patient and physician decision-making.	[Thompson, Alex] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; [Devine, Scott] Merck, Whitehouse Stn, NJ 08889 USA; [Kattan, Mike] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Muir, Andrew] Duke Univ, Sch Med, Durham, NC USA	St Vincent's Hospital Melbourne; Merck & Company; Cleveland Clinic Foundation; Duke University	Devine, S (corresponding author), Merck, Whitehouse Stn, NJ 08889 USA.	scott.devine@gmail.com	Kattan, Michael/AAF-9735-2021	Kattan, Michael/0000-0002-3840-4161	project (Merck)	project (Merck)	The funder of this project (Merck) provided support in the form of salaries for authors [SD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Berg T, 2003, HEPATOLOGY, V37, P600, DOI 10.1053/jhep.2003.50106; Bronowicki JP, 2012, J HEPATOL, V56, pS6, DOI 10.1016/S0168-8278(12)60025-7; Elefsiniotis IS, 2009, INTERVIROLOGY, V52, P247, DOI 10.1159/000228548; Flamm SL, 2013, CLIN GASTROENTEROL H, V11, P81, DOI 10.1016/j.cgh.2012.10.006; Harrell F. E., 2011, RMS REGRESSION MODEL; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Harrell Jr F. E., 2011, HMISC HARRELL MISCEL; Harrell Jr FE, 2001, REGRESION MODELING S; Harrell Jr FE, 2011, VAL PROB VALIDATED P; Jacobson IM, 2012, HEPATOLOGY, V56, P567, DOI 10.1002/hep.25865; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lawitz E, 2012, HEPATOLOGY, V56, p216A; Poordad F, 2012, HEPATOLOGY, V56, p269A; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Thompson A, 2011, HEPATOLOGY, V54; Thompson AJ, 2011, HEPATOLOGY, V54, p436A; Van Buuren S., 2011, MICE MULTIVARIATE IM; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	23	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103370	10.1371/journal.pone.0103370	http://dx.doi.org/10.1371/journal.pone.0103370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084272	gold, Green Published			2022-12-27	WOS:000339819800035
J	Cavaretta, JP; Sherer, KR; Lee, KY; Kim, EH; Issema, RS; Chung, HJ				Cavaretta, John P.; Sherer, Kaitlyn R.; Lee, Kwan Young; Kim, Edward H.; Issema, Rodal S.; Chung, Hee Jung			Polarized Axonal Surface Expression of Neuronal KCNQ Potassium Channels Is Regulated by Calmodulin Interaction with KCNQ2 Subunit	PLOS ONE			English	Article							RECEPTOR-MEDIATED INHIBITION; ENDOPLASMIC-RETICULUM; K+ CHANNELS; INITIAL SEGMENT; RETIGABINE EZOGABINE; KV7 CHANNELS; C-TERMINUS; ANKYRIN-G; PROTEIN; EXCITABILITY	KCNQ potassium channels composed of KCNQ2 and KCNQ3 subunits give rise to the M-current, a slow-activating and non-inactivating voltage-dependent potassium current that limits repetitive firing of action potentials. KCNQ channels are enriched at the surface of axons and axonal initial segments, the sites for action potential generation and modulation. Their enrichment at the axonal surface is impaired by mutations in KCNQ2 carboxy-terminal tail that cause benign familial neonatal convulsion and myokymia, suggesting that their correct surface distribution and density at the axon is crucial for control of neuronal excitability. However, the molecular mechanisms responsible for regulating enrichment of KCNQ channels at the neuronal axon remain elusive. Here, we show that enrichment of KCNQ channels at the axonal surface of dissociated rat hippocampal cultured neurons is regulated by ubiquitous calcium sensor calmodulin. Using immunocytochemistry and the cluster of differentiation 4 (CD4) membrane protein as a trafficking reporter, we demonstrate that fusion of KCNQ2 carboxy-terminal tail is sufficient to target CD4 protein to the axonal surface whereas inhibition of calmodulin binding to KCNQ2 abolishes axonal surface expression of CD4 fusion proteins by retaining them in the endoplasmic reticulum. Disruption of calmodulin binding to KCNQ2 also impairs enrichment of heteromeric KCNQ2/KCNQ3 channels at the axonal surface by blocking their trafficking from the endoplasmic reticulum to the axon. Consistently, hippocampal neuronal excitability is dampened by transient expression of wild-type KCNQ2 but not mutant KCNQ2 deficient in calmodulin binding. Furthermore, coexpression of mutant calmodulin, which can interact with KCNQ2/KCNQ3 channels but not calcium, reduces but does not abolish their enrichment at the axonal surface, suggesting that apo calmodulin but not calcium-bound calmodulin is necessary for their preferential targeting to the axonal surface. These findings collectively reveal calmodulin as a critical player that modulates trafficking and enrichment of KCNQ channels at the neuronal axon.	[Cavaretta, John P.; Sherer, Kaitlyn R.; Lee, Kwan Young; Kim, Edward H.; Issema, Rodal S.; Chung, Hee Jung] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Sherer, Kaitlyn R.; Chung, Hee Jung] Univ Illinois, Neurosci Program, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chung, HJ (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	chunghj@life.illinois.edu		Kim, Edward/0000-0003-4098-1002; Issema, Rodal/0000-0001-8818-2803; Chung, Hee Jung/0000-0002-5555-9907; Lee, Kwan Young/0000-0003-2890-0580	March of Dimes Foundation [5-FY11-105]; Roy J. Carver Charitable Trust [11-3887]; University of Illinois at Urbana Champaign	March of Dimes Foundation(March of Dimes); Roy J. Carver Charitable Trust; University of Illinois at Urbana Champaign	This work is supported by Basil O'Connor New Investigator Award 5-FY11-105 (H.J.C.) from March of Dimes Foundation (www.marchofdimes.com), New Investigator Grant 11-3887 (H.J.C.) from Roy J. Carver Charitable Trust (www.carvertrust.org), and ICR Start-up fund from the University of Illinois at Urbana Champaign (H.J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; Bal M, 2010, J NEUROSCI, V30, P2311, DOI 10.1523/JNEUROSCI.5175-09.2010; Borgatti R, 2004, NEUROLOGY, V63, P57, DOI 10.1212/01.WNL.0000132979.08394.6D; BROWN DA, 1981, FED PROC, V40, P2625; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P629, DOI 10.1073/pnas.0811615106; Clark BD, 2009, NEUROSCIENTIST, V15, P651, DOI 10.1177/1073858409341973; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Dencker D, 2008, EPILEPSY BEHAV, V12, P49, DOI 10.1016/j.yebeh.2007.09.023; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Duflocq A, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-66; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Etzioni A, 2011, J NEUROSCI, V31, P14158, DOI 10.1523/JNEUROSCI.2666-11.2011; Fache MP, 2004, J CELL BIOL, V166, P571, DOI 10.1083/jcb.200312155; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Garrido JJ, 2003, BIOL CELL, V95, P437, DOI 10.1016/S0248-4900(03)00091-1; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Geiger J, 2006, NEUROSCI LETT; Gomez-Posada JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025508; Goraya TA, 2005, CELL SIGNAL, V17, P789, DOI 10.1016/j.cellsig.2004.12.017; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Gunthorpe MJ, 2012, EPILEPSIA, V53, P412, DOI 10.1111/j.1528-1167.2011.03365.x; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Halling D Brent, 2006, Sci STKE, V2006, per1; Hansen HH, 2007, EUR J PHARMACOL, V570, P77, DOI 10.1016/j.ejphar.2007.05.029; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Higashida H, 2005, NEUROSCI RES, V51, P231, DOI 10.1016/j.neures.2004.11.009; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Korsgaard MPG, 2005, J PHARMACOL EXP THER, V314, P282, DOI 10.1124/jpet.105.083923; Kosenko A, 2012, EMBO J, V31, P3147, DOI 10.1038/emboj.2012.156; KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315, DOI 10.1091/mbc.6.10.1315; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Large CH, 2012, EPILEPSIA, V53, P425, DOI 10.1111/j.1528-1167.2011.03364.x; Lewis TL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001021; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Liu WJ, 2014, MOL CELL NEUROSCI, V58, P40, DOI 10.1016/j.mcn.2013.12.005; Liu XB, 2012, EPILEPSIA, V53, P45, DOI 10.1111/j.1528-1167.2012.03474.x; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; Maljevic S, 2010, PFLUG ARCH EUR J PHY, V460, P277, DOI 10.1007/s00424-010-0831-3; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mruk K, 2012, P NATL ACAD SCI USA, V109, P13579, DOI 10.1073/pnas.1207606109; Munro G, 2007, J MED CHEM, V50, P2576, DOI 10.1021/jm060989l; Nunez JL, 2009, NEUROSCIENCE, V158, P623, DOI 10.1016/j.neuroscience.2008.09.061; Orth CB, 2007, J COMP NEUROL, V504, P441, DOI 10.1002/cne.21445; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Rasmussen HB, 2007, J CELL SCI, V120, P953, DOI 10.1242/jcs.03396; Regev N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006586; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Roche JP, 2002, BRIT J PHARMACOL, V137, P1173, DOI 10.1038/sj.bjp.0704989; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; Saitsu H, 2012, ANN NEUROL, V72, P298, DOI 10.1002/ana.23620; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sanchez-Ponce D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048557; Schmitt B, 2005, EPILEPSY RES, V65, P161, DOI 10.1016/j.eplepsyres.2005.05.009; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Shah MM, 2011, J PHYSIOL-LONDON, V589, P6029, DOI 10.1113/jphysiol.2011.220913; Shahidullah M, 2005, P NATL ACAD SCI USA, V102, P16454, DOI 10.1073/pnas.0503966102; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Terasaki M, 1996, DEV BIOL, V179, P320, DOI 10.1006/dbio.1996.0263; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P10232, DOI 10.1073/pnas.1004644107; Tzingounis AV, 2008, P NATL ACAD SCI USA, V105, P19974, DOI 10.1073/pnas.0810535105; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Weber YG, 2006, BRAIN RES; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu WW, 2008, J NEUROPHYSIOL, V100, P1897, DOI 10.1152/jn.90346.2008; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu Q, 2013, J MOL BIOL, V425, P378, DOI 10.1016/j.jmb.2012.11.023; Yap CC, 2008, J CELL SCI, V121, P1514, DOI 10.1242/jcs.022442; Yap CC, 2008, J CELL BIOL, V180, P827, DOI 10.1083/jcb.200707143; Yue C, 2006, J NEUROPHYSIOL; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	99	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103655	10.1371/journal.pone.0103655	http://dx.doi.org/10.1371/journal.pone.0103655			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077630	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800064
J	Das, A; Barker, DA; Wang, T; Lau, CM; Lin, Y; Botchwey, EA				Das, Anusuya; Barker, Daniel A.; Wang, Tiffany; Lau, Cheryl M.; Lin, Yong; Botchwey, Edward A.			Delivery of Bioactive Lipids from Composite Microgel-Microsphere Injectable Scaffolds Enhances Stem Cell Recruitment and Skeletal Repair	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; ENDOTHELIAL GROWTH-FACTOR; IN-VITRO DEGRADATION; SPHINGOSINE 1-PHOSPHATE; DEFECT MODEL; REGENERATION; FTY720; TISSUE; SPHINGOSINE-1-PHOSPHATE; RABBIT	In this study, a microgel composed of chitosan and inorganic phosphates was used to deliver poly(lactic-co-glycolic acid) (PLAGA) microspheres loaded with sphingolipid growth factor FTY720 to critical size cranial defects in Sprague Dawley rats. We show that sustained release of FTY720 from injected microspheres used alone or in combination with recombinant human bone morphogenic protein-2 (rhBMP2) improves defect vascularization and bone formation in the presence and absence of rhBMP2 as evaluated by quantitative microCT and histological measurements. Moreover, sustained delivery of FTY720 from PLAGA and local targeting of sphingosine 1-phosphate (S1P) receptors reduces CD45+ inflammatory cell infiltration, promotes endogenous recruitment of CD29+CD90+ bone progenitor cells and enhances the efficacy of rhBMP2 from chitosan microgels. Companion in vitro studies suggest that selective activation of sphingosine receptor subtype-3 (S1P(3)) via FTY720 treatment induces smad-1 phosphorylation in bone-marrow stromal cells. Additionally, FTY720 enhances stromal cell-derived factor-1 (SDF-1) mediated chemotaxis of CD90+CD11B-CD45- bone progenitor cells in vitro after stimulation with rhBMP2. We believe that use of such small molecule delivery formulations to recruit endogenous bone progenitors may be an attractive alternative to exogenous cell-based therapy.	[Das, Anusuya] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA; [Das, Anusuya; Lin, Yong] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Barker, Daniel A.] Univ Virginia, Dept Otolaryngol, Charlottesville, VA USA; [Wang, Tiffany; Lau, Cheryl M.; Botchwey, Edward A.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA	University of Virginia; University of Virginia; University of Virginia; University System of Georgia; Georgia Institute of Technology	Das, A (corresponding author), Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA.	ad8rt@virginia.edu; Edward.Botchwey@bme.gatech	Lin, Yong/I-4505-2016; , Yong/T-4079-2019	Lin, Yong/0000-0002-2839-5740; 	National Institutes of Health [R01 DE019935]; NIH [R01 AR056445]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health R01 DE019935 and NIH R01 AR056445. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita S, 2004, WOUND REPAIR REGEN, V12, P252, DOI 10.1111/j.1067-1927.2004.012118.x; Argraves KM, 2008, J BIOL CHEM, V283, P25074, DOI 10.1074/jbc.M801214200; Aronin CEP, 2010, BIOMATERIALS, V31, P6417, DOI 10.1016/j.biomaterials.2010.04.061; Aronin CEP, 2010, TISSUE ENG PT A, V16, P1801, DOI [10.1089/ten.tea.2009.0539, 10.1089/ten.TEA.2009.0539]; Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110; Bayless KJ, 2003, BIOCHEM BIOPH RES CO, V312, P903, DOI 10.1016/j.bbrc.2003.11.017; Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001; CAPLAN AI, 1983, CLIN ORTHOP RELAT R, P243; Cooper PR, 2010, J DENT, V38, P687, DOI 10.1016/j.jdent.2010.05.016; Das A, 2014, J BIOMED MATER RES A, V102, P1210, DOI 10.1002/jbm.a.34779; Das A, 2013, BIOMATERIALS, V34, P9853, DOI 10.1016/j.biomaterials.2013.08.015; DRUSHEL RF, 1985, CELL DIFFER DEV, V16, P13, DOI 10.1016/0045-6039(85)90603-7; Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264; Gomez G, 2006, J CRANIOFAC SURG, V17, P935; Hou R, 2005, ZHONGGUI XIU FU CHON, V19, P8818; Hou R, 2007, J BIOMED MATER RES A, V80A, P85, DOI 10.1002/jbm.a.30840; Huang C, 2012, CELL TISSUE RES, V347, P553, DOI 10.1007/s00441-011-1217-3; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Kalazic I, 2007, J BONE MINER RES, V22, pS61; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Keul P, 2011, CIRC RES, V108, P314, DOI 10.1161/CIRCRESAHA.110.235028; Kimura T, 2004, BLOOD, V103, P4478, DOI 10.1182/blood-2003-03-0875; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F; Mathews S, 2011, CELL PROLIFERAT, V44, P537, DOI 10.1111/j.1365-2184.2011.00788.x; Meno-Tetang GML, 2006, DRUG METAB DISPOS, V34, P1480, DOI 10.1124/dmd.105.009001; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Nair LS, 2007, BIOMACROMOLECULES, V8, P3779, DOI 10.1021/bm7006967; Nyangoga H, 2010, ACTA BIOMATER, V6, P3310, DOI 10.1016/j.actbio.2010.01.042; Oktay EO, 2010, J ORAL IMPLANTOL, V36, P175, DOI 10.1563/AAID-JOI-D-09-00023; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; Ratanavaraporn J, 2012, BIOMATERIALS, V33, P304, DOI 10.1016/j.biomaterials.2011.09.050; Rau CR, 2011, AM J PATHOL, V178, P1770, DOI 10.1016/j.ajpath.2011.01.003; REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3; Roelofsen T, 2008, J CELL BIOCHEM, V105, P1128, DOI 10.1002/jcb.21915; Roviezzo F, 2011, J PHARMACOL EXP THER, V337, P830, DOI 10.1124/jpet.111.179168; Rumi MN, 2005, J ORTHOP RES, V23, P34, DOI 10.1016/j.orthres.2004.05.003; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Sato C, 2012, BIOCHEM BIOPH RES CO, V423, P200, DOI 10.1016/j.bbrc.2012.05.130; Sefcik LS, 2011, TISSUE ENG PT A, V17, P617, DOI [10.1089/ten.tea.2010.0404, 10.1089/ten.TEA.2010.0404]; Shinohara K, 2011, J ORTHOP RES, V29, P1064, DOI 10.1002/jor.21374; Siu RK, 2012, TISSUE ENG PT A, V18, P252, DOI [10.1089/ten.tea.2011.0142, 10.1089/ten.TEA.2011.0142]; Stephan SJ, 2010, LARYNGOSCOPE, V120, P895, DOI 10.1002/lary.20624; TRUETA J, 1960, J BONE JOINT SURG BR, V42, P367, DOI 10.1302/0301-620X.42B2.367; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Volarevic V, 2011, STEM CELLS, V29, P5, DOI 10.1002/stem.556; Walker DH, 2007, ARTERIOSCLER THRMOB, V27, P275; Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131; Woo EJ, 2013, CLIN ORTHOP RELAT R, V471, P1707, DOI 10.1007/s11999-012-2684-x; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yonamine Y, 2010, ORAL SURG ORAL MED O, V109, P225, DOI 10.1016/j.tripleo.2009.09.010; Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510; Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200	56	25	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101276	10.1371/journal.pone.0101276	http://dx.doi.org/10.1371/journal.pone.0101276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077607	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800004
J	Greyling, A; Ras, RT; Zock, PL; Lorenz, M; Hopman, MT; Thijssen, DHJ; Draijer, R				Greyling, Arno; Ras, Rouyanne T.; Zock, Peter L.; Lorenz, Mario; Hopman, Maria T.; Thijssen, Dick H. J.; Draijer, Richard			The Effect of Black Tea on Blood Pressure: A Systematic Review with Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							CLINICAL-TRIALS; CONSUMPTION; FLAVONOIDS; RISK; MORTALITY; STROKE; GREEN; DRINKING; CORONARY; IMPACT	Objective: Epidemiological evidence has linked consumption of black tea, produced from Camellia sinensis, with a reduced risk of cardiovascular diseases. However, intervention studies on the effects of tea consumption on blood pressure (BP) have reported inconsistent results. Our objective was to conduct a systematic literature review with meta-analysis of controlled human intervention studies examining the effect of tea consumption on BP. Methods: We systematically searched Medline, Biosis, Chemical Abstracts and EMBASE databases through July 2013. For inclusion, studies had to meet the following pre-defined criteria: 1) placebo controlled design in human adults, 2) minimum of 1 week black tea consumption as the sole intervention, 3) reported effects on systolic BP (SBP) or diastolic BP (DBP) or both. A random effects model was used to calculate the pooled overall effect of black tea on BP. Results: Eleven studies (12 intervention arms, 378 subjects, dose of 4-5 cups of tea) met our inclusion criteria. The pooled mean effect of regular tea ingestion was -1.8 mmHg (95% CI: -2.8, -0.7; P = 0.0013) for SBP and -1.3 mmHg (95% CI: - 1.8, -0.8; P<0.0001) for DBP. In covariate analyses, we found that the method of tea preparation (tea extract powders versus leaf tea), baseline SBP and DBP, and the quality score of the study affected the effect size of the tea intervention (all P<0.05). No evidence of publication bias could be detected. Conclusions: Our meta-analysis indicates that regular consumption of black tea can reduce BP. Although the effect is small, such effects could be important for cardiovascular health at population level.	[Greyling, Arno; Ras, Rouyanne T.; Zock, Peter L.; Draijer, Richard] Unilever Res Labs, Vlaardingen, Netherlands; [Greyling, Arno; Hopman, Maria T.; Thijssen, Dick H. J.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6525 ED Nijmegen, Netherlands; [Zock, Peter L.] Top Inst Food & Nutr, Wageningen, Netherlands; [Lorenz, Mario] Charite, Dept Cardiol & Angiol, D-13353 Berlin, Germany; [Lorenz, Mario] DZHK German Ctr Cardiovasc Res, Berlin, Germany; [Thijssen, Dick H. J.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England	Unilever; Radboud University Nijmegen; Top Institute Food & Nutrition; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Liverpool John Moores University	Greyling, A (corresponding author), Unilever Res Labs, Vlaardingen, Netherlands.	arno.greyling@unilever.com	Thijssen, Dick HJ/E-8731-2016; Hopman, Maria/A-4205-2014; Thijssen, Dick/D-3430-2009	Thijssen, Dick HJ/0000-0002-7707-5567; Lorenz, Mario/0000-0001-5267-4101; Greyling, Arno/0000-0002-9633-1546; Zock, Peter/0000-0002-0322-0565	Unilever RD Vlaardingen; Netherlands Heart Foundation [2009T064]	Unilever RD Vlaardingen(Unilever); Netherlands Heart Foundation(Netherlands Heart Foundation)	Unilever R&D Vlaardingen is the funder of this review and four of the authors are employed by this company. All authors were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript. DHJT is supported by the Netherlands Heart Foundation (2009T064).	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Arab L, 2009, STROKE, V40, P1786, DOI 10.1161/STROKEAHA.108.538470; Astill C, 2001, J AGR FOOD CHEM, V49, P5340, DOI 10.1021/jf010759+; Bingham SA, 1997, BRIT J NUTR, V78, P41, DOI 10.1079/BJN19970117; Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dharmashankar K, 2010, CURR HYPERTENS REP, V12, P448, DOI 10.1007/s11906-010-0150-2; Dong JY, 2011, BRIT J NUTR, V106, P317, DOI 10.1017/S0007114511000262; Duffy SJ, 2001, CIRCULATION, V104, P151, DOI 10.1161/01.CIR.104.2.151; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FITZPATRICK DF, 1995, J CARDIOVASC PHARM, V26, P90, DOI 10.1097/00005344-199507000-00015; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Grassi D, 2012, CIRCULATION, V125; Grassi D, 2008, J NUTR, V138, P1554; Grassi D, 2009, J HYPERTENS, V27, P774, DOI 10.1097/HJH.0b013e328326066c; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hodgson JM, 2003, J NUTR, V133, P2883, DOI 10.1093/jn/133.9.2883; Hodgson JM, 2002, CLIN SCI, V102, P195, DOI 10.1042/CS20010120; Hodgson JM, 1999, J HYPERTENS, V17, P457, DOI 10.1097/00004872-199917040-00002; Hodgson JM, 2012, ARCH INTERN MED, V172, P186, DOI 10.1001/archinte.172.2.186; Hodgson JM, 2010, MOL ASPECTS MED, V31, P495, DOI 10.1016/j.mam.2010.09.004; Hooper L, 2008, AM J CLIN NUTR, V88, P38, DOI 10.1093/ajcn/88.1.38; Kay CD, 2012, MOL NUTR FOOD RES, V56, P1605, DOI 10.1002/mnfr.201200363; Larsson SC, 2013, ANN EPIDEMIOL, V23, P157, DOI 10.1016/j.annepidem.2012.12.006; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; McCullough ML, 2012, AM J CLIN NUTR, V95, P454, DOI 10.3945/ajcn.111.016634; Mukamal KJ, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.07.008; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Organization WH, 2009, GLOB HLTH RISKS MORT; Peterson JJ, 2012, NUTR REV, V70, P491, DOI 10.1111/j.1753-4887.2012.00508.x; Ras RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016974; Ried K, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008893.pub2, 10.1002/14651858.CD008893.pub3]; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Schreuder THA, 2014, APPL PHYSIOL NUTR ME, V39, P145, DOI 10.1139/apnm-2012-0450; Shen L, 2012, J ZHEJIANG UNIV-SC B, V13, P652, DOI 10.1631/jzus.B1201001; Song WO, 2008, J NUTR, V138, P1543; STENSVOLD I, 1992, PREV MED, V21, P546, DOI 10.1016/0091-7435(92)90062-M; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Taubert D, 2007, ARCH INTERN MED, V167, P626, DOI 10.1001/archinte.167.7.626; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Vogiatzoglou A, 2013, BR J NUTR, P1; Zamora-Ros R, 2013, EUR J CLIN NUTR, V67, P779, DOI 10.1038/ejcn.2013.89	48	55	58	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103247	10.1371/journal.pone.0103247	http://dx.doi.org/10.1371/journal.pone.0103247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079225	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800035
J	Lin, JY; Li, ML; Brewer, G				Lin, Jing-Yi; Li, Mei-Ling; Brewer, Gary			mRNA Decay Factor AUF1 Binds the Internal Ribosomal Entry Site of Enterovirus 71 and Inhibits Virus Replication	PLOS ONE			English	Article							MOUTH-DISEASE; HOST FACTORS; HNRNP A1; PROTEIN; ELEMENT; TRANSLATION; INFECTION; INTERACTS; INITIATION; OUTBREAK	AU-rich element binding factor 1 (AUF1) has a role in the replication cycles of different viruses. Here we demonstrate that AUF1 binds the internal ribosome entry site (IRES) of enterovirus 71 (EV71) and negatively regulates IRES-dependent translation. During EV71 infection, AUF1 accumulates in the cytoplasm where viral replication occurs, whereas AUF1 localizes predominantly in the nucleus in mock-infected cells. AUF1 knockdown in infected cells increases IRES activity and synthesis of viral proteins. Taken together, the results suggest that AUF1 interacts with the EV71 IRES to negatively regulate viral translation and replication.	[Lin, Jing-Yi] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Li, Mei-Ling; Brewer, Gary] Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Taipei Medical University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Brewer, G (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	brewerga@rwjms.rutgers.edu		Lin, Jing-Yi/0000-0002-5692-5657	National Institutes of Health [R01 CA052443]; Taiwan NCS [102-2320-B-038-055-MY3]; Taipei Medical University [TMU102-AE1-B24]; NATIONAL CANCER INSTITUTE [R01CA052443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan NCS; Taipei Medical University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health, R01 CA052443; Taiwan NCS grant 102-2320-B-038-055-MY3; Taipei Medical University grant TMU102-AE1-B24. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Cathcart AL, 2014, J GEN VIROL IN PRESS; Cathcart AL, 2013, J VIROL, V87, P10423, DOI 10.1128/JVI.01049-13; Cook HL, 2004, MOL CELL BIOL, V24, P4522, DOI 10.1128/MCB.24.10.4522-4533.2004; Dempsey LA, 1998, J BIOL CHEM, V273, P29224, DOI 10.1074/jbc.273.44.29224; Fuentes-Panana EM, 2000, J VIROL, V74, P8166, DOI 10.1128/JVI.74.17.8166-8175.2000; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Hino K, 2013, J VIROL, V87, P6582, DOI 10.1128/JVI.02495-12; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang PN, 2011, NUCLEIC ACIDS RES, V39, P9633, DOI 10.1093/nar/gkr682; Hutin S, 2013, J VIROL, V87, P4672, DOI 10.1128/JVI.00159-13; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Knapinska AM, 2011, MOL CELL BIOL, V31, P1419, DOI 10.1128/MCB.00907-10; KRAUSSLICH HG, 1987, J VIROL, V61, P2711; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lee N, 2012, RNA, V18, P2073, DOI 10.1261/rna.034900.112; Lenarcic EM, 2013, J VIROL, V87, P8697, DOI 10.1128/JVI.00950-13; Levengood JD, 2013, RNA BIOL, V10, P1136, DOI 10.4161/rna.25107; Li ML, 2008, J VIROL, V82, P6880, DOI 10.1128/JVI.00517-08; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Lin JY, 2009, NUCLEIC ACIDS RES, V37, P47, DOI 10.1093/nar/gkn901; Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106; Lund N, 2012, NUCLEIC ACIDS RES, V40, P3663, DOI 10.1093/nar/gkr1238; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Paek KY, 2008, J VIROL, V82, P12082, DOI 10.1128/JVI.01405-08; Rozovics JM, 2012, MBIO, V3, DOI 10.1128/mBio.00431-12; Rui E, 2001, VIRUS RES, V74, P59, DOI 10.1016/S0168-1702(00)00245-8; RUTKA JT, 1987, ACTA NEUROPATHOL, V75, P92, DOI 10.1007/BF00686798; Shih SR, 2011, J VIROL, V85, P9658, DOI 10.1128/JVI.05063-11; Shih SR, 2004, J BIOMED SCI, V11, P239, DOI 10.1159/000076036; Sinsimer KS, 2008, MOL CELL BIOL, V28, P5223, DOI 10.1128/MCB.00431-08; Sweeney TR, 2014, EMBO J, V33, P76, DOI 10.1002/embj.201386124; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Wong J, 2013, FASEB J, V27, P2777, DOI 10.1096/fj.12-226498; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Yasumura Y., 1963, NIPPON RINSHO, V21, P9; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zucconi BE, 2010, J BIOL CHEM, V285, P39127, DOI 10.1074/jbc.M110.180182; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103827	10.1371/journal.pone.0103827	http://dx.doi.org/10.1371/journal.pone.0103827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077793	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800085
J	Seo, JH; Maki, T; Maeda, M; Miyamoto, N; Liang, AC; Hayakawa, K; Pham, LDD; Suwa, F; Taguchi, A; Matsuyama, T; Ihara, M; Kim, KW; Lo, EH; Arai, K				Seo, Ji Hae; Maki, Takakuni; Maeda, Mitsuyo; Miyamoto, Nobukazu; Liang, Anna C.; Hayakawa, Kazuhide; Pham, Loc-Duyen D.; Suwa, Fumihiko; Taguchi, Akihiko; Matsuyama, Tomohiro; Ihara, Masafumi; Kim, Kyu-Won; Lo, Eng H.; Arai, Ken			Oligodendrocyte Precursor Cells Support Blood-Brain Barrier Integrity via TGF-beta Signaling	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-BETA; CEREBRAL ENDOTHELIUM; NEUROVASCULAR NICHE; IN-VITRO; STROKE; MECHANISMS; PERICYTES; DISEASE; INJURY	Trophic coupling between cerebral endothelium and their neighboring cells is required for the development and maintenance of blood-brain barrier (BBB) function. Here we report that oligodendrocyte precursor cells (OPCs) secrete soluble factor TGF-beta 1 to support BBB integrity. Firstly, we prepared conditioned media from OPC cultures and added them to cerebral endothelial cultures. Our pharmacological experiments showed that OPC-conditioned media increased expressions of tight-junction proteins and decreased in vitro BBB permeability by activating TGB-b-receptor-MEK/ERK signaling pathway. Secondly, our immuno-electron microscopic observation revealed that in neonatal mouse brains, OPCs attach to cerebral endothelial cells via basal lamina. And finally, we developed a novel transgenic mouse line that TGF-beta 1 is knocked down specifically in OPCs. Neonates of these OPC-specific TGF-beta 1 deficient mice (OPC-specific TGF-beta 1 partial KO mice: Pdgfra(Cre)/Tgfb1(flox/wt) mice or OPC-specific TGF-beta 1 total KO mice: Pdgfra(Cre)/Tgfb1(flox/flox) mice) exhibited cerebral hemorrhage and loss of BBB function. Taken together, our current study demonstrates that OPCs increase BBB tightness by upregulating tight junction proteins via TGF-beta signaling. Although astrocytes and pericytes are well-known regulators of BBB maturation and maintenance, these findings indicate that OPCs also play a pivotal role in promoting BBB integrity.	[Seo, Ji Hae; Maki, Takakuni; Miyamoto, Nobukazu; Liang, Anna C.; Hayakawa, Kazuhide; Pham, Loc-Duyen D.; Lo, Eng H.; Arai, Ken] Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Charlestown, MA 02129 USA; [Seo, Ji Hae; Maki, Takakuni; Miyamoto, Nobukazu; Liang, Anna C.; Hayakawa, Kazuhide; Pham, Loc-Duyen D.; Lo, Eng H.; Arai, Ken] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Seo, Ji Hae; Maki, Takakuni; Miyamoto, Nobukazu; Liang, Anna C.; Hayakawa, Kazuhide; Pham, Loc-Duyen D.; Lo, Eng H.; Arai, Ken] Harvard Univ, Sch Med, Charlestown, MA USA; [Seo, Ji Hae; Kim, Kyu-Won] Seoul Natl Univ, Coll Pharm, SNU Harvard NeuroVasc Protect Res Ctr, Seoul, South Korea; [Seo, Ji Hae; Kim, Kyu-Won] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Maeda, Mitsuyo; Suwa, Fumihiko] Osaka Dent Univ, Dept Anat, Osaka, Japan; [Maeda, Mitsuyo; Taguchi, Akihiko] Inst Biomed Res & Innovat, Dept Regenerat Med, Kobe, Hyogo, Japan; [Matsuyama, Tomohiro] Hyogo Coll Med, Inst Adv Med Sci, Lab Neurogenesis & CNS Repair, Nishinomiya, Hyogo, Japan; [Ihara, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Osaka, Japan; [Kim, Kyu-Won] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Kim, Kyu-Won] Seoul Natl Univ, Coll Med, Coll Pharm, Seoul, South Korea	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Seoul National University (SNU); Seoul National University (SNU); Institute for Biomedical Research & Innovation (IBRI); Hyogo College of Medicine; National Cerebral & Cardiovascular Center - Japan; Seoul National University (SNU); Seoul National University (SNU)	Lo, EH (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, Charlestown, MA 02129 USA.	lo@helix.mgh.harvard.edu; karai@partners.org	Kim, Kyu Won/AAJ-7213-2020; Ihara, Masafumi/O-5020-2019; 眞木, 崇州/AAO-1160-2020	Ihara, Masafumi/0000-0002-7102-4048; 	National Institutes of Health; National Research Foundation of Korea through the Global Research Laboratory Program [2011-0021874]; National Research Foundation of Korea through the Basic Science Research Program [2011-357-E00022]; Uehara Memorial Foundation; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055104, R37NS037074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea through the Global Research Laboratory Program(National Research Foundation of Korea); National Research Foundation of Korea through the Basic Science Research Program(National Research Foundation of Korea); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by the National Institutes of Health, National Research Foundation of Korea through the Global Research Laboratory Program (2011-0021874), Basic Science Research Program (2011-357-E00022), the Uehara Memorial Foundation, and the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Arai K, 2009, BIOL PHARM BULL, V32, P1639, DOI 10.1248/bpb.32.1639; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Carmichael ST, 2010, STROKE, V41, pS124, DOI 10.1161/STROKEAHA.110.597146; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Garcia CM, 2004, DEV BRAIN RES, V152, P25, DOI 10.1016/j.devbrainres.2004.05.008; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hayakawa K, 2012, NEUROSCI LETT, V513, P42, DOI 10.1016/j.neulet.2012.02.004; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; Maki T, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00275; Maki T, 2013, CNS NEUROL DISORD-DR, V12, P302, DOI 10.2174/1871527311312030004; Manole MD, 2011, CURR PHARM DESIGN, V17, P3854; Miyamoto N, 2014, CELL MOL LIFE SCI, V71, P1055, DOI 10.1007/s00018-013-1488-9; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Pallast S, 2009, J NEUROCHEM, V111, P882, DOI 10.1111/j.1471-4159.2009.06379.x; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Ronaldson PT, 2012, CURR PHARM DESIGN, V18, P3624; Seo JH, 2013, J CLIN INVEST, V123, P782, DOI 10.1172/JCI65863; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Zhang RL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00201; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	46	96	99	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103174	10.1371/journal.pone.0103174	http://dx.doi.org/10.1371/journal.pone.0103174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078775	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800032
J	Zhao, YJ; Rennaker, RL; Hutchens, C; Ibrahim, TS				Zhao, Yujuan; Rennaker, Robert L.; Hutchens, Chris; Ibrahim, Tamer S.			Implanted Miniaturized Antenna for Brain Computer Interface Applications: Analysis and Design	PLOS ONE			English	Article							TRANSMISSION; COMMUNICATION; EXCITATION; FREQUENCY	Implantable Brain Computer Interfaces (BCIs) are designed to provide real-time control signals for prosthetic devices, study brain function, and/or restore sensory information lost as a result of injury or disease. Using Radio Frequency (RF) to wirelessly power a BCI could widely extend the number of applications and increase chronic in-vivo viability. However, due to the limited size and the electromagnetic loss of human brain tissues, implanted miniaturized antennas suffer low radiation efficiency. This work presents simulations, analysis and designs of implanted antennas for a wireless implantable RF-powered brain computer interface application. The results show that thin (on the order of 100 micrometers thickness) biocompatible insulating layers can significantly impact the antenna performance. The proper selection of the dielectric properties of the biocompatible insulating layers and the implantation position inside human brain tissues can facilitate efficient RF power reception by the implanted antenna. While the results show that the effects of the human head shape on implanted antenna performance is somewhat negligible, the constitutive properties of the brain tissues surrounding the implanted antenna can significantly impact the electrical characteristics (input impedance, and operational frequency) of the implanted antenna. Three miniaturized antenna designs are simulated and demonstrate that maximum RF power of up to 1.8 milli-Watts can be received at 2 GHz when the antenna implanted around the dura, without violating the Specific Absorption Rate (SAR) limits.	[Zhao, Yujuan; Ibrahim, Tamer S.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Rennaker, Robert L.] Univ Texas Dallas, Erik Jonsson Sch Engn, Richardson, TX 75083 USA; [Hutchens, Chris] Oklahoma State Univ, Sch Elect & Comp Engn, Stillwater, OK 74078 USA; [Ibrahim, Tamer S.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Dallas; Oklahoma State University System; Oklahoma State University - Stillwater; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ibrahim, TS (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	tibrahim@pitt.edu	Hutchens, Chriswell/F-1472-2016; Rennaker II, Robert/K-9049-2013	Rennaker II, Robert/0000-0003-1260-1973	NIH [R01NS062065]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062065] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01NS062065 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti G, 2001, J MEMBRANE SCI, V185, P73, DOI 10.1016/S0376-7388(00)00635-9; Andreuccetti D., 1997, CALCULATION DIELECTR; [Anonymous], 1998, HEALTH PHYS, V74, P494; Balanis C. A., 2005, ANTENNA THEORY ANAL; Chen ZN, 2009, IEEE T ANTENN PROPAG, V57, P1850, DOI 10.1109/TAP.2009.2019933; Chestek CA, 2009, IEEE T NEUR SYS REH, V17, P330, DOI 10.1109/TNSRE.2009.2023293; Endo T, 2000, ELECTRON COMM JPN 2, V83, P52, DOI 10.1002/(SICI)1520-6432(200001)83:1<52::AID-ECJB7>3.0.CO;2-7; Farshchi S, 2010, IEEE T NEUR SYS REH, V18, P134, DOI 10.1109/TNSRE.2009.2039606; Fenwick R.C., 1963, IEEE T ANTENN PROPAG, V11, P296; Gosalia K, 2004, IEEE T MICROW THEORY, V52, P1925, DOI 10.1109/TMTT.2004.832007; Hall P.S., 2006, ANTENNAS PROPAGATION; Harrison RR, 2009, IEEE T NEUR SYS REH, V17, P322, DOI 10.1109/TNSRE.2009.2023298; Hertel TW, 2003, IEEE T ANTENN PROPAG, V51, P1771, DOI 10.1109/TAP.2003.815414; Hutchens C, 2011, IEEE ENG MED BIO, P2886, DOI 10.1109/IEMBS.2011.6090796; Ibrahim TS, 2007, J MAGN RESON IMAGING, V26, P1362, DOI 10.1002/jmri.21148; Ibrahim TS, 2009, NMR BIOMED, V22, P927, DOI 10.1002/nbm.1406; Ibrahim TS, 2001, MAGN RESON IMAGING, V19, P1339, DOI 10.1016/S0730-725X(01)00404-0; IEEE, 2005, IEEE STAND SAF LEV R; Irazoqui PP, 2005, IEEE ENG MED BIOL, V24, P48, DOI 10.1109/MEMB.2005.1549730; Kim J, 2004, IEEE T MICROW THEORY, V52, P1934, DOI 10.1109/TMTT.2004.832018; Kim S, 2007, SENSOR ACTUAT A-PHYS, V136, P467, DOI 10.1016/j.sna.2006.10.048; King R. W. P., 1981, ANTENNAS MATTER FUND; Kiourti A, 2013, BIOELECTROMAGNETICS, V34, P167, DOI 10.1002/bem.21753; Kobayashi T, 1998, SOLID STATE IONICS, V106, P219, DOI 10.1016/S0167-2738(97)00512-2; Krishnamurthy N, 2013, J MAGN RESON IMAGING; MALONEY JG, 1994, IEEE T ANTENN PROPAG, V42, P289, DOI 10.1109/8.277228; MALONEY JG, 1992, IEEE T ANTENN PROPAG, V40, P323, DOI 10.1109/8.135475; Merli F, 2011, IEEE T ANTENN PROPAG, V59, P21, DOI 10.1109/TAP.2010.2090465; NAKANO H, 1984, IEEE T ANTENN PROPAG, V32, P385, DOI 10.1109/TAP.1984.1143321; Poon ASY, 2010, IEEE T ANTENN PROPAG, V58, P1739, DOI 10.1109/TAP.2010.2044310; Skrivervik AK, 2001, IEEE ANTENN PROPAG M, V43, P12, DOI 10.1109/74.951556; Song YK, 2009, IEEE T NEUR SYS REH, V17, P339, DOI 10.1109/TNSRE.2009.2024310; Soontornpipit P, 2004, IEEE T MICROW THEORY, V52, P1944, DOI 10.1109/TMTT.2004.831976; Taflove A., 2005, FINITE DIFFERENCE TI, V2010, P1006; Tang L, 2011, CONCEPT MAGN RESON B, V39B, P11, DOI 10.1002/cmr.b.20185; Warty R, 2008, IEEE T MICROW THEORY, V56, P2366, DOI 10.1109/TMTT.2008.2004254; Yakovlev A, 2012, IEEE COMMUN MAG, V50, P152, DOI 10.1109/MCOM.2012.6178849; Zhao HP, 2009, IEEE ANTENN WIREL PR, V8, P1131, DOI 10.1109/LAWP.2009.2034398; Zhao YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077759	39	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103945	10.1371/journal.pone.0103945	http://dx.doi.org/10.1371/journal.pone.0103945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079941	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000339954800099
J	Favaro, L; Ozella, L; Pessani, D				Favaro, Livio; Ozella, Laura; Pessani, Daniela			The Vocal Repertoire of the African Penguin (Spheniscus demersus): Structure and Function of Calls	PLOS ONE			English	Article							INDIVIDUAL RECOGNITION; BEHAVIOR; EMOTION; JITTER; BIRDS; FORM; AGE	The African Penguin (Spheniscus demersus) is a highly social and vocal seabird. However, currently available descriptions of the vocal repertoire of African Penguin are mostly limited to basic descriptions of calls. Here we provide, for the first time, a detailed description of the vocal behaviour of this species by collecting audio and video recordings from a large captive colony. We combine visual examinations of spectrograms with spectral and temporal acoustic analyses to determine vocal categories. Moreover, we used a principal component analysis, followed by signal classification with a discriminant function analysis, for statistical validation of the vocalisation types. In addition, we identified the behavioural contexts in which calls were uttered. The results show that four basic vocalisations can be found in the vocal repertoire of adult African Penguin, namely a contact call emitted by isolated birds, an agonistic call used in aggressive interactions, an ecstatic display song uttered by single birds, and a mutual display song vocalised by pairs, at their nests. Moreover, we identified two distinct vocalisations interpreted as begging calls by nesting chicks (begging peep) and unweaned juveniles (begging moan). Finally, we discussed the importance of specific acoustic parameters in classifying calls and the possible use of the source-filter theory of vocal production to study penguin vocalisations.	[Favaro, Livio; Ozella, Laura; Pessani, Daniela] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	University of Turin	Favaro, L (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	livio.favaro@unito.it	Ozella, Laura/ABD-9898-2020; Favaro, Livio/B-8337-2013	Favaro, Livio/0000-0002-8698-472X; Ozella, Laura/0000-0001-7371-3309	Fiat Group Automobiles S.p.A. (Verrone plant) research grant; University of Torino; Italian Ministry of Instruction University and Research	Fiat Group Automobiles S.p.A. (Verrone plant) research grant; University of Torino; Italian Ministry of Instruction University and Research(Ministry of Education, Universities and Research (MIUR))	Livio Favaro is a Postdoctoral Researcher at the University of Torino and was supported for part of this study by a Fiat Group Automobiles S.p.A. (Verrone plant) research grant. Laura Ozella is supported by the University of Torino and the Italian Ministry of Instruction University and Research with a PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom Per, 2003, Bulletin of the British Ornithologists' Club, V123A, P114; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Aubin T, 2000, P ROY SOC B-BIOL SCI, V267, P1081, DOI 10.1098/rspb.2000.1112; Aubin T, 2004, AN ACAD BRAS CIENC, V76, P279, DOI 10.1590/S0001-37652004000200015; BACHOROWSKI JA, 1995, PSYCHOL SCI, V6, P219, DOI 10.1111/j.1467-9280.1995.tb00596.x; Baldo S, 2011, J FIELD ORNITHOL, V82, P249, DOI 10.1111/j.1557-9263.2011.00328.x; Barham PJ, 2006, OSTRICH, V77, P202, DOI 10.2989/00306520609485534; Barros KS, 2011, ETHOLOGY, V117, P83, DOI 10.1111/j.1439-0310.2010.01853.x; BIRDLIFE INTERNATIONAL, 2012, IUCN 2012 IUCN RED L; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Boersma P, 2004, STEM SPRAAK TAALPATH, V12, P237; Boersma P., 2013, PRAAT DOING PHONETIC; Boersma P, 2009, FOLIA PHONIATR LOGO, V61, P305, DOI 10.1159/000245159; Boersma PD, 1976, LIVING BIRD, V15, P43; Borker AL, 2014, CONSERV BIOL, V28, P1100, DOI 10.1111/cobi.12264; Brandes TS, 2008, BIRD CONSERV INT, V18, pS163, DOI 10.1017/S0959270908000415; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; Brockmann M, 2011, J VOICE, V25, P44, DOI 10.1016/j.jvoice.2009.07.002; Budka M, 2013, ETHOLOGY, V119, P960, DOI 10.1111/eth.12141; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Cheng JK, 2012, BIOACOUSTICS, V21, P157, DOI 10.1080/09524622.2012.669664; Crawford RJM, 2011, AFR J MAR SCI, V33, P139, DOI 10.2989/1814232X.2011.572377; Crawford RJM, 1995, S AFR J MARINE SCI, V16, P101; Deaux EC, 2013, BEHAVIOUR, V150, P75, DOI 10.1163/1568539X-00003038; EGGLETON P, 1979, OSTRICH, V50, P139, DOI 10.1080/00306525.1979.9634105; Fant G., 1960, ACOUSTIC THEORY SPEE; Farrus M., 2007, P 8 ANN C INT SPEECH, P778; Favaro L, 2014, ACTA ACUST UNITED AC, V100, P782, DOI 10.3813/AAA.918758; Fitch WT, 1999, J ZOOL, V248, P31, DOI 10.1017/S095283699900504X; Goller F, 1997, P NATL ACAD SCI USA, V94, P14787, DOI 10.1073/pnas.94.26.14787; Greenewalt C.H., 1968, BIRD SONG ACOUSTICS; HEATH RGM, 1985, J ZOOL, V205, P91; Jouventin P, 2002, ANIM BEHAV, V64, P747, DOI 10.1006/anbe.2002.4002; Jouventin P, 1982, ADV ETHOL, V58, P3; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Laiolo P, 2010, BIOL CONSERV, V143, P1635, DOI 10.1016/j.biocon.2010.03.025; Li X, 2007, INT CONF ACOUST SPEE, P1081, DOI 10.1109/ICMLC.2007.4370304; Midling Kjell, 2002, Bioacoustics, V12, P233; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Riede T, 2004, J EXP BIOL, V207, P4025, DOI 10.1242/jeb.01256; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Stachowicz JB, 2014, J ZOOL, V292, P1, DOI 10.1111/jzo.12083; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Thumser N. N., 1998, Marine Ornithology, V26, P41; TITZE IR, 1987, J SPEECH HEAR RES, V30, P252, DOI 10.1044/jshr.3002.252; TITZE IR, 1993, J SPEECH HEAR RES, V36, P1120, DOI 10.1044/jshr.3606.1120; WAZA, 2005, 60 ANN C WORLD ASS Z	49	30	30	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103460	10.1371/journal.pone.0103460	http://dx.doi.org/10.1371/journal.pone.0103460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076136	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800048
J	Horacio, AN; Lopes, JP; Ramirez, M; Melo-Cristino, J				Horacio, Andreia N.; Lopes, Joana P.; Ramirez, Mario; Melo-Cristino, Jose		Portuguese Grp Study Streptococcal	Non-Invasive Pneumococcal Pneumonia in Portugal-Serotype Distribution and Antimicrobial Resistance	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CONJUGATE VACCINE; POLYSACCHARIDE VACCINE; TYPING METHODS; ADULTS; INFECTIONS; DISEASE; MULTICENTER; COVERAGE	There is limited information on the serotypes causing non-invasive pneumococcal pneumonia (NIPP). Our aim was to characterize pneumococci causing NIPP in adults to determine recent changes in serotype prevalence, the potential coverage of pneumococcal vaccines and changes in antimicrobial resistance. Serotypes and antimicrobial susceptibility profiles of a sample of 1300 isolates recovered from adult patients (>= 18 yrs) between 1999 and 2011 (13 years) were determined. Serotype 3 was the most frequent cause of NIPP accounting for 18% of the isolates. The other most common serotypes were 11A (7%), 19F (7%), 19A (5%), 14 (4%), 22F (4%), 23F (4%) and 9N (4%). Between 1999 and 2011, there were significant changes in the proportion of isolates expressing vaccine serotypes, with a steady decline of the serotypes included in the 7-valent conjugate vaccine from 31% (1999-2003) to 11% (2011) (P<0.001). Taking together the most recent study years (2009-2011), the potential coverage of the 13-valent conjugate vaccine was 44% and of the 23-valent polysaccharide vaccine was 66%. While erythromycin resistance increased from 8% in 1999-2003 to 18% in 2011 (P<0.001), no significant trend was identified for penicillin non-susceptibility, which had an average value of 18.5%. The serotype distribution found in this study for NIPP was very different from the one previously described for IPD, with only two serotypes in common to the ones responsible for half of each presentation in 2009-2011 - serotypes 3 and 19A. In spite of these differences, the overall prevalence of resistant isolates was similar in NIPP and in IPD.	[Horacio, Andreia N.; Lopes, Joana P.; Ramirez, Mario; Melo-Cristino, Jose; Portuguese Grp Study Streptococcal] Univ Lisbon, Fac Med, Inst Mol Med, Inst Microbiol, P-1699 Lisbon, Portugal	Universidade de Lisboa	Ramirez, M (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Inst Microbiol, P-1699 Lisbon, Portugal.	ramirez@fm.ul.pt	Ramirez, Mario/B-4993-2008; Melo-Cristino, Jose A G/H-3726-2013	Ramirez, Mario/0000-0002-4084-6233; Melo-Cristino, Jose A G/0000-0001-8643-1722; Goncalves, Elsa/0000-0003-2789-7068; Tome, Rui/0000-0001-5381-2705; Toscano, Cristina/0000-0002-4674-6065	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/81205/2011, PTDC/DTP-EPI/1759/2012]; Pfizer; GlaxoSmithKline	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline)	A.N. Horacio was supported by grant SFRH/BD/81205/2011, from Fundacao para a Ciencia e Tecnologia, Portugal. This work was partially supported by Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/DTP-EPI/1759/2012) and unrestricted research grants from Pfizer and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Aguiar SI, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.12.20750; Aguiar SI, 2010, VACCINE, V28, P5167, DOI 10.1016/j.vaccine.2010.06.008; Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; Almeida ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090974; Benfield T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072743; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonten M, 2014, PNEUMONIA, V3, P95; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Cilloniz C, 2012, J BRAS PNEUMOL, V38, P419, DOI 10.1590/S1806-37132012000400002; Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUSC; Clinical and Laboratory Standards Institute, 2013, PERF STAND ANT SUSC; Domenech A, 2011, J ANTIMICROB CHEMOTH, V66, P487, DOI 10.1093/jac/dkq480; Fedson DS, 2011, EXPERT REV VACCINES, V10, P1143, DOI [10.1586/ERV.11.99, 10.1586/erv.11.99]; Grabenstein JD, 2012, CLIN INFECT DIS, V55, P255, DOI 10.1093/cid/cis354; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Horacio AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073704; Horacio AN, 2012, VACCINE, V30, P218, DOI 10.1016/j.vaccine.2011.11.022; Huijts SM, 2013, EUR RESPIR J, V42, P1283, DOI 10.1183/09031936.00137412; Melo-Cristino J, 2003, MICROB DRUG RESIST, V9, P73, DOI 10.1089/107662903764736364; Polverino E, 2013, THORAX, V68, P1007, DOI 10.1136/thoraxjnl-2013-203828; Regev-Yochay G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088406; Rodrigo C, 2014, THORAX, V69, P168, DOI 10.1136/thoraxjnl-2013-203987; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Sherwin RL, 2013, J INFECT DIS, V208, P1813, DOI 10.1093/infdis/jit506; Smith AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003238; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; Truck J, 2012, CLIN INFECT DIS, V55, P1577, DOI 10.1093/cid/cis700	31	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103092	10.1371/journal.pone.0103092	http://dx.doi.org/10.1371/journal.pone.0103092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075961	gold, Green Submitted, Green Published			2022-12-27	WOS:000340028800026
J	Kivisakk, P; Francois, K; Mbianda, J; Gandhi, R; Weiner, HL; Khoury, SJ				Kivisaekk, Pia; Francois, Katiana; Mbianda, Julvet; Gandhi, Roopali; Weiner, Howard L.; Khoury, Samia J.			Effect of Natalizumab Treatment on Circulating Plasmacytoid Dendritic Cells: A Cross-Sectional Observational Study in Patients with Multiple Sclerosis	PLOS ONE			English	Article							ADHESION MOLECULES; B-CELLS; MIGRATION; IDENTIFICATION; MECHANISMS; EXPRESSION; INDUCTION; SUBSETS; IFN; CNS	Objectives: Dendritic cells (DCs) serve a critical role both in promoting and inhibiting adaptive immunity. The goal of this study was to investigate the effect of natalizumab (NTZ) treatment on DC numbers, phenotype, and function in patients with multiple sclerosis (MS). Methods: Frequency and phenotype of myeloid and plasmacytoid DCs (MDCs and PDCs, respectively) were analyzed in blood from two separate cohorts of untreated, interferon-treated, or NTZ-treated MS patients. In addition, PDCs were stimulated with CpG-containing oligonucleotides or co-cultured with homologous T cells in the presence or absence of NTZ in vitro to determine functional effects of NTZ treatment. Results: We observed that NTZ treatment was associated with a 25-50% reduction in PDC frequency in peripheral blood as compared to untreated MS patients, while the frequency of MDCs was unchanged. PDCs in NTZ-treated patients displayed a mature, activated phenotype with increased expression of HLA-DR, TLR9, CCR7, IL-6 and IL-12. In contrast, in vitro treatment with NTZ did not increase markers of PDC activation or their ability to induce T cell differentiation. Conclusion: Our study shows that NTZ treatment is associated with a reduced frequency of PDCs in the peripheral circulation, but that PDCs in NTZ-treated individuals display an activated phenotype. Taken together the data suggests that transmigration of activated PDCs is preferentially affected by blockade of integrin alpha 4 leading to an increased frequency of activated PDCs in blood.	[Kivisaekk, Pia; Francois, Katiana; Mbianda, Julvet; Gandhi, Roopali; Weiner, Howard L.; Khoury, Samia J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Weiner, Howard L.; Khoury, Samia J.] Harvard Univ, Brigham & Womens Hosp, Dept Neurol, Partners Multiple Sclerosis Ctr, Boston, MA 02115 USA; [Khoury, Samia J.] Amer Univ Beirut, Abu Haidar Neurosci Inst, Beirut, Lebanon	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; American University of Beirut	Khoury, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	skhoury@rics.bwh.harvard.edu			Biogen Idec [US 002-09-NAT]	Biogen Idec(Biogen)	This study was supported by an investigator initiated research grant from Biogen Idec (Protocol No. US 002-09-NAT). The funders provided input on study design and performed a courtesy review of the manuscript before publication. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bornsen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047578; de Andres Clara, 2012, PLoS One, V7, pe34103, DOI 10.1371/journal.pone.0034103; de la Rosa G, 2003, J LEUKOCYTE BIOL, V73, P639, DOI 10.1189/jlb.1002516; Diacovo TG, 2005, J EXP MED, V202, P687, DOI 10.1084/jem.20051035; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Goodin DS, 2008, NEUROLOGY, V71, P766, DOI 10.1212/01.wnl.0000320512.21919.d2; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Guery L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00059; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Jing D, 2010, BONE MARROW TRANSPL, V45, P1489, DOI 10.1038/bmt.2009.381; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Khademi M, 2008, EUR J NEUROL, V15, P309, DOI 10.1111/j.1468-1331.2007.02037.x; Kivisakk P, 2009, NEUROLOGY, V72, P1922, DOI 10.1212/WNL.0b013e3181a8266f; Koudriavtseva T, 2014, CLIN EXP IMMUNOL, V176, P320, DOI 10.1111/cei.12261; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Krumbholz M, 2008, NEUROLOGY, V71, P1350, DOI 10.1212/01.wnl.0000327671.91357.96; Martin MD, 2008, ARCH NEUROL-CHICAGO, V65, P1596, DOI 10.1001/archneur.65.12.noc80051; Matsutani T, 2007, INT IMMUNOL, V19, P1031, DOI 10.1093/intimm/dxm088; Mellergard J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081685; Niino M, 2006, ANN NEUROL, V59, P748, DOI 10.1002/ana.20859; Nuyts AH, 2013, MULT SCLER J, V19, P995, DOI 10.1177/1352458512473189; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; Planas R, 2012, EUR J IMMUNOL, V42, P790, DOI 10.1002/eji.201142108; Puig-Kroger A, 2000, J IMMUNOL, V165, P4338, DOI 10.4049/jimmunol.165.8.4338; Putzki N, 2010, EUR NEUROL, V63, P311, DOI 10.1159/000302687; Ramos-Cejudo J, 2011, J CLIN IMMUNOL, V31, P623, DOI 10.1007/s10875-011-9522-x; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; SATO T, 1995, J IMMUNOL, V155, P2938; Schmidt SV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00274; Skarica M, 2011, J NEUROIMMUNOL, V235, P70, DOI 10.1016/j.jneuroim.2011.02.010; Stenner MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003319; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858	35	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103716	10.1371/journal.pone.0103716	http://dx.doi.org/10.1371/journal.pone.0103716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075741	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800074
J	Al-Furoukh, N; Kardon, JR; Kruger, M; Szibor, M; Baker, TA; Braun, T				Al-Furoukh, Natalie; Kardon, Julia R.; Krueger, Marcus; Szibor, Marten; Baker, Tania A.; Braun, Thomas			NOA1, a Novel ClpXP Substrate, Takes an Unexpected Nuclear Detour Prior to Mitochondrial Import	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; BIOGENESIS; BINDING; GENE; YQEH; PHOSPHORYLATION; IDENTIFICATION; TRANSLOCATION; TRANSLATION; ACTIVATION	The mitochondrial matrix GTPase NOA1 is a nuclear encoded protein, essential for mitochondrial protein synthesis, oxidative phosphorylation and ATP production. Here, we demonstrate that newly translated NOA1 protein is imported into the nucleus, where it localizes to the nucleolus and interacts with UBF1 before nuclear export and import into mitochondria. Mutation of the nuclear localization signal (NLS) prevented both nuclear and mitochondrial import while deletion of the N-terminal mitochondrial targeting sequence (MTS) or the C-terminal RNA binding domain of NOA1 impaired mitochondrial import. Absence of the MTS resulted in accumulation of NOA1 in the nucleus and increased caspase-dependent apoptosis. We also found that export of NOA1 from the nucleus requires a leptomycin-B sensitive, Crm1-dependent nuclear export signal (NES). Finally, we show that NOA1 is a new substrate of the mitochondrial matrix protease complex ClpXP. Our results uncovered an unexpected, mandatory detour of NOA1 through the nucleolus before uptake into mitochondria. We propose that nucleo-mitochondrial translocation of proteins is more widespread than previously anticipated providing additional means to control protein bioavailability as well as cellular communication between both compartments.	[Al-Furoukh, Natalie; Krueger, Marcus; Szibor, Marten; Braun, Thomas] Max Planck Inst Heart & Lung Res Bad Nauheim, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany; [Kardon, Julia R.; Baker, Tania A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res Bad Nauheim, Dept Cardiac Dev & Remodeling, Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008	Kardon, Julia/0000-0002-6621-4461; Schindler, Natalie/0000-0001-7281-4597; Braun, Thomas/0000-0002-6165-4804	Max-Planck-Society	Max-Planck-Society(Max Planck Society)	Max-Planck-Society (URL: www.mpg.de) supported NA, MK, MS, and T. Braun. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Al-Furoukh N, 2013, BBA-MOL CELL RES, V1833, P2933, DOI 10.1016/j.bbamcr.2013.07.022; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; Heidler J, 2011, J BIOL CHEM, V286, P32086, DOI 10.1074/jbc.M111.221986; Igwe EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-408; Kang HJ, 2010, J BIOL CHEM, V285, P21258, DOI 10.1074/jbc.M109.084590; Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kolanczyk M, 2011, MOL BIOL CELL, V22, P1, DOI 10.1091/mbc.E10-07-0643; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Li WG, 2005, J BIOL CHEM, V280, P28430, DOI 10.1074/jbc.M410601200; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Loh PC, 2007, GENES GENET SYST, V82, P281, DOI 10.1266/ggs.82.281; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Matsushima Y, 2012, BBA-GENE REGUL MECH, V1819, P1080, DOI 10.1016/j.bbagrm.2011.11.008; McKinsey TA, 2005, INHIBITION NUCL EXPO; Melchior F, 1998, METH MOL B, V88, P265; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; Rossmanith W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019152; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; So HS, 2006, CELL DEATH DIFFER, V13, P1763, DOI 10.1038/sj.cdd.4401863; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Tang TD, 2009, J BIOL CHEM, V284, P5414, DOI 10.1074/jbc.M807797200; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Vongsamphanh R, 2001, MOL CELL BIOL, V21, P1647, DOI 10.1128/MCB.21.5.1647-1655.2001; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004	39	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103141	10.1371/journal.pone.0103141	http://dx.doi.org/10.1371/journal.pone.0103141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072814	Green Published, Green Submitted, gold			2022-12-27	WOS:000341307600025
J	Moyersoen, B; Weiss, M				Moyersoen, Bernard; Weiss, Michael			New Neotropical Sebacinales Species from a Pakaraimaea dipterocarpacea Forest in the Guayana Region, Southern Venezuela: Structural Diversity and Phylogeography	PLOS ONE			English	Article							ECTOMYCORRHIZAL FUNGI; GENETIC DIVERSITY; NUCLEOTIDE-SEQUENCES; COMMUNITY STRUCTURE; RAIN-FOREST; HOST; SOIL; DNA; IDENTIFICATION; ORCHIDACEAE	Pakaraimaea dipterocarpacea, a member of the Dipterocarpaceae endemic in the Guayana region, is associated with a diverse community of ectomycorrhizal (ECM) fungi. Amongst the 41 ECM fungal species detected in a 400 m(2) P. dipterocarpacea ssp. nitida plot in Southern Venezuela, three species belonged to the Sebacinales. We tested whether ECM anatomotype characterization can be used as a feasible element in an integrative taxonomy in this diverse fungal group, where the relevance of fruitbody morphology for species delimitation seems limited. Using a combination of ECM morpho-anatomical characterizations and phylogenetic analyses based on nuclear ITS and LSU sequences, we report three new species. The main distinguishing features of Sebacina guayanensis are the yellowish cell walls together with conspicuous undifferentiated, uniform compact (type B) rhizomorphs. Staghorn-like hyphae are characteristic of S. tomentosa. The combination of clusters of thick-walled emanating hyphae, including hyphae similar to awl-shaped cystidia with basal dichotomous or trichotomous ramifications, and the presence of type B rhizomorphs were characteristic of a third, yet unnamed species. The three species belong to three different, possibly specifically tropical clades in Sebacinales Group A. The geographic distribution of phylogenetically related strains was wide, including a Dicymbe forest in Guyana and an Ecuadorian rainforest with Coccoloba species. We show that ECM morpho-anatomy can be used, in combination with other analyses, to delineate species within Sebacinales Group A. In addition to phylogenetic information, type B rhizomorphs observed in different Sebacinales clades have important ecological implications for this fungal group. The phylogeography of Sebacinales suggests that dispersion and host jump are important radiation mechanisms that shaped P. dipterocarpacea ECM fungal community. This study emphasizes the need for more sequence data to evaluate the hypothesis that phylogeographic relationships between neo- and paleotropical ECM fungal species could be attributed to the vicariance of cross-continental hosts such as the Dipterocarpacae.	[Moyersoen, Bernard] Univ Aberdeen, Sch Biol Sci, Aberdeen AB9 1FX, Scotland; [Weiss, Michael] Univ Tubingen, Dept Biol, Tubingen, Germany	University of Aberdeen; Eberhard Karls University of Tubingen	Weiss, M (corresponding author), Univ Tubingen, Dept Biol, Tubingen, Germany.	michael.weiss@uni-tuebingen.de			Instituto Venezolano de Investigaciones Cientificas; University Simon Bolivar; University of Tubingen; 'Fonds de la Recherche Scientifique' (FNRS); German Research Foundation (DFG); University of Aberdeen	Instituto Venezolano de Investigaciones Cientificas; University Simon Bolivar; University of Tubingen; 'Fonds de la Recherche Scientifique' (FNRS)(Fonds de la Recherche Scientifique - FNRS); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Aberdeen	The Instituto Venezolano de Investigaciones Cientificas, the University Simon Bolivar and the University of Tubingen provided support including lab facilities. Costs for field trips were partially funded by the 'Fonds de la Recherche Scientifique' (FNRS). Financial support for the molecular analyses was provided by the German Research Foundation (DFG) and the University of Aberdeen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer R, 2001, MYCORRHIZA, V11, P107, DOI 10.1007/s005720100108; AGERER R, 1991, METHOD MICROBIOL, V23, P25; Agerer R., 2004, DEEMY INFORM SYSTEM; Agerer R, 2006, MYCOL PROG, V5, P67, DOI 10.1007/s11557-006-0505-x; Alexander IJ, 2006, NEW PHYTOL, V172, P589, DOI 10.1111/j.1469-8137.2006.01930.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashton P. S., 1969, Biological Journal of the Linnean Society, V1, P155, DOI 10.1111/j.1095-8312.1969.tb01818.x; Azul Anabela Marisa, 2006, Descriptions of Ectomycorrhizae, V9-10, P87; Bandala VM, 2011, MYCOTAXON, V118, P147, DOI 10.5248/118.147; Bereau M, 1997, CAN J BOT, V75, P711, DOI 10.1139/b97-080; Brandbyge J., 1993, FLOWERING PLANTS DIC, P531, DOI [10.1007/978-3-662-02899-563, 10.1007/978-3-662-02899-5_63, DOI 10.1007/978-3-662-02899-5_63]; Brearley FQ, 2012, BIOTROPICA, V44, P637, DOI 10.1111/j.1744-7429.2012.00862.x; Ciferri R.\, 1961, QUADERNO, V19, P1; Dayanandan S, 1999, AM J BOT, V86, P1182, DOI 10.2307/2656982; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Roman M, 2005, MYCOL RES, V109, P1063, DOI 10.1017/S0953756205003564; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Diedhiou AG, 2014, ECTOMYCORRHIZAL SYMB, P1; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Garnica S, 2013, FEMS MICROBIOL ECOL, V83, P265, DOI 10.1111/j.1574-6941.2012.01473.x; Geml J, 2012, J BIOGEOGR, V39, P74, DOI 10.1111/j.1365-2699.2011.02588.x; Givnish TJ, 2004, INT J PLANT SCI, V165, pS1, DOI 10.1086/424022; Hambleton S, 2005, STUD MYCOL, P1; Hawksworth DL, 2012, MYCOSPHERE, V3, P143, DOI [10.5943/mycosphere/3/2/4, 10.5598/imafungus.2012.03.01.03]; Henkel TW, 2004, MYCOTAXON, V89, P433; Henkel TW, 2002, MYCOL RES, V106, P515, DOI 10.1017/S0953756202005919; Hibbett DS, 2013, NAT REV MICROBIOL, V11, P129, DOI 10.1038/nrmicro2963; Hynson NA, 2013, MOL ECOL, V22, P1473, DOI 10.1111/mec.12180; Jairus T, 2011, NEW PHYTOL, V192, P179, DOI 10.1111/j.1469-8137.2011.03775.x; Kass E, 1997, MOL PHYLOGENET EVOL, V8, P65, DOI 10.1006/mpev.1997.0410; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kennedy AH, 2011, MOL ECOL, V20, P1303, DOI 10.1111/j.1365-294X.2011.05000.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kropp BR, 2009, ADV MYCORRHIZAL SCI, P153; Lowy B, 1971, FLORA NEOTROP, V6, P1; MAGUIRE B, 1977, TAXON, V26, P341; MAGUIRE B, 1980, TAXON, V29, P225, DOI 10.2307/1220284; Maguire B, 1981, MEM NY BOT GARD, V32, P306; Matheny PB, 2009, J BIOGEOGR, V36, P577, DOI 10.1111/j.1365-2699.2008.02055.x; McGuire KL, 2010, OECOLOGIA, V164, P785, DOI 10.1007/s00442-010-1686-1; McNeill J., 2012, 18 INT BOT C MELB AU; Morris MH, 2008, MYCORRHIZA, V18, P375, DOI 10.1007/s00572-008-0186-1; Morris MH, 2009, FEMS MICROBIOL ECOL, V69, P274, DOI 10.1111/j.1574-6941.2009.00704.x; Moyersoen B, 2003, NEW PHYTOL, V160, P569, DOI 10.1046/j.1469-8137.2003.00908.x; Moyersoen B, 2012, DESCR ECTOMYC, V13, P16; Moyersoen B, 2014, ECTOMYCORRHIZAL SYMB, P79; Moyersoen B, 2012, DESCR ECTOMYC, V13, P42; Moyersoen B., 1993, SCI GUAIANAE, V3; Moyersoen B, 2006, NEW PHYTOL, V172, P753, DOI 10.1111/j.1469-8137.2006.01860.x; Moyersoen Bernard, 2012, Descriptions of Ectomycorrhizae, V13, P25; Moyersoen B, 2012, TROPICAL FORESTS, P93; Oberwinkler F, 2013, MYCOL PROG, V12, P1, DOI 10.1007/s11557-012-0880-4; Peay KG, 2013, ISME J, V7, P1852, DOI 10.1038/ismej.2013.66; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; Phosri C, 2012, BIODIVERS CONSERV, V21, P2287, DOI 10.1007/s10531-012-0250-1; Pirozynski KA, 1998, AUST J BOT SUPPL SER, V10, P137; Rambaut A., 2009, FIGTREE VERSION 1 3; Riess K, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-102; Riviere T, 2007, MYCORRHIZA, V17, P415, DOI 10.1007/s00572-007-0117-6; Roy M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-51; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Selosse MA, 2002, MOL ECOL, V11, P1831, DOI 10.1046/j.1365-294X.2002.01553.x; Selosse MA, 2002, NEW PHYTOL, V155, P183, DOI 10.1046/j.1469-8137.2002.00442.x; Selosse MA, 2004, MICROB ECOL, V47, P416, DOI 10.1007/s00248-003-2034-3; Selosse MA, 2007, NEW PHYTOL, V174, P864, DOI 10.1111/j.1469-8137.2007.02064.x; Selosse MA, 2009, MYCOL RES, V113, P1062, DOI 10.1016/j.mycres.2009.07.004; Setaro Sabrina D, 2011, PLoS Curr, V3, pRRN1227, DOI 10.1371/currents.RRN1227; Setaro SD, 2012, BIODIVERS CONSERV, V21, P2269, DOI 10.1007/s10531-011-0205-y; SINGER R, 1979, Acta Amazonica, V9, P25; Smith ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055160; Smith ME, 2011, NEW PHYTOL, V192, P699, DOI 10.1111/j.1469-8137.2011.03844.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tedersoo L, 2003, NEW PHYTOL, V159, P153, DOI 10.1046/j.1469-8137.2003.00792.x; Tedersoo L, 2011, MOL ECOL, V20, P3071, DOI 10.1111/j.1365-294X.2011.05145.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2010, ISME J, V4, P465, DOI 10.1038/ismej.2009.131; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tello SA, 2014, MYCOL PROG, V13, P471, DOI 10.1007/s11557-013-0928-0; Twieg B, 2009, MANUAL CONCISE DESCR, VCDE28; Urban A, 2003, MYCOL RES, V107, P3, DOI 10.1017/S0953756202007116; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wei J, 2011, MYCORRHIZA, V21, P105, DOI 10.1007/s00572-010-0312-8; Weiss M, 2004, MYCOL RES, V108, P1003, DOI 10.1017/S0953756204000772; Weiss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016793; WELLS K, 1982, MYCOLOGIA, V74, P325, DOI 10.2307/3792902; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; ZAK B, 1978, CAN J BOT, V56, P1416, DOI 10.1139/b78-164	88	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103076	10.1371/journal.pone.0103076	http://dx.doi.org/10.1371/journal.pone.0103076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072467	Green Submitted, Green Published, gold			2022-12-27	WOS:000341307600021
J	Wu, RD; Long, YC; Malanson, GP; Garber, PA; Zhang, S; Li, DQ; Zhao, P; Wang, LZ; Duo, HR				Wu, Ruidong; Long, Yongcheng; Malanson, George P.; Garber, Paul A.; Zhang, Shuang; Li, Diqiang; Zhao, Peng; Wang, Longzhu; Duo, Hairui			Optimized Spatial Priorities for Biodiversity Conservation in China: A Systematic Conservation Planning Perspective	PLOS ONE			English	Article							SCALE	By addressing several key features overlooked in previous studies, i.e. human disturbance, integration of ecosystem-and species-level conservation features, and principles of complementarity and representativeness, we present the first national-scale systematic conservation planning for China to determine the optimized spatial priorities for biodiversity conservation. We compiled a spatial database on the distributions of ecosystem-and species-level conservation features, and modeled a human disturbance index (HDI) by aggregating information using several socioeconomic proxies. We ran Marxan with two scenarios (HDI-ignored and HDI-considered) to investigate the effects of human disturbance, and explored the geographic patterns of the optimized spatial conservation priorities. Compared to when HDI was ignored, the HDI-considered scenario resulted in (1) a marked reduction (similar to 9%) in the total HDI score and a slight increase (similar to 7%) in the total area of the portfolio of priority units, (2) a significant increase (similar to 43%) in the total irreplaceable area and (3) more irreplaceable units being identified in almost all environmental zones and highly-disturbed provinces. Thus the inclusion of human disturbance is essential for cost-effective priority-setting. Attention should be targeted to the areas that are characterized as moderately-disturbed, <2,000 m in altitude, and/or intermediately-to extremely-rugged in terrain to identify potentially important regions for implementing cost-effective conservation. We delineated 23 primary large-scale priority areas that are significant for conserving China's biodiversity, but those isolated priority units in disturbed regions are in more urgent need of conservation actions so as to prevent immediate and severe biodiversity loss. This study presents a spatially optimized national-scale portfolio of conservation priorities - effectively representing the overall biodiversity of China while minimizing conflicts with economic development. Our results offer critical insights for current conservation and strategic land-use planning in China. The approach is transferable and easy to implement by end-users, and applicable for national- and local-scale systematic conservation prioritization practices.	[Wu, Ruidong] Yunnan Univ, Inst Int Rivers & Ecosecur, Kunming, Yunnan, Peoples R China; [Wu, Ruidong] Yunnan Univ, Yunnan Key Lab Int Rivers & Transboundary Eco Sec, Kunming, Yunnan, Peoples R China; [Long, Yongcheng; Zhang, Shuang; Zhao, Peng; Wang, Longzhu] Nat Conservancy China Program, Kunming, Yunnan, Peoples R China; [Malanson, George P.] Univ Iowa, Dept Geog, Iowa City, IA 52242 USA; [Garber, Paul A.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Li, Diqiang] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Duo, Hairui] Beijing Forestry Univ, Sch Nat Reserve, Beijing, Peoples R China	Yunnan University; Yunnan University; University of Iowa; University of Illinois System; University of Illinois Urbana-Champaign; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Beijing Forestry University	Wu, RD (corresponding author), Yunnan Univ, Inst Int Rivers & Ecosecur, Kunming, Yunnan, Peoples R China.	rdwu@ynu.edu.cn	Wu, Ruidong/H-6325-2019	Wu, Ruidong/0000-0002-9908-1802	National Natural Science Foundation of China [31260148]; National Key Technologies R&D Program of China [2011BAC09B07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program)	This study was funded by the National Natural Science Foundation of China (No. 31260148) and the National Key Technologies R&D Program of China (No. 2011BAC09B07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardon J.A., 2010, MARXAN GOOD PRACTICE, V2; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Carwardine J, 2008, P NATL ACAD SCI USA, V105, P11446, DOI 10.1073/pnas.0707157105; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chen C. D, 1998, BIODIVERSITY CHINA C; Chen L, 1993, CHINAS BIODIVERSITY; Crous CJ, 2013, J APPL ECOL, V50, P205, DOI 10.1111/1365-2664.12012; Fan J, 2009, J GEOGR SCI, V19, P515, DOI 10.1007/s11442-009-0515-0; Fu L.K., 1992, CHINA PLANT RED DATA; Groves C.R., 2003, DRAFTING CONSERVATIO; Institute of Botany, 2009, SUBJ DAT CHIN PLANTS; Institute of Zoology, 2009, DAT FAUN SIN; IUCN, 2012, IUCN RED LIST THREAT; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Lea C., 2010, NPS2010NRR2010204 US; [李炳元 Li Bingyuan], 2008, [第四纪研究, Quaternary Sciences], V28, P535; Li D., 2003, RES NATL FORESTRY NA; Linke S, 2012, J APPL ECOL, V49, P1036, DOI 10.1111/j.1365-2664.2012.02177.x; Liu J., 2013, ENCY BIODIVERSITY, P372, DOI DOI 10.1016/B978-0-12-384719-5.00335-X; Lu YH, 2013, ENVIRON SCI POLICY, V33, P346, DOI 10.1016/j.envsci.2013.05.007; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Ministry of Environment Protection of China, 2011, CHIN NAT BIOD CONS S; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Pan Jiahua, 2012, Science, V336, P1397, DOI 10.1126/science.1224009; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; State Forestry Administration of China, 2009, NAT KEY PROT WILD PL; State Forestry Administration of China, 2009, NAT KEY TERR WILDL R; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; The Ministry of Environmental Protection of China, 2011, ISS SICH BIOD CONS S; The State Council of China, 2011, CIRC STAT COUNC ISS; USGS, 2004, SHUTTL RAD TOP MISS; Venter O, 2013, CONSERV LETT, V6, P116, DOI 10.1111/j.1755-263X.2012.00287.x; Wang S., 1998, CHINA RED DATA BOOK; WCS, 2005, CHIN SPEC INF SERV; Withey JC, 2012, ECOL LETT, V15, P1249, DOI 10.1111/j.1461-0248.2012.01847.x; Wu RD, 2011, FRONT ECOL ENVIRON, V9, P383, DOI 10.1890/100093; Wu RD, 2011, ENVIRON SCI POLLUT R, V18, P800, DOI 10.1007/s11356-011-0440-5; [徐卫华 XU WeiHua], 2006, [生态学报, Acta Ecologica Sinica], V26, P271; Yang XH, 2009, INT J ENV RES PUB HE, V6, P3025, DOI 10.3390/ijerph6123025; Zhang RZ, 1997, DISTRIBUTIONS CHINA; Zhang YB, 2008, BIODIVERS CONSERV, V17, P1783, DOI 10.1007/s10531-008-9384-6; 马克平, 2001, 植物生态学报, V25	45	35	43	4	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103783	10.1371/journal.pone.0103783	http://dx.doi.org/10.1371/journal.pone.0103783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072933	Green Submitted, Green Published, gold			2022-12-27	WOS:000341307600086
J	Huang, SB; Lv, TY; Zhang, XZ; Yang, YE; Zheng, WM; Wen, C				Huang, Shaobin; Lv, Tianyang; Zhang, Xizhe; Yang, Yange; Zheng, Weimin; Wen, Chao			Identifying Node Role in Social Network Based on Multiple Indicators	PLOS ONE			English	Article							COMPLEX; DYNAMICS	It is a classic topic of social network analysis to evaluate the importance of nodes and identify the node that takes on the role of core or bridge in a network. Because a single indicator is not sufficient to analyze multiple characteristics of a node, it is a natural solution to apply multiple indicators that should be selected carefully. An intuitive idea is to select some indicators with weak correlations to efficiently assess different characteristics of a node. However, this paper shows that it is much better to select the indicators with strong correlations. Because indicator correlation is based on the statistical analysis of a large number of nodes, the particularity of an important node will be outlined if its indicator relationship doesn't comply with the statistical correlation. Therefore, the paper selects the multiple indicators including degree, ego-betweenness centrality and eigenvector centrality to evaluate the importance and the role of a node. The importance of a node is equal to the normalized sum of its three indicators. A candidate for core or bridge is selected from the great degree nodes or the nodes with great ego-betweenness centrality respectively. Then, the role of a candidate is determined according to the difference between its indicators' relationship with the statistical correlation of the overall network. Based on 18 real networks and 3 kinds of model networks, the experimental results show that the proposed methods perform quite well in evaluating the importance of nodes and in identifying the node role.	[Huang, Shaobin; Lv, Tianyang; Yang, Yange] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China; [Zhang, Xizhe; Wen, Chao] Northeastern Univ, Coll Informat Sci & Engn, Shenyang, Peoples R China; [Lv, Tianyang; Zheng, Weimin] Tsinghua Univ, Coll Comp Sci & Technol, Beijing 100084, Peoples R China; [Lv, Tianyang] Audit Res Inst, Natl Audit Off, Beijing, Peoples R China	Harbin Engineering University; Northeastern University - China; Tsinghua University	Lv, TY (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Peoples R China.	raynor1979@163.com	Zhang, Xizhe/H-3429-2019; Zhang, Xizhe/B-9848-2019	Zhang, Xizhe/0000-0002-8684-4591	Ministry of Science and Technology of China [2012BAH08B02]; Natural Science Foundation of China [71272216, 60903080, 60093009]; Fundamental Research Funds for the Central Universities [HEUCF1212, HEUCF1208]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is sponsored by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China under grant number 2012BAH08B02, by the Natural Science Foundation of China under grant number 71272216, 60903080, 60093009, and by the Fundamental Research Funds for the Central Universities under grant number HEUCF1212, HEUCF1208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Adamic LA, 2000, SCIENCE, V287, DOI 10.1126/science.287.5461.2115a; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Burt R.S., 1992, STRUCTURAL HOLES SOC, DOI DOI 10.1016/J.JET.2007.01.006; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Paparo GD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02773; De Nooy W, 1999, POETICS, V26, P385, DOI 10.1016/S0304-422X(99)00009-1; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; ERDOS P, 1960, B INT STATIST INST, V38, P343; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Freeman L., 2004, DEV SOCIAL NETWORK A; Freeman SC, 1979, SOCIAL SCI RES REPOR, V46; Ghoshal G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1396; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.017101; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Jacob LM, 1960, SOCIOMETRY READER; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Knuth DE., 1993, STANFORD GRAPH BASE; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Marsden PV, 2002, SOC NETWORKS, V24, P407, DOI 10.1016/S0378-8733(02)00016-3; Michael JH, 1997, FOREST PROD J, V47, P25; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Putnam R., 2000, BOWLING ALONE COLLAP; Radicchi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017249; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; SCOTT J., 1991, SOCIAL NETWORK ANAL; SCOWEN RS, 1965, COMMUN ACM, V8, P669, DOI 10.1145/365660.365678; SMITH DA, 1992, SOC FORCES, V70, P857, DOI 10.2307/2580193; Vaccaro R, 1984, IEEE INT C ICASSP, V9, P224; Wang X., 2006, COMPLEX NETWORK THEO; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White HC, 1970, CHAINS OPPORTUNITY; Wuchty S, 2003, J THEOR BIOL, V223, P45, DOI 10.1016/S0022-5193(03)00071-7; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	44	17	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103733	10.1371/journal.pone.0103733	http://dx.doi.org/10.1371/journal.pone.0103733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25089823	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700047
J	Kubota, C; Okada, T; Aleksic, B; Nakamura, Y; Kunimoto, S; Morikawa, M; Shiino, T; Tamaji, A; Ohoka, H; Banno, N; Morita, T; Murase, S; Goto, S; Kanai, A; Masuda, T; Ando, M; Ozaki, N				Kubota, Chika; Okada, Takashi; Aleksic, Branko; Nakamura, Yukako; Kunimoto, Shohko; Morikawa, Mako; Shiino, Tomoko; Tamaji, Ai; Ohoka, Harue; Banno, Naomi; Morita, Tokiko; Murase, Satomi; Goto, Setsuko; Kanai, Atsuko; Masuda, Tomoko; Ando, Masahiko; Ozaki, Norio			Factor Structure of the Japanese Version of the Edinburgh Postnatal Depression Scale in the Postpartum Period	PLOS ONE			English	Article							ANXIETY; SYMPTOMS; REPLICABILITY; SCREEN; WOMEN; RISK	Background: The Edinburgh Postnatal Depression Scale (EPDS) is a widely used screening tool for postpartum depression (PPD). Although the reliability and validity of EPDS in Japanese has been confirmed and the prevalence of PPD is found to be about the same as Western countries, the factor structure of the Japanese version of EPDS has not been elucidated yet. Methods: 690 Japanese mothers completed all items of the EPDS at 1 month postpartum. We divided them randomly into two sample sets. The first sample set (n = 345) was used for exploratory factor analysis, and the second sample set was used (n = 345) for confirmatory factor analysis. Results: The result of exploratory factor analysis indicated a three-factor model consisting of anxiety, depression and anhedonia. The results of confirmatory factor analysis suggested that the anxiety and anhedonia factors existed for EPDS in a sample of Japanese women at 1 month postpartum. The depression factor varies by the models of acceptable fit. Conclusions: We examined EPDS scores. As a result, "anxiety" and "anhedonia" exist for EPDS among postpartum women in Japan as already reported in Western countries. Cross-cultural research is needed for future research.	[Kubota, Chika; Okada, Takashi; Aleksic, Branko; Nakamura, Yukako; Kunimoto, Shohko; Morikawa, Mako; Shiino, Tomoko; Tamaji, Ai; Banno, Naomi; Ozaki, Norio] Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Ohoka, Harue] Nihon Fukushi Univ, Chuo Coll Social Serv, Nagoya, Aichi, Japan; [Morita, Tokiko] Meijo Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Murase, Satomi] Liaison Med Marunouchi, Nagoya, Aichi, Japan; [Goto, Setsuko] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Kanai, Atsuko] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi 4648601, Japan; [Masuda, Tomoko] Nagoya Univ, Grad Sch Law, Nagoya, Aichi 4648601, Japan; [Ando, Masahiko] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Nagoya, Aichi 4648601, Japan	Nagoya University; Meijo University; Nagoya University; Nagoya University; Nagoya University; Nagoya University	Okada, T (corresponding author), Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	okada@med.nagoya-u.ac.jp	Shiino, Tomoko/M-8903-2014; ANDO, Masahiko/F-7035-2015; Shiino, Tomoko/ABA-7481-2020; nakamura, yukako/M-8889-2014; Aleksic, Branko/G-1540-2011; Aleksic, Branko/L-7851-2019; Ozaki, Norio/M-8908-2014; OKADA, Takashi/M-8902-2014	Shiino, Tomoko/0000-0002-8750-0854; Shiino, Tomoko/0000-0002-8750-0854; nakamura, yukako/0000-0002-3306-7127; Aleksic, Branko/0000-0001-8982-4580; Aleksic, Branko/0000-0001-8982-4580; Ozaki, Norio/0000-0002-7360-4898; OKADA, Takashi/0000-0001-5580-9913	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes, Meijo University; Core Research for Evolutional Science and Technology; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [21B-2]; Specific Research Fund for East Japan Great Earthquake Revival by The New Technology Development Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes, Meijo University; Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan); Specific Research Fund for East Japan Great Earthquake Revival by The New Technology Development Foundation	Funding for this study was provided by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Ministry of Health, Labor and Welfare of Japan; The Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes, Meijo University; the Core Research for Evolutional Science and Technology; Intramural Research Grant (21B-2) for Neurological and Psychiatric Disorders of NCNP; and the Specific Research Fund 2012 for East Japan Great Earthquake Revival by The New Technology Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTBURY J, 1994, AUST J PUBLIC HEALTH, V18, P176; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; Beck CT, 1998, ARCH PSYCHIAT NURS, V12, P12, DOI 10.1016/S0883-9417(98)80004-6; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bollen K. A., 1993, TESTING STRUCTURAL E; Brouwers EPM, 2001, J PSYCHOSOM RES, V51, P659, DOI 10.1016/S0022-3999(01)00245-8; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Buist A, 1998, AUST NZ J PSYCHIAT, V32, P370, DOI 10.3109/00048679809065529; Carlson M, 2011, PSYCHOL ASSESSMENT, V23, P558, DOI 10.1037/a0022484; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Ishikawa N, 2011, J PSYCHOSOM RES, V71, P264, DOI 10.1016/j.jpsychores.2011.02.001; Jomeen J, 2007, J PSYCHIATR MENT HLT, V14, P319, DOI 10.1111/j.1365-2850.2007.01084.x; Joreskog K.G., 1993, LISREL 8 USERS GUIDE; Kabir K, 2008, PEDIATRICS, V122, pE696, DOI 10.1542/peds.2007-1759; Kelloway E. K., 1998, USING LISREL STRUCTU; King PAL, 2012, ARCH WOMEN MENT HLTH, V15, P77, DOI 10.1007/s00737-012-0260-8; Lau Y, 2010, INT J NURS STUD, V47, P1139, DOI 10.1016/j.ijnurstu.2010.02.005; Lindahl V, 2005, ARCH WOMEN MENT HLTH, V8, P77, DOI 10.1007/s00737-005-0080-1; Lobato G, 2011, ARCH WOMEN MENT HLTH, V14, P187, DOI 10.1007/s00737-011-0206-6; Luoma I, 2001, J AM ACAD CHILD PSY, V40, P1367, DOI 10.1097/00004583-200112000-00006; Lydiard RB, 1998, J CLIN PSYCHIAT, V59, P10; Matthey S, 2012, J AFFECT DISORD; Matthey S, 2008, DEPRESS ANXIETY, V25, P926, DOI 10.1002/da.20415; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.2307/1131637; Oates MR, 2004, BRIT J PSYCHIAT, V184, pS10, DOI 10.1192/bjp.184.46.s10; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Okano T, 1996, ARCH PSYCHIATR DIAGN, V7, P525; Phillips J, 2009, J AFFECT DISORDERS, V118, P101, DOI 10.1016/j.jad.2009.02.004; POP VJ, 1992, J AFFECT DISORDERS, V26, P105, DOI 10.1016/0165-0327(92)90041-4; Ross L E, 2003, Arch Womens Ment Health, V6, P51, DOI 10.1007/s00737-002-0155-1; Sato Y, 2008, J EPIDEMIOL, V18, P84, DOI 10.2188/jea.18.84; Small R, 2007, SOC PSYCH PSYCH EPID, V42, P70, DOI 10.1007/s00127-006-0134-3; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; STAVRAKAKI C, 1986, BRIT J PSYCHIAT, V149, P7, DOI 10.1192/bjp.149.1.7; Swalm D, 2010, ARCH WOMEN MENT HLTH, V13, P515, DOI 10.1007/s00737-010-0170-6; Tamaki R, 1997, PSYCHIAT CLIN NEUROS, V51, P93, DOI 10.1111/j.1440-1819.1997.tb02368.x; Tuohy A, 2008, BRIT J CLIN PSYCHOL, V47, P153, DOI 10.1111/j.2044-8260.2008.tb00463.x; Weissman MM, 2002, J CLIN PSYCHIAT, V63, P641, DOI 10.4088/JCP.v63n0717; Yelland J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-771	39	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103941	10.1371/journal.pone.0103941	http://dx.doi.org/10.1371/journal.pone.0103941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25089523	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700066
J	Nilvebrant, J; Astrand, M; Georgieva-Kotseva, M; Bjoernmalm, M; Lofblom, J; Hober, S				Nilvebrant, Johan; Astrand, Mikael; Georgieva-Kotseva, Maria; Bjoernmalm, Mattias; Loefblom, John; Hober, Sophia			Engineering of Bispecific Affinity Proteins with High Affinity for ERBB2 and Adaptable Binding to Albumin	PLOS ONE			English	Article							PICOMOLAR AFFINITY; STRUCTURAL BASIS; SURFACE DISPLAY; HER2; DOMAINS; SELECTION; COMPLEX; MODULE	The epidermal growth factor receptor 2, ERBB2, is a well-validated target for cancer diagnostics and therapy. Recent studies suggest that the over-expression of this receptor in various cancers might also be exploited for antibody-based payload delivery, e. g. antibody drug conjugates. In such strategies, the full-length antibody format is probably not required for therapeutic effect and smaller tumor-specific affinity proteins might be an alternative. However, small proteins and peptides generally suffer from fast excretion through the kidneys, and thereby require frequent administration in order to maintain a therapeutic concentration. In an attempt aimed at combining ERBB2-targeting with antibody-like pharmacokinetic properties in a small protein format, we have engineered bispecific ERBB2-binding proteins that are based on a small albumin-binding domain. Phage display selection against ERBB2 was used for identification of a lead candidate, followed by affinity maturation using second-generation libraries. Cell surface display and flow-cytometric sorting allowed stringent selection of top candidates from pools pre-enriched by phage display. Several affinity-matured molecules were shown to bind human ERBB2 with sub-nanomolar affinity while retaining the interaction with human serum albumin. Moreover, parallel selections against ERBB2 in the presence of human serum albumin identified several amino acid substitutions that dramatically modulate the albumin affinity, which could provide a convenient means to control the pharmacokinetics. The new affinity proteins competed for ERBB2-binding with the monoclonal antibody trastuzumab and recognized the native receptor on a human cancer cell line. Hence, high affinity tumor targeting and tunable albumin binding were combined in one small adaptable protein.	[Nilvebrant, Johan; Astrand, Mikael; Georgieva-Kotseva, Maria; Bjoernmalm, Mattias; Loefblom, John; Hober, Sophia] KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, Stockholm, Sweden	Royal Institute of Technology	Hober, S (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, Div Prot Technol, Stockholm, Sweden.	sophia@biotech.kth.se	Björnmalm, Mattias/H-7721-2014	Björnmalm, Mattias/0000-0002-9876-7079; Lofblom, John/0000-0001-9423-0541	Swedish Research Council; Royal Swedish Academy of Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Swedish Academy of Sciences	This work was funded by the Swedish Research Council. JN acknowledges support from the Royal Swedish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm T, 2010, BIOTECHNOL J, V5, P605, DOI 10.1002/biot.201000041; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dennis MS, 2007, CANCER RES, V67, P254, DOI 10.1158/0008-5472.CAN-06-2531; Eigenbrot C, 2010, P NATL ACAD SCI USA, V107, P15039, DOI 10.1073/pnas.1005025107; Feldwisch Joachim, 2012, Methods Mol Biol, V899, P103, DOI 10.1007/978-1-61779-921-1_7; Feldwisch J, 2010, J MOL BIOL, V398, P232, DOI 10.1016/j.jmb.2010.03.002; Frejd F. Y., 2012, THERAPEUTIC PROTEINS; Gostring L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040023; Gulich S, 2000, J BIOTECHNOL, V80, P169, DOI 10.1016/S0168-1656(00)00259-5; He YN, 2007, PROTEIN SCI, V16, P1490, DOI 10.1110/ps.072799507; Herschman HR, 2003, SCIENCE, V302, P605, DOI 10.1126/science.1090585; Jost C, 2013, STRUCTURE, V21, P1979, DOI 10.1016/j.str.2013.08.020; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kronqvist N, 2008, PROTEIN ENG DES SEL, V21, P247, DOI 10.1093/protein/gzm090; Kronqvist N, 2011, PROTEIN ENG DES SEL, V24, P385, DOI 10.1093/protein/gzq118; Lejon S, 2004, J BIOL CHEM, V279, P42924, DOI 10.1074/jbc.M406957200; Miao Z, 2011, AMINO ACIDS, V41, P1037, DOI 10.1007/s00726-010-0503-9; Nahta R, 2012, BREAST CANCER-TARGET, V4, P53, DOI 10.2147/BCTT.S24976; Nilsson FY, 2007, CURR OPIN DRUG DISC, V10, P167; Nilvebrant J, 2013, COMPUT STRUCT BIOTEC, V6, DOI 10.5936/csbj.201303009; Nilvebrant J, 2013, CELL MOL LIFE SCI, V70, P3973, DOI 10.1007/s00018-013-1370-9; Nilvebrant J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025791; NYGREN PA, 1991, VACCINES 91, P363; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; Rosenstein R, 2009, APPL ENVIRON MICROB, V75, P811, DOI 10.1128/AEM.01982-08; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Tolmachev V, 2007, CANCER RES, V67, P2773, DOI 10.1158/0008-5472.CAN-06-1630; Wittrup KD, 2012, METHOD ENZYMOL, V503, P255, DOI 10.1016/B978-0-12-396962-0.00010-0; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028; Zahnd C, 2006, J BIOL CHEM, V281, P35167, DOI 10.1074/jbc.M602547200; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724	36	39	44	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103094	10.1371/journal.pone.0103094	http://dx.doi.org/10.1371/journal.pone.0103094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089830	Green Published, gold			2022-12-27	WOS:000339812700014
J	Kadonosono, T; Yabe, E; Furuta, T; Yamano, A; Tsubaki, T; Sekine, T; Kuchimaru, T; Sakurai, M; Kizaka-Kondoh, S				Kadonosono, Tetsuya; Yabe, Etsuri; Furuta, Tadaomi; Yamano, Akihiro; Tsubaki, Takuya; Sekine, Takuya; Kuchimaru, Takahiro; Sakurai, Minoru; Kizaka-Kondoh, Shinae			A Fluorescent Protein Scaffold for Presenting Structurally Constrained Peptides Provides an Effective Screening System to Identify High Affinity Target-Binding Peptides	PLOS ONE			English	Article							PHAGE DISPLAY; IN-VIVO; BREAST CARCINOMAS; IMAGING AGENT; CELL-SURFACE; LIBRARY; GFP; INHIBITION; INSERTIONS; CASPASE-3	Peptides that have high affinity for target molecules on the surface of cancer cells are crucial for the development of targeted cancer therapies. However, unstructured peptides often fail to bind their target molecules with high affinity. To efficiently identify high-affinity target-binding peptides, we have constructed a fluorescent protein scaffold, designated gFPS, in which structurally constrained peptides are integrated at residues K131-L137 of superfolder green fluorescent protein. Molecular dynamics simulation supported the suitability of this site for presentation of exogenous peptides with a constrained structure. gFPS can present 4 to 12 exogenous amino acids without a loss of fluorescence. When gFPSs presenting human epidermal growth factor receptor type 2 (HER2)-targeting peptides were added to the culture medium of HER2-expressing cells, we could easily identify the peptides with high HER2-affinity and -specificity based on gFPS fluorescence. In addition, gFPS could be expressed on the yeast cell surface and applied for a high-throughput screening. These results demonstrate that gFPS has the potential to serve as a powerful tool to improve screening of structurally constrained peptides that have a high target affinity, and suggest that it could expedite the one-step identification of clinically applicable cancer cell-binding peptides.	[Kadonosono, Tetsuya; Yabe, Etsuri; Yamano, Akihiro; Tsubaki, Takuya; Sekine, Takuya; Kuchimaru, Takahiro; Kizaka-Kondoh, Shinae] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan; [Furuta, Tadaomi; Sakurai, Minoru] Tokyo Inst Technol, Ctr Biol Resources & Informat, Yokohama, Kanagawa 227, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Kizaka-Kondoh, S (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan.	skondoh@bio.titech.ac.jp	Kondoh, Shinae/AAF-8745-2020; Furuta, Tadaomi/D-5225-2015; Kuchimaru, Takahiro/B-9269-2015; Kadonosono, Tetsuya/D-4651-2019; Kondoh, Shinae/C-6937-2015	Kondoh, Shinae/0000-0003-3085-5782; Furuta, Tadaomi/0000-0003-4568-9043; Kuchimaru, Takahiro/0000-0002-5355-3165; Kondoh, Shinae/0000-0003-3085-5782	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for Promotion of Science [22700469]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Integrative Research on Cancer Microenvironment Network" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to SKK) and partially supported by Grants-in-Aid from the Japan Society for Promotion of Science 22700469 (to T. Kadonosono). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi MR, 1998, NUCLEIC ACIDS RES, V26, P623, DOI 10.1093/nar/26.2.623; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chiang CF, 2001, ARCH BIOCHEM BIOPHYS, V394, P229, DOI 10.1006/abbi.2001.2537; Dai M, 2008, PROTEIN ENG DES SEL, V21, P413, DOI 10.1093/protein/gzn016; DENNIS MS, 1995, J BIOL CHEM, V270, P25411, DOI 10.1074/jbc.270.43.25411; Deutscher SL, 2010, CHEM REV, V110, P3196, DOI 10.1021/cr900317f; Deutscher SL, 2009, J LABELLED COMPD RAD, V52, P583, DOI 10.1002/jlcr.1691; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P2737; Flores-Ramirez Gabriela, 2007, BMC Chemical Biology, V7, P1, DOI 10.1186/1472-6769-7-1; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Ganesan R, 2006, J MOL BIOL, V359, P1378, DOI 10.1016/j.jmb.2006.04.051; Herman RE, 2007, J BIOL CHEM, V282, P9813, DOI 10.1074/jbc.M610722200; Howell RC, 2007, BIOCONJUGATE CHEM, V18, P1739, DOI 10.1021/bc060330u; Hufton SE, 2000, FEBS LETT, V475, P225, DOI 10.1016/S0014-5793(00)01701-4; Karasseva NG, 2002, J PROTEIN CHEM, V21, P287, DOI 10.1023/A:1019749504418; Kelly KA, 2008, CANCER RES, V68, P2286, DOI 10.1158/0008-5472.CAN-07-1349; Kelly KA, 2008, PLOS MED, V5, P657, DOI 10.1371/journal.pmed.0050085; Kiss C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl681; Kuchimaru T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015736; Kumar SR, 2007, CLIN CANCER RES, V13, P6070, DOI 10.1158/1078-0432.CCR-07-0160; Kumar SR, 2010, CANCER BIOTHER RADIO, V25, P693, DOI 10.1089/cbr.2010.0820; Kuroda K, 2009, APPL MICROBIOL BIOT, V82, P713, DOI 10.1007/s00253-008-1808-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LADNER RC, 1995, TRENDS BIOTECHNOL, V13, P426, DOI 10.1016/S0167-7799(00)88997-0; Nakajima H, 2008, BREAST CANCER-TOKYO, V15, P65, DOI 10.1007/s12282-007-0018-8; Park BW, 2000, NAT BIOTECHNOL, V18, P194, DOI 10.1038/72651; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; Pavoor TV, 2009, P NATL ACAD SCI USA, V106, P11895, DOI 10.1073/pnas.0902828106; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peelle B, 2001, CHEM BIOL, V8, P521, DOI 10.1016/S1074-5521(01)00031-X; Shadidi M, 2003, DRUG RESIST UPDATE, V6, P363, DOI 10.1016/j.drup.2003.11.002; Shi HD, 2001, ENZYME MICROB TECH, V28, P25, DOI 10.1016/S0141-0229(00)00281-7; Shibasaki S, 2001, APPL MICROBIOL BIOT, V55, P471, DOI 10.1007/s002530000539; Sulpizi M, 2003, BIOPHYS J, V84, P2207, DOI 10.1016/S0006-3495(03)75026-7; Tan M, 2006, CANCER RES, V66, P3764, DOI 10.1158/0008-5472.CAN-05-2747; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Uchiyama F, 2005, J BIOSCI BIOENG, V99, P448, DOI 10.1263/jbb.99.448; Woodman R, 2005, J MOL BIOL, V352, P1118, DOI 10.1016/j.jmb.2005.08.001; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	40	7	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103397	10.1371/journal.pone.0103397	http://dx.doi.org/10.1371/journal.pone.0103397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084350	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800036
J	Rizwani, W; Fasim, A; Sharma, D; Reddy, DJ; Bin Omar, NAM; Singh, SS				Rizwani, Wasia; Fasim, Aneesa; Sharma, Deepshikha; Reddy, Divya J.; Bin Omar, Nabil A. M.; Singh, Surya S.			S137 Phosphorylation of Profilin 1 Is an Important Signaling Event in Breast Cancer Progression	PLOS ONE			English	Article							PROTEIN-KINASE-C; ACTIN-BINDING PROTEIN; POLY L-PROLINE; PHOSPHATIDYLINOSITOL 3-KINASE; CELL-PROLIFERATION; GROWTH-FACTOR; ANTIESTROGEN RESISTANCE; INTRACELLULAR MOTILITY; UP-REGULATION; IN-VITRO	Background: Profilins are actin-modulating proteins regulating many intracellular functions based on their multiple and diverse ligand interactions. They have been implicated to play a role in many pathological conditions such as allergies, cardiovascular diseases, muscular atrophy, diabetes, dementia and cancer. Post-translational modifications of profilin 1 can alter its properties and subsequently its function in a cell. In the present study, we identify the importance of phosphorylation of profilin 1 at serine 137 (S137) residue in breast cancer progression. Methods/Principal Findings: We found elevated profilin 1 (PFN) in human breast cancer tissues when compared to adjacent normal tissues. Overexpression of wild-type profilin 1 (PFN-WT) in breast cancer MCF7 cells made them more migratory, invasive and adherent independent in comparison to empty vector transfected cells. Mutation in serine phosphorylation site (S137) of profilin 1 (PFN-S137A) significantly abrogated these properties. Mutation affecting actin-binding ability (PFN-R74E) of profilin 1 enhanced its tumorigenic function whereas mutation affecting its poly-L-proline binding function (PFN-H133S) alleviated these mechanisms in breast cancer cells. PFN-WT was found to activate matrix metalloproteinases by zymography, MMP2 and MMP9 in presence of PDBu (phorbol 12, 13 dibutyrate, PI3K agonist) to enhance migration and invasion in MCF7 cells while PFN-S137A did not. Phosphorylation increased migration and invasion in other mutants of profilin 1. Nuclear profilin levels also increased in the presence of PDBu. Conclusions: Previous studies show that profilin could be executing a dual role in cancer by either suppressing or promoting tumorigenesis in a context dependent manner. In this study we demonstrate for the first time that phosphorylation of profilin 1 at serine 137 enhances oncogenic properties in breast cancer cells. Inhibitors targeting profilin 1 phosphorylation directly or indirectly through inhibition of kinases that phosphorylate profilin could be valuable therapeutic agents that can alter its activity and thereby control the progression of cancer.	[Rizwani, Wasia; Fasim, Aneesa; Sharma, Deepshikha; Reddy, Divya J.; Bin Omar, Nabil A. M.; Singh, Surya S.] Osmania Univ, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India	Osmania University	Rizwani, W (corresponding author), Osmania Univ, Dept Biochem, Hyderabad 500007, Andhra Pradesh, India.	wasia.rizwani@gmail.com; suryasingh.oubioc@gmail.com		Fasim, Anees/0000-0003-0504-235X	UGC-MRP (India); UGC (University Grants Commission); CSIR (Council for Scientific and Industrial Research); UGC; ICCR (Indian Council for Cultural Relations Fellowship)	UGC-MRP (India); UGC (University Grants Commission)(University Grants Commission, India); CSIR (Council for Scientific and Industrial Research)(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India); ICCR (Indian Council for Cultural Relations Fellowship)	This work was financially supported by UGC-MRP (India) funding to SSS. WR received a fellowship from UGC (University Grants Commission). DS is supported by a fellowship from CSIR (Council for Scientific and Industrial Research), DJR from UGC and NBO from ICCR (Indian Council for Cultural Relations Fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2006, MOL CANCER THER, V5, P1183, DOI 10.1158/1535-7163.MCT-05-0400; Alvi AJ, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr563; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Bhargavi V, 1998, BIOCHEM MOL BIOL INT, V46, P241; BjorkegrenSjogren C, 1997, FEBS LETT, V418, P258, DOI 10.1016/S0014-5793(97)01376-8; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; CLARKE R, 1989, P NATL ACAD SCI USA, V86, P3649, DOI 10.1073/pnas.86.10.3649; Dai YP, 2006, VASC PHARMACOL, V44, P275, DOI 10.1016/j.vph.2005.11.008; Das T, 2009, J CELL PHYSIOL, V218, P436, DOI 10.1002/jcp.21618; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Fan Y, 2014, NAT CELL BIOL, V16, P445, DOI 10.1038/ncb2954; Fan YH, 2012, SOL PHYS, V277, P1, DOI 10.1007/s11207-011-9913-4; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Geese M, 2002, MOL BIOL CELL, V13, P2383, DOI 10.1091/mbc.E02-01-0058; Gershtein ES, 1999, CLIN CHIM ACTA, V287, P59, DOI 10.1016/S0009-8981(99)00118-7; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; GOLDSCHMIDTCLERMONT PJ, 1991, SCIENCE, V251, P1231, DOI 10.1126/science.1848725; Grenklo S, 2003, EMBO REP, V4, P523, DOI 10.1038/sj.embor.embor823; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Huang CM, 2006, PROTEOMICS, V6, P6107, DOI 10.1002/pmic.200600287; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Kasina S, 2006, NITRIC OXIDE-BIOL CH, V14, P65, DOI 10.1016/j.niox.2005.09.008; Kasina S, 2005, J BIOCHEM, V138, P687, DOI 10.1093/jb/mvi163; Korenbaum E, 1998, BIOCHEMISTRY-US, V37, P9274, DOI 10.1021/bi9803675; Korupolu RV, 2009, INT J BIOL MACROMOL, V45, P265, DOI 10.1016/j.ijbiomac.2009.06.001; Krause M, 2002, J CELL SCI, V115, P4721, DOI 10.1242/jcs.00218; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Matias-Roman S, 2005, BLOOD, V105, P3956, DOI 10.1182/blood-2004-06-2382; Mayboroda O, 1997, CELL MOTIL CYTOSKEL, V37, P166, DOI 10.1002/(SICI)1097-0169(1997)37:2<166::AID-CM9>3.0.CO;2-6; Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; NAKAMURA H, 1994, BIOCHEM BIOPH RES CO, V198, P568, DOI 10.1006/bbrc.1994.1083; Oh JE, 2006, AMINO ACIDS, V31, P289, DOI 10.1007/s00726-005-0256-z; Rawe VY, 2006, HUM REPROD, V21, P1143, DOI 10.1093/humrep/dei480; Rizwani W, 2009, CELL CYCLE, V8, P1621, DOI 10.4161/cc.8.10.8578; Romeo GR, 2013, DIABETES, V62, P3718, DOI 10.2337/db13-0050; Rothkegel M, 1996, J CELL SCI, V109, P83; Roy P, 2004, CELL MOTIL CYTOSKEL, V57, P84, DOI 10.1002/cm.10160; Roy P, 2002, NAT CELL BIOL, V4, pE91, DOI 10.1038/ncb0402-e91; SANGER JM, 1995, CELL MOTIL CYTOSKEL, V30, P38, DOI 10.1002/cm.970300106; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032802; Shetty P, 2012, LANCET, V379, P992, DOI 10.1016/S0140-6736(12)60415-2; Singh SS, 1996, RECEPT SIGNAL TRANS, V6, P77; Singh SS, 1996, BIOCHEMISTRY-US, V35, P16544, DOI 10.1021/bi9609634; Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2; Soderberg E, 2012, NUCLEUS-PHILA, V3, P290, DOI 10.4161/nucl.20327; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Tamura M, 2000, J AM SOC NEPHROL, V11, P423, DOI 10.1681/ASN.V113423; Tamura M, 2000, J AM SOC NEPHROL, V11, P1620, DOI 10.1681/ASN.V1191620; TANAKA M, 1992, CANCER RES, V52, P3372; TATE EH, 1983, CYTOMETRY, V4, P211, DOI 10.1002/cyto.990040304; THERIOT JA, 1993, CELL, V75, P835, DOI 10.1016/0092-8674(93)90527-W; Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8; Upadhyay AK, 2008, CURR CANCER DRUG TAR, V8, P741, DOI 10.2174/156800908786733405; Urtreger AJ, 2012, IUBMB LIFE, V64, P18, DOI 10.1002/iub.574; Vemuri B, 2001, CELL SIGNAL, V13, P433, DOI 10.1016/S0898-6568(01)00164-4; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873; Wu N, 2006, PROTEOMICS, V6, P6095, DOI 10.1002/pmic.200500321; Xiao HL, 2010, MOL CELL BIOL, V30, P5545, DOI 10.1128/MCB.00382-10; Zhang YH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2883; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449	70	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103868	10.1371/journal.pone.0103868	http://dx.doi.org/10.1371/journal.pone.0103868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084196	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800094
J	Younes, A; Abdel-Aty, M				Younes, Ahmed; Abdel-Aty, Mahmoud			Collapsing a Perfect Superposition to a Chosen Quantum State without Measurement	PLOS ONE			English	Article							STORAGE	Given a perfect superposition of 2(n) states on a quantum system of n qubits. We propose a fast quantum algorithm for collapsing the perfect superposition to a chosen quantum state vertical bar x(s)> without applying any measurements. The basic idea is to use a phase destruction mechanism. Two operators are used, the first operator applies a phase shift and a temporary entanglement to mark vertical bar x(s)> in the superposition, and the second operator applies selective phase shifts on the states in the superposition according to their Hamming distance with vertical bar x(s)>. The generated state can be used as an excellent input state for testing quantum memories and linear optics quantum computers. We make no assumptions about the used operators and applied quantum gates, but our result implies that for this purpose the number of qubits in the quantum register offers no advantage, in principle, over the obvious measurement-based feedback protocol.	[Younes, Ahmed] Univ Alexandria, Fac Sci, Dept Math & Comp Sci, Alexandria, Egypt; [Abdel-Aty, Mahmoud] Univ Sci & Technol, Zewail City Sci & Technol, Cairo, Egypt; [Abdel-Aty, Mahmoud] Sohag Univ, Fac Sci, Dept Math, Sohag, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Sohag University	Younes, A (corresponding author), Univ Alexandria, Fac Sci, Dept Math & Comp Sci, Alexandria, Egypt.	ayounes2@yahoo.com	Abdel-Aty, Mahmoud/N-9553-2019; Abdel-Aty, Mahmoud/H-4358-2017; Younes, Ahmed/O-6505-2017	Abdel-Aty, Mahmoud/0000-0002-9058-7938; Younes, Ahmed/0000-0002-1594-1589				Bao XH, 2012, NAT PHYS, V8, P517, DOI 10.1038/nphys2324; Bapst V, 2013, PHYS REP, V523, P127, DOI 10.1016/j.physrep.2012.10.002; BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Darquie B, 2005, SCIENCE, V309, P454, DOI 10.1126/science.1113394; Grover L. K., 1996, Proceedings of the Twenty-Eighth Annual ACM Symposium on the Theory of Computing, P212, DOI 10.1145/237814.237866; Han Y, 2010, REV MOD PHYS, V83, P1; Kitaev A., 2002, CLASSICAL QUANTUM CO, VVolume 47; Kuhn A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067901; Lapert M, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.033406; LIN H, 1995, OPT LETT, V20, P1658, DOI 10.1364/OL.20.001658; Macfarlane RM, 2002, J LUMIN, V100, P1, DOI 10.1016/S0022-2313(02)00450-7; Neergaard-Nielsen JS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.083604; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; Younes A, 2008, PHYSICA D, V237, P1074, DOI 10.1016/j.physd.2007.12.005; Younes A, 2013, QUANTUM INF PROCESS, V12, P2977, DOI 10.1007/s11128-013-0575-z	17	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103612	10.1371/journal.pone.0103612	http://dx.doi.org/10.1371/journal.pone.0103612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084459	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800057
J	Zhang, W; Zeng, LQ; Liu, YJ; Pan, Y; Zhang, W; Zhang, CQ; Zeng, BF; Chen, YF				Zhang, Wen; Zeng, Langqing; Liu, Yanjie; Pan, Yao; Zhang, Wei; Zhang, Changqing; Zeng, Bingfang; Chen, Yunfeng			The Mechanical Benefit of Medial Support Screws in Locking Plating of Proximal Humerus Fractures	PLOS ONE			English	Article							INTERNAL-FIXATION; OPEN REDUCTION; FAILURE; PLATES; HEAD; SITE	Background: The purpose of this study was to evaluate the biomechanical advantages of medial support screws (MSSs) in the locking proximal humeral plate for treating proximal humerus fractures. Methods: Thirty synthetic left humeri were randomly divided into 3 subgroups to establish two-part surgical neck fracture models of proximal humerus. All fractures were fixed with a locking proximal humerus plate. Group A was fixed with medial cortical support and no MSSs; Group B was fixed with 3 MSSs but without medial cortical support; Group C was fixed with neither medial cortical support nor MSSs. Axial compression, torsional stiffness, shear stiffness, and failure tests were performed. Results: Constructs with medial support from cortical bone showed statistically higher axial and shear stiffness than other subgroups examined (P<0.0001). When the proximal humerus was not supported by medial cortical bone, locking plating with medial support screws exhibited higher axial and torsional stiffness than locking plating without medial support screws (P <= 0.0207). Specimens with medial cortical bone failed primarily by fracture of the humeral shaft or humeral head. Specimens without medial cortical bone support failed primarily by significant plate bending at the fracture site followed by humeral head collapse or humeral head fracture. Conclusions: Anatomic reduction with medial cortical support was the stiffest construct after a simulated two-part fracture. Significant biomechanical benefits of MSSs in locking plating of proximal humerus fractures were identified. The reconstruction of the medial column support for proximal humerus fractures helps to enhance mechanical stability of the humeral head and prevent implant failure.	[Zhang, Wen; Liu, Yanjie; Pan, Yao; Zhang, Wei; Zhang, Changqing; Zeng, Bingfang; Chen, Yunfeng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed Surg, Shanghai 200030, Peoples R China; [Zeng, Langqing] Jinan Univ, Affiliated Zhuhai Hosp, Zhuhai Peoples Hosp, Dept Orthopaed, Jinan, Guangdong, Peoples R China	Shanghai Jiao Tong University; Jinan University; University of Jinan	Chen, YF (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed Surg, Shanghai 200030, Peoples R China.	chenyunfeng1969@163.com		zhang, changqing/0000-0002-7408-4126				Agudelo J, 2007, J ORTHOP TRAUMA, V21, P676, DOI 10.1097/BOT.0b013e31815bb09d; [Anonymous], 2009, J ORTHOP TRAUMA, V23, P113, DOI 10.1097/BOT.0b013e31819344bf; Badman B, 2011, J SHOULDER ELB SURG, V20, P616, DOI 10.1016/j.jse.2010.08.030; Bogner R, 2008, J BONE JOINT SURG BR, V90B, P1602, DOI 10.1302/0301-620X.90B12.20269; Brunner F, 2009, J ORTHOP TRAUMA, V23, P163, DOI 10.1097/BOT.0b013e3181920e5b; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; Egol KA, 2012, J SHOULDER ELB SURG, V21, P741, DOI 10.1016/j.jse.2011.09.017; Friess DM, 2008, ORTHOPEDICS, V31, P1183, DOI 10.3928/01477447-20081201-07; Gardner MJ, 2007, J ORTHOP TRAUMA, V21, P185, DOI 10.1097/BOT.0b013e3180333094; Hardeman F, 2012, INJURY, V43, P153, DOI 10.1016/j.injury.2011.04.003; Helmy N, 2006, CLIN ORTHOP RELAT R, P100, DOI 10.1097/01.blo.0000194674.56764.c0; Hepp P, 2003, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000092968.12414.a8; Hettrich CM, 2012, J ORTHOP TRAUMA, V26, P212, DOI 10.1097/BOT.0b013e318243909c; Koval KJ, 1996, J TRAUMA, V40, P778, DOI 10.1097/00005373-199605000-00017; Krappinger D, 2011, INJURY, V42, P1283, DOI 10.1016/j.injury.2011.01.017; Lescheid J, 2010, J TRAUMA, V69, P1235, DOI 10.1097/TA.0b013e3181beed96; Liew ASL, 2000, J SHOULDER ELB SURG, V9, P423, DOI 10.1067/mse.2000.107089; Micic ID, 2009, J ORTHOP SCI, V14, P596, DOI 10.1007/s00776-009-1382-3; Osterhoff G, 2011, J SHOULDER ELB SURG, V20, P740, DOI 10.1016/j.jse.2010.10.040; Schulte LM, 2011, J SHOULDER ELB SURG, V20, P1234, DOI 10.1016/j.jse.2010.12.015; Sproul RC, 2011, INJURY, V42, P408, DOI 10.1016/j.injury.2010.11.058; Volgas DA, 2004, CLIN ORTHOP RELAT R, P46, DOI 10.1097/01.blo.0000118697.84243.6c; Weeks CA, 2013, J SHOULDER ELB SURG, V22, P1552, DOI 10.1016/j.jse.2013.02.003; Zhang L, 2011, INT ORTHOP, V35, P1655, DOI 10.1007/s00264-011-1227-5	24	32	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103297	10.1371/journal.pone.0103297	http://dx.doi.org/10.1371/journal.pone.0103297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084520	Green Submitted, gold, Green Published			2022-12-27	WOS:000339819800028
J	Beguy, D; Mumah, J; Gottschalk, L				Beguy, Donatien; Mumah, Joyce; Gottschalk, Lindsey			Unintended Pregnancies among Young Women Living in Urban Slums: Evidence from a Prospective Study in Nairobi City, Kenya	PLOS ONE			English	Article							SEXUAL RISK-TAKING; ADOLESCENT PREGNANCY; REPRODUCTIVE HEALTH; CONTRACEPTIVE USE; ADVERSE OUTCOMES; TRENDS; BEHAVIOR; CHILDBEARING; FERTILITY; PATTERNS	Background: Despite the significant proportion of young people residing in slum communities, little attention has been paid to the sexual and reproductive health (SRH) challenges they face during their transition to adulthood within this harsh environment. Little is known about the extent to which living in extreme environments, like slums, impact SRH outcomes, especially during this key developmental period. This paper aims to fill this research gap by examining the levels of and factors associated with unintended pregnancies among young women aged 15-22 in two informal settlements in Nairobi, Kenya. Methods: We use data from two waves of a 3-year prospective survey that collected information from adolescents living in the two slums in 2007-2010. In total, 849 young women aged 15-22 were considered for analysis. We employed Cox and logistic regression models to investigate factors associated with timing of pregnancy experience and unintended pregnancy among adolescents who were sexually active by Wave 1 or Wave 2. Findings: About two thirds of sexually experienced young women (69%) have ever been pregnant by Wave 2. For 41% of adolescents, the pregnancies were unintended, with 26% being mistimed and 15% unwanted. Multivariate analysis shows a significant association between a set of factors including age at first sex, schooling status, living arrangements and timing of pregnancy experience. In addition, marital status, schooling status, age at first sex and living arrangements are the only factors that are significantly associated with unintended pregnancy among the young women. Conclusions: Overall, this study underscores the importance of looking at reproductive outcomes of early sexual initiation, the serious health risks early fertility entail, especially among out-of school girls, and sexual activity in general among young women living in slum settlements. This provides greater impetus for addressing reproductive behaviors among young women living in resource-poor settings such as slums.	[Beguy, Donatien; Mumah, Joyce] African Populat & Hlth Res Ctr, Urbanizat & Wellbeing & Populat Dynam & Reprod Hl, Nairobi, Kenya; [Gottschalk, Lindsey] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA	African Population & Health Research Centre; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Beguy, D (corresponding author), African Populat & Hlth Res Ctr, Urbanizat & Wellbeing & Populat Dynam & Reprod Hl, Nairobi, Kenya.	dbeguy@aphrc.org		Mumah, Joyce/0000-0001-6181-6837; Gottschalk, Lindsey/0000-0001-5110-9493	Wellcome Trust; Strengthening Evidence for Programming on Unintended Pregnancy (STEP UP) Research Program Consortium through UK Department for International Development; Measurement, Learning and Evaluation project (MLE) through Bill and Melinda Gates Foundation; William and Flora Hewlett Foundation; Swedish International Development Agency (SIDA); Department for International Development (DFID) [201398] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Strengthening Evidence for Programming on Unintended Pregnancy (STEP UP) Research Program Consortium through UK Department for International Development; Measurement, Learning and Evaluation project (MLE) through Bill and Melinda Gates Foundation; William and Flora Hewlett Foundation; Swedish International Development Agency (SIDA); Department for International Development (DFID)	Collection of data used in this study is funded by the Wellcome Trust. Analysis and writing time was supported by funding from the Strengthening Evidence for Programming on Unintended Pregnancy (STEP UP) Research Program Consortium through a grant by UK Department for International Development and the Measurement, Learning and Evaluation project (MLE) through a grant from the Bill and Melinda Gates Foundation. This research was also made possible through the generous core funding to APHRC by the William and Flora Hewlett Foundation and dSwedish International Development Agency (SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyinka DA, 2010, J MATERN-FETAL NEO M, V23, P785, DOI 10.3109/14767050903572166; African Population and Health Research Center, 2002, POP HLTH DYN NAIR IN; Anand G., PLANNING CITIES AFRI; Babalola Stella, 2005, Afr J Reprod Health, V9, P49; Beguy D, 2011, J URBAN HEALTH, V88, P318, DOI 10.1007/s11524-011-9547-8; Beguy D, 2010, DEMOGR RES, V23, P549, DOI 10.4054/DemRes.2010.23.20; Blanc AK, 1998, STUD FAMILY PLANN, V29, P106, DOI 10.2307/172153; Chen N, 1998, MIGRATION, URBANIZATION, AND DEVELOPMENT : NEW DIRECTIONS AND ISSUES, P59; Cleves M., 2008, INTRO SURVIVAL ANAL; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1972, J R STAT SOC B, V34, P187; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Dodoo FNA, 2002, RURAL SOCIOL, V67, P46, DOI 10.1111/j.1549-0831.2002.tb00093.x; Emina J, 2011, J URBAN HEALTH, V88, P200, DOI 10.1007/s11524-011-9594-1; Erulkar A., 2007, ADOLESCENCE KIBERA S; Ezeh AC, 2010, STUD FAMILY PLANN, V41, P109, DOI 10.1111/j.1728-4465.2010.00231.x; Fotso JC, 2008, J URBAN HEALTH, V85, P428, DOI 10.1007/s11524-008-9263-1; Fotso JC, 2009, MATERN CHILD HLTH J, V13, P130, DOI 10.1007/s10995-008-0326-4; Gage AJ, 1998, STUD FAMILY PLANN, V29, P154, DOI 10.2307/172156; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; GLASIER A, 2006, LANCET, V368, P1595, DOI DOI 10.1016/S0140-6736(06)69478-6; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Gupta N, 2003, ARCH SEX BEHAV, V32, P41, DOI 10.1023/A:1021841312539; Gupta N, 2003, DEMOGR RES, V8, P93; Hussain R., 2012, GUTTMACHER I SERIES; Kabakyenga JK, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-73; Kabiru CW, 2010, J YOUTH STUD, V13, P453, DOI 10.1080/13676261003801754; Kennedy E, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-11; KIRAGU K, 1995, INT FAM PLAN PERSPEC, V21, P108, DOI 10.2307/2133184; Klein JD, 2005, PEDIATRICS, V116, P281, DOI 10.1542/peds.2005-0999; Kravdal O, 2002, DEMOGRAPHY, V39, P233, DOI 10.2307/3088337; Kumi-Kyereme Akwasi, 2007, Afr J Reprod Health, V11, P133, DOI 10.2307/25549736; Liran D, 2012, J MATERN-FETAL NEO M, P1; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; MARQUES NM, 1991, J TROP PEDIATRICS, V37, P194, DOI 10.1093/tropej/37.4.194; Marston C, 2003, POP STUD-J DEMOG, V57, P77, DOI 10.1080/0032472032000061749; Muganda-Onyando R, 2008, DRAM COUNTING COST T; Ngom P, 2003, J ADOLESCENT HEALTH, V33, P369, DOI 10.1016/S1054-139X(03)00213-1; Ochako R, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-1; Olukoya Peju, 2004, Afr J Reprod Health, V8, P57, DOI 10.2307/3583306; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Place F, 2007, WORLD DEV, V35, P312, DOI 10.1016/j.worlddev.2006.10.005; Population Reference Bureau, 2012, PRB WORLD POP DAT SH; Rashid SF, 2006, REPROD HEALTH MATTER, V14, P151, DOI 10.1016/S0968-8080(06)27221-5; Rashid SF, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S3-S3; Ringheim K, 2010, IMPROVING REPROD HLT; Rodgers KB, 1999, J MARRIAGE FAM, V61, P99, DOI 10.2307/353886; Rogers W, 1993, STATA TECHNICAL B, V13; Shah L, 2004, REPROD HEALTH MATTER, V12, P9, DOI 10.1016/S0968-8080(04)24002-2; Singh S, 2000, FAM PLANN PERSPECT, V32, P14, DOI 10.2307/2648144; Singh S, 1998, STUD FAMILY PLANN, V29, P117, DOI 10.2307/172154; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Stata Corporation, 2011, STAT SE 12 WIND; Temin M., 2009, START GIRL NEW AGEND; UN-HABITAT, 2010, STAT AFR CIT 2010 GO; UN-HABITAT, 2003, SLUMS WORLD FAC URB; UN-Habitat, 2008, STAT WORLDS CIT 2008; UN-HABITAT, 2003, CHALL SLUMS GLOB REP; Uzun AK, 2012, J MATERN-FETAL NEO M, P1; WHO, 2010, SOCIAL DETERMINANTS; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; World Health Organization, 2013, UNS AB GLOB REG EST; Zulu EM, 2002, POP STUD-J DEMOG, V56, P311, DOI 10.1080/00324720215933	63	34	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101034	10.1371/journal.pone.0101034	http://dx.doi.org/10.1371/journal.pone.0101034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6EF	25080352	Green Submitted, gold, Green Published			2022-12-27	WOS:000339954800002
J	Komiyama, T; Iwama, H; Osada, N; Nakamura, Y; Kobayashi, H; Tateno, Y; Gojobori, T				Komiyama, Tomoyoshi; Iwama, Hisakazu; Osada, Naoki; Nakamura, Yoji; Kobayashi, Hiroyuki; Tateno, Yoshio; Gojobori, Takashi			Dopamine Receptor Genes and Evolutionary Differentiation in the Domestication of Fighting Cocks and Long-Crowing Chickens	PLOS ONE			English	Article							EXON-III; PERSONALITY VARIATION; JAPANESE GAMECOCKS; ALLELE FREQUENCY; NOVELTY SEEKING; DRD4; POLYMORPHISMS; POPULATION; ASSOCIATION; IDENTIFICATION	The chicken domestication process represents a typical model of artificial selection, and gives significant insight into the general understanding of the influence of artificial selection on recognizable phenotypes. Two Japanese domesticated chicken varieties, the fighting cock (Shamo) and the long-crowing chicken (Naganakidori), have been selectively bred for dramatically different phenotypes. The former has been selected exclusively for aggressiveness and the latter for long crowing with an obedient sitting posture. To understand the particular mechanism behind these genetic changes during domestication, we investigated the degree of genetic differentiation in the aforementioned chickens, focusing on dopamine receptor D2, D3, and D4 genes. We studied other ornamental chickens such as Chabo chickens as a reference for comparison. When genetic differentiation was measured by an index of nucleotide differentiation (N-ST) newly devised in this study, we found that the N-ST value of DRD4 for Shamo (0.072) was distinctively larger than those of the other genes among the three populations, suggesting that aggressiveness has been selected for in Shamo by collecting a variety of single nucleotide polymorphisms. In addition, we found that in DRD4 in Naganakidori, there is a deletion variant of one proline at the 24th residue in the repeat of nine prolines of exon 1. We thus conclude that artificial selection has operated on these different kinds of genetic variation in the DRD4 genes of Shamo and Naganakidori so strongly that the two domesticated varieties have differentiated to obtain their present opposite features in a relatively short period of time.	[Komiyama, Tomoyoshi] Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa 25911, Japan; [Komiyama, Tomoyoshi; Kobayashi, Hiroyuki] Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa 25911, Japan; [Iwama, Hisakazu] Kagawa Univ, Life Sci Res Ctr, Takamatsu, Kagawa 760, Japan; [Osada, Naoki; Gojobori, Takashi] Natl Inst Genet, Shizuoka, Japan; [Nakamura, Yoji] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Kanagawa, Japan; [Tateno, Yoshio] Daegu Gyoungbuk Inst Sci & Technol, Sch New Biol, Taegu, South Korea; [Gojobori, Takashi] SOKENDAI, Dept Genet, Grad Sch Adv Studies, Hayama, Kanagawa, Japan; [Gojobori, Takashi] King Abdullah Univ Sci & Technol, BESE, CBRC, Thuwal, Saudi Arabia	Tokai University; Tokai University; Kagawa University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Fisheries Research & Education Agency (FRA); Graduate University for Advanced Studies - Japan; King Abdullah University of Science & Technology	Komiyama, T (corresponding author), Tokai Univ, Sch Med, Dept Clin Pharmacol, Isehara, Kanagawa 25911, Japan.	komiyama@tokai-u.jp; yt.tateno@gmail.com; tgojobor@nig.ac.jp	Osada, Naoki/J-3790-2019	Osada, Naoki/0000-0003-0180-5372; Komiyama, Tomoyoshi/0000-0003-2138-0084	KAKENHI [21570241]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (21570241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J MOL EVOL, V72, P253, DOI 10.1007/s00239-011-9432-9; Bachner-Melman R, 2007, AM J MED GENET B, V144B, P748, DOI 10.1002/ajmg.b.30505; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; Boehmler W, 2007, GENES BRAIN BEHAV, V6, P155, DOI 10.1111/j.1601-183X.2006.00243.x; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; Bunzow JR, 1991, CLONING GENE HUMAN D; Daniel, 2000, CHICKEN BOOK; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Dundes A, 1994, HIST JAPANESE CHICKE; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Fidler AE, 2007, P ROY SOC B-BIOL SCI, V274, P1685, DOI 10.1098/rspb.2007.0337; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Grady DL, 2013, J NEUROSCI, V33, P286, DOI 10.1523/JNEUROSCI.3515-12.2013; Hejjas K, 2007, MAMM GENOME, V18, P871, DOI 10.1007/s00335-007-9070-0; HUDSON RR, 1992, GENETICS, V132, P583; Inoue-Murayama M, 2002, J VET MED SCI, V64, P747, DOI 10.1292/jvms.64.747; Isaac E., 1970, GEOGRAPHY DOMESTICAT; Ito H, 2004, J VET MED SCI, V66, P815, DOI 10.1292/jvms.66.815; Iwama H, 2002, MOL BIOL EVOL, V19, P1891, DOI 10.1093/oxfordjournals.molbev.a004013; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kiyohara C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-89; Komiyama T, 2004, MOL PHYLOGENET EVOL, V33, P16, DOI 10.1016/j.ympev.2004.04.019; Komiyama T, 2004, GENE, V333, P91, DOI 10.1016/j.gene.2004.02.035; Komiyama T, 2003, GENE, V317, P195, DOI 10.1016/S0378-1119(03)00703-0; Korsten P, 2010, MOL ECOL, V19, P832, DOI 10.1111/j.1365-294X.2009.04518.x; Kubikova L, 2010, J COMP NEUROL, V518, P741, DOI 10.1002/cne.22255; Larsen SA, 2005, DNA CELL BIOL, V24, P795, DOI 10.1089/dna.2005.24.795; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu YP, 2006, BIOCHEM GENET, V44, P18, DOI 10.1007/s10528-006-9012-7; Momozawa Y, 2005, MAMM GENOME, V16, P538, DOI 10.1007/s00335-005-0021-3; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Niimi Y, 2001, J HERED, V92, P433, DOI 10.1093/jhered/92.5.433; Oana H, 1951, HIST JAPANECE CHICKE, p[25, 48, 74]; Ptacek R, 2011, MED SCI MONITOR, V17, pRA215, DOI 10.12659/MSM.881925; Robertson D, 2011, PRIMER AUTONOMIC NER, P63; Sauer Carl O., 1952, AGR ORIGINS DISPERSA; Sokoloff P, 1990, MOL CLONIGN CHARACTE; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sugiyama A, 2004, ZOOL SCI, V21, P941, DOI 10.2108/zsj.21.941; Sweitzer MM, 2013, SOC COGN AFFECT NEUR, V8, P499, DOI 10.1093/scan/nss020; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Yamaguchi K, 1998, CHICKEN, P80; Yamaguchi K, 1968, ENCY CHICKEN, P12	46	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101778	10.1371/journal.pone.0101778	http://dx.doi.org/10.1371/journal.pone.0101778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078403	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800009
J	Pongor, LS; Vera, R; Ligeti, B				Pongor, Loerinc S.; Vera, Roberto; Ligeti, Balazs			Fast and Sensitive Alignment of Microbial Whole Genome Sequencing Reads to Large Sequence Datasets on a Desktop PC: Application to Metagenomic Datasets and Pathogen Identification	PLOS ONE			English	Article							GENERATION; DOMAIN; BLAST; ALGORITHM; DATABASE; EGGNOG; TOOL	Next generation sequencing (NGS) of metagenomic samples is becoming a standard approach to detect individual species or pathogenic strains of microorganisms. Computer programs used in the NGS community have to balance between speed and sensitivity and as a result, species or strain level identification is often inaccurate and low abundance pathogens can sometimes be missed. We have developed Taxoner, an open source, taxon assignment pipeline that includes a fast aligner (e.g. Bowtie2) and a comprehensive DNA sequence database. We tested the program on simulated datasets as well as experimental data from Illumina, IonTorrent, and Roche 454 sequencing platforms. We found that Taxoner performs as well as, and often better than BLAST, but requires two orders of magnitude less running time meaning that it can be run on desktop or laptop computers. Taxoner is slower than the approaches that use small marker databases but is more sensitive due the comprehensive reference database. In addition, it can be easily tuned to specific applications using small tailored databases. When applied to metagenomic datasets, Taxoner can provide a functional summary of the genes mapped and can provide strain level identification. Taxoner is written in C for Linux operating systems. The code and documentation are available for research applications at http://code.google.com/p/taxoner.	[Pongor, Loerinc S.; Vera, Roberto; Ligeti, Balazs] Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary; [Pongor, Loerinc S.] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Vera, Roberto] Int Ctr Genet Engn & Biotechnol, Prot Struct & Bioinformat Grp, I-34012 Trieste, Italy	Semmelweis University; International Center for Genetic Engineering & Biotechnology (ICGEB)	Pongor, LS (corresponding author), Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary.	pongorlorinc@gmail.com	Pongor, Lorinc/AAA-9835-2021	Pongor, Lorinc/0000-0001-5917-4628; Vera Alvarez, Roberto/0000-0002-4108-5982	Hungarian Academy of Sciences; Hungarian National Innovation Office [TET 10-1-2011-0058, TAMOP-4.2.1.B-11/2/KMR-2011-0002, TAMOP-4.2.2/B-10/1-2010-0014]; ICGEB	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian National Innovation Office; ICGEB(Department of Biotechnology (DBT) India)	LSP was partially funded by a Lendulet grant from the Hungarian Academy of Sciences to Dr. B. Gyorffy (Lendulet Cancer Biomarker Research Group, Centre for Natural Sciences, Hungarian Academy of Sciences). The research at Pazmany Peter Catholic University, Budapest was partially supported by Hungarian National Innovation Office grants TET 10-1-2011-0058, TAMOP-4.2.1.B-11/2/KMR-2011-0002, and TAMOP-4.2.2/B-10/1-2010-0014. Funding for open access charge and for the services of a scientific writer/editor was provided by ICGEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bayer R., 1972, ACTA INFORM, V1, P173, DOI [10.1007/bf00288683, DOI 10.1007/BF00288683, 10.1007/BF00288683]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Dhir S, 2010, CURR PROTEIN PEPT SC, V11, P538, DOI 10.2174/138920310794109148; Droge J, 2012, BRIEF BIOINFORM, V13, P646, DOI 10.1093/bib/bbs031; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Koslicki D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091784; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lu SY, 1999, J BIOL CHEM, V274, P20473, DOI 10.1074/jbc.274.29.20473; Maravic G, 2003, J MOL BIOL, V332, P99, DOI 10.1016/S0022-2836(03)00863-5; Maravic G, 2003, NUCLEIC ACIDS RES, V31, P4941, DOI 10.1093/nar/gkg666; Moore CB, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S2-S6; Murvai J, 1999, BIOINFORMATICS, V15, P343, DOI 10.1093/bioinformatics/15.4.343; Neelakanta Girish, 2013, Microbiol Insights, V6, P37, DOI 10.4137/MBI.S10819; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shiryev SA, 2007, BIOINFORMATICS, V23, P2949, DOI 10.1093/bioinformatics/btm479; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teeling H, 2012, BRIEF BIOINFORM, V13, P728, DOI 10.1093/bib/bbs039; Vera R, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat051; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	32	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103441	10.1371/journal.pone.0103441	http://dx.doi.org/10.1371/journal.pone.0103441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077800	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800045
J	Berumen, ML; Braun, CD; Cochran, JEM; Skomal, GB; Thorrold, SR				Berumen, Michael L.; Braun, Camrin D.; Cochran, Jesse E. M.; Skomal, Gregory B.; Thorrold, Simon R.			Movement Patterns of Juvenile Whale Sharks Tagged at an Aggregation Site in the Red Sea	PLOS ONE			English	Article							RHINCODON-TYPUS; SATELLITE TRACKING; NINGALOO REEF; VERTICAL MOVEMENTS; GENETIC-STRUCTURE; DIVING BEHAVIOR; FISHERIES; ECOLOGY; BIOLOGY; OCEAN	Conservation efforts aimed at the whale shark, Rhincodon typus, remain limited by a lack of basic information on most aspects of its ecology, including global population structure, population sizes and movement patterns. Here we report on the movements of 47 Red Sea whale sharks fitted with three types of satellite transmitting tags from 2009-2011. Most of these sharks were tagged at a single aggregation site near Al-Lith, on the central coast of the Saudi Arabian Red Sea. Individuals encountered at this site were all juveniles based on size estimates ranging from 2.5-7 m total length with a sex ratio of approximately 1:1. All other known aggregation sites for juvenile whale sharks are dominated by males. Results from tagging efforts showed that most individuals remained in the southern Red Sea and that some sharks returned to the same location in subsequent years. Diving data were recorded by 37 tags, revealing frequent deep dives to at least 500 m and as deep as 1360 m. The unique temperature-depth profiles of the Red Sea confirmed that several whale sharks moved out of the Red Sea while tagged. The wide-ranging horizontal movements of these individuals highlight the need for multinational, cooperative efforts to conserve R. typus populations in the Red Sea and Indian Ocean.	[Berumen, Michael L.; Braun, Camrin D.; Cochran, Jesse E. M.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Braun, Camrin D.; Thorrold, Simon R.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Skomal, Gregory B.] Massachusetts Div Marine Fisheries, New Bedford, MA USA	King Abdullah University of Science & Technology; Woods Hole Oceanographic Institution; Massachusetts Division of Marine Fisheries	Berumen, ML (corresponding author), King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia.	michael.berumen@kaust.edu.sa	Thorrold, Simon R/B-7565-2012; Berumen, Michael/F-7745-2011	Thorrold, Simon R/0000-0002-1533-7517; Braun, Camrin/0000-0002-9317-9489; Berumen, Michael/0000-0003-2463-2742	KAUST [USA00002, KSA 00011]; United States National Science Foundation [OCE 0825148]	KAUST(King Abdullah University of Science & Technology); United States National Science Foundation(National Science Foundation (NSF))	Financial support was provided in part by KAUST baseline research funds (to MLB), KAUST award nos. USA00002 and KSA 00011 (to SRT), and the United States National Science Foundation (OCE 0825148 to SRT and GBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhilesh KV, 2013, ENVIRON BIOL FISH, V96, P713, DOI 10.1007/s10641-012-0063-9; Alava MNR, 2002, FISHERY TRADE WHALE, P132; Beckley LE, 1997, ENVIRON BIOL FISH, V50, P343, DOI 10.1023/A:1007355709632; Berumen ML, 2013, CORAL REEFS, V32, P737, DOI 10.1007/s00338-013-1055-8; Borrell A, 2011, ENVIRON BIOL FISH, V92, P559, DOI 10.1007/s10641-011-9879-y; Borrell A, 2011, ICES J MAR SCI, V68, P547, DOI 10.1093/icesjms/fsq170; Bouwmeester J, 2011, CORAL REEFS, V30, P1011, DOI 10.1007/s00338-011-0796-5; Braun CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088170; Brunnschweiler JM, 2009, J FISH BIOL, V74, P706, DOI 10.1111/j.1095-8649.2008.02155.x; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Chen VY, 2002, MANAGEMENT TRADE WHA; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Couturier LIE, 2013, LIPIDS, V48, P1029, DOI 10.1007/s11745-013-3829-8; Dingle Hugh, 2001, P247; Eckert SA, 2002, J ZOOL, V257, P111, DOI 10.1017/S0952836902000705; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Fowler SL, 2000, MANAGEMENT TRADE WHA; Galuardi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037829; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Gifford A, 2007, FISH RES, V84, P17, DOI 10.1016/j.fishres.2006.11.011; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Gudger AEW, 1938, COPEIA, V1938, P170; Gunn JS, 1999, MAR BIOL, V135, P553, DOI 10.1007/s002270050656; Hanfee F., 2001, TRADE WHALE SHARK IT; Hearn A.R., 2013, ANIM BIOTELEMETRY, V1, P1, DOI [10.1186/2050-3385-1-11, DOI 10.1186/2050-3385-1-11]; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hsu HH, 2012, J FISH BIOL, V80, P1595, DOI 10.1111/j.1095-8649.2012.03234.x; Hsu HH, 2007, FISH RES, V84, P25, DOI 10.1016/j.fishres.2006.11.030; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; Lam CH, 2010, MAR ECOL PROG SER, V419, P71, DOI 10.3354/meps08862; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Li W, 2012, J FISH BIOL, V80, P1608, DOI 10.1111/j.1095-8649.2012.03250.x; Maguire J. J., 2006, STATE WORLD HIGHLY M; Motta PJ, 2010, ZOOLOGY, V113, P199, DOI 10.1016/j.zool.2009.12.001; Musyl MK, 2011, MAR ECOL PROG SER, V433, P1, DOI 10.3354/meps09202; Newman HE, 2002, EL BIOD CONS MAN P I, P230; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Norman B, 2004, REV CURRENT CONSERVA; Norman B. M., 1999, ASPECTS BIOL ECOTOUR; R Development Core Team, 2014, R LANG ENV STAT COMP; Raitsos DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064909; Ramirez-Macias D, 2012, J FISH BIOL, V80, P1401, DOI 10.1111/j.1095-8649.2012.03258.x; Robinson DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058255; Rohner CA, 2013, MAR ECOL PROG SER, V493, P219, DOI 10.3354/meps10500; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Rowat D, 2011, MAR FRESHWATER RES, V62, P621, DOI 10.1071/MF10135; Schmidt JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004988; Sequeira AMM, 2013, J FISH BIOL, V82, P367, DOI 10.1111/jfb.12017; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V390, P84, DOI 10.1016/j.jembe.2010.05.009; Spaet JLY, 2012, J FISH BIOL, V80, P952, DOI 10.1111/j.1095-8649.2011.03178.x; Spaet JLY, 2011, ZOOL MIDDLE EAST, V52, P118, DOI 10.1080/09397140.2011.10638488; Stevens JD, 2007, FISH RES, V84, P4, DOI 10.1016/j.fishres.2006.11.008; Stewart BS, 2005, ENVIRON BIOL FISH, V74, P184, DOI 10.1007/s10641-005-2229-1; Taylor G., 1994, WHALE SHARKS GIANTS; Taylor JG, 1996, MAR FRESHWATER RES, V47, P637, DOI 10.1071/MF9960637; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Vignaud TM, 2014, MOL ECOL, V23, P2590, DOI 10.1111/mec.12754; Wang YM, 2012, INTEGR ZOOL, V7, P94, DOI [10.1111/j.1749-4877.2012.00279.x, 10.1111/j.1749-4877.2011.00278.x]; Wilson SG, 2007, FISH OCEANOGR, V16, P547, DOI 10.1111/j.1365-2419.2007.00450.x; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8	62	42	42	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103536	10.1371/journal.pone.0103536	http://dx.doi.org/10.1371/journal.pone.0103536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076407	Green Published, gold, Green Submitted			2022-12-27	WOS:000340028800060
J	Florez-Vargas, O; Bramhall, M; Noyes, H; Cruickshank, S; Stevens, R; Brass, A				Florez-Vargas, Oscar; Bramhall, Michael; Noyes, Harry; Cruickshank, Sheena; Stevens, Robert; Brass, Andy			The Quality of Methods Reporting in Parasitology Experiments	PLOS ONE			English	Article							EXPERIMENTAL CEREBRAL MALARIA; TRYPANOSOMA-CRUZI INFECTION; GENE-EXPRESSION PROFILES; TOXOPLASMA-GONDII; CHAGAS-DISEASE; MICROARRAY ANALYSIS; IMMUNE-RESPONSES; T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; DIFFERENTIAL EXPRESSION	There is a growing concern both inside and outside the scientific community over the lack of reproducibility of experiments. The depth and detail of reported methods are critical to the reproducibility of findings, but also for making it possible to compare and integrate data from different studies. In this study, we evaluated in detail the methods reporting in a comprehensive set of trypanosomiasis experiments that should enable valid reproduction, integration and comparison of research findings. We evaluated a subset of other parasitic (Leishmania, Toxoplasma, Plasmodium, Trichuris and Schistosoma) and non-parasitic (Mycobacterium) experimental infections in order to compare the quality of method reporting more generally. A systematic review using PubMed (2000-2012) of all publications describing gene expression in cells and animals infected with Trypanosoma spp was undertaken based on PRISMA guidelines; 23 papers were identified and included. We defined a checklist of essential parameters that should be reported and have scored the number of those parameters that are reported for each publication. Bibliometric parameters (impact factor, citations and h-index) were used to look for association between Journal and Author status and the quality of method reporting. Trichuriasis experiments achieved the highest scores and included the only paper to score 100% in all criteria. The mean of scores achieved by Trypanosoma articles through the checklist was 65.5% (range 32-90%). Bibliometric parameters were not correlated with the quality of method reporting (Spearman's rank correlation coefficient <-0.5; p>0.05). Our results indicate that the quality of methods reporting in experimental parasitology is a cause for concern and it has not improved over time, despite there being evidence that most of the assessed parameters do influence the results. We propose that our set of parameters be used as guidelines to improve the quality of the reporting of experimental infection models as a pre-requisite for integrating and comparing sets of data.	[Florez-Vargas, Oscar; Bramhall, Michael; Stevens, Robert; Brass, Andy] Univ Manchester, Sch Comp Sci, Biohlth Informat Grp, Manchester, Lancs, England; [Noyes, Harry] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Cruickshank, Sheena; Brass, Andy] Univ Manchester, Fac Life Sci, Manchester Immunol Grp, Manchester, Lancs, England	University of Manchester; University of Liverpool; University of Manchester	Brass, A (corresponding author), Univ Manchester, Sch Comp Sci, Biohlth Informat Grp, Manchester, Lancs, England.	andy.brass@manchester.ac.uk	Bramhall, Michael/M-4227-2019	Bramhall, Michael/0000-0001-5938-158X; Brass, Andrew/0000-0002-0389-7058; Cruickshank, Sheena/0000-0002-3047-5475; Florez-Vargas, Oscar/0000-0002-4393-2612	Colciencias; EPSRC; Epistem Ltd; Engineering and Physical Sciences Research Council [1168835] Funding Source: researchfish	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Epistem Ltd; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research is supported by a scholarship 'Francisco Jose de Caldas' from Colciencias to Oscar Florez- Vargas and a co-funding scholarship from EPSRC and Epistem Ltd awarded to Michael Bramhall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270; Amin DN, 2010, AM J TROP MED HYG, V82, P983, DOI 10.4269/ajtmh.2010.09-0770; Angyalosi G, 2001, INFECT IMMUN, V69, P5874, DOI 10.1128/IAI.69.9.5874-5882.2001; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Beisiegel M, 2009, EUR J IMMUNOL, V39, P3369, DOI 10.1002/eji.200939615; Bertholet S, 2005, INFECT IMMUN, V73, P6620, DOI 10.1128/IAI.73.10.6620-6628.2005; Betts CJ, 2000, PARASITOLOGY, V121, P631; Bickle Q, 2007, PARASITE IMMUNOL, V29, P93, DOI 10.1111/j.1365-3024.2006.00923.x; Biswas A, 2011, EUR J IMMUNOL, V41, P992, DOI 10.1002/eji.201040940; Brandan CP, 2006, EXP PARASITOL, V114, P89, DOI 10.1016/j.exppara.2006.02.014; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brunner C, 2007, EMBO J, V26, P3191, DOI 10.1038/sj.emboj.7601742; Burke ML, 2011, MOL IMMUNOL, V49, P191, DOI 10.1016/j.molimm.2011.08.014; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000686; Bystrom J, 2006, EUR J HAEMATOL, V77, P181, DOI 10.1111/j.1600-0609.2006.00699.x; CAMANDAROBA Edson Luiz P., 2002, Rev. Inst. Med. trop. S. Paulo, V44, P97, DOI 10.1590/S0036-46652002000200008; Capewell P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003686; Carapau D, 2007, CELL MICROBIOL, V9, P1738, DOI 10.1111/j.1462-5822.2007.00910.x; Casadevall A, 2010, INFECT IMMUN, V78, P4972, DOI 10.1128/IAI.00908-10; Chessler ADC, 2009, J IMMUNOL, V182, P2288, DOI 10.4049/jimmunol.0800621; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Costales JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-252; Cummings KL, 2004, INFECT IMMUN, V72, P4081, DOI 10.1128/IAI.72.7.4081-4089.2004; Guedes PMD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000604; Ramirez JD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002041; de Araujo FF, 2011, HUM PATHOL, V42, P299, DOI 10.1016/j.humpath.2010.10.002; de la Torre-Escudero E, 2012, J PROTEOMICS, V77, P129, DOI 10.1016/j.jprot.2012.07.015; De Lima AR, 2008, EXP PARASITOL, V119, P336, DOI 10.1016/j.exppara.2008.03.003; Fraga LAD, 2010, J INFECT DIS, V201, P464, DOI 10.1086/649841; Delahaye NF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-452; Delic D, 2011, PARASITOL RES, V108, P1111, DOI 10.1007/s00436-010-2152-z; Desolme B, 2000, VACCINE, V18, P2512, DOI 10.1016/S0264-410X(00)00035-9; Dixon H, 2006, EUR J IMMUNOL, V36, P1753, DOI 10.1002/eji.200535492; Goldenberg RCDS, 2009, MICROBES INFECT, V11, P1140, DOI 10.1016/j.micinf.2009.08.009; Drummond C., 2009, EV METH MACH LEARN W; Ehrchen JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000871; Fang R, 2009, VET PARASITOL, V164, P134, DOI 10.1016/j.vetpar.2009.06.012; Filippi C, 2003, J EXP MED, V198, P201, DOI 10.1084/jem.20021893; Fux B, 2003, INFECT IMMUN, V71, P6392, DOI 10.1128/IAI.71.11.6392-6401.2003; Gail M, 2001, MOL GENET GENOMICS, V265, P905, DOI 10.1007/s004380100487; Garg N, 2004, BIOCHEM J, V381, P743, DOI 10.1042/BJ20040356; Genovesio A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019733; Giammanco S, 1997, ARCH PHYSIOL BIOCHEM, V105, P445, DOI 10.1076/apab.105.5.445.3287; Goodhead I, 2013, MBIO, V4, DOI 10.1128/mBio.00197-13; Goodhead I, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000880; Graefe SEB, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000057; GraphPad, GRAPHPAD PRISM VERS; GREENBLATT HC, 1984, INFECT IMMUN, V43, P337, DOI 10.1128/IAI.43.1.337-340.1984; Guerfali FZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-238; Guilbride DL, 2012, TRENDS PARASITOL, V28, P142, DOI 10.1016/j.pt.2012.01.002; Hashimoto M, 2005, INT J PARASITOL, V35, P1587, DOI 10.1016/j.ijpara.2005.08.004; Hasnain SZ, 2011, PARASITE IMMUNOL, V33, P45, DOI 10.1111/j.1365-3024.2010.01258.x; Hepworth MR, 2010, EUR J IMMUNOL, V40, P406, DOI 10.1002/eji.200939589; Hill EW, 2005, VET IMMUNOL IMMUNOP, V105, P247, DOI 10.1016/j.vetimm.2005.02.004; Hotez PJ, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002300, 10.1371/journal.pntd.0002570]; Humphreys NE, 2004, PARASITE IMMUNOL, V26, P187, DOI 10.1111/j.0141-9838.2004.00702.x; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jayakumar A, 2008, J PARASITOL, V94, P84, DOI 10.1645/GE-1153.1; JOHNSON AM, 1984, Z PARASITENKD, V70, P303, DOI 10.1007/BF00927816; Johnston CE, 2005, PARASITE IMMUNOL, V27, P69, DOI 10.1111/j.1365-3024.2005.00746.x; Ju CH, 2009, J IMMUNOL, V183, P7420, DOI 10.4049/jimmunol.0900640; Keller C, 2004, TUBERCULOSIS, V84, P144, DOI 10.1016/j.tube.2003.12.003; Kierstein S, 2006, GENES IMMUN, V7, P667, DOI 10.1038/sj.gene.6364345; Kinjyo I, 2006, J EXP MED, V203, P1021, DOI 10.1084/jem.20052333; Klein SL, 2012, ENDOCRINOLOGY, V153, P2544, DOI 10.1210/en.2011-2120; Knight BC, 2006, J NEUROIMMUNOL, V179, P126, DOI 10.1016/j.jneuroim.2006.06.002; Kotner J, 2007, INFECT IMMUN, V75, P861, DOI 10.1128/IAI.01500-06; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee CJ, 2013, J AM SOC INF SCI TEC, V64, P2, DOI 10.1002/asi.22784; Li SQ, 2011, EXP PARASITOL, V128, P256, DOI 10.1016/j.exppara.2011.02.027; Li SQ, 2009, PARASITOL RES, V104, P385, DOI 10.1007/s00436-008-1211-1; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lopez R, 2008, J IMMUNOL, V181, P4908, DOI 10.4049/jimmunol.181.7.4908; Lovegrove FE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-295; Maddocks S, 2009, TUBERCULOSIS, V89, P285, DOI 10.1016/j.tube.2009.05.003; MAJIWA PAO, 1986, PARASITOLOGY, V93, P291, DOI 10.1017/S0031182000051465; Manque PA, 2011, INFECT IMMUN, V79, P1855, DOI 10.1128/IAI.00643-10; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; Meade KG, 2009, MOL IMMUNOL, V47, P196, DOI 10.1016/j.molimm.2009.09.042; Mekata H, 2012, PARASITE IMMUNOL, V34, P318, DOI 10.1111/j.1365-3024.2012.01362.x; MILES MA, 1981, LANCET, V1, P1338; Miu J, 2008, INFECT IMMUN, V76, P1812, DOI 10.1128/IAI.01650-07; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; Mukherjee S, 2003, PARASITOL RES, V91, P187, DOI 10.1007/s00436-003-0937-z; Mukherjee S, 2008, GENOMICS, V91, P423, DOI 10.1016/j.ygeno.2008.01.008; MUTAYOBA BM, 1988, ACTA TROP, V45, P225; Noyes HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005170; O'Gorman GM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-207; Oakley MS, 2008, INFECT IMMUN, V76, P4518, DOI 10.1128/IAI.00525-08; Okomo-Adhiambo M, 2006, INFECT IMMUN, V74, P4254, DOI 10.1128/IAI.00386-05; Park AY, 2000, J IMMUNOL, V165, P896, DOI 10.4049/jimmunol.165.2.896; Soares MBP, 2010, J INFECT DIS, V202, P416, DOI 10.1086/653481; Perry CR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001178; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Randall LM, 2008, INFECT IMMUN, V76, P3312, DOI 10.1128/IAI.01475-07; Ray D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001912; ROBERTS CW, 1995, INFECT IMMUN, V63, P2549, DOI 10.1128/IAI.63.7.2549-2555.1995; Rosanas-Urgell A, 2012, MEM I OSWALDO CRUZ, V107, P410, DOI 10.1590/S0074-02762012000300017; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Schuster JP, 2001, PARASITOL RES, V87, P985; Schuster JP, 2001, PARASITOL RES, V87, P994; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956; Silver RF, 2009, AM J RESP CELL MOL, V40, P491, DOI 10.1165/rcmb.2008-0219OC; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Singh KP, 2006, ANN TROP MED PARASIT, V100, P611, DOI 10.1179/136485906X118530; Soares MBP, 2011, CELL CYCLE, V10, P1448, DOI 10.4161/cc.10.9.15487; StataCorp, STAT STAT SOFTW REL; Svensson M, 2010, IMMUNOLOGY, V129, P257, DOI 10.1111/j.1365-2567.2009.03178.x; Tanowitz HB, 2011, CELL CYCLE, V10, P1132, DOI 10.4161/cc.10.7.15207; Tato CM, 2003, J IMMUNOL, V170, P3139, DOI 10.4049/jimmunol.170.6.3139; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Turay A. A., 2005, Journal of Vector Borne Diseases, V42, P15; Vasconcelos RHT, 2012, CYTOKINE, V59, P203, DOI 10.1016/j.cyto.2012.04.035; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VESPA GNR, 1994, INFECT IMMUN, V62, P5177, DOI 10.1128/IAI.62.11.5177-5182.1994; Villarino AV, 2008, INT IMMUNOL, V20, P739, DOI 10.1093/intimm/dxn032; Vivarini AD, 2011, FASEB J, V25, P4162, DOI 10.1096/fj.11-185165; Volpe E, 2006, IMMUNOLOGY, V118, P449, DOI 10.1111/j.1365-2567.2006.02378.x; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Xu YZ, 2003, CHINESE MED J-PEKING, V116, P1070; Ylostalo J, 2005, J INFECT DIS, V191, P400, DOI 10.1086/426868; Zhang M, 2011, PARASITE IMMUNOL, V33, P199, DOI 10.1111/j.1365-3024.2010.01265.x; Zhou DH, 2011, PARASITOL RES, V109, P1637, DOI 10.1007/s00436-011-2435-z; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009; Zuim NR, 2012, INTERDISCIP PERSPECT, V2012	131	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e101131	10.1371/journal.pone.0101131	http://dx.doi.org/10.1371/journal.pone.0101131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076044	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800007
J	Holt, D; Okusanya, O; Judy, R; Venegas, O; Jiang, J; DeJesus, E; Eruslanov, E; Quatromoni, J; Bhojnagarwala, P; Deshpande, C; Albelda, S; Nie, S; Singhal, S				Holt, David; Okusanya, Olugbenga; Judy, Ryan; Venegas, Ollin; Jiang, Jack; DeJesus, Elizabeth; Eruslanov, Evgeniy; Quatromoni, Jon; Bhojnagarwala, Pratik; Deshpande, Charuhas; Albelda, Steven; Nie, Shuming; Singhal, Sunil			Intraoperative Near-Infrared Imaging Can Distinguish Cancer from Normal Tissue but Not Inflammation	PLOS ONE			English	Article							ENHANCED PERMEABILITY; IN-VIVO; SURGERY; RETENTION; ONCOLOGY; NANOTECHNOLOGY; RESECTION; MODELS	Introduction: Defining tumor from non-tumor tissue is one of the major challenges of cancer surgery. Surgeons depend on visual and tactile clues to select which tissues should be removed from a patient. Recently, we and others have hypothesized near-infrared (NIR) imaging can be used during surgery to differentiate tumors from normal tissue. Methods: We enrolled 8 canines and 5 humans undergoing cancer surgery for NIR imaging. The patients were injected with indocyanine green (ICG), an FDA approved non-receptor specific NIR dye that accumulates in hyperpermeable tissues, 16-24 hours prior to surgery. During surgery, NIR imaging was used to discriminate the tumor from non-tumor tissue. Results: NIR imaging identified all tumors with a mean signal-to-background ratio of 6.7. Optical images were useful during surgery in discriminating normal tissue from cancer. In 3 canine cases and 1 human case, the tissue surrounding the tumor was inflamed due to obstruction of the vascular supply due to mass effect. In these instances, NIR imaging could not distinguish tumor tissue from tissue that was congested, edematous and did not contain cancer. Conclusions: This study shows that NIR imaging can identify tumors from normal tissues, provides excellent tissue contrast, and it facilitates the resection of tumors. However, in situations where there is significant peritumoral inflammation, NIR imaging with ICG is not helpful. This suggests that non-targeted NIR dyes that accumulate in hyperpermeable tissues will have significant limitations in the future, and receptor-specific NIR dyes may be necessary to overcome this problem.	[Holt, David] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA; [Okusanya, Olugbenga; Judy, Ryan; Venegas, Ollin; Jiang, Jack; DeJesus, Elizabeth; Eruslanov, Evgeniy; Quatromoni, Jon; Bhojnagarwala, Pratik; Singhal, Sunil] Univ Penn, Perelman Sch Med, Dept Surg, Philadelphia, PA 19104 USA; [Deshpande, Charuhas] Univ Penn, Perelman Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Albelda, Steven] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Nie, Shuming] Emory Univ, Dept Biomed Engn, Atlanta, GA 30322 USA; [Nie, Shuming] Emory Univ, Dept Chem, Atlanta, GA 30322 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Emory University; Emory University	Holt, D (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA.	dholt@vet.upenn.edu	Okusanya, Olugbenga/AAH-9534-2020; Eruslanov, Evgeniy/AAS-1277-2020; Nie, Shuming/E-4843-2011	Multhoff, Gabriele/0000-0002-2616-3137; Okusanya, Olugbenga/0000-0002-4304-9651	American Surgical Association; National Institutes of Health Transformative [R01 CA163256-01]; NATIONAL CANCER INSTITUTE [R01CA163256] Funding Source: NIH RePORTER	American Surgical Association; National Institutes of Health Transformative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Surgical Association (SS) and National Institutes of Health Transformative R01 CA163256-01 (DH, MW, SN, SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliperti LA, 2011, ANN SURG ONCOL, V18, P603, DOI 10.1245/s10434-010-1442-0; BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]; Crane LMA, 2011, MOL IMAGING BIOL, V13, P1043, DOI 10.1007/s11307-010-0425-7; de Oliveira RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074942; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Frangioni JV, 2006, NAT BIOTECHNOL, V24, P909, DOI 10.1038/nbt0806-909; Greish K, 2007, J DRUG TARGET, V15, P457, DOI 10.1080/10611860701539584; Greish K, 2010, METHODS MOL BIOL, V624, P25, DOI 10.1007/978-1-60761-609-2_3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hutteman M, 2011, EJSO-EUR J SURG ONC, V37, P252, DOI 10.1016/j.ejso.2010.12.014; Ignatius SH, 2008, CHEST, V133, P662, DOI 10.1378/chest.07-1306; Jackaman C, 2003, J IMMUNOL, V171, P5051, DOI 10.4049/jimmunol.171.10.5051; Judy BF, 2012, NEOPLASIA, V14, P352, DOI 10.1593/neo.12208; Klimberg VS, 1999, SURG ONCOL, V8, P77, DOI 10.1016/S0960-7404(99)00031-6; Madajewski B, 2012, CLIN CANCER RES, V18, P5741, DOI 10.1158/1078-0432.CCR-12-1188; Mohs AM, 2010, ANAL CHEM, V82, P9058, DOI 10.1021/ac102058k; NCI, 2009, SURV EP RES SEER PRO; Nguyen QT, 2013, NAT REV CANCER, V13, P653, DOI 10.1038/nrc3566; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Okusanya OT, 2013, TECHNOL CANC RES TRE; Polom K, 2011, CANCER-AM CANCER SOC, V117, P4812, DOI 10.1002/cncr.26087; Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561; Predina JD, 2011, CANCER GENE THER, V18, P871, DOI 10.1038/cgt.2011.56; Predina JD, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-34; Predina JD, 2012, CANCER BIOL THER, V13, P745, DOI 10.4161/cbt.20557; Predina JD, 2012, AM J TRANSL RES, V4, P206; Schaafsma B. E, 2011, J SURG ONCOL; Schulz MD, 2010, ANN THORAC SURG, V89, pS2188, DOI 10.1016/j.athoracsur.2010.02.111; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Singhal S, 2010, ANNU REV MED, V61, P359, DOI 10.1146/annurev.med.60.052907.094936; Terwisscha van Scheltinga AG, 2011, J NUCL MED; Vaidya A, 2001, UROLOGY, V57, P949, DOI 10.1016/S0090-4295(01)00904-9; van der Vorst JR, 2013, CANCER-AM CANCER SOC, V119, P3411, DOI 10.1002/cncr.28203; Veiseh M, 2007, CANCER RES, V67, P6882, DOI 10.1158/0008-5472.CAN-06-3948	35	81	83	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103342	10.1371/journal.pone.0103342	http://dx.doi.org/10.1371/journal.pone.0103342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072388	Green Submitted, gold, Green Published			2022-12-27	WOS:000341307600040
J	Viboud, C; Charu, V; Olson, D; Ballesteros, S; Gog, J; Khan, F; Grenfell, B; Simonsen, L				Viboud, Cecile; Charu, Vivek; Olson, Donald; Ballesteros, Sebastien; Gog, Julia; Khan, Farid; Grenfell, Bryan; Simonsen, Lone			Demonstrating the Use of High-Volume Electronic Medical Claims Data to Monitor Local and Regional Influenza Activity in the US	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; UNITED-STATES; PANDEMIC INFLUENZA; CHILDREN; MORTALITY; SURVEILLANCE; PNEUMONIA; EPIDEMICS; COVERAGE; ILLNESS	Introduction: Fine-grained influenza surveillance data are lacking in the US, hampering our ability to monitor disease spread at a local scale. Here we evaluate the performances of high-volume electronic medical claims data to assess local and regional influenza activity. Material and Methods: We used electronic medical claims data compiled by IMS Health in 480 US locations to create weekly regional influenza-like-illness (ILI) time series during 2003-2010. IMS Health captured 62% of US outpatient visits in 2009. We studied the performances of IMS-ILI indicators against reference influenza surveillance datasets, including CDC-ILI outpatient and laboratory-confirmed influenza data. We estimated correlation in weekly incidences, peak timing and seasonal intensity across datasets, stratified by 10 regions and four age groups (< 5, 5-29, 30-59, and 60+ years). To test IMS-Health performances at the city level, we compared IMS-ILI indicators to syndromic surveillance data for New York City. We also used control data on laboratory-confirmed Respiratory Syncytial Virus (RSV) activity to test the specificity of IMS-ILI for influenza surveillance. Results: Regional IMS-ILI indicators were highly synchronous with CDC's reference influenza surveillance data (Pearson correlation coefficients rho >= 0.89; range across regions, 0.80-0.97, P < 0.001). Seasonal intensity estimates were weakly correlated across datasets in all age data (rho <= 0.52), moderately correlated among adults (rho >= 0.64) and uncorrelated among school-age children. IMS-ILI indicators were more correlated with reference influenza data than control RSV indicators (rho = 0.93 with influenza v. rho = 0.33 with RSV, P < 0.05). City-level IMS-ILI indicators were highly consistent with reference syndromic data (rho >= 0.86). Conclusion: Medical claims-based ILI indicators accurately capture weekly fluctuations in influenza activity in all US regions during inter-pandemic and pandemic seasons, and can be broken down by age groups and fine geographical areas. Medical claims data provide more reliable and fine-grained indicators of influenza activity than other high-volume electronic algorithms and should be used to augment existing influenza surveillance systems.	[Viboud, Cecile; Charu, Vivek; Gog, Julia; Grenfell, Bryan; Simonsen, Lone] Fogarty Int Ctr, NIH, Bethesda, MD 20892 USA; [Charu, Vivek] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Olson, Donald] New York City Dept Hlth & Mental Hyg, New York, NY USA; [Ballesteros, Sebastien; Grenfell, Bryan] Princeton Univ, Dept Evolut Biol, Princeton, NJ 08544 USA; [Gog, Julia] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 9EW, England; [Khan, Farid] IMS Hlth, Plymouth, PA USA; [Simonsen, Lone] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Johns Hopkins University; New York City Department of Health & Mental Hygiene; Princeton University; University of Cambridge; George Washington University	Viboud, C (corresponding author), Fogarty Int Ctr, NIH, Bethesda, MD 20892 USA.	viboudc@mail.nih.gov	Simonsen, Lone/K-4531-2014	Simonsen, Lone/0000-0003-1535-8526; Gog, Julia/0000-0003-1240-7214; Olson, Donald/0000-0002-5980-229X	Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security (to JG, LS, BG), and the in-house influenza program of the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Benoit SR, 2013, EPIDEMIOL INFECT, V141, P805, DOI 10.1017/S0950268812001549; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Brammer L, 2009, INFLUENZA OTHER RESP, V3, P51, DOI 10.1111/j.1750-2659.2009.00077.x; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Cortese MM, 2010, PEDIATR INFECT DIS J, V29, P489, DOI 10.1097/INF.0b013e3181d95b53; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fleming DM, 2005, J EPIDEMIOL COMMUN H, V59, P586, DOI 10.1136/jech.2004.026450; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gog J, 2013, PLOS COMPUT IN PRESS; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Haynes AK, 2013, MMWR-MORBID MORTAL W, V62, P141; Kalies H, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-82; Light M, 2008, PEDIATR INFECT DIS J, V27, P512, DOI 10.1097/INF.0b013e318168daf1; Nelson MI, 2011, J VIROL, V85, P828, DOI 10.1128/JVI.01762-10; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Olson Donald R, 2011, PLoS Curr, V3, pRRN1251, DOI 10.1371/currents.RRN1251; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Plagianos MG, 2011, EMERG INFECT DIS, V17, P1724, DOI 10.3201/eid1709.101357; Rha B, 2013, EMERG INFECT DIS, V19, P1214, DOI 10.3201/eid1908.130483; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Schuck-Paim C, 2013, VACCINE, V31, P5983, DOI 10.1016/j.vaccine.2013.10.038; SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753; Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; United States Census Bureau, POP EST; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	36	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102429	10.1371/journal.pone.0102429	http://dx.doi.org/10.1371/journal.pone.0102429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072598	Green Submitted, gold, Green Published			2022-12-27	WOS:000341307600012
J	Ohashi, S; Kikuchi, O; Tsurumaki, M; Nakai, Y; Kasai, H; Horimatsu, T; Miyamoto, S; Shimizu, A; Chiba, T; Muto, M				Ohashi, Shinya; Kikuchi, Osamu; Tsurumaki, Mihoko; Nakai, Yukie; Kasai, Hiroi; Horimatsu, Takahiro; Miyamoto, Shin'ichi; Shimizu, Akira; Chiba, Tsutomu; Muto, Manabu			Preclinical Validation of Talaporfin Sodium-Mediated Photodynamic Therapy for Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							ASPARTYL CHLORIN E(6); DIODE-LASER; PHASE-II; CANCER; DEATH; DIFFERENTIATION; PHOTORADIATION; TRANSFORMATION; METASTASIS; EXPRESSION	Photodynamic therapy (PDT) kills cancer cells via a photochemical reaction mediated by an oncotropic photosensitizer. Herein, we performed an experimental preclinical study to validate the anti-tumour effect of talaporfin sodium-mediated PDT (t-PDT) for esophageal squamous cell carcinoma (ESCC) cells. We used human ESCC cells derived from various differentiation grades or resistant to 5-fluorouracil (5-FU). The cytotoxic effect of t-PDT was determined by evaluating cell viability, apoptosis and generation of reactive oxygen species (ROS) and DNA double-strand breaks. Furthermore, the antitumour effect of t-PDT was assessed using an anchorage-independent cell-growth assay and xenograft transplantation models. t-PDT induced potent cytotoxicity in ESCC cells independent of their differentiation grade or 5-FU resistance. Moreover, t-PDT induced robust apoptosis, as indicated by cell shrinkage, perinuclear vacuolization, nuclear fragmentation and induction of annexin V-positive cells. This apoptotic response was accompanied by concurrent activation of ROS, and induction of DNA double-strand breakage. Importantly, t-PDT suppressed efficiently anchorage-independent cell growth as well as ESCC-xenografted tumor formation. In aggregate, t-PDT showed anti-tumor potential for ESCC cells with various histological grades or chemoresistance, providing a novel translational rationale of t-PDT for the treatment of ESCC.	[Ohashi, Shinya; Tsurumaki, Mihoko; Nakai, Yukie; Horimatsu, Takahiro; Muto, Manabu] Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Sakyo Ku, Kyoto, Japan; [Kikuchi, Osamu; Miyamoto, Shin'ichi; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto, Japan; [Kasai, Hiroi; Shimizu, Akira] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Sakyo Ku, Kyoto 606, Japan	Kyoto University; Kyoto University; Kyoto University	Muto, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Sakyo Ku, Kawahara Cho, Kyoto, Japan.	mmuto@kuhp.kyoto-u.ac.jp	Ohashi, Shinya/AAD-8920-2022	Horimatsu, Takahiro/0000-0002-4188-9059; Kikuchi, Osamu/0000-0001-5012-5897	Health and Labor Sciences Research Grant, Research on Clinical Trial on Development of New Drugs and Medical Devices [H24-012]; Grants-in-Aid for Scientific Research [25293069] Funding Source: KAKEN	Health and Labor Sciences Research Grant, Research on Clinical Trial on Development of New Drugs and Medical Devices; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Health and Labor Sciences Research Grant, Research on Clinical Trial on Development of New Drugs and Medical Devices (H24-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Allison RR, 2013, CLIN ENDOSC, V46, P24, DOI 10.5946/ce.2013.46.1.24; BIEL MA, 1994, LARYNGOSCOPE, V104, P399; CALAF G, 1993, CARCINOGENESIS, V14, P483, DOI 10.1093/carcin/14.3.483; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; DOUGHERTY TJ, 1979, J NATL CANCER I, V62, P231; DOUGHERTY TJ, 1978, CANCER RES, V38, P2628; EDELL ES, 1989, CHEST, V96, P919, DOI 10.1378/chest.96.4.919; Evans HH, 1997, PHOTOCHEM PHOTOBIOL, V66, P690, DOI 10.1111/j.1751-1097.1997.tb03208.x; Grosjean P, 1996, J Clin Laser Med Surg, V14, P281; Kato H, 2003, LUNG CANCER, V42, P103, DOI 10.1016/S0169-5002(03)00242-3; KATO H, 1993, JPN J CANCER RES, V84, P1209, DOI 10.1111/j.1349-7006.1993.tb02823.x; Katsumi TA, 1996, PHOTOCHEM PHOTOBIOL, V64, P671, DOI 10.1111/j.1751-1097.1996.tb03122.x; Kishi K, 2010, INT J ONCOL, V36, P313, DOI 10.3892/ijo_00000502; Liu L, 2011, FREE RADICAL BIO MED, V51, P53, DOI 10.1016/j.freeradbiomed.2011.03.042; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Luna MC, 2000, CANCER RES, V60, P1637; MCCORMICK JJ, 1990, PROG CLIN BIOL RES, V340, P195; MCMAHON KS, 1994, CANCER RES, V54, P5374; Miki Y, 2013, BIOL PHARM BULL, V36, P215, DOI 10.1248/bpb.b12-00567; NISHIHIRA T, 1993, J CANCER RES CLIN, V119, P441, DOI 10.1007/BF01215923; Nozoe T, 2006, ONCOLOGY-BASEL, V71, P402, DOI 10.1159/000108611; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; Overholt BF, 1999, GASTROINTEST ENDOSC, V49, P1, DOI 10.1016/S0016-5107(99)70437-2; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Saito K, 2000, JPN J CANCER RES, V91, P560, DOI 10.1111/j.1349-7006.2000.tb00981.x; Savary JF, 1998, ENDOSCOPY, V30, P258, DOI 10.1055/s-2007-1001252; SCHWEITZER VG, 1990, OTOLARYNG HEAD NECK, V102, P225, DOI 10.1177/019459989010200304; Taber SW, 1998, CLIN CANCER RES, V4, P2741; Tajima Y, 2000, CANCER, V88, P1285; TAPAROWSKY EJ, 1987, CANCER RES, V47, P4125; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; Yano T, 2012, INT J CANCER, V131, P1228, DOI 10.1002/ijc.27320	34	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103126	10.1371/journal.pone.0103126	http://dx.doi.org/10.1371/journal.pone.0103126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090101	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700017
J	Friedlander, AM; Ballesteros, E; Fay, M; Sala, E				Friedlander, Alan M.; Ballesteros, Enric; Fay, Michael; Sala, Enric			Marine Communities on Oil Platforms in Gabon, West Africa: High Biodiversity Oases in a Low Biodiversity Environment	PLOS ONE			English	Article							RIGS-TO-REEFS; SANTA-BARBARA CHANNEL; FLOWER GARDEN BANKS; OFFSHORE OIL; FISH ASSEMBLAGES; CONTINENTAL-SHELF; TROPHIC STRUCTURE; ARTIFICIAL REEFS; GULF; SEA	The marine biodiversity of Gabon, West Africa has not been well studied and is largely unknown. Our examination of marine communities associated with oil platforms in Gabon is the first scientific investigation of these structures and highlights the unique ecosystems associated with them. A number of species previously unknown to Gabonese waters were recorded during our surveys on these platforms. Clear distinctions in benthic communities were observed between older, larger platforms in the north and newer platforms to the south or closer to shore. The former were dominated by a solitary cup coral, Tubastraea sp., whereas the latter were dominated by the barnacle Megabalanus tintinnabulum, but with more diverse benthic assemblages compared to the northerly platforms. Previous work documented the presence of limited zooxanthellated scleractinian corals on natural rocky substrate in Gabon but none were recorded on platforms. Total estimated fish biomass on these platforms exceeded one ton at some locations and was dominated by barracuda (Sphyraena spp.), jacks (Carangids), and rainbow runner (Elagatis bipinnulata). Thirty-four percent of fish species observed on these platforms are new records for Gabon and 6% are new to tropical West Africa. Fish assemblages closely associated with platforms had distinct amphi-Atlantic affinities and platforms likely extend the distribution of these species into coastal West Africa. At least one potential invasive species, the snowflake coral (Carijoa riisei), was observed on the platforms. Oil platforms may act as stepping stones, increasing regional biodiversity and production but they may also be vectors for invasive species. Gabon is a world leader in terrestrial conservation with a network of protected areas covering >10% of the country. Oil exploration and biodiversity conservation currently co-exist in terrestrial and freshwater ecosystems in Gabon. Efforts to increase marine protection in Gabon may benefit by including oil platforms in the marine protected area design process.	[Friedlander, Alan M.] Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Friedlander, Alan M.; Fay, Michael; Sala, Enric] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Ballesteros, Enric; Sala, Enric] CSIC, Ctr Estudis Avancats, Blanes, Spain; [Fay, Michael] Wildlife Conservat Soc, Bronx, NY USA	University of Hawaii System; National Geographic Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Wildlife Conservation Society	Friedlander, AM (corresponding author), Univ Hawaii, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA.	alan.friedlander@hawaii.edu			Waitt Foundation; Blancpain; Davidoff Cool Water; National Geographic Society; Wildlife Conservation Society	Waitt Foundation; Blancpain; Davidoff Cool Water; National Geographic Society(National Geographic Society); Wildlife Conservation Society	This work was funded by the Waitt Foundation, Blancpain, Davidoff Cool Water, National Geographic Society, and the Wildlife Conservation Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso Pedro, 1999, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V17A, P65; Almada VC., 2013, FRONT BIOGEOGR, V5, P1, DOI [10.21425/F55114493, DOI 10.21425/F5FBG14493, 10.21425/F5FBG14493]; Arnand F., 1976, Bulletin Mus natn Hist nat Paris (Ecol gen), VNo. 30, P49; Atchison AD, 2008, J EXP MAR BIOL ECOL, V365, P1, DOI 10.1016/j.jembe.2008.07.002; Baudin F, 2010, MAR PETROL GEOL, V27, P995, DOI 10.1016/j.marpetgeo.2010.02.006; Bentahila Y, 2006, MAR GEOL, V226, P323, DOI 10.1016/j.margeo.2005.11.014; BIANCHI G, 1992, MAR ECOL PROG SER, V85, P9, DOI 10.3354/meps085009; Bohnsack J.A., 1991, P61; BOHNSACK JA, 1989, B MAR SCI, V44, P631; BULL AS, 1994, B MAR SCI, V55, P1086; Caselle JE, 2002, ICES J MAR SCI, V59, pS258, DOI 10.1006/jmsc.2002.1264; Cebrian E, 2000, OCEANOL ACTA, V23, P311, DOI 10.1016/S0399-1784(00)00131-6; Clarke K., 2001, PRIMER VERSION 5 USE; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Ferreira CEL, 2004, J BIOGEOGR, V31, P1093, DOI 10.1111/j.1365-2699.2004.01044.x; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Floeter SR, 2004, J FISH BIOL, V64, P1680, DOI 10.1111/j.0022-1112.2004.00428.x; Friedlander AM, 2013, AQUAT CONSERV, V23, P515, DOI 10.1002/aqc.2333; Friedlander AM, 2012, REV BIOL TROP, V60, P321; Gallaway BJ, 1981, 10BS8227 FWS; Gonzalez-Correa JM, 2005, J EXP MAR BIOL ECOL, V320, P65, DOI 10.1016/j.jembe.2004.12.032; Hamzah BA, 2003, MAR POLICY, V27, P339, DOI 10.1016/S0308-597X(03)00040-X; Helvey M, 2002, ICES J MAR SCI, V59, pS266, DOI 10.1006/jmsc.2002.1226; Jernelov A, 2010, AMBIO, V39, P353, DOI 10.1007/s13280-010-0085-5; Jorgensen T, 2002, ICES J MAR SCI, V59, pS288, DOI 10.1006/jmsc.2001.1165; Kritzer J.P., 2010, MARINE METAPOPULATIO; Laborel J., 1974, P 2 INT COR REEF S, V1, P425; Le Loeuff P, 1998, ACTA OECOL, V19, P309; Lee Michelle E., 2006, Bulletin of the Biological Society of Washington, V12, P229; Longhurst AR, 1987, ECOLOGY TROPICAL OCE; Love MS, 2006, FISH B-NOAA, V104, P383; Love MS, 2000, FISH B-NOAA, V98, P96; Ludwig J. A., 1988, STAT ECOLOGY; Macreadie PI, 2012, FRONT ECOL ENVIRON, V10, P179, DOI 10.1890/12.WB.013; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; MCGLADE JM, 2002, GULF GUINEA LARGE MA; OLSGARD F, 1995, MAR ECOL PROG SER, V122, P277, DOI 10.3354/meps122277; Ondreas H, 2005, GEO-MAR LETT, V25, P281, DOI 10.1007/s00367-005-0213-6; Page HM, 2006, MAR ECOL PROG SER, V325, P101, DOI 10.3354/meps325101; Parente V, 2006, ENERG POLICY, V34, P1992, DOI 10.1016/j.enpol.2005.02.008; POLOVINA JJ, 1989, B MAR SCI, V44, P997; Pradella N, 2014, J FISH BIOL, V84, P247, DOI 10.1111/jfb.12274; Reggio V. C., 1989, PETROLEUM STRUCTURES, P47; Reid Gordon Mcgregor, 1996, Proceedings of the Royal Society of Edinburgh Section B (Biological Sciences), V104, P285; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rooker JR, 1997, CORAL REEFS, V16, P83, DOI 10.1007/s003380050062; Roy KOL, 2007, MAR ECOL-EVOL PERSP, V28, P115, DOI 10.1111/j.1439-0485.2006.00145.x; Sala E, 2003, B MAR SCI, V72, P103; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Sammarco PW, 2010, AQUAT INVASIONS, V5, P131, DOI 10.3391/ai.2010.5.2.02; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SCHELTEMA RS, 1995, AM MALACOL BULL, V11, P99; Scheltema RS, 1971, 4 EUR MAR BIOL S, P7; Schroeder DM, 2002, CAL COOP OCEAN FISH, V43, P182; Schroeder DM, 2004, OCEAN COAST MANAGE, V47, P21, DOI 10.1016/j.ocecoaman.2004.03.002; Seranne M, 2008, B SOC GEOL FR, V179, P29, DOI 10.2113/gssgfbull.179.1.29; Shipp RL, 2009, REV FISH SCI, V17, P41, DOI 10.1080/10641260802104244; Sibuet M, 2009, DEEP-SEA RES PT II, V56, P2156, DOI 10.1016/j.dsr2.2009.04.015; Smilauer tBa, 2002, CANOCO REFERENCE MAN; Soldal AV, 2002, ICES J MAR SCI, V59, pS281, DOI 10.1006/jmsc.2002.1279; STANLEY DR, 1990, FISH B-NOAA, V88, P719; STANLEY DR, 1989, B MAR SCI, V44, P767; Street GT, 1996, MAR BIOL, V126, P271, DOI 10.1007/BF00347452; Sumaila UR, 2012, CAN J FISH AQUAT SCI, V69, P499, DOI [10.1139/F2011-171, 10.1139/f2011-171]; ter Braak CJF, 1994, ECOSCIENCE, V1, P127, DOI 10.1080/11956860.1994.11682237; tersBraak C., 1995, AQUAT SCI, V57, P1; Trevors JT, 2010, WATER AIR SOIL POLL, V211, P1, DOI 10.1007/s11270-010-0527-5; Vanden Bossche JP, 1990, 181 CIFA FAO, V2; Voituriez B, 1982, RAPPORTS PROCES VERB, V180, P114; Wauthy B, 1983, OCEANOGR TROP, V18, P103; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Wirtz P, 2003, J MAR BIOL ASSOC UK, V83, P735, DOI 10.1017/S0025315403007720h; Wirtz P, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1523.1.1; Wirtz Peter, 2012, Arquipelago-Life and Marine Sciences, P77; Wirtz P, 2013, SPIXIANA, V36, P113; Wirtz Peter, 2001, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V18A, P81; Wirtz Peter, 2004, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, P83; WOLFSON A, 1979, MAR ECOL PROG SER, V1, P81, DOI 10.3354/meps001081; Yeo DCJ, 2010, BIOFOULING, V26, P179, DOI 10.1080/08927010903402438; Zar J.H., 1999, BIOSTATISTICAL ANAL, P4	81	67	69	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103709	10.1371/journal.pone.0103709	http://dx.doi.org/10.1371/journal.pone.0103709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083704	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800069
J	Hufton, SE; Risley, P; Ball, CR; Major, D; Engelhardt, OG; Poole, S				Hufton, Simon E.; Risley, Paul; Ball, Christina R.; Major, Diane; Engelhardt, Othmar G.; Poole, Stephen			The Breadth of Cross Sub-Type Neutralisation Activity of a Single Domain Antibody to Influenza Hemagglutinin Can Be Increased by Antibody Valency	PLOS ONE			English	Article							HEAVY-CHAIN ANTIBODIES; MONOCLONAL-ANTIBODY; HIGH-AFFINITY; RECEPTOR-BINDING; IN-VITRO; VIRUS; H5N1; FRAGMENTS; TRANSMISSION; MECHANISMS	The response to the 2009 A(H1N1) influenza pandemic has highlighted the need for additional strategies for intervention which preclude the prior availability of the influenza strain. Here, 18 single domain VHH antibodies against the 2009 A(H1N1) hemagglutinin (HA) have been isolated from a immune alpaca phage displayed library. These antibodies have been grouped as having either (i) non-neutralising, (ii) H1N1 restricted neutralising or (iii) broad cross-subtype neutralising activity. The ability to neutralise different viral subtypes, including highly pathogenic avian influenza (H5N1), correlated with the absence of hemagglutination inhibition activity, loss of binding to HA at acid pH and the absence of binding to the head domain containing the receptor binding site. This data supports their binding to epitopes in the HA stem region and a mechanism of action other than blocking viral attachment to cell surface receptors. After conversion of cross-neutralising antibodies R1a-B6 and R1a-A5 into a bivalent format, no significant enhancement in neutralisation activity was seen against A(H1N1) and A(H5N1) viruses. However, bivalent R1a-B6 showed an 18 fold enhancement in potency against A(H9N2) virus and, surprisingly, gained the ability to neutralise an A(H2N2) virus. This demonstrates that cross-neutralising antibodies, which make lower affinity interactions with the membrane proximal stem region of more divergent HA sub-types, can be optimised by bivalency so increasing their breadth of anti-viral activity. The broad neutralising activity and favourable characteristics, such as high stability, simple engineering into bivalent molecules and low cost production make these single domain antibodies attractive candidates for diagnostics and immunotherapy of pandemic influenza.	[Hufton, Simon E.; Risley, Paul; Poole, Stephen] Ctr Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Biotherapeut Grp, Potters Bar, Herts, England; [Hufton, Simon E.; Risley, Paul; Poole, Stephen] Ctr Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Biotherapeut Grp, Potters Bar, Herts, England; [Major, Diane; Engelhardt, Othmar G.] Ctr Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Div Virol, Potters Bar, Herts, England; [Ball, Christina R.] Ctr Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Potters Bar, Herts, England	National Institute for Biological Standards & Control; National Institute for Biological Standards & Control; National Institute for Biological Standards & Control; National Institute for Biological Standards & Control	Hufton, SE (corresponding author), Ctr Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand & Control, Biotherapeut Grp, Potters Bar, Herts, England.	simon.hufton@nibsc.org	Hufton, Simon E/E-3949-2013; Risley, Paul/E-2489-2013; hufton, simon/AAA-8245-2019	hufton, simon/0000-0003-1756-0306				Beerli RR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-224; Chen J, 1995, P NATL ACAD SCI USA, V92, P12205, DOI 10.1073/pnas.92.26.12205; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epstein SL, 1997, J IMMUNOL, V158, P1222; Feshchenko E, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-77; Finlay WJ, 2009, J MOL BIOL, V388, P541, DOI 10.1016/j.jmb.2009.03.019; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GIGANT B, 1995, PROTEINS, V23, P115, DOI 10.1002/prot.340230113; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; HARMON MW, 1988, J CLIN MICROBIOL, V26, P333, DOI 10.1128/JCM.26.2.333-337.1988; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Heyndrickx L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036438; Hoag H, 2013, NAT MED, V19, P12, DOI 10.1038/nm0113-12; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Ibanez LI, 2011, J INFECT DIS, V203, P1063, DOI 10.1093/infdis/jiq168; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lachmann P, 2009, VACCINE, V27, pG33, DOI 10.1016/j.vaccine.2009.09.137; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Lee PS, 2012, P NATL ACAD SCI USA, V109, P17040, DOI 10.1073/pnas.1212371109; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Maass DR, 2007, J IMMUNOL METHODS, V324, P13, DOI 10.1016/j.jim.2007.04.008; Marasco WA, 2007, NAT BIOTECHNOL, V25, DOI 10.1038/nbt1363; Martinez O, 2009, INT REV IMMUNOL, V28, P69, DOI 10.1080/08830180802593540; de Jong MD, 2008, PEDIATR INFECT DIS J, V27, pS54, DOI 10.1097/INF.0b013e3181684d2d; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Robertson JS, 2010, VIRUSES-BASEL, V2, P532, DOI 10.3390/v2020532; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Sakabe S, 2010, ANTIVIR RES, V88, P249, DOI 10.1016/j.antiviral.2010.09.007; Schofield DJ, 1997, J GEN VIROL, V78, P2431, DOI 10.1099/0022-1317-78-10-2431; Serruys B, 2009, HEPATOLOGY, V49, P39, DOI 10.1002/hep.22609; Shen JQ, 2006, J BIOL CHEM, V281, P10706, DOI 10.1074/jbc.M513415200; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sriwilaijaroen N, 2012, P JPN ACAD B-PHYS, V88, P226, DOI 10.2183/pjab.88.226; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WILSON IA, 1983, BIOCHEM SOC T, V11, P145, DOI 10.1042/bst0110145; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	77	23	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103294	10.1371/journal.pone.0103294	http://dx.doi.org/10.1371/journal.pone.0103294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084445	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800027
J	Soares, CC; Georg, I; Lampe, E; Lewis, L; Morgado, MG; Nicol, AF; Pinho, AA; Salles, RCS; Teixeira, SLM; Vicente, ACP; Viscidi, RP; Gomes, SA				Soares, Caroline C.; Georg, Ingebourg; Lampe, Elisabeth; Lewis, Lia; Morgado, Mariza G.; Nicol, Alcina F.; Pinho, Adriana A.; Salles, Regina C. S.; Teixeira, Sylvia L. M.; Vicente, Ana Carolina P.; Viscidi, Raphael P.; Gomes, Selma A.			HIV-1, HBV, HCV, HTLV, HPV-16/18, and Treponema pallidum Infections in a Sample of Brazilian Men Who Have Sex with Men	PLOS ONE			English	Article							INJECTION-DRUG USERS; C VIRUS-INFECTION; HPV INFECTION; BEHAVIORAL SURVEILLANCE; HIDDEN POPULATIONS; HEPATITIS-B; PREVALENCE; SEROPREVALENCE; TRANSMISSION; TYPE-1	Background: Men who have sex with men (MSM) are more vulnerable to blood-borne infections and/or sexually-transmitted infections (STI). This study was conducted to estimate the prevalences of mono and co-infections of HIV-1 and other blood-borne/STIs in a sample of MSM in Campinas, Brazil. Methods: Responding Driven Sampling (RDS) was used for recruitment of MSM. Serum samples collected from 558 MSM were analyzed for the presence of serological markers for HIV-1, HBV, HCV, HTLV, HPV-16/18, and T. pallidum infections. Results: The highest prevalences of infection in serum samples were found for HPV-16 and 18 (31.9% and 20.3%, respectively). Approximately 8% of the study population showed infection with HIV-1, and within that group, 27.5% had recently become infected with HIV-1. HBV infection and syphilis were detected in 11.4% and 10% of the study population, respectively, and the rates of HTLV and HCV infection were 1.5% and 1%, respectively. With the exception of HTLV, all other studied infections were usually found as co-infections rather then mono-infections. The rates of co-infection for HCV, HPV-18, and HIV-1 were the highest among the studied infections (100%, 83%, and 85%, respectively). Interestingly, HTLV infection was usually found as a mono-infection in the study group, whereas HCV was found only as a co-infection. Conclusions: The present findings highlight the need to educate the MSM population concerning their risk for STIs infections and methods of prevention. Campaigns to encourage vaccination against HBV and HPV could decrease the rates of these infections in MSM.	[Soares, Caroline C.; Gomes, Selma A.] IOC, Lab Virol Mol, Rio De Janeiro, Brazil; [Georg, Ingebourg] IPEC, Lab Anal Clin, Rio De Janeiro, Brazil; [Lampe, Elisabeth; Lewis, Lia] IOC, Lab Ref Nacl Hepatites Virais, Rio De Janeiro, Brazil; [Morgado, Mariza G.; Teixeira, Sylvia L. M.] IOC, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil; [Nicol, Alcina F.] IOC, Lab Interdisclinar Pesquisas Med, Rio De Janeiro, Brazil; [Pinho, Adriana A.] Inst Oswaldo Cruz, Posdoutoranda Lab Educ & Ambinete, Rio De Janeiro, Brazil; [Salles, Regina C. S.] Lab Municipal Patol Clin Campinas, Sao Paulo, Brazil; [Vicente, Ana Carolina P.] IOC, Lab Genet Mol & Microorganismos, Rio De Janeiro, Brazil; [Viscidi, Raphael P.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Johns Hopkins University	Gomes, SA (corresponding author), IOC, Lab Virol Mol, Rio De Janeiro, Brazil.	selma@ioc.fiocruz.br	Soares, Caroline Cordeiro/ABM-8961-2022; gomes, selma A/D-2762-2015	Lewis-Ximenez, Lia Laura/0000-0002-3447-4621; Viscidi, Raphael/0000-0002-7906-8002; Gomes, Selma/0000-0003-0233-3370	Oswaldo Cruz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI106701] Funding Source: NIH RePORTER	Oswaldo Cruz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Oswaldo Cruz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2011, SEMIN LIVER DIS, V31, P340, DOI 10.1055/s-0031-1297923; Amon JJ, 2008, CLIN INFECT DIS, V46, P1852, DOI 10.1086/588297; Backes DM, 2009, CANCER CAUSE CONTROL, V20, P449, DOI 10.1007/s10552-008-9276-9; Carneiro-Proietti ABF, 2006, REV PANAM SALUD PUBL, V19, P44, DOI 10.1590/S1020-49892006000100007; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; Frank Ove, 2000, SURV METHODOL, V26, P87; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Grangeiro A, 2009, CAD SAUDE PUBLICA, V25, P2053, DOI 10.1590/S0102-311X2009000900019; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Kahn J, 2002, CLIN INFECT DIS, V35, P1382, DOI 10.1086/343044; Kendall C, 2008, AIDS BEHAV, V12, pS97, DOI 10.1007/s10461-008-9390-4; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; LEPKOWSKI JM, 1991, J NUTR, V121, P416, DOI 10.1093/jn/121.3.416; Lu BB, 2011, CANCER EPIDEM BIOMAR, V20, P990, DOI 10.1158/1055-9965.EPI-10-1160; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; MARGOLIS HS, 1991, SEMIN LIVER DIS, V11, P84, DOI 10.1055/s-2008-1040427; Mello M, 2008, RES REPORT ASSESSMEN; Ministerio da Saude, 2011, B EP AIDS DST AN 8 1; Ministerio da Saude, 2012, B EP HEP VIR AN 3 1; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Moriuchi H, 2013, PEDIATR INFECT DIS J, V32, P175, DOI 10.1097/INF.0b013e31827efc39; Nicol AF, 2013, J CLIN VIROL, V57, P147, DOI 10.1016/j.jcv.2013.02.007; Nicol AF, 2010, J CLIN VIROL, V47, P208, DOI 10.1016/j.jcv.2009.12.005; Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Pando MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039834; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Parisi SG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-150; Pinto MT, 2012, REV INST MED TROP SP, V54, P123, DOI 10.1590/S0036-46652012000300002; Ramirez-Valles J, 2005, AIDS BEHAV, V9, P387, DOI 10.1007/s10461-005-9012-3; Ribeiro D, 2012, SEX TRANSM INFECT, V88, P32, DOI 10.1136/sextrans-2011-050066; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Cavalcanti AMS, 2012, BRAZ J INFECT DIS, V16, P157, DOI [10.1590/S1413-86702012000200009, 10.1016/S1413-8670(12)70298-2]; Semaan Salaam, 2002, AIDS Reviews, V4, P213; Souza CA, 1993, REV INST MED TROP SP, V35, P45; SUDMAN S, 1988, SCIENCE, V240, P991, DOI 10.1126/science.240.4855.991; Viscidi RP, 2003, J INFECT DIS, V187, P194, DOI 10.1086/346052	37	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e102676	10.1371/journal.pone.0102676	http://dx.doi.org/10.1371/journal.pone.0102676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083768	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800010
J	DiMeglio, LM; Staudt, G; Yu, HR; Davis, TM				DiMeglio, Laura M.; Staudt, Guenter; Yu, Hongrun; Davis, Thomas M.			A Phylogenetic Analysis of the Genus Fragaria (Strawberry) Using Intron-Containing Sequence from the ADH-1 Gene	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACERS; DIPLOID STRAWBERRY; NUCLEAR GENES; LINKAGE MAP; DNA; ROSACEAE; EVOLUTION; MARKERS; UTILITY; ORIGIN	The genus Fragaria encompasses species at ploidy levels ranging from diploid to decaploid. The cultivated strawberry, Fragariaxananassa, and its two immediate progenitors, F. chiloensis and F. virginiana, are octoploids. To elucidate the ancestries of these octoploid species, we performed a phylogenetic analysis using intron-containing sequences of the nuclear ADH-1 gene from 39 germplasm accessions representing nineteen Fragaria species and one outgroup species, Dasiphora fruticosa. All trees from Maximum Parsimony and Maximum Likelihood analyses showed two major clades, Clade A and Clade B. Each of the sampled octoploids contributed alleles to both major clades. All octoploid-derived alleles in Clade A clustered with alleles of diploid F. vesca, with the exception of one octoploid allele that clustered with the alleles of diploid F. mandshurica. All octoploid-derived alleles in clade B clustered with the alleles of only one diploid species, F. iinumae. When gaps encoded as binary characters were included in the Maximum Parsimony analysis, tree resolution was improved with the addition of six nodes, and the bootstrap support was generally higher, rising above the 50% threshold for an additional nine branches. These results, coupled with the congruence of the sequence data and the coded gap data, validate and encourage the employment of sequence sets containing gaps for phylogenetic analysis. Our phylogenetic conclusions, based upon sequence data from the ADH-1 gene located on F. vesca linkage group II, complement and generally agree with those obtained from analyses of protein-encoding genes GBSSI-2 and DHAR located on F. vesca linkage groups V and VII, respectively, but differ from a previous study that utilized rDNA sequences and did not detect the ancestral role of F. iinumae.	[DiMeglio, Laura M.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Yu, Hongrun] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA; [Davis, Thomas M.] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire; Loma Linda University; University System Of New Hampshire; University of New Hampshire	Davis, TM (corresponding author), Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA.	tom.davis@unh.edu			USDA-CSREES NRI Plant Genome Grant [2008-35300-04411]; New Hampshire Agricultural Experiment Station	USDA-CSREES NRI Plant Genome Grant(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); New Hampshire Agricultural Experiment Station	Partial funding in support of this research was provided by USDA-CSREES NRI Plant Genome Grant 2008-35300-04411, and also by the New Hampshire Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRINGHURST RS, 1990, HORTSCIENCE, V25, P879, DOI 10.21273/HORTSCI.25.8.879; BRINGHURST RS, 1970, AM J BOT, V57, P969, DOI 10.2307/2440994; Clegg MT, 1997, P NATL ACAD SCI USA, V94, P7791, DOI 10.1073/pnas.94.15.7791; Darrow G.M., 1966, STRAWBERRY; Davis TM, 2010, ACTA HORTIC, V859, P221; Davis TM, 2009, ACTA HORTIC, V842, P533; Davis TM, 2006, J AM SOC HORTIC SCI, V131, P506, DOI 10.21273/JASHS.131.4.506; Davis TM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-81; Davis TM, 1997, J HERED, V88, P215, DOI 10.1093/oxfordjournals.jhered.a023091; DAVIS TM, 2004, PLANT ANIMAL GENOME, V12; Deng C, 2001, THEOR APPL GENET, V103, P316, DOI 10.1007/s001220100648; DiMeglio L, 2003, RESOLVING RETICULTE; Eriksson T, 1998, PLANT SYST EVOL, V211, P155, DOI 10.1007/BF00985357; Eriksson T, 2003, INT J PLANT SCI, V164, P197, DOI 10.1086/346163; FEDOROVA N. J., 1946, Doklady Akademii nauk SSSR, V52, P545; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folta KM, 2006, CRIT REV PLANT SCI, V25, P399, DOI 10.1080/07352680600824831; Fujita MK, 2004, MOL PHYLOGENET EVOL, V31, P1031, DOI 10.1016/j.ympev.2003.09.016; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hancock J.F., 1999, STRAWBERRIES, P25; HANFSTINGL U, 1994, GENETICS, V138, P811; Harrison RE, 1997, J AM SOC HORTIC SCI, V122, P63, DOI 10.21273/JASHS.122.1.63; Howarth DG, 2002, MOL PHYLOGENET EVOL, V23, P525, DOI 10.1016/S1055-7903(02)00035-0; Hummer KE, 2008, HORTSCIENCE, V43, P1623, DOI 10.21273/HORTSCI.43.5.1623; Hummer KE, 2006, HORTSCIENCE, V41, P993; Hummer Kim E., 2012, Journal of the Botanical Research Institute of Texas, V6, P9; Hummer KE, 2009, AM J BOT, V96, P713, DOI 10.3732/ajb.0800285; Ichijima K, 1926, GENETICS, V11, P590; Iketani H, 2010, JAP J BOT, V26, P13; Kawakita A, 2003, MOL BIOL EVOL, V20, P87, DOI 10.1093/molbev/msg007; Lei JJ, 2005, HORTSCIENCE, V40, P1194, DOI 10.21273/HORTSCI.40.5.1194; Lin J, 2000, THEOR APPL GENET, V101, P415, DOI 10.1007/s001220051498; Lin J, 2000, THESIS, P96; Liu B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-157; Lundberg M, 2009, MOL PHYLOGENET EVOL, V51, P269, DOI 10.1016/j.ympev.2009.02.020; Mahoney LL, 2010, ACTA HORTIC, V859, P301, DOI 10.17660/ActaHortic.2010.859.35; Monfort A, 2006, MOL ECOL NOTES, V6, P197, DOI 10.1111/j.1471-8286.2005.01191.x; MORGAN DR, 1994, AM J BOT, V81, P890, DOI 10.2307/2445770; Ogden TH, 2007, MOL PHYLOGENET EVOL, V42, P817, DOI 10.1016/j.ympev.2006.07.021; Oh SH, 2003, MOL PHYLOGENET EVOL, V29, P203, DOI 10.1016/S1055-7903(03)00093-9; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Potter D, 2000, SYST BOT, V25, P337, DOI 10.2307/2666646; Rousseau-Gueutin M, 2009, MOL PHYLOGENET EVOL, V51, P515, DOI 10.1016/j.ympev.2008.12.024; Sambrook J., 2001, MOL CLONING LAB MANU; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Sang T, 1999, SYST BOT, V24, P148, DOI 10.2307/2419546; Sargent DJ, 2007, THEOR APPL GENET, V114, P373, DOI 10.1007/s00122-006-0441-9; Sargent DJ, 2006, THEOR APPL GENET, V112, P1349, DOI 10.1007/s00122-006-0237-y; Sargent DJ, 2004, ANN BOT-LONDON, V94, P787, DOI 10.1093/aob/mch217; Sargent DJ, 2004, THEOR APPL GENET, V109, P1385, DOI 10.1007/s00122-004-1767-9; Sargent DJ, 2009, GENETICS GENOMICS RO; SENANAYAKE YD, 1967, AM J BOT, V54, P221, DOI 10.2307/2440801; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Small RL, 1998, AM J BOT, V85, P1301, DOI 10.2307/2446640; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; STAUDT G, 1973, Willdenowia, V7, P101; Staudt G, 2009, ACTA HORTIC, V842, P71; Staudt G., 1999, U CALIFORNIA PUBLICA, V81; Staudt G., 2005, BOT JAHR SYST PFLANZ, V126, P163, DOI [10.1127/0006-8152/2005/0126-0163, DOI 10.1127/0006-8152/2005/0126-0163]; Staudt G., 1989, ACTA HORTIC, V265, P23, DOI [10.17660/ActaHortic.1989.265.1, DOI 10.17660/ACTAHORTIC.1989.265.1]; Staudt Guenter, 2003, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V124, P397, DOI 10.1127/0006-8152/2003/0124-0397; Staudt Guenter, 2001, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V123, P341; Staudt Guenter, 2008, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V127, P317, DOI 10.1127/0006-8152/2008/0127-0317; Staudt Guenter, 2006, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V126, P483, DOI 10.1127/0006-8152/2006/0126-0483; Staudt Gunter, 2003, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V125, P53, DOI 10.1127/0006-8152/2003/0125-0053; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TORRES AM, 1993, THEOR APPL GENET, V85, P937, DOI 10.1007/BF00215032; Vilanova S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-67; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; WOLYN DJ, 1990, PLANT MOL BIOL, V14, P855, DOI 10.1007/BF00016518	73	30	34	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102237	10.1371/journal.pone.0102237	http://dx.doi.org/10.1371/journal.pone.0102237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078607	Green Published, gold			2022-12-27	WOS:000339954800011
J	Lee, JH; Pooley, NJ; Mohd-Adnan, A; Martin, SAM				Lee, Jun-Hoe; Pooley, Nicholas J.; Mohd-Adnan, Adura; Martin, Samuel A. M.			Cloning and Characterisation of Multiple Ferritin Isoforms in the Atlantic Salmon (Salmo salar)	PLOS ONE			English	Article							GENE-EXPRESSION; TREMATOMUS-BERNACCHII; IRON HOMEOSTASIS; EVOLUTION; PROTEIN; CELLS; PHYLOGENY; RESPONSES; IMMUNITY	Ferritin is a highly-conserved iron-storage protein that has also been identified as an acute phase protein within the innate immune system. The iron-storage function is mediated through complementary roles played by heavy (H)-chain subunit as well as the light (L) in mammals or middle (M)-chain in teleosts, respectively. In this study, we report the identification of five ferritin subunits (H1, H2, M1, M2, M3) in the Atlantic salmon that were supported by the presence of iron-regulatory regions, gene structure, conserved domains and phylogenetic analysis. Tissue distribution analysis across eight different tissues showed that each of these isoforms is differentially expressed. We also examined the expression of the ferritin isoforms in the liver and kidney of juvenile Atlantic salmon that was challenged with Aeromonas salmonicida as well as in muscle cell culture stimulated with interleukin-1 beta. We found that each isoform displayed unique expression profiles, and in certain conditions the expressions between the isoforms were completely diametrical to each other. Our study is the first report of multiple ferritin isoforms from both the H- and M-chains in a vertebrate species, as well as ferritin isoforms that showed decreased expression in response to infection. Taken together, the results of our study suggest the possibility of functional differences between the H- and M-chain isoforms in terms of tissue localisation, transcriptional response to bacterial exposure and stimulation by specific immune factors.	[Lee, Jun-Hoe; Pooley, Nicholas J.; Martin, Samuel A. M.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Lee, Jun-Hoe; Mohd-Adnan, Adura] Univ Kebangsaan, Fac Sci & Technol, Sch Biosci & Biotechnol, Selangor, Malaysia; [Mohd-Adnan, Adura] Minist Sci Technol & Innovat, Malaysia Genome Inst, Selangor, Malaysia	University of Aberdeen; Universiti Kebangsaan Malaysia	Martin, SAM (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.	sam.martin@abdn.ac.uk	Lee, Jun-Hoe/F-4197-2017	Lee, Jun-Hoe/0000-0002-6331-3472; Martin, Samuel/0000-0003-0289-6317	Malaysian Ministry of Science, Technology and Innovation [07-05-MGI-GMB009]; Universiti Kebangsaan Malaysia [UKM-DLP-2011-027]; Biotechnology and Biological Sciences Research Council, UK studentship at the University of Aberdeen	Malaysian Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Kebangsaan Malaysia; Biotechnology and Biological Sciences Research Council, UK studentship at the University of Aberdeen	This work was supported by a grant from the Malaysian Ministry of Science, Technology and Innovation (07-05-MGI-GMB009) and Universiti Kebangsaan Malaysia (UKM-DLP-2011-027). NJP was supported by a Biotechnology and Biological Sciences Research Council, UK studentship at the University of Aberdeen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN O, 1995, MOL MAR BIOL BIOTECH, V4, P164; Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Bower NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011100; Burns M, 2008, EUR FOOD RES TECHNOL, V226, P1513, DOI 10.1007/s00217-007-0683-z; Bury N, 2003, COMP BIOCHEM PHYS C, V135, P97, DOI 10.1016/S1532-0456(03)00021-8; Campillos M, 2010, NUCLEIC ACIDS RES, V38, pW360, DOI 10.1093/nar/gkq371; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Ceciliani F, 2002, PROTEIN PEPTIDE LETT, V9, P211, DOI 10.2174/0929866023408779; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Giorgi A, 2008, ARCH BIOCHEM BIOPHYS, V478, P69, DOI 10.1016/j.abb.2008.06.022; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Hilton KB, 2008, GENE, V415, P40, DOI 10.1016/j.gene.2008.02.016; Hu YH, 2010, FISH SHELLFISH IMMUN, V28, P678, DOI 10.1016/j.fsi.2010.01.001; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Jain S, 2011, J PHARM BIOALLIED SC, V3, P118, DOI 10.4103/0975-7406.76489; Ju Z, 2002, MOL GENET GENOMICS, V268, P87, DOI 10.1007/s00438-002-0727-9; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Lawson MJ, 2009, NUCLEIC ACIDS RES, V37, P4570, DOI 10.1093/nar/gkp421; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee J-H, 2012, TRENDS EVOL BIOL, V4, pe3, DOI [10.4081/eb.2012.e3, DOI 10.4081/EB.2012.E3]; Marsden MJ, 1996, INFECT IMMUN, V64, P3863, DOI 10.1128/IAI.64.9.3863-3869.1996; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; MATSCHAK TW, 1995, EXPERIENTIA, V51, P260, DOI 10.1007/BF01931109; Mignogna G, 2002, EUR J BIOCHEM, V269, P1600, DOI 10.1046/j.1432-1327.2002.02762.x; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Neves JV, 2009, DEV COMP IMMUNOL, V33, P848, DOI 10.1016/j.dci.2009.02.001; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Pooley NJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-747; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Quaresima B, 1994, GENOME RES, V4, P85; Recalcati S, 2008, J AUTOIMMUN, V30, P84, DOI 10.1016/j.jaut.2007.11.003; Takezaki N, 2003, MOL BIOL EVOL, V20, P287, DOI 10.1093/molbev/msg040; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vegusdal A, 2004, LIPIDS, V39, P649, DOI 10.1007/s11745-004-1278-3; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Yamashita M, 1996, J BIOL CHEM, V271, P26908, DOI 10.1074/jbc.271.43.26908; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye JM, 2011, DEV COMP IMMUNOL, V35, P1273, DOI 10.1016/j.dci.2011.03.005; Zhang X, 2010, FISH SHELLFISH IMMUN, V28, P735, DOI 10.1016/j.fsi.2009.11.027; Zheng WJ, 2010, FISH SHELLFISH IMMUN, V28, P829, DOI 10.1016/j.fsi.2010.01.013	53	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103729	10.1371/journal.pone.0103729	http://dx.doi.org/10.1371/journal.pone.0103729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078784	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800072
J	Mahdavi-Arab, N; Meyer, ST; Mehrparvar, M; Weisser, WW				Mahdavi-Arab, Nafiseh; Meyer, Sebastian T.; Mehrparvar, Mohsen; Weisser, Wolfgang W.			Complex Effects of Fertilization on Plant and Herbivore Performance in the Presence of a Plant Competitor and Activated Carbon	PLOS ONE			English	Article							INSECT HERBIVORES; ANTAGONISTIC INTERACTIONS; NITROGEN-FERTILIZATION; CEREAL APHIDS; BOTTOM-UP; GROWTH; HOMOPTERA; REPRODUCTION; DEFOLIATION; PREDATORS	Plant-herbivore interactions are influenced by host plant quality which in turn is affected by plant growth conditions. Competition is the major biotic and nutrient availability a major abiotic component of a plant's growth environment. Yet, surprisingly few studies have investigated impacts of competition and nutrient availability on herbivore performance and reciprocal herbivore effects on plants. We studied growth of the specialist aphid, Macrosiphoniella tanacetaria, and its host plant tansy, Tanacetum vulgare, under experimental addition of inorganic and organic fertilizer crossed with competition by goldenrod, Solidago canadensis. Because of evidence that competition by goldenrod is mediated by allelopathic compounds, we also added a treatment with activated carbon. Results showed that fertilization increased, and competition with goldenrod decreased, plant biomass, but this was likely mediated by resource competition. There was no evidence from the activated carbon treatment that allelopathy played a role which instead had a fertilizing effect. Aphid performance increased with higher plant biomass and depended on plant growth conditions, with fertilization and AC increasing, and plant competition decreasing aphid numbers. Feedbacks of aphids on plant performance interacted with plant growth conditions in complex ways depending on the relative magnitude of the effects on plant biomass and aphid numbers. In the basic fertilization treatment, tansy plants profited from increased nutrient availability by accumulating more biomass than they lost due to an increased number of aphids under fertilization. When adding additional fertilizer, aphid numbers increased so high that tansy plants suffered and showed reduced biomass compared with controls without aphids. Thus, the ecological cost of an infestation with aphids depends on the balance of effects of growth conditions on plant and herbivore performance. These results emphasize the importance to investigate both perspectives in plant herbivore interactions and characterize the effects of growth conditions on plant and herbivore performance and their respective feedbacks.	[Mahdavi-Arab, Nafiseh] Univ Jena, Inst Ecol, Jena, Germany; [Mahdavi-Arab, Nafiseh; Meyer, Sebastian T.; Weisser, Wolfgang W.] Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany; [Mehrparvar, Mohsen] Grad Univ Adv Technol, Inst Sci & High Technol & Environm Sci, Dept Biodivers, Kerman, Iran	Friedrich Schiller University of Jena; Technical University of Munich; Graduate University of Advanced Technology	Meyer, ST (corresponding author), Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany.	sebastian.t.meyer@tum.de	Weisser, Wolfgang W/B-9718-2014; Meyer, Sebastian Tobias/AAH-3856-2021	Weisser, Wolfgang W/0000-0002-2757-8959; Meyer, Sebastian Tobias/0000-0003-0833-1472; Mehrparvar, Mohsen/0000-0002-6051-5845	TUM Diversity Scholarship; German Research Foundation (DFG); Technische Universitat Munchen;  [WE 3081/15-2]	TUM Diversity Scholarship; German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen; 	This study was financially supported by grant WE 3081/15-2 and by a TUM Diversity Scholarship to NMA. Publication of this work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding program open access publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilasha D, 2008, J ECOL, V96, P993, DOI 10.1111/j.1365-2745.2008.01413.x; ADDICOTT JF, 1978, CAN J ZOOL, V56, P2554, DOI 10.1139/z78-343; Agrawal AA, 2004, AM NAT, V164, P113, DOI 10.1086/420980; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; Bethke JA, 1998, ENTOMOL EXP APPL, V88, P41, DOI 10.1023/A:1003208222531; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Butcko VM, 2002, AM MIDL NAT, V148, P253, DOI 10.1674/0003-0031(2002)148[0253:EOTSAA]2.0.CO;2; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Cappuccino N, 2006, BIOL LETTERS, V2, P189, DOI 10.1098/rsbl.2005.0433; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; CHOUDHURY D, 1984, OIKOS, V43, P401, DOI 10.2307/3544159; Cisneros JJ, 2001, ENVIRON ENTOMOL, V30, P501, DOI 10.1603/0046-225X-30.3.501; CRAWLEY MJ, 1989, ANNU REV ENTOMOL, V34, P531, DOI 10.1146/annurev.en.34.010189.002531; de Sassi C, 2012, ECOLOGY, V93, P1892, DOI 10.1890/11-1839.1; Dixon AFG, 1998, APHID ECOLOGY OPTIMI; Duffield SJ, 1997, ANN APPL BIOL, V130, P13, DOI 10.1111/j.1744-7348.1997.tb05779.x; EDELSTEINKESHET L, 1986, J MATH BIOL, V24, P25, DOI 10.1007/BF00275719; FOSTER WA, 1984, OIKOS, V42, P97, DOI 10.2307/3544614; FOWLER N, 1986, ANNU REV ECOL SYST, V17, P89, DOI 10.1146/annurev.es.17.110186.000513; Garratt MPD, 2010, AGR FOREST ENTOMOL, V12, P307, DOI 10.1111/j.1461-9563.2010.00480.x; Gash AFJ, 2012, AGRONOMY-BASEL, V2, P1, DOI 10.3390/agronomy2010001; Haag JJ, 2004, J ECOL, V92, P156, DOI 10.1111/j.1365-2745.2004.00847.x; Hartvigsen G, 1995, OIKOS, V74, P463, DOI 10.2307/3545991; Hassell MP., 1978, DYNAMICS ARTHROPOD P; Hierro JL, 2003, PLANT SOIL, V256, P29, DOI 10.1023/A:1026208327014; Holman J., 2009, HOST PLANT CATALOGUE; Inderjit, 2003, PLANT SOIL, V256, P1, DOI 10.1023/A:1026242418333; Inderjit, 2006, TRENDS PLANT SCI, V11, P574, DOI 10.1016/j.tplants.2006.10.004; Kleine S, 2013, PHYTOCHEMISTRY, V96, P123, DOI 10.1016/j.phytochem.2013.09.018; Ladner DT, 2005, ENTOMOL EXP APPL, V116, P9, DOI 10.1111/j.1570-7458.2005.00308.x; Lau JA, 2008, NEW PHYTOL, V178, P412, DOI 10.1111/j.1469-8137.2007.02360.x; LEE TD, 1980, J ECOL, V68, P813, DOI 10.2307/2259457; Louda S. M., 1990, Perspectives on plant competition., P413; LOUDA SM, 1992, ECOLOGY, V73, P153, DOI 10.2307/1938728; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MCNAUGHTON SJ, 1986, AM NAT, V128, P765, DOI 10.1086/284602; MCNAUGHTON SJ, 1985, ECOLOGY, V66, P1617, DOI 10.2307/1938024; Mehrparvar M, 2013, BIOL CONTROL, V65, P142, DOI 10.1016/j.biocontrol.2012.12.009; Meyer GA, 1996, ECOL ENTOMOL, V21, P270, DOI 10.1111/j.1365-2311.1996.tb01244.x; MITICH LW, 1992, WEED TECHNOL, V6, P242, DOI 10.1017/S0890037X00034643; Muller CB, 2005, OECOLOGIA, V143, P419, DOI 10.1007/s00442-004-1795-9; Nevo E, 2001, J ECON ENTOMOL, V94, P27, DOI 10.1603/0022-0493-94.1.27; Newingham BA, 2006, OIKOS, V114, P397, DOI 10.1111/j.2006.0030-1299.14345.x; Nowak H, 2010, OECOLOGIA, V163, P973, DOI 10.1007/s00442-010-1652-y; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; Petermann JS, 2010, J ANIM ECOL, V79, P709, DOI 10.1111/j.1365-2656.2010.01674.x; Pietikainen J, 2000, OIKOS, V89, P231, DOI 10.1034/j.1600-0706.2000.890203.x; Pisula NL, 2010, AM MIDL NAT, V163, P161, DOI 10.1674/0003-0031-163.1.161; R Development Core Team, 2010, LANG ENV STAT COMP; Rebele F, 2000, PLANT ECOL, V147, P77, DOI 10.1023/A:1009808810378; Sarfraz RM, 2009, EUR J ENTOMOL, V106, P583, DOI 10.14411/eje.2009.073; Sarkar D., 2019, NLME LINEAR NONLINEA; Schadler M, 2007, ECOLOGY, V88, P1490, DOI 10.1890/06-0647; Stadler B, 2004, ECOL ENTOMOL, V29, P106, DOI 10.1111/j.0307-6946.2004.00577.x; Tsai JH, 2001, ENVIRON ENTOMOL, V30, P44, DOI 10.1603/0046-225X-30.1.44; Weisser WW, 2000, ENTOMOL EXP APPL, V97, P83, DOI 10.1023/A:1004096312093; Weisshuhn K, 2009, BASIC APPL ECOL, V10, P500, DOI 10.1016/j.baae.2008.10.009; Wurst S, 2010, PLANT ECOL, V211, P19, DOI 10.1007/s11258-010-9767-0; Zehnder CB, 2008, ECOL ENTOMOL, V33, P24, DOI 10.1111/j.1365-2311.2007.00945.x; Zvereva EL, 2010, OECOLOGIA, V163, P949, DOI 10.1007/s00442-010-1633-1	62	3	3	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103731	10.1371/journal.pone.0103731	http://dx.doi.org/10.1371/journal.pone.0103731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078980	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800073
J	Rakitin, A; Eglit, T; Koks, S; Lember, M; Haldre, S				Rakitin, Aleksei; Eglit, Triin; Koks, Sulev; Lember, Margus; Haldre, Sulev			Comparison of the Metabolic Syndrome Risk in Valproate-Treated Patients with Epilepsy and the General Population in Estonia	PLOS ONE			English	Article							INSULIN-RESISTANCE; SODIUM VALPROATE; WEIGHT-GAIN; LAMOTRIGINE MONOTHERAPY; OBESITY; PREVALENCE; ACID; SECRETION; CHILDREN; REGION	Background: No study has explored the risk of metabolic syndrome (MS) in patients with epilepsy treated with valproate (VPA) at the population level. The aim of this study was to compare the risk of MS in VPA-treated patients in Estonia to the risk in the general population. Methods: This study involved 118 patients with epilepsy (63 men, 55 women) who received VPA monotherapy. MS was diagnosed according to the National Cholesterol Education Program Adult Treatment Panel III criteria. Data were compared with the results of a population-based study of the prevalence of MS in the same geographic region (N = 493; 213 men, 280 women). Results: In the multiple logistic regression analysis, after adjustment for age and sex, the risk of MS in VPA-treated patients was not increased compared to the control subjects (odds ratio [OR] = 1.00; 95% confidence interval [CI], 0.59-1.68). VPA-treated patients had higher serum insulin concentrations than control subjects, independent of body mass index (BMI). A positive association was found between MS development and BMI (OR = 1.47; 95% CI, 1.25-1.73) in VPA-treated patients, but there were no associations with the VPA dosage or the homeostasis model assessment-estimated insulin resistance (HOMA-IR) index. In control subjects, BMI and HOMA-IR had similar predictive abilities for MS occurrence. In VPA-treated patients, the predictive ability of the HOMA-IR index was significantly lower than that of BMI, with areas under the receiver operating characteristic curves of 0.808 and 0.897 (P = 0.05), respectively. Conclusions: The risk of MS is not increased among VPA-treated patients with epilepsy in Estonia compared to the general population. The HOMA-IR index likely has a lower predictive ability for MS in VPA-treated patients compared to its predictive ability in the general population.	[Rakitin, Aleksei; Haldre, Sulev] Univ Tartu, Dept Neurol & Neurosurg, EE-50090 Tartu, Estonia; [Eglit, Triin; Lember, Margus] Univ Tartu, Dept Internal Med, EE-50090 Tartu, Estonia; [Koks, Sulev] Univ Tartu, Dept Pathophysiol, EE-50090 Tartu, Estonia; [Koks, Sulev] Univ Tartu, Ctr Translat Med, EE-50090 Tartu, Estonia; [Rakitin, Aleksei; Haldre, Sulev] Tartu Univ Hosp, Neurol Clin, Tartu, Estonia; [Eglit, Triin; Lember, Margus] Tartu Univ Hosp, Internal Med Clin, Tartu, Estonia	University of Tartu; University of Tartu; University of Tartu; University of Tartu	Rakitin, A (corresponding author), Univ Tartu, Dept Neurol & Neurosurg, Ulikooli 18, EE-50090 Tartu, Estonia.	aleksei.rakitin@kliinikum.ee	Lember, Margus/H-2306-2015; Koks, Sulev/H-3655-2015; Rakitin, Aleksei/AAL-2172-2020	Koks, Sulev/0000-0001-6087-6643; Rakitin, Aleksei/0000-0002-8001-3463	Estonian Science Foundation [9309]; Estonian Ministry of Education and Research [SF0180081s07]	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This study was supported by the Estonian Science Foundation (grant no. 9309), targeted financing from the Estonian Ministry of Education and Research (no. SF0180081s07), and institutional research support from the Internal Medicine Department of Tartu University (no. IUT 2-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkerwi A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-4; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Belcastro V, 2013, EPILEPSY RES, V107, P1, DOI 10.1016/j.eplepsyres.2013.08.016; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Biton V, 2001, NEUROLOGY, V56, P172, DOI 10.1212/WNL.56.2.172; Chiang JK, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-93; Clinical and Laboratory Standards Institute (CLSI), 2013, EP09A3 CLSI, Vthird; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DINESEN H, 1984, ACTA NEUROL SCAND, V70, P65; EGGER J, 1981, BMJ-BRIT MED J, V283, P577, DOI 10.1136/bmj.283.6291.577; Eglit T, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/951672; El-Khatib F, 2007, SEIZURE-EUR J EPILEP, V16, P226, DOI 10.1016/j.seizure.2006.12.009; Fang JJ, 2012, SEIZURE-EUR J EPILEP, V21, P578, DOI 10.1016/j.seizure.2012.06.001; Gallagher EJ, 2010, MT SINAI J MED, V77, P511, DOI 10.1002/msj.20212; Gavrila D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-562; Gundogan K, 2009, METAB SYNDR RELAT D, V7, P427, DOI 10.1089/met.2008.0068; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; Isojarvi JIT, 1996, ANN NEUROL, V39, P579, DOI 10.1002/ana.410390506; Luef G, 2002, J NEUROL, V249, P835, DOI 10.1007/S00415-002-0731-3; Marquez-Sandoval F, 2011, PUBLIC HEALTH NUTR, V14, P1702, DOI 10.1017/S1368980010003320; Oun A, 2006, EUR J NEUROL, V13, P465, DOI 10.1111/j.1468-1331.2006.01268.x; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Pylvanen V, 2003, NEUROLOGY, V60, P571, DOI 10.1212/01.WNL.0000048209.07526.86; Pylvanen V, 2006, EPILEPSIA, V47, P1460, DOI 10.1111/j.1528-1167.2006.00546.x; Pylvanen V, 2006, EPILEPSY BEHAV, V8, P643, DOI 10.1016/j.yebeh.2006.02.008; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Steinhoff BJ, 1996, EPILEPSIA, V37, P1221, DOI 10.1111/j.1528-1157.1996.tb00557.x; Stephen LJ, 2001, EPILEPSIA, V42, P1002, DOI 10.1046/j.1528-1157.2001.0420081002.x; Verrotti A, 2011, OBES REV, V12, pe32, DOI 10.1111/j.1467-789X.2010.00800.x; Verrotti A, 2010, EPILEPSIA, V51, P268, DOI 10.1111/j.1528-1167.2009.02206.x; Verrotti A, 2009, HORM RES, V71, P125, DOI 10.1159/000197868	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103856	10.1371/journal.pone.0103856	http://dx.doi.org/10.1371/journal.pone.0103856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078464	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800090
J	Sammar, M; Nisamblatt, S; Gonen, R; Huppertz, B; Gizurarson, S; Osol, G; Meiri, H				Sammar, Marei; Nisamblatt, Shahar; Gonen, Ron; Huppertz, Berthold; Gizurarson, Sveinbjorn; Osol, George; Meiri, Hamutal			The Role of the Carbohydrate Recognition Domain of Placental Protein 13 (PP13) in Pregnancy Evaluated with Recombinant PP13 and the DelT(221) PP13 Variant	PLOS ONE			English	Article							MESSENGER-RNA; PREECLAMPSIA; EXPRESSION; PLACENTAL-PROTEIN-13; TROPHOBLASTS; MANAGEMENT; HELLP	Introduction: Placental protein 13 (PP13), a placenta specific protein, is reduced in the first trimester of pregnancy in women who subsequently develop preeclampsia. A naturally occurring PP13 deletion of thymidine at position 221 (DelT(221) or truncated variant) is associated with increased frequency of severe preeclampsia. In this study we compared the full length (wildtype) PP13 and the truncated variant. Methods: Full length PP13 or its DelT(221) variant were cloned, expressed and purified from E-Coli. Both variants were administrated into pregnant rats at day 8 of pregnancy for slow release (. 5 days) through osmotic pumps and rat blood pressure was measured. Animals were sacrificed at day 15 or day 21 and their utero-placental vasculature was examined. Results: The DelT(221) variant (11 kDA) lacked exon 4 and a part of exon 3, and is short of 2 amino acids involved in the carbohydrate (CRD) binding of the wildtype (18 kDA). Unlike the wildtype PP13, purification of DelT(221) variant required special refolding. PP13 specific poly-clonal antibodies recognized both PP13 and DelT(221) but PP13 specific monoclonal antibodies recognized only the wildtype, indicating the loss of major epitopes. Wildtype PP13 mRNA and its respective proteins were both lower in PE patients compared to normal pregnancies. The DelT(221) mutant was not found in a large Caucasian cohort. Pregnant rats exposed to wildtype or DelT(221) PP13 variants had significantly lower blood pressure compared to control. The wildtype but not the DelT(221) mutant caused extensive vein expansion. Conclusion: This study revealed the importance of PP13 in regulating blood pressure and expanding the utero-placental vasculature in pregnant rats. PP13 mutant lacking amino acids of the PP13 CRD domain fails to cause vein expansion but did reduce blood pressure. The study provides a basis for replenishing patients at risk for preeclampsia by the full length but not the truncated PP13.	[Sammar, Marei; Nisamblatt, Shahar] ORT Braude Coll, Prof Ephraim Katzir Dept Biotechnol Engn, Karmiel, Israel; [Gonen, Ron] Bnai Zion Med Ctr, Dept Obstet & Gynecol, Haifa, Israel; [Gonen, Ron] Technion Israel Inst Technol, Haifa, Israel; [Huppertz, Berthold] Med Univ Graz, Inst Cell Biol Histol & Embryol, Biobank Graz, Graz, Austria; [Gizurarson, Sveinbjorn] Univ Iceland, Sch Hlth Sci, Fac Pharmaceut Sci, Reykjavik, Iceland; [Osol, George] Univ Vermont, Coll Med, Dept Obstet Gynecol & Reprod Sci, Burlington, VT USA; [Meiri, Hamutal] Telemarpe Ltd, Tel Aviv, Israel; [Meiri, Hamutal] Hy Labs, Rehovot, Israel	Bnai Zion Medical Center; Technion Israel Institute of Technology; Medical University of Graz; University of Iceland; University of Vermont	Sammar, M (corresponding author), ORT Braude Coll, Prof Ephraim Katzir Dept Biotechnol Engn, Karmiel, Israel.	sammar@braude.ac.il	Gizurarson, Sveinbjörn/M-1489-2015; Huppertz, Berthold/I-2331-2019; Sammar, Marei/Q-1410-2019	Gizurarson, Sveinbjörn/0000-0001-7824-9752; Huppertz, Berthold/0000-0003-4814-2158; 	EC FP7 project ASPRE [601852]; Foundation of Helgu Jonsdottur and Sigurlioa Kristjansson (Iceland); Hananja ehf (Iceland)	EC FP7 project ASPRE; Foundation of Helgu Jonsdottur and Sigurlioa Kristjansson (Iceland); Hananja ehf (Iceland)	Part of this study excluding the rat studies, was sponsored in part by the EC FP7 project ASPRE (#601852.) funded to HM and SG. Animal studies were sponsored by the Foundation of Helgu Jonsdottur and Sigurlioa Kristjansson (Iceland) and Hananja ehf (Iceland) (SG). All other funding came from internal resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balogh A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.023; BOHN H, 1983, ONCODEV BIOL MED, V4, P343; Burger O, 2004, PLACENTA, V25, P608, DOI 10.1016/j.placenta.2003.12.009; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Cetin I, 2011, PLACENTA, V32, pS4, DOI 10.1016/j.placenta.2010.11.022; Farina A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.043; Garrec J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003057; Gebhardt S, 2009, J REPROD IMMUNOL, V82, P166, DOI 10.1016/j.jri.2009.07.004; Gizurarson S, 2013, FETAL DIAGN THER, V33, P257, DOI 10.1159/000345964; Gonen-Gross T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008941; Grimpel YI, 2011, PLACENTA, V32, pS55, DOI 10.1016/j.placenta.2010.11.019; Huppertz B, 2008, FETAL DIAGN THER, V24, P230, DOI 10.1159/000151344; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Huppertz B, 2013, HUM REPROD UPDATE, V19, P391, DOI 10.1093/humupd/dmt003; Kliman HJ, 2012, REPROD SCI, V19, P16, DOI 10.1177/1933719111424445; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Lindheimer MD, 2009, J CLIN HYPERTENS, V11, P214, DOI 10.1111/j.1751-7176.2009.00085.x; Moutquin JM, 2003, BJOG-INT J OBSTET GY, V110, P30, DOI 10.1016/S1470-0328(03)00021-1; Than NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021564; Osol G, 2014, MICROCIRCULATION, V21, P38, DOI 10.1111/micc.12080; Pijnenborg R, 2008, HYPERTENS PREGNANCY, V27, P183, DOI 10.1080/10641950701826711; Redman CWG, 2008, PLACENTA, V29, pS73, DOI 10.1016/j.placenta.2007.11.016; Sammar M, 2011, PLACENTA, V32, pS30, DOI 10.1016/j.placenta.2010.09.006; Sekizawa A, 2009, REPROD SCI, V16, P408, DOI 10.1177/1933719108328615; Shimizu H, 2009, PRENATAL DIAG, V29, P1231, DOI 10.1002/pd.2380; Sibai BM, 2011, AM J OBSTET GYNECOL, V205, P191, DOI 10.1016/j.ajog.2011.07.017; Sibai BM, 2004, OBSTET GYNECOL, V103, P981, DOI 10.1097/01.AOG.0000126245.35811.2a; Stolk M, 2006, P ISHHP; Than NG, 2008, PLACENTA, V29, pS83, DOI 10.1016/j.placenta.2007.10.008; Than NG, 2008, VIRCHOWS ARCH, V453, P387, DOI 10.1007/s00428-008-0658-x; Than NG, 2012, TRENDS ENDOCRIN MET, V23, P23, DOI 10.1016/j.tem.2011.09.003; Than NG, 2009, P NATL ACAD SCI USA, V106, P9731, DOI 10.1073/pnas.0903568106; Than NG, 2004, EUR J BIOCHEM, V271, P1065, DOI 10.1111/j.1432-1033.2004.04004.x; Than NG, 1999, PLACENTA, V20, P703, DOI 10.1053/plac.1999.0436; Visegrady B, 2001, PROTEIN ENG, V14, P875, DOI 10.1093/protein/14.11.875; Wang SY, 2011, J BIOL CHEM, V286, P29376, DOI 10.1074/jbc.M111.233346; WHO, 2005, MAK EV MOTH CHILD CO	37	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102832	10.1371/journal.pone.0102832	http://dx.doi.org/10.1371/journal.pone.0102832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079598	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800017
J	Xu, JW; Liao, YM; Liu, H; Nie, RH; Havumaki, J				Xu, Jian-wei; Liao, Yuan-mei; Liu, Hui; Nie, Ren-hua; Havumaki, Joshua			Use of Bed Nets and Factors That Influence Bed Net Use among Jinuo Ethnic Minority in Southern China	PLOS ONE			English	Article							MALARIA ELIMINATION	Background: Insecticide-treated nets (ITNs) are an integral part of vector control recommendations for malaria elimination in China. This study investigated the extent to which bed nets were used and which factors influence bed net use among Jinuo Ethnic Minority in China-Myanmar-Laos border areas. Methods and Findings: This study combined a quantitative household questionnaire survey and qualitative semi-structured in-depth interviews (SDI). Questionnaires were administered to 352 heads of households. SDIs were given to 20 key informants. The bed net to person ratio was 1: 2.1 (i.e., nearly one net for every two people), however only 169 (48.0%) households owned at least one net and 623 (47.2%) residents slept under bed nets the prior night. The percentages of residents who regularly slept under nets (RSUN) and slept under nets the prior night (SUNPN) were similar (48.0% vs. 47.2%, P>0.05), however the percentage correct use of nets (CUN) was significantly lower (34.5%, P <0.0001). The annual cash income per person (ACIP) was an independent factor that influenced bed net use (P <0.0001), where families with an ACIP of CNY10000 or more were much more likely to use nets. House type was strongly associated with bed net use (OR: 4.71, 95% CI: 2.81, 7.91; P<0.0001), where those with traditional wood walls and terracotta roofs were significantly more likely to use nets, and the head of household's knowledge was an independent factor (OR: 5.04, 95% CI: 2.72, 9.35; P <0.0001), where those who knew bed nets prevent malaria were significantly more likely to use nets too. Conclusions: High bed net availability does not necessarily mean higher coverage or bed net use. Household income, house type and knowledge of the ability of bed nets to prevent malaria are all independent factors that influence bed net use among Jinuo Ethnic Minority.	[Xu, Jian-wei; Liu, Hui; Nie, Ren-hua] Yunnan Inst Parasit Dis, Puer, Peoples R China; [Liao, Yuan-mei] Hlth Sch Ganzhou, Ganzhou, Jiangxi, Peoples R China; [Havumaki, Joshua] Fdn Innovat New Diagnost, Cointrin Geneva, Switzerland	Foundation For Innovative New Diagnostics	Liu, H (corresponding author), Yunnan Inst Parasit Dis, Puer, Peoples R China.	liubible@126.com	Xu, Jian-wei/ABI-7923-2020	Xu, Jian-wei/0000-0003-2769-819X	China of the Global Fund to fight AIDS, Tuberculosis and Malaria	China of the Global Fund to fight AIDS, Tuberculosis and Malaria	The authors thank the fifth grant to China of the Global Fund to fight AIDS, Tuberculosis and Malaria for financial sponsorship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, FACTORS AFFECT SUCCE; [Anonymous], WHO GLOB MAL PROGR P; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-119; China Centre for Diseases Control and Prevention, 2011, TECHN GUID MAL EL; COTTER C, 2013, LANCET; Dong XS, 2010, MOSQUITO FAUNA YUNNA, P49; Dong XueShu, 2000, Chinese Journal of Parasitic Disease Control, V13, P144; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gai X, 1986, JINUO YU JIANZHI; Gosling RD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-346; Li BenFu, 2013, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V8, P448; Ministry of Health People's Republic of China, 2010, MAL EL ACT PLAN 2010; Mishra RN, 2010, TROP MED INT HEALTH, V15, P36, DOI 10.1111/j.1365-3156.2010.02544.x; Ngo DT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007369; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Sochantha T, 2010, TROP MED INT HEALTH, V15, P336, DOI 10.1111/j.1365-3156.2009.02457.x; Tatem AJ, 2010, LANCET, V376, P1579, DOI 10.1016/S0140-6736(10)61301-3; Tsuang A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-211; Ward KA, 2011, EMERG INFECT DIS, V17, P1409, DOI 10.3201/eid1708.100842; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Xia Zhi-Gui, 2012, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V30, P419; Xu JW, 2012, SE ASIAN J TROP MED, V43, P819; Xu JianWei, 2010, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V21, P527; Xu JianWei, 2004, China Tropical Medicine, V4, P319; Xu JianWei, 2004, Chinese Journal of Schistosomiasis Control, V16, P51; Xu Jianwei, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P456; Zhou HN, 1994, J PRACTICAL PARASIT, V2, P44; [周升 ZHOU Sheng], 2009, [中国媒介生物学及控制杂志, Chinese Journal of Vector Biology and Control], V20, P326; Zhu DF, 1997, J PRACTICAL PARASIT, V5, P45	29	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103780	10.1371/journal.pone.0103780	http://dx.doi.org/10.1371/journal.pone.0103780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080267	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800081
J	Abbott, DS; Chin-Smith, EC; Seed, PT; Chandiramani, M; Shennan, AH; Tribe, RM				Abbott, Danielle S.; Chin-Smith, Evonne C.; Seed, Paul T.; Chandiramani, Manju; Shennan, Andrew H.; Tribe, Rachel M.			Raised Trappin2/elafin Protein in Cervico-Vaginal Fluid Is a Potential Predictor of Cervical Shortening and Spontaneous Preterm Birth	PLOS ONE			English	Article							VITAMIN-D; NEUTROPHIL ELASTASE; INNATE IMMUNITY; ELAFIN; INHIBITOR; BIOMARKERS; TRAPPIN-2; INJURY	Early spontaneous preterm birth is associated with inflammation/infection and shortening of the cervix. We hypothesised that cervico-vaginal production of trappin2/elafin (peptidase inhibitor 3) and cathelicidin antimicrobial peptide (cathelicidin), key components of the innate immune system, are altered in women who have a spontaneous preterm birth. The aim was to determine the relationship between cervico-vaginal fluid (CVF) trappin2/elafin and cathelicidin protein concentrations with cervical length in woman at risk of spontaneous preterm birth. Trappin2/elafin and cathelicidin were measured using ELISA in longitudinal CVF samples (taken between 13 to 30 weeks' gestation) from 74 asymptomatic high risk women (based on obstetric history) recruited prospectively. Thirty six women developed a short cervix (<25 mm) by 24 weeks' and 38 women did not. Women who developed a short cervix had 2.71 times higher concentrations of CVF trappin2/ elafin from 14 weeks' versus those who did not (CI 1.94-3.79, p<0.0005). CVF trappin2/elafin before 24 weeks' was 1.79 times higher in women who had a spontaneous preterm birth <37 weeks' (CI: 1.05-3.05, p = 0.034). Trappin2/elafin (>200 ng/ml) measured between 14(+0) -14(+6) weeks' of pregnancy predicted women who subsequently developed a short cervix (n = 11, ROC area = 1.00, p = 0.008) within 8 weeks. Cathelicidin was not predictive of spontaneous delivery. Vitamin D status did not correlate with CVF antimicrobial peptide concentrations. Raised CVF trappin2/elafin has potential as an early pregnancy test for prediction of cervical shortening and spontaneous preterm birth. This justifies validation in a larger cohort.	[Abbott, Danielle S.; Chin-Smith, Evonne C.; Seed, Paul T.; Shennan, Andrew H.; Tribe, Rachel M.] Kings Coll London, Div Womens Hlth, Womens Hlth Acad Ctr Kings Hlth Partners, London WC2R 2LS, England; [Chandiramani, Manju] Univ London Imperial Coll Sci Technol & Med, Parturit Res Grp, Dept Surg & Canc, London, England; [Tribe, Rachel M.] Kings Coll London, Div Womens Hlth, Womens Hlth Acad Ctr KHP, London WC2R 2LS, England	King's Health Partners; University of London; King's College London; Imperial College London; King's Health Partners; University of London; King's College London	Tribe, RM (corresponding author), Kings Coll London, Div Womens Hlth, Womens Hlth Acad Ctr Kings Hlth Partners, London WC2R 2LS, England.	rachel.tribe@kcl.ac.uk	Chin-Smith, Evonne/AAQ-6957-2020; Seed, Paul T/C-4435-2008	Chin-Smith, Evonne/0000-0002-1935-2941; Seed, Paul T/0000-0001-7904-7933; Tribe, Rachel/0000-0003-3675-9978; Shennan, Andrew/0000-0001-5273-3132	Action Medical Research [S/P/4113]; Tommy's Charity; Sutton Place Foundation General Charitable Trust; Wellbeing of Women; British Maternal and Fetal Medicine Society	Action Medical Research; Tommy's Charity; Sutton Place Foundation General Charitable Trust; Wellbeing of Women(Wellbeing of Women (WoW)); British Maternal and Fetal Medicine Society	Action Medical Research, grant number S/P/4113 (Registered Charity No: 208701; www.action.org.uk) to RMT AHS. Tommy's Charity (Registered Charity No: 1060508; http://www.tommys.org/) to RMT AHS. The Sutton Place Foundation General Charitable Trust (Registered Charity No: 1136264) RMT AHS. Wellbeing of Women (Registered Charity No: 239281; http://www.wellbeingofwomen.org.uk) to DSA AHS RMT. British Maternal and Fetal Medicine Society (http://www.rcog.org.uk/ content/british-maternal-fetal-medicine-society) to DSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SR, 2012, BIOCHEM PHARMACOL, V83, P695, DOI 10.1016/j.bcp.2011.11.003; AMEMIYA T, 1973, ECONOMETRICA, V41, P997, DOI 10.2307/1914031; Baranger K, 2008, FEBS J, V275, P2008, DOI 10.1111/j.1742-4658.2008.06355.x; Bastek JA, 2013, OBSTET GYNECOL, V122, P283, DOI 10.1097/AOG.0b013e31829ab714; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203; Bodnar LM, 2014, AM J EPIDEMIOL, V179, P168, DOI 10.1093/aje/kwt237; Chandiramani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052412; Chowdhury MA, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-49; Drannik AG, 2013, J VIROL, V87, P7526, DOI 10.1128/JVI.02243-12; Frew L, 2011, REPRODUCTION, V141, P725, DOI 10.1530/REP-10-0537; Ghosh M, 2010, IMMUNOLOGY, V129, P207, DOI 10.1111/j.1365-2567.2009.03165.x; Ginzberg HH, 2001, AM J PHYSIOL-GASTR L, V281, pG705, DOI 10.1152/ajpgi.2001.281.3.G705; Grundmann M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-146; Guyot N, 2008, J BIOL CHEM, V283, P32377, DOI 10.1074/jbc.M803707200; Henriksen PA, 2008, INT J BIOCHEM CELL B, V40, P1095, DOI 10.1016/j.biocel.2008.01.004; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Horne AW, 2008, REPRODUCTION, V135, P739, DOI 10.1530/REP-07-0564; Hunt KK, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3374; Menon R, 2011, REPROD SCI, V18, P1046, DOI 10.1177/1933719111415548; Motta JP, 2011, GASTROENTEROLOGY, V140, P1272, DOI 10.1053/j.gastro.2010.12.050; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Paczesny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000406; Patel MV, 2013, AM J REPROD IMMUNOL, V69, P463, DOI 10.1111/aji.12078; Scott A, 2011, BIOCHEM SOC T, V39, P1437, DOI 10.1042/BST0391437; Spong CY, 2007, OBSTET GYNECOL, V110, P405, DOI 10.1097/01.AOG.0000275287.08520.4a; Stock SJ, 2009, REPROD SCI, V16, P1125, DOI 10.1177/1933719109341998; Takahashi K, 2002, IMMUNOPHARM IMMUNOT, V24, P335, DOI 10.1081/IPH-120014721; Tejera P, 2009, AM J RESP CELL MOL, V41, P696, DOI 10.1165/rcmb.2008-0410OC; Tromp G, 2004, AM J OBSTET GYNECOL, V191, P1331, DOI 10.1016/j.ajog.2004.07.010; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; Verrier T, 2012, INT J BIOCHEM CELL B, V44, P1377, DOI 10.1016/j.biocel.2012.05.007; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wilkinson TS, 2011, BIOCHEM SOC T, V39, P1409, DOI 10.1042/BST0391409; Zhu Y, 2001, Respir Res, V2, P300, DOI 10.1186/rr73	35	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e100771	10.1371/journal.pone.0100771	http://dx.doi.org/10.1371/journal.pone.0100771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075964	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800006
J	Freeth, T				Freeth, Tony			Eclipse Prediction on the Ancient Greek Astronomical Calculating Machine Known as the Antikythera Mechanism	PLOS ONE			English	Article								The ancient Greek astronomical calculating machine, known as the Antikythera Mechanism, predicted eclipses, based on the 223-lunar month Saros cycle. Eclipses are indicated on a four-turn spiral Saros Dial by glyphs, which describe type and time of eclipse and include alphabetical index letters, referring to solar eclipse inscriptions. These include Index Letter Groups, describing shared eclipse characteristics. The grouping and ordering of the index letters, the organization of the inscriptions and the eclipse times have previously been unsolved. A new reading and interpretation of data from the back plate of the Antikythera Mechanism, including the glyphs, the index letters and the eclipse inscriptions, has resulted in substantial changes to previously published work. Based on these new readings, two arithmetical models are presented here that explain the complete eclipse prediction scheme. The first model solves the glyph distribution, the grouping and anomalous ordering of the index letters and the structure of the inscriptions. It also implies the existence of lost lunar eclipse inscriptions. The second model closely matches the glyph times and explains the four-turn spiral of the Saros Dial. Together, these models imply a surprisingly early epoch for the Antikythera Mechanism. The ancient Greeks built a machine that can predict, for many years ahead, not only eclipses but also a remarkable array of their characteristics, such as directions of obscuration, magnitude, colour, angular diameter of the Moon, relationship with the Moon's node and eclipse time. It was not entirely accurate, but it was an astonishing achievement for its era.	[Freeth, Tony] Antikythera Mech Res Project, London, England; [Freeth, Tony] Images First Ltd, London, England		Freeth, T (corresponding author), Antikythera Mech Res Project, London, England.	tony@images-first.com		Freeth, Tony/0000-0001-9375-4247				Anastasiou M, 2013, J HIST ASTRONOMY; [Anonymous], 1963, PAPHS, V107, P528; Brack-Bernsen L, 1999, DIBNER INST STUD HIS, P149; Brack-Bernsen L, 1997, PREDICTIONS LUNAR PH, P5; Cullen C, 2002, JHA, Vxxxiii; Edmunds MG, 2011, J HIST ASTRON, V42, P307, DOI 10.1177/002182861104200302; Epping J., 1890, STIMMEN MARIA-LAACH, V39, P225; Espenak F, 2013, ECLIPSE MAPS FIGURES; Evans James, 2006, GEMINOS INTRO PHENOM; Freeth T, 2006, NATURE, V444, P587, DOI 10.1038/nature05357; Freeth T., 2012, ISAW PAPERS; Freeth T, 2008, NATURE, V454, P614, DOI 10.1038/nature07130; Gautschy R, 2012, JHA, Vxliii; Goldstein BR, 2005, COLORS ECLIPSES MEDI, V5, P11; Gray SL, 2012, P ROY SOC A-MATH PHY, V468, P1839, DOI 10.1098/rspa.2012.0007; Hannah R., 2008, TIME ANTIQUITY; Heath TL., 1921, HIST GREEK MATH; Kent J. H., 1966, CORINTH RESULTS EX 3, P14; Malzbender T, 2001, COMP GRAPH, P519, DOI 10.1145/383259.383320; NEUGEBAUER O, 1948, B AM MATH SOC, V54, P1013, DOI 10.1090/S0002-9904-1948-09089-9; Neugebauer O, 1967, ASTRONOMICAL J, V72; Neugebauer O., 1955, ASTRONOMICAL CUNEIFO, V1-3; Neugebauer O., 1975, HIST ANCIENT MATH AS; Ossendrijver M., 2012, BABYLONIAN MATH ASTR; Price D, 1959, SCI AM, P60; Price D de S, 1974, T AM PHILOS SOC, V64, P1; Ramsey AT, 2003, INT S CT IM PROC IND; Schaefer BE, 1996, Q J ROY ASTRON SOC, V37, P759; Steele JM, 2000, ARCH HIST EXACT SCI, V54, P421, DOI 10.1007/s004070050007; Steele JM, 1997, J HIST ASTRON, V28, P119; Steele JM, 1997, J HIST ASTRON, V28, P133; Toomer G.J., 1974, CENTARUS, V18, P6, DOI [10.1111/j.1600-0498.1974.tb00205.x, DOI 10.1111/J.1600-0498.1974.TB00205.X]; Toomer Gerald J., 1984, PTOLEMYS ALMAGEST; Tracy StephenV., 1990, ATTIC LETT CUTTERS 2; Wright M. T., 2006, ANTIQUARIAN HOROLOGY, V29, P319; Wright MT, 2003, B SCI INSTRUM SOC, Vlxxx, P4	36	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103275	10.1371/journal.pone.0103275	http://dx.doi.org/10.1371/journal.pone.0103275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075747	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800034
J	Harper, DM; Else, BM; Bartley, MJ; Arey, AM; Barnett, AL; Rosemergey, BE; Paynter, CA; Verdenius, I; Harper, SM; Harris, GD; Groner, JA; Malnar, GJ; Wall, J; Bonham, AJ				Harper, Diane M.; Else, Britney M.; Bartley, Mitchell J.; Arey, Anne M.; Barnett, Angela L.; Rosemergey, Beth E.; Paynter, Christopher A.; Verdenius, Inge; Harper, Sean M.; Harris, George D.; Groner, Jennifer A.; Malnar, Gerard J.; Wall, Jeffrey; Bonham, Aaron J.			In a Safety Net Population HPV4 Vaccine Adherence Worsens as BMI Increases	PLOS ONE			English	Article							BODY-MASS INDEX; CERVICAL-CANCER; AFRICAN-AMERICAN; RISK-FACTORS; SEXUAL-BEHAVIOR; HISPANIC WOMEN; NEEDLE LENGTH; HEALTH-CARE; OBESITY; WEIGHT	Objectives: Obesity adversely inhibits antibody response to vaccination. Three doses of HPV4 may or may not provide adequate long term protection against HPV 16/18 in obese females. The aim of this study was to determine whether adherence to HPV4 vaccination in a safety net population was reduced with increasing body mass index (BMI). Methods: We designed a historical prospective study evaluating the number and dates of HPV4 dosing that occurred from July 1, 2006 through October 1, 2009 by the demographic characteristics of the 10-26 year old recipient females. The defined dosing intervals were adapted from the literature and obesity categories were defined by the WHO. Results: 1240 females with BMI measurements received at least one dose of HPV4; 38% were obese (class I, II and III) and 25% were overweight. Females with normal BMI received on-time triplet dosing significantly more often than did the obese class II and III females (30% vs. 18%, p<0.001). Obese class II/III females have a significant 45% less chance of completing the on-time triplet HPV4 series than normal women (OR = 0.55, 95% CI: 0.37, 0.83). Pregnancy history has a significant influence on BMI and HPV4 dosing compliance in this safety net population where 71% had been gravid. Hispanic females were less likely to complete HPV4 dosing regardless of BMI (aOR = 0.39, 95% CI: 0.16, 0.95). Conclusions: Obesity, as well as gravidity and Hispanic race, are risk factors for lack of HPV4 vaccine adherence among young females in a safety net population.	[Harper, Diane M.; Else, Britney M.; Bartley, Mitchell J.; Arey, Anne M.; Barnett, Angela L.; Rosemergey, Beth E.; Paynter, Christopher A.; Harris, George D.; Groner, Jennifer A.] Univ Missouri, Dept Community & Family Med, Sch Med, Kansas City, MO 64108 USA; [Harper, Diane M.; Malnar, Gerard J.; Wall, Jeffrey] Univ Missouri, Sch Med, Dept Obstet & Gynecol, Kansas City, MO 64108 USA; [Harper, Diane M.; Bonham, Aaron J.] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64108 USA; [Verdenius, Inge] Radboud Univ Nijmegen, Dept Obstet & Gynecol, NL-6525 ED Nijmegen, Netherlands; [Harper, Sean M.] Hampshire Coll, Amherst, MA 01002 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Radboud University Nijmegen	Harper, DM (corresponding author), Univ Missouri, Dept Community & Family Med, Sch Med, Kansas City, MO 64108 USA.	diane.m.harper@gmail.com	Harper, Diane M./I-2180-2014	Harper, Diane M./0000-0001-7648-883X				Abrams B, 2013, OBESITY, V21, P1514, DOI 10.1002/oby.20503; American Cancer Society, 2008, CANC PREV EARL DET F; Amy NK, 2006, INT J OBESITY, V30, P147, DOI 10.1038/sj.ijo.0803105; Banerjea R, 2008, WOMEN HEALTH, V47, P1, DOI 10.1080/03630240802099261; Baylor NW, 2009, FDA APPROVAL LETT HU; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chang VW, 2010, JAMA-J AM MED ASSOC, V303, P1274, DOI 10.1001/jama.2010.339; Cokkinides VE, 2012, CA-CANCER J CLIN, V62, P353, DOI 10.3322/caac.21155; Coughlin SS, 2004, PREV CHRONIC DIS, V1, pA04; Datta GD, 2006, CANCER, V106, P664, DOI 10.1002/cncr.21660; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Eliakim A, 2006, AUTOIMMUNITY, V39, P137, DOI 10.1080/08916930600597326; Fagan HB, 2011, J OBES, V2011, DOI 10.1155/2011/218250; Ferrante JM, 2007, AM J PREV MED, V32, P525, DOI 10.1016/j.amepre.2007.02.004; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fontaine KR, 1998, ARCH FAM MED, V7, P381, DOI 10.1001/archfami.7.4.381; Freeman HP, 2005, NIH PUB; GARFINKEL L, 1985, ANN INTERN MED, V103, P1034, DOI 10.7326/0003-4819-103-6-1034; Hall HI, 2002, CANCER EPIDEM BIOMAR, V11, P137; Harper DM, 2009, PUBLIC HEALTH GENOM, V12, P319, DOI 10.1159/000214922; Harper DM, 2010, J VACCINES VACCIN, V1; IBM Corp, 2011, IBM SPSS STAT WIND V; IBM Corp, 2012, COCHR ARM TEST TREND; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; Koster MP, 2009, PEDIATRICS, V124, P667, DOI 10.1542/peds.2008-1127; Kraschnewski JL, 2012, PREV MED, V54, P302, DOI 10.1016/j.ypmed.2012.02.010; Lee SK, 2005, OBES RES, V13, P1263, DOI 10.1038/oby.2005.150; Leone LA, 2012, J COMMUN HEALTH, V37, P299, DOI 10.1007/s10900-011-9445-8; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Marshall HS, 2013, VACCINE, V31, P2647, DOI 10.1016/j.vaccine.2013.03.037; Middleman AB, 2010, PEDIATRICS, V125, pE508, DOI 10.1542/peds.2009-1592; Miller R, 2014, INT J OBESITY, V38, P397, DOI 10.1038/ijo.2013.126; Mitchell RS, 2008, AM J PREV MED, V35, P127, DOI 10.1016/j.amepre.2008.03.031; Nagelkerke NJD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-199; Nelson JC, 2009, AM J PUBLIC HEALTH, V99, pS389, DOI 10.2105/AJPH.2008.151332; Nelson W, 2009, J WOMENS HEALTH, V18, P1759, DOI 10.1089/jwh.2009.1430; Neuzil KM, 2011, JAMA-J AM MED ASSOC, V305, P1424, DOI 10.1001/jama.2011.407; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Ostbye T, 2005, AM J PUBLIC HEALTH, V95, P1623, DOI 10.2105/AJPH.2004.047803; Paich HA, 2013, OBESITY, V21, P2377, DOI 10.1002/oby.20383; Park JK, 2012, ASIAN PAC J CANCER P, V13, P3271, DOI 10.7314/APJCP.2012.13.7.3271; Reuman PD, 1997, VACCINE, V15, P1157, DOI 10.1016/S0264-410X(96)00310-6; Scarinci IC, 2010, CANCER-AM CANCER SOC, V116, P2531, DOI 10.1002/cncr.25065; Segerstrom SC, 2012, BRAIN BEHAV IMMUN, V26, P747, DOI 10.1016/j.bbi.2011.10.009; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005; Smith AMA, 2011, J WOMENS HEALTH, V20, P1091, DOI 10.1089/jwh.2010.2585; Smolen KK, 2012, VACCINE, V30, P3572, DOI 10.1016/j.vaccine.2012.03.051; StatSoft Inc, 2010, STATISTICA; Verdenius I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071295; WEBER DJ, 1985, JAMA-J AM MED ASSOC, V254, P3187, DOI 10.1001/jama.254.22.3187; WEBER DJ, 1986, NEW ENGL J MED, V314, P1393; Wee CC, 2005, OBES RES, V13, P1275, DOI 10.1038/oby.2005.152; Wee CC, 2000, ANN INTERN MED, V132, P697, DOI 10.7326/0003-4819-132-9-200005020-00003; Wee CC, 2008, OBESITY, V16, P2552, DOI 10.1038/oby.2008.394; White SJ, 2013, VACCINE, V31, P1666, DOI 10.1016/j.vaccine.2013.01.032; Wolfe WS, 1997, INT J OBESITY, V21, P802, DOI 10.1038/sj.ijo.0800478; WOOD RC, 1993, JAMA-J AM MED ASSOC, V270, P2935, DOI 10.1001/jama.270.24.2935; World Health Organization (WHO), 2013, GLOB DAT BOD MASS IN; Wu HY, 2006, OBESITY, V14, P526; Young KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082779	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103172	10.1371/journal.pone.0103172	http://dx.doi.org/10.1371/journal.pone.0103172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25076128	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800028
J	Puechmaille, SJ; Borissov, IM; Zsebok, S; Allegrini, B; Hizem, M; Kuenzel, S; Schuchmann, M; Teeling, EC; Siemers, BM				Puechmaille, Sebastien J.; Borissov, Ivailo M.; Zsebok, Sandor; Allegrini, Benjamin; Hizem, Mohammed; Kuenzel, Sven; Schuchmann, Maike; Teeling, Emma C.; Siemers, Bjoern M.			Female Mate Choice Can Drive the Evolution of High Frequency Echolocation in Bats: A Case Study with Rhinolophus mehelyi	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; GREATER HORSESHOE BATS; SEXUAL SELECTION; PAIRWISE RELATEDNESS; CONCOMITANT SHIFTS; CALL FREQUENCIES; ACOUSTIC-SIGNALS; MOUSTACHED BAT; SOCIAL CALLS; CHIROPTERA	Animals employ an array of signals (i.e. visual, acoustic, olfactory) for communication. Natural selection favours signals, receptors, and signalling behaviour that optimise the received signal relative to background noise. When the signal is used for more than one function, antagonisms amongst the different signalling functions may constrain the optimisation of the signal for any one function. Sexual selection through mate choice can strongly modify the effects of natural selection on signalling systems ultimately causing maladaptive signals to evolve. Echolocating bats represent a fascinating group in which to study the evolution of signalling systems as unlike bird songs or frog calls, echolocation has a dual role in foraging and communication. The function of bat echolocation is to generate echoes that the calling bat uses for orientation and food detection with call characteristics being directly related to the exploitation of particular ecological niches. Therefore, it is commonly assumed that echolocation has been shaped by ecology via natural selection. Here we demonstrate for the first time using a novel combined behavioural, ecological and genetic approach that in a bat species, Rhinolophus mehelyi: (1) echolocation peak frequency is an honest signal of body size; (2) females preferentially select males with high frequency calls during the mating season; (3) high frequency males sire more off-spring, providing evidence that echolocation calls may play a role in female mate choice. Our data refute the sole role of ecology in the evolution of echolocation and highlight the antagonistic interplay between natural and sexual selection in shaping acoustic signals.	[Puechmaille, Sebastien J.; Borissov, Ivailo M.; Zsebok, Sandor; Schuchmann, Maike; Siemers, Bjoern M.] Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany; [Puechmaille, Sebastien J.; Teeling, Emma C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Puechmaille, Sebastien J.; Borissov, Ivailo M.; Zsebok, Sandor; Schuchmann, Maike; Siemers, Bjoern M.] Tabachka Bat Res Stn, Tabachka, Bulgaria; [Zsebok, Sandor] MTA ELTE MTM Ecol Res Grp, Budapest, Hungary; [Allegrini, Benjamin] Naturalia Environm, Gallargues Le Montueux, France; [Hizem, Mohammed] Tunis Super Inst Biol Appl Sci, Tunis, Tunisia; [Kuenzel, Sven] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany	Max Planck Society; University College Dublin; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Max Planck Society	Puechmaille, SJ (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Zool, Greifswald, Germany.	s.puechmaille@gmail.com	Zsebők, Sándor/H-4768-2015; Puechmaille, Sebastien/D-1612-2010	Zsebők, Sándor/0000-0003-4463-4753; Puechmaille, Sebastien/0000-0001-9517-5775; Teeling, Emma/0000-0002-3309-1346	IRCSET-Marie Curie International Mobility Fellowships in Science, Engineering and Technology; Max Planck Society; ERC Starting grant	IRCSET-Marie Curie International Mobility Fellowships in Science, Engineering and Technology; Max Planck Society(Max Planck SocietyFoundation CELLEX); ERC Starting grant(European Research Council (ERC))	The study was funded by an IRCSET-Marie Curie International Mobility Fellowships in Science, Engineering and Technology to S.J.P., by the Max Planck Society (B.M.S.) and an ERC Starting grant (E.C.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonduriansky R, 2011, AM NAT, V178, P729, DOI 10.1086/662665; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Canadian Council On Animal Care, 2003, CCAC SPEC SPEC REC B, P1; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Clutton-Brock T, 2009, Q REV BIOL, V84, P3, DOI 10.1086/596461; Crichton E. G., 2000, REPROD BIOL BATS; DAVIES NB, 1978, NATURE, V274, P683, DOI 10.1038/274683a0; Dietz C, 2007, MAMM BIOL, V72, P129, DOI 10.1016/j.mambio.2006.07.005; Dietz C., 2009, BATS BRITAIN EUROPE; Ellers J, 2003, EVOLUTION, V57, P1100, DOI 10.1111/j.0014-3820.2003.tb00319.x; Fenton M.B., 1985, COMMUNICATION CHIROP; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Francis Charles M., 1998, P169; Galeotti P, 2005, BEHAV ECOL, V16, P301, DOI 10.1093/beheco/arh165; Gray DA, 1997, ANIM BEHAV, V54, P1553, DOI 10.1006/anbe.1997.0584; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; HUFFMAN RF, 1993, J COMP PHYSIOL A, V171, P735, DOI 10.1007/BF00213070; HUFFMAN RF, 1993, J COMP PHYSIOL A, V171, P725, DOI 10.1007/BF00213069; Jacobs DS, 2007, OECOLOGIA, V152, P583, DOI 10.1007/s00442-007-0679-1; Jiang TL, 2013, ETHOLOGY, V119, P881, DOI 10.1111/eth.12130; JONES G, 1993, P ROY SOC B-BIOL SCI, V252, P125, DOI 10.1098/rspb.1993.0055; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Jones G, 1997, ADV STUD BEHAV, V26, P317, DOI 10.1016/S0065-3454(08)60383-6; Jones G, 2013, P I CIVIL ENG-ENERGY, V166, P1, DOI 10.1680/ener.2013.166.1.1; Knornschild M, 2012, P ROY SOC B-BIOL SCI, V279, P4827, DOI 10.1098/rspb.2012.1995; LI CC, 1993, HUM HERED, V43, P45, DOI 10.1159/000154113; Liu Y, 2013, CHINESE SCI BULL, V58, P2179, DOI 10.1007/s11434-013-5793-3; LYNCH M, 1988, MOL BIOL EVOL, V5, P584; Ma J, 2006, J COMP PHYSIOL A, V192, P535, DOI 10.1007/s00359-006-0094-9; MASTERS WM, 1995, ANIM BEHAV, V50, P1243, DOI 10.1016/0003-3472(95)80041-7; Milligan BG, 2003, GENETICS, V163, P1153; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Pfalzer G, 2003, J ZOOL, V261, P21, DOI 10.1017/S0952836903003935; Puechmaille S, 2005, MOL ECOL NOTES, V5, P941, DOI 10.1111/j.1471-8286.2005.01123.x; Puechmaille Sebastien J., 2012, Vespertilio, V16, P211; Puechmaille SJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1582; Puechmaille SJ, 2009, CONSERV GENET, V10, P1073, DOI 10.1007/s10592-008-9691-1; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Riede T, 1999, J EXP BIOL, V202, P2859; Rozen S, 2000, Methods Mol Biol, V132, P365; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; Salsamendi E, 2005, J MAMMAL, V16, P149; SCHERRER JA, 1993, ANIM BEHAV, V46, P847, DOI 10.1006/anbe.1993.1270; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schuchmann M, 2012, ACTA CHIROPTEROL, V14, P161, DOI 10.3161/150811012X654376; Schuchmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012842; Schuchmann M, 2010, AM NAT, V176, P72, DOI 10.1086/652993; Sell A, 2010, P ROY SOC B-BIOL SCI, V277, P3509, DOI 10.1098/rspb.2010.0769; Servedio MR, 2011, TRENDS ECOL EVOL, V26, P389, DOI 10.1016/j.tree.2011.04.005; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Siemers BM, 2005, ACTA CHIROPTEROL, V7, P259, DOI 10.3161/1733-5329(2005)7[259:ISISAO]2.0.CO;2; Siemers BM, 2004, BEHAV ECOL SOCIOBIOL, V56, P464, DOI 10.1007/s00265-004-0807-4; SIMMONS LW, 1988, ANIM BEHAV, V36, P380, DOI 10.1016/S0003-3472(88)80009-5; SMITH JM, 1991, TRENDS ECOL EVOL, V6, P146, DOI 10.1016/0169-5347(91)90055-3; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105; Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Voigt CC, 2008, J MAMMAL, V89, P1401, DOI 10.1644/08-MAMM-S-060.1; Thong VD, 2012, J MAMMAL, V93, P1, DOI 10.1644/11-MAMM-A-073.1; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Wang JL, 2002, GENETICS, V160, P1203; Ward HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087199; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	72	53	54	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103452	10.1371/journal.pone.0103452	http://dx.doi.org/10.1371/journal.pone.0103452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075972	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800046
J	Shi, F; Shi, JK; Li, YF				Shi, Feng; Shi, Jikui; Li, Yongfu			Mechanochemical Phosphorylation and Solubilisation of beta-D-Glucan from Yeast Saccharomyces cerevisiae and Its Biological Activities	PLOS ONE			English	Article							MECHANICAL ACTIVATION; ANTITUMOR ACTIVITIES; PHYSICOCHEMICAL CHARACTERIZATION; CHAIN CONFORMATION; RESPONSE MODIFIER; ANTIOXIDANT; CELLULOSE; POLYSACCHARIDES; DERIVATIVES; PRODUCTS	To obtain a water-soluble beta-D-glucan derivative cleanly and conveniently, a highly efficient mechanochemical method, planetary ball milling, was used to phosphorylate beta-D-glucan isolated from yeast Saccharomyces cerevisiae in solid state. Soluble beta-D-glucan phosphate (GP) with a high degree of substitution (0.77-2.09) and an apparent PEAK molecular weight of 6.6-10.0 kDa was produced when beta-D-glucan was co-milled with sodium hexametaphosphate at 139.5-186.0 rad/s for 12-20 min. The energy transferred was 3.03-11.98 KJ/g. The phosphorylation of GPs was demonstrated by Fourier transform infrared spectroscopy and C-13 and P-31 Nuclear magnetic resonance spectroscopy. Three GP products with different degree of substitution (DS) and degree of polymerisation (DP) were able to upregulate the functional events mediated by activated murine macrophage RAW264.7 cells, among which GP-2 with a DS of 1.24 and DP of 30.5 exerted the highest immunostimulating activity. Our results indicate that mechanochemical processing is an efficient method for preparing water-soluble and biologically active GP with high DS.	[Shi, Feng; Shi, Jikui] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Shi, Feng; Shi, Jikui] Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China; [Shi, Feng; Shi, Jikui] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China; [Li, Yongfu] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University; Jiangnan University	Shi, F (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	shifeng@jiangnan.edu.cn			Science and Technology Support Project of Jiangsu Province [BE2012428]; Fundamental Research Funds for the Central Universities [JUSRP 21109]	Science and Technology Support Project of Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by grants from Science and Technology Support Project of Jiangsu Province (BE2012428) and Fundamental Research Funds for the Central Universities (JUSRP 21109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avolio R, 2012, CARBOHYD POLYM, V87, P265, DOI 10.1016/j.carbpol.2011.07.047; Balaz P, 2009, MINER ENG, V22, P681, DOI 10.1016/j.mineng.2009.01.014; BROWDER W, 1990, ANN SURG, V211, P605; BURGIO N, 1991, NUOVO CIMENTO D, V13, P459, DOI 10.1007/BF02452130; Chen R, 2010, CARBOHYD POLYM, V81, P188, DOI 10.1016/j.carbpol.2010.02.012; Chen XY, 2009, CARBOHYD POLYM, V78, P581, DOI 10.1016/j.carbpol.2009.05.019; Colombo I, 2009, J PHARM SCI-US, V98, P3961, DOI 10.1002/jps.21733; Ding JZ, 2013, INT J FOOD SCI TECH, V48, P253, DOI 10.1111/j.1365-2621.2012.03181.x; Du ZJ, 2013, INT J BIOL MACROMOL, V58, P329, DOI 10.1016/j.ijbiomac.2013.04.037; GORIN PAJ, 1981, ADV CARBOHYDRATE CHE, V41; Ha TZ, 2006, AM J PHYSIOL-HEART C, V291, pH1910, DOI 10.1152/ajpheart.01264.2005; Huang QL, 2011, CARBOHYD POLYM, V83, P1363, DOI 10.1016/j.carbpol.2010.09.057; Huang ZQ, 2012, BIORESOURCE TECHNOL, V118, P624, DOI 10.1016/j.biortech.2012.05.082; Hunter KW, 2002, LETT APPL MICROBIOL, V35, P267, DOI 10.1046/j.1472-765X.2002.01201.x; James SL, 2012, CHEM SOC REV, V41, P413, DOI 10.1039/c1cs15171a; Kogan G, 2005, CARBOHYD POLYM, V61, P18, DOI 10.1016/j.carbpol.2005.02.010; Lee DY, 2002, BIOSCI BIOTECH BIOCH, V66, P233, DOI 10.1271/bbb.66.233; Lee JS, 2009, CARBOHYD POLYM, V78, P162, DOI 10.1016/j.carbpol.2009.04.036; Leyva A, 2008, BIOLOGICALS, V36, P134, DOI 10.1016/j.biologicals.2007.09.001; Liao ZD, 2011, BIORESOURCE TECHNOL, V102, P7953, DOI 10.1016/j.biortech.2011.05.067; Muller A, 1996, J IMMUNOL, V156, P3418; Passauer L, 2010, CARBOHYD POLYM, V82, P809, DOI 10.1016/j.carbpol.2010.05.050; Passauer L, 2009, STARCH-STARKE, V61, P621, DOI 10.1002/star.200900168; Qin F, 2012, CARBOHYD POLYM, V90, P1092, DOI 10.1016/j.carbpol.2012.06.048; Rahar S, 2011, J ADV PHARM TECHNOL, V2, P94, DOI 10.4103/2231-4040.82953; Roy A, 2012, BIORESOURCE TECHNOL, V107, P222, DOI 10.1016/j.biortech.2011.11.073; Sakai Y, 2007, J BIOSCI BIOENG, V103, P161, DOI 10.1263/jbb.103.161; Sandula J, 1999, CARBOHYD POLYM, V38, P247, DOI 10.1016/S0144-8617(98)00099-X; Sandula J, 1995, INT J BIOL MACROMOL, V17, P323, DOI 10.1016/0141-8130(96)81839-3; Shi YK, 2012, CARBOHYD POLYM, V87, P160, DOI 10.1016/j.carbpol.2011.07.032; SOLTES L, 1993, J APPL POLYM SCI, V48, P1313; Sun LQ, 2012, CARBOHYD POLYM, V87, P1206, DOI 10.1016/j.carbpol.2011.08.097; Sun ZW, 2009, CARBOHYD POLYM, V77, P628, DOI 10.1016/j.carbpol.2009.02.001; Synytsya A, 2013, CARBOHYD POLYM, V92, P792, DOI 10.1016/j.carbpol.2012.09.077; Trebichavsky I, 2001, FOLIA MICROBIOL, V46, P353, DOI 10.1007/BF02815626; Tsiapali E, 2001, FREE RADICAL BIO MED, V30, P393, DOI 10.1016/S0891-5849(00)00485-8; Medeiros SDV, 2012, INT J MOL SCI, V13, P8142, DOI 10.3390/ijms13078142; WILLIAMS DL, 1992, CARBOHYD RES, V235, P247, DOI 10.1016/0008-6215(92)80093-G; WILLIAMS DL, 1991, CARBOHYD RES, V219, P203, DOI 10.1016/0008-6215(91)89052-H; WILLIAMS DL, 1991, IMMUNOPHARMACOLOGY, V22, P139, DOI 10.1016/0162-3109(91)90039-2; Zhang LN, 2000, BIOSCI BIOTECH BIOCH, V64, P2172, DOI 10.1271/bbb.64.2172; Zhang M, 2003, CARBOHYD RES, V338, P2863, DOI 10.1016/j.carres.2003.08.013; Zhang W, 2008, COMPOS SCI TECHNOL, V68, P2479, DOI 10.1016/j.compscitech.2008.05.005; Zhang YJ, 2013, STARCH-STARKE, V65, P461, DOI 10.1002/star.201200174	44	16	17	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103494	10.1371/journal.pone.0103494	http://dx.doi.org/10.1371/journal.pone.0103494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075740	Green Submitted, gold, Green Published			2022-12-27	WOS:000340028800054
J	Nigro, N; Wildi, K; Mueller, C; Schuetz, P; Mueller, B; Fluri, F; Christ-Crain, M; Katan, M				Nigro, Nicole; Wildi, Karin; Mueller, Christian; Schuetz, Philipp; Mueller, Beat; Fluri, Felix; Christ-Crain, Mirjam; Katan, Mira			BNP but Not s-cTnln Is Associated with Cardioembolic Aetiology and Predicts Short and Long Term Prognosis after Cerebrovascular Events	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; BRAIN NATRIURETIC PEPTIDE; CARDIAC TROPONIN ASSAYS; ATRIAL-FIBRILLATION; HEART-FAILURE; MYOCARDIAL-INFARCTION; EARLY-DIAGNOSIS; ARTERY-DISEASE; T ELEVATION; MORTALITY	Background: We analyzed the prognostic value of b-type natriuretic peptide (BNP) and sensitive cardiac Troponin (s-cTnI) in patients with ischemic stroke or transient ischemic attack (TIA) and their significance in predicting stroke aetiology. Methods: In a prospectively enrolled cohort we measured BNP and s-cTnI levels upon admission. Primary endpoints were mortality, unfavorable functional outcome and stroke recurrence after 90 days and after 12 months. Secondary endpoint was cardioembolic aetiology. Results: In 441 patients BNP but not s-cTnI remained an independent predictor for death with an adjusted HR of 1.2 (95% CI 1.1-1.4) after 90 days and 1.2 (95% CI 1.0-1.3) after one year. The comparison of the Area under Receiver Operating Characteristic (AUROC) of model A (age, NIHSS) and model B (age, NIHSS, BNP) showed an improvement in the prediction of mortality (0.85 (95% CI 0.79-0.90) vs. 0.86 (95% CI 0.81-0.92), Log Rank p = 0.004). Furthermore the category free net reclassification improvement (cfNRI) when adding BNP to the multivariate model was 57.5%, p < 0.0001. For the prediction of functional outcome or stroke recurrence both markers provided no incremental value. Adding BNP to a model including age, atrial fibrillation and heart failure lead to a higher discriminatory accuracy for identification of cardioembolic stroke than the model without BNP (AUC 0.75 (95% CI 0.70-0.80) vs. AUC 0.79, (95% CI 0.75-0.84), p = 0.008). Conclusion: BNP is an independent prognostic maker for overall mortality in patients with ischemic stroke or TIA and may improve the diagnostic accuracy to identify cardioembolic aetiology.	[Nigro, Nicole; Christ-Crain, Mirjam; Katan, Mira] Univ Basel Hosp, Dept Endocrinol, CH-4031 Basel, Switzerland; [Wildi, Karin; Mueller, Christian] Univ Basel Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; [Schuetz, Philipp; Mueller, Beat] Med Univ Clin, Aarau, Switzerland; [Schuetz, Philipp; Mueller, Beat] Kantonsspital Aarau, Div Endocrinol Diabetol & Metab, Aarau, Switzerland; [Katan, Mira] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Fluri, Felix] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Nigro, Nicole; Wildi, Karin; Mueller, Christian; Schuetz, Philipp; Mueller, Beat; Fluri, Felix; Christ-Crain, Mirjam; Katan, Mira] Univ Basel Hosp, Dept Clin Res, CH-4031 Basel, Switzerland	University of Basel; University of Basel; Kantonsspital Aarau AG (KSA); University of Zurich; University Zurich Hospital; University of Basel; University of Basel	Nigro, N (corresponding author), Univ Basel Hosp, Dept Endocrinol, CH-4031 Basel, Switzerland.	Nicole.Nigro@usb.ch	Wildi, Karin/AAN-3644-2020; Müller, Christian/AAB-4783-2022; Mueller, Beat/G-2662-2012; schuetz, philipp/C-8475-2013	Wildi, Karin/0000-0002-6520-2696; Müller, Christian/0000-0002-1120-6405; schuetz, philipp/0000-0001-6400-4949; Katan, Mira/0000-0002-9265-8066; Christ-Crain, Mirjam/0000-0002-6336-0965	Department of Endocrinology and Metabolism from the University Hospital of Basel; Swiss National Science Foundation [PP00P3_123346, PZ00P3_142422]; foundation Leduqc; Abbott	Department of Endocrinology and Metabolism from the University Hospital of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); foundation Leduqc; Abbott(Abbott Laboratories)	This study was supported by an unrestricted research grant from Abbott. However Abbott was not involved in data collection, management, analysis and interpretation of the data. As well as grants from the Department of Endocrinology and Metabolism from the University Hospital of Basel. MCC was supported by a grant from the Swiss National Science Foundation (PP00P3_123346). MK was supported by a transatlantic career development award from the foundation Leduqc and a grant from the Swiss National Science Foundation (PZ00P3_142422). All supporting funders had no role in study design, data collection, management, analysis, interpretation of the data, the preparation or approval of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Christensen H, 2004, CEREBROVASC DIS, V18, P194, DOI 10.1159/000079941; Codognotto M, 2007, CLIN CHEM, V53, P2097, DOI 10.1373/clinchem.2007.089656; DAVIS M, 1994, LANCET, V343, P440, DOI 10.1016/S0140-6736(94)92690-5; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di Angelantonio E, 2005, J NEUROL NEUROSUR PS, V76, P76, DOI 10.1136/jnnp.2004.041491; Etgen T, 2005, STROKE, V36, P270, DOI 10.1161/01.STR.0000151364.19066.a1; Faiz KW, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-96; Foerch C, 2009, NEUROLOGY, V73, P393, DOI 10.1212/WNL.0b013e3181b05ef9; Garcia-Berrocoso T, 2013, NEUROLOGY, V81, P1976, DOI 10.1212/01.wnl.0000436937.32410.32; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Hendrikx T, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-41; Idris I, 2010, AGE AGEING, V39, P752, DOI 10.1093/ageing/afq098; Jensen JK, 2012, EUR NEUROL, V68, P287, DOI 10.1159/000341340; Jensen JK, 2007, AM J CARDIOL, V99, P108, DOI 10.1016/j.amjcard.2006.07.071; Caballero PEJ, 2013, J STROKE CEREBROVASC, V22, pE214, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.014; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Katan M, 2011, EXPERT REV NEUROTHER, V11, P225, DOI 10.1586/ERN.10.200; Katan M, 2010, J AM COLL CARDIOL, V56, P1045, DOI 10.1016/j.jacc.2010.02.071; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Koenig IR, 2008, STROKE, V39, P1821, DOI 10.1161/STROKEAHA.107.505867; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Lainchbury JG, 2003, J AM COLL CARDIOL, V42, P728, DOI 10.1016/S0735-1097(03)00787-3; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Makikallio AM, 2005, STROKE, V36, P1016, DOI 10.1161/01.STR.0000162751.54349.ae; Mingels A, 2009, CLIN CHEM, V55, P101, DOI 10.1373/clinchem.2008.106427; Montaner J, 2012, CEREBROVASC DIS, V34, P240, DOI 10.1159/000341858; Montaner J, 2008, STROKE, V39, P2280, DOI 10.1161/STROKEAHA.107.505354; Mortezabeigi H R, 2013, Pak J Biol Sci, V16, P1393; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Reiter M, 2012, EUR HEART J, V33, P988, DOI 10.1093/eurheartj/ehr376; Rizos T, 2012, STROKE, V43, P2689, DOI 10.1161/STROKEAHA.112.654954; Rost NS, 2012, STROKE, V43, P441, DOI 10.1161/STROKEAHA.111.629212; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Shibazaki K, 2011, EUR J NEUROL, V18, P165, DOI 10.1111/j.1468-1331.2010.03101.x; Shibazaki K, 2009, INTERNAL MED, V48, P1601, DOI 10.2169/internalmedicine.48.2166; Shibazaki K, 2009, INTERNAL MED, V48, P259, DOI 10.2169/internalmedicine.48.1475; Szabo K, 2001, STROKE, V32, P1323, DOI 10.1161/01.STR.32.6.1323; Tang WH, ARTERIOSCLER THROMB, V30, P634; Wright SP, 2003, J AM COLL CARDIOL, V42, P1793, DOI 10.1016/j.jacc.2003.05.011	42	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102704	10.1371/journal.pone.0102704	http://dx.doi.org/10.1371/journal.pone.0102704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072816	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600015
J	Wen, Y; Zhang, F; Li, CY; He, SL; Tan, WH; Lei, YX; Zhang, Q; Yu, HJ; Zheng, JJ; Guo, X				Wen, Yan; Zhang, Feng; Li, Chunyan; He, Shulan; Tan, Wuhong; Lei, Yanxia; Zhang, Qiang; Yu, Hanjie; Zheng, Jingjing; Guo, Xiong			Gene Expression Analysis Suggests Bone Development-Related Genes GDF5 and DIO2 Are Involved in the Development of Kashin-Beck Disease in Children Rather than Adults	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; CHONDROCYTES; PROFILES; BETA	Objective: To investigate the differences in gene expression between children and adults with Kashin-Beck disease (KBD). Methods: 12 children with KBD and 12 healthy children were selected and divided into 4 KBD vs. control pairs matched according to age and gender, with each pair having 3 KBD children and 3 healthy children. Additionally, 15 adults with KBD and 15 healthy adults were selected and divided into 5 KBD vs. control pairs matched according to age and gender, with each pair having 3 KBD adults and 3 healthy adults. Total RNA was isolated from peripheral blood mononuclear cells (PBMCs) respectively. A total of 367 target genes were selected based on previous genome-wide gene expression profile analysis. Expression levels of the 367 genes were evaluated by customized oligonucleotide microarray and the differentially expressed genes were identified. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was conducted to validate the microarray data. Results: A total of 95 (25.9%) genes in KBD children and 158 (43.1%) genes in KBD adults were found to exhibit more than two-fold change in gene expression level relative to healthy controls. By comparing differentially expressed genes identified in KBD children to those of KBD adults, 42 genes were found to be differentially expressed only in KBD children. And 105 genes were found to be differentially expressed only in KBD adults. Further, 16 differentially expressed genes common to both KBD children and adults were found to be asynchronously expressed in KBD children compared to KBD adults. Conclusion: Significant differences in gene expression pattern were identified between KBD children and KBD adults, indicating different molecular mechanisms underlying cartilage lesions of KBD children and KBD adults. In addition, bone development-related genes GDF5 (expression ratio = 2.14 +/- 0.02) and DIO2 (expression ratio = 0.11 +/- 0.05) may contribute to the development of KBD in children rather than in adults.	[Wen, Yan; Zhang, Feng; Li, Chunyan; He, Shulan; Tan, Wuhong; Lei, Yanxia; Zheng, Jingjing; Guo, Xiong] Xi An Jiao Tong Univ, Sch Publ Hlth, Hlth Sci Ctr,Key Lab Trace Elements & Endem Dis,M, Key Lab Environm & Gene Related Dis,Minist Educ, Xian 710049, Peoples R China; [Zhang, Qiang] Qinghai Inst Endem Dis Control & Prevent, Dept Kashin Beck Dis, Xining, Qinghai, Peoples R China; [Yu, Hanjie] Northwest Univ, Natl Engn Res Ctr Miniaturized Detect Syst, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Northwest University Xi'an	Guo, X (corresponding author), Xi An Jiao Tong Univ, Sch Publ Hlth, Hlth Sci Ctr,Key Lab Trace Elements & Endem Dis,M, Key Lab Environm & Gene Related Dis,Minist Educ, Xian 710049, Peoples R China.	guox@mail.xjtu.edu.cn	Yu, Hanjie/E-7819-2016; He, Shulan/O-3614-2019	Yu, Hanjie/0000-0003-2684-8715; 	"13115'' major program of the Technology Science Innovation Project of Shaanxi Province [2009ZDKG-79]; National Natural Scientific Foundation of China [30972556]	"13115'' major program of the Technology Science Innovation Project of Shaanxi Province; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the "13115'' major program of the Technology Science Innovation Project of Shaanxi Province (2009ZDKG-79) and the National Natural Scientific Foundation of China (30972556). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Duan C, 2010, ARTHRITIS RHEUM-US, V62, P771, DOI 10.1002/art.27282; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Gao X-y, 2010, J XIAN JIAOTONG U ME, V4; Guo X, 2006, J BONE MINER METAB, V24, P319, DOI 10.1007/s00774-006-0690-3; Guo X., 1993, CHIN J CTRL ENDEM DI, V08, P82; Hinsenkamp M, 2001, INT ORTHOP, V25, P133, DOI 10.1007/s002640000177; KOLSTEREN P, 1992, ANN SOC BELG MED TR, V72, P81; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Moreno-Reyes R, 2001, INT ORTHOP, V25, P164, DOI 10.1007/s002640000216; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; Schlegel W, 2009, J CELL MOL MED, V13, P3398, DOI 10.1111/j.1582-4934.2009.00953.x; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Wang L, 2010, J BONE MINER RES, V25, P1138, DOI 10.1002/jbmr.5; Wang S, 2012, GENES CELLS, V17, P619, DOI 10.1111/j.1365-2443.2012.01620.x; Wang SH, 2006, J RHEUMATOL, V33, P615; Wang Shi-jie, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P643; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028439; Wang W, 2013, OSTEOARTHR CARTILAGE, V21, P1781, DOI 10.1016/j.joca.2013.08.002; Wang WZ, 2009, OSTEOARTHR CARTILAGE, V17, P83, DOI 10.1016/j.joca.2008.05.008; Wang WZ, 2008, J RHEUMATOL, V35, P696; [吴泰相 WU Taixiang], 2008, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V8, P86; Xiong G, 2001, INT ORTHOP, V25, P147, DOI 10.1007/s002640100248; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022983	24	14	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103618	10.1371/journal.pone.0103618	http://dx.doi.org/10.1371/journal.pone.0103618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072641	Green Published, Green Submitted, gold			2022-12-27	WOS:000341307600072
J	Chen, C; Shen, L; Cao, SP; Li, XX; Xuan, WL; Zhang, JW; Huang, XB; Bin, JP; Xu, DL; Li, GF; Kitakaze, M; Liao, YL				Chen, Ci; Shen, Liang; Cao, Shiping; Li, Xixian; Xuan, Wanling; Zhang, Jingwen; Huang, Xiaobo; Bin, Jianping; Xu, Dingli; Li, Guofeng; Kitakaze, Masafumi; Liao, Yulin			Cytosolic CARP Promotes Angiotensin II- or Pressure Overload-Induced Cardiomyocyte Hypertrophy through Calcineurin Accumulation	PLOS ONE			English	Article							ANKYRIN REPEAT PROTEIN; DILATED CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; SKELETAL-MUSCLE; GENE-EXPRESSION; HEART-FAILURE; ANKRD1 MUTATIONS; CALPAIN; PATHWAY; DISEASE	The gene ankyrin repeat domain 1 (Ankrd1) is an enigmatic gene and may exert pleiotropic function dependent on its expression level, subcellular localization and even types of pathological stress, but it remains unclear how these factors influence the fate of cardiomyocytes. Here we attempted to investigate the role of CARP on cardiomyocyte hypertrophy. In neonatal rat ventricular cardiomyocytes (NRVCs), angiotensin II (Ang II) increased the expression of both calpain 1 and CARP, and also induced cytosolic translocation of CARP, which was abrogated by a calpain inhibitor. In the presence of Ang-II in NRVCs, infection with a recombinant adenovirus containing rat Ankrd1 cDNA (Ad-Ankrd1) enhanced myocyte hypertrophy, the upregulation of atrial natriuretic peptide and beta-myosin heavy chain genes and calcineurin proteins as well as nuclear translocation of nuclear factor of activated T cells. Cyclosporin A attenuated Ad-Ankrd1-enhanced cardiomyocyte hypertrophy. Intra-myocardial injection of Ad-Ankrd1 in mice with transverse aortic constriction (TAC) markedly increased the cytosolic CARP level, the heart weight/body weight ratio, while short hairpin RNA targeting Ankrd1 inhibited TAC-induced hypertrophy. The expression of calcineurin was also significantly increased in Ad-Ankrd1-infected TAC mice. Olmesartan (an Ang II receptor antagonist) prevented the upregulation of CARP in both Ang II-stimulated NRVCs and hearts with pressure overload. These findings indicate that overexpression of Ankrd1 exacerbates pathological cardiac remodeling through the enhancement of cytosolic translocation of CARP and upregulation of calcineurin.	[Chen, Ci; Shen, Liang; Cao, Shiping; Li, Xixian; Xuan, Wanling; Zhang, Jingwen; Huang, Xiaobo; Bin, Jianping; Xu, Dingli; Kitakaze, Masafumi; Liao, Yulin] Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Li, Guofeng] Southern Med Univ, Nanfang Hosp, Dept Pharm, Guangzhou, Guangdong, Peoples R China; [Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Med, Div Cardiovasc, Osaka, Japan	Southern Medical University - China; Southern Medical University - China; National Cerebral & Cardiovascular Center - Japan	Cao, SP (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Cardiol, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	csp2012@126.com; liao18@msn.com	Zhang, Jing/GWZ-7332-2022; Xu, Dingli/AAA-6176-2019; Liao, Yulin/AAP-6315-2021	xuan, wanling/0000-0002-5443-8994; Xu, Dingli/0000-0002-3193-4354	National Natural Science Foundation of China [81170146, 31271513]; Team Program of Natural Science Foundation of Guangdong Province, China [S2011030003134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Team Program of Natural Science Foundation of Guangdong Province, China	This work was supported by grants from the National Natural Science Foundation of China (81170146, 31271513 to Y.L.), the Team Program of Natural Science Foundation of Guangdong Province, China (S2011030003134, to Y.L. and B.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2000, HYPERTENSION, V36, P48, DOI 10.1161/01.HYP.36.1.48; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Boengler K, 2003, CARDIOVASC RES, V59, P573, DOI 10.1016/S0008-6363(03)00511-X; Crocini C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0349-x; Duboscq-Bidot L, 2009, EUR HEART J, V30, P2128, DOI 10.1093/eurheartj/ehp225; Fu MG, 1999, HEART VESSELS, V14, P283, DOI 10.1007/BF03257240; Gaussin V, 2003, CIRCULATION, V108, P2926, DOI 10.1161/01.CIR.0000101922.18151.7B; Hsu SC, 2013, CARDIOVASC RES, V100, P222, DOI 10.1093/cvr/cvt190; Ishiguro N, 2002, AM J PATHOL, V160, P1767, DOI 10.1016/S0002-9440(10)61123-6; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Kitakaze M, 2007, LANCET, V370, P1483, DOI 10.1016/S0140-6736(07)61634-1; Kojic S, 2011, CRIT REV CL LAB SCI, V48, P269, DOI 10.3109/10408363.2011.643857; Laure L, 2010, FEBS J, V277, P4322, DOI 10.1111/j.1742-4658.2010.07820.x; Letavernier E, 2012, CARDIOVASC RES, V96, P38, DOI 10.1093/cvr/cvs099; Liao YL, 2002, AM J PHYSIOL-HEART C, V282, pH1703, DOI 10.1152/ajpheart.00238.2001; Mestroni L, 2009, J AM COLL CARDIOL, V54, P343, DOI 10.1016/j.jacc.2009.04.029; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nanni L, 2006, J MOL CELL CARDIOL, V41, P934, DOI 10.1016/j.yjmcc.2006.08.009; Patterson C, 2011, CIRC RES, V109, P453, DOI 10.1161/CIRCRESAHA.110.239749; Scurr LL, 2008, CLIN CANCER RES, V14, P6924, DOI 10.1158/1078-0432.CCR-07-5189; Shi Y, 2005, AM J PATHOL, V166, P303, DOI 10.1016/S0002-9440(10)62254-7; Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050436; Stam FJ, 2007, EUR J NEUROSCI, V25, P3629, DOI 10.1111/j.1460-9568.2007.05597.x; Torrado Mario, 2005, J Mol Cell Cardiol, V38, P353, DOI 10.1016/j.yjmcc.2004.11.034; Wei YJ, 2009, EUR J HEART FAIL, V11, P559, DOI 10.1093/eurjhf/hfp049; Xuan WL, 2011, CARDIOVASC RES, V92, P385, DOI 10.1093/cvr/cvr221; Yatabe J, 2009, AM J PHYSIOL-RENAL, V296, pF1052, DOI 10.1152/ajprenal.00580.2007; Zolk O, 2002, BIOCHEM BIOPH RES CO, V293, P1377, DOI 10.1016/S0006-291X(02)00387-X	33	15	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104040	10.1371/journal.pone.0104040	http://dx.doi.org/10.1371/journal.pone.0104040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089522	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700088
J	Uchida, N; Hsieh, MM; Platner, C; Saunthararajah, Y; Tisdale, JF				Uchida, Naoya; Hsieh, Matthew M.; Platner, Charlotte; Saunthararajah, Yogen; Tisdale, John F.			Decitabine Suspends Human CD34(+) Cell Differentiation and Proliferation during Lentiviral Transduction	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; FETAL-HEMOGLOBIN LEVELS; GENE-THERAPY; MYELODYSPLASTIC SYNDROMES; REPOPULATING CELLS; SELF-RENEWAL; IN-VIVO; VECTOR; IMMUNODEFICIENCY; DISEASE	Efficient ex vivo transduction of hematopoietic stem cells (HSCs) is encumbered by differentiation which reduces engraftment. We hypothesized that inhibiting DNA methyltransferase with decitabine would block differentiation of transduced CD34(+) cells under cytokine stimulation and thus improve transduction efficiency for engrafting HSCs. Human CD34(+) cells in cytokine-containing media were treated with or without decitabine for 24 or 48 hours, and then these cells were transduced with a GFP-expressing lentiviral vector. Utilizing decitabine pre-treatment for 48 hours, we observed an equivalent percentage of successfully transduced cells (GFP-positivity) and a higher percentage of cells that retained CD34 positivity, compared to no decitabine exposure. Cell proliferation was inhibited after decitabine exposure. Similar results were observed among CD34(+) cells from six different donors. Repopulating activity was evaluated by transplantation into NOD/SCID/IL2R gamma(null) mice and demonstrated an equivalent percentage of GFP-positivity in human cells from decitabine-treated samples and a trend for higher human cell engraftment (measured 20-24 weeks after transplantation), compared to no decitabine exposure. In conclusion, ex vivo decitabine exposure inhibits both differentiation and proliferation in transduced human CD34(+) cells and modestly increases the engraftment ability in xenograft mice, while the transduction efficiency is equivalent in decitabine exposure, suggesting improvement of lentiviral transduction for HSCs.	[Uchida, Naoya; Hsieh, Matthew M.; Platner, Charlotte; Tisdale, John F.] NIH, NIDDK, NHLBI, Bethesda, MD 20892 USA; [Saunthararajah, Yogen] Cleveland Clin, Taussig Canc Inst, Translat Hematol & Oncol Res, Cleveland, OH 44106 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cleveland Clinic Foundation	Tisdale, JF (corresponding author), NIH, NIDDK, NHLBI, Bethesda, MD 20892 USA.	johntis@mail.nih.gov			intramural research program of the National Heart, Lung, and Blood Institute (NHLBI); National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH)	intramural research program of the National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the intramural research program of the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Araki H, 2006, EXP HEMATOL, V34, P140, DOI 10.1016/j.exphem.2005.10.002; Arumugam PI, 2009, MOL THER, V17, P1929, DOI 10.1038/mt.2009.183; Atweh George F, 2003, Hematology Am Soc Hematol Educ Program, P14, DOI 10.1182/asheducation-2003.1.14; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chung YS, 2009, BLOOD, V114, P4968, DOI 10.1182/blood-2009-01-197780; De Felice LD, 2005, CANCER RES, V65, P1505, DOI 10.1158/0008-5472.CAN-04-3063; DeSimone J, 2002, BLOOD, V99, P3905, DOI 10.1182/blood.V99.11.3905; Evans ME, 2014, MOL THER, V22, P348, DOI 10.1038/mt.2013.256; Green R, 2011, BLOOD, V118; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hanawa H, 2005, J VIROL, V79, P8410, DOI 10.1128/JVI.79.13.8410-8421.2005; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Heckl D, 2012, MOL THER, V20, P1187, DOI 10.1038/mt.2012.59; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Milhem M, 2004, BLOOD, V103, P4102, DOI 10.1182/blood-2003-07-2431; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Saunthararajah Y, 2003, BLOOD, V102, P3865, DOI 10.1182/blood-2003-05-1738; Saunthararajah Y, 2008, BRIT J HAEMATOL, V141, P126, DOI 10.1111/j.1365-2141.2008.07027.x; Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661; Seet LF, 2009, EUR J HAEMATOL, V82, P124, DOI 10.1111/j.1600-0609.2008.01169.x; Stone RM, 2009, BLOOD, V113, P6296, DOI 10.1182/blood-2008-09-038935; Suzuki M, 2004, AM J HEMATOL, V77, P313, DOI 10.1002/ajh.20178; Uchida N, 2011, GENE THER, V18, P1078, DOI 10.1038/gt.2011.63; Uchida N, 2012, MOL THER, V20; Uchida N, 2013, HUM GENE THER METHOD, V24, P117, DOI 10.1089/hgtb.2012.152; Uchida N, 2012, MOL THER, V20, P1882, DOI 10.1038/mt.2012.159; Uchida N, 2011, MOL THER, V19, P133, DOI 10.1038/mt.2010.218; Uchida N, 2009, J VIROL, V83, P9854, DOI 10.1128/JVI.00357-09; Uchida Naoya, 2009, Journal of Nippon Medical School, V76, P134; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Young JC, 2004, CYTOTHERAPY, V6, P328, DOI 10.1080/14653240410004899	40	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104022	10.1371/journal.pone.0104022	http://dx.doi.org/10.1371/journal.pone.0104022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089909	Green Submitted, gold, Green Published			2022-12-27	WOS:000339812700081
J	Xiao, ZS; Huang, JS; Cao, L; Liang, YJ; Han, XB; Quarles, LD				Xiao, Zhousheng; Huang, Jinsong; Cao, Li; Liang, Yingjuan; Han, Xiaobin; Quarles, Leigh Darryl			Osteocyte-Specific Deletion of Fgfr1 Suppresses FGF23	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; VITAMIN-D; FACTOR RECEPTOR-1; GENE-EXPRESSION; MOUSE MODEL; PHOSPHATE HOMEOSTASIS; MINERAL METABOLISM; SIGNALING PATHWAYS; FGF-23 EXPRESSION; TARGETED ABLATION	Increases in fibroblastic growth factor 23 (FGF23 or Fgf23) production by osteocytes result in hypophosphatemia and rickets in the Hyp mouse homologue of X-linked hypophosphatemia (XLH). Fibroblastic growth factor (FGF) signaling has been implicated in the pathogenesis of Hyp. Here, we conditionally deleted FGF receptor 1 (FGFR1 or Fgfr1) in osteocytes of Hyp mice to investigate the role of autocrine/paracrine FGFR signaling in regulating FGF23 production by osteocytes. Crossing dentin matrix protein 1 (Dmp1)-Cre;Fgfr1(null/+) mice with female Hyp; Fgfr1(flox/flox) mice created Hyp and Fgfr1 (Fgfr1(Dmp1-cKO))-null mice (Hyp; Fgfr1(Dmp1-cKO)) with a 70% decrease in bone Fgfr1 transcripts. Fgfr1(Dmp1-cKO)-null mice exhibited a 50% reduction in FGF23 expression in bone and 3-fold reduction in serum FGF23 concentrations, as well as reductions in sclerostin (Sost), phosphate regulating endopeptidase on X chromosome (PHEX or Phex), matrix extracellular phosphoglycoprotein (Mepe), and Dmp1 transcripts, but had no demonstrable alterations in phosphate or vitamin D homeostasis or skeletal morphology. Hyp mice had hypophosphatemia, reductions in 1,25(OH)(2)D levels, rickets/osteomalacia and elevated FGF2 expression in bone. Compared to Hyp mice, compound Hyp; Fgfr1(Dmp1-cKO)-null mice had significant improvement in rickets and osteomalacia in association with a decrease in serum FGF23 (3607 to 1099 pg/ml), an increase in serum phosphate (6.0 mg/dl to 9.3 mg/dl) and 1,25(OH)(2)D (121 +/- 23 to 192 +/- 34 pg/ml) levels, but only a 30% reduction in bone FGF23 mRNA expression. FGF23 promoter activity in osteoblasts was stimulated by FGFR1 activation and inhibited by overexpression of a dominant negative FGFR1(TK-), PLC gamma and MAPK inhibitors. FGF2 also stimulated the translation of an FGF23 cDNA transfected into osteoblasts via a FGFR1 and PI3K/Akt-dependent mechanism. Thus, activation of autocrine/paracrine FGF pathways is involved in the pathogenesis of Hyp through FGFR1-dependent regulation of FGF23 by both transcriptional and post-transcriptional mechanisms. This may serve to link local bone metabolism with systemic phosphate and vitamin D homeostasis.	[Xiao, Zhousheng; Huang, Jinsong; Cao, Li; Liang, Yingjuan; Han, Xiaobin; Quarles, Leigh Darryl] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Quarles, LD (corresponding author), Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA.	dquarles@uthsc.edu		Quarles, L. Darryl/0000-0002-5082-7896; xiao, zhousheng/0000-0002-3363-5673	National Institutes of Health [R01-AR045955]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grant R01-AR045955 to LDQ from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono Y, 2009, J BONE MINER RES, V24, P1879, DOI [10.1359/JBMR.090509, 10.1359/jbmr.090509]; Beckman MJ, 1996, BIOCHEMISTRY-US, V35, P8465, DOI 10.1021/bi960658i; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Brown WW, 2009, J CLIN ENDOCR METAB, V94, P17, DOI 10.1210/jc.2008-0220; Chlebova K, 2009, CELL MOL LIFE SCI, V66, P225, DOI 10.1007/s00018-008-8440-4; David V, 2013, ENDOCRINOLOGY, V154, P4469, DOI 10.1210/en.2013-1627; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Freeman KW, 2003, CANCER RES, V63, P6237; Gattineni J, 2011, AM J PHYSIOL-RENAL, V301, pF371, DOI 10.1152/ajprenal.00740.2010; Haupt LM, 2009, J CELL PHYSIOL, V220, P780, DOI 10.1002/jcp.21825; Hoenderop JGJ, 2004, KIDNEY INT, V65, P531, DOI 10.1111/j.1523-1755.2004.00402.x; Ichikawa S, 2012, J BONE MINER RES, V27, P453, DOI 10.1002/jbmr.544; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Kawata T, 2007, J AM SOC NEPHROL, V18, P2683, DOI 10.1681/ASN.2006070783; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Li H, 2011, AM J PHYSIOL-ENDOC M, V300, pE508, DOI 10.1152/ajpendo.00499.2010; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Lim YH, 2014, HUM MOL GENET, V23, P397, DOI 10.1093/hmg/ddt429; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Liu SG, 2008, AM J PHYSIOL-ENDOC M, V295, pE254, DOI 10.1152/ajpendo.90201.2008; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Martin A, 2011, FASEB J; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Martin A, 2008, J BONE MINER RES, V23, P2040, DOI 10.1359/JBMR.080708; Miyagawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093840; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Pendurthi UR, 1999, BLOOD, V94, P579, DOI 10.1182/blood.V94.2.579.414k23_579_586; Pond AC, 2010, CANCER RES, V70, P4868, DOI 10.1158/0008-5472.CAN-09-4404; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Quarles LD, 2011, NAT MED, V17, P428, DOI 10.1038/nm0411-428; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Samadfam R, 2009, ENDOCRINOLOGY, V150, P4835, DOI 10.1210/en.2009-0472; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Senarath-Yapa K, 2013, INT J MOL SCI, V14, P5978, DOI 10.3390/ijms14035978; Shalhoub V, 2011, CALCIFIED TISSUE INT, V89, P140, DOI 10.1007/s00223-011-9501-5; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Stachowiak EK, 2003, J NEUROCHEM, V84, P1296, DOI 10.1046/j.1471-4159.2003.01624.x; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Stevens DA, 2003, MOL ENDOCRINOL, V17, P1751, DOI 10.1210/me.2003-0137; Stubbs J, 2007, SEMIN DIALYSIS, V20, P302, DOI 10.1111/j.1525-139X.2007.00308.x; Stubbs JR, 2012, J BONE MINER RES, V27, P38, DOI 10.1002/jbmr.516; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang O, 2001, DEVELOPMENT, V128, P3867; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; Wohrle S, 2013, J BONE MINER RES, V28, P899, DOI 10.1002/jbmr.1810; Wohrle S, 2011, J BONE MINER RES, V26, P2486, DOI 10.1002/jbmr.478; Wohrle S, 2011, J BONE MINER RES; Wu AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057322; Xiao LP, 2013, J BONE MINER RES, V28, P35, DOI 10.1002/jbmr.1721; Xiao LP, 2010, J BIOL CHEM, V285, P2834, DOI 10.1074/jbc.M109.030577; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xiao ZS, 1998, AM J PHYSIOL-ENDOC M, V275, pE700, DOI 10.1152/ajpendo.1998.275.4.E700; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Xu N, 2007, J CLIN ENDOCR METAB, V92, P1155, DOI 10.1210/jc.2006-1183; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yang WC, 2013, J CELL SCI, V126, P4085, DOI 10.1242/jcs.118596; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Yuan B, 2008, J CLIN INVEST, V118, P722, DOI 10.1172/JCI32702; Yuan BZ, 2013, J BONE MINER RES, V28, P56, DOI 10.1002/jbmr.1738; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	83	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104154	10.1371/journal.pone.0104154	http://dx.doi.org/10.1371/journal.pone.0104154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089825	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700102
J	Zeng, XQ; Chen, GQ; Liu, XH; Dong, B; Shi, HB; Lu, JP; Lin, FC				Zeng, Xiao-Qing; Chen, Guo-Qing; Liu, Xiao-Hong; Dong, Bo; Shi, Huan-Bin; Lu, Jian-Ping; Lin, Fucheng			Crosstalk between SNF1 Pathway and the Peroxisome-Mediated Lipid Metabolism in Magnaporthe oryzae	PLOS ONE			English	Article							RICE BLAST FUNGUS; APPRESSORIUM TURGOR GENERATION; PLANT-PATHOGENIC FUNGUS; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; GLYOXYLATE CYCLE; GENE-EXPRESSION; BETA-OXIDATION; MAP KINASE; VIRULENCE	The SNF1/AMPK pathway has a central role in response to nutrient stress in yeast and mammals. Previous studies on SNF1 function in phytopathogenic fungi mostly focused on the catalytic subunit Snf1 and its contribution to the derepression of cell wall degrading enzymes (CWDEs). However, the MoSnf1 in Magnaporthe oryzae was reported not to be involved in CWDEs regulation. The mechanism how MoSnf1 functions as a virulence determinant remains unclear. In this report, we demonstrate that MoSnf1 retains the ability to respond to nutrient-free environment via its participation in peroxisomal maintenance and lipid metabolism. Observation of GFP-tagged peroxisomal targeting signal-1 (PTS1) revealed that the peroxisomes of Delta Mosnf1 were enlarged in mycelia and tended to be degraded before conidial germination, leading to the sharp decline of peroxisomal amount during appressorial development, which might impart the mutant great retard in lipid droplets mobilization and degradation. Consequently, Delta Mosnf1 exhibited inability to maintain normal appressorial cell wall porosity and turgor pressure, which are key players in epidermal infection process. Exogenous glucose could partially restore the appressorial function and virulence of Delta Mosnf1. Toward a further understanding of SNF1 pathway, the beta-subunit MoSip2, gamma-subunit MoSnf4, and two putative Snf1-activating kinases, MoSak1 and MoTos3, were additionally identified and characterized. Here we show the null mutants Delta Mosip2 and Delta Mosnf4 performed multiple disorders as Delta Mosnf1 did, suggesting the complex integrity is essential for M. oryzae SNF1 kinase function. And the upstream kinases, MoSak1 and MoTos3, play unequal roles in SNF1 activation with a clear preference to MoSak1 over MoTos3. Meanwhile, the mutant lacking both of them exhibited a severe phenotype comparable to Delta Mosnf1, uncovering a cooperative relationship between MoSak1 and MoTos3. Taken together, our data indicate that the SNF1 pathway is required for fungal development and facilitates pathogenicity by its contribution to peroxisomal maintenance and lipid metabolism in M. oryzae.	[Zeng, Xiao-Qing; Liu, Xiao-Hong; Shi, Huan-Bin; Lin, Fucheng] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Guo-Qing] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Peoples R China; [Dong, Bo] Zhejiang Acad Agr Sci, Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Lu, Jian-Ping] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Fucheng] Zhengzhou Tobacco Inst CNTC, China Tobacco Gene Res Ctr, Zhengzhou, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang Academy of Agricultural Sciences; Zhejiang University; Zhengzhou Tobacco Research Institute of CNTC	Lin, FC (corresponding author), Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	fuchenglin@zju.edu.cn	Lin, Fucheng/ABE-7591-2021; Chen, Guoqing/W-5308-2019	Lin, Fucheng/0000-0002-4127-8143; Chen, Guoqing/0000-0002-8448-6938; Liu, Xiaohong/0000-0002-7466-1261; Shi, Huanbin/0000-0002-4870-749X; Lu, Jian-Ping/0000-0001-9601-0040	National Natural Science Foundation of China [31371890, 31370171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants (No. 31371890 and 31370171) funded by the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Bhadauria V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036266; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; Chen GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067804; Clement ST, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004143; Deng YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079128; FERNANDEZ E, 1992, EUR J BIOCHEM, V204, P983, DOI 10.1111/j.1432-1033.1992.tb16720.x; Fernandez J, 2013, ANN REV PHYTOPATHOL; Fernandez J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002673; Goh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028220; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Hynes MJ, 2006, EUKARYOT CELL, V5, P794, DOI 10.1128/EC.5.5.794-805.2006; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Kimura A, 2001, PLANT CELL, V13, P1945, DOI 10.1105/tpc.13.8.1945; Kunze M, 2006, BBA-MOL CELL RES, V1763, P1441, DOI 10.1016/j.bbamcr.2006.09.009; Lau GW, 1998, FUNGAL GENET BIOL, V24, P228, DOI 10.1006/fgbi.1998.1053; Lazarow PB, 2003, CURR OPIN CELL BIOL, V15, P489, DOI 10.1016/S0955-0674(03)00082-6; Lee SH, 2009, EUKARYOT CELL, V8, P116, DOI 10.1128/EC.00176-08; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085252; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Liu Y, 2011, EUKARYOT CELL, V10, P313, DOI 10.1128/EC.00291-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JP, 2007, FUNGAL GENET BIOL, V44, P819, DOI 10.1016/j.fgb.2007.06.003; McCartney R, 2005, CURR GENET, V47, P335, DOI 10.1007/s00294-005-0576-2; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Min K, 2012, MOL PLANT MICROBE IN, V25, P1617, DOI 10.1094/MPMI-06-12-0149-R; Nadal M, 2010, PHYTOPATHOLOGY, V100, P1364, DOI 10.1094/PHYTO-01-10-0011; Ohneda M, 2002, FUNGAL GENET BIOL, V37, P29, DOI 10.1016/S1087-1845(02)00033-6; Ospina-Giraldo MD, 2003, CURR GENET, V44, P49, DOI 10.1007/s00294-003-0419-y; Palecek SP, 2002, MOL MICROBIOL, V45, P453, DOI 10.1046/j.1365-2958.2002.03024.x; Perez-Sampietro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058283; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Ratnakumar S, 2010, J BIOL CHEM, V285, P10703, DOI 10.1074/jbc.M109.079848; Rho HS, 2001, MOL CELLS, V12, P407; Ruijter GJG, 1997, FEMS MICROBIOL LETT, V151, P103, DOI 10.1016/S0378-1097(97)00161-4; Ruiz A, 2012, P NATL ACAD SCI USA, V109, P8652, DOI 10.1073/pnas.1206280109; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; SIMON M, 1992, YEAST, V8, P303, DOI 10.1002/yea.320080407; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Titorenko VI, 2001, NAT REV MOL CELL BIO, V2, P357, DOI 10.1038/35073063; Tonukari NJ, 2000, PLANT CELL, V12, P237, DOI 10.1105/tpc.12.2.237; Tucker SL, 2001, ANNU REV PHYTOPATHOL, V39, P385, DOI 10.1146/annurev.phyto.39.1.385; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Vincent O, 1998, EMBO J, V17, P7002, DOI 10.1093/emboj/17.23.7002; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113, DOI 10.1104/pp.104.4.1113; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wang ZY, 2005, BIOCHEM SOC T, V33, P384, DOI 10.1042/BST0330384; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Wilson RA, 2010, P NATL ACAD SCI USA, V107, P21902, DOI 10.1073/pnas.1006839107; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Yang J, 2012, CURR GENET, V58, P139, DOI 10.1007/s00294-012-0372-8; Yi M, 2008, FUNGAL GENET BIOL, V45, P1172, DOI 10.1016/j.fgb.2008.05.003; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang M, 2013, MOL CELL BIOL, V33, P4701, DOI 10.1128/MCB.00198-13	64	20	20	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103124	10.1371/journal.pone.0103124	http://dx.doi.org/10.1371/journal.pone.0103124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090011	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700016
J	Amodeo, GF; Scorciapino, MA; Messina, A; De Pinto, V; Ceccarelli, M				Amodeo, Giuseppe Federico; Scorciapino, Mariano Andrea; Messina, Angela; De Pinto, Vito; Ceccarelli, Matteo			Charged Residues Distribution Modulates Selectivity of the Open State of Human Isoforms of the Voltage Dependent Anion-Selective Channel	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; VDAC ISOFORMS; PERMEABILITY TRANSITION; BROWNIAN DYNAMICS; ION PERMEATION; N-TERMINUS; MITOCHONDRIAL; PROTEIN; MEMBRANE; CONFORMATION	Voltage Dependent Anion-selective Channels (VDACs) are pore-forming proteins located in the outer mitochondrial membrane. They are responsible for the access of ions and energetic metabolites into the inner membrane transport systems. Three VDAC isoforms exist in mammalian, but their specific role is unknown. In this work we have performed extensive (overall similar to 5 mu s) Molecular Dynamics (MD) simulations of the human VDAC isoforms to detect structural and conformational variations among them, possibly related to specific functional roles of these proteins. Secondary structure analysis of the N-terminal domain shows a high similarity among the three human isoforms of VDAC but with a different plasticity. In particular, the N-terminal domain of the hVDAC1 is characterized by a higher plasticity, with a similar to 20% occurrence for the 'unstructured' conformation throughout the folded segment, while hVDAC2, containing a peculiar extension of 11 amino acids at the N-terminal end, presents an additional 310-helical folded portion comprising residues 109 to 3, adhering to the barrel wall. The N-terminal sequences of hVDAC isoforms are predicted to have a low flexibility, with possible consequences in the dynamics of the human VDACs. Clear differences were found between hVDAC1 and hVDAC3 against hVDAC2: a significantly modified dynamics with possible important consequence on the voltage-gating mechanism. Charge distribution inside and at the mouth of the pore is responsible for a different preferential localization of ions with opposite charge and provide a valuable rationale for hVDAC1 and hVDAC3 having a Cl-/K+ selectivity ratio of 1.8, whereas hVDAC2 of 1.4. Our conclusion is that hVDAC isoforms, despite sharing a similar scaffold, have modified working features and a biological work is now requested to give evidence to the described dissimilarities.	[Amodeo, Giuseppe Federico] Univ Cagliari, Dept Chem & Geol Sci, Cagliari, Italy; [Scorciapino, Mariano Andrea; Ceccarelli, Matteo] Univ Cagliari, Dept Phys, Cagliari, Italy; [Scorciapino, Mariano Andrea; Ceccarelli, Matteo] CNR, Ist Officina Mat, Cagliari, Italy; [Messina, Angela; De Pinto, Vito] Univ Catania, Dept Biol Geol & Environm Sci, Mol Biol Sect, Catania, Italy; [Messina, Angela; De Pinto, Vito] Natl Inst Biomembranes & Biosyst, Catania, Italy	University of Cagliari; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Catania	Ceccarelli, M (corresponding author), Univ Cagliari, Dept Phys, Cagliari, Italy.	matteo.ceccarelli@dsf.unica.it	Amodeo, Giuseppe/E-6810-2017; Amodeo, Giuseppe Federico/AAC-7068-2020; De Pinto, Vito/AAC-2634-2019; Ceccarelli, Matteo/C-8557-2018; Messina, Angela/ABC-9518-2020; Scorciapino, Mariano Andrea/AAD-1256-2020	Amodeo, Giuseppe/0000-0002-5316-2770; Amodeo, Giuseppe Federico/0000-0002-5316-2770; Ceccarelli, Matteo/0000-0003-4272-902X; SCORCIAPINO, MARIANO ANDREA/0000-0001-7502-7265; De Pinto, Vito/0000-0001-5513-2906; MESSINA, Angela Anna/0000-0002-5745-9846	MIUR [PRIN 2010CSJX4F]	MIUR(Ministry of Education, Universities and Research (MIUR))	The financial support of MIUR (PRIN 2010CSJX4F) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bathori G, 1998, BIOCHEM BIOPH RES CO, V243, P258, DOI 10.1006/bbrc.1997.7926; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; Beutner G, 1997, BIOCHEM SOC T, V25, P151, DOI 10.1042/bst0250151; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; De Pinto V, 2007, CHEMBIOCHEM, V8, P744, DOI 10.1002/cbic.200700009; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; De Stefani D, 2012, CELL DEATH DIFFER, V19, P267, DOI 10.1038/cdd.2011.92; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hiller S, 2009, CURR OPIN STRUC BIOL, V19, P396, DOI 10.1016/j.sbi.2009.07.013; Huizing M, 1994, LANCET, V344, P1206; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7; John E., 2007, CRC HDB CHEM PHYS; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Krammer EM, 2013, BBA-BIOMEMBRANES, V1828, P1284, DOI 10.1016/j.bbamem.2012.12.018; Krammer EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027994; Kumar A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee KI, 2011, BIOPHYS J, V100, P611, DOI 10.1016/j.bpj.2010.12.3708; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; Maurya SR, 2013, J BIOL CHEM, V288, P25584, DOI 10.1074/jbc.M113.493692; Menzel VA, 2009, BIOSCIENCE REP, V29, P351, DOI 10.1042/BSR20080123; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Mezei M, 2010, J COMPUT CHEM, V31, P2658, DOI 10.1002/jcc.21551; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P67, DOI 10.1016/j.bbadis.2012.09.003; Reina S, 2013, BBA-BIOENERGETICS, V1827, P793, DOI 10.1016/j.bbabio.2013.03.007; Reina S, 2010, FEBS LETT, V584, P2837, DOI 10.1016/j.febslet.2010.04.066; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Rui HA, 2011, BIOPHYS J, V100, P602, DOI 10.1016/j.bpj.2010.12.3711; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Schredelseker J, 2014, J BIOL CHEM, V289, P12566, DOI 10.1074/jbc.M113.497438; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Shoshan-Barmatz V, 2012, CURR MED CHEM, V19, P714, DOI 10.2174/092986712798992110; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sindhikara DJ, 2009, J CHEM THEORY COMPUT, V5, P1624, DOI 10.1021/ct800573m; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; Teijido O, 2012, J BIOL CHEM, V287, P11437, DOI 10.1074/jbc.M111.314229; Tomasello F, 2009, CELL RES, V19, P1363, DOI 10.1038/cr.2009.98; Tomasello MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081522; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; Yehezkel G, 2007, J CELL PHYSIOL, V212, P551, DOI 10.1002/jcp.21048; Zachariae U, 2012, STRUCTURE, V20, P1540, DOI 10.1016/j.str.2012.06.015	65	35	35	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103879	10.1371/journal.pone.0103879	http://dx.doi.org/10.1371/journal.pone.0103879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084457	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800097
J	Freeman, CM; Stolberg, VR; Crudgington, S; Martinez, FJ; Han, MK; Chensue, SW; Arenberg, DA; Meldrum, CA; McCloskey, L; Curtis, JL				Freeman, Christine M.; Stolberg, Valerie R.; Crudgington, Sean; Martinez, Fernando J.; Han, MeiLan K.; Chensue, Stephen W.; Arenberg, Douglas A.; Meldrum, Catherine A.; McCloskey, Lisa; Curtis, Jeffrey L.			Human CD56+Cytotoxic Lung Lymphocytes Kill Autologous Lung Cells in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							CD8(+) T-CELLS; VOLUME-REDUCTION SURGERY; SMOKE-INDUCED EMPHYSEMA; NATURAL-KILLER; MOUSE MODEL; NK CELLS; CYTOTOXIC FUNCTION; EFFECTOR FUNCTION; MEDICAL THERAPY; COPD	CD56+ natural killer (NK) and CD56+ T cells, from sputum or bronchoalveolar lavage of subjects with chronic obstructive pulmonary disease (COPD) are more cytotoxic to highly susceptible NK targets than those from control subjects. Whether the same is true in lung parenchyma, and if NK activity actually contributes to emphysema progression are unknown. To address these questions, we performed two types of experiments on lung tissue from clinically-indicated resections (n = 60). First, we used flow cytometry on fresh single-cell suspension to measure expression of cell-surface molecules (CD56, CD16, CD8, NKG2D and NKp44) on lung lymphocytes and of the 6D4 epitope common to MICA and MICB on lung epithelial (CD326+) cells. Second, we sequentially isolated CD56+, CD8+ and CD4+ lung lymphocytes, co-cultured each with autologous lung target cells, then determined apoptosis of individual target cells using Annexin-V and 7-AAD staining. Lung NK cells (CD56+ CD3-) and CD56+ T cells (CD56+ CD3+) were present in a range of frequencies that did not differ significantly between smokers without COPD and subjects with COPD. Lung NK cells had a predominantly "cytotoxic'' CD56+ CD16+ phenotype; their co-expression of CD8 was common, but the percentage expressing CD8 fell as FEV1 % predicted decreased. Greater expression by autologous lung epithelial cells of the NKG2D ligands, MICA/MICB, but not expression by lung CD56+ cells of the activating receptor NKG2D, correlated inversely with FEV1 % predicted. Lung CD56+ lymphocytes, but not CD4+ or CD8+ conventional lung T cells, rapidly killed autologous lung cells without additional stimulation. Such natural cytotoxicity was increased in subjects with severe COPD and was unexplained in multiple regression analysis by age or cancer as indication for surgery. These data show that as spirometry worsens in COPD, CD56+ lung lymphocytes exhibit spontaneous cytotoxicity of autologous structural lung cells, supporting their potential role in emphysema progression.	[Freeman, Christine M.; Stolberg, Valerie R.] VA Ann Arbor Healthcare Syst, Res Serv, Ann Arbor, MI 48105 USA; [Freeman, Christine M.; Crudgington, Sean; Martinez, Fernando J.; Han, MeiLan K.; Arenberg, Douglas A.; Meldrum, Catherine A.; McCloskey, Lisa; Curtis, Jeffrey L.] Univ Michigan Hlth Syst, Dept Internal Med, Dept Pulm & Crit Care Med, Ann Arbor, MI USA; [Chensue, Stephen W.; Curtis, Jeffrey L.] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Chensue, Stephen W.] VA Ann Arbor Healthcare Syst, Pathol & Lab Med Serv, Ann Arbor, MI USA; [Chensue, Stephen W.] Univ Michigan Hlth Syst, Dept Pathol, Ann Arbor, MI USA; [Curtis, Jeffrey L.] VA Ann Arbor Healthcare Syst, Med Serv, Pulm & Crit Care Med Sect, Ann Arbor, MI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Freeman, CM (corresponding author), VA Ann Arbor Healthcare Syst, Res Serv, Ann Arbor, MI 48105 USA.	cmfreema@umich.edu	Arenberg, Douglas/P-7251-2014	Arenberg, Douglas/0000-0001-7707-5092; Curtis, Jeffrey/0000-0001-5191-4847	Biomedical Laboratory Research & Development Service, Department of Veterans Affairs [1 I01 BX001389]; United States Public Health Service [R01 HL082480, K23 HL093351, K24 HL04212]; Tissue Procurement Core of the University of Michigan Comprehensive Cancer Center [P30 CA46952]; Lung Tissue Research Consortium (Clinical Centers) [N01 HR046162]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL093351, K24HL004212, R01HL082480] Funding Source: NIH RePORTER	Biomedical Laboratory Research & Development Service, Department of Veterans Affairs(US Department of Veterans Affairs); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Tissue Procurement Core of the University of Michigan Comprehensive Cancer Center; Lung Tissue Research Consortium (Clinical Centers); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Sources of support Merit Review Award 1 I01 BX001389 from the Biomedical Laboratory Research & Development Service, Department of Veterans Affairs (C.M.F.); R01 HL082480 (J.L.C.), K23 HL093351 (M.K.H.), and K24 HL04212 (F.J.M.) from the United States Public Health Service. These investigations were also supported in part by the Tissue Procurement Core of the University of Michigan Comprehensive Cancer Center, Grant P30 CA46952; and by the Lung Tissue Research Consortium (Clinical Centers), grant N01 HR046162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar T, 2008, NATURAL KILLER T CEL; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Borchers MT, 2007, EXP MOL PATHOL, V83, P301, DOI 10.1016/j.yexmp.2007.08.020; Borchers MT, 2006, AM J PHYSIOL-LUNG C, V291, pL222, DOI 10.1152/ajplung.00327.2005; Borchers MT, 2009, J CLIN INVEST, V119, P636, DOI 10.1172/JCI34462; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO;2-F; Chi SY, 2012, RESPIROLOGY, V17, P486, DOI 10.1111/j.1440-1843.2011.02104.x; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; Curtis Jeffrey L, 2007, Proc Am Thorac Soc, V4, P512, DOI 10.1513/pats.200701-002FM; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Esin S, 2008, INFECT IMMUN, V76, P1719, DOI 10.1128/IAI.00870-07; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Forsslund H, 2014, CHEST, V145, P711, DOI 10.1378/chest.13-0873; Freeman CM, 2007, AM J PATHOL, V171, P767, DOI 10.2353/ajpath.2007.061177; Freeman CM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-13; Freeman CM, 2010, J IMMUNOL, V184, P6504, DOI 10.4049/jimmunol.1000006; Gao B, 2011, HEPATOLOGY, V53, P1076, DOI 10.1002/hep.24275; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hodge G, 2013, RESPIROLOGY, V18, P369, DOI 10.1111/j.1440-1843.2012.02287.x; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Imai K, 2005, EUR RESPIR J, V25, P250, DOI 10.1183/09031936.05.00023704; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Majo J, 2001, EUR RESPIR J, V17, P946, DOI 10.1183/09031936.01.17509460; Martinez FJ, 2008, AM J RESP CRIT CARE, V178, P491, DOI 10.1164/rccm.200709-1383OC; McCubbrey AL, 2012, J IMMUNOL, V189, P112, DOI 10.4049/jimmunol.1200984; Michel T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051230; Minino Arialdi M, 2010, Natl Vital Stat Rep, V59, P1; Morice WG, 2007, AM J CLIN PATHOL, V127, P881, DOI 10.1309/Q49CRJ030L22MHLF; Motz GT, 2010, AM J RESP CRIT CARE, V181, P1223, DOI 10.1164/rccm.200910-1485OC; Motz GT, 2010, J IMMUNOL, V184, P4460, DOI 10.4049/jimmunol.0903654; Motz GT, 2008, J IMMUNOL, V181, P8036, DOI 10.4049/jimmunol.181.11.8036; Naunheim KS, 2006, ANN THORAC SURG, V82, P431, DOI 10.1016/j.athoracsur.2006.05.069; OShaughnessy TC, 1997, AM J RESP CRIT CARE, V155, P852, DOI 10.1164/ajrccm.155.3.9117016; Piet B, 2011, J CLIN INVEST, V121, P2254, DOI 10.1172/JCI44675; Poggi A, 2005, J IMMUNOL, V175, P6352, DOI 10.4049/jimmunol.175.10.6352; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Roos-Engstrand E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-128; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Shi FD, 2011, NAT REV IMMUNOL, V11, P658, DOI 10.1038/nri3065; Shimoda S, 2011, HEPATOLOGY, V53, P1270, DOI 10.1002/hep.24194; Solana R, 2000, VACCINE, V18, P1613, DOI 10.1016/S0264-410X(99)00495-8; Spaggiari GM, 2001, EUR J IMMUNOL, V31, P1656, DOI 10.1002/1521-4141(200106)31:6<1656::AID-IMMU1656>3.0.CO;2-V; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stolberg VR, 2014, AM J PATHOL, V184, P454, DOI 10.1016/j.ajpath.2013.10.017; Sullivan AK, 2005, AM J RESP CRIT CARE, V172, P590, DOI 10.1164/rccm.200410-1332OC; Urbanowicz RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-76; Urbanowicz RA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-53; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; Wortham BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078735; Wortham BW, 2012, J IMMUNOL, V188, P4468, DOI 10.4049/jimmunol.1102643	58	35	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103840	10.1371/journal.pone.0103840	http://dx.doi.org/10.1371/journal.pone.0103840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078269	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800088
J	Egekwu, N; Sonenshine, DE; Bissinger, BW; Roe, RM				Egekwu, Noble; Sonenshine, Daniel E.; Bissinger, Brooke W.; Roe, R. Michael			Transcriptome of the Female Synganglion of the Black-Legged Tick Ixodes scapularis (Acari: Ixodidae) with Comparison between Illumina and 454 Systems	PLOS ONE			English	Article							AMERICAN DOG TICK; DERMACENTOR-VARIABILIS ACARI; SALIVARY-GLANDS; ANNOTATED CATALOG; LYME-DISEASE; HARD TICK; GENES; EXPRESSION; SEQUENCE; IMMUNOREACTIVITY	Illumina and 454 pyrosequencing were used to characterize genes from the synganglion of female Ixodes scapularis. GO term searching success for biological processes was similar for samples sequenced by both methods. However, for molecular processes, it was more successful for the Illumina samples than for 454 samples. Functional assignments of transcripts predicting neuropeptides, neuropeptide receptors, neurotransmitter receptors and other genes of interest was done, supported by strong e-values (<-6), and high consensus sequence alignments. Transcripts predicting 15 putative neuropeptide prepropeptides ((allatostatin, allatotropin, bursicon a, corticotropin releasing factor (CRF), CRF-binding protein, eclosion hormone, FMRFamide, glycoprotein A, insulin-like peptide, ion transport peptide, myoinhibitory peptide, inotocin (= neurophysin-oxytocin), Neuropeptide F, sulfakinin and SIFamide)) and transcripts predicting receptors for 14 neuropeptides (allatostatin, calcitonin, cardioacceleratory peptide, corazonin, CRF, eclosion hormone, gonadotropin-releasing hormone/AKH-like, insulin-like peptide, neuropeptide F, proctolin, pyrokinin, SIFamide, sulfakinin and tachykinin) are reported. Similar to Dermacentor variabilis, we found transcripts matching pro-protein convertase, essential for converting neuropeptide hormones to their mature form. Additionally, transcripts predicting 6 neurotransmitter/neuromodulator receptors (acetylcholine, GABA, dopamine, glutamate, octopamine and serotonin) and 3 neurotransmitter transporters (GABA transporter, noradrenalin-norepinephrine transporter and Na+-neurotransmitter/symporter) are described. Further, we found transcripts predicting genes for pheromone odorant receptor, gustatory receptor, novel GPCR messages, ecdysone nuclear receptor, JH esterase binding protein, steroidogenic activating protein, chitin synthase, chitinase, and other genes of interest. Also found were transcripts predicting genes for spermatogenesis-associated protein, major sperm protein, spermidine oxidase and spermidine synthase, genes not normally expressed in the female CNS of other invertebrates. The diversity of messages predicting important genes identified in this study offers a valuable resource useful for understanding how the tick synganglion regulates important physiological functions.	[Egekwu, Noble; Sonenshine, Daniel E.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Bissinger, Brooke W.] TyraTech Inc, Morrisville, NC USA; [Roe, R. Michael] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	Old Dominion University; University of North Carolina; North Carolina State University	Sonenshine, DE (corresponding author), Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.	dsonensh@odu.edu	Sonenshine, Daniel/AAF-3625-2020	Roe, Richard/0000-0002-6386-0994; Noble, Noble/0000-0002-8380-6792	National Science Foundation [IOS-0949194]; Department of Entomology	National Science Foundation(National Science Foundation (NSF)); Department of Entomology	Funding for the laboratory of D.E.S. and R.M.R. was provided by a grant from the National Science Foundation (IOS-0949194). B.W.B. was supported by a research and teaching assistantship from the Department of Entomology under the administration of George Kennedy. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alarcon-Chaidez FJ, 2007, INSECT BIOCHEM MOLEC, V37, P48, DOI 10.1016/j.ibmb.2006.10.002; Andersen SA, 2005, INSECT BIOCHEM MOLEC, V35, P1181, DOI 10.1016/j.ibmb.2005.05.009; Anderson JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-552; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Baxter GD, 2002, INSECT BIOCHEM MOLEC, V32, P815, DOI 10.1016/S0965-1748(01)00168-0; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Bhate C, 2011, J AM ACAD DERMATOL, V64, P619, DOI 10.1016/j.jaad.2010.03.046; Bissinger BW, 2011, INSECT MOL BIOL, V20, P465, DOI 10.1111/j.1365-2583.2011.01086.x; Blow N, 2009, NATURE, V458, P239, DOI 10.1038/458239a; Bowman AS, 2004, PARASITOLOGY, V129, pS67, DOI 10.1017/S0031182004006468; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; Buresova V, 2009, DEV COMP IMMUNOL, V33, P489, DOI 10.1016/j.dci.2008.09.011; Cayre M, 2001, J NEUROBIOL, V48, P315, DOI 10.1002/neu.1060; Centers for Disease Control and Prevention, 2012, LYM DIS DAT; Chapman R.F., 1998, INSECTS, V4th; Choi M, 2012, FRONT ENDOCRINOL, V20, P323; Christie AE, 2008, GEN COMP ENDOCR, V157, P174, DOI 10.1016/j.ygcen.2008.03.027; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; DEES WH, 1984, J MED ENTOMOL, V21, P514, DOI 10.1093/jmedent/21.5.514; Donohue KV, 2010, INSECT BIOCHEM MOLEC, V40, P79, DOI 10.1016/j.ibmb.2009.12.014; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; Duvall LB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001337; Francischetti IMB, 2005, INSECT BIOCHEM MOLEC, V35, P1142, DOI 10.1016/j.ibmb.2005.05.007; Gonzalez R, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.5701; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guerrero F., 2014, BIOL TICKS, VVolume 2, P353; Hille C, 2008, J EXP BIOL, V211, P568, DOI 10.1242/jeb.010207; Hummel NA, 2007, EXP APPL ACAROL, V43, P265, DOI 10.1007/s10493-007-9120-z; Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013; Hynes W, 2005, MED VET ENTOMOL, V36, P207; Kaufman WR, 2010, J EXP BIOL, V213, P2820, DOI 10.1242/jeb.044412; Lees K, 2010, INSECT MOL BIOL, V19, P273, DOI 10.1111/j.1365-2583.2009.00968.x; Lees Kristin, 2007, Invertebrate Neuroscience, V7, P183, DOI 10.1007/s10158-007-0060-4; Lindgren E, 2006, LYME BORRELIOSIS EUR, P1; Lucien J, 1995, EXP APPL ACAROL, V19, P617, DOI 10.1007/BF00145251; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARZOUK AS, 1985, J MED ENTOMOL, V22, P385, DOI 10.1093/jmedent/22.4.385; Mulenga A, 2004, INSECT MOL BIOL, V13, P423, DOI 10.1111/j.0962-1075.2004.00502.x; Mulenga A, 2003, INSECT MOL BIOL, V12, P185, DOI 10.1046/j.1365-2583.2003.00400.x; Murray TS, 2010, CLIN LAB MED, V30, P311, DOI 10.1016/j.cll.2010.01.003; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Neese PA, 2000, J INSECT PHYSIOL, V46, P477, DOI 10.1016/S0022-1910(99)00134-1; Neupert S, 2009, J PROTEOMICS, V72, P1040, DOI 10.1016/j.jprot.2009.06.007; Pfluger HJ, 2011, PHYSIOLOGY, V26, P293, DOI 10.1152/physiol.00002.2011; Pound M, 1984, J MORPHOL, V173, P159; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Roberts KP, 2007, ASIAN J ANDROL, V9, P508, DOI 10.1111/j.1745-7262.2007.00318.x; Roller L, 2010, PEPTIDES, V31, P429, DOI 10.1016/j.peptides.2009.11.022; Santos IKFD, 2004, ANN NY ACAD SCI, V1026, P242, DOI 10.1196/annals.1307.037; Sauer JR, 2000, J INSECT PHYSIOL, V46, P1069, DOI 10.1016/S0022-1910(99)00210-3; SAUER JR, 1995, ANNU REV ENTOMOL, V40, P245, DOI 10.1146/annurev.en.40.010195.001333; Scott JD, 2012, J PARASITOL, V98, P49, DOI 10.1645/GE-2874.1; Silva FD, 2009, J BIOL CHEM, V284, P34735, DOI 10.1074/jbc.M109.016410; Simo L, 2014, BIOL TICKS, P560; Simo L, 2009, CELL TISSUE RES, V335, P639, DOI 10.1007/s00441-008-0731-4; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; Sonenshine DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024711; Sonenshine DE., 1991, BIOL TICKS; Stafflinger E, 2008, P NATL ACAD SCI USA, V105, P3262, DOI 10.1073/pnas.0710897105; Sun W, 2012, INSECT BIOCHEM MOLEC, V42, P935, DOI 10.1016/j.ibmb.2012.09.006; Temeyer KB, 2013, CHEM-BIOL INTERACT, V203, P319, DOI 10.1016/j.cbi.2012.09.010; Thompson DM, 2005, J INSECT PHYSIOL, V51, P1105, DOI 10.1016/j.jinsphys.2005.05.011; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Van Wielendaele P, 2013, GEN COMP ENDOCR, V188, P23, DOI 10.1016/j.ygcen.2013.02.005; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Wegener C, 2011, J NEUROCHEM, V118, P581, DOI 10.1111/j.1471-4159.2010.07130.x; Zhu XX, 2001, EXP APPL ACAROL, V25, P1005, DOI 10.1023/A:1020664211999	71	38	40	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102667	10.1371/journal.pone.0102667	http://dx.doi.org/10.1371/journal.pone.0102667			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075967	Green Submitted, gold, Green Published			2022-12-27	WOS:000340028800016
J	Mohammadrezaei, M; Toghyani, M; Gheisari, A; Toghyani, M; Eghbalsaied, S				Mohammadrezaei, Mohammad; Toghyani, Majid; Gheisari, Abbasali; Toghyani, Mehdi; Eghbalsaied, Shahin			Synergistic Effect of Fadrozole and Insulin-Like Growth Factor-I on Female-To-Male Sex Reversal and Body Weight of Broiler Chicks	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ESTROGEN-RECEPTOR-ALPHA; IGF-I; GRANULOSA-CELLS; AROMATASE EXPRESSION; GONADAL DEVELOPMENT; ANDROGEN RECEPTOR; GALLUS-DOMESTICUS; JAPANESE-QUAIL; LARON-SYNDROME	The aim of this study was to investigate the effects of Fadrozole hydrochloride and recombinant human insulin-like growth factor I (rhIGF-I) on female-to-male sex reversal, hatching traits, and body weight of broiler chickens. On the third day of incubation, fertile eggs were randomly assigned to five experimental groups comprising (i) Fadrozole (0.1 mg/egg), (ii) rhIGF-I (100 ng/egg), (iii) Fadrozole (0.1 mg/egg) + rhIGF-I (100 ng/egg), (iv) vehicle injection (10 mM acetic acid and 0.1% BSA), and (v) non-injected eggs. Eggs in the rhIGF-I-injected groups showed the mode of hatching time at the 480th hour of incubation, 12 hours earlier compared to the other groups, with no statistically significant difference in mortality and hatchability. On Day 1 and 42 of production, 90% of genetically female chicks were masculinized using Fadrozole treatment, while 100% female-to-male phenotypic sex reversal was observed in the Fadrozole+rhIGF-I group. Fadrozole equalized the body weight of both genders, although rhIGF-I was effective on the body weight of male chicks only. Interestingly, combined rhIGF-I and Fadrozole could increase the body weight in both sexes compared to the individual injections (P<0.05). These findings revealed that (i) IGF-I-treated chicken embryos were shown to be an effective option for overcoming the very long chicken deprivation period, (ii) the simultaneous treatment with Fadrozole and IGF-I could maximize the female-to-male sex reversal chance, (iii) the increase in the body weight of masculinized chickens via Fadrozole could be equal to their genetically male counterparts, and (iv) the IGF-I effectiveness, specifically along with the application of aromatase inhibitors in female chicks, indicates that estrogen synthesis could be a stumbling block for the IGF-I action mechanism in female embryos.	[Mohammadrezaei, Mohammad; Toghyani, Mehdi; Eghbalsaied, Shahin] Islamic Azad Univ, Khorasgan Isfahan Branch, Young Researchers & Elite Club, Esfahan, Iran; [Toghyani, Majid; Eghbalsaied, Shahin] Islamic Azad Univ, Khorasgan Isfahan Branch, Dept Anim Sci, Esfahan, Iran; [Gheisari, Abbasali] Isfahan Res Ctr Nat Resources & Agr, Dept Anim Sci, Esfahan, Iran; [Toghyani, Mehdi] Univ New England, Dept Anim Sci, Sch Environm & Rural Sci, Armidale, NSW, Australia	Islamic Azad University; Islamic Azad University; University of New England	Eghbalsaied, S (corresponding author), Islamic Azad Univ, Khorasgan Isfahan Branch, Young Researchers & Elite Club, Esfahan, Iran.	shahin.eghbal@khuisf.ac.ir	Eghbalsaied, Shahin/AAC-8686-2019; Toghyani, Mehdi/ABH-8543-2020; Toghyani, Majid/ABA-5571-2020; mohammadrezaei, mohammad/H-8385-2016; Toghyani, Majid/B-7766-2010	Eghbalsaied, Shahin/0000-0002-9030-8679; mohammadrezaei, mohammad/0000-0003-3855-3412; Toghyani, Majid/0000-0003-0470-856X; Toghyani, Mehdi/0000-0002-5065-1739				ADASHI EY, 1985, ENDOCR REV, V6, P400, DOI 10.1210/edrv-6-3-400; Agbaje IM, 2007, HUM REPROD, V22, P1871, DOI 10.1093/humrep/dem077; Andrews JE, 1997, GEN COMP ENDOCR, V108, P182, DOI 10.1006/gcen.1997.6978; Ayers KL, 2013, SEX DEV, V7, P80, DOI 10.1159/000342358; BALLARD FJ, 1990, GEN COMP ENDOCR, V79, P459, DOI 10.1016/0016-6480(90)90076-X; BASSAS L, 1987, J EXP ZOOL, P299; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Berensztein EB, 2006, PEDIATR RES, V60, P740, DOI 10.1203/01.pdr.0000246072.04663.bb; BICSAK TA, 1990, ENDOCRINOLOGY, V126, P2184, DOI 10.1210/endo-126-4-2184; Breier BH, 1996, ENDOCRINOLOGY, V137, P4061, DOI 10.1210/en.137.9.4061; Burke WH, 1999, POULTRY SCI, V78, P1019, DOI 10.1093/ps/78.7.1019; Cardinale M, 2006, J STRENGTH COND RES, V20, P103; Careghi C, 2005, POULTRY SCI, V84, P1314, DOI 10.1093/ps/84.8.1314; Casa AJ, 2012, BREAST CANCER RES TR, V132, P61, DOI 10.1007/s10549-011-1540-0; Chandrashekar V, 2004, BIOL REPROD, V71, P17, DOI 10.1095/biolreprod.103.027060; CHATELAIN PG, 1991, ENDOCRINOLOGY, V128, P1857, DOI 10.1210/endo-128-4-1857; Clemmons DR, 2009, TRENDS ENDOCRIN MET, V20, P349, DOI 10.1016/j.tem.2009.04.002; DAVIS JG, 1971, BIOCHEMISTRY-US, V10, P39, DOI 10.1021/bi00777a006; Davis LG, 1986, INTRO BASICS MOL BIO, P2; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; Decuypere E, 2001, WORLD POULTRY SCI J, V57, P127, DOI 10.1079/WPS20010010; Deprem T, 2007, TURK J VET ANIM SCI, V31, P233; DUCLOS MJ, 1991, J ENDOCRINOL, V128, P35, DOI 10.1677/joe.0.1280035; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Elis S, 2011, DIS MODEL MECH, V4, P649, DOI 10.1242/dmm.006775; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; ERICKSON GF, 1990, J CLIN ENDOCR METAB, V70, P894, DOI 10.1210/jcem-70-4-894; ERICKSON GF, 1989, J CLIN ENDOCR METAB, V69, P716, DOI 10.1210/jcem-69-4-716; ERICKSON GF, 1978, ENDOCRINOLOGY, V102, P1275, DOI 10.1210/endo-102-4-1275; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Fuxjager MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051482; Garcia-Segura LM, 2010, PROG BRAIN RES, V181, P251, DOI 10.1016/S0079-6123(08)81014-X; Hayashi RM, 2013, J APPL POULTRY RES, V22, P9, DOI 10.3382/japr.2012-00488; IMATAKA H, 1989, GEN COMP ENDOCR, V73, P69, DOI 10.1016/0016-6480(89)90056-7; KAJIMOTO Y, 1989, MOL ENDOCRINOL, V3, P1907, DOI 10.1210/mend-3-12-1907; KITAMOTO T, 1982, J BIOCHEM, V92, P1679, DOI 10.1093/oxfordjournals.jbchem.a134097; Klinger B, 1998, CLIN ENDOCRINOL, V48, P81; Kocamis H, 1998, POULTRY SCI, V77, P1913, DOI 10.1093/ps/77.12.1913; Kocamis H, 2000, POULTRY SCI, V79, P1345, DOI 10.1093/ps/79.9.1345; Lambeth LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068362; Laron Z, 1998, EUR J ENDOCRINOL, V138, P176, DOI 10.1530/eje.0.1380176; Lazaros L, 2012, HUM REPROD, V27, P3385, DOI 10.1093/humrep/des334; Lee IW, 2011, HUM REPROD, V26, P1585, DOI 10.1093/humrep/der062; Lee PLM, 2002, EVOLUTION, V56, P2548; Li WM, 2008, POULTRY SCI, V87, P2231, DOI 10.3382/ps.2008-00139; LINEWEAVER H, 1947, J BIOL CHEM, V171, P565; Liu HH, 2011, J APPL PHYSIOL, V111, P1789, DOI 10.1152/japplphysiol.00551.2011; Matsushita S, 2006, POULTRY SCI, V85, P1641, DOI 10.1093/ps/85.9.1641; Mattsson A, 2008, REPRODUCTION, V136, P175, DOI 10.1530/REP-08-0100; MCMURTRY JP, 1994, J ENDOCRINOL, V142, P225, DOI 10.1677/joe.0.1420225; McMurtry JP, 1997, DOMEST ANIM ENDOCRIN, V14, P199, DOI 10.1016/S0739-7240(97)00019-2; MEANS GD, 1991, MOL ENDOCRINOL, V5, P2005, DOI 10.1210/mend-5-12-2005; Mendoza RA, 2011, J ENDOCRINOL, V208, P1, DOI 10.1677/JOE-10-0235; NAGASE H, 1983, J BIOL CHEM, V258, P7481; Nakabayashi O, 1998, J MOL ENDOCRINOL, V20, P193, DOI 10.1677/jme.0.0200193; Philippou A, 2007, IN VIVO, V21, P45; Rappaport MS, 1996, BIOL REPROD, V54, P446, DOI 10.1095/biolreprod54.2.446; RAPPAPORT MS, 1995, BIOL REPROD, V52, P419, DOI 10.1095/biolreprod52.2.419; Rondini EA, 2011, MOL CARCINOGEN, V50, P370, DOI 10.1002/mc.20720; Saxena I, 1997, CELL MOL LIFE SCI, V53, P13, DOI 10.1007/PL00000575; SHOHAM Z, 1992, FERTIL STERIL, V57, P1044; Sirianni R, 2007, CANCER RES, V67, P8368, DOI 10.1158/0008-5472.CAN-06-4064; Smith CA, 2003, BIOL REPROD, V68, P560, DOI 10.1095/biolreprod.102.007294; Smith CA, 1997, J STEROID BIOCHEM, V60, P295, DOI 10.1016/S0960-0760(96)00196-3; STEINKAMPF MP, 1988, MOL CELL ENDOCRINOL, V59, P93, DOI 10.1016/0303-7207(88)90199-2; Vaillant S, 2003, MOL REPROD DEV, V65, P420, DOI 10.1002/mrd.10318; Vaillant S, 2001, J EXP ZOOL, V290, P727, DOI 10.1002/jez.1123; Wang Y, 2014, ANIMAL, V8, P610, DOI 10.1017/S175173111400007X; WARTENBERG H, 1992, ANDROLOGIA, V24, P1; Willemsen H, 2010, WORLD POULTRY SCI J, V66, P177, DOI 10.1017/S0043933910000243; Yang X, 2008, SEX DEV, V2, P309, DOI 10.1159/000195680; Zhao D, 2010, NATURE, V464, P237, DOI 10.1038/nature08852	72	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103570	10.1371/journal.pone.0103570	http://dx.doi.org/10.1371/journal.pone.0103570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075864	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800065
J	Tulipani, DC; Lipcius, RN				Tulipani, Diane C.; Lipcius, Romuald N.			Evidence of Eelgrass (Zostera marina) Seed Dispersal by Northern Diamondback Terrapin (Malaclemys terrapin terrapin) in Lower Chesapeake Bay	PLOS ONE			English	Article							SEAGRASS MEADOWS; SALT-MARSH; GROWTH; GERMINATION; MACROPHYTE; INGESTION; TORTOISES; PATTERNS; TURTLES	The initial discovery in May 2009 of eelgrass (Zostera marina) seeds in fecal samples of wild-caught northern diamondback terrapins (Malaclemys terrapin terrapin) was the first field evidence of eelgrass seed ingestion in this species. This finding suggested the potential of terrapins as seed dispersers in eelgrass beds, which we sampled for two additional years (2010 and 2011). Seeds were only found in feces of terrapins captured prior to June 8 in all three years, coinciding with eelgrass seed maturation and release. Numbers of seeds in terrapin feces varied annually and decreased greatly in 2011 after an eelgrass die off in late 2010. The condition of seeds in terrapin feces was viable-mature, germinated, damaged, or immature. Of terrapins captured during time of seed release, 97% were males and juvenile females, both of which had head widths < 30 mm. The fraction of individuals with ingested seeds was 33% for males, 35% for small females, and only 6% for large (mature) females. Probability of seed ingestion decreased exponentially with increasing terrapin head width; only males and small females (head width <30 mm) were likely to be vectors of seed dispersal. The characteristic that diamondback terrapins have well-defined home ranges allowed us to estimate the number of terrapins potentially dispersing eelgrass seeds annually. In seagrass beds of the Goodwin Islands region (lower York River, Virginia), there were 559 to 799 terrapins, which could disperse between 1,341 and 1,677 eelgrass seeds annually. These would represent a small proportion of total seed production within a single seagrass bed. However, based on probable home range distances, terrapins can easily traverse eelgrass meadow boundaries, thereby dispersing seeds beyond the bed of origin. Given the relatively short dispersion distance of eelgrass seeds, the diamondback terrapin may be a major source of inter-bed seed dispersal and genetic diversity.	[Tulipani, Diane C.; Lipcius, Romuald N.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	William & Mary; Virginia Institute of Marine Science	Tulipani, DC (corresponding author), Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA.	dctvims09@gmail.com			Virginia Institute of Marine Science; Chesapeake Bay National Estuarine Research Reserve in Virginia [NA10NOS4200026]; National Science Foundations [DGE-0840804]; Virginia Sea Grant; Diamondback Terrapin Working Group; National Oceanic and Atmospheric Administration-National Estuarine Research Reserve GRF	Virginia Institute of Marine Science; Chesapeake Bay National Estuarine Research Reserve in Virginia; National Science Foundations(National Science Foundation (NSF)); Virginia Sea Grant; Diamondback Terrapin Working Group; National Oceanic and Atmospheric Administration-National Estuarine Research Reserve GRF	Funding provided by Virginia Institute of Marine Science graduate student fellowship (2007-2010) http://www.vims.edu/gateways/prospectivestudents/index.php, National Oceanic and Atmospheric Administration-National Estuarine Research Reserve GRF with Chesapeake Bay National Estuarine Research Reserve in Virginia (NA10NOS4200026, 2010-2012) http://nerrs.noaa.gov/Fellowship.aspx, National Science Foundations GK-12 PERFECT fellowship (DGE-0840804, 2012-2013) http://www.vims.edu/education/graduate/gk12/, Virginia Sea Grant research grant http://vaseagrant.vims.edu/ and Diamondback Terrapin Working Group research grant (2009) http://www.dtwg.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; Birkhead RD, 2005, AM MIDL NAT, V154, P143, DOI 10.1674/0003-0031(2005)154[0143:POFASI]2.0.CO;2; Blake S, 2012, J BIOGEOGR, V39, P1961, DOI 10.1111/j.1365-2699.2011.02672.x; Bonin F, 2006, TURTLES WORLD; Butler J.A., 2002, POPULATION ECOLOGY H; CAGLE FRED R., 1939, COPEIA, V1939, P170, DOI 10.2307/1436818; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Elbers JP, 2011, WETLANDS, V31, P757, DOI 10.1007/s13157-011-0192-5; Erazmus K. R., 2012, THESIS HOFSTRA U HEM; Ernst CH, 2009, TURTLES US CANADA; Gibbons J. Whitfield, 2001, Chelonian Conservation and Biology, V4, P66; Guzman A, 2008, AMPHIBIA-REPTILIA, V29, P463, DOI 10.1163/156853808786230442; Harden Leigh Anne, 2007, Journal of the North Carolina Academy of Science, V123, P154; Harwell MC, 2002, ECOLOGY, V83, P3319, DOI 10.2307/3072082; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; Holliday DK, 2009, ENVIRON TOXICOL CHEM, V28, P338, DOI 10.1897/08-145.1; HURD LE, 1979, ESTUARIES, V2, P28, DOI 10.2307/1352036; Jarvis JC, 2009, THESIS COLL WILLIAM; Jerozolimski A, 2009, OECOLOGIA, V161, P517, DOI 10.1007/s00442-009-1396-8; Kendrick GA, 2012, BIOSCIENCE, V62, P56, DOI 10.1525/bio.2012.62.1.10; Kimmons JB, 2010, CHELONIAN CONSERV BI, V9, P289, DOI 10.2744/CCB-0797.1; Liu H, 2004, OECOLOGIA, V138, P539, DOI 10.1007/s00442-003-1445-7; MOLL D, 1995, BIOTROPICA, V27, P121, DOI 10.2307/2388909; MOORE KA, 1993, AQUAT BOT, V45, P79, DOI 10.1016/0304-3770(93)90054-Z; Moore KA, 2014, ESTUARIES COASTS S1, pS20; Moore KA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P361; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; OLIVIERI I, 1995, AM NAT, V146, P202, DOI 10.1086/285795; Orth R.J., 2011, 153 VIRG I MAR SCI; ORTH RJ, 1986, AQUAT BOT, V24, P335, DOI 10.1016/0304-3770(86)90100-2; ORTH RJ, 1994, ECOLOGY, V75, P1927, DOI 10.2307/1941597; Orth RJ, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P111; Orth RJ, 2012, MAR ECOL PROG SER, V448, P177, DOI 10.3354/meps09522; Rook MA, 2009, THESIS COLL WILLIAM; Roosenburg Willem M., 1999, Chelonian Conservation and Biology, V3, P425; SCHMIDTNIELSEN K, 1958, NATURE, V182, P783, DOI 10.1038/182783a0; SCHUPP EW, 1993, VEGETATIO, V108, P15; Sheridan CM, 2010, MOL ECOL, V19, P5497, DOI 10.1111/j.1365-294X.2010.04876.x; SILBERHORN GM, 1983, AQUAT BOT, V15, P133, DOI 10.1016/0304-3770(83)90024-4; Spivey P.B., 1998, THESIS U GEORGIA ATH; Sumoski SE, 2012, MAR ECOL PROG SER, V471, P1, DOI 10.3354/meps10145; THAYER GW, 1984, ESTUARIES, V7, P351, DOI 10.2307/1351619; TUCKER AD, 1995, HERPETOLOGICA, V51, P167; Tulipani D. C, 2013, THESIS COLL WILLIAM; VANMONTFRANS J, 1984, ESTUARIES, V7, P289, DOI 10.2307/1351615	45	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103346	10.1371/journal.pone.0103346	http://dx.doi.org/10.1371/journal.pone.0103346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072473	gold, Green Published			2022-12-27	WOS:000341307600041
J	Zhimulev, IF; Zykova, TY; Goncharov, FP; Khoroshko, VA; Demakova, OV; Semeshin, VF; Pokholkova, GV; Boldyreva, LV; Demidova, DS; Babenko, VN; Demakov, SA; Belyaeva, ES				Zhimulev, Igor F.; Zykova, Tatyana Yu.; Goncharov, Fyodor P.; Khoroshko, Varvara A.; Demakova, Olga V.; Semeshin, Valeriy F.; Pokholkova, Galina V.; Boldyreva, Lidiya V.; Demidova, Darya S.; Babenko, Vladimir N.; Demakov, Sergey A.; Belyaeva, Elena S.			Genetic Organization of Interphase Chromosome Bands and Interbands in Drosophila melanogaster	PLOS ONE			English	Article							POLYTENE CHROMOSOMES; FUNCTIONAL-ORGANIZATION; REVISED MAP; INTERCALARY HETEROCHROMATIN; X-CHROMOSOME; BINDING; IDENTIFICATION; TRANSCRIPTION; EXPRESSION; HYPOTHESIS	Drosophila melanogaster polytene chromosomes display specific banding pattern; the underlying genetic organization of this pattern has remained elusive for many years. In the present paper, we analyze 32 cytology-mapped polytene chromosome interbands. We estimated molecular locations of these interbands, described their molecular and genetic organization and demonstrate that polytene chromosome interbands contain the 59 ends of housekeeping genes. As a rule, interbands display preferential "head-to-head'' orientation of genes. They are enriched for "broad'' class promoters characteristic of housekeeping genes and associate with open chromatin proteins and Origin Recognition Complex (ORC) components. In two regions, 10A and 100B, coding sequences of genes whose 5'-ends reside in interbands map to constantly loosely compacted, early-replicating, so-called "grey'' bands. Comparison of expression patterns of genes mapping to late-replicating dense bands vs genes whose promoter regions map to interbands shows that the former are generally tissue-specific, whereas the latter are represented by ubiquitously active genes. Analysis of RNA-seq data (modENCODE-FlyBase) indicates that transcripts from interband-mapping genes are present in most tissues and cell lines studied, across most developmental stages and upon various treatment conditions. We developed a special algorithm to computationally process protein localization data generated by the modENCODE project and show that Drosophila genome has about 5700 sites that demonstrate all the features shared by the interbands cytologically mapped to date.	[Zhimulev, Igor F.; Zykova, Tatyana Yu.; Goncharov, Fyodor P.; Khoroshko, Varvara A.; Demakova, Olga V.; Semeshin, Valeriy F.; Pokholkova, Galina V.; Boldyreva, Lidiya V.; Demidova, Darya S.; Demakov, Sergey A.; Belyaeva, Elena S.] Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia; [Zhimulev, Igor F.; Demidova, Darya S.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Babenko, Vladimir N.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia	Russian Academy of Sciences; Novosibirsk State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Zhimulev, IF (corresponding author), Russian Acad Sci, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia.	zhimulev@mcb.nsc.ru	Boldyreva, Lidiya/N-6978-2015; Zykova (Vatolina), Tatyana/I-3897-2014; Goncharov, Fedor/C-8891-2018; Sidorenko, Darya S./N-9524-2015; Zhimulev, Igor F/N-7978-2015; Pokholkova, Galina/N-7554-2015; Demakova, Olga/N-7478-2015	Boldyreva, Lidiya/0000-0003-0716-4545; Goncharov, Fedor/0000-0001-9728-2670; Sidorenko, Darya S./0000-0002-1230-2722; Babenko, Vladimir/0000-0002-3077-9559; Zhimulev, Igor/0000-0002-6220-3028; Demakova, Olga/0000-0002-8538-7384; Demakov, Sergey/0000-0002-5526-6784	Russian Scientific Foundation [14-14- 00934]; Russian Science Foundation [14-14-00934] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This research was funded by grant of Russian Scientific Foundation #14-14- 00934(http://www.rscf.ru/sites/default/files/docfiles/Spisok_pobediteley.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyenkova NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083319; Ashburner M, 1972, INT C SER ENDOCRINOL, V273, P315; Ashburner M., 2004, DROSOPHILA LAB HDB; Babenko V N, 2013, Tsitologiia, V55, P181; BEERMANN W., 1965, Genetics today. Proceedings of the XI International Congress of Genetics, The Hague, the Netherlands, September, 1963., V2, P375; Beermann W, 1967, HERITAGE MENDEL, P179; Belyaeva ES, 2008, CHROMOSOMA, V117, P411, DOI 10.1007/s00412-008-0163-7; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Belyakin SN, 2005, P NATL ACAD SCI USA, V102, P8269, DOI 10.1073/pnas.0502702102; Belyakin SN, 2010, CHROMOSOMA, V119, P589, DOI 10.1007/s00412-010-0280-y; Braunschweig U, 2009, EMBO J, V28, P3635, DOI 10.1038/emboj.2009.301; Bridges CB, 1938, J HERED, V29, P11, DOI 10.1093/oxfordjournals.jhered.a104399; Bridges CB, 1939, J HERED, V30, P475, DOI 10.1093/oxfordjournals.jhered.a104634; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Bridges PN, 1942, J HERED, V33, P403, DOI 10.1093/oxfordjournals.jhered.a105104; Bridges PN, 1941, J HERED, V32, P64, DOI 10.1093/oxfordjournals.jhered.a104998; Bridges PN, 1941, J HERED, V32, P299, DOI 10.1093/oxfordjournals.jhered.a105069; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; CRICK F, 1971, NATURE, V234, P25, DOI 10.1038/234025a0; DAVIDSON EH, 1973, Q REV BIOL, V48, P565, DOI 10.1086/407817; Demakov SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-566; Ding Y, 2009, DEV BIOL, V334, P253, DOI 10.1016/j.ydbio.2009.07.027; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eggert H, 2004, J CELL SCI, V117, P4253, DOI 10.1242/jcs.01292; Feller C, 2012, NUCLEIC ACIDS RES, V40, P1509, DOI 10.1093/nar/gkr869; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; FUJITA S, 1965, NATURE, V206, P742, DOI 10.1038/206742a0; GERSH ES, 1975, J THEOR BIOL, V50, P413, DOI 10.1016/0022-5193(75)90090-9; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Kaufmann BP, 1939, P NATL ACAD SCI USA, V25, P571, DOI 10.1073/pnas.25.11.571; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kolesnikova TD, 2011, FLY, V5, P181, DOI 10.4161/fly.5.3.16729; Koltzoff N., 1934, Science, V80, P312, DOI 10.1126/science.80.2075.312; KOSSWIG C, 1947, J HERED, V38, P235, DOI 10.1093/oxfordjournals.jhered.a105740; KOZLOVA TY, 1994, GENETICS, V136, P1063; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; LEFEVRE G, 1971, GENETICS, V67, P497; Makunin IV, 2002, GENETICS, V160, P1023; Miele V, 2008, NUCLEIC ACIDS RES, V36, P3746, DOI 10.1093/nar/gkn262; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; MOJENA R, 1977, COMPUT J, V20, P359, DOI 10.1093/comjnl/20.4.359; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; PAUL J, 1972, NATURE, V238, P444, DOI 10.1038/238444a0; Petesch SJ, 2012, TRENDS GENET, V28, P285, DOI 10.1016/j.tig.2012.02.005; Pindyurin AV, 2007, J CELL SCI, V120, P2344, DOI 10.1242/jcs.006007; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; Semeshin VF, 2004, METH MOL B, V247, P305; SEMESHIN VF, 1979, CHROMOSOMA, V73, P163, DOI 10.1007/BF00331569; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sher N, 2012, GENOME RES, V22, P64, DOI 10.1101/gr.126003.111; Sokoloff S, 1977, THESIS U TUBINGEN; SORSA V, 1975, HEREDITAS, V81, P77; Sorsa V., 1968, Suomalaisen Tiedeakat Toim (Ser A 4 Biol), VNo. 134, P1; Sorsa V, 1984, INSECT ULTRASTRUCTUR, V2, P75; SPEISER C, 1974, THEOR APPL GENET, V44, P97, DOI 10.1007/BF02981919; Spradling AC, 2011, P NATL ACAD SCI USA, V108, P15948, DOI 10.1073/pnas.1112960108; Taramasco O, 2013, RHMM HIDDEN MARKOV M; Vatolina TY, 2011, RUSS J GENET+, V47, P521, DOI 10.1134/S1022795411040144; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; Wakano C, 2012, BBA-GENE REGUL MECH, V1819, P688, DOI 10.1016/j.bbagrm.2012.02.006; Weber CC, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r23; White R, 2012, BRIEF FUNCT GENOMICS, V11, P347, DOI 10.1093/bfgp/els020; Yao CF, 2012, CHROMOSOMA, V121, P209, DOI 10.1007/s00412-011-0355-4; Zhang P, 2012, NUCLEIC ACIDS RES, P1; ZHIMULEV IF, 1975, CHROMOSOMA, V49, P219, DOI 10.1007/BF00361067; Zhimulev IF, 2003, CHROMOSOMA, V111, P377, DOI 10.1007/s00412-002-0218-0; Zhimulev IF, 1999, ADV GENET, V39, P1, DOI 10.1016/S0065-2660(08)60476-9; ZHIMULEV IF, 1975, THEOR APPL GENET, V45, P335, DOI 10.1007/BF00277673; Zhimulev IF, 2012, BIOESSAYS, V34, P498, DOI 10.1002/bies.201100142	76	48	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e101631	10.1371/journal.pone.0101631	http://dx.doi.org/10.1371/journal.pone.0101631			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072930	Green Submitted, Green Published, gold			2022-12-27	WOS:000341307600006
J	Petursdottir, DH; Chuquimia, OD; Freidl, R; Fernandez, C				Petursdottir, Dagbjort H.; Chuquimia, Olga D.; Freidl, Raphaela; Fernandez, Carmen			Macrophage Control of Phagocytosed Mycobacteria Is Increased by Factors Secreted by Alveolar Epithelial Cells through Nitric Oxide Independent Mechanisms	PLOS ONE			English	Article							INTERFERON-GAMMA; IFN-GAMMA; DIFFERENTIAL REGULATION; SIGNAL-TRANSDUCTION; RESPIRATORY BURST; IMMUNE-RESPONSES; L-ARGININE; IN-VITRO; II CELLS; ACTIVATION	Tissue-resident macrophages are heterogeneous with tissue-specific and niche-specific functions. Thus, simplified models of macrophage activation do not explain the extent of heterogeneity seen in vivo. We focus here on the respiratory tract and ask whether factors secreted by alveolar epithelial cells (AEC) can influence the functionality of resident pulmonary macrophages (PuM). We have previously reported that factors secreted by AEC increase control of intracellular growth of BCG in macrophages. In the current study, we also aimed to investigate possible mechanisms by which AEC-derived factors increase intracellular control of BCG in both primary murine interstitial macrophages, and bone marrow-derived macrophages and characterize further the effect of these factors on macrophage differentiation. We show that; a) in contrast to other macrophage types, IFN-gamma did not increase intracellular growth control of Mycobacterium bovis, Bacillus Calmette-Guerin (BCG) by interstitial pulmonary macrophages although the same macrophages could be activated by factors secreted by AEC; b) the lack of response of pulmonary macrophages to IFN-gamma was apparently regulated by suppressor of cytokine signaling (SOCS) 1; c) AEC-derived factors did not induce pro-inflammatory pathways induced by IFN-gamma e.g. expression of inducible nitric oxide synthase (iNOS), secretion of nitric oxide (NO), or IL-12, d) in contrast to IFN-gamma, intracellular bacterial destruction induced by AEC-derived factors was not dependent on iNOS transcription and NO production. Collectively, our data show that PuM were restricted in inflammatory responses mediated by IFN-gamma through SOCS1 and that factors secreted by AEC-enhanced the microbicidal capacities of macrophages by iNOS independent mechanisms.	[Petursdottir, Dagbjort H.; Chuquimia, Olga D.; Freidl, Raphaela; Fernandez, Carmen] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	Stockholm University	Petursdottir, DH (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	dagbjort.petursdottir@su.se		Petursdottir, Dagbjort/0000-0003-0665-7719	European Commission [HEALTH-F3-2008-200732]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grant FP7 (HEALTH-F3-2008-200732) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Alvarez E, 2002, INT IMMUNOPHARMACOL, V2, P849, DOI 10.1016/S1567-5769(02)00032-2; Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; BARRERA LF, 1994, IMMUNOLOGY, V82, P457; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Carow B, 2011, J BIOL CHEM, V286, P26873, DOI 10.1074/jbc.M111.238287; Cassetta L, 2011, THESCIENTIFICWORLDJO, V11, P2391, DOI 10.1100/2011/213962; Chuquimia OD, 2013, INFECT IMMUN, V81, P381, DOI 10.1128/IAI.00950-12; Chuquimia OD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032125; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Debbabi H, 2005, AM J PHYSIOL-LUNG C, V289, pL274, DOI 10.1152/ajplung.00004.2005; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fehrenbach H, 2012, EUR RESPIR J, V39, P240, DOI 10.1183/09031936.00162111; FLESCH IEA, 1991, INFECT IMMUN, V59, P3213, DOI 10.1128/IAI.59.9.3213-3218.1991; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gwinn MR, 2006, J TOXICOL ENV HEAL B, V9, P27, DOI 10.1080/15287390500196081; HIBBS JB, 1987, J IMMUNOL, V138, P550; Humphreys IR, 2006, MICROBES INFECT, V8, P1339, DOI 10.1016/j.micinf.2005.12.023; Laskin DL, 2001, J LEUKOCYTE BIOL, V70, P163; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lefevre L, 2013, IMMUNITY, V38, P1038, DOI 10.1016/j.immuni.2013.04.010; Lo B, 2008, J IMMUNOL, V180, P881, DOI 10.4049/jimmunol.180.2.881; LOHMANNMATTHES ML, 1994, EUR RESPIR J, V7, P1678; Mantovani A, 2009, BLOOD, V114, P3135, DOI 10.1182/blood-2009-07-231795; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Orme J, 2012, DISCOV MED, V13, P151; Pechkovsky DV, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-75; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Rahman MJ, 2011, INFECT IMMUN, V79, P4649, DOI 10.1128/IAI.05724-11; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; Sato K, 1998, CLIN EXP IMMUNOL, V112, P63; Schneberger D, 2011, CELL TISSUE RES, V343, P97, DOI 10.1007/s00441-010-1032-2; Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Steinmuller C, 2000, AM J RESP CELL MOL, V22, P481, DOI 10.1165/ajrcmb.22.4.3336; TAUB DD, 1995, J IMMUNOL METHODS, V184, P187, DOI 10.1016/0022-1759(95)00087-Q; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Tschernig Thomas, 2009, BMC Pulm Med, V9, P39, DOI 10.1186/1471-2466-9-39; Vereyken EJF, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-58; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103411	10.1371/journal.pone.0103411	http://dx.doi.org/10.1371/journal.pone.0103411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089618	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700023
J	Zhao, WR; Ai, ZY; Dai, JS; Zhang, M				Zhao, Weirong; Ai, Zhuyu; Dai, Jiusong; Zhang, Meng			Enhanced Photocatalytic Activity for H-2 Evolution under Irradiation of UV-Vis Light by Au-Modified Nitrogen-Doped TiO2	PLOS ONE			English	Article							VISIBLE-LIGHT; HYDROGEN-PRODUCTION; SURFACE CHARACTERIZATION; TITANIUM-DIOXIDE; TEMPERATURE; NANOPARTICLES; REDUCTION; ORIGIN; OXIDE; NANOFIBERS	Background Purpose: Photocatalytic water splitting for hydrogen evolution is a potential way to solve many energy and environmental issues. Developing visible-light-active photocatalysts to efficiently utilize sunlight and finding proper ways to improve photocatalytic activity for H-2 evolution have always been hot topics for research. This study attempts to expand the use of sunlight and to enhance the photocatalytic activity of TiO2 by N doping and Au loading. Methods: Au/N-doped TiO2 photocatalysts were synthesized and successfully used for photocatalytic water splitting for H-2 evolution under irradiation of UV and UV-vis light, respectively. The samples were characterized using X-ray diffraction (XRD), transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS), UV-vis diffuse reflectance spectroscopy (DRS), photoluminescence spectroscopy (PL), and photoelectrochemical characterizations. Results: DRS displayed an extension of light absorption into the visible region by doping of N and depositing with Au, respectively. PL analysis indicated electron-hole recombination due to N doping and an efficient inhibition of electron-hole recombination due to the loaded Au particles. Under the irradiation of UV light, the photocatalytic hydrogen production rate of the as-synthesized samples followed the order Au/TiO2. Au/N-doped TiO2. TiO2. N-doped TiO2. While under irradiation of UV-vis light, the N-TiO2 and Au/N-TiO2 samples show higher H-2 evolution than their corresponding nitrogenfree samples (TiO2 and Au/TiO2). This inconsistent result could be attributed to the doping of N and the surface plasmonic resonance (SPR) effect of Au particles extending the visible light absorption. The photoelectrochemical characterizations further indicated the enhancement of the visible light response of Au/N-doped TiO2. Conclusion: Comparative studies have shown that a combination of nitrogen doping and Au loading enhanced the visible light response of TiO2 and increased the utilization of solar energy, greatly boosting the photocatalytic activity for hydrogen production under UV-vis light.	[Zhao, Weirong; Ai, Zhuyu; Dai, Jiusong; Zhang, Meng] Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhao, WR (corresponding author), Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China.	weirong@mail.hz.zj.cn		zhao, weirong/0000-0002-8597-2292	National Nature Science Foundation of China [51178412, 51278456]; National Key Technologies RD Program [2013BAC16B01]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program)	This work has been partially supported by the National Nature Science Foundation of China (Grant nos. 51178412 and 51278456, http://www.nsfc.gov.cn) and the National Key Technologies R&D Program (Grant no. 2013BAC16B01, http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessekhouad Y, 2012, J PHOTOCH PHOTOBIO A, V248, P15, DOI 10.1016/j.jphotochem.2012.08.013; Chen JJ, 2011, J PHYS CHEM C, V115, P210, DOI 10.1021/jp1074048; Cong Y, 2007, J PHYS CHEM C, V111, P6976, DOI 10.1021/jp0685030; DeSario PA, 2013, NANOSCALE, V5, P8073, DOI 10.1039/c3nr01429k; Di Valentin C, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.085116; Di Valentin C, 2007, CHEM PHYS, V339, P44, DOI 10.1016/j.chemphys.2007.07.020; Dong F, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/36/365607; Epling WS, 1996, J PHYS CHEM-US, V100, P9929, DOI 10.1021/jp960593t; Erdem B, 2001, LANGMUIR, V17, P2664, DOI 10.1021/la0015213; Garcia MA, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/28/283001; Graciani J, 2008, J AM CHEM SOC, V130, P12056, DOI 10.1021/ja802861u; Hoang S, 2012, NANO LETT, V12, P26, DOI 10.1021/nl2028188; Iliev V, 2006, APPL CATAL A-GEN, V313, P115, DOI 10.1016/j.apcata.2006.06.039; Jia TT, 2014, CHEM COMMUN, V50, P1185, DOI 10.1039/c3cc47301e; Jiang Z, 2008, CHEM COMMUN, P6372, DOI 10.1039/b815430a; Kominami H, 2014, CHEM COMMUN, V50, P4558, DOI 10.1039/c3cc49340g; Li P, 2011, J AM CHEM SOC, V133, P5660, DOI 10.1021/ja111102u; Li XF, 2008, MICROPOR MESOPOR MAT, V116, P478, DOI 10.1016/j.micromeso.2008.05.007; Lin ZS, 2005, J PHYS CHEM B, V109, P20948, DOI 10.1021/jp053547e; Liu ZW, 2011, NANO LETT, V11, P1111, DOI 10.1021/nl104005n; Livraghi S, 2006, J AM CHEM SOC, V128, P15666, DOI 10.1021/ja064164c; Mao YB, 2006, J AM CHEM SOC, V128, P8217, DOI 10.1021/ja0607483; Min YL, 2013, SEP PURIF TECHNOL, V106, P97, DOI 10.1016/j.seppur.2012.12.023; Ohno T, 2014, APPL CATAL B-ENVIRON, V152, P309, DOI 10.1016/j.apcatb.2014.01.048; Seh ZW, 2012, ADV MATER, V24, P2310, DOI 10.1002/adma.201104241; Sreethawong T, 2009, CATAL COMMUN, V10, P538, DOI 10.1016/j.catcom.2008.10.029; Taboada E, 2014, J CATAL, V309, P460, DOI 10.1016/j.jcat.2013.10.025; Tanaka A, 2012, LANGMUIR, V28, P13105, DOI 10.1021/la301944b; Tian BZ, 2009, CATAL COMMUN, V10, P925, DOI 10.1016/j.catcom.2008.12.029; Wang DA, 2013, ANGEW CHEM INT EDIT, V52, P11252, DOI 10.1002/anie.201303693; Wang HB, 2011, J MATER CHEM, V21, P5430, DOI 10.1039/c1jm00049g; Wang J, 2009, J AM CHEM SOC, V131, P12290, DOI 10.1021/ja903781h; Wang JW, 2007, J PHYS CHEM C, V111, P1010, DOI 10.1021/jp066156o; Wang P, 2012, PHYS CHEM CHEM PHYS, V14, P9813, DOI 10.1039/c2cp40823f; Wang P, 2011, CHEMCATCHEM, V3, P360, DOI 10.1002/cctc.201000380; Wu DY, 2010, J ALLOY COMPD, V502, P289, DOI 10.1016/j.jallcom.2010.04.189; Wu YM, 2009, J PHYS CHEM C, V113, P14689, DOI 10.1021/jp904465d; Xiang QJ, 2011, CHEM COMMUN, V47, P6906, DOI 10.1039/c1cc11740h; Xin BF, 2005, APPL SURF SCI, V252, P2050, DOI 10.1016/j.apsusc.2005.03.172; Yang GR, 2013, NANOSCALE, V5, P12432, DOI 10.1039/c3nr03462c; Yu JG, 2003, J PHYS CHEM B, V107, P13871, DOI 10.1021/jp036158y; Zhang JL, 2010, ENERG ENVIRON SCI, V3, P715, DOI 10.1039/b927575d; Zhang JY, 2013, ACS APPL MATER INTER, V5, P1031, DOI 10.1021/am302726y; Zhang P, 2012, J HAZARD MATER, V237, P331, DOI 10.1016/j.jhazmat.2012.08.054; Zhao W, 2013, APPL CATAL B-ENVIRON, V144, P468; Zheng ZF, 2013, CHEM-EUR J, V19, P5731, DOI 10.1002/chem.201203961; Zhou XM, 2012, J MATER CHEM, V22, P21337, DOI 10.1039/c2jm31902k	47	28	30	4	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103671	10.1371/journal.pone.0103671	http://dx.doi.org/10.1371/journal.pone.0103671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090093	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700039
J	Cheng, W; Tian, J; Burgunder, JM; Hunziker, W; Eng, HL				Cheng, Wei; Tian, Jing; Burgunder, Jean-Marc; Hunziker, Walter; Eng, How-Lung			Myotonia Congenita-Associated Mutations in Chloride Channel-1 Affect Zebrafish Body Wave Swimming Kinematics	PLOS ONE			English	Article							LARVAL ZEBRAFISH; ONTOGENY; DOMINANT; TRACKING	Myotonia congenita is a human muscle disorder caused by mutations in CLCN1, which encodes human chloride channel 1 (CLCN1). Zebrafish is becoming an increasingly useful model for human diseases, including muscle disorders. In this study, we generated transgenic zebrafish expressing, under the control of a muscle specific promoter, human CLCN1 carrying mutations that have been identified in human patients suffering from myotonia congenita. We developed video analytic tools that are able to provide precise quantitative measurements of movement abnormalities in order to analyse the effect of these CLCN1 mutations on adult transgenic zebrafish swimming. Two new parameters for body-wave kinematics of swimming reveal changes in body curvature and tail offset in transgenic zebrafish expressing the disease-associated CLCN1 mutants, presumably due to their effect on muscle function. The capability of the developed video analytic tool to distinguish wild-type from transgenic zebrafish could provide a useful asset to screen for compounds that reverse the disease phenotype, and may be applicable to other movement disorders besides myotonia congenita.	[Cheng, Wei; Hunziker, Walter] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Epithelial Cell Biol Lab, Singapore, Singapore; [Tian, Jing; Eng, How-Lung] Agcy Sci Technol & Res, Inst Infocomm Res, Singapore, Singapore; [Burgunder, Jean-Marc] Univ Bern, Dept Neurol, Bern, Switzerland; [Burgunder, Jean-Marc] Univ Bern, Deparment Clin Res, Bern, Switzerland; [Hunziker, Walter] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Hunziker, Walter] Singapore Eye Res Inst, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); University of Bern; University of Bern; National University of Singapore; National University of Singapore; Singapore National Eye Center	Hunziker, W (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Epithelial Cell Biol Lab, Singapore, Singapore.	hunziker@imcb.a-star.edu.sg; howlungeng@zweec.com	Hunziker, Walter/GSM-8190-2022; Hunziker, Walter/B-3140-2010; Tian, Jing/ABI-2886-2020	Hunziker, Walter/0000-0002-5265-4933; Tian, Jing/0000-0002-4084-6911	Council Office of the Agency for Science Technology and Research (A*STAR), Singapore [10/03/EG/05/02, 1031C004]	Council Office of the Agency for Science Technology and Research (A*STAR), Singapore	This work was funded by grants 10/03/EG/05/02 and 1031C004 from the Joint Council Office of the Agency for Science Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bassett DI, 2003, HUM MOL GENET, V12, pR265, DOI 10.1093/hmg/ddg279; Becker PE, 1973, NEW DEV ELECTROMYOGR, P407; Becker RE, 1977, TOPICS HUMAN GENETIC; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; Budick SA, 2000, J EXP BIOL, V203, P2565; Burgunder JM, 2008, NEUROMUSCULAR DISORD, V18, P633, DOI 10.1016/j.nmd.2008.05.007; Cachat JM, 2011, NEUROMETHODS, V51, P191, DOI 10.1007/978-1-60761-953-6_16; Cario CL, 2011, J PHYSIOL-LONDON, V589, P3703, DOI 10.1113/jphysiol.2011.207308; Danos N, 2007, J EXP BIOL, V210, P3374, DOI 10.1242/jeb.007484; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; Flinn L, 2008, J NEUROCHEM, V106, P1991, DOI 10.1111/j.1471-4159.2008.05463.x; Fontaine E, 2008, J EXP BIOL, V211, P1305, DOI 10.1242/jeb.010272; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; Green MH, 2011, J EXP BIOL, V214, P3111, DOI 10.1242/jeb.057497; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Jing Tian, 2011, 2011 IEEE 15th International Symposium on Consumer Electronics, P268, DOI 10.1109/ISCE.2011.5973830; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Liu TM, 2007, IEEE SIGNAL PROC MAG, V24, P126, DOI 10.1109/MSP.2007.273080; Lossin C, 2008, ADV GENET, V63, P25, DOI 10.1016/S0065-2660(08)01002-X; Martineau PR, 2013, METHODS, V62, P292, DOI 10.1016/j.ymeth.2013.05.002; McClenahan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032295; Mikut R, 2013, ZEBRAFISH, V10, P401, DOI 10.1089/zeb.2013.0886; Schaefer AT, 2012, CURR OPIN NEUROBIOL, V22, P170, DOI 10.1016/j.conb.2011.11.004; Stewart AM, 2012, BRAIN RES, V1451, P44, DOI 10.1016/j.brainres.2012.02.064; Suster Maximiliano L, 2009, Methods Mol Biol, V561, P41, DOI 10.1007/978-1-60327-019-9_3	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103445	10.1371/journal.pone.0103445	http://dx.doi.org/10.1371/journal.pone.0103445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083883	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800041
J	Hobaiter, C; Schel, AM; Langergraber, K; Zuberbuhler, K				Hobaiter, Catherine; Schel, Anne Marijke; Langergraber, Kevin; Zuberbuehler, Klaus			'Adoption' by Maternal Siblings in Wild Chimpanzees	PLOS ONE			English	Article							ALTRUISM; HELP	The adoption of unrelated orphaned infants is something chimpanzees and humans have in common. Providing parental care has fitness implications for both the adopter and orphan, and cases of adoption have thus been cited as evidence for a shared origin of an altruistic behaviour. We provide new data on adoptions in the free-living Sonso chimpanzee community in Uganda, together with an analysis of published data from other long-term field sites. As a default pattern, we find that orphan chimpanzees do not become adopted by adult group members but wherever possible associate with each other, usually as maternal sibling pairs. This occurs even if both partners are still immature, with older individuals effectively becoming 'child household heads'. Adoption of orphans by unrelated individuals does occur but usually only if no maternal siblings or other relatives are present and only after significant delays. In conclusion, following the loss of their mother, orphaned chimpanzees preferentially associate along pre-existing social bonds, which are typically strongest amongst maternal siblings.	[Hobaiter, Catherine; Zuberbuehler, Klaus] Univ St Andrews, Ctr Social Learning & Cognit Evolut, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Hobaiter, Catherine; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, Scottish Primate Res Grp, St Andrews, Fife, Scotland; [Schel, Anne Marijke] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Schel, Anne Marijke] Ecole Normale Super, Inst Jean Nicod, F-75231 Paris, France; [Langergraber, Kevin] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Langergraber, Kevin] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Zuberbuehler, Klaus] Univ Neuchatel, Inst Biol, Dept Comparat Cognit, CH-2000 Neuchatel, Switzerland; [Hobaiter, Catherine; Schel, Anne Marijke; Zuberbuehler, Klaus] Budongo Conservat Field Stn, Masindi, Uganda	University of St Andrews; University of St Andrews; University of York - UK; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Boston University; Max Planck Society; University of Neuchatel	Hobaiter, C (corresponding author), Univ St Andrews, Ctr Social Learning & Cognit Evolut, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	clh42@st-andrews.ac.uk	Zuberbühler, Klaus/A-9053-2011	Zuberbühler, Klaus/0000-0001-8378-088X; Hobaiter, Cat/0000-0002-3893-0524	Leverhulme Trust Research Leadership Award [F/00268/AP]; Wenner-Gren Foundation Dissertation Fieldwork grant; British Academy Grant [SG411998]; Royal Zoological Society of Scotland; European Union [283871]; Max Planck Society; Boston University; Leakey Foundation	Leverhulme Trust Research Leadership Award(Leverhulme Trust); Wenner-Gren Foundation Dissertation Fieldwork grant; British Academy Grant; Royal Zoological Society of Scotland; European Union(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Boston University; Leakey Foundation	This research was funded by the Leverhulme Trust Research Leadership Award F/00268/AP (http://www.leverhulme.ac.uk/), a Wenner-Gren Foundation Dissertation Fieldwork grant (http://www.wennergren.org/), the British Academy Grant SG411998 (http://www.brit.ac.uk) and the Royal Zoological Society of Scotland (http://www.rzss.org.uk). This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 283871. Genetic analyses were funded by the Max Planck Society, Boston University, and the Leakey Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2008, AM J PRIMATOL, V70, P519, DOI 10.1002/ajp.20524; Boesch C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008901; Bshary R, 2008, J EVOLUTION BIOL, V21, P405, DOI 10.1111/j.1420-9101.2007.01482.x; EGGELING WJ, 1947, J ECOL, V34, P20, DOI 10.2307/2256760; Foster G., 1997, HLTH T REV S2, V7, P155; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Greenberg JR, 2010, ANIM BEHAV, V80, P873, DOI 10.1016/j.anbehav.2010.08.008; Hirata S, 2011, BIOL LETTERS, V7, P686, DOI 10.1098/rsbl.2011.0214; Hirata S, 2009, PRIMATES, V50, P3, DOI 10.1007/s10329-008-0122-1; Langergraber K, 2009, AM J PRIMATOL, V71, P840, DOI 10.1002/ajp.20711; Langergraber KE, 2014, AM J PRIMATOL, V76, P640, DOI 10.1002/ajp.22258; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Lehmann J, 2004, BEHAV ECOL SOCIOBIOL, V56, P207, DOI 10.1007/s00265-004-0781-x; Lehmann J, 2006, BEHAVIOUR, V143, P931, DOI 10.1163/156853906778623635; Lehmann L, 2006, J EVOLUTION BIOL, V19, P337; Liebal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084299; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Melis AP, 2011, P ROY SOC B-BIOL SCI, V278, P1405, DOI 10.1098/rspb.2010.1735; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Plumtre AJ, 2003, ALBERTINE RIFT TECHN, V2; Pruetz Jill D., 2009, Paleoanthropology, V2009, P252; Reynolds V., 2005, CHIMPANZEES BUDONGO; SAKURA O, 1994, INT J PRIMATOL, V15, P167, DOI 10.1007/BF02735272; Silk JB., 1987, CULTURAL ANTHR, V2, P39, DOI [10.1525/can.1987.2.1.02a00050, DOI 10.1525/CAN.1987.2.1.02A00050]; Silk JB, 2011, P NATL ACAD SCI USA, V108, P10910, DOI 10.1073/pnas.1100305108; THIERRY B, 1986, INT J PRIMATOL, V7, P191, DOI 10.1007/BF02692318; UEHARA S, 1983, Primates, V24, P456, DOI 10.1007/BF02381679; WEISNER TS, 1977, CURR ANTHROPOL, V18, P169, DOI 10.1086/201883; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; Wroblewski E, 2010, THESIS U MINNESOTA; Wroblewski EE, 2008, AM J PRIMATOL, V70, P995, DOI 10.1002/ajp.20582; Yamamoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007416; Zuberbuhler K, 2013, SONSO CHIMPANZEE DAT	36	21	21	6	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103777	10.1371/journal.pone.0103777	http://dx.doi.org/10.1371/journal.pone.0103777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084521	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800078
J	Liu, Y; Carson-Walter, E; Walter, KA				Liu, Yang; Carson-Walter, Eleanor; Walter, Kevin A.			Chemokine Receptor CXCR7 Is a Functional Receptor for CXCL12 in Brain Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR; TUMOR-GROWTH; IN-VIVO; HEPATOCELLULAR-CARCINOMA; PROGENITOR CELLS; GENE-EXPRESSION; ANGIOGENESIS; GLIOBLASTOMA; INVASION; PROLIFERATION	The chemokine CXCL12 regulates multiple cell functions through its receptor, CXCR4. However, recent studies have shown that CXCL12 also binds a second receptor, CXCR7, to potentiate signal transduction and cell activity. In contrast to CXCL12/CXCR4, few studies have focused on the role of CXCR7 in vascular biology and its role in human brain microvascular endothelial cells (HBMECs) remains unclear. In this report, we used complementary methods, including immunocytofluorescence, Western blot, and flow cytometry analyses, to demonstrate that CXCR7 was expressed on HBMECs. We then employed short hairpin RNA (shRNA) technology to knockdown CXCR7 in HBMECs. Knockdown of CXCR7 in HBMECs resulted in significantly reduced HBMEC proliferation, tube formation, and migration, as well as adhesion to matrigel and tumor cells. Blocking CXCR7 with a specific antibody or small molecule antagonist similarly disrupted HBMEC binding to matrigel or tumor cells. We found that tumor necrosis factor (TNF)-alpha induced CXCR7 in a time and dose-response manner and that this increase preceded an increase in vascular cell adhesion molecule-1 (VCAM-1). Knockdown of CXCR7 resulted in suppression of VCAM-1, suggesting that the reduced binding of CXCR7-knockdown HBMECs may result from suppression of VCAM-1. Collectively, CXCR7 acted as a functional receptor for CXCL12 in brain endothelial cells. Targeting CXCR7 in tumor vasculature may provide novel opportunities for improving brain tumor therapy.	[Liu, Yang; Carson-Walter, Eleanor; Walter, Kevin A.] Univ Rochester, Sch Med & Dent, Dept Neurosurg, Rochester, NY 14627 USA; [Walter, Kevin A.] Univ Rochester, Sch Med & Dent, Wilmot Canc Ctr, Rochester, NY USA	University of Rochester; University of Rochester	Liu, Y (corresponding author), Univ Rochester, Sch Med & Dent, Dept Neurosurg, Rochester, NY 14627 USA.	yang_liu@urmc.rochester.edu; kevin_walter@urmc.rochester.edu			University of Rochester Clinical and Translational Science Institute Pilot Studies Award; National Institutes of Health [NINDS K08 NS046461]; American Brain Tumor Association; Ronald Bittner Brain Tumor Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS046461] Funding Source: NIH RePORTER	University of Rochester Clinical and Translational Science Institute Pilot Studies Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association; Ronald Bittner Brain Tumor Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the University of Rochester Clinical and Translational Science Institute Pilot Studies Award to Y.L., the National Institutes of Health (NINDS K08 NS046461) to K.A.W., the American Brain Tumor Association to K.A.W., and the Ronald Bittner Brain Tumor Research Fund to K.A.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2006, CANCER RES, V66, P9054, DOI 10.1158/0008-5472.CAN-05-3759; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Brown JM, 2013, SEMIN RADIAT ONCOL, V23, P281, DOI 10.1016/j.semradonc.2013.05.002; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Costello CM, 2012, EUR RESPIR J, V39, P1415, DOI 10.1183/09031936.00044911; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Dai XZ, 2011, J CELL MOL MED, V15, P1299, DOI 10.1111/j.1582-4934.2011.01301.x; Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387; Glushakova O, 2008, J AM SOC NEPHROL, V19, P1712, DOI 10.1681/ASN.2007121304; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Huang P, 2012, CANCER RES, V72, P1428, DOI 10.1158/0008-5472.CAN-11-2621; Jung H, 2008, ONCOGENE, V27, P2635, DOI 10.1038/sj.onc.1210914; Kanda S, 2003, J BIOL CHEM, V278, P257, DOI 10.1074/jbc.M204771200; Kenig S, 2010, CANCER LETT, V289, P53, DOI 10.1016/j.canlet.2009.07.014; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Liu Y, 2010, J NEURO-ONCOL, V99, P13, DOI 10.1007/s11060-009-0105-0; Luker KE, 2012, ONCOGENE, V31, P4750, DOI 10.1038/onc.2011.633; Madden SL, 2004, AM J PATHOL, V165, P601, DOI 10.1016/S0002-9440(10)63324-X; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9; Molino M, 2000, BBA-MOL BASIS DIS, V1500, P227, DOI 10.1016/S0925-4439(99)00110-6; Monnier J, 2012, EUR J CANCER, V48, P138, DOI 10.1016/j.ejca.2011.06.044; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Radeff-Huang J, 2007, J BIOL CHEM, V282, P863, DOI 10.1074/jbc.M601698200; Rao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033005; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Salmaggi A, 2009, CANCER BIOL THER, V8, P1615, DOI 10.4161/cbt.8.17.9202; Schutyser E, 2007, EUR CYTOKINE NETW, V18, P59, DOI 10.1684/ecn.2007.0087; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takano S, 2010, J ONCOL, V2010, DOI 10.1155/2010/351908; Totonchy JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069828; Walters MJ, 2014, BR J CANC; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Watanabe K, 2010, ARTHRITIS RHEUM-US, V62, P3211, DOI 10.1002/art.27650; Wurth R, 2011, J NEUROIMMUNOL, V234, P115, DOI 10.1016/j.jneuroim.2011.01.006; Yan XQ, 2012, J CELL BIOCHEM, V113, P1437, DOI 10.1002/jcb.24015; Zagzag D, 2008, AM J PATHOL, V173, P545, DOI 10.2353/ajpath.2008.071197; Zheng K, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-31; Zheng YH, 2013, J BIOL CHEM, V288, P31488, DOI 10.1074/jbc.M113.499020; Zhou J, 2002, INFLAMM RES, V51, P332, DOI 10.1007/PL00000312; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	49	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103938	10.1371/journal.pone.0103938	http://dx.doi.org/10.1371/journal.pone.0103938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084358	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800106
J	Sonego, F; Castanheira, FVS; Czaikoski, PG; Kanashiro, A; Souto, FO; Franca, RO; Nascimento, DC; Freitas, A; Spiller, F; Cunha, LD; Zamboni, DS; Alves, JC; Cunha, FQ				Sonego, Fabiane; Castanheira, Fernanda V. S.; Czaikoski, Paula G.; Kanashiro, Alexandre; Souto, Fabricio O.; Franca, Rafael O.; Nascimento, Daniele C.; Freitas, Andressa; Spiller, Fernando; Cunha, Larissa D.; Zamboni, Dario S.; Alves-Filho, Jose C.; Cunha, Fernando Q.			MyD88-, but Not Nod1- and/or Nod2-Deficient Mice, Show Increased Susceptibility to Polymicrobial Sepsis due to Impaired Local Inflammatory Response	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS; NEUTROPHIL MIGRATION; SEPTIC PERITONITIS; ORGAN INJURY; IN-VIVO; CHEMOKINE; CELLS; MURAMYLDIPEPTIDE; RECRUITMENT	Pathogen recognition and triggering of the inflammatory response following infection in mammals depend mainly on Toll like and Nod-like receptors. Here we evaluated the role of Nod1, Nod2 and MyD88-dependent signaling in the chemokine production and neutrophil recruitment to the infectious site during sepsis induced by cecal ligation and puncture (CLP) in C57BI/6 mice. We demonstrate that Nodi and Nod2 are not involved in the release of chemokines and recruitment of neutrophils to the infectious site during CLP-induced septic peritonitis because these events were similar in wild-type Nod Nod2-, Nod1/Nod2- and Rip2-deficient mice. Consequently, the local and systemic bacterial loads were not altered. Accordingly, her Nod1 nor Nod2 was involved in the production of he circulating cytokines and in the accumulation of leukocytes in By contrast, we showed that MyD88-dependent signaling is crucial for the establishment of the local inflammatory response during CLP-induced sepsis. MyD88-deficient mice were susceptible to sepsis because of an impaired local production chemokines and defective neutrophil recruitment to the infection site. Altogether, these data show that Nod1, Nod2 and Rip2 are not required for local chemokine production and neutrophil recruitment during CLP-Induced sepsis, and they importance of MyD88-dependent signaling for initiation of a protective host response.	[Sonego, Fabiane; Castanheira, Fernanda V. S.; Czaikoski, Paula G.; Kanashiro, Alexandre; Souto, Fabricio O.; Franca, Rafael O.; Nascimento, Daniele C.; Freitas, Andressa; Spiller, Fernando; Alves-Filho, Jose C.; Cunha, Fernando Q.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, BR-14049 Ribeirao Preto, SP, Brazil; [Cunha, Larissa D.; Zamboni, Dario S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogent, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Cunha, FQ (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, BR-14049 Ribeirao Preto, SP, Brazil.	fdqcunha@fmrp.usp.br	Kanashiro, Alexandre/AAX-3823-2020; Souto, Fabricio/AAS-7671-2020; Cunha, Fernando Q/M-3090-2014; de Freitas, Andressa/B-7264-2012; Kanashiro, Alexandre/C-9435-2012; Alves-Filho, Jose Carlos/B-5814-2008; Cunha, Larissa D/I-4204-2012; Souto, Fabricio/AAX-8668-2021; Freitas de Oliveira Franca, Rafael/ABB-2376-2021; Spiller, Fernando/P-2265-2017; Zamboni, Dario S/D-3024-2012	Kanashiro, Alexandre/0000-0003-0367-7503; de Freitas, Andressa/0000-0001-8453-7742; Kanashiro, Alexandre/0000-0003-0367-7503; Alves-Filho, Jose Carlos/0000-0002-9918-8714; Souto, Fabricio/0000-0002-2392-8499; Freitas de Oliveira Franca, Rafael/0000-0002-1846-6007; Spiller, Fernando/0000-0002-4875-5483; Zamboni, Dario S/0000-0002-7856-7512; Cunha, Fernando Queiroz/0000-0003-4755-1670; Castanheira, Fernanda/0000-0002-2024-7858; Dias da Cunha, Larissa/0000-0002-1290-0263	Sao Paulo Research Foundation (FAPESP) [2008/11593-4, 2011/19670-0]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); European Community [HEALTH-F4-2011-281608]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Community(European Commission)	This work was supported by Sao Paulo Research Foundation (FAPESP), grant #2008/11593-4 and #2011/19670-0, CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and European Community's Seventh Framework Programme [FP7-2007-2013] under grant agreement number HEALTH-F4-2011-281608. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens P, 2004, PEDIATR RES, V55, P652, DOI 10.1203/01.PDR.0000112100.61253.85; Alves JC, 2006, CRIT CARE MED, V34, P461, DOI 10.1097/01.CCM.0000198527.71819.E1; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Benjamim CF, 2000, J INFECT DIS, V182, P214, DOI 10.1086/315682; Cartwright N, 2007, AM J RESP CRIT CARE, V175, P595, DOI 10.1164/rccm.200608-1103OC; Castoldi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037584; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Dharancy S, 2010, GASTROENTEROLOGY, V138, P1546, DOI 10.1053/j.gastro.2009.12.008; Ekman AK, 2010, IMMUNOLOGY, V130, P55, DOI 10.1111/j.1365-2567.2009.03212.x; Farkas L, 2008, SCAND J IMMUNOL, V68, P315, DOI 10.1111/j.1365-3083.2008.02145.x; Feng Y, 2011, ANESTHESIOLOGY, V115, P555, DOI 10.1097/ALN.0b013e31822a22f7; Freitas A, 2009, J IMMUNOL, V182, P7846, DOI 10.4049/jimmunol.0803039; Frutuoso MS, 2010, MICROBES INFECT, V12, P819, DOI 10.1016/j.micinf.2010.05.006; Gais P, 2012, J IMMUNOL, V188, P5833, DOI 10.4049/jimmunol.1200038; Godshall CJ, 2002, J SURG RES, V102, P45, DOI 10.1006/jsre.2001.6319; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Marriott I, 2005, INFECT IMMUN, V73, P2967, DOI 10.1128/IAI.73.5.2967-2973.2005; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Moyer MW, 2012, NAT MED, V18, P999, DOI 10.1038/nm0712-999; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oh SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003351; Park JH, 2007, J IMMUNOL, V179, P514, DOI 10.4049/jimmunol.179.1.514; Peck-Palmer OM, 2008, J LEUKOCYTE BIOL, V83, P1009, DOI 10.1189/jlb.0807528; Reim D, 2011, J LEUKOCYTE BIOL, V90, P613, DOI 10.1189/jlb.1110602; Seeley EJ, 2012, AM J PHYSIOL-LUNG C, V303, pL355, DOI 10.1152/ajplung.00069.2012; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Soehnlein O, 2008, CLIN EXP IMMUNOL, V151, P139, DOI 10.1111/j.1365-2249.2007.03532.x; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tavares-Murta BM, 2002, CRIT CARE MED, V30, P1056, DOI 10.1097/00003246-200205000-00017; Trevelin SC, 2012, CRIT CARE MED, V40, P2631, DOI 10.1097/CCM.0b013e318258fb70; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Weighardt H, 2002, J IMMUNOL, V169, P2823, DOI 10.4049/jimmunol.169.6.2823; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2	38	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103734	10.1371/journal.pone.0103734	http://dx.doi.org/10.1371/journal.pone.0103734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084278	Green Published, gold			2022-12-27	WOS:000339819800075
J	Vineretsky, KA; Karagas, MR; Kuriger-Laber, JK; Waterboer, T; Pawlita, M; Nelson, HH				Vineretsky, Karin A.; Karagas, Margaret R.; Kuriger-Laber, Jacquelyn K.; Waterboer, Tim; Pawlita, Michael; Nelson, Heather H.			HLA-C-35kb Expression SNP Is Associated with Differential Control of beta-HPV Infection in Squamous Cell Carcinoma Cases and Controls	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; DELTA T-CELLS; HUMAN-PAPILLOMAVIRUS INFECTION; HLA-C; EPIDERMODYSPLASIA-VERRUCIFORMIS; SKIN-CANCER; BASAL-CELL; IMMUNE-SURVEILLANCE; POPULATION; SYSTEM	A single nucleotide polymorphism (SNP) 35 kb upstream of the HLA-C gene is associated with HLA-C expression, and the high expressing genotype (CC) has been associated with HIV-1 control. HLA-C is unique among the classical MHC class I molecules for its role in the control of viral infections and recognition of abnormal or missing self. This immunosurveillance is central to the pathogenesis of non-melanoma skin cancer (NMSC) and of squamous cell carcinoma (SCC) in particular e sun exposure is a major risk factor for these cancers, cutaneous infections with genus beta-HPV have been implicated in the development of SCC. We hypothesized that the high expression HLA-C genotype is associated with beta-HPV infections. Therefore we investigated the association between beta-HPV serology and the -35 kb SNP (rs9264942) in a population-based case-control study of 510 SCC cases and 608 controls. Among controls the high expression -35 kb SNP genotype (CC) reduced the likelihood of positive serology for multiple (>= 2) beta-HPV infections (OR=0.49, 95% CI: 0.25-0.97), and beta-HPV species 2 infection (OR=0.43, 95% CI: 0.23-0.79). However, no association with beta-HPV status was observed among SCC cases. Our findings suggest that underlying immunogenotype plays an important role in differential control of beta-HPV in SCC cases and controls.	[Vineretsky, Karin A.] Univ Minnesota, Sch Publ Hlth, Dept Environm Hlth Sci, Minneapolis, MN 55455 USA; [Karagas, Margaret R.] Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Dept Community & Family Med, Hanover, NH USA; [Waterboer, Tim; Pawlita, Michael] German Canc Res Ctr, Heidelberg, Germany; [Kuriger-Laber, Jacquelyn K.; Nelson, Heather H.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Kuriger-Laber, Jacquelyn K.; Nelson, Heather H.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Dartmouth College; Norris Cotton Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Nelson, HH (corresponding author), Univ Minnesota, Sch Publ Hlth, Dept Environm Hlth Sci, Minneapolis, MN 55455 USA.	hhnelson@umn.edu	Waterboer, Tim/G-1252-2010	Pawlita, Michael/0000-0002-4720-8306; Nelson, Heather/0000-0003-1901-9513	NIH [R01 CA 82354, R01 CA057494, R01 CA118443]; NATIONAL CANCER INSTITUTE [R01CA118443, R01CA057494, R01CA082354, P30CA023108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH R01 CA 82354, R01 CA057494, R01 CA118443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], RS9264942 NAT CTR BI; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Athar M, 2011, ARCH BIOCHEM BIOPHYS, V508, P159, DOI 10.1016/j.abb.2011.01.004; Bernard HU, 2013, INFECT GENET EVOL, V18, P357, DOI 10.1016/j.meegid.2013.03.011; Blais ME, 2011, IMMUNOLOGY, V133, P1, DOI 10.1111/j.1365-2567.2011.03422.x; Boyman O, 2007, TRENDS IMMUNOL, V28, P51, DOI 10.1016/j.it.2006.12.005; Chen D, 2011, HUM MOL GENET, V20, P4714, DOI 10.1093/hmg/ddr383; Chen HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002514; Christoph T, 2000, BRIT J DERMATOL, V142, P862, DOI 10.1046/j.1365-2133.2000.03464.x; Crequer A, 2013, J CLIN IMMUNOL, V33, P14, DOI 10.1007/s10875-012-9749-1; de Koning MNC, 2007, J GEN VIROL, V88, P1489, DOI 10.1099/vir.0.82732-0; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Dell'Oste V, 2009, J INVEST DERMATOL, V129, P1026, DOI 10.1038/jid.2008.317; Doorbar J., 2005, J CLIN VIROL, V32, pS7, DOI DOI 10.1016/j.jcv.2004.12.006; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Eisemann N, 2014, J INVEST DERMATOL, V134, P43, DOI 10.1038/jid.2013.304; Farzan SF, 2013, INT J CANCER, V133, P1713, DOI 10.1002/ijc.28176; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Ferrarini M, 2002, TRENDS IMMUNOL, V23, P14, DOI 10.1016/S1471-4906(01)02110-X; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Harwood CA, 2004, BRIT J DERMATOL, V150, P949, DOI 10.1111/j.1365-2133.2004.05847.x; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Herman Sara, 2007, Skinmed, V6, P234, DOI 10.1111/j.1540-9740.2007.06174.x; Hundhausen C, 2012, J INVEST DERMATOL, V132, P635, DOI 10.1038/jid.2011.378; Iannacone MR, 2014, INT J CANCER, V134, P2231, DOI 10.1002/ijc.28552; Karagas MR, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c2986; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Karagas MR, 1998, ENVIRON HEALTH PERSP, V106, P1047, DOI 10.1289/ehp.98106s41047; Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R; Karagas MR, 2006, CANC EPIDEMIOLOGY PR, P1230, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0064; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Kulpa DA, 2011, IMMUNOLOGY, V134, P116, DOI 10.1111/j.1365-2567.2011.03474.x; Kuo IH, 2013, J ALLERGY CLIN IMMUN, V131, P266, DOI 10.1016/j.jaci.2012.12.1563; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Lazarczyk M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039995; MAJEWSKI S, 1990, J AM ACAD DERMATOL, V22, P423, DOI 10.1016/0190-9622(90)70058-P; Miller KL, 2006, CARCINOGENESIS, V27, P1670, DOI 10.1093/carcin/bgi376; Muehleisen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040754; Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008; Patel AS, 2008, INT J CANCER, V122, P2377, DOI 10.1002/ijc.23377; Proby CM, 2011, AM J TRANSPLANT, V11, P1498, DOI 10.1111/j.1600-6143.2011.03589.x; Rees JR, 2007, J AM ACAD DERMATOL, V56, P781, DOI 10.1016/j.jaad.2006.11.038; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Viarisio D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002125; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Zavattaro E, 2014, MODERN PATHOLOGY, DOI [10.1038/mod-pathol.2013.240, DOI 10.1038/MOD-PATHOL.2013.240]	48	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103710	10.1371/journal.pone.0103710	http://dx.doi.org/10.1371/journal.pone.0103710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083782	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800070
J	Xu, H; Sun, YJ; Wang, XJ; Fu, Y; Dong, YF; Li, Y				Xu, Hao; Sun, Yujun; Wang, Xinjie; Fu, Yao; Dong, Yunfei; Li, Ying			Nonlinear Mixed-Effects (NLME) Diameter Growth Models for Individual China-Fir (Cunninghamia lanceolata) Trees in Southeast China	PLOS ONE			English	Article							DOMINANT HEIGHT GROWTH; INCREMENT MODEL; SLASH PINE; STONE PINE; STANDS	An individual-tree diameter growth model was developed for Cunninghamia lanceolata in Fujian province, southeast China. Data were obtained from 72 plantation-grown China-fir trees in 24 single-species plots. Ordinary non-linear least squares regression was used to choose the best base model from among 5 theoretical growth equations; selection criteria were the smallest absolute mean residual and root mean square error and the largest adjusted coefficient of determination. To account for autocorrelation in the repeated-measures data, we developed one-level and nested two-level nonlinear mixed-effects (NLME) models, constructed on the selected base model; the NLME models incorporated random effects of the tree and plot. The best random-effects combinations for the NLME models were identified by Akaike's information criterion, Bayesian information criterion and -2 logarithm likelihood. Heteroscedasticity was reduced with two residual variance functions, a power function and an exponential function. The autocorrelation was addressed with three residual autocorrelation structures: a first-order autoregressive structure [AR(1)], a combination of first-order autoregressive and moving average structures [ARMA(1,1)] and a compound symmetry structure (CS). The one-level (tree) NLME model performed best. Independent validation data were used to test the performance of the models and to demonstrate the advantage of calibrating the NLME models.	[Xu, Hao; Sun, Yujun; Wang, Xinjie; Fu, Yao; Dong, Yunfei] Beijing Forestry Univ, Coll Forestry, Key Lab Silviculture & Conservat, Minist Educ, Beijing, Peoples R China; [Li, Ying] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Sun, YJ (corresponding author), Beijing Forestry Univ, Coll Forestry, Key Lab Silviculture & Conservat, Minist Educ, Beijing, Peoples R China.	sunyj@bjfu.edu.cn			Special Public Interest Research and Industry Fund of Forestry [200904003-1]; project of forestry science and technology research [2012-07]	Special Public Interest Research and Industry Fund of Forestry; project of forestry science and technology research	Total expense of field investigation was borne by the Special Public Interest Research and Industry Fund of Forestry (No. 200904003-1) and the project of forestry science and technology research (No. 2012-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame P, 2008, FOREST ECOL MANAG, V255, P1011, DOI 10.1016/j.foreco.2007.10.019; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barrio-Anta M, 2006, CAN J FOREST RES, V36, P1461, DOI 10.1139/X06-028; BIGING GS, 1985, FOREST SCI, V31, P248; Calama R, 2005, SILVA FENN, V39, P37, DOI 10.14214/sf.394; Calama R, 2004, CAN J FOREST RES, V34, P150, DOI [10.1139/x03-199, 10.1139/X03-199]; Castedo-Dorado F, 2007, ANN FOREST SCI, V64, P609, DOI 10.1051/forest:2007039; CHENG C, 2012, FORESTRY, V2, P271; Crecente-Campo F, 2010, FOREST ECOL MANAG, V260, P1965, DOI 10.1016/j.foreco.2010.08.044; Davidian M., 1995, NONLINEAR MODELS REP; Fang ZX, 2001, FOREST SCI, V47, P287; Fontes L, 2003, FORESTRY, V76, P509, DOI 10.1093/forestry/76.5.509; Fox JC, 2001, FOREST ECOL MANAG, V154, P261, DOI 10.1016/S0378-1127(00)00632-0; Fu LY, 2013, FOREST ECOL MANAG, V302, P210, DOI 10.1016/j.foreco.2013.03.036; GREGOIRE TG, 1995, CAN J FOREST RES, V25, P137, DOI 10.1139/x95-017; GREGOIRE TG, 1987, FOREST SCI, V33, P423; IHAKA R, 2004, R LANG ENV STAT COMP; Jordan L, 2005, FOREST SCI, V51, P357; Keselman HJ, 1999, BRIT J MATH STAT PSY, V52, P63, DOI 10.1348/000711099158964; Kitikidou K, 2012, RENEW SUST ENERG REV, V16, P1323, DOI 10.1016/j.rser.2011.10.010; LAPPI J, 1994, FOREST SCI, V40, P715; Lappi J, 1986, COMMUNICATIONS I FOR; Laubhann D, 2009, FOREST ECOL MANAG, V258, P1751, DOI 10.1016/j.foreco.2008.09.050; LEAK W, 1966, FOREST SCI, V12, P69; Leites LP, 2009, CAN J FOREST RES, V39, P655, DOI 10.1139/X08-205; Lhotka JM, 2011, FOREST ECOL MANAG, V261, P770, DOI 10.1016/j.foreco.2010.12.008; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Meng SX, 2009, FOREST SCI, V55, P238; Nigh G, 2012, FOREST CHRON, V88, P340, DOI 10.5558/tfc2012-061; OMULE SAY, 1991, CAN J FOREST RES, V21, P1418, DOI 10.1139/x91-199; PALMER MJ, 1991, BIOMETRICS, V47, P623, DOI 10.2307/2532151; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pinheiro JC, 1995, MODEL BUILDING NONLI; Porte A, 2002, ECOL MODEL, V150, P141, DOI 10.1016/S0304-3800(01)00476-8; Rathbun LC, 2011, ECOL MODEL, V222, P2234, DOI 10.1016/j.ecolmodel.2011.04.004; Schabenberger Oliver, 1995, Silva Fennica, V29, P49; Timilsina N, 2013, FOREST SCI, V59, P27, DOI 10.5849/forsci.10-028; Uzoh FCC, 2008, FOREST ECOL MANAG, V256, P438, DOI 10.1016/j.foreco.2008.04.046; Vanclay J. K., 1994, Modelling forest growth and yield: applications to mixed tropical forests.; Vonesh E.F., 1997, LINEAR AND NONLINEAR; Weiss RE., 2005, MODELING LONGITUDINA, DOI 10.1007/0-387-28314-5; WEST PW, 1984, FOREST ECOL MANAG, V7, P207, DOI 10.1016/0378-1127(84)90068-9; WOLFINGER RD, 1999, FITTING NONLINEAR MI; WYKOFF WR, 1990, FOREST SCI, V36, P1077; Yang YQ, 2009, EUR J FOREST RES, V128, P415, DOI 10.1007/s10342-009-0286-2; Zhang J.G., 2011, SELF THINNING GROWTH; Zhao L, 2012, J FOREST RES, V4, P305	47	27	31	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104012	10.1371/journal.pone.0104012	http://dx.doi.org/10.1371/journal.pone.0104012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084538	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800118
J	Flensborg-Madsen, T; Mortensen, EL				Flensborg-Madsen, Trine; Mortensen, Erik Lykke			Infant SES as a Predictor of Personality-Is the Association Mediated by Intelligence?	PLOS ONE			English	Article							SOCIAL DESIRABILITY SCALES; ALL-CAUSE-MORTALITY; EPQ LIE SCALE; SOCIOECONOMIC-STATUS; DUAL NATURE; PSYCHOTICISM SCALE; ADULT MORTALITY; HEART-DISEASE; YOUNG-ADULTS; RISK-FACTORS	Background: Although research into the continuity and change of personality traits during a lifespan has been fairly extensive, little research has been conducted on childhood predictors of adult personality. Purpose: We aimed to investigate the association between infant socioeconomic status (SES), and Eysenck personality traits in adulthood. An additional aim was to investigate whether intelligence and education may mediate this association. Methods: SES of 9125 children in the Copenhagen Perinatal Cohort was recorded at a 1-year examination. A subsample of this cohort, comprising 1182 individuals, participated in a follow-up at 20-34 years and was administered the Eysenck Personality Questionnaire (EPQ) which includes measures of neuroticism, extraversion, psychoticism and the so-called lie-scale. Associations of SES with each of the four personality traits were analysed by bivariate and partial correlations, and the mediating effects of intelligence and years of education were analysed. Results: Higher SES in infancy was associated with lower neuroticism (r = -0.06; p = 0.05), lower lie-scale scores (r = -0.11; p = 0.0002), and higher psychoticism (r = 0.09; p = 0.003). However, analyses of mediation revealed no direct effect of infant SES on any of the adult personality traits, but only indirect effects mediated by intelligence and years of education, with intelligence being the main mediating factor. Conclusion: Only weak associations were observed between infant SES and personality in young adulthood, and the observed associations were mediated by adult intelligence and educational level. Thus, factors associated with infant SES or family background appears to have weak direct effects on personality development.	[Flensborg-Madsen, Trine; Mortensen, Erik Lykke] Univ Copenhagen, Unit Med Psychol, Inst Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Fac Med & Hlth Sci, Ctr Healthy Aging, Copenhagen, Denmark; [Mortensen, Erik Lykke] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Flensborg-Madsen, T (corresponding author), Univ Copenhagen, Unit Med Psychol, Inst Publ Hlth, Copenhagen, Denmark.	tfma@sund.ku.dk		Flensborg-Madsen, Trine/0000-0002-6753-335X; Mortensen, Erik Lykke/0000-0002-6985-451X	IMK Almene Fond; National Institute of Child Health and Human Development [HD-17655, HD-20263]; National Institute of Drug Abuse [DA05056]; Danish Research Council [9700093]; Danish National Board of Health [1400/2-4-1997]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017655, R01HD020263] Funding Source: NIH RePORTER	IMK Almene Fond; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Danish Research Council(Det Frie Forskningsrad (DFF)); Danish National Board of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by a grant from the IMK Almene Fond to Trine Flensborg-Madsen. In addition, the study was supported by grants HD-17655 and HD-20263 from the National Institute of Child Health and Human Development to June Reinisch, grant DA05056 from the National Institute of Drug Abuse to June Reinisch, grant 9700093 from the Danish Research Council to Erik Lykke Mortensen, and grant 1400/2-4-1997 from the Danish National Board of Health to Erik Lykke Mortensen. The authors acknowledge the crucial role of AL Villumsen and B Zachau-Christiansen in the establishment of the Copenhagen Perinatal Cohort and thank the Steering Committee for permission to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ackerman PL, 1997, PSYCHOL BULL, V121, P219, DOI 10.1037/0033-2909.121.2.219; Allin M, 2006, PEDIATRICS, V117, P309, DOI 10.1542/peds.2005-0539; Andersen SL, 2013, J GERONTOL B-PSYCHOL, V68, P739, DOI 10.1093/geronb/gbs117; Antoniou EE, 2013, J GERONTOL B-PSYCHOL, V68, P730, DOI 10.1093/geronb/gbt003; Batty GD, 2008, HEART, V94, P1541, DOI 10.1136/hrt.2008.149567; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Bernard NS, 2002, J PERS ASSESS, V78, P321, DOI 10.1207/S15327752JPA7802_07; BIRENBAUM M, 1989, EUR J PERSONALITY, V3, P47, DOI 10.1002/per.2410030106; Bosma H, 1999, BRIT MED J, V319, P1469, DOI 10.1136/bmj.319.7223.1469; Bosma H, 2005, SOC SCI MED, V60, P737, DOI 10.1016/j.socscimed.2004.06.018; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Chapman BP, 2010, AM J EPIDEMIOL, V171, P83, DOI 10.1093/aje/kwp323; CROOKES TG, 1976, IRISH J PSYCHOL, V3, P134, DOI 10.1080/03033910.1976.10557626; DeYoung C. G., 2011, CAMBRIDGE HDB INTELL, P711, DOI DOI 10.1017/CBO9780511977244.036; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; Eysenck HJ., 1976, PSYCHOTICISM DIMENSI; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1; Ferrando PJ, 2008, PERS INDIV DIFFER, V44, P1784, DOI 10.1016/j.paid.2008.02.005; Flensborg-Madsen Trine, 2014, BMC Psychol, V2, P8, DOI 10.1186/2050-7283-2-8; FRANCIS LJ, 1991, PERS INDIV DIFFER, V12, P1255, DOI 10.1016/0191-8869(91)90197-J; FRANCIS LJ, 1991, PERS INDIV DIFFER, V12, P989, DOI 10.1016/0191-8869(91)90028-A; FRANCIS LJ, 1983, PSYCHOL REP, V52, P551, DOI 10.2466/pr0.1983.52.2.551; Frank JW, 2003, SOC SCI MED, V57, P2305, DOI 10.1016/j.socscimed.2003.08.003; Furnham, 2005, PERSONALITY INTELLEC; FURNHAM A, 1986, PERS INDIV DIFFER, V7, P385, DOI 10.1016/0191-8869(86)90014-0; Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174; Graffar M., 1960, MOD PROBL PADIAT, V5, P30; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hansen HS, 2004, DOKUMENTATION DANSKE; Harper S, 2002, INT J EPIDEMIOL, V31, P395, DOI 10.1093/ije/31.2.395; Harris JA, 1999, EUR J PERSONALITY, V13, P121, DOI 10.1002/(SICI)1099-0984(199903/04)13:2<121::AID-PER324>3.0.CO;2-U; HARRIS JA, 1996, BEHAV GENET, V26, P587; Heaven PCL, 2013, BRIT J PSYCHOL, V104, P481, DOI 10.1111/bjop.12002; HOWARTH E, 1986, BRIT J PSYCHOL, V77, P223, DOI 10.1111/j.2044-8295.1986.tb01996.x; Jokela M, 2013, OBES REV, V14, P315, DOI 10.1111/obr.12007; JOKELA M, 2013, AM J EPIDEMIOL; Jonassaint CR, 2007, PSYCHOSOM MED, V69, P319, DOI 10.1097/PSY.0b013e318052e27d; Jonassaint CR, 2011, INT J BEHAV MED, V18, P13, DOI 10.1007/s12529-009-9069-x; KIRTON M, 1977, PSYCHOL REP, V40, P279, DOI 10.2466/pr0.1977.40.1.279; Lucas R. E., 2008, HDB PERSONALITY; Luciano M, 2006, PERS INDIV DIFFER, V40, P1189, DOI 10.1016/j.paid.2005.10.013; Mackintosh Nicholas John, 2011, IQ HUMAN INTELLIGENC; MASSEY A, 1980, IRISH J PSYCHOL, V4, P172; Matthews G., 2009, PERSONALITY TRAITS; Matthews KA, 2008, HEALTH PSYCHOL, V27, P576, DOI 10.1037/0278-6133.27.5.576; MCCRAE RR, 1983, J CONSULT CLIN PSYCH, V51, P882, DOI 10.1037/0022-006X.51.6.882; Millar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058256; Mortensen EL, 2005, BRIT J PSYCHIAT, V187, P407, DOI 10.1192/bjp.187.5.407; Mortensen EL, 2014, J AGING HEALTH, V26, P21, DOI 10.1177/0898264313519317; ODONOVAN D, 1969, RES PSYCHOL, V3, P13; PEARSON PR, 1989, PERS INDIV DIFFER, V10, P1041, DOI 10.1016/0191-8869(89)90255-9; Pincombe JL, 2007, TWIN RES HUM GENET, V10, P462, DOI 10.1375/twin.10.3.462; Power C, 1996, BRIT MED J, V313, P449; REINISCH JM, 1993, ACTA PSYCHIAT SCAND, V87, P54, DOI 10.1111/j.1600-0447.1993.tb05361.x; ROBERTS BW, 2008, HDB PERSONALITY; Schmidt LA, 2008, PEDIATRICS, V122, pE181, DOI 10.1542/peds.2007-3747; Smith GD, 1997, BMJ-BRIT MED J, V314, P547, DOI 10.1136/bmj.314.7080.547; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; Smith TW, 2006, ANNU REV CLIN PSYCHO, V2, P435, DOI 10.1146/annurev.clinpsy.2.022305.095257; Sutin AR, 2010, PSYCHOL MED, V40, P1485, DOI 10.1017/S0033291709992029; TEASDALE TW, 1984, NATURE, V309, P620, DOI 10.1038/309620a0; TEASDALE TW, 1985, THESIS GLEERUP MALMO; Terracciano A, 2004, ADDICTION, V99, P472, DOI 10.1111/j.1360-0443.2004.00687.x; Terracciano A, 2008, PSYCHOSOM MED, V70, P621, DOI 10.1097/PSY.0b013e31817b9371; VAGERO D, 1994, LANCET, V343, P1224, DOI 10.1016/S0140-6736(94)92432-5; Villumsen, 1970, ENV FACTORS CONGENIT; Wamala SP, 2001, INT J EPIDEMIOL, V30, P275, DOI 10.1093/ije/30.2.275; WECHSLER D, 2012, MEASUREMENT APPRAISA; Wechsler D, 1958, MEASUREMENT APPRAISA; WIDIGER TA, 2008, HDB PERSONALITY; Wilson RS, 2004, J GERONTOL B-PSYCHOL, V59, pP110, DOI 10.1093/geronb/59.3.P110; Zachau-Christiansen B., 1972, INFLUENCE PRENATAL P; ZACHAUCHRISTIAN.B, 1975, BABIES HUMAN DEV 1 Y	73	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103846	10.1371/journal.pone.0103846	http://dx.doi.org/10.1371/journal.pone.0103846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6EF	25078408	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800089
J	You, XX; Liu, LZ; Zeng, YH; Li, RH; He, J; Ma, XH; Jiang, CH; Zhu, CM; Chen, LS; Yu, MJ; Ou, GL; Wu, YM				You, Xiaoxing; Liu, Liangzhuan; Zeng, Yanhua; Li, Ranhui; He, Jun; Ma, Xiaohua; Jiang, Chuanhao; Zhu, Cuiming; Chen, Liesong; Yu, Minjun; Ou, Guangli; Wu, Yimou			Macrophage-Activating Lipopeptide-2 Requires Mal and PI3K for Efficient Induction of Heme Oxygenase-1	PLOS ONE			English	Article							MYD88 ADAPTER-LIKE; BRUTONS TYROSINE KINASE; MYCOPLASMA-GENITALIUM INFECTION; AIRWAY EPITHELIAL-CELLS; TOLL-LIKE RECEPTOR-2; NF-KAPPA-B; SIGNAL-TRANSDUCTION; HUMAN MONOCYTES; INFLAMMATORY RESPONSES; NEGATIVE REGULATION	Aims: This study is to investigate the mechanisms by which macrophage-activating lipopeptide-2 (MALP-2) induces heme oxygenase (HO)-1, a cytoprotective enzyme that catalyzes the degradation of heme, in human monocytes. Methods: Human monocytic THP-1 cells were cultured for transient transfection with plasmids and stimulation with MALP-2 for indicative time intervals. After incubation with MALP-2, cells were collected and disrupted, before being tested for promoter activity using luciferase assay. For analysis of proteins, immunoreactive bands were detected using an enhanced chemiluminescence Western blotting system, and the band intensity was measured by densitometryic analysis. For the detection of co-immunoprecipitation, SDS-PAGE was performed and the membranes were probed using respective antibodies. To investigate the cellular localization of NF-E2-related factor 2 (Nrf2), cells underwent immunofluorescence staining and confocal microscopy, and were analyzed using electrophoretic mobility shift assay. Results: MALP-2-induced HO-1 expression and promoter activity were abrogated by transfection with dominant negative (DN) plasmids of TLR2 and TLR6, or their neutralizing antibodies. However, inhibition of MyD88 or transfection with the DN-MyD88 was insufficient to attenuate HO-1 expression. In contrast, mutation or silencing of MyD88 adapter-like (Mal) by DN-Mal or siRNA almost completely blocked HO-1 induction. Btk, c-Src and PI3K were also involved in MALP-2-induced HO-1 expression, as revealed by specific inhibitors LFM-A13, PP1 and LY294002, or by transfection with siRNA of c-Src. MALP-2-induced activation of PI3K was attenuated by transfection with DN mutant of Mal, and by pretreatment with LFM-A13 or PP1. Furthermore, MALP-2 stimulated the translocation of Nrf2 from the cytosol to the nucleus and Nrf2 binding to the ARE site in the HO-1 promoter, which could also be inhibited by pretreatment with a PI3K inhibitor, LY294002. Conclusions: These results indicated that MALP-2 required TLR2/6, Btk, Mal and c-Src to activate PI3K, which in turn initiated the activation of Nrf2 for efficient HO-1 induction.	[You, Xiaoxing; Liu, Liangzhuan; Zeng, Yanhua; Li, Ranhui; He, Jun; Ma, Xiaohua; Jiang, Chuanhao; Zhu, Cuiming; Chen, Liesong; Yu, Minjun; Ou, Guangli; Wu, Yimou] Univ South China, Coll Med, Inst Pathogen Biol, Hengyang City, Peoples R China; [Ma, Xiaohua] Changsha Cent Hosp, Dept Clin Lab, Chagnsha City, Peoples R China; [He, Jun] Univ South China, Affiliated Nanhua Hosp, Dept Clin Lab, Hengyang City, Peoples R China	University of South China; University of South China	Wu, YM (corresponding author), Univ South China, Coll Med, Inst Pathogen Biol, Hengyang City, Peoples R China.	yimouwu82503@163.com	Chen, Liesong/GZK-2499-2022; MA, XIAO/HHN-5611-2022		National Natural Science Foundation of China [31000091]; Hunan Provincial Natural Science Foundation of China [14JJ2090]; Science and Technology Planning Project of Hunan Province [2013TT2013]; construct program of the key discipline in Hunan Province [2011-75]; Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control Foundation [2014-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Science and Technology Planning Project of Hunan Province; construct program of the key discipline in Hunan Province; Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control Foundation	This work was supported by the National Natural Science Foundation of China (No. 31000091), Hunan Provincial Natural Science Foundation of China (No. 14JJ2090), the Science and Technology Planning Project of Hunan Province (Grant No. 2013TT2013), construct program of the key discipline in Hunan Province (No. 2011-75) and Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control Foundation (No. 2014-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo ECB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-89; Bao Y, 2012, J BIOL CHEM, V287, P23769, DOI 10.1074/jbc.M112.372425; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Byeon SE, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/512926; Catrein I, 2011, PROTEOMICS, V11, P3614, DOI 10.1002/pmic.201100076; Chen HH, 2012, FREE RADICAL BIO MED, V52, P1054, DOI 10.1016/j.freeradbiomed.2011.12.012; Citti C, 2013, TRENDS MICROBIOL, V21, P196, DOI 10.1016/j.tim.2013.01.003; Dunne A, 2010, J BIOL CHEM, V285, P18276, DOI 10.1074/jbc.M109.098137; Gonzalez-Serrano ME, 2012, J CLIN IMMUNOL, V32, P967, DOI 10.1007/s10875-012-9706-z; Gao F, 2010, TOXICOL APPL PHARM, V247, P146, DOI 10.1016/j.taap.2010.06.007; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Honda F, 2012, NAT IMMUNOL, V13, P369, DOI 10.1038/ni.2234; Into T, 2007, INFECT IMMUN, V75, P2253, DOI 10.1128/IAI.00141-07; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kandasamy P, 2011, J BIOL CHEM, V286, P7841, DOI 10.1074/jbc.M110.170241; Kaufmann A, 1999, INFECT IMMUN, V67, P6303; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Lee KE, 2013, J CLIN IMMUNOL, V33, P1117, DOI 10.1007/s10875-013-9909-y; Lijeroos M, 2007, CELL SIGNAL, V19, P625, DOI 10.1016/j.cellsig.2006.08.013; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Ma XH, 2013, CLIN VACCINE IMMUNOL, V20, P827, DOI 10.1128/CVI.00716-12; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; McGowin CL, 2013, J INFECT DIS, V207, P1857, DOI 10.1093/infdis/jit101; McGowin CL, 2012, INFECT IMMUN, V80, P3842, DOI 10.1128/IAI.00819-12; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Nishiguchi M, 2001, J IMMUNOL, V166, P2610, DOI 10.4049/jimmunol.166.4.2610; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; OSUSKY M, 1995, J BIOL CHEM, V270, P25729, DOI 10.1074/jbc.270.43.25729; Park SY, 2010, CHEM-BIOL INTERACT, V188, P437, DOI 10.1016/j.cbi.2010.09.007; Rawadi G, 1999, J IMMUNOL, V162, P2193; Rushworth SA, 2005, J IMMUNOL, V175, P4408, DOI 10.4049/jimmunol.175.7.4408; Rushworth SA, 2008, J IMMUNOL, V181, P6730, DOI 10.4049/jimmunol.181.10.6730; Rushworth SA, 2011, J IMMUNOL, V187, P702, DOI 10.4049/jimmunol.1004117; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Singhal E, 2011, J BIOL CHEM, V286, P32054, DOI 10.1074/jbc.M111.271247; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Truchetet ME, 2011, J INFECT DIS, V204, P1796, DOI 10.1093/infdis/jir630; Ulrichts P, 2010, J CELL SCI, V123, P256, DOI 10.1242/jcs.056002; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Vijayan V, 2011, J IMMUNOL, V187, P817, DOI 10.4049/jimmunol.1003631; Waites KB, 2012, J MOL DIAGN, V14, P437, DOI 10.1016/j.jmoldx.2012.06.001; Wang Y, 2012, J IMMUNOL, V188, P3371, DOI 10.4049/jimmunol.1100573; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang QH, 2012, J BIOL CHEM, V287, P6208, DOI 10.1074/jbc.M111.310375	52	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103433	10.1371/journal.pone.0103433	http://dx.doi.org/10.1371/journal.pone.0103433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077631	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800044
J	Golden-Mason, L; Hahn, YS; Strong, M; Cheng, LL; Rosen, HR				Golden-Mason, Lucy; Hahn, Young S.; Strong, Michael; Cheng, Linling; Rosen, Hugo R.			Extracellular HCV-Core Protein Induces an Immature Regulatory Phenotype in NK Cells: Implications for Outcome of Acute Infection	PLOS ONE			English	Article							HEPATITIS-C VIRUS; NATURAL-KILLER-CELLS; ENVELOPE PROTEIN; EXPRESSION; CYTOTOXICITY; FREQUENCY; IMMUNITY; ALPHA; REPLICATION; PERSISTENCE	Background: Hepatitis C viral (HCV) proteins, including core, demonstrate immuno-modulatory properties; however, the effect of extracellular core on natural killer (NK) cells has not previously been investigated. Aims: To characterise NKs in acute HCV infection over time, and, to examine the effect of exogenous HCV-core protein on NK cell phenotype and function. Methods: Acute HCV patients (n = 22), including 10 subjects who spontaneously recovered, were prospectively studied. Flow-cytometry was used to measure natural cytotoxicity and to phenotype NKs directly ex vivo and after culture with HCV-core protein. Microarray analysis was used to identify pathways involved in the NK cell response to exogenous HCV-core. Results: Direct ex vivo analysis demonstrated an increased frequency of immature/regulatory CD56(bright) NKs early in acute HCV infection per se which normalized with viral clearance. Natural cytotoxicity was reduced and did not recover after viral clearance. There was a statistically significant correlation between the frequency of CD56(bright) NKs and circulating serum levels of HCV core protein. In vitro culture of purified CD56(bright) NK cells with HCV-core protein in the presence of IL-15 maintained a significant proportion of NKs in the CD56(bright) state. The in vitro effect of core closely correlates with NK characteristics measured directly ex vivo in acute HCV infection. Pathway analysis suggests that HCV-core protein attenuates NK interferon type I responses. Conclusions: Our data suggest that HCV-core protein alters NK cell maturation and may influence the outcome of acute infection.	[Golden-Mason, Lucy; Cheng, Linling; Rosen, Hugo R.] Univ Colorado, Div Gastroenterol & Hepatol, Aurora, CO 80045 USA; [Golden-Mason, Lucy; Cheng, Linling; Rosen, Hugo R.] Univ Colorado, Hepatitis Ctr C, Aurora, CO USA; [Hahn, Young S.] Univ Virginia, Dept Pathol & Microbiol, Beirne Carter Ctr Immunol Res, Charlottesville, VA USA; [Strong, Michael] Univ Colorado, Dept Med, Aurora, CO USA; [Rosen, Hugo R.] Denver Vet Affairs VA, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Virginia; University of Colorado System; University of Colorado Anschutz Medical Campus	Rosen, HR (corresponding author), Univ Colorado, Div Gastroenterol & Hepatol, Aurora, CO 80045 USA.	Hugo.Rosen@UCHSC.edu		Golden-Mason, Lucy/0000-0002-2087-4405; Golden-Mason, Lucy/0000-0003-3347-4192	HCV center grant [U19 A 1066328]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066328, R01AI098126] Funding Source: NIH RePORTER	HCV center grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U19 A 1066328 (HCV center grant, HRR and YSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2004, J LEUKOCYTE BIOL, V76, P743, DOI 10.1189/jlb.0304197; Alter G, 2011, J HEPATOL, V55, P278, DOI 10.1016/j.jhep.2010.11.030; Amadei B, 2010, GASTROENTEROLOGY, V138, P1536, DOI 10.1053/j.gastro.2010.01.006; Biggins SW, 2012, LIVER TRANSPLANT, V18, P1471, DOI 10.1002/lt.23551; Biron CA, 2012, P NATL ACAD SCI USA, V109, P1814, DOI 10.1073/pnas.1120528109; BONAVITA MS, 1993, INT J TISSUE REACT, V15, P11; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bozzano F, 2011, EUR J IMMUNOL, V41, P2905, DOI 10.1002/eji.201041361; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Corado J, 1997, CLIN EXP IMMUNOL, V109, P451, DOI 10.1046/j.1365-2249.1997.4581355.x; Crotta S, 2002, J EXP MED, V195, P35, DOI 10.1084/jem.20011124; De Maria A, 2007, EUR J IMMUNOL, V37, P445, DOI 10.1002/eji.200635989; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Golden-Mason L, 2008, GUT, V57, P1121, DOI 10.1136/gut.2007.130963; Golden-Mason L, 2007, J VIROL, V81, P9292, DOI 10.1128/JVI.00834-07; Golden-Mason L, 2013, IMMUNOL REV, V255, P68, DOI 10.1111/imr.12090; Golden-Mason L, 2012, HEPATOLOGY, V56, P1214, DOI 10.1002/hep.25771; Golden-Mason L, 2010, HEPATOLOGY, V52, P1581, DOI 10.1002/hep.23896; Heeg M, 2012, HEPATOLOGY, V56, P1197, DOI 10.1002/hep.25858; Herzer K, 2003, J VIROL, V77, P8299, DOI 10.1128/JVI.77.15.8299-8309.2003; Jinushi M, 2004, J IMMUNOL, V173, P6072, DOI 10.4049/jimmunol.173.10.6072; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Large MK, 1999, J IMMUNOL, V162, P931; Li Y, 2004, J LEUKOCYTE BIOL, V76, P1171, DOI 10.1189/jlb.0604372; Lunemann S, 2013, J INFECT DIS, V2013; Marras F, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/152430; Meier UC, 2005, J VIROL, V79, P12365, DOI 10.1128/JVI.79.19.12365-12374.2005; Mondelli MU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00351; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; Morishima C, 2006, HEPATOLOGY, V43, P573, DOI 10.1002/hep.21073; Nattermann J, 2006, GUT, V55, P869, DOI 10.1136/gut.2005.076463; Nattermann J, 2005, AM J PATHOL, V166, P443, DOI 10.1016/S0002-9440(10)62267-5; Oliviero B, 2013, J HEPATOL; Par G, 2002, J HEPATOL, V37, P514, DOI 10.1016/S0168-8278(02)00218-0; Pelletier S, 2010, J HEPATOL, V53, P805, DOI 10.1016/j.jhep.2010.05.013; Rehermann B, 2013, HEPATOLOGY, DOI 10.1002/hep.26353; Rosen HR, 2013, J CLIN INVEST, V123, P4121, DOI 10.1172/JCI67714; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Shilling HG, 2002, J IMMUNOL, V169, P239, DOI 10.4049/jimmunol.169.1.239; Stegmann KA, 2012, J INFECT DIS, V205, P1351, DOI 10.1093/infdis/jis210; Stegmann KA, 2010, GASTROENTEROLOGY, V138, P1885, DOI 10.1053/j.gastro.2010.01.051; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Yao ZQ, 2004, J VIROL, V78, P6409, DOI 10.1128/JVI.78.12.6409-6419.2004	49	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103219	10.1371/journal.pone.0103219	http://dx.doi.org/10.1371/journal.pone.0103219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076408	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800030
J	Lundberg, M; Curbo, S; Reiser, K; Masterman, T; Braesch-Andersen, S; Arestrom, I; Ahlborg, N				Lundberg, Mathias; Curbo, Sophie; Reiser, Kathrin; Masterman, Thomas; Braesch-Andersen, Sten; Arestrom, Irene; Ahlborg, Niklas			Methodological Aspects of ELISA Analysis of Thioredoxin 1 in Human Plasma and Cerebrospinal Fluid	PLOS ONE			English	Article							OXIDATIVE STRESS MARKER; CIRCULATING ANTIBODIES; REDOX REGULATION; S-NITROSYLATION; INTERFERENCE; SPECIFICITY; DISEASE; SYSTEMS; IMMUNOGLOBULIN; IMMUNOASSAYS	Thioredoxin-1 (Trx1) is a protein antioxidant involved in major cellular processes. Increased plasma levels of Trx1 have been associated with human diseases suggesting that Trx1 is a marker for oxidative stress with putative clinical use. However, the reported mean levels of Trx1 in the control cohorts vary a hundred-fold between studies (0.8-87 ng/ml), possibly due to methodological differences between the capture ELISA used in the different studies. The aim of this study was to investigate methodological aspects related to the ELISA measurement of Trx1. ELISAs utilizing different capture and detection combinations of antibodies to Trx1 and as well as recombinant human (rh) Trx1 standards from two sources were characterized. The different ELISAs were subsequently used to measure Trx1 in human plasma and cerebrospinal fluid samples (CSF) from healthy donors and from patients with various neurological diagnoses. The Trx1 standards differed in their content of monomeric and oligomeric Trx1, which affected the ELISAs composed of different antibody combinations. Thus, the levels of Trx1 determined in human plasma and CSF samples varied depending on the antibody used in the ELISAs and on the rhTrx1 standard. Furthermore, the relevance of preventing interference by heterophilic antibodies (HA) in human plasma and CSF was investigated. The addition of a HA blocking buffer to human samples drastically reduced the ELISA signals in many samples showing that HA are likely to cause false positive results unless they are blocked. In conclusion, the study shows that the design of a Trx1 ELISA in regards to antibodies and standards used has an impact on the measured Trx1 levels. Importantly, analyses of human plasma and CSF without preventing HA interference may obscure the obtained data. Overall, the results of this study are crucial for the improvement of future studies on the association of Trx1 levels with various diseases.	[Lundberg, Mathias] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Curbo, Sophie; Reiser, Kathrin] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Masterman, Thomas] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Braesch-Andersen, Sten; Arestrom, Irene; Ahlborg, Niklas] Mabtech, Nacka, Sweden; [Ahlborg, Niklas] Stockholm Univ, Dept Immunol, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm University	Lundberg, M (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden.	Mathias.Lundberg@ki.se	curbo, sophie/AAA-8614-2020	curbo, sophie/0000-0002-0964-0712	Karolinska Institutet research foundation; Soderstrom-Konigska Foundation	Karolinska Institutet research foundation(Karolinska Institutet); Soderstrom-Konigska Foundation	This work was generously supported by the Karolinska Institutet research foundation and the Soderstrom-Konigska Foundation. Mabtech provided support in the form of salaries for authors NA, IA & SB-A, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Arodin L, 2014, ALTERATION THIOREDOX; Berndt C, 2007, AM J PHYSIOL-HEART C, V292, pH1227, DOI 10.1152/ajpheart.01162.2006; BOSCATO LM, 1986, CLIN CHEM, V32, P1491; Callister ME, 2006, THORAX, V61, P521, DOI 10.1136/thx.2005.053041; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Gil-Bea FJ, 2010, J ALZHEIMERS DIS, V22, P405, DOI 10.3233/JAD-2010-100795; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; Hofer S, 2009, CRIT CARE MED, V37, P2155, DOI 10.1097/CCM.0b013e31819fff67; Hokamaki J, 2005, INT J CARDIOL, V99, P225, DOI 10.1016/j.ijcard.2004.01.010; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HUNTER WM, 1980, LANCET, V2, P1136; Jikimoto T, 2002, MOL IMMUNOL, V38, P765, DOI 10.1016/S0161-5890(01)00113-4; Kakisaka Y, 2002, HORM METAB RES, V34, P160, DOI 10.1055/s-2002-23201; Kondo N, 2006, ANTIOXID REDOX SIGN, V8, P1881, DOI 10.1089/ars.2006.8.1881; Kwon YW, 2003, BIOL CHEM, V384, P991, DOI 10.1515/BC.2003.111; Leoni V, 2004, CLIN CHEM LAB MED, V42, P186, DOI 10.1515/CCLM.2004.034; Lundberg M, 2004, BIOCHEM BIOPH RES CO, V319, P801, DOI 10.1016/j.bbrc.2004.04.199; Nakamura H, 1996, INT IMMUNOL, V8, P603, DOI 10.1093/intimm/8.4.603; Owe-Larsson B, 2011, PROG NEURO-PSYCHOPH, V35, P1117, DOI 10.1016/j.pnpbp.2011.03.012; PRINCE AM, 1973, LANCET, V1, P1346; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Sahaf B, 1997, EXP CELL RES, V236, P181, DOI 10.1006/excr.1997.3699; Sehlin D, 2010, J ALZHEIMERS DIS, V21, P1295, DOI 10.3233/JAD-2010-100609; Sengupta R, 2013, ANTIOXID REDOX SIGN, V18, P259, DOI 10.1089/ars.2012.4716; Takahashi KI, 2008, ANTIOXID REDOX SIGN, V10, P715, DOI 10.1089/ars.2007.1949; THOMPSON RJ, 1986, CLIN CHEM, V32, P476; Wahlgren CM, 2005, EUR J VASC ENDOVASC, V29, P281, DOI 10.1016/j.ejvs.2004.12.020; Zhang XY, 2009, SCHIZOPHR RES, V113, P151, DOI 10.1016/j.schres.2009.05.016; ZWEIG MH, 1987, CLIN CHEM, V33, P840	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103554	10.1371/journal.pone.0103554	http://dx.doi.org/10.1371/journal.pone.0103554			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075746	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800064
J	Solca, MD; Bastos, LA; Guedes, CES; Bordoni, M; Borja, LS; Larangeira, DF; Tuy, PGDE; Amorim, LDAF; Nascimento, EG; Oliveira, GGD; dos-Santos, WLC; Fraga, DBM; Veras, PST				Solca, Manuela da Silva; Bastos, Leila Andrade; Sampaio Guedes, Carlos Eduardo; Bordoni, Marcelo; Borja, Lairton Souza; Larangeira, Daniela Farias; da Silva Estrela Tuy, Petala Gardenia; Alves Ferreira Amorim, Leila Denise; Nascimento, Eliane Gomes; De Sa Oliveira, Geraldo Gileno; Conrado dos-Santos, Washington Luis; Mothe Fraga, Deborah Bittencourt; Tavares Veras, Patricia Sampaio			Evaluating the Accuracy of Molecular Diagnostic Testing for Canine Visceral Leishmaniasis Using Latent Class Analysis	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; INFANTUM DNA; REFERENCE-STANDARDS; EXPANDING ZOONOSIS; SEROLOGICAL ASSAYS; INFECTED-DOGS; CHAGASI; ASPIRATIONS; AMAZONENSIS	Host tissues affected by Leishmania infantum have differing degrees of parasitism. Previously, the use of different biological tissues to detect L. infantum DNA in dogs has provided variable results. The present study was conducted to evaluate the accuracy of molecular diagnostic testing (qPCR) in dogs from an endemic area for canine visceral leishmaniasis (CVL) by determining which tissue type provided the highest rate of parasite DNA detection. Fifty-one symptomatic dogs were tested for CVL using serological, parasitological and molecular methods. Latent class analysis (LCA) was performed for accuracy evaluation of these methods. qPCR detected parasite DNA in 100% of these animals from at least one of the following tissues: splenic and bone marrow aspirates, lymph node and skin fragments, blood and conjunctival swabs. Using latent variable as gold standard, the qPCR achieved a sensitivity of 95.8% (CI 90.4-100) in splenic aspirate; 79.2% (CI 68-90.3) in lymph nodes; 77.3% (CI 64.5-90.1) in skin; 75% (CI 63.1-86.9) in blood; 50% (CI 30-70) in bone marrow; 37.5% (CI 24.2-50.8) in left-eye; and 29.2% (CI 16.7-41.6) in right-eye conjunctival swabs. The accuracy of qPCR using splenic aspirates was further evaluated in a random larger sample (n = 800), collected from dogs during a prevalence study. The specificity achieved by qPCR was 76.7% (CI 73.7-79.6) for splenic aspirates obtained from the greater sample. The sensitivity accomplished by this technique was 95% (CI 93.5-96.5) that was higher than those obtained for the other diagnostic tests and was similar to that observed in the smaller sampling study. This confirms that the splenic aspirate is the most effective type of tissue for detecting L. infantum infection. Additionally, we demonstrated that LCA could be used to generate a suitable gold standard for comparative CVL testing.	[Solca, Manuela da Silva; Bastos, Leila Andrade; Sampaio Guedes, Carlos Eduardo; Bordoni, Marcelo; Borja, Lairton Souza; De Sa Oliveira, Geraldo Gileno; Conrado dos-Santos, Washington Luis; Mothe Fraga, Deborah Bittencourt; Tavares Veras, Patricia Sampaio] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Lab Patol & Biointervencao, Salvador, BA, Brazil; [Larangeira, Daniela Farias; Mothe Fraga, Deborah Bittencourt] Univ Fed Bahia, Escola Med Vet, Salvador, BA, Brazil; [da Silva Estrela Tuy, Petala Gardenia; Alves Ferreira Amorim, Leila Denise] Univ Fed Bahia, Inst Matemat, Dept Estat, Salvador, BA, Brazil; [Nascimento, Eliane Gomes] Ctr Referencia Doencas Endem Piraja da Silva PIEJ, Jequie, BA, Brazil; [De Sa Oliveira, Geraldo Gileno; Mothe Fraga, Deborah Bittencourt; Tavares Veras, Patricia Sampaio] Inst Nacl Ciencia & Tecnol Doencas Trop, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal da Bahia	Veras, PST (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Lab Patol & Biointervencao, Salvador, BA, Brazil.	pveras@bahia.fiocruz.br	Borja, Lairton/ABG-2554-2021; Amorim, Leila/B-4508-2015; Amorim, Leila/ABG-9480-2021; Veras, Patricia S T Sampaio Tavares/I-9632-2014; de Sá Oliveira, Geraldo Gileno/AAO-4099-2021; Fraga, Deborah/AAL-5342-2021; dos-Santos, Washington LC/AAO-4649-2021; da Silva Solcà, Manuela/J-6386-2015	Amorim, Leila/0000-0002-1112-2332; Amorim, Leila/0000-0002-1112-2332; Veras, Patricia S T Sampaio Tavares/0000-0001-8308-9263; de Sá Oliveira, Geraldo Gileno/0000-0001-6065-6480; dos-Santos, Washington LC/0000-0002-5075-1254; da Silva Solcà, Manuela/0000-0001-9014-8903; Tuy, Petala/0000-0001-5312-8911	INCT (Instituto Nacional de Ciencia e Tecnologia em Doencs Tropicais) [576269/2008-5]; PPUS - FAPESB (Programa de Pesquisa para o Sistema Unico de Saude - Fundacao de Amparo a Pesquisa no Estado da Bahia) [SUS0011/2010]	INCT (Instituto Nacional de Ciencia e Tecnologia em Doencs Tropicais); PPUS - FAPESB (Programa de Pesquisa para o Sistema Unico de Saude - Fundacao de Amparo a Pesquisa no Estado da Bahia)	This work was supported by grants and fellowships from INCT (Instituto Nacional de Ciencia e Tecnologia em Doencs Tropicais - http://inctdt.cebio.org - Grant number: 576269/2008-5) and PPUS - FAPESB (Programa de Pesquisa para o Sistema Unico de Saude - Fundacao de Amparo a Pesquisa no Estado da Bahia - http://www.fapesb.ba.gov.br - Grant number: SUS0011/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Baleeiro CO, 2006, VET PARASITOL, V139, P21, DOI 10.1016/j.vetpar.2006.02.033; Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001; BARRAL A, 1991, AM J TROP MED HYG, V44, P536, DOI 10.4269/ajtmh.1991.44.536; Barrouin-Melo SM, 2006, VET J, V171, P331, DOI 10.1016/j.tvjl.2004.11.010; Barrouin-Melo SM, 2004, MEM I OSWALDO CRUZ, V99, P195, DOI 10.1590/S0074-02762004000200014; Batista LFD, 2012, AM J TROP MED HYG, V86, P799, DOI 10.4269/ajtmh.2012.11-0300; Baughman AL, 2008, CLIN VACCINE IMMUNOL, V15, P106, DOI 10.1128/CVI.00223-07; Boelaert M, 2004, AM J TROP MED HYG, V70, P72, DOI 10.4269/ajtmh.2004.70.72; Brasil MdSd, 2006, MAN VIG CONTR LEISHM; Butler JC, 2003, J INFECT DIS, V187, P1416, DOI 10.1086/374623; Carvalho D, 2009, PESQUI VET BRASIL, V29, P120, DOI 10.1590/S0100-736X2009000200006; Ciaramella P, 1997, VET REC, V141, P539, DOI 10.1136/vr.141.21.539; Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291; DEANE L M, 1955, Rev Bras Malariol Doencas Trop, V7, P131; Desjeux P, 2004, NAT REV MICROBIOL, V2, P692, DOI 10.1038/nrmicro981; Marques LHD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001955; Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125; Ferreira ED, 2007, VET PARASITOL, V146, P235, DOI 10.1016/j.vetpar.2007.02.015; Ferreira SD, 2008, VET PARASITOL, V152, P257, DOI 10.1016/j.vetpar.2007.12.022; Ferreira SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001596; Francino O, 2006, VET PARASITOL, V137, P214, DOI 10.1016/j.vetpar.2006.01.011; Garrett ES, 2000, BIOMETRICS, V56, P1055, DOI 10.1111/j.0006-341X.2000.01055.x; Giambernardi TA, 1998, BIOTECHNIQUES, V25, P564, DOI 10.2144/98254bm03; Gomes YM, 2008, VET J, V175, P45, DOI 10.1016/j.tvjl.2006.10.019; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; Hartnack S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002068; Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2; Koutinas AF, 1999, J AM ANIM HOSP ASSOC, V35, P376, DOI 10.5326/15473317-35-5-376; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lachaud L, 2002, PARASITOLOGY, V125, P197, DOI 10.1017/S0031182002002081; LAINSON R, 1978, NATURE, V273, P595, DOI 10.1038/273595a0; Lima IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087742; Lombardo G, 2012, VET PARASITOL, V184, P10, DOI 10.1016/j.vetpar.2011.08.010; de Assis TSM, 2012, TROP MED INT HEALTH, V17, P1202, DOI 10.1111/j.1365-3156.2012.03064.x; Madeira MF, 2006, T ROY SOC TROP MED H, V100, P442, DOI 10.1016/j.trstmh.2005.07.011; Maia C, 2008, VET PARASITOL, V158, P274, DOI 10.1016/j.vetpar.2008.07.028; Maia C, 2009, VET J, V179, P142, DOI 10.1016/j.tvjl.2007.08.009; Maia C, 2010, ACTA TROP, V116, P193, DOI 10.1016/j.actatropica.2010.08.001; Manna L, 2008, VET J, V177, P279, DOI 10.1016/j.tvjl.2007.04.013; Manna L, 2006, VET PARASITOL, V142, P271, DOI 10.1016/j.vetpar.2006.06.028; Manna L, 2009, RES VET SCI, V87, P76, DOI 10.1016/j.rvsc.2008.12.009; Martinez V, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-57; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Miro G, 2008, TRENDS PARASITOL, V24, P371, DOI 10.1016/j.pt.2008.05.003; MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4; Moreira MAB, 2007, VET PARASITOL, V145, P245, DOI 10.1016/j.vetpar.2006.12.012; Muthen B, 2012, PSYCHOL METHODS, V17, P313, DOI 10.1037/a0026802; Muthen L.K., 2007, MPLUS STAT ANAL LATE; Naranjo C, 2012, VET J, V193, P168, DOI 10.1016/j.tvjl.2011.10.001; Nascimento MC, 2007, J CLIN MICROBIOL, V45, P715, DOI 10.1128/JCM.01264-06; Ndao M., 2009, Interdisciplinary Perspectives on Infectious Diseases, V2009, P278246, DOI 10.1155/2009/278246; Pan-ngum W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050765; ParanhosSilva M, 1996, AM J TROP MED HYG, V55, P39, DOI 10.4269/ajtmh.1996.55.39; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005; Reale S, 1999, J CLIN MICROBIOL, V37, P2931, DOI 10.1128/JCM.37.9.2931-2935.1999; Reis AB, 2006, RES VET SCI, V81, P68, DOI 10.1016/j.rvsc.2005.09.011; Rodriguez-Cortes A, 2010, AM J TROP MED HYG, V82, P251, DOI 10.4269/ajtmh.2010.09-0366; Machado CJS, 2010, HIST CIENC SAUDE-MAN, V17, P87, DOI 10.1590/S0104-59702010000100006; Sanchez MA, 2004, AM J TROP MED HYG, V70, P618, DOI 10.4269/ajtmh.2004.70.618; Solano-Gallego L, 2007, VET PARASITOL, V147, P315, DOI 10.1016/j.vetpar.2007.04.013; Solano-Gallego L, 2001, J CLIN MICROBIOL, V39, P560, DOI 10.1128/JCM.39.2.560-563.2001; Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022; Solca MD, 2012, VET PARASITOL, V184, P133, DOI 10.1016/j.vetpar.2011.08.026; Sundar S, 2002, CLIN DIAGN LAB IMMUN, V9, P951, DOI 10.1128/CDLI.9.5.951-958.2002; Tolezano JE, 2007, VET PARASITOL, V149, P280, DOI 10.1016/j.vetpar.2007.07.008; Troncarelli MZ, 2009, VET PARASITOL, V164, P118, DOI 10.1016/j.vetpar.2009.06.027; Uebersax J., 2009, PRACTICAL GUIDE COND; Watson AT, 2011, VET RADIOL ULTRASOUN, V52, P317, DOI 10.1111/j.1740-8261.2010.01778.x; Wu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-79	73	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103635	10.1371/journal.pone.0103635	http://dx.doi.org/10.1371/journal.pone.0103635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076494	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800071
J	Thomsen, O; Collin, R; Carrillo-Baltodano, A				Thomsen, Olaf; Collin, Rachel; Carrillo-Baltodano, Allan			The Effects of Experimentally Induced Adelphophagy in Gastropod Embryos	PLOS ONE			English	Article							NURSE EGGS; HATCHING SIZE; VERMETID GASTROPOD; CREPIDULA-DILATATA; LARVAL DEVELOPMENT; SEX-CHANGE; CALYPTRAEIDAE; REPRODUCTION; PROSOBRANCHIA; EVOLUTION	Adelphophagy, development where embryos grow large by consuming morphologically distinct nutritive embryos or their own normal siblings is widespread but uncommon among animal phyla. Among invertebrates it is particularly common in some families of marine gastropods and segmented worms, but rare or unknown in other closely related families. In calyptraeid gastropods phylogenetic analysis indicates that adelphophagy has arisen at least 9 times from species with planktotrophic larval development. This pattern of frequent parallel evolution of adelphophagy suggests that the embryos of planktotrophic species might be predisposed to evolve adelphophagy. Here we used embryos of three species of planktotrophic calyptraeids, one from each of three major genera in the family (Bostrycapulus, Crucibulum, and Crepidula), to answer the following 3 questions: (1) Can embryos of species with planktotrophic development benefit, in terms of pre-hatching growth, from the ingestion of yolk and tissue from experimentally damaged siblings? (2) Does ingestion of this material from damaged siblings increase variation in pre-hatching size? and (3) Does this experimentally induced adelphophagy alter the allometry between the velum and the shell, increasing morphological similarity to embryos of normally adelphophagic species? We found an overall increase in shell length and velum diameter when embryos feed on damaged siblings within their capsules. There was no detectable increase in variation in shell length or velum diameter, or changes in allometry. The overall effect of our treatment was small compared to the embryonic growth observed in naturally adelphophagic development. However each embryo in our experiment probably consumed less than one sibling on average, whereas natural adelphophages often each consume 10-30 or more siblings. These results suggest that the ability to consume, assimilate, and benefit from yolk and tissue of their siblings is widespread across calyptraeids.	[Thomsen, Olaf; Collin, Rachel; Carrillo-Baltodano, Allan] Smithsonian Trop Res Inst, Balboa, Panama; [Thomsen, Olaf] Carl von Ossietzky Univ Oldenburg, D-26111 Oldenburg, Germany	Smithsonian Institution; Smithsonian Tropical Research Institute; Carl von Ossietzky Universitat Oldenburg	Collin, R (corresponding author), Smithsonian Trop Res Inst, Balboa, Panama.	collinr@si.edu	Collin, Rachel/Q-7100-2019; Collin, Rachel/G-2001-2010; Carrillo-Baltodano, Allan Martin/HGE-5684-2022	Collin, Rachel/0000-0001-5103-4460; Carrillo-Baltodano, Allan Martin/0000-0001-6297-8782	United States National Science Foundation [IOS 1019727]; Smithsonian Tropical Research Institute; Division Of Integrative Organismal Systems [1019727] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by United States National Science Foundation grant IOS 1019727 to R. Collin and the Smithsonian Tropical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbuj A, 2014, INVERTEBR REPROD DEV, V58, P138, DOI 10.1080/07924259.2013.875949; Blake JA, 1999, HYDROBIOLOGIA, V402, P57, DOI 10.1023/A:1003784324125; Brante A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067050; Calvo M, 2004, INVERTEBR BIOL, V123, P289; Chaparro OR, 2002, BIOL BULL, V203, P80, DOI 10.2307/1543460; Chaparro OR, 1999, J EXP MAR BIOL ECOL, V232, P261, DOI 10.1016/S0022-0981(98)00115-4; Collin R, 2004, EVOLUTION, V58, P1488; Collin R, 2003, MAR ECOL PROG SER, V247, P103, DOI 10.3354/meps247103; Collin R, 2000, VELIGER, V43, P24; Collin R, 2007, BIOL BULL-US, V212, P83, DOI 10.2307/25066586; Collin R, 2013, BIOL BULL-US, V225, P8, DOI 10.1086/BBLv225n1p8; Collin R, 2012, BIOL BULL-US, V223, P268, DOI 10.1086/BBLv223n3p268; Collin R, 2012, BIOL J LINN SOC, V106, P763, DOI 10.1111/j.1095-8312.2012.01908.x; Collin R, 2012, INTEGR COMP BIOL, V52, P128, DOI 10.1093/icb/ics065; Collin R, 2010, MAR ECOL PROG SER, V410, P89, DOI 10.3354/meps08638; Cubillos VM, 2007, MAR FRESHWATER RES, V58, P1152, DOI 10.1071/MF07094; Fioroni P., 1982, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V108, P375; GALLARDO CS, 1987, INT J INVER REP DEV, V11, P239, DOI 10.1080/01688170.1987.10510284; Gibson G, 2012, INTEGR COMP BIOL, V52, P151, DOI 10.1093/icb/ics054; Henry JJ, 2010, BIOL BULL-US, V218, P211, DOI 10.1086/BBLv218n3p211; HOAGLAND KE, 1986, AM MALACOL BULL, V4, P173; Kamel SJ, 2010, INTEGR COMP BIOL, V50, P619, DOI 10.1093/icb/icq104; Klinzing MSE, 2000, J EXP MAR BIOL ECOL, V252, P255; Kohn A.J., 1994, LIFE HIST BIOGEOGRAP; Lesoway MP, 2014, INT J DEV B IN PRESS; McDonald KA, 2014, INVERTEBR BIOL, V133, P213, DOI 10.1111/ivb.12057; Merot C, 2012, MAR ECOL PROG SER, V449, P173, DOI 10.3354/meps09536; Oyarzun FX, 2011, INTEGR COMP BIOL, V51, P81, DOI 10.1093/icb/icr009; RIVEST BR, 1983, J EXP MAR BIOL ECOL, V69, P217, DOI 10.1016/0022-0981(83)90071-0; Smith KE, 2013, ECOLOGY, V94, P2263, DOI 10.1890/12-1701.1; Smith KE, 2013, HELGOLAND MARINE RES, P1; SPIGHT TM, 1975, OECOLOGIA, V21, P1, DOI 10.1007/BF00345889; SPIGHT TM, 1976, BIOL BULL, V150, P491, DOI 10.2307/1540687; Strathmann MF, 2006, PAC SCI, V60, P97, DOI 10.1353/psc.2005.0062; STRATHMANN RR, 1993, BIOL BULL, V185, P232, DOI 10.2307/1542003; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Veliz D, 2003, MAR BIOL, V143, P131, DOI 10.1007/s00227-003-1042-7; Veliz D, 2001, MAR BIOL, V139, P527, DOI 10.1007/s002270100601; Veliz D, 2012, MOLLUSCAN RES, V32, P145	41	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103366	10.1371/journal.pone.0103366	http://dx.doi.org/10.1371/journal.pone.0103366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072671	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600043
J	Attili, S; Hughes, SM				Attili, Seetharamaiah; Hughes, Simon M.			Anaesthetic Tricaine Acts Preferentially on Neural Voltage-Gated Sodium Channels and Fails to Block Directly Evoked Muscle Contraction	PLOS ONE			English	Article							UNION-OF-PHARMACOLOGY; SKELETAL-MUSCLE; CALCIUM-CHANNEL; ELECTRICAL-STIMULATION; VENTRICULAR MYOCYTES; LOCAL-ANESTHETICS; ION CHANNELS; ZEBRAFISH; EXPRESSION; LIDOCAINE	Movements in animals arise through concerted action of neurons and skeletal muscle. General anaesthetics prevent movement and cause loss of consciousness by blocking neural function. Anaesthetics of the amino amide-class are thought to act by blockade of voltage-gated sodium channels. In fish, the commonly used anaesthetic tricaine methanesulphonate, also known as 3-aminobenzoic acid ethyl ester, metacaine or MS-222, causes loss of consciousness. However, its role in blocking action potentials in distinct excitable cells is unclear, raising the possibility that tricaine could act as a neuromuscular blocking agent directly causing paralysis. Here we use evoked electrical stimulation to show that tricaine efficiently blocks neural action potentials, but does not prevent directly evoked muscle contraction. Nifedipine-sensitive L-type Ca-v channels affecting movement are also primarily neural, suggesting that muscle Na-v channels are relatively insensitive to tricaine. These findings show that tricaine used at standard concentrations in zebrafish larvae does not paralyse muscle, thereby diminishing concern that a direct action on muscle could mask a lack of general anaesthesia.	[Attili, Seetharamaiah; Hughes, Simon M.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of London; King's College London	Hughes, SM (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, Guys Campus, London WC2R 2LS, England.	simon.hughes@kcl.ac.uk	Hughes, Simon M/S-1073-2016	Hughes, Simon M/0000-0001-8227-9225	Biotechnology and Biological Sciences Research Council [BB/K0101151/1]; UK-India Partnering Award;  [G1001029]; MRC [G1001029] Funding Source: UKRI; Medical Research Council [G1001029] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK-India Partnering Award; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SMH is a Medical Research Council Scientist (www.mrc.ac.uk) with Programme Grant G1001029 support, which funded this study. Additional support to SMH that contributed to the work came from a Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) project grant BB/K0101151/1 and UK-India Partnering Award grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; BARRY WH, 1985, BRIT J PHARMACOL, V85, P51, DOI 10.1111/j.1476-5381.1985.tb08830.x; BUTTERWORTH JF, 1990, ANESTHESIOLOGY, V72, P711, DOI 10.1097/00000542-199004000-00022; CARMELIET E, 1986, J PHYSIOL-LONDON, V376, P143, DOI 10.1113/jphysiol.1986.sp016146; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Catterall WA, 2011, COLD SPRING HARBOR P, V3; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Chen R, 2014, BIOCHEM BIOPH RES CO, V446, P370, DOI 10.1016/j.bbrc.2014.02.115; Chopra SS, 2010, CIRC RES, V106, P1342, DOI 10.1161/CIRCRESAHA.109.213132; Couchoux H, 2007, J PHYSIOL-LONDON, V580, P745, DOI 10.1113/jphysiol.2006.124198; Dahm R, 2006, MAR BIOTECHNOL, V8, P329, DOI 10.1007/s10126-006-5139-0; Denvir MA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-21; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; Etard C, 2005, DEV DYNAM, V234, P1016, DOI 10.1002/dvdy.20592; Galvani L, 1791, VIRIBUS ELECTRICITAT; Hedrick MS, 2003, AM J PHYSIOL-REG I, V284, pR405, DOI 10.1152/ajpregu.00418.2002; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; JOSEPHSON IR, 1988, J MOL CELL CARDIOL, V20, P593, DOI 10.1016/S0022-2828(88)80117-2; Lacmova L, 2005, GEN PHYSIOL BIOPHYS, V24, P1; Maffiuletti NA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-137; Matthews G. G., 2003, CELLULAR PHYSL NERVE; Nau C, 2004, J MEMBRANE BIOL, V201, P1, DOI 10.1007/s00232-004-0702-y; Nguemo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053407; Novak AE, 2006, DEV DYNAM, V235, P1962, DOI 10.1002/dvdy.20811; Nuss HB, 1995, J GEN PHYSIOL, V106, P1193, DOI 10.1085/jgp.106.6.1193; OYAMA Y, 1988, BRAIN RES, V442, P223, DOI 10.1016/0006-8993(88)91507-7; Pette D, 1999, MUSCLE NERVE, V22, P666, DOI 10.1002/(SICI)1097-4598(199906)22:6<666::AID-MUS3>3.0.CO;2-Z; Piriz J, 2003, J PHARMACOL EXP THER, V306, P658, DOI 10.1124/jpet.103.051524; Readman GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073773; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082; SALMONS S, 1976, NATURE, V263, P30, DOI 10.1038/263030a0; Sanhueza D, 2009, ZYGOTE, V17, P131, DOI 10.1017/S0967199408005108; Scholz A, 2002, BRIT J ANAESTH, V89, P52, DOI 10.1093/bja/aef163; Shang LJL, 2005, J BIOL CHEM, V280, P933, DOI 10.1074/jbc.M409977200; Skromne I, 2008, DEV DYNAM, V237, P861, DOI 10.1002/dvdy.21484; Spath M, 1997, N-S ARCH PHARMACOL, V297, P9; Strube C, 2000, BIOPHYS J, V78, P1282, DOI 10.1016/S0006-3495(00)76684-7; Svoboda KR, 2001, DEVELOPMENT, V128, P3511; Toal CB, 2012, BLOOD PRESSURE, V21, P3, DOI 10.3109/08037051.2012.690615; Venkatesh B, 2005, CURR BIOL, V15, P2069, DOI 10.1016/j.cub.2005.10.068; Wang GK, 2008, MOL PHARMACOL, V73, P940, DOI 10.1124/mol.107.041541; Westerfield M., 2000, ZEBRAFISH BOOK A GUI; Windisch A, 1998, J PHYSIOL-LONDON, V510, P623, DOI 10.1111/j.1469-7793.1998.623bk.x; WINLOW W, 1992, GEN PHARMACOL, V23, P985, DOI 10.1016/0306-3623(92)90276-P; Wong D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088030; Yamakage M, 2002, CAN J ANAESTH, V49, P151, DOI 10.1007/BF03020488; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1	50	38	38	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103751	10.1371/journal.pone.0103751	http://dx.doi.org/10.1371/journal.pone.0103751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090007	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700049
J	de Almeida Curi, NH; de Oliveira Paschoal, AM; Massara, RL; Marcelino, AP; Ribeiro, AA; Passamani, M; Demetrio, GR; Chiarello, AG				de Almeida Curi, Nelson Henrique; de Oliveira Paschoal, Ana Maria; Massara, Rodrigo Lima; Marcelino, Andreza Pain; Ribeiro, Adriana Aparecida; Passamani, Marcelo; Demetrio, Guilherme Ramos; Chiarello, Adriano Garcia			Factors Associated with the Seroprevalence of Leishmaniasis in Dogs Living around Atlantic Forest Fragments	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; INFANTUM INFECTION; RISK-FACTORS; WILDLIFE; AREA; TRANSMISSION; PSYCHODIDAE; PREVALENCE; DISEASES; DIPTERA	Canine visceral leishmaniasis is an important zoonosis in Brazil. However, infection patterns are unknown in some scenarios such as rural settlements around Atlantic Forest fragments. Additionally, controversy remains over risk factors, and most identified patterns of infection in dogs have been found in urban areas. We conducted a cross-sectional epidemiological survey to assess the prevalence of leishmaniasis in dogs through three different serological tests, and interviews with owners to assess features of dogs and households around five Atlantic Forest remnants in southeastern Brazil. We used Generalized Linear Mixed Models and Chi-square tests to detect associations between prevalence and variables that might influence Leishmania infection, and a nearest neighbor dispersion analysis to assess clustering in the spatial distribution of seropositive dogs. Our findings showed an average prevalence of 20% (ranging from 10 to 32%) in dogs. Nearly 40% (ranging from 22 to 55%) of households had at least one seropositive dog. Some individual traits of dogs (height, sterilization, long fur, age class) were found to positively influence the prevalence, while some had negative influence (weight, body score, presence of ectoparasites). Environmental and management features (number of cats in the households, dogs with free-ranging behavior) also entered models as negative associations with seropositivity. Strong and consistent negative (protective) influences of the presence of chickens and pigs in dog seropositivity were detected. Spatial clustering of cases was detected in only one of the five study sites. The results showed that different risk factors than those found in urban areas may drive the prevalence of canine leishmaniasis in farm/forest interfaces, and that humans and wildlife risk infection in these areas. Domestic dog population limitation by gonadectomy, legal restriction of dog numbers per household and owner education are of the greatest importance for the control of visceral leishmaniasis in rural zones near forest fragments.	[de Almeida Curi, Nelson Henrique; Passamani, Marcelo; Demetrio, Guilherme Ramos] Univ Fed Lavras, Postgrad Program Appl Ecol, Dept Biol, Lavras, Brazil; [de Oliveira Paschoal, Ana Maria; Massara, Rodrigo Lima] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biol, Postgrad Program Ecol Conservat & Management, Belo Horizonte, MG, Brazil; [Marcelino, Andreza Pain; Ribeiro, Adriana Aparecida] Ezequiel Dias Foundation FUNED, Lab Leishmaniasis, Belo Horizonte, MG, Brazil; [Chiarello, Adriano Garcia] Univ Sao Paulo, Dept Biol, Ribeirao Preto, Brazil	Universidade Federal de Lavras; Universidade Federal de Minas Gerais; Universidade de Sao Paulo	de Almeida Curi, NH (corresponding author), Univ Fed Lavras, Postgrad Program Appl Ecol, Dept Biol, Lavras, Brazil.	nelsoncuri@hotmail.com	Massara, Rodrigo Lima/Q-2223-2015; Chiarello, Adriano Garcia/G-2510-2012; Passamani, Marcelo/N-1168-2019; Demetrio, Guilherme/R-4979-2019; Passamani, Marcelo/H-3361-2015; Passamani, Marcelo/ABG-8886-2020; Ribeiro, Adriana/GZB-0082-2022	Massara, Rodrigo Lima/0000-0003-1221-2185; Chiarello, Adriano Garcia/0000-0003-1914-5480; Demetrio, Guilherme/0000-0002-6481-1633; Passamani, Marcelo/0000-0002-0940-4074; Ribeiro, Adriana/0000-0002-9765-7441	CAPES; Brazilian Science Council [CNPq 472802/2010-0]; Minas Gerais Science Foundation [FAPEMIG APQ 01145-10]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Science Council; Minas Gerais Science Foundation	Thanks to CAPES, who provided the scholarship for the first author. The Brazilian Science Council (CNPq 472802/2010-0) and Minas Gerais Science Foundation (FAPEMIG APQ 01145-10) also provided funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander B, 2002, EMERG INFECT DIS, V8, P1480, DOI 10.3201/eid0812.010485; Alexander KA, 2010, FRONT ECOL ENVIRON, V8, P522, DOI 10.1890/090057; Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213; AYRES M., 2007, BIOESTAT 5 0 APLICAC; Belo VS, 2013, VET PARASITOL, V195, P1, DOI 10.1016/j.vetpar.2013.03.010; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; Caldas AJM, 2002, T ROY SOC TROP MED H, V96, P21, DOI 10.1016/S0035-9203(02)90227-0; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cleaveland S, 2006, NATURE, V440, P605, DOI 10.1038/440605b; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cottontail VM, 2009, PARASITOLOGY, V136, P1133, DOI 10.1017/S0031182009990485; Coura-Vital W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091009; Coura-Vital W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071833; Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291; Courtenay O, 2002, PARASITOLOGY, V125, P407, DOI 10.1017/S0031182002002238; Curi NHD, 2006, MEM I OSWALDO CRUZ, V101, P99, DOI 10.1590/S0074-02762006000100019; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; Dantas-Torres F, 2011, TRENDS PARASITOL, V27, P155, DOI 10.1016/j.pt.2010.12.006; Dantas-Torres F, 2010, VET PARASITOL, V170, P313, DOI 10.1016/j.vetpar.2010.02.019; Xavier SCD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001647; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dias Flávio de Oliveira Passos, 2003, Cad. Saúde Pública, V19, P1373, DOI 10.1590/S0102-311X2003000500015; Donalisio Maria Rita, 2012, J Trop Med, V2012, P642910, DOI 10.1155/2012/642910; Faye B, 2011, T ROY SOC TROP MED H, V105, P333, DOI 10.1016/j.trstmh.2011.02.009; Gavgani ASM, 2002, AM J TROP MED HYG, V67, P511, DOI 10.4269/ajtmh.2002.67.511; Gompper ME, 2014, FREE-RANGING DOGS AND WILDLIFE CONSERVATION, P1; GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993; Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001; Halliday JEB, 2007, J R SOC INTERFACE, V4, P973, DOI 10.1098/rsif.2007.0237; Lacerda ACR, 2009, ANIM CONSERV, V12, P477, DOI 10.1111/j.1469-1795.2009.00277.x; Loss Scott R, 2013, Nat Commun, V4, P1396, DOI 10.1038/ncomms2380; Luppi MM, 2008, VET PARASITOL, V155, P146, DOI 10.1016/j.vetpar.2008.04.024; Maarschalkerweerd RJ, 1997, VET REC, V140, P617, DOI 10.1136/vr.140.24.617; Membrive NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047050; Moraes-Silva E, 2006, ACTA TROP, V98, P176, DOI 10.1016/j.actatropica.2006.04.002; Moreira ED, 2003, AM J TROP MED HYG, V69, P393, DOI 10.4269/ajtmh.2003.69.393; Noguera Pedro, 2006, Biomed., V26, P57; Otranto D, 2010, ACTA TROP, V113, P80, DOI 10.1016/j.actatropica.2009.09.014; Otranto D, 2009, TRENDS PARASITOL, V25, P157, DOI 10.1016/j.pt.2009.01.003; de Almeida ADPF, 2012, REV BRAS PARASITOL V, V21, P359, DOI 10.1590/S1984-29612012005000005; Paschoal AMO, 2012, MAMMALIA, V76, P67, DOI 10.1515/mammalia-2012-0501; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Pinto ID, 2012, J VECTOR ECOL, V37, P90, DOI 10.1111/j.1948-7134.2012.00204.x; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; QUINNELL RJ, 1994, MED VET ENTOMOL, V8, P219, DOI 10.1111/j.1365-2915.1994.tb00502.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rabinowitz Peter M., 2005, EcoHealth, V2, P26, DOI 10.1007/s10393-004-0151-1; Reithinger R, 2003, T ROY SOC TROP MED H, V97, P141, DOI 10.1016/S0035-9203(03)90101-5; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodriguez-Cortes A, 2013, VET PARASITOL, V191, P363, DOI 10.1016/j.vetpar.2012.09.009; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Skov T, 1998, INT J EPIDEMIOL, V27, P91, DOI 10.1093/ije/27.1.91; Souza TD, 2014, VET PARASITOL, V200, P233, DOI 10.1016/j.vetpar.2013.12.025; Spain CV, 2004, JAVMA-J AM VET MED A, V224, P380, DOI 10.2460/javma.2004.224.380; Suzan G., 2012, NEW DIRECTIONS CONSE; Vanak AT, 2010, J APPL ECOL, V47, P1225, DOI 10.1111/j.1365-2664.2010.01870.x; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Woodroffe R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030099; Young JK, 2011, BIOSCIENCE, V61, P125, DOI 10.1525/bio.2011.61.2.7	61	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104003	10.1371/journal.pone.0104003	http://dx.doi.org/10.1371/journal.pone.0104003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089629	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700078
J	Islam, MA; Sundaraj, K; Ahmad, RB; Sundaraj, S; Ahamed, NU; Ali, MA				Islam, Md. Anamul; Sundaraj, Kenneth; Ahmad, R. Badlishah; Sundaraj, Sebastian; Ahamed, Nizam Uddin; Ali, Md. Asraf			Longitudinal, Lateral and Transverse Axes of Forearm Muscles Influence the Crosstalk in the Mechanomyographic Signals during Isometric Wrist Postures	PLOS ONE			English	Article							SURFACE ELECTROMYOGRAPHY; EXTENSOR; CLASSIFICATION; ACCELEROMETER; PROPAGATION; FREQUENCY; FATIGUE	Problem Statement: In mechanomyography (MMG), crosstalk refers to the contamination of the signal from the muscle of interest by the signal from another muscle or muscle group that is in close proximity. Purpose: The aim of the present study was two-fold: i) to quantify the level of crosstalk in the mechanomyographic (MMG) signals from the longitudinal (L-o), lateral (L-a) and transverse (T-r) axes of the extensor digitorum (ED), extensor carpi ulnaris (ECU) and flexor carpi ulnaris (FCU) muscles during isometric wrist flexion (WF) and extension (WE), radial (RD) and ulnar (UD) deviations; and ii) to analyze whether the three-directional MMG signals influence the level of crosstalk between the muscle groups during these wrist postures. Methods: Twenty, healthy right-handed men (mean +/- SD: age = 26.7 +/- 3.83 y; height = 174.47 +/- 6.3 cm; mass = 72.79 +/- 14.36 kg) participated in this study. During each wrist posture, the MMG signals propagated through the axes of the muscles were detected using three separate tri-axial accelerometers. The x-axis, y-axis, and z-axis of the sensor were placed in the L-o, L-a, and T-r directions with respect to muscle fibers. The peak cross-correlations were used to quantify the proportion of crosstalk between the different muscle groups. Results: The average level of crosstalk in the MMG signals generated by the muscle groups ranged from: 34.28-69.69% for the L-o axis, 27.32-52.55% for the L-a axis and 11.38-25.55% for the T-r axis for all participants and their wrist postures. The T-r axes between the muscle groups showed significantly smaller crosstalk values for all wrist postures [F (2, 38) = 14-63, p<0.05, eta(2) = 0.416-0.769]. Significance: The results may be applied in the field of human movement research, especially for the examination of muscle mechanics during various types of the wrist postures.	[Islam, Md. Anamul; Sundaraj, Kenneth; Ahmad, R. Badlishah; Ahamed, Nizam Uddin; Ali, Md. Asraf] Univ Malaysia Perlis, Al Rehab Res Grp, Arau, Perlis, Malaysia; [Sundaraj, Sebastian] Malaysian Minist Hlth, Klang, Selangor, Malaysia	Universiti Malaysia Perlis; Kementerian Kesihatan Malaysia	Islam, MA (corresponding author), Univ Malaysia Perlis, Al Rehab Res Grp, Arau, Perlis, Malaysia.	anamulislam.phd@gmail.com	Sundaraj, Kenneth/AAD-1783-2019; Ahmad, RB/U-3211-2019; Ahmad, Badlishah/A-4703-2019; Rather, R A/J-3509-2019; Ahamed, Nizam Uddin/J-6248-2012	Sundaraj, Kenneth/0000-0001-7221-0072; Ahmad, RB/0000-0002-4862-2728; Ahmad, Badlishah/0000-0002-4862-2728; Ahamed, Nizam Uddin/0000-0003-0497-7356; Islam, Md. Anamul/0000-0001-6214-7081; Ali, Dr. Md Asraf/0000-0002-4732-5529				Al-Zahrani E, 2009, J ELECTROMYOGR KINES, V19, P695, DOI 10.1016/j.jelekin.2007.12.007; Alves N, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-23; Archer AA, 2012, J ELECTROMYOGR KINES, V22, P51, DOI 10.1016/j.jelekin.2011.09.011; BARRY DT, 1987, BIOPHYS J, V51, P769, DOI 10.1016/S0006-3495(87)83403-3; Basmajian J.V., 1985, MUSCLES ALIVE THEIR; Beck TW, 2010, HUM MOVEMENT SCI, V29, P165, DOI 10.1016/j.humov.2009.11.005; Beck TW, 2010, APPL MECHANOMYOGRAPH, V37, P95; Cescon C, 2006, J ELECTROMYOGR KINES, V16, P17, DOI 10.1016/j.jelekin.2005.02.005; Cescon C, 2008, MED BIOL ENG COMPUT, V46, P871, DOI 10.1007/s11517-008-0357-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cramer J T, 2003, Electromyogr Clin Neurophysiol, V43, P293; Dillon MA, 2011, CLIN KINESIOLOGY J A, V65; DOBRUNZ LE, 1990, BIOPHYS J, V58, P557, DOI 10.1016/S0006-3495(90)82399-7; Ebersole KT, 2001, ISOKINET EXERC SCI, V9, P11, DOI 10.3233/IES-2001-0058; Farina D, 2002, MUSCLE NERVE, V26, P681, DOI 10.1002/mus.10256; Farina D, 1985, J APPL PHYSIOL, V92, P235; Farina D, 2008, J BIOMECH, V41, P2843, DOI 10.1016/j.jbiomech.2008.07.007; FRANGIONI JV, 1987, BIOPHYS J, V51, P775, DOI 10.1016/S0006-3495(87)83404-5; Hagg GM, 1997, CLIN BIOMECH, V12, P39, DOI 10.1016/S0268-0033(96)00049-6; Islam MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096628; Islam MA, 2013, IEEE SENS J, V13, P2499, DOI 10.1109/JSEN.2013.2255982; Islam MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058902; Jaskolska A, 2004, J ELECTROMYOGR KINES, V14, P217, DOI 10.1016/j.jelekin.2003.08.001; Kim Tae-Kwang, 2008, Journal of Physiological Anthropology, V27, P121, DOI 10.2114/jpa2.27.121; Kong YK, 2010, J ELECTROMYOGR KINES, V20, P1223, DOI 10.1016/j.jelekin.2010.08.001; Li ZM, 2005, CLIN BIOMECH, V20, P177, DOI 10.1016/j.clinbiomech.2004.10.002; Lowery MM, 2003, J APPL PHYSIOL, V94, P1324, DOI 10.1152/japplphysiol.00698.2002; Matta TTd, 2005, REV BRAS MED ESPORTE, V11, P306; Mogk JPM, 2003, J ELECTROMYOGR KINES, V13, P63, DOI 10.1016/S1050-6411(02)00071-8; Orizio C, 2003, EUR J APPL PHYSIOL, V90, P326, DOI 10.1007/s00421-003-0924-1; Perotto A., 2005, ANATOMICAL GUIDE ELE; Riek S, 2000, J ELECTROMYOGR KINES, V10, P249, DOI 10.1016/S1050-6411(00)00017-1; Scheeren EM, 2010, J MED BIOL ENG, V30, P373, DOI 10.5405/jmbe.757; WINTER DA, 1994, J ELECTROMYOGR KINES, V4, P15, DOI 10.1016/1050-6411(94)90023-X; Xie HB, 2009, PHYSIOL MEAS, V30, P441, DOI 10.1088/0967-3334/30/5/002; Yoshimi Hidehiro, 2009, Head Face Med, V5, P7, DOI 10.1186/1746-160X-5-7; Yung M, 2013, J ELECTROMYOGR KINES, V23, P664, DOI 10.1016/j.jelekin.2013.01.001	37	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104280	10.1371/journal.pone.0104280	http://dx.doi.org/10.1371/journal.pone.0104280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090008	gold, Green Submitted, Green Published			2022-12-27	WOS:000339812700115
J	Shirazi, SH; ul Haq, N; Hayat, K; Naz, S; ul Haque, I				Shirazi, Syed Hamad; ul Haq, Nuhman; Hayat, Khizar; Naz, Saeeda; ul Haque, Ihsan			Curvelet Based Offline Analysis of SEM Images	PLOS ONE			English	Article							WATERSHED SEGMENTATION; LEVEL	Manual offline analysis, of a scanning electron microscopy (SEM) image, is a time consuming process and requires continuous human intervention and efforts. This paper presents an image processing based method for automated offline analyses of SEM images. To this end, our strategy relies on a two-stage process, viz. texture analysis and quantification. The method involves a preprocessing step, aimed at the noise removal, in order to avoid false edges. For texture analysis, the proposed method employs a state of the art Curvelet transform followed by segmentation through a combination of entropy filtering, thresholding and mathematical morphology (MM). The quantification is carried out by the application of a box-counting algorithm, for fractal dimension (FD) calculations, with the ultimate goal of measuring the parameters, like surface area and perimeter. The perimeter is estimated indirectly by counting the boundary boxes of the filled shapes. The proposed method, when applied to a representative set of SEM images, not only showed better results in image segmentation but also exhibited a good accuracy in the calculation of surface area and perimeter. The proposed method outperforms the well-known Watershed segmentation algorithm.	[Shirazi, Syed Hamad; ul Haq, Nuhman; Hayat, Khizar; Naz, Saeeda] COMSATS Inst Informat Technol, Abbottabad, Pakistan; [ul Haque, Ihsan] Univ Peshawar, Centralized Resource Lab, Peshawar, Pakistan; [Hayat, Khizar] Univ Nizwa, Nizwa, Oman	COMSATS University Islamabad (CUI); University of Peshawar; University of Nizwa	Hayat, K (corresponding author), COMSATS Inst Informat Technol, Abbottabad, Pakistan.	khizarhayat@ciit.net.pk	Shirazi, Syed Hamad/GQI-1993-2022; Ul Haq, Nuhman/AGY-8616-2022; Hayat, Khizar/P-8954-2019	Shirazi, Syed Hamad/0000-0001-9534-4719; Hayat, Khizar/0000-0001-5216-6019				ap Gwynn I., 2001, European Cells & Materials, V1, P1; Baojun W, 2009, P INT C IM SIGN PROC, P1; Bennis H, 2010, S I V COMM MOB NETW, P1; Chen Q, 2010, SIGNAL PROCESS, V90, P44, DOI 10.1016/j.sigpro.2009.05.015; Cointault F., 2007, 2007 Third International IEEE Conference on Signal-Image Technologies and Internet-Based System (SITIS), P696, DOI 10.1109/SITIS.2007.80; Dettori L, 2007, COMPUT BIOL MED, V37, P486, DOI 10.1016/j.compbiomed.2006.08.002; Erikson M, 2006, PATTERN RECOGN LETT, V27, P160, DOI 10.1016/j.patrec.2005.07.010; Fattal R, 2007, ACM T GRAPHIC, P26; Flores FC, 2010, IMAGE VISION COMPUT, V28, P1491, DOI 10.1016/j.imavis.2009.06.015; Hafemeister L, 1994, P OCEANS 94 OC ENG T, V2, P69; Hamarneh G, 2009, IMAGE VISION COMPUT, V27, P59, DOI 10.1016/j.imavis.2006.10.009; Haq N, 2012, OPT COMMUN, V285; Herman GT, 2000, INT J IMAG SYST TECH, V11, P12, DOI 10.1002/(SICI)1098-1098(2000)11:1<12::AID-IMA3>3.0.CO;2-N; Hernandez BK, 2000, IEEE T IMAGE PROCESS; Holecz F, 1989, GEOSC REM SENS S 198, V5, P2789; Jiang XY, 2000, IMAGE VISION COMPUT, V18, P817, DOI 10.1016/S0262-8856(99)00049-9; Kayser K, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S10; Kim DH, 2010, NUCL INSTRUM METH A, V620, P112, DOI 10.1016/j.nima.2010.03.134; Li J., 2010, P IEEE INT C SERV OR, P1, DOI DOI 10.1109/S0CA.2010.5707146; LI JL, 2009, EMBC 2009 ANN INT C, P1449; Li PJ, 2004, GEOSCI J, V8, P325, DOI 10.1007/BF02910252; Li QW, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-5, P2037, DOI 10.1109/ROBIO.2007.4522481; Lu CW, 2008, LECT NOTES COMPUT SC, V5370, P687; Lu Zhengyu, 2010, Proceedings 2010 International Conference on Intelligent System Design and Engineering Application (ISDEA 2010), P189, DOI 10.1109/ISDEA.2010.172; Ma W. Y., 1995, Proceedings. International Conference on Image Processing (Cat. No.95CB35819), P256, DOI 10.1109/ICIP.1995.537463; Malkucsh W, 2002, TECHNICAL REPORT; Mizoguchi Masanobu, 2009, 2009 International Symposium on Micro-NanoMechatronics and Human Science (MHS), P426, DOI 10.1109/MHS.2009.5351865; Mukhopadhyay S, 2000, SIGNAL PROCESS, V80, P685, DOI 10.1016/S0165-1684(99)00161-9; Myers B, HITACHI S 3500N VP S; Nemati KM, 1997, SCANNING, V19, P426; Nencini F, 2007, INFORM FUSION, V8, P143, DOI 10.1016/j.inffus.2006.02.001; Niwas S. Issac, 2010, 2010 5th International Conference on Industrial and Information Systems (ICIIS 2010), P348, DOI 10.1109/ICIINFS.2010.5578679; Padma MG, ENTROPY BASED TEXTUR; Prakongkep N, 2010, GEODERMA, V156, P20, DOI 10.1016/j.geoderma.2010.01.003; Salzer M, 2012, MATER CHARACT, V69, P115, DOI 10.1016/j.matchar.2012.04.003; SARKAR N, 1992, PATTERN RECOGN, V25, P1035, DOI 10.1016/0031-3203(92)90066-R; Sheppard AP, 2004, PHYSICA A, V339, P145, DOI 10.1016/j.physa.2004.03.057; Soroushian P, 2005, CEMENT CONCRETE COMP, V27, P823, DOI 10.1016/j.cemconcomp.2004.07.008; Sun W, 2009, IEEE T SEMICONDUCT M, V22, P180, DOI 10.1109/TSM.2008.2011174; Tremeau A, 2000, IEEE T IMAGE PROCESS, V9, P735, DOI 10.1109/83.841950; Tuceryan M, 1998, HDB PATTERN RECOGNIT, P1; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Weidong Chen, 2010, 2010 IEEE International Conference on Intelligent Computing and Intelligent Systems (ICIS 2010), P891, DOI 10.1109/ICICISYS.2010.5658369; Woodward JD, 2010, ULTRAMICROSCOPY, V110, P170, DOI 10.1016/j.ultramic.2009.11.001; Xu X., 2010, IGNEOUS PETROLOGY, P1; Yang Z, 2007, ADV POWDER TECHNOL, V18, P187, DOI 10.1163/156855207780208655; Yuan Li-hong, 2010, Journal of Computer Applications, V30, P44, DOI 10.3724/SP.J.1087.2010.00044; Zebaze R, 2013, BONE, V54, P8, DOI 10.1016/j.bone.2013.01.007; Zhang YJ, 1996, PATTERN RECOGN, V29, P1335, DOI 10.1016/0031-3203(95)00169-7	49	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103942	10.1371/journal.pone.0103942	http://dx.doi.org/10.1371/journal.pone.0103942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089617	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700067
J	Muletz, C; Caruso, NM; Fleischer, RC; McDiarmid, RW; Lips, KR				Muletz, Carly; Caruso, Nicholas M.; Fleischer, Robert C.; McDiarmid, Roy W.; Lips, Karen R.			Unexpected Rarity of the Pathogen Batrachochytrium dendrobatidis in Appalachian Plethodon Salamanders: 1957-2011	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; NORTH-CAROLINA; LOW-PREVALENCE; WIDESPREAD; DISEASE; CHYTRIDIOMYCOSIS; INFECTION; DECLINES; POPULATIONS; MORBIDITY	Widespread population declines in terrestrial Plethodon salamanders occurred by the 1980s throughout the Appalachian Mountains, the center of global salamander diversity, with no evident recovery. We tested the hypothesis that the historic introduction and spread of the pathogenic fungus Batrachochytrium dendrobatidis (Bd) Plethodon population declines. We expected to detect elevated prevalence of Bd prior to population declines as observed for Central American plethodontids. We tested 1,498 Plethodon salamanders of 12 species (892 museum specimens, 606 wild individuals) for the presence of Bd, and tested 94 of those for Batrachochytrium salamandrivorans (Bs) and for ranavirus. Field samples were collected in 2011 from 48 field sites across a 767 km transect. Historic samples from museum specimens ere collected at five sites with the greatest number and longest duration of collection (1957-987), four of which were sampled in the field in 2011. None of the museum specimens were positive for Bd, but four P. cinereus from field surveys positive The overall Bd prevalence from 1957-2011 for 12 Plethodon species sampled across a 757 km transect was 0.2% (95% CI 0.1-0.7%). All 94 samples were negative for Bs and ranavirus. We conclude that known amphibian pathogens are unlikely causes for declines in these Plethodon populations. Furthermore, these exceptionally low levels of Bd, in a region known to harbor Bd, may indicate that Plethodon specific traits limit Bd infection.	[Muletz, Carly; Caruso, Nicholas M.; Lips, Karen R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Caruso, Nicholas M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Muletz, Carly; Fleischer, Robert C.] Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Natl Zool Pk, Washington, DC USA; [McDiarmid, Roy W.] Smithsonian Inst, USGS Patuxent Wildlife Res Ctr, Natl Museum Nat Hist, Washington, DC 20560 USA	University System of Maryland; University of Maryland College Park; University of Alabama System; University of Alabama Tuscaloosa; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of the Interior; United States Geological Survey	Muletz, C (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	cmuletz@umd.edu	Muletz-Wolz, Carly/N-3816-2013	Muletz-Wolz, Carly/0000-0001-5047-9601; Lips, Karen/0000-0002-2719-1551; Caruso, Nicholas/0000-0002-1059-6907	National Science Foundation [DEB 0917653, 0213851, 0234386]; University of Maryland; Smithsonian Seed Grant Program; Direct For Biological Sciences [1120161] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Maryland; Smithsonian Seed Grant Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Science Foundation (http://www.nsf.gov/) provided support to KRL (DEB 0917653, 0213851, 0234386). Funding for this project was provided by the University of Maryland and Smithsonian Seed Grant Program (http://www.sgsi.umd.edu/) to KRL, RCF and RWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Becker RA, 2013, MAPS DRAW GEOGRAPHIC; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Brunner JL, 2009, EVOL ECOL RES, V11, P1169; Caruso NM, 2014, GLOBAL CHANGE BIOL, V20, P1751, DOI 10.1111/gcb.12550; Caruso NM, 2013, DIVERS DISTRIB, V19, P38, DOI 10.1111/j.1472-4642.2012.00938.x; Chatfield MWH, 2012, PLOS ONE, V7; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Chinnadurai SK, 2009, J WILDLIFE DIS, V45, P631, DOI 10.7589/0090-3558-45.3.631; Collins JP, 2003, DIVERSITY DISTRIBUTI, V9; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Gandon S, 2002, AM NAT, V159, P658, DOI 10.1086/339993; Grant EHC, 2008, APPL HERPETOL, V5, P233; Gratwicke B., 2011, Herpetological Review, V42, P217; Gray Matthew J., 2009, Herpetological Review, V40, P316; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; Harrell FE., 2021, HMISC HARRELL MISCEL; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Highton R, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P34; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kiemnec-Tyburczy Karen M., 2012, Herpetological Review, V43, P85; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JR, 2007, J WILDLIFE MANAGE, V71, P435, DOI 10.2193/2006-345; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Miller DAW, 2012, METHODS ECOL EVOL, V3, P850, DOI 10.1111/j.2041-210X.2012.00216.x; Muletz CR, 2012, BIOL CONSERV, V152, P119, DOI 10.1016/j.biocon.2012.03.022; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; R Core Team, 2021, R LANGUAGE ENV STAT; Richards-Hrdlicka KL, 2013, DIS AQUAT ORGAN, V102, P169, DOI 10.3354/dao02552; Richards-Hrdlicka KL, 2012, METHODS ECOL EVOL, V3, P842, DOI 10.1111/j.2041-210X.2012.00228.x; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Rovito SM, 2009, P NATL ACAD SCI USA, V106, P3231, DOI 10.1073/pnas.0813051106; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Vazquez VM, 2009, DIS AQUAT ORGAN, V84, P1, DOI 10.3354/dao02026; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Woodhams DC, 2006, J WILDLIFE DIS, V42, P207, DOI 10.7589/0090-3558-42.2.207	46	37	39	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103728	10.1371/journal.pone.0103728	http://dx.doi.org/10.1371/journal.pone.0103728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084159	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800074
J	Seong, CS; Varela-Ramirez, A; Tang, XL; Anchondo, B; Magallanes, D; Aguilera, RJ				Seong, Chang-Soo; Varela-Ramirez, Armando; Tang, Xiaolei; Anchondo, Brenda; Magallanes, Diego; Aguilera, Renato J.			Cloning and Characterization of a Novel Drosophila Stress Induced DNase	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; IMMUNE-RESPONSES; GENE-EXPRESSION; HOST-DEFENSE; MAMMALIAN DNA; ENDONUCLEASE; NUCLEASE; IDENTIFICATION; INFECTION; MELANOGASTER	Drosophila melanogaster flies mount an impressive immune response to a variety of pathogens with an efficient system comprised of both humoral and cellular responses. The fat body is the main producer of the anti-microbial peptides (AMPs) with anti-pathogen activity. During bacterial infection, an array of secreted peptidases, proteases and other enzymes are involved in the dissolution of debris generated by pathogen clearance. Although pathogen destruction should result in the release a large amount of nucleic acids, the mechanisms for its removal are still not known. In this report, we present the characterization of a nuclease gene that is induced not only by bacterial infection but also by oxidative stress. Expression of the identified protein has revealed that it encodes a potent nuclease that has been named Stress Induced DNase (SID). SID belongs to a family of evolutionarily conserved cation-dependent nucleases that degrade both single and double-stranded nucleic acids. Down-regulation of sid expression via RNA interference leads to significant reduction of fly viability after bacterial infection and oxidative stress. Our results indicate that SID protects flies from the toxic effects of excess DNA/RNA released by pathogen destruction and from oxidative damage.	[Seong, Chang-Soo; Varela-Ramirez, Armando; Anchondo, Brenda; Magallanes, Diego; Aguilera, Renato J.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Seong, Chang-Soo; Varela-Ramirez, Armando; Anchondo, Brenda; Magallanes, Diego; Aguilera, Renato J.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Tang, Xiaolei] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; Loma Linda University	Aguilera, RJ (corresponding author), Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA.	raguilera@utep.edu	Tang, Xiaolei/AAT-7669-2021; Varela-Ramirez, Armando/ABI-4315-2020	Tang, Xiaolei/0000-0003-1492-9622; Varela-Ramirez, Armando/0000-0002-2071-4874; seong, changsoo/0000-0001-9426-9534	Research Centers for Minority Institutions grant from the National Institutes on Minority Health and Health Disparities (NIMHD) [5G12MD007592]; NIGMS SCORE Grants [1SC3GM088069, 1SC3GM103713]; RISE Scholars Program at UTEP through NIGMS [R25GM069621-10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM103713, SC3GM088069, R25GM069621] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	Research Centers for Minority Institutions grant from the National Institutes on Minority Health and Health Disparities (NIMHD); NIGMS SCORE Grants; RISE Scholars Program at UTEP through NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The Biomolecule Analysis, Genomic Analysis and the Cytometry, Screening and Imaging Core Facilities that were used in this work were supported by a Research Centers for Minority Institutions grant 5G12MD007592 from the National Institutes on Minority Health and Health Disparities (NIMHD). The authors also acknowledge support from the NIGMS SCORE Grants 1SC3GM088069 and 1SC3GM103713 to RJA. DM was supported by the RISE Scholars Program at UTEP through NIGMS Grant No. R25GM069621-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova VE, 2008, GENE, V418, P41, DOI 10.1016/j.gene.2008.04.005; Ayres JS, 2008, GENETICS, V178, P1807, DOI 10.1534/genetics.107.083782; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Ayres JS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000150; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Benedik MJ, 1998, FEMS MICROBIOL LETT, V165, P1; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Brun S, 2006, GENES CELLS, V11, P397, DOI 10.1111/j.1365-2443.2006.00953.x; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Calvo E, 2006, J EXP BIOL, V209, P2651, DOI 10.1242/jeb.02267; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chakrabarti S, 2012, CELL HOST MICROBE, V12, P60, DOI 10.1016/j.chom.2012.06.001; Chambers MC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002970; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; FRIEDHOFF P, 1994, NUCLEIC ACIDS RES, V22, P3280, DOI 10.1093/nar/22.16.3280; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Holm CK, 2013, CURR OPIN IMMUNOL, V25, P13, DOI 10.1016/j.coi.2012.12.006; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kawane K, 2010, P NATL ACAD SCI USA, V107, P19432, DOI 10.1073/pnas.1010603107; Kwon SY, 2008, DEV BIOL, V316, P538, DOI 10.1016/j.ydbio.2008.01.033; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liu X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042725; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luce-Fedrow A, 2009, INFECT IMMUN, V77, P4815, DOI 10.1128/IAI.00594-09; McIlroy D, 2000, GENE DEV, V14, P549; Miller MD, 1996, PROTEIN SCI, V5, P24; MILLER MD, 1994, NAT STRUCT BIOL, V1, P461, DOI 10.1038/nsb0794-461; Molthathong S, 2007, FISH SHELLFISH IMMUN, V22, P617, DOI 10.1016/j.fsi.2006.08.008; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Nunes LM, 2014, AAPS J, V16, P872, DOI 10.1208/s12248-014-9617-4; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Patterson RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061773; Rangarajan ES, 2001, FEMS MICROBIOL REV, V25, P583, DOI 10.1111/j.1574-6976.2001.tb00593.x; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; Robles-Escajeda E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073508; Schafer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Scholz SR, 2003, BIOCHEMISTRY-US, V42, P9288, DOI 10.1021/bi0348765; Senger K, 2004, MOL CELL, V13, P19, DOI 10.1016/S1097-2765(03)00500-8; Senger K, 2006, P NATL ACAD SCI USA, V103, P15957, DOI 10.1073/pnas.0607608103; Seong CS, 2006, CELL IMMUNOL, V240, P5, DOI 10.1016/j.cellimm.2006.05.007; Silverman N, 2009, ISJ-INVERT SURVIV J, V6, P163; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Wang WY, 2000, BIOCHEM J, V346, P799, DOI 10.1042/0264-6021:3460799; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94; Wertheim B, 2011, MOL ECOL, V20, P932, DOI 10.1111/j.1365-294X.2010.04911.x; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	59	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103564	10.1371/journal.pone.0103564	http://dx.doi.org/10.1371/journal.pone.0103564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083901	Green Submitted, gold, Green Published			2022-12-27	WOS:000339819800051
J	Zhu, GL; Wang, LJ; Tang, WQ; Liu, D; Yang, JQ				Zhu, Guoli; Wang, Liangjiang; Tang, Wenqiao; Liu, Dong; Yang, Jinquan			De Novo Transcriptomes of Olfactory Epithelium Reveal the Genes and Pathways for Spawning Migration in Japanese Grenadier Anchovy (Coilia nasus)	PLOS ONE			English	Article							JUVENILE SOCKEYE SALMON; RECEPTOR NEURONS; YANGTZE-RIVER; CHLORIDE ACCUMULATION; SIGNAL-TRANSDUCTION; ADENYLYL-CYCLASE; ATLANTIC SALMON; DESENSITIZATION; PHEROMONE; CELLS	Background: Coilia nasus (Japanese grenadier anchovy) undergoes spawning migration from the ocean to fresh water inland. Previous studies have suggested that anadromous fish use olfactory cues to perform successful migration to spawn. However, limited genomic information is available for C. nasus. To understand the molecular mechanisms of spawning migration, it is essential to identify the genes and pathways involved in the migratory behavior of C. nasus. Results: Using de novo transcriptome sequencing and assembly, we constructed two transcriptomes of the olfactory epithelium from wild anadromous and non-anadromous C. nasus. Over 178 million high-quality clean reads were generated using Illumina sequencing technology and assembled into 176,510 unigenes (mean length: 843 bp). About 51% (89,456) of the unigenes were functionally annotated using protein databases. Gene ontology analysis of the transcriptomes indicated gene enrichment not only in signal detection and transduction, but also in regulation and enzymatic activity. The potential genes and pathways involved in the migratory behavior were identified. In addition, simple sequence repeats and single nucleotide polymorphisms were analyzed to identify potential molecular markers. Conclusion: We, for the first time, obtained high-quality de novo transcriptomes of C. nasus using a high-throughput sequencing approach. Our study lays the foundation for further investigation of C. nasus spawning migration and genome evolution.	[Zhu, Guoli; Tang, Wenqiao; Liu, Dong; Yang, Jinquan] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Wang, Liangjiang] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA	Shanghai Ocean University; Clemson University	Tang, WQ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China.	wqtang@shou.edu.cn			Special Fund for Agro-Scientific Research in the Public Interest [201203065]; National Natural Science Foundation of China [31172407]; Ministry of Education's Doctoral Discipline Foundation [20123104110006]; Shanghai Universities First-class Disciplines Project of Fisheries	Special Fund for Agro-Scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education's Doctoral Discipline Foundation; Shanghai Universities First-class Disciplines Project of Fisheries	This study was supported by the Special Fund for Agro-Scientific Research in the Public Interest (No. 201203065), the National Natural Science Foundation of China (No. 31172407), the Ministry of Education's Doctoral Discipline Foundation (No. 20123104110006), and Shanghai Universities First-class Disciplines Project of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Bandoh H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016051; Barbin GP, 1998, ENVIRON BIOL FISH, V53, P283, DOI 10.1023/A:1007469232698; Barry PH, 2003, J GEN PHYSIOL, V122, P247, DOI 10.1085/jgp.200308910; Boekhoff I, 1997, J BIOL CHEM, V272, P4606, DOI 10.1074/jbc.272.7.4606; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; Cheng Wan-Xiu, 2011, Chinese Journal of Zoology, V46, P33; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; DOVING KB, 1985, CAN J FISH AQUAT SCI, V42, P1658, DOI 10.1139/f85-207; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; [管卫兵 Guan Weibing], 2010, [海洋渔业, Marine Fisheries], V32, P73; Guo Hong-yi, 2006, Journal of Fisheries of China, V30, P347; Jahn LA, 1967, PROGR FISH CULTURIST, V38, P207; Johnstone KA, 2011, MOL ECOL, V20, P4059, DOI 10.1111/j.1365-294X.2011.05251.x; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Kolmakov NN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-429; KURAHASHI T, 1993, NATURE, V363, P71, DOI 10.1038/363071a0; LOWE G, 1993, NATURE, V366, P283, DOI 10.1038/366283a0; Mashukova A, 2006, J NEUROSCI, V26, P9902, DOI 10.1523/JNEUROSCI.2897-06.2006; MCBRIDE JR, 1964, CAN J ZOOLOG, V42, P245, DOI 10.1139/z64-023; Moon C, 1998, J NEUROSCI, V18, P3195; Nakamura T, 2000, COMP BIOCHEM PHYS A, V126, P17, DOI 10.1016/S1095-6433(00)00191-4; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Nickell WT, 2007, J PHYSIOL-LONDON, V583, P1005, DOI 10.1113/jphysiol.2007.129601; NORDENG H, 1971, NATURE, V233, P411, DOI 10.1038/233411a0; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Ronnett GV, 2002, ANNU REV PHYSIOL, V64, P189, DOI 10.1146/annurev.physiol.64.082701.102219; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Sorensen PW, 2005, NAT CHEM BIOL, V1, P324, DOI 10.1038/nchembio739; TARRANT RM, 1966, T AM FISH SOC, V95, P112, DOI 10.1577/1548-8659(1966)95[112:TOPOEI]2.0.CO;2; Wei J, 1998, NEURON, V21, P495, DOI 10.1016/S0896-6273(00)80561-9; Whitehead P., 1988, FAO FISHERIES SYNOPS, V125, P460; WISBY WARREN J., 1954, JOUR FISH RES BD CANADA, V11, P472; Xu G, 2013, J FISHERY SCI CHINA, V18, P537; [徐钢春 Xu Gangchun], 2012, [上海海洋大学学报, Journal of Shanghai Ocean University], V21, P481; [徐钢春 Xu Gangchun], 2012, [华中农业大学学报, Journal of Huazhong Agricultural University], V31, P247; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008633; Yang Jin-Quand, 2008, Chinese Journal of Zoology, V43, P8; YANO K, 1992, ICHTHYOL RES, V39, P67; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yuan C.M., 1980, J NANJING U, V3, P67; Zheng Fei, 2012, Chinese Journal of Zoology, V47, P24; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	54	20	28	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103832	10.1371/journal.pone.0103832	http://dx.doi.org/10.1371/journal.pone.0103832			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084282	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800085
J	Gao, X; Wang, GJ; Yuan, YY; Xin, F; Han, MY; Lu, JQ; Zhao, H; Yu, F; Xu, JC; Zhang, MG; Dong, J; Lin, X; Dai, P				Gao, Xue; Wang, Guo-Jian; Yuan, Yong-Yi; Xin, Feng; Han, Ming-Yu; Lu, Jing-Qiao; Zhao, Hui; Yu, Fei; Xu, Jin-Cao; Zhang, Mei-Guang; Dong, Jiang; Lin, Xi; Dai, Pu			Novel Compound Heterozygous Mutations in MYO7A Associated with Usher Syndrome 1 in a Chinese Family	PLOS ONE			English	Article							MYOSIN VIIA GENE; SYNDROME TYPE-I; SYNDROME TYPE-1; DEAFNESS; FREQUENCY	Usher syndrome is an autosomal recessive disease characterized by sensorineural hearing loss, age-dependent retinitis pigmentosa (RP), and occasionally vestibular dysfunction. The most severe form is Usher syndrome type 1 (USH1). Mutations in the MYO7A gene are responsible for USH1 and account for 29-55% of USH1 cases. Here, we characterized a Chinese family (no. 7162) with USH1. Combining the targeted capture of 131 known deafness genes, next-generation sequencing, and bioinformatic analysis, we identified two deleterious compound heterozygous mutations in the MYO7A gene: a reported missense mutation c.73G>A (p.G25R) and a novel nonsense mutation c.462C>A (p.C154X). The two compound variants are absent in 219 ethnicity-matched controls, co-segregates with the USH clinical phenotypes, including hearing loss, vestibular dysfunction, and age-dependent penetrance of progressive RP, in family 7162. Therefore, we concluded that the USH1 in this family was caused by compound heterozygous mutations in MYO7A.	[Gao, Xue; Wang, Guo-Jian; Yuan, Yong-Yi; Xin, Feng; Han, Ming-Yu; Zhao, Hui; Yu, Fei; Dai, Pu] Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Gao, Xue; Wang, Guo-Jian; Han, Ming-Yu; Zhao, Hui; Dai, Pu] Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Otolaryngol, Sanya, Peoples R China; [Lu, Jing-Qiao; Lin, Xi] Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA 30322 USA; [Gao, Xue; Xu, Jin-Cao; Zhang, Mei-Guang] Second Artillery Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Dong, Jiang] Xian Res Inst Hitech, Xian, Shaanxi, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Emory University	Lin, X (corresponding author), Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA 30322 USA.	xlin2@emory.edu; daipu301@vip.sina.com	lin, xi/GZL-4959-2022	Yuan, Yongyi/0000-0002-7936-4776	National Natural Science Foundation of China [30801285, 81230020, 81200751, 81070792, 81000415, 81360159]; China Postdoctoral Science Foundation [2012M521878, 2013T60947]; State 863 High Technology R&D Key Project of China [2011AA02A112, 2012AA020101]; National Basic Research Program of China (973 Program) [2014CB541706]; Beijing technology new star project [2010B081]; NIH [R33 DC010476];  [2012BAI09B02];  [201202005]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R33DC010476] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); State 863 High Technology R&D Key Project of China(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Beijing technology new star project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the Project of the National Natural Science Foundation of China (Grant Nos. 30801285, 81230020, 81200751, 81070792, 81000415, 81360159), grants from China Postdoctoral Science Foundation (No. 2012M521878, No. 2013T60947), a grant from State 863 High Technology R&D Key Project of China (2011AA02A112, 2012AA020101), a grant from Minister of Science and Technology of China (2012BAI09B02), a grant from the National Basic Research Program of China (973 Program) (2014CB541706), a grant from Beijing technology new star project (2010B081) and a grant from Minister of Health of China (201202005). Work performed in the Lin lab was supported by a grant from NIH (R33 DC010476). We sincerely thank all the family members for their participation and cooperation in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Baux David, 2008, Hum Mutat, V29, pE76, DOI 10.1002/humu.20780; Bharadwaj AK, 2000, EXP EYE RES, V71, P173, DOI 10.1006/exer.2000.0863; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; Cohen M, 2007, INT J AUDIOL, V46, P82, DOI 10.1080/14992020600975279; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Jaijo T, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045377; Jaijo T, 2006, Hum Mutat, V27, P290, DOI 10.1002/humu.9404; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kuhlenbaumer G, 2011, HUM MUTAT, V32, P144, DOI 10.1002/humu.21400; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Nakanishi H, 2010, J HUM GENET, V55, P796, DOI 10.1038/jhg.2010.115; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rizel L, 2011, MOL VIS, V17, P3548; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; Simpson Claire L, 2011, BMC Proc, V5 Suppl 9, pS83, DOI 10.1186/1753-6561-5-S9-S83; Stabej PL, 2012, J MED GENET, V49, P27, DOI 10.1136/jmedgenet-2011-100468; Tang WX, 2012, GENET TEST MOL BIOMA, V16, P536, DOI 10.1089/gtmb.2011.0187; Tang WS, 2011, GENETIC TES IN PRESS; Udovichenko IP, 2002, J CELL SCI, V115, P445; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	31	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103415	10.1371/journal.pone.0103415	http://dx.doi.org/10.1371/journal.pone.0103415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080338	Green Submitted, gold, Green Published			2022-12-27	WOS:000339954800042
J	Montory, JA; Pechenik, JA; Diederich, CM; Chaparro, OR				Montory, Jaime A.; Pechenik, Jan A.; Diederich, Casey M.; Chaparro, Oscar R.			Effects of Low Salinity on Adult Behavior and Larval Performance in the Intertidal Gastropod Crepipatella peruviana (Calyptraeidae)	PLOS ONE			English	Article							MARINE INVERTEBRATE LARVAE; VERTICAL-DISTRIBUTION; OXYGEN-CONSUMPTION; REDUCED SALINITY; TEMPORAL VARIABILITY; FECUNDA GASTROPODA; FOOD PATCHES; EGG CAPSULES; TEMPERATURE; CREPIDULA	Shallow-water coastal areas suffer frequent reductions in salinity due to heavy rains, potentially stressing the organisms found there, particularly the early stages of development (including pelagic larvae). Individual adults and newly hatched larvae of the gastropod Crepipatella peruviana were exposed to different levels of salinity stress (32(control), 25, 20 or 15), to quantify the immediate effects of exposure to low salinities on adult and larval behavior and on the physiological performance of the larvae. For adults we recorded the threshold salinity that initiates brood chamber isolation. For larvae, we measured the impact of reduced salinity on velar surface area, velum activity, swimming velocity, clearance rate (CR), oxygen consumption (OCR), and mortality (LC50); we also documented the impact of salinity discontinuities on the vertical distribution of veliger larvae in the water column. The results indicate that adults will completely isolate themselves from the external environment by clamping firmly against the substrate at salinities <= 24. Moreover, the newly hatched larvae showed increased mortality at lower salinities, while survivors showed decreased velum activity, decreased exposed velum surface area, and decreased mean swimming velocity. The clearance rates and oxygen consumption rates of stressed larvae were significantly lower than those of control individuals. Finally, salinity discontinuities affected the vertical distribution of larvae in the water column. Although adults can protect their embryos from low salinity stress until hatching, salinities < 24 clearly affect survival, physiology and behavior in early larval life, which will substantially affect the fitness of the species under declining ambient salinities.	[Montory, Jaime A.; Chaparro, Oscar R.] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Pechenik, Jan A.; Diederich, Casey M.] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Montory, Jaime A.] Univ Austral Chile, Programa Doctorado Ciencias Menc & Ecol & Evoluc, Valdivia, Chile	Universidad Austral de Chile; Tufts University; Universidad Austral de Chile	Montory, JA (corresponding author), Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	jaimemontory@gmail.com	Montory, Jaime/E-6077-2010; Montory, Jaime/AAL-5187-2020; Chaparro, Oscar R/A-5070-2009	Montory, Jaime/0000-0003-3383-7467; Montory, Jaime/0000-0003-3383-7467; 	Comision Nacional de Investigacion Cientifica y Tecnologica-Chile [24121345]; Fondo Nacional de Investigacion Cientifica y Tecnologica-Chile [1100335]	Comision Nacional de Investigacion Cientifica y Tecnologica-Chile; Fondo Nacional de Investigacion Cientifica y Tecnologica-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Comision Nacional de Investigacion Cientifica y Tecnologica-Chile Doctoral fellowship 24121345 JAM. Fondo Nacional de Investigacion Cientifica y Tecnologica-Chile grant 1100335 ORC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSET AV, 1990, MAR ECOL PROG SER, V58, P217; Allen JD, 2010, BIOL BULL-US, V218, P189, DOI 10.1086/BBLv218n2p189; ALMATAR SM, 1984, MAR BIOL, V80, P117, DOI 10.1007/BF02180178; Amado EM, 2011, COMP BIOCHEM PHYS A, V158, P542, DOI 10.1016/j.cbpa.2010.12.019; AMEYAWAKUMFI C, 1987, MAR ECOL PROG SER, V37, P153, DOI 10.3354/meps037153; Anger K, 1998, J EXP MAR BIOL ECOL, V220, P287, DOI 10.1016/S0022-0981(97)00110-X; Arellano SM, 2012, J EXP MAR BIOL ECOL, V414, P28, DOI 10.1016/j.jembe.2012.01.008; Barria A, 2012, REV BIOL MAR OCEANOG, V47, P461, DOI 10.4067/S0718-19572012000300009; Baylon J, 2007, AQUACULTURE, V269, P390, DOI 10.1016/j.aquaculture.2007.03.024; Berger VJ, 1997, HYDROBIOLOGIA, V355, P115, DOI 10.1023/A:1003023322263; Bodinier C, 2009, J ANAT, V214, P318, DOI 10.1111/j.1469-7580.2009.01050.x; BOUDREAU B, 1992, J EXP MAR BIOL ECOL, V162, P35, DOI 10.1016/0022-0981(92)90123-R; Chan HY, 2008, MAR BIOL, V153, P735, DOI 10.1007/s00227-007-0850-6; Chaparro OR, 2008, J EXP MAR BIOL ECOL, V365, P38, DOI 10.1016/j.jembe.2008.07.038; Chaparro OR, 2008, ESTUAR COAST SHELF S, V76, P861, DOI 10.1016/j.ecss.2007.08.014; Chaparro OR, 2009, MAR ECOL PROG SER, V374, P145, DOI 10.3354/meps07777; Chaparro OR, 1999, BIOL BULL, V197, P104, DOI 10.2307/1543001; Chaparro OR, 2005, J MAR BIOL ASSOC UK, V85, P157, DOI 10.1017/S0025315405010982h; Chaparro OR, 2004, MAR BIOL, V144, P79, DOI 10.1007/s00227-003-1176-7; Chaparro OR, 2002, BIOL BULL, V203, P80, DOI 10.2307/1543460; Chaparro OR, 2002, J SHELLFISH RES, V21, P233; CHAPMAN PM, 1982, AQUAT TOXICOL, V2, P47, DOI 10.1016/0166-445X(82)90005-4; Charmantier G, 2001, J EXP BIOL, V204, P967; COUGHLAN J, 1969, MAR BIOL, V2, P356, DOI 10.1007/BF00355716; Cubillos VM, 2007, MAR FRESHWATER RES, V58, P1152, DOI 10.1071/MF07094; Dahlhoff EP, 2002, INTEGR COMP BIOL, V42, P862, DOI 10.1093/icb/42.4.862; Daigle RM, 2011, J EXP MAR BIOL ECOL, V409, P89, DOI 10.1016/j.jembe.2011.08.008; Diederich CM, 2011, J EXP MAR BIOL ECOL, V397, P94, DOI 10.1016/j.jembe.2010.11.019; Fretter V., 1994, BRIT PROSOBRANCH MOL; Gallager SM, 1996, MAR BIOL, V124, P679, DOI 10.1007/BF00351049; GALLARDO CS, 1979, STUD NEOTROP FAUNA E, V14, P215, DOI 10.1080/01650527909360557; GALLARDO CS, 1977, MAR BIOL, V39, P241, DOI 10.1007/BF00390998; Genio L, 2008, J SEA RES, V59, P133, DOI 10.1016/j.seares.2007.09.001; HADFIELD MG, 1989, B MAR SCI, V45, P377; Iriarte JL, 2007, ESTUAR COAST SHELF S, V74, P471, DOI 10.1016/j.ecss.2007.05.015; Ismael D, 1997, COMP BIOCHEM PHYS A, V118, P871, DOI 10.1016/S0300-9629(97)00016-9; Kim WS, 2001, MAR BIOL, V138, P157, DOI 10.1007/s002270000430; Kinne O., 1966, Netherlands Journal of Sea Research, V3, P222, DOI 10.1016/0077-7579(66)90013-5; Kinne O., 1971, MARINE ECOLOGY 2, V1; Klinzing MSE, 2000, J EXP MAR BIOL ECOL, V252, P255; Liu JY, 2006, J APPL ICHTHYOL, V22, P244, DOI 10.1111/j.1439-0426.2007.00960.x; MANN R, 1991, MAR ECOL PROG SER, V68, P257; Mardones ML, 2013, J EXP MAR BIOL ECOL, V443, P141, DOI 10.1016/j.jembe.2013.02.041; Marsden ID, 2004, MAR ECOL PROG SER, V266, P157, DOI 10.3354/meps266157; MCFARLANE ID, 1980, MAR BEHAV PHYSIOL, V7, P95, DOI 10.1080/10236248009386974; Metaxas A, 1998, MAR BIOL, V130, P433, DOI 10.1007/s002270050264; Montory JA, 2009, MAR ECOL PROG SER, V374, P157, DOI 10.3354/meps07780; Morritt D, 1996, J EXP MAR BIOL ECOL, V207, P191, DOI 10.1016/S0022-0981(96)02634-2; Navarro JM, 1998, AQUACULTURE, V167, P315, DOI 10.1016/S0044-8486(98)00310-X; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; PECHENIK JA, 1983, J EXP MAR BIOL ECOL, V71, P165, DOI 10.1016/0022-0981(93)90071-U; PECHENIK JA, 1982, J EXP MAR BIOL ECOL, V63, P195, DOI 10.1016/0022-0981(82)90178-2; Przeslawski R, 2005, GLOBAL CHANGE BIOL, V11, P515, DOI 10.1111/j.1365-2486.2005.00918.x; Richmond CE, 1996, MAR ECOL PROG SER, V133, P167, DOI 10.3354/meps133167; Richmond CE, 1999, MAR BIOL, V134, P259, DOI 10.1007/s002270050544; ROBERTS MH, 1971, BIOL BULL, V140, P104, DOI 10.2307/1540030; ROLLER RA, 1989, J EXP MAR BIOL ECOL, V125, P235, DOI 10.1016/0022-0981(89)90099-3; Sameoto JA, 2008, BIOL BULL-US, V214, P329, DOI 10.2307/25470674; Sameoto JA, 2008, J EXP MAR BIOL ECOL, V367, P131, DOI 10.1016/j.jembe.2008.09.003; Saranchova OL, 2001, RUSS J MAR BIOL, V27, P87, DOI DOI 10.1023/A:1016643213691; SHUMWAY SE, 1977, J COMP PHYSIOL, V116, P269, DOI 10.1007/BF00689036; Sokolova IM, 2000, J COMP PHYSIOL B, V170, P91, DOI 10.1007/s003600050264; Spicer JI, 2003, SARSIA, V88, P302, DOI 10.1080/00364820310002263; STICKLE WB, 1976, MAR BIOL, V37, P125, DOI 10.1007/BF00389123; STRATHMANN RR, 1972, BIOL BULL-US, V142, P505, DOI 10.2307/1540326; STRATHMANN RR, 1979, BIOL BULL, V157, P524, DOI 10.2307/1541035; Studer A, 2012, J EXP MAR BIOL ECOL, V412, P110, DOI 10.1016/j.jembe.2011.11.008; Surbida KL, 2001, PHYSIOL BIOCHEM ZOOL, V74, P894, DOI 10.1086/324474; TEDENGREN M, 1988, MAR ECOL PROG SER, V47, P107, DOI 10.3354/meps047107; Torres G, 2002, J EXP MAR BIOL ECOL, V277, P43, DOI 10.1016/S0022-0981(02)00244-7; Torres G, 2006, J EXP MAR BIOL ECOL, V338, P134, DOI 10.1016/j.jembe.2006.07.003; Tsuzuki MY, 2008, BRAZ ARCH BIOL TECHN, V51, P563, DOI 10.1590/S1516-89132008000300017; Underwood A.J., 1979, Advances in Marine Biology, V16, P111, DOI 10.1016/S0065-2881(08)60293-X; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Veliz D, 2012, MOLLUSCAN RES, V32, P145; Verween A, 2007, J EXP MAR BIOL ECOL, V348, P111, DOI 10.1016/j.jembe.2007.04.011; WIDDOWS J, 1991, AQUACULTURE, V94, P147, DOI 10.1016/0044-8486(91)90115-N; Wuenschel MJ, 2004, J FISH BIOL, V64, P1088, DOI 10.1111/j.1095-8649.2004.00374.x; Yen PT, 2008, AQUACULTURE, V280, P124, DOI 10.1016/j.aquaculture.2008.04.035; Zhang HY, 2014, MAR POLLUT BULL, V79, P39, DOI 10.1016/j.marpolbul.2014.01.008; [No title captured]	81	17	18	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103820	10.1371/journal.pone.0103820	http://dx.doi.org/10.1371/journal.pone.0103820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077484	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800083
J	Pavey, L; Churchill, S				Pavey, Louisa; Churchill, Sue			Promoting the Avoidance of High-Calorie Snacks: Priming Autonomy Moderates Message Framing Effects	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; LOSS-FRAMED MESSAGES; PHYSICAL-ACTIVITY; BEHAVIOR; RESPONSES; INTENTIONS	The beneficial effects of gain-framed vs. loss-framed messages promoting health protective behaviors have been found to be inconsistent, and consideration of potential moderating variables is essential if framed health promotion messages are to be effective. This research aimed to determine the influence of highlighting autonomy (choice and freedom) and heteronomy (coercion) on the avoidance of high-calorie snacks following reading gain-framed or loss-framed health messages. In Study 1 (N = 152) participants completed an autonomy, neutral, or heteronomy priming task, and read a gain-framed or loss-framed health message. In Study 2 (N = 242) participants read a gain-framed or loss-framed health message with embedded autonomy or heteronomy primes. In both studies, snacking intentions and behavior were recorded after seven days. In both studies, when autonomy was highlighted, the gain-framed message (compared to the loss-framed message) resulted in stronger intentions to avoid high-calorie snacks, and lower self-reported snack consumption after seven days. Study 2 demonstrated this effect occurred only for participants to whom the information was most relevant (BMI>25). The results suggest that messages promoting healthy dietary behavior may be more persuasive if the autonomy-supportive vs. coercive nature of the health information is matched to the message frame. Further research is needed to examine potential mediating processes.	[Pavey, Louisa] Univ Kingston, Kingston Upon Thames KT1 2EE, Surrey, England; [Churchill, Sue] Univ Chichester, Chichester, England	Kingston University; University of Chichester	Pavey, L (corresponding author), Univ Kingston, Kingston Upon Thames KT1 2EE, Surrey, England.	l.pavey@kingston.ac.uk	Pavey, Louisa/AAM-4375-2021	Pavey, Louisa/0000-0002-7646-099X				Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006777.pub2; Brug Johannes, 2003, Nutrition and Health (Bicester), V17, P9; Chatzisarantis NLD, 2012, BRIT J SOC PSYCHOL, V51, P690, DOI 10.1111/j.2044-8309.2011.02033.x; Chatzisarantis NLD, 2009, PSYCHOL HEALTH, V24, P29, DOI 10.1080/08870440701809533; Churchill S, 2013, BRIT J HEALTH PSYCH, V18, P610, DOI 10.1111/bjhp.12007; Covey J, 2014, HEALTH PSYCHOL, V33, P52, DOI 10.1037/a0029305; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Gallagher KM, 2012, ANN BEHAV MED, V43, P101, DOI 10.1007/s12160-011-9308-7; Gerend MA, 2008, ANN BEHAV MED, V35, P221, DOI 10.1007/s12160-008-9024-0; Gerend MA, 2011, HEALTH PSYCHOL, V30, P420, DOI 10.1037/a0021981; Hagger MS, 2006, PERS SOC PSYCHOL B, V32, P131, DOI 10.1177/0146167205279905; Hodgins HS, 2006, MOTIV EMOTION, V30, P283, DOI 10.1007/s11031-006-9036-7; Huang TTK, 2005, OBES RES, V13, P1205, DOI 10.1038/oby.2005.143; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kiene SM, 2005, HEALTH PSYCHOL, V24, P321, DOI 10.1037/0278-6133.24.3.321; Levesque C, 2003, PERS SOC PSYCHOL B, V29, P1570, DOI 10.1177/0146167203256877; McCall LA, 2004, J APPL BIOBEHAV RES, V9, P122; Millar MG, 2000, J APPL SOC PSYCHOL, V30, P853, DOI 10.1111/j.1559-1816.2000.tb02827.x; O'Keefe DJ, 2007, J HEALTH COMMUN, V12, P623, DOI 10.1080/10810730701615198; O'Keefe DJ, 2006, COMM YEARB, V30, P1, DOI 10.1207/s15567419cy3001_1; Pavey L, 2009, MOTIV EMOTION, V33, P277, DOI 10.1007/s11031-009-9137-1; Pavey LJ, 2008, EUR J SOC PSYCHOL, V38, P852, DOI 10.1002/ejsp.477; Pavey LJ, 2012, PSYCHOL HEALTH, V27, P259, DOI 10.1080/08870446.2011.556251; Pavey LJ, 2010, PSYCHOL HEALTH, V25, P855, DOI 10.1080/08870440902929528; Pears SL, 2012, APPETITE, V58, P1164, DOI 10.1016/j.appet.2012.02.017; Rains SA, 2007, HUM COMMUN RES, V33, P241, DOI 10.1111/j.1468-2958.2007.00298.x; Rothman A.J., 2010, PERSPECTIVES FRAMING, P257; Rothman AJ, 1999, PERS SOC PSYCHOL B, V25, P1355, DOI 10.1177/0146167299259003; Rothman AJ, 1997, PSYCHOL BULL, V121, P3, DOI 10.1037/0033-2909.121.1.3; ROTHMAN AJ, 1993, J EXP SOC PSYCHOL, V29, P408, DOI 10.1006/jesp.1993.1019; Rothman AJ, 2006, J COMMUN, V56, pS202, DOI 10.1111/j.1460-2466.2006.00290.x; Sherman DK, 2006, MOTIV EMOTION, V30, P165, DOI 10.1007/s11031-006-9001-5; Silva MN, 2010, J BEHAV MED, V33, P110, DOI 10.1007/s10865-009-9239-y; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Van't Riet J, 2009, HLTH ED RES, V23, P243; Werrij MQ, 2011, J HEALTH PSYCHOL, V16, P199, DOI 10.1177/1359105310374779; Williams GC, 1999, ARCH PEDIAT ADOL MED, V153, P959, DOI 10.1001/archpedi.153.9.959; Williams GC, 2007, HEALTH PSYCHOL, V26, P728, DOI 10.1037/0278-6133.26.6.728; Williams GC, 2009, ANN BEHAV MED, V37, P315, DOI 10.1007/s12160-009-9090-y; Yan CM, 2010, J COMMUN, V60, P344, DOI 10.1111/j.1460-2466.2010.01485.x	40	12	13	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103892	10.1371/journal.pone.0103892	http://dx.doi.org/10.1371/journal.pone.0103892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6EF	25078965	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000339954800093
J	Freeman, TCA; Leung, J; Wufong, E; Orchard-Mills, E; Carlile, S; Alais, D				Freeman, Tom C. A.; Leung, Johahn; Wufong, Ella; Orchard-Mills, Emily; Carlile, Simon; Alais, David			Discrimination Contours for Moving Sounds Reveal Duration and Distance Cues Dominate Auditory Speed Perception	PLOS ONE			English	Article							MOTION; MOVEMENT; DIRECTION; NEURONS; CORTEX; TIME; RESPONSES; PARIETAL; VELOCITY; POSITION	Evidence that the auditory system contains specialised motion detectors is mixed. Many psychophysical studies confound speed cues with distance and duration cues and present sound sources that do not appear to move in external space. Here we use the 'discrimination contours' technique to probe the probabilistic combination of speed, distance and duration for stimuli moving in a horizontal arc around the listener in virtual auditory space. The technique produces a set of motion discrimination thresholds that define a contour in the distance-duration plane for different combination of the three cues, based on a 3-interval oddity task. The orientation of the contour (typically elliptical in shape) reveals which cue or combination of cues dominates. If the auditory system contains specialised motion detectors, stimuli moving over different distances and durations but defining the same speed should be more difficult to discriminate. The resulting discrimination contours should therefore be oriented obliquely along iso-speed lines within the distance-duration plane. However, we found that over a wide range of speeds, distances and durations, the ellipses aligned with distance-duration axes and were stretched vertically, suggesting that listeners were most sensitive to duration. A second experiment showed that listeners were able to make speed judgements when distance and duration cues were degraded by noise, but that performance was worse. Our results therefore suggest that speed is not a primary cue to motion in the auditory system, but that listeners are able to use speed to make discrimination judgements when distance and duration cues are unreliable.	[Freeman, Tom C. A.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales; [Leung, Johahn; Carlile, Simon] Univ Sydney, Dept Physiol, Auditory Neurosci Lab, Sydney, NSW 2006, Australia; [Leung, Johahn; Carlile, Simon] Univ Sydney, Bosch Inst, Sch Med, Sydney, NSW 2006, Australia; [Wufong, Ella; Orchard-Mills, Emily; Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Cardiff University; University of Sydney; University of Sydney; University of Sydney	Freeman, TCA (corresponding author), Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales.	freeman@cardiff.ac.uk	Freeman, Tom/A-1587-2010	Freeman, Tom/0000-0002-5989-9183	Royal Society [CAR004]; Wellcome Trust [WT 081581MA]	Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust)	Funding provided by Royal Society Travel Grant to TF (CAR004) and Wellcome Trust Project Grant to TF (WT 081581MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHISSAR M, 1992, J NEUROPHYSIOL, V67, P203, DOI 10.1152/jn.1992.67.1.203; ALTMAN JA, 1968, EXP NEUROL, V22, P13, DOI 10.1016/0014-4886(68)90016-2; Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Bompas A, 2013, SYSTEMATIC BIASES AD, V13, P1; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Carlile S, 2002, J ACOUST SOC AM, V111, P1026, DOI 10.1121/1.1436067; Champion RA, 2010, J VISION, V10, DOI 10.1167/10.6.14; Chandler DW, 1992, J ACOUSTICAL SOC AM, V91; Dong CJ, 2000, PERCEPT PSYCHOPHYS, V62, P1099, DOI 10.3758/BF03212091; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Farina A, 2007, AUSIO ENG SOC CONVEN, P122; Freeman TCA, 2002, PERCEPTION, V31, P603, DOI 10.1068/p3256; GEGENFURTNER KR, 1995, VISION RES, V35, P1547, DOI 10.1016/0042-6989(94)00264-M; Getzmann S, 2011, EUR J NEUROSCI, V33, P1339, DOI 10.1111/j.1460-9568.2011.07617.x; Getzrnann S, 2011, HEARING RES, V272, P21, DOI 10.1016/j.heares.2010.11.005; GRANTHAM DW, 1989, PERCEPT PSYCHOPHYS, V45, P129, DOI 10.3758/BF03208047; Grantham DW, 1997, BINAURAL SPATIAL HEA; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Grzeschik R, 2010, EXP BRAIN RES, V203, P159, DOI 10.1007/s00221-010-2221-7; Jenison RL, 2001, J NEUROSCI, V21, P4408, DOI 10.1523/JNEUROSCI.21-12-04408.2001; Jiang H, 2000, HEARING RES, V139, P69, DOI 10.1016/S0378-5955(99)00176-8; Kaczmarek T, 2005, J ACOUST SOC AM, V117, P3149, DOI 10.1121/1.1880832; LAPPIN JS, 1975, J EXP PSYCHOL HUMAN, V1, P383, DOI 10.1037/0096-1523.1.4.383; Lutfi RA, 1999, J ACOUST SOC AM, V106, P919, DOI 10.1121/1.428033; Magezi DA, 2013, J NEUROPHYSIOL, V109, P321, DOI 10.1152/jn.00625.2012; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Mollon JD, 1974, NEW SCI, V61, P479; NAKAYAMA K, 1985, VISION RES, V25, P625, DOI 10.1016/0042-6989(85)90171-3; Neelon MF, 2003, HEARING RES, V180, P57, DOI 10.1016/S0378-5955(03)00095-9; NOORLANDER C, 1980, J OPT SOC AM, V70, P1116, DOI 10.1364/JOSA.70.001116; Pavani F, 2002, CURR BIOL, V12, P1584, DOI 10.1016/S0960-9822(02)01143-0; PERROTT DR, 1993, J ACOUST SOC AM, V93, P1053, DOI 10.1121/1.405553; PERROTT DR, 1989, J ACOUST SOC AM, V85, P1773, DOI 10.1121/1.397968; Perrott DR, 1988, MINIMUM AUDIBLE MOVE, P1522; POIRSON AB, 1990, J OPT SOC AM A, V7, P783, DOI 10.1364/JOSAA.7.000783; Pralong D, 1996, VIRTUAL AUDITORY SPA; Reisbeck TE, 1999, VISION RES, V39, P3267, DOI 10.1016/S0042-6989(99)00017-6; SOVIJARVI AR, 1974, BRAIN RES, V73, P455, DOI 10.1016/0006-8993(74)90669-6; SPITZER MW, 1993, J NEUROPHYSIOL, V69, P1245, DOI 10.1152/jn.1993.69.4.1245; TORONCHUK JM, 1992, EXP BRAIN RES, V88, P169, DOI 10.1007/BF02259138; Wagner H, 1997, TRENDS NEUROSCI, V20, P583, DOI 10.1016/S0166-2236(97)01110-7; WANDELL BA, 1985, J OPT SOC AM A, V2, P62, DOI 10.1364/JOSAA.2.000062; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wuerger S, 2010, INFORM FUSION, V11, P45, DOI 10.1016/j.inffus.2009.04.005; Xiao X, 1997, J ACOUST SOC AM, V102, P1907, DOI 10.1121/1.421013; ZAKARAUSKAS P, 1991, HEARING RES, V52, P233, DOI 10.1016/0378-5955(91)90203-L	48	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102864	10.1371/journal.pone.0102864	http://dx.doi.org/10.1371/journal.pone.0102864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076211	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000340028800019
J	Kerkhoff, AD; Wood, R; Vogt, M; Lawn, SD				Kerkhoff, Andrew D.; Wood, Robin; Vogt, Monica; Lawn, Stephen D.			Prognostic Value of a Quantitative Analysis of Lipoarabinomannan in Urine from Patients with HIV-Associated Tuberculosis	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; DIAGNOSTIC-ACCURACY; ANTIRETROVIRAL THERAPY; POSITIVE PATIENTS; LOW-COST; ASSAY; ANTIGEN; MORTALITY; INFECTION; PATHOLOGY	Background: Detection of the mycobacterial cell wall antigen lipoarabinomannan (LAM) in urine can be used to diagnose HIV-associated tuberculosis (TB) using a qualitative (positive/negative) read-out. However, it is not known whether the quantity of LAM present in urine provides additional prognostic information. Methods/Findings: Consecutively recruited adult outpatients initiating antiretroviral therapy (ART) in South Africa were investigated for TB regardless of clinical symptoms using sputum smear microscopy and liquid culture (reference standard). Urine samples were tested using the Clearview TB-ELISA for LAM and the Xpert MTB/RIF assay. The ELISA optical densities (OD) were used as a quantitative assessment of urine LAM. Among 514 patients with complete sputum and urine LAM OD results, culture-confirmed TB was diagnosed in 84 patients. Twenty-three (27.3%) were LAM-positive with a median LAM OD of 0.68 (IQR 0.16-2.43; range, 0.10-3.29) and 61 (72.6%) were LAM negative (LAM OD <0.1 above background). Higher LAM ODs were associated with a range of prognostic indices, including lower CD4 cell counts, lower haemoglobin levels, higher blood neutrophil counts and higher mycobacterial load as assessed using both sputum and urine samples. The median LAM OD among patients who died was more than 6.8-fold higher than that of patients who remained alive at 3 months (P<0.001). The small number of deaths, however, precluded adequate assessment of mortality risk stratified according to urine LAM OD. Conclusions: In patients with HIV-associated TB, concentrations of LAM in urine were strongly associated with a range of poor prognostic characteristics known to be associated with mortality risk. Urine LAM assays with a semi-quantitative (negative vs. low-positive vs. high-positive) read-out may have improved clinical utility over assays with a simple binary result.	[Kerkhoff, Andrew D.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Kerkhoff, Andrew D.; Wood, Robin; Vogt, Monica; Lawn, Stephen D.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Kerkhoff, Andrew D.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Kerkhoff, Andrew D.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Lawn, Stephen D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Lawn, Stephen D.] Univ Cape Town, Dept Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	George Washington University; University of Cape Town; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Lawn, SD (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	stephen.lawn@lshtm.ac.uk			Wellcome Trust [088590]; National Institutes of Health (NIH) [RO1 A1058736-01A1, 5UO1A1069519-02]	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SDL is funded by the Wellcome Trust (Grant no 088590). RW is funded by the National Institutes of Health (NIH) through grants RO1 A1058736-01A1 and 5UO1A1069519-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Gounder CR, 2011, JAIDS-J ACQ IMM DEF, V58, P219, DOI 10.1097/QAI.0b013e31822b75d4; Kerkhoff AD, 2014, JAIDS-J ACQ IMM DEF, V66, P33, DOI 10.1097/QAI.0000000000000091; Kerkhoff AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067956; Lanjewar D N, 2001, HIV Med, V2, P266, DOI 10.1046/j.1468-1293.2001.00079.x; Lawn SD, 2013, INT J TUBERC LUNG D, V17, P636, DOI 10.5588/ijtld.12.0811; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P1354, DOI 10.5588/ijtld.12.0174; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-231; Lawn SD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-407; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-103; Lawn SD, 2012, AIDS, V26, P1635, DOI 10.1097/QAD.0b013e3283553685; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lawn SD, 2011, J INFECT DIS, V204, pS1159, DOI 10.1093/infdis/jir411; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Lowe DM, 2013, EUR RESPIR J, V42, P1752, DOI 10.1183/09031936.00140913; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Rylance J, 2010, LANCET INFECT DIS, V10, P886, DOI 10.1016/S1473-3099(10)70201-2; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Talbot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032876; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2011, SER FERR CONC ASS IR; Zumla A, 2013, LANCET INFECT DIS, V13, P285, DOI 10.1016/S1473-3099(13)70039-2	35	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103285	10.1371/journal.pone.0103285	http://dx.doi.org/10.1371/journal.pone.0103285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075867	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800035
J	Viguiliouk, E; Kendall, CWC; Mejia, SB; Cozma, AI; Ha, V; Mirrahimi, A; Jayalath, VH; Augustin, LSA; Chiavaroli, L; Leiter, LA; de Souza, RJ; Jenkins, DJA; Sievenpiper, JL				Viguiliouk, Effie; Kendall, Cyril W. C.; Mejia, Sonia Blanco; Cozma, Adrian I.; Ha, Vanessa; Mirrahimi, Arash; Jayalath, Viranda H.; Augustin, Livia S. A.; Chiavaroli, Laura; Leiter, Lawrence A.; de Souza, Russell J.; Jenkins, David J. A.; Sievenpiper, John L.			Effect of Tree Nuts on Glycemic Control in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Dietary Trials	PLOS ONE			English	Article							MONOUNSATURATED FATTY-ACIDS; MEDITERRANEAN DIET; WALNUT CONSUMPTION; GLUCOSE-TOLERANCE; NUTRITION THERAPY; LOW-CARBOHYDRATE; MAGNESIUM INTAKE; TYPE-2; RISK; PREVENTION	Background: Tree nut consumption has been associated with reduced diabetes risk, however, results from randomized trials on glycemic control have been inconsistent. Objective: To provide better evidence for diabetes guidelines development, we conducted a systematic review and meta-analysis of randomized controlled trials to assess the effects of tree nuts on markers of glycemic control in individuals with diabetes. Data Sources: MEDLINE, EMBASE, CINAHL, and Cochrane databases through 6 April 2014. Study Selection: Randomized controlled trials >= 3 weeks conducted in individuals with diabetes that compare the effect of diets emphasizing tree nuts to isocaloric diets without tree nuts on HbA1c, fasting glucose, fasting insulin, and HOMA-IR. Data Extraction and Synthesis: Two independent reviewer's extracted relevant data and assessed study quality and risk of bias. Data were pooled by the generic inverse variance method and expressed as mean differences (MD) with 95% CI's. Heterogeneity was assessed (Cochran Q-statistic) and quantified (I-2). Results: Twelve trials (n = 450) were included. Diets emphasizing tree nuts at a median dose of 56 g/d significantly lowered HbA1c (MD = -0.07% [95% CI: -0.10, -0.03%]; P = 0.0003) and fasting glucose (MD = -0.15 mmol/L [95% CI: -0.27, -0.02 mmol/L]; P = 0.03) compared with control diets. No significant treatment effects were observed for fasting insulin and HOMA-IR, however the direction of effect favoured tree nuts. Limitations: Majority of trials were of short duration and poor quality. Conclusions: Pooled analyses show that tree nuts improve glycemic control in individuals with type 2 diabetes, supporting their inclusion in a healthy diet. Owing to the uncertainties in our analyses there is a need for longer, higher quality trials with a focus on using nuts to displace high-glycemic index carbohydrates.	[Viguiliouk, Effie; Kendall, Cyril W. C.; Mejia, Sonia Blanco; Cozma, Adrian I.; Ha, Vanessa; Mirrahimi, Arash; Jayalath, Viranda H.; Augustin, Livia S. A.; Chiavaroli, Laura; Leiter, Lawrence A.; de Souza, Russell J.; Jenkins, David J. A.; Sievenpiper, John L.] St Michaels Hosp, Clin Nutr & Risk Factor Modificat Ctr, Toronto Knowledge Synth & Clin Trials Unit 3D, Toronto, ON M5B 1W8, Canada; [Viguiliouk, Effie; Kendall, Cyril W. C.; Mejia, Sonia Blanco; Cozma, Adrian I.; Ha, Vanessa; Mirrahimi, Arash; Augustin, Livia S. A.; Chiavaroli, Laura; Leiter, Lawrence A.; de Souza, Russell J.; Jenkins, David J. A.; Sievenpiper, John L.] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada; [Sievenpiper, John L.] McMaster Univ, Fac Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Leiter, Lawrence A.; Jenkins, David J. A.] St Michaels Hosp, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada; [Leiter, Lawrence A.; Jenkins, David J. A.; Sievenpiper, John L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Kendall, Cyril W. C.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada; [de Souza, Russell J.] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Mirrahimi, Arash] Queens Univ, Fac Hlth Sci, Sch Med, Kingston, ON, Canada; [Jayalath, Viranda H.] Univ Guelph, Coll Biol Sci, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Saskatchewan; McMaster University; Queens University - Canada; University of Guelph	Kendall, CWC (corresponding author), St Michaels Hosp, Clin Nutr & Risk Factor Modificat Ctr, Toronto Knowledge Synth & Clin Trials Unit 3D, 30 Bond St, Toronto, ON M5B 1W8, Canada.	cyril.kendall@utoronto.ca	de Souza, Russell J/ABB-7735-2021; Leiter, Lawrence/AAG-4059-2020; Augustin, Livia/AAC-9009-2022	de Souza, Russell J/0000-0001-8945-513X; Augustin, Livia/0000-0002-6673-8281	International Tree Nut Council Nutrition Research & Education Foundation; Canadian Institutes of Health Research through the Canada-wide Human Nutrition Trialists' Network (NTN) [129920]; Canada Foundation for Innovation (CFI); Ministry of Research and Innovation's Ontario Research Fund (ORF); Province of Ontario Graduate Scholarships; Canadian Institutes of Health Research (CIHR)-Fredrick Banting; Charles Best Canada Graduate Scholarship; Banting and Best Diabetes Centre (BBDC)-Novo Nordisk Studentship; CIHR; Government of Canada through the Canada Research Chair Endowment	International Tree Nut Council Nutrition Research & Education Foundation; Canadian Institutes of Health Research through the Canada-wide Human Nutrition Trialists' Network (NTN)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ministry of Research and Innovation's Ontario Research Fund (ORF); Province of Ontario Graduate Scholarships; Canadian Institutes of Health Research (CIHR)-Fredrick Banting(Canadian Institutes of Health Research (CIHR)); Charles Best Canada Graduate Scholarship; Banting and Best Diabetes Centre (BBDC)-Novo Nordisk Studentship; CIHR(Canadian Institutes of Health Research (CIHR)); Government of Canada through the Canada Research Chair Endowment	This work was supported by the International Tree Nut Council Nutrition Research & Education Foundation and (Davis, California) and the Canadian Institutes of Health Research (funding reference number, 129920) through the Canada-wide Human Nutrition Trialists' Network (NTN). The Diet, Digestive tract, and Disease (3-D) Centre, funded through the Canada Foundation for Innovation (CFI) and the Ministry of Research and Innovation's Ontario Research Fund (ORF), provided the infrastructure for the conduct of this project. VH and AC were funded by Province of Ontario Graduate Scholarships. AC was also funded by a Canadian Institutes of Health Research (CIHR)-Fredrick Banting and Charles Best Canada Graduate Scholarship and Banting and Best Diabetes Centre (BBDC)-Novo Nordisk Studentship. RJdS was funded by a CIHR Postdoctoral Fellowship Award. DJAJ was funded by the Government of Canada through the Canada Research Chair Endowment. None of the sponsors had a role in any aspect of the present study, including design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, approval of the manuscript or decision to publish.	Alasalvar Cesarettin, 2009, V9, P185; Azadbakht L, 2011, DIABETES CARE, V34, P55, DOI 10.2337/dc10-0676; Bao Y, 2013, NEW ENGL J MED, V369, P2001, DOI 10.1056/NEJMoa1307352; Barbagallo Mario, 2003, Molecular Aspects of Medicine, V24, P39, DOI 10.1016/S0098-2997(02)00090-0; Bullo M, 2011, CURR TOP MED CHEM, V11, P1797, DOI 10.2174/156802611796235062; Casas-Agustench P, 2010, ASIA PAC J CLIN NUTR, V19, P124; Cheng AYY, 2013, CAN J DIABETES, V37, pS291, DOI 10.1016/j.jcjd.2013.01.048; Cohen AE, 2011, METABOLISM, V60, P1312, DOI 10.1016/j.metabol.2011.01.017; Damavandi RD, 2013, J RES MED SCI, V18, P314; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Elhayany A, 2010, DIABETES OBES METAB, V12, P204, DOI 10.1111/j.1463-1326.2009.01151.x; Esposito K, 2010, DIABETES RES CLIN PR, V89, P97, DOI 10.1016/j.diabres.2010.04.019; Esposito K, 2009, ANN INTERN MED, V151, P306, DOI 10.7326/0003-4819-151-5-200909010-00004; Evert AB, 2013, DIABETES CARE, V36, P3821, DOI 10.2337/dc13-2042; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Hosseini, 2012, IRAN J ENDOCRINOL ME, V14, P325; Jenkins DJA, 2011, DIABETES CARE, V34, P1706, DOI 10.2337/dc11-0338; Jiang R, 2002, JAMA-J AM MED ASSOC, V288, P2554, DOI 10.1001/jama.288.20.2554; Kendall CWC, 2010, BRIT J NUTR, V104, P465, DOI 10.1017/S0007114510001546; Kochar J, 2010, EUR J CLIN NUTR, V64, P75, DOI 10.1038/ejcn.2009.121; Kris-Etherton PN, 2008, J NUTR, V138, p1746S; Larsson SC, 2007, J INTERN MED, V262, P208, DOI 10.1111/j.1365-2796.2007.01840.x; Lasa A, 2014, EUR J CLIN NUTR, V68, P767, DOI 10.1038/ejcn.2014.1; Li SC, 2011, METABOLISM, V60, P474, DOI 10.1016/j.metabol.2010.04.009; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; Lopez S, 2011, AM J CLIN NUTR, V93, P494, DOI 10.3945/ajcn.110.003251; Lovejoy JC, 2002, AM J CLIN NUTR, V76, P1000, DOI 10.1093/ajcn/76.5.1000; Luo C, 2014, AM J CLIN NUTR; Ma YY, 2010, DIABETES CARE, V33, P227, DOI 10.2337/dc09-1156; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mann JI, 2004, NUTR METAB CARDIOVAS, V14, P373, DOI 10.1016/S0939-4753(04)80028-0; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moon JH, 2010, LIPIDS, V45, P1109, DOI 10.1007/s11745-010-3475-3; Pan A, 2013, J NUTR, V143, P512, DOI 10.3945/jn.112.172171; Parker ED, 2003, JAMA-J AM MED ASSOC, V290, P38, DOI 10.1001/jama.290.1.38; Ros E, 2010, NUTRIENTS, V2, P652, DOI 10.3390/nu2070652; Sabate J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79; Salas-Salvado J, 2011, NUTR METAB CARDIOVAS, V21, pB32, DOI 10.1016/j.numecd.2011.03.009; Salas-Salvado J, 2006, BRIT J NUTR, V96, pS45, DOI 10.1017/BJN20061863; Salas-Salvado J, 2014, ANN INTERN MED, V160, P1, DOI 10.7326/M13-1725; Saudek C D, 2005, J Assoc Physicians India, V53, P299; Sauder KA, 2013, FASEB J, V27; Schwingshackl L, 2011, ANN NUTR METAB, V58, P290, DOI 10.1159/000331214; Segura R, 2006, BRIT J NUTR, V96, pS36, DOI 10.1017/BJN20061862; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Sievenpiper JL, 2013, CAN J DIABETES, V37, P51, DOI 10.1016/j.jcjd.2012.11.001; Singh RB, 2002, LANCET, V360, P1455, DOI 10.1016/S0140-6736(02)11472-3; Song Y, 2006, DIABETIC MED, V23, P1050, DOI 10.1111/j.1464-5491.2006.01852.x; SUAREZ A, 1995, DIABETOLOGIA, V38, P1262; Tapsell LC, 2009, EUR J CLIN NUTR, V63, P1008, DOI 10.1038/ejcn.2009.19; Tapsell LC, 2004, DIABETES CARE, V27, P2777, DOI 10.2337/diacare.27.12.2777; U. S. Department of Agriculture, 2013, USDA NAT NUTR DAT ST; US Food and Drug Administration (FDA), 2009, GUID IND FOOD LAB GU; Wien MA, 2003, INT J OBESITY, V27, P1365, DOI 10.1038/sj.ijo.0802411; Zhou D YH, 2014, AM J CLIN NUTR	57	94	96	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103376	10.1371/journal.pone.0103376	http://dx.doi.org/10.1371/journal.pone.0103376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076495	Green Published, gold			2022-12-27	WOS:000340028800041
J	Devonshire, IM; Davis, J; Fairweather, S; Highfield, L; Thaker, C; Walsh, A; Wilson, R; Hathway, GJ				Devonshire, Ian M.; Davis, Jenny; Fairweather, Sophie; Highfield, Lauren; Thaker, Chandni; Walsh, Ashleigh; Wilson, Rachel; Hathway, Gareth J.			Risk-Based Learning Games Improve Long-Term Retention of Information among School Pupils	PLOS ONE			English	Article							COGNITIVE-DEVELOPMENT; TAKING BEHAVIOR; EDUCATION; NEUROSCIENCE; SCIENCE; BRAIN; CALIBRATION; REWARDS	Risk heightens motivation and, if used appropriately, may have the potential to improve engagement in the classroom. We have developed a risk-based learning game for school pupils in order to test whether such learning games can improve later recall of information. The study was performed during a series of public engagement workshops delivered by undergraduate students. Undergraduate neuroscience students delivered 90-minute science workshops to 9-10 year old school pupils (n = 448) that were divided into 'Risk', 'No risk' and 'Control' classes. 'Risk' classes received periodic multiple-choice questions (MCQs) during the workshops which required small teams of pupils to assign tokens to the answer(s) they believed to be correct. Tokens assigned to the correct answer were returned to the group and an equal number given back as a prize; tokens assigned to incorrect answers were lost. Participation was incentivised by the promise of a brain-related prize to the team with the most tokens at the end of the workshop. 'No risk' classes received MCQs without the risk component whilst the 'Control' classes received no MCQs. When presented with a neuroscience quiz based on workshop content at the end of the workshop, pupils in the 'Risk' classes exhibited significantly greater recall of information one week later. Quiz scores were higher than scores from the day of the workshop which suggested pupils may have discussed the workshop content outside of the classroom, thereby increasing knowledge over and above what was learned during the workshop. This is supported by feedback from pupils in 'Risk' classes which indicated that 'Risk' workshops were more interesting than 'No risk' and 'Control' workshops. These data suggest that there is a role for risk in the classroom but further investigations are required to elucidate the causal mechanisms of improved retention of information.	[Devonshire, Ian M.; Davis, Jenny; Fairweather, Sophie; Highfield, Lauren; Thaker, Chandni; Walsh, Ashleigh; Wilson, Rachel; Hathway, Gareth J.] Univ Nottingham, Sch Med, Sch Life Sci, Queens Med Ctr,Lab Dev Nocicept, Nottingham, England	University of Nottingham	Hathway, GJ (corresponding author), Univ Nottingham, Sch Med, Sch Life Sci, Queens Med Ctr,Lab Dev Nocicept, Nottingham, England.	gareth.hathway@nottingham.ac.uk		Hathway, Gareth/0000-0003-4347-9667; Devonshire, Ian/0000-0003-3250-3852	School of Life Sciences; University of Nottingham	School of Life Sciences; University of Nottingham	This project was funded by the School of Life Sciences teaching fund and a University of Nottingham 'Cascade Award'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliance for Useful Evidence, 2013, EV FRONTL; ATKINSON JW, 1957, PSYCHOL REV, V64, P359, DOI 10.1037/h0043445; Barr DA, 2013, J CHIPROPR EDUC, V27, P21, DOI 10.7899/JCE-12-018; Burgess AW, 2014, ACAD MED, V89, P678, DOI 10.1097/ACM.0000000000000162; Callan DE, 2008, HUM BRAIN MAPP, V29, P237, DOI 10.1002/hbm.20383; Cameron J, 2005, J EDUC PSYCHOL, V97, P641, DOI 10.1037/0022-0663.97.4.641; Cameron J., 2002, REWARDS INTRINSIC MO; Carew TJ, 2010, NEURON, V67, P685, DOI 10.1016/j.neuron.2010.08.028; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Curtis D, 2002, INT ED J, V3, P43; Della Salla S, 2012, NEUROSCIENCE ED GOOD; Dennison C, 2000, YOUNG PEOPLE GENDER; Devonshire IM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001761; Devonshire IM, 2010, NEUROSCIENTIST, V16, P349, DOI 10.1177/1073858410370900; Divjak B, 2011, J INF ORGAN SCI, V35, P15; Education Endowment Foundation, 2014, NEUR ED REV ED INT A; Egenfeldt-Nielsen S, 2006, NORD J DIGIT LIT, V1, P184; Erk S, 2003, NEUROIMAGE, V18, P439, DOI 10.1016/S1053-8119(02)00015-0; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Galdman-Rakic P, 1987, HDB PHYSL; Garris R., 2002, Simulation & Gaming, V33, P441, DOI 10.1177/1046878102238607; Gullone E, 2000, J ADOLESCENCE, V23, P393, DOI 10.1006/jado.2000.0327; HAYS RT, 2005, EFFECTIVENESS INSTRU; Hoffmann KF, 2009, TEACH TEACH EDUC, V25, P843, DOI 10.1016/j.tate.2008.12.004; Howard-Jones P, 2011, MIND BRAIN EDUC, V5, P33, DOI 10.1111/j.1751-228X.2011.01108.x; Howard-Jones PA, 2009, INSTR SCI, V37, P519, DOI 10.1007/s11251-008-9073-6; Leclercq D, 1983, EVALUATION ED, V6, P161, DOI [10.1016/0191-765X(82)90011-8, DOI 10.1016/0191-765X(82)90011-8]; Levin IP, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00015; Li MC, 2013, J SCI EDUC TECHNOL, V22, P877, DOI 10.1007/s10956-013-9436-x; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Malone T. W., 1981, COGNITIVE SCI, V4, P333, DOI DOI 10.1016/S0364-0213(81)80017-1; Matvey G, 2006, MEMORY, V14, P253, DOI 10.1080/09658210500216844; Moore S, 1996, J YOUTH ADOLESCENCE, V25, P343, DOI 10.1007/BF01537389; Pearson Education, 2012, LIT REV GAM ED; Pincham HL, 2014, TRENDS NEUROSCI EDUC, V3, P28, DOI 10.1016/j.tine.2014.02.002; Sandseter EBH, 2011, EVOL PSYCHOL-US, V9, P257, DOI 10.1177/147470491100900212; Sigman M, 2014, NAT NEUROSCI, V17, P497, DOI 10.1038/nn.3672; Slavin R.E., 2002, EDUC RES-UK, V31, P15, DOI [10.3102/0013189X031007015, DOI 10.3102/0013189X031007015]; Steinberg L, 2007, CURR DIR PSYCHOL SCI, V16, P55, DOI 10.1111/j.1467-8721.2007.00475.x; Stone NJ, 2000, EDUC PSYCHOL REV, V12, P437, DOI 10.1023/A:1009084430926; Studer B, 2011, COGN AFFECT BEHAV NE, V11, P144, DOI 10.3758/s13415-011-0025-2; TANG SH, 1995, APPL COGNITIVE PSYCH, V9, P365, DOI 10.1002/acp.2350090502; Tenney ER, 2011, DEV PSYCHOL, V47, P1065, DOI 10.1037/a0023273; Tymula A, 2012, P NATL ACAD SCI USA, V109, P17135, DOI 10.1073/pnas.1207144109; UK Government Cabinet Office, 2012, TEST LEARN AD DEV PU	45	7	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103640	10.1371/journal.pone.0103640	http://dx.doi.org/10.1371/journal.pone.0103640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KU	25072799	gold, Green Published, Green Submitted			2022-12-27	WOS:000341307600074
J	Knapp, AR; Wang, HY; Parthun, MR				Knapp, Amy R.; Wang, Huanyu; Parthun, Mark R.			The Yeast Histone Chaperone Hif1p Functions with RNA in Nucleosome Assembly	PLOS ONE			English	Article							HIR PROTEINS; SACCHAROMYCES-CEREVISIAE; CHROMATIN REPLICATION; DNA-REPLICATION; COMPLEX; SEQUENCE; ACETYLTRANSFERASE; ACID; NASP	Background: Hif1p is an H3/H4-specific histone chaperone that associates with the nuclear form of the Hat1p/Hat2p complex (NuB4 complex) in the yeast Saccharomyces cerevisiae. While not capable of depositing histones onto DNA on its own, Hif1p can act in conjunction with a yeast cytosolic extract to assemble nucleosomes onto a relaxed circular plasmid. Results: To identify the factor(s) that function with Hif1p to carry out chromatin assembly, multiple steps of column chromatography were carried out to fractionate the yeast cytosolic extract. Analysis of partially purified fractions indicated that Hif1p-dependent chromatin assembly activity resided in RNA rather than protein. Fractionation of isolated RNA indicated that the chromatin assembly activity did not simply purify with bulk RNA. In addition, the RNA-mediated chromatin assembly activity was blocked by mutations in the human homolog of Hif1p, sNASP, that prevent the association of this histone chaperone with histone H3 and H4 without altering its electrostatic properties. Conclusions: These results suggest that specific RNA species may function in concert with histone chaperones to assemble chromatin.	[Knapp, Amy R.; Wang, Huanyu; Parthun, Mark R.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Parthun, MR (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	Parthun.1@osu.edu	Wang, Huanyu/W-3145-2019	Wang, Huanyu/0000-0002-5982-6371	National Institutes of Health [GM062970]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (GM062970). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Corpet A, 2009, TRENDS CELL BIOL, V19, P29, DOI 10.1016/j.tcb.2008.10.002; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; Froberg JE, 2013, J MOL BIOL, V425, P3698, DOI 10.1016/j.jmb.2013.06.031; Ge ZQ, 2011, J BIOL CHEM, V286, P16790, DOI 10.1074/jbc.M110.216846; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Keller C, 2013, CHROMOSOME RES, V21, P627, DOI 10.1007/s10577-013-9390-8; KLEINSCHMIDT J, 1986, EMBO J, V5, P3547, DOI 10.1002/j.1460-2075.1986.tb04681.x; KLEINSCHMIDT JA, 1985, J BIOL CHEM, V260, P1166; LOWARY PT, 1989, P NATL ACAD SCI USA, V86, P8266, DOI 10.1073/pnas.86.21.8266; Marchese FP, 2013, EPIGENETICS, V9; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; NELSON T, 1981, BIOCHEMISTRY-US, V20, P2594, DOI 10.1021/bi00512a035; Ohsawa Ryosuke, 2013, Frontiers in Genetics, V4, P136, DOI 10.3389/fgene.2013.00136; ORAND MG, 1992, DEV BIOL, V154, P37, DOI 10.1016/0012-1606(92)90045-I; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Richardson RT, 2000, J BIOL CHEM, V275, P30378, DOI 10.1074/jbc.M003781200; Saxena A, 2011, BIOESSAYS, V33, P830, DOI 10.1002/bies.201100084; Sharp JA, 2002, GENE DEV, V16, P85, DOI 10.1101/gad.925302; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Spitale RC, 2011, EPIGENETICS-US, V6, P539, DOI 10.4161/epi.6.5.15221; TATCHELL K, 1977, BIOCHEMISTRY-US, V16, P5295, DOI 10.1021/bi00643a021; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Verzijlbergen KF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002284; Wang HY, 2008, NUCLEIC ACIDS RES, V36, P5763, DOI 10.1093/nar/gkn574; Wang HY, 2012, NUCLEIC ACIDS RES, V40, P660, DOI 10.1093/nar/gkr781; WELCH JE, 1990, BIOL REPROD, V43, P559, DOI 10.1095/biolreprod43.4.559	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e100299	10.1371/journal.pone.0100299	http://dx.doi.org/10.1371/journal.pone.0100299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072697	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600003
J	Mendez, X; Espada, JP; Orgiles, M; Llavona, LM; Garcia-Fernandez, JM				Mendez, Xavier; Espada, Jose P.; Orgiles, Mireia; Llavona, Luis M.; Garcia-Fernandez, Jose M.			Children's Separation Anxiety Scale (CSAS): Psychometric Properties	PLOS ONE			English	Article							CHILDHOOD; DISORDERS; SENSITIVITY; SYMPTOMS; VERSION; SCREEN	This study describes the psychometric properties of the Children's Separation Anxiety Scale (CSAS), which assesses separation anxiety symptoms in childhood. Participants in Study 1 were 1,908 schoolchildren aged between 8 and 11. Exploratory factor analysis identified four factors: worry about separation, distress from separation, opposition to separation, and calm at separation, which explained 46.91% of the variance. In Study 2, 6,016 children aged 8-11 participated. The factor model in Study 1 was validated by confirmatory factor analysis. The internal consistency (alpha = 0.82) and temporal stability (r = 0.83) of the instrument were good. The convergent and discriminant validity were evaluated by means of correlations with other measures of separation anxiety, childhood anxiety, depression and anger. Sensitivity of the scale was 85% and its specificity, 95%. The results support the reliability and validity of the CSAS.	[Mendez, Xavier] Univ Murcia, Dept Personal Psychol Assessment & Treatment, Murcia, Spain; [Espada, Jose P.; Orgiles, Mireia] Miguel Hernandez Univ, Dept Hlth Psychol, Elche, Spain; [Llavona, Luis M.] Univ Complutense, Dept Personal Psychol Assessment & Treatment Clin, E-28040 Madrid, Spain; [Garcia-Fernandez, Jose M.] Univ Alicante, Dept Dev Psychol & Teaching, E-03080 Alicante, Spain	University of Murcia; Universidad Miguel Hernandez de Elche; Complutense University of Madrid; Universitat d'Alacant	Mendez, X (corresponding author), Univ Murcia, Dept Personal Psychol Assessment & Treatment, Murcia, Spain.	xmendezc@um.es	Fernández, José Manuel García/AAF-8106-2021; Orgilés, Mireia/J-8651-2014; ESPADA, JOSE P/L-7482-2014	Fernández, José Manuel García/0000-0002-4760-064X; Orgilés, Mireia/0000-0003-1064-9199; ESPADA, JOSE P./0000-0001-5248-6258	Spanish National Plan for Research, Development and Technological Innovation Grant [EDU2008-05060]; BANCAJA-UMH Grant	Spanish National Plan for Research, Development and Technological Innovation Grant; BANCAJA-UMH Grant	This research was supported by the Spanish National Plan for Research, Development and Technological Innovation Grant (EDU2008-05060) awarded to Xavier Mendez, and by BANCAJA-UMH Grant (2007-2009), awarded to Mireia Orgiles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JL, 2010, J ANXIETY DISORD, V24, P946, DOI 10.1016/j.janxdis.2010.06.022; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2011, ANXIETY DISORDERS CH; Barrett PM, 2004, FRIENDS LIFE GROUPS, V4; Barrio V Del, 2009, STAXI NA INVENTARIO; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Bittner A, 2007, J CHILD PSYCHOL PSYC, V48, P1174, DOI 10.1111/j.1469-7610.2007.01812.x; Broadwin IT, 1932, AM J ORTHOPSYCHIAT, V2, P253, DOI 10.1111/j.1939-0025.1932.tb05183.x; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Del Barrio V., 2004, CDI INVENTARIO DEPRE; Eisen AR, 2005, SEPARATION ANXIETY C; Gonzalez MC, 2003, THESIS U MURCIA; Grills-Taquechel AE, 2013, PHOBIC ANXIETY DISOR; Hambleton RK, 2005, ADAPTING EDUCATIONAL AND PSYCHOLOGICAL TESTS FOR CROSS- CULTURAL ASSESSMENT, P3; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; In-Albon T, 2013, CHILD PSYCHIAT HUM D, V44, P689, DOI 10.1007/s10578-013-0364-z; Kendall PC, 1990, COPING CAT WORKBOOK; KOVACS M, 1981, ACTA PAEDOPSYCHIATR, V46, P305; Lang P.J., 1968, RES PSYCHOTHER, P90, DOI [10.1037/10546-004, DOI 10.1037/10546-004]; Lewinsohn PM, 2008, J AM ACAD CHILD PSY, V47, P548, DOI 10.1097/CHI.0b013e31816765e7; Garcia-Fernandez JM, 2010, PSICOTHEMA, V22, P502; Mendez F.X, 1999, PSICOTHEMA, V11, P65; Mendez F.X, 2004, BEHAV PSYCHOL, V12, P5; Mendez X, 2008, ANSIEDAD SEPARACION; Mendez X, 2008, EUR CHILD ADOLES PSY, V17, P365, DOI 10.1007/s00787-008-0678-8; Muris P, 2002, BEHAV RES THER, V40, P753, DOI 10.1016/S0005-7967(01)00056-0; Orgiles M, 2012, CHILD PSYCHIAT HUM D, V43, P271, DOI 10.1007/s10578-011-0265-y; Paul G. L., 1966, INSIGHT VS DESENSITI; Sandin B, 2002, PSICOTHEMA, V14, P333; Sandin B, 2002, DIAGNOSTICO TRASTORN; Seisdedos N, 2009, STAIC CUESTIONARIO A; Shear K, 2006, AM J PSYCHIAT, V163, P1074, DOI 10.1176/appi.ajp.163.6.1074; Silverman W, 1996, ANXIETY DISORDERS IN; SILVERMAN WK, 1991, J CLIN CHILD PSYCHOL, V20, P162, DOI 10.1207/s15374424jccp2002_7; Silverman WK, 2001, ENTREVISTA DIAGNOSTI; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Spence SH, 1997, J ABNORM PSYCHOL, V106, P280, DOI 10.1037/0021-843X.106.2.280; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spielberger CD, 1999, STAXI 2 STATE TRAIT; Vigil-Colet A, 2009, INT J CLIN HLTH PSYC, V9, P313; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	42	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103212	10.1371/journal.pone.0103212	http://dx.doi.org/10.1371/journal.pone.0103212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KU	25072402	Green Published, Green Submitted, gold			2022-12-27	WOS:000341307600030
J	Jin, MF; Yang, ZJ; Ye, WP; Xu, HL; Hua, XL				Jin, Minfei; Yang, Zujing; Ye, Weiping; Xu, Hongling; Hua, Xiaolin			MicroRNA-150 Predicts a Favorable Prognosis in Patients with Epithelial Ovarian Cancer, and Inhibits Cell Invasion and Metastasis by Suppressing Transcriptional Repressor ZEB1	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; POOR-PROGNOSIS; EXPRESSION; LYMPHOMA; MIR-150; GROWTH; BIOMARKERS; UPDATE	MicroRNA (miR)-150 has been reported to be dramatically downregulated in human epithelial ovarian cancer (EOC) tissues and patients' serum compared to normal controls. This study aimed to investigate clinical significance and molecular mechanisms of miR-150 in EOC. In the current study, quantitative real-time PCR analysis showed that miR-150 was significantly downregulated in human EOC tissues compared to normal tissue samples. Then, we demonstrated the significant associations of miR-150 downregulation with aggressive clinicopathological features of EOC patients, including high clinical stage and pathological grade, and shorter overall and progression-free survivals. More importantly, the multivariate analysis identified miR-150 expression as an independent prognostic biomarker in EOC. After that, luciferase reporter assays demonstrated that Zinc Finger E-Box Binding Homeobox 1 (ZEB1), a crucial regulator of epithelial-to-mesenchymal transition (EMT), was a direct target of miR-150 in EOC cells. Moreover, we found that the ectopic expression of miR-150 could efficiently inhibit cell proliferation, invasion and metastasis by suppressing the expression of ZEB1. Furthermore, we also observed a significantly negative correlation between miR-150 and ZEB1 mRNA expression in EOC tissues (rs = -0.45, P < 0.001). In conclusion, these findings offer the convincing evidence that aberrant expression of miR-150 may play a role in tumor progression and prognosis in patients with EOC. Moreover, our data reveal that miR-150 may function as a tumor suppressor and modulate EOC cell proliferation, and invasion by directly and negatively regulating ZEB1, implying the re-expression of miR-150 might be a potential therapeutic strategy for EOC.	[Jin, Minfei; Yang, Zujing; Ye, Weiping; Xu, Hongling; Hua, Xiaolin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Hua, XL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China.	huaxiaolin2014@163.com			Natural Science Foundation of Shanghai Municipal Health Bureau [20114y079]; Medicine and Engineering Foundation of Shanghai Jiaotong University [YG2011MS33]	Natural Science Foundation of Shanghai Municipal Health Bureau; Medicine and Engineering Foundation of Shanghai Jiaotong University	This study was supported by the Natural Science Foundation of Shanghai Municipal Health Bureau (No. 20114y079); Medicine and Engineering Foundation of Shanghai Jiaotong University (No. YG2011MS33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen DY, 2013, INT J GYNECOL CANCER, V23, P1357, DOI 10.1097/IGC.0b013e3182a5e760; Chen ZL, 2013, HUM PATHOL, V44, P2097, DOI 10.1016/j.humpath.2013.04.001; Coleman RL, 2013, NAT REV CLIN ONCOL, V10, P211, DOI 10.1038/nrclinonc.2013.5; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Foley OW, 2013, ONCOLOGY-NY, V27, P288; Gebauer N, 2014, CANCER GENOM PROTEOM, V11, P51; Gu XY, 2014, TUMOR BIOL IN PRESS; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Ito M, 2014, BLOOD, V123, P1499, DOI 10.1182/blood-2013-09-527739; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Liu YQ, 2014, J BIOL CHEM, V289, P4116, DOI 10.1074/jbc.M113.533505; Lobert S, 2013, BIOCHEMISTRY-US, V52, P5482, DOI 10.1021/bi400340g; Luo ZL, 2013, STEM CELLS, V31, P1749, DOI 10.1002/stem.1448; Minig L, 2013, CLIN TRANSL ONCOL, V15, P259, DOI 10.1007/s12094-012-0963-3; Mraz M, 2014, BLOOD IN PRESS; Quan Y, 2014, CANC BIOL T IN PRESS; Roche Joelle, 2013, Cancers (Basel), V5, P334, DOI 10.3390/cancers5020334; Shapira I, 2014, BRIT J CANCER, V110, P976, DOI 10.1038/bjc.2013.795; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; Vang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058226; Wang M, 2014, EXP MOL PATHOL, V96, P261, DOI 10.1016/j.yexmp.2014.02.015; Wang YQ, 2013, J CELL BIOCHEM, V114, P1464, DOI 10.1002/jcb.24488; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Wu HJ, 2013, BIOCHEM BIOPH RES CO, V441, P693, DOI 10.1016/j.bbrc.2013.10.053; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xu LJ, 2013, J CANCER RES CLIN, V139, P1257, DOI 10.1007/s00432-013-1435-z; Yang Y, 2014, J CLIN INVE IN PRESS; Yeh YM, 2013, INT J CANCER, V133, P867, DOI 10.1002/ijc.28086; Yokobori T, 2013, CANCER SCI, V104, P48, DOI 10.1111/cas.12030; Zaman MS, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-44; Zhang GJ, 2013, ONCOL LETT, V5, P564, DOI 10.3892/ol.2012.1026	32	62	64	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103965	10.1371/journal.pone.0103965	http://dx.doi.org/10.1371/journal.pone.0103965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090005	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700071
J	Li, LL; Sun, J; Xu, CQ; Zhang, HY; Wu, JF; Liu, BJ; Dong, JC				Li, Lulu; Sun, Jing; Xu, Changqing; Zhang, Hongying; Wu, Jinfeng; Liu, Baojun; Dong, Jingcheng			Icariin Ameliorates Cigarette Smoke Induced Inflammatory Responses via Suppression of NF-kappa B and Modulation of GR In Vivo and In Vitro	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; AIRWAY INFLAMMATION; EPITHELIAL-CELLS; LUNG-FUNCTION; ASTHMA; TRANSCRIPTION; RESISTANCE; PATHWAY; BURDEN	Purpose: To investigate the effects of icariin, a major constituent of flavonoids isolated from the herb Epimedium, on cigarette smoke (CS) induced inflammatory responses in vivo and in vitro. Methods: In vivo, BALB/c mice were exposed to smoke of 15 cigarettes for 1 h/day, 6 days/week for 3 months and dosed with icariin (25, 50 and 100 mg/kg) or dexamethasone (1 mg/kg). In vitro, A549 cells were incubated with icariin (10, 50 and 100 mu M) followed by treatments with CSE (2.5%). Results: We found that icariin significantly protected pulmonary function and attenuated CS-induced inflammatory response by decreasing inflammatory cells and production of TNF-alpha, IL-8 and MMP-9 in both the serum and BALF of CS-exposed mice and decreasing production of TNF-alpha and IL-8 in the supernatant of CSE-exposed A549 cells. Icariin also showed properties in inhibiting the phosphorylation of NF-kappa B p65 protein and blocking the degradation of IKB-alpha protein. Further studies revealed that icariin administration markedly restore CS-reduced GR protein and mRNA expression, which might subsequently contribute to the attenuation of CS-induced respiratory inflammatory response. Conclusion: Together these results suggest that icariin has anti-inflammatory effects in cigarette smoke induced inflammatory models in vivo and in vitro, possibly achieved by suppressing NF-kappa B activation and modulating GR protein expression.	[Li, Lulu; Sun, Jing; Zhang, Hongying; Wu, Jinfeng; Liu, Baojun; Dong, Jingcheng] Fudan Univ, Huashan Hosp, Dept Integrated Tradit Chinese & Western Med, Shanghai 200433, Peoples R China; [Xu, Changqing] Hangzhou Normal Univ, Sch Med, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China	Fudan University; Hangzhou Normal University	Dong, JC (corresponding author), Fudan Univ, Huashan Hosp, Dept Integrated Tradit Chinese & Western Med, Shanghai 200433, Peoples R China.	jcdong2004@126.com		Dong, Jingcheng/0000-0002-5194-367X; Wu, Jinfeng/0000-0002-9579-9163	National Basic Science Program of China [2009CB523000]; National Natural Science Foundation of China [81102541, 81173390, 81302931]; Inheritance base of Yun's converged traditional and western medicine	National Basic Science Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inheritance base of Yun's converged traditional and western medicine	This project was funded by grants from National Basic Science Program of China (2009CB523000), National Natural Science Foundation of China (81102541, 81173390 and 81302931) and Inheritance base of Yun's converged traditional and western medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock Ian M, 2005, Proc Am Thorac Soc, V2, P313, DOI 10.1513/pats.200504-035SR; Baginski TK, 2006, AM J RESP CELL MOL, V35, P165, DOI 10.1165/rcmb.2005-0259OC; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes Peter J, 2004, Proc Am Thorac Soc, V1, P345, DOI 10.1513/pats.200409-045MS; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barnes PJ, 2004, LANCET, V363, P731, DOI 10.1016/S0140-6736(04)15650-X; Barnes PJ, 2003, ANNU REV MED, V54, P113, DOI 10.1146/annurev.med.54.101601.152209; Barnes PJ, 2000, AM J RESP CRIT CARE, V161, P342; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P74, DOI 10.1164/rccm.200409-1257OC; Chen SR, 2010, BIOL PHARM BULL, V33, P1307, DOI 10.1248/bpb.33.1307; Culpitt SV, 1999, AM J RESP CRIT CARE, V160, P1635, DOI 10.1164/ajrccm.160.5.9811058; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; Edwards MR, 2009, PHARMACOL THERAPEUT, V121, P1, DOI 10.1016/j.pharmthera.2008.09.003; HE W, 1995, ARZNEIMITTELFORSCH, V45-2, P910; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P542, DOI 10.1164/ajrccm.155.2.9032192; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Korn SH, 1998, RESP MED, V92, P1102, DOI 10.1016/S0954-6111(98)90402-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Marwick JA, 2009, AM J RESP CRIT CARE, V179, P542, DOI 10.1164/rccm.200810-1570OC; Panayiotidis MI, 2004, CHEM-BIOL INTERACT, V147, P87, DOI 10.1016/j.cbi.2003.10.009; Plumb J, 2011, INT IMMUNOPHARMACOLO; Rahman I, 1998, THORAX, V53, P601, DOI 10.1136/thx.53.7.601; Rahman I, 2003, J BIOCHEM MOL BIOL, V36, P95; Sabroe I, 2007, AM J RESP CRIT CARE, V175, P306, DOI 10.1164/rccm.200606-777PP; SAETTA M, 1985, AM REV RESPIR DIS, V131, P764; Saetta M, 2001, AM J RESP CRIT CARE, V163, P1304, DOI 10.1164/ajrccm.163.6.2009116; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Triantaphyllopoulos K, 2011, AM J PHYSIOL-LUNG C, V300, pL691, DOI 10.1152/ajplung.00252.2010; Turato G, 2002, AM J RESP CRIT CARE, V166, P105, DOI 10.1164/rccm.2111084; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Wu JF, 2011, IMMUNOPHARM IMMUNOT, V33, P49, DOI 10.3109/08923971003725144; Wu JF, 2011, PHARMACOL BIOCHEM BE, V98, P273, DOI 10.1016/j.pbb.2011.01.008; Xu CQ, 2010, EUR J PHARMACOL, V642, P146, DOI 10.1016/j.ejphar.2010.05.012; Zeng LX, 2010, PULM PHARMACOL THER, V23, P411, DOI 10.1016/j.pupt.2010.05.004	41	30	39	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102345	10.1371/journal.pone.0102345	http://dx.doi.org/10.1371/journal.pone.0102345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089961	gold, Green Submitted, Green Published			2022-12-27	WOS:000339812700005
J	Liu, CH; Hu, RH; Huang, MJ; Lai, IR; Chen, CH; Lai, HS; Wu, YM; Huang, MC				Liu, Chiung-Hui; Hu, Rey-Heng; Huang, Miao-Juei; Lai, I-Rue; Chen, Chia-Hua; Lai, Hong-Shiee; Wu, Yao-Ming; Huang, Min-Chuan			C1GALT1 Promotes Invasive Phenotypes of Hepatocellular Carcinoma Cells by Modulating Integrin beta 1 Glycosylation and Activity	PLOS ONE			English	Article							N-ACETYLGALACTOSAMINYLTRANSFERASE 6; FOCAL ADHESION KINASE; BREAST-CANCER; ALPHA-2-BETA-1 INTEGRIN; O-GLYCOSYLATION; METASTASIS; GROWTH; EXPRESSION; BETA-1-INTEGRIN; PROGRESSION	Cancer cell invasion and metastasis are the primary causes of treatment failure and death in hepatocellular carcinoma (HCC). We previously reported that core 1 beta 1,3-galactosyltransferase (C1GALT1) is frequently overexpressed in HCC tumors and its expression is associated with advanced tumor stage, metastasis, and poor survival. However, the underlying mechanisms of C1GALT1 in HCC malignancy remain unclear. In this study, we found that overexpression of C1GALT1 enhanced HCC cell adhesion to extracellular matrix (ECM) proteins, migration, and invasion, whereas RNAi-mediated knockdown of C1GALT1 suppressed these phenotypes. The promoting effect of C1GALT1 on the metastasis of HCC cells was demonstrated in a mouse xenograft model. Mechanistic investigations showed that the C1GALT1-enhanced phenotypic changes in HCC cells were significantly suppressed by anti-integrin beta 1 blocking antibody. Moreover, C1GALT1 was able to modify O-glycans on integrin beta 1 and regulate integrin beta 1 activity as well as its downstream signaling. These results suggest that C1GALT1 could enhance HCC invasiveness through integrin beta 1 and provide novel insights into the roles of O-glycosylation in HCC metastasis.	[Liu, Chiung-Hui; Huang, Miao-Juei; Lai, I-Rue; Chen, Chia-Hua; Huang, Min-Chuan] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei, Taiwan; [Hu, Rey-Heng; Lai, I-Rue; Lai, Hong-Shiee; Wu, Yao-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Huang, Miao-Juei; Wu, Yao-Ming; Huang, Min-Chuan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Wu, YM (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	wyaoming@gmail.com; mchuang@ntu.edu.tw	Liu, Chiung-Hui/K-2974-2016	Liu, Chiung-Hui/0000-0002-2656-2576; Chen, Chia-Hua/0000-0003-0536-8085	National Taiwan University [101R7808]; National Science Council NSC [NSC 99-3111-B-002-006, NSC 101-2314-B-002-053-MY2, NSC 101-2320-B-002-007-MY3]	National Taiwan University(National Taiwan University); National Science Council NSC(Ministry of Science and Technology, Taiwan)	This study was supported by the grants from the National Taiwan University 101R7808 (Dr. Min-Chuan Huang), the National Science Council NSC NSC 99-3111-B-002-006 (Dr. Yao-Ming Wu), NSC 101-2314-B-002-053-MY2 (Dr. Rey-Heng Hu), and NSC 101-2320-B-002-007-MY3 (Dr. Min-Chuan Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Chang HH, 2013, CLIN CANCER RES, V19, P1705, DOI 10.1158/1078-0432.CCR-12-2367; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Chigaev A, 2009, J BIOL CHEM, V284, P14337, DOI 10.1074/jbc.M901178200; Clement M, 2004, J CELL SCI, V117, P5059, DOI 10.1242/jcs.01350; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fransvea E, 2009, HEPATOLOGY, V49, P839, DOI 10.1002/hep.22731; Fujii T, 2004, J HEPATOL, V41, P104, DOI 10.1016/j.jhep.2004.03.029; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Ke AW, 2011, GASTROENTEROLOGY, V140, P1629, DOI 10.1053/j.gastro.2011.02.008; Kotani N, 1999, BIOCHEM BIOPH RES CO, V260, P94, DOI 10.1006/bbrc.1999.0872; Lee SH, 2009, J BIOL CHEM, V284, P17157, DOI 10.1074/jbc.M109.010934; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Li Y, 2012, NAT REV GASTRO HEPAT, V9, P32, DOI 10.1038/nrgastro.2011.196; Liao WC, 2012, PLACENTA, V33, P1005, DOI 10.1016/j.placenta.2012.08.007; Liu YJ, 2009, DEVELOPMENT, V136, P843, DOI 10.1242/dev.027805; LOTAN R, 1975, J BIOL CHEM, V250, P8518; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Marcucci F, 2013, INT J CANC; Masumoto A, 1999, HEPATOLOGY, V29, P68, DOI 10.1002/hep.510290146; Mccall-Culbreath KD, 2008, BLOOD, V111, P3562, DOI 10.1182/blood-2007-08-107664; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Park JH, 2011, NEOPLASIA, V13, P320, DOI 10.1593/neo.101440; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Perrine C, 2009, GLYCOBIOLOGY, V19, P321, DOI 10.1093/glycob/cwn143; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Remmers N, 2013, CLIN CANCER RES, V19, P1981, DOI 10.1158/1078-0432.CCR-12-2662; Shen XH, 2010, WORLD J SURG, V34, P1028, DOI 10.1007/s00268-010-0400-0; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Vakhrushev SY, 2013, MOL CELL PROTEOMICS, V12, P932, DOI 10.1074/mcp.O112.021972; Wei YY, 2008, J HEPATOL, V49, P1029, DOI 10.1016/j.jhep.2008.09.003; Wu YM, 2013, CANCER RES, V73, P5580, DOI 10.1158/0008-5472.CAN-13-0869; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Yan Y, 2013, HEPATOLOGY, V57, P667, DOI 10.1002/hep.26071; Yang CQ, 2003, CANCER RES, V63, P8312; Zhang HJ, 2011, CANCER RES, V71, P4846, DOI 10.1158/0008-5472.CAN-11-0414	48	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e94995	10.1371/journal.pone.0094995	http://dx.doi.org/10.1371/journal.pone.0094995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089569	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700001
J	Qiu, YJ; Nakao, R; Ohnuma, A; Kawamori, F; Sugimoto, C				Qiu, Yongjin; Nakao, Ryo; Ohnuma, Aiko; Kawamori, Fumihiko; Sugimoto, Chihiro			Microbial Population Analysis of the Salivary Glands of Ticks; A Possible Strategy for the Surveillance of Bacterial Pathogens	PLOS ONE			English	Article							SPOTTED-FEVER; BOOPHILUS-MICROPLUS; FUKUI PREFECTURE; BORNE PATHOGENS; SPIROPLASMA-SP; RICKETTSIA; COXIELLA; SPP.; DNA; ENDOSYMBIONTS	Ticks are one of the most important blood-sucking vectors for infectious microorganisms in humans and animals. When feeding they inject saliva, containing microbes, into the host to facilitate the uptake of blood. An understanding of the microbial populations within their salivary glands would provide a valuable insight when evaluating the vectorial capacity of ticks. Three tick species (Ixodes ovatus, I. persulcatus and Haemaphysalis flava) were collected in Shizuoka Prefecture of Japan between 2008 and 2011. Each tick was dissected and the salivary glands removed. Bacterial communities in each salivary gland were characterized by 16S amplicon pyrosequencing using a 454 GS-Junior Next Generation Sequencer. The Ribosomal Database Project (RDP) Classifier was used to classify sequence reads at the genus level. The composition of the microbial populations of each tick species were assessed by principal component analysis (PCA) using the Metagenomics RAST (MG-RAST) metagenomic analysis tool. Rickettsia-specific PCR was used for the characterization of rickettsial species. Almost full length of 16S rDNA was amplified in order to characterize unclassified bacterial sequences obtained in I. persulcatus female samples. The numbers of bacterial genera identified for the tick species were 71 (I. ovatus), 127 (I. persulcatus) and 59 (H. flava). Eighteen bacterial genera were commonly detected in all tick species. The predominant bacterial genus observed in all tick species was Coxiella. Spiroplasma was detected in Ixodes, and not in H. flava. PCA revealed that microbial populations in tick salivary glands were different between tick species, indicating that host specificities may play an important role in determining the microbial complement. Four female I. persulcatus samples contained a high abundance of several sequences belonging to Alphaproteobacteria symbionts. This study revealed the microbial populations within the salivary glands of three species of ticks, and the results will contribute to the knowledge and prediction of emerging tick-borne diseases.	[Qiu, Yongjin; Sugimoto, Chihiro] Hokkaido Univ, Res Ctr Zoonosis Control, Div Collaborat & Educ, Sapporo, Hokkaido, Japan; [Nakao, Ryo] Hokkaido Univ, Res Ctr Zoonosis Control, Unit Risk Anal & Management, Sapporo, Hokkaido, Japan; [Ohnuma, Aiko] Hokkaido Univ, Res Ctr Zoonosis Control, Adm Off, Sapporo, Hokkaido, Japan; [Kawamori, Fumihiko] Shizuoka Prefectural Inst Publ Hlth & Environm Sc, Dept Microbiol, Shizuoka, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Sugimoto, C (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Collaborat & Educ, Sapporo, Hokkaido, Japan.	sugimoto@czc.hokudai.ac.jp	Sugimoto, Chihiro/F-6583-2012	Sugimoto, Chihiro/0000-0002-8708-0140; Qiu, Yongjin/0000-0001-8621-5472	Japan Initiative for the Global Research Network on Infectious Diseases (J-GRID); Program for Leading Graduate Schools "Fostering Global Leaders in Veterinary Science for Contributing to One Health" from the Ministry of Education, Culture, Sports, Science and Technology (NEXT)	Japan Initiative for the Global Research Network on Infectious Diseases (J-GRID); Program for Leading Graduate Schools "Fostering Global Leaders in Veterinary Science for Contributing to One Health" from the Ministry of Education, Culture, Sports, Science and Technology (NEXT)	This work was funded by the Japan Initiative for the Global Research Network on Infectious Diseases (J-GRID) (http://www.crnid.riken.jp/jgrid/en/) and the Program for Leading Graduate Schools "Fostering Global Leaders in Veterinary Science for Contributing to One Health" (http://www.jsps.go.jp/english/index.html) from the Ministry of Education, Culture, Sports, Science and Technology (NEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahantarig A, 2013, FOLIA MICROBIOL, V58, P419, DOI 10.1007/s12223-013-0222-1; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Bastian FO, 2007, J MED MICROBIOL, V56, P1235, DOI 10.1099/jmm.0.47159-0; BENACH JL, 1987, J INFECT DIS, V155, P1300, DOI 10.1093/infdis/155.6.1300; Bernasconi MV, 2002, INFECT GENET EVOL, V2, P111, DOI 10.1016/S1567-1348(02)00092-8; Berrada ZL, 2009, TOP COMPANION ANIM M, V24, P175, DOI 10.1053/j.tcam.2009.06.005; Bonnet S, 2013, VECTOR-BORNE ZOONOT, V13, P226, DOI 10.1089/vbz.2011.0933; Burgdorfer W., 1981, RICKETTSIAE RICKETTS, P585; Carpi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025604; Carroll IM, 2012, NEUROGASTROENT MOTIL, V24, P521, DOI 10.1111/j.1365-2982.2012.01891.x; Cooper A, 2013, VECTOR-BORNE ZOONOT, V13, P12, DOI 10.1089/vbz.2011.0853; Erickson DL, 2009, J MED ENTOMOL, V46, P1532, DOI 10.1603/033.046.0642; Fournier PE, 2002, J CLIN MICROBIOL, V40, P2176, DOI 10.1128/JCM.40.6.2176-2181.2002; Fujita H, 2007, ANN REPORT OHARA GEN, V47, P4; Fujita H, 2006, INT J SYST EVOL MICR, V56, P2365, DOI 10.1099/ijs.0.64177-0; Futse JE, 2003, J CLIN MICROBIOL, V41, P3829, DOI 10.1128/JCM.41.8.3829-3834.2003; Gorenflot A, 1998, ANN TROP MED PARASIT, V92, P489, DOI 10.1080/00034989859465; Hashimoto S, 2007, J EPIDEMIOL, V17, pS48, DOI 10.2188/jea.17.S48; Henning K, 2006, INT J MED MICROBIOL, V296, P157, DOI 10.1016/j.ijmm.2006.01.012; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Ishiguro F, 2008, MICROBIOL IMMUNOL, V52, P305, DOI 10.1111/j.1348-0421.2008.00042.x; Kawahara M, 1999, J CLIN MICROBIOL, V37, P1123, DOI 10.1128/JCM.37.4.1123-1129.1999; Kim YS, 2011, J MICROBIOL, V49, P340, DOI 10.1007/s12275-011-0302-3; Klyachko O, 2007, APPL ENVIRON MICROB, V73, P6584, DOI 10.1128/AEM.00537-07; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtti TJ, 2002, J MED ENTOMOL, V39, P534, DOI 10.1603/0022-2585-39.3.534; Lee JH, 2004, MICROBIOL IMMUNOL, V48, P125, DOI 10.1111/j.1348-0421.2004.tb03498.x; Liu LM, 2013, APPL ENVIRON MICROB, V79, P2450, DOI 10.1128/AEM.03575-12; Macaluso KR, 2002, J MED ENTOMOL, V39, P809, DOI 10.1603/0022-2585-39.6.809; Mahara F, 1997, EMERG INFECT DIS, V3, P105, DOI 10.3201/eid0302.970203; Matsuura Y, 2012, APPL ENVIRON MICROB, V78, P4149, DOI 10.1128/AEM.00673-12; Mediannikov O Iu, 2004, Zh Mikrobiol Epidemiol Immunobiol, P7; Menchaca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067129; Nakao R, 2013, ISME J, V7, P1003, DOI 10.1038/ismej.2012.171; Nakao R, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-137; Niebylski ML, 1997, APPL ENVIRON MICROB, V63, P3933, DOI 10.1128/AEM.63.10.3933-3940.1997; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Noji Y, 2005, JPN J INFECT DIS, V58, P112; Parola P, 2005, VET RES, V36, P469, DOI 10.1051/vetres:2005004; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; PETER TF, 1995, J CLIN MICROBIOL, V33, P166, DOI 10.1128/JCM.33.1.166-172.1995; Popov VL, 2007, VECTOR-BORNE ZOONOT, V7, P699, DOI 10.1089/vbz.2007.0148; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; Santos AS, 2002, VECTOR-BORNE ZOONOT, V2, P165, DOI 10.1089/15303660260613738; Shibata S, 2000, J CLIN MICROBIOL, V38, P1331, DOI 10.1128/JCM.38.4.1331-1338.2000; Socolovschi C, 2009, VET RES, V40, DOI 10.1051/vetres/2009017; Sonenshine DE, 2005, TICK-BORNE DISEASES OF HUMANS, P12; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taroura S, 2005, J VET MED SCI, V67, P1277, DOI 10.1292/jvms.67.1277; TULLY JG, 1981, SCIENCE, V212, P1043, DOI 10.1126/science.7233197; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Wojcik-Fatla A, 2012, ANN AGR ENV MED, V19, P656; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	55	74	75	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103961	10.1371/journal.pone.0103961	http://dx.doi.org/10.1371/journal.pone.0103961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089898	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700070
J	Egede, LE; Gebregziabher, M; Zhao, YM; Dismuke, CE; Walker, RJ; Hunt, KJ; Axon, RN				Egede, Leonard E.; Gebregziabher, Mulugeta; Zhao, Yumin; Dismuke, Clara E.; Walker, Rebekah J.; Hunt, Kelly J.; Axon, R. Neal			Impact of Mental Health Visits on Healthcare Cost in Patients with Diabetes and Comorbid Mental Health Disorders	PLOS ONE			English	Article							RANDOMIZED-TRIAL; PSYCHOLOGICAL DISTRESS; MEDICAL-CARE; VETERANS; INDIVIDUALS; DEPRESSION; OUTCOMES; TELEPSYCHIATRY; MANAGEMENT; ILLNESS	Purpose: To assess the impact of mental health visits (MHV) on the cost of care for Veterans with diabetes and comorbid mental health conditions. Methods: A national cohort of 120,852 Veterans with diabetes and at least one mental health diagnosis (i.e., substance abuse, depression or psychoses) in 2002 was followed through 2006. Outcomes were pharmacy, inpatient and outpatient costs in 2012 dollars. Results: Least-square covariate adjusted estimates from the joint model of total VA costs of the number of MHV using December 31, 2012 value dollars indicate that relative to those with fewer MHV, those with 3+ MHV had the lowest mean inpatient cost ($21,406), but the highest mean outpatient and pharmacy cost ($9,727 and $2,015, respectively). If all Veterans who received zero MHV actually received 3+ MHV, we estimate through simulated scenarios that between $32,272,329 and $181,460,247 in inpatient costs would be saved. However, these savings would be offset by additional expenditures of between $1,166,017,547 and $1,166,224,787 in outpatient costs and between $151,604,683 and $161,439,632 in pharmacy costs. Conclusions: Among Veterans with diabetes and comorbid mental disorders having three or more mental health visits is associated with marginally decreased inpatient cost, but these potential savings seem to be offset by increased outpatient and pharmacy costs.	[Gebregziabher, Mulugeta; Zhao, Yumin; Dismuke, Clara E.; Walker, Rebekah J.; Hunt, Kelly J.; Axon, R. Neal] Ralph H Johnson Dept Vet Affairs Med Ctr, Hlth Equity & Rural Outreach Innovat Ctr, Charleston, SC USA; [Egede, Leonard E.; Zhao, Yumin; Dismuke, Clara E.; Walker, Rebekah J.; Axon, R. Neal] Med Univ S Carolina, Div Gen Internal Med, Ctr Hlth Dispar Res, Charleston, SC 29425 USA; [Gebregziabher, Mulugeta; Hunt, Kelly J.] Med Univ S Carolina, Div Biostat & Epidemiol, Charleston, SC 29425 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina	Egede, LE (corresponding author), Med Univ S Carolina, Div Gen Internal Med, Ctr Hlth Dispar Res, Charleston, SC 29425 USA.	egedel@musc.edu		Gebregziabher, Mulugeta/0000-0002-4826-481X; Walker, Rebekah/0000-0002-7773-557X	VHA Health Services Research and Development (HSRD) program [IIR-06-219]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK093699] Funding Source: NIH RePORTER	VHA Health Services Research and Development (HSRD) program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant #IIR-06-219 funded by the VHA Health Services Research and Development (HSR&D) program. The funding agency did not participate in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Dickerson F, 2008, PSYCHOSOMATICS, V49, P109, DOI 10.1176/appi.psy.49.2.109; Dieterich M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007906.pub2; Dixon LB, 2004, PSYCHIAT SERV, V55, P892, DOI 10.1176/appi.ps.55.8.892; Druss BG, 2010, AM J PSYCHIAT, V167, P151, DOI 10.1176/appi.ajp.2009.09050691; Egede LE, 2002, DIABETES CARE, V25, P464, DOI 10.2337/diacare.25.3.464; Egede LE, 2012, DIABETES CARE, V35, P2533, DOI 10.2337/dc12-0572; Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0; Egede LE, 2011, DIABETES CARE, V34, P938, DOI 10.2337/dc10-1504; Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024; Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x; Frueh BC, 2007, J TELEMED TELECARE, V13, P142, DOI 10.1258/135763307780677604; Germain V, 2010, CYBERPSYCH BEH SOC N, V13, P29, DOI 10.1089/cyber.2009.0139; Hultsjo SM, 2012, J PSYCHIATR MENT HLT, V19, P891, DOI 10.1111/j.1365-2850.2012.01874.x; Hutter N, 2010, DIABETOLOGIA, V53, P2470, DOI 10.1007/s00125-010-1873-y; Jimenez-Garcia R, 2012, PRIM CARE DIABETES, V6, P149, DOI 10.1016/j.pcd.2011.10.002; Kalsekar Iftekhar D, 2006, Manag Care Interface, V19, P39; Kreyenbuhl J, 2008, SCHIZOPHR RES, V101, P256, DOI 10.1016/j.schres.2008.02.004; Kreyenbuhl J, 2010, SCHIZOPHRENIA BULL, V36, P428, DOI 10.1093/schbul/sbn106; McGuire J, 2009, ADM POLICY MENT HLTH, V36, P255, DOI 10.1007/s10488-009-0210-6; Miller DR, 2004, DIABETES CARE, V27, pB10, DOI 10.2337/diacare.27.suppl_2.B10; Morland LA, 2010, J CLIN PSYCHIAT, V71, P855, DOI 10.4088/JCP.09m05604blu; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Pirraglia Paul A, 2012, Prev Chronic Dis, V9, pE51; Ruskin PE, 2004, AM J PSYCHIAT, V161, P1471, DOI 10.1176/appi.ajp.161.8.1471; Saxon AJ, 2006, MED CARE, V44, P334, DOI 10.1097/01.mlr.0000204052.95507.5c; West AN, 2010, J RURAL HEALTH, V26, P301, DOI 10.1111/j.1748-0361.2010.00298.x	26	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103804	10.1371/journal.pone.0103804	http://dx.doi.org/10.1371/journal.pone.0103804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4JL	25083903	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800081
J	Adriaanse, SM; Binnewijzend, MAA; Ossenkoppele, R; Tijms, BM; van der Flier, WM; Koene, T; Smits, LL; Wink, AM; Scheltens, P; van Berckel, BNM; Barkhof, F				Adriaanse, Sofie M.; Binnewijzend, Maja A. A.; Ossenkoppele, Rik; Tijms, Betty M.; van der Flier, Wiesje M.; Koene, Teddy; Smits, Lieke L.; Wink, Alle Meije; Scheltens, Philip; van Berckel, Bart N. M.; Barkhof, Frederik			Widespread Disruption of Functional Brain Organization in Early-Onset Alzheimer's Disease	PLOS ONE			English	Article							RESTING-STATE FMRI; CONNECTIVITY; NETWORK; PATTERNS; MEMORY; GREY	Early-onset Alzheimer's disease (AD) patients present a different clinical profile than late-onset AD patients. This can be partially explained by cortical atrophy, although brain organization might provide more insight. The aim of this study was to examine functional connectivity in early-onset and late-onset AD patients. Resting-state fMRI scans of 20 early-onset (<65 years old), 28 late-onset (>= 65 years old) AD patients and 15 "young'' (<65 years old) and 31 "old'' (>= 65 years old) age-matched controls were available. Resting-state network-masks were used to create subject-specific maps. Group differences were examined using a non-parametric permutation test, accounting for gray-matter. Performance on five cognitive domains were used in a correlation analysis with functional connectivity in AD patients. Functional connectivity was not different in any of the RSNs when comparing the two control groups (young vs. old controls), which implies that there is no general effect of aging on functional connectivity. Functional connectivity in early-onset AD was lower in all networks compared to age-matched controls, where late-onset AD showed lower functional connectivity in the default-mode network. Functional connectivity was lower in early-onset compared to late-onset AD in auditory-, sensory-motor, dorsal-visual systems and the default mode network. Across patients, an association of functional connectivity of the default mode network was found with visuoconstruction. Functional connectivity of the right dorsal visual system was associated with attention across patients. In late-onset AD patients alone, higher functional connectivity of the sensory-motor system was associated with poorer memory performance. Functional brain organization was more widely disrupted in early-onset AD when compared to late-onset AD. This could possibly explain different clinical profiles, although more research into the relationship of functional connectivity and cognitive performance is needed.	[Adriaanse, Sofie M.; Binnewijzend, Maja A. A.; Ossenkoppele, Rik; Tijms, Betty M.; Wink, Alle Meije; van Berckel, Bart N. M.; Barkhof, Frederik] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Binnewijzend, Maja A. A.; Tijms, Betty M.; van der Flier, Wiesje M.; Scheltens, Philip] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Alzheimerctr Amsterdam, Amsterdam, Netherlands; [van der Flier, Wiesje M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Koene, Teddy; Smits, Lieke L.] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Adriaanse, Sofie M.; Binnewijzend, Maja A. A.; Ossenkoppele, Rik; Tijms, Betty M.; van der Flier, Wiesje M.; Smits, Lieke L.; Wink, Alle Meije; Scheltens, Philip; van Berckel, Bart N. M.; Barkhof, Frederik] Neurosci Campus Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam	Adriaanse, SM (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands.	s.adriaanse@vumc.nl	Ossenkoppele, Rik/J-5826-2013; Wink, Alle Meije/R-6403-2017; Tijms, Betty M./I-2218-2019; Barkhof, Frederik/AAJ-6226-2020; Scheltens, Philip/AAL-9631-2020	Wink, Alle Meije/0000-0002-8197-0118; Tijms, Betty M./0000-0002-2612-1797; Barkhof, Frederik/0000-0003-3543-3706; Scheltens, Philip/0000-0002-1046-6408; van der Flier, Wiesje/0000-0001-8766-6224; Ossenkoppele, Rik/0000-0003-1584-7477	Dutch Foundation for Brain Research (De Hersenstichting) [KS2011(1)-24]; Internationale Stichting Alzheimer Onderzoek (ISAO) [11539]; Alzheimer Nederland; Stichting VUmc fonds; Stichting Dioraphte	Dutch Foundation for Brain Research (De Hersenstichting); Internationale Stichting Alzheimer Onderzoek (ISAO); Alzheimer Nederland; Stichting VUmc fonds; Stichting Dioraphte	This work was supported by the Dutch Foundation for Brain Research (De Hersenstichting [grant number KS2011(1)-24]) and by the Internationale Stichting Alzheimer Onderzoek (ISAO) [grant number #11539]. The VUmc Alzheimer center is supported by Alzheimer Nederland and Stichting VUmc fonds. The clinical database structure was developed with funding from Stichting Dioraphte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2010, HUM BRAIN MAPP, V31, P515, DOI 10.1002/hbm.20883; Alzheimer's Disease International, LANCET, V366, P2112; Andersson J.L.R, 2007, TR07JA2 FMRIB; [Anonymous], NEURORADIOLOGY, V49, P967; Bear MF, 2007, NEUROSCIENCE EXPLORI; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beckmann CF, 2009, OHBM 2011; Binnewijzend MAA, 2012, NEUROBIOL AGING, V33, P2018, DOI 10.1016/j.neurobiolaging.2011.07.003; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; de Waal H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.013; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Frisoni GB, 2007, BRAIN, V130, P720, DOI 10.1093/brain/awl377; Fujimori M, 1998, ALZ DIS ASSOC DIS, V12, P163, DOI 10.1097/00002093-199809000-00007; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gour N, 2014, HUM BRAIN MAPP, V35, P2978, DOI 10.1002/hbm.22379; Gour N, 2011, NEUROIMAGE, V58, P687, DOI 10.1016/j.neuroimage.2011.05.090; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; Hodges JR, 2006, BRAIN, V129, P2811, DOI 10.1093/brain/awl275; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kalpouzos G, 2005, J NEUROL, V252, P548, DOI 10.1007/s00415-005-0685-3; Kim EJ, 2005, BRAIN, V128, P1790, DOI 10.1093/brain/awh539; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Koedam ELGE, 2010, J ALZHEIMERS DIS, V19, P1401, DOI 10.3233/JAD-2010-1337; Koss E, 1996, NEUROLOGY, V46, P136, DOI 10.1212/WNL.46.1.136; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moller C, 2013, NEUROBIOL AGING, V34, P2014, DOI 10.1016/j.neurobiolaging.2013.02.013; Ossenkoppele R, 2012, BRAIN, V135, P2115, DOI 10.1093/brain/aws113; Rabinovici GD, 2010, BRAIN, V133, P512, DOI 10.1093/brain/awp326; Salmon E, 2008, NEUROPSYCHOLOGIA, V46, P1613, DOI 10.1016/j.neuropsychologia.2007.11.022; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smits LL, 2012, J ALZHEIMERS DIS, V30, P101, DOI 10.3233/JAD-2012-111934; Verhage F., 1964, INTELLIGENCE AGE RES; WATSON RT, 1986, ARCH NEUROL-CHICAGO, V43, P787, DOI 10.1001/archneur.1986.00520080035016; Whitwell Jennifer L, 2005, Top Magn Reson Imaging, V16, P409, DOI 10.1097/01.rmr.0000245457.98029.e1; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	44	36	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102995	10.1371/journal.pone.0102995	http://dx.doi.org/10.1371/journal.pone.0102995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080229	gold, Green Submitted, Green Published			2022-12-27	WOS:000339954800021
J	Dubois, MS; Morello, S; Rayment, K; Markel, MD; Vanderby, R; Kalscheur, VL; Hao, ZL; McCabe, RP; Marquis, P; Muir, P				Dubois, Marie-Soleil; Morello, Samantha; Rayment, Kelsey; Markel, Mark D.; Vanderby, Ray, Jr.; Kalscheur, Vicki L.; Hao, Zhengling; McCabe, Ronald P.; Marquis, Patricia; Muir, Peter			Computed Tomographic Imaging of Subchondral Fatigue Cracks in the Distal End of the Third Metacarpal Bone in the Thoroughbred Racehorse Can Predict Crack Micromotion in an Ex-Vivo Model	PLOS ONE			English	Article							METATARSAL BONES; CONDYLAR FRACTURES; METACARPO/METATARSOPHALANGEAL JOINT; 135 HORSES; PATHOLOGY; RADIOGRAPHY; ADAPTATION; FATALITIES; STRENGTH; EXERCISE	Articular stress fracture arising from the distal end of the third metacarpal bone (MC3) is a common serious injury in Thoroughbred racehorses. Currently, there is no method for predicting fracture risk clinically. We describe an ex-vivo biomechanical model in which we measured subchondral crack micromotion under compressive loading that modeled high speed running. Using this model, we determined the relationship between subchondral crack dimensions measured using computed tomography (CT) and crack micromotion. Thoracic limbs from 40 Thoroughbred racehorses that had sustained a catastrophic injury were studied. Limbs were radiographed and examined using CT. Parasagittal subchondral fatigue crack dimensions were measured on CT images using image analysis software. MC3 bones with fatigue cracks were tested using five cycles of compressive loading at -7,500N (38 condyles, 18 horses). Crack motion was recorded using an extensometer. Mechanical testing was validated using bones with 3 mm and 5 mm deep parasagittal subchondral slots that modeled naturally occurring fatigue cracks. After testing, subchondral crack density was determined histologically. Creation of parasagittal subchondral slots induced significant micromotion during loading (p<0.001). In our biomechanical model, we found a significant positive correlation between extensometer micromotion and parasagittal crack area derived from reconstructed CT images (S-R = 0.32, p<0.05). Correlations with transverse and frontal plane crack lengths were not significant. Histologic fatigue damage was not significantly correlated with crack dimensions determined by CT or extensometer micromotion. Bones with parasagittal crack area measurements above 30 mm(2) may have a high risk of crack propagation and condylar fracture in vivo because of crack micromotion. In conclusion, our results suggest that CT could be used to quantify subchondral fatigue crack dimensions in racing Thoroughbred horses in-vivo to assess risk of condylar fracture. Horses with parasagittal crack arrays that exceed 30 mm(2) may have a high risk for development of condylar fracture.	[Dubois, Marie-Soleil; Morello, Samantha; Rayment, Kelsey; Markel, Mark D.; Kalscheur, Vicki L.; Hao, Zhengling; Marquis, Patricia; Muir, Peter] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Vanderby, Ray, Jr.; McCabe, Ronald P.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthopaed & Rehabil, Madison, WI 53706 USA; [Marquis, Patricia] Gulfstream Pk, Hallandale Beach, FL USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	muirp@vetmed.wisc.edu	Muir, Peter/AAH-8057-2021	Muir, Peter/0000-0003-0028-6005; Morello, Samantha/0000-0001-5209-051X	AO Foundation [AOVET-12-05M]	AO Foundation	This research [Project AOVET-12-05M] was supported by a grant from the AO Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr ED, 2009, EQUINE VET J, V41, P366, DOI 10.2746/042516409X368372; Bassage LH, 1998, J AM VET MED ASSOC, V212, P1757; Boyde A, 1999, EQUINE VET J, V31, P122, DOI 10.1111/j.2042-3306.1999.tb03805.x; BURR DB, 1995, BONE, V17, P431, DOI 10.1016/S8756-3282(95)00241-3; Clegg PD, 2011, EQUINE VET J, V43, P643, DOI 10.1111/j.2042-3306.2011.00457.x; Currey JD, 2003, J BONE MINER RES, V18, P591, DOI 10.1359/jbmr.2003.18.4.591; Desbrosse FG, 2008, EQUINE VET EDUC, V20, P93, DOI 10.2746/095777308X272085; ELLIS DR, 1994, EQUINE VET J, V26, P178, DOI 10.1111/j.2042-3306.1994.tb04365.x; Estberg L, 1998, PREV VET MED, V33, P159, DOI 10.1016/S0167-5877(97)00047-0; HORNOF WJ, 1981, VET RADIOLOGY, V22, P98, DOI 10.1111/j.1740-8261.1981.tb01359.x; Jacklin BD, 2012, EQUINE VET J, V44, P707, DOI 10.1111/j.2042-3306.2012.00558.x; KANEKO M, 1993, J VET MED SCI, V55, P181, DOI 10.1292/jvms.55.181; KROOK L, 1988, CORNELL VET, V78, P7; McKee S. L., 1995, Equine Veterinary Education, V7, P202, DOI 10.1111/j.2042-3292.1995.tb01225.x; Morgan JW, 2006, VET SURG, V35, P611, DOI 10.1111/j.1532-950X.2006.00198.x; Muir P, 2008, J ANAT, V213, P706, DOI 10.1111/j.1469-7580.2008.00996.x; Muir P, 2006, BONE, V38, P342, DOI 10.1016/j.bone.2005.08.020; NUNAMAKER DM, 1990, J ORTHOPAED RES, V8, P604, DOI 10.1002/jor.1100080417; O'Brien T, 2011, VET SURG, V40, P942, DOI 10.1111/j.1532-950X.2011.00881.x; Pool R.R., 1996, JOINT DIS HORSE, P87; Radtke CL, 2003, AM J VET RES, V64, P1110, DOI 10.2460/ajvr.2003.64.1110; Reilly GC, 1997, J ORTHOP RES, V15, P862, DOI 10.1002/jor.1100150611; RICHARDSON DW, 1984, J AM VET MED ASSOC, V185, P761; Riggs CM, 1999, EQUINE VET J, V31, P130, DOI 10.1111/j.2042-3306.1999.tb03806.x; Riggs CM, 1999, EQUINE VET J, V31, P140, DOI 10.1111/j.2042-3306.1999.tb03807.x; Rooney J R, 1974, Mod Vet Pract, V55, P113; RUBIN CT, 1982, J EXP BIOL, V101, P187; Stepnik MW, 2004, VET SURG, V33, P2, DOI 10.1111/j.1532-950x.2004.04007.x; Stover SM, 2008, VET CLIN N AM-EQUINE, V24, P21, DOI 10.1016/j.cveq.2007.11.009; Taylor D, 2003, J BIOMECH, V36, P1103, DOI 10.1016/S0021-9290(03)00104-0; Taylor D, 1998, J ORTHOPAED RES, V16, P163, DOI 10.1002/jor.1100160203; Zekas LJ, 1999, EQUINE VET J, V31, P309, DOI 10.1111/j.2042-3306.1999.tb03822.x; Zekas LJ, 1999, EQUINE VET J, V31, P304, DOI 10.1111/j.2042-3306.1999.tb03821.x	33	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101230	10.1371/journal.pone.0101230	http://dx.doi.org/10.1371/journal.pone.0101230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077477	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800003
J	Fukuda, K; Yatera, K; Ogawa, M; Kawanami, T; Yamasaki, K; Noguchi, S; Murphy, RS; Mukae, H; Taniguchi, H				Fukuda, Kazumasa; Yatera, Kazuhiro; Ogawa, Midori; Kawanami, Toshinori; Yamasaki, Kei; Noguchi, Shingo; Murphy, Robert S.; Mukae, Hiroshi; Taniguchi, Hatsumi			An Unclassified Microorganism: Novel Pathogen Candidate Lurking in Human Airways	PLOS ONE			English	Article							INTRACELLULAR GROWTH; GENOME SEQUENCE; IDENTIFICATION; MICROBIOME; DIVERSITY; ALIGNMENT; BACTERIA; LUNG	During the assessments of the correlation of the diseases and the microbiota of various clinical specimens, unique 16S ribosomal RNA (rRNA) gene sequences (less than 80% similarity to known bacterial type strains) were predominantly detected in a bronchoalveolar lavage fluid (BALF) specimen from a patient with chronic lower respiratory tract infection. The origin of this unique sequence is suspected to be the causative agent of the infection. We temporarily named the owner organism of this sequence "IOLA" (Infectious Organism Lurking in Airways). In order to evaluate the significance of IOLA in human lung disorders, we performed several experiments. IOLA-16S rRNA genes were detected in 6 of 386 clone libraries constructed from clinical specimens of patients with respiratory diseases (in our study series). The gene sequences (1,427 bp) are identical, and no significantly similar sequence was found in public databases (using NCBI blastn) except for the 8 shorter sequences detected from patients with respiratory diseases in other studies from 2 other countries. Phylogenetic analyses revealed that the 16S rRNA gene of IOLA is more closely related to eukaryotic mitochondria than bacteria. However, the size and shape of IOLA seen by fluorescent in-situ hybridization are similar to small bacteria (approximately 1 mm with a spherical shape). Furthermore, features of both bacteria and mitochondria were observed in the genomic fragment (about 19 kb) of IOLA, and the GC ratio of the sequence was extremely low (20.5%). Two main conclusions were reached: (1) IOLA is a novel bacteria-like microorganism that, interestingly, possesses features of eukaryotic mitochondria. (2) IOLA is a novel pathogen candidate, and it may be the causative agent of human lung or airway disease. IOLA exists in BALF specimens from patients with remarkable symptoms; this information is an important piece for helping solve the elusive etiology of chronic respiratory disorders.	[Fukuda, Kazumasa; Ogawa, Midori; Taniguchi, Hatsumi] Univ Occupat & Environm Hlth, Dept Microbiol, Kitakyushu, Fukuoka 807, Japan; [Yatera, Kazuhiro; Kawanami, Toshinori; Yamasaki, Kei; Noguchi, Shingo; Mukae, Hiroshi] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka 807, Japan; [Murphy, Robert S.] Univ Kitakyushu, Ctr Fundamental Educ, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Kitakyushu	Fukuda, K (corresponding author), Univ Occupat & Environm Hlth, Dept Microbiol, Kitakyushu, Fukuoka 807, Japan.	kfukuda@med.uoeh-u.ac.jp			University of Occupational and Environmental Health, Japan	University of Occupational and Environmental Health, Japan(University of Occupational & Environmental Health - Japan)	This work was supported by University of Occupational and Environmental Health, Japan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Aoki R, 2013, OPHTHALMOLOGY, V120, P668, DOI 10.1016/j.ophtha.2012.10.001; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brindefalk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024457; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Cardenas PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046803; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Dollive S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r60; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hotopp JCD, 2006, PLOS GENET, V2, P2176, DOI 10.1371/journal.pgen.0020213; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Kawanami T, 2011, CHEST, V139, P600, DOI 10.1378/chest.10-0460; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Kolesnikov AA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1424, DOI 10.1134/S0006297912130020; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lin MQ, 2009, NUCLEIC ACIDS RES, V37, P6076, DOI 10.1093/nar/gkp642; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Maruta K, 1998, AM J RESP CRIT CARE, V157, P1967, DOI 10.1164/ajrccm.157.6.9710108; Maughan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045791; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nakayama K, 2008, DNA RES, V15, P185, DOI 10.1093/dnares/dsn011; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Nomoto M, 2009, MICROBIOL IMMUNOL, V53, P550, DOI 10.1111/j.1348-0421.2009.00158.x; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x; Yamasaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063103; Yoshimura K, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.018; Yutin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036972	48	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103646	10.1371/journal.pone.0103646	http://dx.doi.org/10.1371/journal.pone.0103646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080337	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800062
J	Klein, DJ; Baym, M; Eckhoff, P				Klein, Daniel J.; Baym, Michael; Eckhoff, Philip			The Separatrix Algorithm for Synthesis and Analysis of Stochastic Simulations with Applications in Disease Modeling	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; GENETIC ALGORITHMS; MALARIA VACCINES; TRANSMISSION; OPTIMIZATION; STRATEGIES; REGRESSION; INFECTION; DESIGNS; POLIOMYELITIS	Decision makers in epidemiology and other disciplines are faced with the daunting challenge of designing interventions that will be successful with high probability and robust against a multitude of uncertainties. To facilitate the decision making process in the context of a goal-oriented objective (e.g., eradicate polio by 2018), stochastic models can be used to map the probability of achieving the goal as a function of parameters. Each run of a stochastic model can be viewed as a Bernoulli trial in which "success'' is returned if and only if the goal is achieved in simulation. However, each run can take a significant amount of time to complete, and many replicates are required to characterize each point in parameter space, so specialized algorithms are required to locate desirable interventions. To address this need, we present the Separatrix Algorithm, which strategically locates parameter combinations that are expected to achieve the goal with a user-specified probability of success (e.g. 95%). Technically, the algorithm iteratively combines density-corrected binary kernel regression with a novel information-gathering experiment design to produce results that are asymptotically correct and work well in practice. The Separatrix Algorithm is demonstrated on several test problems, and on a detailed individual-based simulation of malaria.	[Klein, Daniel J.; Baym, Michael; Eckhoff, Philip] Inst Dis Modeling, Bellevue, WA USA; [Baym, Michael] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Baym, Michael] MIT, Dept Math, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Klein, DJ (corresponding author), Inst Dis Modeling, Bellevue, WA USA.	dklein@intven.com		Baym, Michael/0000-0003-1303-5598	Bill and Melinda Gates through the Global Good Fund at Intellectual Ventures Laboratory	Bill and Melinda Gates through the Global Good Fund at Intellectual Ventures Laboratory	This work was supported by Bill and Melinda Gates through the Global Good Fund at Intellectual Ventures Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON IS, 1982, ANN STAT, V10, P1217, DOI 10.1214/aos/1176345986; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Ankenman B, 2008, 2008 WINTER SIMULATION CONFERENCE, VOLS 1-5, P362, DOI 10.1109/WSC.2008.4736089; Baesler FF, 2001, WSC'01: PROCEEDINGS OF THE 2001 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P1405, DOI 10.1109/WSC.2001.977463; Barton RR, 1998, 1998 WINTER SIMULATION CONFERENCE PROCEEDINGS, VOLS 1 AND 2, P167, DOI 10.1109/WSC.1998.744912; Barton RR, 2006, HBK OPERAT RES MANAG, V13, P535, DOI 10.1016/S0927-0507(06)13018-2; BERNARDO JM, 1979, ANN STAT, V7, P686, DOI 10.1214/aos/1176344689; BLANNING RW, 1975, SIMULATION, V24, P177, DOI 10.1177/003754977502400606; BOX GEP, 1951, J R STAT SOC B, V13, P1, DOI 10.1111/j.2517-6161.1951.tb00067.x; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Brown ST, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-353; Castiglione F, 2007, BIOINFORMATICS, V23, P3350, DOI 10.1093/bioinformatics/btm408; Chaloner K, 1995, STAT SCI, V10, P273, DOI 10.1214/ss/1177009939; Chick SE, 2002, PROCEEDINGS OF THE 2002 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P400, DOI 10.1109/WSC.2002.1172910; Chick SE, 2006, PROCEEDINGS OF THE 2006 WINTER SIMULATION CONFERENCE, VOLS 1-5, P96, DOI 10.1109/WSC.2006.323042; DeGroot M. H., 1970, OPTIMAL STAT DECISIO; DONOHUE JM, 1994, 1994 WINTER SIMULATION CONFERENCE PROCEEDINGS, P200; Eckhoff P, 2013, AM J TROP MED HYG, V88, P817, DOI 10.4269/ajtmh.12-0007; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fang HB, 2006, ENG OPTIMIZ, V38, P407, DOI 10.1080/03052150500422294; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; HALL P, 1991, J AM STAT ASSOC, V86, P665; Hall P, 2001, ANN STAT, V29, P624; Hazelton ML, 2007, COMPUT STAT DATA AN, V51, P4393, DOI 10.1016/j.csda.2006.06.012; Helton JC, 2003, RELIAB ENG SYST SAFE, V81, P23, DOI 10.1016/S0951-8320(03)00058-9; HENDERSON RH, 1989, ANN NY ACAD SCI, V569, P69, DOI 10.1111/j.1749-6632.1989.tb27359.x; Jin RC, 2005, J STAT PLAN INFER, V134, P268, DOI 10.1016/j.jspi.2004.02.014; Jourdan A, 2010, ASTA-ADV STAT ANAL, V94, P341, DOI 10.1007/s10182-010-0145-y; Khuri AI, 2010, WIRES COMPUT STAT, V2, P128, DOI 10.1002/wics.73; Kleijnen JPC, 2009, EUR J OPER RES, V192, P707, DOI 10.1016/j.ejor.2007.10.013; Kleijnen JPC, 2004, J OPER RES SOC, V55, P876, DOI 10.1057/palgrave.jors.2601747; Kleijnen JPC, 2005, EUR J OPER RES, V164, P287, DOI 10.1016/j.ejor.2004.02.005; LINDLEY DV, 1956, ANN MATH STAT, V27, P986, DOI 10.1214/aoms/1177728069; Lollini PL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-352; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; MATLAB, 2012, MATLAB VERS 8 1 R201; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; McKenzie FE, 2002, AM J TROP MED HYG, V67, P571, DOI 10.4269/ajtmh.2002.67.571; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Pappalardo F, 2006, LECT NOTES ARTIF INT, V3849, P223; Patel R, 2005, J THEOR BIOL, V234, P201, DOI 10.1016/j.jtbi.2004.11.032; SABIN AB, 1960, JAMA-J AM MED ASSOC, V173, P1521, DOI 10.1001/jama.1960.03020320001001; Sabuncuoglu I, 2002, INT J PROD RES, V40, P2483, DOI 10.1080/00207540210135596; Sacks J., 1989, STAT SCI, V4, P409, DOI [10.1214/ss/1177012413, DOI 10.1214/SS/1177012413]; SALK JE, 1955, JAMA-J AM MED ASSOC, V158, P1239, DOI 10.1001/jama.1955.02960140001001; SAUL AJ, 1990, J APPL ECOL, V27, P123, DOI 10.2307/2403572; SMITH AFM, 1980, BIOMETRIKA, V67, P613, DOI 10.1093/biomet/67.3.613; Smith T, 2008, PARASITOLOGY, V135, P1507, DOI 10.1017/S0031182008000371; Smith T, 2006, AM J TROP MED HYG, V75, P1; Stover J, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010157; Stover J, 2011, CURR OPIN HIV AIDS, V6, P108, DOI 10.1097/COH.0b013e328343ac05; Tekin E, 2004, IIE TRANS, V36, P1067, DOI 10.1080/07408170490500654; Thompson KM, 2008, SYST DYNAM REV, V24, P433, DOI 10.1002/sdr.419; Van Beers W. C., 2004, SIM C 2004 P 2004 WI, V1; Wahba G., 1990, SPLINE MODELS OBSERV, V59; Wenger EA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-126	61	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103467	10.1371/journal.pone.0103467	http://dx.doi.org/10.1371/journal.pone.0103467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078087	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800047
J	Kramer, A; Paun, L; Imhoff, JF; Kempken, F; Labes, A				Kramer, Annemarie; Paun, Linda; Imhoff, Johannes F.; Kempken, Frank; Labes, Antje			Development and Validation of a Fast and Optimized Screening Method for Enhanced Production of Secondary Metabolites Using the Marine Scopulariopsis brevicaulis Strain LF580 Producing Anti-Cancer Active Scopularide A and B	PLOS ONE			English	Article							MICROTITER PLATES; FILAMENTOUS FUNGI; NATURAL-PRODUCTS; GROWTH; AERATION; LIGHT	Natural compounds from marine fungi are an excellent source for the discovery and development of new drug leads. The distinct activity profiles of the two cyclodepsipeptides scopularide A and B against cancer cell lines set their marine producer strain Scopulariopsis brevicaulis LF580 into the focus of the EU project MARINE FUNGI. One of the main goals was the development of a sustainable biotechnological production process for these compounds. The secondary metabolite production of strain LF580 was optimized by random mutagenesis employing UV radiation. For a fast and reliable detection of the intracellular secondary metabolite production level, a miniaturized bioactivity-independent screening method was developed, as the random mutagenesis yielded a large number of mutants to be analysed quantitatively and none of the existing hyphenated bioassay-dependent screening systems could be applied. The method includes decreased cultivation volume, a fast extraction procedure as well as an optimized LC-MS analysis. We show that deviation could be specifically reduced at each step of the process: The measuring deviation during the analysis could be minimized to 5% and technical deviation occurring in the downstream part to 10-15%. Biological variation during the cultivation process still has the major influence on the overall variation. However, the approach led to a 10-fold reduction of time and similar effects on costs and effort compared to standard reference screening methods. The method was applied to screen the UV-mutants library of Scopulariopsis brevicaulis LF580. For validation purposes, the occurring variations in the miniaturized scale were compared to those in the classical Erlenmeyer flask scale. This proof of concept was performed using the wild type strain and 23 randomly selected mutant strains. One specific mutant strain with an enhanced production behavior could be obtained.	[Kramer, Annemarie; Imhoff, Johannes F.; Labes, Antje] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel Ctr Marine Nat Prod, Kiel, Germany; [Paun, Linda; Kempken, Frank] Univ Kiel, Inst Bot, Dept Genet & Mol Biol Bot, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Labes, A (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel Ctr Marine Nat Prod, Kiel, Germany.	alabes@geomar.de	Labes, Antje/AGK-3198-2022; Imhoff, Johannes F./D-2515-2010; Imhoff, Johannes F./AAB-8765-2022	Labes, Antje/0000-0002-4807-3378; Imhoff, Johannes F./0000-0001-8789-0728; Imhoff, Johannes F./0000-0001-8789-0728; Kempken, Frank/0000-0002-7853-8009	European Commission [265926]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The project is funded by the European Commission under the 7th Framework Program, project MARINE FUNGI, grant number 265926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bills GF, 2008, J APPL MICROBIOL, V104, P1644, DOI 10.1111/j.1365-2672.2008.03735.x; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Bugni TS, 2004, NAT PROD REP, V21, P143, DOI 10.1039/b301926h; Cai MH, 2013, FOLIA MICROBIOL, V58, P537, DOI 10.1007/s12223-013-0242-x; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Debbab A, 2010, MICROB BIOTECHNOL, V3, P544, DOI 10.1111/j.1751-7915.2010.00179.x; Doig SD, 2005, CHEM ENG SCI, V60, P2741, DOI 10.1016/j.ces.2004.12.025; Duetz WA, 2000, APPL ENVIRON MICROB, V66, P2641, DOI 10.1128/AEM.66.6.2641-2646.2000; Duetz WA, 2001, BIOCHEM ENG J, V7, P113, DOI 10.1016/S1369-703X(00)00109-1; Duetz WA, 2007, TRENDS MICROBIOL, V15, P469, DOI 10.1016/j.tim.2007.09.004; Fan YH, 2011, J INVERTEBR PATHOL, V106, P274, DOI 10.1016/j.jip.2010.11.003; Ferreira-Torres C, 2005, BIOPROC BIOSYST ENG, V28, P83, DOI 10.1007/s00449-005-0422-4; Imhoff JF, 2010, Patent WO, Patent No. [2010/142258, 2010142258]; Imhoff JF, 2011, BIOTECHNOL ADV, V29, P468, DOI 10.1016/j.biotechadv.2011.03.001; John GT, 2003, BIOTECHNOL BIOENG, V81, P829, DOI 10.1002/bit.10534; Jones EBG, 2011, FUNGAL DIVERS, V50, P73, DOI 10.1007/s13225-011-0119-8; Kensy F, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-68; Linde T, 2014, LETT APPL MICROBIOL; Micheletti M, 2006, CURR OPIN BIOTECH, V17, P611, DOI 10.1016/j.copbio.2006.10.006; Minas W, 2000, STREPTOMYCETES MICRO; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; Silber J, 2013, MAR DRUGS, V11, P3309, DOI 10.3390/md11093309; Wickerham L. J., 1951, TYTB 1029, P1; Wu CY, 2006, GENE, V384, P96, DOI 10.1016/j.gene.2006.07.017; Yu ZG, 2008, J NAT PROD, V71, P1052, DOI 10.1021/np070580e	25	14	14	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103320	10.1371/journal.pone.0103320	http://dx.doi.org/10.1371/journal.pone.0103320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079364	Green Published, Green Accepted, gold			2022-12-27	WOS:000339954800036
J	Choi, J; Song, N; Han, S; Chung, S; Sung, H; Lee, JY; Jung, S; Park, SK; Yoo, KY; Han, W; Lee, JW; Noh, DY; Kang, D; Choi, JY				Choi, Jaesung; Song, Nan; Han, Sohee; Chung, Seokang; Sung, Hyuna; Lee, Ji-young; Jung, Sunjae; Park, Sue K.; Yoo, Keun-Young; Han, Wonshik; Lee, Jong Won; Noh, Dong-Young; Kang, Daehee; Choi, Ji-Yeob			The Associations between Immunity-Related Genes and Breast Cancer Prognosis in Korean Women	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; THYMIC STROMAL LYMPHOPOIETIN; HEPATOCYTE GROWTH-FACTOR; LUNG-CANCER; SURVIVAL; RECEPTOR; RISK; EXPRESSION; VARIANTS; PHOSPHORYLATION	We investigated the role of common genetic variation in immune-related genes on breast cancer disease-free survival (DFS) in Korean women. 107 breast cancer patients of the Seoul Breast Cancer Study (SEBCS) were selected for this study. A total of 2,432 tag single nucleotide polymorphisms (SNPs) in 283 immune-related genes were genotyped with the GoldenGate Oligonucleotide pool assay (OPA). A multivariate Cox-proportional hazard model and polygenic risk score model were used to estimate the effects of SNPs on breast cancer prognosis. Harrell's C index was calculated to estimate the predictive accuracy of polygenic risk score model. Subsequently, an extended gene set enrichment analysis (GSEA-SNP) was conducted to approximate the biological pathway. In addition, to confirm our results with current evidence, previous studies were systematically reviewed. Sixty-two SNPs were statistically significant at p-value less than 0.05. The most significant SNPs were rs1952438 in SOCS4 gene (hazard ratio (HR) = 11.99, 95% CI = 3.62-39.72, P = 4.84E-05), rs2289278 in TSLP gene (HR = 4.25, 95% CI = 2.10-8.62, P = 5.99E-05) and rs2074724 in HGF gene (HR = 4.63, 95% CI = 2.18-9.87, P = 7.04E-05). In the polygenic risk score model, the HR of women in the 3rd tertile was 6.78 (95% CI = 1.48-31.06) compared to patients in the 1st tertile of polygenic risk score. Harrell's C index was 0.813 with total patients and 0.924 in 4-fold cross validation. In the pathway analysis, 18 pathways were significantly associated with breast cancer prognosis (P<0.1). The IL-6R, IL-8, IL-10RB, IL-12A, and IL-12B was associated with the prognosis of cancer in data of both our study and a previous study. Therefore, our results suggest that genetic polymorphisms in immune-related genes have relevance to breast cancer prognosis among Korean women.	[Choi, Jaesung; Chung, Seokang; Park, Sue K.; Kang, Daehee; Choi, Ji-Yeob] Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea; [Song, Nan; Park, Sue K.; Han, Wonshik; Noh, Dong-Young; Kang, Daehee; Choi, Ji-Yeob] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Han, Sohee; Jung, Sunjae; Park, Sue K.; Yoo, Keun-Young; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Sung, Hyuna] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Lee, Ji-young] Yonsei Univ Hlth Syst, Cardiovasc Res Inst, Seoul, South Korea; [Lee, Ji-young] Yonsei Univ Hlth Syst, Cardiovasc Genome Ctr, Seoul, South Korea; [Han, Wonshik; Noh, Dong-Young] Seoul Natl Univ, Dept Surg, Coll Med, Seoul, South Korea; [Lee, Jong Won] Univ Ulsan, Dept Surg, Coll Med, Seoul, South Korea; [Lee, Jong Won] ASAN Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); University of Ulsan	Choi, JY (corresponding author), Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea.	jiyeob.choi@gmail.com	Song, Nan/F-5774-2019; Jung, Sun Jae/ABC-7826-2020; Han, Wonshik/B-3699-2008; Jung, Sun Jae/GVU-7200-2022	Song, Nan/0000-0002-9182-1060; Han, Wonshik/0000-0001-7310-0764; Jung, Sun Jae/0000-0002-5194-7339; Lee, Ji-Young/0000-0002-7784-1401; Kang, Daehee/0000-0003-4031-5878	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C0065]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C0065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschebrook-Kilfoy B, 2012, J CANCER SURVIV, V6, P102, DOI 10.1007/s11764-010-0164-4; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bewick MA, 2011, J CANCER RES CLIN, V137, P543, DOI 10.1007/s00432-010-0915-7; Bi N, 2010, CLIN CANCER RES, V16, P2383, DOI 10.1158/1078-0432.CCR-09-2793; Biason P, 2012, PHARMACOGENOMICS J, V12, P476, DOI 10.1038/tpj.2011.33; Bondurant KL, 2013, INT J CANCER, V132, P905, DOI 10.1002/ijc.27660; Boyle P, 2008, WORLD CANC REPORT; Buytaert E, 2008, ONCOGENE, V27, P1916, DOI 10.1038/sj.onc.1210825; Castro FA, 2011, EUR J CANCER, V47, P1203, DOI 10.1016/j.ejca.2010.12.011; Cerhan JR, 2007, BLOOD, V109, P5439, DOI 10.1182/blood-2006-11-058040; Charbonneau B, 2012, AM J HEMATOL, V87, P880, DOI 10.1002/ajh.23273; Chiang YC, 2003, J BIOL CHEM, V278, P19286, DOI 10.1074/jbc.M212043200; Dai JC, 2012, INT J CANCER, V130, P671, DOI 10.1002/ijc.26067; Dan T, 2014, BREAST CANCER RES TR, V143, P11, DOI 10.1007/s10549-013-2758-9; DeMichele A, 2009, CANCER RES, V69, P4184, DOI 10.1158/0008-5472.CAN-08-2989; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Gaire RK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S7; Goode EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053903; Guan X, 2011, BMC CANCER, V11; Guirado M, 2012, HUM IMMUNOL, V73, P668, DOI 10.1016/j.humimm.2012.03.006; Habermann TM, 2008, BLOOD, V112, P2694, DOI 10.1182/blood-2007-09-111658; Haffner MC, 2008, J BIOL CHEM, V283, P22089, DOI 10.1074/jbc.M801041200; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hilton DJ, 1999, CELL MOL LIFE SCI, V55, P1568, DOI 10.1007/s000180050396; Holden M, 2008, BIOINFORMATICS, V24, P2784, DOI 10.1093/bioinformatics/btn516; Hu XB, 2013, GENET TEST MOL BIOMA, V17, P453, DOI 10.1089/gtmb.2012.0494; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jemal A, 2012, LANCET, V380, P1797, DOI 10.1016/S0140-6736(12)61688-2; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kyng KJ, 2005, ONCOGENE, V24, P5026, DOI 10.1038/sj.onc.1208692; Lee JM, 2011, ANN SURG, V253, P918, DOI 10.1097/SLA.0b013e318216f374; Lee JY, 2009, CARCINOGENESIS, V30, P1528, DOI 10.1093/carcin/bgp084; Lenci RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050692; LEWIS CE, 1995, J LEUKOCYTE BIOL, V57, P747, DOI 10.1002/jlb.57.5.747; Liu E, 2003, EMBO J, V22, P5036, DOI 10.1093/emboj/cdg503; Liu W, 2012, EXP LUNG RES, V38, P375, DOI 10.3109/01902148.2012.714840; Lu S, 2013, INT J CANC; Lundberg M, 2010, ORAL ONCOL, V46, P369, DOI 10.1016/j.oraloncology.2010.02.012; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Ohguchi H, 2008, MOL CELL BIOL, V28, P3917, DOI 10.1128/MCB.02154-07; Olkhanud PB, 2011, J IMMUNOL, V186, P5656, DOI 10.4049/jimmunol.1100463; Park SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045274; Parr C, 2004, CLIN CANCER RES, V10, P202, DOI 10.1158/1078-0432.CCR-0553-3; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Perez CA, 2007, ONCOGENE, V26, P7363, DOI 10.1038/sj.onc.1210561; Pine SR, 2007, J NATL CANCER I, V99, P1401, DOI 10.1093/jnci/djm128; Reeves GK, 2010, JAMA-J AM MED ASSOC, V304, P426, DOI 10.1001/jama.2010.1042; Reid-Lombardo KM, 2013, ANN SURG, V257, P1096, DOI 10.1097/SLA.0b013e318275b7e5; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; SARIEGO J, 1995, AM J SURG, V170, P243, DOI 10.1016/S0002-9610(05)80007-8; Sasi W, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-178; Schabath MB, 2013, CARCINOGENESIS, V34, P2525, DOI 10.1093/carcin/bgt244; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schreibelt G, 2010, CANCER IMMUNOL IMMUN, V59, P1573, DOI 10.1007/s00262-010-0833-1; Schutz FAB, 2013, LANCET ONCOL, V14, P81, DOI 10.1016/S1470-2045(12)70517-X; Shimada M, 2009, CANCER RES, V69, P1768, DOI 10.1158/0008-5472.CAN-08-3016; Slattery ML, 2011, CARCINOGENESIS, V32, P1660, DOI 10.1093/carcin/bgr189; Smirnov DA, 2006, CANCER RES, V66, P2918, DOI 10.1158/0008-5472.CAN-05-4003; Sung WW, 2011, CLIN CANCER RES, V17, P5991, DOI 10.1158/1078-0432.CCR-11-0227; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Vangsted AJ, 2009, BONE MARROW TRANSPL, V43, P539, DOI 10.1038/bmt.2008.351; Witz IP, 2006, CANCER LETT, V242, P1, DOI 10.1016/j.canlet.2005.12.005; Xue SL, 2013, MED ONCOL, V30; YAMASHITA J, 1994, CANCER RES, V54, P1630; Yang CX, 2013, TISSUE ANTIGENS, V81, P221, DOI 10.1111/tan.12096; You YH, 2013, BREAST CANCER RES TR, V137, P893, DOI 10.1007/s10549-012-2401-1; Yuan X, 2013, PLOS ONE, V8; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076147; Ziegler SF, 2013, ADV PHARMACOL, V66, P129, DOI 10.1016/B978-0-12-404717-4.00004-4; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	77	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103593	10.1371/journal.pone.0103593	http://dx.doi.org/10.1371/journal.pone.0103593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075970	Green Published, gold, Green Submitted			2022-12-27	WOS:000340028800066
J	Pandey, R; Lucent, D; Kumari, K; Sharma, P; Lal, R; Oakeshott, JG; Pandey, G				Pandey, Rinku; Lucent, Del; Kumari, Kirti; Sharma, Pooja; Lal, Rup; Oakeshott, John G.; Pandey, Gunjan			Kinetic and Sequence-Structure-Function Analysis of LinB Enzyme Variants with beta- and delta-Hexachlorocyclohexane	PLOS ONE			English	Article							SPHINGOMONAS-PAUCIMOBILIS UT26; HALOALKANE DEHALOGENASE LINB; SITE-DIRECTED MUTAGENESIS; GAMMA-HEXACHLOROCYCLOHEXANE; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; DEGRADATION; SUBSTRATE; BACTERIUM; RESIDUES	Organochlorine insecticide hexachlorocyclohexane (HCH) has recently been classified as a 'Persistent Organic pollutant' by the Stockholm Convention. The LinB haloalkane dehalogenase is a key upstream enzyme in the recently evolved Lin pathway for the catabolism of HCH in bacteria. Here we report a sequence-structure-function analysis of ten naturally occurring and thirteen synthetic mutants of LinB. One of the synthetic mutants was found to have similar to 80 fold more activity for beta- and delta-hexachlorocyclohexane. Based on detailed biophysical calculations, molecular dynamics and ensemble docking calculations, we propose that the latter variant is more active because of alterations to the shape of its active site and increased conformational plasticity.	[Pandey, Rinku; Kumari, Kirti; Sharma, Pooja; Oakeshott, John G.; Pandey, Gunjan] CSIRO Ecosyst Sci, Acton, ACT, Australia; [Lucent, Del] CSIRO, Ctr Mat Sci & Engn, Parkville, Vic, Australia; [Lucent, Del] Wilkes Univ, Div Phys & Engn, Wilkes Barre, PA 18766 USA; [Kumari, Kirti; Sharma, Pooja; Lal, Rup] Univ Delhi, Dept Zool, Delhi 110007, India	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Wilkes University; University of Delhi	Pandey, G (corresponding author), CSIRO Ecosyst Sci, Acton, ACT, Australia.	gunjan.pandey@csiro.au	Lal, Rup/AFP-1009-2022; Oakeshott, John G/B-5365-2009; Pandey, Gunjan/B-8133-2009; Pandey, Gunjan/I-6993-2019	Oakeshott, John G/0000-0001-8324-7874; Pandey, Gunjan/0000-0002-3514-4624; 	Indian Australian Strategic Research Fund; Commonwealth Scientific and Industrial Research Organisation's Office of the Chief Executive Postdoctoral Fellowship scheme; Council of Scientific and Industrial Research-University Grants Commission, Government of India	Indian Australian Strategic Research Fund; Commonwealth Scientific and Industrial Research Organisation's Office of the Chief Executive Postdoctoral Fellowship scheme; Council of Scientific and Industrial Research-University Grants Commission, Government of India(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India)	Part of the work was supported by the Indian Australian Strategic Research Fund and Commonwealth Scientific and Industrial Research Organisation's Office of the Chief Executive Postdoctoral Fellowship scheme. KK and PS acknowledge Council of Scientific and Industrial Research-University Grants Commission, Government of India, for providing their research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohac M, 2002, BIOCHEMISTRY-US, V41, P14272, DOI 10.1021/bi026427v; Brittain DRB, 2011, CHEM COMMUN, V47, P976, DOI 10.1039/c0cc02925d; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Damborsky J, 1999, PROTEIN ENG, V12, P989, DOI 10.1093/protein/12.11.989; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynkova K, 1999, FEBS LETT, V446, P177, DOI 10.1016/S0014-5793(99)00199-4; Ito M, 2007, ARCH MICROBIOL, V188, P313, DOI 10.1007/s00203-007-0251-8; Jit S, 2011, ENVIRON SCI POLLUT R, V18, P586, DOI 10.1007/s11356-010-0401-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lal R, 2006, TRENDS BIOTECHNOL, V24, P121, DOI 10.1016/j.tibtech.2006.01.005; Lal R, 2010, MICROBIOL MOL BIOL R, V74, P58, DOI 10.1128/MMBR.00029-09; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Marek J, 2000, BIOCHEMISTRY-US, V39, P14082, DOI 10.1021/bi001539c; Nagata Y, 1997, APPL ENVIRON MICROB, V63, P3707, DOI 10.1128/AEM.63.9.3707-3710.1997; Nagata Y, 2007, APPL MICROBIOL BIOT, V76, P741, DOI 10.1007/s00253-007-1066-x; Oakley AJ, 2004, BIOCHEMISTRY-US, V43, P870, DOI 10.1021/bi034748g; Okai M, 2013, J BACTERIOL, V195, P2642, DOI 10.1128/JB.02020-12; Pavlova M, 2009, NAT CHEM BIOL, V5, P727, DOI 10.1038/nchembio.205; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sharma P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025128; Vijgen J, 2011, ENVIRON SCI POLLUT R, V18, P152, DOI 10.1007/s11356-010-0417-9; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weber R, 2008, ENVIRON SCI POLLUT R, V15, P363, DOI 10.1007/s11356-008-0024-1	28	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103632	10.1371/journal.pone.0103632	http://dx.doi.org/10.1371/journal.pone.0103632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076214	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800069
J	Abreu, PMV; Gaspar, CG; Buss, DS; Ventura, JA; Ferreira, PCG; Fernandes, PMB				Abreu, Paolla M. V.; Gaspar, Clicia G.; Buss, David S.; Ventura, Jose A.; Ferreira, Paulo C. G.; Fernandes, Patricia M. B.			Carica papaya MicroRNAs Are Responsive to Papaya meleira virus Infection	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; PLANT MICRORNAS; ARABIDOPSIS ARGONAUTE1; PROTEASOME SYSTEM; IDENTIFICATION; UBIQUITIN; DICER-LIKE1; BIOGENESIS; SUPPRESSOR; SEQUENCES	MicroRNAs are implicated in the response to biotic stresses. Papaya meleira virus (PMeV) is the causal agent of sticky disease, a commercially important pathology in papaya for which there are currently no resistant varieties. PMeV has a number of unusual features, such as residence in the laticifers of infected plants, and the response of the papaya to PMeV infection is not well understood. The protein levels of 20S proteasome subunits increase during PMeV infection, suggesting that proteolysis could be an important aspect of the plant defense response mechanism. To date, 10,598 plant microRNAs have been identified in the Plant miRNAs Database, but only two, miR162 and miR403, are from papaya. In this study, known plant microRNA sequences were used to search for potential microRNAs in the papaya genome. A total of 462 microRNAs, representing 72 microRNA families, were identified. The expression of 11 microRNAs, whose targets are involved in 20S and 26S proteasomal degradation and in other stress response pathways, was compared by real-time PCR in healthy and infected papaya leaf tissue. We found that the expression of miRNAs involved in proteasomal degradation increased in response to very low levels of PMeV titre and decreased as the viral titre increased. In contrast, miRNAs implicated in the plant response to biotic stress decreased their expression at very low level of PMeV and increased at high PMeV levels. Corroborating with this results, analysed target genes for this miRNAs had their expression modulated in a dependent manner. This study represents a comprehensive identification of conserved miRNAs inpapaya. The data presented here might help to complement the available molecular and genomic tools for the study of papaya. The differential expression of some miRNAs and identifying their target genes will be helpful for understanding the regulation and interaction of PMeV and papaya.	[Abreu, Paolla M. V.; Buss, David S.; Ventura, Jose A.; Fernandes, Patricia M. B.] Univ Fed Espirito Santo, Vitoria, Espirito Santo, Spain; [Gaspar, Clicia G.; Ferreira, Paulo C. G.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil; [Ventura, Jose A.] Inst Capixaba Pesquisa Assistencia Tecn & Extensa, Vitoria, Espirito Santo, Spain	Universidade Federal do Rio de Janeiro	Fernandes, PMB (corresponding author), Univ Fed Espirito Santo, Vitoria, Espirito Santo, Spain.	patricia.fernandes@ufes.br	Ferreira, Paulo C G/I-2836-2015; Fernandes, Patricia M B/AAL-5991-2021	Ferreira, Paulo C G/0000-0002-5510-999X; Fernandes, Patricia M B/0000-0003-2695-3638	FINEP (Financiadora de Estudos e Projetos); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPES (Fundacao de Amparo a Pesquisa do Estado do Espirito Santo)	FINEP (Financiadora de Estudos e Projetos)(Financiadora de Inovacao e Pesquisa (Finep)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPES (Fundacao de Amparo a Pesquisa do Estado do Espirito Santo)	This work was supported by grants from FINEP (Financiadora de Estudos e Projetos), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and FAPES (Fundacao de Amparo a Pesquisa do Estado do Espirito Santo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu PMV, 2012, J VIROL METHODS, V180, P11, DOI 10.1016/j.jviromet.2011.12.003; Alcaide-Loridan C, 2012, PLANT PHYSIOL, V160, P72, DOI 10.1104/pp.112.201905; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; [Anonymous], 2013, J INTEGR AGR, DOI [DOI 10.1016/S2095-3119(13)60311-1, DOI 10.1007/s00425-009-0889-3]; Aryal R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-682; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; BECKER F, 1993, PLANT J, V3, P875, DOI 10.1111/j.1365-313X.1993.00875.x; Camborde L, 2010, PLANT CELL, V22, P3142, DOI 10.1105/tpc.109.072090; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chenon M, 2012, EMBO J, V31, P741, DOI 10.1038/emboj.2011.424; Citovsky V, 2009, SEMIN CELL DEV BIOL, V20, P1048, DOI 10.1016/j.semcdb.2009.05.012; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dielen AS, 2010, MOL PLANT PATHOL, V11, P293, DOI 10.1111/j.1364-3703.2009.00596.x; El Moussaoui A, 2001, CELL MOL LIFE SCI, V58, P556, DOI 10.1007/PL00000881; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Gleave AP, 2008, TREE GENET GENOMES, V4, P343, DOI 10.1007/s11295-007-0113-1; Guo Q, 2007, CHINESE SCI BULL, V52, P2380, DOI 10.1007/s11434-007-0359-x; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Jagadeeswaran G, 2009, NEW PHYTOL, V184, P85, DOI 10.1111/j.1469-8137.2009.02915.x; Jin HL, 2006, PLANT PHYSIOL, V142, P651, DOI 10.1104/pp.106.083519; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jover-Gil S, 2005, INT J DEV BIOL, V49, P733, DOI 10.1387/ijdb.052015sj; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kitajima E. W., 1993, Fitopatologia Brasileira, V18, P118; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Lang QL, 2011, MOL BIOL REP, V38, P1523, DOI 10.1007/s11033-010-0260-6; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Liang G, 2013, PLANTA, V238, P739, DOI 10.1007/s00425-013-1929-6; Lu YZ, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/128297; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Marino D, 2012, PLANT PHYSIOL, V160, P15, DOI 10.1104/pp.112.199281; Moissiard G, 2004, MOL PLANT PATHOL, V5, P71, DOI 10.1111/j.1364-3703.2004.00207.x; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rodrigues SP, 2012, J PROTEOMICS, V75, P3191, DOI 10.1016/j.jprot.2012.03.021; Rodrigues SP, 2011, PROTEOMICS, V11, P2592, DOI 10.1002/pmic.201000757; Rodrigues SP, 2009, PLANT CELL REP, V28, P861, DOI 10.1007/s00299-009-0673-7; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Szczesniak MW, 2012, NUCLEIC ACIDS RES, V40, pD198, DOI 10.1093/nar/gkr1159; Tagami Y, 2007, DNA RES, V14, P227, DOI 10.1093/dnares/dsm022; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Ventura J. A., 2004, DIS FRUITS VEGETABLE, VII, P201; Wang MB, 2012, MOL PLANT MICROBE IN, V25, P1275, DOI 10.1094/MPMI-04-12-0093-CR; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zhu X, 2012, PLOS ONE, V7; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	63	22	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103401	10.1371/journal.pone.0103401	http://dx.doi.org/10.1371/journal.pone.0103401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072834	Green Published, Green Submitted, gold			2022-12-27	WOS:000341307600045
J	Rasakham, K; Schmidt, HD; Kay, K; Huizenga, MN; Calcagno, N; Pierce, RC; Spires-Jones, TL; Sadri-Vakili, G				Rasakham, Khampaseuth; Schmidt, Heath D.; Kay, Kevin; Huizenga, Megan N.; Calcagno, Narghes; Pierce, R. Christopher; Spires-Jones, Tara L.; Sadri-Vakili, Ghazaleh			Synapse Density and Dendritic Complexity Are Reduced in the Prefrontal Cortex following Seven Days of Forced Abstinence from Cocaine Self-Administration	PLOS ONE			English	Article							INDUCED STRUCTURAL PLASTICITY; DRUG-SEEKING BEHAVIOR; NUCLEUS-ACCUMBENS; INDUCED REINSTATEMENT; ORBITOFRONTAL CORTEX; FRONTAL-CORTEX; ALTERS; SPINES; NEURONS; SENSITIZATION	Chronic cocaine exposure in both human addicts and in rodent models of addiction reduces prefrontal cortical activity, which subsequently dysregulates reward processing and higher order executive function. The net effect of this impaired gating of behavior is enhanced vulnerability to relapse. Previously we have shown that cocaine-induced increases in brain-derived neurotrophic factor (BDNF) expression in the medial prefrontal cortex (PFC) is a neuroadaptive mechanism that blunts the reinforcing efficacy of cocaine. As BDNF is known to affect neuronal survival and synaptic plasticity, we tested the hypothesis that abstinence from cocaine self-administration would lead to alterations in neuronal morphology and synaptic density in the PFC. Using a novel technique, array tomography and Golgi staining, morphological changes in the rat PFC were analyzed following 14 days of cocaine self-administration and 7 days of forced abstinence. Our results indicate that overall dendritic branching and total synaptic density are significantly reduced in the rat PFC. In contrast, the density of thin dendritic spines are significantly increased on layer V pyramidal neurons of the PFC. These findings indicate that dynamic structural changes occur during cocaine abstinence that may contribute to the observed hypo-activity of the PFC in cocaine-addicted individuals.	[Rasakham, Khampaseuth; Kay, Kevin; Huizenga, Megan N.; Calcagno, Narghes; Spires-Jones, Tara L.; Sadri-Vakili, Ghazaleh] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA; [Schmidt, Heath D.; Pierce, R. Christopher] Univ Penn, Ctr Neurobiol & Behav, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine	Sadri-Vakili, G (corresponding author), Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA.	gsadrivakili@partners.org	Spires-Jones, Tara/AAR-7697-2020	Spires-Jones, Tara/0000-0003-2530-0598; Thapa, Khampaseuth/0000-0001-6395-2891; Calcagno, Narghes/0000-0003-0615-891X	NIDA [DA22339, DA033641, DA18678];  [DA030445]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022339, R01DA033641, K01DA030445, K02DA018678] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIDA grants DA22339 and DA033641 (R. C. P. & G. S. V.) and DA18678 (R. C. P.). H. D. S. was supported by an individual K01 award (DA030445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Chen YI, 2011, EUR J NEUROSCI, V34, P800, DOI 10.1111/j.1460-9568.2011.07806.x; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; Dumitriu D, 2012, J NEUROSCI, V32, P6957, DOI 10.1523/JNEUROSCI.5718-11.2012; GABBOTT PL, 1984, J NEUROSCI METH, V11, P221, DOI 10.1016/0165-0270(84)90084-0; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; IZZO PN, 1987, NEUROSCIENCE, V20, P577, DOI 10.1016/0306-4522(87)90111-4; Jayaram P, 2005, EUR J NEUROSCI, V21, P2035, DOI 10.1111/j.1460-9568.2005.04000.x; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lu HB, 2012, NEUROIMAGE, V62, P1857, DOI 10.1016/j.neuroimage.2012.05.076; Madayag A, 2007, J NEUROSCI, V27, P13968, DOI 10.1523/JNEUROSCI.2808-07.2007; McFarland K, 2003, J NEUROSCI, V23, P3531; McFarland K, 2001, J NEUROSCI, V21, P8655; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Miguens M, 2008, PSYCHOPHARMACOLOGY, V196, P303, DOI 10.1007/s00213-007-0958-x; Munoz-Cuevas FJ, 2013, NAT NEUROSCI, V16, P1367, DOI 10.1038/nn.3498; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Pierce RC, 1998, NEUROSCIENCE, V82, P1103; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 2001, SYNAPSE, V39, P257; Sadri-Vakili G, 2010, J NEUROSCI, V30, P11735, DOI 10.1523/JNEUROSCI.2328-10.2010; Sarti F, 2007, EUR J NEUROSCI, V26, P749, DOI 10.1111/j.1460-9568.2007.05689.x; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Sun WL, 2006, J NEUROSCI, V26, P8004, DOI 10.1523/JNEUROSCI.1413-06.2006; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Trantham H, 2002, NEUROSCIENCE, V113, P749, DOI 10.1016/S0306-4522(02)00246-4; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; VOLKOW ND, 1988, BRIT J PSYCHIAT, V152, P641, DOI 10.1192/bjp.152.5.641; Winstanley CA, 2009, PHARMACOL BIOCHEM BE, V93, P278, DOI 10.1016/j.pbb.2008.12.007	36	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102524	10.1371/journal.pone.0102524	http://dx.doi.org/10.1371/journal.pone.0102524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072653	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600013
J	Hemamalini, R; Khare, S				Hemamalini, R.; Khare, Sunil			A Proteomic Approach to Understand the Role of the Outer Membrane Porins in the Organic Solvent-Tolerance of Pseudomonas aeruginosa PseA	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; PROTEIN; MECHANISMS; STRAIN; DIVERSITY; TOXICITY; BINDING; TOLUENE; GROWTH	Solvent-tolerant microbes have the unique ability to thrive in presence of organic solvents. The present study describes the effect of increasing hydrophobicity (log P-ow values) of organic solvents on the outer membrane proteome of the solvent-tolerant Pseudomonas aeruginosa PseA cells. The cells were grown in a medium containing 33% (v/v) alkanes of increasing log Pow values. The outer membrane proteins were extracted by alkaline extraction from the late log phase cells and changes in the protein expression were studied by 2-D gel electrophoresis. Seven protein spots showed significant differential expression in the solvent exposed cells. The tryptic digest of the differentially regulated proteins were identified by LC-ESI MS/MS. The identity of these proteins matched with porins OprD, OprE, OprF, OprH, Opr86, LPS assembly protein and A-type flagellin. The reported pI values of these proteins were in the range of 4.94-8.67 and the molecular weights were in the range of 19.5-104.5 kDa. The results suggest significant down-regulation of the A-type flagellin, OprF and OprD and up-regulation of OprE, OprH, Opr86 and LPS assembly protein in presence of organic solvents. OprF and OprD are implicated in antibiotic uptake and outer membrane stability, whereas A-type flagellin confers motility and chemotaxis. Upregulated OprE is an anaerobically-induced porin while Opr86 is responsible for transport of small molecules and assembly of the outer membrane proteins. Differential regulation of the above porins clearly indicates their role in adaptation to solvent exposure.	[Hemamalini, R.; Khare, Sunil] Indian Inst Technol, Dept Chem, Enzyme & Microbial Biochem Lab, New Delhi 110016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Khare, S (corresponding author), Indian Inst Technol, Dept Chem, Enzyme & Microbial Biochem Lab, New Delhi 110016, India.	skkhare@chemistry.iitd.ac.in		Khare, Sunil Kumar/0000-0002-7339-3058	Indian Council of Medical Research, New Delhi, India	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	RH gratefully acknowledges the Indian Council of Medical Research, New Delhi, India for providing research fellowship. ICMR Sanction Order No. No. 3/1/3/JRF-2010/MPD-47(36165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2003, MICROBIOL-SGM, V149, P1265, DOI 10.1099/mic.0.25927-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceylan S, 2011, CAN J MICROBIOL, V57, P295, DOI [10.1139/w11-009, 10.1139/W11-009]; Chantal W Nde, 2009, ENVIRON SCI TECHNOL, V43, P8406; Fito-Boncompte L, 2011, INFECT IMMUN, V79, P1176, DOI 10.1128/IAI.00850-10; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Gaur R, 2009, LETT APPL MICROBIOL, V49, P372, DOI 10.1111/j.1472-765X.2009.02671.x; Gupta A, 2006, BIORESOURCE TECHNOL, V97, P1788, DOI 10.1016/j.biortech.2005.09.006; Gupta A, 2009, CRIT REV BIOTECHNOL, V29, P44, DOI 10.1080/07388550802688797; HANCOCK REW, 1990, MOL MICROBIOL, V4, P1069, DOI 10.1111/j.1365-2958.1990.tb00680.x; INOUE A, 1989, NATURE, V338, P264, DOI 10.1038/338264a0; Joshi C, 2013, BIOCATAL AGR BIOTECH, V2, P32, DOI 10.1016/j.bcab.2012.08.006; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li H, 2012, INT J MED MICROBIOL, V302, P63, DOI 10.1016/j.ijmm.2011.10.001; Mastrobuoni G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-215; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Na KS, 2005, J BIOSCI BIOENG, V99, P378, DOI 10.1263/jbb.99.378; Nouwens AS, 2003, PROTEOMICS MICROORGA, P128; Ramos JL, 2002, ANNU REV MICROBIOL, V56, P743, DOI 10.1146/annurev.micro.56.012302.161038; Rawling EG, 1998, J BACTERIOL, V180, P3556, DOI 10.1128/JB.180.14.3556-3562.1998; Roma-Rodrigues C, 2010, J PROTEOMICS, V73, P1461, DOI 10.1016/j.jprot.2010.02.003; Sardessai YN, 2004, BIOTECHNOL PROGR, V20, P655, DOI 10.1021/bp0200595; Schliep M, 2012, MOL BIOSYST, V8, P3017, DOI 10.1039/c2mb25212k; Segura A, 2001, J BACTERIOL, V183, P4127, DOI 10.1128/JB.183.14.4127-4133.2001; Segura A, 2012, CURR OPIN BIOTECH, V23, P415, DOI 10.1016/j.copbio.2011.11.015; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Siqueira R, 2010, PROCESS BIOCHEM, V45, P1504; Spangenberg C, 1996, FEBS LETT, V396, P213, DOI 10.1016/0014-5793(96)01099-X; Sugawara E, 2006, J BIOL CHEM, V281, P16220, DOI 10.1074/jbc.M600680200; Tashiro Y, 2008, J BACTERIOL, V190, P3969, DOI 10.1128/JB.02004-07; TRIAS J, 1990, J BIOL CHEM, V265, P15680; van Beilen JB, 2003, OIL GAS SCI TECHNOL, V58, P427, DOI 10.2516/ogst:2003026; VERMUE M, 1993, BIOTECHNOL BIOENG, V42, P747, DOI 10.1002/bit.260420610; Watanabe R, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-58; WOODRUFF WA, 1989, J BACTERIOL, V171, P3304, DOI 10.1128/jb.171.6.3304-3309.1989; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422	37	12	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103788	10.1371/journal.pone.0103788	http://dx.doi.org/10.1371/journal.pone.0103788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089526	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700055
J	Adkins, I; Kamanova, J; Kocourkova, A; Svedova, M; Tomala, J; Janova, H; Masin, J; Chladkova, B; Bumba, L; Kovar, M; Ross, PJ; Tuckova, L; Spisek, R; Mills, KHG; Sebo, P				Adkins, Irena; Kamanova, Jana; Kocourkova, Aneta; Svedova, Martina; Tomala, Jakub; Janova, Hana; Masin, Jiri; Chladkova, Barbora; Bumba, Ladislav; Kovar, Marek; Ross, Padraig J.; Tuckova, Ludmila; Spisek, Radek; Mills, Kingston H. G.; Sebo, Peter			Bordetella Adenylate Cyclase Toxin Differentially Modulates Toll-Like Receptor-Stimulated Activation, Migration and T Cell Stimulatory Capacity of Dendritic Cells	PLOS ONE			English	Article							RESPIRATORY-INFECTION; INTERLEUKIN-10 PRODUCTION; PROTECTIVE IMMUNITY; IL-12 PRODUCTION; PERTUSSIS TOXIN; 3RD SIGNAL; RESPONSES; INHIBITION; BINDING; MOLECULE	Adenylate cyclase toxin (CyaA) is a key virulence factor of the whooping cough agent Bordetella pertussis. The toxin targets CD11b-expressing phagocytes and delivers into their cytosol an adenylyl cyclase (AC) enzyme that subverts cellular signaling by increasing cAMP levels. In the present study, we analyzed the modulatory effects of CyaA on adhesive, migratory and antigen presenting properties of Toll-like receptor (TLR)-activated murine and human dendritic cells (DCs). cAMP signaling of CyaA enhanced TLR-induced dissolution of cell adhesive contacts and migration of DCs towards the lymph node-homing chemokines CCL19 and CCL21 in vitro. Moreover, we examined in detail the capacity of toxin-treated DCs to induce CD4(+) and CD8(+) T cell responses. Exposure to CyaA decreased the capacity of LPS-stimulated DCs to present soluble protein antigen to CD4(+) T cells independently of modulation of co-stimulatory molecules and cytokine production, and enhanced their capacity to promote CD4(+) CD25(+) Foxp3(+) T regulatory cells in vitro. In addition, CyaA decreased the capacity of LPS-stimulated DCs to induce CD8(+) T cell proliferation and limited the induction of IFN-gamma producing CD8(+) T cells while enhancing IL-10 and IL-17-production. These results indicate that through activation of cAMP signaling, the CyaA may be mobilizing DCs impaired in T cell stimulatory capacity and arrival of such DCs into draining lymph nodes may than contribute to delay and subversion of host immune responses during B. pertussis infection.	[Adkins, Irena; Kamanova, Jana; Svedova, Martina; Janova, Hana; Masin, Jiri; Bumba, Ladislav; Sebo, Peter] Acad Sci Czech Republ, Inst Microbiol, Lab Mol Biol Bacterial Pathogens, Prague, Czech Republic; [Tomala, Jakub; Kovar, Marek] Acad Sci Czech Republ, Inst Microbiol, Lab Tumor Immunol, Prague, Czech Republic; [Chladkova, Barbora; Tuckova, Ludmila] Acad Sci Czech Republ, Inst Microbiol, Lab Specif Cellular Immun, Prague, Czech Republic; [Kocourkova, Aneta; Spisek, Radek] Charles Univ Prague, Fac Med 2, Inst Immunol, Prague, Czech Republic; [Kocourkova, Aneta; Spisek, Radek] Univ Hosp Motol, Prague, Czech Republic; [Mills, Kingston H. G.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Immune Regulat Res Grp, Dublin 2, Ireland	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Motol University Hospital; Trinity College Dublin	Adkins, I (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Lab Mol Biol Bacterial Pathogens, Prague, Czech Republic.	adkins@sotio.com	Mills, Kingston H/F-5684-2013; Bumba, Ladislav/ABC-9943-2020; Kovar, Marek/H-7793-2014; Bumba, Ladislav/H-2494-2014; Tomala, Jakub/J-6042-2014; SEBO, Peter/N-2043-2019; Kamanova, Jana/Q-4477-2017; Masin, Jiri/H-3125-2014; Chládková, Barbora/J-6882-2014; SEBO, Peter/F-7423-2011	Mills, Kingston H/0000-0003-3646-8222; Bumba, Ladislav/0000-0001-6659-5447; Tomala, Jakub/0000-0002-6315-2832; SEBO, Peter/0000-0002-9755-7715; Kamanova, Jana/0000-0001-6574-4404; SEBO, Peter/0000-0002-9755-7715; Masin, Jiri/0000-0001-6258-4599	National Science Foundation of the Czech Republic [GA310/08/0447, GA310/09/P582, P301/11/0325]; Czech Ministry of Health [IGA NT12402-5]; Science Foundation Ireland [06/IN.1/B87]; Ministry of Education of Czech Republic; Charles University in Prague, Czech Republic [33779266]; FEBS short-term fellowship;  [1M0506]	National Science Foundation of the Czech Republic; Czech Ministry of Health(Ministry of Health, Czech Republic); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Ministry of Education of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague, Czech Republic(Czech Republic Government); FEBS short-term fellowship; 	This work was supported by the grant No. GA310/08/0447 (to PS), No. GA310/09/P582 (to IA) and No. P301/11/0325 (to MK) of the National Science Foundation of the Czech Republic, the Research center 1M0506, and by research grant IGA NT12402-5 from the Czech Ministry of Health. KM and PR are supported by a principal investigator grant (06/IN.1/B87) from Science Foundation Ireland. MS was a recipient of a stipend from the Ministry of Education of Czech Republic and of the support from the Specific Research Project No. 33779266 of the Charles University in Prague, Czech Republic. The support from a FEBS short-term fellowship granted to IA is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins I, 2008, MICROBES INFECT, V10, P798, DOI 10.1016/j.micinf.2008.04.014; Anderson P, 2010, MOL CELL BIOL, V30, P2537, DOI 10.1128/MCB.01282-09; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bartoszewski R, 2011, J BIOL CHEM, V286, P41862, DOI 10.1074/jbc.M111.304956; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Boschwitz JS, 1997, J INFECT DIS, V176, P678, DOI 10.1086/514090; Boyd AP, 2005, J IMMUNOL, V175, P730, DOI 10.4049/jimmunol.175.2.730; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Challier J, 2013, IMMUNOLOGY, V138, P402, DOI 10.1111/imm.12053; Coleman MM, 2012, FEMS IMMUNOL MED MIC, V64, P413, DOI 10.1111/j.1574-695X.2011.00927.x; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; Dirix V, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/795958; Dunne A, 2010, J IMMUNOL, V185, P1711, DOI 10.4049/jimmunol.1000105; Dunne PJ, 2009, J IMMUNOL, V183, P400, DOI 10.4049/jimmunol.0900169; Eby JC, 2013, INFECT IMMUN, V81, P1390, DOI 10.1128/IAI.00110-13; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Fedele G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008734; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; Granados DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-10; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hickey FB, 2008, J LEUKOCYTE BIOL, V84, P234, DOI 10.1189/jlb.0208113; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kamanova J, 2008, J IMMUNOL, V181, P5587, DOI 10.4049/jimmunol.181.8.5587; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Lamberti YA, 2010, INFECT IMMUN, V78, P907, DOI 10.1128/IAI.01031-09; Leef M, 2000, J EXP MED, V191, P1841, DOI 10.1084/jem.191.11.1841; Lutz MB, 1997, J IMMUNOL, V159, P3707; Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b; Matousek MP, 1998, INFECT IMMUN, V66, P3480, DOI 10.1128/IAI.66.7.3480-3484.1998; Matousek MP, 1996, J IMMUNOL, V156, P4137; McGuirk P, 2000, EUR J IMMUNOL, V30, P415, DOI 10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.3.CO;2-O; McGuirk P, 1998, EUR J IMMUNOL, V28, P153, DOI 10.1002/(SICI)1521-4141(199801)28:01<153::AID-IMMU153>3.3.CO;2-R; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; MILLS KHG, 1993, INFECT IMMUN, V61, P399, DOI 10.1128/IAI.61.2.399-410.1993; Paccani SR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000325; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; PEARSON RD, 1987, J IMMUNOL, V139, P2749; Plotkin SA, 2014, CLIN INFECT DIS, V58, P830, DOI 10.1093/cid/cit934; Ricart BG, 2011, J IMMUNOL, V186, P53, DOI 10.4049/jimmunol.1002358; Rieber N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017271; Ross PJ, 2004, INFECT IMMUN, V72, P1568, DOI 10.1128/IAI.72.3.1568-1579.2004; Schmidt CS, 2002, J IMMUNOL, V168, P5521, DOI 10.4049/jimmunol.168.11.5521; Spensieri F, 2006, INFECT IMMUN, V74, P2831, DOI 10.1128/IAI.74.5.2831-2838.2006; Spisek R, 2004, VACCINE, V22, P2761, DOI 10.1016/j.vaccine.2004.01.006; Tanaka Y, 1999, EUR J IMMUNOL, V29, P1561; Tartz S, 2006, INFECT IMMUN, V74, P2277, DOI 10.1128/IAI.74.4.2277-2285.2006; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011	57	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104064	10.1371/journal.pone.0104064	http://dx.doi.org/10.1371/journal.pone.0104064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084094	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800123
J	Al-Saffar, NMS; Marshall, LV; Jackson, LE; Balarajah, G; Eykyn, TR; Agliano, A; Clarke, PA; Jones, C; Workman, P; Pearson, ADJ; Leach, MO				Al-Saffar, Nada M. S.; Marshall, Lynley V.; Jackson, L. Elizabeth; Balarajah, Geetha; Eykyn, Thomas R.; Agliano, Alice; Clarke, Paul A.; Jones, Chris; Workman, Paul; Pearson, Andrew D. J.; Leach, Martin O.			Lactate and Choline Metabolites Detected In Vitro by Nuclear Magnetic Resonance Spectroscopy Are Potential Metabolic Biomarkers for PI3K Inhibition in Pediatric Glioblastoma	PLOS ONE			English	Article							HIGH-GRADE GLIOMA; BREAST-CANCER CELLS; BRAIN-TUMORS; PHARMACODYNAMIC MARKERS; CLINICAL-TRIALS; HISTONE H3.3; TEMOZOLOMIDE; MUTATIONS; ADULT; RADIOTHERAPY	The phosphoinositide 3-kinase (PI3K) pathway is believed to be of key importance in pediatric glioblastoma. Novel inhibitors of the PI3K pathway are being developed and are entering clinical trials. Our aim is to identify potential non-invasive biomarkers of PI3K signaling pathway inhibition in pediatric glioblastoma using in vitro nuclear magnetic resonance (NMR) spectroscopy, to aid identification of target inhibition and therapeutic response in early phase clinical trials of PI3K inhibitors in childhood cancer. Treatment of SF188 and KNS42 human pediatric glioblastoma cell lines with the dual pan-Class I PI3K/ mTOR inhibitor PI-103, inhibited the PI3K signaling pathway and resulted in a decrease in phosphocholine (PC), total choline (tCho) and lactate levels (p<0.02) as detected by phosphorus (P-31)-and proton (H-1)-NMR. Similar changes were also detected using the pan-Class I PI3K inhibitor GDC-0941 which lacks significant mTOR activity and is entering Phase II clinical trials. In contrast, the DNA damaging agent temozolomide (TMZ), which is used as current frontline therapy in the treatment of glioblastoma postoperatively (in combination with radiotherapy), increased PC, glycerophosphocholine (GPC) and tCho levels (p<0.04). PI-103-induced NMR changes were associated with alterations in protein expression levels of regulatory enzymes involved in glucose and choline metabolism including GLUT1, HK2, LDHA and CHKA. Our results show that by using NMR we can detect distinct biomarkers following PI3K pathway inhibition compared to treatment with the DNA-damaging anti-cancer agent TMZ. This is the first study reporting that lactate and choline metabolites are potential non-invasive biomarkers for monitoring response to PI3K pathway inhibitors in pediatric glioblastoma.	[Al-Saffar, Nada M. S.; Jackson, L. Elizabeth; Balarajah, Geetha; Eykyn, Thomas R.; Agliano, Alice; Leach, Martin O.] Inst Canc Res, Div Radiotherapy & Imaging, Canc Res UK & EPSRC Canc Imaging Ctr, London SW3 6JB, England; [Al-Saffar, Nada M. S.; Marshall, Lynley V.; Jackson, L. Elizabeth; Balarajah, Geetha; Eykyn, Thomas R.; Agliano, Alice; Clarke, Paul A.; Jones, Chris; Workman, Paul; Pearson, Andrew D. J.; Leach, Martin O.] Royal Marsden NHS Fdn Trust, London, England; [Marshall, Lynley V.; Jones, Chris] Inst Canc Res, Div Mol Pathol, London SW3 6JB, England; [Marshall, Lynley V.; Clarke, Paul A.; Jones, Chris; Workman, Paul; Pearson, Andrew D. J.] Inst Canc Res, Div Canc Therapeut, London SW3 6JB, England; [Marshall, Lynley V.; Pearson, Andrew D. J.] Inst Canc Res, Div Clin Studies, London SW3 6JB, England; [Eykyn, Thomas R.] Kings Coll London, St Thomas Hosp, Div Imaging Sci & Biomed Engn, London, England; [Clarke, Paul A.; Workman, Paul] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Al-Saffar, NMS (corresponding author), Inst Canc Res, Div Radiotherapy & Imaging, Canc Res UK & EPSRC Canc Imaging Ctr, London SW3 6JB, England.	Nada.Al-Saffar@icr.ac.uk	leach, martin o/C-2248-2008; Eykyn, Thomas/J-3284-2016; Jones, Chris/ABE-6059-2021	leach, martin o/0000-0002-0756-5368; Eykyn, Thomas/0000-0003-1768-3808; Jones, Chris/0000-0001-8118-2296; Clarke, Paul/0000-0001-9342-1290	Brain Tumour Charity [6/54]; Oak Foundation [OCay-04-169]; Cancer Research UK; EPSRC; MRC; Department of Health (England) [C1060/A10334, C1060/6916]; Cancer Research UK Life Chair and Programme Grant included within a Cancer Research UK ICR Core Award [C347/A15403]; Cancer Research UK [C309/A2187, C309/A8274]; National Health Service; EPSRC [EP/H046526/1] Funding Source: UKRI; Cancer Research UK [11566, 16464] Funding Source: researchfish; Engineering and Physical Sciences Research Council [GR/S23612/01, EP/H046526/1] Funding Source: researchfish; The Brain Tumour Charity [6/54] Funding Source: researchfish	Brain Tumour Charity; Oak Foundation; Cancer Research UK(Cancer Research UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); Cancer Research UK Life Chair and Programme Grant included within a Cancer Research UK ICR Core Award; Cancer Research UK(Cancer Research UK); National Health Service; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); The Brain Tumour Charity	This work was supported by The Brain Tumour Charity [www.thebraintumourcharity.org] (6/54) to NMSA, GB and AA; The Oak Foundation (www.oakfnd.org] (OCay-04-169) to LVM; Cancer Research UK and EPSRC Cancer Imaging Centre in association with the MRC and Department of Health (England) (C1060/A10334, C1060/6916) to MOL, NMSA, LEJ and TE; Cancer Research UK Life Chair and Programme Grant included within a Cancer Research UK ICR Core Award (C347/A15403) to AP; Cancer Research UK (C309/A2187, C309/A8274) to PW and PAC. PW is a Cancer Research UK Life Fellow; MOL is an NIHR senior investigator. The Institute of Cancer Research co-authors acknowledge National Health Service funding to the Biomedical Research Centre. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Al-Saffar NMS, 2010, CANCER RES, V70, P5507, DOI 10.1158/0008-5472.CAN-09-4476; Al-Saffar NMS, 2006, CANCER RES, V66, P427, DOI 10.1158/0008-5472.CAN-05-1338; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; Beloueche-Babari M, 2006, MOL CANCER THER, V5, P187, DOI 10.1158/1535-7163.MCT-03-0220; Beloueche-Babari M, 2010, BRIT J CANCER, V102, P1, DOI 10.1038/sj.bjc.6605457; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Braccini L., 2012, Advances in Biological Regulation, V52, P389, DOI 10.1016/j.jbior.2012.04.002; Broniscer A, 2006, J NEURO-ONCOL, V76, P313, DOI 10.1007/s11060-005-7409-5; Bulik M, 2013, CLIN NEUROL NEUROSUR, V115, P146, DOI 10.1016/j.clineuro.2012.11.002; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chung YL, 2003, J NATL CANCER I, V95, P1624, DOI 10.1093/jnci/djg084; Clarke PA, 2012, J CLIN ONCOL, V30, P331, DOI 10.1200/JCO.2011.38.7167; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Gadian D. G, 1995, NMR ITS APPL LIVING, P29; Gallia GL, 2006, MOL CANCER RES, V4, P709, DOI 10.1158/1541-7786.MCR-06-0172; Gaspar N, 2010, CANCER RES, V70, P9243, DOI 10.1158/0008-5472.CAN-10-1250; Guillard S, 2009, CELL CYCLE, V8, P443, DOI 10.4161/cc.8.3.7643; HaasKogan DA, 1996, INT J RADIAT ONCOL, V36, P95, DOI 10.1016/S0360-3016(96)00244-1; Hargrave Darren R, 2007, Expert Rev Neurother, V7, P1029, DOI 10.1586/14737175.7.8.1029; HEISS WD, 1990, J NUCL MED, V31, P302; Hill DK, 2013, NMR BIOMED, V26, P1321, DOI 10.1002/nbm.2957; Hill DK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071996, 10.1371/journal.pone.0074627]; Jones C, 2012, NAT REV CLIN ONCOL, V9, P400, DOI 10.1038/nrclinonc.2012.87; Kelly CJ, 2012, NUCL MED BIOL, V39, P986, DOI 10.1016/j.nucmedbio.2012.04.006; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Lee SC, 2013, NMR BIOMED, V26, P106, DOI 10.1002/nbm.2825; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lucignani G, 2011, EUR J NUCL MED MOL I, V38, P179, DOI 10.1007/s00259-010-1661-4; Murphy PS, 2004, BRIT J CANCER, V90, P781, DOI 10.1038/sj.bjc.6601593; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Nelson SJ, 2011, NMR BIOMED, V24, P734, DOI 10.1002/nbm.1669; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Peet AC, 2012, NAT REV CLIN ONCOL, V9, P700, DOI 10.1038/nrclinonc.2012.187; Popov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056328; Nguyen QD, 2011, TRANSL ONCOL, V4, P241, DOI 10.1593/tlo.11118; Quon H, 2011, ANTICANCER RES, V31, P3559; Ruggiero A, 2006, J NEURO-ONCOL, V77, P89, DOI 10.1007/s11060-005-9011-2; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shuttleworth SJ, 2011, CURR MED CHEM, V18, P2686; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Su JS, 2012, NMR BIOMED, V25, P379, DOI 10.1002/nbm.1764; Takeshita I, 1987, Neurol Med Chir (Tokyo), V27, P581, DOI 10.2176/nmc.27.581; Tyagi RK, 1996, MAGN RESON MED, V35, P194, DOI 10.1002/mrm.1910350210; Venkatesh HS, 2012, NEURO-ONCOLOGY, V14, P315, DOI 10.1093/neuonc/nor209; Workman P, 2006, JNCI-J NATL CANCER I, V98, P580, DOI 10.1093/jnci/djj162; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6	51	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103835	10.1371/journal.pone.0103835	http://dx.doi.org/10.1371/journal.pone.0103835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084455	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800087
J	Arroteia, KF; Barbieri, MF; Souza, GHMF; Tanaka, H; Eberlin, MN; Hyslop, S; Alvares, LE; Pereira, LAVD				Arroteia, Kelen Fabiola; Barbieri, Mainara Ferreira; Martins Ferreira Souza, Gustavo Henrique; Tanaka, Hiromitsu; Eberlin, Marcos Nogueira; Hyslop, Stephen; Alvares, Lucia Elvira; Violin Dias Pereira, Luis Antonio			Albumin Is Synthesized in Epididymis and Aggregates in a High Molecular Mass Glycoprotein Complex Involved in Sperm-Egg Fertilization	PLOS ONE			English	Article							RAT EPIDIDYMIS; CYSTATIN CRES; PROTEINS; SPERMATOZOA; IDENTIFICATION; EXPRESSION; ANTIGEN; MICE; MATURATION; FERTILITY	The epididymis has an important role in the maturation of sperm for fertilization, but little is known about the epididymal molecules involved in sperm modifications during this process. We have previously described the expression pattern for an antigen in epididymal epithelial cells that reacts with the monoclonal antibody (mAb) TRA 54. Immunohistochemical and immunoblotting analyses suggest that the epitope of the epididymal antigen probably involves a sugar moiety that is released into the epididymal lumen in an androgen-dependent manner and subsequently binds to luminal sperm. Using column chromatography, SDS-PAGE with in situ digestion and mass spectrometry, we have identified the protein recognized by mAb TRA 54 in mouse epididymal epithelial cells. The similar to 65 kDa protein is part of a high molecular mass complex (similar to 260 kDa) that is also present in the sperm acrosomal vesicle and is completely released after the acrosomal reaction. The amino acid sequence of the protein corresponded to that of albumin. Immunoprecipitates with anti-albumin antibody contained the antigen recognized by mAb TRA 54, indicating that the epididymal molecule recognized by mAb TRA 54 is albumin. RT-PCR detected albumin mRNA in the epididymis and fertilization assays in vitro showed that the glycoprotein complex containing albumin was involved in the ability of sperm to recognize and penetrate the egg zona pellucida. Together, these results indicate that epididymal-derived albumin participates in the formation of a high molecular mass glycoprotein complex that has an important role in egg fertilization.	[Arroteia, Kelen Fabiola; Barbieri, Mainara Ferreira; Alvares, Lucia Elvira; Violin Dias Pereira, Luis Antonio] State Univ Campinas UNICAMP, Inst Biol, Dept Histol & Embryol, Campinas, SP, Brazil; [Martins Ferreira Souza, Gustavo Henrique; Hyslop, Stephen] State Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil; [Martins Ferreira Souza, Gustavo Henrique; Eberlin, Marcos Nogueira] State Univ Campinas UNICAMP, Inst Chem, Dept Organ Chem, ThoMSon Mass Spectrometry Lab, Campinas, SP, Brazil; [Tanaka, Hiromitsu] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki, Japan	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Nagasaki International University	Pereira, LAVD (corresponding author), State Univ Campinas UNICAMP, Inst Biol, Dept Histol & Embryol, Campinas, SP, Brazil.	lviolin@unicamp.br	Alvares, Lúcia Elvira E/O-6557-2014; Pereira, Luis A V D/A-5263-2019; SOUZA, GUSTAVO HENRIQUE MARTINS FERREIRA/B-5101-2017; Pereira, Luís Antônio Violin Dias/C-5570-2014; Hyslop, Stephen/F-2910-2012	Alvares, Lúcia Elvira E/0000-0002-2229-8966; SOUZA, GUSTAVO HENRIQUE MARTINS FERREIRA/0000-0002-9410-8578; Pereira, Luís Antônio Violin Dias/0000-0002-9332-7285; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [130779/2012-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [01/12773-7, 01/00016-7, 05/04007-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	KFA and MFB were supported by a PhD and MSc scholarship, from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; http://www.capes.gov.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; http://www.cnpq.br, grant number 130779/2012-1), respectively. GHMFS was supported by a PhD scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). MNE and SH were supported by research fellowships from Conselho Nacional de Pesquisa e Desenvolvimento Cientifico (CNPq). This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; http://www.fapesp.br, grant numbers 01/12773-7, 01/00016-7 and 05/04007-3) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002829; Arroteia KF, 2004, J ANDROL, V25, P914; Boue F, 1996, BIOL REPROD, V54, P1018, DOI 10.1095/biolreprod54.5.1018; BROOKS DE, 1980, J REPROD FERTIL, V59, P363, DOI 10.1530/jrf.0.0590363; Brooks DE, 1998, ANN NY ACAD SCI, V513, P179; CARLES C, 1992, REPROD NUTR DEV, V32, P277, DOI 10.1051/rnd:19920307; Castella S, 2004, BIOL REPROD, V70, P319, DOI 10.1095/biolreprod.103.022459; Chau KM, 2011, BIOL REPROD, V84, P140, DOI 10.1095/biolreprod.110.084855; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Dacheux JL, 2009, MOL CELL ENDOCRINOL, V306, P45, DOI 10.1016/j.mce.2009.03.007; Dacheux JL, 2005, THERIOGENOLOGY, V63, P319, DOI 10.1016/j.theriogenology.2004.09.015; DACHEUX JL, 1987, ANN NY ACAD SCI, V513, P560, DOI 10.1111/j.1749-6632.1987.tb25107.x; FOURNIERDELPECH S, 1988, REPROD NUTR DEV, V28, P1283, DOI 10.1051/rnd:19880809; FOURNIERDELPECH S, 1988, CR ACAD SCI III-VIE, V306, P333; FournierDelpech S, 1997, MOL REPROD DEV, V47, P483, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;483::AID-MRD15&gt;3.0.CO;2-X; FOURNIERDELPECH S, 1985, J ANDROL, V6, P246; Hall JC, 1996, BIOL REPROD, V54, P914, DOI 10.1095/biolreprod54.4.914; Hamil KG, 2000, ENDOCRINOLOGY, V141, P1245, DOI 10.1210/en.141.3.1245; Heisig M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-163; Kaunisto K, 1999, BIOL REPROD, V61, P1521, DOI 10.1095/biolreprod61.6.1521; Kirchhoff C, 1998, ANDROLOGIA, V30, P225; Kirchhoff C, 1996, MOL HUM REPROD, V2, P177, DOI 10.1093/molehr/2.3.177; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; LEE SH, 1987, J REPROD FERTIL, V80, P65, DOI 10.1530/jrf.0.0800065; Legare C, 1999, ENDOCRINOLOGY, V140, P3318, DOI 10.1210/en.140.7.3318; Lokhov PG, 2004, PROTEOMICS, V4, P633, DOI 10.1002/pmic.200300580; MAHADEVAN MM, 1985, FERTIL STERIL, V43, P263; Manandhar G, 2001, BIOL REPROD, V65, P1425, DOI 10.1095/biolreprod65.5.1425; Mathur PP, 2000, ASIAN J ANDROL, V2, P57; NAHON JL, 1988, J BIOL CHEM, V263, P11436; Nishio H, 1996, P NATL ACAD SCI USA, V93, P7557, DOI 10.1073/pnas.93.15.7557; Pereira LAVD, 1998, INT J ANDROL, V21, P34; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PRIMAKOFF P, 1994, AM J REPROD IMMUNOL, V31, P208, DOI 10.1111/j.1600-0897.1994.tb00869.x; Saxena DK, 1999, J REPROD FERTIL, V117, P17, DOI 10.1530/jrf.0.1170017; Shamay A, 2005, J DAIRY SCI, V88, P569, DOI 10.3168/jds.S0022-0302(05)72719-3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sipila P, 2002, MOL ENDOCRINOL, V16, P2603, DOI 10.1210/me.2002-0100; TANPHAICHITR N, 1994, MOL REPROD DEV, V37, P326, DOI 10.1002/mrd.1080370312; TAO J, 1993, MOL REPROD DEV, V36, P183, DOI 10.1002/mrd.1080360209; TULSIANI DRP, 1993, BIOL REPROD, V48, P417, DOI 10.1095/biolreprod48.2.417; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; von Horsten HH, 2007, J BIOL CHEM, V282, P32912, DOI 10.1074/jbc.M703956200; Wassler M, 2002, BIOL REPROD, V67, P795, DOI 10.1095/biolreprod.102.003970; WATANABE D, 1992, MOL REPROD DEV, V33, P307, DOI 10.1002/mrd.1080330312	46	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103566	10.1371/journal.pone.0103566	http://dx.doi.org/10.1371/journal.pone.0103566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084016	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800052
J	Gerzova, L; Videnska, P; Faldynova, M; Sedlar, K; Provaznik, I; Cizek, A; Rychlik, I				Gerzova, Lenka; Videnska, Petra; Faldynova, Marcela; Sedlar, Karel; Provaznik, Ivo; Cizek, Alois; Rychlik, Ivan			Characterization of Microbiota Composition and Presence of Selected Antibiotic Resistance Genes in Carriage Water of Ornamental Fish	PLOS ONE			English	Article							REAL-TIME PCR; ANTIMICROBIAL RESISTANCE; BACTERIAL COMMUNITIES; TREATMENT-PLANT; GUT MICROBIOTA; QUANTIFICATION; PREVALENCE; INTEGRONS; TETRACYCLINE; PLASMID	International trade with ornamental fish is gradually recognized as an important source of a wide range of different antibiotic resistant bacteria. In this study we therefore characterized the prevalence of selected antibiotic resistance genes in the microbiota found in the carriage water of ornamental fish originating from 3 different continents. Real-time PCR quantification showed that the sul1 gene was present in 11 out of 100 bacteria. tet(A) was present in 6 out of 100 bacteria and strA, tet(G), sul2 and aadA were present in 1-2 copies per 100 bacteria. Class I integrons were quite common in carriage water microbiota, however, pyrosequencing showed that only 12 different antibiotic gene cassettes were present in class I integrons. The microbiota characterized by pyrosequencing of the V3/V4 variable region of 16S rRNA genes consisted of Proteobacteria (48%), Bacteroidetes (29.5%), Firmicutes (17.8%), Actinobacteria (2.1%) and Fusobacteria (1.6%). Correlation analysis between antibiotic resistance gene prevalence and microbiota composition verified by bacterial culture showed that major reservoirs of sul1 sul2, tet(A), tet(B) tet(G), cat, cml, bla, strA, aacA, aph and aadA could be found among Alpha-, Beta-and Gammaproteobacteria with representatives of Enterobacteriaceae, Pseudomonadaceae, Rhizobiaceae and Comamonadaceae being those most positively associated with the tested antibiotic resistance genes.	[Gerzova, Lenka; Videnska, Petra; Faldynova, Marcela; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic; [Sedlar, Karel; Provaznik, Ivo] Brno Univ Technol, Dept Biomed Engn, CS-61090 Brno, Czech Republic; [Cizek, Alois] Univ Vet & Pharmaceut Sci, Brno, Czech Republic	Czech Veterinary Research Institute; Brno University of Technology; University of Veterinary Sciences Brno	Rychlik, I (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	Sedlar, Karel/K-1120-2014; , Ivan/GPS-9674-2022; Cizek, Alois/G-8833-2014; Provaznik, Ivo/F-4121-2012	Sedlar, Karel/0000-0002-8269-4020; , Ivan/0000-0001-7995-6483; Cizek, Alois/0000-0001-5706-4601; Provaznik, Ivo/0000-0002-3422-7938	PROMISE project 7th Framework Programme of Czech Ministry of Agriculture [MZE0002716202]; Czech Ministry of Education [CZ.1.05/2.1.00/01.0006-ED0006/01/01]; CEITEC, project of the European Regional Development Fund [CZ.1.05/1.1.00/02.0068]	PROMISE project 7th Framework Programme of Czech Ministry of Agriculture; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); CEITEC, project of the European Regional Development Fund	This study was supported by PROMISE project 7th Framework Programme, project MZE0002716202 of the Czech Ministry of Agriculture and AdmireVet project CZ.1.05/2.1.00/01.0006-ED0006/01/01 from the Czech Ministry of Education. A. Cizek was also supported by CEITEC, project of the European Regional Development Fund (CZ.1.05/1.1.00/02.0068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06; Cizek A, 2010, VET MICROBIOL, V142, P435, DOI 10.1016/j.vetmic.2009.10.001; Faldynova M, 2013, VET MED-CZECH, V58, P298, DOI 10.17221/6865-VETMED; GALIMAND M, 1993, ANTIMICROB AGENTS CH, V37, P1456, DOI 10.1128/AAC.37.7.1456; Geraylou Z, 2013, FEMS MICROBIOL ECOL, V86, P357, DOI 10.1111/1574-6941.12169; HOPKINS JD, 1991, ANTIMICROB AGENTS CH, V35, P1605, DOI 10.1128/AAC.35.8.1605; Hradecka H, 2008, J ANTIMICROB CHEMOTH, V62, P938, DOI 10.1093/jac/dkn286; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Lim LC, 2003, AQUAC RES, V34, P923, DOI 10.1046/j.1365-2109.2003.00946.x; Lin CH, 2007, FEBS J, V274, P2946, DOI 10.1111/j.1742-4658.2007.05828.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mann E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086950; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; Moura A, 2007, J ANTIMICROB CHEMOTH, V60, P1243, DOI 10.1093/jac/dkm340; Roe MT, 2003, EMERG INFECT DIS, V9, P822, DOI 10.3201/eid0907.020529; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Tseng CP, 2003, CLIN CHEM, V49, P306, DOI 10.1373/49.2.306; Vaz-Moreira I, 2011, ANTON LEEUW INT J G, V100, P245, DOI 10.1007/s10482-011-9583-0; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verner-Jeffreys DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008388; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-30; Ye L, 2013, APPL MICROBIOL BIOT, V97, P2681, DOI 10.1007/s00253-012-4082-4; Yu ZT, 2005, APPL ENVIRON MICROB, V71, P6926, DOI 10.1128/AEM.71.11.6926-6933.2005; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P397, DOI 10.1007/s00253-008-1829-z	30	28	29	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103865	10.1371/journal.pone.0103865	http://dx.doi.org/10.1371/journal.pone.0103865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084116	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800093
J	Ma, LJ; Liu, HM; Xie, ZL; Yang, SA; Xu, W; Hou, JB; Yu, B				Ma, Lijia; Liu, Huimin; Xie, Zulong; Yang, Shuang; Xu, Wei; Hou, Jingbo; Yu, Bo			Ginsenoside Rb3 Protects Cardiomyocytes against Ischemia-Reperfusion Injury via the Inhibition of JNK-Mediated NF-kappa B Pathway: A Mouse Cardiomyocyte Model	PLOS ONE			English	Article							MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; PC12 CELLS; MATRIX METALLOPROTEINASE-2; SIGNALING PATHWAYS; IN-VITRO; ACTIVATION; EXPRESSION; APOPTOSIS; INFLAMMATION; DEATH	Ginsenoside Rb3 is extracted from the plant Panax ginseng and plays important roles in cardiovascular diseases, including myocardial ischemia-reperfusion (I/R) injury. NF-kappa B is an important transcription factor involved in I/R injury. However, the underlying mechanism of ginsenoside Rb3 in myocardial I/R injury remains poorly understood. In the current study, a model of myocardial I/R injury was induced via oxygen and glucose deprivation (OGD) followed by reperfusion (OGD-Rep) in mouse cardiac myoblast H9c2 cells. Our data demonstrate that ginsenoside Rb3 suppresses OGD-Rep-induced cell apoptosis by the suppression of ROS generation. By detecting the NF-kappa B signaling pathway, we discover that the protective effect of ginsenoside Rb3 on the OGD-Rep injury is closely related to the inhibition of NF-kappa B activity. Ginsenoside Rb3 inhibits the upregulation of phospho-I kappa B-alpha and nuclear translocation of NF-kappa B subunit p65 which are induced by ORD-Rep injury. In addition, the extract also inhibits the OGD-Rep-induced increase in the expression of inflammation-related factors, such as IL-6, TNF-alpha, monocyte chemotactic protein-1 (MCP-1), MMP-2 and MMP-9. However, LPS treatment alleviates the protective roles of ginsenoside Rb3 and activates the NF-kappa B pathway. Finally, the upstream factors of NF-kappa B were analyzed, including the Akt/Foxo3a and MAPK signaling pathways. We find that ginsenoside Rb3 pretreatment only decreases the phosphorylation of JNK induced by OGD-Rep injury, an indicator of the MAPK pathway. Importantly, an inhibitor of phospho-JNK, SP600125, protects against OGD-Rep induced apoptosis and inhibited NF-kappa B signaling pathway, similar to the roles of ginsenoside Rb3. Taken together, our results demonstrate that the protective effect of ginsenoside Rb3 on the OGD-Rep injury is attributed to the inhibition of JNK-mediated NF-kappa B activation, suggesting that ginsenoside Rb3 has the potential to serve as a novel therapeutic agent for myocardial I/R injury.	[Ma, Lijia; Liu, Huimin; Xie, Zulong; Yang, Shuang; Xu, Wei; Hou, Jingbo; Yu, Bo] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Key Lab Myocardial Ischemia Mech & Treatment Mini, Harbin 150006, Heilongjiang, Peoples R China	Harbin Medical University	Yu, B (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Key Lab Myocardial Ischemia Mech & Treatment Mini, Harbin 150006, Heilongjiang, Peoples R China.	yubo200012@163.com		Yu, Bo/0000-0002-2045-8567; Hou, Jingbo/0000-0002-9671-5099	State natural key project [81330033/H18]; National Natural Science Foundation of China [81171430/H1816]	State natural key project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the State natural key project (No: 81330033/H18, the effect of NF-kappaB signaling pathway on the interaction between the bracket and vascular wall) and the National Natural Science Foundation of China (No: 81171430/H1816, Studying the effect of stent thrombosis on the intimal healing mode and its regulation mechanism by the application of VIVI-OCT). The URL is http://isisn.nsfc.gov.cn/egrantweb/contract/index. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Cheung PY, 2000, CIRCULATION, V101, P1833, DOI 10.1161/01.CIR.101.15.1833; Chung JW, 2012, ARCH PHARM RES, V35, P723, DOI 10.1007/s12272-012-0417-z; Ekshyyan O, 2004, FRONT BIOSCI-LANDMRK, V9, P1567, DOI 10.2741/1357; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Gross GJ, 2007, J MOL CELL CARDIOL, V42, P12, DOI 10.1016/j.yjmcc.2006.09.009; Gu JH, 2012, EUR J PHARM SCI, V47, P652, DOI 10.1016/j.ejps.2012.07.016; Higa JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045082; Himaya SWA, 2012, TOXICOL IN VITRO, V26, P878, DOI 10.1016/j.tiv.2012.04.022; Kang CH, 2013, INT IMMUNOPHARMACOL; Kim MS, 2012, J TOXICOL SCI, V37, P1275, DOI 10.2131/jts.37.1275; Kim SO, 2013, EVID-BASED COMPL ALT, V2013; Kim YS, 2010, INT HEART J, V51, P348, DOI 10.1536/ihj.51.348; Lee CS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/580135; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Lu CY, 2013, ACTA TROP, V127, P14, DOI 10.1016/j.actatropica.2013.03.004; Mestre JR, 2001, J BIOL CHEM, V276, P3977, DOI 10.1074/jbc.M005077200; Mozaffari MS, 2013, AM J CARDIOVASC DIS, V3, P180; Nakamura M, 2000, CARDIOVASC RES, V45, P661, DOI 10.1016/S0008-6363(99)00393-4; Onai Y, 2004, CARDIOVASC RES, V63, P51, DOI 10.1016/j.cardiores.2004.03.002; Palladini G, 2014, SCI WORLD J, DOI 10.1155/2014/867548; Pan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079084; Parks RJ, 2018, METHODS MOL BIOL, V1782, P187, DOI [10.1007/978-1-61779-382-0_15, 10.1007/978-1-4939-7831-1_11]; Poynter JA, 2011, J AM COLL SURGEONS, V213, P253, DOI 10.1016/j.jamcollsurg.2011.04.005; Qi LW, 2011, PHYTOCHEMISTRY, V72, P689, DOI 10.1016/j.phytochem.2011.02.012; Ramachandran S, 2012, TRANSPL IMMUNOL, V26, P201, DOI 10.1016/j.trim.2012.01.001; Stokes SE, 2013, TOXICOL SCI; Tabakman R, 2005, ANN NY ACAD SCI, V1053, P84, DOI 10.1196/annals.1344.008; Thirunavukkarasu M, 2008, J AGR FOOD CHEM, V56, P6733, DOI 10.1021/jf801473v; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang X, 2013, J MOL HISTOL; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070956; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Xiao XH, 2008, EUR J PHARMACOL, V591, P21, DOI 10.1016/j.ejphar.2008.06.045; Zhu JR, 2010, ACTA PHARMACOL SIN, V31, P273, DOI 10.1038/aps.2010.9	35	84	86	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103628	10.1371/journal.pone.0103628	http://dx.doi.org/10.1371/journal.pone.0103628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084093	gold, Green Submitted, Green Published			2022-12-27	WOS:000339819800063
J	Riera, F; Trong, TT; Sinnapah, S; Hue, O				Riera, Florence; Than Tran Trong; Sinnapah, Stephane; Hue, Olivier			Physical and Perceptual Cooling with Beverages to Increase Cycle Performance in a Tropical Climate	PLOS ONE			English	Article							EXERCISE PERFORMANCE; THERMOREGULATORY RESPONSES; ENDURANCE CAPACITY; PROLONGED EXERCISE; DRINK TEMPERATURE; BODY-TEMPERATURE; ICE SLURRY; INGESTION; HEAT; COLD	Purpose: This study compares the effects of neutral temperature, cold and ice-slush beverages, with and without 0.5% menthol on cycling performance, core temperature (T-co) and stress responses in a tropical climate (hot and humid conditions). Methods: Twelve trained male cyclists/triathletes completed six 20-km exercise trials against the clock in 30.7 degrees C +/- 0.8 degrees C and 78%+/- 0.03% relative humidity. Before and after warm-up, and before exercise and every 5 km during exercise, athletes drank 190 mL of either aromatized (i.e., with 0.5 mL of menthol (5 gr/L)) or a non-aromatized beverage (neutral temperature: 23 degrees C +/- 0.1 degrees C, cold: 3 degrees C +/- 0.1 degrees C, or ice-slush: -1 degrees C +/- 0.7 degrees C). During the trials, heart rate (HR) was continuously monitored, whereas core temperature (T-co), thermal comfort (TC), thermal sensation (TS) and rate of perceived exertion (RPE) were measured before and after warm-up, every 5 km of exercise, and at the end of exercise and after recovery. Results: Both the beverage aroma (P<0.02) and beverage temperature (P<0.02) had significant and positive effects on performance, which was considerably better with ice-slush than with a neutral temperature beverage, whatever the aroma (P<0.002), and with menthol vs non-menthol (P<0.02). The best performances were obtained with ice-slush/menthol and cold/menthol, as opposed to neutral/menthol. No differences were noted in HR and T-co between trials. Conclusion: Cold water or ice-slush with menthol aroma seems to be the most effective beverage for endurance exercise in a tropical climate. Further studies are needed to explore its effects in field competition.	[Riera, Florence; Than Tran Trong; Sinnapah, Stephane; Hue, Olivier] Univ Antilles Guyane, Lab ACTES EA 3596, Point A Pitre, France		Riera, F (corresponding author), Univ Antilles Guyane, Lab ACTES EA 3596, Campus Fouillole, Point A Pitre, France.	florence.riera@gmail.com	Riera, Florence/AAG-5588-2020	Riera, Florence/0000-0002-3778-7295; Hue, Olivier/0000-0002-2155-0816				BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Burdon CA, 2010, J SPORTS SCI; Burdon CA, 2010, INT J SPORT NUTR EXE, V20, P166, DOI 10.1123/ijsnem.20.2.166; Cheung SS, 2007, PROG BRAIN RES, V162, P45, DOI 10.1016/S0079-6123(06)62004-9; Cotter JD, 2001, COMP BIOCHEM PHYS A, V128, P667, DOI 10.1016/S1095-6433(01)00273-2; Crewe H, 2008, EUR J APPL PHYSIOL, V103, P569, DOI 10.1007/s00421-008-0741-7; ECCLES R, 1990, J PHARM PHARMACOL, V42, P652, DOI 10.1111/j.2042-7158.1990.tb06625.x; Eccles R, 2000, APPETITE, V34, P29, DOI 10.1006/appe.1999.0291; ECCLES R, 1994, J PHARM PHARMACOL, V46, P618, DOI 10.1111/j.2042-7158.1994.tb03871.x; Gillis DJ, 2010, EUR J APPL PHYSIOL, V110, P609, DOI 10.1007/s00421-010-1533-4; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; Gonzalez-Alonso J, 2007, SPORTS MED, V37, P371, DOI 10.2165/00007256-200737040-00025; GREEN BG, 1985, PERCEPT PSYCHOPHYS, V38, P110, DOI 10.3758/BF03198847; Guest S, 2007, PHYSIOL BEHAV, V92, P975, DOI 10.1016/j.physbeh.2007.07.004; Hodder SG, 2007, INT J BIOMETEOROL, V51, P233, DOI 10.1007/s00484-006-0050-y; Hopkins WG, 2001, MED SCI SPORT EXER, V33, P1588, DOI 10.1097/00005768-200109000-00023; Hue O, 2013, INT J SPORT PHYSIOL, V8, P442, DOI 10.1123/ijspp.8.4.442; Hue O, 2011, INT J SPORT PHYSIOL, V6, P443, DOI 10.1123/ijspp.6.4.443; HUNT JN, 1954, J PHYSIOL-LONDON, V126, P459, DOI 10.1113/jphysiol.1954.sp005222; Ihsan M, 2010, INT J SPORT PHYSIOL, V5, P140, DOI 10.1123/ijspp.5.2.140; Jay O, 2007, J APPL PHYSIOL, V103, P443, DOI 10.1152/japplphysiol.00117.2007; Lee JKW, 2008, MED SCI SPORT EXER, V40, P1637, DOI 10.1249/MSS.0b013e318178465d; Lee JKW, 2008, J SPORT SCI, V26, P583, DOI 10.1080/02640410701697388; Lee JKW, 2007, J SPORT SCI, V25, P975, DOI 10.1080/02640410600959947; Marino FE, 2002, BRIT J SPORT MED, V36, P89, DOI 10.1136/bjsm.36.2.89; Maughan RJ, 2010, SCAND J MED SCI SPOR, V20, P95, DOI 10.1111/j.1600-0838.2010.01214.x; Morris NB, 2014, J APPL PHYSIOL, V116, P1088, DOI 10.1152/japplphysiol.01059.2013; Mundel T, 2006, EXP PHYSIOL, V91, P925, DOI 10.1113/expphysiol.2006.034223; Mundel T, 2010, EUR J APPL PHYSIOL, V109, P59, DOI 10.1007/s00421-009-1180-9; Naito Kensei, 1997, Auris Nasus Larynx, V24, P159, DOI 10.1016/S0385-8146(96)00005-3; Noakes TD, 1998, MED SCI SPORT EXER, V30, P1381, DOI 10.1097/00005768-199809000-00007; Nybo L, 2010, SCAND J MED SCI SPOR, V20, P71, DOI 10.1111/j.1600-0838.2010.01211.x; Nybo L, 2008, J APPL PHYSIOL, V104, P871, DOI 10.1152/japplphysiol.00910.2007; Ross MLR, 2011, MED SCI SPORT EXER, V43, P123, DOI 10.1249/MSS.0b013e3181e93210; Siegel R, 2012, SPORTS MED, V42, P89, DOI 10.2165/11596870-000000000-00000; Siegel R, 2010, MED SCI SPORT EXER, V42, P717, DOI 10.1249/MSS.0b013e3181bf257a; Voltaire B, 2002, CAN J APPL PHYSIOL, V27, P551, DOI 10.1139/h02-031; Wegmann M, 2012, SPORTS MED, V42, P545, DOI 10.2165/11630550-000000000-00000; Yeo ZW, 2012, INT J SPORTS MED, V33, P859, DOI 10.1055/s-0032-1304643	39	39	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103718	10.1371/journal.pone.0103718	http://dx.doi.org/10.1371/journal.pone.0103718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084009	Green Submitted, gold, Green Published			2022-12-27	WOS:000339819800072
J	Kunicka, T; Vaclavikova, R; Hlavac, V; Vrana, D; Pecha, V; Raus, K; Trnkova, M; Kubackova, K; Ambrus, M; Vodickova, L; Vodicka, P; Soucek, P				Kunicka, Tereza; Vaclavikova, Radka; Hlavac, Viktor; Vrana, David; Pecha, Vaclav; Raus, Karel; Trnkova, Marketa; Kubackova, Katerina; Ambrus, Miloslav; Vodickova, Ludmila; Vodicka, Pavel; Soucek, Pavel			Non-Coding Polymorphisms in Nucleotide Binding Domain 1 in ABCC1 Gene Associate with Transcript Level and Survival of Patients with Breast Cancer	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN-1; TRANSPORTER GENES; MRP1 GENE; EXPRESSION; CHEMOTHERAPY; CELLS; MRP1/ABCC1; MUTATIONS; CARCINOMA; SUBTYPES	Objectives: ATP-Binding Cassette (ABC) transporters may cause treatment failure by transporting of anticancer drugs outside of the tumor cells. Multidrug resistance-associated protein 1 coded by the ABCC1 gene has recently been suggested as a potential prognostic marker in breast cancer patients. This study aimed to explore tagged haplotype covering nucleotide binding domain 1 of ABCC1 in relation with corresponding transcript levels in tissues and clinical phenotype of breast cancer patients. Methods: The distribution of twelve ABCC1 polymorphisms was assessed by direct sequencing in peripheral blood DNA (n = 540). Results: Tumors from carriers of the wild type genotype in rs35623 or rs35628 exhibited significantly lower levels of ABCC1 transcript than those from carriers of the minor allele (p = 0.003 and p = 0.004, respectively). The ABCC1 transcript levels significantly increased in the order CT-GT>CC-GT>CC-GG for the predicted rs35626-rs4148351 diplotype. Chemotherapy-treated patients carrying the T allele in rs4148353 had longer disease-free survival than those with the GG genotype (p = 0.043). On the other hand, hormonal therapy-treated patients with the AA genotype in rs35628 had significantly longer disease-free survival than carriers of the G allele (p = 0.012). Conclusions: Taken together, our study shows that genetic variability in the nucleotide binding domain 1 has a significant impact on the ABCC1 transcript level in the target tissue and may modify survival of breast cancer patients.	[Kunicka, Tereza; Vaclavikova, Radka; Hlavac, Viktor; Vrana, David; Vodickova, Ludmila; Soucek, Pavel] Natl Inst Publ Hlth, Dept Toxicogen, Prague, Czech Republic; [Kunicka, Tereza; Hlavac, Viktor] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Vrana, David] Palacky Univ, Dept Oncol, Sch Med, CR-77147 Olomouc, Czech Republic; [Vrana, David] Teaching Hosp, Olomouc, Czech Republic; [Pecha, Vaclav; Raus, Karel] Inst Care Mother & Child, Prague, Czech Republic; [Trnkova, Marketa] Biolab Praha Ks, Prague, Czech Republic; [Kubackova, Katerina] Motol Univ Hosp, Dept Oncol, Prague, Czech Republic; [Ambrus, Miloslav] Fac Hosp Kralovske Vinohrady, Dept Radiotherapy & Oncol, Prague, Czech Republic; [Vodickova, Ludmila; Vodicka, Pavel] Acad Sci Czech Republ, Inst Expt Med, Prague, Czech Republic; [Vodicka, Pavel] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic	National Institute of Public Health (SZU) - Czech Republic; Charles University Prague; Palacky University Olomouc; University Hospital Olomouc; Motol University Hospital; University Hospital Vinohrady; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague	Soucek, P (corresponding author), Natl Inst Publ Hlth, Dept Toxicogen, Prague, Czech Republic.	psoucek@szu.cz	Soucek, Pavel/H-8018-2019	Soucek, Pavel/0000-0002-4294-6799; Hlavac, Viktor/0000-0003-0695-0552; Vodicka, Pavel/0000-0003-2376-1243	Internal Grant Agency of the Czech Ministry of Health [NT13679-4]; Czech Science Foundation [P303/12/G163]; Biolab Praha, k.s	Internal Grant Agency of the Czech Ministry of Health; Czech Science Foundation(Grant Agency of the Czech Republic); Biolab Praha, k.s	This work was supported by grant of the Internal Grant Agency of the Czech Ministry of Health (www.mzcr.cz), no.: NT13679-4 and by the project of the Czech Science Foundation no.: P303/12/G163 (www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biolab Praha, k.s provided support in the form of salary for author MT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akan I, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-22; [Anonymous], 2008, IARC CANCERBASE; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIEDLER JL, 1970, CANCER RES, V30, P1174; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brynychova V, 2013, FUTURE ONCOL, V9, P427, DOI [10.2217/fon.12.200, 10.2217/FON.12.200]; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2014, ANNU REV PHARMACOL, V54, P95, DOI 10.1146/annurev-pharmtox-011613-135959; Conrad S, 2002, PHARMACOGENETICS, V12, P321, DOI 10.1097/00008571-200206000-00008; Conrad S, 2001, J HUM GENET, V46, P656, DOI 10.1007/s100380170017; Ferguson LR, 2005, MUTAT RES-FUND MOL M, V591, P24, DOI 10.1016/j.mrfmmm.2005.02.030; Filipits M, 2005, J CLIN ONCOL, V23, P1161, DOI 10.1200/JCO.2005.03.033; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Grant CE, 1997, GENOMICS, V45, P368, DOI 10.1006/geno.1997.4950; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; Hlavac V, 2013, PHARMACOGENOMICS, V14, P515, DOI [10.2217/PGS.13.26, 10.2217/pgs.13.26]; Iram SH, 2011, J BIOL CHEM, V286, P7202, DOI 10.1074/jbc.M110.166959; Kim B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062766; Kiyotani K, 2012, DRUG METAB PHARMACOK, V27, P122, DOI 10.2133/dmpk.DMPK-11-RV-084; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Leslie EM, 2003, BIOCHEMISTRY-US, V42, P5214, DOI 10.1021/bi027076n; Letourneau IJ, 2005, PHARMACOGENET GENOM, V15, P647, DOI 10.1097/01.fpc.0000173484.51807.48; Lips EH, 2013, BREAST CANCER RES TR, V140, P63, DOI 10.1007/s10549-013-2620-0; Liscovitch Mordechai, 2002, IDrugs, V5, P349; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McDonagh EM, 2011, BIOMARK MED, V5, P795, DOI [10.2217/BMM.11.94, 10.2217/bmm.11.94]; Oselin K, 2003, EUR J CLIN PHARMACOL, V59, P347, DOI 10.1007/s00228-003-0625-z; Qin L, 2008, BIOCHEMISTRY-US, V47, P13952, DOI 10.1021/bi801532g; Ramaen O, 2006, J MOL BIOL, V359, P940, DOI 10.1016/j.jmb.2006.04.005; Rungsardthong K, 2012, BIOINFORMATION, V8, P907, DOI 10.6026/97320630008907; Soucek P, 2005, STEM CELLS, V23, P1417, DOI 10.1634/stemcells.2005-0066; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Teft WA, 2011, DRUG METAB DISPOS, V39, P558, DOI 10.1124/dmd.110.036160; Thomas Hilary, 2003, Cancer Control, V10, P159; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; TOPIC E, 1991, EUR J CLIN CHEM CLIN, V29, P327; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vaclavikova R, 2008, PHARMACOGENET GENOM, V18, P263, DOI 10.1097/FPC.0b013e3282f60a91; Vulsteke C, 2013, ANN ONCOL, V24, P1513, DOI 10.1093/annonc/mdt008; Wang ZH, 2005, HUM MOL GENET, V14, P2075, DOI 10.1093/hmg/ddi212; Yamada A, 2013, BREAST CANCER RES TR, V137, P773, DOI 10.1007/s10549-012-2398-5; Yin JY, 2009, PHARMACOGENET GENOM, V19, P206, DOI 10.1097/FPC.0b013e328323f680	49	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101740	10.1371/journal.pone.0101740	http://dx.doi.org/10.1371/journal.pone.0101740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078270	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800008
J	Lei, BL; Mace, B; Dawson, HN; Warner, DS; Laskowitz, DT; James, ML				Lei, Beilei; Mace, Brian; Dawson, Hana N.; Warner, David S.; Laskowitz, Daniel T.; James, Michael L.			Anti-Inflammatory Effects of Progesterone in Lipopolysaccharide-Stimulated BV-2 Microglia	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; CEREBRAL-ARTERY OCCLUSION; PRIMARY GLIAL CULTURES; INTRACEREBRAL HEMORRHAGE; RATS; EXPRESSION; ISCHEMIA	Female sex is associated with improved outcome in experimental brain injury models, such as traumatic brain injury, ischemic stroke, and intracerebral hemorrhage. This implies female gonadal steroids may be neuroprotective. A mechanism for this may involve modulation of post-injury neuroinflammation. As the resident immunomodulatory cells in central nervous system, microglia are activated during acute brain injury and produce inflammatory mediators which contribute to secondary injury including proinflammatory cytokines, and nitric oxide (NO) and prostaglandin E-2 (PGE(2)), mediated by inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2), respectively. We hypothesized that female gonadal steroids reduce microglia mediated neuroinflammation. In this study, the progesterone's effects on tumor necrosis factor alpha (TNF-alpha), iNOS, and COX-2 expression were investigated in lipopolysaccharide (LPS)-stimulated BV-2 microglia. Further, investigation included nuclear factor kappa B (NF-kappa B) and mitogen activated protein kinase (MAPK) pathways. LPS (30 ng/ml) upregulated TNF-alpha, iNOS, and COX-2 protein expression in BV-2 cells. Progesterone pretreatment attenuated LPS-stimulated TNF-alpha, iNOS, and COX-2 expression in a dose-dependent fashion. Progesterone suppressed LPS-induced NF-kappa B activation by decreasing inhibitory kappa B alpha and NF-kappa B p65 phosphorylation and p65 nuclear translocation. Progesterone decreased LPS-mediated phosphorylation of p38, c-Jun N-terminal kinase and extracellular regulated kinase MAPKs. These progesterone effects were inhibited by its antagonist mifepristone. In conclusion, progesterone exhibits pleiotropic anti-inflammatory effects in LPS-stimulated BV-2 microglia by down-regulating proinflammatory mediators corresponding to suppression of NF-kappa B and MAPK activation. This suggests progesterone may be used as a potential neurotherapeutic to treat inflammatory components of acute brain injury.	[Lei, Beilei; Warner, David S.; Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Med Ctr, Multidisciplinary Neuroprotect Labs, Durham, NC 27708 USA; [Lei, Beilei; Warner, David S.; Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Mace, Brian; Dawson, Hana N.; Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Warner, David S.; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	James, ML (corresponding author), Duke Univ, Med Ctr, Multidisciplinary Neuroprotect Labs, Durham, NC 27708 USA.	Michael.james@duke.edu	James, Michael L./AAJ-5592-2020	James, Michael L./0000-0002-8715-5210; Mace, Brian/0000-0002-5478-6227	American Heart Association-Scientist Development Grant	American Heart Association-Scientist Development Grant(American Heart Association)	This work was supported by American Heart Association-Scientist Development Grant (MLJ). The funders had no role in study design, data collection and analysis, decision to publish, or prearation of the manuscript.	Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Bhat NR, 2002, J BIOL CHEM, V277, P29584, DOI 10.1074/jbc.M204994200; Bhat NR, 1998, J NEUROSCI, V18, P1633; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; DAcquisto F, 1997, FEBS LETT, V418, P175, DOI 10.1016/S0014-5793(97)01377-X; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; Floden AM, 2006, J NEUROSCI, V26, P4644, DOI 10.1523/JNEUROSCI.4822-05.2006; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Gomes-Leal W, 2012, BRAIN BEHAV, V2, P345, DOI 10.1002/brb3.51; Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009; Hardy DB, 2008, MOL ENDOCRINOL, V22, P1812, DOI 10.1210/me.2007-0443; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Jang BC, 2005, CELL SIGNAL, V17, P625, DOI 10.1016/j.cellsig.2004.10.001; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Lei BL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-103; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mani S, 2008, ENDOCRINOLOGY, V149, P2750, DOI 10.1210/en.2008-0097; Mani SK, 2012, FRONT ENDOCRINOL, V3, P7, DOI DOI 10.3389/FENDO.2012.00007; Marks-Konczalik J, 1998, J BIOL CHEM, V273, P22201, DOI 10.1074/jbc.273.35.22201; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; NELSON JF, 1992, ENDOCRINOLOGY, V130, P805, DOI 10.1210/en.130.2.805; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Singh M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00159; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vallee M, 1997, P NATL ACAD SCI USA, V94, P14865, DOI 10.1073/pnas.94.26.14865; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Wagner CK, 2006, FRONT NEUROENDOCRIN, V27, P340, DOI 10.1016/j.yfrne.2006.07.003; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yan F, 2013, NEUROSCI LETT, V543, P163, DOI 10.1016/j.neulet.2013.03.005; Zhang P, 1998, NEUROCHEM RES, V23, P219, DOI 10.1023/A:1022489127107; Zhao XR, 2007, J NEUROCHEM, V101, P652, DOI 10.1111/j.1471-4159.2006.04414.x; Zhou ZG, 2010, PAIN, V151, P296, DOI 10.1016/j.pain.2010.06.017; Zhu Y, 2008, COMP BIOCHEM PHYS C, V148, P381, DOI 10.1016/j.cbpc.2008.05.019	52	88	94	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103969	10.1371/journal.pone.0103969	http://dx.doi.org/10.1371/journal.pone.0103969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080336	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800102
J	Dvorkin-Gheva, A; Hassell, JA				Dvorkin-Gheva, Anna; Hassell, John A.			Identification of a Novel Luminal Molecular Subtype of Breast Cancer	PLOS ONE			English	Article							EXPRESSION; CARCINOMAS; RESISTANCE; PREDICTOR; SIGNATURE; SURVIVAL; RECEPTOR; MARKERS	The molecular classification of human breast tumors has afforded insights into subtype specific biological processes, patient prognosis and response to therapies. However, using current methods roughly one quarter of breast tumors cannot be classified into one or another molecular subtype. To explore the possibility that the unclassifiable samples might comprise one or more novel subtypes we employed a collection of publically available breast tumor datasets with accompanying clinical information to assemble 1,593 transcript profiles: 25% of these samples could not be assigned to one of the current molecular subtypes of breast cancer. All of the unclassifiable samples could be grouped into a new molecular subtype, which we termed ''luminal-like''. We also identified the luminal-like subtype in an independent collection of tumor samples (NKI295). We found that patients harboring tumors of the luminal-like subtype have a better prognosis than those with basal-like breast cancer, a similar prognosis to those with ERBB2+, luminal B or claudin-low tumors, but a worse prognosis than patients with luminal A or normal-like breast tumors. Our findings suggest the occurrence of another molecular subtype of breast cancer that accounts for the vast majority of previously unclassifiable breast tumors.	[Dvorkin-Gheva, Anna; Hassell, John A.] McMaster Univ, Dept Biochem & Biomed Sci, Ctr Funct Genom, Hamilton, ON L8N 3Z5, Canada	McMaster University	Hassell, JA (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Ctr Funct Genom, Hamilton, ON L8N 3Z5, Canada.	hassell@mcmaster.ca		Dvorkin-Gheva, Anna/0000-0001-7295-7440	Canadian Breast Cancer Foundation (CBCF), Ontario	Canadian Breast Cancer Foundation (CBCF), Ontario	The Canadian Breast Cancer Foundation (CBCF), Ontario chapter supported the research described herein. AD-G is supported by a postdoctoral fellowship from the CBCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2011, J PATHOL, V223, P646, DOI 10.1002/path.2833; Aoudjit Fawzi, 2012, Chemother Res Pract, V2012, P283181, DOI 10.1155/2012/283181; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Benjamini Y, 2001, ANN STAT, V29, P1165; CLAYTON F, 1991, CANCER, V68, P1309, DOI 10.1002/1097-0142(19910915)68:6<1309::AID-CNCR2820680621>3.0.CO;2-I; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Dvorkin-Gheva A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026023; Everitt B. S., 1981, FINITE MIXTURE DISTR; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Gradishar WJ, 2012, NEW ENGL J MED, V366, P176, DOI 10.1056/NEJMe1113641; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Isidoro A, 2005, CARCINOGENESIS, V26, P2095, DOI 10.1093/carcin/bgi188; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; Lee DD, 2001, ADV NEUR IN, V13, P556; Maffei R, 2012, HAEMATOL-HEMATOL J, V97, P952, DOI 10.3324/haematol.2011.054924; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Menard S, 2000, J CELL PHYSIOL, V182, P150, DOI 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E; Oh EJ, 2003, LEUKEMIA RES, V27, P903, DOI 10.1016/S0145-2126(03)00026-2; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poirot M, 2012, CURR OPIN PHARMACOL, V12, P683, DOI 10.1016/j.coph.2012.09.007; Prat A, 2012, BREAST CANCER RES TR, V135, P301, DOI 10.1007/s10549-012-2143-0; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sanga S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-59; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105	31	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103514	10.1371/journal.pone.0103514	http://dx.doi.org/10.1371/journal.pone.0103514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076125	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800058
J	Hui, FL; Ren, YC; Chen, L; Li, Y; Zhang, L; Niu, QH				Hui, Fengli; Ren, Yongcheng; Chen, Liang; Li, Ying; Zhang, Lin; Niu, Qiuhong			Molecular Phylogenetic Analysis Reveals the New Genus Hemisphaericaspora of the Family Debaryomycetaceae	PLOS ONE			English	Article							XYLOSE-FERMENTING YEAST; SP-NOV.; ASCOMYCETOUS YEASTS; WOOD; GENERA; SUBSTITUTIONS; BEETLES; GUT; DNA	Four strains of a novel ascomycetous yeast species were recovered from the frass of wood-boring beetles collected from the Baotianman Nature Reserve and the Laojieling Nature Reserve in Henan Province, China. This species produced unconjugated and deliquescent asci with hemispheroid or helmet-shaped ascospores. Analysis of gene sequences for the D1/D2 domain of the large subunit (LSU) rRNA, as well as analysis of concatenated gene sequences for the nearly complete small subunit (SSU) rRNA and D1/D2 domain of the large subunit (LSU) rRNA placed the novel species in a small clade including only one recognised species, Candida insectamans, in the family Debaryomycetaceae (Saccharomycotina, Ascomycota). DNA sequence analyses demonstrated that the novel species was distinct from all currently recognised teleomorphic yeast genus. The name Hemisphaericaspora nanyangensis gen nov., sp. nov. is proposed to accommodate the novel genus and species. The new genus can be distinguished from closely related teleomorphic genera Lodderomyces and Spathaspora through sequence comparison and ascospore morphology. The ex-type strain of H. nanyangensis is CBS 13020(T) (= CICC 33021 = NYNU 13717). Furthermore, based on phenotypic and genotypic characteristics, C. insectamans is transferred to the newly described genus as Hemisphaericaspora insectamans comb. nov., in accordance with the changes in the International Code of Nomenclature for algae, fungi and plants.	[Hui, Fengli; Ren, Yongcheng; Chen, Liang; Li, Ying; Zhang, Lin; Niu, Qiuhong] Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang, Peoples R China	Nanyang Normal College	Hui, FL (corresponding author), Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang, Peoples R China.	huifl@126.com		liang, CHEN/0000-0001-7429-4505	National Natural Science Foundation of China [31370073]; Research Planning Project of Basic and Advanced Technology of Henan Province, China [122300410032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Planning Project of Basic and Advanced Technology of Henan Province, China	This work was supported by the National Natural Science Foundation of China (31370073) and the Research Planning Project of Basic and Advanced Technology of Henan Province, China (122300410032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbogbo FK, 2008, BIOTECHNOL LETT, V30, P1515, DOI 10.1007/s10529-008-9728-z; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARNETT JA, 2000, YEASTS CHARACTERISTI; Cadete RM, 2013, ANTON LEEUW INT J G, V103, P421, DOI 10.1007/s10482-012-9822-z; Cadete RM, 2009, FEMS YEAST RES, V9, P1338, DOI 10.1111/j.1567-1364.2009.00582.x; Chen L, 2013, INT J SYST EVOL MICR, V63, P3501, DOI 10.1099/ijs.0.053686-0; Dlauchy D, 2011, ANTON LEEUW INT J G, V99, P619, DOI 10.1007/s10482-010-9534-1; Hui FL, 2013, ANTON LEEUW INT J G, V103, P899, DOI 10.1007/s10482-012-9871-3; Hui FL, 2013, INT J SYST EVOL MICR, V63, P1174, DOI 10.1099/ijs.0.048637-0; Hui FL, 2012, INT J SYST EVOL MICR, V62, P2805, DOI 10.1099/ijs.0.044214-0; Jindamorakot S, 2007, FEMS YEAST RES, V7, P1409, DOI 10.1111/j.1567-1364.2007.00305.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kurtzman Cletus P., 2006, Mycoscience, V47, P65, DOI 10.1007/s10267-006-0280-1; Kurtzman CP, 2013, FEMS YEAST RES, V13, P23, DOI 10.1111/1567-1364.12006; Kurtzman CP, 2011, ANTON LEEUW INT J G, V99, P13, DOI 10.1007/s10482-010-9505-6; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P887, DOI 10.1016/B978-0-444-52149-1.00078-1; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P561, DOI 10.1016/B978-0-444-52149-1.00044-6; Kurtzman CP, 2010, MYCOSCIENCE, V51, P2, DOI 10.1007/s10267-009-0011-5; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P987, DOI 10.1016/B978-0-444-52149-1.00090-2; Nguyen NH, 2006, MYCOL RES, V110, P1232, DOI 10.1016/j.mycres.2006.07.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith MT, 2012, IMA FUNGUS, V3, P179, DOI 10.5598/imafungus.2012.03.02.10; Sugita T, 1999, SYST APPL MICROBIOL, V22, P79, DOI 10.1016/S0723-2020(99)80030-7; Suh SO, 2003, MOL ECOL, V12, P3137, DOI 10.1046/j.1365-294X.2003.01973.x; Suh SO, 2013, INT J SYST EVOL MICR, V63, P4330, DOI 10.1099/ijs.0.053009-0; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urbina H, 2013, FUNGAL ECOL, V6, P339, DOI 10.1016/j.funeco.2013.06.005; VANDERWALT JP, 1972, MYCOPATH MYCOL APPL, V47, P221; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	35	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103737	10.1371/journal.pone.0103737	http://dx.doi.org/10.1371/journal.pone.0103737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075963	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800076
J	Melville, J; Smith, K; Hobson, R; Hunjan, S; Shoo, L				Melville, Jane; Smith, Katie; Hobson, Rod; Hunjan, Sumitha; Shoo, Luke			The Role of Integrative Taxonomy in the Conservation Management of Cryptic Species: The Taxonomic Status of Endangered Earless Dragons (Agamidae: Tympanocryptis) in the Grasslands of Queensland, Australia	PLOS ONE			English	Article							DARLING DOWNS; EASTERN; INFERENCE; REPTILIA; GENETICS; LIZARDS; DNA	Molecular phylogenetics is increasingly highlighting the prevalence of cryptic species, where morphologically similar organisms have long independent evolutionary histories. When such cryptic species are known to be declining in numbers and are at risk of extinction due to a range of threatening processes, the disjunction between molecular systematics research and conservation policy becomes a significant problem. We investigate the taxonomic status of Tympanocryptis populations in Queensland, which have previously been assigned to T. tetraporophora, using three species delimitation approaches. The taxonomic uncertainties in this species-group are of particular importance in the Darling Downs Earless Dragon (T. cf. tetraporophora), which is ranked as an endangered 'species' of high priority for conservation by the Queensland Department of Environment and Heritage Protection. We undertook a morphological study, integrated with a comprehensive genetic study and species delimitation analyses, to investigate the species status of populations in the region. Phylogenetic analyses of two gene regions (mtDNA: ND2; nuclear: RAG1) revealed high levels of genetic divergence between populations, indicating isolation over long evolutionary time frames, and strongly supporting two independent evolutionary lineages in southeastern Queensland, from the Darling Downs, and a third in the Gulf Region of northern Queensland. Of the three species delimitation protocols used, we found integrative taxonomy the most applicable to this cryptic species complex. Our study demonstrates the utility of integrative taxonomy as a species delimitation approach in cryptic complexes of species with conservation significance, where limited numbers of specimens are available.	[Melville, Jane; Smith, Katie; Hunjan, Sumitha] Museum Victoria, Dept Sci, Melbourne, Vic, Australia; [Hobson, Rod] Queensland Parks & Wildlife Serv, Toowoomba, Qld, Australia; [Shoo, Luke] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	Museum Victoria; University of Queensland	Melville, J (corresponding author), Museum Victoria, Dept Sci, Melbourne, Vic, Australia.	jmelv@museum.vic.gov.au	Smith, Katie Elizabeth/GXH-2114-2022; Shoo, Luke P/A-2715-2009	Melville, Jane/0000-0002-9994-6423	Pittsworth District Landcare Assn Inc; Mt Tyson District Landcare Group; Australian Research Council Discovery [DP0452082]	Pittsworth District Landcare Assn Inc; Mt Tyson District Landcare Group; Australian Research Council Discovery(Australian Research Council)	Funding provided to JM by Pittsworth District Landcare Assn Inc and Mt Tyson District Landcare Group (www.pittsworthlandcare.com) and to JM by an Australian Research Council Discovery grant (DP0452082) www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin JJ, 2006, MOL ECOL NOTES, V6, P1089, DOI 10.1111/j.1471-8286.2006.01443.x; Covacevich J. A., 1998, Memoirs of the Queensland Museum, V42, P475; Greer A.E., 1989, BIOL EVOLUTION AUSTR; Harris P.S., 1999, CENTRAL DARLING DOWN; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Melville J, 2011, MOL PHYLOGENET EVOL, V58, P257, DOI 10.1016/j.ympev.2010.11.025; Melville J, 2007, CONSERV GENET, V8, P185, DOI 10.1007/s10592-006-9161-6; Melville J, 2009, MOL PHYLOGENET EVOL, V52, P898, DOI 10.1016/j.ympev.2008.12.027; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; MITCHELL FRANCIS J., 1948, REC S AUSTRAL MUS, V9, P57; Nylander JAA., 2004, BIOINFORMATICS; Rambaut A, 2007, TRACER V 1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Silcock RG, 2007, TROP GRASSLANDS, V41, P154; Smith WJS, 1999, AUST J ZOOL, V47, P551, DOI 10.1071/ZO99028; Solis R, 2013, Complete Guide to Physical Security, P175; Starr CR, 2006, J WILDLIFE MANAGE, V70, P897, DOI 10.2193/0022-541X(2006)70[897:HUBTDD]2.0.CO;2; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880	22	16	22	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e101847	10.1371/journal.pone.0101847	http://dx.doi.org/10.1371/journal.pone.0101847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076129	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800008
J	Iga, M; Nakaoka, T; Suzuki, Y; Kataoka, H				Iga, Masatoshi; Nakaoka, Takayoshi; Suzuki, Yutaka; Kataoka, Hiroshi			Pigment Dispersing Factor Regulates Ecdysone Biosynthesis via Bombyx Neuropeptide G Protein Coupled Receptor-B2 in the Prothoracic Glands of Bombyx mori	PLOS ONE			English	Article							IMMUNOREACTIVE NEURONS; DEVELOPMENTAL PROFILE; KINASE ERK; HORMONE; SILKWORM; ECDYSTEROIDOGENESIS; STIMULATION; PEPTIDES; PDF; HEMOLYMPH	Ecdysone is the key hormone regulating insect growth and development. Ecdysone synthesis occurs in the prothoracic glands (PGs) and is regulated by several neuropeptides. Four prothoracicotropic and three prothoracicostatic factors have been identified to date, suggesting that ecdysone biosynthesis is intricately regulated. Here, we demonstrate that the neuropeptide pigment dispersing factor (PDF) stimulates ecdysone biosynthesis and that this novel signaling pathway partially overlaps with the prothoracicotropic hormone (PTTH) signaling pathway. We performed transcriptome analysis and focused on receptors predominantly expressed in the PGs. From this screen, we identified a candidate orphan G protein coupled receptor (GPCR), Bombyx neuropeptide GPCR-B2 (BNGR-B2). BNGR-B2 was predominantly expressed in ecdysteroidogenic tissues, and the expression pattern in the PGs corresponded to the ecdysteroid titer in the hemolymph. Furthermore, we identified PDF as a ligand for BNGR-B2. PDF stimulated ecdysone biosynthesis in the PGs, but the stimulation was only observed in the PGs during a specific larval stage. PDF did not affect the transcript level of known ecdysone biosynthetic enzymes, and inhibiting transcription did not suppress ecdysone biosynthesis, suggesting that the effects of PDF might be mediated by translational regulation and/or post-translational modification. In addition, the participation of protein kinase A (PKA), phosphatidylinositol 3-kinase (PI3K), target of rapamycin (TOR) and eukaryotic translation initiation factor 4E (eIF4E)-binding protein (4E-BP) in the PDF signaling pathway was discovered.	[Iga, Masatoshi; Nakaoka, Takayoshi; Suzuki, Yutaka; Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan	University of Tokyo	Iga, M (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	masatoshiiga@ib.k.u-tokyo.ac.jp; kataoka@k.u-tokyo.ac.jp			Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japan Society for the Promotion of Science [19380034]	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to H. K. (Grant# 19380034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARROW GM, 1981, P NATL ACAD SCI-BIOL, V78, P5866, DOI 10.1073/pnas.78.9.5866; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gilbert Lawrence I., 1997, Invertebrate Neuroscience, V3, P205, DOI 10.1007/BF02480376; Gu SH, 1998, INSECT BIOCHEM MOLEC, V28, P861, DOI 10.1016/S0965-1748(98)00074-5; Gu SH, 2012, INSECT BIOCHEM MOLEC, V42, P296, DOI 10.1016/j.ibmb.2011.12.010; Hamanaka Y, 2005, J COMP NEUROL, V491, P390, DOI 10.1002/cne.20712; HelfrichForster C, 1997, J COMP NEUROL, V380, P335, DOI 10.1002/(SICI)1096-9861(19970414)380:3<335::AID-CNE4>3.0.CO;2-3; Hikiba J, 2013, J CHROMATOGR B, V915, P52, DOI 10.1016/j.jchromb.2012.12.014; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Iga M, 2012, BIOL PHARM BULL, V35, P838, DOI 10.1248/bpb.35.838; Kagawa N, 1999, DRUG METAB REV, V31, P333, DOI 10.1081/DMR-100101921; Kaneko Y, 2006, ZOOL SCI, V23, P533, DOI 10.2108/zsj.23.533; Kanematsu S, 2014, GENE, V533, P520, DOI 10.1016/j.gene.2013.08.005; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; KEIGHTLEY DA, 1990, MOL CELL ENDOCRINOL, V74, P229, DOI 10.1016/0303-7207(90)90228-Z; Koyama T, 2004, J INSECT PHYSIOL, V50, P123, DOI 10.1016/j.jinsphys.2003.09.009; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lin JL, 2007, J INSECT PHYSIOL, V53, P622, DOI 10.1016/j.jinsphys.2007.03.004; Meelkop E, 2011, PROG NEUROBIOL, V93, P125, DOI 10.1016/j.pneurobio.2010.10.004; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Mizoguchi A, 2001, INSECT BIOCHEM MOLEC, V31, P349, DOI 10.1016/S0965-1748(00)00127-2; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Persson MGS, 2001, J NEUROBIOL, V48, P19, DOI 10.1002/neu.1040; RAO KR, 1993, ANN NY ACAD SCI, V680, P78, DOI 10.1111/j.1749-6632.1993.tb19676.x; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Rewitz KF, 2009, INSECT BIOCHEM MOLEC, V39, P475, DOI 10.1016/j.ibmb.2009.04.005; RYBCZYNSKI R, 1994, INSECT BIOCHEM MOLEC, V24, P175, DOI 10.1016/0965-1748(94)90084-1; Rybczynski R, 2001, MOL CELL ENDOCRINOL, V184, P1, DOI 10.1016/S0303-7207(01)00664-5; Sakurai S, 1998, J INSECT PHYSIOL, V44, P867, DOI 10.1016/S0022-1910(98)00075-4; SMITH WA, 1985, MOL CELL ENDOCRINOL, V39, P71, DOI 10.1016/0303-7207(85)90093-0; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tanaka Yoshiaki, 2011, Front Endocrinol (Lausanne), V2, P107, DOI 10.3389/fendo.2011.00107; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Watanabe K, 2007, MOL CELL ENDOCRINOL, V273, P51, DOI 10.1016/j.mce.2007.05.008; Yamanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P2808, DOI 10.1271/bbb.70420; Yamanaka N, 2011, J COMP NEUROL, V519, P238, DOI 10.1002/cne.22517; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384	42	31	32	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103239	10.1371/journal.pone.0103239	http://dx.doi.org/10.1371/journal.pone.0103239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072638	Green Submitted, Green Published, gold			2022-12-27	WOS:000341307600032
J	Kandra, KL; Ranney, LM; Lee, JGL; Goldstein, AO				Kandra, Kelly L.; Ranney, Leah M.; Lee, Joseph G. L.; Goldstein, Adam O.			Physicians' Attitudes and Use of E-Cigarettes as Cessation Devices, North Carolina, 2013	PLOS ONE			English	Article							SMOKING-CESSATION; ELECTRONIC CIGARETTES; CALL	Introduction: Electronic cigarettes (e-cigarettes) are not currently approved or recommended by the Food and Drug Administration (FDA) or various medical organizations; yet, they appear to play a substantial role in tobacco users' cessation attempts. This study reports on a physician survey that measured beliefs, attitudes, and behavior related to e-cigarettes and smoking cessation. To our knowledge this is the first study to measure attitudes toward e-cigarettes among physicians treating adult smokers. Methods: Using a direct marketing company, a random sample of 787 North Carolina physicians were contacted in 2013 through email, with 413 opening the email and 128 responding (response rate = 31%). Physicians' attitudes towards e-cigarettes were measured through a series of close-ended questions. Recommending e-cigarettes to patients served as the outcome variable for a logistic regression analysis. Results: Two thirds (67%) of the surveyed physicians indicated e-cigarettes are a helpful aid for smoking cessation, and 35% recommended them to their patients. Physicians were more likely to recommend e-cigarettes when their patients asked about them or when the physician believed e-cigarettes were safer than smoking standard cigarettes. Conclusions: Many North Carolina physicians are having conversations about e-cigarettes with their patients, and some are recommending them. Future FDA regulation of e-cigarettes may help provide evidence-based guidance to physicians about e-cigarettes and will help ensure that patients receive evidence-based recommendations about the safety and efficacy of e-cigarettes in tobacco cessation.	[Kandra, Kelly L.] Benedictine Univ, Dept Psychol, Lisle, IL 60532 USA; [Ranney, Leah M.; Goldstein, Adam O.] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA; [Lee, Joseph G. L.] Univ N Carolina, Dept Family Med & Hlth Behav, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kandra, KL (corresponding author), Benedictine Univ, Dept Psychol, Lisle, IL 60532 USA.	kkandra@ben.edu		Lee, Joseph/0000-0001-9698-649X	North Carolina Department of Health and Human Services (NC DHHS); National Cancer Institute of the National Institutes of Health (NIH) [1P50CA180907-01]; NATIONAL CANCER INSTITUTE [P50CA180907] Funding Source: NIH RePORTER	North Carolina Department of Health and Human Services (NC DHHS); National Cancer Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by the North Carolina Department of Health and Human Services (NC DHHS, URL: http://www.ncdhhs.gov/) and Award Number 1P50CA180907-01 from the National Cancer Institute of the National Institutes of Health (NIH, URL: http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NC DHHS or NIH.	American Lung Association, AM LUNG ASS STAT CIG; American Medical Association, 2014, AMA STRENGTH POS REG; American Medical Association, H 490 909 US EL CIG; Bourque L.B., 2003, CONDUCT SELF ADM MAI; Caponnetto P, 2012, EXPERT REV RESP MED, V6, P63, DOI [10.1586/ers.11.92, 10.1586/ERS.11.92]; Center for Public Health and Tobacco Policy, E CIG FACT SHEET; Fiore MC, 2008, TREATING TOBACCO USE; Folan P, AM THORACIC SOC SERI; Foulds J, 2011, INT J CLIN PRACT, V65, P1037, DOI 10.1111/j.1742-1241.2011.02751.x; Hampton T, 2014, JAMA-J AM MED ASSOC, V311, P123, DOI 10.1001/jama.2013.285292; McLeod CC, 2013, EVAL HEALTH PROF, V36, P106, DOI 10.1177/0163278712474001; Mills EJ, 2012, ANN MED, V44, P588, DOI 10.3109/07853890.2012.705016; Palazzolo Dominic L, 2013, Front Public Health, V1, P56, DOI 10.3389/fpubh.2013.00056; Pepper JK, 2014, TOB CONTROL, V23, P375, DOI 10.1136/tobaccocontrol-2013-051122; Pepper JK, 2014, J ADOLESCENT HEALTH, V54, P678, DOI 10.1016/j.jadohealth.2013.10.001; Pokhrel P, 2013, AM J PUBLIC HEALTH, V103, pE57, DOI 10.2105/AJPH.2013.301453; Regan AK, 2013, TOB CONTROL, V22, P19, DOI 10.1136/tobaccocontrol-2011-050044; Schnoll RA, 2006, AM J PREV MED, V31, P233, DOI 10.1016/j.amepre.2006.05.001; Shih TH, 2009, EDUC RES REV-NETH, V4, P26, DOI 10.1016/j.edurev.2008.01.003; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; Williams RJ, 2014, AM J MANAG CARE, V20, pE82; Zhu SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079332, 10.1371/journal.pone.0071555]	22	75	75	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103462	10.1371/journal.pone.0103462	http://dx.doi.org/10.1371/journal.pone.0103462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KU	25072466	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600051
J	Frew, L; Makieva, S; McKinlay, ATM; McHugh, BJ; Doust, A; Norman, JE; Davidson, DJ; Stock, SJ				Frew, Lorraine; Makieva, Sofia; McKinlay, Andrew T. M.; McHugh, Brian J.; Doust, Ann; Norman, Jane E.; Davidson, Donald J.; Stock, Sarah J.			Human Cathelicidin Production by the Cervix	PLOS ONE			English	Article							DEFENSE PEPTIDE LL-37; RECEPTOR-LIKE 1; VITAMIN-D DEFICIENCY; P2X(7) RECEPTOR; GROWTH-FACTOR; PLASMA-LEVEL; ACTIVATION; EXPRESSION; PREGNANCY; PATHWAYS	hCAP18/LL-37 is the sole human cathelicidin; a family of host defence peptides with key roles in innate host defence. hCAP18/LL-37 is expressed primarily by neutrophils and epithelial cells, but its production and function in the lower genital tract is largely uncharacterised. Despite the significant roles for cathelicidin in multiple organs and inflammatory processes, its impact on infections that could compromise fertility and pregnancy is unknown. The aim of this study was to investigate cathelicidin production, regulation and function in the cervix. hCAP18/LL-37 was found to be present in cervicovaginal secretions collected from women in the first trimester of pregnancy and to be expressed at significantly higher levels in samples from women with alterations in vaginal bacterial flora characteristic of bacterial vaginosis. In endocervical epithelial cell lines, expression of the gene encoding hCAP18/LL-37 (CAMP) was not affected by TLR agonists, but was found to be upregulated by both 1, 25 hydroxyvitamin D-3 and 25 hydroxyvitamin D-3 . However, no association was found between serum levels of vitamin D and hCAP18/LL-37 concentrations in cervicovaginal secretions (n = 116). Exposure to synthetic LL-37 had a pro-inflammatory effect on endocervical epithelial cell lines, increasing secretion of inflammatory cytokine IL-8. Together these data demonstrate inducible expression of hCAP18/LL-37 in the female lower reproductive tract in vivo and suggest the capacity for this peptide to modulate host defence to infection in this system. Further investigation will elucidate the effects of hCAP18/LL-37 on the physiology and pathophysiology of labour, and may lead to strategies for the prevention of infection-associated preterm birth.	[Frew, Lorraine; Makieva, Sofia; McKinlay, Andrew T. M.; Doust, Ann; Norman, Jane E.; Stock, Sarah J.] Univ Edinburgh, MRC Ctr Reprod Hlth, Tommys Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland; [McHugh, Brian J.; Davidson, Donald J.] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Stock, SJ (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Tommys Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland.	sarah.stock@ed.ac.uk	McKinlay, Andrew T. M./B-3613-2010	McKinlay, Andrew T. M./0000-0002-5639-3267; Norman, Jane/0000-0001-6031-6953; McHugh, Brian/0000-0003-4747-0643; Makieva, Sofia/0000-0001-6143-3553	Academy of Medical Sciences [R41286]; Jennifer Brown Research Laboratory [D20309]; MRC Senior Non-clinical Fellowship [G1002046]; Medical Research Council [G1002046, G0901697, G1002033] Funding Source: researchfish; MRC [G1002033, G1002046, G0901697] Funding Source: UKRI	Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Jennifer Brown Research Laboratory; MRC Senior Non-clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by grants from the Academy of Medical Sciences (R41286) and the Jennifer Brown Research Laboratory (D20309) to JEN and SJS, with infrastructure support from Tommy's Centre for Maternal and Fetal Health (R40738). DJD is supported by a MRC Senior Non-clinical Fellowship (G1002046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Barlow PG, 2006, J LEUKOCYTE BIOL, V80, P509, DOI 10.1189/jlb.1005560; Beaumont PE, 2013, LL 37 IMMUNOMODULATO; Bhan I, 2011, J ALLERGY CLIN IMMUN, V127, P1302, DOI 10.1016/j.jaci.2010.12.1097; Byfield FJ, 2011, AM J PHYSIOL-CELL PH, V300, pC105, DOI 10.1152/ajpcell.00158.2010; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Dixon Brian M, 2012, BMC Res Notes, V5, P575, DOI 10.1186/1756-0500-5-575; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Erdag G, 2002, ANN SURG, V235, P113, DOI 10.1097/00000658-200201000-00015; Gombart AF, 2009, CLIN INFECT DIS, V48, P418, DOI 10.1086/596314; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Haggarty P, 2013, BRIT J NUTR, V109, P898, DOI 10.1017/S0007114512002255; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Havelka AM, 2010, ACTA PAEDIATR, V99, P836, DOI 10.1111/j.1651-2227.2010.01726.x; Hertting O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015580; Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28; Johnson DD, 2011, AM J PERINAT, V28, P7, DOI 10.1055/s-0030-1262505; Kaewsrichan J, 2006, FEMS IMMUNOL MED MIC, V48, P75, DOI 10.1111/j.1574-695X.2006.00124.x; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Lau YE, 2005, INFECT IMMUN, V73, P583, DOI 10.1128/IAI.73.1.583-591.2005; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Levinson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031996; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu Q, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-15; McAree T, 2013, MATERN CHILD NUTR, V9, P23, DOI 10.1111/mcn.12014; Mitchell C, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.019; Montreekachon P, 2011, J PERIODONTAL RES, V46, P327, DOI 10.1111/j.1600-0765.2011.01346.x; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; National Collaborating Centre for Ws and Children's H, 2008, ANT CAR ROUT CAR HLT; Nell MJ, 2004, FEMS IMMUNOL MED MIC, V42, P225, DOI 10.1016/j.femsim.2004.05.013; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Ruiz-Gonzalez V, 2009, INT J DERMATOL, V48, P846, DOI 10.1111/j.1365-4632.2008.03924.x; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Stock SJ, 2009, REPROD SCI, V16, P1125, DOI 10.1177/1933719109341998; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Toher C, 2013, J HUM NUTR DIET; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wantha S, 2013, CIRC RES, V112, P792, DOI 10.1161/CIRCRESAHA.112.300666; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147	51	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103434	10.1371/journal.pone.0103434	http://dx.doi.org/10.1371/journal.pone.0103434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089904	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700026
J	Ruano, EG; Canivell, S; Vieira, E				Ruano, Elena G.; Canivell, Silvia; Vieira, Elaine			REV-ERB ALPHA Polymorphism Is Associated with Obesity in the Spanish Obese Male Population	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; CLOCK GENE; TRANSCRIPTION FACTOR; METABOLIC SYNDROME; EXPRESSION; SUSCEPTIBILITY; CORTISOL; LEPTIN; IMPACT; BMAL1	REV-ERB ALPHA has been shown to link metabolism with circadian rhythms. We aimed to identify new polymorphisms in the promoter of REV-ERB ALPHA and tested whether these polymorphisms could be associated with obesity in the Spanish population. Of the 1197 subjects included in our study, 779 were obese (BMI 34.38 +/- 3.1 kg/m(2)) and 418 lean (BMI 23.27 +/- 1.5 kg/m(2)). In the obese group, 469 of the 779 had type 2 diabetes. Genomic DNA from all the subjects was obtained from peripheral blood cells and the genotyping in the REV-ERB ALPHA promoter was analyzed by High Resolution Melting. We found six polymorphisms in the REV-ERB ALPHA promoter and identified rs939347 as a SNP with the highest frequency in the total population. We did not find any association between rs939347 and type 2 diabetes (p = 0.101), but rs939347 was associated with obesity (p = 0.036) with the genotype AA exhibiting higher frequency in the obese (5.2% in total obese vs 2.4% in lean). This association was found only in men (p = 0.031; 6.5% AA-carriers in obese men vs 1.9% AA-carriers in lean men), with no association found in the female population (p = 0.505; 4.4% AA-carriers in obese women vs 2.7% AA-carriers in lean women). Our results suggest that the REV-ERB ALPHA rs939347 polymorphism could modulate body fat mass in men. The present work supports the role of REV-ERB ALPHA in the development of obesity as well as a potential target for the treatment of obesity.	[Ruano, Elena G.; Vieira, Elaine] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain; [Ruano, Elena G.; Canivell, Silvia; Vieira, Elaine] IDIBAPS, Diabet & Obes Res Lab, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Vieira, E (corresponding author), CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain.	evieira@ciberdem.org	Vieira, Elaine/F-7273-2019; Vieira, Elaine/AAG-1127-2020	Vieira, Elaine/0000-0002-0621-9367; Vieira, Elaine/0000-0002-0621-9367; Canivell, Silvia/0000-0002-0280-5035	EC [279171]; Spanish Ministry of Science and Innovation [SAF 2010-19527]; CIBER de Diabetes y Enfermedades Metabolicas	EC(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBER de Diabetes y Enfermedades Metabolicas	This work was supported by the EC Seventh Framework Programme theme FP7-HEALTH-2011 (279171), Spanish Ministry of Science and Innovation (SAF 2010-19527), and CIBER de Diabetes y Enfermedades Metabolicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Barbadoro P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063289; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben Ali S, 2009, CLIN BIOCHEM, V42, P1642, DOI 10.1016/j.clinbiochem.2009.08.019; Buss J, 2012, WORKPLACE HEALTH SAF, V60, P453, DOI 10.3928/21650799-20120926-66; Butun I, 2013, BRATISL MED J, V114, P129, DOI 10.4149/BLL_2013_028; CHAWLA A, 1993, J BIOL CHEM, V268, P16265; Corbalan-Tutau D, 2014, PHYSIOL BEHAV, V123, P231, DOI 10.1016/j.physbeh.2012.06.005; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Galbete C, 2012, CHRONOBIOL INT, V29, P1397, DOI 10.3109/07420528.2012.728657; Garaulet M, 2014, MOL NUTR FOOD RES, V58, P821, DOI 10.1002/mnfr.201300361; Garaulet M, 2009, AM J CLIN NUTR, V90, P1466, DOI 10.3945/ajcn.2009.27536; Goumidi L, 2013, INT J OBESITY, V37, P666, DOI 10.1038/ijo.2012.117; Hemmeryckx B, 2011, OBESITY, V19, P659, DOI 10.1038/oby.2010.266; Husse J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052983; Laitinen S, 2005, BIOCHIMIE, V87, P21, DOI 10.1016/j.biochi.2004.12.006; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lardone P, 2013, CURR PHARM DES; Mantele S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037123; Migita H, 2004, FEBS LETT, V561, P69, DOI 10.1016/S0014-5793(04)00118-8; Praveen EP, 2011, DIABET METAB SYND OB, V4, P347, DOI 10.2147/DMSO.S23915; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Severino G, 2009, BIPOLAR DISORD, V11, P215, DOI 10.1111/j.1399-5618.2009.00667.x; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Stratmann M, 2012, CELL METAB, V15, P791, DOI 10.1016/j.cmet.2012.05.006; Travison TG, 2007, CLIN ENDOCRINOL, V67, P71, DOI 10.1111/j.1365-2265.2007.02837.x; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vieira E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069939; Vieira E, 2012, ENDOCRINOLOGY, V153, P592, DOI 10.1210/en.2011-1595; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; who, WHO OB OV; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	40	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104065	10.1371/journal.pone.0104065	http://dx.doi.org/10.1371/journal.pone.0104065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089907	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700092
J	Sivanandhan, G; Selvaraj, N; Ganapathi, A; Manickavasagam, M				Sivanandhan, Ganeshan; Selvaraj, Natesan; Ganapathi, Andy; Manickavasagam, Markandan			Enhanced Biosynthesis of Withanolides by Elicitation and Precursor Feeding in Cell Suspension Culture of Withania somnifera (L.) Dunal in Shake-Flask Culture and Bioreactor	PLOS ONE			English	Article							PHENYLETHANOID GLYCOSIDES; SECONDARY METABOLITES; METHYL JASMONATE; ROOT CULTURES; WITHAFERIN; ACCUMULATION; STRATEGIES; PATHWAYS; GROWTH	The present study investigated the biosynthesis of major and minor withanolides of Withania somnifera in cell suspension culture using shake-flask culture and bioreactor by exploiting elicitation and precursor feeding strategies. Elicitors like cadmium chloride, aluminium chloride and chitosan, precursors such as cholesterol, mevalonic acid and squalene were examined. Maximum total withanolides detected [withanolide A (7606.75 mg), withanolide B (4826.05 mg), withaferin A (3732.81 mg), withanone (6538.65 mg), 12 deoxy withanstramonolide (3176.63 mg), withanoside IV (2623.21 mg) and withanoside V (2861.18 mg)] were achieved in the combined treatment of chitosan (100 mg/l) and squalene (6 mM) along with 1 mg/l picloram, 0.5 mg/l KN, 200 mg/l L-glutamine and 5% sucrose in culture at 4 h and 48 h exposure times respectively on 28th day of culture in bioreactor. We obtained higher concentrations of total withanolides in shake-flask culture (2.13-fold) as well as bioreactor (1.66-fold) when compared to control treatments. This optimized protocol can be utilized for commercial level production of withanolides from suspension culture using industrial bioreactors in a short culture period.	[Sivanandhan, Ganeshan; Ganapathi, Andy; Manickavasagam, Markandan] Bharathidasan Univ, Sch Life Sci, Dept Biotechnol & Genet Engn, Tiruchirappalli 620017, Tamil Nadu, India; [Selvaraj, Natesan] Govt Arts Coll, Kulithalai, Tamil Nadu, India	Bharathidasan University	Sivanandhan, G (corresponding author), Bharathidasan Univ, Sch Life Sci, Dept Biotechnol & Genet Engn, Tiruchirappalli 620017, Tamil Nadu, India.	gsivabdu@gmail.com; manickbiotech@gmail.com	Sivanandhan, Ganeshan/H-8864-2015	Sivanandhan, Ganeshan/0000-0001-7917-2371	Council of Scientific and Industrial Research (CSIR) [38(1180/08/EMR-II)]; University Grants Commission (UGC), Government of India; Council of Scientific and Industrial Research (CSIR), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), Government of India(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by Council of Scientific and Industrial Research (CSIR) [38(1180/08/EMR-II)]. Prof. A. Ganapathi is thankful to the University Grants Commission (UGC), Government of India, for the award of UGC-BSR (Basic Scientific Research Fellowship). The first author thankfully acknowledges the Council of Scientific and Industrial Research (CSIR), Government of India, for the award of CSIR SRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, BIOTECHNOL BIOPROC E, DOI [DOI 10.1007/BF02933747, 10.1007/BF02933747]; Baldi A, 2008, APPL BIOCHEM BIOTECH, V151, P556, DOI 10.1007/s12010-008-8231-2; Baldi A, 2008, BIORESOURCE TECHNOL, V99, P4609, DOI 10.1016/j.biortech.2007.06.061; Bourgaud F, 2001, PLANT SCI, V161, P839, DOI 10.1016/S0168-9452(01)00490-3; Cardellina JH, 2002, J NAT PROD, V65, P1073, DOI 10.1021/np0200515; Chaurasiya ND, 2012, PLANT CELL REP, V31, P1889, DOI 10.1007/s00299-012-1302-4; Ciddi Veeresham, 2006, Indian Journal of Pharmaceutical Sciences, V68, P490; Dias LLC, 2009, PLANT CELL TISS ORG, V99, P199, DOI 10.1007/s11240-009-9594-y; DORNENBURG H, 1995, ENZYME MICROB TECH, V17, P674, DOI 10.1016/0141-0229(94)00108-4; Flores-Sanchez IJ, 2002, PLANT CELL PHYSIOL, V43, P1502, DOI 10.1093/pcp/pcf181; Khan S, 2009, VACCINE, V27, P6080, DOI 10.1016/j.vaccine.2009.07.011; Krzyzanowska J, 2012, PLANT CELL TISS ORG, V108, P73, DOI 10.1007/s11240-011-0014-8; Ku SK, 2014, VASC PHARMACOL, V60, P120, DOI 10.1016/j.vph.2014.01.009; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Liu JY, 2007, BIOCHEM ENG J, V33, P88, DOI 10.1016/j.bej.2006.09.002; Lucumi E, 2002, PLANT CELL TISS ORG, V68, P293, DOI 10.1023/A:1013993403959; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Malik F, 2007, LIFE SCI, V80, P1525, DOI 10.1016/j.lfs.2007.01.029; Mishra B, 2014, PROTOPLASMA, V251, P1031, DOI 10.1007/s00709-014-0613-4; Mishra L C, 2000, Altern Med Rev, V5, P334; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mustafa NR, 2011, NAT PROTOC, V6, P715, DOI 10.1038/nprot.2010.144; Nagella P, 2011, PLANT CELL TISS ORG, V104, P119, DOI 10.1007/s11240-010-9799-0; Nagella P, 2010, BIORESOURCE TECHNOL, V101, P6735, DOI 10.1016/j.biortech.2010.03.078; Ouyang J, 2005, PROCESS BIOCHEM, V40, P3480, DOI 10.1016/j.procbio.2005.02.025; Patil JG, 2013, APPL MICROBIOL BIOT, V97, P2379, DOI 10.1007/s00253-012-4489-y; Rao RS, 2002, BIOTECHNOL ADV, V20, P1; Rhee HS, 2010, PLANT CELL TISS ORG, V101, P295, DOI 10.1007/s11240-010-9688-6; Sabir F, 2012, J PLANT GROWTH REGUL, V31, P537, DOI 10.1007/s00344-012-9264-x; Sabir F, 2011, PLANT BIOTECHNOL REP, V5, P127, DOI 10.1007/s11816-011-0165-4; Sangwan RS, 2008, PHYSIOL PLANTARUM, V133, P278, DOI 10.1111/j.1399-3054.2008.01076.x; Sangwan RS, 2004, CURR SCI INDIA, V86, P461; Sharada M., 2008, RECENT ADV PLANT BIO, P645; Singh M, 2012, BIOPROC BIOSYST ENG, V35, P943, DOI 10.1007/s00449-012-0679-3; Sivanandhan G, 2012, IND CROP PROD, V37, P124, DOI 10.1016/j.indcrop.2011.11.022; Sivanandhan G, 2013, PROTOPLASMA, V250, P885, DOI 10.1007/s00709-012-0471-x; Sivanandhan G, 2013, PLANT CELL TISS ORG, V114, P121, DOI 10.1007/s11240-013-0297-z; Sivanandhan G, 2012, APPL BIOCHEM BIOTECH, V168, P681, DOI 10.1007/s12010-012-9809-2; Sivanandhan G, 2011, ACTA PHYSIOL PLANT, V33, P2279, DOI 10.1007/s11738-011-0768-y; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Vasconsuelo A, 2007, PLANT SCI, V172, P861, DOI 10.1016/j.plantsci.2007.01.006; Verpoorte R, 1999, BIOTECHNOL LETT, V21, P467, DOI 10.1023/A:1005502632053; Zhang CH, 2007, PLANT SCI, V172, P158, DOI 10.1016/j.plantsci.2006.08.002; Zhang W, 2002, ENZYME MICROB TECH, V30, P688, DOI 10.1016/S0141-0229(02)00041-8; Zhao J, 2005, BIOTECHNOL ADV, V23, P283, DOI 10.1016/j.biotechadv.2005.01.003; Zhao J, 2001, APPL MICROBIOL BIOT, V55, P693, DOI 10.1007/s002530000568; Zhao JL, 2010, APPL MICROBIOL BIOT, V87, P137, DOI 10.1007/s00253-010-2443-4	48	59	60	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104005	10.1371/journal.pone.0104005	http://dx.doi.org/10.1371/journal.pone.0104005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089711	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700079
J	Chettier, R; Ward, K; Albertsen, HM				Chettier, Rakesh; Ward, Kenneth; Albertsen, Hans M.			Endometriosis Is Associated with Rare Copy Number Variants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DISEASE; POPULATION; SOFTWARE; SAMPLE; LOCUS; RISK	Endometriosis is a complex gynecological condition that affects 6-10% of women in their reproductive years and is defined by the presence of endometrial glands and stroma outside the uterus. Twin, family, and genome-wide association (GWA) studies have confirmed a genetic role, yet only a small part of the genetic risk can be explained by SNP variation. Copy number variants (CNVs) account for a greater portion of human genetic variation than SNPs and include more recent mutations of large effect. CNVs, likely to be prominent in conditions with decreased reproductive fitness, have not previously been examined as a genetic contributor to endometriosis. Here we employ a high-density genotyping microarray in a genome-wide survey of CNVs in a case-control population that includes 2,126 surgically confirmed endometriosis cases and 17,974 population controls of European ancestry. We apply stringent quality filters to reduce the false positive rate common to many CNV-detection algorithms from 77.7% to 7.3% without noticeable reduction in the true positive rate. We detected no differences in the CNV landscape between cases and controls on the global level which showed an average of 1.92 CNVs per individual with an average size of 142.3 kb. On the local level we identify 22 CNV-regions at the nominal significance threshold (P<0.05), which is greater than the 8.15 CNV-regions expected based on permutation analysis (P<0.001). Three CNV's passed a genome-wide P-value threshold of 9.3x10(-4); a deletion at SGCZ on 8p22 (P = 7.3x10(-4), OR = 8.5, Cl = 2.3-31.7), a deletion in MALRD1 on 10p12.31 (P = 5.6x10(-4), OR = 14.1, Cl = 2.7-90.9), and a deletion at 11q14.1 (P = 5.7x10(-4), OR = 33.8, Cl = 3.3-1651). Two SNPs within the 22 CNVRs show significant genotypic association with endometriosis after adjusting for multiple testing; rs758316 in DPP6 on 7q36.2 (P = 0.0045) and rs4837864 in ASTN2 on 9q33.1 (P = 0.0002). Together, the CNV-loci are detected in 6.9% of affected women compared to 2.1% in the general population.	[Chettier, Rakesh; Ward, Kenneth; Albertsen, Hans M.] Juneau Biosci LLC, Salt Lake City, UT 84109 USA		Ward, K (corresponding author), Juneau Biosci LLC, Salt Lake City, UT 84109 USA.	kenw@juneaubiosciences.com; halbertsen@juneaubiosciences.com			Juneau Biosciences, LLC	Juneau Biosciences, LLC	This study was funded by Juneau Biosciences, LLC. The funder provided support in the form of salaries for authors RC, KW and HA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albertsen HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058257; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de Arellano ML, 2014, J MOL MED; Dyson MT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004158; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Glessner JT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1346; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Iafrate A, 2004, DATABASE GENOMIC VAR; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Medicine ASfR, 1997, FERTIL STERIL, V67, P817; Mhawech-Fauceglia P, 2013, GYNECOL ONCOL, V130, P174, DOI 10.1016/j.ygyno.2013.03.030; Munksgaard PS, 2012, GYNECOL ONCOL, V124, P164, DOI 10.1016/j.ygyno.2011.10.001; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Nyholt DR, 2012, NAT GENET, V44, P1355, DOI 10.1038/ng.2445; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie ME, 2009, BIOINFORMATICS, V25, P2621, DOI 10.1093/bioinformatics/btp470; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Saare M, 2012, HUM REPROD, V27, P1857, DOI 10.1093/humrep/des125; Satten GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086272; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Sebat J, 2007, NAT GENET, V39, pS3, DOI 10.1038/ng2095; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Stefanson H, 2002, HUM REPROD, V17, P555, DOI 10.1093/humrep/17.3.555; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Treloar SA, 1999, FERTIL STERIL, V71, P701, DOI 10.1016/S0015-0282(98)00540-8; Uno S, 2010, NAT GENET, V42, P707, DOI 10.1038/ng.612; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhao W, 2012, OBESITY, V20, P2431, DOI 10.1038/oby.2012.162	33	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103968	10.1371/journal.pone.0103968	http://dx.doi.org/10.1371/journal.pone.0103968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083881	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800111
J	Da Ros, S; Zorzan, E; Giantin, M; Shahidian, LZ; Palumbo, M; Dacasto, M; Sissi, C				Da Ros, Silvia; Zorzan, Eleonora; Giantin, Mery; Shahidian, Lara Zorro; Palumbo, Manlio; Dacasto, Mauro; Sissi, Claudia			Sequencing and G-Quadruplex Folding of the Canine Proto-Oncogene KIT Promoter Region: Might Dog Be Used as a Model for Human Disease?	PLOS ONE			English	Article							MAST-CELL TUMORS; OF-FUNCTION MUTATIONS; C-KIT; SMALL-MOLECULE; LYMPHOMA; DOMAIN	Downregulation of gene expression by induction of non-canonical DNA structures at promotorial level is a novel attractive anticancer strategy. In human, two guanine-rich sequences (h_kit1 and h_kit2) were identified in the promotorial region of oncogene KIT. Their stabilization into G-quadruplex structures can find applications in the treatment of leukemias, mastocytosis, gastrointestinal stromal tumor, and lung carcinomas which are often associated to c-kit mis-regulation. Also the most common skin cancer in domestic dog, mast cell tumor, is linked to a mutation and/or to an over-expression of c-kit, thus supporting dog as an excellent animal model. In order to assess if the G-quadruplex mediated mechanism of regulation of c-kit expression is conserved among the two species, herein we cloned and sequenced the canine KIT promoter region and we compared it with the human one in terms of sequence and conformational equilibria in physiologically relevant conditions. Our results evidenced a general conserved promotorial sequence between the two species. As experimentally confirmed, this grants that the conformational features of the canine kit1 sequence are substantially shared with the human one. Conversely, two isoforms of the kit2 sequences were identified in the analyzed dog population. In comparison with the human counterpart, both of them showed an altered distribution among several folded conformations.	[Da Ros, Silvia; Palumbo, Manlio; Sissi, Claudia] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, PD, Italy; [Zorzan, Eleonora; Giantin, Mery; Shahidian, Lara Zorro; Dacasto, Mauro] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy	University of Padua; University of Padua	Dacasto, M (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, PD, Italy.	mauro.dacasto@unipd.it; claudia.sissi@unipd.it	Giantin, Mery/AAX-3235-2020	SISSI, CLAUDIA/0000-0002-9713-1415; Zorro Shahidian, Lara/0000-0002-3182-9642; Palumbo, Manlio/0000-0002-3163-1564	Italian Ministry of Education (PRIN) [20105YY2HL]; University of Padova [CPDA114388]	Italian Ministry of Education (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Padova	This research was supported by the Italian Ministry of Education (PRIN 2010-11, code 20105YY2HL) and by University of Padova (grant #CPDA114388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato J, 2011, BIOCONJUGATE CHEM, V22, P654, DOI 10.1021/bc100444v; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bejugam M, 2007, J AM CHEM SOC, V129, P12926, DOI 10.1021/ja075881p; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Boerkamp KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071094; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Castor KJ, 2013, CHEM-EUR J, V19, P17836, DOI 10.1002/chem.201301590; Chauhan A, 2014, BIOORG MED CHEM; D'allard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060961; Dash J, 2008, CHEM COMMUN, P3055, DOI 10.1039/b806042h; Davis JT, 2007, CHEM SOC REV, V36, P296, DOI 10.1039/b600282j; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; Frost D, 2003, VET PATHOL, V40, P42, DOI 10.1354/vp.40-1-42; Giantin M, 2012, J VET DIAGN INVEST, V24, P116, DOI 10.1177/1040638711425945; Gordon I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000161; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Hsueh YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065762; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Jantos K, 2006, J AM CHEM SOC, V128, P13662, DOI 10.1021/ja064713e; Kuryavyi V, 2010, NUCLEIC ACIDS RES, V38, P6757, DOI 10.1093/nar/gkq558; Letard S, 2008, MOL CANCER RES, V6, P1137, DOI 10.1158/1541-7786.MCR-08-0067; London CA, 1999, EXP HEMATOL, V27, P689, DOI 10.1016/S0301-472X(98)00075-7; London CA, 2009, CLIN CANCER RES, V15, P3856, DOI 10.1158/1078-0432.CCR-08-1860; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Marconato L, 2013, HEMATOL ONCOL, V31, P1, DOI 10.1002/hon.2017; Marech I, 2013, CRIT REV ONCOL HEMAT; McLuckie KIE, 2011, J AM CHEM SOC, V133, P2658, DOI 10.1021/ja109474c; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Nielsen MC, 2014, EUR J MED CHEM, V72, P119, DOI 10.1016/j.ejmech.2013.11.027; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Pawlak A, 2013, POSTEP HIG MED DOSW, V67, P471, DOI 10.5604/17322693.1050411; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Rammohan A, 2013, WORLD J GASTRO ONCOL, V5, P102, DOI 10.4251/wjgo.v5.i6.102; Randazzo A, 2013, TOP CURR CHEM, V330, P67, DOI 10.1007/128_2012_331; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Shirude PS, 2007, J AM CHEM SOC, V129, P7484, DOI 10.1021/ja070497d; Simpson RM, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12185; Todd AK, 2007, NUCLEIC ACIDS RES, V35, P5799, DOI 10.1093/nar/gkm609; Waller ZAE, 2009, J AM CHEM SOC, V131, P12628, DOI 10.1021/ja901892u; Warland J, 2013, VET J, V197, P496, DOI 10.1016/j.tvjl.2013.02.017; Wei DG, 2012, NUCLEIC ACIDS RES, V40, P4691, DOI 10.1093/nar/gks023; Welle MM, 2008, VET DERMATOL, V19, P321, DOI 10.1111/j.1365-3164.2008.00694.x; Withrow SJ, 2009, CANCER TREAT RES, V152, P439, DOI 10.1007/978-1-4419-0284-9_24; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; Zemke D, 2002, VET PATHOL, V39, P529, DOI 10.1354/vp.39-5-529; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	50	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103876	10.1371/journal.pone.0103876	http://dx.doi.org/10.1371/journal.pone.0103876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084283	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800095
J	den Uil, CA; Lagrand, WK; van der Ent, MD; Nieman, K; Struijs, A; Jewbali, LSD; Constantinescu, AA; Spronk, PE; Simoons, ML				den Uil, Corstiaan A.; Lagrand, Wim K.; van der Ent, Martin; Nieman, Koen; Struijs, Ard; Jewbali, Lucia S. D.; Constantinescu, Alina A.; Spronk, Peter E.; Simoons, Maarten L.			Conventional Hemodynamic Resuscitation May Fail to Optimize Tissue Perfusion: An Observational Study on the Effects of Dobutamine, Enoximone, and Norepinephrine in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock	PLOS ONE			English	Article							SEVERE HEART-FAILURE; SEPTIC SHOCK; BLOOD-FLOW; MICROCIRCULATION; NITROGLYCERIN; ASSOCIATION; INHIBITORS; SUPPORT	Aim: To investigate the effects of inotropic agents on parameters of tissue perfusion in patients with cardiogenic shock. Methods and Results: Thirty patients with cardiogenic shock were included. Patients received dobutamine, enoximone, or norepinephrine. We performed hemodynamic measurements at baseline and after titration of the inotropic agent until cardiac index (CI) >= 2.5 L.min(-1).m(-2) or mixed-venous oxygen saturation (SvO(2)) >= 70% (dobutamine or enoximone), and mean arterial pressure (MAP) >= 70 mmHg (norepinephrine). As parameters of tissue perfusion, we measured central-peripheral temperature gradient (delta-T) and sublingual perfused capillary density (PCD). All patients reached predefined therapeutic targets. The inotropes did not significantly change delta-T. Dobutamine did not change PCD. Enoximone increased PCD (9.1 [8.9-10.2] vs. 11.4 [8.4-13.9] mm.mm(-2); p<0.05), and norepinephrine tended to decrease PCD (9.8 [8.5-11.9] vs. 8.8 [8.2-9.6] mm.mm(-2), p = 0.08). Fifteen patients (50%) died within 30 days after admission. Patients who had low final PCD (<= 10.3 mm.mm(-2); 64%) were more likely to die than patients who had preserved PCD (>10.3 mm.mm(-2); mortality 72% vs. 17%, p = 0.003). Conclusion: This study demonstrates the effects of commonly used inotropic agents on parameters of tissue perfusion in patients with cardiogenic shock. Despite hemodynamic optimization, tissue perfusion was not sufficiently restored in most patients. In these patients, mortality was high. Interventions directed at improving microcirculation may eventually help bridging the gap between improved hemodynamics and dismal patient outcome in cardiogenic shock.	[den Uil, Corstiaan A.; Nieman, Koen; Struijs, Ard; Jewbali, Lucia S. D.; Constantinescu, Alina A.; Simoons, Maarten L.] Erasmus MC, Thoraxctr, Dept Cardiol & Intens Care Med, Rotterdam, Netherlands; [Lagrand, Wim K.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands; [van der Ent, Martin] Maasstad Hosp, Dept Cardiol, Rotterdam, Netherlands; [Spronk, Peter E.] Gelre Hosp, Dept Intens Care Med, Apeldoorn, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Maasstad Hospital; Gelre Hospitals	den Uil, CA (corresponding author), Erasmus MC, Thoraxctr, Dept Cardiol & Intens Care Med, Rotterdam, Netherlands.	c.denuil@erasmusmc.nl	Struijs, Ard/A-5597-2016	Struijs, Ard/0000-0002-5531-4969				Bezemer R, 2011, MED BIOL ENG COMPUT, V49, P1269, DOI 10.1007/s11517-011-0824-1; BOLDT J, 1993, BRIT J CLIN PHARMACO, V36, P309, DOI 10.1111/j.1365-2125.1993.tb00369.x; CALDICOTT LD, 1993, EUR HEART J, V14, P696, DOI 10.1093/eurheartj/14.5.696; Cuschieri J, 2005, INTENS CARE MED, V31, P818, DOI 10.1007/s00134-005-2602-8; De Backer D, 2006, CRIT CARE MED, V34, P403, DOI 10.1097/01.CCM.0000198107.61493.5A; De Backer D, 2004, AM HEART J, V147, P91, DOI 10.1016/j.ahj.2003.07.006; De Backer D, 2007, CRIT CARE, V11, DOI 10.1186/cc6118; den Uil CA, 2008, J THORAC CARDIOV SUR, V136, P129, DOI 10.1016/j.jtcvs.2007.10.046; den Uil CA, 2010, EUR HEART J, V31, P3032, DOI 10.1093/eurheartj/ehq324; den Uil CA, 2009, INTENS CARE MED, V35, P1893, DOI 10.1007/s00134-009-1591-4; den Uil CA, 2009, CARDIOLOGY, V114, P42, DOI 10.1159/000212060; den Uil CA, 2009, J HEART LUNG TRANSPL, V28, P906, DOI 10.1016/j.healun.2009.05.010; den Uil CA, 2009, EUR J HEART FAIL, V11, P386, DOI 10.1093/eurjhf/hfp021; den Uil CA, 2008, PROG CARDIOVASC DIS, V51, P161, DOI 10.1016/j.pcad.2008.07.002; Dobbe JGG, 2008, MED BIOL ENG COMPUT, V46, P659, DOI 10.1007/s11517-008-0349-4; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Hollenberg SM, 2013, CHEST, V143, P1480, DOI 10.1378/chest.12-1901; Hubble SMA, 2009, MICROCIRCULATION, V16, P183, DOI 10.1080/10739680802461935; Jhanji S, 2009, CRIT CARE MED, V37, P1961, DOI 10.1097/CCM.0b013e3181a00a1c; Jolly S, 2005, AM J CARDIOL, V96, P1617, DOI 10.1016/j.amjcard.2005.07.076; JOLY HR, 1969, CIRCULATION, V39, P131, DOI 10.1161/01.CIR.39.1.131; Kaluski E, 2009, CARDIOLOGY, V114, P39, DOI 10.1159/000212059; Kern H, 2001, CRIT CARE MED, V29, P1519, DOI 10.1097/00003246-200108000-00004; Lauten A, 2011, EUR J HEART FAIL, V13, P711, DOI 10.1093/eurjhf/hfr043; Lima A, 2009, CRIT CARE MED, V37, P934, DOI 10.1097/CCM.0b013e31819869db; Maier S, 2009, BRIT J ANAESTH, V102, P485, DOI 10.1093/bja/aep018; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; MUELLER H, 1970, J CLIN INVEST, V49, P1885, DOI 10.1172/JCI106408; Petersen John W, 2008, Crit Care Med, V36, pS106, DOI 10.1097/01.CCM.0000296273.72952.39; Pirracchio R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071659; Salgado DR, 2013, CLIN HEMORHEOL MICRO, V54, P87, DOI 10.3233/CH-2012-1569; SAXENA PR, 1985, PFLUG ARCH EUR J PHY, V403, P128, DOI 10.1007/BF00584089; Shah MR, 2001, J CARD FAIL, V7, P105, DOI 10.1054/jcaf.2001.24131; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Struijker-Boudier HAJ, 2007, EUR HEART J, V28, P2834, DOI 10.1093/eurheartj/ehm448; Trzeciak S, 2008, INTENS CARE MED, V34, P2210, DOI 10.1007/s00134-008-1193-6; Woolsey CA, 2006, CURR OPIN CRIT CARE, V12, P155, DOI 10.1097/01.ccx.0000216584.72427.e4	37	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103978	10.1371/journal.pone.0103978	http://dx.doi.org/10.1371/journal.pone.0103978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084171	gold, Green Submitted, Green Published			2022-12-27	WOS:000339819800114
J	Mola, JM; Varner, JM; Jules, ES; Spector, T				Mola, John M.; Varner, J. Morgan; Jules, Erik S.; Spector, Tova			Altered Community Flammability in Florida's Apalachicola Ravines and Implications for the Persistence of the Endangered Conifer Torreya taxifolia	PLOS ONE			English	Article							BURNING CHARACTERISTICS; LITTER FLAMMABILITY; LEAF TRAITS; FIRE; FOREST; OAKS; MESOPHICATION; DYNAMICS; PLANT	Plant species and communities often reflect historic fire regimes via ecological and evolutionary responses to recurrent fires. Plant communities of the southeastern USA experience a wide array of fire regimes, perhaps nowhere more marked than the juxtaposition of fire-prone uplands and adjacent mesic ravines along Florida's Apalachicola River. The ravines contain many endemic and disjunct species, most notably the endangered endemic conifer Torreya taxifolia. A rapid decline in T. taxifolia over the past 60 years has been associated with widespread replacement by other tree species. To understand the changes accompanying the shift in ravine composition, we compared leaf litter flammability of nine historic and contemporary species. We measured maximum flame height, flame duration, smoldering duration, mass loss, absorptive capacity, and drying rate. Ordination and perMANOVA suggest the nine species segregated into three distinct groups: the fire-impeding T. taxifolia and Taxus floridana; an intermediate group of three deciduous angiosperms; and a mixed cluster of four flammable species. Results suggest T. taxifolia and T. floridana were fire-impeding species in these communities, while contemporary dominants burn similarly to the upslope pyric species. The increasing presence of fire-facilitating species may portend a shifting fire regime that further imperils T. taxifolia and other rare species in the formerly fire-safe ravines.	[Mola, John M.; Jules, Erik S.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; [Varner, J. Morgan] Mississippi State Univ, Forest & Wildlife Res Ctr, Dept Forestry, Mississippi State, MS 39762 USA; [Spector, Tova] Environm Protect Dept, Florida Pk Serv, Panama City, FL USA; [Mola, John M.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA	California State University System; California State Polytechnic University, Humboldt; Mississippi State University; University of California System; University of California Davis	Mola, JM (corresponding author), Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA.	jmmola@ucdavis.edu		Mola, John/0000-0002-5394-9071	National Science Foundation (NSF) Research Experience for Undergraduates Program [REU 0755466]; NSF Graduate Research Fellowship Program [1049702]; Mississippi Forest & Wildlife Research Center	National Science Foundation (NSF) Research Experience for Undergraduates Program(National Science Foundation (NSF)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Mississippi Forest & Wildlife Research Center	Funding for this research was provided by the National Science Foundation (NSF) Research Experience for Undergraduates Program (REU 0755466 to S.F. Craig and M.D. Johnson), the NSF Graduate Research Fellowship Program (Grant 1049702 to J.M.M.) and the Mississippi Forest & Wildlife Research Center (http://fwrc.msstate.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson H. E., 1970, Fire Technology, V6, P312, DOI 10.1007/BF02588932; Balch JK, 2008, GLOBAL CHANGE BIOL, V14, P2276, DOI 10.1111/j.1365-2486.2008.01655.x; Beckage B, 2009, AM NAT, V174, P805, DOI 10.1086/648458; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; Chen E., 1990, ECOSYSTEMS FLORIDA, P11; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; de Magalhaes RMQ, 2012, J ECOL, V100, P1153, DOI 10.1111/j.1365-2745.2012.01987.x; Ellair DP, 2013, J ECOL, V101, P192, DOI 10.1111/1365-2745.12008; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Engber EA, 2012, CAN J FOREST RES, V42, P1965, DOI 10.1139/x2012-138; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fonda RW, 2001, FOREST SCI, V47, P390; Gagnon PR, 2010, ECOLOGY, V91, P3481, DOI 10.1890/10-0291.1; GLITZENSTEIN JS, 1995, ECOL MONOGR, V65, P441, DOI 10.2307/2963498; Godfrey R K, 1962, Science, V136, P900, DOI 10.1126/science.136.3519.900-a; Harper R.M., 1914, 6TH FLOR STAT GEOL S, P163; Hiers JK, 2014, J WILDLIFE MANAGE, V78, P383, DOI 10.1002/jwmg.676; Hintze JL, 2006, NUMBER CRUNCHING STA; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; Kane JM, 2008, FOREST ECOL MANAG, V256, P2039, DOI 10.1016/j.foreco.2008.07.039; Kreye JK, 2013, ECOL APPL, V23, P1976, DOI 10.1890/13-0503.1; Kwit C, 1998, J TORREY BOT SOC, V125, P309, DOI 10.2307/2997244; Metz MR, 2013, ECOLOGY, V94, P2152, DOI 10.1890/13-0915.1; MUTCH R W, 1970, Ecology (Washington D C), V51, P1046, DOI 10.2307/1933631; Nowacki GJ, 2008, BIOSCIENCE, V58, P123, DOI 10.1641/B580207; Ormeno E, 2009, FOREST ECOL MANAG, V257, P471, DOI 10.1016/j.foreco.2008.09.019; R Core Team, 2021, R LANGUAGE ENV STAT; Robbins L. E., 1992, TALL TIMBERS RES STA, V8; Scarff FR, 2006, FUNCT ECOL, V20, P745, DOI 10.1111/j.1365-2435.2006.01174.x; SCHWARTZ MW, 1993, B TORREY BOT CLUB, V120, P275, DOI 10.2307/2996992; SCHWARTZ MW, 1995, ECOL APPL, V5, P501, DOI 10.2307/1942039; Schwartz MW, 2000, CONSERV BIOL, V14, P1023, DOI 10.1046/j.1523-1739.2000.98393.x; Schwartz MW, 1999, J TORREY BOT SOC, V126, P307, DOI 10.2307/2997314; Schwilk DW, 2011, J ECOL, V99, P970, DOI 10.1111/j.1365-2745.2011.01828.x; Smith JA, 2011, PLANT DIS, V95, P633, DOI 10.1094/PDIS-10-10-0703; Spector T, 2009, FLORIDA PARK SERVICE; Stein BA, 2000, PRECIOUS HERITAGE ST; US Fish and Wildlife Service (USFWS), 1986, FLOR TORR TORR TAX R	38	14	14	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103933	10.1371/journal.pone.0103933	http://dx.doi.org/10.1371/journal.pone.0103933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084166	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800104
J	Wolfrom, CM; Laurent, M; Deschatrette, J				Wolfrom, Claire M.; Laurent, Michel; Deschatrette, Jean			Can We Negotiate with a Tumor?	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; GROWTH-RATES; CELLS; PROGRESSION; HYPOXIA; MODEL; LIVER; TIME	Recent progress in deciphering the molecular portraits of tumors promises an era of more personalized drug choices. However, current protocols still follow standard fixed-time schedules, which is not entirely coherent with the common observation that most tumors do not grow continuously. This unpredictability of the increases in tumor mass is not necessarily an obstacle to therapeutic efficiency, particularly if tumor dynamics could be exploited. We propose a model of tumor mass evolution as the integrated result of the dynamics of two linked complex systems, tumor cell population and tumor microenvironment, and show the practical relevance of this nonlinear approach.	[Wolfrom, Claire M.; Laurent, Michel; Deschatrette, Jean] Univ Paris 11, Inserm Unite 757, Equipe Dynam Cellulaires & Modelisat, Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Laurent, M (corresponding author), Univ Paris 11, Inserm Unite 757, Equipe Dynam Cellulaires & Modelisat, Orsay, France.	michel.laurent@u-psud.fr			INSERM; Association Biologie du Cancer et Dynamiques Complexes	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Biologie du Cancer et Dynamiques Complexes	Funding from INSERM and additional funding from the Association Biologie du Cancer et Dynamiques Complexes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Baik M, 2011, ANN NY ACAD SCI, V1229, P29, DOI 10.1111/j.1749-6632.2011.06100.x; Balschun K, 2011, J MOL DIAGN, V13, P436, DOI 10.1016/j.jmoldx.2011.03.002; BARBARA L, 1992, HEPATOLOGY, V16, P132, DOI 10.1002/hep.1840160122; Bennewith KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-504; Bindea G, 2011, SEMIN IMMUNOPATHOL, V33, P335, DOI 10.1007/s00281-011-0264-x; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cara S, 2001, ANN ONCOL, V12, P23, DOI 10.1023/A:1008389706725; Colombo M, 1998, HEPATO-GASTROENTEROL, V45, P1221; Coulon A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-2; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dancey JE, 2009, EUR J CANCER, V45, P281, DOI 10.1016/j.ejca.2008.10.042; de la Cruz-Merino L, 2008, ONCOLOGIST, V13, P1246, DOI 10.1634/theoncologist.2008-0166; Demicheli R, 2008, ANN ONCOL, V19, P1821, DOI 10.1093/annonc/mdn386; Deschatrette J., 2003, ComPlexUs, V1, P134, DOI 10.1159/000076101; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Ehemann V, 2003, CANCER LETT, V194, P125, DOI 10.1016/S0304-3835(03)00054-5; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Enderling H, 2009, BRIT J CANCER, V100, P1917, DOI 10.1038/sj.bjc.6605071; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferguson RD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3089; Filipski E, 2005, JNCI-J NATL CANCER I, V97, P507, DOI 10.1093/jnci/dji083; Frei E, 1999, BONE MARROW TRANSPL, V24, P939, DOI 10.1038/sj.bmt.1702012; Galluzzo M, 2009, J CLIN INVEST, V119, P865, DOI 10.1172/JCI36579; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gatenby RA, 2009, CANCER RES, V69, P7499, DOI 10.1158/0008-5472.CAN-09-1354; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Gwyther SJ, 2008, EUR J CANCER, V44, P39, DOI 10.1016/j.ejca.2007.10.010; HEUSER L, 1979, CANCER, V43, P1888, DOI 10.1002/1097-0142(197905)43:5<1888::AID-CNCR2820430545>3.0.CO;2-M; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jennings SG, 2006, RADIOLOGY, V241, P554, DOI 10.1148/radiol.2412051185; Jensen AR, 2007, RADIOTHER ONCOL, V84, P5, DOI 10.1016/j.radonc.2007.04.001; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Kasuya H, 2006, NEUROSURG REV, V29, P293, DOI 10.1007/s10143-006-0039-3; Kaufmann Y, 2005, J IMMUNOL, V175, P6940, DOI 10.4049/jimmunol.175.10.6940; Klotz L, 2007, NAT CLIN PRACT ONCOL, V4, P692, DOI 10.1038/ncponc0966; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kucerova L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-129; Kunkle DA, 2007, J UROLOGY, V177, P849, DOI 10.1016/j.juro.2006.10.073; Lam WA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-35; Laurent M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009346; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li XM, 2010, CANCER RES, V70, P3351, DOI 10.1158/0008-5472.CAN-09-4235; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Meggiato T, 2000, PANCREAS, V20, P117, DOI 10.1097/00006676-200003000-00002; Moen I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006381; Nguyen LK, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-51; Nieman KM, 2010, NAT MED, V17, P1498; NORTON L, 1988, CANCER RES, V48, P7067; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Pantel K, NAT REV CANC, V8, P329; Pikovsky AS, 1997, PHYSICA D, V104, P219, DOI 10.1016/S0167-2789(96)00301-6; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; PREHN RT, 1991, CANCER RES, V51, P2; Raa A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-23; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; RETSKY MW, 1987, CANCER RES, V47, P4982; RETSKY MW, 1990, MED HYPOTHESES, V33, P95, DOI 10.1016/0306-9877(90)90186-I; Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Ronnov-Jessen L, 2009, TRENDS MOL MED, V15, P5, DOI 10.1016/j.molmed.2008.11.001; Sargent DJ, 2009, EUR J CANCER, V45, P290, DOI 10.1016/j.ejca.2008.10.030; Silva AS, 2009, CANCER RES, V69, P2677, DOI 10.1158/0008-5472.CAN-08-2394; Slade MJ, 2009, BRIT J CANCER, V100, P160, DOI 10.1038/sj.bjc.6604773; Smyth EC, 2012, CURR TREAT OPTION ON, V13, P377, DOI 10.1007/s11864-012-0192-6; SPEER JF, 1984, CANCER RES, V44, P4124; STAUNTON MJ, 1995, AM J CLIN PATHOL, V103, P300, DOI 10.1093/ajcp/103.3.300; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tanaka Y, 2003, J NEUROSURG, V98, P359, DOI 10.3171/jns.2003.98.2.0359; Teng MWL, 2008, J LEUKOCYTE BIOL, V84, P988, DOI 10.1189/jlb.1107774; TUBIANA M, 1991, BREAST CANCER RES TR, V18, P125, DOI 10.1007/BF01990028; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Vassileva V, 2008, MOL CANCER THER, V7, P630, DOI 10.1158/1535-7163.MCT-07-2117; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Whittle IR, 2004, LANCET, V363, P1535, DOI 10.1016/S0140-6736(04)16153-9; Wolfrom C, 2007, FEBS LETT, V581, P125, DOI 10.1016/j.febslet.2006.12.007; Wu JH, 2011, CANCER RES, V71, P2622, DOI 10.1158/0008-5472.CAN-10-3837; Zahl PH, 2011, LANCET ONCOL, V12, P1118, DOI 10.1016/S1470-2045(11)70250-9; Zhang JB, 2009, RADIOLOGY, V250, P137, DOI 10.1148/radiol.2501071712	85	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103834	10.1371/journal.pone.0103834	http://dx.doi.org/10.1371/journal.pone.0103834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084359	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800086
J	Clapauch, R; Mourao, AF; Mecenas, AS; Maranhao, PA; Rossini, A; Bouskela, E				Clapauch, Ruth; Mourao, Andre Felipe; Mecenas, Anete S.; Maranhao, Priscila A.; Rossini, Ana; Bouskela, Eliete			Endothelial Function and Insulin Resistance in Early Postmenopausal Women with Cardiovascular Risk Factors: Importance of ESR1 and NOS3 Polymorphisms	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ESTROGEN-RECEPTOR-ALPHA; CORONARY-ARTERY-DISEASE; GENE POLYMORPHISMS; BREAST-CANCER; HEART-DISEASE; ASSOCIATION; DYSFUNCTION; LOCALIZATION; MECHANISMS	Cardiovascular benefits from estradiol activation of nitric oxide endothelial production may depend on vascular wall and on estrogen receptor alpha (ESR1) and nitric oxide synthase (NOS3) polymorphisms. We have evaluated the microcirculation in vivo through nailfold videocapillaroscopy, before and after acute nasal estradiol administration at baseline and after increased sheer stress (postocclusive reactive hyperemia response) in 100 postmenopausal women, being 70 controls (healthy) and 30 simultaneously hypertensive and diabetic (HD), correlating their responses to PvuII and XbaI ESR1 polymorphisms and to VNTR, T-786C and G894T NOS3 variants. In HD women, C variant allele of ESR1 Pvull was associated to higher vasodilatation after estradiol (1.72 vs 1.64 mm/s, p = 0.01 compared to TT homozygotes) while G894T and T-786C NOS3 polymorphisms were connected to lower increment after shear stress (15% among wild type and 10% among variant alleles, p = 0.02 and 0.04). The G variant allele of ESR1 XbaI polymorphism was associated to higher HOMA-IR (3.54 vs. 1.64, p = 0.01) in HD and higher glucose levels in healthy women (91.8 vs. 87.1 mg/dl, p = 0.01), in which increased waist and HOMA-IR were also related to the G allele in NOS3 G894T (waist 93.5 vs 88.2 cm, p = 0.02; HOMA-IR 2.89 vs 1.48, p = 0.05). ESR1 Pvull, NOS3 G894T and T-786C polymorphism analysis may be considered in HD postmenopausal women for endothelial response prediction following estrogen therapy but were not discriminatory for endothelial response in healthy women. ESR1 XbaI and G894T NOS3 polymorphisms may be useful in accessing insulin resistance and type 2 diabetes risks in all women, even before menopause and occurrence of metabolic disease.	[Clapauch, Ruth; Mecenas, Anete S.; Maranhao, Priscila A.; Bouskela, Eliete] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, Brazil; [Clapauch, Ruth] Minist Hlth, Endocrinol Sect, Hosp da Lagoa, Rio De Janeiro, Brazil; [Mourao, Andre Felipe; Rossini, Ana] Univ Estado Rio De Janeiro, IBRAG, Dept Bioquim, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Clapauch, R (corresponding author), Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, Brazil.	rclapauch@uol.com.br		Maranhao, Priscila/0000-0002-4804-4999	National Research Council of Brazil (CNPq) [474116/2008-5]; State of Rio de Janeiro Research Supporting Agency (FAPERJ) [E-26/110.318/2007]	National Research Council of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Rio de Janeiro Research Supporting Agency (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grant 474116/2008-5 from the National Research Council of Brazil (CNPq- htpp://www.cnpq.br) and grant E-26/110.318/2007 from the State of Rio de Janeiro Research Supporting Agency (FAPERJ - htpp://www.faperj.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevizaki M, 2007, EUR J ENDOCRINOL, V156, P489, DOI 10.1530/EJE-06-0685; Almeida S, 2006, BRAZ J MED BIOL RES, V39, P447, DOI 10.1590/S0100-879X2006000400004; ANDERSEN TI, 1994, HUM GENET, V94, P665; Arnal JF, 2010, ARTERIOSCL THROM VAS, V30, P1506, DOI 10.1161/ATVBAHA.109.191221; Asif AR, 2009, J PROTEOME RES, V8, P3161, DOI 10.1021/pr800998k; Billon-Gales A, 2009, CIRCULATION, V120, P2567, DOI 10.1161/CIRCULATIONAHA.109.898445; Bollig A, 2000, MOL ENDOCRINOL, V14, P634, DOI 10.1210/me.14.5.634; Casazza K, 2010, BIOL RES NURS, V12, P84, DOI 10.1177/1099800410371118; Channon KM, 2002, J PHYSIOL PHARMACOL, V53, P515; Chow RWY, 2010, ENDOCRINOLOGY, V151, P2411, DOI 10.1210/en.2009-1456; Clapauch R, 2012, MENOPAUSE, V19, P672, DOI 10.1097/gme.0b013e31823a8f43; Clapauch R, 2009, MICROVASC RES, V78, P405, DOI 10.1016/j.mvr.2009.08.003; Doshi AA, 2010, J CARD FAIL, V16, P314, DOI 10.1016/j.cardfail.2009.12.013; Gallagher CJ, 2007, DIABETES, V56, P2135, DOI 10.2337/db06-1017; Gavin KM, 2009, J CLIN ENDOCR METAB, V94, P3513, DOI 10.1210/jc.2009-0278; Gilchrist M, 2011, CARDIOVASC RES, V89, P492, DOI 10.1093/cvr/cvq309; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Holm P, 1997, J CLIN INVEST, V100, P821, DOI 10.1172/JCI119597; Ingelsson E, 2008, J HUM HYPERTENS, V22, P569, DOI 10.1038/jhh.2008.37; Joshi MS, 2007, FASEB J, V21, P2655, DOI 10.1096/fj.06-7088com; Kim KH, 2009, MOL CELL ENDOCRINOL, V308, P3, DOI 10.1016/j.mce.2009.03.025; Kjaergaard AD, 2007, CIRCULATION, V115, P861, DOI 10.1161/CIRCULATIONAHA.106.615567; Knowlton AA, 2012, PHARMACOL THERAPEUT, V135, P54, DOI 10.1016/j.pharmthera.2012.03.007; Leeson CPM, 2002, CIRC RES, V90, P1153, DOI 10.1161/01.RES.0000020562.07492.D4; Li RL, 2004, AM J HYPERTENS, V17, P560, DOI 10.1016/j.amjhyper.2004.02.013; Liu SH, 2009, ISLETS, V1, P273, DOI 10.4161/isl.1.3.9781; Lo JC, 2006, AM J MED, V119, P69, DOI 10.1016/j.amjmed.2006.07.009; Lu H, 2002, ARTERIOSCL THROM VAS, V22, P817, DOI 10.1161/01.ATV.0000014424.18209.21; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Masood DEN, 2010, CURR DRUG METAB, V11, P693, DOI 10.2174/138920010794233477; Matic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057458; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meshkani R, 2012, MOL CELL BIOCHEM, V359, P225, DOI 10.1007/s11010-011-1017-9; Mikkola TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063347; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; Neves FJ, 2010, J HYPERTENS, V28, P764, DOI 10.1097/HJH.0b013e328334f55c; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; Nofer JR, 2012, J MOL ENDOCRINOL, V48, pR13, DOI 10.1530/JME-11-0145; OSTERGREN J, 1986, INT J MICROCIRC, V5, P37; Rasool AHG, 2009, MICROVASC RES, V78, P230, DOI 10.1016/j.mvr.2009.05.005; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Rodriguez-Manas L, 2009, AGING CELL, V8, P226, DOI 10.1111/j.1474-9726.2009.00466.x; Safarinejad MR, 2013, UROL ONCOL-SEMIN ORI, V31, P1132, DOI 10.1016/j.urolonc.2012.01.002; Safarinejad MR, 2010, J STEROID BIOCHEM, V122, P193, DOI 10.1016/j.jsbmb.2010.06.011; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Shearman AM, 2006, CIRC RES, V98, P590, DOI 10.1161/01.RES.0000210578.62102.a6; Shearman AM, 2003, JAMA-J AM MED ASSOC, V290, P2263, DOI 10.1001/jama.290.17.2263; Shen C, 2012, EUR J INTERN MED, V23, P175, DOI 10.1016/j.ejim.2011.05.006; Simoncini T, 2005, MATURITAS, V50, P247, DOI 10.1016/j.maturitas.2004.04.001; Speroff L, 2000, ANN NY ACAD SCI, V900, P26; Tanus-Santos JE, 2002, PHARMACOGENETICS, V12, P407, DOI 10.1097/00008571-200207000-00008; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Vanhoutte PM, 2008, J PHYSIOL-LONDON, V586, P5295, DOI 10.1113/jphysiol.2008.161430; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; YAICH L, 1992, CANCER RES, V52, P77	57	7	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103444	10.1371/journal.pone.0103444	http://dx.doi.org/10.1371/journal.pone.0103444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077953	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800046
J	Mezzina, MP; Wetzler, DE; Catone, MV; Bucci, H; Di Paola, M; Pettinari, MJ				Mezzina, Mariela P.; Wetzler, Diana E.; Catone, Mariela V.; Bucci, Hernan; Di Paola, Matias; Pettinari, M. Julia			A Phasin with Many Faces: Structural Insights on PhaP from Azotobacter sp FA8	PLOS ONE			English	Article							GRANULE-ASSOCIATED PROTEIN; RALSTONIA-EUTROPHA H16; POLYHYDROXYALKANOIC ACID GRANULES; AEROMONAS-HYDROPHILA; PHB GRANULES; EXPRESSION; POLYHYDROXYBUTYRATE; PURIFICATION; DEGRADATION; PREDICTION	Phasins are a group of proteins associated to granules of polyhydroxyalkanoates (PHAs). Apart from their structural role as part of the PHA granule cover, different structural and regulatory functions have been found associated to many of them, and several biotechnological applications have been developed using phasin protein fusions. Despite their remarkable functional diversity, the structure of these proteins has not been analyzed except in very few studies. PhaP from Azotobacter sp. FA8 (PhaP(Az)) is a representative of the prevailing type in the multifunctional phasin protein family. Previous work performed in our laboratory using this protein have demonstrated that it has some very peculiar characteristics, such as its stress protecting effects in recombinant Escherichia coli, both in the presence and absence of PHA. The aim of the present work was to perform a structural characterization of this protein, to shed light on its properties. Its aminoacid composition revealed that it lacks clear hydrophobic domains, a characteristic that appears to be common to most phasins, despite their lipid granule binding capacity. The secondary structure of this protein, consisting of a-helices and disordered regions, has a remarkable capacity to change according to its environment. Several experimental data support that it is a tetramer, probably due to interactions between coiled-coil regions. These structural features have also been detected in other phasins, and may be related to their functional diversity.	[Mezzina, Mariela P.; Wetzler, Diana E.; Catone, Mariela V.; Bucci, Hernan; Di Paola, Matias; Pettinari, M. Julia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IQUIBICEN CONICET, Dept Quim Biol, Buenos Aires, DF, Argentina	University of Buenos Aires	Wetzler, DE (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, IQUIBICEN CONICET, Dept Quim Biol, Buenos Aires, DF, Argentina.	diana.wetzler@gmail.com; jul@qb.fcen.uba.ar	Pettinari, M. Julia/B-7404-2011	Pettinari, Julia/0000-0002-6130-4740; Wetzler, Diana Elena/0000-0003-2231-6690; Mezzina, Mariela Paula/0000-0003-0026-173X	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires (UBA); Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT); CONICET	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires (UBA)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the University of Buenos Aires (UBA), and Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT). DEW and MJP are career members of CONICET, and MPM, HB and MDP have scholarships from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Barnard GC, 2005, APPL ENVIRON MICROB, V71, P5735, DOI 10.1128/AEM.71.10.5735-5742.2005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BUCK M, 1995, BIOCHEMISTRY-US, V34, P4041, DOI 10.1021/bi00012a023; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; de Almeida A, 2007, APPL ENVIRON MICROB, V73, P7912, DOI 10.1128/AEM.01900-07; de Almeida A, 2011, APPL ENVIRON MICROB, V77, P6622, DOI 10.1128/AEM.05469-11; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Galan B, 2011, MOL MICROBIOL, V79, P402, DOI 10.1111/j.1365-2958.2010.07450.x; Handrick R, 2004, J BACTERIOL, V186, P2466, DOI 10.1128/JB.186.8.2466-2475.2004; Hanley SZ, 1999, FEBS LETT, V447, P99, DOI 10.1016/S0014-5793(99)00235-5; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Keshavarz T, 2010, CURR OPIN MICROBIOL, V13, P321, DOI 10.1016/j.mib.2010.02.006; Kuchta K, 2007, BIOMACROMOLECULES, V8, P657, DOI 10.1021/bm060912e; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Luo YZ, 1998, J MOL BIOL, V279, P49, DOI 10.1006/jmbi.1998.1774; Maestro B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056904; McCool GJ, 1999, J BACTERIOL, V181, P585, DOI 10.1128/JB.181.2.585-592.1999; Moldes C, 2004, APPL ENVIRON MICROB, V70, P3205, DOI 10.1128/AEM.70.6.3205-3212.2004; Neumann L, 2008, J BACTERIOL, V190, P2911, DOI 10.1128/JB.01486-07; Peralta-Gil M, 2002, J BACTERIOL, V184, P5672, DOI 10.1128/JB.184.20.5672-5677.2002; Pfeiffer D, 2012, J BACTERIOL, V194, P5909, DOI 10.1128/JB.00779-12; PIEPERFURST U, 1994, J BACTERIOL, V176, P4328, DOI 10.1128/jb.176.14.4328-4337.1994; Potter M, 2005, BIOMACROMOLECULES, V6, P552, DOI 10.1021/bm049401n; Potter M, 2004, MICROBIOL-SGM, V150, P2301, DOI 10.1099/mic.0.26970-0; Prieto MA, 1999, J BACTERIOL, V181, P858, DOI 10.1128/JB.181.3.858-868.1999; Qi Q, 2000, APPL MICROBIOL BIOT, V54, P37, DOI 10.1007/s002530000357; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Slavik J, 1995, BIOCHIM BIOPHYS ACTA, V694, P1; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Tian SJ, 2005, FEMS MICROBIOL LETT, V244, P19, DOI 10.1016/j.femsle.2005.01.020; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; WIECZOREK R, 1995, J BACTERIOL, V177, P2425, DOI 10.1128/jb.177.9.2425-2435.1995; Xue B, 2011, BIOCHIM BIOPHYS ACTA, V1804, P996; York GM, 2001, J BACTERIOL, V183, P2394, DOI 10.1128/JB.183.7.2394-2397.2001; Zhao ML, 2006, ACTA CRYSTALLOGR F, V62, P814, DOI 10.1107/S1744309106025000	38	20	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103012	10.1371/journal.pone.0103012	http://dx.doi.org/10.1371/journal.pone.0103012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077609	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800024
J	Weymann, A; Radovits, T; Schmack, B; Korkmaz, S; Li, SL; Chaimow, N; Patzold, I; Becher, PM; Hartyanszky, I; Soos, P; Merkely, G; Nemeth, BT; Istok, R; Veres, G; Merkely, B; Terytze, K; Karck, M; Szabo, G				Weymann, Alexander; Radovits, Tamas; Schmack, Bastian; Korkmaz, Sevil; Li, Shiliang; Chaimow, Nicole; Paetzold, Ines; Becher, Peter Moritz; Hartyanszky, Istvan; Soos, Pal; Merkely, Gergo; Nemeth, Balazs Tamas; Istok, Roland; Veres, Gabor; Merkely, Bela; Terytze, Konstantin; Karck, Matthias; Szabo, Gabor			Total Aortic Arch Replacement: Superior Ventriculo-Arterial Coupling with Decellularized Allografts Compared with Conventional Prostheses	PLOS ONE			English	Article							INPUT IMPEDANCE; THORACIC AORTA; PERFUSION; MISMATCH; GRAFT; HEMODYNAMICS; VENTRICLE; ANEURYSMS; HEART	Background: To date, no experimental or clinical study provides detailed analysis of vascular impedance changes after total aortic arch replacement. This study investigated ventriculoarterial coupling and vascular impedance after replacement of the aortic arch with conventional prostheses vs. decellularized allografts. Methods: After preparing decellularized aortic arch allografts, their mechanical, histological and biochemical properties were evaluated and compared to native aortic arches and conventional prostheses in vitro. In open-chest dogs, total aortic arch replacement was performed with conventional prostheses and compared to decellularized allografts (n = 5/group). Aortic flow and pressure were recorded continuously, left ventricular pressure-volume relations were measured by using a pressure-conductance catheter. From the hemodynamic variables end-systolic elastance (Ees), arterial elastance (Ea) and ventriculoarterial coupling were calculated. Characteristic impedance (Z) was assessed by Fourier analysis. Results: While Ees did not differ between the groups and over time (4.1 +/- 1.19 vs. 4.58 +/- 1.39 mmHg/mL and 3.21 +/- 0.97 vs. 3.96 +/- 1.16 mmHg/mL), Ea showed a higher increase in the prosthesis group (4.01 +/- 0.67 vs. 6.18 +/- 0.20 mmHg/mL, P<0.05) in comparison to decellularized allografts (5.03 +/- 0.35 vs. 5.99 +/- 1.09 mmHg/mL). This led to impaired ventriculoarterial coupling in the prosthesis group, while it remained unchanged in the allograft group (62.5 +/- 50.9 vs. 3.9 +/- 23.4%). Z showed a strong increasing tendency in the prosthesis group and it was markedly higher after replacement when compared to decellularized allografts (44.6 +/- 8.3dyn.sec.cm(-5) vs. 32.4 +/- 2.0dyn.sec.cm(-5), P<0.05). Conclusions: Total aortic arch replacement leads to contractility-afterload mismatch by means of increased impedance and invert ventriculoarterial coupling ratio after implantation of conventional prostheses. Implantation of decellularized allografts preserves vascular impedance thereby improving ventriculoarterial mechanoenergetics after aortic arch replacement.	[Weymann, Alexander; Schmack, Bastian; Korkmaz, Sevil; Li, Shiliang; Chaimow, Nicole; Paetzold, Ines; Soos, Pal; Veres, Gabor; Karck, Matthias; Szabo, Gabor] Heidelberg Univ, Heart & Marfan Ctr, Dept Cardiac Surg, Heidelberg, Germany; [Radovits, Tamas; Hartyanszky, Istvan; Soos, Pal; Merkely, Gergo; Nemeth, Balazs Tamas; Veres, Gabor; Merkely, Bela] Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary; [Becher, Peter Moritz] Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Istok, Roland] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Terytze, Konstantin] Fed Environm Agcy, Dessau Rosslau, Germany; [Terytze, Konstantin] Free Univ Berlin, Dept Earth Sci, Berlin, Germany	Ruprecht Karls University Heidelberg; Semmelweis University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Semmelweis University; Free University of Berlin	Weymann, A (corresponding author), Heidelberg Univ, Heart & Marfan Ctr, Dept Cardiac Surg, Heidelberg, Germany.	weymann.alexander@googlemail.com	Weymann, Alexander/AAQ-5115-2021; Merkely, Gergő/O-1124-2015	Merkely, Gergő/0000-0001-6660-6994; Szabo, Gabor/0000-0001-6038-9968	Land Baden-Wurttemberg, Germany; Medical Faculty of the University of Heidelberg, Germany; Hungarian Academy of Sciences; Hungarian Research Fund [OTKA 105555]; National Development Agency of Hungary [TAMOP-4.2.2-08/1/KMR-2008-004, TAMOP-4.2.2/B-10/1-2010-0013]	Land Baden-Wurttemberg, Germany; Medical Faculty of the University of Heidelberg, Germany; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency of Hungary	This work was supported by the Land Baden-Wurttemberg, Germany, the Medical Faculty of the University of Heidelberg, Germany (to S.K.), the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to T.R.), the Hungarian Research Fund [OTKA 105555 to B.M.] and by grants from the National Development Agency of Hungary [TAMOP-4.2.2-08/1/KMR-2008-004, TAMOP-4.2.2/B-10/1-2010-0013]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376; ATTINGER EO, 1966, BIOPHYS J, V6, P291, DOI 10.1016/S0006-3495(66)86657-2; Bauernschmitt R, 1999, ANN THORAC SURG, V67, P676, DOI 10.1016/S0003-4975(99)00046-6; Cho SW, 2005, ANN SURG, V241, P506, DOI 10.1097/01.sla.0000154268.12239.ed; Dobson G, 2006, EUR J VASC ENDOVASC, V32, P129, DOI 10.1016/j.ejvs.2006.01.020; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Estrera AL, 2010, EUR J CARDIO-THORAC, V38, P293, DOI 10.1016/j.ejcts.2010.02.021; Fabjan E, 2006, CRIT REV TOXICOL, V36, P695, DOI 10.1080/10408440600894914; Gao Yong, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P644; GROSS RE, 1951, ANN SURG, V134, P753, DOI 10.1097/00000658-195113440-00020; Ito R K, 1990, ASAIO Trans, V36, pM175; Kamiya H, 2007, ANN THORAC SURG, V83, P1055, DOI 10.1016/j.athoracsur.2006.09.085; KIM SY, 1995, ANN THORAC SURG, V59, P981, DOI 10.1016/0003-4975(95)00068-V; Korkmaz S, 2009, CIRCULATION, V120, P677, DOI 10.1161/CIRCULATIONAHA.109.870774; Kuzmik GA, 2012, J VASC SURG, V56, P565, DOI 10.1016/j.jvs.2012.04.053; LeMaire SA, 2011, ANN THORAC SURG, V91, P700, DOI 10.1016/j.athoracsur.2010.11.008; MAETA H, 1985, JPN CIRC J, V49, P232, DOI 10.1253/jcj.49.232; MEHIGAN DG, 1985, J CARDIOVASC SURG, V26, P147; Mekkaoui C, 2003, J THORAC CARDIOV SUR, V125, P699, DOI 10.1067/mtc.2003.104; Milewski RK, 2010, ANN THORAC SURG, V89, P1448, DOI 10.1016/j.athoracsur.2010.01.056; MITSUI T, 1986, J CARDIOVASC SURG, V27, P201; Rourke M, 1967, CIRC RES, V19, P365; Scharfschwerdt M, 2007, ANN THORAC SURG, V83, P954, DOI 10.1016/j.athoracsur.2006.10.056; Schulz S, 1997, Biomed Sci Instrum, V34, P263; SUNAGAWA K, 1983, AM J PHYSIOL, V245, pH773, DOI 10.1152/ajpheart.1983.245.5.H773; Szabo G, 2003, J THORAC CARDIOV SUR, V125, P1061, DOI 10.1067/mtc.2003.405; VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006; Weston MW, 1996, J BIOMECH, V29, P187, DOI 10.1016/0021-9290(95)00028-3; Weymann A, 2013, CIRC J, V77, P207, DOI 10.1253/circj.CJ-12-0540; Weymann A, 2011, CIRC J, V75, P852, DOI 10.1253/circj.CJ-10-0717; Weymann A, 2010, J HEART VALVE DIS, V19, P279	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103588	10.1371/journal.pone.0103588	http://dx.doi.org/10.1371/journal.pone.0103588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079587	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000339954800057
J	Raza, H; John, A; Shafarin, J				Raza, Haider; John, Annie; Shafarin, Jasmin			NAC Attenuates LPS-Induced Toxicity in Aspirin-Sensitized Mouse Macrophages via Suppression of Oxidative Stress and Mitochondrial Dysfunction	PLOS ONE			English	Article							ACETYLSALICYLIC-ACID; LIVER-INJURY; APOPTOSIS; ACETAMINOPHEN; MECHANISMS; CYTOKINES; PROTEINS; CELLS	Bacterial endotoxin lipopolysaccharide (LPS) induces the production of inflammatory cytokines and reactive oxygen species (ROS) under in vivo and in vitro conditions. Acetylsalicylic acid (ASA, aspirin) is a commonly used anti-inflammatory drug. Our aim was to study the effects of N-acetyl cysteine (NAC), an antioxidant precursor of GSH synthesis, on aspirin-sensitized macrophages treated with LPS. We investigated the effects of LPS alone and in conjunction with a sub-toxic concentration of ASA, on metabolic and oxidative stress, apoptosis, and mitochondrial function using J774.2 mouse macrophage cell line. Protection from LPS-induced toxicity by NAC was also studied. LPS alone markedly induced ROS production and oxidative stress in macrophage cells. When ASA was added to LPS-treated macrophages, the increase in oxidative stress was significantly higher than that with LPS alone. Similarly, alteration in glutathione-dependent redox metabolism was also observed in macrophages after treatment with LPS and ASA. The combination of LPS and ASA selectively altered the CYP 3A4, CYP 2E1 and CYP 1A1 catalytic activities. Mitochondrial respiratory complexes and ATP production were also inhibited by LPS-ASA treatment. Furthermore a higher apoptotic cell death was also observed in LPS-ASA treated macrophages. NAC pre-treatment showed protection against oxidative stress induced apoptosis and mitochondrial dysfunction. These effects are presumed, at least in part, to be associated with alterations in NF-kappa B/Nrf-2 mediated cell signaling. These results suggest that macrophages are more sensitive to LPS when challenged with ASA and that NAC pre-treatment protects the macrophages from these deleterious effects.	[Raza, Haider; John, Annie; Shafarin, Jasmin] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates	United Arab Emirates University	Raza, H (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates.	h.raza@uaeu.ac.ae		Raza, Haider/0000-0001-9680-5388	Sheikh Hamdan bin Rashid Al Maktoum Award [MRG01/2011-2012]; College of Medicine and Health Sciences; Terry Fox Cancer Research Fund	Sheikh Hamdan bin Rashid Al Maktoum Award; College of Medicine and Health Sciences; Terry Fox Cancer Research Fund	This work was supported by Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, MRG01/2011-2012 (HR), College of Medicine and Health Sciences, and Terry Fox Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Belooshi T, 2010, FOOD CHEM TOXICOL, V48, P2624, DOI 10.1016/j.fct.2010.06.031; Bhagwat SV, 1999, TOXICOL APPL PHARM, V156, P231, DOI 10.1006/taap.1999.8646; Bian K, 2001, FREE RADICAL BIO MED, V31, P421, DOI 10.1016/S0891-5849(01)00600-1; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Brune B, 2013, ANTIOXID REDOX SIGN, V19, P595, DOI 10.1089/ars.2012.4785; Bykov I, 2003, SCAND J GASTROENTERO, V38, P1256, DOI 10.1080/00365520310007116; Cederbaum AI, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/582790; Cosgrove BD, 2009, TOXICOL APPL PHARM, V237, P317, DOI 10.1016/j.taap.2009.04.002; Crowley SD, 2014, ANTIOXID REDOX SIGN, V20, P102, DOI 10.1089/ars.2013.5258; Cuschieri J, 2007, ANTIOXID REDOX SIGN, V9, P1485, DOI 10.1089/ars.2007.1670; Duan YZ, 2014, BMB REP, V47, P45, DOI 10.5483/BMBRep.2014.47.1.089; Endres S, 1996, IMMUNOLOGY, V87, P264, DOI 10.1046/j.1365-2567.1996.472535.x; Hartel C, 2004, SCAND J IMMUNOL, V60, P412, DOI 10.1111/j.0300-9475.2004.01481.x; Ho LJ, 2001, SCAND J RHEUMATOL, V30, P346; Kang PT, 2014, BIOCHEM PHARMACOL, V89, P490, DOI 10.1016/j.bcp.2014.03.012; Kim KM, 2005, J BIOL CHEM, V280, P41047, DOI 10.1074/jbc.M503713200; Lacour S, 2009, J IMMUNOTOXICOL, V6, P84, DOI 10.1080/15476910902938250; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskin DL, 2001, TOXICOLOGY, V160, P111, DOI 10.1016/S0300-483X(00)00437-6; Lu YK, 2005, AM J PHYSIOL-GASTR L, V289, pG308, DOI 10.1152/ajpgi.00054.2005; Lu YK, 2010, GENES NUTR, V5, P149, DOI 10.1007/s12263-009-0150-5; Nandakishore Ravindran, 2014, Curr Drug Discov Technol, V11, P127; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; Raza H, 1996, BIOCHEM PHARMACOL, V52, P1639, DOI 10.1016/S0006-2952(96)00526-6; Raza H, 2014, HAMDAN MED IN PRESS; Raza H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036325; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; Roberts RA, 2009, TOXICOL SCI, V112, P4, DOI 10.1093/toxsci/kfp179; Stark LA, 2007, CARCINOGENESIS, V28, P968, DOI 10.1093/carcin/bgl220; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292; Zhao GQ, 2013, MOL PHARMACOL, V83, P167, DOI 10.1124/mol.112.080762	33	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103379	10.1371/journal.pone.0103379	http://dx.doi.org/10.1371/journal.pone.0103379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075522	gold, Green Submitted, Green Published			2022-12-27	WOS:000340028800042
J	Awoliyi, S; Ball, D; Parkinson, N; Preedy, VR				Awoliyi, Susanna; Ball, David; Parkinson, Norman; Preedy, Victor R.			Alcohol Misuse among University Staff: A Cross-Sectional Study	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; BINGE DRINKING; TEST AUDIT; WORKPLACE; HEALTH; CONSUMPTION; PREVALENCE; POPULATION; WORKFORCE	Objectives: To examine the prevalence of hazardous drinking among staff in a UK university and its association with key socio-demographic features. Design: A cross-sectional study. Setting: A university in the UK. Participants: All employees on the university employee database were eligible to participate. Those who completed and returned the questionnaire were included in the sample. Respondents were 131 university employees. Primary and Secondary Outcome Measures: An AUDIT cut-off score of >= 8 was used as a measure of hazardous drinking. AUDIT total score as well as a score of >= 1 in each of the three conceptual domains of alcohol consumption (questions 1-3), dependence symptoms (questions 4-6) and alcohol-related problems (questions 7-10) were used as indicators of levels of drinking and alcohol-related consequences. Secondary outcomes were employees' demographics. Results: Over one third (35%) of respondents were classified as hazardous drinkers. Twenty three per cent reported having blackouts after drinking and 14% had injuries or had injured someone. The odds of being a hazardous drinker for an employee in central departments (Human Resources, Registry etc) is only one third of that of an employee in science and health-related departments (OR = 0.35, 95% CI = 0.14 to 0.91). The proportion of hazardous drinkers was higher in males compared to females (43% and 30% respectively), part-time compared to full-time (46% and 34% respectively), and academic compared to non-academic employees (39% and 32% respectively), although these were not statistically significant (p>0.05). Furthermore, age, religion and ethnic origin were not found to be significantly associated with hazardous drinking, although total scores were significantly lower for ethnic minorities compared to white employees (p = 0.019). Conclusions: In this study, hazardous drinking was highly prevalent among university employees. However, overt recruiting of staff to address sensitive issues such as alcohol misuse is problematic.	[Awoliyi, Susanna; Parkinson, Norman] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England; [Awoliyi, Susanna] Kings Coll London, Dept Nutr & Dietet, London, England; [Ball, David] Kings Coll London, Inst Psychiat, London, England; [Preedy, Victor R.] Kings Coll London, Diabet & Nutr Sci Div, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Preedy, VR (corresponding author), Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England.	victor.preedy@kcl.ac.uk						Aertgeerts B, 2001, BRIT J GEN PRACT, V51, P206; Alcohol Concern, 2006, ACQ ALC CONC Q INF R; Alcohol Concern, 2011, MAK ALC HLTH PRIOR O; [Anonymous], 2010, ALC US DIS PREV HARM; Babor TF., 2001, AUDIT ALCOHOL USE DI; Berry JG, 2007, ADDICTION, V102, P1399, DOI 10.1111/j.1360-0443.2007.01893.x; Boniface S, 2013, EUR J PUBLIC HEALTH, V23, P1076, DOI 10.1093/eurpub/ckt016; British Medical Association Board of Science, 2008, ALC MIS TACKL UK EP; Chan-Pensley E, 1999, ALCOHOL ALCOHOLISM, V34, P882, DOI 10.1093/alcalc/34.6.882; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1046/j.1360-0443.1995.901013496.x; Curry SJ, 2002, ALCOHOL ALCOHOLISM, V37, P289, DOI 10.1093/alcalc/37.3.289; Davey JD, 2000, DRUG ALCOHOL REV, V19, P49; David Annette M, 2010, Hawaii Med J, V69, P45; Department of Health Home Office Department for Education and Skills Department for Culture Media and Sport, 2007, SAF SENS SOC NEXT ST; Foster A I, 1997, J Ky Med Assoc, V95, P105; Frone MR, 2006, J STUD ALCOHOL, V67, P147, DOI 10.15288/jsa.2006.67.147; Gill JS, 2002, ALCOHOL ALCOHOLISM, V37, P109, DOI 10.1093/alcalc/37.2.109; Health Inprovement Analytic Team, 2008, COST ALC HARM NHS EN; Hermansson U, 2000, ALCOHOL CLIN EXP RES, V24, P180, DOI 10.1097/00000374-200002000-00008; Home Office, 2012, GOV ALC STRAT; Home Office Statistics Unit, 2011, CRIM ENGL WAL 2010 1; Institute of Alcohol Studies, 2009, ALC WORKPL IAS FACTS; Mahmoud AO, 2011, MIDDLE EAST AFR J OP, V18, P164, DOI 10.4103/0974-9233.80707; Matano RA, 2003, ADDICT BEHAV, V28, P1299, DOI 10.1016/S0306-4603(02)00248-4; Matano RA, 2002, J BEHAV HEALTH SER R, V29, P30, DOI 10.1007/BF02287830; National Audit Office, 2008, RED ALC HARM HLTH SE; O'Malley PM, 2002, J STUD ALCOHOL, P23, DOI 10.15288/jsas.2002.s14.23; Poikolainen K, 2005, COMPREHENSIVE HDB AL, P49; *PRIM MIN STRAT UN, 2004, ALC HARM RED STRAT E; Roman PM, 2002, ALCOHOL RES HEALTH, V26, P49; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SEPPA K, 1995, ALCOHOL CLIN EXP RES, V19, P999, DOI 10.1111/j.1530-0277.1995.tb00980.x; Taylor C, 2007, BRIT J PSYCHIAT, V190, P268, DOI 10.1192/bjp.bp.106.023234; The NHS Information Centre, 2009, AD PSYCH MORB SURV 2; The NHS Information Centre Lifestyle Statistics, 2011, STAT ALC ENGL 2011; Trades Union Congress, 2003, ALC WORK POT COCKT T; Vasianovich A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-58; WHO, 1994, LEX ALC DRUG TERMS	38	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e98134	10.1371/journal.pone.0098134	http://dx.doi.org/10.1371/journal.pone.0098134			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072628	gold, Green Published, Green Submitted			2022-12-27	WOS:000341307600002
J	Baboota, RK; Singh, DP; Sarma, SM; Kaur, J; Sandhir, R; Boparai, RK; Kondepudi, KK; Bishnoi, M				Baboota, Ritesh K.; Singh, Dhirendra P.; Sarma, Siddhartha M.; Kaur, Jaspreet; Sandhir, Rajat; Boparai, Ravneet K.; Kondepudi, Kanthi K.; Bishnoi, Mahendra			Capsaicin Induces "Brite" Phenotype in Differentiating 3T3-L1 Preadipocytes	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ADIPOSE-TISSUE; HIGH-FAT; KAPPA-B; ENERGY-METABOLISM; SPICY COMPONENT; GENE-EXPRESSION; ADIPONECTIN; ADIPOGENESIS; TRPV1	Objective: Targeting the energy storing white adipose tissue (WAT) by pharmacological and dietary means in order to promote its conversion to energy expending "brite'' cell type holds promise as an anti-obesity approach. Present study was designed to investigate/revisit the effect of capsaicin on adipogenic differentiation with special reference to induction of "brite'' phenotype during differentiation of 3T3-L1 preadipocytes. Methods: Multiple techniques such as Ca2+ influx assay, Oil Red-O staining, nutrigenomic analysis in preadipocytes and matured adipocytes have been employed to understand the effect of capsaicin at different doses. In addition to in-vitro experiments, in-vivo studies were carried out in high-fat diet (HFD) fed rats treated with resiniferatoxin (RTX) (a TRPV1 agonist) and in mice administered capsaicin. Results: TRPV1 channels are expressed in preadipocytes but not in adipocytes. In preadipocytes, both capsaicin and RTX stimulate Ca2+ influx in dose-dependent manner. This stimulation may be prevented by capsazepine, a TRPV1 antagonist. At lower doses, capsaicin inhibits lipid accumulation and stimulates TRPV1 gene expression, while at higher doses it enhances accumulation of lipids and suppresses expression of its receptor. In doses of 0.1-100 mu M, capsaicin promotes expression of major pro-adipogenic factor PPAR gamma and some of its downstream targets. In concentrations of 1 mu M, capsaicin up-regulates anti-adipogenic genes. Low-dose capsaicin treatment of 3T3-L1 preadipocytes differentiating into adipocytes results in increased expression of brown fat cell marker genes. In white adipose of mice, capsaicin administration leads to increase in browning-specific genes. Global TRPV1 ablation (i.p. by RTX administration) leads to increase in locomotor activity with no change in body weight. Conclusion: Our findings suggest the dual modulatory role of capsaicin in adipogenesis. Capsaicin inhibits adipogenesis in 3T3-L1 via TRPV1 activation and induces brown-like phenotype whereas higher doses.	[Baboota, Ritesh K.; Singh, Dhirendra P.; Sarma, Siddhartha M.; Kondepudi, Kanthi K.; Bishnoi, Mahendra] Natl Agri Food Biotechnol Inst NABI, Sas Nagar, Punjab, India; [Kaur, Jaspreet] Panjab Univ, UIET, Dept Biotechnol, Chandigarh 160014, India; [Sandhir, Rajat; Boparai, Ravneet K.] Panjab Univ, Dept Biochem, Chandigarh 160014, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Panjab University; Panjab University	Bishnoi, M (corresponding author), Natl Agri Food Biotechnol Inst NABI, Sas Nagar, Punjab, India.	mbishnoi@gmail.com	Baboota, Ritesh Kumar/AAQ-2606-2020; Bishnoi, Mahendra/CAG-3229-2022; Kondepudi, Kanthi Kiran/P-8336-2014	Kondepudi, Kanthi Kiran/0000-0001-8036-7555; Singh, Dhirendra Pratap/0000-0002-9454-9752; Bishnoi, Mahendra/0000-0002-7785-1204	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The authors would like to thank Department of Biotechnology, Government of India, for research grants given to National Agri-Food Biotechnology Institute (NABI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, AM J PHYSIOL-REG I, V288, pR1220, DOI 10.1152/ajpregu.00397.2004; Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bishnoi M, 2011, J PAIN, V12, P991, DOI 10.1016/j.jpain.2011.03.005; Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002; Bruun JM, 2002, MOL CELL ENDOCRINOL, V190, P91, DOI 10.1016/S0303-7207(02)00007-2; Chandrasekar B, 2008, J BIOL CHEM, V283, P4200, DOI 10.1074/jbc.M708142200; Chavez M, 1997, AM J PHYSIOL-REG I, V272, pR1657, DOI 10.1152/ajpregu.1997.272.5.R1657; Cheng X, 2012, J BIOL CHEM, V287, P36896, DOI 10.1074/jbc.M112.409516; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Clegg ME, 2013, EUR J NUTR, V52, P1579, DOI 10.1007/s00394-012-0463-9; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gaur V, 2010, BRAIN RES BULL, V82, P57, DOI 10.1016/j.brainresbull.2010.01.010; Gonzalez LE, 1996, BRAIN RES, V732, P145, DOI 10.1016/0006-8993(96)00517-3; Hsu CL, 2007, J AGR FOOD CHEM, V55, P1730, DOI 10.1021/jf062912b; Jeffry JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007021; Kang JH, 2007, FEBS LETT, V581, P4389, DOI 10.1016/j.febslet.2007.07.082; Kang JH, 2010, OBESITY, V18, P780, DOI 10.1038/oby.2009.301; Kawabata F, 2009, BIOSCI BIOTECH BIOCH, V73, P2690, DOI 10.1271/bbb.90555; KAWADA T, 1986, P SOC EXP BIOL MED, V183, P250; Kim CS, 2004, J MED FOOD, V7, P267, DOI 10.1089/jmf.2004.7.267; Kobayashi Y, 2001, PLANTA MED, V67, P628, DOI 10.1055/s-2001-17353; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; Lee MS, 2011, PHYTOTHER RES, V25, P935, DOI 10.1002/ptr.3339; Li HF, 2010, MOL CELL ENDOCRINOL, V323, P201, DOI 10.1016/j.mce.2010.03.021; Lihn AS, 2004, MOL CELL ENDOCRINOL, V219, P9, DOI 10.1016/j.mce.2004.03.002; Lira FS, 2012, CYTOKINE, V57, P98, DOI 10.1016/j.cyto.2011.10.001; Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100; Marshall NJ, 2013, HYPERTENSION, V61, P246, DOI 10.1161/HYPERTENSIONAHA.112.201434; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; Park JY, 2004, FEBS LETT, V572, P266, DOI 10.1016/j.febslet.2004.06.084; Premkumar LS, 2010, AAPS J, V12, P361, DOI 10.1208/s12248-010-9196-y; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; Safieh-Garabedian B, 2013, NEUROSCIENCE, V250, P455, DOI 10.1016/j.neuroscience.2013.07.031; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Schwarz NA, 2013, NUTR RES; Sukumar P, 2012, CIRC RES, V111, P191, DOI [10.1161/CIRCRESAHA.112.270751, 10.1161/circresaha.112.270751]; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606; Yoshioka M, 1998, BRIT J NUTR, V80, P503, DOI 10.1017/S0007114598001597; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b	51	89	92	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103093	10.1371/journal.pone.0103093	http://dx.doi.org/10.1371/journal.pone.0103093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072597	gold, Green Published, Green Submitted			2022-12-27	WOS:000341307600022
J	Smith, MA; Canfell, K				Smith, Megan A.; Canfell, Karen			Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; ADOLESCENT MALES; COST-EFFECTIVENESS; PREDICTED IMPACT; CERVICAL-CANCER; SEXUAL-BEHAVIOR; NATIONAL-SURVEY; HERD-IMMUNITY; UNITED-STATES; ACCEPTABILITY	Background: Vaccines against HPV16/18 are approved for use in females and males but most countries currently have female-only programs. Cultural and geographic factors associated with HPV vaccine uptake might also influence sexual partner choice; this might impact post-vaccination outcomes. Our aims were to examine the population-level impact of adding males to HPV vaccination programs if factors influencing vaccine uptake also influence partner choice, and additionally to quantify how this changes the post-vaccination distribution of disease between subgroups, using incident infections as the outcome measure. Methods: A dynamic model simulated vaccination of pre-adolescents in two scenarios: 1) vaccine uptake was correlated with factors which also affect sexual partner choice ("correlated"); 2) vaccine uptake was unrelated to these factors ("unrelated"). Coverage and degree of heterogeneity in uptake were informed by observed data from Australia and the USA. Population impact was examined via the effect on incident HPV16 infections. The rate ratio for post-vaccination incident HPV16 in the lowest compared to the highest coverage subgroup (RRL) was calculated to quantify between-group differences in outcomes. Results: The population-level incremental impact of adding males was lower if vaccine uptake was "correlated", however the difference in population-level impact was extremely small (<1%) in the Australia and USA scenarios, even under the conservative and extreme assumption that subgroups according to coverage did not mix at all sexually. At the subgroup level, "correlated" female-only vaccination resulted in RRL = 1.9 (Australia) and 1.5 (USA) in females, and RRL = 1.5 and 1.3 in males. "Correlated" both-sex vaccination increased RRL to 4.2 and 2.1 in females and 3.9 and 2.0 in males in the Australia and USA scenarios respectively. Conclusions: The population-level incremental impact of male vaccination is unlikely to be substantially impacted by feasible levels of heterogeneity in uptake. However, these findings emphasize the continuing importance of prioritizing high coverage across all groups in HPV vaccination programs in terms of achieving equality of outcomes.	[Smith, Megan A.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Smith, Megan A.; Canfell, Karen] UNSW Australia, Prince Wales Clin Sch, Sydney, NSW, Australia	University of Sydney; University of New South Wales Sydney	Smith, MA (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	megan.smith@unsw.edu.au		Smith, Megan/0000-0002-0401-2653; Canfell, Karen/0000-0002-6443-6618	National Health and Medical Research Council [440200, 1007518]; Cancer Council NSW; National Health and Medical Research Council Australia [CDF1007994]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia)	Development of the model used in this analysis was partially funded by National Health and Medical Research Council Project Grants #440200, #1007518 and by Cancer Council NSW. Karen Canfell receives salary support from the National Health and Medical Research Council Australia (CDF1007994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No specific funding was received for the current analysis.	Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; Australian Bureau of Statistics, 2008, POP AG SEX AUSTR STA, V3201; Barbaro B, 2012, MED J AUSTRALIA, V196, P445, DOI 10.5694/mja11.11360; Bogaards JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001147; Brisson M, 2011, J INFECT DIS, V204, P372, DOI 10.1093/infdis/jir285; Bundesministerium fur Gesundheit (Austrian Federal Ministry for Health), 2013, AUSB KIND IMPFPR AUF; Canfell K, 2012, VACCINE, V30, pF157, DOI 10.1016/j.vaccine.2012.06.091; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P1705; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Dempsey AF, 2012, J ADOLESCENT HEALTH, V50, P421, DOI 10.1016/j.jadohealth.2011.08.017; Department of Health and Ageing, 2011, HUM PAP HPV IMM AUST; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Dorell Christina, 2011, Morbidity and Mortality Weekly Report, V60, P1117; European Centre for Disease Prevention and Control, 2012, INTR HPV VACC EU COU; Fisher H, 2013, INT J EPIDEMIOL, V42, P896, DOI 10.1093/ije/dyt049; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; Gilkey MB, 2012, VACCINE, V30, P5928, DOI 10.1016/j.vaccine.2012.07.045; Hamlish T, 2012, VACCINE, V30, P6472, DOI 10.1016/j.vaccine.2012.07.085; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Keenan K, 2012, HEALTH PSYCHOL, V31, P31, DOI 10.1037/a0026812; Kessels SJ, 2012, VACCINE; Kim JJ, 2010, LANCET INFECT DIS, V10, P845, DOI 10.1016/S1473-3099(10)70219-X; Kumar VM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-172; LECLERC A, 1990, INT J EPIDEMIOL, V19, P1001, DOI 10.1093/ije/19.4.1001; Lenselink CH, 2008, EUR J OBSTET GYN R B, V137, P103, DOI 10.1016/j.ejogrb.2007.02.012; Liddon N, 2010, J ADOLESCENT HEALTH, V46, P113, DOI 10.1016/j.jadohealth.2009.11.199; Liddon NC, 2012, AM J PREV MED, V42, P44, DOI 10.1016/j.amepre.2011.09.024; Malagon T, 2013, VACCINE, V31, P1740, DOI 10.1016/j.vaccine.2013.01.026; Marlow LAV, 2011, BRIT J CANCER, V105, P486, DOI 10.1038/bjc.2011.272; Musto R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-640; National Advisory Committee on Immunization, 2012, CAN COMMUNDIS REP; Ogilvie GS, 2008, SEX TRANSM INFECT, V84, P318, DOI 10.1136/sti.2007.029389; Palefsky JM, 2010, J ADOLESCENT HEALTH, V46, pS12, DOI 10.1016/j.jadohealth.2010.01.010; Pharmaceutical Benefits Advisory Committee, 2011, NOV 2011 PBAC OUTC P; Preston SH, 1981, IUSSP 19 INT POP C L, P233; Reiter PL, 2013, VACCINE, V31, P2816, DOI 10.1016/j.vaccine.2013.04.010; Reiter PL, 2011, VACCINE, V29, P5595, DOI 10.1016/j.vaccine.2011.06.020; Reiter PL, 2010, VACCINE, V28, P6292, DOI 10.1016/j.vaccine.2010.06.114; Sadigh G, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18456; Shafer LA, 2013, VACCINE, V31, P4848, DOI 10.1016/j.vaccine.2013.07.073; Simatherai D, 2009, SEX TRANSM INFECT, V85, P148, DOI 10.1136/sti.2008.032581; Smith L, 2012, HPV IMMUNISATION PRO; Smith M, 2013, NATL CERVICAL SCREEN; Smith MA, 2008, INT J CANCER, V123, P1854, DOI 10.1002/ijc.23633; Smith MA, 2011, VACCINE, V29, P9112, DOI 10.1016/j.vaccine.2011.02.091; U. S. Census Bureau, 2011, NSTEST201101 US CENS; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Walker R, 2012, STAT MED, V31, P3419, DOI 10.1002/sim.5545; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; Zhang SK, 2013, VACCINE, V31, P3244, DOI 10.1016/j.vaccine.2013.05.046	54	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e101048	10.1371/journal.pone.0101048	http://dx.doi.org/10.1371/journal.pone.0101048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25089637	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700002
J	Curtis, FA; Malay, AD; Trotter, AJ; Wilson, LA; Barradell-Black, MMH; Bowers, LY; Reed, P; Hillyar, CRT; Yeo, RP; Sanderson, JM; Heddle, JG; Sharples, GJ				Curtis, Fiona A.; Malay, Ali D.; Trotter, Alexander J.; Wilson, Lindsay A.; Barradell-Black, Michael M. H.; Bowers, Laura Y.; Reed, Patricia; Hillyar, Christopher R. T.; Yeo, Robert P.; Sanderson, John M.; Heddle, Jonathan G.; Sharples, Gary J.			Phage Orf Family Recombinases: Conservation of Activities and Involvement of the Central Channel in DNA Binding	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; ESCHERICHIA-COLI RECO; CIRCULAR-DICHROISM SPECTRA; LAMBDA ORF; HOMOLOGOUS RECOMBINATION; REPLICATION; REPAIR; RECFOR; DAMAGE; RNA	Genetic and biochemical evidence suggests that lambda Orf is a recombination mediator, promoting nucleation of either bacterial RecA or phage Red beta recombinases onto single-stranded DNA (ssDNA) bound by SSB protein. We have identified a diverse family of Orf proteins that includes representatives implicated in DNA base flipping and those fused to an HNH endonuclease domain. To confirm a functional relationship with the Orf family, a distantly-related homolog, YbcN, from Escherichia coli cryptic prophage DLP12 was purified and characterized. As with its lambda relative, YbcN showed a preference for binding ssDNA over duplex. Neither Orf nor YbcN displayed a significant preference for duplex DNA containing mismatches or 1-3 nucleotide bulges. YbcN also bound E. coli SSB, although unlike Orf, it failed to associate with an SSB mutant lacking the flexible C-terminal tail involved in coordinating heterologous protein-protein interactions. Residues conserved in the Orf family that flank the central cavity in the lambda Orf crystal structure were targeted for mutagenesis to help determine the mode of DNA binding. Several of these mutant proteins showed significant defects in DNA binding consistent with the central aperture being important for substrate recognition. The widespread conservation of Orf-like proteins highlights the importance of targeting SSB coated ssDNA during lambdoid phage recombination.	[Curtis, Fiona A.; Trotter, Alexander J.; Wilson, Lindsay A.; Barradell-Black, Michael M. H.; Bowers, Laura Y.; Reed, Patricia; Hillyar, Christopher R. T.; Yeo, Robert P.; Sharples, Gary J.] Univ Durham, Biophys Sci Inst, Sch Biol & Biomed Sci, Durham, England; [Malay, Ali D.; Heddle, Jonathan G.] RIKEN, Heddle Initiat Res Unit, Wako, Saitama, Japan; [Sanderson, John M.] Univ Durham, Biophys Sci Inst, Dept Chem, Durham, England	Durham University; RIKEN; Durham University	Sharples, GJ (corresponding author), Univ Durham, Biophys Sci Inst, Sch Biol & Biomed Sci, Durham, England.	gary.sharples@durham.ac.uk	Hillyar, Christopher/AAM-5755-2021; Heddle, Jonathan G/H-4586-2014; Heddle, Jonathan/AAP-7167-2020; Sharples, Gary/B-8638-2016; Sanderson, John/E-6562-2012; Malay, Ali/N-9136-2015	Sharples, Gary/0000-0003-2495-0062; Sanderson, John/0000-0001-7023-8442; Malay, Ali/0000-0003-0885-5524; Reed, Patricia/0000-0002-4263-6993; Hillyar, Christopher/0000-0001-8316-5772	Biotechnology and Biological Sciences Research Council [BB/C514523/1, BB/FO20503/1]; RIKEN Initiative; BBSRC [BB/F020503/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F020503/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); RIKEN Initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk/) grants BB/C514523/1 and BB/FO20503/1 to GS. JGH and ADM were funded by RIKEN Initiative Research Funding awarded to JGH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Balaji S, 2007, NUCLEIC ACIDS RES, V35, P5658, DOI 10.1093/nar/gkm558; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; CHASE JW, 1984, J BIOL CHEM, V259, P805; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Court R, 2007, J MOL BIOL, V371, P25, DOI 10.1016/j.jmb.2007.05.037; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Curtis FA, 2011, J MOL RECOGNIT, V24, P333, DOI 10.1002/jmr.1079; De Paepe M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004181; Donaldson JR, 2004, GENETICS, V166, P1631, DOI 10.1534/genetics.166.4.1631; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; GOHLKE C, 1994, P NATL ACAD SCI USA, V91, P11660, DOI 10.1073/pnas.91.24.11660; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Li XT, 2013, MOL MICROBIOL, V88, P906, DOI 10.1111/mmi.12231; LILLEY DMJ, 1995, P NATL ACAD SCI USA, V92, P7140, DOI 10.1073/pnas.92.16.7140; Liu J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-357; Mahdi AA, 1996, J MOL BIOL, V257, P561, DOI 10.1006/jmbi.1996.0185; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Maxwell KL, 2005, P NATL ACAD SCI USA, V102, P11260, DOI 10.1073/pnas.0503399102; Moore T, 2003, EMBO J, V22, P735, DOI 10.1093/emboj/cdg048; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Morimatsu K, 2012, J BIOL CHEM, V287, P35621, DOI 10.1074/jbc.M112.397034; Murphy KC, 2007, J MOL BIOL, V371, P19, DOI 10.1016/j.jmb.2007.05.085; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; Poteete AR, 2004, J BACTERIOL, V186, P2699, DOI 10.1128/JB.186.9.2699-2707.2004; Poteete AR, 2001, FEMS MICROBIOL LETT, V201, P9, DOI 10.1016/S0378-1097(01)00242-7; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Sakai A, 2009, J BIOL CHEM, V284, P3264, DOI 10.1074/jbc.M807220200; SAWITZKE JA, 1992, GENETICS, V130, P7; Sawitzke JA, 1997, GENETICS, V147, P357; Sharples GJ, 2004, J MOL BIOL, V340, P739, DOI 10.1016/j.jmb.2004.05.030; Sharples GJ, 2002, MOL MICROBIOL, V44, P549, DOI 10.1046/j.1365-2958.2002.02916.x; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SHUB DA, 1994, TRENDS BIOCHEM SCI, V19, P402, DOI 10.1016/0968-0004(94)90086-8; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stahl MM, 1997, GENETICS, V147, P961; Swofford DL., 2003, PAUP PHYLOGENETIC AN; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	55	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e102454	10.1371/journal.pone.0102454	http://dx.doi.org/10.1371/journal.pone.0102454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083707	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000339819800009
J	Gu, SH; Sun, L; Yang, RN; Wu, KM; Guo, YY; Li, XC; Zhou, JJ; Zhang, YJ				Gu, Shao-Hua; Sun, Liang; Yang, Ruo-Nan; Wu, Kong-Ming; Guo, Yu-Yuan; Li, Xian-Chun; Zhou, Jing-Jiang; Zhang, Yong-Jun			Molecular Characterization and Differential Expression of Olfactory Genes in the Antennae of the Black Cutworm Moth Agrotis ipsilon	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; SEX-PHEROMONE GLAND; CHEMOSENSORY PROTEINS; IMMUNOCYTOCHEMICAL LOCALIZATION; CHEMORECEPTOR SUPERFAMILY; TRANSCRIPTOME ANALYSIS; REGENERATING LEGS; FEMALE ANTENNAE; RECEPTORS; IDENTIFICATION	Insects use their sensitive and selective olfactory system to detect outside chemical odorants, such as female sex pheromones and host plant volatiles. Several groups of olfactory proteins participate in the odorant detection process, including odorant binding proteins (OBPs), chemosensory proteins (CSPs), odorant receptors (ORs), ionotropic receptors (IRs) and sensory neuron membrane proteins (SNMPs). The identification and functional characterization of these olfactory proteins will enhance our knowledge of the molecular basis of insect chemoreception. In this study, we report the identification and differential expression profiles of these olfactory genes in the black cutworm moth Agrotis ipsilon. In total, 33 OBPs, 12 CSPs, 42 ORs, 24 IRs, 2 SNMPs and 1 gustatory receptor (GR) were annotated from the A. ipsilon antennal transcriptomes, and further RT-PCR and RT-qPCR revealed that 22 OBPs, 3 CSPs, 35 ORs, 14 IRs and the 2 SNMPs are uniquely or primarily expressed in the male and female antennae. Furthermore, one OBP (AipsOBP6) and one CSP (AipsCSP2) were exclusively expressed in the female sex pheromone gland. These antennae-enriched OBPs, CSPs, ORs, IRs and SNMPs were suggested to be responsible for pheromone and general odorant detection and thus could be meaningful target genes for us to study their biological functions in vivo and in vitro.	[Gu, Shao-Hua; Sun, Liang; Yang, Ruo-Nan; Wu, Kong-Ming; Guo, Yu-Yuan; Li, Xian-Chun; Zhang, Yong-Jun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Zhou, Jing-Jiang] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England; [Sun, Liang] Nanjing Agr Univ, Coll Plant Protect, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Nanjing Agricultural University	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yjzhang@ippcaas.cn			China National 973 Basic Research Program [2012CB114104]; National Natural Science Foundation of China [31071694, 31171858, 31272048]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [31321004]; BBSRC [BBS/E/C/00005194] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194] Funding Source: researchfish	China National 973 Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the China National 973 Basic Research Program (Grant No. 2012CB114104) the National Natural Science Foundation of China (Grant No. 31071694, 31171858 and 31272048) and the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (Grant No. 31321004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson I, 1998, BIOINFORMATICS, V14, P349, DOI 10.1093/bioinformatics/14.4.349; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Carlsson MA, 2002, CHEM SENSES, V27, P231, DOI 10.1093/chemse/27.3.231; Chen YA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-416; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Clement S. L., 1982, California Agriculture, V36, P20; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Greiner B, 2004, J COMP NEUROL, V475, P202, DOI 10.1002/cne.20173; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073524; Gu SH, 2013, J INSECT PHYSIOL, V59, P430, DOI 10.1016/j.jinsphys.2013.02.003; Gu SH, 2013, INSECT BIOCHEM MOLEC, V43, P237, DOI 10.1016/j.ibmb.2012.12.009; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; Jin X, 2005, CELL MOL LIFE SCI, V62, P1156, DOI 10.1007/s00018-005-5014-6; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Mamidala P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056555; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nishimura O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050664; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 1996, J NEUROBIOL, V30, P3; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Rings R.W., 1974, OHIO AGR RES DEV CEN, V198, P1; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rogers ME, 2001, CELL TISSUE RES, V303, P433, DOI 10.1007/s004410000305; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schneider D, 1998, J COMP PHYSIOL A, V182, P153, DOI 10.1007/s003590050166; Smadja C, 2009, MOL BIOL EVOL, V26, P2073, DOI 10.1093/molbev/msp116; Steinbrecht RA, 1997, INT J INSECT MORPHOL, V26, P229, DOI 10.1016/S0020-7322(97)00024-X; STEINBRECHT RA, 1992, CELL TISSUE RES, V270, P287, DOI 10.1007/BF00328015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x	94	55	64	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103420	10.1371/journal.pone.0103420	http://dx.doi.org/10.1371/journal.pone.0103420			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083706	gold, Green Submitted, Green Published			2022-12-27	WOS:000339819800039
J	Oh, YT; Cho, HJ; Kim, JK; Lee, JH; Rho, K; Seo, YJ; Choi, YS; Jung, HJ; Song, HS; Kong, DS; Seol, HJ; Lee, JI; Yoon, Y; Kim, SH; Nam, DH; Joo, KM				Oh, Young Taek; Cho, Hee Jin; Kim, Jinkuk; Lee, Ji-Hyun; Rho, Kyoohyoung; Seo, Yun-Jee; Choi, Yeon-Sook; Jung, Hye Jin; Song, Hyeon Suk; Kong, Doo-Sik; Seol, Ho Jun; Lee, Jung-Il; Yoon, Yeup; Kim, Sunghoon; Nam, Do-Hyun; Joo, Kyeung Min			Translational Validation of Personalized Treatment Strategy Based on Genetic Characteristics of Glioblastoma	PLOS ONE			English	Article							RECURSIVE PARTITIONING ANALYSIS; CENTRAL-NERVOUS-SYSTEM; NUDE-MOUSE MODEL; TUMOR MICROENVIRONMENT; PANCREATIC-CANCER; DRUG DEVELOPMENT; MULTIFORME; TEMOZOLOMIDE; XENOGRAFT; BRAIN	Glioblastoma (GBM) heterogeneity in the genomic and phenotypic properties has potentiated personalized approach against specific therapeutic targets of each GBM patient. The Cancer Genome Atlas (TCGA) Research Network has been established the comprehensive genomic abnormalities of GBM, which sub-classified GBMs into 4 different molecular subtypes. The molecular subtypes could be utilized to develop personalized treatment strategy for each subtype. We applied a classifying method, NTP (Nearest Template Prediction) method to determine molecular subtype of each GBM patient and corresponding orthotopic xenograft animal model. The models were derived from GBM cells dissociated from patient's surgical sample. Specific drug candidates for each subtype were selected using an integrated pharmacological network database (PharmDB), which link drugs with subtype specific genes. Treatment effects of the drug candidates were determined by in vitro limiting dilution assay using patient-derived GBM cells primarily cultured from orthotopic xenograft tumors. The consistent identification of molecular subtype by the NTP method was validated using TCGA database. When subtypes were determined by the NTP method, orthotopic xenograft animal models faithfully maintained the molecular subtypes of parental tumors. Subtype specific drugs not only showed significant inhibition effects on the in vitro clonogenicity of patient-derived GBM cells but also synergistically reversed temozolomide resistance of MGMT-unmethylated patient-derived GBM cells. However, inhibitory effects on the clonogenicity were not totally subtype-specific. Personalized treatment approach based on genetic characteristics of each GBM could make better treatment outcomes of GBMs, although more sophisticated classifying techniques and subtype specific drugs need to be further elucidated.	[Oh, Young Taek; Cho, Hee Jin; Kim, Jinkuk; Seo, Yun-Jee; Choi, Yeon-Sook; Jung, Hye Jin; Song, Hyeon Suk; Kong, Doo-Sik; Seol, Ho Jun; Lee, Jung-Il; Yoon, Yeup; Nam, Do-Hyun; Joo, Kyeung Min] Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Oh, Young Taek; Cho, Hee Jin; Kim, Jinkuk; Seo, Yun-Jee; Choi, Yeon-Sook; Jung, Hye Jin; Song, Hyeon Suk; Kong, Doo-Sik; Seol, Ho Jun; Lee, Jung-Il; Yoon, Yeup; Nam, Do-Hyun; Joo, Kyeung Min] Samsung Med Ctr, Inst Refractory Canc Res, Seoul, South Korea; [Oh, Young Taek; Cho, Hee Jin; Yoon, Yeup; Nam, Do-Hyun; Joo, Kyeung Min] Sungkyunkwan Univ, SAIHST, Seoul, South Korea; [Kong, Doo-Sik; Seol, Ho Jun; Lee, Jung-Il; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Dept Neurosurg, Seoul, South Korea; [Joo, Kyeung Min] Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Seoul, South Korea; [Kim, Jinkuk] Samsung Elect Co Ltd, Samsung Adv Inst Technol, Seoul, South Korea; [Lee, Ji-Hyun; Rho, Kyoohyoung; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Med Bioconvergence Res Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung; Seoul National University (SNU)	Kim, SH (corresponding author), Seoul Natl Univ, Coll Pharm, Med Bioconvergence Res Ctr, Seoul, South Korea.	sungkim@snu.ac.kr; nsnam@skku.edu; kmjoo@skku.edu	Kim, Jinkuk/AAJ-1999-2020; Kim, Sunghoon/AAE-8314-2020; Oh, Michael/AAO-8026-2020	Oh, Michael/0000-0001-8356-2428; kim, sunghoon/0000-0002-1570-3230	Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [H109C1552]	Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Health Technology R & D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (H109C1552). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Groves MD, 2002, J CLIN ONCOL, V20, P1383, DOI 10.1200/JCO.20.5.1383; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; HORTEN BC, 1981, J NEUROPATH EXP NEUR, V40, P493, DOI 10.1097/00005072-198109000-00002; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Joo KM, 2013, CELL REP, V3, P260, DOI 10.1016/j.celrep.2012.12.013; Karam JA, 2011, EUR UROL, V59, P619, DOI 10.1016/j.eururo.2010.11.043; Kreth FW, 1999, CANCER, V86, P2117, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2117::AID-CNCR33>3.3.CO;2-#; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Lee HS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-80; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Martens T, 2008, CLIN CANCER RES, V14, P5447, DOI 10.1158/1078-0432.CCR-08-0147; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Scott CB, 1998, INT J RADIAT ONCOL, V40, P51, DOI 10.1016/S0360-3016(97)00485-9; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taillandier L, 2003, J NEUROSCI METH, V125, P147, DOI 10.1016/S0165-0270(03)00043-8; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-465; Xie Q, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-77; Zhuo Ying, 2010, Zhongguo Fei Ai Za Zhi, V13, P568, DOI 10.3779/j.issn.1009-3419.2010.06.020	32	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103327	10.1371/journal.pone.0103327	http://dx.doi.org/10.1371/journal.pone.0103327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084005	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800032
J	Ramdasi, AY; Arya, RP; Arankalle, VA				Ramdasi, Ashwini Y.; Arya, Ravi P.; Arankalle, Vidya A.			Effect of Pregnancy on Anti-HEV Antibody Titres, Plasma Cytokines and the Corresponding Gene Expression Levels in the PBMCs of Patients Presenting with Self-Recovering Clinical and Subclinical Hepatitis E	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; E VIRUS-INFECTION; FULMINANT-HEPATITIS; VIRAL LOAD; IMMUNE-RESPONSES; INFLUENZA; SEVERITY; CELLS; SERUM; RISK	High mortality in pregnant women (PR) is a characteristic of hepatitis E in developing countries. To understand the pathogenesis of HEV infection in self-limiting disease during pregnancy, we compared clinical (PR-patients) and subclinical-HEV-infections in pregnant women in the first (SC-PR-1) and later (2nd and 3rd, SC-PR-2+3) trimesters with the respective healthy controls and acute non-PR patients. The SC-PR-2+3 exhibited lower ALT, bilirubin levels, anti-HEV-IgM/IgG titres than the acute-PR/non-PR-patients (p<0.05-0.0001). IFN gamma/IL4ratios indicated Th2/Th1 bias in non-PR and PR-patients respectively. Raised levels of 10/20 plasma cytokines in the non-PR-patients reflect predominant inflammatory response, unaltered-IFN gamma/reduced-IFN alpha responses and a robust chemokine secretion. On contrary, the acute-PR-patients exhibited drastic reduction in majority of the cytokines relative to in the non-PR-patients. Importantly, diminished or unaltered response was noted in the acute-PR-group when compared to the corresponding controls. The only exception was sIL2RA, increasing in both patient categories. Of the 14 genes evaluated, the expression of IFN gamma/IL10/IL1A/IL7/CCL2/CCL3/CXCL8/CXCL10 was higher in the non-PR patients. Of these, the expression of IFN gamma/IL10/IL1A/CCL2/CCL3/CXCL8 and, additionally, IL2/IL6/TNF genes was higher in the clinical-PRs. Almost identical pattern was noted in the control-PR-2+3 category indicating no influence of HEV infection. Comparison of patient-categories identified significant elevation of IFN gamma(P<0.001), CCL2(p<0.01), CXCL8(P<0.05), IL1B(p<0.05) and IL10(P<0.0001) and decrease in CXCL10(<0.05) in the PR-patients. The results suggest antibody-dependent disease severity and impaired immune response in the PR patients. Higher expression of cytokine-genes in the PBMCs did not correlate with the plasma-cytokine levels in the PR-patients.	[Ramdasi, Ashwini Y.; Arya, Ravi P.; Arankalle, Vidya A.] Natl Inst Virol, Hepatitis Div, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Arankalle, VA (corresponding author), Natl Inst Virol, Hepatitis Div, Pune, Maharashtra, India.	varankalle@yahoo.com	ARYA, RAVI/AAF-4108-2020; ARYA, RAVI/F-7684-2015	ARYA, RAVI/0000-0001-9255-610X; ARYA, RAVI/0000-0001-9255-610X; Arankalle, Vidya/0000-0002-9940-3437	Indian Council of Medical Research (ICMR), Ministry of health and family welfare, Government of India	Indian Council of Medical Research (ICMR), Ministry of health and family welfare, Government of India(Indian Council of Medical Research (ICMR))	Financial support for this study was provided by the Indian Council of Medical Research (ICMR), Ministry of health and family welfare, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SK, 1996, HEPATOLOGY, V23, P1448, DOI 10.1053/jhep.1996.v23.pm0008675163; Arankalle VA, 2007, J VIRAL HEPATITIS, V14, P435, DOI 10.1111/j.1365-2893.2006.00801.x; Arankalle VA, 1998, J VIRAL HEPATITIS, V5, P199, DOI 10.1046/j.1365-2893.1998.00096.x; ARANKALLE VA, 1995, J VIRAL HEPATITIS, V2, P189, DOI 10.1111/j.1365-2893.1995.tb00028.x; ARANKALLE VA, 1993, INDIAN J MED RES-A, V97, P4; Arankalle VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013099; Borkakoti J, 2013, J MED VIROL, V85, P620, DOI 10.1002/jmv.23508; Bose PD, 2011, J HEPATOL, V54, P1107, DOI 10.1016/j.jhep.2010.08.037; Cabrera R, 2010, SCAND J IMMUNOL, V72, P293, DOI 10.1111/j.1365-3083.2010.02427.x; Chadha M.S., 1991, IND J COMM MED, V16, P153; Fossum C, 1998, DOMEST ANIM ENDOCRIN, V15, P439, DOI 10.1016/S0739-7240(98)80001-5; Gu X, 2011, EXP LUNG RES, V37, P445, DOI 10.3109/01902148.2011.587136; Harger JH, 2002, J INFECT DIS, V185, P422, DOI 10.1086/338832; Jilani N, 2007, J GASTROEN HEPATOL, V22, P676, DOI 10.1111/j.1440-1746.2007.04913.x; Kar P, 2008, AM J GASTROENTEROL, V103, P2495, DOI 10.1111/j.1572-0241.2008.02032.x; Keay SD, 2004, BJOG-INT J OBSTET GY, V111, P1218, DOI 10.1111/j.1471-0528.2004.00412.x; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0; Kraus TA, 2012, J CLIN IMMUNOL, V32, P300, DOI 10.1007/s10875-011-9627-2; Kraus TA, 2010, AM J REPROD IMMUNOL, V64, P411, DOI 10.1111/j.1600-0897.2010.00889.x; Lederman M M, 1984, Chest, V86, p6S, DOI 10.1378/chest.86.3_Supplement.6S; Lygnos MC, 2006, IN VIVO, V20, P157; Madan K, 1998, J GASTROEN HEPATOL, V13, P125, DOI 10.1111/j.1440-1746.1998.tb00626.x; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; Rathod SB, 2014, J VIRAL HEPATITIS, V21, P141, DOI 10.1111/jvh.12125; Saravanabalaji S, 2009, INTERVIROLOGY, V52, P78, DOI 10.1159/000214862; Srivastava R, 2011, J GASTROEN HEPATOL, V26, P306, DOI 10.1111/j.1440-1746.2010.06356.x; Stockman LJ, 2004, EMERG INFECT DIS, V10, P1689, DOI 10.3201/eid1009.040244; Tripathy AS, 2012, EUR J CLIN MICROBIOL, V31, P179, DOI 10.1007/s10096-011-1291-1; TSAREV SA, 1995, J INFECT DIS, V172, P31, DOI 10.1093/infdis/172.1.31; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Yajnik CS, 2008, DIABETOLOGIA, V51, P39, DOI 10.1007/s00125-007-0847-1	32	15	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103257	10.1371/journal.pone.0103257	http://dx.doi.org/10.1371/journal.pone.0103257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084004	gold, Green Submitted, Green Published			2022-12-27	WOS:000339819800022
J	Chen, XN; Wang, XD; Liebman, M; Cavigelli, M; Wander, M				Chen, Xianni; Wang, Xudong; Liebman, Matt; Cavigelli, Michel; Wander, Michelle			Influence of Residue and Nitrogen Fertilizer Additions on Carbon Mineralization in Soils with Different Texture and Cropping Histories	PLOS ONE			English	Article							ORGANIC-MATTER FRACTIONS; CONVENTIONAL FARMING SYSTEMS; MICROBIAL BIOMASS; POULTRY MANURE; DECOMPOSITION; TEMPERATURE; TILLAGE; AVAILABILITY; PARTICULATE; MOISTURE	To improve our ability to predict SOC mineralization response to residue and N additions in soils with different inherent and dynamic organic matter properties, a 330-day incubation was conducted using samples from two long-term experiments (clay loam Mollisols in Iowa [IAsoil] and silt loam Ultisols in Maryland [MDsoil]) comparing conventional grain systems (Conv) amended with inorganic fertilizers with 3 yr (Med) and longer (Long), more diverse cropping systems amended with manure. A double exponential model was used to estimate the size (C-a, C-s) and decay rates (k(a), k(s)) of active and slow C pools which we compared with total particulate organic matter (POM) and occluded-POM (OPOM). The high-SOC IAsoil containing highly active smectite clays maintained smaller labile pools and higher decay rates than the low-SOC MDsoil containing semi-active kaolinitic clays. Net SOC loss was greater (2.6 g kg(-1); 8.6%) from the IAsoil than the MDsoil (0.9 g kg(-1), 6.3%); fractions and coefficients suggest losses were principally from IAsoil's resistant pool. Cropping history did not alter SOC pool size or decay rates in IAsoil where rotation-based differences in OPOM-C were small. In MDsoil, use of diversified rotations and manure increased k(a) by 32% and k(s) by 46% compared to Conv; differences mirrored in POM- and OPOM-C contents. Residue addition prompted greater increases in C-a (340% vs 230%) and C-s (38% vs 21%) and decreases in k(a) (58% vs 9%) in IAsoil than MDsoil. Reduced losses of SOC from residue-amended MDsoil were associated with increased OPOM-C. Nitrogen addition dampened CO2-C release. Clay type and C saturation dominated the IAsoil's response to external inputs and made labile and stable fractions more vulnerable to decay. Trends in OPOM suggest aggregate protection influences C turnover in the low active MDsoil. Clay charge and OPOM-C contents were better predictors of soil C dynamics than clay or POM-C contents.	[Chen, Xianni; Wang, Xudong] Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi, Peoples R China; [Liebman, Matt] Iowa State Univ, Dept Agron, Ames, IA USA; [Cavigelli, Michel] Agr Res Ctr, Sustainable Agr Syst Lab, Beltsville, MD USA; [Wander, Michelle] Univ Illinois, Dept NRES, Urbana, IL 61801 USA	Northwest A&F University - China; Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign	Wang, XD (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Shaanxi, Peoples R China.	wangxudong01@126.com; mwander@illinois.edu		Liebman, Matt/0000-0001-6193-3849	NIFA (Hatch) [LLU-875-320]; Leopold Center for Sustainable Agriculture [2010-E02]; Iowa Soybean Association; Ministry of Science and Technology-Technology Integration and Demonstration of Agriculture-Fruit-Livestock Industry Recycling in Loss Plantae, China [2012BAD14B11]; ARS [ARS-0424914] Funding Source: Federal RePORTER	NIFA (Hatch); Leopold Center for Sustainable Agriculture; Iowa Soybean Association; Ministry of Science and Technology-Technology Integration and Demonstration of Agriculture-Fruit-Livestock Industry Recycling in Loss Plantae, China; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Financial support was given by NIFA (Hatch) LLU-875-320, and grants from the Leopold Center for Sustainable Agriculture (Project 2010-E02) and the Iowa Soybean Association. This project was also partially funded by the National 15th Key Technology R&D Program of the Ministry of Science and Technology-Technology Integration and Demonstration of Agriculture-Fruit-Livestock Industry Recycling in Loss Plantae, China (2012BAD14B11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiku SGK, 2008, PLANT SOIL, V311, P29, DOI 10.1007/s11104-008-9652-y; Arrouays D, 2006, SOIL USE MANAGE, V22, P48, DOI 10.1111/j.1475-2743.2006.00020.x; Bailey VL, 2002, SOIL BIOL BIOCHEM, V34, P997, DOI 10.1016/S0038-0717(02)00033-0; Bauer J, 2008, GEODERMA, V145, P17, DOI 10.1016/j.geoderma.2008.01.026; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; BONDE TA, 1987, SOIL SCI SOC AM J, V51, P1508, DOI 10.2136/sssaj1987.03615995005100060019x; Borchardt G, 1989, SSSA BOOK SERIES; Brady NC, 2004, ELEMENTS NATURE PROP, P386; Bukowski R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033047, 10.1371/journal.pone.0047149]; Chivenge P, 2011, AGR ECOSYST ENVIRON, V140, P361, DOI 10.1016/j.agee.2010.12.004; Cochran RL, 2007, BIOL FERT SOILS, V43, P479, DOI 10.1007/s00374-006-0126-1; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; Dixon J.B., 1989, SSSA BOOK SERIES; Fontaine S, 2003, SOIL BIOL BIOCHEM, V35, P837, DOI 10.1016/S0038-0717(03)00123-8; Franzluebbers AJ, 1997, SOIL SCI SOC AM J, V61, P1382, DOI 10.2136/sssaj1997.03615995006100050014x; Franzluebbers AJ, 1996, SOIL BIOL BIOCHEM, V28, P1367, DOI 10.1016/S0038-0717(96)00143-5; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Govaerts B, 2009, CRIT REV PLANT SCI, V28, P97, DOI 10.1080/07352680902776358; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P453, DOI 10.2136/sssaj1995.03615995005900020026x; Gulde S, 2008, SOIL SCI SOC AM J, V72, P605, DOI 10.2136/sssaj2007.0251; Hassink J, 1997, SOIL SCI SOC AM J, V61, P131, DOI 10.2136/sssaj1997.03615995006100010020x; Hobbie SE, 2000, ECOSYSTEMS, V3, P484, DOI 10.1007/s100210000042; Jindaluang W, 2013, GEODERMA, V195, P207, DOI 10.1016/j.geoderma.2012.12.003; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Kleber M, 2007, BIOGEOCHEMISTRY, V85, P9, DOI 10.1007/s10533-007-9103-5; Kremen C, 2012, ECOL SOC, V17, DOI 10.5751/ES-05035-170440; LADD JN, 1981, SOIL BIOL BIOCHEM, V13, P119, DOI 10.1016/0038-0717(81)90007-9; Lazicki PA, 2011, THESIS U ILLINOIS CH; Li LJ, 2013, EUR J SOIL BIOL, V54, P1, DOI 10.1016/j.ejsobi.2012.11.002; Liebman M, 2008, AGRON J, V100, P600, DOI 10.2134/agronj2007.0222; Lipson DA, 2000, SOIL BIOL BIOCHEM, V32, P441, DOI 10.1016/S0038-0717(99)00068-1; Marriott EE, 2006, SOIL SCI SOC AM J, V70, P950, DOI 10.2136/sssaj2005.0241; Marriott EE, 2006, SOIL BIOL BIOCHEM, V38, P1527, DOI 10.1016/j.soilbio.2005.11.009; Martin JV, 2012, SOIL RES, V50, P222, DOI 10.1071/SR11170; MCGILL WB, 1996, NATO ASI SERIES I, V38, P111, DOI DOI 10.1007/978-3-642-61094-3_9; Miyittah M, 2003, SOIL SCI PLANT NUTR, V49, P61, DOI 10.1080/00380768.2003.10409980; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; PARTON WJ, 1988, BIOGEOCHEMISTRY, V5, P109, DOI 10.1007/BF02180320; Paustian K, 1995, AUST J EXP AGR, V35, P929, DOI 10.1071/EA9950929; Peterson GA, 1998, SOIL TILL RES, V47, P207, DOI 10.1016/S0167-1987(98)00107-X; Qi Y, 2001, PLANT SOIL, V237, P15, DOI 10.1023/A:1013368800287; Rodrigo A, 1997, ECOL MODEL, V102, P325, DOI 10.1016/S0304-3800(97)00067-7; Saby NPA, 2008, SOIL USE MANAGE, V24, P254, DOI 10.1111/j.1475-2743.2008.00159.x; Sakala WD, 2000, SOIL BIOL BIOCHEM, V32, P679, DOI 10.1016/S0038-0717(99)00204-7; Saviozzi A, 1997, BIOL FERT SOILS, V25, P401, DOI 10.1007/s003740050332; Scott NA, 1996, SOIL SCI SOC AM J, V60, P1102, DOI 10.2136/sssaj1996.03615995006000040020x; Setia R, 2011, SOIL BIOL BIOCHEM, V43, P667, DOI 10.1016/j.soilbio.2010.12.004; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Spargo JT, 2011, NUTR CYCL AGROECOSYS, V90, P253, DOI 10.1007/s10705-011-9426-4; Stewart CE, 2008, SOIL BIOL BIOCHEM, V40, P1741, DOI 10.1016/j.soilbio.2008.02.014; Townsend AR, 1997, BIOGEOCHEMISTRY, V38, P1, DOI 10.1023/A:1017942918708; VANVEEN JA, 1985, SOIL BIOL BIOCHEM, V17, P747, DOI 10.1016/0038-0717(85)90128-2; Waldrop MP, 2004, OECOLOGIA, V138, P275, DOI 10.1007/s00442-003-1419-9; Wander M, 2004, ADV AGROECOL, P67; Wander MM, 2007, PLANT SOIL, V291, P311, DOI 10.1007/s11104-007-9198-4; WANDER MM, 1994, SOIL SCI SOC AM J, V58, P1130, DOI 10.2136/sssaj1994.03615995005800040018x; Wang WJ, 2003, SOIL BIOL BIOCHEM, V35, P273, DOI 10.1016/S0038-0717(02)00274-2; Wang WJ, 2004, SOIL BIOL BIOCHEM, V36, P2045, DOI 10.1016/j.soilbio.2004.05.023; Yang XM, 2001, SOIL TILL RES, V59, P107, DOI 10.1016/S0167-1987(01)00162-3; Yoo G, 2008, SOIL SCI SOC AM J, V72, P670, DOI 10.2136/sssaj2007.0110; Zentner RP, 2002, AGRON J, V94, P216, DOI 10.2134/agronj2002.0216; Zhang WW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052849, 10.1371/journal.pone.0054779]; Zhang XH, 2007, J ENVIRON SCI, V19, P319, DOI 10.1016/S1001-0742(07)60052-7	63	5	6	6	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103720	10.1371/journal.pone.0103720	http://dx.doi.org/10.1371/journal.pone.0103720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078458	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800070
J	Fonin, AV; Sulatskaya, AI; Kuznetsova, IM; Turoverov, KK				Fonin, Alexander V.; Sulatskaya, Anna I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.			Fluorescence of Dyes in Solutions with High Absorbance. Inner Filter Effect Correction	PLOS ONE			English	Article							THIOFLAVIN T; AMYLOID FIBRILS; QUANTUM YIELD; RIGHT-ANGLE; LUMINESCENCE; ABSORPTION; SPECTRA; PHOTOLUMINESCENCE; EMISSION; BINDING	Fluorescence is a proven tool in all fields of knowledge, including biology and medicine. A significant obstacle in its use is the nonlinearity of the dependence of the fluorescence intensity on fluorophore concentration that is caused by the so-called primary inner filter effect. The existing methods for correcting the fluorescence intensity are hard to implement in practice; thus, it is generally considered best to use dilute solutions. We showed that correction must be performed always. Furthermore, high-concentration solutions (high absorbance) are inherent condition in studying of the photophysical properties of fluorescent dyes and the functionally significant interactions of biological macromolecules. We proposed an easy to use method to correct the experimentally recorded total fluorescence intensity and showed that informative component of fluorescence intensity numerically equals to the product of the absorbance and the fluorescence quantum yield of the object. It is shown that if dye molecules do not interact with each other and there is no reabsorption (as for NATA) and spectrofluorimeter provides the proportionality of the detected fluorescence intensity to the part of the absorbed light (that is possible for spectrofluorimeter with horizontal slits) then the dependence of experimentally detected total fluorescence intensity of the dye on its absorbance coincides with the calculated dependence and the correction factor for eliminating the primary inner filter effect can be calculated on the basis of solution absorbance. It was experimentally shown for NATA fluorescence in the wide range of absorbance (at least up to 60). For ATTO-425, which fluorescence and absorption spectra overlap, the elimination of the primary and secondary filter effects and additional spectral analysis allow to conclude that the most probable reason of the deviation of experimentally detected fluorescence intensity dependence on solution absorbance from the calculated dependence is the dye molecules self-quenching, which accompanies resonance radiationless excitation energy transfer.	[Fonin, Alexander V.; Sulatskaya, Anna I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Prot Folding, St Petersburg 194064, Russia; [Turoverov, Konstantin K.] St Petersburg State Polytech Univ, Dept Biophys, St Petersburg 194064, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Peter the Great St. Petersburg Polytechnic University	Turoverov, KK (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Prot Folding, St Petersburg 194064, Russia.	kkt@incras.ru	Sulatskaya, Anna/I-6042-2014; Fonin, Alexander/F-4361-2017; Kuznetsova, Irina M./R-9844-2017; Turoverov, Konstantin/S-2079-2016	Sulatskaya, Anna/0000-0002-1207-3384; Fonin, Alexander/0000-0003-4469-2531; Kuznetsova, Irina M./0000-0002-3336-4834; Turoverov, Konstantin/0000-0002-6977-1896	Program "Molecular and Cell Biology'' of the Russian Academy of Sciences, Russian Foundation of Basic Research [14-04-90024_Bel, 12-04-01651, 12-04-31708, 13-04-01842, 13-04-02068]; Ministry of Education and Science of the Russian Federation [14.132.21.1311, 8830]; RF President fellowships [SP-2390.2012.4, SP-776.2012.4]	Program "Molecular and Cell Biology'' of the Russian Academy of Sciences, Russian Foundation of Basic Research; Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); RF President fellowships	This work was supported by the Program "Molecular and Cell Biology'' of the Russian Academy of Sciences, Russian Foundation of Basic Research, grant 14-04-90024_Bel (K. K. T.), 12-04-01651 (K. K. T.), 12-04-31708 (A. V. F.), 13-04-01842 (I. M. K.), 13-04-02068 (A. I. S.) by Ministry of Education and Science of the Russian Federation, Agreements 14.132.21.1311 (A. I. S.) and 8830 (K. K. T.) and by RF President fellowships SP-2390.2012.4 (A. V. F.) and SP-776.2012.4 (A. I. S.). Fluorescence measurements by Fluorolog-3 (Horiba, Japan) were carried out in the Resource Center for Optical and Laser Materials Research of St. Petersburg State University, Russia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRDSALL B, 1983, ANAL BIOCHEM, V132, P353, DOI 10.1016/0003-2697(83)90020-9; BRITTEN A, 1978, ANALYST, V103, P928, DOI 10.1039/an9780300928; Brouwer AM, 2011, PURE APPL CHEM, V83, P2213, DOI 10.1351/PAC-REP-10-09-31; Credi A, 1998, SPECTROCHIM ACTA A, V54, P159, DOI 10.1016/S1386-1425(97)00224-2; EFTINK MR, 1995, J PHYS CHEM-US, V99, P5713, DOI 10.1021/j100015a064; Fanget B, 2003, ANAL CHEM, V75, P2790, DOI 10.1021/ac0262255; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GALANIN MD, 1955, SOV PHYS JETP-USSR, V1, P317; GAUTHIER TD, 1986, ENVIRON SCI TECHNOL, V20, P1162, DOI 10.1021/es00153a012; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; HOLLAND JF, 1977, ANAL CHEM, V49, P706, DOI 10.1021/ac50014a011; Jameson DM, 2003, METHOD ENZYMOL, V360, P1; KUBISTA M, 1994, ANALYST, V119, P417, DOI 10.1039/an9941900417; Kuznetsova IM, 2012, MOL NEUROBIOL, V45, P488, DOI 10.1007/s12035-012-8272-y; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030724; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LEESE RA, 1978, ANAL CHEM, V50, P1193, DOI 10.1021/ac50030a047; MATSUI T, 1991, APPL SPECTROSC, V45, P32, DOI 10.1366/0003702914337795; MODE VA, 1974, ANAL CHEM, V46, P200, DOI 10.1021/ac60338a013; Morimoto K, 2009, J BIOCHEM, V145, P677, DOI 10.1093/jb/mvp025; PARKER CA, 1957, ANALYST, V82, P606, DOI 10.1039/an9578200606; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; Perrin J, 1929, CR HEBD ACAD SCI, V189, P1213; RATZLAFF EH, 1983, ANAL CHEM, V55, P348, DOI 10.1021/ac00253a036; Riesz J, 2005, SPECTROCHIM ACTA A, V61, P2153, DOI 10.1016/j.saa.2004.08.014; Steensrud J, 2012, SELECTING CORRECT SP, P25; STREET KW, 1985, ANALYST, V110, P1169, DOI 10.1039/an9851001169; Sulatskaya AI, 2012, J PHYS CHEM B, V116, P2538, DOI 10.1021/jp2083055; TANKE HJ, 1982, CYTOMETRY, V2, P359; Territo PR, 2007, APPL SPECTROSC, V61, P138, DOI 10.1366/000370207779947530; Turoverov K K, 1998, Tsitologiia, V40, P806; Vavilov S. I., 1949, DOKL AKAD NAUK SSSR, V67, P811; YAPPERT MC, 1989, APPL SPECTROSC, V43, P759, DOI 10.1366/0003702894202120; Zhadin NN, 1998, J BIOMED OPT, V3, P171, DOI 10.1117/1.429874	36	148	152	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103878	10.1371/journal.pone.0103878	http://dx.doi.org/10.1371/journal.pone.0103878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072376	Green Submitted, gold, Green Published			2022-12-27	WOS:000341307600090
J	Giatsis, C; Sipkema, D; Smidt, H; Verreth, J; Verdegem, M				Giatsis, Christos; Sipkema, Detmer; Smidt, Hauke; Verreth, Johan; Verdegem, Marc			The Colonization Dynamics of the Gut Microbiota in Tilapia Larvae	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; 16S RIBOSOMAL-RNA; EARLY-LIFE STAGES; GADUS-MORHUA; FISH; POPULATIONS; GENES; DETERMINANT; COMMUNITIES; AQUACULTURE	The gut microbiota of fish larvae evolves fast towards a complex community. Both host and environment affect the development of the gut microbiota; however, the relative importance of both is poorly understood. Determining specific changes in gut microbial populations in response to a change in an environmental factor is very complicated. Interactions between factors are difficult to separate and any response could be masked due to high inter-individual variation even for individuals that share a common environment. In this study we characterized and quantified the spatio-temporal variation in the gut microbiota of tilapia larvae, reared in recirculating aquaculture systems (RAS) or active suspension tanks (AS). Our results showed that variation in gut microbiota between replicate tanks was not significantly higher than within tank variation, suggesting that there is no tank effect on water and gut microbiota. However, when individuals were reared in replicate RAS, gut microbiota differed significantly. The highest variation was observed between individuals reared in different types of system (RAS vs. AS). Our data suggest that under experimental conditions in which the roles of deterministic and stochastic factors have not been precisely determined, compositional replication of the microbial communities of an ecosystem is not predictable.	[Giatsis, Christos; Verreth, Johan; Verdegem, Marc] Wageningen Univ, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands; [Sipkema, Detmer; Smidt, Hauke] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Giatsis, C (corresponding author), Wageningen Univ, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands.	christos.giatsis@wur.nl	Verreth, Johan/ABD-7198-2020; Smidt, Hauke/D-7054-2014; Verdegem, Marc/C-6659-2014	Verreth, Johan/0000-0001-7277-5129; Smidt, Hauke/0000-0002-6138-5026; Verdegem, Marc/0000-0002-2058-3894	European Community [227197]	European Community(European Commission)	This work was funded by The European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement no. 227197 Promicrobe "Microbes as positive actors for more sustainable aquaculture''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PRIM PLYMOUTH, V214; Avnimelech Y, 2007, AQUACULTURE, V264, P140, DOI 10.1016/j.aquaculture.2006.11.025; Bakke I, 2013, ENV MICROBIOL REP, V5, P537, DOI 10.1111/1758-2229.12042; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Burford MA, 2003, AQUACULTURE, V219, P393, DOI 10.1016/S0044-8486(02)00575-6; CAHILL MM, 1990, MICROB ECOL, V19, P21, DOI 10.1007/BF02015051; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chapman MG, 1999, MAR ECOL PROG SER, V180, P257, DOI 10.3354/meps180257; Clarke K.R., 1993, AUST J ECOL; Crab R, 2012, AQUACULTURE, V356, P351, DOI 10.1016/j.aquaculture.2012.04.046; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Ercolini D, 2004, J MICROBIOL METH, V56, P297, DOI 10.1016/j.mimet.2003.11.006; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Fjellheim A. J., 2011, AQUAC RES, P1; Fjellheim AJ, 2007, AQUACULTURE, V269, P98, DOI 10.1016/j.aquaculture.2007.04.021; Gatesoupe F, 2012, AQUAC RES, P1; Gatesoupe FJ, 1999, AQUACULTURE, V180, P147, DOI 10.1016/S0044-8486(99)00187-8; Gomez GD, 2008, FEMS IMMUNOL MED MIC, V52, P145, DOI 10.1111/j.1574-695X.2007.00343.x; Goodhead AK, 2013, ENV SCI POL IN PRESS; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hansen GH, 1999, MICROB ECOL, V38, P1, DOI 10.1007/s002489900158; Joossens M, 2011, FEMS MICROBIOL ECOL, V75, P343, DOI 10.1111/j.1574-6941.2010.01008.x; Kowalchuk GA, 2006, SOIL BIOL BIOCHEM, V38, P2852, DOI 10.1016/j.soilbio.2006.04.043; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Li W, 2014, MICROBIOL R IN PRESS; Li XM, 2012, J MICROBIOL, V50, P29, DOI 10.1007/s12275-012-1340-1; Machiels K, 2013, GUT IN PRESS; Mouchet MA, 2012, FEMS MICROBIOL ECOL, V79, P568, DOI 10.1111/j.1574-6941.2011.01241.x; Muyzer G, 1999, CURR OPIN MICROBIOL, V2, P317, DOI 10.1016/S1369-5274(99)80055-1; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; Nubel U, 1996, J BACTERIOL, V178, P5636; Ringo E, 2008, AQUAC RES, V39, P1087, DOI 10.1111/j.1365-2109.2008.01972.x; Romero J, 2006, MICROB ECOL, V51, P422, DOI 10.1007/s00248-006-9037-9; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Temmerman R, 2003, APPL ENVIRON MICROB, V69, P220, DOI 10.1128/AEM.69.1.220-226.2003; Thompson CL, 2014, ANAL COMMUNITY DYNAM; Tourlomousis P, 2010, MICROB ECOL, V59, P776, DOI 10.1007/s00248-009-9613-x; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Verschuere L, 1997, J APPL MICROBIOL, V83, P603, DOI 10.1046/j.1365-2672.1997.00270.x; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wilson JM, 2011, FISH PHYSIOL, V30, P1, DOI 10.1016/S1546-5098(10)03001-3	52	56	57	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103641	10.1371/journal.pone.0103641	http://dx.doi.org/10.1371/journal.pone.0103641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072852	Green Published, Green Submitted, gold			2022-12-27	WOS:000341307600075
J	Halbroth, BR; Heil, A; Distler, E; Dass, M; Wagner, EM; Plachter, B; Probst, HC; Strand, D; Hartwig, UF; Karner, A; Aichinger, G; Kistner, O; Landfester, K; Herr, W				Halbroth, Benedict R.; Heil, Alexander; Distler, Eva; Dass, Martin; Wagner, Eva M.; Plachter, Bodo; Probst, Hans Christian; Strand, Dennis; Hartwig, Udo F.; Karner, Anita; Aichinger, Gerald; Kistner, Otfried; Landfester, Katharina; Herr, Wolfgang			Superior In Vitro Stimulation of Human CD8(+) T-Cells by Whole Virus versus Split Virus Influenza Vaccines	PLOS ONE			English	Article							DENDRITIC CELLS; VACCINATION STRATEGIES; AVIAN INFLUENZA; H5N1 INFLUENZA; A VIRUSES; RESPONSES; IMMUNITY; CULTURE; LYMPHOCYTES; EPITOPES	Pandemic and seasonal influenza viruses cause considerable morbidity and mortality in the general human population. Protection from severe disease may result from vaccines that activate antigen-presenting DC for effective stimulation of influenza-specific memory T cells. Special attention is paid to vaccine-induced CD8(+) T-cell responses, because they are mainly directed against conserved internal influenza proteins thereby presumably mediating cross-protection against circulating seasonal as well as emerging pandemic virus strains. Our study showed that influenza whole virus vaccines of major seasonal A and B strains activated DC more efficiently than those of pandemic swine-origin H1N1 and pandemic-like avian H5N1 strains. In contrast, influenza split virus vaccines had a low ability to activate DC, regardless which strain was investigated. We also observed that whole virus vaccines stimulated virus-specific CD8(+) memory T cells much stronger compared to split virus counterparts, whereas both vaccine formats activated CD4(+) Th cell responses similarly. Moreover, our data showed that whole virus vaccine material is delivered into the cytosolic pathway of DC for effective activation of virus-specific CD8(+) T cells. We conclude that vaccines against seasonal and pandemic (-like) influenza strains that aim to stimulate cross-reacting CD8(+) T cells should include whole virus rather than split virus formulations.	[Halbroth, Benedict R.; Heil, Alexander; Distler, Eva; Wagner, Eva M.; Hartwig, Udo F.; Herr, Wolfgang] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 3, D-55122 Mainz, Germany; [Dass, Martin; Landfester, Katharina] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Plachter, Bodo] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Virol, D-55122 Mainz, Germany; [Probst, Hans Christian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, D-55122 Mainz, Germany; [Strand, Dennis] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 1, D-55122 Mainz, Germany; [Karner, Anita; Aichinger, Gerald; Kistner, Otfried] Baxter, Vienna, Austria; [Herr, Wolfgang] Univ Med Ctr Regensburg, Dept Med 3, Regensburg, Germany	Johannes Gutenberg University of Mainz; Max Planck Society; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Regensburg	Herr, W (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 3, D-55122 Mainz, Germany.	wolfgang.herr@ukr.de	Landfester, Katharina/F-9449-2011; Hartwig, Udo/L-1308-2013	Landfester, Katharina/0000-0001-9591-4638; Hartwig, Udo/0000-0002-6714-6923; Juerchott, Alexander/0000-0003-0556-908X; PROBST, Hans Christian/0000-0002-7926-0651; Halbroth, Benedict/0000-0002-1253-2843	Deutsche Forschungsgemeinschaft [KFO183-TP5, KFO183-TP8a]; Baxter	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baxter	This work was supported in part by grant no. KFO183-TP5 from the 'Deutsche Forschungsgemeinschaft' (http://www.dfg.de/en/index.jsp) to E.D. and W.H., and by grant no. KFO183-TP8a from the 'Deutsche Forschungsgemeinschaft' (http://www.dfg.de/en/index.jsp) to B.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Unrestricted supply of influenza vaccine preparations was provided by G.A., A.K. and O.K. (Baxter, Vienna, Austria) to W.H.G.A., A.K. and O.K. are employed by Baxter. Baxter provided support in the form of salaries for authors G.A., A.K. and O.K., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19; BENDER A, 1995, J EXP MED, V182, P1663, DOI 10.1084/jem.182.6.1663; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; Brown LE, 2009, IMMUNOL CELL BIOL, V87, P300, DOI 10.1038/icb.2009.16; Budimir N, 2010, VACCINE, V28, P8280, DOI 10.1016/j.vaccine.2010.10.007; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Cerundolo V, 1997, EUR J IMMUNOL, V27, P336, DOI 10.1002/eji.1830270148; Chomczynski P, 1993, BIOTECHNIQUES, V15, P536; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; European Medicines Agency (EMA), 2012, VEP INFL VACC WHOL V; Furuya Y, 2010, J VIROL, V84, P4212, DOI 10.1128/JVI.02508-09; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Goy K, 2008, INFLUENZA OTHER RESP, V2, P115, DOI 10.1111/j.1750-2659.2008.00046.x; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Howard MK, 2008, BIOL CHEM, V389, P569, DOI 10.1515/BC.2008.060; Jameson J, 1999, J IMMUNOL, V162, P7578; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kleemann P, 2012, HAEMATOL-HEMATOL J, V97, P874, DOI 10.3324/haematol.2011.052597; Koyama S, 2009, EXPERT REV VACCINES, V8, P1099, DOI 10.1586/ERV.09.57; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Kreijtz JHCM, 2009, HUM VACCINES, V5, P126, DOI 10.4161/hv.5.3.6986; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Neumann G, 2011, INFLUENZA OTHER RESP, V5, P157, DOI 10.1111/j.1750-2659.2011.00231.x; NICHOLSON KG, 1979, J BIOL STAND, V7, P123, DOI 10.1016/S0092-1157(79)80044-X; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rimmelzwaan GF, 2009, VACCINE, V27, P6363, DOI 10.1016/j.vaccine.2009.01.016; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tambyah PA, 2012, VACCINE, V30, P329, DOI 10.1016/j.vaccine.2011.10.088; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103392	10.1371/journal.pone.0103392	http://dx.doi.org/10.1371/journal.pone.0103392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072749	Green Submitted, Green Published, gold			2022-12-27	WOS:000341307600044
J	Cruz, E; Lopez, AV; Porter, JT				Cruz, Emmanuel; Lopez, Ana V.; Porter, James T.			Spontaneous Recovery of Fear Reverses Extinction- Induced Excitability of Infralimbic Neurons	PLOS ONE			English	Article							INTRINSIC EXCITABILITY; CONDITIONED FEAR; AMYGDALA; EXPRESSION; MEMORY; CONSOLIDATION; PLASTICITY	In rodents, the infralimbic (IL) region of the medial prefrontal cortex plays a key role in the recall of fear extinction. Previously we showed that fear conditioning decreases the intrinsic excitability of IL neurons, and that fear extinction reverses the depressed excitability. In the current study, we examined the time course of the extinction-induced changes in adolescent rats. Immediately after extinction, IL neurons continued to show depressed excitability. However 4 hours after extinction, IL neurons showed an increase in evoked spikes that correlated with a reduced fast afterhyperpolarizing potential. This suggests that acquisition of fear extinction induces an increase in spike firing 4 hours later, during the consolidation of extinction. We also examined IL excitability in a group of rats that showed spontaneous recovery of fear 17 days after extinction (SR group). Similar to neurons after fear conditioning, IL neurons from the SR group showed depressed intrinsic excitability compared to neurons 4 hours after extinction, suggesting that extinction-induced enhancement in intrinsic excitability decreases with time reverting back to a depressed state. These results suggest that plasticity in IL contributes to the spontaneous recovery of fear and preventing this depression of IL excitability could prolong fear extinction.	[Cruz, Emmanuel; Lopez, Ana V.; Porter, James T.] Ponce Sch Med, Dept Physiol & Pharmacol, Ponce, PR 00716 USA		Porter, JT (corresponding author), Ponce Sch Med, Dept Physiol & Pharmacol, Ponce, PR 00716 USA.	jporter@psm.edu		Porter, James/0000-0002-8122-6487	National Institutes of Health [MBRS-RISE R25 GM082406]; RCMI [G12 MD007579, R15 MH101700]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM082406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH101700] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RCMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the following grants from the National Institutes of Health grants: MBRS-RISE R25 GM082406 to EC and by RCMI G12 MD007579 and R15 MH101700 to JTP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2010, NAT NEUROSCI, V13, P489, DOI 10.1038/nn.2499; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Cho JH, 2013, NEURON, V80, P1491, DOI 10.1016/j.neuron.2013.09.025; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Fontanez-Nuin DE, 2011, CEREB CORTEX, V21, P727, DOI 10.1093/cercor/bhq147; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Holmes A, 2012, NAT NEUROSCI, V15, P1359, DOI 10.1038/nn.3204; Hugues S, 2007, LEARN MEMORY, V14, P520, DOI 10.1101/lm.625407; Kim JH, 2011, CEREB CORTEX, V21, P530, DOI 10.1093/cercor/bhq116; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; McCallum J, 2010, NEUROPSYCHOPHARMACOL, V35, P2134, DOI 10.1038/npp.2010.92; Mickley GA, 2007, BRAIN RES, V1152, P139, DOI 10.1016/j.brainres.2007.03.050; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Orsini CA, 2012, NEUROSCI BIOBEHAV R, V36, P1773, DOI 10.1016/j.neubiorev.2011.12.014; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pare D, 2012, CURR OPIN NEUROBIOL, V22, P717, DOI 10.1016/j.conb.2012.02.014; Pattwell SS, 2012, P NATL ACAD SCI USA, V109, P16318, DOI 10.1073/pnas.1206834109; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2002, LEARN MEMORY, V9, P402, DOI 10.1101/lm.49602; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rescorla RA, 2004, LEARN MEMORY, V11, P501, DOI 10.1101/lm.77504; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Santini E, 2008, J NEUROSCI, V28, P4028, DOI 10.1523/JNEUROSCI.2623-07.2008; Santini E, 2010, J NEUROSCI, V30, P12379, DOI 10.1523/JNEUROSCI.1295-10.2010; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Sepulveda-Orengo MT, 2013, J NEUROSCI, V33, P7184, DOI 10.1523/JNEUROSCI.5198-12.2013; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Vouimba RM, 2011, NEUROPSYCHOPHARMACOL, V36, P2276, DOI 10.1038/npp.2011.115	34	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103596	10.1371/journal.pone.0103596	http://dx.doi.org/10.1371/journal.pone.0103596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089624	Green Submitted, gold, Green Published			2022-12-27	WOS:000339812700034
J	Soh, SX; Lim, JYS; Huang, JWJ; Jiang, N; Yeoh, AEJ; Ong, ST				Soh, Sheila Xinxuan; Lim, Joshua Yew Suang; Huang, John W. J.; Jiang, Nan; Yeoh, Allen Eng Juh; Ong, S. Tiong			Multi-Agent Chemotherapy Overcomes Glucocorticoid Resistance Conferred by a BIM Deletion Polymorphism in Pediatric Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; GERMLINE GENETIC-VARIATION; CELLULAR-DRUG RESISTANCE; INDUCED APOPTOSIS; KINASE INHIBITORS; CHILDREN; CELLS; EXPRESSION; PREDICTION; CANCER	A broad range of anti-cancer agents, including glucocorticoids (GCs) and tyrosine kinase inhibitors (TKIs), kill cells by upregulating the pro-apoptotic BCL2 family member, BIM. A common germline deletion in the BIM gene was recently shown to favor the production of non-apoptotic BIM isoforms, and to predict inferior responses in TKI-treated chronic myeloid leukemia (CML) and EGFR-driven lung cancer patients. Given that both in vitro and in vivo GC resistance are predictive of adverse outcomes in acute lymphoblastic leukemia (ALL), we hypothesized that this polymorphism would mediate GC resistance, and serve as a biomarker of poor response in ALL. Accordingly, we used zinc finger nucleases to generate ALL cell lines with the BIM deletion, and confirmed the ability of the deletion to mediate GC resistance in vitro. In contrast to CML and lung cancer, the BIM deletion did not predict for poorer clinical outcome in a retrospective analysis of 411 pediatric ALL patients who were uniformly treated with GCs and chemotherapy. Underlying the lack of prognostic significance, we found that the chemotherapy agents used in our cohort (vincristine, L-asparaginase, and methotrexate) were each able to induce ALL cell death in a BIM-independent fashion, and resensitize BIM deletion-containing cells to GCs. Together, our work demonstrates how effective therapy can overcome intrinsic resistance in ALL patients, and suggests the potential of using combinations of drugs that work via divergent mechanisms of cell killing to surmount BIM deletion-mediated drug resistance in other cancers.	[Soh, Sheila Xinxuan; Huang, John W. J.; Ong, S. Tiong] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Lim, Joshua Yew Suang; Jiang, Nan; Yeoh, Allen Eng Juh] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore; [Yeoh, Allen Eng Juh] Natl Univ Hlth Syst, Natl Univ Canc Inst, Singapore, Singapore; [Yeoh, Allen Eng Juh] Viva Univ, Natl Univ Hlth Syst, Univ Childrens Med Inst, Childrens Canc Ctr, Singapore, Singapore; [Yeoh, Allen Eng Juh] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore; [Ong, S. Tiong] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore; [Ong, S. Tiong] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Ong, S. Tiong] Duke Univ, Med Ctr, Div Med Oncol, Durham, NC USA	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; National Cancer Centre Singapore (NCCS); Duke University	Ong, ST (corresponding author), Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore.	sintiong.ong@duke-nus.edu.sg	Yeoh, Allen EJ/D-9663-2015	Yeoh, Allen EJ/0000-0002-6454-976X; Jiang, Nan/0000-0002-7661-5728; Ong, S. Tiong/0000-0001-9460-3483	Leukemia & Lymphoma Society Translational Research Program [R913-302-026-597]; Singapore National Medical Research Council [NMRC/0582/2001, NMRC/CSA/003/2008]; A*STAR [SCS-POU98, NMRC/CSI/004/2005]; Children's Cancer Foundation, Singapore; VIVA Foundation for Children with Cancer, Singapore	Leukemia & Lymphoma Society Translational Research Program(Leukemia and Lymphoma Society); Singapore National Medical Research Council(National Medical Research Council, Singapore); A*STAR(Agency for Science Technology & Research (A*STAR)); Children's Cancer Foundation, Singapore; VIVA Foundation for Children with Cancer, Singapore	STO was supported by the Leukemia & Lymphoma Society Translational Research Program Grant (R913-302-026-597) www.lls.org. AEY was supported by the Singapore National Medical Research Council (NMRC/0582/2001, NMRC/CSA/003/2008). www.nmrc.gov.sg, and by A*STAR (SCS-POU98, NMRC/CSI/004/2005). www.a-star.edu.sg, and by Children's Cancer Foundation, Singapore. www.ccf.org.sg, and by VIVA Foundation for Children with Cancer, Singapore. www.viva.sg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MT, 2004, J BIOL CHEM, V279, P55809, DOI 10.1074/jbc.M411767200; Aichberger KJ, 2005, CANCER RES, V65, P9436, DOI 10.1158/0008-5472.CAN-05-0972; Augis V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078582; Bachmann PS, 2010, BLOOD, V116, P3013, DOI 10.1182/blood-2010-05-284968; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Coate L, 2010, J CLIN ONCOL, V28, P4029, DOI 10.1200/JCO.2009.27.2336; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Den Boer ML, 2003, J CLIN ONCOL, V21, P3262, DOI 10.1200/JCO.2003.11.031; DeVita Jr VT, 2008, DEVITA HELLMAN ROSEN, p[427, 451, 490]; Dordelmann M, 1999, BLOOD, V94, P1209, DOI 10.1182/blood.V94.4.1209.416k05_1209_1217; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Gagne V, 2013, CLIN CANCER RES, V19, P5240, DOI 10.1158/1078-0432.CCR-13-1215; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Jabbour E, 2009, MAYO CLIN PROC, V84, P161, DOI 10.1016/S0025-6196(11)60824-0; Jiang N, 2011, EXP HEMATOL, V39, P321, DOI 10.1016/j.exphem.2010.11.009; Juan WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095210; Kaspers GJL, 1998, BLOOD, V92, P259, DOI 10.1182/blood.V92.1.259.413k21_259_266; KASPERS GJL, 1995, LEUKEMIA LYMPHOMA, V19, P407, DOI 10.3109/10428199509112198; Kuribara R, 2004, MOL CELL BIOL, V24, P6172, DOI 10.1128/MCB.24.14.6172-6183.2004; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lauten M, 2012, HAEMATOL-HEMATOL J, V97, P1048, DOI 10.3324/haematol.2011.047613; Locatelli F, 2012, BLOOD, V120, P2807, DOI 10.1182/blood-2012-02-265884; Martinelli G, 2009, J CLIN ONCOL, V27, P5202, DOI 10.1200/JCO.2008.21.6408; McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139; MIYAGI T, 1993, INT J CANCER, V53, P457, DOI 10.1002/ijc.2910530318; Morel F, 2003, LEUKEMIA LYMPHOMA, V44, P1333, DOI 10.1080/1042819031000097384; Mullighan CG, 2012, HEMATOL-AM SOC HEMAT, P389, DOI 10.1182/asheducation-2012.1.389; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Perez-Andreu V, 2013, NAT GENET, V45, P1494, DOI 10.1038/ng.2803; PIETERS R, 1993, LEUKEMIA, V7, P392; Ploner C, 2008, LEUKEMIA, V22, P370, DOI 10.1038/sj.leu.2405039; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Radtke S, 2013, BLOOD, V121, P5145, DOI 10.1182/blood-2013-01-480335; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Rocha JCC, 2005, BLOOD, V105, P4752, DOI 10.1182/blood-2004-11-4544; Sanchez R, 2014, HAEMATOLOGICA, V99, P314, DOI 10.3324/haematol.2013.085340; Schmidt S, 2006, BLOOD, V107, P2061, DOI 10.1182/blood-2005-07-2853; Schrappe M, 1998, BLOOD, V92, P2730; STONG RC, 1985, BLOOD, V65, P21, DOI 10.1182/blood.V65.1.21.21; Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Xu H, 2012, J CLIN ONCOL, V30, P751, DOI 10.1200/JCO.2011.38.0345; Yang JJ, 2012, BLOOD, V120, P4197, DOI 10.1182/blood-2012-07-440107; Yang JJ, 2009, JAMA-J AM MED ASSOC, V301, P393, DOI 10.1001/jama.2009.7; Yeoh AEJ, 2012, J CLIN ONCOL, V30, P2384, DOI 10.1200/JCO.2011.40.5936; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	50	8	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103435	10.1371/journal.pone.0103435	http://dx.doi.org/10.1371/journal.pone.0103435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090024	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700027
J	Myakalwar, AK; Dingari, NC; Dasari, RR; Barman, I; Gundawar, MK				Myakalwar, Ashwin Kumar; Dingari, Narahara Chari; Dasari, Ramachandra Rao; Barman, Ishan; Gundawar, Manoj Kumar			Non-Gated Laser Induced Breakdown Spectroscopy Provides a Powerful Segmentation Tool on Concomitant Treatment of Characteristic and Continuum Emission	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; RAMAN-SPECTRA; CLASSIFICATION; CHEMOMETRICS; FLUORESCENCE; SUBTRACTION; TABLETS; LIBS	We demonstrate the application of non-gated laser induced breakdown spectroscopy (LIBS) for characterization and classification of organic materials with similar chemical composition. While use of such a system introduces substantive continuum background in the spectral dataset, we show that appropriate treatment of the continuum and characteristic emission results in accurate discrimination of pharmaceutical formulations of similar stoichiometry. Specifically, our results suggest that near-perfect classification can be obtained by employing suitable multivariate analysis on the acquired spectra, without prior removal of the continuum background. Indeed, we conjecture that pre-processing in the form of background removal may introduce spurious features in the signal. Our findings in this report significantly advance the prior results in time-integrated LIBS application and suggest the possibility of a portable, non-gated LIBS system as a process analytical tool, given its simple instrumentation needs, real-time capability and lack of sample preparation requirements.	[Myakalwar, Ashwin Kumar; Gundawar, Manoj Kumar] Univ Hyderabad, ACRHEM, Hyderabad 500134, Andhra Pradesh, India; [Dingari, Narahara Chari; Dasari, Ramachandra Rao] MIT, GR Harrison Spect Lab, Laser Biomed Res Ctr, Cambridge, MA 02139 USA; [Barman, Ishan] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA	Defence Research & Development Organisation (DRDO); Advanced Centre Research in High Energy Materials (ACRHEM); University of Hyderabad; Massachusetts Institute of Technology (MIT); Johns Hopkins University	Gundawar, MK (corresponding author), Univ Hyderabad, ACRHEM, Hyderabad 500134, Andhra Pradesh, India.	manojsp@uohyd.ernet.in	Myakalwar, Ashwin kumar/AAN-2411-2020	Myakalwar, Ashwin kumar/0000-0002-5794-0605	Defence Research and Development Organization, India; Council of Scientific & Industrial Research, India; National Institute of Biomedical Imaging and Bioengineering [9P41EB015871-26A1]; JHU Whiting School of Engineering and ME Department; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015871] Funding Source: NIH RePORTER	Defence Research and Development Organization, India(Defence Research & Development Organisation (DRDO)); Council of Scientific & Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); JHU Whiting School of Engineering and ME Department; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	GMK and AKM acknowledge the support from Defence Research and Development Organization, India. AKM acknowledges the senior research fellowship from Council of Scientific & Industrial Research, India. NCD and RRD acknowledge the support of National Institute of Biomedical Imaging and Bioengineering (9P41EB015871-26A1); IB is grateful for the funding of JHU Whiting School of Engineering and ME Department startup fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2012, ANAL CHEM, V84, P7938, DOI 10.1021/ac301696p; Barman I, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3520131; Beier BD, 2009, ANALYST, V134, P1198, DOI 10.1039/b821856k; Cao A, 2007, J RAMAN SPECTROSC, V38, P1199, DOI 10.1002/jrs.1753; De Giacomo A, 2010, SPECTROCHIM ACTA B, V65, P385, DOI 10.1016/j.sab.2010.03.016; Dingari NC, 2012, ANAL CHEM, V84, P2686, DOI 10.1021/ac202755e; Diwakar PK, 2007, SPECTROCHIM ACTA B, V62, P1466, DOI 10.1016/j.sab.2007.10.001; Doucet FR, 2008, J ANAL ATOM SPECTROM, V23, P694, DOI 10.1039/b714219f; Hahn DW, 2010, APPL SPECTROSC, V64, p335A, DOI 10.1366/000370210793561691; Harmon RS, 2006, APPL GEOCHEM, V21, P730, DOI 10.1016/j.apgeochem.2006.02.003; Hinz DC, 2006, ANAL BIOANAL CHEM, V384, P1036, DOI 10.1007/s00216-005-3394-y; Kearton B, 2008, NAT PHOTONICS, V2, P537; Kwiatkowski A, 2010, METROL MEAS SYST, V17, P549, DOI 10.2478/v10178-010-0045-1; Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518; Lopez-Moreno C, 2005, J ANAL ATOM SPECTROM, V20, P552, DOI 10.1039/b419173k; Miziolek AW, 2006, LASER-INDUCED BREAKDOWN SPECTROSCOPY (LIBS): FUNDAMENTALS AND APPLICATIONS, P1; Moros J, 2010, ANAL CHEM, V82, P1389, DOI 10.1021/ac902470v; Mueller M, 2007, ANAL CHEM, V79, P4419, DOI 10.1021/ac0621470; Myakalwar AK, 2011, TALANTA, V87, P53, DOI 10.1016/j.talanta.2011.09.040; Sasic S, 2007, PHARM RES-DORDR, V24, P58, DOI 10.1007/s11095-006-9118-y; Schulmerich MV, 2010, ANAL CHEM, V82, P6273, DOI 10.1021/ac1014194; Singh JP, 2007, LASER INDUCED BREAKD, P3; Sirven JB, 2006, ANAL CHEM, V78, P1462, DOI 10.1021/ac051721p; St-Onge L, 2002, SPECTROCHIM ACTA B, V57, P1131, DOI 10.1016/S0584-8547(02)00062-9; Tognoni E, 2010, SPECTROCHIM ACTA B, V65, P1, DOI 10.1016/j.sab.2009.11.006	25	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103546	10.1371/journal.pone.0103546	http://dx.doi.org/10.1371/journal.pone.0103546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084522	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800048
J	Obata, J; Takeshita, T; Shibata, Y; Yamanaka, W; Unemori, M; Akamine, A; Yamashita, Y				Obata, Junko; Takeshita, Toru; Shibata, Yukie; Yamanaka, Wataru; Unemori, Masako; Akamine, Akifumi; Yamashita, Yoshihisa			Identification of the Microbiota in Carious Dentin Lesions Using 165 rRNA Gene Sequencing	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; MOLECULAR ANALYSIS; CARIES; MUTANS; PROFILES; DATABASE; UNIFRAC; TEETH	While mutans streptococci have long been assumed to be the specific pathogen responsible for human dental caries, the concept of a complex dental caries-associated microbiota has received significant attention in recent years. Molecular analyses revealed the complexity of the microbiota with the predominance of Lactobacillus and Prevotella in carious dentine lesions. However, characterization of the dentin caries-associated microbiota has not been extensively explored in different ethnicities and races. In the present study, the bacterial communities in the carious dentin of Japanese subjects were analyzed comprehensively with molecular approaches using the16S rRNA gene. Carious dentin lesion samples were collected from 32 subjects aged 4-76 years, and the 16S rRNA genes, amplified from the extracted DNA with universal primers, were sequenced with a pyrosequencer. The bacterial composition was classified into clusters I, II, and III according to the relative abundance (high, middle, low) of Lactobacillus. The bacterial composition in cluster II was composed of relatively high proportions of Olsenella and Propionibacterium or subdominated by heterogeneous genera. The bacterial communities in cluster III were characterized by the predominance of Atopobium, Prevotella, or Propionibacterium with Streptococcus or Actinomyces. Some samples in clusters II and III, mainly related to Atopobium and Propionibacterium, were novel combinations of microbiota in carious dentin lesions and may be characteristic of the Japanese population. Clone library analysis revealed that Atopobium sp. HOT-416 and P. acidifaciens were specific species associated with dentinal caries among these genera in a Japanese population. We summarized the bacterial composition of dentinal carious lesions in a Japanese population using next-generation sequencing and found typical Japanese types with Atopobium or Propionibacterium predominating.	[Obata, Junko; Takeshita, Toru; Shibata, Yukie; Yamanaka, Wataru; Yamashita, Yoshihisa] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka 812, Japan; [Obata, Junko; Unemori, Masako; Akamine, Akifumi] Kyushu Univ, Fac Dent Sci, Dept Endodontol & Operat Dent, Div Oral Rehabil, Fukuoka 812, Japan	Kyushu University; Kyushu University	Yamashita, Y (corresponding author), Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka 812, Japan.	yoshi@dent.kyushu-u.ac.jp	Takeshita, Toru/AAT-2321-2021		Ministry of Education, Culture, Sports, Science and Technology of Japan [25463249, 25463251, 25293428]; Grants-in-Aid for Scientific Research [25463249] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in Aid for Scientific Research 25463249 (T. T.), 25463251 (Y. S.) and 25293428 (Y. Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Bagramian RA, 2009, AM J DENT, V22, P3; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CARLSSON P, 1989, SCAND J DENT RES, V97, P120; Chaussain-Miller C, 2006, J DENT RES, V85, P22, DOI 10.1177/154405910608500104; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLLINS MD, 1992, FEMS MICROBIOL LETT, V95, P235, DOI 10.1111/j.1574-6968.1992.tb05372.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edwardsson S, 1974, Odontol Revy Suppl, V32, P1; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HAHN CL, 1991, ARCH ORAL BIOL, V36, P147, DOI 10.1016/0003-9969(91)90077-8; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Helderman WHV, 1996, J DENT RES, V75, P535, DOI 10.1177/00220345960750010501; HOSHINO E, 1985, J DENT RES, V64, P1195, DOI 10.1177/00220345850640100301; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kraatz M, 2011, INT J SYST EVOL MICR, V61, P795, DOI 10.1099/ijs.0.022954-0; Lima KC, 2011, CARIES RES, V45, P21, DOI 10.1159/000322299; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mason MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077287; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; Nadkarni MA, 2004, J CLIN MICROBIOL, V42, P5238, DOI 10.1128/JCM.42.11.5238-5244.2004; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Preza D, 2008, J CLIN MICROBIOL, V46, P2015, DOI 10.1128/JCM.02411-07; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; R Development Core Team, 2012, R LANG ENV STAT COMP; Reich E, 1999, INT DENT J, V49, P15, DOI 10.1111/j.1875-595X.1999.tb00503.x; Takeshita T, 2007, ORAL MICROBIOL IMMUN, V22, P419, DOI 10.1111/j.1399-302X.2007.00384.x; Tjaderhane L, 1998, J DENT RES, V77, P1622, DOI 10.1177/00220345980770081001; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wei GX, 1999, ORAL MICROBIOL IMMUN, V14, P348, DOI 10.1034/j.1399-302X.1999.140603.x	35	50	51	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103712	10.1371/journal.pone.0103712	http://dx.doi.org/10.1371/journal.pone.0103712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083880	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800071
J	Selvamani, SP; Mishra, R; Singh, SK				Selvamani, Sakthi Priya; Mishra, Ritu; Singh, Sunit K.			Chikungunya Virus Exploits miR-146a to Regulate NF-kappa B Pathway in Human Synovial Fibroblasts	PLOS ONE			English	Article							MICRORNA-146A EXPRESSION; TARGETING TRAF6; MOUSE MODEL; ARTHRITIS; MECHANISM; DISEASE; PATHOGENESIS; BIOGENESIS; INDUCTION; FEATURES	Objectives: Chikungunya virus causes chronic infection with manifestations of joint pain. Human synovial fibroblasts get infected with CHIKV and could lead to pro-inflammatory responses. MicroRNAs have potentials to regulate the gene expression of various anti-viral and pro-inflammatory genes. The study aims to investigate the role of miR-146a in modulation of inflammatory responses of human synovial fibroblasts by Chikungunya virus. Methods: To study the role of miR-146a in CHIKV pathogenesis in human synovial cells and underlying inflammatory manifestations, we performed CHIKV infection in primary human synovial fibroblasts. Western blotting, real-time PCR, luciferase reporter assay, overexpression and knockdown of cellular miR-146a strategies have been employed to validate the role of miR-146a in regulation of pro-inflammatory NF-kappa B pathway. Results: CHIKV infection induced the expression of cellular miR-146a, which resulted into down-regulation of TRAF6, IRAK1, IRAK2 and increased replication of CHIKV in human synovial fibroblasts. Exogenous expression of miR-146a in human synovial fibroblasts led to decreased expression of TRAF6, IRAK1, IRAK2 and decreased replication of CHIKV. Inhibition of cellular miR-146a by anti-miR-146a restored the expression levels of TRAF6, IRAK1 and IRAK2. Downregulation of TRAF6, IRAK1 and IRAK2 led to downstream decreased NF-kappa B activation through negative feedback loop. Conclusion: This study demonstrated the mechanism of exploitation of cellular miR-146a by CHIKV in modulating the host antiviral immune response in primary human synovial fibroblasts.	[Selvamani, Sakthi Priya; Mishra, Ritu; Singh, Sunit K.] Ctr Cellular & Mol Biol, CSIR, Lab Neurovirol & Inflammat Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Singh, SK (corresponding author), Ctr Cellular & Mol Biol, CSIR, Lab Neurovirol & Inflammat Biol, Hyderabad 500007, Andhra Pradesh, India.	sunitsingh2000@gmail.com	Singh, Sunit K/AAO-4760-2021	Singh, Sunit K/0000-0002-8802-1169; Mishra, Ritu/0000-0002-4090-0893	Indo-Korean Grant - Department of Science and Technology, Govt. of India, New Delhi [INT/Korea/P-08]	Indo-Korean Grant - Department of Science and Technology, Govt. of India, New Delhi	Authors acknowledge the financial support through Indo-Korean Grant (INT/Korea/P-08) funded by Department of Science and Technology, Govt. of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075854; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; CALISHER CH, 1980, INTERVIROLOGY, V14, P229, DOI 10.1159/000149190; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Jensen LE, 2000, J IMMUNOL, V164, P5277, DOI 10.4049/jimmunol.164.10.5277; Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003; Kandasamy S, 2014, VACCINE, V32, P816, DOI 10.1016/j.vaccine.2013.12.039; Kovalchuk L. V., 2009, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P100; Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Labbaye C, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-13; Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Nakasa T, 2011, ARTHRITIS RHEUM-US, V63, P1582, DOI 10.1002/art.30321; Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631; Paik JH, 2011, CLIN CANCER RES, V17, P4761, DOI 10.1158/1078-0432.CCR-11-0494; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Sarma NJ, 2014, J VIROL, V88, P3733, DOI 10.1128/JVI.03060-13; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Sehnert B, 2013, P NATL ACAD SCI USA, V110, P16556, DOI 10.1073/pnas.1218219110; Shi XL, 2013, CRIT CARE, V17, DOI 10.1186/cc13171; Singh SK, 2008, FEBS J, V275, P4929, DOI 10.1111/j.1742-4658.2008.06624.x; Singh SK, 2011, REV MED VIROL, V21, P78, DOI 10.1002/rmv.681; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Teo TH, 2012, IMMUNOL RES, V53, P136, DOI 10.1007/s12026-012-8266-x; TESH RB, 1982, ANNU REV MED, V33, P31, DOI 10.1146/annurev.me.33.020182.000335; Thon-Hon VG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-213; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Wu SY, 2013, J INFECTION, V67, P329, DOI 10.1016/j.jinf.2013.05.003; Xu WD, 2012, INFLAMMATION, V35, P1525, DOI 10.1007/s10753-012-9467-0; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zhuo Y, 2013, CELL PHYSIOL BIOCHEM, V32, P499, DOI 10.1159/000354455	52	43	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103624	10.1371/journal.pone.0103624	http://dx.doi.org/10.1371/journal.pone.0103624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083878	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800061
J	Wypych, M; Nagy, A; Mochol, G; Foik, A; Benedek, G; Waleszczyk, WJ				Wypych, Marek; Nagy, Attila; Mochol, Gabriela; Foik, Andrzej; Benedek, Gyoergy; Waleszczyk, Wioletta J.			Spectral Characteristics of Phase Sensitivity and Discharge Rate of Neurons in the Ascending Tectofugal Visual System	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; LATERAL SUPRASYLVIAN CORTEX; POSTERIOR-PULVINAR COMPLEX; RECEPTIVE-FIELD PROPERTIES; STRIATE-RECIPIENT ZONE; RESPONSE PROPERTIES; SUPERIOR COLLICULUS; SINGLE NEURONS; FUNCTIONAL ARCHITECTURE; SUPRAGENICULATE NUCLEUS	Drifting gratings can modulate the activity of visual neurons at the temporal frequency of the stimulus. In order to characterize the temporal frequency modulation in the cat's ascending tectofugal visual system, we recorded the activity of single neurons in the superior colliculus, the suprageniculate nucleus, and the anterior ectosylvian cortex during visual stimulation with drifting sine-wave gratings. In response to such stimuli, neurons in each structure showed an increase in firing rate and/or oscillatory modulated firing at the temporal frequency of the stimulus (phase sensitivity). To obtain a more complete characterization of the neural responses in spatiotemporal frequency domain, we analyzed the mean firing rate and the strength of the oscillatory modulations measured by the standardized Fourier component of the response at the temporal frequency of the stimulus. We show that the spatiotemporal stimulus parameters that elicit maximal oscillations often differ from those that elicit a maximal discharge rate. Furthermore, the temporal modulation and discharge-rate spectral receptive fields often do not overlap, suggesting that the detection range for visual stimuli provided jointly by modulated and unmodulated response components is larger than the range provided by a one response component.	[Wypych, Marek; Mochol, Gabriela; Foik, Andrzej; Waleszczyk, Wioletta J.] Nencki Inst Expt Biol, Warsaw, Poland; [Nagy, Attila; Benedek, Gyoergy] Univ Szeged, Szeged, Hungary	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Szeged University	Waleszczyk, WJ (corresponding author), Nencki Inst Expt Biol, Warsaw, Poland.	w.waleszczyk@nencki.gov.pl	Waleszczyk, Wioletta/F-6027-2010; Foik, Andrzej/F-6014-2010; Wypych, Marek/C-1371-2019; Foik, Andrzej/AAB-8105-2019	Foik, Andrzej/0000-0003-1110-9223; Wypych, Marek/0000-0002-8710-0244; Foik, Andrzej/0000-0003-1110-9223; Waleszczyk, Wioletta/0000-0002-7300-6193	Hungarian Brain Research Program KTIA [13 NAP-A-I/15]; OTKA Hungary [K83810]; Polish National Science Centre [N N303 820640]; Polish-Hungarian bilateral academic grants; EU [264173]	Hungarian Brain Research Program KTIA; OTKA Hungary(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Polish National Science Centre; Polish-Hungarian bilateral academic grants; EU(European Commission)	This work was supported by Hungarian Brain Research Program KTIA 13 NAP-A-I/15 grant, OTKA Hungary Grant K83810, Polish National Science Centre Grant N N303 820640, Polish-Hungarian bilateral academic grants for years (2011-2016) and EU FP7 Project, GA No 264173 (Bio-Imagine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON BP, 1988, J COMP NEUROL, V271, P397, DOI 10.1002/cne.902710308; Benedek G, 1996, PROG BRAIN RES, V112, P325; Berman RA, 2011, J NEUROSCI, V31, P373, DOI 10.1523/JNEUROSCI.4738-10.2011; Berman RA, 2010, J NEUROSCI, V30, P6342, DOI 10.1523/JNEUROSCI.6176-09.2010; Brosseau-Lachaine O, 2001, CEREB CORTEX, V11, P989, DOI 10.1093/cercor/11.10.989; Burke W, 1998, EUR J NEUROSCI, V10, P8; CASANOVA C, 1989, J NEUROPHYSIOL, V62, P544, DOI 10.1152/jn.1989.62.2.544; CASANOVA C, 1993, EXP BRAIN RES, V96, P247; CRONER LJ, 1993, P NATL ACAD SCI USA, V90, P8128, DOI 10.1073/pnas.90.17.8128; Crowder NA, 2003, J NEUROPHYSIOL, V90, P1829, DOI 10.1152/jn.00654.2002; Crowder NA, 2002, J COMP PHYSIOL A, V188, P109, DOI 10.1007/s00359-002-0280-3; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Eordegh G, 2005, BRAIN RES BULL, V67, P281, DOI 10.1016/j.brainresbull.2005.06.036; Guirado S, 2005, BRAIN RES BULL, V66, P290, DOI 10.1016/j.brainresbull.2005.02.015; HICKS TP, 1988, J NEUROPHYSIOL, V60, P397, DOI 10.1152/jn.1988.60.2.397; Hietanen MA, 2013, NEUROSCIENCE, V237, P19, DOI 10.1016/j.neuroscience.2013.01.030; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; IBBOTSON MR, 1994, J NEUROPHYSIOL, V72, P2927, DOI 10.1152/jn.1994.72.6.2927; Kara P, 2003, J NEUROSCI, V23, P8547; LEHMKUHLE S, 1980, J NEUROPHYSIOL, V43, P520, DOI 10.1152/jn.1980.43.2.520; Lui LL, 2007, EUR J NEUROSCI, V25, P1780, DOI 10.1111/j.1460-9568.2007.05453.x; Lyon DC, 2010, NEURON, V65, P270, DOI 10.1016/j.neuron.2010.01.003; Markus Z, 2009, NEUROSCI LETT, V454, P76, DOI 10.1016/j.neulet.2009.02.063; Mechler F, 2002, J NEUROSCI, V22, P6129; Mechler F, 2002, VISION RES, V42, P1017, DOI 10.1016/S0042-6989(02)00025-1; Merabet L, 2000, NEUROSCIENCE, V97, P611, DOI 10.1016/S0306-4522(00)00056-7; MORRONE MC, 1986, J NEUROPHYSIOL, V56, P969, DOI 10.1152/jn.1986.56.4.969; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; MUCKE L, 1982, EXP BRAIN RES, V46, P1; Nagy A, 2003, EXP BRAIN RES, V151, P108, DOI 10.1007/s00221-003-1488-3; Nagy AJ, 2011, NEUROSCI LETT, V503, P52, DOI 10.1016/j.neulet.2011.08.007; Nagy A, 2008, EUR J NEUROSCI, V27, P1801, DOI 10.1111/j.1460-9568.2008.06137.x; Nolt MJ, 2004, J NEUROPHYSIOL, V92, P1708, DOI 10.1152/jn.00176.2004; NORITA M, 1986, EXP BRAIN RES, V62, P225; OCarroll DC, 1996, NATURE, V382, P63, DOI 10.1038/382063a0; Ouellette BG, 2004, NEUROSCIENCE, V123, P231, DOI 10.1016/j.neuroscience.2003.09.002; Paroczy Z, 2006, NEUROSCIENCE, V137, P1397, DOI 10.1016/j.neuroscience.2005.10.068; Passaglia CL, 2001, J NEUROSCI, V21, P5794, DOI 10.1523/JNEUROSCI.21-15-05794.2001; Perrone JA, 2001, NAT NEUROSCI, V4, P526, DOI 10.1038/87480; PINTER RB, 1981, BRAIN RES, V207, P73, DOI 10.1016/0006-8993(81)90680-6; Priebe NJ, 2006, J NEUROSCI, V26, P2941, DOI 10.1523/JNEUROSCI.3936-05.2006; RACZKOWSKI D, 1983, J NEUROSCI, V3, P1912; Rathbun DL, 2010, J NEUROSCI, V30, P13558, DOI 10.1523/JNEUROSCI.0909-10.2010; ROWE MH, 1993, VISUAL NEUROSCI, V10, P765, DOI 10.1017/S0952523800005459; SCHNEIDER GE, 1969, SCIENCE, V163, P895, DOI 10.1126/science.163.3870.895; SIEGEL S., 1956, NONPARAMETRIC STAT B; SIRETEANU R, 1979, EXP BRAIN RES, V34, P591; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SNIDER RS, 1964, STEREOTAXIC ATLAS CA; Sommer MA, 2008, PERCEPTION, V37, P408, DOI 10.1068/p5873; Sprague JM, 1996, PROG BRAIN RES, V112, P1; SUR M, 1982, J NEUROPHYSIOL, V47, P869, DOI 10.1152/jn.1982.47.5.869; Tardif E, 2000, NEUROSCIENCE, V97, P625, DOI 10.1016/S0306-4522(00)00061-0; TOLHURST DJ, 1981, PROC R SOC SER B-BIO, V213, P183, DOI 10.1098/rspb.1981.0061; TROY JB, 1989, VISUAL NEUROSCI, V3, P213, DOI 10.1017/S0952523800009974; TROY JB, 1995, VISUAL NEUROSCI, V12, P285, DOI 10.1017/S0952523800007975; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; van Kleef JP, 2010, J PHYSIOL-LONDON, V588, P3457, DOI 10.1113/jphysiol.2010.191452; Victor JD, 2007, J PHYSIOL-LONDON, V579, P29, DOI 10.1113/jphysiol.2006.122283; VICTOR JD, 1988, J PHYSIOL-LONDON, V405, P289, DOI 10.1113/jphysiol.1988.sp017334; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; VICTOR JD, 1977, P NATL ACAD SCI USA, V74, P3068, DOI 10.1073/pnas.74.7.3068; Villeneuve MY, 2003, J NEUROSCI METH, V129, P19, DOI 10.1016/S0165-0270(03)00198-5; Waleszczyk WJ, 2007, EXP BRAIN RES, V181, P87, DOI 10.1007/s00221-007-0908-1; Waleszczyk WJ, 2004, ACTA NEUROBIOL EXP, V64, P209; Waleszczyk WJ, 1999, NEUROSCIENCE, V93, P1063, DOI 10.1016/S0306-4522(99)00190-6; Wylie DRW, 2000, J NEUROPHYSIOL, V84, P2529, DOI 10.1152/jn.2000.84.5.2529; Wypych M, 2012, VISION RES, V72, P14, DOI 10.1016/j.visres.2012.09.004; Wypych M, 2009, 41 EBBS C 13 18 09 2, V09, P13; ZUMBROICH TJ, 1987, J NEUROSCI, V7, P482	76	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103557	10.1371/journal.pone.0103557	http://dx.doi.org/10.1371/journal.pone.0103557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083715	Green Published, gold			2022-12-27	WOS:000339819800049
J	Afify, A; Horlacher, B; Roller, J; Galizia, CG				Afify, Ali; Horlacher, Berenice; Roller, Johannes; Galizia, C. Giovanni			Different Repellents for Aedes aegypti against Blood-Feeding and Oviposition	PLOS ONE			English	Article							HOST-SEEKING; ANOPHELES-GAMBIAE; DIETHYL-BENZAMIDE; FIELD-EVALUATION; MOSQUITO; CULICIDAE; DIPTERA; RESPONSES; ODOR; DEET	Methyl N, N-dimethyl anthranilate (MDA), ethyl anthranilate (EA) and butyl anthranilate (BA) were previously shown to repel Aedes aegypti mosquitoes from landing on human skin. However, the effect of these compounds on the orientation of flying mosquitoes in a choice situation and their effect on mosquito oviposition are not yet known. Here, we used a modified Y-tube olfactometer to test the effect of these compounds on the orientation of Aedes aegypti flying towards skin odor (human fingers), and we tested their effect on Aedes aegypti oviposition choice in a cage assay. In both behavioral situations we compared the effect to the well-documented repellent N, N-diethyl-meta-toluamide (DEET). MDA, EA, and DEET inhibited Aedes aegypti from flying towards skin odor while BA had no such effect. Conversely, MDA had no effect on oviposition while EA, BA, and DEET deterred oviposition, with the strongest effect observed for BA. Thus, we confirm that EA and DEET are generally repellent, while MDA is repellent only in a host-seeking context, and BA is deterrent only in an oviposition context. These compounds appear of potential use in mosquito control programs.	[Afify, Ali; Galizia, C. Giovanni] Univ Konstanz, Constance, Germany; [Horlacher, Berenice; Roller, Johannes] Heinrich Suso Gymnasium, Constance, Germany	University of Konstanz	Afify, A (corresponding author), Univ Konstanz, Constance, Germany.	ali.aliafify@fulbrightmail.org	Afify, Ali/AAI-6590-2020; Galizia, C Giovanni/A-1771-2009	Galizia, C Giovanni/0000-0001-8292-6031; Afify, Ali/0000-0002-6954-5776	International Max Planck Research School (IMPRS) for Organismal Biology; German Research Foundation (DFG); University of Konstanz	International Max Planck Research School (IMPRS) for Organismal Biology; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Konstanz	1 International Max Planck Research School (IMPRS) for Organismal Biology: http://www.orn.mpg.de/2453/Short_portrait, 2 German Research Foundation (DFG): http://www.dfg.de/en/, 3 University of Konstanz: http://www.uni-konstanz.de/en/welcome/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SA, 2006, J MED ENTOMOL, V43, P225, DOI 10.1603/0022-2585(2006)043[0225:LEOAOF]2.0.CO;2; Bosch OJ, 2000, CHEM SENSES, V25, P323, DOI 10.1093/oxfordjournals.chemse.a014042; DAVIS EE, 1984, J INSECT PHYSIOL, V30, P179, DOI 10.1016/0022-1910(84)90124-0; DETHIER VG, 1960, J ECON ENTOMOL, V53, P134, DOI 10.1093/jee/53.1.134; Dube FF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-375; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; Frances SP, 2014, J AM MOSQUITO CONTR, V30, P65, DOI 10.2987/13-6366.1; Geier M, 1999, CHEM SENSES, V24, P647, DOI 10.1093/chemse/24.6.647; Geier M, 1999, J EXP BIOL, V202, P1639; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; KLOWDEN MJ, 1979, J INSECT PHYSIOL, V25, P231, DOI 10.1016/0022-1910(79)90048-9; KRAMER WL, 1979, ENVIRON ENTOMOL, V8, P1111, DOI 10.1093/ee/8.6.1111; Mittal PK, 2011, INDIAN J MED RES, V133, P426; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; Qualls WA, 2011, J MED ENTOMOL, V48, P1247, DOI 10.1603/ME11072; R Core Team, 2021, R LANGUAGE ENV STAT; RAO SS, 1991, J MED ENTOMOL, V28, P303, DOI 10.1093/jmedent/28.3.303; Silberbush A, 2010, ECOL LETT, V13, P1129, DOI 10.1111/j.1461-0248.2010.01501.x; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Szyszka P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036096; Takken W, 2001, J INSECT PHYSIOL, V47, P303, DOI 10.1016/S0022-1910(00)00107-4; Tikar SN, 2014, PARASITOL RES, V113, P101, DOI 10.1007/s00436-013-3631-9; Trexler JD, 1998, J MED ENTOMOL, V35, P967, DOI 10.1093/jmedent/35.6.967	24	27	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103765	10.1371/journal.pone.0103765	http://dx.doi.org/10.1371/journal.pone.0103765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079819	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800078
J	Dabire, RK; Namountougou, M; Diabate, A; Soma, DD; Bado, J; Toe, HK; Bass, C; Combary, P				Dabire, Roch K.; Namountougou, Moussa; Diabate, Abdoulaye; Soma, Dieudonne D.; Bado, Joseph; Toe, Hyacinthe K.; Bass, Chris; Combary, Patrice			Distribution and Frequency of kdr Mutations within Anopheles gambiae s.I. Populations and First Report of the Ace. 1G119S Mutation in Anopheles arabiensis from Burkina Faso (West Africa)	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; MOLECULAR-FORMS; ACE-1(R) MUTATION; S.L. POPULATIONS; MALARIA VECTORS; TREATED NETS; EFFICACY; BENIN	An entomological survey was carried out at 15 sites dispersed throughout the three eco-climatic regions of Burkina Faso (West Africa) in order to assess the current distribution and frequency of mutations that confer resistance to insecticides in An. gambiae s.I. populations in the country. Both knockdown (kdr) resistance mutation variants (L1014F and L1014S), that confer resistance to pyrethroid insecticides, were identified concomitant with the ace-1 G119S mutation confirming the presence of multiple resistance mechanisms in the An. gambiae complex in Burkina Faso. Compared to the last survey, the frequency of the L1014F kdr mutation appears to have remained largely stable and relatively high in all species. In contrast, the distribution and frequency of the L1014S mutation has increased significantly in An. gambiae s.I. across much of the country. Furthermore we report, for the first time, the identification of the ace.1 G116S mutation in An. arabiensis populations collected at 8 sites. This mutation, which confers resistance to organophosphate and carbamate insecticides, has been reported previously only in the An. gambiae S and M molecular forms. This finding is significant as organophosphates and carbamates are used in indoor residual sprays (IRS) to control malaria vectors as complementary strategies to the use of pyrethroid impregnated bednets. The occurrence of the three target-site resistance mutations in both An. gambiae molecular forms and now An. arabiensis has significant implications for the control of malaria vector populations in Burkina Faso and for resistance management strategies based on the rotation of insecticides with different modes of action.	[Dabire, Roch K.; Namountougou, Moussa; Diabate, Abdoulaye; Soma, Dieudonne D.; Bado, Joseph; Toe, Hyacinthe K.] Ctr Muraz, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Toe, Hyacinthe K.] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Bass, Chris] Biol Chem & Crop Protect Rothamsted Res, Harpenden, Herts, England; [Combary, Patrice] Minist Hlth, Natl Malaria Control Programme, Ouagadougou, Burkina Faso	Centre Muraz; Liverpool School of Tropical Medicine; University of Liverpool	Dabire, RK (corresponding author), Ctr Muraz, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso.	dabire_roch@hotmail.com	Dabire, Roch Kounbobr/ABF-3525-2020	DIABATE, Abdoulaye/0000-0002-9666-9395; Bass, Chris/0000-0002-2590-1492	National Malaria Control Program (NMCP) of Burkina Faso; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005193] Funding Source: researchfish; BBSRC [BBS/E/C/00005193] Funding Source: UKRI	National Malaria Control Program (NMCP) of Burkina Faso; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the National Malaria Control Program (NMCP) of Burkina Faso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoulaye D, 2003, J MED ENTOMOL, V40, P195, DOI 10.1603/0022-2585-40.2.195; Aikpon R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-192; Awolola TS, 2005, ACTA TROP, V95, P204, DOI 10.1016/j.actatropica.2005.06.002; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Carnevale P, 1998, B SOC PATHOL EXOT, V81, P832; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Chandre F, 1997, J MED ENTOMOL, V34, P664, DOI 10.1093/jmedent/34.6.664; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Dabire KR, 2012, INSECTICIDES - PEST ENGINEERING, P479; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Dabire KR, 2009, TROP MED INT HEALTH, V14, P396, DOI 10.1111/j.1365-3156.2009.02243.x; Dabire RK, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-127; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; Fanello C, 2000, T R SOC TROP MED HYG, V94, P132; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Jones CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045995; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Namountougou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048412; Namountougou M, 2013, ACTA TROP, V125, P123, DOI 10.1016/j.actatropica.2012.10.012; Osse R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-163; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Scott JG, 1996, J PESTIC SCI, V21, P241; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b	42	50	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101484	10.1371/journal.pone.0101484	http://dx.doi.org/10.1371/journal.pone.0101484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077792	Green Published, Green Accepted, gold			2022-12-27	WOS:000339954800005
J	Machado, FB; Machado, FB; Faria, MA; Lovatel, VL; da Silva, AFA; Radic, CP; De Brasi, CD; Rios, AFL; Lopes, SMCD; da Silveira, LS; Ruiz-Miranda, CR; Ramos, ES; Medina-Acosta, E				Machado, Filipe Brum; Machado, Fabricio Brum; Faria, Milena Amendro; Lovatel, Viviane Lamim; Alves da Silva, Antonio Francisco; Pamela Radic, Claudia; Daniel De Brasi, Carlos; Lopes Rios, Alvaro Fabricio; Lopes, Susana Marina Chuva de Sousa; da Silveira, Leonardo Serafim; Ruiz-Miranda, Carlos Ramon; Ramos, Ester Silveira; Medina-Acosta, Enrique			5(me)CpG Epigenetic Marks Neighboring a Primate-Conserved Core Promoter Short Tandem Repeat Indicate X-Chromosome Inactivation	PLOS ONE			English	Article							ANDROGEN-RECEPTOR GENE; CAG REPEAT; DNA; METHYLATION; ESCAPE; LOCI; IDENTIFICATION; POLYMORPHISM; MUTATIONS; EXPANSION	X-chromosome inactivation (XCI) is the epigenetic transcriptional silencing of an X-chromosome during the early stages of embryonic development in female eutherian mammals. XCI assures monoallelic expression in each cell and compensation for dosage-sensitive X-linked genes between females (XX) and males (XY). DNA methylation at the carbon-5 position of the cytosine pyrimidine ring in the context of a CpG dinucleotide sequence (5(me)CpG) in promoter regions is a key epigenetic marker for transcriptional gene silencing. Using computational analysis, we revealed an extragenic tandem GAAA repeat 230-bp from the landmark CpG island of the human X-linked retinitis pigmentosa 2 RP2 promoter whose 5(me)CpG status correlates with XCI. We used this RP2 onshore tandem GAAA repeat to develop an allele-specific 5(me)CpG-based PCR assay that is highly concordant with the human androgen receptor (AR) exonic tandem CAG repeat-based standard HUMARA assay in discriminating active (Xa) from inactive (Xi) X-chromosomes. The RP2 onshore tandem GAAA repeat contains neutral features that are lacking in the AR disease-linked tandem CAG repeat, is highly polymorphic (heterozygosity rates approximately 0.8) and shows minimal variation in the Xa/Xi ratio. The combined informativeness of RP2/AR is approximately 0.97, and this assay excels at determining the 5(me)CpG status of alleles at the Xp (RP2) and Xq (AR) chromosome arms in a single reaction. These findings are relevant and directly translatable to nonhuman primate models of XCI in which the AR CAG-repeat is monomorphic. We conducted the RP2 onshore tandem GAAA repeat assay in the naturally occurring chimeric New World monkey marmoset (Callitrichidae) and found it to be informative. The RP2 onshore tandem GAAA repeat will facilitate studies on the variable phenotypic expression of dominant and recessive X-linked diseases, epigenetic changes in twins, the physiology of aging hematopoiesis, the pathogenesis of age-related hematopoietic malignancies and the clonality of cancers in human and nonhuman primates.	[Machado, Filipe Brum; Ramos, Ester Silveira] Univ Sao Paulo, Sch Med, Dept Genet, Sao Paulo, Brazil; [Machado, Fabricio Brum; Faria, Milena Amendro; Lovatel, Viviane Lamim; Alves da Silva, Antonio Francisco; Lopes Rios, Alvaro Fabricio; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Biotechnol Lab, Rio De Janeiro, Brazil; [Pamela Radic, Claudia; Daniel De Brasi, Carlos] Natl Acad Med, Inst Expt Med, Lab Mol Genet Hemophilia, Buenos Aires, DF, Argentina; [Lopes, Susana Marina Chuva de Sousa] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, South Holland, Netherlands; [da Silveira, Leonardo Serafim] Univ Estadual Norte Fluminense, Ctr Studies & Res Wildlife, Lab Anim Morphol & Pathol, Rio De Janeiro, Brazil; [Ruiz-Miranda, Carlos Ramon] Univ Estadual Norte Fluminense, Lab Environm Sci, Sect Studies Ethol Reintroduct & Conservat Wild A, Rio De Janeiro, Brazil; [Medina-Acosta, Enrique] Hosp Escola Alvaro Alvim, Mol Identificat & Diagnost Unit, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Universidade Estadual do Norte Fluminense; Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Ramos, ES (corresponding author), Univ Sao Paulo, Sch Med, Dept Genet, Sao Paulo, Brazil.	esramos@fmrp.usp.br; quique@uenf.br	Ruiz-Miranda, Carlos R/A-4719-2008; Medina-Acosta, E./AAN-9724-2021; Ramos, Ester Silveira/E-3200-2019; Medina-Acosta, Enrique/G-3041-2010; Ruiz, Carlos R/I-4446-2016; Ruiz-Miranda, Carlos R/H-7308-2015; Rios, Álvaro Fabrício Lopes/AGN-5862-2022	Ruiz-Miranda, Carlos R/0000-0001-9786-5315; Medina-Acosta, E./0000-0002-2529-0548; Ramos, Ester Silveira/0000-0001-7253-2143; Medina-Acosta, Enrique/0000-0002-2529-0548; Ruiz-Miranda, Carlos R/0000-0001-7360-0304; De Brasi, Carlos Daniel/0000-0003-2379-4379; Lamim Lovatel, Viviane/0000-0001-8493-5855	FAPERJ; CNPq; FAPESP; CAPES-NUFFIC [302731/2009-1, E- 26/111.450/2012, E- 111.398/2013, E-26/111.788/2013, E-26/110.035/201]; CAPES	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES-NUFFIC(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research leading to these results has received funding from FAPERJ (http://www.faperj.br), CNPq (http://www.cnpq.br), FAPESP (http://www.fapesp.br/en/), CAPES-NUFFIC (http://www.capes.gov.br/cooperacao-internacional/holanda/programa-capesnuffic), under grant agreements 302731/2009-1, E- 26/111.450/2012, E- 111.398/2013, E-26/111.788/2013, E-26/110.035/201, and graduate fellowships by FAPESP(FiBM), FAPERJ (FaBM and MAF), CAPES (VLL) and CNPq (AFAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002781; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Bacher J, 1998, PROFILES DNA, V2, P3; Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132; Beever C, 2003, AM J MED GENET A, V120A, P439, DOI 10.1002/ajmg.a.20045; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Berletch JB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-213; Bertelsen B, 2011, J MOL DIAGN, V13, P537, DOI 10.1016/j.jmoldx.2011.05.003; Bird A, 2011, J MOL BIOL, V409, P47, DOI 10.1016/j.jmb.2011.01.056; Busque L, 1996, BLOOD, V88, P59; Busque L, 2009, BLOOD, V113, P3472, DOI 10.1182/blood-2008-12-195677; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Choong CS, 1998, J MOL EVOL, V47, P334, DOI 10.1007/PL00006391; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Gu ML, 2012, MOL BIOL REP, V39, P2615, DOI 10.1007/s11033-011-1014-9; HENDRIKS RW, 1992, HUM MOL GENET, V1, P187, DOI 10.1093/hmg/1.3.187; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Ji JP, 1996, NUCLEIC ACIDS RES, V24, P2835, DOI 10.1093/nar/24.14.2835; Kar S, 2012, EPIGENETICS-US, V7, P994, DOI 10.4161/epi.21568; Kawaji H, 2011, NUCLEIC ACIDS RES, V39, pD856, DOI 10.1093/nar/gkq1112; Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Machado FB, 2011, HAEMOPHILIA, V17, P257, DOI 10.1111/j.1365-2516.2010.02404.x; Machado FB, 2009, HAEMOPHILIA, V15, P1135, DOI 10.1111/j.1365-2516.2009.02056.x; Machado FB, 2009, HAEMOPHILIA, V15, P297, DOI 10.1111/j.1365-2516.2008.01866.x; Mossner M, 2013, J MED GENET, V50, P108, DOI 10.1136/jmedgenet-2012-101093; Mubiru JN, 2012, J MED PRIMATOL, V41, P67, DOI 10.1111/j.1600-0684.2011.00517.x; Ohadi M, 2012, GENE, V507, P61, DOI 10.1016/j.gene.2012.07.001; Pessia E, 2012, P NATL ACAD SCI USA, V109, P5346, DOI 10.1073/pnas.1116763109; Radic CP, 2009, PRENATAL DIAG, V29, P1183, DOI 10.1002/pd.2393; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rossetti LC, 2008, J THROMB HAEMOST, V6, P830, DOI 10.1111/j.1538-7836.2008.02926.x; Sales ID, 2010, VET PARASITOL, V171, P123, DOI 10.1016/j.vetpar.2010.02.044; Sambrook J., 2001, MOL CLONING LAB MANU; Santacroce R, 2008, J HUM GENET, V53, P275, DOI 10.1007/s10038-007-0238-y; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Sharp AJ, 2011, GENOME RES, V21, P1592, DOI 10.1101/gr.112680.110; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Sin HS, 2013, EPIGENETICS-US, V8, P887, DOI 10.4161/epi.25672; Sweeney CG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-98; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	51	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103714	10.1371/journal.pone.0103714	http://dx.doi.org/10.1371/journal.pone.0103714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078280	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800068
J	Bartels, T; Kim, NC; Luth, ES; Selkoe, DJ				Bartels, Tim; Kim, Nora C.; Luth, Eric S.; Selkoe, Dennis J.			N-Alpha-Acetylation of alpha-Synuclein Increases Its Helical Folding Propensity, GM1 Binding Specificity and Resistance to Aggregation	PLOS ONE			English	Article							LIPID-PEPTIDE INTERACTIONS; PARKINSONS-DISEASE; MEMBRANE INTERACTIONS; TERMINAL ACETYLATION; FIBRIL FORMATION; PACKING DEFECTS; IN-VITRO; GANGLIOSIDE; THERMODYNAMICS; TETRAMER	A switch in the conformational properties of alpha-synuclein (alpha S) is hypothesized to be a key step in the pathogenic mechanism of Parkinson's disease (PD). Whereas the beta-sheet-rich state of alpha S has long been associated with its pathological aggregation in PD, a partially alpha-helical state was found to be related to physiological lipid binding; this suggests a potential role of the alpha-helical state in controlling synaptic vesicle cycling and resistance to beta-sheet rich aggregation. N-terminal acetylation is the predominant post-translational modification of mammalian alpha S. Using circular dichroism, isothermal titration calorimetry, and fluorescence spectroscopy, we have analyzed the effects of N-terminal acetylation on the propensity of recombinant human alpha S to form the two conformational states in interaction with lipid membranes. Small unilamellar vesicles of negatively charged lipids served as model membranes. Consistent with previous NMR studies using phosphatidylserine, we found that membrane-induced alpha-helical folding was enhanced by N-terminal acetylation and that greater exothermic heat could be measured upon vesicle binding of the modified protein. Interestingly, the folding and lipid binding enhancements with phosphatidylserine in vitro were weak when compared to that of alpha S with GM1, a lipid enriched in presynaptic membranes. The resultant increase in helical folding propensity of N-acetylated alpha S enhanced its resistance to aggregation. Our findings demonstrate the significance of the extreme N-terminus for folding nucleation, for relative GM1 specificity of alpha S-membrane interaction, and for a protective function of N-terminal-acetylation against alpha S aggregation mediated by GM1.	[Bartels, Tim] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bartels, T (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	tbartels@partners.org	Bartels, Tim/AAD-6128-2021	Bartels, Tim/0000-0002-4071-5612	Harvard NeuroDiscovery Center (HNDC Pilot Award); Parkinson's Disease Foundation [PDF-IRG-1204]; Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083845] Funding Source: NIH RePORTER	Harvard NeuroDiscovery Center (HNDC Pilot Award); Parkinson's Disease Foundation; Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Harvard NeuroDiscovery Center (HNDC 2012 Pilot Award) and the Parkinson's Disease Foundation (PDF-IRG-1204) to TB and the Fidelity Biosciences Research Initiative to DJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bevington PR., 1969, DATA REDUCTION ERROR; Bodner CR, 2009, J MOL BIOL; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; DeWitt DC, 2013, BIOCHEMISTRY-US, V52, P2385, DOI 10.1021/bi4002369; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Leftin A, 2013, J MOL BIOL, V425, P2973, DOI 10.1016/j.jmb.2013.04.002; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Moriarty GM, 2013, FEBS LETT, V587, P1128, DOI 10.1016/j.febslet.2013.02.049; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Ohrfelt A, 2011, NEUROCHEM RES, V36, P2029, DOI 10.1007/s11064-011-0527-x; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Perlmutter JD, 2009, J BIOL CHEM, V284, P7177, DOI 10.1074/jbc.M808895200; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Roze E, 2005, MOVEMENT DISORD, V20, P1366, DOI 10.1002/mds.20593; Schneider JS, 2013, J NEUROL SCI, V324, P140, DOI 10.1016/j.jns.2012.10.024; Schneider JS, 2010, J NEUROL SCI, V292, P45, DOI 10.1016/j.jns.2010.02.009; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Vamvaca K., 2009, J MOL BIOL; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Wu GS, 2012, J NEUROSCI RES, V90, P1997, DOI 10.1002/jnr.23090; Wu GS, 2011, NEUROCHEM RES, V36, P1706, DOI 10.1007/s11064-011-0437-y; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200	48	102	105	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103727	10.1371/journal.pone.0103727	http://dx.doi.org/10.1371/journal.pone.0103727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075858	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800075
J	Calabro, SR; Maczurek, AE; Morgan, AJ; Tu, T; Wen, VW; Yee, C; Mridha, A; Lee, M; d'Avigdor, W; Locarnini, SA; McCaughan, GW; Warner, FJ; McLennan, SV; Shackel, NA				Calabro, Sarah R.; Maczurek, Annette E.; Morgan, Alison J.; Tu, Thomas; Wen, Victoria W.; Yee, Christine; Mridha, Auvro; Lee, Maggie; d'Avigdor, William; Locarnini, Stephen A.; McCaughan, Geoffrey W.; Warner, Fiona J.; McLennan, Susan V.; Shackel, Nicholas A.			Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; HEPATITIS-C VIRUS; CELLS IN-VITRO; HEPATOCELLULAR-CARCINOMA; RHEUMATOID-ARTHRITIS; TISSUE INHIBITOR; INDUCER EMMPRIN; 4-AMINOPHENYLMERCURIC ACETATE; IMMUNOGLOBULIN SUPERFAMILY; MONOCLONAL-ANTIBODIES	Background: The classical paradigm of liver injury asserts that hepatic stellate cells (HSC) produce, remodel and turnover the abnormal extracellular matrix (ECM) of fibrosis via matrix metalloproteinases (MMPs). In extrahepatic tissues MMP production is regulated by a number of mechanisms including expression of the glycoprotein CD147. Previously, we have shown that CD147 is expressed on hepatocytes but not within the fibrotic septa in cirrhosis [1]. Therefore, we investigated if hepatocytes produce MMPs, regulated by CD147, which are capable of remodelling fibrotic ECM independent of the HSC. Methods: Non-diseased, fibrotic and cirrhotic livers were examined for MMP activity and markers of fibrosis in humans and mice. CD147 expression and MMP activity were co-localised by in-situ zymography. The role of CD147 was studied in-vitro with siRNA to CD147 in hepatocytes and in-vivo in mice with CCl4 induced liver injury using a CD147 antibody intervention. Results: In liver fibrosis in both human and mouse tissue MMP expression and activity (MMP-2, -9, -13 and -14) increased with progressive injury and localised to hepatocytes. Additionally, as expected, MMPs were abundantly expressed by activated HSC. Further, with progressive fibrosis there was expression of CD147, which localised to hepatocytes but not to HSC. Functionally significant in-vitro regulation of hepatocyte MMP production by CD147 was demonstrated using siRNA to CD147 that decreased hepatocyte MMP-2 and -9 expression/activity. Further, in-vivo alpha-CD147 antibody intervention decreased liver MMP-2, -9, -13, -14, TGF-beta and alpha-SMA expression in CCl4 treated mice compared to controls. Conclusion: We have shown that hepatocytes produce active MMPs and that the glycoprotein CD147 regulates hepatocyte MMP expression. Targeting CD147 regulates hepatocyte MMP production both in-vitro and in-vivo, with the net result being reduced fibrotic matrix turnover in-vivo. Therefore, CD147 regulation of hepatocyte MMP is a novel pathway that could be targeted by future anti-fibrogenic agents.	[Calabro, Sarah R.; Maczurek, Annette E.; Morgan, Alison J.; Tu, Thomas; Wen, Victoria W.; Yee, Christine; Lee, Maggie; d'Avigdor, William; Warner, Fiona J.; Shackel, Nicholas A.] Centenary Inst, Sydney, NSW, Australia; [Calabro, Sarah R.; Maczurek, Annette E.; Morgan, Alison J.; Tu, Thomas; Wen, Victoria W.; Yee, Christine; Mridha, Auvro; Lee, Maggie; d'Avigdor, William; McCaughan, Geoffrey W.; Warner, Fiona J.; McLennan, Susan V.; Shackel, Nicholas A.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Locarnini, Stephen A.] Victorian Infect Dis Lab, Melbourne, Vic, Australia; [McLennan, Susan V.] Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW, Australia; [McCaughan, Geoffrey W.; Shackel, Nicholas A.] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney; Victorian Infectious Diseases Reference Laboratory; University of Sydney; University of Sydney	Shackel, NA (corresponding author), Centenary Inst, Sydney, NSW, Australia.	n.shackel@centenary.usyd.edu.au	Tu, Thomas/H-2894-2019	Tu, Thomas/0000-0002-0482-4387; Mridha, Auvro/0000-0001-5045-6899; MCCAUGHAN, GEOFFREY/0000-0002-1483-1636; Yee, Christine/0000-0001-7243-5634	NHMRC [571408, 512283, 1063515, 1009815]; University of Sydney Australian Postgraduate Awards; Rebecca L Cooper Medical Foundation	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney Australian Postgraduate Awards; Rebecca L Cooper Medical Foundation	This research was funded by NHMRC grants 571408, 512283, 1063515 and 1009815. SC and AM were supported by University of Sydney Australian Postgraduate Awards and W. d'A by a scholarship from the Rebecca L Cooper Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SM, 2011, BBA-MOL BASIS DIS, V1812, P213, DOI 10.1016/j.bbadis.2010.07.018; Arthur MJP, 1998, DIGESTION, V59, P376, DOI 10.1159/000007492; ARTHUR MJP, 1994, PATHOL RES PRACT, V190, P825; ARTHUR MJP, 1990, SEMIN LIVER DIS, V10, P47, DOI 10.1055/s-2008-1040456; Arthur MJP, 1997, HEPATOLOGY, V26, P1069, DOI 10.1002/hep.510260440; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2005, HEPATOLOGY, V41, P1046, DOI 10.1002/hep.20665; Bertolino P, 1998, EUR J IMMUNOL, V28, P221, DOI 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.3.CO;2-6; Betsuyaku T, 2003, AM J RESP CELL MOL, V28, P600, DOI 10.1165/rcmb.2002-0059OC; Cho JY, 2001, BLOOD, V98, P374, DOI 10.1182/blood.V98.2.374; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Garcia-Irigoyen O, 2013, LIVER INT; Guillot S, 2006, EXP LUNG RES, V32, P81, DOI 10.1080/01902140600710512; Hamzavi J, 2008, J CELL MOL MED, V12, P2130, DOI 10.1111/j.1582-4934.2008.00262.x; Han YP, 2006, J GASTROEN HEPATOL, V21, pS88, DOI 10.1111/j.1440-1746.2006.04586.x; Haruyama T, 2000, BIOCHEM BIOPH RES CO, V272, P681, DOI 10.1006/bbrc.2000.2837; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Henkel C, 2005, Z GASTROENTEROL, V43, P23, DOI 10.1055/s-2004-813911; Hou Q, 2011, CANCER SCI, V102, P1287, DOI 10.1111/j.1349-7006.2011.01933.x; HOWE RC, 1988, J IMMUNOL, V140, P1047; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; Ikeda M, 1998, VIRUS RES, V56, P157, DOI 10.1016/S0168-1702(98)00063-X; Iredale JP, 2013, BBA-MOL BASIS DIS, V1832, P876, DOI 10.1016/j.bbadis.2012.11.002; Iredale JP, 1997, INT J BIOCHEM CELL B, V29, P43, DOI 10.1016/S1357-2725(96)00118-5; ITOH Y, 1995, BIOCHEM J, V308, P645, DOI 10.1042/bj3080645; Jia L, 2008, CANCER INVEST, V26, P977, DOI 10.1080/07357900802072723; JOSEPH J, 1993, ADV EXP MED BIOL, V342, P389; Kasinrerk W, 1999, IMMUNOLOGY, V96, P184; Knittel T, 1999, J HEPATOL, V30, P48, DOI 10.1016/S0168-8278(99)80007-5; Kuno N, 1998, FEBS LETT, V425, P191, DOI 10.1016/S0014-5793(98)00213-0; Leon MDG, 2006, EXP MOL PATHOL, V80, P97, DOI 10.1016/j.yexmp.2005.03.008; MACDONALD HR, 1985, J IMMUNOL, V135, P3944; Matsumoto G, 2002, J IMMUNOL, V169, P7087, DOI 10.4049/jimmunol.169.12.7087; McLennan SV, 2012, J HEPATOL; Min DQ, 2006, ELECTROPHORESIS, V27, P357, DOI 10.1002/elps.200500484; Noguchi M, 1996, IN VITRO CELL DEV-AN, V32, P135; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; Ohteki T, 1999, J IMMUNOL, V162, P3753; Paizis G, 2005, GUT, V54, P1790, DOI 10.1136/gut.2004.062398; Pinzani M, 2004, DIGEST LIVER DIS, V36, P231, DOI 10.1016/j.dld.2004.01.003; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Roeb E, 2005, WORLD J GASTROENTERO, V11, P1096, DOI 10.3748/wjg.v11.i8.1096; Sawanyawisuth K, 2012, ASIAN PAC J CANCER P, V13, P89, DOI 10.7314/APJCP.2012.13.KKSuppl.89; Serandour AL, 2005, HEPATOLOGY, V41, P478, DOI 10.1002/hep.20602; Shackel NA, 2001, GUT, V49, P565, DOI 10.1136/gut.49.4.565; Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5; Shi ZD, 1997, P NATL ACAD SCI USA, V94, P10663, DOI 10.1073/pnas.94.20.10663; Tang J, 2012, CELL DEATH DIFFER, V19, P1779, DOI 10.1038/cdd.2012.60; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tang Y, 2004, MOL CANCER RES, V2, P73; Thomas JA, 2011, HEPATOLOGY; Tomita T, 2002, ARTHRITIS RHEUM, V46, P373, DOI 10.1002/art.10050; Toole BP, 2003, CURR TOP DEV BIOL, V54, P371, DOI 10.1016/S0070-2153(03)54015-7; Treese C, 2008, CYTOM PART A, V73A, P351, DOI 10.1002/cyto.a.20532; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Veidal SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024753; Wang CH, 2011, J CELL MOL MED, V15, P850, DOI 10.1111/j.1582-4934.2010.01084.x; Watanabe T, 2001, J HEPATOL, V35, P465, DOI 10.1016/S0168-8278(01)00177-5; Xu Q, 2002, INFLAMM RES, V51, P44, DOI 10.1007/PL00000281; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625; Zhanet DW, 2012, J HEPATOL, V57, P1283, DOI 10.1016/j.jhep.2012.07.042; Zhang DW, 2012, J HEPATOL; Zhao P, 2010, CANCER SCI, V101, P387, DOI 10.1111/j.1349-7006.2009.01420.x; Zhu P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1899	66	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e90571	10.1371/journal.pone.0090571	http://dx.doi.org/10.1371/journal.pone.0090571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076423	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800001
J	Ferrara, MA; Dardano, P; De Stefano, L; Rea, I; Coppola, G; Rendina, I; Congestri, R; Antonucci, A; De Stefano, M; De Tommasi, E				Ferrara, Maria Antonietta; Dardano, Principia; De Stefano, Luca; Rea, Ilaria; Coppola, Giuseppe; Rendina, Ivo; Congestri, Roberta; Antonucci, Alessandra; De Stefano, Mario; De Tommasi, Edoardo			Optical Properties of Diatom Nanostructured Biosilica in Arachnoidiscus sp: Micro-Optics from Mother Nature	PLOS ONE			English	Article							SILICA	Some natural structures show three-dimensional morphologies on the micro-and nano-scale, characterized by levels of symmetry and complexity well far beyond those fabricated by best technologies available. This is the case of diatoms, unicellular microalgae, whose protoplasm is enclosed in a nanoporous microshell, made of hydrogenated amorphous silica, called frustule. We have studied the optical properties of Arachnoidiscus sp. single valves both in visible and ultraviolet range. We found photonic effects due to diffraction by ordered pattern of pores and slits, accordingly to an elaborated theoretical model. For the first time, we experimentally revealed spatial separation of focused light in different spots, which could be the basis of a micro-bio-spectrometer. Characterization of such intricate structures can be of great inspiration for photonic devices of next generation.	[Ferrara, Maria Antonietta; Dardano, Principia; De Stefano, Luca; Rea, Ilaria; Coppola, Giuseppe; Rendina, Ivo; De Tommasi, Edoardo] CNR, Dept Naples, Inst Microelect & Microsyst, I-80125 Naples, Italy; [Congestri, Roberta] Univ Roma Tor Vergata, Dept Biol, Lab Biol Algae, I-00173 Rome, Italy; [Antonucci, Alessandra; De Stefano, Mario] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Microelettronica e Microsistemi (IMM-CNR); University of Rome Tor Vergata; Universita della Campania Vanvitelli	Ferrara, MA (corresponding author), CNR, Dept Naples, Inst Microelect & Microsyst, I-80125 Naples, Italy.	antonella.ferrara@na.imm.cnr.it	Dardano, Principia/AAG-3720-2022; De Stefano, Luca/H-7103-2019; Rea, Ilaria/ABC-4892-2020; De Tommasi, Edoardo/B-7365-2015; Dardano, Principia/AFK-5115-2022; Rendina, Ivo/F-8266-2013; Antonucci, Alessandra/AAC-2135-2020; Coppola, Giuseppe/B-3991-2012; Ferrara, Maria Antonietta/E-5111-2016	De Stefano, Luca/0000-0002-9442-4175; Rea, Ilaria/0000-0003-0568-9911; De Tommasi, Edoardo/0000-0003-2030-4557; Rendina, Ivo/0000-0002-3861-373X; Antonucci, Alessandra/0000-0002-5456-5336; Coppola, Giuseppe/0000-0001-7139-3719; Ferrara, Maria Antonietta/0000-0001-5291-1373; Dardano, Principia/0000-0002-0616-3914	Ministero Istruzione Universita e Ricerca (MIUR) Programma "Futuro in Ricerca'' FIRB [RBFR08QXL2/2008]	Ministero Istruzione Universita e Ricerca (MIUR) Programma "Futuro in Ricerca'' FIRB(Ministry of Education, Universities and Research (MIUR))	Funding provided by Ministero Istruzione Universita e Ricerca (MIUR) Programma "Futuro in Ricerca'' FIRB project RBFR08QXL2/2008 http://futuroinricerca.miur.it EDT MDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biro LP, 2011, LASER PHOTONICS REV, V5, P27, DOI 10.1002/lpor.200900018; Brown NE, 1993, ARACHNOIDISCUS ACCOU; De Stefano L, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2140087; De Stefano L, 2009, SUPERLATTICE MICROST, V46, P84, DOI 10.1016/j.spmi.2008.10.031; De Stefano L, 2007, OPT EXPRESS, V15, P18082, DOI 10.1364/OE.15.018082; De Tommasi E, 2010, OPT EXPRESS, V18, P12203, DOI 10.1364/OE.18.012203; De Tommasi E, 2008, P SPIE MICROOPTICS, V6992, P69920; Di Caprio G, 2012, J BIOPH, V5, P1, DOI DOI 10.1002/JBIO.201200198; Ehrlich PR, 1981, J RES LEPIDOPTERA, V20, P199; Gale DK, 2009, ADV FUNCT MATER, V19, P926, DOI 10.1002/adfm.200801137; Goodman J. W., 1996, INTRO FOURIER OPTICS; HADLEY GR, 1992, OPT LETT, V17, P1426, DOI 10.1364/OL.17.001426; Kammer M, 2010, ANAL BIOANAL CHEM, V398, P509, DOI 10.1007/s00216-010-3924-0; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Lettieri S, 2008, ADV FUNCT MATER, V18, P1257, DOI 10.1002/adfm.200701124; Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u; Milligan AJ, 2002, SCIENCE, V297, P1848, DOI 10.1126/science.1074958; NAZARATHY M, 1980, J OPT SOC AM, V70, P150, DOI 10.1364/JOSA.70.000150; Palik E.D, 1991, HDB OPTICAL CONSTANT, V2; Polini A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00607; Potyrailo RA, 2007, NAT PHOTONICS, V1, P123, DOI 10.1038/nphoton.2007.2; Pris AD, 2012, NAT PHOTONICS, V6, P195, DOI [10.1038/nphoton.2011.355, 10.1038/NPHOTON.2011.355]; Qin T, 2008, J NANOSCI NANOTECHNO, V8, P2392, DOI 10.1166/jnn.2008.241; Round F. E., 1990, DIATOMS BIOL MORPHOL; Schmid A.M., 1976, NOVA HEDWIGIA, V28, P309; SCHMID AMM, 1979, PROTOPLASMA, V100, P267, DOI 10.1007/BF01279316; Setaro A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768027; Wang C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01025; Yu LF, 2001, J OPT SOC AM A, V18, P1033, DOI 10.1364/JOSAA.18.001033	29	65	66	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103750	10.1371/journal.pone.0103750	http://dx.doi.org/10.1371/journal.pone.0103750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076045	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800077
J	Liu, YW; Huang, YT				Liu, Ya-Wei; Huang, Yi-Tsau			Inhibitory Effect of Tanshinone IIA on Rat Hepatic Stellate Cells	PLOS ONE			English	Article							SALVIANOLIC-ACID-B; TNF-ALPHA; LIVER; FIBROSIS; MILTIORRHIZA; ACTIVATION; EXPRESSION; RECEPTOR; MIGRATION; LIPOPOLYSACCHARIDE	Background: Anti-inflammation via inhibition of NF-kappa B pathways in hepatic stellate cells (HSCs) is one therapeutic approach to hepatic fibrosis. Tanshinone IIA (C19H18O3, Tan IIA) is a lipophilic diterpene isolated from Salvia miltiorrhiza Bunge, with reported anti-inflammatory activity. We tested whether Tan IIA could inhibit HSC activation. Materials and Methods: The cell line of rat hepatic stellate cells (HSC-T6) was stimulated with lipopolysaccharide (LPS) (100 ng/ml). Cytotoxicity was assessed by MTT assay. HSC-T6 cells were pretreated with Tan IIA (1, 3 and 10 mu M), then induced by LPS (100 ng/ml). NF-kappa B activity was evaluated by the luciferase reporter gene assay. Western blotting analysis was performed to measure NF-kappa B-p65, and phosphorylations of MAPKs (ERK, JNK, p38). Cell chemotaxis was assessed by both wound-healing assay and trans-well invasion assay. Quantitative real-time PCR was used to detect gene expression in HSC-T6 cells. Results: All concentrations of drugs showed no cytotoxicity against HSC-T6 cells. LPS stimulated NF-kappa B luciferase activities, nuclear translocation of NF-kappa B-p65, and phosphorylations of ERK, JNK and p38, all of which were suppressed by Tan IIA. In addition, Tan IIA significantly inhibited LPS-induced HSCs chemotaxis, in both wound-healing and trans-well invasion assays. Moreover, Tan IIA attenuated LPS-induced mRNA expressions of CCL2, CCL3, CCL5, IL-1 beta, TNF-alpha, IL-6, ICAM-1, iNOS, and alpha-SMA in HSC-T6 cells. Conclusion: Our results demonstrated that Tan IIA decreased LPS-induced HSC activation.	[Liu, Ya-Wei; Huang, Yi-Tsau] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Huang, Yi-Tsau] Minist Hlth & Welf, Natl Res Inst Chinese Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine	Huang, YT (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan.	huangyt@nricm.edu.tw			National Science Council [NSC99-2628-B-077-001-MY3, NSC-102-2320-B-077-001]; National Research Institute of Chinese Medicine in Taiwan [NRICM99-DBCM-05]	National Science Council(Ministry of Science and Technology, Taiwan); National Research Institute of Chinese Medicine in Taiwan	This work was supported by the National Science Council (NSC99-2628-B-077-001-MY3, NSC-102-2320-B-077-001) and the National Research Institute of Chinese Medicine (NRICM99-DBCM-05) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonacchi A, 2003, GASTROENTEROLOGY, V125, P1060, DOI 10.1016/S0016-5085(03)01194-6; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen HJ, 2013, J ETHNOPHARMACOL, V150, P835, DOI 10.1016/j.jep.2013.08.049; Chen YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040165; Chen YH, 2001, J CELL BIOCHEM, V82, P512, DOI 10.1002/jcb.1176; Choi HS, 2004, ARCH PHARM RES, V27, P1233, DOI 10.1007/BF02975887; Fan GW, 2009, J STEROID BIOCHEM, V113, P275, DOI 10.1016/j.jsbmb.2009.01.011; Feng Yibin, 2009, Chin Med, V4, P16, DOI 10.1186/1749-8546-4-16; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Friedman SL, 2012, P NATL ACAD SCI USA, V109, P9230, DOI 10.1073/pnas.1206645109; Gao B, 2011, AM J PHYSIOL-GASTR L, V300, pG516, DOI 10.1152/ajpgi.00537.2010; Han JY, 2008, PHARMACOL THERAPEUT, V117, P280, DOI 10.1016/j.pharmthera.2007.09.008; Hsu CJ, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-68; Hsu YC, 2005, J BIOMED SCI, V12, P185, DOI 10.1007/s11373-004-8167-7; Hsu YC, 2007, J GASTROEN HEPATOL, V22, P99, DOI 10.1111/j.1440-1746.2006.04361.x; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Huang XY, 2009, J CANCER RES CLIN, V135, P1245, DOI 10.1007/s00432-009-0566-8; Inokuchi S, 2011, ALCOHOL CLIN EXP RES, V35, P1509, DOI 10.1111/j.1530-0277.2011.01487.x; Jang SI, 2003, PLANTA MED, V69, P1057, DOI 10.1055/s-2003-45157; Joe Y, 2012, J PHARMACOL EXP THER, V341, P850, DOI 10.1124/jpet.111.190736; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kong XN, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00069; Kuo YF, 2006, J PHARM PHARMACOL, V58, P521, DOI 10.1211/jpp.58.4.0012; Lee TF, 2011, LIVER INT, V31, P618, DOI 10.1111/j.1478-3231.2011.02485.x; Lee TY, 2003, J PHARMACOL SCI, V91, P202, DOI 10.1254/jphs.91.202; Lee Y, 2010, PROG MOL BIOL TRANSL, V97, P151, DOI 10.1016/B978-0-12-385233-5.00006-4; Lin YL, 2006, J ETHNOPHARMACOL, V105, P215, DOI 10.1016/j.jep.2005.10.021; Lin YL, 2009, J GASTROEN HEPATOL, V24, P453, DOI 10.1111/j.1440-1746.2008.05573.x; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Marra F, 2004, AM J PHYSIOL-GASTR L, V287, pG18, DOI 10.1152/ajpgi.00336.2003; Novo E, 2007, AM J PATHOL, V170, P1942, DOI 10.2353/ajpath.2007.060887; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Parajuli DR, 2013, MOLECULES, V18, P2122, DOI 10.3390/molecules18022122; Pradere JP, 2013, HEPATOLOGY; Schrimpf C, 2011, CURR OPIN NEPHROL HY, V20, P297, DOI 10.1097/MNH.0b013e328344c3d4; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Ueng YF, 2004, LIFE SCI, V74, P885, DOI 10.1016/j.lfs.2003.07.035; Vogel S, 2000, J LIPID RES, V41, P882; Wang B, 2009, J HEPATOL, V51, P1037, DOI 10.1016/j.jhep.2009.06.020; Weng TC, 2012, PHYTOTHER RES, V26, P344, DOI 10.1002/ptr.3539; Xu Y, 2008, J CLIN IMMUNOL, V28, P512, DOI 10.1007/s10875-008-9206-3; Yamamoto M, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/240365; Yeligar SM, 2009, J IMMUNOL, V183, P5964, DOI 10.4049/jimmunol.0901564; Yin HQ, 2008, ARCH PHARM RES, V31, P659, DOI 10.1007/s12272-001-1209-2; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zimmermann Henning W., 2011, Inflammation & Allergy Drug Targets, V10, P509	56	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103229	10.1371/journal.pone.0103229	http://dx.doi.org/10.1371/journal.pone.0103229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076488	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800031
J	Yasuda, K; Watkins, AA; Kochar, GS; Wilson, GE; Laskow, B; Richez, C; Bonegio, RG; Rifkin, IR				Yasuda, Kei; Watkins, Amanda A.; Kochar, Guneet S.; Wilson, Gabriella E.; Laskow, Bari; Richez, Christophe; Bonegio, Ramon G.; Rifkin, Ian R.			Interferon Regulatory Factor-5 Deficiency Ameliorates Disease Severity in the MRL/lpr Mouse Model of Lupus in the Absence of a Mutation in DOCK2	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; RAC ACTIVATOR DOCK2; B-CELLS; GENETIC-VARIANTS; I INTERFERON; IRF5; ERYTHEMATOSUS; MICE; RISK; ASSOCIATION	Interferon regulatory factor 5 (IRF5) polymorphisms are strongly associated with an increased risk of developing the autoimmune disease systemic lupus erythematosus. In mouse lupus models, IRF5-deficiency was shown to reduce disease severity consistent with an important role for IRF5 in disease pathogenesis. However these mouse studies were confounded by the recent demonstration that the IRF5 knockout mouse line contained a loss-of-function mutation in the dedicator of cytokinesis 2 (DOCK2) gene. As DOCK2 regulates lymphocyte trafficking and Toll-like receptor signaling, this raised the possibility that some of the protective effects attributed to IRF5 deficiency in the mouse lupus models may instead have been due to DOCK2 deficiency. We have therefore here evaluated the effect of IRF5-deficiency in the MRL/lpr mouse lupus model in the absence of the DOCK2 mutation. We find that IRF5-deficient (IRF5(-/-)) MRL/lpr mice develop much less severe disease than their IRF5-sufficient (IRF5(+/+)) littermates. Despite markedly lower serum levels of anti-nuclear autoantibodies and reduced total splenocyte and CD4(+) T cell numbers, IRF5(-/-) MRL/lpr mice have similar numbers of all splenic B cell subsets compared to IRF5(+/+) MRL/lpr mice, suggesting that IRF5 is not involved in B cell development up to the mature B cell stage. However, IRF5(-/-) MRL/lpr mice have greatly reduced numbers of spleen plasmablasts and bone marrow plasma cells. Serum levels of B lymphocyte stimulator (BLyS) were markedly elevated in the MRL/lpr mice but no effect of IRF5 on serum BLyS levels was seen. Overall our data demonstrate that IRF5 contributes to disease pathogenesis in the MRL/lpr lupus model and that this is due, at least in part, to the role of IRF5 in plasma cell formation. Our data also suggest that combined therapy targeting both IRF5 and BLyS might be a particularly effective therapeutic approach in lupus.	[Yasuda, Kei; Watkins, Amanda A.; Kochar, Guneet S.; Wilson, Gabriella E.; Laskow, Bari; Richez, Christophe; Bonegio, Ramon G.; Rifkin, Ian R.] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA	Boston University	Yasuda, K (corresponding author), Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA.	kyasuda@bu.edu; irifkin@bu.edu		Yasuda, Kei/0000-0002-6791-4531	National Institutes of Health [P01 AR050256, 1K01AR060857-01, R01 DK090558, T32DK007053, AI007309-23]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR060857, P01AR050256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007053, R01DK095058, R01DK090558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health (http://www.nih.gov/) (P01 AR050256 to I. R. R., 1K01AR060857-01 to K. Y., R01 DK090558 to R. G. B., T32DK007053 to K. Y. and AI007309-23 to A. A. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Baudino L, 2006, SPRINGER SEMIN IMMUN, V28, P175, DOI 10.1007/s00281-006-0037-0; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018; Brink R, 2014, CURR OPIN IMMUNOL, V28, P97, DOI 10.1016/j.coi.2014.03.001; Bronson PG, 2012, CURR OPIN IMMUNOL, V24, P530, DOI 10.1016/j.coi.2012.07.008; Cash H, 2010, J RHEUMATOL, V37, P60, DOI 10.3899/jrheum.090194; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Douagi I, 2009, J IMMUNOL, V182, P1991, DOI 10.4049/jimmunol.0802257; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Feng D, 2012, EUR J IMMUNOL, V42, P1477, DOI 10.1002/eji.201141642; Feng D, 2010, ARTHRITIS RHEUM-US, V62, P562, DOI 10.1002/art.27223; Ferreiro-Neira I, 2007, GENES IMMUN, V8, P429, DOI 10.1038/sj.gene.6364407; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Graham DSC, 2007, HUM MOL GENET, V16, P579, DOI 10.1093/hmg/ddl469; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Greenspan NS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-3; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; Hedl M, 2012, J IMMUNOL, V188, P5348, DOI 10.4049/jimmunol.1103319; Hu GD, 2009, J BIOL CHEM, V284, P2767, DOI 10.1074/jbc.M804744200; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lien CY, 2010, P NATL ACAD SCI USA, V107, P4664, DOI 10.1073/pnas.0911193107; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Panchanathan R, 2011, J IMMUNOL; Panchanathan R, 2013, MOL IMMUNOL, V53, P15, DOI 10.1016/j.molimm.2012.06.013; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; Purtha WE, 2012, P NATL ACAD SCI USA, V109, pE898, DOI 10.1073/pnas.1118155109; Richez C, 2010, J IMMUNOL, V184, P796, DOI 10.4049/jimmunol.0901748; Savitsky DA, 2010, P NATL ACAD SCI USA, V107, P10154, DOI 10.1073/pnas.1005599107; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Steinhagen F, 2013, EUR J IMMUNOL, V43, P1896, DOI 10.1002/eji.201242792; Stohl W, 2012, NAT BIOTECHNOL, V30, P69, DOI 10.1038/nbt.2076; Tada Y, 2011, ARTHRITIS RHEUM-US, V63, P738, DOI 10.1002/art.30183; TAKAHASHI S, 1991, J IMMUNOL, V147, P515; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Xu Y, 2012, J IMMUNOL, V188, P4113, DOI 10.4049/jimmunol.1103113; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yasuda K, 2007, J IMMUNOL, V178, P6876, DOI 10.4049/jimmunol.178.11.6876; Yasuda K, 2013, INT IMMUNOL, V25, P295, DOI 10.1093/intimm/dxs114	53	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103478	10.1371/journal.pone.0103478	http://dx.doi.org/10.1371/journal.pone.0103478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076492	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800051
J	Kawano, R; Tsuji, Y; Kamiya, K; Kodama, T; Osaki, T; Miki, N; Takeuchi, S				Kawano, Ryuji; Tsuji, Yutaro; Kamiya, Koki; Kodama, Taiga; Osaki, Toshihisa; Miki, Norihisa; Takeuchi, Shoji			A Portable Lipid Bilayer System for Environmental Sensing with a Transmembrane Protein	PLOS ONE			English	Article							MICROFLUIDIC DEVICE; CHIP	This paper describes a portable measurement system for current signals of an ion channel that is composed of a planar lipid bilayer. A stable and reproducible lipid bilayer is formed in outdoor environments by using a droplet contact method with a micropipette. Using this system, we demonstrated that the single-channel recording of a transmembrane protein (alpha-hemolysin) was achieved in the field at a high-altitude (similar to 3623 m). This system would be broadly applicable for obtaining environmental measurements using membrane proteins as a highly sensitive sensor.	[Kawano, Ryuji; Tsuji, Yutaro; Kamiya, Koki; Kodama, Taiga; Osaki, Toshihisa; Miki, Norihisa; Takeuchi, Shoji] KAST, Artificial Cell Membrane Syst Grp, Takatsu Ku, Kawasaki, Kanagawa, Japan; [Tsuji, Yutaro; Kodama, Taiga; Miki, Norihisa] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Osaki, Toshihisa; Takeuchi, Shoji] Univ Tokyo, CIRMM IIS, Meguro Ku, Tokyo, Japan	Kanagawa Academy Science & Technology; Keio University; University of Tokyo	Takeuchi, S (corresponding author), KAST, Artificial Cell Membrane Syst Grp, Takatsu Ku, Kawasaki, Kanagawa, Japan.	takeuchi@iis.u-tokyo.ac.jp	Takeuchi, Shoji/J-5349-2019; Kawano, Ryuji/A-3177-2011; Kamiya, Koki/F-9889-2018; OSAKI, Toshihisa/F-3815-2012; Miki, Norihisa/F-7659-2014; Kamiya, Koki/AAL-6950-2020	Kawano, Ryuji/0000-0001-6523-0649; OSAKI, Toshihisa/0000-0003-1659-2541; Kamiya, Koki/0000-0001-9143-9841; Takeuchi, Shoji/0000-0001-6946-0409	MEXT (KAKENHI) in Japan [23107534, 24655072, 25708024, 25246071]	MEXT (KAKENHI) in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 23107534), Challenging Exploratory Research (No. 24655072), Young Scientists (A) (No. 25708024), and Scientific Research (A) (No. 25246071) from MEXT (KAKENHI) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JN, 1997, ION CHANNELS, V207; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Du LP, 2013, BIOSENS BIOELECTRON, V42, P570, DOI 10.1016/j.bios.2012.09.001; Funakoshi K, 2006, ANAL CHEM, V78, P8169, DOI 10.1021/ac0613479; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Jeon TJ, 2008, LAB CHIP, V8, P1742, DOI 10.1039/b807932c; Kang XF, 2007, J AM CHEM SOC, V129, P4701, DOI 10.1021/ja068654g; Kawano R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01995; Kawano R, 2011, J AM CHEM SOC, V133, P8474, DOI 10.1021/ja2026085; Kawano R, 2010, SMALL, V6, P2100, DOI 10.1002/smll.201000997; Nielsen CH, 2009, ANAL BIOANAL CHEM, V395, P697, DOI 10.1007/s00216-009-2960-0; Sarles SA, 2010, LAB CHIP, V10, P710, DOI 10.1039/b916736f; Shim JW, 2007, ANAL CHEM, V79, P2207, DOI 10.1021/ac0614285; Tsuji Y, 2013, ANAL CHEM, V85, P10913, DOI 10.1021/ac402299z; Tsuji Y, 2013, LAB CHIP, V13, P1476, DOI 10.1039/c3lc41359d; WONDERLIN WF, 1990, BIOPHYS J, V58, P289, DOI 10.1016/S0006-3495(90)82376-6; Wu HC, 2008, J AM CHEM SOC, V130, P6813, DOI 10.1021/ja8004607	18	41	41	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102427	10.1371/journal.pone.0102427	http://dx.doi.org/10.1371/journal.pone.0102427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072468	Green Published, Green Submitted, gold			2022-12-27	WOS:000341307600011
J	Moll, K; Kunze, S; Neuhoff, N; Bruder, J; Schulte-Koerne, G				Moll, Kristina; Kunze, Sarah; Neuhoff, Nina; Bruder, Jennifer; Schulte-Koerne, Gerd			Specific Learning Disorder: Prevalence and Gender Differences	PLOS ONE			English	Article							DEVELOPMENTAL DYSCALCULIA; READING-DISABILITY; COMORBIDITY; DIFFICULTIES; MATHEMATICS; DEFICITS; CHILDREN; PSYCHOPATHOLOGY; IMPAIRMENT; PRECURSORS	Comprehensive models of learning disorders have to consider both isolated learning disorders that affect one learning domain only, as well as comorbidity between learning disorders. However, empirical evidence on comorbidity rates including all three learning disorders as defined by DSM-5 (deficits in reading, writing, and mathematics) is scarce. The current study assessed prevalence rates and gender ratios for isolated as well as comorbid learning disorders in a representative sample of 1633 German speaking children in 3rd and 4th Grade. Prevalence rates were analysed for isolated as well as combined learning disorders and for different deficit criteria, including a criterion for normal performance. Comorbid learning disorders occurred as frequently as isolated learning disorders, even when stricter cutoff criteria were applied. The relative proportion of isolated and combined disorders did not change when including a criterion for normal performance. Reading and spelling deficits differed with respect to their association with arithmetic problems: Deficits in arithmetic co-occurred more often with deficits in spelling than with deficits in reading. In addition, comorbidity rates for arithmetic and reading decreased when applying stricter deficit criteria, but stayed high for arithmetic and spelling irrespective of the chosen deficit criterion. These findings suggest that the processes underlying the relationship between arithmetic and reading might differ from those underlying the relationship between arithmetic and spelling. With respect to gender ratios, more boys than girls showed spelling deficits, while more girls were impaired in arithmetic. No gender differences were observed for isolated reading problems and for the combination of all three learning disorders. Implications of these findings for assessment and intervention of learning disorders are discussed.	[Moll, Kristina; Kunze, Sarah; Neuhoff, Nina; Bruder, Jennifer; Schulte-Koerne, Gerd] Univ Munich, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany	University of Munich	Moll, K (corresponding author), Univ Munich, Dept Child & Adolescent Psychiat Psychosomat & Ps, Marchioninistr 15, Munich, Germany.	kristina.moll@gmail.com	Schulte-Körne, Gerd/AAI-4828-2021; Moll, Kristina/AAZ-1087-2021; Bruder, Jennifer/GLN-6445-2022	Schulte-Körne, Gerd/0000-0002-9960-1572; Bruder, Jennifer/0000-0002-3815-6313	European Community's EU [018696]	European Community's EU	The research leading to these results has received funding from the European Community's EU, within the context of the Sixth Framework Program LifeScienceHealth project "Dyslexia genes and neurobiological pathways'' (Neurodys, 018696). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DSM 4; American Psychiatric Association, 2013, DSM 5; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1111/1469-7610.00424; Badian N. A., 1983, PROGR LEARNING DISAB, V5, P235; Badian NA, 1999, ANN DYSLEXIA, V49, P45; Barbaresi WJ, 2005, AMBUL PEDIATR, V5, P281, DOI 10.1367/A04-209R.1; Bishop DVM, 2008, J PAEDIATR CHILD H, V44, P520, DOI 10.1111/j.1440-1754.2008.01358.x; Bishop DVM, 2001, J CHILD PSYCHOL PSYC, V42, P189, DOI 10.1111/1469-7610.00710; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Bull R, 1997, J EXP CHILD PSYCHOL, V65, P1, DOI 10.1006/jecp.1996.2358; Cain K., 2010, READING DEV DIFFICUL; CARON C, 1991, J CHILD PSYCHOL PSYC, V32, P1063, DOI 10.1111/j.1469-7610.1991.tb00350.x; Dirks E, 2008, J LEARN DISABIL-US, V41, P460, DOI 10.1177/0022219408321128; Ehri L. C., 1992, RECONCEPTUALIZING DE; Ehri L. C., 1997, LEARNING SPELL RES T, P237; Fischbach A., 2013, LERNEN LERNSTORUNGEN, P65, DOI DOI 10.1024/2235-0977/A000035; Frith U., 1985, SURFACE DYSLEXIA, V32; Geary DC, 2001, APHASIOLOGY, V15, P635, DOI 10.1080/02687040143000113; GrossTsur V, 1996, DEV MED CHILD NEUROL, V38, P25, DOI 10.1111/j.1469-8749.1996.tb15029.x; Grund M, 2003, DRT 4 DIAGNOSTISCHER; Haffner J., 2005, HEIDELBERGER RECHENT; Helzer J.E., 2008, DIMENSIONAL APPROACH; HULME C, 1992, COGNITIVE NEUROPSYCH, V9, P47, DOI 10.1080/02643299208252052; Hulme C., 2013, DEV DISORDERS LANGUA; KLAUER KJ, 1992, Z ENTWICKL PADAGOGIS, V24, P48; Knopik VS, 1997, BEHAV GENET, V27, P447, DOI 10.1023/A:1025622400239; Kovas Y, 2007, J CHILD PSYCHOL PSYC, V48, P914, DOI 10.1111/j.1469-7610.2007.01748..x; LABERGE D, 1974, COGNITIVE PSYCHOL, V6, P293, DOI 10.1016/0010-0285(74)90015-2; Landerl K, 2013, TRENDS NEUROSCI EDUC, V2, P38, DOI 10.1016/j.tine.2013.06.002; Landerl K, 2010, J CHILD PSYCHOL PSYC, V51, P287, DOI 10.1111/j.1469-7610.2009.02164.x; LEWIS C, 1994, J CHILD PSYCHOL PSYC, V35, P283, DOI 10.1111/j.1469-7610.1994.tb01162.x; Mayringer H, 2003, SALZBURGER LESE SCRE; Moll K, 2014, LEARN INSTR, V29, P65, DOI 10.1016/j.learninstruc.2013.09.003; Moll K, 2009, SCI STUD READ, V13, P359, DOI 10.1080/10888430903162878; Muller R., 2004, DRT 3 DIAGNOSTISCHER; Murphy MM, 2007, J LEARN DISABIL-US, V40, P458, DOI 10.1177/00222194070400050901; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Perfetti C. A., 1997, PSYCHOLINGUISTICS SP; Perfetti C.A., 1985, READING ABILITY; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; Rutter M., 2006, GENES BEHAV; SIEGEL LS, 1989, J LEARN DISABIL-US, V22, P469, DOI 10.1177/002221948902200803; Siegel LS, 2003, IQ DISCREPANCY DEFIN; Snowling MJ, 2012, J CHILD PSYCHOL PSYC, V53, P593, DOI 10.1111/j.1469-7610.2011.02495.x; Snowling MJ, 2003, CHILD DEV, V74, P358, DOI 10.1111/1467-8624.7402003; von Aster M, 2007, Z ENTWICKL PADAGOGIS, V39, P85, DOI 10.1026/0049-8637.39.2.85; Willcutt EG, 2013, J LEARN DISABIL-US, V46, P500, DOI 10.1177/0022219413477476; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wimmer H, 2002, J EDUC PSYCHOL, V94, P272, DOI 10.1037//0022-0663.94.2.272; World Health Organization, 1992, ICD 10 CLASSIFICATIO	51	137	141	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103537	10.1371/journal.pone.0103537	http://dx.doi.org/10.1371/journal.pone.0103537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KU	25072465	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000341307600060
J	Adachi, A; Higuchi, Y; Fujikawa, A; Machida, T; Sueyoshi, S; Harigaya, K; Ono, J; Saeki, N				Adachi, Akihiko; Higuchi, Yoshinori; Fujikawa, Atsushi; Machida, Toshio; Sueyoshi, Shigeo; Harigaya, Kenichi; Ono, Junichi; Saeki, Naokatsu			Risk Factors in Chronic Subdural Hematoma: Comparison of Irrigation with Artificial Cerebrospinal Fluid and Normal Saline in a Cohort Analysis	PLOS ONE			English	Article							MODEL	Background: Chronic subdural hematoma (CSDH) is known to have a substantial recurrence rate. Artificial cerebrospinal fluid (ACF) is an effective irrigation solution in general open craniotomy and endoneurosurgery, but no evidence of its use in burr-hole surgery exists. Objective: To identify the potential of ACF irrigation to prevent CSDH recurrence. More specifically, to investigate the perioperative and intraoperative prognostic factors, and to identify controllable ones. Methods: To examine various prognostic factors, 120 consecutive patients with unilateral CSDH treated with burr-hole drainage between September 2007 and March 2013 were analyzed. Intraoperative irrigation was performed with one of two irrigation solutions: normal saline (NS; n = 60) or ACF (n = 60). All patients were followed-up for at least 6 months postoperatively. We also examined the morphological alternations of the hematoma outer membranes after incubation with different solutions. Results: Eleven patients (9.2%) had recurrence. Nine patients (15%) required additional surgery in the NS group, whereas only 2 patients (3.3%) in the ACF group required additional surgery. Among preoperative and intraoperative data, age (, 80 years old, P =.044), thrombocyte (>22.0, P=.037), laterality (right, P=.03), and irrigation solution (ACF, P=.027) were related to smaller recurrence rates by log-rank tests. Only the type of irrigation solution used significantly correlated with recurrence in favor of ACF in both Cox proportional hazards (relative hazard: 0.20, 95% confidence interval (CI): 0.04-0.99; P=.049) and logistic regression models (odds ratio, 0.17, 95% CI: 0.03-0.92; P=.04) using these factors. Histological examinations of the hematoma membranes showed that the membranes incubated with NS were loose and infiltrated by inflammatory cells compared with those incubated with ACF. Conclusion: Irrigation with ACF decreased the rate of CSDH recurrence.	[Adachi, Akihiko; Higuchi, Yoshinori; Fujikawa, Atsushi; Machida, Toshio; Ono, Junichi] Chiba Cardiovasc Ctr, Dept Neurosurg, Ichihara, Chiba, Japan; [Sueyoshi, Shigeo] Chiba Cardiovasc Ctr, Dept Clin Lab, Ichihara, Chiba, Japan; [Adachi, Akihiko; Higuchi, Yoshinori; Saeki, Naokatsu] Chiba Univ, Grad Sch Med, Dept Neurol Surg, Chiba, Japan; [Sueyoshi, Shigeo] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan; [Harigaya, Kenichi] Chiba Univ, Grad Sch Med, Dept Mol & Tumor Pathol, Chiba, Japan	Chiba University; Chiba University; Chiba University	Adachi, A (corresponding author), Chiba Cardiovasc Ctr, Dept Neurosurg, Ichihara, Chiba, Japan.	adachi-cib@umin.ac.jp	Higuchi, Yoshinori/B-3459-2017	Higuchi, Yoshinori/0000-0001-5689-3416; Adachi, Akihiko/0000-0002-9172-8974				De Bonis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068732; Doi K, 2009, J TOXICOL SCI, V34, P511, DOI 10.2131/jts.34.511; ELLIOTT KAC, 1949, J NEUROSURG, V6, P140, DOI 10.3171/jns.1949.6.2.0140; Fujita Y, 2010, J NEUROSURG, V112, P824, DOI 10.3171/2009.7.JNS09561; Iwata S, 2013, UMIN 000010359; Janowski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035634; Koizumi S, 2012, WORLD NEUROSURG, V77, P153, DOI 10.1016/j.wneu.2011.03.039; Kristof RA, 2008, J NEUROSURG, V108, P275, DOI 10.3171/JNS/2008/108/2/0275; Leen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042745; Lum HD, 2012, J GEN INTERN MED, V27, P1467, DOI 10.1007/s11606-012-2116-3; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; Nordstrom A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001151; Oka K, 1996, NEUROSURGERY, V38, P733, DOI 10.1227/00006123-199604000-00019; Pont LMEB, 2012, NEUROSURGERY, V70, P873, DOI 10.1227/NEU.0b013e31823672ad; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Serizawa T, 2006, NEUROTRAUMATOLOGY, V29, P44; Shimizu H, 2011, NEUROSURGERY, V69, P677, DOI 10.1227/NEU.0b013e3182195509; Sucu HK, 2005, STROKE, V36, P998, DOI 10.1161/01.STR.0000162714.46038.0f; Tang JY, 2011, ACTA NEUROCHIR SUPPL, V111, P25, DOI 10.1007/978-3-7091-0693-8_5; Uno M, 2013, UMIN 000009401; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Virchow R, 1857, VERH PHYS MED GES WR, V7, P132	22	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103703	10.1371/journal.pone.0103703	http://dx.doi.org/10.1371/journal.pone.0103703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089621	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700045
J	Guillaud-Bataille, M; Ragazzon, B; de Reynies, A; Chevalier, C; Francillard, I; Barreau, O; Steunou, V; Guillemot, J; Tissier, F; Rizk-Rabin, M; Rene-Corail, F; Al Ghuzlan, A; Assie, G; Bertagna, X; Baudin, E; Le Bouc, Y; Bertherat, J; Clauser, E				Guillaud-Bataille, Marine; Ragazzon, Bruno; de Reynies, Aurelien; Chevalier, Claire; Francillard, Isabelle; Barreau, Olivia; Steunou, Virginie; Guillemot, Johann; Tissier, Frederique; Rizk-Rabin, Marthe; Rene-Corail, Fernande; Al Ghuzlan, Abir; Assie, Guillaume; Bertagna, Xavier; Baudin, Eric; Le Bouc, Yves; Bertherat, Jerome; Clauser, Eric			IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma	PLOS ONE			English	Article							FACTOR-II GENE; MESSENGER-RNA; FACTOR SYSTEM; LARGE COHORT; INSULIN; TUMORS; EXPRESSION; TUMORIGENESIS; MALIGNANCY; RECEPTOR	Insulin-like growth factor 2 (IGF2) overexpression is an important molecular marker of adrenocortical carcinoma (ACC), which is a rare but devastating endocrine cancer. It is not clear whether IGF2 overexpression modifies the biology and growth of this cancer, thus more studies are required before IGF2 can be considered as a major therapeutic target. We compared the phenotypical, clinical, biological, and molecular characteristics of ACC with or without the overexpression of IGF2, to address these issues. We also carried out a similar analysis in an ACC cell line (H295R) in which IGF2 expression was knocked down with si-or shRNA. We found no significant differences in the clinical, biological and molecular (transcriptomic) traits between IGF2-high and IGF2-low ACC. The absence of IGF2 overexpression had little influence on the activation of tyrosine kinase pathways both in tumors and in H295 cells that express low levels of IGF2. In IGF2-low tumors, other growth factors (FGF9, PDGFA) are more expressed than in IGF2-high tumors, suggesting that they play a compensatory role in tumor progression. In addition, IGF2 knock-down in H295R cells substantially impaired growth (>50% inhibition), blocked cells in G1 phase, and promoted apoptosis (>2-fold). Finally, analysis of the 11p15 locus showed a paternal uniparental disomy in both IGF2-high and IGF2-low tumors, but low IGF2 expression could be explained in most IGF2-low ACC by an additional epigenetic modification at the 11p15 locus. Altogether, these observations confirm the active role of IGF2 in adrenocortical tumor growth, but also suggest that other growth promoting pathways may be involved in a subset of ACC with low IGF2 expression, which creates opportunities for the use of other targeted therapies.	[Guillaud-Bataille, Marine; Chevalier, Claire; Francillard, Isabelle; Guillemot, Johann; Clauser, Eric] Univ Paris 05, Paris Cardiovasc Ctr, Inst Natl Sante & Rech Med U970, Paris, France; [Guillaud-Bataille, Marine; Francillard, Isabelle; Clauser, Eric] Hop Cochin, AP HP, Dept Biol Hormonale, F-75674 Paris, France; [Ragazzon, Bruno; Barreau, Olivia; Tissier, Frederique; Rizk-Rabin, Marthe; Rene-Corail, Fernande; Assie, Guillaume; Bertagna, Xavier; Bertherat, Jerome] Univ Paris 05, Inst Cochin, Inst Natl Sante & Rech Med U1016, Ctr Natl Rech Scientif UMR8104, Paris, France; [de Reynies, Aurelien] Ligue Natl Ctr, Programme Cartes Identite Tumeurs, Paris, France; [Barreau, Olivia; Assie, Guillaume; Bertagna, Xavier; Bertherat, Jerome] Hop Cochin, AP HP, Dept Endocrinol, F-75674 Paris, France; [Steunou, Virginie; Le Bouc, Yves] Univ Paris 06, Inst Natl Sante & Rech Med U938, Paris, France; [Steunou, Virginie; Le Bouc, Yves] Hop Armand Trousseau, AP HP, Lab Explorat Fonct Endocrinienn, Paris, France; [Tissier, Frederique] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Serv Anat Pathol, Paris, France; [Al Ghuzlan, Abir] Inst Gustave Roussy, Dept Biol & Pathol Med, Villejuif, France; [Baudin, Eric] Inst Gustave Roussy, Dept Imagerie Med, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Clauser, E (corresponding author), Univ Paris 05, Paris Cardiovasc Ctr, Inst Natl Sante & Rech Med U970, Paris, France.	eric.clauser@inserm.fr	Ragazzon, Bruno/E-6541-2017; de Reyniès, Aurélien/Q-8640-2017; Guillemot, Johann/O-1066-2013; Rizk-Rabin, Marthe/A-1698-2018	Ragazzon, Bruno/0000-0001-9476-4973; de Reyniès, Aurélien/0000-0002-1328-5290; Guillemot, Johann/0000-0002-5902-9188; Al Ghuzlan, Abir/0000-0001-5198-6111; chevalier, claire/0000-0003-0902-0756; BERTHERAT, Jerome/0000-0003-2551-3008; Rizk-Rabin, Marthe/0000-0003-1558-737X; Assie, Guillaume/0000-0001-9590-0906	INSERM; Assistance Publique Hopitaux de Paris	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Assistance Publique Hopitaux de Paris	INSERM; Assistance Publique Hopitaux de Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MQ, 2008, J CLIN ENDOCR METAB, V93, P3524, DOI 10.1210/jc.2008-0065; Azzi S, 2011, HUM MUTAT, V32, P249, DOI 10.1002/humu.21403; Azzi S, 2009, HUM MOL GENET, V18, P4724, DOI 10.1093/hmg/ddp435; Barlaskar FM, 2009, J CLIN ENDOCR METAB, V94, P204, DOI 10.1210/jc.2008-1456; Boulle N, 1998, J CLIN ENDOCR METAB, V83, P1713, DOI 10.1210/jc.83.5.1713; Callan AC, 2009, CANCER CAUSE CONTROL, V20, P1783, DOI 10.1007/s10552-009-9378-z; CARIANI E, 1988, CANCER RES, V48, P6844; Cerquetti L, 2008, ENDOCR-RELAT CANCER, V15, P623, DOI 10.1677/erc.1.1315; de Fraipont F, 2005, J CLIN ENDOCR METAB, V90, P1819, DOI 10.1210/jc.2004-1075; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Doghman M, 2007, MOL ENDOCRINOL, V21, P2968, DOI 10.1210/me.2007-0120; Drelon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044171; Edgren M, 1997, ANTICANCER RES, V17, P1303; ELBADRY OM, 1989, J CLIN INVEST, V84, P829, DOI 10.1172/JCI114243; Else T, 2013, ENDOCRINE REV; Fassnacht M, 2005, J CLIN ENDOCR METAB, V90, P4366, DOI 10.1210/jc.2004-2198; Fassnacht M, 2009, CANCER-AM CANCER SOC, V115, P243, DOI 10.1002/cncr.24030; Figueiredo BC, 1999, J CLIN ENDOCR METAB, V84, P1116, DOI 10.1210/jc.84.3.1116; Gicquel C, 1997, HORM RES, V47, P269, DOI 10.1159/000185475; GICQUEL C, 1994, J CLIN ENDOCR METAB, V78, P1444, DOI 10.1210/jc.78.6.1444; Gicquel C, 1997, J CLIN ENDOCR METAB, V82, P2559, DOI 10.1210/jc.82.8.2559; Gicquel C, 2001, CANCER RES, V61, P6762; Giordano TJ, 2003, ENDOCR PATHOL, V14, P107, DOI 10.1385/EP:14:2:107; GOURMELEN M, 1994, NUCL MED BIOL, V21, P297, DOI 10.1016/0969-8051(94)90053-1; Groussin L, 2000, J CLIN ENDOCR METAB, V85, P345, DOI 10.1210/jc.85.1.345; Haluska P, 2010, CANCER CHEMOTH PHARM, V65, P765, DOI 10.1007/s00280-009-1083-9; Harris LK, 2012, GROWTH FACTORS, V30, P1, DOI 10.3109/08977194.2011.640325; Heaton JH, 2012, AM J PATHOL, V181, P1017, DOI 10.1016/j.ajpath.2012.05.026; KAMIO T, 1991, AM J PATHOL, V138, P83; Kaneda A, 2007, P NATL ACAD SCI USA, V104, P20926, DOI 10.1073/pnas.0710359105; Leboulleux S, 2001, EUR J ENDOCRINOL, V144, P163, DOI 10.1530/eje.0.1440163; Libe R, 2007, CLIN CANCER RES, V13, P844, DOI 10.1158/1078-0432.CCR-06-2085; Logie A, 1999, J MOL ENDOCRINOL, V23, P23, DOI 10.1677/jme.0.0230023; LUTON JP, 1990, NEW ENGL J MED, V322, P1195, DOI 10.1056/NEJM199004263221705; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Ragazzon B, 2006, ENDOCRINOLOGY, V147, P1805, DOI 10.1210/en.2005-1279; Ribeiro TC, 2012, MOL CELL ENDOCRINOL, V351, P96, DOI 10.1016/j.mce.2011.09.042; Shen Wen, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P88; TRICOLI JV, 1986, CANCER RES, V46, P6169; Velazquez-Fernandez D, 2005, SURGERY, V138, P1087, DOI 10.1016/j.surg.2005.09.031; Weber MM, 1997, EUR J ENDOCRINOL, V136, P296, DOI 10.1530/eje.0.1360296; Weber MM, 2000, EUR J CLIN INVEST, V30, P69, DOI 10.1046/j.1365-2362.2000.0300s3069.x; WEISS LM, 1989, AM J SURG PATHOL, V13, P202, DOI 10.1097/00000478-198903000-00004; West AN, 2007, CANCER RES, V67, P600, DOI 10.1158/0008-5472.CAN-06-3767; ZHAN SL, 1994, J CLIN INVEST, V94, P445, DOI 10.1172/JCI117344	46	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103744	10.1371/journal.pone.0103744	http://dx.doi.org/10.1371/journal.pone.0103744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089899	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700048
J	Kissick, HT; Dunn, LK; Ghosh, S; Nechama, M; Kobzik, L; Arredouani, MS				Kissick, Haydn T.; Dunn, Laura K.; Ghosh, Sanjukta; Nechama, Morris; Kobzik, Lester; Arredouani, Mohamed S.			The Scavenger Receptor MARCO Modulates TLR-Induced Responses in Dendritic Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SR-AI/II; T-CELLS; IMMUNOSUPPRESSION; INTERLEUKIN-12; MACROPHAGES; ACTIVATION; EXPRESSION; PARTICLES; PROGRAM	The scavenger receptor MARCO mediates macrophage recognition and clearance of pathogens and their polyanionic ligands. However, recent studies demonstrate MARCO expression and function in dendritic cells, suggesting MARCO might serve to bridge innate and adaptive immunity. To gain additional insight into the role of MARCO in dendritic cell activation and function, we profiled transcriptomes of mouse splenic dendritic cells obtained from MARCO deficient mice and their wild type counterparts under resting and activating conditions. In silico analysis uncovered major alterations in gene expression in MARCO deficient dendritic cells resulting in dramatic alterations in key dendritic cell-specific pathways and functions. Specifically, changes in CD209, FCGR4 and Complement factors can have major consequences on DC-mediated innate responses. Notably, these perturbations were magnified following activation with the TLR-4 agonist lipopolysaccharide. To validate our in silico data, we challenged DC's with various agonists that recognize all mouse TLRs and assessed expression of a set of immune and inflammatory marker genes. This approach identified a differential contribution of MARCO to TLR activation and validated a major role for MARCO in mounting an inflammatory response. Together, our data demonstrate that MARCO differentially affects TLR-induced DC activation and suggest targeting of MARCO could lead to different outcomes that depend on the inflammatory context encountered by DC.	[Kissick, Haydn T.; Dunn, Laura K.; Arredouani, Mohamed S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Surg, Sch Med, Boston, MA 02215 USA; [Ghosh, Sanjukta; Kobzik, Lester] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Nechama, Morris] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Kobzik, Lester] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Arredouani, MS (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Surg, Sch Med, Boston, MA 02215 USA.	marredou@bidmc.harvard.edu	Kissick, Haydn/AAS-6292-2021	Kissick, Haydn/0000-0001-7624-5598	Prostate Cancer Foundation; Department of Defense Prostate Cancer Research Program [W81XWH-09-1-0448]	Prostate Cancer Foundation; Department of Defense Prostate Cancer Research Program(United States Department of Defense)	This work was supported by the Prostate Cancer Foundation Young Investigator Award (M.S. Arredouani) and the Department of Defense Prostate Cancer Research Program New Investigator Award W81XWH-09-1-0448 (M. S. Arredouani). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Amiel E, 2009, J LEUKOCYTE BIOL, V85, P595, DOI 10.1189/jlb.1008631; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Arredouani MS, 2007, J IMMUNOL, V178, P5912, DOI 10.4049/jimmunol.178.9.5912; Arredouani MS, 2004, CELL MOL BIOL, V50, P657; Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brown JM, 2007, AM J RESP CELL MOL, V36, P43, DOI 10.1165/rcmb.2006-0197OC; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Cools N, 2008, J CELL MOL MED, V12, P690, DOI 10.1111/j.1582-4934.2007.00084.x; Czerkies M, 2013, IMMUNOBIOLOGY, V218, P1217, DOI 10.1016/j.imbio.2013.04.005; Dahl M, 2007, J CLIN INVEST, V117, P757, DOI 10.1172/JCI29968; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Ghosh S, 2011, AM J RESP CELL MOL, V45, P1036, DOI 10.1165/rcmb.2010-0349OC; Granucci F, 2003, BLOOD, V102, P2940, DOI 10.1182/blood-2002-12-3651; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; Grolleau A, 2003, J IMMUNOL, V171, P2879, DOI 10.4049/jimmunol.171.6.2879; Haram KM, 2008, PROSTATE, V68, P1517, DOI 10.1002/pros.20803; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Jozefowski S, 2006, J LEUKOCYTE BIOL, V80, P870, DOI 10.1189/jlb.0705357; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kobie JJ, 2003, CANCER RES, V63, P1860; Komine H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067795; Matsushita N, 2010, CANCER IMMUNOL IMMUN, V59, P875, DOI 10.1007/s00262-009-0813-5; Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Ngiow SF, 2013, TRENDS IMMUNOL, V34, P548, DOI 10.1016/j.it.2013.07.004; Saas P, 2012, CRIT REV IMMUNOL, V32, P529, DOI 10.1615/CritRevImmunol.2013005868; Shen ZH, 1997, J IMMUNOL, V158, P2723; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wojtowicz-Praga S, 2003, INVEST NEW DRUG, V21, P21, DOI 10.1023/A:1022951824806	37	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104148	10.1371/journal.pone.0104148	http://dx.doi.org/10.1371/journal.pone.0104148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089703	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700101
J	Modi, KK; Jana, A; Ghosh, S; Watson, R; Pahan, K				Modi, Khushbu K.; Jana, Arundhati; Ghosh, Supurna; Watson, Richard; Pahan, Kalipada			A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; RESPONSE ELEMENT-BINDING; KAPPA-B ACTIVATION; NEURODEGENERATIVE DISORDERS; MOUSE MODEL; IN-VITRO; INHIBITION; KINASE; GLYCOGEN-SYNTHASE-KINASE-3; HYPERPHOSPHORYLATION	Alzheimer's disease (AD), the leading cause of dementia in the aging population, is characterized by the presence of neuritic plaques, neurofibrillary tangles and extensive neuronal apoptosis. Neuritic plaques are mainly composed of aggregates of amyloid-beta (A beta) protein while neurofibrillary tangles are composed of the hyperphosphorylated tau protein. Despite intense investigations, no effective therapy is currently available to halt the progression of this disease. Here, we have undertaken a novel approach to attenuate apoptosis and tau phosphorylation in cultured neuronal cells and in a transgenic animal model of AD. RNS60 is a 0.9% saline solution containing oxygenated nanobubbles that is generated by subjecting normal saline to Taylor-Couette-Poiseuille (TCP) flow under elevated oxygen pressure. In our experiments, fibrillar A beta 1-42, but not the reverse peptide A beta 42-1, induced apoptosis and cell death in human SHSY5Y neuronal cells. RNS60, but not NS (normal saline), RNS10.3 (TCP-modified saline without excess oxygen) or PNS60 (saline containing excess oxygen without TCP modification), attenuated A beta(1-42)-induced cell death. RNS60 inhibited neuronal cell death via activation of the type 1A phosphatidylinositol-3 (PI-3) kinase - Akt - BAD pathway. Furthermore, RNS60 also decreased A beta(1-42)-induced tau phosphorylation via (PI-3 kinase - Akt)-mediated inhibition of GSK-3 beta. Similarly, RNS60 treatment suppressed neuronal apoptosis, attenuated Tau phosphorylation, inhibited glial activation, and reduced the burden of Ab in the hippocampus and protected memory and learning in 5XFAD transgenic mouse model of AD. Therefore, RNS60 may be a promising pharmaceutical candidate in halting or delaying the progression of AD.	[Modi, Khushbu K.; Jana, Arundhati; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Ghosh, Supurna; Watson, Richard] Revalesio Corp, Tacoma, WA USA	Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu			Revalesio Corporation	Revalesio Corporation	This work was supported by the Revalesio Corporation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Citron M, 2000, MOL MED TODAY, V6, P392, DOI 10.1016/S1357-4310(00)01759-7; Corbett GT, 2013, J BIOL CHEM, V288, P8299, DOI 10.1074/jbc.M112.426536; Corbett GT, 2012, J IMMUNOL, V189, P1002, DOI 10.4049/jimmunol.1102624; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Elyaman W, 2002, EUR J NEUROSCI, V15, P651, DOI 10.1046/j.1460-9568.2002.01899.x; Ferrer I., 2005, Current Alzheimer Research, V2, P3, DOI 10.2174/1567205052772713; Franke TF, 1997, NATURE, V390, P116, DOI 10.1038/36442; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gajewski TF, 1996, CELL, V87, P589, DOI 10.1016/S0092-8674(00)81377-X; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Goedert M, 1998, PROG BRAIN RES, V117, P287; Hernandez F, 2013, J ALZHEIMERS DIS; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Jana A, 2013, J NEUROIMMUNE PHARM, V8, P739, DOI 10.1007/s11481-013-9447-7; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Johansson S, 2006, NEUROREPORT, V17, P907, DOI 10.1097/01.wnr.0000221844.35502.29; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Khasnavis S, 2013, J NEUROIMMUNE PHARM; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Ksiezak-Reding H, 2003, BBA-MOL BASIS DIS, V1639, P159, DOI 10.1016/j.bbadis.2003.09.001; Lee CWC, 2003, NEUROREPORT, V14, P257, DOI 10.1097/00001756-200302100-00020; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li X, 2006, J NEURAL TRANSM, V113, P93, DOI 10.1007/s00702-005-0303-7; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; Mondal S., 2012, PLOS ONE, V7; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051869; Mondal S, 2012, J NEUROIMMUNE PHARM, V7, P544, DOI 10.1007/s11481-012-9377-9; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Noh MY, 2009, J NEUROCHEM, V108, P1116, DOI 10.1111/j.1471-4159.2008.05837.x; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Prut L, 2007, BEHAV BRAIN RES, V179, P107, DOI 10.1016/j.bbr.2007.01.017; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roy A, 2013, CELL REP, V4, P724, DOI 10.1016/j.celrep.2013.07.028; Saha RN, 2006, ANTIOXID REDOX SIGN, V8, P929, DOI 10.1089/ars.2006.8.929; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; Takashima A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P309; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008	45	46	53	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103606	10.1371/journal.pone.0103606	http://dx.doi.org/10.1371/journal.pone.0103606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089827	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700036
J	Willis, CM; Kluppel, M				Willis, Catherine M.; Klueppel, Michael			Chondroitin Sulfate-E Is a Negative Regulator of a Pro-Tumorigenic Wnt/Beta-Catenin-Collagen 1 Axis in Breast Cancer Cells	PLOS ONE			English	Article							STAGE PROSTATE-CANCER; COSTELLO SYNDROME; CARCINOMA CELLS; GLYCOSAMINOGLYCANS; DISEASE; GROWTH; CHONDROITIN-4-SULFOTRANSFERASE-1; MORPHOGENESIS; PROGRESSION; INDUCTION	Expression of the glycosaminoglycan chondroitin sulfate-E (CS-E) is misregulated in many human cancers, including breast cancer. Cell-surface associated CS-E has been shown to have pro-tumorigenic functions, and pharmacological treatment with exogenous CS-E has been proposed to interfere with tumor progression mediated by endogenous CS-E. However, the effects of exogenous CS-E on breast cancer cell behavior, and the molecular mechanisms deployed by CS-E are not well understood. We show here that treatment with CS-E, but not other chondroitin forms, could interfere with the invasive protrusion formation and migration of breast cancer cells in three-dimensional organotypic cultures. Microarray analysis identified transcriptional programs controlled by CS-E in these cells. Importantly, negative regulation of the pro-metastatic extracellular matrix gene Col1a1 was required for the anti-migratory effects of exogenous CS-E. Knock-down of Col1a1 gene expression mimics the effects of CS-E treatment, while exposing cells to a preformed collagen I matrix interfered with the anti-migratory effects of CS-E. In addition, CS-E specifically interfered with Wnt/beta-catenin signaling, a known pro-tumorigenic pathway. Lastly, we demonstrate that Col1a1 is a positively regulated target gene of the Wnt/beta-catenin pathway in breast cancer cells. Together, our data identify treatment with exogenous CS-E as negative regulatory mechanism of breast cancer cell motility through interference with a pro-tumorigenic Wnt/beta-catenin - Collagen I axis.	[Willis, Catherine M.; Klueppel, Michael] Stanley Manne Childrens Res Inst, Chicago, IL 60614 USA; [Willis, Catherine M.; Klueppel, Michael] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Pediat, Chicago, IL 60611 USA; [Klueppel, Michael] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Kluppel, M (corresponding author), Stanley Manne Childrens Res Inst, Chicago, IL 60614 USA.	m-kluppel@northwestern.edu			US Department of Defense Breast Cancer Program [BC097232]; Ann and Robert H. Lurie Children's Hospital of Chicago Research Center	US Department of Defense Breast Cancer Program(United States Department of Defense); Ann and Robert H. Lurie Children's Hospital of Chicago Research Center	This study was supported by 1) US Department of Defense Breast Cancer Program (Grant #BC097232) http://cdmrp.army.mil/bcrp/ 2) Internal grants from Ann and Robert H. Lurie Children's Hospital of Chicago Research Center http://www.luriechildrensresearch.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALINI M, 1991, CANCER RES, V51, P1443; Anderson WF, 2011, J NATL CANCER I, V103, P1397, DOI 10.1093/jnci/djr257; Basappa, 2009, GLYCOBIOLOGY, V19, P735, DOI 10.1093/glycob/cwp041; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Brown AMC, 2001, BREAST CANCER RES, V3, P351, DOI 10.1186/bcr321; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hinek A, 2005, AM J MED GENET A, V133A, P1, DOI 10.1002/ajmg.a.30495; Hirata A, 2013, DEVELOPMENT, V140, P66, DOI 10.1242/dev.084103; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Kalathas D, 2009, ONCOL REP, V22, P369, DOI 10.3892/or_00000447; Karangelis DE, 2010, CURR MED CHEM, V17, P4018; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Kluppel M, 2012, EUR J HUM GENET, V20, P870, DOI 10.1038/ejhg.2012.12; Kluppel M, 2011, MOL CELL BIOCHEM, V351, P1, DOI 10.1007/s11010-010-0705-1; Kluppel M, 2010, PROG MOL BIOL TRANSL, V93, P113, DOI 10.1016/S1877-1173(10)93006-8; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kluppel M, 2002, MECH DEVELOP, V118, P77, DOI 10.1016/S0925-4773(02)00198-3; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Lu JM, 2009, BIOORG MED CHEM LETT, V19, P3825, DOI 10.1016/j.bmcl.2009.04.040; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Monzavi-Karbassi B, 2007, INT J CANCER, V120, P1179, DOI 10.1002/ijc.22424; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; OLSEN EB, 1988, ACTA OBSTET GYN SCAN, V67, P539, DOI 10.3109/00016348809029866; Pothacharoen P, 2006, J BIOCHEM, V140, P517, DOI 10.1093/jb/mvj181; Prinz RD, 2011, GENET MOL RES, V10, P3901, DOI 10.4238/2011.December.8.9; Prinz RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092381; Ramaswamy S, 2003, LANCET, V361, P1576, DOI 10.1016/S0140-6736(03)13322-3; Ricciardelli C, 1997, CLIN CANCER RES, V3, P983; Ricciardelli C, 1999, CANCER RES, V59, P2324; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willis CM, 2009, GENET MOL RES, V8, P1331, DOI 10.4238/vol8-4gmr673; Willis CM, 2012, J BIOL CHEM, V287, P37042, DOI 10.1074/jbc.M112.391490; Zeltz C, 2013, BIOCH BIOPHYS ACTA	44	38	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103966	10.1371/journal.pone.0103966	http://dx.doi.org/10.1371/journal.pone.0103966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090092	Green Submitted, gold, Green Published			2022-12-27	WOS:000339812700072
J	Xu, G; Chen, J; Pan, QS; Huang, KT; Pan, JY; Zhang, WH; Chen, J; Yu, FY; Zhou, TL; Wang, YM				Xu, Gang; Chen, Jie; Pan, Qinshi; Huang, Keta; Pan, Jingye; Zhang, Wenhui; Chen, Jian; Yu, Fangyou; Zhou, Tieli; Wang, Yumin			Long Noncoding RNA Expression Profiles of Lung Adenocarcinoma Ascertained by Microarray Analysis	PLOS ONE			English	Article							PROSTATE-CANCER; GENE; METASTASIS; EVOLUTION; SURVIVAL; DATABASE; NSCLC; STATE; CELLS	Background: Long noncoding RNAs (lncRNAs) have been shown to be involved in the development and progression of lung cancer. However, the roles of lncRNAs in lung cancer are not well understood. Methodology/Principal Findings: We used a high-throughput microarray to compare the lncRNA and messenger RNA (mRNA) expression profiles in lung adenocarcinoma and normal tissue (NT) samples. Several candidate adenocarcinoma-associated lncRNAs were verified by real-time quantitative reverse transcription polymerase chain reaction (PCR) analysis. Using abundant and varied probes, we were able to assess 30,586 lncRNAs and 26,109 mRNAs in our microarray. We found that 2,420 lncRNAs and 1,109 mRNAs were differentially expressed (>= 2-fold change) in lung adenocarcinoma samples and NT, indicating that many lncRNAs were significantly upregulated or downregulated in lung adenocarcinoma. We also found, via quantitative PCR, that 19 lncRNAs were aberrantly expressed in lung adenocarcinoma compared with matched histologically normal lung tissues. Among these, LOC100132354 and RPLP0P2 were the most aberrantly expressed lncRNAs, as estimated by quantitative PCR in 100 pairs of lung adenocarcinoma and NT samples. Conclusions/Significance: Our study ascertained the expression patterns of lncRNAs in lung adenocarcinoma by microarray. The results revealed that many lncRNAs were differentially expressed in lung adenocarcinoma tissues and NT, suggesting that they may play a key role in tumor development.	[Xu, Gang; Pan, Qinshi; Zhang, Wenhui; Chen, Jian; Yu, Fangyou; Zhou, Tieli; Wang, Yumin] Wenzhou Med Univ, Affiliated Hosp 1, Dept Lab Med, Wenzhou, Peoples R China; [Huang, Keta] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pathol, Wenzhou, Peoples R China; [Chen, Jie; Pan, Jingye] Wenzhou Med Univ, Affiliated Hosp 1, Dept Intens Care Unit, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wang, YM (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Lab Med, Wenzhou, Peoples R China.	wym0577@163.com			National Natural Science Foundation of China [81171614, 81271906]; Wenzhou Municipal Science and Technology Bureau of China [Y20110041, Y20130170]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Municipal Science and Technology Bureau of China	This work was supported by the National Natural Science Foundation of China (81171614, 81271906), Wenzhou Municipal Science and Technology Bureau of China (Y20110041, Y20130170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Dinger ME, 2009, NUCLEIC ACIDS RES, V37, pD122, DOI 10.1093/nar/gkn617; Fu XQ, 2006, DNA CELL BIOL, V25, P135, DOI 10.1089/dna.2006.25.135; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gridelli C, 2003, ONCOGENE, V22, P6629, DOI 10.1038/sj.onc.1206957; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Han L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0694-5; Hauptman N, 2013, INT J MOL SCI, V14, P4655, DOI 10.3390/ijms14034655; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Khachane AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010316; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mattick JS, 2010, DEV CELL, V19, P485, DOI 10.1016/j.devcel.2010.10.003; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Ogawa E, 2008, ANN SURG ONCOL, V15, P547, DOI 10.1245/s10434-007-9653-8; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rachet B, 2008, BRIT J CANCER, V99, pS2, DOI 10.1038/sj.bjc.6604571; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Stewart DJ, 2010, CRIT REV ONCOL HEMAT, V75, P173, DOI 10.1016/j.critrevonc.2009.11.006; Thai P, 2013, AM J RESP CELL MOL, V49, P204, DOI 10.1165/rcmb.2013-0159RC; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065309; Zhang H, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-37	25	54	57	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104044	10.1371/journal.pone.0104044	http://dx.doi.org/10.1371/journal.pone.0104044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089627	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700089
J	Adegbola, RA; DeAntonio, R; Hill, PC; Roca, A; Usuf, E; Hoet, B; Greenwood, BM				Adegbola, Richard A.; DeAntonio, Rodrigo; Hill, Philip C.; Roca, Anna; Usuf, Effua; Hoet, Bernard; Greenwood, Brian M.			Carriage of Streptococcus pneumoniae and Other Respiratory Bacterial Pathogens in Low and Lower-Middle Income Countries: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PNEUMOCOCCAL CONJUGATE VACCINE; INFLUENZAE TYPE-B; VITAMIN-A SUPPLEMENTATION; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; MENINGOCOCCAL CARRIAGE; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; SEROTYPE DISTRIBUTION; INVASIVE-DISEASE	Background: Infection with Streptococcus pneumoniae is a major cause of childhood morbidity and mortality worldwide, especially in low income countries where pneumococcal conjugate vaccines (PCVs) are still underused. In countries where PCVs have been introduced, much of their efficacy has resulted from their impact on nasopharyngeal carriage in vaccinated children. Understanding the epidemiology of carriage for S. pneumoniae and other common respiratory bacteria in developing countries is crucial for implementing appropriate vaccination strategies and evaluating their impact. Methods and Findings: We have systematically reviewed published studies reporting nasopharyngeal or oropharyngeal carriage of S. pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Neisseria meningitidis in children and adults in low and lower-middle income countries. Studies reporting pneumococcal carriage for healthy children <5 years of age were selected for a meta-analysis. The prevalences of carriage for S. pneumoniae, H. influenzae, and M. catarrhalis were generally higher in low income than in lower-middle income countries and were higher in young children than in adults. The prevalence of S. aureus was high in neonates. Meta-analysis of data from young children before the introduction of PCVs showed a pooled prevalence estimate of 64.8% (95% confidence interval, 49.8%-76.1%) in low income countries and 47.8% (95% confidence interval, 44.7%-50.8%) in lower-middle income countries. The most frequent serotypes were 6A, 6B, 19A, 19F, and 23F. Conclusions: In low and lower-middle income countries, pneumococcal carriage is frequent, especially in children, and the spectrum of serotypes is wide. However, because data are limited, additional studies are needed to adequately assess the impact of PCV introduction on carriage of respiratory bacteria in these countries.	[Adegbola, Richard A.; DeAntonio, Rodrigo; Hoet, Bernard] GlaxoSmithKline Vaccines, Wavre, Belgium; [Hill, Philip C.; Roca, Anna; Usuf, Effua] MRC Unit, Banjul, Gambia; [Hill, Philip C.] Univ Otago, Sch Med, Ctr Int Hlth, Dunedin, New Zealand; [Greenwood, Brian M.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England	GlaxoSmithKline; University of London; London School of Hygiene & Tropical Medicine; University of Otago; University of London; London School of Hygiene & Tropical Medicine	Adegbola, RA (corresponding author), GlaxoSmithKline Vaccines, Wavre, Belgium.	richard.a.adegbola@gsk.com	DeAntonio, Rodrigo/AAM-2032-2021	DeAntonio, Rodrigo/0000-0003-2586-4115	GSK Biologicals SA; Medical Research Council [MC_EX_MR/L100001/1, MC_U190085849] Funding Source: researchfish; MRC [MC_EX_MR/L100001/1, MC_U190085849] Funding Source: UKRI	GSK Biologicals SA(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	GSK Biologicals SA paid for all costs associated with the development and the publishing of the present manuscript. The sponsor contributed to all stages of the study, including study design, data analyses, data interpretation, and the writing of this report.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447; Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; Adegbola RA, 1998, J INFECT DIS, V177, P1758, DOI 10.1086/517440; Adetifa IMO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030548; Agrawal A, 2011, J CLIN MICROBIOL, V49, P3728, DOI 10.1128/JCM.05476-11; Akinsola AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031050; AMIR M, 1995, EUR J CLIN MICROBIOL, V14, P34, DOI 10.1007/BF02112615; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P373; Anthony L, 2012, INT J INFECT DIS, V16, pE753, DOI 10.1016/j.ijid.2012.05.1037; Anwar Muhammad Saeed, 2004, J Coll Physicians Surg Pak, V14, P661; Blossom DB, 2006, INT J INFECT DIS, V10, P458, DOI 10.1016/j.ijid.2006.05.010; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Bogaert D, 2002, J CLIN MICROBIOL, V40, P3903, DOI 10.1128/JCM.40.11.3903-3908.2002; Bogaert D, 2001, J CLIN MICROBIOL, V39, P3316, DOI 10.1128/JCM.39.9.3316-3320.2001; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Casey JR, 2010, PEDIATR INFECT DIS J, V29, P304, DOI 10.1097/INF.0b013e3181c1bc48; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; CHEESBROUGH JS, 1995, EPIDEMIOL INFECT, V114, P75, DOI 10.1017/S0950268800051931; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Choi YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026190; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Coles CL, 2008, J NUTR, V138, P2462, DOI 10.3945/jn.108.095422; Coles CL, 2011, J NUTR, V141, P1907, DOI 10.3945/jn.111.141622; Coles CL, 2001, J NUTR, V131, P255, DOI 10.1093/jn/131.2.255; Dagan R, 2000, CLIN INFECT DIS, V30, P319, DOI 10.1086/313645; Das B. K., 2002, Indian Journal of Pediatrics, V69, P775, DOI 10.1007/BF02723690; Das Bhattacharya S, 2012, INDIAN J PEDIATR, V79, P1447, DOI 10.1007/s12098-012-0762-4; Davis SM, 2013, VACCINE, V32, P133, DOI 10.1016/j.vaccine.2013.05.005; De Wals P, 2012, VACCINE, V30, P6416, DOI 10.1016/j.vaccine.2012.08.017; Denno Donna M, 2002, West Afr J Med, V21, P233; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devi U, 2012, INDIAN J MED RES, V136, P495; Donkor ES, 2010, SCAND J INFECT DIS, V42, P254, DOI 10.3109/00365540903490000; Dunne EM, 2013, VACCINE, V31, P2333, DOI 10.1016/j.vaccine.2013.03.024; Egere U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049143; Fedson DS, 1999, VACCINE, V17, pS11, DOI 10.1016/S0264-410X(99)00122-X; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Feikin DR, 2004, LANCET INFECT DIS, V4, P445, DOI 10.1016/S1473-3099(04)01060-6; Fervers B, 2008, TUMORI, V94, P154; Flasche S, 2011, EUROSURVEILLANCE, V16, P13; Gessner BD, 1998, PEDIATR INFECT DIS J, V17, pS179, DOI 10.1097/00006454-199809001-00018; Gilks CF, 1997, T ROY SOC TROP MED H, V91, P627, DOI 10.1016/S0035-9203(97)90498-3; Gill CJ, 2008, J INFECT DIS, V197, P1000, DOI 10.1086/528806; Gill CJ, 2008, B WORLD HEALTH ORGAN, V86, P929, DOI 10.2471/BLT.07.049668; Goldblatt D, 2013, VACCINE, V32, P146, DOI 10.1016/j.vaccine.2013.06.040; Granat SM, 2007, PEDIATR INFECT DIS J, V26, P319, DOI 10.1097/01.inf.0000257425.24492.11; Greenberg D, 2004, J CLIN MICROBIOL, V42, P4604, DOI 10.1128/JCM.42.10.4604-4609.2004; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; ICHHPUJANI R L, 1990, Journal of Communicable Diseases, V22, P264; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Jacoby P, 2011, PEDIATR INFECT DIS J, V30, P480, DOI 10.1097/INF.0b013e318217dc6e; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Kateete David P, 2012, BMC Res Notes, V5, P28, DOI 10.1186/1756-0500-5-28; Kellner JD, 2009, CLIN INFECT DIS, V49, P205, DOI 10.1086/599827; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; LANKINEN KS, 1994, J CLIN MICROBIOL, V32, P2948, DOI 10.1128/JCM.32.12.2948-2952.1994; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; Lijek RS, 2012, CURR OPIN IMMUNOL, V24, P417, DOI 10.1016/j.coi.2012.05.005; LloydEvans N, 1996, PEDIATR INFECT DIS J, V15, P866, DOI 10.1097/00006454-199610000-00007; Lupisan SP, 2000, AM J TROP MED HYG, V62, P341, DOI 10.4269/ajtmh.2000.62.341; Mackenzie GA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001161; Martinelli D, 2013, HUM VACCIN IMMUNOTHE, V10; MASTRO TD, 1993, PEDIATR INFECT DIS J, V12, P824, DOI 10.1097/00006454-199310000-00006; Millar EV, 2008, CLIN INFECT DIS, V47, P989, DOI 10.1086/591966; Millar EV, 2009, PEDIATR INFECT DIS J, V28, P711, DOI 10.1097/INF.0b013e3181a06303; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moyo SJ, 2012, J MED MICROBIOL, V61, P952, DOI 10.1099/jmm.0.042598-0; Mueller JE, 2007, EMERG INFECT DIS, V13, P847, DOI 10.3201/eid1306.061395; Mueller JE, 2008, TROP MED INT HEALTH, V13, P1543, DOI 10.1111/j.1365-3156.2008.02165.x; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Mwenya DM, 2010, ANTIMICROB AGENTS CH, V54, P3756, DOI 10.1128/AAC.01409-09; Nicolas P, 2007, VACCINE, V25, pA53, DOI 10.1016/j.vaccine.2007.04.041; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; O'Brien KL, 2014, PEDIATR INFECT DIS J, V33, pS107, DOI 10.1097/INF.0000000000000075; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; ODUGBEMI T, 1992, ETHIOPIAN MED J, V30, P33; Odutola A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075558; Ota MO, 2011, VACCINE, V29, P2999, DOI 10.1016/j.vaccine.2011.01.098; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Pradeepa R, 2012, DIABETES TECHNOL THE, V14, pS59, DOI 10.1089/dia.2012.0065; Raymond J, 2000, J INFECT DIS, V181, P1983, DOI 10.1086/315505; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Regev-Yochay G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035061; Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554; Roca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072198; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Rupa V, 2012, INT J PEDIATR OTORHI, V76, P1835, DOI 10.1016/j.ijporl.2012.09.013; Rusen ID, 1997, PEDIATR INFECT DIS J, V16, P656, DOI 10.1097/00006454-199707000-00007; Russell FM, 2006, ANN TROP PAEDIATR, V26, P187, DOI 10.1179/146532806X120273; Saha SK, 2003, J CLIN MICROBIOL, V41, P5582, DOI 10.1128/JCM.41.12.5582-5587.2003; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; SEHGAL SC, 1994, INFECTION, V22, P193, DOI 10.1007/BF01716701; Sekhar S, 2009, EPIDEMIOL INFECT, V137, P156, DOI 10.1017/S095026880800071X; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Soewignjo S, 2001, CLIN INFECT DIS, V32, P1039, DOI 10.1086/319605; Steens A, 2013, VACCINE; Tigoi CC, 2012, CLIN INFECT DIS, V55, P180, DOI 10.1093/cid/cis371; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8; Usuf E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085001; Utsunomiya Y, 1998, J TROP PEDIATRICS, V44, P338, DOI 10.1093/tropej/44.6.338; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x; Verduin CM, 2002, CLIN MICROBIOL REV, V15, P125, DOI 10.1128/CMR.15.1.125-144.2002; Vives M, 1997, PEDIATR INFECT DIS J, V16, P852, DOI 10.1097/00006454-199709000-00007; Wang SA, 2013, MMWR-MORBID MORTAL W, V62, P308; Wattal C, 2007, INDIAN J PEDIATR, V74, P905, DOI 10.1007/s12098-007-0166-z; Weinberger DM, 2013, AM J EPIDEMIOL; Wenger JD, 2010, PEDIATR INFECT DIS J, V29, P251, DOI 10.1097/INF.0b013e3181bdbed5; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; WHO, 2012, EST HIB PNEUM DEATHS; Wiertsema SP, 2011, VACCINE, V29, P5163, DOI 10.1016/j.vaccine.2011.05.035; Williams EJ, 2011, J CLIN MICROBIOL, V49, P1323, DOI 10.1128/JCM.02200-10; World Bank, 2012, COUNTR LEND GROUPS	124	109	111	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103293	10.1371/journal.pone.0103293	http://dx.doi.org/10.1371/journal.pone.0103293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084351	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800026
J	Clague, J; Reynolds, P; Henderson, KD; Sullivan-Halley, J; Ma, HY; Lacey, JV; Chang, SN; Delclos, GL; Du, XLL; Forman, MR; Bernstein, L				Clague, Jessica; Reynolds, Peggy; Henderson, Katherine D.; Sullivan-Halley, Jane; Ma, Huiyan; Lacey, James V., Jr.; Chang, Shine; Delclos, George L.; Du, Xianglin L.; Forman, Michele R.; Bernstein, Leslie			Menopausal Hormone Therapy and Lung Cancer-Specific Mortality Following Diagnosis: The California Teachers Study	PLOS ONE			English	Article							REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; NEVER SMOKERS; ESTROGEN; SURVIVAL; INFLAMMATION; OUTCOMES; RISK; BETA	Previous results from research on menopausal hormone therapy (MHT) and lung cancer survival have been mixed and most have not studied women who used estrogen therapy (ET) exclusively. We examined the associations between MHT use reported at baseline and lung cancer-specific mortality in the prospective California Teachers Study cohort. Among 727 postmenopausal women diagnosed with lung cancer from 1995 through 2007, 441 women died before January 1, 2008. Hazard Ratios (HR) and 95% Confidence Intervals (CI) for lung-cancer-specific mortality were obtained by fitting multivariable Cox proportional hazards regression models using age in days as the timescale. Among women who used ET exclusively, decreases in lung cancer mortality were observed (HR, 0.69; 95% CI, 0.52-0.93). No association was observed for estrogen plus progestin therapy use. Among former users, shorter duration (<5 years) of exclusive ET use was associated with a decreased risk of lung cancer mortality (HR, 0.56; 95% CI, 0.35-0.89), whereas among recent users, longer duration (>15 years) was associated with a decreased risk (HR, 0.60; 95% CI, 0.38-0.95). Smoking status modified the associations with deceases in lung cancer mortality observed only among current smokers. Exclusive ET use was associated with decreased lung cancer mortality.	[Clague, Jessica; Henderson, Katherine D.; Sullivan-Halley, Jane; Ma, Huiyan; Lacey, James V., Jr.; Bernstein, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Div Canc Etiol, Duarte, CA 91010 USA; [Reynolds, Peggy] Canc Prevent Inst Calif, Fremont, CA USA; [Chang, Shine] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Delclos, George L.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Houston, TX 77030 USA; [Du, Xianglin L.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol, Houston, TX 77030 USA; [Forman, Michele R.] Coll Nat Sci, Dell Pediat Res Inst, Dept Nutr Sci, Austin, TX USA	City of Hope; Beckman Research Institute of City of Hope; Cancer Prevention Institute of California; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Bernstein, L (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Div Canc Etiol, Duarte, CA 91010 USA.	lbernstein@coh.org		Chang, Shine/0000-0003-3804-9697	National Cancer Institute [R01 CA77398, K05 CA 136967, R25T CA57730]; National Cancer Institute's Surveillance, Epidemiology and End Results Program [N01-PC-35136]; Northern California Cancer Center [N01-PC-35139]; University of Southern California [N01-PC-35139]; Public Health Institute [N02-PC-15105]; Centers for Disease Control and Prevention's National Program of Cancer Registries [U55/CCR921930-02]; NATIONAL CANCER INSTITUTE [R01CA077398, K05CA136967, R25CA057730] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute's Surveillance, Epidemiology and End Results Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Northern California Cancer Center; University of Southern California; Public Health Institute; Centers for Disease Control and Prevention's National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work reported here was supported by National Cancer Institute grants R01 CA77398, K05 CA 136967 and R25T CA57730. The collection of cancer incidence data used in this study was supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract N01-PC-35136 awarded to the Northern California Cancer Center (now known as the Cancer Prevention Institute of California), contract N01-PC-35139 awarded to the University of Southern California, and contract N02-PC-15105 awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement #U55/CCR921930-02 awarded to the Public Health Institute. The ideas and opinions expressed herein are those of the authors. Endorsement by the State of California, Department of Health Services, the National Cancer Institute, and the Centers for Disease Control and Prevention or their contractors and subcontractors is not intended nor should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayeni O, 2009, CURR ONCOL, V16, P162; Bernstein L, 2002, CANCER CAUSE CONTROL, V13, P625, DOI 10.1023/A:1019552126105; Chlebowski RT, 2010, JNCI-J NATL CANCER I, V102, P1413, DOI 10.1093/jnci/djq285; Chlebowski RT, 2009, LANCET, V374, P1243, DOI 10.1016/S0140-6736(09)61526-9; Ettinger B, 1996, OBSTET GYNECOL, V87, P6, DOI 10.1016/0029-7844(95)00358-4; Flototto T, 2001, HORM METAB RES, V33, P451, DOI 10.1055/s-2001-16936; Ganti AK, 2006, J CLIN ONCOL, V24, P59, DOI 10.1200/JCO.2005.02.9827; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Horn-Ross PL, 2004, CANCER EPIDEM BIOMAR, V13, P405; Huang B, 2009, CANCER, V115, P4167, DOI 10.1002/cncr.24475; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kovacs EJ, 2005, EXP GERONTOL, V40, P549, DOI 10.1016/j.exger.2005.04.009; Meireles SI, 2010, CANCER PREV RES, V3, P707, DOI 10.1158/1940-6207.CAPR-09-0162; Niikawa H, 2008, CLIN CANCER RES, V14, P4417, DOI 10.1158/1078-0432.CCR-07-1950; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Schabath MB, 2004, CLIN CANCER RES, V10, P113, DOI 10.1158/1078-0432.CCR-0911-3; Sekine I, 2009, JPN J CLIN ONCOL, V39, P707, DOI 10.1093/jjco/hyp095; Siegfried JM, 2001, LANCET ONCOL, V2, P506, DOI 10.1016/S1470-2045(01)00457-0; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Thomas L, 2005, CHEST, V128, P370, DOI 10.1378/chest.128.1.370; Wakelee HA, 2007, J CLIN ONCOL, V25, P472, DOI 10.1200/JCO.2006.07.2983	24	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103735	10.1371/journal.pone.0103735	http://dx.doi.org/10.1371/journal.pone.0103735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079077	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800074
J	Deshmukh, R; Trivedi, V				Deshmukh, Rohitas; Trivedi, Vishal			Phagocytic Uptake of Oxidized Heme Polymer Is Highly Cytotoxic to Macrophages	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; MALARIA PIGMENT HEMOZOIN; NF-KAPPA-B; IN-VITRO; CEREBRAL MALARIA; MONONUCLEAR-CELLS; OXIDATIVE STRESS; DENDRITIC CELLS; HUMAN MONOCYTE; METHEMOGLOBIN	Apoptosis in macrophages is responsible for immune-depression and pathological effects during malaria. Phagocytosis of PRBC causes induction of apoptosis in macrophages through release of cytosolic factors from infected cells. Heme polymer or beta-hematin causes dose-dependent death of macrophages with LC50 of 132 mu g/ml and 182 mu g/ml respectively. The toxicity of hemin or heme polymer was amplified several folds in the presence of non-toxic concentration of methemoglobin. beta-hematin uptake in macrophage through phagocytosis is crucial for enhanced toxicological effects in the presence of methemoglobin. Higher accumulation of beta-hematin is observed in macrophages treated with beta-hematin along with methemoglobin. Light and scanning electron microscopic observations further confirm accumulation of beta-hematin with cellular toxicity. Toxicological potentiation of pro-oxidant molecules toward macrophages depends on generation of H2O2 and independent to release of free iron from pro-oxidant molecules. Methemoglobin oxidizes beta-hematin to form oxidized beta-hematin (beta H*) through single electron transfer mechanism. Pre-treatment of reaction mixture with spin-trap Phenyl-N-t-butyl-nitrone dose-dependently reverses the beta-hematin toxicity, indicates crucial role of beta H* generation with the toxicological potentiation. Acridine orange/ethidium bromide staining and DNA fragmentation analysis indicate that macrophage follows an oxidative stress dependent apoptotic pathway to cause death. In summary, current work highlights mutual co-operation between methemoglobin and different pro-oxidant molecules to enhance toxicity towards macrophages. Hence, methemoglobin peroxidase activity can be probed for subduing cellular toxicity of pro-oxidant molecules and it may in-turn make up for host immune response against the malaria parasite.	[Deshmukh, Rohitas; Trivedi, Vishal] Indian Inst Technol Guwahati, Dept Biotechnol, Malaria Res Grp, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Trivedi, V (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Malaria Res Grp, Gauhati, Assam, India.	vtrivedi@iitg.ernet.in	Deshmukh, Rohitas/AAU-3455-2021	Deshmukh, Rohitas/0000-0002-8962-6821				Anstey NM, 1996, T ROY SOC TROP MED H, V90, P147, DOI 10.1016/S0035-9203(96)90118-2; Arkusz J, 2006, TOXICOL IN VITRO, V20, P109, DOI 10.1016/j.tiv.2005.06.044; Ashikawa K, 2002, J IMMUNOL, V169, P6490, DOI 10.4049/jimmunol.169.11.6490; Balaji S. N., 2013, Journal of Basic and Clinical Physiology and Pharmacology, V24, P105, DOI 10.1515/jbcpp-2012-0058; Balaji SN, 2013, FEBS LETT, V587, P350, DOI 10.1016/j.febslet.2012.12.015; Balde AT, 2000, PARASITE IMMUNOL, V22, P307, DOI 10.1046/j.1365-3024.2000.00307.x; BALDE AT, 1995, IMMUNOL LETT, V46, P59, DOI 10.1016/0165-2478(95)00017-Y; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; Buehler PW, 2010, ANTIOXID REDOX SIGN, V12, P275, DOI 10.1089/ars.2009.2799; Burhop K, 2004, ARTIF CELL BLOOD SUB, V32, P353, DOI 10.1081/LABB-200027429; Cai H, 2011, CURR GENOMICS, V12, P417, DOI 10.2174/138920211797248565; Cambos M, 2011, J LEUKOCYTE BIOL, V89, P159, DOI 10.1189/jlb.0510249; Carmona-Fonseca J, 2009, AM J TROP MED HYG, V80, P188, DOI 10.4269/ajtmh.2009.80.188; Carney CK, 2006, J BIOL INORG CHEM, V11, P917, DOI 10.1007/s00775-006-0147-0; Chua CLL, 2013, TRENDS PARASITOL, V29, P26, DOI 10.1016/j.pt.2012.10.002; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Deshmukh Rohitas, 2013, Inflammation & Allergy Drug Targets, V12, P68; Deshmukh R, 2013, TOXICOL IN VITRO, V27, P16, DOI 10.1016/j.tiv.2012.09.016; Dostert C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006510; Eberson L, 1998, J CHEM SOC PERK T 2, P41, DOI 10.1039/a704637e; Eda S, 2002, CELL PHYSIOL BIOCHEM, V12, P373, DOI 10.1159/000067908; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; FRANCIS SE, 1994, EMBO J, V13, P306, DOI 10.1002/j.1460-2075.1994.tb06263.x; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Huy NT, 2006, PARASITOL INT, V55, P75, DOI 10.1016/j.parint.2005.10.003; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Kamchonwongpaisan S, 1997, MOL BIOCHEM PARASIT, V86, P179, DOI 10.1016/S0166-6851(97)02855-7; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lee HJ, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-176; Leitner WW, 1997, PARASITE IMMUNOL, V19, P103, DOI 10.1046/j.1365-3024.1997.d01-188.x; LIEGLER TJ, 1995, CLIN DIAGN LAB IMMUN, V2, P369, DOI 10.1128/CDLI.2.3.369-376.1995; Lucchi NW, 2011, PLACENTA, V32, P579, DOI 10.1016/j.placenta.2011.05.003; Newton CRJC, 1998, AM J TROP MED HYG, V58, P673, DOI 10.4269/ajtmh.1998.58.673; Nuchsongsin F, 2007, AM J TROP MED HYG, V77, P617, DOI 10.4269/ajtmh.2007.77.617; OO MM, 1987, J NEUROPATH EXP NEUR, V46, P223, DOI 10.1097/00005072-198703000-00009; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; PICHYANGKUL S, 1994, AM J TROP MED HYG, V51, P430, DOI 10.4269/ajtmh.1994.51.430; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; Reimer T, 2010, EUR J IMMUNOL, V40, P764, DOI 10.1002/eji.200939996; RODKEY FL, 1979, CLIN CHEM, V25, P1388; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sakamoto M, 2002, NEUROL RES, V24, P301, DOI 10.1179/016164102101199783; Salman H, 2000, CRYOBIOLOGY, V41, P66, DOI 10.1006/cryo.2000.2267; Schwarzer E., 2008, Parassitologia (Rome), V50, P143; Schwarzer E, 1996, BBA-MOL BASIS DIS, V1316, P169, DOI 10.1016/0925-4439(96)00021-X; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Scorza T, 1999, PARASITE IMMUNOL, V21, P545, DOI 10.1046/j.1365-3024.1999.00254.x; SHERRY BA, 1995, J INFLAMM, V45, P85; Srivastava K, 2007, EXP PARASITOL, V116, P171, DOI 10.1016/j.exppara.2006.12.003; ToureBalde A, 1996, INFECT IMMUN, V64, P744, DOI 10.1128/IAI.64.3.744-750.1996; Trivedi V, 2005, J BIOL CHEM, V280, P41129, DOI 10.1074/jbc.M501563200; Urban BC, 2002, CURR OPIN IMMUNOL, V14, P458, DOI 10.1016/S0952-7915(02)00368-0; WINTERBOURN CC, 1990, METHOD ENZYMOL, V186, P265	60	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103706	10.1371/journal.pone.0103706	http://dx.doi.org/10.1371/journal.pone.0103706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078090	Green Submitted, gold, Green Published			2022-12-27	WOS:000339954800067
J	Hassanzadeh, R; Eslahchi, C; Sung, WK				Hassanzadeh, Reza; Eslahchi, Changiz; Sung, Wing-Kin			Do Triplets Have Enough Information to Construct the Multi-Labeled Phylogenetic Tree?	PLOS ONE			English	Article							ROOTED TRIPLETS; GENE TREES; MULTILABELED TREES; POLYNOMIAL-TIME; NETWORKS; EVOLUTION; SET	The evolutionary history of certain species such as polyploids are modeled by a generalization of phylogenetic trees called multi-labeled phylogenetic trees, or MUL trees for short. One problem that relates to inferring a MUL tree is how to construct the smallest possible MUL tree that is consistent with a given set of rooted triplets, or SMRT problem for short. This problem is NP-hard. There is one algorithm for the SMRT problem which is exact and runs in O(7(n)) time, where n is the number of taxa. In this paper, we show that the SMRT does not seem to be an appropriate solution from the biological point of view. Indeed, we present a heuristic algorithm named MTRT for this problem and execute it on some real and simulated datasets. The results of MTRT show that triplets alone cannot provide enough information to infer the true MUL tree. So, it is inappropriate to infer a MUL tree using triplet information alone and considering the minimum number of duplications. Finally, we introduce some new problems which are more suitable from the biological point of view.	[Hassanzadeh, Reza] Shahid Beheshti Univ, Dept Math, GC, Tehran, Iran; [Eslahchi, Changiz] Shahid Beheshti Univ, Dept Comp Sci, GC, Tehran, Iran; [Sung, Wing-Kin] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore; [Sung, Wing-Kin] Genome Inst Singapore, Singapore, Singapore	Shahid Beheshti University; Shahid Beheshti University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Eslahchi, C (corresponding author), Shahid Beheshti Univ, Dept Comp Sci, GC, Tehran, Iran.	ch-eslahchi@sbu.ac.ir		Sung, Wing-Kin/0000-0001-7806-7086; Hassanzadeh, Reza/0000-0001-8819-8864				AHO AV, 1981, SIAM J COMPUT, V10, P405, DOI 10.1137/0210030; Berry A., 2000, International Journal of Foundations of Computer Science, V11, P397, DOI 10.1142/S0129054100000211; BUI TN, 1992, INFORM PROCESS LETT, V42, P153, DOI 10.1016/0020-0190(92)90140-Q; Byrka J, 2010, DISCRETE APPL MATH, V158, P1136, DOI 10.1016/j.dam.2010.03.004; Critchlow DE, 1996, SYST BIOL, V45, P323, DOI 10.2307/2413567; Cui Y, 2012, J COMPUT BIOL, V19, P1073, DOI 10.1089/cmb.2012.0008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ganapathy G, 2006, IEEE ACM T COMPUT BI, V3, P334, DOI 10.1109/TCBB.2006.57; Guillemot S, 2011, IEEE ACM T COMPUT BI, V8, P1141, DOI 10.1109/TCBB.2010.77; Huber KT, 2006, MOL BIOL EVOL, V23, P1784, DOI 10.1093/molbev/msl045; Huber KT, 2011, IEEE ACM T COMPUT BI, V8, P1029, DOI 10.1109/TCBB.2010.122; Jansson J, 2006, BIOINFORMATICS, V18, P337; Lott M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-216; Lott M, 2009, BIOINFORMATICS, V25, P1199, DOI 10.1093/bioinformatics/btp133; Maddison WP, 2011, MESQUITE MODULAR SYS; Marcussen T, 2012, SYST BIOL, V61, P107, DOI 10.1093/sysbio/syr096; Nelson G., 1981, SYSTEMATICS BIOGEORA; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; PAGE RDM, 1993, INT J PARASITOL, V23, P499, DOI 10.1016/0020-7519(93)90039-2; Popp M, 2005, SYST BOT, V30, P302, DOI 10.1600/0363644054223648; Scornavacca C, 2011, INFORM COMPUT, V209, P590, DOI 10.1016/j.ic.2010.11.022; Scornavacca C, 2009, LECT NOTES COMPUT SC, V5457, P702, DOI 10.1007/978-3-642-00982-2_60; To TH, 2009, LECT NOTES COMPUT SC, V5577, P275, DOI 10.1007/978-3-642-02441-2_25; van Iersel L, 2011, ALGORITHMICA, V60, P207, DOI 10.1007/s00453-009-9333-0; van Iersel L, 2009, IEEE ACM T COMPUT BI, V6, P667, DOI 10.1109/TCBB.2009.22	26	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103622	10.1371/journal.pone.0103622	http://dx.doi.org/10.1371/journal.pone.0103622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080217	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800061
J	Kittelmann, S; Pinares-Patino, CS; Seedorf, H; Kirk, MR; Ganesh, S; McEwan, JC; Janssen, PH				Kittelmann, Sandra; Pinares-Patino, Cesar S.; Seedorf, Henning; Kirk, Michelle R.; Ganesh, Siva; McEwan, John C.; Janssen, Peter H.			Two Different Bacterial Community Types Are Linked with the Low-Methane Emission Trait in Sheep	PLOS ONE			English	Article							IN-VITRO; SP-NOV; GEN. NOV.; RUMEN; FERMENTATION; ENTEROTYPES; METABOLISM; MICROBIOTA; STARCH; GROWTH	The potent greenhouse gas methane (CH4) is produced in the rumens of ruminant animals from hydrogen produced during microbial degradation of ingested feed. The natural animal-to-animal variation in the amount of CH4 emitted and the heritability of this trait offer a means for reducing CH4 emissions by selecting low-CH4 emitting animals for breeding. We demonstrate that differences in rumen microbial community structure are linked to high and low CH4 emissions in sheep. Bacterial community structures in 236 rumen samples from 118 high-and low-CH4 emitting sheep formed gradual transitions between three ruminotypes. Two of these (Q and S) were linked to significantly lower CH4 yields (14.4 and 13.6 g CH4/kg dry matter intake [DMI], respectively) than the third type (H; 15.9 g CH4/kg DMI; p<0.001). Low-CH4 ruminotype Q was associated with a significantly lower ruminal acetate to propionate ratio (3.7 +/- 0.4) than S (4.4 +/- 0.7; p<0.001) and H (4.3 +/- 0.5; p<0.001), and harbored high relative abundances of the propionate-producing Quinella ovalis. Low-CH4 ruminotype S was characterized by lactate-and succinate-producing Fibrobacter spp., Kandleria vitulina, Olsenella spp., Prevotella bryantii, and Sharpea azabuensis. High-CH4 ruminotype H had higher relative abundances of species belonging to Ruminococcus, other Ruminococcaceae, Lachnospiraceae, Catabacteriaceae, Coprococcus, other Clostridiales, Prevotella, other Bacteroidales, and Alphaproteobacteria, many of which are known to form significant amounts of hydrogen. We hypothesize that lower CH4 yields are the result of bacterial communities that ferment ingested feed to relatively less hydrogen, which results in less CH4 being formed.	[Kittelmann, Sandra; Pinares-Patino, Cesar S.; Seedorf, Henning; Kirk, Michelle R.; Ganesh, Siva; Janssen, Peter H.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand; [McEwan, John C.] AgResearch Ltd, Invermay Agr Ctr, Mosgiel, New Zealand	AgResearch - New Zealand; AgResearch - New Zealand	Janssen, PH (corresponding author), AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand.	peter.janssen@agresearch.co.nz	Seedorf, Henning/AAW-6023-2020; McEwan, John/A-1143-2008	Seedorf, Henning/0000-0002-5763-0236; McEwan, John/0000-0003-4801-6207; Kittelmann, Sandra/0000-0002-6019-9854; Janssen, Peter/0000-0002-1022-3502; Ganesh, Siva/0000-0001-8148-1704; Pinares Patino, Cesar Silvino/0000-0001-9195-8844	Pastoral Greenhouse Gas Research Consortium; Beef+ Lamb New Zealand	Pastoral Greenhouse Gas Research Consortium; Beef+ Lamb New Zealand	This research was funded by the Pastoral Greenhouse Gas Research Consortium (www.pggrc.co.nz). All the authors are employees of AgResearch Ltd., which is a Crown Research Institute. The animals were part of the Ovita partnership and the related Central Progeny Test, both supported by funding from Beef+ Lamb New Zealand (www.beeflambnz.com). The funders did play a role in the decision to publish, but did not play a role in study design, data collection and analysis, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Blaxter KL, 1967, ENERGY METABOLISM RU; BRYANT MP, 1954, J DAIRY SCI, V37, P1176, DOI 10.3168/jds.S0022-0302(54)91387-9; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dewhirst FE, 2001, INT J SYST EVOL MICR, V51, P1797, DOI 10.1099/00207713-51-5-1797; Fievez V, 2003, ANIM FEED SCI TECH, V104, P41, DOI 10.1016/S0377-8401(02)00330-9; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; Goopy JP, 2014, BRIT J NUTR, V111, P578, DOI 10.1017/S0007114513002936; Haisan J, 2014, J DAIRY SCI, V97, P3110, DOI 10.3168/jds.2013-7834; Hegarty RS, 1999, AUST J AGR RES, V50, P1321, DOI 10.1071/AR99008; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; HOLDEMAN LV, 1974, INT J SYST BACTERIOL, V24, P260, DOI 10.1099/00207713-24-2-260; HOWLETT MR, 1976, APPL ENVIRON MICROB, V32, P274, DOI 10.1128/AEM.32.2.274-283.1976; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Janssen PH, 2010, ANIM FEED SCI TECH, V160, P1, DOI 10.1016/j.anifeedsci.2010.07.002; Jeyanathan J, 2011, FEMS MICROBIOL ECOL, V76, P311, DOI 10.1111/j.1574-6941.2011.01056.x; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; KRUMHOLZ LR, 1993, INT J SYST BACTERIOL, V43, P293, DOI 10.1099/00207713-43-2-293; MILLER TL, 1985, ARCH MICROBIOL, V141, P116, DOI 10.1007/BF00423270; Miller TL, 2001, J DAIRY SCI, V84, P1445, DOI 10.3168/jds.S0022-0302(01)70177-4; Moeller AH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2159; Morita H, 2008, INT J SYST EVOL MICR, V58, P2682, DOI 10.1099/ijs.0.65543-0; NEWBOLD CJ, 1995, LETT APPL MICROBIOL, V21, P230, DOI 10.1111/j.1472-765X.1995.tb01048.x; Nkrumah JD, 2006, J ANIM SCI, V84, P145; Pinares-Patino CS, 2013, ANIMAL, V7, P316, DOI 10.1017/S1751731113000864; Pinares-Patino CS, 2003, J AGR SCI-CAMBRIDGE, V140, P205, DOI 10.1017/S0021859603003046; Pinares-Patino CS, 2003, J AGR SCI-CAMBRIDGE, V140, P227, DOI 10.1017/S0021859603003071; Popova M, 2013, APPL ENVIRON MICROB, V79, P1777, DOI 10.1128/AEM.03115-12; Popova M, 2011, ANIM FEED SCI TECH, V166-67, P113, DOI 10.1016/j.anifeedsci.2011.04.060; Poulsen M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2432; Quin J. I., 1943, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V18, P91; Rius AG, 2012, J DAIRY SCI, V95, P5024, DOI 10.3168/jds.2012-5392; Ross EM, 2013, J DAIRY SCI, V96, P6030, DOI 10.3168/jds.2013-6766; Salvetti E, 2011, INT J SYST EVOL MICR, V61, P2520, DOI 10.1099/ijs.0.029231-0; SHARPE ME, 1973, J GEN MICROBIOL, V77, P37, DOI 10.1099/00221287-77-1-37; Shi WB, 2014, GENOME RES, V24, P1517, DOI 10.1101/gr.168245.113; Stewart CS., 1997, RUMEN MICROBIAL ECOS, P10, DOI [10.1007/978-94-009-1453-7_2, DOI 10.1007/978-94-009-1453-7_2]; Sun XZ, 2011, ANIM FEED SCI TECH, V166-67, P391, DOI 10.1016/j.anifeedsci.2011.04.027; VICINI JL, 1987, APPL ENVIRON MICROB, V53, P1273, DOI 10.1128/AEM.53.6.1273-1276.1987; Wedlock DN, 2013, ANIMAL, V7, P244, DOI 10.1017/S1751731113000682; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zeitz JO, 2013, EUR J PROTISTOL, V49, P389, DOI 10.1016/j.ejop.2013.02.003; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08	46	155	166	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103171	10.1371/journal.pone.0103171	http://dx.doi.org/10.1371/journal.pone.0103171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078564	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800031
J	Koelzer, S; Kolsch, Y; Panfilio, KA				Koelzer, Stefan; Koelsch, Yvonne; Panfilio, Kristen A.			Visualizing Late Insect Embryogenesis: Extraembryonic and Mesodermal Enhancer Trap Expression in the Beetle Tribolium castaneum	PLOS ONE			English	Article							EMBRYONIC LETHAL MUTATIONS; CHITIN-SYNTHASE GENES; RED FLOUR BEETLE; TBX20-RELATED GENES; SEGMENTATION CLOCK; SEROSA; CELL; MORPHOGENESIS; ANTERIOR; MARKER	The beetle Tribolium castaneum has increasingly become a powerful model for comparative research on insect development. One recent resource is a collection of piggyBac transposon-based enhancer trap lines. Here, we provide a detailed analysis of three selected lines and demonstrate their value for investigations in the second half of embryogenesis, which has thus far lagged behind research on early stages. Two lines, G12424 and KT650, show enhanced green fluorescent protein (EGFP) expression throughout the extraembryonic serosal tissue and in a few discrete embryonic domains. Intriguingly, both lines show for the first time a degree of regionalization within the mature serosa. However, their expression profiles illuminate distinct aspects of serosal biology: G12424 tracks the tissue's rapid maturation while KT650 expression likely reflects ongoing physiological processes. The third line, G04609, is stably expressed in mesodermal domains, including segmental muscles and the heart. Genomic mapping followed by in situ hybridization for genes near to the G04609 insertion site suggests that the transposon has trapped enhancer information for the Tribolium orthologue of midline (Tc-mid). Altogether, our analyses provide the first live imaging, long-term characterizations of enhancer traps from this collection. We show that EGFP expression is readily detected, including in heterozygote crosses that permit the simultaneous visualization of multiple tissue types. The tissue specificity provides live, endogenous marker gene expression at key developmental stages that are inaccessible for whole mount staining. Furthermore, the nonlocalized EGFP in these lines illuminates both the nucleus and cytoplasm, providing cellular resolution for morphogenesis research on processes such as dorsal closure and heart formation. In future work, identification of regulatory regions driving these enhancer traps will deepen our understanding of late developmental control, including in the extraembryonic domain, which is a hallmark of insect development but which is not yet well understood.	[Koelzer, Stefan; Koelsch, Yvonne; Panfilio, Kristen A.] Univ Cologne, Inst Dev Biol, D-50931 Cologne, Germany	University of Cologne	Panfilio, KA (corresponding author), Univ Cologne, Inst Dev Biol, D-50931 Cologne, Germany.	Kristen.Panfilio@alum.swarthmore.edu	Panfilio, Kristen/S-3179-2019	Panfilio, Kristen/0000-0002-6417-251X	Deutsche Forschungsgemeinschaft (German Research Foundation) [PA 2044/1-1]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was supported by Emmy Noether grant PA 2044/1-1 from the Deutsche Forschungsgemeinschaft (German Research Foundation) to K.A.P. The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay T, 2001, J NEUROPHYSIOL, V85, P594, DOI 10.1152/jn.2001.85.2.594; Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Arakane Y, 2004, INSECT BIOCHEM MOLEC, V34, P291, DOI 10.1016/j.ibmb.2003.11.004; Beermann A, 2011, DEVELOPMENT, V138, P2793, DOI 10.1242/dev.063644; Benton MA, 2013, DEVELOPMENT, V140, P3210, DOI 10.1242/dev.096271; Berghammer A, 1999, DEV GENES EVOL, V209, P382, DOI 10.1007/s004270050268; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Blanchard GB, 2009, NAT METHODS, V6, P458, DOI [10.1038/nmeth.1327, 10.1038/NMETH.1327]; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; Brown S. J., 2009, COLD SPRING HARB PRO, V2009; Chen G, 2000, DEVELOPMENT, V127, P5145; da Fonseca RN, 2008, DEV CELL, V14, P605, DOI 10.1016/j.devcel.2008.02.011; DORN A, 1976, ZOOMORPHOLOGIE, V85, P111, DOI 10.1007/BF00995407; El-Sherif E, 2012, DEVELOPMENT, V139, P4341, DOI 10.1242/dev.085126; ENSLEE EC, 1981, J EMBRYOL EXP MORPH, V61, P35; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Grossmann D, 2012, DEV BIOL, V370, P264, DOI 10.1016/j.ydbio.2012.08.005; Grossmann D, 2009, DEV GENES EVOL, V219, P469, DOI 10.1007/s00427-009-0310-z; Hammonds AS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r140; Handel K, 2005, DEV GENES EVOL, V215, P13, DOI 10.1007/s00427-004-0446-9; Handel K, 2000, DEV GENES EVOL, V210, P167, DOI 10.1007/s004270050301; Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Jacobs CGC, 2013, DEV COMP IMMUNOL, V41, P263, DOI 10.1016/j.dci.2013.05.017; Jacobs CGC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1082; Janssen R, 2008, EVOL DEV, V10, P155, DOI 10.1111/j.1525-142X.2008.00223.x; Jin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003195; Kittelmann S, 2013, DEV BIOL, V374, P174, DOI 10.1016/j.ydbio.2012.11.026; Lamer A, 2001, TISSUE CELL, V33, P580, DOI 10.1054/tice.2001.0213; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Miskolczi-McCallum CM, 2005, DEV BIOL, V278, P459, DOI 10.1016/j.ydbio.2004.11.026; MORI H, 1972, J INSECT PHYSIOL, V18, P675, DOI 10.1016/0022-1910(72)90193-X; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Panfilio KA, 2008, DEV BIOL, V313, P471, DOI 10.1016/j.ydbio.2007.11.004; Panfilio KA, 2013, BIOL OPEN, V2, P1108, DOI 10.1242/bio.20136072; Panfilio KA, 2010, DEV BIOL, V340, P100, DOI 10.1016/j.ydbio.2009.12.034; Panfilio KA, 2009, DEV BIOL, V333, P297, DOI 10.1016/j.ydbio.2009.06.036; Peel AD, 2010, DEV DYNAM, V239, P2875, DOI 10.1002/dvdy.22423; Qian L, 2005, DEV BIOL, V279, P509, DOI 10.1016/j.ydbio.2005.01.013; Reim I, 2005, MECH DEVELOP, V122, P1056, DOI 10.1016/j.mod.2005.04.006; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sarrazin AF, 2012, SCIENCE, V336, P338, DOI 10.1126/science.1218256; Schinko JB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-53; Schinko JB, 2012, DEV GENES EVOL, V222, P287, DOI 10.1007/s00427-012-0412-x; Schmitt-Engel C, 2012, DEV BIOL, V364, P224, DOI 10.1016/j.ydbio.2012.01.024; Sharma R, 2013, GENE EXPR PATTERNS, V13, P362, DOI 10.1016/j.gep.2013.07.002; Sharma R, 2013, DEV BIOL, V381, P121, DOI 10.1016/j.ydbio.2013.05.031; STANLEY MSM, 1970, ANN ENTOMOL SOC AM, V63, P1248, DOI 10.1093/aesa/63.5.1248; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Trauner J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-73; TRUCKENBRODT W, 1973, Z MORPHOL TIERE, V76, P193, DOI 10.1007/BF00280672; van der Zee M, 2005, CURR BIOL, V15, P624, DOI 10.1016/j.cub.2005.02.057; Yoshihara M, 2004, NEUROSCIENTIST, V10, P566, DOI 10.1177/1073858404268770; ZILL SN, 1985, J EXP BIOL, V116, P435	56	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103967	10.1371/journal.pone.0103967	http://dx.doi.org/10.1371/journal.pone.0103967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080214	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800101
J	Olivares, S; Green, RM; Henkel, AS				Olivares, Shantel; Green, Richard M.; Henkel, Anne S.			Endoplasmic Reticulum Stress Activates the Hepatic Activator Protein 1 Complex via Mitogen Activated Protein Kinase-Dependent Signaling Pathways	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; FATTY LIVER-DISEASE; CELL-DEATH; DOWN-REGULATION; AP-1; TRANSCRIPTION; APOPTOSIS; CANCER; GRP78; DYSREGULATION	Background and Aims: Endoplasmic reticulum (ER) stress is induced in many forms of chronic liver disease and may promote the development of hepatocellular carcinoma. The activator protein 1 (AP-1) complex is a transcription factor that promotes hepatic carcinogenesis in response to cellular stress. The aim of this study was to determine the role of ER stress in the regulation of the hepatic AP-1 complex. Methods: Human hepatocellular carcinoma (HepG2) cells and C57BL/6J mice were subjected to pharmacologic ER stress and the expression of AP-1-associated genes and proteins was assessed. To determine the role of MAPK signaling in ER stress-induced AP-1 activation, ER stress was induced in JNK-and ERK-inhibited HepG2 cells. Results: Induction of ER stress promoted the activation of both Jun- and Fos-related genes and proteins of the AP-1 complex in HepG2 cells and murine liver. Inhibition of ERK phosphorylation in HepG2 cells completely prevented ER stress-induced activation of the fos-related components of AP-1 whereas activation of Jun-related components was only partially attenuated. Conversely, inhibition of JNK phosphorylation in HepG2 cells reduced ER stress-induced activation of Jun-related components but did not prevent activation of fos-related components. Conclusions: ER stress activates the hepatic AP-1 complex via MAPK-dependent signaling pathways. ER stress-induced activation of Fos-related components is dependent primarily on ERK activation whereas ER stress-induced activation of Jun-related components is dependent primarily on JNK activation, although there is interplay between these regulatory pathways. These data implicate a novel signaling pathway by which sustained ER stress, as observed in many chronic liver diseases, may promote hepatic carcinogenesis.	[Olivares, Shantel; Green, Richard M.; Henkel, Anne S.] Northwestern Univ, Feinberg Sch Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Henkel, AS (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA.	a-henkel2@northwestern.edu			NIH/NIDDK [R01DK080810, K08DK095992]; AGA Research Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093807, R01DK080810, K08DK095992] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGA Research Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NIDDK grants R01DK080810 and K08DK095992 and an AGA Research Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Belfi CA, 1999, BIOCHEM BIOPH RES CO, V257, P361, DOI 10.1006/bbrc.1999.0472; Chang QS, 2009, J HEPATOL, V50, P323, DOI 10.1016/j.jhep.2008.07.037; Chen R, 2011, FOLIA BIOL-PRAGUE, V57, P87; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Han Hui, 2013, Frontiers in Genetics, V4, P224, DOI 10.3389/fgene.2013.00224; Henkel AS, 2011, J LIPID RES, V52, P289, DOI 10.1194/jlr.M012781; Henkel AS, 2009, J BIOL CHEM, V284, P31807, DOI 10.1074/jbc.M109.017970; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Honma Y, 2013, EXP CELL RES; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kawada N, 2009, J GASTROENTEROL, V44, P1190, DOI 10.1007/s00535-009-0112-0; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Liu P, 2002, J HEPATOL, V37, P63, DOI 10.1016/S0168-8278(02)00064-8; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Nguyen DT, 2004, MOL BIOL CELL, V15, P4248, DOI 10.1091/mbc.E03-11-0851; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Tang J, 2012, CELL DEATH DIFFER, V19, P1779, DOI 10.1038/cdd.2012.60; Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu M, 2012, HEPATOL RES; Yang F, 2011, NEOPLASIA, V13, P590, DOI 10.1593/neo.11422; Yi P, 2012, MOL CANCER THER, V11, P2610, DOI 10.1158/1535-7163.MCT-12-0516; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	46	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103828	10.1371/journal.pone.0103828	http://dx.doi.org/10.1371/journal.pone.0103828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077945	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800086
J	Pirolli, D; Sciandra, F; Bozzi, M; Giardina, B; Brancaccio, A; De Rosa, MC				Pirolli, Davide; Sciandra, Francesca; Bozzi, Manuela; Giardina, Bruno; Brancaccio, Andrea; De Rosa, Maria Cristina			Insights from Molecular Dynamics Simulations: Structural Basis for the V567D Mutation-Induced Instability of Zebrafish Alpha-Dystroglycan and Comparison with the Murine Model	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; MUSCULAR-DYSTROPHY; IMMUNOGLOBULIN SUPERFAMILY; GLYCOSYLATION; DISEASE; DOMAIN; SERVER; CLASSIFICATION; DETERMINANTS; ARCHITECTURE	A missense amino acid mutation of valine to aspartic acid in 567 position of alpha-dystroglycan (DG), identified in dag1-mutated zebrafish, results in a reduced transcription and a complete absence of the protein. Lacking experimental structural data for zebrafish DG domains, the detailed mechanism for the observed mutation-induced destabilization of the DG complex and membrane damage, remained unclear. With the aim to contribute to a better clarification of the structure-function relationships featuring the DG complex, three-dimensional structural models of wild-type and mutant (V567D) C-terminal domain of alpha-DG from zebrafish were constructed by a template-based modelling approach. We then ran extensive molecular dynamics (MD) simulations to reveal the structural and dynamic properties of the C-terminal domain and to evaluate the effect of the single mutation on alpha-DG stability. A comparative study has been also carried out on our previously generated model of murine alpha-DG C-terminal domain including the I591D mutation, which is topologically equivalent to the V567D mutation found in zebrafish. Trajectories from MD simulations were analyzed in detail, revealing extensive structural disorder involving multiple beta-strands in the mutated variant of the zebrafish protein whereas local effects have been detected in the murine protein. A biochemical analysis of the murine alpha-DG mutant I591D confirmed a pronounced instability of the protein. Taken together, the computational and biochemical analysis suggest that the V567D/I591D mutation, belonging to the G beta-strand, plays a key role in inducing a destabilization of the alpha-DG C-terminal Ig-like domain that could possibly affect and propagate to the entire DG complex. The structural features herein identified may be of crucial help to understand the molecular basis of primary dystroglycanopathies.	[Pirolli, Davide; Bozzi, Manuela; Giardina, Bruno] Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, Rome, Italy; [Sciandra, Francesca; Giardina, Bruno; Brancaccio, Andrea; De Rosa, Maria Cristina] Univ Cattolica Sacro Cuore, CNR, Ist Chim Riconoscimento Mol, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Brancaccio, A (corresponding author), Univ Cattolica Sacro Cuore, CNR, Ist Chim Riconoscimento Mol, Rome, Italy.	andrea.brancaccio@icrm.cnr.it; mariacristina.derosa@icrm.cnr.it	De Rosa, Maria Cristina/K-3814-2014; Sciandra, Francesca/AAY-4650-2020; Brancaccio, Andrea/C-5876-2009	De Rosa, Maria Cristina/0000-0002-9611-2490; Sciandra, Francesca/0000-0002-2123-1516; Brancaccio, Andrea/0000-0003-4690-8826; Pirolli, Davide/0000-0003-2303-2577				Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Bozic D, 2004, J BIOL CHEM, V279, P44812, DOI 10.1074/jbc.C400353200; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; DAGGETT V, 1993, ANNU REV BIOPH BIOM, V22, P353, DOI 10.1146/annurev.bb.22.060193.002033; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Rosa MC, 2011, J MOL GRAPH MODEL, V29, P1015, DOI 10.1016/j.jmgm.2011.04.008; Durbeej M, 1998, CURR OPIN CELL BIOL, V10, P594, DOI 10.1016/S0955-0674(98)80034-3; Gajendrarao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059206; Geis T, 2013, NEUROGENETICS, V14, P205, DOI 10.1007/s10048-013-0374-9; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Gupta V, 2011, HUM MOL GENET, V20, P1712, DOI 10.1093/hmg/ddr047; Guyon JR, 2007, BBA-MOL BASIS DIS, V1772, P205, DOI 10.1016/j.bbadis.2006.07.003; Halaby DM, 1998, J MOL EVOL, V46, P389, DOI 10.1007/PL00006318; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Johnson Nathan M, 2013, PLoS Curr, V5, DOI 10.1371/currents.md.8273cf41db10e2d15dd3ab827cb4b027; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kawahara Genri, 2013, Drug Discov Today Technol, V10, pe91, DOI 10.1016/j.ddtec.2012.03.001; Kawahara G, 2010, HUM MOL GENET, V19, P623, DOI 10.1093/hmg/ddp528; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Moore CJ, 2008, GENOMICS, V92, P159, DOI 10.1016/j.ygeno.2008.05.008; Morlacchi S, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-14; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Muntoni F, 2004, NAT MED, V10, P676, DOI 10.1038/nm0704-676; Muntoni F, 2011, CURR OPIN NEUROL, V24, P437, DOI 10.1097/WCO.0b013e32834a95e3; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Parsons MJ, 2002, DEVELOPMENT, V129, P3505; Sciandra F, 2013, CURR PROTEIN PEPT SC, V14, P626; Sciandra F, 2012, EXP CELL RES, V318, P2460, DOI 10.1016/j.yexcr.2012.07.006; Sciandra F, 2009, FEBS J, V276, P4933, DOI 10.1111/j.1742-4658.2009.07196.x; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Stocker U, 2000, PROTEINS, V40, P145, DOI 10.1002/(SICI)1097-0134(20000701)40:1<145::AID-PROT160>3.0.CO;2-Y; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Waite A, 2011, HUM MUTAT, V32, P1246, DOI 10.1002/humu.21561; Wang JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031048; Watanabe N, 2007, GENES CELLS, V12, P75, DOI 10.1111/j.1365-2443.2006.01033.x; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Winder Steve J, 2011, PLoS Curr, V3, pRRN1286, DOI 10.1371/currents.RRN1286; Wood AJ, 2011, HUM MOL GENET, V20, P4879, DOI 10.1093/hmg/ddr426; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Yang, 2014, Proteins, V82 Suppl 2, P175, DOI 10.1002/prot.24341	60	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103866	10.1371/journal.pone.0103866	http://dx.doi.org/10.1371/journal.pone.0103866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078606	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800091
J	Xu, P; Mohorianu, I; Yang, L; Zhao, HS; Gao, ZM; Dalmay, T				Xu, Ping; Mohorianu, Irina; Yang, Li; Zhao, Hansheng; Gao, Zhimin; Dalmay, Tamas			Small RNA Profile in Moso Bamboo Root and Leaf Obtained by High Definition Adapters	PLOS ONE			English	Article							MESSENGER-RNA; CELL-DEATH; MICRORNAS; ARABIDOPSIS; IDENTIFICATION; EXPRESSION; GENES; TARGETS; TRANSCRIPTS; SEQUENCES	Moso bamboo (Phyllostachy heterocycla cv. pubescens L.) is an economically important fast-growing tree. In order to gain better understanding of gene expression regulation in this important species we used next generation sequencing to profile small RNAs in leaf and roots of young seedlings. Since standard kits to produce cDNA of small RNAs are biased for certain small RNAs, we used High Definition adapters that reduce ligation bias. We identified and experimentally validated five new microRNAs and a few other small non-coding RNAs that were not microRNAs. The biological implication of microRNA expression levels and targets of microRNAs are discussed.	[Xu, Ping; Mohorianu, Irina; Dalmay, Tamas] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Yang, Li; Zhao, Hansheng; Gao, Zhimin] Int Ctr Bamboo, State Forestry Adm, Key Open Lab Sci & Technol Bamboo & Rattan, Beijing, Peoples R China	University of East Anglia; International Centre for Bamboo & Rattan	Dalmay, T (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	t.dalmay@uea.ac.uk	zhao, hansheng/GRS-2764-2022; Mohorianu, Irina/J-2549-2019; Dalmay, Tamas/E-1377-2011	Dalmay, Tamas/0000-0003-1492-5429; Mohorianu, Irina/0000-0003-4863-761X	State Forestry Administration of China [2011-4-55]; Biotechnology and Biological Sciences Research Council [BB/J021601/1]; BBSRC [BB/J021601/1] Funding Source: UKRI	State Forestry Administration of China; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The project received financial support from the State Forestry Administration of China (http://english.forestry.gov.cn) to ZG (grant 2011-4-55) and the Biotechnology and Biological Sciences Research Council (http://bbsrc.ac.uk) to TD (grant BB/J021601/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Goyal AK, 2010, BIOINFORMATION, V5, P184, DOI 10.6026/97320630005184; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; He CY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-119; Javelle M, 2012, NAT PROTOC, V7, P533, DOI 10.1038/nprot.2012.006; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Kang MM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-360; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kruszka K, 2012, J PLANT PHYSIOL, V169, P1664, DOI 10.1016/j.jplph.2012.03.009; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Lu SF, 2013, P NATL ACAD SCI USA, V110, P10848, DOI 10.1073/pnas.1308936110; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meng YJ, 2009, PLANTA, V230, P883, DOI 10.1007/s00425-009-0994-3; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sorefan Karim, 2012, Silence, V3, P4, DOI 10.1186/1758-907X-3-4; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Szittya G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000838; Wang B, 2012, GENE, V498, P36, DOI 10.1016/j.gene.2012.01.075; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang XH, 2011, FEBS LETT, V585, P435, DOI 10.1016/j.febslet.2010.12.036; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078755; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137	51	13	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103590	10.1371/journal.pone.0103590	http://dx.doi.org/10.1371/journal.pone.0103590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079776	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000339954800058
J	Choi, K; Ghaddar, B; Moya, C; Shi, H; Sridharan, GV; Lee, K; Jayaraman, A				Choi, KyungOh; Ghaddar, Bassel; Moya, Colby; Shi, Hai; Sridharan, Gautham V.; Lee, Kyongbum; Jayaraman, Arul			Analysis of Transcription Factor Network Underlying 3T3-L1 Adipocyte Differentiation	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; ELEMENT-BINDING PROTEIN-1; PPAR-GAMMA; FATTY-ACIDS; C/EBP-ALPHA; EXPRESSION; ADIPOGENESIS; BETA; GENE; LIGANDS	Lipid accumulation in adipocytes reflects a balance between enzymatic pathways leading to the formation and breakdown of esterified lipids, primarily triglycerides. This balance is extremely important, as both high and low lipid levels in adipocytes can have deleterious consequences. The enzymes responsible for lipid synthesis and breakdown (lipogenesis and lipolysis, respectively) are regulated through the coordinated actions of several transcription factors (TFs). In this study, we examined the dynamics of several key transcription factors (TFs) - PPAR gamma, C/EBP beta, CREB, NFAT, FoxO1, and SREBP-1c-during adipogenic differentiation (week 1) and ensuing lipid accumulation. The activation profiles of these TFs at different times following induction of adipogenic differentiation were quantified using 3T3-L1 reporter cell lines constructed to secrete the Gaussia luciferase enzyme upon binding of a TF to its DNA binding element. The dynamics of the TFs was also modeled using a combination of logical gates and ordinary differential equations, where the logical gates were used to explore different combinations of activating inputs for PPAR gamma, C/EBP beta, and SREBP-1c. Comparisons of the experimental profiles and model simulations suggest that SREBP-1c could be independently activated by either insulin or PPAR gamma, whereas PPAR gamma activation required both C/EBP beta as well as a putative ligand. Parameter estimation and sensitivity analysis indicate that feedback activation of SREBP-1c by PPAR gamma is negligible in comparison to activation of SREBP-1c by insulin. On the other hand, the production of an activating ligand could quantitatively contribute to a sustained elevation in PPAR gamma activity.	[Choi, KyungOh; Moya, Colby; Jayaraman, Arul] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; [Ghaddar, Bassel; Shi, Hai; Sridharan, Gautham V.; Lee, Kyongbum] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA	Texas A&M University System; Texas A&M University College Station; Tufts University	Lee, K (corresponding author), Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.	kyongbum.lee@tufts.edu; arulj@tamu.edu		Lee, Kyongbum/0000-0002-0699-8057; Choi, Kyungoh/0000-0001-8585-1266	National Science Foundation (CBET) [0846453]; National Institutes of Health [1R56DK081768]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK081768] Funding Source: NIH RePORTER	National Science Foundation (CBET)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Science Foundation (CBET 0846453) to AJ and the National Institutes of Health (1R56DK081768) to AJ and KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Arner P, 2011, NATURE, V478, P110, DOI 10.1038/nature10426; Bergalet J, 2011, MOL CANCER RES, V9, P485, DOI 10.1158/1541-7786.MCR-10-0351; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Chan CP, 2010, J CELL SCI, V123, P1438, DOI 10.1242/jcs.067819; Chehab FF, 2008, ENDOCRINOLOGY, V149, P925, DOI 10.1210/en.2007-1355; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Fu MG, 2001, CIRC RES, V89, P1058, DOI 10.1161/hh2301.099642; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Joshi M, 2006, METAB ENG, V8, P447, DOI 10.1016/j.ymben.2006.04.003; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Kraeutler MJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-157; Krell T, 2007, J MOL BIOL, V369, P1188, DOI 10.1016/j.jmb.2007.04.025; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Limor R, 2008, AM J HYPERTENS, V21, P219, DOI 10.1038/ajh.2007.39; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Morris MK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001099; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; OLEFSKY JM, 1977, ENDOCRINOLOGY, V100, P1169; Penumetcha M, 2012, PPAR RES, V2012, DOI 10.1155/2012/858352; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; RON D, 1992, J CLIN INVEST, V89, P223, DOI 10.1172/JCI115566; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Savage David B., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405008793; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; SHOBACK DM, 1984, METABOLISM, V33, P509, DOI 10.1016/0026-0495(84)90004-0; Si YG, 2007, AM J PHYSIOL-ENDOC M, V292, pE1637, DOI 10.1152/ajpendo.00670.2006; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Simicevic J, 2013, NAT METHODS, V10, P570, DOI [10.1038/NMETH.2441, 10.1038/nmeth.2441]; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; Waite KJ, 2001, J BIOL CHEM, V276, P7062, DOI 10.1074/jbc.M007894200; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Wickelgren I, 1998, SCIENCE, V280, P1364, DOI 10.1126/science.280.5368.1364; Wittmann DM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-98; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; Yang TTC, 2003, J BIOL CHEM, V278, P15874, DOI 10.1074/jbc.M211560200; Yang XY, 2000, J BIOL CHEM, V275, P4541, DOI 10.1074/jbc.275.7.4541; Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	61	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e100177	10.1371/journal.pone.0100177	http://dx.doi.org/10.1371/journal.pone.0100177			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075860	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800005
J	Dijoux, L; Viard, F; Payri, C				Dijoux, Laury; Viard, Frederique; Payri, Claude			The More We Search, the More We Find: Discovery of a New Lineage and a New Species Complex in the Genus Asparagopsis	PLOS ONE			English	Article							MARINE ALGAL FLORA; TAXIFORMIS BONNEMAISONIALES; SARGASSUM-MANGAREVENSE; CRYPTIC INTRODUCTIONS; MOLECULAR EVIDENCE; TURBINARIA-ORNATA; INVASION PATTERNS; GENETIC DIVERSITY; RHODOPHYTA; PHYLOGEOGRAPHY	In the past few decades, in the marine realm in particular, the use of molecular tools has led to the discovery of hidden taxonomic diversity, revealing complexes of sister species. A good example is the red algal genus Asparagopsis. The two species (A. armata and A. taxiformis) recognized in this genus have been introduced in many places around the world. Within the nominal species A. taxiformis, previous molecular analyses have uncovered several lineages, suggesting the existence of sister species or subspecies. Although the genus has been well studied in some regions (e.g., the Mediterranean Sea and Hawaii), it remains poorly investigated in others (e.g., South Pacific). Our study mainly focused on these latter areas to clarify lineages and better determine lineage status (i.e., native vs. introduced). A total of 188 specimens were collected from 61 sites, 58 of which had never been sampled before. We sequenced the DNA from samples for three markers and obtained 112 sequences for the chloroplastic RuBisCo spacer, 118 sequences for the nuclear LSU rRNA gene, and 174 for the mitochondrial spacer cox2-3. Phylogenetic analyses using all three markers suggested the existence of two cryptic sister species with the discovery of a new clade within A. armata. This clade was found only in Western Australia, Tasmania and New Zealand, and is thus restricted to a subregional biogeographic unit. We also discovered a new, fifth lineage for A. taxiformis restricted to the South Pacific and Western Australia. Except for this newly described lineage, all other lineages showed a global distribution influenced by introduction events. These results illustrate the difficulty in accurately defining cosmopolitan species. Our findings also highlight the need for targeted (i.e., in poorly studied areas) and geographically extensive sampling efforts when studying taxa that have been introduced globally and that are likely to hide species complexes.	[Dijoux, Laury; Payri, Claude] Inst Rech Dev, CoReUs LabEx CORAIL UR227, Noumea, New Caledonia; [Dijoux, Laury; Viard, Frederique] Univ Paris 06, Sorbonne Univ, UMR 7144, Stn Biol Roscoff, Roscoff, France; [Dijoux, Laury; Viard, Frederique] CNRS, UMR 7144, Divco Team, Stn Biol Roscoff, Roscoff, France	Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Dijoux, L (corresponding author), Inst Rech Dev, CoReUs LabEx CORAIL UR227, Noumea, New Caledonia.	laury.dijoux@ird.fr; claude.payri@ird.fr	Payri, Claude/K-5646-2016; Viard, Frédérique/O-4360-2018	Payri, Claude/0000-0002-0393-6811; Viard, Frédérique/0000-0001-5603-9527	ERA-net NETBIOME; ANR [PCS-10-NET-BIOME00]; Province Sud (New Caledonia)	ERA-net NETBIOME; ANR(French National Research Agency (ANR)); Province Sud (New Caledonia)	This work was supported by ERA-net NETBIOME and ANR grants, project SEAPROLIF (PCS-10-NET-BIOME00). L.D. also wishes to acknowledge support provided through a PhD grant by the Province Sud (New Caledonia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IA, 1984, LIMU ETHNOBOTANY HAW; Adams NM, 1994, COMMON SEAWEEDS NZ; Altamirano Maria, 2008, Acta Botanica Malacitana, V33, P5; Andreakis N, 2004, EUR J PHYCOL, V39, P273, DOI 10.1080/0967026042000236436; Andreakis N, 2009, MOL ECOL, V18, P212, DOI 10.1111/j.1365-294X.2008.04022.x; Andreakis N, 2007, MOL ECOL, V16, P2285, DOI 10.1111/j.1365-294X.2007.03306.x; Appeltans W, 2011, WORLD REGISTER MARIN; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barber PH, 2006, EVOLUTION, V60, P1825; Blomster J, 2002, AM J BOT, V89, P1756, DOI 10.3732/ajb.89.11.1756; Bolton JJ, 2011, AFR J MAR SCI, V33, P263, DOI 10.2989/1814232X.2011.600339; BONIN DR, 1987, NEW ZEAL J BOT, V25, P577, DOI 10.1080/0028825X.1987.10410088; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; Carlton James T., 2009, V204, P13; Carlton JT, 1996, ECOLOGY, V77, P1653, DOI 10.2307/2265767; Chualain FN, 2004, J PHYCOL, V40, P1112, DOI 10.1111/j.1529-8817.2004.03135.x; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Coyer JA, 2011, MOL PHYLOGENET EVOL, V58, P283, DOI 10.1016/j.ympev.2010.11.015; Crandall ED, 2008, MOL ECOL, V17, P611, DOI 10.1111/j.1365-294X.2007.03600.x; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Delile AR, 1813, HIST NATURELLE, V2, P145; Farnham W.F., 1980, SYSTEMATICS ASS SPEC, V17B, P875; Feldmann J, 1939, CR HEBD ACAD SCI, V208, P1420; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flagella MM, 2007, MAR POLLUT BULL, V54, P1395, DOI 10.1016/j.marpolbul.2007.05.015; Freshwater DW, 2010, CRYPTOGAMIE ALGOL, V31, P435; Freshwater D. Wilson, 1999, Phycological Research, V47, P33, DOI 10.1111/j.1440-1835.1999.tb00281.x; Gaither MR, 2013, J BIOGEOGR, V40, P1638, DOI 10.1111/jbi.12126; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Gonzalez A, 2012, J PHYCOL, V48, P1153, DOI 10.1111/j.1529-8817.2012.01200.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guerra-Garcia JM, 2012, J EXP MAR BIOL ECOL, V416, P121, DOI 10.1016/j.jembe.2012.02.018; Guiry MD, 2014, ALGAEBASE; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harvey W.H., 1855, T R IRISH ACAD, V22, P525, DOI DOI 10.5962/BHL.TITLE.112433; Haydar D, 2011, DIVERS DISTRIB, V17, P68, DOI 10.1111/j.1472-4642.2010.00718.x; Haydar D, 2012, DIVERS DISTRIB, V18, P101, DOI 10.1111/j.1472-4642.2011.00863.x; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Jousson O, 2000, NATURE, V408, P157, DOI 10.1038/35041623; Kato A, 2009, PHYCOL RES, V57, P74, DOI 10.1111/j.1440-1835.2008.00523.x; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; Klein J, 2008, MAR POLLUT BULL, V56, P205, DOI 10.1016/j.marpolbul.2007.09.043; Kraan S, 2005, J APPL PHYCOL, V17, P103, DOI 10.1007/s10811-005-2799-5; Layeghifard M, 2012, MOL PHYLOGENET EVOL, V64, P190, DOI 10.1016/j.ympev.2012.03.016; Lee KM, 2014, J APPL PHYCOL, V26, P491, DOI 10.1007/s10811-013-0052-1; LENAERS G, 1989, J MOL EVOL, V29, P40, DOI 10.1007/BF02106180; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mackie JA, 2006, MAR BIOL, V149, P285, DOI 10.1007/s00227-005-0196-x; MAGGS CA, 1992, J PHYCOL, V28, P214, DOI 10.1111/j.0022-3646.1992.00214.x; Mattio L, 2010, CRYPTOGAMIE ALGOL, V31, P467; May V, 1953, NATL HERBARIUM, V2, P38; McIvor L, 2001, MOL ECOL, V10, P911, DOI 10.1046/j.1365-294X.2001.01240.x; Meinesz Alexandre, 2001, Biological Invasions, V3, P201, DOI 10.1023/A:1014549500678; Mineur F, 2007, MAR BIOL, V151, P1299, DOI 10.1007/s00227-006-0567-y; Mineur F, 2010, P ROY SOC B-BIOL SCI, V277, P2693, DOI 10.1098/rspb.2010.0494; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Muirhead JR, 2006, FRESHWATER BIOL, V51, P1696, DOI 10.1111/j.1365-2427.2006.01614.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; N'Yeurt ADR, 2006, CRYPTOGAMIE ALGOL, V27, P111; N'Yeurt ADR, 2010, CRYPTOGAMIE ALGOL, V31, P3; Posada D, 2006, MOL ECOL NOTES, V6, P590, DOI 10.1111/j.1471-8286.2006.01368.x; Price J. H., 1986, B BRIT MUS NAT HIST, V15, P1; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Sala E, 1997, J EXP MAR BIOL ECOL, V212, P25, DOI 10.1016/S0022-0981(96)02745-1; Sauvageau C, 1925, CR HEBD ACAD SCI, V180, P1887; Schaffelke B, 2002, MAR POLLUT BULL, V44, P204, DOI 10.1016/S0025-326X(01)00202-8; Schmidt H, 2000, ZOOL SCR, V29, P17, DOI 10.1046/j.1463-6409.2000.00026.x; Sherwood AR, 2008, PHYCOLOGIA, V47, P79, DOI 10.2216/07-39.1; SILVA P.C., 1996, U CALIFORNIA PUBLICA, V79, P1, DOI DOI 10.2216/i0031-8884-38-4-342b.1; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stiger V, 1999, BOT MAR, V42, P295, DOI 10.1515/BOT.1999.033; Stiger V, 1999, MAR ECOL PROG SER, V191, P91, DOI 10.3354/meps191091; Streftaris N, 2006, MEDITERR MAR SCI, V7, P87, DOI 10.12681/mms.180; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor R., 1999, Botanical Journal of Scotland, V51, P195; Tellier F, 2009, MOL PHYLOGENET EVOL, V53, P679, DOI 10.1016/j.ympev.2009.07.030; Todaro MA, 1996, MAR BIOL, V125, P735, DOI 10.1007/BF00349256; Trevisan VBA, 1845, SEMINARIE PADOUE, P1; Verlaque M, 2004, BIOL INVASIONS, V6, P269, DOI 10.1023/B:BINV.0000034589.18347.d3; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Womerseley HBS, 1996, FLORA AUSTR 5 S, V5, P325; Zanolla M, 2014, PHYCOLOGIA, V53, P233, DOI 10.2216/13-247.1; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x; Zuccarello GC, 1999, MOL ECOL, V8, P1443, DOI 10.1046/j.1365-294x.1999.00710.x; Zuccarello GC, 2002, PHYCOLOGIA, V41, P49, DOI 10.2216/i0031-8884-41-1-49.1	90	48	48	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103826	10.1371/journal.pone.0103826	http://dx.doi.org/10.1371/journal.pone.0103826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076489	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800081
J	Kenett, DY; Morstatter, F; Stanley, HE; Liu, H				Kenett, Dror Y.; Morstatter, Fred; Stanley, H. Eugene; Liu, Huan			Discovering Social Events through Online Attention	PLOS ONE			English	Article							BEHAVIOR; SCIENCE	Twitter is a major social media platform in which users send and read messages ("tweets") of up to 140 characters. In recent years this communication medium has been used by those affected by crises to organize demonstrations or find relief. Because traffic on this media platform is extremely heavy, with hundreds of millions of tweets sent every day, it is difficult to differentiate between times of turmoil and times of typical discussion. In this work we present a new approach to addressing this problem. We first assess several possible "thermostats" of activity on social media for their effectiveness in finding important time periods. We compare methods commonly found in the literature with a method from economics. By combining methods from computational social science with methods from economics, we introduce an approach that can effectively locate crisis events in the mountains of data generated on Twitter. We demonstrate the strength of this method by using it to locate the social events relating to the Occupy Wall Street movement protests at the end of 2011.	[Kenett, Dror Y.; Stanley, H. Eugene] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Kenett, Dror Y.; Stanley, H. Eugene] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Morstatter, Fred; Liu, Huan] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ USA	Boston University; Boston University; Arizona State University; Arizona State University-Tempe	Kenett, DY (corresponding author), Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA.	drorkenett@gmail.com		Stanley, H./0000-0003-2800-4495	Office of Naval Research (ONR) [N00014-09-1-0380, N00014-12-1-0548, N000141010091, N000141110527]; Keck Foundation; National Science Foundation	Office of Naval Research (ONR)(Office of Naval Research); Keck Foundation(W.M. Keck Foundation); National Science Foundation(National Science Foundation (NSF))	HES and DYK thank the Office of Naval Research (ONR, Grant N00014-09-1-0380, Grant N00014-12-1-0548), Keck Foundation, and the National Science Foundation for support. FM and HL thank the support of the Office of Naval Research (ONR, Grant N000141010091 and N000141110527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, WASHINGTON POST 1021; Bennett S, 2011, MEDIA BISTRO; Berrett D., 2011, CHRONICLE HIGHER ED; Boyd D., 2010, 43 HAW INT C SYST SC, V2010, P1, DOI DOI 10.1109/HICSS.2010.412; Boydstun AE, 2014, POLICY STUD J, V42, P173, DOI 10.1111/psj.12055; Campbell D., 2011, EGYPT UNSHACKLED USI; Cheng Z., 2010, P 19 ACM INT C INF K, P759, DOI DOI 10.1145/1871437.1871535; Ciulla F, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds8; Conte R, 2012, EUR PHYS J-SPEC TOP, V214, P325, DOI 10.1140/epjst/e2012-01697-8; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; De Longueville Bertrand, 2009, P 2009 INT WORKSH LO, P73, DOI [DOI 10.1145/1629890.1629907, 10.1145/1629890.1629907]; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Efron M, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P787; Gallos LK, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031014; Gao JB, 2012, J R SOC INTERFACE, V9, P1956, DOI 10.1098/rsif.2011.0846; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Havlin S, 2012, EUR PHYS J-SPEC TOP, V214, P273, DOI 10.1140/epjst/e2012-01695-x; Huang C., 2011, NATL ABU DHABI MEDIA, V6; Jianshu Weng, 2010, Proceedings 2010 10th IEEE International Conference on Data Mining (ICDM 2010), P1121, DOI 10.1109/ICDM.2010.34; Kenett DY, 2012, P NATL ACAD SCI USA, V109, P11472, DOI 10.1073/pnas.1209306109; Kumar S, 2014, TWITTER DATA ANAL; Kumar S., 2011, 5 INT AAAI C WEBL SO; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Li R., 2012, P 18 ACM SIGKDD INT, P1023, DOI DOI 10.1145/2339530.2339692; MCCLELLAND CA, 1961, WORLD POLIT, V14, P182, DOI 10.2307/2009561; McClelland CA, 1968, ACCESS BERLIN QUANTI; Mendoza M., 2010, P 1 WORKSH SOC MED A, P71, DOI DOI 10.1145/1964858.1964869; Moat HS, 2014, BEHAV BRAIN SCI, V37, P92, DOI 10.1017/S0140525X13001817; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Morstatter F., 2013, PROC INT AAAI C WEBL, V7, P400; Morstatter F, 2014, ASS COMP LING WORKSH; Mourtada R, 2011, CIVIL MOVEMENTS IMPA; Nagarajan M, 2010, 4 INT AAAI C WEBL SO; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pozdnoukhov A, 2011, P 3 ACM SIGSPATIAL I, P1, DOI DOI 10.1145/2063212.2063223; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Rhoades SA, 1993, FEDERAL RESERVE B, V79, P188; Romero D. M., 2011, P 20 INT C WORLD WID, P695, DOI [10.1145/1963405.1963503, DOI 10.1145/1963405.1963503]; Rybski D, 2012, SCI REPORTS; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Swets JA, 1996, SCI PSYCH S; TSUKAYAMA H., 2013, WASHINGTON POST; Yang L., 2012, P 21 INT C WORLD WID, P261, DOI [DOI 10.1145/2187836.2187872, 10.1145/2187836.2187872]; Yin Z., 2011, P 20 INT C WORLD WID, P247, DOI DOI 10.1145/1963405.1963443	45	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102001	10.1371/journal.pone.0102001	http://dx.doi.org/10.1371/journal.pone.0102001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076410	Green Published, gold			2022-12-27	WOS:000340028800010
J	Sampasa-Kanyinga, H; Roumeliotis, P; Xu, H				Sampasa-Kanyinga, Hugues; Roumeliotis, Paul; Xu, Hao			Associations between Cyberbullying and School Bullying Victimization and Suicidal Ideation, Plans and Attempts among Canadian Schoolchildren	PLOS ONE			English	Article							GENERAL STRAIN THEORY; SUBSTANCE USE; ADOLESCENTS; STUDENTS; BEHAVIOR; INTERNET; YOUTH; DEPRESSION; IMPACT; RISK	Purpose: The negative effects of peer aggression on mental health are key issues for public health. The purpose of this study was to examine the associations between cyberbullying and school bullying victimization with suicidal ideation, plans and attempts among middle and high school students, and to test whether these relationships were mediated by reports of depression. Methods: Data for this study are from the 2011 Eastern Ontario Youth Risk Behaviour Survey, which is a cross-sectional regional school-based survey that was conducted among students in selected Grade 7 to 12 classes (1658 girls, 1341 boys; mean +/- SD age: 14.3 +/- 1.8 years). Results: Victims of cyberbullying and school bullying incurred a significantly higher risk of suicidal ideation (cyberbullying: crude odds ratio, 95% confidence interval = 3.31, 2.16-5.07; school bullying: 3.48, 2.48-4.89), plans (cyberbullying: 2.79, 1.63-4.77; school bullying: 2.76, 2.20-3.45) and attempts (cyberbullying: 1.73, 1.26-2.38; school bullying: 1.64, 1.18-2.27) compared to those who had not encountered such threats. Results were similar when adjusting for sociodemographic characteristics, substance use, and sedentary activities. Mediation analyses indicated that depression fully mediated the relationship between cyberbullying victimization and each of the outcomes of suicidal ideation, plans and attempts. Depression also fully mediated the relationship between school bullying victimization and suicide attempts, but partially mediated the relationship between school bullying victimization and both suicidal ideation and plans. Conclusion: These findings support an association between both cyberbullying and school bullying victimization and risk of suicidal ideation, plans and attempts. The mediating role of depression on these links justifies the need for addressing depression among victims of both forms of bullying to prevent the risk of subsequent suicidal behaviours.	[Sampasa-Kanyinga, Hugues; Roumeliotis, Paul; Xu, Hao] Eastern Ontario Hlth Unit, Cornwall, ON, Canada; [Roumeliotis, Paul] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada	McGill University	Sampasa-Kanyinga, H (corresponding author), Eastern Ontario Hlth Unit, Cornwall, ON, Canada.	huguessampasa@gmail.com	Sampasa-Kanyinga, Hugues/ABE-8565-2020	Sampasa-Kanyinga, Hugues/0000-0002-7195-8086				AGNEW R, 1992, CRIMINOLOGY, V30, P47, DOI 10.1111/j.1745-9125.1992.tb01093.x; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bauman S, 2013, J ADOLESCENCE, V36, P341, DOI 10.1016/j.adolescence.2012.12.001; Blair J, 2003, ED WEEK, V22, P6; Bond L, 2001, BRIT MED J, V323, P480, DOI 10.1136/bmj.323.7311.480; Canadian Mental Health Association (ND) Youth and Suicide, YOUTH SUIC; Cash SJ, 2009, CURR OPIN PEDIATR, V21, P613, DOI 10.1097/MOP.0b013e32833063e1; Centers for Disease Control and Prevention, YOUTH RISK BEH SURV; Dehue F, 2008, CYBERPSYCHOL BEHAV, V11, P217, DOI 10.1089/cpb.2007.0008; Dooley JJ, 2009, Z PSYCHOL, V217, P182, DOI 10.1027/0044-3409.217.4.182; Eastern Ontario Health Unit, 2009, E ONT INJ REP; Gamez-Guadix M, 2013, J ADOLESCENT HEALTH, V53, P446, DOI 10.1016/j.jadohealth.2013.03.030; Goebert D, 2011, MATERN CHILD HLTH J, V15, P1282, DOI 10.1007/s10995-010-0672-x; Hinduja S, 2008, J ADOLESCENCE, V31, P125, DOI 10.1016/j.adolescence.2007.05.004; Hinduja S, 2010, ARCH SUICIDE RES, V14, P206, DOI 10.1080/13811118.2010.494133; Hinduja Sameer, 2014, BULLYING SCHOOLYARD; Hirsch JK, 2006, CRISIS, V27, P189, DOI 10.1027/0227-5910.27.4.189; Kaltiala-Heino R, 1999, BRIT MED J, V319, P348, DOI 10.1136/bmj.319.7206.348; Kim Young Shin, 2008, Int J Adolesc Med Health, V20, P133; Kowalski R. M., 2008, CYBER BULLYING BULLY; Li Q, 2005, COMPUT HUM BEHAV, P1777; Litwiller BJ, 2013, J YOUTH ADOLESCENCE, V42, P675, DOI 10.1007/s10964-013-9925-5; Machmutow K, 2012, EMOT BEHAV DIFFIC, V17, P403, DOI 10.1080/13632752.2012.704310; Messias E, 2011, SUICIDE LIFE-THREAT, V41, P307, DOI 10.1111/j.1943-278X.2011.00030.x; Mishna F, 2010, AM J ORTHOPSYCHIAT, V80, P362, DOI 10.1111/j.1939-0025.2010.01040.x; Olweus D., 1993, AGGRESSIVE BEHAV CUR; Paglia-Boak A., 2012, CAMH RES DOCUMENT SE, V34; Patchin JW, 2011, YOUTH SOC, V43, P727, DOI 10.1177/0044118X10366951; Patchin Justin W., 2006, YOUTH VIOLENCE JUV J, V4, P148, DOI [10.1177/1541204006286288, DOI 10.1177/1541204006286288]; Perren S., 2010, CHILD ADOLESCENT PSY, V4, P28, DOI [10.1186/1753-2000-4-28, DOI 10.1186/1753-2000-4-28]; Price M., 2010, Youth Studies Australia, V29, P51; Schneider SK, 2012, AM J PUBLIC HEALTH, V102, P171, DOI 10.2105/AJPH.2011.300308; Slonje R, 2008, SCAND J PSYCHOL, V49, P147, DOI 10.1111/j.1467-9450.2007.00611.x; Smith PK, 2008, J CHILD PSYCHOL PSYC, V49, P376, DOI 10.1111/j.1469-7610.2007.01846.x; Snell P.A., 2010, J SOC SCI, V6, P510, DOI [10.3844/jssp.2010.510.514, DOI 10.3844/JSSP.2010.510.514]; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Tokunaga RS, 2010, COMPUT HUM BEHAV, V26, P277, DOI 10.1016/j.chb.2009.11.014; Wallace L. H., 2005, W CRIMINOLOGY REV, V6; Xu H, 2011, ANAL RISK BEHAV YOUT	39	96	101	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102145	10.1371/journal.pone.0102145	http://dx.doi.org/10.1371/journal.pone.0102145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25076490	gold, Green Published			2022-12-27	WOS:000340028800011
J	Martinez-Gonzalez, MA; Garcia-Arellano, A; Toledo, E; Bes-Rastrollo, M; Bullo, M; Corella, D; Fito, M; Ros, E; Lamuela-Raventos, RM; Rekondo, J; Gomez-Gracia, E; Fiol, M; Santos-Lozano, JM; Serra-Majem, L; Martinez, JA; Eguaras, S; Saez-Tormo, G; Pinto, X; Estruch, R				Martinez-Gonzalez, Miguel A.; Garcia-Arellano, Ana; Toledo, Estefania; Bes-Rastrollo, Maira; Bullo, Monica; Corella, Dolores; Fito, Montserrat; Ros, Emilio; Maria Lamuela-Raventos, Rosa; Rekondo, Javier; Gomez-Gracia, Enrique; Fiol, Miquel; Manuel Santos-Lozano, Jose; Serra-Majem, Lluis; Alfredo Martinez, J.; Eguaras, Sonia; Saez-Tormo, Guillermo; Pinto, Xavier; Estruch, Ramon			Obesity Indexes and Total Mortality among Elderly Subjects at High Cardiovascular Risk: The PREDIMED Study	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY QUESTIONNAIRE; ALL-CAUSE MORTALITY; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; ASSOCIATION; DISEASE; OVERWEIGHT; ADIPOSITY; ADULTS	Background: Different indexes of regional adiposity have been proposed for identifying persons at higher risk of death. Studies specifically assessing these indexes in large cohorts are scarce. It would also be interesting to know whether a dietary intervention may counterbalance the adverse effects of adiposity on mortality. Methods: We assessed the association of four different anthropometric indexes (waist-to-height ratio (WHtR), waist circumference (WC), body mass index (BMI) and height) with all-cause mortality in 7447 participants at high cardiovascular risk from the PREDIMED trial. Forty three percent of them were men (55 to 80 years) and 57% were women (60 to 80 years). All of them were initially free of cardiovascular disease. The recruitment took place in 11 recruiting centers between 2003 and 2009. Results: After adjusting for age, sex, smoking, diabetes, hypertension, intervention group, family history of coronary heart disease, and leisure-time physical activity, WC and WHtR were found to be directly associated with a higher mortality after 4.8 years median follow-up. The multivariable-adjusted HRs for mortality of WHtR (cut-off points: 0.60, 0.65, 0.70) were 1.02 (0.78-1.34), 1.30 (0.97-1.75) and 1.55 (1.06-2.26). When we used WC (cut-off points: 100, 105 and 110 cm), the multivariable adjusted Hazard Ratios (HRs) for mortality were 1.18 (0.88-1.59), 1.02 (0.74-1.41) and 1.57 (1.19-2.08). In all analyses, BMI exhibited weaker associations with mortality than WC or WHtR. The direct association between WHtR and overall mortality was consistent within each of the three intervention arms of the trial. Conclusions: Our study adds further support to a stronger association of abdominal obesity than BMI with total mortality among elderly subjects at high risk of cardiovascular disease. We did not find evidence to support that the PREDIMED intervention was able to counterbalance the harmful effects of increased adiposity on total mortality.	[Martinez-Gonzalez, Miguel A.; Garcia-Arellano, Ana; Toledo, Estefania; Bes-Rastrollo, Maira; Bullo, Monica; Corella, Dolores; Fito, Montserrat; Ros, Emilio; Maria Lamuela-Raventos, Rosa; Rekondo, Javier; Gomez-Gracia, Enrique; Fiol, Miquel; Manuel Santos-Lozano, Jose; Serra-Majem, Lluis; Alfredo Martinez, J.; Eguaras, Sonia; Saez-Tormo, Guillermo; Pinto, Xavier; Estruch, Ramon] Inst Salud Carlos II, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Martinez-Gonzalez, Miguel A.; Garcia-Arellano, Ana; Toledo, Estefania; Bes-Rastrollo, Maira; Bullo, Monica; Maria Lamuela-Raventos, Rosa; Rekondo, Javier; Gomez-Gracia, Enrique; Serra-Majem, Lluis; Alfredo Martinez, J.; Saez-Tormo, Guillermo; Pinto, Xavier; Estruch, Ramon] Inst Salud Carlos III, PREDIMED Prevenc Con Dieta Mediterranea Network, Madrid, Spain; [Martinez-Gonzalez, Miguel A.; Garcia-Arellano, Ana; Toledo, Estefania; Bes-Rastrollo, Maira; Eguaras, Sonia] Univ Navarra Osasunbidea, Dept Prevent Med & Publ Hlth, Serv Navarro Salud, Pamplona, Spain; [Bullo, Monica] Univ Rovira & Virgili, Hosp Univ Sant Joan, Inst Invest Sanitaria Pere Virgili, Dept Human Nutr, E-43201 Reus, Spain; [Corella, Dolores] Univ Valencia, Dept Prevent Med, Valencia, Spain; [Fito, Montserrat] Hosp Mar, Inst Recerca, Cardiovasc & Nutr Res Grp, Barcelona, Spain; [Ros, Emilio] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Dept Endocrinol & Nutr,Lipid Clin, Barcelona, Spain; [Maria Lamuela-Raventos, Rosa] Univ Barcelona, Inst Invest Nutr & Seguridad Alimentaria, Sch Pharm Xarxa Referencia Tecnol Dels Aliments, Dept Nutr & Food Sci, Barcelona, Spain; [Rekondo, Javier] Univ Hosp Alava, Dept Cardiol, Vitoria, Spain; [Gomez-Gracia, Enrique] Univ Malaga, Dept Prevent Med, E-29071 Malaga, Spain; [Fiol, Miquel] Univ Balear Islands, Inst Hlth Sci, Palma de Mallorca, Spain; [Fiol, Miquel] Hosp Son Espases, Palma de Mallorca, Spain; [Manuel Santos-Lozano, Jose] San Pablo Hlth Ctr, Dept Family Med, Primary Care Div Seville, Seville, Spain; [Serra-Majem, Lluis] Univ Los Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Alfredo Martinez, J.] Univ Navarra, Dept Nutr & Food Sci Physiol & Toxicol, E-31080 Pamplona, Spain; [Saez-Tormo, Guillermo] Univ Valencia, Dept Biochem & Mol Biol, Serv Clin Anal, Valencia, Spain; [Pinto, Xavier] Hosp Univ Bellvitge, Hosp Llobregat, Lipids & Vasc Risk Unit, Barcelona, Spain; [Estruch, Ramon] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Dept Internal Med, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Servicio Navarro de Salud - Osasunbidea; University of Navarra; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Valencia; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Universidad de Malaga; Hospital Universitari Son Espases; University of Navarra; University of Valencia; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Martinez-Gonzalez, MA (corresponding author), Inst Salud Carlos II, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain.	mamartinez@unav.es	Estruch, Ramon/AAZ-3723-2020; Bulló, Mònica/F-2925-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Pintó, Xavier/AGI-4297-2022; IBIS, ATENCION PRIMARIA/I-3524-2016; Serra-Majem, Lluis/I-6708-2019; Toledo, Estefania/H-6211-2014; Fiol, Miguel/F-6793-2016; Fito, Montserrat/C-1822-2012; Bes-Rastrollo, Maira/A-1329-2009; Santos-Lozano, JM/J-9312-2018; Lamuela-Raventos, Rosa M/F-3986-2016; Martinez Hernandez, J Alfredo/K-8709-2014	Bulló, Mònica/0000-0002-0218-7046; Pintó, Xavier/0000-0002-2216-2444; Serra-Majem, Lluis/0000-0002-9658-9061; Toledo, Estefania/0000-0002-6263-4434; Fiol, Miguel/0000-0002-5370-1391; Fito, Montserrat/0000-0002-1817-483X; Bes-Rastrollo, Maira/0000-0002-9139-4206; Santos-Lozano, JM/0000-0001-7097-5653; GARCIA ARELLANO, ANA/0000-0003-1491-9627; Saez, Guillermo/0000-0002-8164-4048; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; Lamuela-Raventos, Rosa M/0000-0002-1287-4560; Ros, Emilio/0000-0002-2573-1294; Martinez Hernandez, J Alfredo/0000-0001-5218-6941	Spanish government, Instituto de Salud Carlos III (ISCIII) [RTIC G03/140, RTIC RD 06/0045]; Spanish government, Instituto de Salud Carlos III (ISCIII) through Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion [CIBERobn]; Centro Nacional de Investigaciones Cardiovasculares [CNIC 06/2007]; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional [PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI07/0473, PI10/01407, PI10/02658, PI11/01647, P11/02505]; Ministerio de Ciencia e Innovacion [AGL-2009-13906-C02, AGL2010-22319-C03]; Fundacion Mapfre; Consejeria de Salud de la Junta de Andalucia [PI0105/2007]; Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana [ACOMP06109, GVACOMP2010-181, GVACOMP2011-151, CS2010-AP-111, CS2011-AP-042]; Regional Government of Navarra [P27/2011]	Spanish government, Instituto de Salud Carlos III (ISCIII); Spanish government, Instituto de Salud Carlos III (ISCIII) through Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion [CIBERobn]; Centro Nacional de Investigaciones Cardiovasculares; Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mapfre; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana; Regional Government of Navarra	Supported by the official funding agency for biomedical research of the Spanish government, Instituto de Salud Carlos III (ISCIII), through grants provided to research networks specifically developed for the trial (RTIC G03/140, to Dr. Estruch; RTIC RD 06/0045, to Dr. Martinez-Gonzalez and through Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion [CIBERobn]), and by grants from Centro Nacional de Investigaciones Cardiovasculares (CNIC 06/2007), Fondo de Investigacion Sanitaria-Fondo Europeo de Desarrollo Regional (PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI07/0473, PI10/01407, PI10/02658, PI11/01647, and P11/02505), Ministerio de Ciencia e Innovacion (AGL-2009-13906-C02 and AGL2010-22319-C03), Fundacion Mapfre 2010, Consejeria de Salud de la Junta de Andalucia (PI0105/2007), Public Health Division of the Department of Health of the Autonomous Government of Catalonia, Generalitat Valenciana (ACOMP06109, GVACOMP2010-181, GVACOMP2011-151, CS2010-AP-111, and CS2011-AP-042), and Regional Government of Navarra (P27/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Canning KL, 2013, J GERONTOL A-BIOL, V22; Cox BD, 1998, INT J OBESITY, V22, P966, DOI 10.1038/sj.ijo.0800705; de Hollander EL, 2012, INT J EPIDEMIOL, V41, P805, DOI 10.1093/ije/dys008; De Larochelliere E, 2014, ATHEROSCLEROSIS, V234, P23, DOI 10.1016/j.atherosclerosis.2014.01.053; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Flanders WD, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.84; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gelber RP, 2008, J AM COLL CARDIOL, V52, P605, DOI 10.1016/j.jacc.2008.03.066; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Kahn HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050428; Katzmarzyk PT, 2013, OBESITY, V21, P1070, DOI 10.1002/oby.20151; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Kuk JL, 2009, J AM GERIATR SOC, V57, P2077, DOI 10.1111/j.1532-5415.2009.02486.x; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Masters RK, 2013, AM J EPIDEMIOL, V177, P431, DOI 10.1093/aje/kws325; Mauriege P, 2013, J PHYSIOL BIOCHEM, V69, P497, DOI 10.1007/s13105-013-0237-8; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mombelli G, 2009, METAB SYNDR RELAT D, V7, P477, DOI 10.1089/met.2008.0101; Petursson H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026621; Reis JP, 2009, OBESITY, V17, P1232, DOI 10.1038/oby.2008.664; Reis JP, 2009, ANN EPIDEMIOL, V19, P134, DOI 10.1016/j.annepidem.2008.10.008; Ross R, 2008, OBES REV, V9, P312, DOI 10.1111/j.1467-789X.2007.00411.x; Sairenchi T, 2008, DIABETES CARE, V31, P583, DOI 10.2337/dc07-1390; Schneider Harald J, 2011, Diabetes Care, V34, pe7, DOI 10.2337/dc10-1794; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Tobias DK, 2013, OBESITY, V21, P1746, DOI 10.1002/oby.20602; Zazpe I, 2008, J AM DIET ASSOC, V108, P1134, DOI 10.1016/j.jada.2008.04.011	38	21	23	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103246	10.1371/journal.pone.0103246	http://dx.doi.org/10.1371/journal.pone.0103246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072784	Green Published, gold			2022-12-27	WOS:000341307600034
J	Arreola, SL; Intanon, M; Suljic, J; Kittl, R; Pham, NH; Kosma, P; Haltrich, D; Nguyen, TH				Arreola, Sheryl Lozel; Intanon, Montira; Suljic, Jasmina; Kittl, Roman; Ngoc Hung Pham; Kosma, Paul; Haltrich, Dietmar; Thu-Ha Nguyen			Two beta-Galactosidases from the Human Isolate Bifidobacterium breve DSM 20213: Molecular Cloning and Expression, Biochemical Characterization and Synthesis of Galacto-Oligosaccharides	PLOS ONE			English	Article							HUMAN COLONIC MICROBIOTA; LACTOBACILLUS-REUTERI; PREBIOTIC GALACTOOLIGOSACCHARIDES; ENZYMATIC-HYDROLYSIS; DIETARY MODULATION; BIFIDUM NCIMB41171; INFANTIS HL96; LACTOSE; PURIFICATION; SYNBIOTICS	Two beta-galactosidases, beta-gal I and beta-gal II, from Bifidobacterium breve DSM 20213, which was isolated from the intestine of an infant, were overexpressed in Escherichia coli with co-expression of the chaperones GroEL/GroES, purified to electrophoretic homogeneity and biochemically characterized. Both beta-gal I and beta-gal II belong to glycoside hydrolase family 2 and are homodimers with native molecular masses of 220 and 211 kDa, respectively. The optimum pH and temperature for hydrolysis of the two substrates o-nitrophenyl-beta-D-galactopyranoside (oNPG) and lactose were determined at pH 7.0 and 50 degrees C for beta-gal I, and at pH 6.5 and 55 degrees C for beta-gal II, respectively. The k(cat)/K-m values for oNPG and lactose hydrolysis are 722 and 7.4 mM(-1)s(-1) for beta-gal I, and 543 and 25 mM(-1)s(-1) for beta-gal II. Both beta-gal I and beta-gal II are only moderately inhibited by their reaction products D-galactose and D-glucose. Both enzymes were found to be very well suited for the production of galacto-oligosaccharides with total GOS yields of 33% and 44% of total sugars obtained with beta-gal I and beta-gal II, respectively. The predominant transgalactosylation products are beta-D-Galp-(1 -> 6)-D-Glc (allolactose) and beta-D-Galp-(1 -> 3)-D-Lac, accounting together for more than 75% and 65% of the GOS formed by transgalactosylation by beta-gal I and beta-gal II, respectively, indicating that both enzymes have a propensity to synthesize beta-(1 -> 6) and beta-(1 -> 3)-linked GOS. The resulting GOS mixtures contained relatively high fractions of allolactose, which results from the fact that glucose is a far better acceptor for galactosyl transfer than galactose and lactose, and intramolecular transgalactosylation contributes significantly to the formation of this disaccharide.	[Arreola, Sheryl Lozel; Intanon, Montira; Suljic, Jasmina; Kittl, Roman; Ngoc Hung Pham; Haltrich, Dietmar; Thu-Ha Nguyen] BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Food Biotechnol Lab, Vienna, Austria; [Arreola, Sheryl Lozel] Univ Philippines Los Banos, Inst Chem, College Los Banos, Laguna, Philippines; [Ngoc Hung Pham] Hanoi Univ Sci & Technol, Sch Food Biotechnol & Food Technol, Hanoi, Vietnam; [Kosma, Paul] BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Organ Chem, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of the Philippines System; University of the Philippines Los Banos; Hanoi University of Science & Technology; University of Natural Resources & Life Sciences, Vienna	Nguyen, TH (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Food Biotechnol Lab, Vienna, Austria.	thu-ha.nguyen@boku.ac.at	Haltrich, Dietmar/N-2624-2019; Kosma, Paul/Y-7443-2019	Haltrich, Dietmar/0000-0002-8722-8176; Kosma, Paul/0000-0001-5342-7161; Kittl, Roman/0000-0002-8923-481X; Arreola, Sheryl Lozel/0000-0003-0385-1911; Nguyen, Thu-Ha/0000-0002-5253-6865	Austrian Science Fund (FWF) [P24868-B22, P25313-B20]; Austrian Federal Ministry of Science and Research; European Commission; Austrian Science Fund (FWF) [P 24868, P 25313] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research; European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (FWF: www.fwf.ac.at): Individual grants P24868-B22 for THN, and P25313-B20 for RK. SLA and MI had the scholarships 'Technologiestipendium Sudostasien in the frame of the ASEA-Uninet granted by the OeAD - Austrian Agency for International Cooperation in Education & Research' financed by the Austrian Federal Ministry of Science and Research, and HNP received the Erasmus Mundus scholarship granted by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, ENCY BIOPROCESS TECH; BIAVATI B, 1986, MICROBIOLOGICA, V9, P39; Biavati B, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P322, DOI 10.1007/0-387-30743-5_17; Bouhnik Y, 2004, AM J CLIN NUTR, V80, P1658, DOI 10.1093/ajcn/80.6.1658; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crittenden RG, 1996, TRENDS FOOD SCI TECH, V7, P353, DOI 10.1016/S0924-2244(96)10038-8; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; DEROOS A, 2004, ENZYMES IND, P144; Ganzle MG, 2008, INT DAIRY J, V18, P685, DOI 10.1016/j.idairyj.2008.03.003; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gopal PK, 2001, INT DAIRY J, V11, P19, DOI 10.1016/S0958-6946(01)00026-7; Goulas T, 2009, APPL MICROBIOL BIOT, V84, P899, DOI 10.1007/s00253-009-2009-5; Goulas T, 2009, APPL MICROBIOL BIOT, V82, P1079, DOI 10.1007/s00253-008-1795-5; Goulas TK, 2007, APPL MICROBIOL BIOT, V76, P1365, DOI 10.1007/s00253-007-1099-1; Hinz SWA, 2004, APPL MICROBIOL BIOT, V66, P276, DOI 10.1007/s00253-004-1745-9; Holzapfel WH, 2002, FOOD RES INT, V35, P109, DOI 10.1016/S0963-9969(01)00171-5; Hung MN, 2002, APPL MICROBIOL BIOT, V58, P439, DOI 10.1007/s00253-001-0911-6; Hung MN, 2001, APPL ENVIRON MICROB, V67, P4256, DOI 10.1128/AEM.67.9.4256-4263.2001; Iqbal S, 2011, J AGR FOOD CHEM, V59, P3803, DOI 10.1021/jf103832q; Iqbal S, 2010, CARBOHYD RES, V345, P1408, DOI 10.1016/j.carres.2010.03.028; Juajun O, 2011, APPL MICROBIOL BIOT, V89, P645, DOI 10.1007/s00253-010-2862-2; Juers DH, 2012, PROTEIN SCI, V21, P1792, DOI 10.1002/pro.2165; Jurado E, 2002, ENZYME MICROB TECH, V31, P300, DOI 10.1016/S0141-0229(02)00107-2; Kim CS, 2003, BIOTECHNOL LETT, V25, P1769, DOI 10.1023/A:1026092029785; Kim JW, 2000, FOLIA MICROBIOL, V45, P29, DOI 10.1007/BF02817446; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Macfarlane GT, 2008, J APPL MICROBIOL, V104, P305, DOI 10.1111/j.1365-2672.2007.03520.x; Mahoney RR, 1998, FOOD CHEM, V63, P147, DOI 10.1016/S0308-8146(98)00020-X; Maischberger T, 2010, BIOTECHNOL J, V5, P838, DOI 10.1002/biot.201000126; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Moller PL, 2001, APPL ENVIRON MICROB, V67, P2276, DOI 10.1128/AEM.67.5.2276-2283.2001; Nguyen TH, 2007, FEMS MICROBIOL LETT, V269, P136, DOI 10.1111/j.1574-6968.2006.00614.x; Nguyen TH, 2006, J AGR FOOD CHEM, V54, P4989, DOI 10.1021/jf053126u; Osman A, 2013, J AGR FOOD CHEM, V61, P2213, DOI 10.1021/jf304792g; Osman A, 2012, J AGR FOOD CHEM, V60, P740, DOI 10.1021/jf204719w; Petzelbauer I, 2000, BIOTECHNOL BIOENG, V69, P140, DOI 10.1002/(SICI)1097-0290(20000720)69:2&lt;140::AID-BIT3&gt;3.0.CO;2-R; Pivarnik Lori F., 1995, V38, P1; PRENOSIL JE, 1987, BIOTECHNOL BIOENG, V30, P1019, DOI 10.1002/bit.260300904; Rabiu BA, 2001, APPL ENVIRON MICROB, V67, P2526, DOI 10.1128/AEM.67.6.2526-2530.2001; Rastall RA, 2002, CURR OPIN BIOTECH, V13, P490, DOI 10.1016/S0958-1669(02)00365-8; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Sangwan V, 2011, J FOOD SCI, V76, pR103, DOI 10.1111/j.1750-3841.2011.02131.x; Splechtna Barbara, 2007, Biotechnology Journal, V2, P480, DOI 10.1002/biot.200600230; Splechtna B, 2007, J AGR FOOD CHEM, V55, P6772, DOI 10.1021/jf070643z; Splechtna B, 2006, J AGR FOOD CHEM, V54, P4999, DOI 10.1021/jf053127m; Tanaka R, 1995, OLD HER U M, V8, P141; Nguyen TT, 2012, J AGR FOOD CHEM, V60, P1713, DOI 10.1021/jf203909e; Van Laere KMJ, 2000, APPL ENVIRON MICROB, V66, P1379, DOI 10.1128/AEM.66.4.1379-1384.2000; Yi SH, 2011, NEW BIOTECHNOL, V28, P806, DOI 10.1016/j.nbt.2011.07.006	50	26	28	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104056	10.1371/journal.pone.0104056	http://dx.doi.org/10.1371/journal.pone.0104056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089712	Green Submitted, gold, Green Published			2022-12-27	WOS:000339812700090
J	Ho, MH; Ho, CW; Cheung, E; Chan, PH; Hai, JJ; Chan, KH; Chan, EW; Leung, GKK; Tse, HF; Siu, CW				Ho, Mei Han; Ho, Chi Wai; Cheung, Emmanuel; Chan, Pak Hei; Hai, Jo Jo; Chan, Koon Ho; Chan, Esther W.; Leung, Gilberto Ka Kit; Tse, Hung Fat; Siu, Chung Wah			Continuation of Dabigatran Therapy in "Real-World" Practice in Hong Kong	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; STROKE PREVENTION; ISCHEMIC-STROKE; HEART-FAILURE; WARFARIN; EXPERIENCE; COMMUNITY; REGISTRY; CHINESE; DISEASE	Background: Dabigatran, an oral direct thrombin inhibitor, possesses several advantages over warfarin that can in principle simplify the management of stroke prevention in atrial fibrillation (AF). Nonetheless it remains unclear whether these advantages can translate to clinical practice and encourage long-term therapy. The objective was to describe long-term dabigatran therapy for stroke prevention in AF and to identify risk factors for discontinuation of therapy. Methods and Results: We studied 467 consecutive Chinese patients (72 +/- 11 years, male: 53.8%) with a mean CHA(2)DS(2)-VASc score of 3.6 prescribed dabigatran for stroke prevention in AF from March 2010 to September 2013. Over a mean follow-up of 16 months, 101 patients (21.6%) permanently discontinued dabigatran. The mean time-to-discontinuation was 8 months. The most common reason for discontinuation was dyspepsia (30.7%), followed by other adverse events (17.8%) such as minor bleeding (8.9%), major gastrointestinal bleeding (7.9%), and intracranial hemorrhage (1%). Other reasons included dosing frequency (5.9%), fear of side effects (4.0%), lack of laboratory monitoring (1.0%), and cost (1.0%). Multivariable analysis revealed that low baseline estimated glomerular filtration rate (p = 0.02), absence of hypertension (p = 0.01), and prior use of a proton-pump inhibitor (p = 0.02) and H-2-receptor blocker (p = 0.01) were independent predictors of drug discontinuation. In addition, there were altogether 9 ischemic strokes (1.5%/years), 3 intracranial hemorrhages (0.5%/year), and 24 major gastrointestinal bleedings (4.1%/year). Conclusion: Dabigatran discontinuation is very common amongst Chinese AF patients. This reveals a management gap in the prevention of stroke in AF.	[Ho, Mei Han; Ho, Chi Wai; Cheung, Emmanuel; Chan, Pak Hei; Hai, Jo Jo; Tse, Hung Fat; Siu, Chung Wah] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Chan, Koon Ho] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Div Neurol, Hong Kong, Hong Kong, Peoples R China; [Chan, Esther W.] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Leung, Gilberto Ka Kit] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Siu, CW (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China.	cwdsiu@hku.hk	Siu, Chung Wah/C-6947-2011; Tse, Hung-Fat/C-4426-2009; Ho, Chi Wai/AAH-2387-2021; Leung, Gilberto Ka Kit/C-4337-2009; /M-6666-2014; Chan, Esther Wai Yin/B-3522-2012	Tse, Hung-Fat/0000-0002-9578-7808; Ho, Chi Wai/0000-0001-8008-5646; Tse, Hung Fat/0000-0003-4665-7887; Leung, Gilberto Ka Kit/0000-0003-3147-3057; /0000-0003-1256-982X; Chan, Esther Wai Yin/0000-0002-7602-9470				Bin Yap L, 2014, J THROMB THROMBOLYS, V38, P39, DOI 10.1007/s11239-013-1020-y; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chan HT, 2011, J CARDIOVASC PHARM, V58, P87, DOI 10.1097/FJC.0b013e31821cd888; Chien KL, 2010, INT J CARDIOL, V139, P173, DOI 10.1016/j.ijcard.2008.10.045; Connolly SJ, 2013, CIRCULATION, V128, P237, DOI 10.1161/CIRCULATIONAHA.112.001139; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Ho JCS, 2012, CLIN CARDIOL, V35, pE40, DOI 10.1002/clc.22069; Ho LY, 2011, J HUM HYPERTENS, V25, P304, DOI 10.1038/jhh.2010.57; Hori M, 2014, STROKE, V45, pE43, DOI 10.1161/STROKEAHA.113.002854; HUANG CY, 1990, STROKE, V21, P230, DOI 10.1161/01.STR.21.2.230; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li SY, 2012, CNS NEUROSCI THER, V18, P988, DOI 10.1111/cns.12021; Lin LY, 2011, ATHEROSCLEROSIS, V217, P292, DOI 10.1016/j.atherosclerosis.2011.03.033; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Michel J, 2013, HEART LUNG CIRC, V22, P50, DOI 10.1016/j.hlc.2012.09.002; Miyamoto K, 2014, J ARRYTHM, V30, P58, DOI 10.1016/j.joa.2013.04.010; Nieuwlaat W, 2014, EUROPEAN HEART J S1, V34, DOI [10.1093/eurheartj/eht307.P549, DOI 10.1093/EURHEARTJ/EHT307.P549]; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Siu CW, 2007, HEART, V93, P483, DOI 10.1136/hrt.2006.100628; Tse HF, 2013, HEART RHYTHM, V10, P1082, DOI 10.1016/j.hrthm.2013.03.017; Tsivgoulis G, 2014, THER ADV NEUROL DISO, V7, P155, DOI 10.1177/1756285614528064; Yang QD, 2004, CEREBROVASC DIS, V17, P303, DOI 10.1159/000077341; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C	23	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e101245	10.1371/journal.pone.0101245	http://dx.doi.org/10.1371/journal.pone.0101245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084117	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800004
J	Kim, H; Jones, KE; Heckman, CJ				Kim, Hojeong; Jones, Kelvin E.; Heckman, C. J.			Asymmetry in Signal Propagation between the Soma and Dendrites Plays a Key Role in Determining Dendritic Excitability in Motoneurons	PLOS ONE			English	Article							PERSISTENT INWARD CURRENTS; CHRONIC SPINAL RATS; IN-VIVO; ELECTRICAL-PROPERTIES; ALPHA-MOTONEURONS; PYRAMIDAL NEURONS; LUMBAR MOTONEURONS; PLATEAU POTENTIALS; CALCIUM-CHANNELS; FIRING PATTERN	It is widely recognized that propagation of electrophysiological signals between the soma and dendrites of neurons differs depending on direction, i.e. it is asymmetric. How this asymmetry influences the activation of voltage-gated dendritic channels, and consequent neuronal behavior, remains unclear. Based on the analysis of asymmetry in several types of motoneurons, we extended our previous methodology for reducing a fully reconstructed motoneuron model to a two-compartment representation that preserved asymmetric signal propagation. The reduced models accurately replicated the dendritic excitability and the dynamics of the anatomical model involving a persistent inward current (PIC) dispersed over the dendrites. The relationship between asymmetric signal propagation and dendritic excitability was investigated using the reduced models while varying the asymmetry in signal propagation between the soma and the dendrite with PIC density constant. We found that increases in signal attenuation from soma to dendrites increased the activation threshold of a PIC (hypo-excitability), whereas increases in signal attenuation from dendrites to soma decreased the activation threshold of a PIC (hyper-excitability). These effects were so strong that reversing the asymmetry in the soma-to-dendrite vs. dendrite-to-soma attenuation, reversed the correlation between PIC threshold and distance of this current source from the soma. We propose the tight relation of the asymmetric signal propagation to the input resistance in the dendrites as a mechanism underlying the influence of the asymmetric signal propagation on the dendritic excitability. All these results emphasize the importance of maintaining the physiological asymmetry in dendritic signaling not only for normal function of the cells but also for biophysically realistic simulations of dendritic excitability.	[Kim, Hojeong] Daegu Gyeongbuk Inst Sci & Technol, Div Robot Res, Taegu, South Korea; [Jones, Kelvin E.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Jones, Kelvin E.] Univ Alberta, Fac Phys Educ & Recreat, Edmonton, AB, Canada; [Kim, Hojeong; Heckman, C. J.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Heckman, C. J.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Heckman, C. J.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA	Daegu Gyeongbuk Institute of Science & Technology (DGIST); University of Alberta; University of Alberta; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Kim, H (corresponding author), Daegu Gyeongbuk Inst Sci & Technol, Div Robot Res, Taegu, South Korea.	hojeong.kim03@gmail.com	Jones, Kelvin/M-6487-2019; Jones, Kelvin/AAJ-6112-2021; Jones, Kelvin/AFW-5002-2022	Jones, Kelvin/0000-0003-4764-7031; Heckman, CJ/0000-0002-1324-7278	National Institutes of Health [RO1 N5071951, N562200]; Natural Sciences and Engineering Research Council of Canada; DGIST R&D Program of the Ministry of Science, ICT and Future Planning of Korea [13-01-HRSS-03, 14-RS-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071951, R01NS062200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); DGIST R&D Program of the Ministry of Science, ICT and Future Planning of Korea; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant RO1 N5071951, N562200, the Natural Sciences and Engineering Research Council of Canada, and the DGIST R&D Program of the Ministry of Science, ICT and Future Planning of Korea (13-01-HRSS-03 and 14-RS-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Ballou EW, 2006, J NEUROSCI METH, V156, P257, DOI 10.1016/j.jneumeth.2006.03.014; Bar-Yehuda D, 2008, J NEUROPHYSIOL, V99, P1127, DOI 10.1152/jn.01232.2007; Bennett DJ, 2001, J NEUROPHYSIOL, V86, P1955, DOI 10.1152/jn.2001.86.4.1955; Bennett DJ, 1998, J NEUROPHYSIOL, V80, P2023, DOI 10.1152/jn.1998.80.4.2023; Booth V, 1995, J COMPUT NEUROSCI, V2, P299, DOI 10.1007/BF00961442; Bui TV, 2006, J NEUROPHYSIOL, V95, P225, DOI 10.1152/jn.00646.2005; BUSH PC, 1993, J NEUROSCI METH, V46, P159, DOI 10.1016/0165-0270(93)90151-G; Carlin KP, 2009, J NEUROSCI, V29, P5343, DOI 10.1523/JNEUROSCI.5458-08.2009; Carlin KP, 2000, EUR J NEUROSCI, V12, P1635, DOI 10.1046/j.1460-9568.2000.00055.x; CARNEVALE NT, 1982, J NEUROPHYSIOL, V47, P606, DOI 10.1152/jn.1982.47.4.606; CLEMENTS JD, 1989, J PHYSIOL-LONDON, V409, P63, DOI 10.1113/jphysiol.1989.sp017485; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P291, DOI 10.1113/jphysiol.1955.sp005411; CULLHEIM S, 1987, J COMP NEUROL, V255, P68, DOI 10.1002/cne.902550106; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; ElBasiouny SM, 2006, J PHYSIOL-LONDON, V570, P355, DOI 10.1113/jphysiol.2005.099119; ElBasiouny SM, 2005, J NEUROPHYSIOL, V94, P3961, DOI 10.1152/jn.00391.2005; FLESHMAN JW, 1988, J NEUROPHYSIOL, V60, P60, DOI 10.1152/jn.1988.60.1.60; Gidon A, 2012, NEURON, V75, P330, DOI 10.1016/j.neuron.2012.05.015; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; Hendrickson EB, 2011, J COMPUT NEUROSCI, V30, P301, DOI 10.1007/s10827-010-0258-z; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HOCHMAN S, 1994, J NEUROPHYSIOL, V71, P1468, DOI 10.1152/jn.1994.71.4.1468; HOLMES WR, 1992, J NEUROPHYSIOL, V68, P1421, DOI 10.1152/jn.1992.68.4.1421; HOUNSGAARD J, 1989, J PHYSIOL-LONDON, V414, P265, DOI 10.1113/jphysiol.1989.sp017687; Kim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043654; Kim H, 2011, J COMPUT NEUROSCI, V30, P659, DOI 10.1007/s10827-010-0284-x; Kim H, 2009, J COMPUT NEUROSCI, V27, P321, DOI 10.1007/s10827-009-0145-7; Krenz NR, 1998, NEUROSCI LETT, V243, P61, DOI 10.1016/S0304-3940(98)00101-3; Krichmar JL, 2002, BRAIN RES, V941, P11, DOI 10.1016/S0006-8993(02)02488-5; Lee RH, 2003, J NEUROPHYSIOL, V89, P27, DOI 10.1152/jn.00137.2002; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Lee RH, 1999, J NEUROPHYSIOL, V82, P2518, DOI 10.1152/jn.1999.82.5.2518; Li YR, 2003, J NEUROPHYSIOL, V90, P857, DOI 10.1152/jn.00236.2003; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MAJOR G, 1993, BIOPHYS J, V65, P423, DOI 10.1016/S0006-3495(93)81037-3; Meehan CF, 2010, J NEUROPHYSIOL, V103, P2599, DOI 10.1152/jn.00668.2009; Moritz AT, 2007, J NEUROPHYSIOL, V98, P1042, DOI 10.1152/jn.01294.2006; MULLER W, 1993, J NEUROPHYSIOL, V69, P241, DOI 10.1152/jn.1993.69.1.241; NICOLL RA, 1990, PHYSIOL REV, V70, P513, DOI 10.1152/physrev.1990.70.2.513; Oviedo H, 2005, J NEUROSCI, V25, P4985, DOI 10.1523/JNEUROSCI.0562-05.2005; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SEGEV I, 1990, J NEUROPHYSIOL, V64, P648, DOI 10.1152/jn.1990.64.2.648; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Teskey GC, 2006, SYNAPSE, V59, P1, DOI 10.1002/syn.20215; Thurbon D, 1998, J NEUROPHYSIOL, V79, P2485, DOI 10.1152/jn.1998.79.5.2485; van Elburg RAJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000781; Williams SR, 2004, NAT NEUROSCI, V7, P961, DOI 10.1038/nn1305; YAMADA M, 1988, J NEUROL NEUROSUR PS, V51, P1088, DOI 10.1136/jnnp.51.8.1088; ZADOR AM, 1995, J NEUROSCI, V15, P1669, DOI 10.1523/JNEUROSCI.15-03-01669.1995; ZENGEL JE, 1985, J NEUROPHYSIOL, V53, P1323, DOI 10.1152/jn.1985.53.5.1323; Zomorrodi R, 2008, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.005.2008	58	23	24	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e95454	10.1371/journal.pone.0095454	http://dx.doi.org/10.1371/journal.pone.0095454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083794	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800001
J	Li, NJ; Nattie, E; Li, AH				Li, Ningjing; Nattie, Eugene; Li, Aihua			The Role of Melanin Concentrating Hormone (MCH) in the Central Chemoreflex: A Knockdown Study by siRNA in the Lateral Hypothalamus in Rats	PLOS ONE			English	Article							NUCLEUS-TRACTUS-SOLITARIUS; OREXIN NEURONS; CENTRAL CHEMORECEPTION; FEEDING-BEHAVIOR; BODY-WEIGHT; SLEEP; MICE; EXPRESSION; GENE; MICROINJECTIONS	Melanin concentrating hormone (MCH), a neuropeptide produced mainly in neurons localized to the lateral hypothalamic area (LHA), has been implicated in the regulation of food intake, energy balance, sleep state, and the cardiovascular system. Hypothalamic MCH neurons also have multisynaptic connections with diaphragmatic motoneurons and project to many central chemoreceptor sites. However, there are few studies of MCH involvement in central respiratory control. To test the hypothesis that MCH plays a role in the central chemoreflex, we induced a down regulation of MCH in the central nervous system by knocking down the MCH precursor (pMCH) mRNA in the LHA using a pool of small interfering RNA (siRNA), and measured the resultant changes in breathing, metabolic rate, body weight, and blood glucose levels in conscious rats. The injections of pMCH-siRNA into the LHA successfully produced a similar to 62% reduction of pMCH mRNA expression in the LHA and a similar to 43% decrease of MCH levels in the cerebrospinal fluid relative to scrambled-siRNA treatment (P = 0.006 and P = 0.02 respectively). Compared to the pretreatment baseline and the scrambled-siRNA treated control rats, knockdown of MCH resulted in: 1) an enhanced hypercapnic chemoreflex (similar to 42 & 47% respectively; P < 0.05) only in wakefulness; 2) a decrease in body weight and basal glucose levels; and 3) an unchanged metabolic rate. Our results indicate that MCH participates not only in the regulation of glucose and sleep-wake homeostasis but also the vigilance-state dependent regulation of the central hypercapnic chemoreflex and respiratory control.	[Li, Ningjing; Nattie, Eugene; Li, Aihua] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH 03755 USA	Dartmouth College	Li, AH (corresponding author), Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH 03755 USA.	Aihua.Li@Dartmouth.edu		Li, Ningjing/0000-0002-1170-7971	National Heart, Lung, and Blood Institute [HL 28066]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028066, R37HL028066] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work and the authors were supported by HL 28066 from The National Heart, Lung, and Blood Institute (https://www.nhIbi.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon T, 2006, J NEUROSCI, V26, P389, DOI 10.1523/JNEUROSCI.1203-05.2006; Badami VM, 2010, BRAIN RES, V1323, P119, DOI 10.1016/j.brainres.2010.02.002; BARTLETT D, 1970, RESP PHYSIOL, V10, P384, DOI 10.1016/0034-5687(70)90056-3; Biancardi V, 2008, PFLUG ARCH EUR J PHY, V455, P1119, DOI 10.1007/s00424-007-0338-8; Bittencourt JC, 2011, GEN COMP ENDOCR, V172, P185, DOI 10.1016/j.ygcen.2011.03.028; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Borsu L, 2000, J BIOL CHEM, V275, P40576, DOI 10.1074/jbc.M006524200; Brown SN, 2007, NEUROSCIENCE, V150, P796, DOI 10.1016/j.neuroscience.2007.10.002; Burdakov D, 2005, PHILOS T R SOC B, V360, P2227, DOI 10.1098/rstb.2005.1763; Burdakov D, 2013, PHYSIOL BEHAV, V121, P117, DOI 10.1016/j.physbeh.2013.03.023; Chen LC, 2006, EUR J NEUROSCI, V24, P2039, DOI 10.1111/j.1460-9568.2006.05058.x; Clegg DJ, 2003, AM J PHYSIOL-REG I, V284, pR494, DOI 10.1152/ajpregu.00399.2002; Della-Zuana O, 2002, INT J OBESITY, V26, P1289, DOI 10.1038/sj.ijo.0802079; Egwuenu EJ, 2012, AM J PHYSIOL-REG I, V303, pR624, DOI 10.1152/ajpregu.00215.2012; Elias CF, 2008, J CHEM NEUROANAT, V35, P188, DOI 10.1016/j.jchemneu.2007.10.002; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Guan JL, 2002, INT J OBESITY, V26, P1523, DOI 10.1038/sj.ijo.0802155; Hahn JD, 2010, NEUROSCI LETT, V468, P12, DOI 10.1016/j.neulet.2009.10.047; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kerman IA, 2007, J COMP NEUROL, V505, P586, DOI 10.1002/cne.21511; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Kong D, 2010, CELL METAB, V12, P545, DOI 10.1016/j.cmet.2010.09.013; Lagos P, 2011, BEHAV BRAIN RES, V218, P259, DOI 10.1016/j.bbr.2010.10.035; Lagos P, 2009, BRAIN RES, V1265, P103, DOI 10.1016/j.brainres.2009.02.010; Leinninger GM, 2011, PHYSIOL BEHAV, V104, P572, DOI 10.1016/j.physbeh.2011.04.060; Li AH, 2006, J PHYSIOL-LONDON, V570, P385, DOI 10.1113/jphysiol.2005.099325; Li AH, 2006, J PHYSIOL-LONDON, V577, P307, DOI 10.1113/jphysiol.2006.114504; Li AH, 2010, J PHYSIOL-LONDON, V588, P2935, DOI 10.1113/jphysiol.2010.191288; Li N, 2012, RESP PHYSL NEUROBIOL; Li Y, 2006, J NEUROSCI, V26, P13037, DOI 10.1523/JNEUROSCI.3380-06.2006; Louis GW, 2010, J NEUROSCI, V30, P11278, DOI 10.1523/JNEUROSCI.1340-10.2010; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Messina MM, 2007, REGUL PEPTIDES, V139, P23, DOI 10.1016/j.regpep.2006.08.013; Nahon JL, 2006, CR BIOL, V329, P623, DOI 10.1016/j.crvi.2006.03.021; NAHON JL, 1989, ENDOCRINOLOGY, V125, P2056, DOI 10.1210/endo-125-4-2056; Nattie EE, 2002, J APPL PHYSIOL, V92, P2119, DOI 10.1152/japplphysiol.01128.2001; Nattie E, 2012, PROG BRAIN RES, V198, P25, DOI 10.1016/B978-0-444-59489-1.00004-5; Pereira-Da-Silva M, 2005, J ENDOCRINOL, V186, P193, DOI 10.1677/joe.1.06111; Rao Y, 2008, J NEUROSCI, V28, P9101, DOI 10.1523/JNEUROSCI.1766-08.2008; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Saito Yumiko, 2008, V46, P159, DOI 10.1007/400_2007_052; Sanchez MS, 1999, PEPTIDES, V20, P611, DOI 10.1016/S0196-9781(99)00014-5; Severson CA, 2003, NAT NEUROSCI, V6, P1139, DOI 10.1038/nn1130; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shirasaka T, 2002, REGUL PEPTIDES, V104, P91, DOI 10.1016/S0167-0115(01)00352-4; SKOFITSCH G, 1985, BRAIN RES BULL, V15, P635, DOI 10.1016/0361-9230(85)90213-8; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Wang Y, 2010, GUT, V59, P1625, DOI 10.1136/gut.2010.210526; Watson PG, 1998, RAT BRAIN STEREOTAXI; Whiddon BB, 2013, J NEUROSCI, V33, P2009, DOI 10.1523/JNEUROSCI.3921-12.2013; Williams RH, 2007, P NATL ACAD SCI USA, V104, P10685, DOI 10.1073/pnas.0702676104; Wu M, 2009, P NATL ACAD SCI USA, V106, P17217, DOI 10.1073/pnas.0908200106	56	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103585	10.1371/journal.pone.0103585	http://dx.doi.org/10.1371/journal.pone.0103585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084113	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800053
J	Biesenbach, P; Kain, R; Derfler, K; Perkmann, T; Soleiman, A; Benharkou, A; Druml, W; Rees, A; Saemann, MD				Biesenbach, Peter; Kain, Renate; Derfler, Kurt; Perkmann, Thomas; Soleiman, Afschin; Benharkou, Alexandra; Druml, Wilfred; Rees, Andrew; Saeemann, Marcus D.			Long-Term Outcome of Anti-Glomerular Basement Membrane Antibody Disease Treated with Immunoadsorption	PLOS ONE			English	Article							RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; PROTEIN-A-IMMUNOADSORPTION; PLASMA-EXCHANGE; PLASMAPHERESIS; PROGNOSIS; THERAPY; SLE; IAS	Background: Anti-glomerular basement membrane (GBM) antibody disease may lead to acute crescentic glomerulonephritis with poor renal prognosis. Current therapy favours plasma exchange (PE) for removal of pathogenic antibodies. Immunoadsorption (IAS) is superior to PE regarding efficiency of antibody-removal and safety. Apart from anecdotal data, there is no systemic analysis of the long-term effects of IAS on anti-GBM-disease and antibody kinetics. Objective: To examine the long-term effect of high-frequency IAS combined with standard immunosuppression on patient and renal survival in patients with anti-GBM-disease and to quantify antibody removal and kinetics through IAS. Design: Retrospective review of patients treated with IAS for anti-GBM-antibody disease confirmed by biopsy and/or anti-GBM-antibodies. Setting: University Hospital of Vienna, Austria. Participants: 10 patients with anti-GBM-disease treated with IAS. Measurements: Patient and renal survival, renal histology, anti-GBM-antibodies. Results: Anti-GBM-antibodies were reduced by the first 9 IAS treatments (mean number of 23) to negative levels in all patients. Renal survival was 40% at diagnosis, 70% after the end of IAS, 63% after one year and 50% at the end of observation (mean 84 months, range 9 to 186). Dialysis dependency was successfully reversed in three of six patients. Patient survival was 90% at the end of observation. Conclusion: IAS efficiently eliminates anti-GBM-antibodies suggesting non-inferiority to PE with regard to renal and patient survival. Hence IAS should be considered as a valuable treatment option for anti-GBM-disease, especially in patients presenting with a high percentage of crescents and dialysis dependency due to an unusual high proportion of responders.	[Biesenbach, Peter; Derfler, Kurt; Druml, Wilfred; Saeemann, Marcus D.] Med Univ Vienna, Internal Med Clin Div Nephrol & Dialysis 3, Vienna, Austria; [Kain, Renate; Soleiman, Afschin; Benharkou, Alexandra; Rees, Andrew] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Perkmann, Thomas] Med Univ Vienna, Dept Lab Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Biesenbach, P (corresponding author), Med Univ Vienna, Internal Med Clin Div Nephrol & Dialysis 3, Vienna, Austria.	Peter.biesenbach@meduniwien.ac.at	Perkmann, Thomas/F-3074-2012; Kain, Renate/ACR-4709-2022	Kain, Renate/0000-0002-2428-543X; Perkmann, Thomas/0000-0002-7976-0285; Derfler, Kurt/0000-0003-2062-7620				ANDRASSY K, 1991, NEPHRON, V59, P206, DOI 10.1159/000186552; Aringer M, 1998, ARTHRITIS RHEUM, V41, P414, DOI 10.1002/1529-0131(199803)41:3<414::AID-ART6>3.0.CO;2-N; Biesenbach P, 2009, ATHEROSCLEROSIS SUPP, V10, P114, DOI 10.1016/S1567-5688(09)71824-0; Bolton WK, 1996, KIDNEY INT, V50, P1753, DOI 10.1038/ki.1996.495; COUSER WG, 1988, AM J KIDNEY DIS, V11, P449, DOI 10.1016/S0272-6386(88)80079-9; Cui Z, 2011, MEDICINE, V90, P303, DOI 10.1097/MD.0b013e31822f6f68; Dantal J, 1998, J AM SOC NEPHROL, V9, P1709; Heaf J, 1999, NEPHROL DIAL TRANSPL, V14, P1889, DOI 10.1093/ndt/14.8.1889; Hu WX, 2006, J NEPHROL, V19, P312; Jindal KK, 1999, KIDNEY INT, V55, pS33, DOI 10.1046/j.1523-1755.1999.07005.x; Kaplan AA, 2003, THER APHER DIAL, V7, P165, DOI 10.1046/j.1526-0968.2003.00030.x; Kasperkiewicz M, 2012, CLIN DERMATOL, V30, P84, DOI 10.1016/j.clindermatol.2011.03.014; KNOBL P, 1995, THROMB HAEMOSTASIS, V74, P1035; Laczika K, 2000, AM J KIDNEY DIS, V36, P392, DOI 10.1053/ajkd.2000.8993; Levy JB, 2001, ANN INTERN MED, V134, P1033, DOI 10.7326/0003-4819-134-11-200106050-00009; Madore F, 1996, J AM SOC NEPHROL, V7, P367; MORESO F, 1995, MED CLIN-BARCELONA, V105, P59; PETERS DK, 1982, TRANSPLANT P, V14, P513; Pusey CD, 2003, KIDNEY INT, V64, P1535, DOI 10.1046/j.1523-1755.2003.00241.x; Pusey CD, 2012, BLOOD PURIFICAT, V33, P190, DOI 10.1159/000334155; SAVAGE COS, 1986, BRIT MED J, V292, P301, DOI 10.1136/bmj.292.6516.301; Schmaldienst S, 2002, AM J KIDNEY DIS, V39, P415, DOI 10.1053/ajkd.2002.30564; Schmaldienst S, 2001, RHEUMATOLOGY, V40, P513, DOI 10.1093/rheumatology/40.5.513; Schmaldienst S, 2000, AM J KIDNEY DIS, V36, P490, DOI 10.1053/ajkd.2000.9789; SNYDER HW, 1992, BLOOD, V79, P2237; Stegmayr BG, 1999, INT J ARTIF ORGANS, V22, P81, DOI 10.1177/039139889902200205; Stummvoll GH, 2012, NEPHROL DIAL TRANSPL, V27, P618, DOI 10.1093/ndt/gfr239; Stummvoll GH, 2004, WIEN KLIN WOCHENSCHR, V116, P716, DOI 10.1007/s00508-004-0232-8; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625	29	33	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103568	10.1371/journal.pone.0103568	http://dx.doi.org/10.1371/journal.pone.0103568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079220	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800055
J	Elisabetta, V; Ferrero, V; Pedotti, M; Chiado, A; Simonelli, L; Calzolai, L; Varani, L; Lettieri, T				Elisabetta, Valentina; Ferrero, Viviana; Pedotti, Mattia; Chiado, Alessandro; Simonelli, Luca; Calzolai, Luigi; Varani, Luca; Lettieri, Teresa			Rational Modification of Estrogen Receptor by Combination of Computational and Experimental Analysis	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; LIGAND-BINDING DOMAIN; WASTE-WATER; ALPHA; BETA; HOMEOSTASIS; RIVER; BIOACCUMULATION; IDENTIFICATION; TRANSCRIPTION	In this manuscript, we modulate the binding properties of estrogen receptor protein by rationally modifying the amino acid composition of its ligand binding domain. By combining sequence alignment and structural analysis of known estrogen receptor-ligand complexes with computational analysis, we were able to predict estrogen receptor mutants with altered binding properties. These predictions were experimentally confirmed by producing single point variants with up to an order of magnitude increased binding affinity towards some estrogen disrupting chemicals and reaching an half maximal inhibitory concentration (IC50) value of 2 nM for the 17 alpha-ethinylestradiol ligand. Due to increased affinity and stability, utilizing such mutated estrogen receptor instead of the wild type as bio-recognition element would be beneficial in an assay or biosensor.	[Elisabetta, Valentina; Lettieri, Teresa] European Commiss, Directorate Gen, Joint Res Ctr, Inst Environm & Sustainabil, Ispra, Varese, Italy; [Ferrero, Viviana; Pedotti, Mattia; Chiado, Alessandro; Calzolai, Luigi] Biomed Res Inst, Bellinzona, Switzerland; [Calzolai, Luigi] European Commiss, Directorate Gen, Joint Res Ctr, Inst Hlth & Consumer Protect, Ispra, Varese, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site; Universita della Svizzera Italiana; European Commission Joint Research Centre; EC JRC ISPRA Site	Varani, L (corresponding author), European Commiss, Directorate Gen, Joint Res Ctr, Inst Environm & Sustainabil, Ispra, Varese, Italy.	luca.varani@irb.usi.ch; teresa.lettieri@jrc.ec.europa.eu	Chiadò, Alessandro/I-1501-2019	Chiadò, Alessandro/0000-0002-3230-8427; Lettieri, Teresa/0000-0002-3363-9666; Simonelli, Luca/0000-0001-6331-7716; Varani, Luca/0000-0002-0963-0987	FP7-KBBE/Programme 'Cooperation' - Research Theme: 'Food, agriculture and fisheries, and biotechnology' [265721]; Erasmus program; SVRI; BSJRP; SNF	FP7-KBBE/Programme 'Cooperation' - Research Theme: 'Food, agriculture and fisheries, and biotechnology'; Erasmus program; SVRI; BSJRP; SNF	The whole project achievements were possible thanks to the RADAR FP7 project funds FP7-KBBE/Programme 'Cooperation' - Research Theme: 'Food, agriculture and fisheries, and biotechnology', project number 265721). AC was supported in part by the Erasmus program. LV acknowledges financial support from SVRI, BSJRP and SNF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS H, 1992, RECEPTOR, V2, P77; Allen Y, 1999, SCI TOTAL ENVIRON, V233, P5, DOI 10.1016/S0048-9697(99)00175-8; Aqai P, 2013, ANAL BIOANAL CHEM, V405, P9427, DOI 10.1007/s00216-013-7384-1; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chung AC, 2003, NUCL RECEPTOR SIGNAL, V1, P1; Colasanti T, 2012, ARTHRITIS RHEUM-US, V64, P778, DOI 10.1002/art.33400; Colborn T, 2002, ENVIRON HEALTH PERSP, V110, P363, DOI 10.1289/ehp.02110s3363; Damstra T, 2002, J TOXICOL-CLIN TOXIC, V40, P457, DOI 10.1081/CLT-120006748; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Fu XD, 2008, IUBMB LIFE, V60, P502, DOI 10.1002/iub.80; Gong J, 2012, ENVIRON TOXICOL CHEM, V31, P2456, DOI 10.1002/etc.1961; Greenfield N, 2001, BIOCHEMISTRY-US, V40, P6646, DOI 10.1021/bi002846l; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Haberthur U, 2008, J COMPUT CHEM, V29, P701, DOI 10.1002/jcc.20832; Harries JE, 1997, ENVIRON TOXICOL CHEM, V16, P534, DOI [10.1897/1551-5028(1997)016&lt;0534:EAIFUK&gt;2.3.CO;2, 10.1002/etc.5620160320]; Katzenellenbogen BS, 2000, BREAST CANCER RES, V2, P335, DOI 10.1186/bcr78; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kim S, 2004, J MED CHEM, V47, P2171, DOI 10.1021/jm034243o; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Lai KM, 2002, SCI TOTAL ENVIRON, V289, P159, DOI 10.1016/S0048-9697(01)01036-1; Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154; LEDREAN Y, 1995, MOL CELL ENDOCRINOL, V109, P27, DOI 10.1016/0303-7207(95)03482-M; Liu JL, 2012, ENVIRON POLLUT, V162, P325, DOI 10.1016/j.envpol.2011.11.036; Mater N, 2014, ENVIRON INT, V63, P191, DOI 10.1016/j.envint.2013.11.011; Matthews J, 2000, TOXICOL SCI, V53, P326, DOI 10.1093/toxsci/53.2.326; Matthews J, 2000, J STEROID BIOCHEM, V74, P223, DOI 10.1016/S0960-0760(00)00126-6; Morris GM, 2009, AUTODOCK4 AUTODOCKTO, V16; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Nair SK, 2005, J MOL ENDOCRINOL, V35, P211, DOI 10.1677/jme.1.01830; Noaksson E, 2001, TOXICOL APPL PHARM, V174, P160, DOI 10.1006/taap.2001.9194; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; Pietras RJ, 2007, CLIN CANCER RES, V13, P4672, DOI 10.1158/1078-0432.CCR-07-1373; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108; Ricciardi C, 2013, BIOSENS BIOELECTRON, V40, P407, DOI 10.1016/j.bios.2012.08.043; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruff M, 2000, BREAST CANCER RES, V2, P353, DOI 10.1186/bcr80; SEIELSTAD DA, 1995, BIOCHEMISTRY-US, V34, P12605, DOI 10.1021/bi00039a016; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Snyder SA, 2008, REMOVAL ENDOCRINE DI; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Strauss L, 2009, ENDOCRINOLOGY, V150, P2865, DOI 10.1210/en.2008-1311; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; Sumpter JP, 1998, TOXICOL LETT, V103, P337, DOI 10.1016/S0378-4274(98)00328-2; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Torres NH., 2012, IOSR J ENG, V2, P984, DOI [10.9790/3021-0205984989, DOI 10.9790/3021-0205984989]; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; Vigano L, 2010, ENVIRON POLLUT, V158, P3675, DOI 10.1016/j.envpol.2010.07.033; Watanabe H, 2003, J MOL ENDOCRINOL, V31, P487, DOI 10.1677/jme.0.0310487; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	59	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102658	10.1371/journal.pone.0102658	http://dx.doi.org/10.1371/journal.pone.0102658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075862	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800015
J	Ning, SW; Zhao, ZXL; Ye, JR; Wang, P; Zhi, H; Li, RH; Wang, TT; Wang, JJ; Wang, LH; Li, X				Ning, Shangwei; Zhao, Zuxianglan; Ye, Jingrun; Wang, Peng; Zhi, Hui; Li, Ronghong; Wang, Tingting; Wang, Jianjian; Wang, Lihua; Li, Xia			SNP@lincTFBS: An Integrated Database of Polymorphisms in Human LincRNA Transcription Factor Binding Sites	PLOS ONE			English	Article							LONG NONCODING RNA; CANCER; GENE; PROMOTER; SUSCEPTIBILITY; IDENTIFICATION; ASSOCIATION; METASTASIS; ANNOTATION; EXPRESSION	Large intergenic non-coding RNAs (lincRNAs) are a new class of functional transcripts, and aberrant expression of lincRNAs was associated with several human diseases. The genetic variants in lincRNA transcription factor binding sites (TFBSs) can change lincRNA expression, thereby affecting the susceptibility to human diseases. To identify and annotate these functional candidates, we have developed a database SNP@lincTFBS, which is devoted to the exploration and annotation of single nucleotide polymorphisms (SNPs) in potential TFBSs of human lincRNAs. We identified 6,665 SNPs in 6,614 conserved TFBSs of 2,423 human lincRNAs. In addition, with ChIPSeq dataset, we identified 139,576 SNPs in 304,517 transcription factor peaks of 4,813 lincRNAs. We also performed comprehensive annotation for these SNPs using 1000 Genomes Project datasets across 11 populations. Moreover, one of the distinctive features of SNP@lincTFBS is the collection of disease-associated SNPs in the lincRNA TFBSs and SNPs in the TFBSs of disease-associated lincRNAs. The web interface enables both flexible data searches and downloads. Quick search can be query of lincRNA name, SNP identifier, or transcription factor name. SNP@lincTFBS provides significant advances in identification of disease-associated lincRNA variants and improved convenience to interpret the discrepant expression of lincRNAs.	[Ning, Shangwei; Zhao, Zuxianglan; Ye, Jingrun; Wang, Peng; Zhi, Hui; Li, Ronghong; Wang, Tingting; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Wang, Jianjian; Wang, Lihua] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Wang, LH (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China.	wanglh211@163.com; lixia@hrbmu.edu.cn	wang, tingting/AAK-2640-2020; li, xia/HHZ-7468-2022; Ye, jingrun/GSJ-2822-2022		National High Technology Research and Development Program of China [863 Program] [2014AA021102]; National Natural Science Foundation of China [91129710, 61073136, 61170154]; Undergraduate Innovation Funds of Harbin Medical University [YJSCX2012-226HLJ]	National High Technology Research and Development Program of China [863 Program](National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Undergraduate Innovation Funds of Harbin Medical University	This work was supported by the National High Technology Research and Development Program of China [863 Program, Grant Nos. 2014AA021102], the National Natural Science Foundation of China [Grant Nos. 91129710, 61073136 and 61170154], and the Undergraduate Innovation Funds of Harbin Medical University [Grant Nos. YJSCX2012-226HLJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2011, J BIOL CHEM, V286, P45093, DOI 10.1074/jbc.M111.310250; Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Badano I, 2012, J CLIN VIROL, V53, P54, DOI 10.1016/j.jcv.2011.09.030; Baldinu P, 2004, HUM MUTAT, V23, P318, DOI 10.1002/humu.20015; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Bialkowska-Hobrzanska Hanna, 2006, Can J Urol, V13, P2967; Blanton SH, 2010, CLEFT PALATE-CRAN J, V47, P574, DOI 10.1597/09-153; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Hollingworth P, 2012, MOL PSYCHIATR, V17, P1316, DOI 10.1038/mp.2011.125; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Jendrzejewski J, 2012, P NATL ACAD SCI USA, V109, P8646, DOI 10.1073/pnas.1205654109; Jung M, 2012, YONSEI MED J, V53, P1128, DOI 10.3349/ymj.2012.53.6.1128; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kohanbash G, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19964; Kumar V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003201; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Maruyama R, 2012, BMB REP, V45, P604, DOI 10.5483/BMBRep.2012.45.11.227; Matouk IJ, 2009, EUR J GASTROEN HEPAT, V21, P688, DOI 10.1097/MEG.0b013e328306a3a2; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Nie Y, 2013, CANCER SCI, V104, P458, DOI 10.1111/cas.12092; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Pujana MA, 2007, GENE CHROMOSOME CANC, V46, P155, DOI 10.1002/gcc.20396; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Tan Chen, 2002, Ai Zheng, V21, P449; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang PJ, 2012, J CELL BIOCHEM, V113, P1868, DOI 10.1002/jcb.24055; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Zhang WL, 2013, J MOL HISTOL, V44, P545, DOI 10.1007/s10735-013-9503-x	46	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103851	10.1371/journal.pone.0103851	http://dx.doi.org/10.1371/journal.pone.0103851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075616	Green Published, gold, Green Submitted			2022-12-27	WOS:000340028800083
J	Pelletier, CC; Koppe, L; Alix, PM; Kalbacher, E; Croze, ML; Hadj-Aissa, A; Fouque, D; Guebre-Egziabher, F; Soulage, CO				Pelletier, Caroline C.; Koppe, Laetitia; Alix, Pascaline M.; Kalbacher, Emilie; Croze, Marine L.; Hadj-Aissa, Aoumeur; Fouque, Denis; Guebre-Egziabher, Fitsum; Soulage, Christophe O.			The Relationship between Renal Function and Plasma Concentration of the Cachectic Factor Zinc-Alpha2-Glycoprotein (ZAG) in Adult Patients with Chronic Kidney Disease	PLOS ONE			English	Article							LIPID-MOBILIZING FACTOR; GLOMERULAR-FILTRATION-RATE; BODY-MASS INDEX; ADIPOSE-TISSUE; SERUM-LEVELS; ZINC ALPHA-2-GLYCOPROTEIN; CARDIOVASCULAR EVENTS; ZINC-ALPHA-2-GLYCOPROTEIN; ADIPOKINE; EXPRESSION	Zinc-alpha 2-glycoprotein (ZAG), a potent cachectic factor, is increased in patients undergoing maintenance dialysis. However, there is no data for patients before initiation of renal replacement therapy. The purpose of the present study was to assess the relationship between plasma ZAG concentration and renal function in patients with a large range of glomerular filtration rate (GFR). Plasma ZAG concentration and its relationship to GFR were investigated in 71 patients with a chronic kidney disease (CKD) stage 1 to 5, 17 chronic hemodialysis (HD), 8 peritoneal dialysis (PD) and 18 non-CKD patients. Plasma ZAG concentration was 2.3-fold higher in CKD stage 5 patients and 3-fold higher in HD and PD patients compared to non-CKD controls (P < 0.01). The hemodialysis session further increased plasma ZAG concentration (+39%, P < 0.01). An inverse relationship was found between ZAG levels and plasma protein (r(s) = -0.284; P < 0.01), albumin (rs = -0.282, P < 0.05), hemoglobin (r(s) = 20.267, P < 0.05) and HDL-cholesterol (r(s) = -0.264, P < 0.05) and a positive correlation were seen with plasma urea (r(s) = 0.283; P < 0.01). In multiple regression analyses, plasma urea and HDL-cholesterol were the only variables associated with plasma ZAG (r(2) = 0.406, P < 0.001). In CKD-5 patients, plasma accumulation of ZAG was not correlated with protein energy wasting. Further prospective studies are however needed to better elucidate the potential role of ZAG in end-stage renal disease.	[Pelletier, Caroline C.; Koppe, Laetitia; Alix, Pascaline M.; Kalbacher, Emilie; Croze, Marine L.; Hadj-Aissa, Aoumeur; Fouque, Denis; Guebre-Egziabher, Fitsum; Soulage, Christophe O.] Univ Lyon, F-69600 Oullins, France; [Pelletier, Caroline C.; Koppe, Laetitia; Alix, Pascaline M.; Kalbacher, Emilie; Croze, Marine L.; Fouque, Denis; Guebre-Egziabher, Fitsum; Soulage, Christophe O.] Univ Lyon 1, INSERM, U1060, INSA Lyon,CarMeN, F-69622 Villeurbanne, France; [Pelletier, Caroline C.; Koppe, Laetitia; Alix, Pascaline M.; Kalbacher, Emilie; Guebre-Egziabher, Fitsum] Hop Edouard Herriot, Serv Nephrol, Hosp Civils Lyon, Lyon, France; [Hadj-Aissa, Aoumeur] Hop Edouard Herriot, Hosp Civils Lyon, Lyon, France; [Fouque, Denis] Ctr Hosp Lyon SUD, Serv Nephrol, Hosp Civils Lyon, Pierre Benite, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; CHU Lyon	Soulage, CO (corresponding author), Univ Lyon, F-69600 Oullins, France.	Christophe.Soulage@insa-lyon.fr	SOULAGE, Christophe O/J-2759-2014; Carmen, Team3/Y-7384-2019; KOPPE, Laetitia/I-5978-2015; Carmen, Team1/Y-7382-2019	SOULAGE, Christophe O/0000-0002-8800-2144; Carmen, Team3/0000-0002-3614-0924; KOPPE, Laetitia/0000-0002-5076-2420; Carmen, Team1/0000-0003-4234-1746; Lab, Carmen/0000-0002-5935-3236	governmental institution from France, INSERM; governmental institution from INSA-Lyon; Federation Nationale d'Aide aux Insuffisants Renaux (FNAIR); Societe Francaise de Nephrologie; Academie de Medecine; Fondation pour la Recherche Medicale; French "Ministere de l'Enseignement Superieur et de la Recherche"	governmental institution from France, INSERM; governmental institution from INSA-Lyon; Federation Nationale d'Aide aux Insuffisants Renaux (FNAIR); Societe Francaise de Nephrologie; Academie de Medecine; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French "Ministere de l'Enseignement Superieur et de la Recherche"	This study was supported by two governmental institutions from France, INSERM and INSA-Lyon, and by the Federation Nationale d'Aide aux Insuffisants Renaux (FNAIR). CC.PELLETIER and PM. ALIX held grants from "Societe Francaise de Nephrologie," E KALBACHER was the recipient of a grant from "Academie de Medecine" and L. KOPPE held a fellowship from "Fondation pour la Recherche Medicale". ML CROZE held a grant from the French "Ministere de l'Enseignement Superieur et de la Recherche." The authors have no competing financial interests to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson J, 2011, NEPHROL DIAL TRANSPL, V26, P2485, DOI 10.1093/ndt/gfq755; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Bing Chen, 2011, Curr Opin Support Palliat Care, V5, P356, DOI 10.1097/SPC.0b013e32834bde0e; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUERGI W, 1961, J BIOL CHEM, V236, P1066; Buron F, 2011, TRANSPLANTATION, V92, P1005, DOI 10.1097/TP.0b013e3182301602; Cirillo M, 2005, NEPHROL DIAL TRANSPL, V20, P1791, DOI 10.1093/ndt/gfh962; Cumin F, 1997, INT J OBESITY, V21, P495, DOI 10.1038/sj.ijo.0800428; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; Dubourg L, 2010, ANAL BIOCHEM, V405, P266, DOI 10.1016/j.ab.2010.06.016; EKMAN R, 1976, J CLIN INVEST, V57, P945, DOI 10.1172/JCI108371; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Gao D, 2010, MOL CELL ENDOCRINOL, V325, P135, DOI 10.1016/j.mce.2010.05.020; Gong FY, 2009, INT J OBESITY, V33, P1023, DOI 10.1038/ijo.2009.141; Guebre-Egziabher F, 2005, J RENAL NUTR, V15, P116, DOI 10.1053/j.jrn.2004.09.015; Guebre-Egziabher F, 2005, NEPHROL DIAL TRANSPL, V20, P129, DOI 10.1093/ndt/gfh568; Hassan MI, 2008, MOL CANCER RES, V6, P892, DOI 10.1158/1541-7786.MCR-07-2195; Hirai K, 1998, CANCER RES, V58, P2359; Leal VO, 2012, RENAL FAILURE, V34, P1062, DOI 10.3109/0886022X.2012.712859; Leal VO, 2012, CLIN CHIM ACTA, V413, P616, DOI 10.1016/j.cca.2011.12.002; Letizia C, 1996, SCAND J UROL NEPHROL, V30, P399, DOI 10.3109/00365599609181317; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Merabet E, 1997, J CLIN ENDOCR METAB, V82, P847, DOI 10.1210/jc.82.3.847; Mracek T, 2010, J ENDOCRINOL, V204, P165, DOI 10.1677/JOE-09-0299; Mracek T, 2011, BRIT J CANCER, V104, P441, DOI 10.1038/sj.bjc.6606083; Olofsson LE, 2010, METABOLISM, V59, P1316, DOI 10.1016/j.metabol.2009.12.006; Pelletier CC, 2013, KIDNEY INT, V83, P878, DOI 10.1038/ki.2013.9; Pfau D, 2010, DIABETES CARE, V33, P171, DOI 10.2337/dc09-1351; Philipp A, 2011, METABOLISM, V60, P669, DOI 10.1016/j.metabol.2010.06.019; Rubinger D, 2013, SEMIN DIALYSIS, V26, P333, DOI 10.1111/sdi.12093; Russell ST, 2005, BRIT J CANCER, V92, P876, DOI 10.1038/sj.bjc.6602404; Russell ST, 2004, BBA-MOL CELL BIOL L, V1636, P59, DOI 10.1016/j.bbalip.2003.12.004; Russell ST, 2002, BRIT J CANCER, V86, P424, DOI 10.1038/sj.bjc.6600086; Russell ST, 2012, BBA-MOL CELL BIOL L, V1821, P590, DOI 10.1016/j.bbalip.2011.12.003; Ryden M, 2012, J INTERN MED, V271, P414, DOI 10.1111/j.1365-2796.2011.02441.x; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; Sanders PM, 2004, CANCER LETT, V212, P71, DOI 10.1016/j.canlet.2004.03.021; Schmitt R, 2008, J AM SOC NEPHROL, V19, P2375, DOI 10.1681/ASN.2008010035; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; TADA T, 1991, J HISTOCHEM CYTOCHEM, V39, P1221, DOI 10.1177/39.9.1918940; Tedeschi S, 2012, METABOLISM, V61, P37, DOI 10.1016/j.metabol.2011.05.011; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Ziegelmeier M, 2007, DIABETES CARE, V30, P2588, DOI 10.2337/dc07-0275; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134; Zoccali C, 2002, CIRCULATION, V105, P1354, DOI 10.1161/hc1102.105261	46	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103475	10.1371/journal.pone.0103475	http://dx.doi.org/10.1371/journal.pone.0103475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076420	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800050
J	Regan, FH; Hockenhull, J; Pritchard, JC; Waterman-Pearson, AE; Whay, HR				Regan, Fran H.; Hockenhull, Jo; Pritchard, Joy C.; Waterman-Pearson, Avril E.; Whay, Helen R.			Behavioural Repertoire of Working Donkeys and Consistency of Behaviour over Time, as a Preliminary Step towards Identifying Pain-Related Behaviours	PLOS ONE			English	Article							ASSES EQUUS AFRICANUS; SOCIAL-ORGANIZATION; INTEROBSERVER RELIABILITY; TEST PERSON; TEST-RETEST; RESPONSES; WELFARE; HUMANS; ASINUS; FAMILIARITY	Background: The donkey has a reputation for stoicism and its behavioural repertoire in clinical contexts is under-reported. Lack of understanding of the norms of donkey behaviour and how it may vary over time can compromise use of behavioural measures as indicators of pain or emotional state. The objective of this study was to find out whether the behaviour of working donkeys was influenced by gender, the time of day or differed between days with a view to assessing how robust these measures are for inclusion in a working donkey ethogram. Methodology/Principal Findings: Frequency and consistency of postural and event behaviours were measured in 21 adult working donkeys (12 females; 9 males). Instantaneous (scan) and focal sampling were used to measure maintenance, lying, ingestive and investigative behaviours at hourly intervals for ten sessions on each of two consecutive days. High head carriage and biting were seen more frequently in male donkeys than females (P<0.001). Level head carriage, licking/chewing and head-shaking were observed more frequently in female donkeys (P<0.001). Tail position, ear orientation, foot stamping, rolling/lying and head-shaking behaviours were affected by time of day (P<0.001). However, only two variations in ear orientation were found to be significantly different over the two days of observations (P<0.001). Tail swishing, head shaking, foot stamping, and ears held sideways and downwards were significantly correlated (P<0.001) and are assumed to be behaviours to discourage flies. Conclusions/Significance: All donkeys expressed an extensive behavioural repertoire, although some differences in behaviour were evident between genders. While most behaviours were consistent over time, some behaviours were influenced by time of day. Few behaviours differed between the two test days. The findings can be used to inform the development of a robust, evidence-based ethogram for working donkeys.	[Regan, Fran H.; Hockenhull, Jo; Waterman-Pearson, Avril E.; Whay, Helen R.] Univ Bristol, Sch Vet Sci, Langford, North Somerset, England; [Pritchard, Joy C.] Animals Int Dev, Banwell, North Somerset, England; [Pritchard, Joy C.] Brooke, London, England	University of Bristol	Whay, HR (corresponding author), Univ Bristol, Sch Vet Sci, Langford, North Somerset, England.	bec.whay@bristol.ac.uk		Hockenhull, Jo/0000-0002-9224-7304	The Brooke	The Brooke	The authors received funding from a UK based working equine charity called "The Brooke." One author (JCP) who contributed to preparation of the manuscript is employed part-time for The Brooke, independently of the current work which was carried out under her second affiliation. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen IL, 2000, APPL ANIM BEHAV SCI, V69, P227, DOI 10.1016/S0168-1591(00)00133-7; Ashley FH., 2006, P 5 INT C WORK EQ AD, P15; Ayo JO, 2008, J EQUINE VET SCI, V28, P281, DOI 10.1016/j.jevs.2008.03.003; Berger A, 1999, APPL ANIM BEHAV SCI, V64, P1, DOI 10.1016/S0168-1591(99)00026-X; Burn CC, 2010, APPL ANIM BEHAV SCI, V126, P109, DOI 10.1016/j.applanim.2010.06.007; Canacoo EA, 1998, APPL ANIM BEHAV SCI, V60, P229, DOI 10.1016/S0168-1591(98)00167-1; Chaya W, 2006, APPL ANIM BEHAV SCI, V101, P177, DOI 10.1016/j.applanim.2005.11.009; Gilkeson J, 2009, J EQUINE VET SCI, V29, P491; GONYOU HW, 1994, J ANIM SCI, V72, P2171, DOI 10.2527/1994.7282171x; Gregory NG, 2004, PHYSIOLOGY AND BEHAVIOUR OF ANIMAL SUFFERING, P1, DOI 10.1002/9780470752494; Hay M, 2003, APPL ANIM BEHAV SCI, V82, P201, DOI 10.1016/S0168-1591(03)00059-5; Hemsworth PH, 1996, APPL ANIM BEHAV SCI, V50, P43, DOI 10.1016/0168-1591(96)01067-2; Henry M, 1998, APPL ANIM BEHAV SCI, V60, P263, DOI 10.1016/S0168-1591(98)00175-0; HOLM S, 1979, SCAND J STAT, V6, P65; Klingel H, 1998, APPL ANIM BEHAV SCI, V60, P103, DOI 10.1016/S0168-1591(98)00160-9; Lamoot I, 2005, APPL ANIM BEHAV SCI, V92, P93, DOI 10.1016/j.applanim.2004.10.017; Mcdonnell SM, 2003, EQUID ETHOGRAM; McGreevy P., 2004, EQUINE BEHAV GUIDE V, DOI 10.1016/B978-0-7020-2634-8.50006-X; Moehlman PD, 1998, APPL ANIM BEHAV SCI, V60, P125, DOI 10.1016/S0168-1591(98)00162-2; Moehlman PD, 1998, APPL ANIM BEHAV SCI, V60, P171, DOI 10.1016/S0168-1591(98)00163-4; Molony V, 1997, J ANIM SCI, V75, P266; Murray LMA, 2013, APPL ANIM BEHAV SCI, V143, P67, DOI 10.1016/j.applanim.2012.11.005; Pritchard JC, 2005, PREV VET MED, V69, P265, DOI 10.1016/j.prevetmed.2005.02.002; Rousing T, 2005, APPL ANIM BEHAV SCI, V94, P237, DOI 10.1016/j.applanim.2005.02.011; Rousing T, 2004, APPL ANIM BEHAV SCI, V85, P215, DOI 10.1016/j.applanim.2003.09.014; Rudman R, 1998, APPL ANIM BEHAV SCI, V60, P211, DOI 10.1016/S0168-1591(98)00165-8; Rushen J, 1999, APPL ANIM BEHAV SCI, V65, P285, DOI 10.1016/S0168-1591(99)00089-1; Schrader L, 2002, APPL ANIM BEHAV SCI, V77, P255, DOI 10.1016/S0168-1591(02)00075-8; Smith D, 2008, DONKEY NUTR PROFESSI; Thornton PD, 1999, RES VET SCI, V66, P107, DOI 10.1053/rvsc.1998.0252; Tyler S.J., 1972, Animal Behav Monogr, V5, P85; Visser EK, 2001, APPL ANIM BEHAV SCI, V74, P241, DOI 10.1016/S0168-1591(01)00177-0	32	27	27	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e101877	10.1371/journal.pone.0101877	http://dx.doi.org/10.1371/journal.pone.0101877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076209	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800009
J	Tareque, MI; Begum, S; Saito, Y				Tareque, Md. Ismail; Begum, Sharifa; Saito, Yasuhiko			Inequality in Disability in Bangladesh	PLOS ONE			English	Article							FREE LIFE EXPECTANCY; SOCIOECONOMIC-STATUS; UNITED-STATES; OLDER-ADULTS; DEVELOPING-COUNTRIES; GENDER-DIFFERENCES; HEALTH; POVERTY; MORTALITY	Objective: To investigate inequality in disability in Bangladesh. Methods: The study used both household level and individual level data from a large nationally representative data set, Bangladesh's Household Income and Expenditure Survey - 2010. Principal component analysis was used to construct a wealth index based on household assets from household level data. Then, using data from 49,809 individuals aged 5 years and over, chi-square tests and logistic regression were performed to test the association between wealth level and disability. Findings: Women and older people are significantly more likely to report having disabilities than men and younger people. For middle and rich families, respectively, there is a 14 percent lower likelihood of reporting disabilities than for poor families. Changes in the probability of having disabilities are linear with increasing wealth. In addition, the study identifies some significant factors affecting disability, namely, age, sex, education, marital status, and place of residence including divisional differences. Conclusion: In Bangladesh, worse health among the poor argues for policies prioritizing this group while at the same time giving special attention to women and the elderly.	[Tareque, Md. Ismail] Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh; [Begum, Sharifa] Bangladesh Inst Dev Studies, Populat & Hlth Studies Div, Dhaka, Bangladesh; [Saito, Yasuhiko] Nihon Univ, Adv Res Inst Sci & Humanities, Tokyo, Japan; [Saito, Yasuhiko] Nihon Univ, Sch Med, Tokyo, Japan; [Saito, Yasuhiko] Duke NUS Grad Med Sch, Singapore, Singapore	University of Rajshahi; Bangladesh Institute of Development Studies (BIDS); Nihon University; Nihon University; National University of Singapore	Tareque, MI (corresponding author), Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh.	tareque_pshd@yahoo.com		Tareque, Md Ismail/0000-0002-6507-1171				[Anonymous], 2009, PEOPL DIS IND COMM O; Bangladesh Bureau of Statistics (BBS), 2019, REP HOUS INC EXP SUR; Blane D, 2001, INT J EPIDEMIOL, V30, P292, DOI 10.1093/ije/30.2.292; Bollen KA, 2002, POP STUD-J DEMOG, V56, P81, DOI 10.1080/00324720213796; Braithwaite J, 2009, ALTER, V3, P219, DOI 10.1016/j.alter.2008.10.002; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Chan Y. H., 2004, SMJ Singapore Medical Journal, V45, P149; Danish Bilharziasis Laboratory for the World Bank (DBLWB), 2004, DIS BANGL SIT AN FIN; Demakakos P, 2008, SOC SCI MED, V67, P330, DOI 10.1016/j.socscimed.2008.03.038; Dewhurst F, 2012, AGE AGEING, V41, P517, DOI 10.1093/ageing/afs054; Andrade FCD, 2011, WOMEN HEALTH ISS, V21, P64, DOI 10.1016/j.whi.2010.08.007; Eide A.H., 2009, LIVING CONDITIONS PE; Eide A.H., 2003, LIVING CONDITIONS PE; Eide AH, 2006, NATL REPRESENTATIVE; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 2008, WORLD BANK ECON REV, V22, P141, DOI 10.1093/wber/lhm021; Gannon B., 2004, ECON SOC REV, V35, P135; Groce N, 2011, THIRD WORLD Q, V32, P1493, DOI 10.1080/01436597.2011.604520; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Jarvandi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049929; Lafortune G, 2007, 26 OECD; Loeb ME, 2004, NATL REPRESENTATIVE; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Madans JH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S4-S4; Maulik PK, 2007, PEDIATRICS, V120, pS1, DOI 10.1542/peds.2007-0043B; Miller K, 2011, QUAL QUANT, V45, P801, DOI 10.1007/s11135-010-9370-4; Mitra S, 2014, DISABIL REHABIL, V36, P940, DOI 10.3109/09638288.2013.825333; Mitra S, 2013, WORLD DEV, V41, P1, DOI 10.1016/j.worlddev.2012.05.024; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Organisation for Economic Co-operation and Development, 2009, SICKN DIS WORK KEEP; Palmer MG, 2012, J INT DEV, V24, pS53, DOI 10.1002/jid.1715; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Parodi G, 2008, APPL ECON, V40, P2615, DOI 10.1080/00036840600970211; Rahman MO, 2003, GERONTOLOGIST, V43, P856, DOI 10.1093/geront/43.6.856; Rutstein S. O., 2004, DHS WEALTH INDEX; Saunders P, 2007, AUST J SOC ISSUES, V42, P461, DOI 10.1002/j.1839-4655.2007.tb00072.x; Siegrist J, 2004, SOC SCI MED, V58, P1463, DOI 10.1016/S0277-9536(03)00349-6; Tareque MI, 2013, J AGING HEALTH, V25, P1299, DOI 10.1177/0898264313501388; Trani JF, 2012, J INT DEV, V24, pS19, DOI 10.1002/jid.1709; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; von dem Knesebeck O, 2003, SOC SCI MED, V57, P1643, DOI 10.1016/S0277-9536(03)00020-0; Wall LL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001769; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Yong V, 2012, J GERONTOL B-PSYCHOL, V67, P343, DOI 10.1093/geronb/gbs029; Zimmer Z, 2008, SOC SCI MED, V66, P57, DOI 10.1016/j.socscimed.2007.08.032; Zunzunegui MV, 2009, SOC SCI MED, V68, P235, DOI 10.1016/j.socscimed.2008.10.031	47	27	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103681	10.1371/journal.pone.0103681	http://dx.doi.org/10.1371/journal.pone.0103681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25075513	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800072
J	Vangone, A; Abdel-Azeim, S; Caputo, I; Sblattero, D; Di Niro, R; Cavallo, L; Oliva, R				Vangone, Anna; Abdel-Azeim, Safwat; Caputo, Ivana; Sblattero, Daniele; Di Niro, Roberto; Cavallo, Luigi; Oliva, Romina			Structural Basis for the Recognition in an Idiotype-Anti-Idiotype Antibody Complex Related to Celiac Disease	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; INTER-RESIDUE CONTACTS; ANTIIDIOTYPIC ANTIBODIES; TISSUE TRANSGLUTAMINASE; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; AUTOIMMUNE-DISEASES; ANGSTROM RESOLUTION; PROTEIN COMPLEXES; IDIOTOPE COMPLEX	Anti-idiotype antibodies have potential therapeutic applications in many fields, including autoimmune diseases. Herein we report the isolation and characterization of AIM2, an anti-idiotype antibody elicited in a mouse model upon expression of the celiac disease-specific autoantibody MB2.8 (directed against the main disease autoantigen type 2 transglutaminase, TG2). To characterize the interaction between the two antibodies, a 3D model of the MB2.8-AIM2 complex has been obtained by molecular docking. Analysis and selection of the different obtained docking solutions was based on the conservation within them of the inter-residue contacts. The selected model is very well representative of the different solutions found and its stability is confirmed by molecular dynamics simulations. Furthermore, the binding mode it adopts is very similar to that observed in most of the experimental structures available for idiotype-anti-idiotype antibody complexes. In the obtained model, AIM2 is directed against the MB2.8 CDR region, especially on its variable light chain. This makes the concurrent formation of the MB2.8-AIM2 complex and of the MB2.8-TG2 complex incompatible, thus explaining the experimentally observed inhibitory effect on the MB2.8 binding to TG2.	[Vangone, Anna; Caputo, Ivana; Cavallo, Luigi] Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy; [Abdel-Azeim, Safwat; Cavallo, Luigi] King Abdullah Univ Sci & Technol, Kaust Catalysis Ctr, Thuwal, Saudi Arabia; [Caputo, Ivana] Univ Naples Federico II, European Lab Invest Food Induced Dis ELFID, Naples, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy; [Di Niro, Roberto] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Oliva, Romina] Univ Parthenope Naples, Dept Sci & Technol, Naples, Italy	University of Salerno; King Abdullah University of Science & Technology; University of Naples Federico II; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Parthenope University Naples	Oliva, R (corresponding author), Univ Parthenope Naples, Dept Sci & Technol, Naples, Italy.	romina.oliva@uniparthenope.it	Oliva, Romina/ABA-6313-2021; Cavallo, Luigi/D-5215-2019; Abdel-azeim, Safwat/R-8096-2019; Vangone, Anna/K-4756-2014; cavallo, luigi/C-7272-2015	Oliva, Romina/0000-0002-6156-6249; Cavallo, Luigi/0000-0002-1398-338X; Vangone, Anna/0000-0003-2485-7378; Caputo, Ivana/0000-0003-2825-9711; abdel-Azeim, Safwat sayed/0000-0001-8611-1251; Sblattero, Daniele/0000-0003-4309-242X	Italian MIUR (Ministero dell'Istruzione, dell' Universita della Ricerca) [PRIN2008]; Regione Campania [LR5-2002-AF2008]; EC Marie Curie Research Training Network [MRTN-CT-20010-289964]; King Abdullah University of Science and Technology	Italian MIUR (Ministero dell'Istruzione, dell' Universita della Ricerca); Regione Campania(Regione Campania); EC Marie Curie Research Training Network(European Commission); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	IC and RO were supported by the Italian MIUR (Ministero dell'Istruzione, dell' Universita della Ricerca; Grant PRIN2008). RO was also supported by Regione Campania (LR5-2002-AF2008). DS was supported by EC Marie Curie Research Training Network (contract n. MRTN-CT-20010-289964). LC was supported by the King Abdullah University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Azeim S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S5-S1; Abu-Shakra M, 2007, AUTOANTIBODIES, 2ND EDITION, P69, DOI 10.1016/B978-044452763-9/50014-7; Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; BAN N, 1994, P NATL ACAD SCI USA, V91, P1604, DOI 10.1073/pnas.91.5.1604; BENTLEY GA, 1990, NATURE, V348, P254, DOI 10.1038/348254a0; Bhattacharya-Chatterjee M, 2000, IMMUNOL LETT, V74, P51, DOI 10.1016/S0165-2478(00)00249-2; Boscolo S, 2012, NEW BIOTECHNOL, V29, P477, DOI 10.1016/j.nbt.2011.12.005; Braden BC, 1996, J MOL BIOL, V264, P137, DOI 10.1006/jmbi.1996.0629; Brenke R, 2012, BIOINFORMATICS, V28, P2608, DOI 10.1093/bioinformatics/bts493; Bryson S, 2008, J MOL BIOL, V382, P910, DOI 10.1016/j.jmb.2008.07.057; Burioni R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003423; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caputo I, 2013, AMINO ACIDS, V44, P251, DOI 10.1007/s00726-011-1120-y; Chailyan A, 2012, NUCLEIC ACIDS RES, V40, pD1230, DOI 10.1093/nar/gkr806; Chong G, 2006, ANN ONCOL, V17, P437, DOI 10.1093/annonc/mdj090; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DALGLEISH AG, 1988, VACCINE, V6, P215, DOI 10.1016/0264-410X(88)90213-7; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Debret G, 2009, NUCLEIC ACIDS RES, V37, pW459, DOI 10.1093/nar/gkp304; deGroot BL, 1996, BIOPHYS J, V71, P1707, DOI 10.1016/S0006-3495(96)79372-4; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Niro R, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-46; Di Niro R, 2008, MOL IMMUNOL, V45, P1782, DOI 10.1016/j.molimm.2007.09.025; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; DIETRICH G, 1993, EUR J IMMUNOL, V23, P2945, DOI 10.1002/eji.1830231133; Eigenbrot C, 2003, J MOL BIOL, V331, P433, DOI 10.1016/S0022-2836(03)00735-6; EVANS SV, 1994, J MOL BIOL, V241, P691, DOI 10.1006/jmbi.1994.1544; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2000, PHYS REV E, V62, P8438, DOI 10.1103/PhysRevE.62.8438; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; JAYNE DRW, 1993, J AUTOIMMUN, V6, P221, DOI 10.1006/jaut.1993.1019; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JOST CR, 1994, J BIOL CHEM, V269, P26267; Konc J, 2012, NUCLEIC ACIDS RES, V40, pW214, DOI 10.1093/nar/gks435; Kuroda D, 2009, PROTEINS, V75, P139, DOI 10.1002/prot.22230; Ladjemi MZ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2826; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LUNDKVIST I, 1993, CLIN IMMUNOL IMMUNOP, V67, P192, DOI 10.1006/clin.1993.1064; LUNDKVIST I, 1989, IMMUNOL REV, V110, P105, DOI 10.1111/j.1600-065X.1989.tb00029.x; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Maki M, 1998, DIGEST DIS, V16, P330, DOI 10.1159/000016885; Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170; Mendez R, 2005, PROTEINS, V60, P150, DOI 10.1002/prot.20551; Mohanty K, 2007, BREAST CANCER RES TR, V104, P1, DOI 10.1007/s10549-006-9391-9; Oliva R, 2013, PROTEINS, V81, P1571, DOI 10.1002/prot.24314; PAN Y, 1995, FASEB J, V9, P43, DOI 10.1096/fasebj.9.1.7821758; Paolella G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084403; Park HJ, 2008, BRIT J HAEMATOL, V142, P179, DOI 10.1111/j.1365-2141.2008.07143.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Shoenfeld Y, 1996, J AUTOIMMUN, V9, P235, DOI 10.1006/jaut.1996.0029; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309; Tzioufas AG, 2010, AUTOIMMUN REV, V9, P631, DOI 10.1016/j.autrev.2010.05.013; Vangone A, 2013, PROTEINS, V81, P2210, DOI 10.1002/prot.24423; Vangone A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S19; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; Warncke M, 2011, CANCER IMMUNOL IMMUN, V60, P49, DOI 10.1007/s00262-010-0918-x; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8; Wilks D, 1992, Mol Cell Biol Hum Dis Ser, V1, P283; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; ZANETTI M, 1986, CRC CR REV IMMUNOL, V6, P151; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571	70	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102839	10.1371/journal.pone.0102839	http://dx.doi.org/10.1371/journal.pone.0102839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076134	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000340028800018
J	Lozano, J; Belles, X				Lozano, Jesus; Belles, Xavier			Role of Methoprene-Tolerant (Met) in Adult Morphogenesis and in Adult Ecdysis of Blattella germanica	PLOS ONE			English	Article							BEETLE TRIBOLIUM-CASTANEUM; KRUPPEL HOMOLOG 1; RED FLOUR BEETLE; BHLH-PAS FAMILY; JUVENILE-HORMONE; TRANSCRIPTIONAL REGULATORS; DROSOPHILA-MELANOGASTER; INSECT METAMORPHOSIS; SIGNALING PATHWAY; SYSTEMIC RNAI	Juvenile Hormone (JH) represses metamorphosis of young instars in insects. One of the main players in hormonal signalling is Methoprene-tolerant (Met), which plays the role of JH receptor. Using the Polyneopteran insect Blattella germanica as the model and RNAi for transcript depletion, we have confirmed that Met transduces the antimetamorphic signal of JH in young nymphs and plays a role in the last nymphal instar moult in this species. Previously, the function of Met as the JH receptor had been demonstrated in the Eumetabola clade, with experiments in Holometabola (in the beetle Tribolium castaneum) and in their sister group Paraneoptera (in the bug Pyrrhocoris apterus). Our result shows that the function of Met as JH receptor is also conserved in the more basal Polyneoptera. The function of Met as JH transducer might thus predate the evolutionary innovation of metamorphosis. Moreover, expression of Met was also found in last nymphal instar of B. germanica, when JH is absent. Depletion of Met in this stage provoked deficiencies in wing growth and ecdysis problems in the imaginal moult. Down-regulation of the ecdysone-inducible gene E75A and Insulin-Like-Peptide 1 in these Met-depleted specimens suggest that Met is involved in the ecdysone and insulin signalling pathways in last nymphal instar, when JH is virtually absent.	[Lozano, Jesus; Belles, Xavier] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Belles, X (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Catalonia, Spain.	xavier.belles@ibe.upf-csic.es	Belles, Xavier/G-2354-2015; Lozano-Fernandez, Jesus/H-3704-2016	Belles, Xavier/0000-0002-1566-303X; Lozano-Fernandez, Jesus/0000-0003-3597-1221	Spanish MICINN [CGL2008-03517/BOS]; MINECO [CGL2012-36251]; Catalan Government [2009 SGR 1498]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MINECO(Spanish Government); Catalan Government	Financial support for this research was provided by the Spanish MICINN (grant CGL2008-03517/BOS to XB and predoctoral fellowship to JL) and MINECO (grant CGL2012-36251 to XB), and from the Catalan Government (2009 SGR 1498). The research has also benefited from FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bitra K, 2009, ARCH INSECT BIOCHEM, V70, P90, DOI 10.1002/arch.20281; Bitra K, 2009, GENE, V448, P74, DOI 10.1016/j.gene.2009.08.003; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; Cruz J, 2006, DEV BIOL, V297, P158, DOI 10.1016/j.ydbio.2006.06.048; Gomez-Orte E, 2009, P NATL ACAD SCI USA, V106, P21678, DOI 10.1073/pnas.0907391106; Grimaldi David, 2005, pi; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Nijhout H.F., 1994, INSECT HORMONES; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Sheng ZT, 2011, J BIOL CHEM, V286, P41924, DOI 10.1074/jbc.M111.269845; Smykal V, 2014, DEV BIOL, V390, P221, DOI 10.1016/j.ydbio.2014.03.006; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Treiblmayr K, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.4301; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Xu JJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003535	29	45	47	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103614	10.1371/journal.pone.0103614	http://dx.doi.org/10.1371/journal.pone.0103614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072526	gold, Green Submitted, Green Published			2022-12-27	WOS:000341307600071
J	Vilela, FMP; Syed, DN; Chamcheu, JC; Calvo-Castro, LA; Fortes, VS; Fonseca, MJV; Mukhtar, H				Pinto Vilela, Fernanda Maria; Syed, Deeba N.; Chamcheu, Jean Christopher; Calvo-Castro, Laura A.; Fortes, Vanessa Silveira; Vieira Fonseca, Maria Jose; Mukhtar, Hasan			Biotransformed Soybean Extract (BSE) Inhibits Melanoma Cell Growth and Viability In Vitro: Involvement of Nuclear Factor-Kappa B Signaling	PLOS ONE			English	Article							CANCER CHEMOPREVENTION; BETA-GLUCOSIDASE; INDUCED APOPTOSIS; SKIN-CANCER; ISOFLAVONES; ACTIVATION; PATHWAY; KERATINOCYTES; FISETIN; TRAIL	Melanoma is recognized as one of the most aggressive cancers with a relatively high propensity for metastasis. The prognosis of melanoma remains poor in spite of treatment advances, emphasizing the importance of additional preventive measures. Isoflavonoids have become not only potential chemopreventive, but also important therapeutic natural agents. We evaluated the antiproliferative and proapoptotic properties of biotransformed soybean extract (BSE) in A375 melanoma cells. Previous analyses demonstrated that the concentration of daidzein, genistein and aminoacids/peptides present in BSE, fermented by Aspergillus awamori is much higher than in the non biotransformed extract (NBSE). Experiments comparing the efficacy of the extracts in preventing cancer cell growth showed that treatment (24 h) of aggressive melanoma cells (A375 and 451Lu) with BSE resulted in a dose-dependent inhibition of growth and viability. In contrast, treatment with similar doses of NBSE failed to inhibit melanoma cell viability. Further studies in A375 cells showed that decrease in cell viability with BSE treatment (1.5-1.9 mg/ml; 24 h) was associated with induction of apoptosis. Immunoblot analysis revealed that BSE treatment resulted in induction of PARP cleavage, activation of caspase-3, -7, and -8 and increased expression of TRAIL and its receptor DR4. BSE did not activate the intrinsic apoptotic pathway in A375 cells, as no change was observed in caspase-9 expression. The expression of Bcl-2 apoptotic proteins such as Bid and Bax remained unaffected with BSE treated cells. Interestingly, we also showed that BSE treatment increased the phosphorylation and activation of IKK, I kappa B alpha degradation and p65/NF-kappa B translocation to the nucleus, and that stimulation of the NF-??? B pathway was required for BSE-induced apoptosis of A375 cells. Our findings indicate that the biotransformation of soybean plays a crucial role in the extract anti-cancer effect observed in melanoma cells. However, further studies are warranted to define the active anticancer agent(s) present in BSE.	[Pinto Vilela, Fernanda Maria; Fortes, Vanessa Silveira; Vieira Fonseca, Maria Jose] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Pinto Vilela, Fernanda Maria; Syed, Deeba N.; Chamcheu, Jean Christopher; Mukhtar, Hasan] Univ Wisconsin, Dept Dermatol, Madison, WI USA; [Calvo-Castro, Laura A.] Inst Tecnol Costa Rica, Ctr Invest Biotecnol, Cartago, Costa Rica	Universidade de Sao Paulo; University of Wisconsin System; University of Wisconsin Madison; Instituto Tecnologico de Costa Rica	Mukhtar, H (corresponding author), Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.	hmukhtar@wisc.edu	Vilela, Fernanda/P-3538-2015; Chamcheu, Jean Christopher/J-5451-2018	Chamcheu, Jean Christopher/0000-0002-3927-5664; Calvo-Castro, Laura A./0000-0001-5101-9105	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); CNPQ [200450/2012-3]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are grateful to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil) for the research fellowship. F. M. P. Vilela was the recipient of a CNPQ fellowship (process # 200450/2012-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFAQ F, 2005, MUTAT RES, V57, P1153; Afaq F, 2007, J INVEST DERMATOL, V127, P222, DOI 10.1038/sj.jid.5700510; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Calvo-Castro L, 2013, PHOTOCHEM PHOTOBIOL, V89, P1199, DOI 10.1111/php.12104; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Chen F, 2003, J CELL BIOCHEM, V90, P732, DOI 10.1002/jcb.10668; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Einspahr JG, 2003, RECENT RESULTS CANC, V163, P151; F'guyer S, 2003, PHOTODERMATOL PHOTO, V19, P56, DOI 10.1034/j.1600-0781.2003.00019.x; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Georgetti SR, 2009, J APPL MICROBIOL, V106, P459, DOI 10.1111/j.1365-2672.2008.03978.x; Hsieh MC, 2001, PHYTOCHEMISTRY, V58, P995, DOI 10.1016/S0031-9422(01)00380-6; Huang Y, 2000, CANCER RES, V60, P4426; Khan N, 2008, CARCINOGENESIS, V29, P1049, DOI 10.1093/carcin/bgn078; Kim SB, 2006, FEBS LETT, V580, P311, DOI 10.1016/j.febslet.2005.12.012; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Kurbanov BM, 2007, ONCOGENE, V26, P3364, DOI 10.1038/sj.onc.1210134; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Lin JK, 2002, ARCH PHARM RES, V25, P561, DOI 10.1007/BF02976924; McCue P., 2004, Innovative Food Science & Emerging Technologies, V5, P385, DOI 10.1016/j.ifset.2004.05.003; Otieno DO, 2006, FOOD RES INT, V39, P394, DOI 10.1016/j.foodres.2005.08.010; Sarkar FH, 2004, FRONT BIOSCI-LANDMRK, V9, P2714, DOI 10.2741/1430; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Stark LA, 2001, FASEB J, V15, P1273, DOI 10.1096/fj.00-0529fje; Stark LA, 2007, CARCINOGENESIS, V28, P968, DOI 10.1093/carcin/bgl220; Syed DN, 2007, ONCOGENE, V26, P673, DOI 10.1038/sj.onc.1209829; Syed DN, 2011, J INVEST DERMATOL, V131, P1291, DOI 10.1038/jid.2011.6; Szliszka E, 2011, ONCOL REP, V26, P533, DOI 10.3892/or.2011.1332; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Wang HZ, 2002, J NUTR BIOCHEM, V13, P421, DOI 10.1016/S0955-2863(02)00184-5; Waters JP, 2013, J PATHOL, V230, P241, DOI 10.1002/path.4188; Yin LJ, 2005, BIOSCI BIOTECH BIOCH, V69, P267, DOI 10.1271/bbb.69.267	32	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103248	10.1371/journal.pone.0103248	http://dx.doi.org/10.1371/journal.pone.0103248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072850	gold, Green Published, Green Submitted			2022-12-27	WOS:000341307600035
J	Xu, M; Xiao, YY; Yin, J; Hou, WL; Yu, XY; Shen, L; Liu, F; Wei, L; Jia, WP				Xu, Miao; Xiao, Yuanyuan; Yin, Jun; Hou, Wolin; Yu, Xueying; Shen, Li; Liu, Fang; Wei, Li; Jia, Weiping			Berberine Promotes Glucose Consumption Independently of AMP-Activated Protein Kinase Activation	PLOS ONE			English	Article							FATTY LIVER-DISEASE; 3T3-L1 ADIPOCYTE; ALDOSE REDUCTASE; MESSENGER-RNA; METABOLISM; MECHANISM; METFORMIN; RATS; EXPRESSION; PATHWAY	Berberine is a plant alkaloid with anti-diabetic action. Activation of AMP-activated protein kinase (AMPK) pathway has been proposed as mechanism for berberine's action. This study aimed to examine whether AMPK activation was necessary for berberine's glucose-lowering effect. We found that in HepG2 hepatocytes and C2C12 myotubes, berberine significantly increased glucose consumption and lactate release in a dose-dependent manner. AMPK and acetyl coenzyme A synthetase (ACC) phosphorylation were stimulated by 20 mu mol/L berberine. Nevertheless, berberine was still effective on stimulating glucose utilization and lactate production, when the AMPK activation was blocked by (1) inhibition of AMPK activity by Compound C, (2) suppression of AMPK alpha expression by siRNA, and (3) blockade of AMPK pathway by adenoviruses containing dominant-negative forms of AMPK alpha 1/alpha 2. To test the effect of berberine on oxygen consumption, extracellular flux analysis was performed in Seahorse XF24 analyzer. The activity of respiratory chain complex I was almost fully blocked in C2C12 myotubes by berberine. Metformin, as a positive control, showed similar effects as berberine. These results suggest that berberine and metformin promote glucose metabolism by stimulating glycolysis, which probably results from inhibition of mitochondrial respiratory chain complex I, independent of AMPK activation.	[Xu, Miao; Xiao, Yuanyuan; Yin, Jun; Hou, Wolin; Yu, Xueying; Liu, Fang; Wei, Li; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6,Shanghai Key Lab Diabet, Shanghai Clin Ctr Diabet,Dept Endocrinol & Metab, Shanghai Clin Ctr Metab Dis,Shanghai Diabet Inst, Shanghai 200030, Peoples R China; [Shen, Li] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Clin Nutr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yin, J (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6,Shanghai Key Lab Diabet, Shanghai Clin Ctr Diabet,Dept Endocrinol & Metab, Shanghai Clin Ctr Metab Dis,Shanghai Diabet Inst, Shanghai 200030, Peoples R China.	yinjun@sjtu.edu.cn; weili63@hotmail.com			NSFC fund [31171128, 81200655]; Shanghai Pujiang Project [11PJ1407700]	NSFC fund(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Project(Shanghai Pujiang Program)	This work was supported by NSFC fund (31171128) and Shanghai Pujiang Project (11PJ1407700) to Jun Yin, and NSFC fund (81200655) to Li Shen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2010, AM J PHYSIOL-CELL PH, V299, pC464, DOI 10.1152/ajpcell.00563.2009; Affuso F, 2010, WORLD J CARDIOL, V2, P71, DOI [10.4330/wjc.v2.i3.68, 10.4330/wjc.v2.i4.71]; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Brusq JM, 2006, J LIPID RES, V47, P1281, DOI 10.1194/jlr.M600020-JLR200; Choi BH, 2006, EXP MOL MED, V38, P599, DOI 10.1038/emm.2006.71; Clerc P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034465; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Hu YS, 2012, PHYTOMEDICINE, V19, P861, DOI 10.1016/j.phymed.2012.05.009; Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095; Hwang JM, 2002, ARCH TOXICOL, V76, P664, DOI 10.1007/s00204-002-0351-9; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Jung HA, 2008, ARCH PHARM RES, V31, P1405, DOI 10.1007/s12272-001-2124-z; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Li YY, 2013, TOXICOL APPL PHARM, V273, P325, DOI 10.1016/j.taap.2013.09.006; Liu WH, 2008, ARCH BIOCHEM BIOPHYS, V475, P128, DOI 10.1016/j.abb.2008.04.022; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Nicholls DG, 2010, J VIS EXP, P2511; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Singh AB, 2013, ARTERIOSCLER THROMB; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Wang LH, 2012, PHYTOMEDICINE, V19, P206, DOI 10.1016/j.phymed.2011.11.002; Xing LJ, 2011, EUR J PHARMACOL, V668, P467, DOI 10.1016/j.ejphar.2011.07.036; Yang QH, 2011, CHIN J INTEGR MED, V17, P205, DOI 10.1007/s11655-011-0668-4; Yin J, 2002, METABOLISM, V51, P1439, DOI 10.1053/meta.2002.34715; Yin J., 2001, ACTA U MED SECONDAE, V21, P425; Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; [殷峻 Yin Jun], 2003, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V26, P36; Yin J, 2012, ACTA PHARM SIN B, V2, P327, DOI 10.1016/j.apsb.2012.06.003; Yin J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1275, DOI 10.1152/ajpendo.00092.2009; [殷峻 Yin Jun], 2002, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V18, P488; Zhang LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072092; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	40	63	69	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103702	10.1371/journal.pone.0103702	http://dx.doi.org/10.1371/journal.pone.0103702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072399	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600080
J	Aragon, P; Fitze, PS				Aragon, Pedro; Fitze, Patrick S.			Geographical and Temporal Body Size Variation in a Reptile: Roles of Sex, Ecology, Phylogeny and Ecology Structured in Phylogeny	PLOS ONE			English	Article							BERGMANNS RULE; LACERTID LIZARDS; SPECIES RICHNESS; PSAMMODROMUS SQUAMATA; ECTOTHERMS; PATTERNS; SCALE; BIOGEOGRAPHY; COVARIATION; TEMPERATURE	Geographical body size variation has long interested evolutionary biologists, and a range of mechanisms have been proposed to explain the observed patterns. It is considered to be more puzzling in ectotherms than in endotherms, and integrative approaches are necessary for testing non-exclusive alternative mechanisms. Using lacertid lizards as a model, we adopted an integrative approach, testing different hypotheses for both sexes while incorporating temporal, spatial, and phylogenetic autocorrelation at the individual level. We used data on the Spanish Sand Racer species group from a field survey to disentangle different sources of body size variation through environmental and individual genetic data, while accounting for temporal and spatial autocorrelation. A variation partitioning method was applied to separate independent and shared components of ecology and phylogeny, and estimated their significance. Then, we fed-back our models by controlling for relevant independent components. The pattern was consistent with the geographical Bergmann's cline and the experimental temperature-size rule: adults were larger at lower temperatures (and/or higher elevations). This result was confirmed with additional multi-year independent data-set derived from the literature. Variation partitioning showed no sex differences in phylogenetic inertia but showed sex differences in the independent component of ecology; primarily due to growth differences. Interestingly, only after controlling for independent components did primary productivity also emerge as an important predictor explaining size variation in both sexes. This study highlights the importance of integrating individual-based genetic information, relevant ecological parameters, and temporal and spatial autocorrelation in sex-specific models to detect potentially important hidden effects. Our individual-based approach devoted to extract and control for independent components was useful to reveal hidden effects linked with alternative non-exclusive hypothesis, such as those of primary productivity. Also, including measurement date allowed disentangling and controlling for short-term temporal autocorrelation reflecting sex-specific growth plasticity.	[Aragon, Pedro] Museo Nacl Ciencias Natur, Dept Biogeografi & Cambio Global, Madrid, Spain; [Fitze, Patrick S.] Museo Nacl Ciencias Natur, Dept Biodiversidad Biologi Evolutiva, Madrid, Spain; [Fitze, Patrick S.] Univ Lausanne, Biophore, Dept Ecol & Evolut, Lausanne, Switzerland; [Fitze, Patrick S.] IPE CSIC, Madrid, Spain; [Fitze, Patrick S.] Fundacion Araid, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Aragon, P (corresponding author), Museo Nacl Ciencias Natur, Dept Biogeografi & Cambio Global, Madrid, Spain.	paragon@mncn.csic.es	Aragón, Pedro/B-2598-2009; Fitze, Patrick S./C-1377-2011; Fitze, Patrick S/A-4719-2011	Aragón, Pedro/0000-0002-6849-7274; Fitze, Patrick S./0000-0002-6298-2471; Fitze, Patrick S/0000-0002-6298-2471	Swiss National Science Foundation (SNF); Ramon y Cajal [RYC-2011-07670]; SNF [PPOOP3_128375]; Comunidad de Madrid, Spain [200530M090]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Ramon y Cajal(Spanish Government); SNF; Comunidad de Madrid, Spain(Comunidad de Madrid)	PA was supported by the Swiss National Science Foundation (SNF) and by a Ramon y Cajal contract (RYC-2011-07670). Financial support was provided by the SNF (PPOOP3_128375 to PSF) and by the Comunidad de Madrid, Spain (200530M090 to PSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarello M, 2010, J ARID ENVIRON, V74, P1443, DOI 10.1016/j.jaridenv.2010.05.019; Angilletta MJ, 2003, AM NAT, V162, P332; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Angilletta MJ, 2004, AM NAT, V164, pE168, DOI 10.1086/425222; Aragon P, 2001, CAN J ZOOL, V79, P1965, DOI 10.1139/cjz-79-11-1965; Ashton KG, 2003, EVOLUTION, V57, P1151, DOI 10.1111/j.0014-3820.2003.tb00324.x; ATKINSON D, 1996, ANIMALS TEMPERATURE, P183; Aubad J, 2008, FOREST ECOL MANAG, V255, P1892, DOI 10.1016/j.foreco.2007.12.011; Aubret F, 2012, AM NAT, V179, P756, DOI 10.1086/665653; Bauwens D, 1997, AM NAT, V149, P91, DOI 10.1086/285980; Belliure J, 1996, ECOLOGY, V77, P1163, DOI 10.2307/2265585; Bergmann K., 1847, GOTTINGER STUDIEN, V3, P595; Bini LM, 2009, ECOGRAPHY, V32, P193, DOI 10.1111/j.1600-0587.2009.05717.x; CARRETERO M A, 1991, Amphibia-Reptilia, V12, P395, DOI 10.1163/156853891X00040; Carretero MA, 1994, BUTLL NAT DELT LLOB, V1, P13; Chamaille-Jammes S, 2006, GLOBAL CHANGE BIOL, V12, P392, DOI 10.1111/j.1365-2486.2005.01088.x; Cruz FB, 2005, J EVOLUTION BIOL, V18, P1559, DOI 10.1111/j.1420-9101.2005.00936.x; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Desdevises Y, 2003, EVOLUTION, V57, P2647; Diaz JA, 1996, PHYSIOL ZOOL, V69, P1359, DOI 10.1086/physzool.69.6.30164264; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Diniz JAF, 2007, ECOGRAPHY, V30, P598, DOI 10.1111/j.2007.0906-7590.04988.x; Diniz JAF, 2012, ECOGRAPHY, V35, P239, DOI 10.1111/j.1600-0587.2011.06949.x; Ficetola GF, 2010, GLOBAL ECOL BIOGEOGR, V19, P485, DOI 10.1111/j.1466-8238.2010.00535.x; Fitze PS, 2012, ZOOTAXA, P41; Fitze PS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-347; Fitze PS, 2012, ENCICLOPEDIA VIRTUAL, P18; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Guillaumet A, 2008, J BIOGEOGR, V35, P579, DOI 10.1111/j.1365-2699.2007.01826.x; Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x; Herrel A, 2008, P NATL ACAD SCI USA, V105, P4792, DOI 10.1073/pnas.0711998105; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Horvathova T, 2013, ECOL EVOL, V3, P2424, DOI 10.1002/ece3.613; Huston MA, 2011, ECOL MONOGR, V81, P349, DOI 10.1890/10-1523.1; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Legendre P., 2012, NUMERICAL ECOLOGY; Massot M, 2013, CURR BIOL, V23, P1320, DOI 10.1016/j.cub.2013.05.047; McNab BK, 2010, OECOLOGIA, V164, P13, DOI 10.1007/s00442-010-1621-5; Meiri S, 2011, GLOBAL ECOL BIOGEOGR, V20, P203, DOI 10.1111/j.1466-8238.2010.00577.x; Mousseau TA, 1997, EVOLUTION, V51, P630, DOI [10.2307/2411138, 10.1111/j.1558-5646.1997.tb02453.x]; Olalla-Tarraga MA, 2006, J BIOGEOGR, V33, P781, DOI 10.1111/j.1365-2699.2006.01435.x; Olalla-Tarraga MA, 2011, OIKOS, V120, P1441, DOI 10.1111/j.1600-0706.2011.19319.x; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; Oufiero CE, 2011, EVOLUTION, V65, P3590, DOI 10.1111/j.1558-5646.2011.01405.x; Pascual Gonzalez J.A., 1989, Donana Acta Vertebrata, V16, P45; Pincheira-Donoso D, 2010, THEOR BIOSCI, V129, P247, DOI 10.1007/s12064-010-0101-0; Pincheira-Donoso D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-68; Quinn GP, 2002, EXPERIMENTAL DESIGN; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; San-Jose LM, 2012, CONTRIB ZOOL, V81, P181, DOI 10.1163/18759866-08104001; Stillwell RC, 2010, OIKOS, V119, P1387, DOI 10.1111/j.1600-0706.2010.18670.x; Watt C, 2010, OIKOS, V119, P89, DOI 10.1111/j.1600-0706.2009.17959.x; Yom-Tov Y, 2011, BIOL REV, V86, P531, DOI 10.1111/j.1469-185X.2010.00168.x	55	18	18	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104026	10.1371/journal.pone.0104026	http://dx.doi.org/10.1371/journal.pone.0104026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090025	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700082
J	Chen, M; Huang, Q; Xu, W; She, C; Xie, ZG; Mao, YT; Dong, QR; Ling, M				Chen, Ming; Huang, Qun; Xu, Wei; She, Chang; Xie, Zong-Gang; Mao, Yong-Tao; Dong, Qi-Rong; Ling, Ming			Low-Dose X-Ray Irradiation Promotes Osteoblast Proliferation, Differentiation and Fracture Healing	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; IONIZING-RADIATION; MC3T3-E1 CELLS; STRAND BREAKS; BONE; EXPRESSION; MICE; QUANTIFICATION; MINERALIZATION; EXPOSURE	Great controversy exists regarding the biologic responses of osteoblasts to X-ray irradiation, and the mechanisms are poorly understood. In this study, the biological effects of low-dose radiation on stimulating osteoblast proliferation, differentiation and fracture healing were identified using in vitro cell culture and in vivo animal studies. First, low-dose (0.5 Gy) X-ray irradiation induced the cell viability and proliferation of MC3T3-E1 cells. However, high-dose (5 Gy) X-ray irradiation inhibited the viability and proliferation of osteoblasts. In addition, dynamic variations in osteoblast differentiation markers, including type I collagen, alkaline phosphatase, Runx2, Osterix and osteocalcin, were observed after both low-dose and high-dose irradiation by Western blot analysis. Second, fracture healing was evaluated via histology and gene expression after single-dose X-ray irradiation, and low-dose X-ray irradiation accelerates fracture healing of closed femoral fractures in rats. In low-dose X-ray irradiated fractures, an increase in proliferating cell nuclear antigen (PCNA)-positive cells, cartilage formation and fracture calluses was observed. In addition, we observed more rapid completion of endochondral and intramembranous ossification, which was accompanied by altered expression of genes involved in bone remodeling and fracture callus mineralization. Although the expression level of several osteoblast differentiation genes was increased in the fracture calluses of high-dose irradiated rats, the callus formation and fracture union were delayed compared with the control and low-dose irradiated fractures. These results reveal beneficial effects of low-dose irradiation, including the stimulation of osteoblast proliferation, differentiation and fracture healing, and highlight its potential translational application in novel therapies against bone-related diseases.	[Chen, Ming; Ling, Ming] Shaanxi Prov Peoples Hosp, Dept Orthoped, Xian, Shaanxi, Peoples R China; [Huang, Qun; Xu, Wei; She, Chang; Xie, Zong-Gang; Mao, Yong-Tao; Dong, Qi-Rong] Soochow Univ, Affiliated Hosp 2, Dept Orthoped, Suzhou, Jiangsu, Peoples R China	Xi'an Medical University; Soochow University - China	Dong, QR (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Orthoped, Suzhou, Jiangsu, Peoples R China.	dongqirong@hotmail.com; lingming029@163.com		Mao, Yongtao/0000-0002-3572-3044	National Natural Science Foundation of China [81171730]; Plans for Graduate Research and Innovation in Colleges and Universities of Jiangsu Province [CXZZ12_0841]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plans for Graduate Research and Innovation in Colleges and Universities of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (81171730) and the Plans for Graduate Research and Innovation in Colleges and Universities of Jiangsu Province (CXZZ12_0841). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwood Joshua S, 2012, J Aging Res, V2012, P481983, DOI 10.1155/2012/481983; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Caetano-Lopes J, 2007, ACTA REUMATOL PORT, V32, P103; Chae HU, 1999, J RADIAT RES, V40, P323, DOI 10.1269/jrr.40.323; Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.3.CO;2-Q; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; Green DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064952; He J, 2011, J CRANIOFAC SURG, V22, P1635, DOI 10.1097/SCS.0b013e31822e5f66; Iwaki A, 1997, J BONE MINER RES, V12, P96, DOI 10.1359/jbmr.1997.12.1.96; Jia D, 2011, RADIAT RES, V176, P624, DOI 10.1667/RR2505.1; Lau P, 2010, RADIAT ENVIRON BIOPH, V49, P271, DOI 10.1007/s00411-010-0272-6; Lee IJ, 2009, INT J RADIAT ONCOL, V75, P1084, DOI 10.1016/j.ijrobp.2008.12.052; Li W, 2004, EXP HEMATOL, V32, P1088, DOI 10.1016/j.exphem.2004.07.015; Liang XY, 2011, J RADIAT RES, V52, P380, DOI 10.1269/jrr.10121; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Matsumura S, 1998, RADIAT RES, V149, P463, DOI 10.2307/3579786; Naik AA, 2009, J BONE MINER RES, V24, P251, DOI 10.1359/JBMR.081002; Park SS, 2012, BMB REP, V45, P571, DOI 10.5483/BMBRep.2012.45.10.101; Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335; Peyre HM, 2000, INT J RADIAT BIOL, V76, P87, DOI 10.1080/095530000139041; Phulpin B, 2010, EXP THER MED, V1, P553, DOI 10.3892/etm_00000087; Pramojanee SN, 2012, ARCH ORAL BIOL, V57, P252, DOI 10.1016/j.archoralbio.2011.09.004; Sakurai T, 2007, J RADIAT RES, V48, P515, DOI 10.1269/jrr.07012; Sangsliwan T, 2008, RADIAT RES, V170, P776, DOI 10.1667/RR1399.1; Schnoke M, 2009, BONE, V45, P590, DOI 10.1016/j.bone.2009.05.006; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Smialek MA, 2009, RADIAT RES, V172, P529, DOI 10.1667/RR1684.1; SRIVASTAVA UK, 1989, INDIAN J EXP BIOL, V27, P602; Sugrue T, 2013, STEM CELLS, V31, P137, DOI 10.1002/stem.1222; Szymczyk KH, 2004, BONE, V34, P148, DOI 10.1016/j.bone.2003.09.003; TAKAHASHI S, 1994, J BONE JOINT SURG AM, V76A, P722, DOI 10.2106/00004623-199405000-00014; Theocharopoulos N, 2003, J BONE JOINT SURG AM, V85A, P1698, DOI 10.2106/00004623-200309000-00007; Tsai CJ, 2013, INT J RADIAT ONCOL, V85, P415, DOI 10.1016/j.ijrobp.2012.05.032; Williams HJ, 2006, EUR RADIOL, V16, P619, DOI 10.1007/s00330-005-0010-7; Xu W, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-94; Yu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061362; Zhang MJ, 2011, J BONE MINER RES, V26, P792, DOI 10.1002/jbmr.272; Zhou XZ, 2009, ARCH ORTHOP TRAUM SU, V129, P125, DOI 10.1007/s00402-008-0634-6	39	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104016	10.1371/journal.pone.0104016	http://dx.doi.org/10.1371/journal.pone.0104016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089831	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700080
J	Domagalska-Szopa, M; Szopa, A				Domagalska-Szopa, Malgorzata; Szopa, Andrzej			Gait Pattern Differences between Children with Mild Scoliosis and Children with Unilateral Cerebral Palsy	PLOS ONE			English	Article							SPASTIC HEMIPLEGIA; DEFORMITY; KINEMATICS; PATHOLOGY; SPINE	This study was conducted to investigate the effects of asymmetrical body posture alone, i.e., the effects seen in children with mild scoliosis, vs. the effects of body posture control impairment, i.e., those seen in children with unilateral cerebral palsy on gait patterns. Three-dimensional instrumented gait analysis (3DGA) was conducted in 45 children with hemiplegia and 51 children with mild scoliosis. All the children were able to walk without assistance devices. A set of 35 selected spatiotemporal gait and kinematics parameters were evaluated when subjects walked on a treadmill. A cluster analysis revealed 3 different gait patterns: a scoliotic gait pattern and 2 different hemiplegic gait patterns. The results showed that the discrepancy in gait patterns was not simply a lower limb kinematic deviation in the sagittal plane, as expected. Additional altered kinematics, such as pelvic misorientation in the coronal plane in both the stance and swing phases and inadequate stance phase hip ad/abduction, which resulted from postural pattern features, were distinguished between the 3 gait patterns. Our study provides evidence for a strong correlation between postural and gait patterns in children with unilateral cerebral palsy. Information on differences in gait patterns may be used to improve the guidelines for early therapy for children with hemiplegia before abnormal gait patterns are fully established. The gait pathology characteristic of scoliotic children is a potential new direction for treating scoliosis that complements the standard posture and walking control therapy exercises with the use of biofeedback.	[Domagalska-Szopa, Malgorzata] Med Univ Silesia, Sch Hlth Sci, Dept Physiotherapy, Inst Med Rehabil, Katowice, Poland; [Szopa, Andrzej] Med Univ Silesia, Sch Hlth Sci, Dept Physiotherapy, Inst Physiotherapy, Katowice, Poland	Medical University Silesia; Medical University Silesia	Domagalska-Szopa, M (corresponding author), Med Univ Silesia, Sch Hlth Sci, Dept Physiotherapy, Inst Med Rehabil, Katowice, Poland.	mdomagalska@sum.edu.pl		Domagalska-Szopa, Malgorzata/0000-0001-9086-9970; Szopa, Andrzej/0000-0002-1765-1622				Becher JG., 2002, J PROSTHET ORTHOT, V14, P143, DOI DOI 10.1097/00008526-200212000-00004; Carlberg Eva Brogren, 2005, Neural Plast, V12, P221, DOI 10.1155/NP.2005.221; Chen PQ, 1998, CLIN BIOMECH, V13, pS52, DOI 10.1016/S0268-0033(97)00075-2; Davidson I, 2002, 022 SUNY; Domagalska M, 2013, GAIT POSTURE, V38, P1038, DOI 10.1016/j.gaitpost.2013.05.031; Domagalska Malgorzata, 2006, Ortop Traumatol Rehabil, V8, P291; Domagalska-Szopa M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/462094; GAGE JR, 1995, J BONE JOINT SURG AM, V77, P1607, DOI 10.2106/00004623-199510000-00017; GAGE JR, 1993, CLIN ORTHOP RELAT R, P126; Gage JR, 2004, TREATMENT GAIT PROBL; Graham HK, 2004, CLIN DEV MED, P105; Hullin MG, 1996, J PEDIATR ORTHOP B, V5, P247, DOI 10.1097/01202412-199605040-00006; Mahaudens P, 2009, EUR SPINE J, V18, P512, DOI 10.1007/s00586-009-0899-7; Mahaudens Philippe, 2005, Spine J, V5, P427; Molenaers G, 2006, J BONE JOINT SURG AM, V88A, P161, DOI 10.2106/JBJS.C.01497; Ounpuu S, 1996, J PEDIATR ORTHOPED, V16, P378, DOI 10.1097/01241398-199605000-00017; Paroczai R., 2006, PHYS ED SPORT, V4, P49; Perry J., 1992, GAIT ANAL NORMAL PAT; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; Stebbins J., 2004, GAIT POSTURE, V20, pS82; Syczewska M, 2012, GAIT POSTURE, V35, P209, DOI 10.1016/j.gaitpost.2011.09.008; Syczewska M, 2010, ACTA BIOENG BIOMECH, V12, P25; Unsworth C. A, 2007, PHYS REHABILITATION, P1149; van der Heide Jolanda C., 2005, Neural Plasticity, V12, P197; Winter David A., 2009, BIOMECHANICS MOTOR C, V4th, P75; WINTERS TF, 1987, J BONE JOINT SURG AM, V69A, P437; Woollacott Marjorie Hines, 2005, Neural Plasticity, V12, P211, DOI 10.1155/NP.2005.211	27	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103095	10.1371/journal.pone.0103095	http://dx.doi.org/10.1371/journal.pone.0103095			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089908	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700015
J	Milet, C; Rincheval-Arnold, A; Morieras, A; Clavier, A; Garrigue, A; Mignotte, B; Guenal, I				Milet, Cecile; Rincheval-Arnold, Aurore; Morieras, Angeline; Clavier, Amandine; Garrigue, Alexandrine; Mignotte, Bernard; Guenal, Isabelle			Mutating RBF Can Enhance Its Pro-Apoptotic Activity and Uncovers a New Role in Tissue Homeostasis	PLOS ONE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; PROTEIN INDUCES APOPTOSIS; DROSOPHILA IMAGINAL DISCS; SVM-BASED PREDICTION; CELL-CYCLE CONTROL; COMPENSATORY PROLIFERATION; CASPASE DRONC; CLEAVAGE SITES; MUTANT-CELLS; DEATH	The tumor suppressor retinoblastoma protein (pRb) is inactivated in a wide variety of cancers. While its role during cell cycle is well characterized, little is known about its properties on apoptosis regulation and apoptosis-induced cell responses. pRb shorter forms that can modulate pRB apoptotic properties, resulting from cleavages at caspase specific sites are observed in several cellular contexts. A bioinformatics analysis showed that a putative caspase cleavage site (TELD) is found in the Drosophila homologue of pRb (RBF) at a position similar to the site generating the p76Rb form in mammals. Thus, we generated a punctual mutant form of RBF in which the aspartate of the TELD site is replaced by an alanine. This mutant form, RBFD253A, conserved the JNK-dependent pro-apoptotic properties of RBF but gained the ability of inducing overgrowth phenotypes in adult wings. We show that this overgrowth is a consequence of an abnormal proliferation in wing imaginal discs, which depends on the JNK pathway activation but not on wingless (wg) ectopic expression. These results show for the first time that the TELD site of RBF could be important to control the function of RBF in tissue homeostasis in vivo.	[Milet, Cecile; Rincheval-Arnold, Aurore; Morieras, Angeline; Clavier, Amandine; Garrigue, Alexandrine; Mignotte, Bernard; Guenal, Isabelle] Univ Versailles St Quentin En Yvelines, Ecole Prat Hautes Etud, Lab Genet & Biol Cellulaire EA4589, Montigny Le Bretonneux, France	UDICE-French Research Universities; Universite Paris Saclay	Guenal, I (corresponding author), Univ Versailles St Quentin En Yvelines, Ecole Prat Hautes Etud, Lab Genet & Biol Cellulaire EA4589, Montigny Le Bretonneux, France.	isabelle.guenal@uvsq.fr	Mignotte, Bernard/A-3499-2009; Guenal, Isabelle/F-3415-2019	Mignotte, Bernard/0000-0002-8512-8518; Guenal, Isabelle/0000-0003-1186-1458; Garrigue, Alexandrine/0000-0002-2660-3681	Universite de Versailles Saint-Quentin-en-Yvelines; Association pour la Recherche contre le Cancer; Ligue Nationale Contre le Cancer; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; Ecole Pratique des Hautes Etudes	Universite de Versailles Saint-Quentin-en-Yvelines; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; Ecole Pratique des Hautes Etudes	This work was supported by the Universite de Versailles Saint-Quentin-en-Yvelines and by grants from the Association pour la Recherche contre le Cancer and the Ligue Nationale Contre le Cancer. Cecile Milet held successive fellowships from the Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche and the Ecole Pratique des Hautes Etudes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2012, G3-GENES GENOM GENET, V2, P1459, DOI 10.1534/g3.112.004424; Berge EO, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-173; Bertin-Ciftci J, 2013, CELL DEATH DIFFER, V20, P755, DOI 10.1038/cdd.2013.6; Borges HL, 2005, P NATL ACAD SCI USA, V102, P15587, DOI 10.1073/pnas.0503925102; Bosco G, 2010, NATURE, V466, P1051, DOI 10.1038/4661051a; Boutillier AL, 2000, ONCOGENE, V19, P2171, DOI 10.1038/sj.onc.1203532; Bowen C, 1998, CANCER RES, V58, P3275; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen W D, 1999, Mol Cell Biol Res Commun, V1, P216, DOI 10.1006/mcbr.1999.0132; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Du W, 1999, EMBO J, V18, P916, DOI 10.1093/emboj/18.4.916; Fattman CL, 1998, CANCER LETT, V130, P103, DOI 10.1016/S0304-3835(98)00121-9; Fattman CL, 1997, J CELL BIOCHEM, V67, P399; Ferecatu I, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-50; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Hassler M, 2007, MOL CELL, V28, P371, DOI 10.1016/j.molcel.2007.08.023; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Herrera SC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003446; Hilgendorf KI, 2013, GENE DEV, V27, P1003, DOI 10.1101/gad.211326.112; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Ianari A, 2009, CANCER CELL, V15, P184, DOI 10.1016/j.ccr.2009.01.026; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Janicke RU, 1996, EMBO J, V15, P6969, DOI 10.1002/j.1460-2075.1996.tb01089.x; Knudsen KE, 1999, ONCOGENE, V18, P5239, DOI 10.1038/sj.onc.1202910; Le Floch N, 2010, BIOCHEM BIOPH RES CO, V399, P173, DOI 10.1016/j.bbrc.2010.07.041; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Lemaire C, 2005, ONCOGENE, V24, P3297, DOI 10.1038/sj.onc.1208493; Milet C, 2010, CELL CYCLE, V9, P97, DOI 10.4161/cc.9.1.10251; Mollereau B, 2013, CELL DEATH DIFFER, V20, P181, DOI 10.1038/cdd.2012.82; Moon NS, 2006, MOL CELL BIOL, V26, P7601, DOI 10.1128/MCB.00836-06; Moon NS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000153; MORGENBESSER SD, 1994, NATURE, V371, P72, DOI 10.1038/371072a0; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Perez-Garijo A, 2005, P NATL ACAD SCI USA, V102, P17664, DOI 10.1073/pnas.0508966102; Perez-Garijo A, 2009, DEVELOPMENT, V136, P1169, DOI 10.1242/dev.034017; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Sharma A, 2007, CANCER RES, V67, P6192, DOI 10.1158/0008-5472.CAN-06-4424; Snipas SJ, 2008, CELL DEATH DIFFER, V15, P938, DOI 10.1038/cdd.2008.23; Tan XQ, 1997, J BIOL CHEM, V272, P9613; Tanaka-Matakatsu M, 2009, DEV BIOL, V326, P347, DOI 10.1016/j.ydbio.2008.11.035; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wee LJK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S14; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; Wells BS, 2006, CURR BIOL, V16, P1606, DOI 10.1016/j.cub.2006.07.046; Worley MI, 2012, ANNU REV GENET, V46, P289, DOI 10.1146/annurev-genet-110711-155637; Young AP, 2004, ONCOGENE, V23, P2587, DOI 10.1038/sj.onc.1207330	54	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102902	10.1371/journal.pone.0102902	http://dx.doi.org/10.1371/journal.pone.0102902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089524	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700011
J	Murakami, Y				Murakami, Yohei			Bayesian Parameter Inference and Model Selection by Population Annealing in Systems Biology	PLOS ONE			English	Article							ERK MAP KINASE; NETWORK MOTIFS; MONTE-CARLO; TRANSCRIPTIONAL REGULATION; BIOCHEMICAL PATHWAYS; DYNAMICAL-SYSTEMS; CIRCADIAN CLOCK; PHOSPHORYLATION; OPTIMIZATION; COMPUTATION	Parameter inference and model selection are very important for mathematical modeling in systems biology. Bayesian statistics can be used to conduct both parameter inference and model selection. Especially, the framework named approximate Bayesian computation is often used for parameter inference and model selection in systems biology. However, Monte Carlo methods needs to be used to compute Bayesian posterior distributions. In addition, the posterior distributions of parameters are sometimes almost uniform or very similar to their prior distributions. In such cases, it is difficult to choose one specific value of parameter with high credibility as the representative value of the distribution. To overcome the problems, we introduced one of the population Monte Carlo algorithms, population annealing. Although population annealing is usually used in statistical mechanics, we showed that population annealing can be used to compute Bayesian posterior distributions in the approximate Bayesian computation framework. To deal with un-identifiability of the representative values of parameters, we proposed to run the simulations with the parameter ensemble sampled from the posterior distribution, named "posterior parameter ensemble''. We showed that population annealing is an efficient and convenient algorithm to generate posterior parameter ensemble. We also showed that the simulations with the posterior parameter ensemble can, not only reproduce the data used for parameter inference, but also capture and predict the data which was not used for parameter inference. Lastly, we introduced the marginal likelihood in the approximate Bayesian computation framework for Bayesian model selection. We showed that population annealing enables us to compute the marginal likelihood in the approximate Bayesian computation framework and conduct model selection depending on the Bayes factor.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Div Biol, Kyoto, Japan	Kyoto University	Murakami, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Div Biol, Kyoto, Japan.	murakami@theory.biophys.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Grants for Excellent Graduate Schools, MEXT, Japan; MEXT	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants for Excellent Graduate Schools, MEXT, Japan; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, by Grants for Excellent Graduate Schools, MEXT, Japan and by Grant-in-Aid for Scientific Research of the MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; Ashyraliyev M, 2009, FEBS J, V276, P886, DOI 10.1111/j.1742-4658.2008.06844.x; Barnes CP, 2011, P NATL ACAD SCI USA, V108, P15190, DOI 10.1073/pnas.1017972108; Beaumont MA, 2002, GENETICS, V162, P2025; Eissing T, 2005, IEE P SYST BIOL, V152, P221, DOI 10.1049/ip-syb:20050046; Eydgahi H, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.69; Green PJ, 1995, BIOMETRIKA, V82, P64; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Hayot F, 2005, J THEOR BIOL, V234, P133, DOI 10.1016/j.jtbi.2004.11.010; Hukushima K, 2003, AIP CONF PROC, V690, P200, DOI 10.1063/1.1632130; Iba Y, 2005, KEISAN TOUKEI, P293; Iba Yukito, 2001, T JPN SOC ARTIF INTE, V16, P279, DOI DOI 10.1527/TJSAI.16.279; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kirk P, 2013, CURR OPIN BIOTECH, V24, P767, DOI 10.1016/j.copbio.2013.03.012; Kirk PDW, 2008, BIOPHYS J, V95, P540, DOI 10.1529/biophysj.107.126086; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kondo Y, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042716; Kubota H, 2012, MOL CELL, V46, P820, DOI 10.1016/j.molcel.2012.04.018; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Machta J, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026704; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marin JM, 2012, STAT COMPUT, V22, P1167, DOI 10.1007/s11222-011-9288-2; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; Murakami Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074178; Neal RM, 2001, STAT COMPUT, V11, P125, DOI 10.1023/A:1008923215028; Noguchi R, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.19; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Pullen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088419; Secrier M, 2009, MOL BIOSYST, V5, P1925, DOI 10.1039/b908951a; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Sisson SA, 2011, CH CRC HANDB MOD STA, P313; Sunnaker M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002803; Toni T, 2012, MOL BIOSYST, V8, P1921, DOI 10.1039/c2mb05493k; Toni T, 2010, BIOINFORMATICS, V26, P104, DOI 10.1093/bioinformatics/btp619; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Vyshemirsky V, 2008, BIOINFORMATICS, V24, P833, DOI 10.1093/bioinformatics/btm607; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Zeilinger MN, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100101; Zi ZK, 2005, J COMPUT SCI TECH-CH, V20, P491, DOI 10.1007/s11390-005-0491-5	50	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104057	10.1371/journal.pone.0104057	http://dx.doi.org/10.1371/journal.pone.0104057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089832	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700091
J	Obschonka, M; Schmitt-Rodermund, E; Terracciano, A				Obschonka, Martin; Schmitt-Rodermund, Eva; Terracciano, Antonio			Personality and the Gender Gap in Self-Employment: A Multi-Nation Study	PLOS ONE			English	Article							BIG 5; 5-FACTOR MODEL; RISK-TAKING; ENTREPRENEURSHIP; TRAITS; FEMALE; EFFICACY; CULTURES; INTENTIONS; STABILITY	What role does personality play in the pervasive gender gap in entrepreneurship across the globe? This two-study analysis focuses on self-employment in the working population and underlying gender differences in personality characteristics, thereby considering both single trait dimensions as well as a holistic, configural personality approach. Applying the five-factor model of personality, Study 1, our main study, investigates mediation models in the prediction of self-employment status utilizing self-reported personality data from large-scaled longitudinal datasets collected in the U.S., Germany, the U.K., and Australia (total N = 28,762). Study 2 analyzes (observer-rated) Big Five data collected in 51 cultures (total N = 12,156) to take a more global perspective and to explore the pancultural universality of gender differences in entrepreneurial personality characteristics. Across the four countries investigated in Study 1, none of the major five dimension of personality turned out as a consistent and robust mediator. In contrast, the holistic, configural approach yielded consistent and robust mediation results. Across the four countries, males scored higher on an entrepreneurship-prone personality profile, which in turn predicted self-employment status. These results suggest that gender differences in the intra-individual configuration of personality traits contribute to the gender gap in entrepreneurship across the globe. With the restriction of limited representativeness, the data from Study 2 suggest that the gender difference in the entrepreneurship-prone personality profile (males score higher) is widespread across many cultures, but may not exist in all. The results are discussed with an emphasis on implications for research and practice, which a particular focus on the need for more complex models that incorporate the role of personality.	[Obschonka, Martin; Schmitt-Rodermund, Eva] Univ Jena, Ctr Appl Dev Sci, Jena, Germany; [Obschonka, Martin] Univ Saarland, Dept Psychol, D-66123 Saarbrucken, Germany; [Terracciano, Antonio] Florida State Univ, Coll Med, Dept Geriatr, Tallahassee, FL 32306 USA	Friedrich Schiller University of Jena; Saarland University; State University System of Florida; Florida State University	Obschonka, M (corresponding author), Univ Jena, Ctr Appl Dev Sci, Jena, Germany.	martin.obschonka@uni-jena.de	Terracciano, Antonio/H-7403-2019	Terracciano, Antonio/0000-0001-5799-8885; Obschonka, Martin/0000-0002-0853-7166	PATHWAYS International Postdoctoral Fellowship Programme for the Comparative Study of Productive Youth Development (Jacobs Foundation); Center for Applied Developmental Science (CADS) of the Friedrich-Schiller-University of Jena, Germany; Federal Ministry of Economics and Technology Germany; European Structural Funds, and EXIST - Science based Business Start ups	PATHWAYS International Postdoctoral Fellowship Programme for the Comparative Study of Productive Youth Development (Jacobs Foundation); Center for Applied Developmental Science (CADS) of the Friedrich-Schiller-University of Jena, Germany; Federal Ministry of Economics and Technology Germany(Federal Ministry for Economic Affairs and Energy (BMWi)); European Structural Funds, and EXIST - Science based Business Start ups	The work of the first author on this study was supported by the PATHWAYS International Postdoctoral Fellowship Programme for the Comparative Study of Productive Youth Development (Jacobs Foundation) and the Center for Applied Developmental Science (CADS) of the Friedrich-Schiller-University of Jena, Germany. Work on gender-related issues concerning entrepreneurship ("Female Business Founders - why so few?"; PI: Eva Schmitt-Rodermund) was supported by the Federal Ministry of Economics and Technology Germany, the European Structural Funds, and EXIST - Science based Business Start ups. The data on the 51 cultures were taken from a previous study (McCrae, Terracciano, et al., 2005b), and the contributions to that study by the international collaborators are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHADI S, 1989, J PERS SOC PSYCHOL, V56, P398, DOI 10.1037/0022-3514.56.3.398; Amoros, 2011, GLOBAL ENTREPRENEURS; Barrick MR, 2003, PERS PSYCHOL, V56, P45, DOI 10.1111/j.1744-6570.2003.tb00143.x; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; Blanchflower DG, 2000, LABOUR ECON, V7, P471, DOI 10.1016/S0927-5371(00)00011-7; Blanchflower DG, 2004, SWEDISH EC POL REV, V11, P15, DOI DOI 10.3386/W10286; Bleidorn W, 2013, PSYCHOL SCI, V24, P2530, DOI 10.1177/0956797613498396; BOWEN DD, 1986, ACAD MANAGE REV, V11, P393; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Chen CC, 1998, J BUS VENTURING, V13, P295, DOI 10.1016/S0883-9026(97)00029-3; Cobb-Clark DA, 2012, ECON LETT, V115, P11, DOI 10.1016/j.econlet.2011.11.015; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; COSTA PT, 1984, J APPL PSYCHOL, V69, P390, DOI 10.1037/0021-9010.69.3.390; Costa PT, 2007, REVISED NEO PERSONAL; Cowling M, 2001, SMALL BUS ECON, V16, P167, DOI 10.1023/A:1011195516912; CRONBACH LJ, 1953, PSYCHOL BULL, V50, P456, DOI 10.1037/h0057173; DeFruyt F, 1997, PERS INDIV DIFFER, V23, P87, DOI 10.1016/S0191-8869(97)00004-4; Donnellan MB, 2011, PSYCHOL AGING, V23, P558; EDWARDS JR, 1994, ORGAN BEHAV HUM DEC, V58, P51, DOI 10.1006/obhd.1994.1029; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Fritsch M, 2010, JENA EC RES PAPERS, P2010; Gerlitz J. Y., 2005, RES NOTES, V4; Graham EK, 2012, J GERONTOL B-PSYCHOL, V67, P545, DOI 10.1093/geronb/gbr149; Gupta VK, 2009, ENTREP THEORY PRACT, V33, P397, DOI 10.1111/j.1540-6520.2009.00296.x; Heineck G, 2010, LABOUR ECON, V17, P535, DOI 10.1016/j.labeco.2009.06.001; Holland J. L, 1997, MAKING VOCATIONAL CH; John O, 1991, BIG 5 INVENTORY VERS; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Keyes CLM, 2002, J PERS SOC PSYCHOL, V82, P1007, DOI 10.1037//0022-3514.82.6.1007; Knight, 1933, RISK UNCERTAINTY PRO; Koellinger P, 2013, OXFORD B ECON STAT, V75, P213, DOI 10.1111/j.1468-0084.2011.00689.x; KOHN ML, 1982, AM J SOCIOL, V87, P1257, DOI 10.1086/227593; Kourilsky ML, 1998, J BUS VENTURING, V13, P77, DOI 10.1016/S0883-9026(97)00032-3; KRUEGER N, 1994, DECISION SCI, V25, P385, DOI 10.1111/j.1540-5915.1994.tb01849.x; Leoni T, 2010, SMALL BUS ECON, V34, P167, DOI 10.1007/s11187-008-9114-1; Lucas RE, 2011, J PERS SOC PSYCHOL, V101, P847, DOI 10.1037/a0024298; Lucas RE, 2009, DEV PSYCHOL, V45, P1353, DOI 10.1037/a0013914; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; MAGNUSSON D, 1993, ANNU REV PSYCHOL, V44, P427, DOI 10.1146/annurev.ps.44.020193.002235; Masters Robert, 1988, J SMALL BUS MANAGE, V26, P31; McClelland D.C., 1961, ACHIEVING SOC, P23; McCrae R.R., 2008, HDB PERSONALITY THEO, P159; McCrae RR, 2005, J PERS SOC PSYCHOL, V89, P407, DOI 10.1037/0022-3514.89.3.407; McCrae RR, 2005, J PERS SOC PSYCHOL, V88, P547, DOI 10.1037/0022-3514.88.3.547; Muller J, 2012, J ECON PSYCHOL, V33, P448, DOI 10.1016/j.joep.2011.12.005; Nicolaou N, 2014, J MANAGE INQUIRY, V23, P98, DOI 10.1177/1056492613485914; Nicolaou N, 2009, J BUS VENTURING, V24, P1, DOI 10.1016/j.jbusvent.2007.11.003; Obschonka M, 2013, J PERS SOC PSYCHOL, V105, P104, DOI 10.1037/a0032275; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Prenda KM, 2001, PSYCHOL AGING, V16, P206, DOI 10.1037//0882-7974.16.2.206; Radler BT, 2010, J AGING HEALTH, V22, P307, DOI 10.1177/0898264309358617; Rauch A, 2007, ORGANIZATIONAL FRONT, P41; Raudenbush SW, 2004, SSI; Roberts BW, 2003, J PERS SOC PSYCHOL, V84, P582, DOI 10.1037/0022-3514.84.3.582; SAUCIER G, 1994, J PERS ASSESS, V63, P506, DOI 10.1207/s15327752jpa6303_8; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Schmitt-Rodermund E, 2004, J VOCAT BEHAV, V65, P498, DOI 10.1016/j.jvb.2003.10.007; Schmitt-Rodermund E., 2007, APPROACHES POSITIVE, P205, DOI DOI 10.4135/9781446213803.N11; Schneider B, 1998, J APPL PSYCHOL, V83, P462, DOI 10.1037/0021-9010.83.3.462; Schumpeter Joseph, 1934, THEORY EC DEV INQUIR; SEXTON DL, 1990, J BUS VENTURING, V5, P29, DOI 10.1016/0883-9026(90)90024-N; Shane S, 2010, J APPL PSYCHOL, V95, P1154, DOI 10.1037/a0020294; Stuetzer M, 2013, SMALL BUS E IN PRESS; Terracciano A, 2005, SCIENCE, V310, P96, DOI 10.1126/science.1117199; Tokar DM, 2000, J COUNS PSYCHOL, V47, P380, DOI 10.1037//0022-0167.47.3.380; Turiano NA, 2012, J GERONTOL B-PSYCHOL, V67, P4, DOI 10.1093/geronb/gbr072; van der Loos MJHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060542; Verheul I, 2012, J ECON PSYCHOL, V33, P325, DOI 10.1016/j.joep.2011.02.009; Wagner G. G., 2007, SCHMOLLERS JB, V127, P139, DOI DOI 10.2139/SSRN.1028709; Wagner J, 2007, SMALL BUS ECON, V28, P1, DOI 10.1007/s11187-005-0259-x; Wellington AJ, 2006, LABOUR ECON, V13, P357, DOI 10.1016/j.labeco.2004.10.005; Wilson F, 2007, ENTREP THEORY PRACT, V31, P387, DOI 10.1111/j.1540-6520.2007.00179.x; Wilson F, 2009, J DEV ENTREP, V14, P105, DOI 10.1142/S1084946709001247; Zhao H, 2006, J APPL PSYCHOL, V91, P259, DOI 10.1037/0021-9010.91.2.259; Zhao H, 2010, J MANAGE, V36, P381, DOI 10.1177/0149206309335187	75	25	25	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103805	10.1371/journal.pone.0103805	http://dx.doi.org/10.1371/journal.pone.0103805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25089706	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700057
J	Wang, LG; Zhang, LC; Yan, H; Liu, X; Li, N; Liang, J; Pu, L; Zhang, YB; Shi, HB; Zhao, KB; Wang, LX				Wang, Ligang; Zhang, Longchao; Yan, Hua; Liu, Xin; Li, Na; Liang, Jing; Pu, Lei; Zhang, Yuebo; Shi, Huibi; Zhao, Kebin; Wang, Lixian			Genome-Wide Association Studies Identify the Loci for 5 Exterior Traits in a Large White x Minzhu Pig Population	PLOS ONE			English	Article							SUS-SCROFA CHROMOSOME-7; MEAT QUALITY; BACKFAT THICKNESS; BOAR TAINT; BODY-SIZE; GENE; GROWTH; IDENTIFICATION; HERITABILITY; EXPRESSION	As one of the main breeding selection criteria, external appearance has special economic importance in the hog industry. In this study, an Illumina Porcine SNP60 BeadChip was used to conduct a genome-wide association study (GWAS) in 605 pigs of the F-2 generation derived from a Large White x Minzhu intercross. Traits under study were abdominal circumference (AC), body height (BH), body length (BL), cannon bone circumference (CBC), chest depth (CD), chest width (CW), rump circumference (RC), rump width (RW), scapula width (SW), and waist width (WW). A total of 138 SNPs (the most significant being MARC0033464) on chromosome 7 were found to be associated with BH, BL, CBC, and RC (P-value = 4.15E-6). One SNP on chromosome 1 was found to be associated with CD at genome-wide significance levels. The percentage phenotypic variance of these significant SNPs ranged from 0.1-25.48%. Moreover, a conditional analysis revealed that the significant SNPs were derived from a single quantitative trait locus (QTL) and indicated additional chromosome-wide significant association for 25 SNPs on SSC4 (BL, CBC) and 9 SNPs on SSC7 (RC). Linkage analysis revealed two complete linkage disequilibrium haplotype blocks that contained seven and four SNPs, respectively. In block 1, the most significant SNP, MARC0033464, was present. Annotations from pig reference genome suggested six genes (GRM4, HMGA1, NUDT3, RPS10, SPDEF and PACSIN1) in block 1 (495 kb), and one gene (SCUBE3) in block 3 (124 kb). Functional analysis indicated that HMGA1 and SCUBE3 genes are the potential genes controlling BH, BL, and RC in pigs, with an application in breeding programs. We screened several candidate intervals and genes based on SNP location and gene function, and predicted their function using bioinformatics analyses.	[Wang, Ligang; Zhang, Longchao; Yan, Hua; Liu, Xin; Li, Na; Liang, Jing; Pu, Lei; Zhang, Yuebo; Shi, Huibi; Zhao, Kebin; Wang, Lixian] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China; [Li, Na] Jilin Acad Agr Sci, Changchun, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs; Jilin Academy of Agricultural Sciences	Wang, LX (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China.	iaswlx@263.net			Agricultural Science and Technology Innovation Program (ASTIP-IAS); National Key Technology R&D Program of China [2011BAD28B01]; National Natural Science Foundation of China [31201781]; earmarked fund for Modern Agro-industry Technology Research System; National Technology Program of China [2011ZX08006-003]; Chinese Academy of Agricultural Sciences Foundation [2014ZL006, 2011cj-5, 2012ZL069, 2014ywf-yb-8]	Agricultural Science and Technology Innovation Program (ASTIP-IAS); National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for Modern Agro-industry Technology Research System; National Technology Program of China; Chinese Academy of Agricultural Sciences Foundation(Chinese Academy of Sciences)	This research was supported by The Agricultural Science and Technology Innovation Program (ASTIP-IAS02), National Key Technology R&D Program of China (No. 2011BAD28B01), National Natural Science Foundation of China (31201781), earmarked fund for Modern Agro-industry Technology Research System, National Technology Program of China (No. 2011ZX08006-003) and Chinese Academy of Agricultural Sciences Foundation (No. 2014ZL006, 2011cj-5, No. 2012ZL069 and 2014ywf-yb-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chiappetta G, 1996, ONCOGENE, V13, P2439; Cleynen I, 2008, INT J ONCOL, V32, P289; Demeure O, 2005, J ANIM SCI, V83, P1979; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; Grindflek E, 2011, J ANIM SCI, V89, P680, DOI 10.2527/jas.2010-3290; Grindflek E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-362; Hristov AC, 2010, MODERN PATHOL, V23, P98, DOI 10.1038/modpathol.2009.139; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson ZB, 2003, J ANIM SCI, V81, P1943; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Luo WZ, 2012, INT J BIOL SCI, V8, P870, DOI 10.7150/ijbs.4027; Luo WZ, 2012, INT J BIOL SCI, V8, P580, DOI 10.7150/ijbs.3614; Ma J, 2009, ANIM GENET, V40, P637, DOI 10.1111/j.1365-2052.2009.01892.x; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Melillo RM, 2001, MOL CELL BIOL, V21, P2485, DOI 10.1128/MCB.21.7.2485-2495.2001; Niu P, 2013, GENES GENOM, V35, P523, DOI 10.1007/s13258-013-0098-0; Okumura N, 2013, ANIM GENET, V44, P454, DOI 10.1111/age.12018; Ramos AM, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-35; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schreiweis MA, 2005, GENET SEL EVOL, V37, P677, DOI 10.1051/gse:2005023; Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308; Sironen A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-699; Soller M, 2006, POULTRY SCI, V85, P2061, DOI 10.1093/ps/85.12.2061; Soma Y, 2011, J ANIM SCI, V89, P601, DOI 10.2527/jas.2010-3119; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Uemoto Y, 2008, J ANIM SCI, V86, P2833, DOI 10.2527/jas.2007-0293; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Yang M, 2013, MED HYPOTHESES, V81, P948, DOI 10.1016/j.mehy.2013.09.001	41	21	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103766	10.1371/journal.pone.0103766	http://dx.doi.org/10.1371/journal.pone.0103766			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090094	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700050
J	Conese, M; Castellani, S; Lepore, S; Palumbo, O; Manca, A; Santostasis, T; Polizzi, AM; Copetti, M; Di Gioia, S; Casavola, V; Guerra, L; Diana, A; Montemurro, P; Mariggio, A; Gallo, C; Maffione, AB; Carella, M				Conese, Massimo; Castellani, Stefano; Lepore, Silvia; Palumbo, Orazio; Manca, Antonio; Santostasis, Teresa; Polizzi, Angela Maria; Copetti, Massimiliano; Di Gioia, Sante; Casavola, Valeria; Guerra, Lorenzo; Diana, Anna; Montemurro, Pasqualina; Mariggio, Addolorata; Gallo, Crescenzio; Maffione, Angela Bruna; Carella, Massimo			Evaluation of Genome-Wide Expression Profiles of Blood and Sputum Neutrophils in Cystic Fibrosis Patients Before and After Antibiotic Therapy	PLOS ONE			English	Article							BH3-ONLY PROTEIN NOXA; PULMONARY EXACERBATIONS; GENE-EXPRESSION; LUNG-DISEASE; INFLAMMATORY MARKERS; G-CSF; BIOMARKERS; INFECTION; APOPTOSIS; CYTOKINES	In seeking more specific biomarkers of the cystic fibrosis (CF) lung inflammatory disease that would be sensitive to antibiotic therapy, we sought to evaluate the gene expression profiles of neutrophils in CF patients before treatment in comparison with non-CF healthy individuals and after antibiotic treatment. Genes involved in neutrophil-mediated inflammation, i.e. chemotaxis, respiratory burst, apoptosis, and granule exocytosis, were the targets of this study. Microarray analysis was carried out in blood and airway neutrophils from CF patients and in control subjects. A fold change (log) threshold of 1.4 and a cut-off of p<0.05 were utilized to identify significant genes. Community networks and principal component analysis were used to distinguish the groups of controls, pre- and post-therapy patients. Control subjects and CF patients before therapy were readily separated, whereas a clear distinction between patients before and after antibiotic therapy was not possible. Blood neutrophils before therapy presented 269 genes down-regulated and 56 up-regulated as compared with control subjects. Comparison between the same patients before and after therapy showed instead 44 genes down-regulated and 72 up-regulated. Three genes appeared to be sensitive to therapy and returned to "healthy'' condition: phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1), hydrogen voltage-gated channel 1 (HVCN1), and beta-arrestin 1 (ARRB1). The up-regulation of these genes after therapy were confirmed by real time PCR. In airway neutrophils, 1029 genes were differentially expressed post-vs pre-therapy. Of these, 30 genes were up-regulated and 75 down-regulated following antibiotic treatment. However, biological plausibility determined that only down-regulated genes belonged to the gene classes studied for blood neutrophils. Finally, it was observed that commonly expressed genes showed a greater variability in airway neutrophils than that found in blood neutrophils, both before and after therapy. These results indicate more specific targets for future interventions in CF patients involving respiratory burst, apoptosis, and granule exocytosis.	[Conese, Massimo; Castellani, Stefano; Di Gioia, Sante] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy; [Lepore, Silvia] IRCCS CROB, Lab Preclin & Translat Res, Rionero In Vulture, Italy; [Palumbo, Orazio; Carella, Massimo] CSS Hosp, IRCCS, Med Genet Unit, San Giovanni Rotondo, Italy; [Manca, Antonio; Diana, Anna] Az Univ Osp Policlin, Ctr Riferimento Reg Pugliese Fibrosi Cist, Bari, Italy; [Santostasis, Teresa; Polizzi, Angela Maria] Univ Bari, Dept Biomed Sci & Human Oncol, Sect Pediat, Bari, Italy; [Copetti, Massimiliano] CSS Hosp, IRCCS, Biostat Unit, San Giovanni Rotondo, Italy; [Casavola, Valeria; Guerra, Lorenzo] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Montemurro, Pasqualina; Mariggio, Addolorata] Univ Bari, Dept Biomed Sci & Human Oncol, Sect Hyg, Bari, Italy; [Gallo, Crescenzio; Maffione, Angela Bruna] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy	University of Foggia; IRCCS CROB; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Foggia	Conese, M (corresponding author), Univ Foggia, Dept Med & Surg Sci, Foggia, Italy.	massimo.conese@unifg.it	PALUMBO, ORAZIO/C-1133-2014; Copetti, Massimiliano/K-3186-2016; Maffione, angela bruna/AAC-2193-2022; COPETTI, MASSIMILIANO/AAG-1473-2021; Lepore, Silvia/AAB-8005-2020; Gallo, Crescenzio/AAC-1482-2019; Castellani, Stefano/AAR-4143-2021; Conese, Massimo/AAB-7926-2019; Carella, Massimo/A-2804-2014	PALUMBO, ORAZIO/0000-0001-6583-3482; Copetti, Massimiliano/0000-0002-7960-5947; COPETTI, MASSIMILIANO/0000-0002-7960-5947; Gallo, Crescenzio/0000-0002-3929-462X; castellani, stefano/0000-0003-0201-7298; Conese, Massimo/0000-0003-3465-6641; CASAVOLA, Valeria/0000-0003-4471-4948; Montemurro, Pasqualina/0000-0003-4768-8618; Mariggio, Maria Addolorata/0000-0002-3508-8706; Lepore, Silvia/0000-0002-1918-8547; Carella, Massimo/0000-0002-6830-6829; GUERRA, Lorenzo/0000-0003-3950-9405	Italian law 548/93 project "Study of factors which influence prognosis in cystic fibrosis"	Italian law 548/93 project "Study of factors which influence prognosis in cystic fibrosis"	This work was supported by the Italian law 548/93 for the years 1999-2003, project "Study of factors which influence prognosis in cystic fibrosis". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2008, MOL MED, V14, P36, DOI 10.2119/2007-00081.Adib-Conquy; Bankey PE, 2010, IMMUNOL LETT, V129, P100, DOI 10.1016/j.imlet.2010.01.006; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Brazova J, 2005, CLIN IMMUNOL, V115, P210, DOI 10.1016/j.clim.2005.01.013; Colombo C, 2005, PEDIATR PULM, V40, P15, DOI 10.1002/ppul.20237; Corvol H, 2003, AM J PHYSIOL-LUNG C, V284, pL997, DOI 10.1152/ajplung.00156.2002; Dorlochter Ludger, 2004, J Cyst Fibros, V3, P179, DOI 10.1016/j.jcf.2004.04.005; Downey DG, 2007, PEDIATR PULM, V42, P729, DOI 10.1002/ppul.20646; Downey DG, 2007, PEDIATR PULM, V42, P216, DOI 10.1002/ppul.20553; Fruhwirth M, 1998, INT ARCH ALLERGY IMM, V117, P270, DOI 10.1159/000024022; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; Hauber Hans-Peter, 2004, J Cyst Fibros, V3, P129, DOI 10.1016/j.jcf.2004.03.006; Hauber Hans-Peter, 2003, J Cyst Fibros, V2, P189, DOI 10.1016/S1569-1993(03)00091-2; Horsley AR, 2013, THORAX, V68, P532, DOI 10.1136/thoraxjnl-2012-202538; Jensen PO, 2006, J CYST FIBROS, V5, P145, DOI 10.1016/j.jcf.2005.12.004; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kirschnek S, 2011, CELL DEATH DIFFER, V18, P1805, DOI 10.1038/cdd.2011.69; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Levy H, 2007, PEDIATR PULM, V42, P256, DOI 10.1002/ppul.20563; Makam M, 2009, P NATL ACAD SCI USA, V106, P5779, DOI 10.1073/pnas.0813410106; Mason FM, 2011, J BIOL CHEM, V286, P6577, DOI 10.1074/jbc.M110.190397; McKeon DJ, 2008, THORAX, V63, P660, DOI 10.1136/thx.2008.096834; McLaughlin NJD, 2006, J IMMUNOL, V176, P7039, DOI 10.4049/jimmunol.176.11.7039; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Moriceau S, 2010, J INNATE IMMUN, V2, P260, DOI 10.1159/000295791; Moriceau S, 2009, J IMMUNOL, V182, P7254, DOI 10.4049/jimmunol.0803312; Moser C, 2005, APMIS, V113, P400, DOI 10.1111/j.1600-0463.2005.apm_142.x; Muhlebach MS, 2004, PEDIATR PULM, V37, P393, DOI 10.1002/ppul.20010; Nick JA, 2013, THORAX, V68, P929, DOI 10.1136/thoraxjnl-2012-202278; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Petit-Bertron AF, 2008, CYTOKINE, V41, P54, DOI 10.1016/j.cyto.2007.10.012; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Rosenfeld Margaret, 2007, Proc Am Thorac Soc, V4, P299, DOI 10.1513/pats.200611-178HT; Saavedra MT, 2008, AM J RESP CRIT CARE, V178, P929, DOI 10.1164/rccm.200803-387OC; Sagel SD, 2003, CURR OPIN PULM MED, V9, P516, DOI 10.1097/00063198-200311000-00012; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; Shoki AH, 2013, CHEST, V144, P1659, DOI 10.1378/chest.13-0693; Sun YP, 2005, J BIOL CHEM, V280, P15561, DOI 10.1074/jbc.m412630200; Tirelli AS, 2013, CYTOKINE, V62, P413, DOI 10.1016/j.cyto.2013.03.029; Tirouvanziam R, 2008, P NATL ACAD SCI USA, V105, P4335, DOI 10.1073/pnas.0712386105; WitkoSarsat V, 1996, J IMMUNOL, V157, P2728; Wolter JM, 1999, CLIN DIAGN LAB IMMUN, V6, P260, DOI 10.1128/CDLI.6.2.260-265.1999; Zaman MM, 2004, CLIN DIAGN LAB IMMUN, V11, P819, DOI 10.1128/CDLI.11.5.819-824.2004	46	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104080	10.1371/journal.pone.0104080	http://dx.doi.org/10.1371/journal.pone.0104080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084273	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800125
J	Lian, JM; Huang, XF; Pai, N; Deng, C				Lian, Jiamei; Huang, Xu-Feng; Pai, Nagesh; Deng, Chao			Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; 2ND-GENERATION ANTIPSYCHOTICS; 1ST-EPISODE SCHIZOPHRENIA; FOOD-INTAKE; RECEPTORS; AMPK; H1; THERMOGENESIS; PHARMACOLOGY; ADOLESCENTS	Olanzapine is the one of first line antipsychotic drug for schizophrenia and other serious mental illness. However, it is associated with troublesome metabolic side-effects, particularly body weight gain and obesity. The antagonistic affinity to histamine H-1 receptors (H1R) of antipsychotic drugs has been identified as one of the main contributors to weight gain/obesity side-effects. Our previous study showed that a short term (2 weeks) combination treatment of betahistine (an H1R agonist and H3R antagonist) and olanzapine (O+B) reduced (-45%) body weight gain induced by olanzapine in drug-naive rats. A key issue is that clinical patients suffering with schizophrenia, bipolar disease and other mental disorders often face chronic, even life-time, antipsychotic treatment, in which they have often had previous antipsychotic exposure. Therefore, we investigated the effects of chronic O+B co-treatment in controlling body weight in female rats with chronic and repeated exposure of olanzapine. The results showed that co-administration of olanzapine (3 mg/kg, t.i.d.) and betahistine (9.6 mg/kg, t.i.d.) significantly reduced (-51.4%) weight gain induced by olanzapine. Co-treatment of O+B also led to a decrease in feeding efficiency, liver and fat mass. Consistently, the olanzapine-only treatment increased hypothalamic H1R protein levels, as well as hypothalamic pAMPK alpha, AMPK alpha and NPY protein levels, while reducing the hypothalamic POMC, and UCP1 and PGC-1 alpha protein levels in brown adipose tissue (BAT). The olanzapine induced changes in hypothalamic H1R, pAMPK alpha, BAT UCP1 and PGC-1 alpha could be reversed by co-treatment of O+B. These results supported further clinical trials to test the effectiveness of co-treatment of O+B for controlling weight gain/obesity side-effects in schizophrenia with chronic antipsychotic treatment.	[Lian, Jiamei; Deng, Chao] Univ Wollongong, Illawarra Hlth & Med Res Inst, Antipsychot Res Lab, Wollongong, NSW, Australia; [Lian, Jiamei; Huang, Xu-Feng; Pai, Nagesh; Deng, Chao] Univ Wollongong, Sch Med, Ctr Translat Neurosci, Wollongong, NSW, Australia; [Lian, Jiamei; Huang, Xu-Feng; Pai, Nagesh; Deng, Chao] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Huang, Xu-Feng; Deng, Chao] Schizophrenia Res Inst, Sydney, NSW, Australia	University of Wollongong; University of Wollongong; University of Wollongong	Deng, C (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Antipsychot Res Lab, Wollongong, NSW, Australia.	chao@uow.edu.au	Huang, Xu-Feng/H-7408-2015; Deng, Chao/F-4417-2016; Huang, Xu-Feng/D-6053-2013	Huang, Xu-Feng/0000-0002-5895-2253; Deng, Chao/0000-0003-1147-5741; Huang, Xu-Feng/0000-0002-5895-2253; Lian, Jiamei/0000-0002-8850-2536	Australian National Health and Medical Research Council (NHMRC) [APP1027493, APP1008473]; Schizophrenia Research Institute (SRI); New South Wales Health	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute (SRI); New South Wales Health	This study was supported by the Australian National Health and Medical Research Council (NHMRC, www.nhmrc.gov.au) Project Grants (APP1027493 to XH and CD; APP1008473 to CD), and by the Schizophrenia Research Institute (SRI, www.schizophreniaresearch.org.au), utilising infrastructure funding from New South Wales Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Aravagiri M, 1999, BIOPHARM DRUG DISPOS, V20, P369, DOI 10.1002/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6; Balu DT, 2008, BRAIN RES, V1211, P37, DOI 10.1016/j.brainres.2008.03.023; Botta L, 2001, Acta Otorhinolaryngol Ital, V21, P24; Bustillo JR, 2003, NEUROPSYCHOPHARMACOL, V28, P527, DOI 10.1038/sj.npp.1300089; Cinti S, 2006, NUTR METAB CARDIOVAS, V16, P569, DOI 10.1016/j.numecd.2006.07.009; Coccurello R, 2010, PHARMACOL THERAPEUT, V127, P210, DOI 10.1016/j.pharmthera.2010.04.008; Cooper GD, 2005, PSYCHOPHARMACOLOGY, V181, P80, DOI 10.1007/s00213-005-2224-4; Correll CU, 2010, EUR PSYCHIAT, V25, pS12, DOI 10.1016/S0924-9338(10)71701-6; Correll CU, 2008, INT REV PSYCHIATR, V20, P195, DOI 10.1080/09540260801889179; Correll CU, 2011, TRENDS MOL MED, V17, P97, DOI 10.1016/j.molmed.2010.10.010; Dalvi PS, 2011, AM J PHYSIOL-REG I, V300, pR1030, DOI 10.1152/ajpregu.00649.2010; Das Chandan, 2012, Ann Clin Psychiatry, V24, P225; Davoodi N, 2008, BEHAV PHARMACOL, V19, P121, DOI 10.1097/FBP.0b013e3282f62c66; Deng C, 2007, PROG NEURO-PSYCHOPH, V31, P915, DOI 10.1016/j.pnpbp.2007.02.009; Deng C, 2013, ENDOCRIN METAB CLIN, V42, P545, DOI 10.1016/j.ecl.2013.05.006; Deng C, 2012, J PSYCHOPHARMACOL, V26, P1271, DOI 10.1177/0269881112449396; Deng C, 2010, PROG NEURO-PSYCHOPH, V34, P1, DOI 10.1016/j.pnpbp.2009.11.009; Depping AM, 2010, COCHRANE DB SYST REV, V12; FDA, 2005, EST SAF START DOS CL; Fell MJ, 2004, J PSYCHOPHARMACOL, V18, P149, DOI 10.1177/0269881104042613; Ferno J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020571; Gebhardt S, 2009, J PSYCHIATR RES, V43, P620, DOI 10.1016/j.jpsychires.2008.11.001; Goudie AJ, 2002, J PSYCHOPHARMACOL, V16, P291, DOI 10.1177/026988110201600402; Han M, 2008, PSYCHONEUROENDOCRINO, V33, P569, DOI 10.1016/j.psyneuen.2008.01.018; He M, 2014, PSYCHONEUROENDOCRINO, V42, P153, DOI 10.1016/j.psyneuen.2014.01.018; He M, 2013, CNS DRUGS, V27, P423, DOI 10.1007/s40263-013-0062-1; Hillebrand JJG, 2002, PEPTIDES, V23, P2283, DOI 10.1016/S0196-9781(02)00269-3; Hu YS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093310, 10.1371/journal.pone.0093425, 10.1371/journal.pone.0092099]; Jeck-Thole S, 2006, DRUG SAFETY, V29, P1049, DOI 10.2165/00002018-200629110-00004; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; Kim DH, 2009, NEUROTHERAPEUTICS, V6, P78, DOI 10.1016/j.nurt.2008.10.020; Kim SF, 2007, P NATL ACAD SCI USA, V104, P3456, DOI 10.1073/pnas.0611417104; KOMOSSA K, 2010, COCHRANE DB SYST REV, V17; Kroeze WK, 2003, NEUROPSYCHOPHARMACOL, V28, P519, DOI 10.1038/sj.npp.1300027; Kwok AKH, 2001, AM J OPHTHALMOL, V132, P178, DOI 10.1016/S0002-9394(01)00976-X; Lian JM, 2010, PROG NEURO-PSYCHOPH, V34, P1157, DOI 10.1016/j.pnpbp.2010.03.035; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Maffulli N, 2000, AM J SPORT MED, V28, P857, DOI 10.1177/03635465000280061401; Martins PJF, 2010, DIABETES, V59, P2418, DOI 10.2337/db10-0449; Matsui-Sakata Akiko, 2005, Drug Metab Pharmacokinet, V20, P368, DOI 10.2133/dmpk.20.368; Meltzer HY, 2011, CURR OPIN PHARMACOL, V11, P59, DOI 10.1016/j.coph.2011.02.007; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; Nedergaard J, 2010, ANN NY ACAD SCI, V1212, pE20, DOI 10.1111/j.1749-6632.2010.05905.x; Oh JE, 2012, EXP MOL MED, V44, P545, DOI 10.3858/emm.2012.44.9.062; Olds R.J., 1979, COLOUR ATLAS RAT DIS; Osuntokun O, 2011, J PSYCHOPHARMACOL, V25, P630, DOI 10.1177/0269881110368872; Pai N, 2012, ASIAN J PSYCHIATR, V5, P315, DOI 10.1016/j.ajp.2012.05.005; Patel JK, 2009, SCHIZOPHR RES, V111, P9, DOI 10.1016/j.schres.2009.03.025; Paxinos G, 2007, RAT BRAIN STEROTAXIC, V6; Perez-Iglesias R, 2008, J CLIN PSYCHOPHARM, V28, P289, DOI 10.1097/JCP.0b013e318172b8e6; Poyurovsky M, 2005, INT CLIN PSYCHOPHARM, V20, P101, DOI 10.1097/00004850-200503000-00007; Poyurovsky M, 2007, PSYCHOPHARMACOLOGY, V192, P441, DOI 10.1007/s00213-007-0731-1; Poyurovsky M, 2013, PSYCHOPHARMACOLOGY, V226, P615, DOI 10.1007/s00213-012-2935-2; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Remington G, 2011, PHARMACOL BIOCHEM BE, V100, P86, DOI 10.1016/j.pbb.2011.07.019; Richelson E, 1996, J CLIN PSYCHIAT, V57, P4; Sejima E, 2011, CELL MOL NEUROBIOL, V31, P985, DOI 10.1007/s10571-011-9663-8; Sethi J, 2012, NEUROSCIENCE, V217, P84, DOI 10.1016/j.neuroscience.2012.04.068; Skrede S, 2014, INT J NEUROPSYCHOPH, V17, P91, DOI 10.1017/S1461145713000862; Souza RP, 2012, J PSYCHIATR RES, V46, P462, DOI 10.1016/j.jpsychires.2012.01.010; Stahl SM, 2009, ACTA PSYCHIAT SCAND, V119, P171, DOI 10.1111/j.1600-0447.2008.01334.x; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Tauscher J, 2002, MOL PSYCHIATR, V7, P317, DOI 10.1038/sj.mp.4001009; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vehof J, 2011, PSYCHOPHARMACOLOGY, V216, P257, DOI 10.1007/s00213-011-2211-x; Wan ZX, 2014, OBESITY, V22, P730, DOI 10.1002/oby.20605; Weston-Green K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033548; Weston-Green K, 2012, EUR NEUROPSYCHOPHARM, V22, P364, DOI 10.1016/j.euroneuro.2011.09.003; Weston-Green K, 2011, BEHAV BRAIN RES, V217, P337, DOI 10.1016/j.bbr.2010.10.039; Zhang Q, 2014, INT J NEUROPSYCHOPHA, V17; Zhang QS, 2014, PROG NEURO-PSYCHOPH, V51, P172, DOI 10.1016/j.pnpbp.2014.02.003; Zipursky RB, 2005, BRIT J PSYCHIAT, V187, P537, DOI 10.1192/bjp.187.6.537; Zuddas A, 2011, EUR NEUROPSYCHOPHARM, V21, P600, DOI 10.1016/j.euroneuro.2011.04.001	77	51	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104160	10.1371/journal.pone.0104160	http://dx.doi.org/10.1371/journal.pone.0104160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084453	Green Published, gold			2022-12-27	WOS:000339819800127
J	Reiner, D; Lee, RY; Dekan, G; Epstein, MM				Reiner, Daniela; Lee, Rui-Yun; Dekan, Gerhard; Epstein, Michelle M.			No Adjuvant Effect of Bacillus thuringiensis-Maize on Allergic Responses in Mice	PLOS ONE			English	Article							SALMO-SALAR L.; ATLANTIC SALMON; CRY1AC PROTOXIN; IMMUNE-RESPONSE; BT CORN; PERFORMANCE; ACTIVATION; PROTECTION; MUCOSAL; PROTEIN	Genetically modified (GM) foods are evaluated carefully for their ability to induce allergic disease. However, few studies have tested the capacity of a GM food to act as an adjuvant, i.e. influencing allergic responses to other unrelated allergens at acute onset and in individuals with pre-existing allergy. We sought to evaluate the effect of short-term feeding of GM Bacillus thuringiensis (Bt)-maize (MON810) on the initiation and relapse of allergic asthma in mice. BALB/c mice were provided a diet containing 33% GM or non-GM maize for up to 34 days either before ovalbumin (OVA)-induced experimental allergic asthma or disease relapse in mice with pre-existing allergy. We observed that GM-maize feeding did not affect OVA-induced eosinophilic airway and lung inflammation, mucus hypersecretion or OVA-specific antibody production at initiation or relapse of allergic asthma. There was no adjuvant effect upon GM-maize consumption on the onset or severity of allergic responses in a mouse model of allergic asthma.	[Reiner, Daniela; Lee, Rui-Yun; Epstein, Michelle M.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Dekan, Gerhard] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Epstein, MM (corresponding author), Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria.	Michelle.Epstein@meduniwien.ac.at		Epstein, Michelle/0000-0002-4755-0224	GMSAFOOD project [211820]	GMSAFOOD project	Funding for this research was provided by the GMSAFOOD project (grant number 211820), through the 7th Framework grant, administered by the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2005, ALLERGY, V60, P658, DOI 10.1111/j.1398-9995.2005.00767.x; Adel-Patient K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016346; Andersson HC, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2193; Batista R, 2005, J ALLERGY CLIN IMMUN, V116, P403, DOI 10.1016/j.jaci.2005.04.014; Broderick NA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-11; Carrasco-Yepez M, 2010, PARASITE IMMUNOL, V32, P664, DOI 10.1111/j.1365-3024.2010.01222.x; Codex Alimentarius Commission, 2003, COD AL COMM 25 SESS, P47; Crickmore N, 2005, TRENDS MICROBIOL, V13, P347, DOI 10.1016/j.tim.2005.06.002; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; Custodio MG, 2006, CAN J ANIM SCI, V86, P461, DOI 10.4141/A05-082; EFSA, 2006, EFSA J, V4, DOI 10.2903/j.efsa.2006.99; EFSA, 2009, EFSA J, P1149; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Flachowsky G, 2007, ANIM FEED SCI TECH, V133, P2, DOI 10.1016/j.anifeedsci.2006.08.002; Guimaraes VD, 2008, FOOD AGR IMMUNOL, V19, P325, DOI 10.1080/09540100802495651; Kilic A, 2008, FOOD CHEM TOXICOL, V46, P1164, DOI 10.1016/j.fct.2007.11.016; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; Lee RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052972; Legorreta-Herrera M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/198921; Mojtabavi N, 2002, J IMMUNOL, V169, P4788, DOI 10.4049/jimmunol.169.9.4788; Moreno-Fierros L, 2003, SCAND J IMMUNOL, V57, P45, DOI 10.1046/j.1365-3083.2003.01190.x; Moreno-Fierros L, 2013, INT IMMUNOPHARMACOL, V17, P1051, DOI 10.1016/j.intimp.2013.10.005; Prescott VE, 2005, J AGR FOOD CHEM, V53, P9023, DOI 10.1021/jf050594v; Reuter T, 2002, ARCH ANIM NUTR, V56, P319, DOI 10.1080/00039420215628; Rodriguez-Monroy MA, 2010, SCAND J IMMUNOL, V71, P159, DOI 10.1111/j.1365-3083.2009.02358.x; Rojas-Hernandez S, 2004, INFECT IMMUN, V72, P4368, DOI 10.1128/IAI.72.8.4368-4375.2004; Sanden M, 2006, AQUACULT NUTR, V12, P1, DOI 10.1111/j.1365-2095.2006.00367.x; Sanden M, 2005, J FISH DIS, V28, P317, DOI 10.1111/j.1365-2761.2005.00618.x; Shimada N, 2006, J VET MED SCI, V68, P1113, DOI 10.1292/jvms.68.1113; Trabalza-Marinucci M, 2008, LIVEST SCI, V113, P178, DOI 10.1016/j.livsci.2007.03.009; Vazquez-Padron RI, 2000, BRAZ J MED BIOL RES, V33, P147, DOI 10.1590/S0100-879X2000000200002; Verdin-Teran SL, 2009, SCAND J IMMUNOL, V70, P596, DOI 10.1111/j.1365-3083.2009.02332.x; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011	33	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103979	10.1371/journal.pone.0103979	http://dx.doi.org/10.1371/journal.pone.0103979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084284	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800115
J	Kruh-Garcia, NA; Wolfe, LM; Chaisson, LH; Worodria, WO; Nahid, P; Schorey, JS; Davis, JL; Dobos, KM				Kruh-Garcia, Nicole A.; Wolfe, Lisa M.; Chaisson, Lelia H.; Worodria, William O.; Nahid, Payam; Schorey, Jeff S.; Davis, J. Lucian; Dobos, Karen M.			Detection of Mycobacterium tuberculosis Peptides in the Exosomes of Patients with Active and Latent M. tuberculosis Infection Using MRM-MS	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; MASS-SPECTROMETRY; STATISTICAL-MODEL; PROTEINS; VERIFICATION; MACROPHAGES; BIOMARKERS; IDENTIFICATION; DISCOVERY; APOPTOSIS	The identification of easily measured, accurate diagnostic biomarkers for active tuberculosis (TB) will have a significant impact on global TB control efforts. Because of the host and pathogen complexities involved in TB pathogenesis, identifying a single biomarker that is adequately sensitive and specific continues to be a major hurdle. Our previous studies in models of TB demonstrated that exosomes, such as those released from infected macrophages, contain mycobacterial products, including many Mtb proteins. In this report, we describe the development of targeted proteomics assays employing multiplexed multiple reaction monitoring mass spectrometry (MRM-MS) in order to allow us to follow those proteins previously identified by western blot or shotgun mass spectrometry, and enhance biomarker discovery to include detection of Mtb proteins in human serum exosomes. Targeted MRM-MS assays were applied to exosomes isolated from human serum samples obtained from culture-confirmed active TB patients to detect 76 peptides representing 33 unique Mtb proteins. Our studies revealed the first identification of bacteria-derived biomarker candidates of active TB in exosomes from human serum. Twenty of the 33 proteins targeted for detection were found in the exosomes of TB patients, and included multiple peptides from 8 proteins (Antigen 85B, Antigen 85C, Apa, BfrB, GlcB, HspX, KatG, and Mpt64). Interestingly, all of these proteins are known mycobacterial adhesins and/or proteins that contribute to the intracellular survival of Mtb. These proteins will be included as target analytes in future validation studies as they may serve as markers for persistent active and latent Mtb infection. In summary, this work is the first step in identifying a unique and specific panel of Mtb peptide biomarkers encapsulated in exosomes and reveals complex biomarker patterns across a spectrum of TB disease states.	[Kruh-Garcia, Nicole A.; Wolfe, Lisa M.; Dobos, Karen M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Wolfe, Lisa M.] Colorado State Univ, Prote & Metabol Facil, Ft Collins, CO 80523 USA; [Chaisson, Lelia H.; Nahid, Payam; Davis, J. Lucian] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA USA; [Worodria, William O.] Makerere Univ, Mulago Hosp, Dept Med, Kampala, Uganda; [Nahid, Payam; Davis, J. Lucian] Univ Calif San Francisco, San Francisco Gen Hosp, Curry Int TB Ctr, San Francisco, CA USA; [Schorey, Jeff S.] Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA	Colorado State University; Colorado State University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; Mulago National Referral Hospital; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Notre Dame	Dobos, KM (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	kdobos@colostate.edu	Davis, J. Lucian/AAC-8376-2019; Kruh-Garcia, Nicole/D-5853-2017; Dobos, Karen/D-1170-2017	Davis, J. Lucian/0000-0002-8629-9992; Kruh-Garcia, Nicole/0000-0002-9896-8380; Dobos, Karen/0000-0001-7115-8524; Nahid, Payam/0000-0003-2811-1311	Bill and Melinda Gates Foundation [OPP1039688]; National Institutes of Health [1 R21 Al101714-01]; Colorado State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101714, R01AI052439] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by the Bill and Melinda Gates Foundation (to KMD; OPP1039688), the National Institutes of Health (to JLD; 1 R21 Al101714-01), and internal funds from Colorado State University to KMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addona TA, 2011, NAT BIOTECHNOL, V29, P635, DOI 10.1038/nbt.1899; [Anonymous], 2011, COMM SER TESTS DIAGN; Bartlett JW, 2012, BIOMARK MED, V6, P391, DOI [10.2217/BMM.12.49, 10.2217/bmm.12.49]; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Giri PK, 2010, PROTEOMICS, V10, P3190, DOI 10.1002/pmic.200900840; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Izzo A, 2005, TUBERCULOSIS, V85, P25, DOI 10.1016/j.tube.2004.09.008; Jaffe JD, 2008, MOL CELL PROTEOMICS, V7, P1952, DOI 10.1074/mcp.M800218-MCP200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Kruh-Garcia NA, 2013, J PROTEOMICS; Kruh-Garcia NA, 2012, UNDERSTANDING TUBERCULOSIS - GLOBAL EXPERIENCES AND INNOVATIVE APPROACHES TO THE DIAGNOSIS, P395; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069790; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j; Mahanty S, 2001, J INFECT DIS, V183, P1713, DOI 10.1086/320722; Mehaffy C, 2010, PROTEOMICS, V10, P1966, DOI 10.1002/pmic.200900836; Mustafa T, 2007, CLIN EXP IMMUNOL, V150, P105, DOI 10.1111/j.1365-2249.2007.03476.x; Mustafa T, 2008, VIRCHOWS ARCH, V452, P449, DOI 10.1007/s00428-008-0575-z; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pandey R, 2012, INFECT IMMUN, V80, P3650, DOI 10.1128/IAI.00229-12; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Searle BCaT Mark, 2007, IMPR SENS COMB RES M; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Sjogren M, 2001, CLIN CHEM, V47, P1776; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Worodria W, 2010, EUR RESPIR J, V36, P446, DOI 10.1183/09031936.00010210	37	103	116	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103811	10.1371/journal.pone.0103811	http://dx.doi.org/10.1371/journal.pone.0103811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080351	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800082
J	Kwizera, R; Nguna, J; Kiragga, A; Nakavuma, J; Rajasingham, R; Boulware, DR; Meya, DB				Kwizera, Richard; Nguna, Joyce; Kiragga, Agnes; Nakavuma, Jesca; Rajasingham, Radha; Boulware, David R.; Meya, David B.			Performance of Cryptococcal Antigen Lateral Flow Assay Using Saliva in Ugandans with CD4 < 100	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; ANTIRETROVIRAL THERAPY; MENINGITIS; HIV; SERUM; DIAGNOSIS; CARE	Background: Cryptococcal meningitis can best be diagnosed by cerebrospinal fluid India ink microscopy, cryptococcal antigen detection, or culture. These require invasive lumbar punctures. The utility of cryptococcal antigen detection in saliva is unknown. We evaluated the diagnostic performance of the point-of-care cryptococcal antigen lateral flow assay (CrAg LFA) in saliva. Methods: We screened HIV-infected, antiretroviral therapy naive persons with symptomatic meningitis (n = 130) and asymptomatic persons with CD4+<100 cells/mu L entering into HIV care (n = 399) in Kampala, Uganda. The diagnostic performance of testing saliva was compared to serum/plasma cryptococcal antigen as the reference standard. Results: The saliva lateral flow assay performance was overall more sensitive in symptomatic patients (88%) than in asymptomatic patients (27%). The specificity of saliva lateral flow assay was excellent at 97.8% in the symptomatic patients and 100% in asymptomatic patients. The degree of accuracy of saliva in diagnosing cryptococcosis and the level of agreement between the two sample types was better in symptomatic patients (C-statistic 92.9, kappa-0.82) than in asymptomatic patients (C-statistic 63.5, kappa-0.41). Persons with false negative salvia CrAg tests had lower levels of peripheral blood CrAg titers (P<0.001). Conclusion: There was poor diagnostic performance in testing saliva for cryptococcal antigen, particularly among asymptomatic persons screened for preemptive treatment of cryptococcosis.	[Kwizera, Richard; Nguna, Joyce; Kiragga, Agnes; Rajasingham, Radha; Meya, David B.] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Nakavuma, Jesca] Makerere Univ, Coll Vet Med Anim Resource & Biosecur, Kampala, Uganda; [Rajasingham, Radha; Boulware, David R.; Meya, David B.] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Minneapolis, MN 55455 USA; [Meya, David B.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda	Makerere University; Makerere University; University of Minnesota System; University of Minnesota Twin Cities; Makerere University	Kwizera, R (corresponding author), Makerere Univ, Infect Dis Inst, Kampala, Uganda.	kwizerarichard@ymail.com	Boulware, David R/GRS-0999-2022; Boulware, David R/AAF-7124-2021; Meya, David/AAO-2796-2020; hlupeni, admire/M-1539-2018; Kwizera, Richard/I-5247-2019	Boulware, David R/0000-0002-4715-0060; Kwizera, Richard/0000-0002-5270-3539; Nguna, Joyce/0000-0002-6708-2069; , David/0000-0002-8854-0321	National Institute of Allergy and Infectious Diseases [U01 AI089244]; Centers for Disease Control and Prevention [U01GH11005]; Welcome Trust [087540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI089244] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Welcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this research was provided by the National Institute of Allergy and Infectious Diseases (U01 AI089244), Centers for Disease Control and Prevention (U01GH11005) and Welcome Trust funding (THRiVE, 087540) to Dr. Meya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058377; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Boulware DR, 2014, EMERG INFECT DIS, V20, P45, DOI 10.3201/eid2001.130906; Butler EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051291; Durski KN, 2013, JAIDS-J ACQ IMM DEF, V63, pE101, DOI 10.1097/QAI.0b013e31828e1e56; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Jarvis JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069288; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Lindsley MD, 2011, CLIN INFECT DIS, V53, P321, DOI 10.1093/cid/cir379; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Rajasingham R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001316; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	16	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103156	10.1371/journal.pone.0103156	http://dx.doi.org/10.1371/journal.pone.0103156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078453	Green Published, gold			2022-12-27	WOS:000339954800030
J	Tsuruyama, T				Tsuruyama, Tatsuaki			A Model of Cell Biological Signaling Predicts a Phase Transition of Signaling and Provides Mathematical Formulae	PLOS ONE			English	Article							CONCENTRATION-DEPENDENCE; ACTIN POLYMERIZATION; ATP HYDROLYSIS; PROTEIN; DIFFUSION; OSCILLATION; CASCADE	A biological signal is transmitted by interactions between signaling molecules in the cell. To date, there have been extensive studies regarding signaling pathways using numerical simulation of kinetic equations that are based on equations of continuity and Fick's law. To obtain a mathematical formulation of cell signaling, we propose a stability kinetic model of cell biological signaling of a simple two-parameter model based on the kinetics of the diffusion-limiting step. In the present model, the signaling is regulated by the binding of a cofactor, such as ATP. Non-linearity of the kinetics is given by the diffusion fluctuation in the interaction between signaling molecules, which is different from previous works that hypothesized autocatalytic reactions. Numerical simulations showed the presence of a critical concentration of the cofactor beyond which the cell signaling molecule concentration is altered in a chaos-like oscillation with frequency, which is similar to a discontinuous phase transition in physics. Notably, we found that the frequency is given by the logarithm function of the difference of the outside cofactor concentration from the critical concentration. This implies that the outside alteration of the cofactor concentration is transformed into the oscillatory alteration of cell inner signaling. Further, mathematical stability kinetic analysis predicted a discontinuous dynamic phase transition in the critical state at which the cofactor concentration is equivalent to the critical concentration. In conclusion, the present model illustrates a unique feature of cell signaling, and the stability analysis may provide an analytical framework of the cell signaling system and a novel formulation of biological signaling.	Kyoto Univ, Grad Sch Med, Dept Mol Pathol, Kyoto, Japan	Kyoto University	Tsuruyama, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Pathol, Kyoto, Japan.	tsuruyam@kuhp.kyoto-u.ac.jp			MEXT, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, MEXT, Japan. Project name is "Synergy of fluctuation and Structure". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal I, 2000, J CELL BIOL, V149, P767, DOI 10.1083/jcb.149.4.767; Carles H, 1981, POLYMER, V22, P1165; Carlier M F, 1990, Adv Biophys, V26, P51, DOI 10.1016/0065-227X(90)90007-G; Carlsson AE, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036002; Dorsaz N, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/10/104116; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GALLAGHER WH, 1989, BIOPOLYMERS, V28, P2001, DOI 10.1002/bip.360281115; Godbout C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064560; Hazra P, 2006, BIOPHYS J, V91, P654, DOI 10.1529/biophysj.106.083915; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Ikeda Y, 2013, CELL, V155, P1323, DOI 10.1016/j.cell.2013.10.052; Kasche V, 2003, J CHROMATOGR B, V790, P115, DOI 10.1016/S0021-9673(02)02001-0; Katanaev VL, 2007, BIOCHEM J, V401, P485, DOI 10.1042/BJ20060517; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Nesmelova IV, 2002, BIOPOLYMERS, V63, P132, DOI 10.1002/bip.10023; OLEARY TJ, 1987, BIOPHYS J, V52, P137, DOI 10.1016/S0006-3495(87)83199-5; PANTALONI D, 1985, P NATL ACAD SCI USA, V82, P7207, DOI 10.1073/pnas.82.21.7207; Poincare H, 1892, COURBES DEFINIES EQU; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; TILTON RD, 1990, BIOPHYS J, V58, P1321, DOI 10.1016/S0006-3495(90)82473-5; Woolley DM, 2010, BIOL REV, V85, P453, DOI 10.1111/j.1469-185X.2009.00110.x; Wustner D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-296; Yamahawa H, 1971, MODERN THEORY POLYM, P266; Zilberman M, 2007, J BIOMED MATER RES A, V80A, P679, DOI 10.1002/jbm.a.30985; Zumsande M, 2010, J THEOR BIOL, V265, P481, DOI 10.1016/j.jtbi.2010.04.025	25	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102911	10.1371/journal.pone.0102911	http://dx.doi.org/10.1371/journal.pone.0102911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079957	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800019
J	Escalera-Zamudio, M; Nelson, MI; Guemes, AGC; Lopez-Martinez, I; Cruz-Ortiz, N; Iguala-Vidales, M; Garcia, ER; Barrera-Badillo, G; Diaz-Quinonez, JA; Lopez, S; Arias, CF; Isa, P				Escalera-Zamudio, Marina; Nelson, Martha I.; Cobian Gueemes, Ana Georgina; Lopez-Martinez, Irma; Cruz-Ortiz, Natividad; Iguala-Vidales, Miguel; Rodriguez Garcia, Elvia; Barrera-Badillo, Gisela; Alberto Diaz-Quinonez, Jose; Lopez, Susana; Arias, Carlos F.; Isa, Pavel		Colegio Pediat Estado Veracruz	Molecular Epidemiology of Influenza A/H3N2 Viruses Circulating in Mexico from 2003 to 2012	PLOS ONE			English	Article							A H3N2 VIRUS; SEQUENCE ALIGNMENT; GENETIC EVOLUTION; REASSORTMENT; HEMAGGLUTININ; ORIGIN; PERSISTENCE; RESISTANT; DYNAMICS; REVEALS	In this work, nineteen influenza A/H3N2 viruses isolated in Mexico between 2003 and 2012 were studied. Our findings show that different human A/H3N2 viral lineages co-circulate within a same season and can also persist locally in between different influenza seasons, increasing the chance for genetic reassortment events. A novel minor cluster was also identified, named here as Korea, that circulated worldwide during 2003. Frequently, phylogenetic characterization did not correlate with the determined antigenic identity, supporting the need for the use of molecular evolutionary tools additionally to antigenic data for the surveillance and characterization of viral diversity during each flu season. This work represents the first long-term molecular epidemiology study of influenza A/H3N2 viruses in Mexico based on the complete genomic sequences and contributes to the monitoring of evolutionary trends of A/H3N2 influenza viruses within North and Central America.	[Escalera-Zamudio, Marina; Cobian Gueemes, Ana Georgina; Lopez, Susana; Arias, Carlos F.; Isa, Pavel] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Nelson, Martha I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Lopez-Martinez, Irma; Cruz-Ortiz, Natividad; Iguala-Vidales, Miguel; Rodriguez Garcia, Elvia; Barrera-Badillo, Gisela; Alberto Diaz-Quinonez, Jose] Inst Diagnost & Referencia Epidemiol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Isa, P (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico.	pavel@ibt.unam.mx	Lopez, Susana/H-6661-2017; Lopez, Susana/O-1986-2019; Arias, Carlos/O-4036-2019; Isa, Pavel/GVU-8303-2022; Díaz-Quiñonez, José Alberto/GOV-5928-2022	Lopez, Susana/0000-0001-6336-9209; Lopez, Susana/0000-0001-6336-9209; Arias, Carlos/0000-0003-3130-4501; Díaz-Quiñonez, José Alberto/0000-0002-3503-7079; Escalera-Zamudio, Marina/0000-0002-4773-2773	Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico [PICOSI09-209]; Consejo Nacional de Ciencia y Tecnologia CONACyT-Mexico [S0008-126823]; CONACyT-Mexico	Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico; Consejo Nacional de Ciencia y Tecnologia CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially supported by grant PICOSI09-209 from the Instituto de Ciencia y Tecnologia del Distrito Federal to PI, Mexico and S0008-126823 from Consejo Nacional de Ciencia y Tecnologia CONACyT-Mexico to CFA. Marina Escalera-Zamudio y Ana Georgina Cobian Guemes were supported by a scholarship from CONACyT-Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl J, 2011, P NATL ACAD SCI USA, V108, P19359, DOI 10.1073/pnas.1109314108; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Blanton L., 2007, Morbidity and Mortality Weekly Report, V56, P789; Blanton L., 2006, Morbidity and Mortality Weekly Report, V55, P648; Bokhari SH, 2010, IEEE ACM T COMPUT BI, V7, P288, DOI 10.1109/TCBB.2008.73; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Brammer L, 2013, MMWR-MORBID MORTAL W, V62, P473; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P466; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P631; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P375; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P503; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P516; Dao C., 2008, Morbidity and Mortality Weekly Report, V57, P404; Daum LT, 2005, EMERG INFECT DIS, V11, P1186, DOI 10.3201/eid1108.050302; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fourment M, 2010, J CLIN MICROBIOL, V48, P295, DOI 10.1128/JCM.01687-09; Furuse Y, 2009, J CLIN MICROBIOL, V47, P841, DOI 10.1128/JCM.01622-08; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Jhung M., 2010, Morbidity and Mortality Weekly Report, V59, P423; Jin H, 2005, VIROLOGY, V336, P113, DOI 10.1016/j.virol.2005.03.010; Kang S, 2010, J CLIN MICROBIOL, V48, P2177, DOI 10.1128/JCM.00209-10; Kniss Krista, 2011, Morbidity and Mortality Weekly Report, V60, P705; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2009, VIROLOGY, V388, P270, DOI 10.1016/j.virol.2009.03.026; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000133; Peebles P., 2009, Morbidity and Mortality Weekly Report, V58, P369; Ponstigl H, 2010, SMALT; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Sarkar M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-3; Schweiger B, 2006, VACCINE, V24, P6683, DOI 10.1016/j.vaccine.2006.05.105; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Viboud C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0199; Wang Zhao-guo, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P35; Westgeest KB, 2012, J GEN VIROL, V93, P1996, DOI 10.1099/vir.0.043059-0; WHO webside, 2014, FLUNET; WHO webside, 2014, WHO REC COMP INFL VI; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	47	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102453	10.1371/journal.pone.0102453	http://dx.doi.org/10.1371/journal.pone.0102453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075517	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800012
J	Hu, XW; Yi, ES; Ryu, JH				Hu, Xiaowen; Yi, Eunhee S.; Ryu, Jay H.			Aspiration-Related Deaths in 57 Consecutive Patients: Autopsy Study	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; RISK-FACTORS; PNEUMONIA; DISEASE; MANAGEMENT; MORTALITY; FOOD	Background: Aspiration can cause a diverse spectrum of pulmonary disorders some of which can lead to death but can be difficult to diagnose. Patients and Methods: The medical records and autopsy findings of 57 consecutive patients in whom aspiration was the immediate cause of death at Mayo Clinic (Rochester, MN, USA) over a 9-yr period, from January 1 2004 to December 31 2012 were analyzed. Results: The median age at death was 72 years (range, 13-95 years) and included 39 (68%) males. The most common symptom before death was dyspnea (63%) and chest radiography revealed bilateral infiltrates in the majority (81%). Most common precipitating factors for aspiration were depressed consciousness (46%) and dysphagia (44%). Aspiration-related syndromes leading to death were aspiration pneumonia in 26 (46%), aspiration pneumonitis in 25 (44%), and large airway obstruction in 6 patients (11%). Aspiration was clinically unsuspected in 19 (33%) patients. Antimicrobial therapy had been empirically administered to most patients (90%) with aspiration pneumonia and aspiration pneumonitis. Conclusion: We conclude aspiration-related deaths occur most commonly in the elderly with identifiable risks and presenting bilateral pulmonary infiltrates. One-third of these aspiration-related pulmonary syndromes were clinically unsuspected at the time of death.	[Hu, Xiaowen] Anhui Med Univ, Anhui Prov Hosp, Dept Resp Med, Hefei, Peoples R China; [Yi, Eunhee S.] Mayo Clin, Div Anat Pathol, Rochester, MN USA; [Ryu, Jay H.] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN 55905 USA	Anhui Medical University; Mayo Clinic; Mayo Clinic	Ryu, JH (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN 55905 USA.	ryu.jay@mayo.edu		Ryu, Jay/0000-0002-9576-2272; Hu, Xiaowen/0000-0002-3727-6049				Auroy Y, 2009, ANAESTHESIA, V64, P366, DOI 10.1111/j.1365-2044.2008.05792.x; Barnes TW, 2006, MAYO CLIN PROC, V81, P172, DOI 10.4065/81.2.172; Beck-Schimmer B, 2011, EUR J ANAESTH, V28, P78, DOI 10.1097/EJA.0b013e32834205a8; Berzlanovich AM, 2005, AM J PREV MED, V28, P65, DOI 10.1016/j.amepre.2004.04.002; Chang CY, 2013, STROKE, V44, P1182, DOI 10.1161/STROKEAHA.111.000663; Christ A, 2006, INTENS CARE MED, V32, P1423, DOI 10.1007/s00134-006-0277-4; Chung CH, 2013, ACCIDENT ANAL PREV, V50, P523, DOI 10.1016/j.aap.2012.05.033; IRWIN RS, 1977, JAMA-J AM MED ASSOC, V237, P2744, DOI 10.1001/jama.237.25.2744; Komiya K, 2013, GERIATR GERONTOL INT, V13, P580, DOI 10.1111/j.1447-0594.2012.00940.x; Lanspa MJ, 2013, J HOSP MED, V8, P83, DOI 10.1002/jhm.1996; Marik PE, 2011, CURR OPIN PULM MED, V17, P148, DOI 10.1097/MCP.0b013e32834397d6; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Marik PE, 1999, CHEST, V115, P178, DOI 10.1378/chest.115.1.178; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Mukhopadhyay S, 2007, AM J SURG PATHOL, V31, P752, DOI 10.1097/01.pas.0000213418.08009.f9; Mylotte JM, 2005, J AM GERIATR SOC, V53, P755, DOI 10.1111/j.1532-5415.2005.53258.x; Mylotte JM, 2003, J AM GERIATR SOC, V51, P17, DOI 10.1034/j.1601-5215.2002.51004.x; Raghavendran K, 2011, CRIT CARE MED, V39, P818, DOI 10.1097/CCM.0b013e31820a856b; Taylor JK, 2013, AM J MED, V126, P995, DOI 10.1016/j.amjmed.2013.07.012; Ventura F, 2012, AM J FOREN MED PATH, V33, P259, DOI 10.1097/PAF.0b013e31824e5be0; Wada H, 2001, GERONTOLOGY, V47, P271, DOI 10.1159/000052811; Yang I, 2013, FEMS MICROBIOL REV, V37, P736, DOI 10.1111/1574-6976.12027	23	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103795	10.1371/journal.pone.0103795	http://dx.doi.org/10.1371/journal.pone.0103795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076409	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800080
J	Santos, MJ; Watt, T; Pincetl, S				Santos, Maria Joao; Watt, Terry; Pincetl, Stephanie			The Push and Pull of Land Use Policy: Reconstructing 150 Years of Development and Conservation Land Acquisition	PLOS ONE			English	Article							PROTECTED AREAS; BIODIVERSITY CONSERVATION; CHANGING WORLD; FUTURE	The growth of human populations and their resource needs have stressed the conservation of natural land resources. Many policies and programs have been implemented to address the pressures on land resources and notwithstanding this pressure, significant acquisition of land for conservation has occurred throughout history in the U.S., and internationally. Here we assess the on-the-ground result of the evolution of land use policies in California as a pioneer forerunner, in the form of acquisition of land for conservation (i.e. Open Space), and its impact on the rest of the U.S. and beyond. To this end we describe the timeline and spatial representation of the growth of California's conservation network over the last 150 years, and link it to the history of land use policies. We then assess whether conservation land acquisition has consistently grown through time or occurred in specific decades. About 1/4 of the state is now designated Open Space. Fewer and larger areas conserved and acquired at the beginning of the 20th century; the conservation network was complemented with a larger number of smaller sized properties. Despite acquisition of land in every decade, the process was uneven (E = 0.3 for California, E = 0.14 +/- 0.08 average for the state's counties), mostly due to the large acquisitions and land set asides in the 1900s, followed by 1930s and 1940s. This process was a result of a comprehensive set of legislation that evolved through time, and resulted from the competing needs for development and conservation. Even with the impressive 174,000 km 2 of public lands in California, the future of California's natural infrastructure and natural heritage cannot rely solely on these public lands, nor public agencies and their resources. Critically a future course of land preservation relying on the purchase of new lands - in California and beyond - for conservation is tremendously expensive.	[Santos, Maria Joao] Stanford Univ, Ctr Spatial & Textual Anal, Spatial Hist Project, Stanford, CA 94305 USA; [Santos, Maria Joao] Stanford Univ, Bill Lane Ctr Amer West, Stanford, CA 94305 USA; [Watt, Terry] Terry Watt Planning Associates, San Francisco, CA USA; [Pincetl, Stephanie] Univ Calif Los Angeles, Inst Environm, Calif Ctr Sustainable Commun, Los Angeles, CA USA	Stanford University; Stanford University; University of California System; University of California Los Angeles	Santos, MJ (corresponding author), Stanford Univ, Ctr Spatial & Textual Anal, Spatial Hist Project, Stanford, CA 94305 USA.	mjsantos@stanford.edu	Santos, Maria Joao/M-5034-2013	Santos, Maria Joao/0000-0002-6558-7477	Bill Lane Center for the American West; Spatial History project at Stanford University	Bill Lane Center for the American West; Spatial History project at Stanford University	MJS was funded by a postdoctoral fellowship from the Bill Lane Center for the American West and the Spatial History project at Stanford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmford A, 2003, TRENDS ECOL EVOL, V18, P435, DOI 10.1016/S0169-5347(03)00217-9; Barbour E., 2002, METROPOLITAN GROWTH; Barton G. A., 2000, Environment and History, V6, P187, DOI 10.3197/096734000129342271; BISHOP K, 1995, LAND USE POLICY, V12, P291, DOI 10.1016/0264-8377(95)00030-H; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; California Transportation Commission, 2010, REG TRANSP GUID; Calsbeek R, 2003, MOL ECOL, V12, P1021, DOI 10.1046/j.1365-294X.2003.01794.x; Dear M, 1996, CITY LOS ANGELES URB; Dear Michael, 2004, SPRAWL PUBLIC POLICY; Fogelson RM, 1967, FRAGMENTED METROPOLI; Fulton William B., 1997, RELUCTANT METROPOLIS; GreenInfo Network, 2013, CAL PROT AR DAT CPAD; Hise G, 1997, PLANNING 20 CENTURY; IUCN and UNEP-WCMC, 2013, WORLD DAT PROT AR WD; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; McDonald RI, 2011, BIOL CONSERV, V144, P383, DOI 10.1016/j.biocon.2010.09.016; Moilanen A, 2011, BIOL CONSERV, V144, P1719, DOI 10.1016/j.biocon.2011.03.007; Olmsted F L., 1929, REPORT STATE PARKS S; Pincetl S, 2006, GEOFORUM, V37, P246, DOI 10.1016/j.geoforum.2005.05.001; Pincetl S, 1999, SUNY S URB, P195; Pincetl S, 2004, SPRAWL PUBLIC POLICY; Pincetl S, 1999, TRANSFORMING CA POLI; Pincetl S, 2003, SOCIAL SCI Q, V84, P989; Pincetl S, 2011, GEOFORUM, V42, P427, DOI 10.1016/j.geoforum.2011.03.001; Press DM., 2002, SAVING OPEN SPACE PO; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Radeloff VC, 2013, CONSERV LETT, V6, P58, DOI 10.1111/j.1755-263X.2012.00290.x; Radeloff VC, 2010, P NATL ACAD SCI USA, V107, P940, DOI 10.1073/pnas.0911131107; Schrag P, 1998, PARADISE LOST CA EXP; Silva F. J., 1999, STATE LOCAL FISCAL R; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Thorne JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065258; Walker RA., 2007, WEYERHAEUSER ENV BOO; Watzold F, 2005, BIOL CONSERV, V123, P327, DOI 10.1016/j.biocon.2004.12.001	35	12	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103489	10.1371/journal.pone.0103489	http://dx.doi.org/10.1371/journal.pone.0103489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25075611	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800053
J	Chami, GF; Ahnert, SE; Voors, MJ; Kontoleon, AA				Chami, Goylette F.; Ahnert, Sebastian E.; Voors, Maarten J.; Kontoleon, Andreas A.			Social Network Analysis Predicts Health Behaviours and Self-Reported Health in African Villages	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; 187 COUNTRIES; DISEASE; IDENTIFICATION; INJURIES	The provision of healthcare in rural African communities is a highly complex and largely unsolved problem. Two main difficulties are the identification of individuals that are most likely affected by disease and the prediction of responses to health interventions. Social networks have been shown to capture health outcomes in a variety of contexts. Yet, it is an open question as to what extent social network analysis can identify and distinguish among households that are most likely to report poor health and those most likely to respond to positive behavioural influences. We use data from seven highly remote, post-conflict villages in Liberia and compare two prominent network measures: in-degree and betweenness. We define in-degree as the frequency in which members from one household are named by another household as a friends. Betweenness is defined as the proportion of shortest friendship paths between any two households in a network that traverses a particular household. We find that in-degree explains the number of ill family members, whereas betweenness explains engagement in preventative health. In-degree and betweenness independently explained self-reported health and behaviour, respectively. Further, we find that betweenness predicts susceptibility to, instead of influence over, good health behaviours. The results suggest that targeting households based on network measures rather than health status may be effective for promoting the uptake of health interventions in rural poor villages.	[Chami, Goylette F.; Voors, Maarten J.; Kontoleon, Andreas A.] Univ Cambridge, Dept Land Econ, Cambridge CB3 9EP, England; [Chami, Goylette F.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Ahnert, Sebastian E.] Univ Cambridge, Cavendish Lab, Condensed Matter Theory Grp, Cambridge CB3 0HE, England; [Voors, Maarten J.] Wageningen Univ, Dev Econ Grp, NL-6700 AP Wageningen, Netherlands	University of Cambridge; University of Cambridge; University of Cambridge; Wageningen University & Research	Kontoleon, AA (corresponding author), Univ Cambridge, Dept Land Econ, Cambridge CB3 9EP, England.	ak219@cam.ac.uk		Voors, Maarten/0000-0001-5907-3253; Chami, Goylette/0000-0002-4653-0846	N.W.O. grant [W07.68.116]; ESRC [ES/J017620/1] Funding Source: UKRI; Economic and Social Research Council [ES/J017620/1] Funding Source: researchfish	N.W.O. grant; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by N.W.O. grant #W07.68.116 to Professor Erwin Bulte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Chami GF, 2013, TRENDS PARASITOL, V29, P370, DOI 10.1016/j.pt.2013.04.005; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Goh KI, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.017101; Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kruk ME, 2011, MED CARE, V49, P585, DOI 10.1097/MLR.0b013e31820f0dd4; Liberia Institute of Statistics and Geo-Information Services (LISGIS) Ministry of Health and Social Welfare National AIDS Control Program Macro International Inc, 2008, LIB DEM HLTH SURV 20; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Newman M, 2010, MEASURES METRICS NET, p[168, 185]; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Pruss-Ustun A, 2006, PREVENTING DIS HLTH, P16; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Szell M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01214; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X	26	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103500	10.1371/journal.pone.0103500	http://dx.doi.org/10.1371/journal.pone.0103500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072820	gold, Green Published			2022-12-27	WOS:000341307600055
J	Brunye, TT; Carney, PA; Allison, KH; Shapiro, LG; Weaver, DL; Elmore, JG				Brunye, Tad T.; Carney, Patricia A.; Allison, Kimberly H.; Shapiro, Linda G.; Weaver, Donald L.; Elmore, Joann G.			Eye Movements as an Index of Pathologist Visual Expertise: A Pilot Study	PLOS ONE			English	Article							VIRTUAL SLIDES; IMAGE PERCEPTION; GAZE-TRACKING; PERFORMANCE; EXPERIENCE; ATTENTION	A pilot study examined the extent to which eye movements occurring during interpretation of digitized breast biopsy whole slide images (WSI) can distinguish novice interpreters from experts, informing assessments of competency progression during training and across the physician-learning continuum. A pathologist with fellowship training in breast pathology interpreted digital WSI of breast tissue and marked the region of highest diagnostic relevance (dROI). These same images were then evaluated using computer vision techniques to identify visually salient regions of interest (vROI) without diagnostic relevance. A non-invasive eye tracking system recorded pathologists' (N = 7) visual behavior during image interpretation, and we measured differential viewing of vROIs versus dROIs according to their level of expertise. Pathologists with relatively low expertise in interpreting breast pathology were more likely to fixate on, and subsequently return to, diagnostically irrelevant vROIs relative to experts. Repeatedly fixating on the distracting vROI showed limited value in predicting diagnostic failure. These preliminary results suggest that eye movements occurring during digital slide interpretation can characterize expertise development by demonstrating differential attraction to diagnostically relevant versus visually distracting image regions. These results carry both theoretical implications and potential for monitoring and evaluating student progress and providing automated feedback and scanning guidance in educational settings.	[Brunye, Tad T.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Carney, Patricia A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Allison, Kimberly H.] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; [Shapiro, Linda G.] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Weaver, Donald L.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Weaver, Donald L.] Vermont Canc Ctr, Burlington, VT USA; [Elmore, Joann G.] Univ Washington, Dept Med, Seattle, WA USA	Tufts University; Oregon Health & Science University; Stanford University; University of Washington; University of Washington Seattle; University of Vermont; University of Washington; University of Washington Seattle	Brunye, TT (corresponding author), Tufts Univ, Dept Psychol, Medford, MA 02155 USA.	tbruny01@tufts.edu		Brunye, Tad/0000-0002-8788-8764	National Cancer Institute of the National Institutes of Health [R01 CA172343, KO5 CA104699]; National Cancer Institute [U01CA86082, U01CA70013, U01CA69976, HHSN261201100031C]; NATIONAL CANCER INSTITUTE [R01CA172343, U01CA069976, K05CA104699, U01CA070013, U01CA086082] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers R01 CA172343 and KO5 CA104699 and by the National Cancer Institute-funded Breast Cancer Surveillance Consortium (U01CA86082, U01CA70013, U01CA69976, HHSN261201100031C). The content is solely the responsibility of the authors and does not necessarily represent the views of the National Cancer Institute or the National Institutes of Health. The collection of cancer and vital status data used in this study was supported in part by several state public health departments and cancer registries throughout the U.S. For a full description of these sources, please see: http://www.breastscreening.cancer.gov/work/acknowledgement.html. The authors wish to thank Ventana Medical Systems, Inc., a member of the Roche Group, for use of iScan Coreo Au whole slide imaging system, and HD View SL for the source code used to build our digital viewer. For a full description of HD View SL please see http://hdviewsl.codeplex.com/. No funding was received from these commercial entities, and they have no vested interest in the outcomes of this study. The authors would also like to thank the participating pathologists who kindly donated their time to this study, Tom Morgan and Vignesh Raghunath at University of Washington for their assistance with data collection, and Sarah Tower-Richardi at Tufts University for her assistance with scoring of eye tracking videos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACGME, 2011, ACGME PROGR REQ GRAN, P1; Bombari D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038023; Carney PA, 1996, AM J ROENTGENOL, V167, P367, DOI 10.2214/ajr.167.2.8686606; Carney PA, 2000, AM J EPIDEMIOL, V152, P371, DOI 10.1093/aje/152.4.371; Crowley RS, 2003, J AM MED INFORM ASSN, V10, P39, DOI 10.1197/jamia.M1123; Dalkey NC, 1969, DELPHI METHOD 3 USE; Derry SJ, 1996, EDUC PSYCHOL, V31, P163, DOI 10.1207/s15326985ep3103&4_2; Dreyfus HL, 1986, PLOS ONE, V7; Duchowski A., 2007, EYE TRACKING METHODO; Elstein AS, 1978, MED PROBLEM SOLVING; Everling S., 2011, OXFORD HDB EYE MOVEM, P523; Farr M.J., 1988, NATURE EXPERTISE, P311; Folberg R, 2002, HUM PATHOL, V33, P3, DOI 10.1053/hupa.2002.30226; Greenwood P. E., 1996, GUIDE CHI SQUARED TE, V280; Harel A, 2011, J VISION, V11, DOI 10.1167/11.8.18; Harel A, 2010, CEREB CORTEX, V20, P2304, DOI 10.1093/cercor/bhp316; Harel J, 2006, SALIENCY IMPLEMENTAT; Helle L, 2010, MED EDUC, V44, P621, DOI 10.1111/j.1365-2923.2010.03625.x; Hung AJ, 2011, J UROLOGY, V186, P1019, DOI 10.1016/j.juro.2011.04.064; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Krupinski EA, 2006, HUM PATHOL, V37, P1543, DOI 10.1016/j.humpath.2006.08.024; Kulatunga-Moruzi C, 2004, J EXP PSYCHOL LEARN, V30, P563, DOI 10.1037/0278-7393.30.3.563; Kundel HL, 2008, ACAD RADIOL, V15, P881, DOI 10.1016/j.acra.2008.01.023; Kundel HL, 2007, RADIOLOGY, V242, P396, DOI 10.1148/radiol.2422051997; KUNDEL HL, 1983, RADIOLOGY, V146, P363, DOI 10.1148/radiology.146.2.6849084; KUNDEL HL, 1972, RADIOLOGY, V103, P523, DOI 10.1148/103.3.523; Mello-Thoms C, 2012, ARCH PATHOL LAB MED, V136, P551, DOI 10.5858/arpa.2010-0697-OA; Nodine C, 2010, ROLE EXPERTISE RADIO, P139; Oster NV, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-3; Raghunath Vignesh, 2012, J Pathol Inform, V3, P43, DOI 10.4103/2153-3539.104905; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; SIMON HA, 1973, AM SCI, V61, P394; Treanor D, 2009, HISTOPATHOLOGY, V55, P37, DOI 10.1111/j.1365-2559.2009.03325.x; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285	35	43	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103447	10.1371/journal.pone.0103447	http://dx.doi.org/10.1371/journal.pone.0103447			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084012	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800042
J	Guan, NN; Thor, A; Hallen, K; Wiklund, NP; Gustafsson, LE				Guan, Na N.; Thor, Anna; Hallen, Katarina; Wiklund, N. Peter; Gustafsson, Lars E.			Cascade Bioassay Evidence for the Existence of Urothelium-Derived Inhibitory Factor in Guinea Pig Urinary Bladder	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE; RAT; ATP; RELEASE; TRACT; CONTRACTION; RELAXATION; PROSTAGLANDINS; MODULATION	Our aim was to investigate whether guinea pig urothelium-derived bioactivities compatible with the existence of urothelium-derived inhibitory factor could be demonstrated by in vitro serial bioassay and whether purinergic P1 receptor agonists, nitric oxide, nitrite or prostaglandins might explain observed activities. In a cascade superfusion system, urothelium-denuded guinea pig ureters were used as bioassay tissues, recording their spontaneous rhythmic contractions in presence of scopolamine. Urothelium-intact or -denuded guinea pig urinary bladders were used as donor tissues, stimulated by intermittent application of carbachol before or during the nitric oxide synthase inhibitor N-G-nitro-L-arginine methyl ester (L-NAME), the adenosine/P1 nucleoside receptor antagonist 8-(p-sulfophenyl) theophylline (8-PST) or the cyclooxygenase inhibitor diclofenac infused to bath donor and bioassay tissues. The spontaneous contractions of bioassay ureters were unaltered by application of carbachol 1-5 mu M in the presence of scopolamine 5-30 mu M. When carbachol was applied over the urothelium-denuded bladder, the assay ureter contraction rate was unaltered. Introducing carbachol over the everted urothelium-intact bladder significantly inhibited the contraction frequency of the assay ureter, suggesting the transfer of an inhibitory activity from the bladder to the assay ureter. The transmissible inhibitory activity was not markedly antagonized by L-NAME, 8-PST or diclofenac, while L-NAME nearly abolished nitrite release from the urothelium-intact bladder preparations. We suggest that urothelium-derived inhibitory factor is a transmissible entity over a significant distance as demonstrated in this novel cascade superfusion assay and seems less likely to be nitric oxide, nitrite, an adenosine receptor agonist or subject to inhibition by administration of a cyclo-oxygenase inhibitor.	[Guan, Na N.; Gustafsson, Lars E.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Thor, Anna; Hallen, Katarina; Wiklund, N. Peter] Karolinska Inst, Dept Mol Med & Surg, Urol Sect, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Gustafsson, LE (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	lars.gustafsson@ki.se	Gustafsson, Lars E/E-6950-2013	Wiklund, Peter/0000-0001-6497-4697	Swedish Science Council; Swedish National Space Board; EU FP7 INComb; Karolinska Institutet	Swedish Science Council; Swedish National Space Board; EU FP7 INComb; Karolinska Institutet(Karolinska Institutet)	Supported by the Swedish Science Council, the Swedish National Space Board, the EU FP7 INComb and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; ABRAMS PH, 1979, INVEST UROL, V16, P346; Andersson KE, 2013, J UROLOGY, V190, P1173, DOI 10.1016/j.juro.2013.02.104; BOLAND B, 1993, BRIT J PHARMACOL, V108, P749, DOI 10.1111/j.1476-5381.1993.tb12872.x; Braverman AS, 2007, NEUROUROL URODYNAM, V26, P63, DOI 10.1002/nau.20378; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Canda AE, 2007, UROL INT, V78, P289, DOI 10.1159/000100830; Chaiyaprasithi B, 2003, J UROLOGY, V170, P1897, DOI 10.1097/01.ju.0000091870.51841.ae; DAHLEN SE, 1980, ACTA PHYSIOL SCAND, V109, P137, DOI 10.1111/j.1748-1716.1980.tb06578.x; Davidson ME, 2000, BRIT J PHARMACOL, V129, P661, DOI 10.1038/sj.bjp.0703104; Fathian-Sabet B, 2001, J UROLOGY, V165, P1724, DOI 10.1016/S0022-5347(05)66402-6; Fovaeus M, 1999, J UROLOGY, V161, P649, DOI 10.1016/S0022-5347(01)61988-8; Fovaeus M, 1998, ACTA PHYSIOL SCAND, V162, P115; Fry CH, 2004, SCAND J UROL NEPHROL, V38, P20, DOI 10.1080/03008880410015138; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gopalakrishnan SM, 2002, J PHARMACOL EXP THER, V300, P910, DOI 10.1124/jpet.300.3.910; GRYGLEWSKI RJ, 1986, BRIT J PHARMACOL, V87, P685, DOI 10.1111/j.1476-5381.1986.tb14586.x; GUSTAFSSON LE, 1989, ANN NY ACAD SCI, V559, P178; Hallen K, 2007, BRIT J PHARMACOL, V150, P353, DOI 10.1038/sj.bjp.0706991; Hawthorn MH, 2000, BRIT J PHARMACOL, V129, P416, DOI 10.1038/sj.bjp.0703068; Iselin CE, 1996, J UROLOGY, V155, P763, DOI 10.1016/S0022-5347(01)66517-0; Iversen HH, 1995, UROL RES, V23, P391, DOI 10.1007/BF00698741; IVERSEN HH, 1994, BRIT J PHARMACOL, V113, P1088, DOI 10.1111/j.1476-5381.1994.tb17107.x; Jansson OT, 1998, BRIT J CANCER, V78, P588, DOI 10.1038/bjc.1998.545; Lang RJ, 2002, EXP PHYSIOL, V87, P129, DOI 10.1113/eph8702290; MAGGI CA, 1987, J PHARM PHARMACOL, V39, P653, DOI 10.1111/j.2042-7158.1987.tb03447.x; Mamas MA, 2003, UROLOGY, V61, P1079, DOI 10.1016/S0090-4295(03)00131-6; Mastrangelo D, 2007, J UROLOGY, V178, P702, DOI 10.1016/j.juro.2007.03.099; Mastrangelo D, 2003, J UROLOGY, V170, P1409, DOI 10.1097/01.ju.0000083492.80217.20; McMurray G, 1998, BRIT J PHARMACOL, V123, P1579, DOI 10.1038/sj.bjp.0701774; Munoz A, 2010, BMC UROL, V10, DOI 10.1186/1471-2490-10-10; Murakami S, 2007, BJU INT, V99, P669, DOI 10.1111/j.1464-410X.2006.06679.x; MUTOH S, 1983, UROL INT, V38, P219, DOI 10.1159/000280895; Persson K, 1999, J HISTOCHEM CYTOCHEM, V47, P739, DOI 10.1177/002215549904700603; Santoso AGH, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.06.040; Sui GP, 2014, AM J PHYSIOL-RENAL, V306, pF286, DOI 10.1152/ajprenal.00291.2013; Templeman L, 2002, J UROLOGY, V167, P742, DOI 10.1016/S0022-5347(01)69137-7; Yoshimura N, 2012, BJU INT	38	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103932	10.1371/journal.pone.0103932	http://dx.doi.org/10.1371/journal.pone.0103932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084114	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800103
J	Schoffelen, T; Limonard, GJM; Bleeker-Rovers, CP; Bouwman, JJM; van der Meer, JWM; Nabuurs-Franssen, M; Sprong, T; van Deuren, M				Schoffelen, Teske; Limonard, Gijs J. M.; Bleeker-Rovers, Chantal P.; Bouwman, John J. M.; van der Meer, Jos W. M.; Nabuurs-Franssen, Marrigje; Sprong, Tom; van Deuren, Marcel			Diagnosis of Coxiella burnetii Infection: Comparison of a Whole Blood Interferon-Gamma Production Assay and a Coxiella ELISPOT	PLOS ONE			English	Article							CHRONIC Q-FEVER; T-CELLS; TUBERCULOSIS; IMMUNODIAGNOSIS; CLEARANCE; HISTORY	Diagnosis of ongoing or past infection with Coxiella burnetii, the causative agent of Q fever, relies heavily on serology: the measurement of C. burnetii-specific antibodies, reflecting the host's humoral immune response. However, cell-mediated immune responses play an important, probably even more relevant, role in infections caused by the intracellular C. burnetii bacterium. Recent studies have investigated interferon-gamma (IFN-gamma) based assays, including a whole-blood IFN-gamma production assay and a Coxiella enzyme-linked immunospot (Coxiella ELISPOT), as potential diagnostic tools for Q fever diagnosis. Both are in-house developed assays using stimulating antigens of different origin. The main objective of this study was to compare the test performance of the IFN-gamma production assay and the Coxiella ELISPOT for detecting a cellular immune response to C. burnetii in Q fever patients, and to assess the correlation between both assays. To that end, both tests were performed in a well-defined patient group of chronic Q fever patients (n = 16) and a group of healthy seronegative individuals (n = 17). Among patients, both the Coxiella ELISPOT and the IFN-gamma production assay detected positive response in 14/16. Among controls, none were positive in the Coxiella ELISPOT, whereas the IFN-gamma production assay detected positive results in 1/17 and 3/17, when using Henzerling and Nine Mile as stimulating antigens, respectively. These results suggest the Coxiella ELISPOT has a somewhat higher specificity than the IFN-gamma production assay when Nine Mile is used as antigen stimulus. The assays showed moderate correlation: the Spearman correlation coefficient r ranged between 0.37-0.60, depending on the antigens used. Further investigation of the diagnostic potential for C. burnetii infection of both assays is warranted.	[Schoffelen, Teske; Bleeker-Rovers, Chantal P.; van der Meer, Jos W. M.; van Deuren, Marcel] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Limonard, Gijs J. M.] Diakonessenhuis Utrecht, Dept Pulm Dis, Utrecht, Netherlands; [Bouwman, John J. M.] Univ Appl Sci, Inst Life Sci, Utrecht, Netherlands; [Nabuurs-Franssen, Marrigje; Sprong, Tom] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Sprong, Tom] Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands	Radboud University Nijmegen; Diakonessenhuis; Canisius-Wilhelmina Hospital; Canisius-Wilhelmina Hospital	Schoffelen, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.	Teske.Schoffelen@radboudumc.nl	Bleeker-Rovers, Chantal P/D-4833-2009; van der Meer, Jos W.M./C-8521-2013	Bleeker-Rovers, Chantal P/0000-0003-4900-6262; van der Meer, Jos W.M./0000-0001-5120-3690	Netherlands Organisation for Health Research and Development [205520002]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by The Netherlands Organisation for Health Research and Development www.zonmw.nl [grant number 205520002 to TSc]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson A, 2013, MMWR RECOMM REP, V62, P1; Andoh M, 2007, INFECT IMMUN, V75, P3245, DOI 10.1128/IAI.01767-06; Ghigo E, 2009, ANN NY ACAD SCI, V1166, P55, DOI 10.1111/j.1749-6632.2009.04515.x; Goletti D, 2005, CLIN DIAGN LAB IMMUN, V12, P1311, DOI 10.1128/CDLI.12.11.1311-1316.2005; Kampschreur LM, 2012, CLIN VACCINE IMMUNOL, V19, P1165, DOI 10.1128/CVI.00185-12; Limonard GJM, 2012, FEMS IMMUNOL MED MIC, V64, P57, DOI 10.1111/j.1574-695X.2011.00890.x; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Read AJ, 2010, INFECT IMMUN, V78, P3019, DOI 10.1128/IAI.00101-10; Schoffelen T, 2013, CLIN MICROBIOL INFEC; Schoffelen T, 2013, J INFECTION, V67, P565, DOI 10.1016/j.jinf.2013.08.008; Schoffelen T, 2013, CLIN INFECT DIS, V56, P1742, DOI 10.1093/cid/cit129; Scholvinck E, 2004, J CLIN MICROBIOL, V42, P829, DOI 10.1128/JCM.42.2.829-831.2004; van der Hoek W, 2012, EUROSURVEILLANCE, V17, P16; Wegdam-Blans MCA, 2012, J INFECTION, V64, P247, DOI 10.1016/j.jinf.2011.12.014	16	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103749	10.1371/journal.pone.0103749	http://dx.doi.org/10.1371/journal.pone.0103749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084353	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800076
J	Schwarz, F; Lange, P; Zinsser, D; Greif, M; Boekstegers, P; Schmitz, C; Reiser, MF; Kupatt, C; Becker, HC				Schwarz, Florian; Lange, Philipp; Zinsser, Dominik; Greif, Martin; Boekstegers, Peter; Schmitz, Christoph; Reiser, Maximilian F.; Kupatt, Christian; Becker, Hans C.			CT-Angiography Based Evaluation of the Aortic Annulus for Prosthesis Sizing in Transcatheter Aortic Valve Implantation (TAVI)-Predictive Value and Optimal Thresholds for Major Anatomic Parameters	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; ELDERLY-PATIENTS; ROOT DIMENSIONS; HEART-VALVE; REPLACEMENT; STENOSIS; VALVULOPLASTY; REGURGITATION; DECISION; SURGERY	Background/Objectives: To evaluate the predictive value of CT-derived measurements of the aortic annulus for prosthesis sizing in transcatheter aortic valve implantation (TAVI) and to calculate optimal cutoff values for the selection of various prosthesis sizes. Methods: The local IRB waived approval for this single-center retrospective analysis. Of 441 consecutive TAVI-patients, 90 were excluded (death within 30 days: 13; more than mild aortic regurgitation: 10; other reasons: 67). In the remaining 351 patients, the CoreValve (Medtronic) and the Edwards Sapien XT valve (Edwards Lifesciences) were implanted in 235 and 116 patients. Optimal prosthesis size was determined during TAVI by inflation of a balloon catheter at the aortic annulus. All patients had undergone CT-angiography of the heart or body trunk prior to TAVI. Using these datasets, the diameter of the long and short axis as well as the circumference and the area of the aortic annulus were measured. Multi-Class Receiver-Operator-Curve analyses were used to determine the predictive value of all variables and to define optimal cutoff-values. Results: Differences between patients who underwent implantation of the small, medium or large prosthesis were significant for all except the large vs. medium CoreValve (all p's<0.05). Furthermore, mean diameter, annulus area and circumference had equally high predictive value for prosthesis size for both manufacturers (multi-class AUC's: 0.80, 0.88, 0.91, 0.88, 0.88, 0.89). Using the calculated optimal cutoff-values, prosthesis size is predicted correctly in 85% of cases. Conclusion: CT-based aortic root measurements permit excellent prediction of the prosthesis size considered optimal during TAVI.	[Schwarz, Florian; Zinsser, Dominik; Reiser, Maximilian F.; Becker, Hans C.] Hosp Univ Munich, Inst Clin Radiol, Munich, Germany; [Lange, Philipp; Greif, Martin; Kupatt, Christian] Hosp Univ Munich, Med Clin Cardiol 1, Munich, Germany; [Boekstegers, Peter] HELIOS Kliniken GmbH, HELIOS Klinikum Siegburg, Siegburg, Germany; [Schmitz, Christoph] Hosp Univ Munich, Dept Cardiac Surg, Munich, Germany; [Reiser, Maximilian F.; Kupatt, Christian; Becker, Hans C.] Partner Site Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany	University of Munich; University of Munich; Helios Kliniken; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Schwarz, F (corresponding author), Hosp Univ Munich, Inst Clin Radiol, Munich, Germany.	Florian.Schwarz@med.uni-muenchen.de	Schwarz, Florian/AAE-5840-2022	Schwarz, Florian/0000-0001-9889-5153; Kupatt, Christian/0000-0002-3611-1218; Becker, Hans-Christoph/0000-0001-6059-4937	DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)	DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	This work was supported by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach S, 2012, J CARDIOVASC COMPUT; Altiok E, 2011, HEART, V97, P1578, DOI 10.1136/hrt.2011.223974; [Anonymous], 2010, R LANG ENV STAT COMP; Babaliaros VC, 2010, JACC-CARDIOVASC INTE, V3, P114, DOI 10.1016/j.jcin.2009.09.017; Babaliaros VC, 2008, JACC-CARDIOVASC INTE, V1, P580, DOI 10.1016/j.jcin.2008.06.010; Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Bertaso AG, 2012, INT J CARDIOVAS IMAG, V28, P2091, DOI 10.1007/s10554-012-0018-4; Binder RK, 2013, J AM COLL CARDIOL; Blanke P, 2012, JACC-CARDIOVASC INTE, V5, P984, DOI 10.1016/j.jcin.2012.05.014; Blanke P, 2012, CIRC-CARDIOVASC INTE, V5, P540, DOI 10.1161/CIRCINTERVENTIONS.111.967349; Blanke P, 2010, EUR J CARDIO-THORAC, V38, P750, DOI 10.1016/j.ejcts.2010.03.039; Bolen MA, 2012, J CARDIOVASC COMPUT, V6, P393, DOI 10.1016/j.jcct.2012.10.006; Bouma BJ, 1999, HEART, V82, P143, DOI 10.1136/hrt.82.2.143; Carabello BA, 2009, LANCET, V373, P956, DOI 10.1016/S0140-6736(09)60211-7; Cerillo AG, 2012, ANN CARDIOTHORAC SUR, V1, P245, DOI 10.3978/j.issn.2225-319X.2012.06.13; Cheung A, 2011, CURR OPIN CARDIOL, V26, P106, DOI 10.1097/HCO.0b013e32834398ba; del Valle-Fernandez R, 2010, EUR HEART J, V31, P2170, DOI 10.1093/eurheartj/ehq093; Delgado V, 2011, ANN THORAC SURG, V91, P716, DOI 10.1016/j.athoracsur.2010.09.060; Delgado Victoria, 2010, Expert Rev Cardiovasc Ther, V8, P113, DOI 10.1586/erc.09.135; Delgado V, 2010, EUR HEART J, V31, P1114, DOI 10.1093/eurheartj/ehq018; Gurvitch R, 2011, JACC-CARDIOVASC INTE, V4, P1235, DOI 10.1016/j.jcin.2011.07.014; Halpern EJ, 2012, ACAD RADIOL; Hayashida K, 2012, J AM COLL CARDIOL, V59, pE2142, DOI 10.1016/S0735-1097(12)62143-3; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jilaihawi H, 2012, J AM COLL CARDIOL, V59, P1275, DOI 10.1016/j.jacc.2011.11.045; Krishnaswamy A, 2011, CATHETER CARDIO INTE, V77, P860, DOI 10.1002/ccd.22740; Lehmkuhl L, 2013, INT J CARDIOVAS IMAG, V29, P693, DOI 10.1007/s10554-012-0123-4; Leipsic J, 2011, JACC-CARDIOVASC IMAG, V4, P416, DOI 10.1016/j.jcmg.2011.01.014; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Ng ACT, 2010, CIRC-CARDIOVASC IMAG, V3, P94, DOI 10.1161/CIRCIMAGING.109.885152; Schultz C, 2010, EUROINTERVENTION, V6, P505, DOI 10.4244/EIJ30V6I4A84; Schultz CJ, 2010, EUR HEART J, V31, P849, DOI 10.1093/eurheartj/ehp534; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Wood DA, 2009, AM J CARDIOL, V103, P1295, DOI 10.1016/j.amjcard.2009.01.034; Wuest W, 2012, EUR RADIOL, V22, P51, DOI 10.1007/s00330-011-2233-0	38	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103481	10.1371/journal.pone.0103481	http://dx.doi.org/10.1371/journal.pone.0103481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084451	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800047
J	Zhang, YC; Hu, TY; Hua, CL; Gu, J; Zhang, LY; Hao, S; Liang, HY; Wang, XM; Wang, WL; Xu, J; Liu, HZ; Liu, B; Cheng, T; Yuan, WP				Zhang, Yingchi; Hu, Tianyuan; Hua, Chunlan; Gu, Jie; Zhang, Liyan; Hao, Sha; Liang, Haoyue; Wang, Xiaomin; Wang, Weili; Xu, Jing; Liu, Hanzhi; Liu, Bin; Cheng, Tao; Yuan, Weiping			Rictor Is Required for Early B Cell Development in Bone Marrow	PLOS ONE			English	Article							MTOR COMPLEX 2; PHOSPHOINOSITIDE 3-KINASE; SELF-RENEWAL; RAPAMYCIN; GENE; DIFFERENTIATION; RECEPTOR; HEMATOPOIESIS; TRANSCRIPTION; MECHANISMS	The development of early B cells, which are generated from hematopoietic stem cells (HSCs) in a series of well-characterized stages in bone marrow (BM), represents a paradigm for terminal differentiation processes. Akt is primarily regulated by phosphorylation at Thr308 by PDK1 and at Ser473 by mTORC2, and Akt signaling plays a key role in hematopoiesis. However, the role of mTORC2 in the development of early B cells remains poorly understood. In this study, we investigated the functional role of mTORC2 by specifically deleting an integral component, Rictor, in a hematopoietic system. We demonstrated that the deletion of Rictor induced an aberrant increase in the FoxO1 and Rag-1 proteins in BM B cells and that this increase was accompanied by a significant decrease in the abundance of B cells in the peripheral blood (PB) and the spleen, suggesting impaired development of early B cells in adult mouse BM. A BM transplantation assay revealed that the B cell differentiation defect induced by Rictor deletion was not affected by the BM microenvironment, thus indicating a cell-intrinsic mechanism. Furthermore, the knockdown of FoxO1 in Rictor-deleted HSCs and hematopoietic progenitor cells (HPCs) promoted the maturation of B cells in the BM of recipient mice. In addition, we revealed that treatment with rapamycin (an mTORC1 inhibitor) aggravated the deficiency in B cell development in the PB and BM. Taken together, our results provide further evidence that Rictor regulates the development of early B cells in a cell-intrinsic manner by modifying the expression of FoxO1 and Rag-1.	[Zhang, Yingchi; Hu, Tianyuan; Hua, Chunlan; Gu, Jie; Zhang, Liyan; Hao, Sha; Liang, Haoyue; Wang, Xiaomin; Wang, Weili; Xu, Jing; Liu, Hanzhi; Liu, Bin; Cheng, Tao; Yuan, Weiping] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Zhang, Yingchi; Hu, Tianyuan; Hua, Chunlan; Gu, Jie; Zhang, Liyan; Hao, Sha; Liang, Haoyue; Wang, Xiaomin; Wang, Weili; Xu, Jing; Liu, Hanzhi; Liu, Bin; Cheng, Tao; Yuan, Weiping] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Zhang, Yingchi; Hu, Tianyuan; Hua, Chunlan; Gu, Jie; Zhang, Liyan; Hao, Sha; Liang, Haoyue; Wang, Xiaomin; Wang, Weili; Xu, Jing; Liu, Hanzhi; Liu, Bin; Cheng, Tao; Yuan, Weiping] Peking Union Med Coll, Tianjin, Peoples R China; [Zhang, Yingchi; Hu, Tianyuan; Hua, Chunlan; Gu, Jie; Zhang, Liyan; Hao, Sha; Liang, Haoyue; Wang, Xiaomin; Wang, Weili; Xu, Jing; Liu, Hanzhi; Cheng, Tao; Yuan, Weiping] Chinese Acad Med Sci, Ctr Stem Cell Med, Beijing 100730, Peoples R China; [Liu, Bin] Acad Mil Med Sci, Affiliated Hosp, Ivy Translat Med Ctr 307, Lab Oncol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Academy of Military Medical Sciences - China	Cheng, T (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China.	chengt@pumc.edu.cn; wpyuan@ihcams.ac.cn	Zhang, Li/GWM-7501-2022; Liang, Haoyue/ABI-1811-2020; Liang, Haoyue/D-7940-2017	Liang, Haoyue/0000-0002-3766-7605; Liang, Haoyue/0000-0002-3766-7605; Cheng, Tao/0000-0002-5925-2769	Ministry of Science and Technology of China [2012CB966604, 2013CB966902, 2011CB964801, 2013BA101B09]; National Natural Science Foundation [81090410, 81130074, 81330015, 81070390, 81300374, 81300436]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	Funds from the Ministry of Science and Technology of China (2012CB966604, 2013CB966902, 2011CB964801, 2013BA101B09) supported this study in study design and data collection. WPY and TC received these funds. Funds from National Natural Science Foundation (81090410, 81130074, 81330015, 81070390, 81300374, 81300436) supported this study in analysis, decision to publish and preparation of this manuscript. WPY and TC received these funds.	AAGAARDTILLERY KM, 1994, CELL IMMUNOL, V156, P493, DOI 10.1006/cimm.1994.1193; Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Benhamron S, 2011, EUR J IMMUNOL, V41, P2390, DOI 10.1002/eji.201041336; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Calamito M, 2010, BLOOD, V115, P4043, DOI 10.1182/blood-2009-09-241638; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Donahue AC, 2007, EUR J IMMUNOL, V37, P2923, DOI 10.1002/eji.200737281; Edry E, 2004, J IMMUNOL, V173, P4265, DOI 10.4049/jimmunol.173.7.4265; Fruman DA, 2004, CURR OPIN IMMUNOL, V16, P314, DOI 10.1016/j.coi.2004.03.014; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Hinman RM, 2007, J IMMUNOL, V178, P740, DOI 10.4049/jimmunol.178.2.740; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; KAY JE, 1991, IMMUNOLOGY, V72, P544; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lazorchak AS, 2010, MOL CELL, V39, P433, DOI 10.1016/j.molcel.2010.07.031; Lee K, 2013, BLOOD, V122, P2369, DOI 10.1182/blood-2013-01-477505; Lee K, 2012, J EXP MED, V209, P713, DOI 10.1084/jem.20111470; Limon JJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00228; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Polak R, 2012, BLOOD, V119, P911, DOI 10.1182/blood-2011-07-366203; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ramadani F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001104; Rolink A, 1996, Int Rev Immunol, V13, P341, DOI 10.3109/08830189609061757; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Tang F, 2012, J IMMUNOL, V189, P1850, DOI 10.4049/jimmunol.1201057; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Warr MR, 2011, WIRES SYST BIOL MED, V3, P681, DOI 10.1002/wsbm.145; WICKER LS, 1990, EUR J IMMUNOL, V20, P2277, DOI 10.1002/eji.1830201017; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	40	23	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103970	10.1371/journal.pone.0103970	http://dx.doi.org/10.1371/journal.pone.0103970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084011	Green Submitted, gold, Green Published			2022-12-27	WOS:000339819800112
J	Donlin, MJ; Lomonosova, E; Kiss, A; Cheng, XH; Cao, F; Curto, TM; Di Bisceglie, A; Tavis, JE				Donlin, Maureen J.; Lomonosova, Elena; Kiss, Alexi; Cheng, Xiaohong; Cao, Feng; Curto, Teresa M.; Di Bisceglie, Adrian; Tavis, John E.			HCV Genome-Wide Genetic Analyses in Context of Disease Progression and Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; AMINO-ACID SUBSTITUTIONS; COMPARATIVE SEQUENCE-ANALYSIS; INTERFERON PLUS RIBAVIRIN; OPEN-READING FRAME; CORE PROTEIN; LIVER-DISEASE; ANTIVIRAL THERAPY; F-PROTEIN; GENOTYPES	Hepatitis C virus (HCV) is a major cause of hepatitis and hepatocellular carcinoma (HCC) world-wide. Most HCV patients have relatively stable disease, but approximately 25% have progressive disease that often terminates in liver failure or HCC. HCV is highly variable genetically, with seven genotypes and multiple subtypes per genotype. This variation affects HCV's sensitivity to antiviral therapy and has been implicated to contribute to differences in disease. We sequenced the complete viral coding capacity for 107 HCV genotype 1 isolates to determine whether genetic variation between independent HCV isolates is associated with the rate of disease progression or development of HCC. Consensus sequences were determined by sequencing RT-PCR products from serum or plasma. Positions of amino acid conservation, amino acid diversity patterns, selection pressures, and genome-wide patterns of amino acid covariance were assessed in context of the clinical phenotypes. A few positions were found where the amino acid distributions or degree of positive selection differed between in the HCC and cirrhotic sequences. All other assessments of viral genetic variation and HCC failed to yield significant associations. Sequences from patients with slow disease progression were under a greater degree of positive selection than sequences from rapid progressors, but all other analyses comparing HCV from rapid and slow disease progressors were statistically insignificant. The failure to observe distinct sequence differences associated with disease progression or HCC employing methods that previously revealed strong associations with the outcome of interferon abased therapy implies that variable ability of HCV to modulate interferon responses is not a dominant cause for differential pathology among HCV patients. This lack of significant associations also implies that host and/or environmental factors are the major causes of differential disease presentation in HCV patients.	[Donlin, Maureen J.; Lomonosova, Elena; Kiss, Alexi; Cheng, Xiaohong; Cao, Feng; Di Bisceglie, Adrian; Tavis, John E.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [Donlin, Maureen J.; Cao, Feng] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Tavis, John E.] St Louis Univ, Sch Med, St Louis Liver Ctr, St Louis, MO USA; [Di Bisceglie, Adrian] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO USA; [Curto, Teresa M.] New England Res Inst Inc, Watertown, MA USA	Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University; HealthCore, Inc	Tavis, JE (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA.	tavisje@slu.edu	Kiss, Alexi/AAH-6830-2021; Donlin, Maureen J./M-4709-2019	Donlin, Maureen/0000-0001-7312-079X; Kiss, Alexi/0000-0003-2330-6929	National Institute of Allergy and Infectious Disease [DK045715]; National Cancer Institute [CA126807]; National Institute of Diabetes & Digestive & Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Center for Minority Health and Health Disparities; General Clinical Research Center and Clinical and Translational Science Center grants from the National Center for Research Resources, National Institutes of Health; Hoffmann-La Roche, Ltd; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA126807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R43DK045715] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes & Digestive & Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); General Clinical Research Center and Clinical and Translational Science Center grants from the National Center for Research Resources, National Institutes of Health; Hoffmann-La Roche, Ltd(Hoffmann-La Roche); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institute of Allergy and Infectious Disease grant number DK045715 to JT and National Cancer Institute grant number CA126807 to JT. The authors acknowledge the HALT-C Trial group for providing samples and data for this publication. The HALT-C Trial was funded through contracts from the National Institute of Diabetes & Digestive & Kidney Diseases. Additional support was provided by the National Institute of Allergy and Infectious Diseases, the National Cancer Institute, the National Center for Minority Health and Health Disparities and by General Clinical Research Center and Clinical and Translational Science Center grants from the National Center for Research Resources, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. Additional funding to conduct this study was supplied by Hoffmann-La Roche, Ltd., through a Cooperative Research and Development Agreement with the National Institutes of Health. The HALT-C Trial was registered with clinicaltrials.gov (#NCT00006164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Akuta N, 2007, HEPATOLOGY, V46, P1357, DOI 10.1002/hep.21836; Akuta N, 2011, J MED VIROL, V83, P1016, DOI 10.1002/jmv.22094; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Benvegnu LB, 1997, HEPATOLOGY, V25, P211, DOI 10.1002/hep.510250138; Bostan N, 2010, CRIT REV MICROBIOL, V36, P91, DOI 10.3109/10408410903357455; Bruno S, 1997, HEPATOLOGY, V25, P754, DOI 10.1002/hep.510250344; Caldwell S, 2009, J GASTROENTEROL, V44, P96, DOI 10.1007/s00535-008-2258-6; Campo DS, 2008, P NATL ACAD SCI USA, V105, P9685, DOI 10.1073/pnas.0801774105; Cannon NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002123; De Mitri MS, 2002, J HEPATOL, V36, P116, DOI 10.1016/S0168-8278(01)00235-5; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Donlin MJ, 2007, J VIROL, V81, P8211, DOI 10.1128/JVI.00487-07; Donlin MJ, 2012, J VIROL, V86, P3050, DOI 10.1128/JVI.06857-11; Donlin MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009032; DUSHEIKO G, 1994, HEPATOLOGY, V19, P13, DOI 10.1016/0270-9139(94)90046-9; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Fishman SL, 2009, CLIN CANCER RES, V15, P3205, DOI 10.1158/1078-0432.CCR-08-2418; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gale M, 1999, J VIROL, V73, P6506, DOI 10.1128/JVI.73.8.6506-6516.1999; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gimenez-Barcons M, 2005, J INTERF CYTOK RES, V25, P152, DOI 10.1089/jir.2005.25.152; Gimenez-Barcons M, 2001, HEPATOLOGY, V34, P158, DOI 10.1053/jhep.2001.25512; Gremion C, 2005, REV MED VIROL, V15, P235, DOI 10.1002/rmv.466; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hngtyszyn HJ, 2005, ANTIVIR THER, V10, P1; Hoshida Y, 2005, J INFECT DIS, V192, P266, DOI 10.1086/430924; ICHIMURA H, 1994, J MED VIROL, V43, P212, DOI 10.1002/jmv.1890430303; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jarvis LM, 1996, BLOOD, V87, P3007, DOI 10.1182/blood.V87.7.3007.bloodjournal8773007; Kadokura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024514; Kadoya H, 2005, MICROBIOL IMMUNOL, V49, P265, DOI 10.1111/j.1348-0421.2005.tb03728.x; Kanwal F, 2012, ALIMENT PHARM THER, V36, P257, DOI 10.1111/j.1365-2036.2012.05174.x; Kato N, 2000, HEPATOLOGY, V32, P405, DOI 10.1053/jhep.2000.9198; Kobayashi M, 2010, J MED VIROL, V82, P41, DOI 10.1002/jmv.21629; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lara James, 2011, In Silico Biology, V11, P213, DOI 10.3233/ISB-2012-0456; Lara J, 2011, J VIROL, V85, P3649, DOI 10.1128/JVI.02197-10; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lee Chuan-Mo, 2006, Intervirology, V49, P76, DOI 10.1159/000087267; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Manns MP, 2011, J HEPATOL, V54, P1114, DOI 10.1016/j.jhep.2010.08.040; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2007, AM J MANAG CARE, V13, pS327; Miura M, 2011, HEPATOL INT; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Naas T, 2005, J GEN VIROL, V86, P2185, DOI 10.1099/vir.0.80969-0; Nagayama K, 2000, HEPATOLOGY, V31, P745, DOI 10.1002/hep.510310327; Nelson D R, 1997, Clin Liver Dis, V1, P515, DOI 10.1016/S1089-3261(05)70318-4; Neumann-Haefelin C, 2005, J CLIN VIROL, V32, P75, DOI 10.1016/j.jcv.2004.05.008; Ogata S, 2002, J CLIN MICROBIOL, V40, P3625, DOI 10.1128/JCM.40.10.3625-3630.2002; Pawlotsky JM, 2003, ANTIVIR RES, V59, P1, DOI 10.1016/S0166-3542(03)00088-3; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; POZZATO G, 1994, J MED VIROL, V43, P291, DOI 10.1002/jmv.1890430318; POZZATO G, 1991, LANCET, V338, P509, DOI 10.1016/0140-6736(91)90578-D; Ray SC., 2013, FIELDS VIROL, P795; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romeo R, 1996, J VIRAL HEPATITIS, V3, P183, DOI 10.1111/j.1365-2893.1996.tb00093.x; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Ruster B, 2001, J MED VIROL, V63, P128, DOI 10.1002/1096-9071(20000201)63:2&lt;128::AID-JMV1007&gt;3.0.CO;2-S; Seko Y, 2013, INTERVIROLOGY, V56, P13, DOI 10.1159/000339993; Serfaty L, 1998, HEPATOLOGY, V27, P1435, DOI 10.1002/hep.510270535; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silini E, 1996, GASTROENTEROLOGY, V111, P199, DOI 10.1053/gast.1996.v111.pm8698200; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Sobesky R, 2007, HEPATOLOGY, V46, P1704, DOI 10.1002/hep.21898; Takahashi K, 2001, HEPATOL RES, V20, P161, DOI 10.1016/S1386-6346(00)00141-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavis JE, 2011, GENOME MED, V3, DOI 10.1186/gm222; Thimme R, 2006, ANTIVIR RES, V69, P129, DOI 10.1016/j.antiviral.2005.12.001; Thimme R, 2012, FEMS MICROBIOL REV, V36, P663, DOI 10.1111/j.1574-6976.2011.00319.x; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Vaidya A, 2013, DRUGS, V73, P2093, DOI 10.1007/s40265-013-0153-9; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; Yao E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-88; Zein NN, 1996, AM J GASTROENTEROL, V91, P2560; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744	88	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103748	10.1371/journal.pone.0103748	http://dx.doi.org/10.1371/journal.pone.0103748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079603	Green Published, gold			2022-12-27	WOS:000339954800077
J	Rother, M; Brauner, JM; Ebert, K; Welzel, O; Jung, J; Bauereiss, A; Kornhuber, J; Groemer, TW				Roether, Mareike; Brauner, Jan M.; Ebert, Katrin; Welzel, Oliver; Jung, Jasmin; Bauereiss, Anna; Kornhuber, Johannes; Groemer, Teja W.			Dynamic Properties of the Alkaline Vesicle Population at Hippocampal Synapses	PLOS ONE			English	Article							ENDOCYTOSIS; MEMBRANE; KINETICS; RELEASE; POOL; PROTEINS	In compensatory endocytosis, scission of vesicles from the plasma membrane to the cytoplasm is a prerequisite for intravesicular reacidification and accumulation of neurotransmitter molecules. Here, we provide time-resolved measurements of the dynamics of the alkaline vesicle population which appears upon endocytic retrieval. Using fast perfusion pH-cycling in live-cell microscopy, synapto-pHluorin expressing rat hippocampal neurons were electrically stimulated. We found that the relative size of the alkaline vesicle population depended significantly on the electrical stimulus size: With increasing number of action potentials the relative size of the alkaline vesicle population expanded. In contrast to that, increasing the stimulus frequency reduced the relative size of the population of alkaline vesicles. Measurement of the time constant for reacification and calculation of the time constant for endocytosis revealed that both time constants were variable with regard to the stimulus condition. Furthermore, we show that the dynamics of the alkaline vesicle population can be predicted by a simple mathematical model. In conclusion, here a novel methodical approach to analyze dynamic properties of alkaline vesicles is presented and validated as a convenient method for the detection of intracellular events. Using this method we show that the population of alkaline vesicles is highly dynamic and depends both on stimulus strength and frequency. Our results implicate that determination of the alkaline vesicle population size may provide new insights into the kinetics of endocytic retrieval.	[Roether, Mareike; Brauner, Jan M.; Ebert, Katrin; Welzel, Oliver; Jung, Jasmin; Bauereiss, Anna; Kornhuber, Johannes; Groemer, Teja W.] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Groemer, TW (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany.	teja.groemer@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014	Kornhuber, Johannes/0000-0002-8096-3987; Brauner, Jan/0000-0002-1588-5724	Interdisciplinary Center of Clinical Research (IZKF) in Erlangen [J5]	Interdisciplinary Center of Clinical Research (IZKF) in Erlangen	This work was supported by the Interdisciplinary Center of Clinical Research (IZKF) in Erlangen (to Teja W. Gromer, Project J5 and Mareike Rather, Thesis-Stipend). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EJ, 2002, BIOTECHNIQUES, V33, P1152, DOI 10.2144/02335dd10; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Briggs MS, 2000, CHEM COMMUN, P2323, DOI 10.1039/b007108k; Budzinski KL, 2011, BIOPHYS J, V101, P1580, DOI 10.1016/j.bpj.2011.08.032; Denker Annette, 2010, Front Synaptic Neurosci, V2, P135, DOI 10.3389/fnsyn.2010.00135; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Granseth B, 2008, J PHYSIOL-LONDON, V586, P5969, DOI 10.1113/jphysiol.2008.159715; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hua YF, 2013, NEURON, V80, P343, DOI 10.1016/j.neuron.2013.08.010; Hua YF, 2011, NAT NEUROSCI, V14, P833, DOI 10.1038/nn.2838; Lindgren CA, 1997, J NEUROSCI, V17, P3074; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Royle Stephen J., 2008, V457, P293, DOI 10.1007/978-1-59745-261-8_22; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Welzel O, 2013, J FLUORESC, V23, P487, DOI 10.1007/s10895-013-1164-3; Welzel O, 2011, BIOPHYS J, V100, P593, DOI 10.1016/j.bpj.2010.12.3706; Welzel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013514; Wenzel EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038188; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102723	10.1371/journal.pone.0102723	http://dx.doi.org/10.1371/journal.pone.0102723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079223	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800015
J	Kleemann, B; Loos, B; Scriba, TJ; Lang, D; Davids, LM				Kleemann, Britta; Loos, Benjamin; Scriba, Thomas J.; Lang, Dirk; Davids, Lester M.			St John's Wort (Hypericum perforatum L.) Photomedicine: Hypericin-Photodynamic Therapy Induces Metastatic Melanoma Cell Death	PLOS ONE			English	Article							SUBCELLULAR-DISTRIBUTION; ENDOPLASMIC-RETICULUM; MOLECULAR EFFECTORS; INDUCED APOPTOSIS; CYTOCHROME-C; HELA-CELLS; IN-VITRO; CANCER; MELANOGENESIS; ACTIVATION	Hypericin, an extract from St John's Wort (Hypericum perforatum L.), is a promising photosensitizer in the context of clinical photodynamic therapy due to its excellent photosensitizing properties and tumoritropic characteristics. Hypericin-PDT induced cytotoxicity elicits tumor cell death by various mechanisms including apoptosis, necrosis and autophagy-related cell death. However, limited reports on the efficacy of this photomedicine for the treatment of melanoma have been published. Melanoma is a highly aggressive tumor due to its metastasizing potential and resistance to conventional cancer therapies. The aim of this study was to investigate the response mechanisms of melanoma cells to hypericin-PDT in an in vitro tissue culture model. Hypericin was taken up by all melanoma cells and partially co-localized to the endoplasmic reticulum, mitochondria, lysosomes and melanosomes, but not the nucleus. Light activation of hypericin induced a rapid, extensive modification of the tubular mitochondrial network into a beaded appearance, loss of structural details of the endoplasmic reticulum and concomitant loss of hypericin co-localization. Surprisingly the opposite was found for lysosomal-related organelles, suggesting that the melanoma cells may be using these intracellular organelles for hypericin-PDT resistance. In line with this speculation we found an increase in cellular granularity, suggesting an increase in pigmentation levels in response to hypericin-PDT. Pigmentation in melanoma is related to a melanocyte-specific organelle, the melanosome, which has recently been implicated in drug trapping, chemotherapy and hypericin-PDT resistance. However, hypericin-PDT was effective in killing both unpigmented (A375 and 501mel) and pigmented (UCT Mel-1) melanoma cells by specific mechanisms involving the externalization of phosphatidylserines, cell shrinkage and loss of cell membrane integrity. In addition, this treatment resulted in extrinsic (A375) and intrinsic (UCT Mel-1) caspase-dependent apoptotic modes of cell death, as well as a caspase-independent apoptotic mode that did not involve apoptosis-inducing factor (501 mel). Further research is needed to shed more light on these mechanisms.	[Kleemann, Britta; Lang, Dirk; Davids, Lester M.] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Redox Lab & Confocal & Light Microscope Imaging F, ZA-7925 Cape Town, South Africa; [Loos, Benjamin] Univ Stellenbosch, Dept Physiol Sci, ZA-7600 Stellenbosch, South Africa; [Scriba, Thomas J.] Univ Cape Town, South African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Scriba, Thomas J.] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa	University of Cape Town; Stellenbosch University; University of Cape Town; University of Cape Town	Davids, LM (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Redox Lab & Confocal & Light Microscope Imaging F, ZA-7925 Cape Town, South Africa.	lester.davids@uct.ac.za	Scriba, Thomas/GPX-2573-2022; Scriba, Thomas/AAH-9413-2020; Lang, Dirk/I-2554-2015	Scriba, Thomas/0000-0002-0641-1359; Lang, Dirk/0000-0003-3901-2079; Loos, Ben/0000-0002-5517-373X	National Research Foundation of South Africa (LMD), NRF Thuthuka [TTK2008051600001]	National Research Foundation of South Africa (LMD), NRF Thuthuka	Funding for this study was obtained from the National Research Foundation of South Africa (LMD), NRF Thuthuka Grant ID TTK2008051600001, www.nrf.ac.za. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.30; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Ali SM, 2002, INT J ONCOL, V21, P531; Ali SM, 2002, INT J MOL MED, V9, P461; Ali SM, 2002, INT J MOL MED, V9, P601; Ali SM, 2001, INT J MOL MED, V8, P521; Assefa Z, 1999, J BIOL CHEM, V274, P8788, DOI 10.1074/jbc.274.13.8788; Bahadoran P, 2003, J BIOL CHEM, V278, P11386, DOI 10.1074/jbc.M211996200; Baldea I, 2012, J PHYSIOL PHARMACOL, V63, P109; Ballios BG, 2012, BIOL OPEN, V1, P237, DOI 10.1242/bio.2012027; Baritaud M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.120; Baritaud M, 2010, CELL CYCLE, V9, P3166, DOI 10.4161/cc.9.16.12552; Barliya T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022849; Beattie PE, 2005, BRIT J DERMATOL, V153, P1187, DOI 10.1111/j.1365-2133.2005.06946.x; Berlanda J, 2006, J ENVIRON PATHOL TOX, V25, P173, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.100; Berlanda J, 2010, J PHOTOCH PHOTOBIO B, V100, P173, DOI 10.1016/j.jphotobiol.2010.06.004; Bernd A, 1999, PHOTOCHEM PHOTOBIOL, V69, P218, DOI 10.1111/j.1751-1097.1999.tb03276.x; Blank M, 2004, INT J CANCER, V111, P596, DOI 10.1002/ijc.20285; Blank M, 2003, CANCER RES, V63, P8241; BOISSY RE, 1989, CYTOMETRY, V10, P779, DOI 10.1002/cyto.990100616; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Buytaert E, 2008, ONCOGENE, V27, P1916, DOI 10.1038/sj.onc.1210825; Buytaert E, 2006, AUTOPHAGY, V2, P238, DOI 10.4161/auto.2730; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Carlson JA, 2005, J AM ACAD DERMATOL, V52, P743, DOI 10.1016/j.jaad.2004.08.034; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Chaloupka R, 1999, FEBS LETT, V462, P295, DOI 10.1016/S0014-5793(99)01538-0; Chen KG, 2006, P NATL ACAD SCI USA, V103, P9903, DOI 10.1073/pnas.0600213103; Chen KG, 2009, PIGM CELL MELANOMA R, V22, P740, DOI 10.1111/j.1755-148X.2009.00630.x; Chen KG, 2009, JNCI-J NATL CANCER I, V101, P1259, DOI 10.1093/jnci/djp259; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Clarke L, 2012, EUR J NEUROSCI, V36, P1951, DOI 10.1111/j.1460-9568.2012.08123.x; Colella AD, 2012, ANAL BIOCHEM, V430, P108, DOI 10.1016/j.ab.2012.08.015; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Davids LM, 2011, CANCER TREAT REV, V37, P465, DOI 10.1016/j.ctrv.2010.11.007; Davids LM, 2008, J PHOTOCH PHOTOBIO B, V91, P67, DOI 10.1016/j.jphotobiol.2008.01.011; Davids LM, 2006, CELL BIOL INT, V30, P416, DOI 10.1016/j.cellbi.2006.02.001; Davids LM, 2009, CELL BIOL INT, V33, P1065, DOI 10.1016/j.cellbi.2009.06.026; Davids LM, 2013, MELANOMA EARLY DETEC, P583; Dewaele M, 2011, J CELL MOL MED, V15, P1402, DOI 10.1111/j.1582-4934.2010.01118.x; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; Falk H, 1999, ANGEW CHEM INT EDIT, V38, P3117; Galanou MC, 2008, PHOTOCHEM PHOTOBIOL, V84, P1073, DOI 10.1111/j.1751-1097.2008.00392.x; Garg AD, 2013, AUTOPHAGY, V9, P1292, DOI 10.4161/auto.25399; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Green DR, 2007, APOPTOSIS CELLS, P533; Hadjur C, 1996, PHOTOCHEM PHOTOBIOL, V64, P375, DOI 10.1111/j.1751-1097.1996.tb02474.x; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Handerson T, 2003, CANCER RES, V63, P5363; Handerson T, 2007, J CUTAN PATHOL, V34, P679, DOI 10.1111/j.1600-0560.2006.00681.x; HEARING VJ, 1976, BIOCHEM J, V157, P549, DOI 10.1042/bj1570549; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; Hendrickx N, 2003, J BIOL CHEM, V278, P52231, DOI 10.1074/jbc.M307591200; Hersey P, 2008, PIGM CELL MELANOMA R, V21, P358, DOI 10.1111/j.1755-148X.2008.00467.x; Huntosova V, 2012, PHOTOCH PHOTOBIO SCI, V11, P1428, DOI 10.1039/c2pp05409d; Jakubowska M, 2013, NITRIC OXIDE-BIOL CH, V35, P79, DOI 10.1016/j.niox.2013.08.004; Jendzelovsky R, 2009, PHOTOCH PHOTOBIO SCI, V8, P1716, DOI 10.1039/b9pp00086k; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Karioti A, 2010, INT J MOL SCI, V11, P562, DOI 10.3390/ijms11020562; Kascakova S, 2008, PHOTOCHEM PHOTOBIOL, V84, P120, DOI 10.1111/j.1751-1097.2007.00207.x; Kessel David, 2010, Methods Mol Biol, V635, P35, DOI 10.1007/978-1-60761-697-9_3; Kleban J, 2008, J PHOTOCH PHOTOBIO B, V93, P108, DOI 10.1016/j.jphotobiol.2008.07.007; Krammer B, 2012, CURR MED CHEM, V19, P793, DOI 10.2174/092986712799034842; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Land EJ, 2004, METHOD ENZYMOL, V378, P88; Lavie Gad, 2005, Angiogenesis, V8, P35, DOI 10.1007/s10456-005-3828-3; Lazova R, 2010, J CUTAN PATHOL, V37, P256, DOI 10.1111/j.1600-0560.2009.01359.x; Lazova R, 2009, EXP DERMATOL, V18, P934, DOI 10.1111/j.1600-0625.2009.00933.x; Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93; Lui P, 2007, CANCER TREAT REV, V33, P665, DOI 10.1016/j.ctrv.2007.06.004; Mikes J, 2009, PHOTOCH PHOTOBIO SCI, V8, P1558, DOI 10.1039/b9pp00021f; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Nikolaou VA, 2012, J INVEST DERMATOL, V132, P854, DOI 10.1038/jid.2011.421; OIKAWA A, 1972, ARCH BIOCHEM BIOPHYS, V148, P548, DOI 10.1016/0003-9861(72)90173-7; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Plonka PM, 2003, EXP DERMATOL, V12, P356, DOI 10.1034/j.1600-0625.2002.120401.x; Rebecca VW, 2012, MELANOMA RES, V22, P114, DOI 10.1097/CMR.0b013e328351fa4d; Ritz R, 2008, ANTICANCER RES, V28, P2033; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Sackova V, 2011, INT J MOL SCI, V12, P8388, DOI 10.3390/ijms12128388; Sambrook J, 1989, MOL CLONING LABORATO, p1 25; Sanovic R, 2009, INT J ONCOL, V35, P921, DOI 10.3892/ijo_00000407; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Schempp CM, 2001, FEBS LETT, V493, P26, DOI 10.1016/S0014-5793(01)02268-2; Sevrioukova IF, 2011, APOPTOSIS INDUCING F, P14; Sharma KV, 2012, PHOTODIAGN PHOTODYN, V9, P156, DOI 10.1016/j.pdpdt.2011.09.003; Sharma KV, 2011, CELL BIOL INT, V35, P939, DOI 10.1042/CBI20110103; Siboni G, 2002, PHOTOCH PHOTOBIO SCI, V1, P483, DOI 10.1039/b202884k; Slominski A, 1998, ANTICANCER RES, V18, P3709; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2001, ARCH PATHOL LAB MED, V125, P1295; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Sodhi RK, 2010, VASC PHARMACOL, V53, P77, DOI 10.1016/j.vph.2010.06.003; Theodossiou TA, 2010, PHOTOCHEM PHOTOBIOL, V86, P18, DOI 10.1111/j.1751-1097.2009.00668.x; Theodossiou TA, 2009, MOL PHARMACEUT, V6, P1775, DOI 10.1021/mp900166q; Uzdensky AB, 2001, LASER MED SCI, V16, P276, DOI 10.1007/PL00011364; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vanden Berghe T, 2013, METHODS, V61, P117, DOI 10.1016/j.ymeth.2013.02.011; VanderWerf QM, 1996, LARYNGOSCOPE, V106, P479, DOI 10.1097/00005537-199604000-00016; Vantieghem A, 2001, PHOTOCHEM PHOTOBIOL, V74, P133, DOI 10.1562/0031-8655(2001)074&lt;0133:DPMCCR&gt;2.0.CO;2; Vantieghem A, 1998, FEBS LETT, V440, P19, DOI 10.1016/S0014-5793(98)01416-1; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Volkovova K, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S12; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Wang XL, 2010, J PHARMACOL EXP THER, V334, P847, DOI 10.1124/jpet.110.168856; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Westbroek W, 2003, J INVEST DERMATOL, V120, P465, DOI 10.1046/j.1523-1747.2003.12068.x; WHO, 2014, SKIN CANC; Wiegell SR, 2013, BRIT J DERMATOL, V168, P186, DOI 10.1111/j.1365-2133.2012.11200.x; Wiegell SR, 2012, J EUR ACAD DERMATOL, V26, P673, DOI 10.1111/j.1468-3083.2011.04386.x; Wiegell SR, 2012, BRIT J DERMATOL, V166, P1327, DOI 10.1111/j.1365-2133.2012.10833.x; Wiegell SR, 2011, BRIT J DERMATOL, V164, P1083, DOI 10.1111/j.1365-2133.2011.10209.x; WILSON EL, 1980, CANCER RES, V40, P933; Wood JM, 1999, EXP DERMATOL, V8, P153, DOI 10.1111/j.1600-0625.1999.tb00365.x	121	69	70	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103762	10.1371/journal.pone.0103762	http://dx.doi.org/10.1371/journal.pone.0103762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076130	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800078
J	Thevenard, J; Verzeaux, L; Devy, J; Etique, N; Jeanne, A; Schneider, C; Hachet, C; Ferracci, G; David, M; Martiny, L; Charpentier, E; Khrestchatisky, M; Rivera, S; Dedieu, S; Emonard, H				Thevenard, Jessica; Verzeaux, Laurie; Devy, Jerome; Etique, Nicolas; Jeanne, Albin; Schneider, Christophe; Hachet, Cathy; Ferracci, Geraldine; David, Marion; Martiny, Laurent; Charpentier, Emmanuelle; Khrestchatisky, Michel; Rivera, Santiago; Dedieu, Stephane; Emonard, Herve			Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities	PLOS ONE			English	Article							ERYTHROID CELL-SURVIVAL; NEURITE OUTGROWTH; TIMP-1; BINDING; NEURONS; COMPLEX; DOMAIN; ALPHA(2)-MACROGLOBULIN; DISSECTION; REQUIRES	Tissue inhibitor of metalloproteinases-1 (TIMP-1) regulates the extracellular matrix turnover by inhibiting the proteolytic activity of matrix metalloproteinases (MMPs). TIMP-1 also displays MMP-independent activities that influence the behavior of various cell types including neuronal plasticity, but the underlying molecular mechanisms remain mostly unknown. The trans-membrane receptor low-density lipoprotein receptor-related protein-1 (LRP-1) consists of a large extracellular chain with distinct ligand-binding domains that interact with numerous ligands including TIMP-2 and TIMP-3 and a short transmembrane chain with intracellular motifs that allow endocytosis and confer signaling properties to LRP-1. We addressed TIMP-1 interaction with recombinant ligand-binding domains of LRP-1 expressed by CHO cells for endocytosis study, or linked onto sensor chips for surface plasmon resonance analysis. Primary cortical neurons bound and internalized endogenous TIMP-1 through a mechanism mediated by LRP-1. This resulted in inhibition of neurite outgrowth and increased growth cone volume. Using a mutated inactive TIMP-1 variant we showed that TIMP-1 effect on neurone morphology was independent of its MMP inhibitory activity. We conclude that TIMP-1 is a new ligand of LRP-1 and we highlight a new example of its MMP-independent, cytokine-like functions.	[Thevenard, Jessica; Verzeaux, Laurie; Devy, Jerome; Etique, Nicolas; Jeanne, Albin; Schneider, Christophe; Hachet, Cathy; Martiny, Laurent; Charpentier, Emmanuelle; Dedieu, Stephane; Emonard, Herve] Univ Reims, CNRS, Unite Mixte Rech UMR Matrice Extracellulaire & Dy, Unite Format & Rech UFR Sci Exactes & Nat, Reims, France; [Ferracci, Geraldine] Aix Marseille Univ, CNRS, Ctr Rech Neurobiol & Neurophysiol Marseille CRN2M, Plate Forme Rech Neurosci,UMR 7286, Marseille, France; [David, Marion] VECT HORUS SAS, Fac Med Sect Nord, Marseille, France; [Khrestchatisky, Michel; Rivera, Santiago] Aix Marseille Univ, UMR 7259, Marseille, France; [Khrestchatisky, Michel; Rivera, Santiago] CNRS, UMR 7259, NICN, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Emonard, H (corresponding author), Univ Reims, CNRS, Unite Mixte Rech UMR Matrice Extracellulaire & Dy, Unite Format & Rech UFR Sci Exactes & Nat, Reims, France.	herve.emonard@univ-reims.fr	Emonard, Hervé/AAD-5432-2019; MARTINY, Laurent/ABI-5531-2020; etique, nicolas/J-4159-2017; Emonard, Herve/R-9718-2019	etique, nicolas/0000-0001-6613-9257; Dedieu, Stephane/0000-0003-1447-5640; SCHNEIDER, Christophe/0000-0002-7867-0579; VERZEAUX, Laurie/0000-0001-8644-892X	National Centre for Scientific Research (CNRS); French National Research Agency (ANR) [ANR-08-MNPS-042-04 TIMPAD]; French Ministry of Research; Region Champagne-Ardenne; ANR [ANR-09-BIOT-015-01 VECtoBrain, ANR-2011-MALZ-007-01 PREVENTAD]; Ligue Europeenne Contre la Maladie d'Alzheimer (LECMA)	National Centre for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French National Research Agency (ANR)(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Region Champagne-Ardenne(Region Grand-Est); ANR(French National Research Agency (ANR)); Ligue Europeenne Contre la Maladie d'Alzheimer (LECMA)	This work was supported by The National Centre for Scientific Research (CNRS) and a grant from The French National Research Agency (ANR) grant number [ANR-08-MNPS-042-04 TIMPAD to S.R. and H.E.]. A.J. is recipient of a doctoral fellowship from the French Ministry of Research; L.V. and S.D. are recipients of grants from Region Champagne-Ardenne; M.K. acknowledges support from the ANR [ANR-09-BIOT-015-01 VECtoBrain and ANR-2011-MALZ-007-01 PREVENTAD]; and S.R. acknowledges support from the Ligue Europeenne Contre la Maladie d'Alzheimer (LECMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barmina OY, 1999, J BIOL CHEM, V274, P30087, DOI 10.1074/jbc.274.42.30087; Beaujouin M, 2010, J CELL SCI, V123, P3336, DOI 10.1242/jcs.070938; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Bridoux L, 2013, FEBS LETT, V587, P1524, DOI 10.1016/j.febslet.2013.03.032; BU GJ, 1994, J BIOL CHEM, V269, P18521; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Dedieu S, 2008, MOL CELL BIOL, V28, P2980, DOI 10.1128/MCB.02238-07; Egea V, 2012, P NATL ACAD SCI USA, V109, pE309, DOI 10.1073/pnas.1115083109; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Etique N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/152163; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Lambert E, 2009, INT J BIOCHEM CELL B, V41, P1102, DOI 10.1016/j.biocel.2008.10.017; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Ould-yahoui A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008289; Perez-Martinez L, 2005, J NEUROSCI, V25, P4917, DOI 10.1523/JNEUROSCI.5066-04.2005; Perrot G, 2012, MOL CELL BIOL, V32, P3293, DOI 10.1128/MCB.00228-12; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Ranganathan S, 2011, J NEUROSCI, V31, P10836, DOI 10.1523/JNEUROSCI.5065-10.2011; Ries C, 2014, CELL MOL LIFE SCI, V71, P659, DOI 10.1007/s00018-013-1457-3; Rivera S, 1997, J NEUROSCI, V17, P4223; Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200	40	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103839	10.1371/journal.pone.0103839	http://dx.doi.org/10.1371/journal.pone.0103839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075518	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800082
J	Kong, YJ; Chen, JC; Zhou, ZM; Xia, HJ; Qiu, MH; Chen, CS				Kong, Yanjie; Chen, Jianchao; Zhou, Zhongmei; Xia, Houjun; Qiu, Ming-Hua; Chen, Ceshi			Cucurbitacin E Induces Cell Cycle G2/M Phase Arrest and Apoptosis in Triple Negative Breast Cancer	PLOS ONE			English	Article							INHIBITORY-ACTIVITY; SIGNALING PATHWAY; CARCINOMA; GROWTH; ACTIVATION	Triple negative breast cancer (TNBC) is a highly aggressive form of breast cancer resistant to many common treatments. In this study, we compared the effects of 12 phytochemical drugs on four cancer cell lines, and noticed that Cucurbitacin E (CuE) significantly inhibited TNBC cell growth by inducing cell cycle G2/M phase arrest and apoptosis. CuE reduced expression of Cyclin D1, Survivin, XIAP, Bcl2, and Mcl-1 in MDA-MB-468 and SW527, and within MDA-MB-468, CuE significantly increased activation of JNK and inhibited activation of AKT and ERK. Collectively, these results suggest that CuE may be a viable compound for developing novel TNBC therapeutics.	[Kong, Yanjie; Zhou, Zhongmei; Xia, Houjun; Chen, Ceshi] Chinese Acad Sci, Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Chen, Jianchao; Qiu, Ming-Hua] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China; [Kong, Yanjie] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Qiu, MH (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China.	qiuminghua@mail.kib.ac.cn; chenc@mail.kiz.ac.cn		Xia, Houjun/0000-0003-1045-1465	National Natural Science Foundation of China [81120108019, U1132605, 81325016, U1192604, 39970086]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81120108019, U1132605, and 81325016 to Chen, C; U1192604 and 39970086 to Qiu, M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghasham AA, 2013, INT J HEALTH SCI-IJH, V7, P77, DOI 10.12816/0006025; Chacon RD, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2574; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen JC, 2005, PLANTA MED, V71, P983, DOI 10.1055/s-2005-873110; Chen JC, 2008, J NAT PROD, V71, P153, DOI 10.1021/np0704396; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; Dong YM, 2010, CARCINOGENESIS, V31, P2097, DOI 10.1093/carcin/bgq167; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Huang WW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/952762; Hung CM, 2013, INT J MOL SCI, V14, P17147, DOI 10.3390/ijms140817147; Ishdorj G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-268; Jayaprakasam B, 2003, CANCER LETT, V189, P11, DOI 10.1016/S0304-3835(02)00497-4; Kongtun S, 2009, PLANTA MED, V75, P839, DOI 10.1055/s-0029-1185455; Lan T, 2013, INT J CLIN EXP PATHO, V6, P1799; Li YC, 2010, ANTI-CANCER DRUG, V21, P389, DOI 10.1097/CAD.0b013e328336b383; Liu TY, 2008, EUR ARCH OTO-RHINO-L, V265, P1225, DOI 10.1007/s00405-008-0625-9; Promkan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055732; Shan Xiao-Lei, 2010, Chin J Cancer, V29, P20; Tannin-Spitz T, 2007, BIOCHEM PHARMACOL, V73, P56, DOI 10.1016/j.bcp.2006.09.012; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Wakimoto N, 2008, CANCER SCI, V99, P1793, DOI 10.1111/j.1349-7006.2008.00899.x; Yasuda S, 2010, MOL NUTR FOOD RES, V54, P559, DOI 10.1002/mnfr.200900165; Yin D, 2008, INT J CANCER, V123, P1364, DOI 10.1002/ijc.23648; Zhang MX, 2009, CANCER CHEMOTH PHARM, V63, P635, DOI 10.1007/s00280-008-0780-0; Zhang T, 2012, BREAST CANCER RES TR, V135, P445, DOI 10.1007/s10549-012-2175-5; Zhou XY, 2012, HEPATOL RES, V42, P401, DOI 10.1111/j.1872-034X.2011.00933.x; Zhu JS, 2012, PHARMACOLOGY, V89, P348, DOI 10.1159/000338757	27	48	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103760	10.1371/journal.pone.0103760	http://dx.doi.org/10.1371/journal.pone.0103760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072848	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600085
J	Najjar, RP; Wolf, L; Taillard, J; Schlangen, LJM; Salam, A; Cajochen, C; Gronfier, C				Najjar, Raymond P.; Wolf, Luzian; Taillard, Jacques; Schlangen, Luc J. M.; Salam, Alex; Cajochen, Christian; Gronfier, Claude			Chronic Artificial Blue-Enriched White Light Is an Effective Countermeasure to Delayed Circadian Phase and Neurobehavioral Decrements	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; INTERMITTENT BRIGHT LIGHT; ANTARCTIC WINTER; MELATONIN SUPPRESSION; POLYCHROMATIC-LIGHT; BODY-TEMPERATURE; ACTION SPECTRUM; GANGLION-CELLS; SLEEP QUALITY; NIGHT WORKERS	Studies in Polar Base stations, where personnel have no access to sunlight during winter, have reported circadian misalignment, free-running of the sleep-wake rhythm, and sleep problems. Here we tested light as a countermeasure to circadian misalignment in personnel of the Concordia Polar Base station during the polar winter. We hypothesized that entrainment of the circadian pacemaker to a 24-h light-dark schedule would not occur in all crew members (n = 10) exposed to 100-300 lux of standard fluorescent white (SW) light during the daytime, and that chronic non-time restricted daytime exposure to melanopsin-optimized blue-enriched white (BE) light would establish an a stable circadian phase, in participants, together with increased cognitive performance and mood levels. The lighting schedule consisted of an alternation between SW lighting (2 weeks), followed by a BE lighting (2 weeks) for a total of 9 weeks. Rest-activity cycles assessed by actigraphy showed a stable rest-activity pattern under both SW and BE light. No difference was found between light conditions on the intra-daily stability, variability and amplitude of activity, as assessed by non-parametric circadian analysis. As hypothesized, a significant delay of about 30 minutes in the onset of melatonin secretion occurred with SW, but not with BE light. BE light significantly enhanced well being and alertness compared to SW light. We propose that the superior efficacy of blue-enriched white light versus standard white light involves melanopsin-based mechanisms in the activation of the non-visual functions studied, and that their responses do not dampen with time (over 9-weeks). This work could lead to practical applications of light exposure in working environment where background light intensity is chronically low to moderate (polar base stations, power plants, space missions, etc.), and may help design lighting strategies to maintain health, productivity, and personnel safety.	[Najjar, Raymond P.; Gronfier, Claude] Inserm U846, Stem Cell & Brain Res Inst, Bron, France; [Najjar, Raymond P.; Gronfier, Claude] Univ Lyon, Claude Bernard Lyon 1, Villeurbanne, France; [Wolf, Luzian] Wolf Technolberatung Object Tracker, Perchtoldsdorf, Austria; [Taillard, Jacques] Univ Bordeaux, Sommeil Attent & Neuropsychiat, USR 3413, Bordeaux, France; [Taillard, Jacques] CNRS, Sommeil Attent & Neuropsychiat, USR 3413, Bordeaux, France; [Schlangen, Luc J. M.] Philips Res, NL-5656 AE Eindhoven, Netherlands; [Salam, Alex] Inst Polaire Francais Paul Emile Victor IPEV, Plouzane, France; [Cajochen, Christian] Univ Basel, Ctr Chronobiol Psychiat Univ Clin, Basel, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Philips; Philips Research; University of Basel	Cajochen, C (corresponding author), Univ Basel, Ctr Chronobiol Psychiat Univ Clin, Basel, Switzerland.	christian.cajochen@upkbs.ch; claude.gronfier@inserm.fr	Gronfier, Claude/C-1243-2008; Najjar, Raymond P./J-4979-2019; Cajochen, Christian/N-6748-2014; Taillard, Jacques/H-5063-2018	Gronfier, Claude/0000-0002-6549-799X; Najjar, Raymond P./0000-0002-3770-2300; Taillard, Jacques/0000-0001-9067-8189; Schlangen, Luc/0000-0002-8424-7240	European Space Agency (ESA); Centre National d'Etudes Spatiales (CNES, France); Ministere de l'Enseignement Superieur et de la Recherche Francais; Federation des Aveugles et Handicapes Visuels de France; Wolf Technologieberatung - Object-Tracker	European Space Agency (ESA)(European Space Agency); Centre National d'Etudes Spatiales (CNES, France)(Centre National D'etudes Spatiales); Ministere de l'Enseignement Superieur et de la Recherche Francais; Federation des Aveugles et Handicapes Visuels de France; Wolf Technologieberatung - Object-Tracker	This work was supported by the European Space Agency (ESA), and a grant from the Centre National d'Etudes Spatiales (CNES, France) to CG. RPN was funded by "Ministere de l'Enseignement Superieur et de la Recherche Francais'' and "Federation des Aveugles et Handicapes Visuels de France.'' Light bulbs were provided by Philips Lighting B. V., Eindhoven, The Netherlands. LightWatcher data loggers and the Neurobehavioral Test Battery were provided by Object-Tracker, Austria. The funder, Wolf Technologieberatung - Object-Tracker, provided support in the form of salaries for authors [LW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDT J, 1987, CHRONOBIOL INT, V4, P273, DOI 10.3109/07420528709078534; Arendt J, 2012, CHRONOBIOL INT, V29, P379, DOI 10.3109/07420528.2012.668997; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bhattacharyya M, 2008, INT J BIOMETEOROL, V52, P869, DOI 10.1007/s00484-008-0183-2; Brainard GC, 2001, J NEUROSCI, V21, P6405; BROADWAY J, 1987, NEUROSCI LETT, V79, P185, DOI 10.1016/0304-3940(87)90694-X; BUYSSE DJ, 1991, SLEEP, V14, P331; Chang A-M, 2012, J PHYSL; Chellappa SL, 2012, J CLIN ENDOCR METAB, V97, pE433, DOI 10.1210/jc.2011-2391; Corbett RW, 2012, NEUROSCI LETT, V525, P146, DOI 10.1016/j.neulet.2012.06.046; CZEISLER CA, 1989, SCIENCE, V244, P1328, DOI 10.1126/science.2734611; Deguchi Takatsugu, 1992, Annals of Physiological Anthropology, V11, P37; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Francis G, 2008, J SLEEP RES, V17, P354, DOI 10.1111/j.1365-2869.2008.00664.x; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Gordijn MCM, 2012, J AFFECT DISORDERS, V136, P72, DOI 10.1016/j.jad.2011.08.016; Gronfier C, 2004, AM J PHYSIOL-ENDOC M, V287, pE174, DOI 10.1152/ajpendo.00385.2003; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; HANSEN T, 1987, ACTA PSYCHIAT SCAND, V75, P428, DOI 10.1111/j.1600-0447.1987.tb02811.x; Harris A, 2010, RURAL REMOTE HEALTH, V10; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; KENNAWAY DJ, 1991, AM J PHYSIOL, V260, pR1137, DOI 10.1152/ajpregu.1991.260.6.R1137; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; LEWIS HE, 1957, LANCET, V1, P1262, DOI 10.1016/S0140-6736(57)92298-5; LINGJAERDE O, 1985, ACTA PSYCHIAT SCAND, V71, P506, DOI 10.1111/j.1600-0447.1985.tb05064.x; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Mottram V, 2011, J SLEEP RES, V20, P154, DOI 10.1111/j.1365-2869.2010.00875.x; Najjar RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085837; Noguchi Hiroki, 1999, Applied Human Science, V18, P117, DOI 10.2114/jpa.18.117; OWEN J, 1992, NEUROSCI LETT, V137, P181, DOI 10.1016/0304-3940(92)90399-R; PALINKAS LA, 1995, ACTA PSYCHIAT SCAND, V91, P423, DOI 10.1111/j.1600-0447.1995.tb09803.x; Palinkas LA, 1996, J NERV MENT DIS, V184, P530, DOI 10.1097/00005053-199609000-00003; Palinkas Lawrence A, 2004, Int J Circumpolar Health, V63, P157; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rimmer DW, 2000, AM J PHYSIOL-REG I, V279, pR1574, DOI 10.1152/ajpregu.2000.279.5.R1574; Smith MR, 2009, SLEEP MED, V10, P287, DOI 10.1016/j.sleep.2008.05.005; Smith MR, 2009, CHRONOBIOL INT, V26, P709, DOI 10.1080/07420520902927742; Spiegel K, 2002, JAMA-J AM MED ASSOC, V288, P1471, DOI 10.1001/jama.288.12.1471-a; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Usui A, 2000, PSYCHIAT CLIN NEUROS, V54, P361, DOI 10.1046/j.1440-1819.2000.00715.x; Van Cauter E, 2000, JAMA-J AM MED ASSOC, V284, P861, DOI 10.1001/jama.284.7.861; Van Someren E J, 1997, IEEE Trans Rehabil Eng, V5, P394, DOI 10.1109/86.650297; Vandewalle G, 2011, J BIOL RHYTHM, V26, P249, DOI 10.1177/0748730411401736; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; Weibel L, 1998, J BIOL RHYTHM, V13, P202, DOI 10.1177/074873098129000048; Weibel L, 1997, AM J PHYSIOL-REG I, V272, pR948, DOI 10.1152/ajpregu.1997.272.3.R948; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; Yoneyama S, 1999, AM J PHYSIOL-REG I, V277, pR1091, DOI 10.1152/ajpregu.1999.277.4.R1091; Zeitzer JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022078; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x; Zeitzer JM, 2005, AM J PHYSIOL-REG I, V289, pR839, DOI 10.1152/ajpregu.00232.2005	59	38	41	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102827	10.1371/journal.pone.0102827	http://dx.doi.org/10.1371/journal.pone.0102827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072880	Green Published, Green Submitted, gold			2022-12-27	WOS:000341307600016
J	Allen, KD; Gourov, AV; Harte, C; Gao, P; Lee, C; Sylvain, D; Splett, JM; Oxberry, WC; van de Nes, PS; Troy-Regier, MJ; Wolk, J; Alarcon, JM; Hernandez, AI				Allen, Kim D.; Gourov, Andrei V.; Harte, Christopher; Gao, Peng; Lee, Clarice; Sylvain, Darlene; Splett, Joshua M.; Oxberry, William C.; van de Nes, Paula S.; Troy-Regier, Matthew J.; Wolk, Jason; Alarcon, Juan M.; Hernandez, A. Ivan			Nucleolar Integrity Is Required for the Maintenance of Long-Term Synaptic Plasticity	PLOS ONE			English	Article							RNA-POLYMERASE-I; APLYSIA SENSORY NEURONS; LOCAL PROTEIN-SYNTHESIS; ACTINOMYCIN-D; POLY(ADP-RIBOSE) POLYMERASE; POLYADP-RIBOSYLATION; RIBOSOME BIOGENESIS; MEMORY FORMATION; TRANSCRIPTION; FACILITATION	Long-term memory (LTM) formation requires new protein synthesis and new gene expression. Based on our work in Aplysia, we hypothesized that the rRNA genes, stimulation-dependent targets of the enzyme Poly(ADP-ribose) polymerase-1 (PARP-1), are primary effectors of the activity-dependent changes in synaptic function that maintain synaptic plasticity and memory. Using electrophysiology, immunohistochemistry, pharmacology and molecular biology techniques, we show here, for the first time, that the maintenance of forskolin-induced late-phase long-term potentiation (L-LTP) in mouse hippocampal slices requires nucleolar integrity and the expression of new rRNAs. The activity-dependent upregulation of rRNA, as well as L-LTP expression, are poly(ADP-ribosyl) ation (PAR) dependent and accompanied by an increase in nuclear PARP-1 and Poly(ADP) ribose molecules (pADPr) after forskolin stimulation. The upregulation of PARP-1 and pADPr is regulated by Protein kinase A (PKA) and extracellular signal-regulated kinase (ERK)-two kinases strongly associated with long-term plasticity and learning and memory. Selective inhibition of RNA Polymerase I (Pol I), responsible for the synthesis of precursor rRNA, results in the segmentation of nucleoli, the exclusion of PARP-1 from functional nucleolar compartments and disrupted L-LTP maintenance. Taken as a whole, these results suggest that new rRNAs (28S, 18S, and 5.8S ribosomal components)-hence, new ribosomes and nucleoli integrity-are required for the maintenance of long-term synaptic plasticity. This provides a mechanistic link between stimulation-dependent gene expression and the new protein synthesis known to be required for memory consolidation.	[Allen, Kim D.; Gourov, Andrei V.; Harte, Christopher; Gao, Peng; Lee, Clarice; Sylvain, Darlene; Splett, Joshua M.; Oxberry, William C.; Wolk, Jason; Alarcon, Juan M.; Hernandez, A. Ivan] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA; [Allen, Kim D.] CUNY, Medgar Evers Coll, Sch Sci Hlth & Technol, Dept Biol, Brooklyn, NY 11210 USA; [Oxberry, William C.; Alarcon, Juan M.; Hernandez, A. Ivan] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [van de Nes, Paula S.; Troy-Regier, Matthew J.] Suny Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11203 USA; [van de Nes, Paula S.; Troy-Regier, Matthew J.] Suny Downstate Med Ctr, Dept Pharmacol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; City University of New York (CUNY) System; Medgar Evers College; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Alarcon, JM (corresponding author), Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA.	JuanMarcos.Alarcon@downstate.edu; ivan.hernandez@downstate.edu		Allen, Kim D/0000-0001-9774-5014; Regier, Matthew/0000-0002-4641-3316	Department of Pathology at SUNY-Downstate; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS081625] Funding Source: NIH RePORTER	Department of Pathology at SUNY-Downstate; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Start Up fund to AIH from the Department of Pathology at SUNY-Downstate to carry out this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Boamah EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002442; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CASTELLUCCI VF, 1986, J PHYSIOL-PARIS, V81, P349; Chen M, 2004, ACTA PHARMACOL SIN, V25, P902; Christensen MO, 2004, J BIOL CHEM, V279, P21873, DOI 10.1074/jbc.M400498200; Cohen-Armon M, 2004, SCIENCE, V304, P1820, DOI 10.1126/science.1096775; Day JJ, 2012, NEUROPSYCHOPHARMACOL, V37, P247, DOI 10.1038/npp.2011.85; Day JJ, 2011, NEUROPSYCHOPHARMACOL, V36, P357, DOI 10.1038/npp.2010.125; Desnoyers S, 1996, EXP CELL RES, V227, P146, DOI 10.1006/excr.1996.0259; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; Fontan-Lozano A, 2010, J NEUROSCI, V30, P13305, DOI 10.1523/JNEUROSCI.3010-10.2010; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gobert D, 2008, J NEUROCHEM, V106, P1160, DOI 10.1111/j.1471-4159.2008.05470.x; GOLDBERG IH, 1964, FED PROC, V23, P958; Goldberg S, 2009, J NEUROCHEM, V111, P72, DOI 10.1111/j.1471-4159.2009.06296.x; Gomes C, 2011, J BIOL CHEM, V286, P4357, DOI 10.1074/jbc.M110.170134; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guetg C, 2012, CELL CYCLE, V11, P2217, DOI 10.4161/cc.20622; Guetg C, 2012, MOL CELL, V45, P790, DOI 10.1016/j.molcel.2012.01.024; Haddach M, 2012, BIOORG MED CHEM LETT, V22, P45, DOI 10.1016/j.bmcl.2011.11.087; Hernandez AI, 2009, J NEUROSCI, V29, P9553, DOI 10.1523/JNEUROSCI.1512-09.2009; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V126, P135, DOI 10.1007/s00418-006-0212-3; HERNANDEZVERDUN D, 1991, J CELL SCI, V99, P465; Hetman M, 2012, TRENDS NEUROSCI, V35, P305, DOI 10.1016/j.tins.2012.01.002; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; KATZ JOSEPH J., 1950, COMPAR PSYCHOL MONOGR, V20, P1; Kill IR, 1996, J CELL SCI, V109, P1253; Kiryk A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00207; Klann E, 2008, NEUROBIOL LEARN MEM, V89, P247, DOI 10.1016/j.nlm.2007.08.009; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Parlato R, 2013, J MOL MED, V91, P541, DOI 10.1007/s00109-012-0981-1; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Pietrzak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022585; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Sgambato V, 1998, J NEUROSCI, V18, P8814; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; TOKU S, 1983, J BIOCHEM-TOKYO, V93, P349, DOI 10.1093/oxfordjournals.jbchem.a134187; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Vargas JP, 2000, BRAIN RES, V865, P77, DOI 10.1016/S0006-8993(00)02220-4; Wilson DM, 1999, J HISTOCHEM CYTOCHEM, V47, P1095, DOI 10.1177/002215549904700814	60	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104364	10.1371/journal.pone.0104364	http://dx.doi.org/10.1371/journal.pone.0104364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089620	gold, Green Published			2022-12-27	WOS:000339812700121
J	Hung, CY; Wang, KY; Wu, TJ; Hsieh, YC; Huang, JL; Loh, EW; Lin, CH				Hung, Chen-Ying; Wang, Kuo-Yang; Wu, Tsu-Juey; Hsieh, Yu-Cheng; Huang, Jin-Long; Loh, El-Wui; Lin, Ching-Heng			Resistant Hypertension, Patient Characteristics, and Risk of Stroke	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; GENDER-DIFFERENCES; PREVALENCE; POPULATION; MANAGEMENT; COMMITTEE; DISEASE; STATIN; ADULTS; HEALTH	Background: Little is known about the prognosis of resistant hypertension (RH) in Asian population. This study aimed to evaluate the impacts of RH in Taiwanese patients with hypertension, and to ascertain whether patient characteristics influence the association of RH with adverse outcomes. Methods and Results: Patients aged >= 45 years with hypertension were identified from the National Health Insurance Research Database. Medical records of 111,986 patients were reviewed in this study, and 16,402 (14.6%) patients were recognized as having RH (continuously concomitant use of >= 3 anti-hypertensive medications, including a diuretic, for >= 2 years). Risk of major adverse cardiovascular events (MACE, a composite of all-cause mortality, acute coronary syndrome, and stroke [included both fatal and nonfatal events]) in patients with RH and non-RH was analyzed. A total of 11,856 patients experienced MACE in the follow-up period (average 7.1 +/- 3.0 years). There was a higher proportion of females in the RH group, they were older than the non-RH (63.1 vs. 60.5 years) patients, and had a higher prevalence of cardiovascular comorbidities. Overall, patients with RH had higher risks of MACE (adjusted HR 1.17; 95% CI 1.09-1.26; p<0.001). Significantly elevated risks of stroke (10,211 events; adjusted HR 1.17; 95% CI 1.08-1.27; p<0.001), especially ischemic stroke (6,235 events; adjusted HR 1.34; 95% CI 1.20-1.48; p<0.001), but not all-cause mortality (4,594 events; adjusted HR 1.06; 95% CI 0.95-1.19; p = 0.312) or acute coronary syndrome (2,145 events; adjusted HR 1.17; 95% CI 0.99-1.39; p = 0.070) were noted in patients with RH compared to those with non-RH. Subgroup analysis showed that RH increased the risks of stroke in female and elderly patients. However, no significant influence was noted in young or male patients. Conclusions: Patients with RH were associated with higher risks of MACE and stroke, especially ischemic stroke. The risks were greater in female and elderly patients than in male or young patients.	[Hung, Chen-Ying; Wang, Kuo-Yang; Wu, Tsu-Juey; Hsieh, Yu-Cheng; Huang, Jin-Long] Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung, Taiwan; [Hung, Chen-Ying] Taipei Vet Gen Hosp, Hsinchu Branch, Dept Internal Med, Hsinchu County, Taiwan; [Wang, Kuo-Yang; Wu, Tsu-Juey; Huang, Jin-Long] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Wu, Tsu-Juey; Hsieh, Yu-Cheng; Huang, Jin-Long] Natl Yang Ming Univ, Sch Med, Cardiovasc Res Ctr, Dept Internal Med,Fac Med,Inst Clin Med, Taipei 112, Taiwan; [Loh, El-Wui] Kaohsiung Municipal Kai Syuan Psychiat Hosp, Kaohsiung, Taiwan; [Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan	Taichung Veterans General Hospital; Taipei Veterans General Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital	Wang, KY (corresponding author), Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung, Taiwan.	wky@vghtc.gov.tw; epid@vghtc.gov.tw	Loh, El-Wui/ABD-6129-2020	Loh, El-Wui/0000-0001-9346-6886	Taichung Veterans General Hospital, Taiwan [TCVGH-1027308C, NHIRD-101-560]	Taichung Veterans General Hospital, Taiwan	This study was supported in part by grants from Taichung Veterans General Hospital, Taiwan (TCVGH-1027308C) (Registered number NHIRD-101-560). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brambilla G, 2013, J HYPERTENS, V31, P2018, DOI 10.1097/HJH.0b013e328363823f; Calhoun DA, 2008, CIRCULATION, V117, pE510, DOI 10.1161/CIRCULATIONAHA.108.189141; Chiang CE, 2010, J FORMOS MED ASSOC, V109, P740, DOI 10.1016/S0929-6646(10)60120-9; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Daugherty SL, 2013, J HYPERTENS, V31, P271, DOI 10.1097/HJH.0b013e32835bdc44; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; Daugherty SL, 2011, J HYPERTENS, V29, P1005, DOI 10.1097/HJH.0b013e3283449512; de la Sierra A, 2011, HYPERTENSION, V57, P898, DOI 10.1161/HYPERTENSIONAHA.110.168948; De Nicola L, 2013, J AM COLL CARDIOL, V61, P2461, DOI 10.1016/j.jacc.2012.12.061; Gu QP, 2008, AM J HYPERTENS, V21, P789, DOI 10.1038/ajh.2008.185; Hung CY, 2013, INT J CARDIOL, V168, P1131, DOI 10.1016/j.ijcard.2012.11.087; Hung CY, 2013, AM J MED, V126, P133, DOI 10.1016/j.amjmed.2012.06.027; Kim YS, 2011, GENDER MED, V8, P14, DOI 10.1016/j.genm.2011.01.001; Kumbhani DJ, 2013, EUR HEART J, V34, P1204, DOI 10.1093/eurheartj/ehs368; Lao XQ, 2013, AM J HYPERTENS; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; McDonald M, 2009, J GERONTOL A-BIOL, V64, P256, DOI 10.1093/gerona/gln016; Nishikawa T, 2013, HYPERTENS RES, V36, P924, DOI 10.1038/hr.2013.107; Pierdomenico SD, 2005, AM J HYPERTENS, V18, P1422, DOI 10.1016/j.amjhyper.2005.05.014; Quan HD, 2013, HEART, V99, P715, DOI 10.1136/heartjnl-2012-303152; Roberie DR, 2012, CURR OPIN CARDIOL, V27, P386, DOI 10.1097/HCO.0b013e328353ad6e; Sarafidis PA, 2008, J AM COLL CARDIOL, V52, P1749, DOI 10.1016/j.jacc.2008.08.036; Sim JJ, 2013, MAYO CLIN PROC, V88, P1099, DOI 10.1016/j.mayocp.2013.06.017; Smith SM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000660; Tang Xun, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P379; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	27	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104362	10.1371/journal.pone.0104362	http://dx.doi.org/10.1371/journal.pone.0104362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089520	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700120
J	Miyawaki, T; Norimoto, H; Ishikawa, T; Watanabe, Y; Matsuki, N; Ikegaya, Y				Miyawaki, Takeyuki; Norimoto, Hiroaki; Ishikawa, Tomoe; Watanabe, Yusuke; Matsuki, Norio; Ikegaya, Yuji			Dopamine Receptor Activation Reorganizes Neuronal Ensembles during Hippocampal Sharp Waves In Vitro	PLOS ONE			English	Article							RIPPLE COMPLEXES; MEMORY CONSOLIDATION; NETWORK ACTIVITY; RAT HIPPOCAMPUS; SLICES; MECHANISMS; PATTERNS; MODEL; SCHIZOPHRENIA; INTERNEURONS	Hippocampal sharp wave (SW)/ripple complexes are thought to contribute to memory consolidation. Previous studies suggest that behavioral rewards facilitate SW occurrence in vivo. However, little is known about the precise mechanism underlying this enhancement. Here, we examined the effect of dopaminergic neuromodulation on spontaneously occurring SWs in acute hippocampal slices. Local field potentials were recorded from the CA1 region. A brief (1 min) treatment with dopamine led to a persistent increase in the event frequency and the magnitude of SWs. This effect lasted at least for our recording period of 45 min and did not occur in the presence of a dopamine D-1/D-5 receptor antagonist. Functional multineuron calcium imaging revealed that dopamine-induced SW augmentation was associated with an enriched repertoire of the firing patterns in SW events, whereas the overall tendency of individual neurons to participate in SWs and the mean number of cells participating in a single SW were maintained. Therefore, dopaminergic activation is likely to reorganize cell assemblies during SWs.	[Miyawaki, Takeyuki; Norimoto, Hiroaki; Ishikawa, Tomoe; Watanabe, Yusuke; Matsuki, Norio; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo, Japan; [Ikegaya, Yuji] Ctr Informat & Neural Networks, Suita, Osaka, Japan	University of Tokyo; National Institute of Information & Communications Technology (NICT) - Japan	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Bunkyo Ku, Tokyo, Japan.	ikegaya@mol.f.u-tokyo.ac.jp	Norimoto, Hiroaki/E-1238-2019	Norimoto, Hiroaki/0000-0002-7351-5457; Miyawaki, Takeyuki/0000-0002-5335-7551; Ikegaya, Yuji/0000-0003-2260-8191	Japan Society for the Promotion of Science through the Funding Program for Next Generation World-Leading Researchers (NEXT Program); Council for Science and Technology Policy [LS023];  [22115003];  [25119004]; Grants-in-Aid for Scientific Research [25119004] Funding Source: KAKEN	Japan Society for the Promotion of Science through the Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Science Research on Innovative Areas (22115003; 25119004) (http://www.jsps.go.jp/english/e-grants/grants01.html) and the Japan Society for the Promotion of Science through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), initiated by the Council for Science and Technology Policy (LS023) (http://www.jsps.go.jp/english/e-jisedai/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivar P, 2014, J NEUROSCI, V34, P2989, DOI 10.1523/JNEUROSCI.2826-13.2014; AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; Bahner F, 2011, P NATL ACAD SCI USA, V108, pE607, DOI 10.1073/pnas.1103546108; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bethus I, 2010, J NEUROSCI, V30, P1610, DOI 10.1523/JNEUROSCI.2721-09.2010; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Di Sebastiano AR, 2012, PROG BRAIN RES, V198, P65, DOI 10.1016/B978-0-444-59489-1.00006-9; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Ellender TJ, 2010, J NEUROSCI, V30, P5979, DOI 10.1523/JNEUROSCI.3962-09.2010; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gasbarri A, 1997, PROG NEURO-PSYCHOPH, V21, P1, DOI 10.1016/S0278-5846(96)00157-1; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hajos N, 2013, J NEUROSCI, V33, P11677, DOI 10.1523/JNEUROSCI.5729-12.2013; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ibarz JM, 2010, J NEUROSCI, V30, P16249, DOI 10.1523/JNEUROSCI.3357-10.2010; Ihalainen JA, 1999, NEUROSCI LETT, V277, P71, DOI 10.1016/S0304-3940(99)00840-X; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kubota D, 2003, J NEUROPHYSIOL, V89, P81, DOI 10.1152/jn.00542.2002; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee TH, 1996, J NEUROSCI METH, V67, P221; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Maier N, 2011, NEURON, V72, P137, DOI 10.1016/j.neuron.2011.08.016; Maier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006925; Mizunuma M, 2014, NAT NEUROSCI, V17, P503, DOI 10.1038/nn.3674; Norimoto H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02696; Norimoto H, 2012, BRAIN RES, V1461, P1, DOI 10.1016/j.brainres.2012.04.037; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Papatheodoropoulos C, 2008, NEUROSCIENCE, V157, P495, DOI 10.1016/j.neuroscience.2008.09.040; Reichinnek S, 2012, NEUROIMAGE, V60, P139, DOI 10.1016/j.neuroimage.2011.12.018; Reichinnek S, 2010, J NEUROSCI, V30, P15441, DOI 10.1523/JNEUROSCI.2535-10.2010; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Sasaki T, 2014, EUR J NEUROSCI, V39, P2027, DOI 10.1111/ejn.12554; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Singer AC, 2013, NEURON, V77, P1163, DOI 10.1016/j.neuron.2013.01.027; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Suh J, 2013, NEURON, V80, P484, DOI 10.1016/j.neuron.2013.09.014; Sun Y, 2012, J PHARMACOL SCI, V118, P288, DOI 10.1254/jphs.11199FP; Takahashi Naoya, 2011, Curr Protoc Neurosci, VChapter 2, DOI 10.1002/0471142301.ns0214s57; Takahashi N, 2010, P NATL ACAD SCI USA, V107, P10244, DOI 10.1073/pnas.0914594107; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Weiss T, 2003, EUR J NEUROSCI, V18, P2573, DOI 10.1046/j.1460-9568.2003.02970.x; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Wu CP, 2005, J NEUROPHYSIOL, V94, P741, DOI 10.1152/jn.00086.2005; YLINEN A, 1995, J NEUROSCI, V15, P30; Zylla MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080718	59	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104438	10.1371/journal.pone.0104438	http://dx.doi.org/10.1371/journal.pone.0104438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089705	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700122
J	Tang, SY; Zhang, W; Soffe, R; Nahavandi, S; Shukla, R; Khoshmanesh, K				Tang, Shi-Yang; Zhang, Wei; Soffe, Rebecca; Nahavandi, Sofia; Shukla, Ravi; Khoshmanesh, Khashayar			High Resolution Scanning Electron Microscopy of Cells Using Dielectrophoresis	PLOS ONE			English	Article							PLATFORMS; MORPHOLOGY; PARTICLES; PHEROMONE; TUMORS	Ultrastructural analysis of cells can reveal valuable information about their morphological, physiological, and biochemical characteristics. Scanning electron microscopy (SEM) has been widely used to provide high-resolution images from the surface of biological samples. However, samples need to be dehydrated and coated with conductive materials for SEM imaging. Besides, immobilizing non-adherent cells during processing and analysis is challenging and requires complex fixation protocols. In this work, we developed a novel dielectrophoresis based microfluidic platform for interfacing non-adherent cells with high-resolution SEM at low vacuum mode. The system enables rapid immobilization and dehydration of samples without deposition of chemical residues over the cell surface. Moreover, it enables the on-chip chemical stimulation and fixation of immobilized cells with minimum dislodgement. These advantages were demonstrated for comparing the morphological changes of non-budding and budding yeast cells following Lyticase treatment.	[Tang, Shi-Yang; Zhang, Wei; Soffe, Rebecca; Khoshmanesh, Khashayar] RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic, Australia; [Nahavandi, Sofia] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia; [Shukla, Ravi] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Tang, SY (corresponding author), RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic, Australia.	shiyang.tang@rmit.edu.au; khashayar.khoshmanesh@rmit.edu.au	Tang, Shi-Yang/ABA-1995-2020; Tang, Shiyang/I-3580-2018	Tang, Shiyang/0000-0002-3079-8880; Shukla, Ravi/0000-0002-1537-9637; Khoshmanesh, Khashayar/0000-0001-6036-7371; Soffe, Rebecca/0000-0003-3340-3642	Australian Research Council [DE120101402]	Australian Research Council(Australian Research Council)	K. Khoshmanesh acknowledges the Australian Research Council for funding under Discovery Early Career Researcher Award (DECRA) scheme, (project DE120101402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Baratchi S, 2014, BIOTECHNOL ADV, V32, P333, DOI 10.1016/j.biotechadv.2013.11.008; BOULTON C, 2006, BREWING YEAST FERMEN; Centurione L, 2010, REPROD BIOMED ONLINE, V20, P625, DOI 10.1016/j.rbmo.2010.02.009; Chau LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051577; Chionna A, 2003, EUR J HISTOCHEM, V47, P299, DOI 10.4081/840; Chrimes AF, 2013, BIOSENS BIOELECTRON, V49, P536, DOI 10.1016/j.bios.2013.05.053; Chrimes AF, 2013, CHEM SOC REV, V42, P5880, DOI 10.1039/c3cs35515b; CRUZ YP, 1992, MICROSC RES TECHNIQ, V22, P103; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Dementhon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032621; DENOBEL JG, 1990, YEAST, V6, P491, DOI 10.1002/yea.320060606; Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f; Di Carlo D, 2006, ANAL CHEM, V78, P4925, DOI 10.1021/ac060541s; Docoslis A, 2002, ELECTROPHORESIS, V23, P2174, DOI 10.1002/1522-2683(200207)23:14<2174::AID-ELPS2174>3.0.CO;2-3; GOULD VE, 1980, PATHOL RES PRACT, V167, P45; Gupta S, 2010, LANGMUIR, V26, P3441, DOI 10.1021/la902989r; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Horstmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064764; JENNESS DD, 1983, CELL, V35, P521, DOI 10.1016/0092-8674(83)90186-1; Jesus-Perez NM, 2011, ELECTROPHORESIS, V32, P2331, DOI 10.1002/elps.201100107; Kalantar-zadeh K, 2007, NANOTECHNOLOGY ENABL; Kempaiah R, 2011, ACS NANO, V5, P6025, DOI 10.1021/nn201791k; Khoshmanesh K, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4879457; Khoshmanesh K, 2011, ANAL CHEM, V83, P3217, DOI 10.1021/ac2002142; Khoshmanesh K, 2011, BIOSENS BIOELECTRON, V26, P1800, DOI 10.1016/j.bios.2010.09.022; Khoshmanesh K, 2010, MICROFLUID NANOFLUID, V9, P411, DOI 10.1007/s10404-009-0558-7; Kirk S, 2009, J MICROSC-OXFORD, V233, P205, DOI 10.1111/j.1365-2818.2009.03111.x; Krylova G, 2010, PHYS CHEM CHEM PHYS, V12, P15101, DOI 10.1039/c004517a; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Min KW, 2013, ULTRASTRUCT PATHOL, V37, P23, DOI 10.3109/01913123.2012.707962; Moran P., 2012, MICROSC TODAY, V20, P28, DOI [10.1017/S1551929511001374, DOI 10.1017/S1551929511001374]; Morgan H., 2003, AC ELECTROKINETICS C, Vfirst; Muscariello L, 2005, J CELL PHYSIOL, V205, P328, DOI 10.1002/jcp.20444; Nahavandi S, 2014, LAB CHIP, V14, P1496, DOI 10.1039/c3lc51124c; Namiki Y, 2011, J ELECTRON MICROSC, V60, P157, DOI 10.1093/jmicro/dfq082; Pethig R, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3456626; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Rowan NJ, 1998, APPL ENVIRON MICROB, V64, P2065; Sakr SA, 2012, TOXICOL IND HEALTH, V28, P276, DOI 10.1177/0748233711412427; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; SNYDER LM, 1985, J CLIN INVEST, V76, P1971, DOI 10.1172/JCI112196; Soe AK, 2012, BIOSENS BIOELECTRON, V35, P1, DOI 10.1016/j.bios.2012.02.012; Stewart P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-60; Stockman DL, 2012, AM J SURG PATHOL, V36, P857, DOI 10.1097/PAS.0b013e31824644ac; Tang SY, 2013, ANAL CHEM, V85, P6364, DOI 10.1021/ac400741v; Tang SY, 2013, ELECTROPHORESIS, V34, P1407, DOI 10.1002/elps.201200659; Yarmush ML, 2009, ANNU REV BIOMED ENG, V11, P235, DOI 10.1146/annurev.bioeng.10.061807.160502	51	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104109	10.1371/journal.pone.0104109	http://dx.doi.org/10.1371/journal.pone.0104109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089528	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700099
J	Wang, TS; Gou, ZY; Wang, F; Ma, ML; Zhai, SD				Wang, Tiansheng; Gou, Zhuoyue; Wang, Fei; Ma, Manling; Zhai, Suo-di			Comparison of GLP-1 Analogues versus Sitagliptin in the Management of Type 2 Diabetes: Systematic Review and Meta-Analysis of Head-to-Head Studies	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; RECEPTOR AGONISTS; DPP-4 INHIBITORS; POSTPRANDIAL GLUCOSE; EXENATIDE; EFFICACY; SAFETY; PIOGLITAZONE; METFORMIN	Background: Incretin-based therapies which include glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors are recommended by several practice guidelines as second-line agents for add-on therapy to metformin in patients with type 2 diabetes (T2DM) who do not achieve glycemic control with metformin plus lifestyle interventions alone. The purpose of this study is to perform a systematic review with meta-analysis of existing head to head studies to compare the efficacy and safety of GLP-1 analogues with DPP-4 inhibitors. Methods: We performed a systematic review and meta-analysis of head-to-head studies to compare GLP-1 analogues with DPP-4 inhibitors in the management of type 2 diabetes. A random effects model was selected to perform the meta-analyses, results were expressed as weighted mean differences for continuous outcomes and relative risks for dichotomous outcomes, both with 95% confidence intervals, and with I-2 values and P values as markers of heterogeneity. Results: Four head-to-head randomized controlled studies with 1755 patients were included. Compared to sitagliptin, GLP-1 analogues are more effective in reducing HbA1C (weight mean difference -0.41%, 95% CI -0.51 to -0.31) and body weight (weight mean difference -1.55 kg, 95% CI -1.98 to -1.12). Conversely, GLP-1 analogues are associated with a higher incidence of gastrointestinal adverse events compared to sitagliptin: nausea (relative risk 3.14, 95% CI 2.15 to 4.59), vomiting (relative risk 2.60, 95% CI 1.48 to 4.56), diarrhea (relative risk 1.82, 95% CI 1.24 to 2.69), and constipation (relative risk 2.50, 95% CI 1.33 to 4.70). Conclusions: The result of this meta-analysis demonstrates that compared to sitagliptin, GLP-1 analogues are more effective for glycemic control and weight loss, but have similar efficacy in reducing blood pressure and lipid parameters, however, GLP-1 analogues are associated with a higher incidence of gastrointestinal adverse events and a similar incidence of hypoglycemia compared to sitagliptin.	[Wang, Tiansheng] Peking Univ, Hlth Sci Ctr, Dept Pharm Adm & Clin Pharm, Beijing 100871, Peoples R China; [Gou, Zhuoyue; Ma, Manling] Harbin Med Univ, Affiliated Hosp 1, Dept Pharm, Harbin, Peoples R China; [Wang, Fei] Univ Connecticut, Sch Pharm, Dept Pharm Practice, Storrs, CT USA; [Wang, Tiansheng; Zhai, Suo-di] Peking Univ, Dept Pharm, Hosp 3, Beijing 100871, Peoples R China	Peking University; Harbin Medical University; University of Connecticut; Peking University	Zhai, SD (corresponding author), Peking Univ, Dept Pharm, Hosp 3, Beijing 100871, Peoples R China.	zhaisuodi@163.com						Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; [Anonymous], 2013, NES PACK INS; [Anonymous], 2011, TRADJ; [Anonymous], 2011, BYETT; [Anonymous], 2010, VICT; [Anonymous], 2011, ONGL; [Anonymous], 2012, BYD PACK INS; Arnolds S, 2010, DIABETES CARE, V33, P1509, DOI 10.2337/dc09-2191; Berg JK, 2011, DIABETES OBES METAB, V13, P982, DOI 10.1111/j.1463-1326.2011.01428.x; Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; Best JH, 2011, DIABETES CARE, V34, P314, DOI 10.2337/dc10-1119; Brunton S, 2014, INT J CLIN PRACT, V68, P557, DOI 10.1111/ijcp.12361; Cates Christopher J, 2002, BMC Med Res Methodol, V2, P1, DOI 10.1186/1471-2288-2-1; Charbonnel B, 2013, DIABETOLOGIA, V56, P1503, DOI 10.1007/s00125-013-2905-1; DEACON CF, 1995, J CLIN ENDOCR METAB, V80, P952, DOI 10.1210/jc.80.3.952; Deeks J., 2011, COCHRANE HDB SYST RE, V5; DeFronzo RA, 2008, CURR MED RES OPIN, V24, P2943, DOI 10.1185/03007990802418851 ; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esposito K, 2011, DIABETES OBES METAB, V13, P594, DOI 10.1111/j.1463-1326.2011.01380.x; Fakhoury WKH, 2010, PHARMACOLOGY, V86, P44, DOI 10.1159/000314690; Garber AJ, 2013, ENDOCR PRACT, V19, P100, DOI 10.4158/EP12325.OR; Higgins JPT, 2011, COCHRANE HDB SYSTEMA; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Karagiannis T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1369; Madsbad S, 2012, EUR J INTERN MED, V23, P132, DOI 10.1016/j.ejim.2011.11.003; *MERCK CO INC, 2007, JAN PACK INS; Monami M, 2010, NUTR METAB CARDIOVAS, V20, P224, DOI 10.1016/j.numecd.2009.03.015; National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB NEW AG; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Pinelli NR, 2011, ANN PHARMACOTHER, V45, P850, DOI 10.1345/aph.1Q024; Pratley R, 2011, INT J CLIN PRACT, V65, P397, DOI 10.1111/j.1742-1241.2011.02656.x; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Richter B, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006739.pub2; Russell-Jones D, 2012, DIABETES CARE, V35, P252, DOI 10.2337/dc11-1107; Scheen AJ, 2012, EUR J INTERN MED, V23, P126, DOI 10.1016/j.ejim.2011.10.007; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Vilsboll T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7771; Wysham C, 2011, DIABETIC MED, V28, P705, DOI 10.1111/j.1464-5491.2011.03301.x	41	30	35	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103798	10.1371/journal.pone.0103798	http://dx.doi.org/10.1371/journal.pone.0103798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089625	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700056
J	Jockel-Schneider, Y; Harks, I; Haubitz, I; Fickl, S; Eigenthaler, M; Schlagenhauf, U; Baulmann, J				Jockel-Schneider, Yvonne; Harks, Inga; Haubitz, Imme; Fickl, Stefan; Eigenthaler, Martin; Schlagenhauf, Ulrich; Baulmann, Johannes			Arterial Stiffness and Pulse Wave Reflection Are Increased in Patients Suffering from Severe Periodontitis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR EVENTS; CLINICAL-APPLICATIONS; AORTIC STIFFNESS; RISK; VELOCITY; METAANALYSIS; ASSOCIATION; MORTALITY	Aim: This single blind cross-sectional study compared the vascular health of subjects suffering from severe chronic periodontitis, severe aggressive periodontitis and periodontal healthy controls by evaluating pulse wave velocity (PWV), augmentation index (AIx) and pulse pressure amplification (PPA). Material and Methods: In a total of 158 subjects, 92 suffering from severe periodontitis and 66 matched periodontal healthy controls, PWV, AIx, central and peripheral blood pressure were recorded using an oscillometric device (Arteriograph). Results: Subjects suffering from severe chronic or aggressive periodontitis exhibited significantly higher PWV (p = 0.00004), higher AIx (p = 0.0049) and lower PPA (p = 0.028) than matched periodontal healthy controls. Conclusions: The results of this study confirm the association between periodontal inflammation and increased cardiovascular risk shown by impaired vascular health in case of severe periodontitis. As impaired vascular health is a common finding in patients suffering from severe periodontal disease a concomitant routine cardiovascular evaluation may be advised.	[Jockel-Schneider, Yvonne; Haubitz, Imme; Fickl, Stefan; Eigenthaler, Martin; Schlagenhauf, Ulrich] Univ Hosp Wuerzburg, Dept Periodontol, Wurzburg, Germany; [Harks, Inga] Univ Hosp Muenster, Dept Periodontol, Munster, Germany; [Baulmann, Johannes] Univ Hosp Schleswig Holstein, Clin Internal Med 2, Lubeck, Germany	University of Wurzburg; University of Munster; University of Kiel; Schleswig Holstein University Hospital	Jockel-Schneider, Y (corresponding author), Univ Hosp Wuerzburg, Dept Periodontol, Wurzburg, Germany.	jockel_y@klinik.uni-wuerzburg.de	Stefanadis, Christodoulos/ABH-2232-2020; Jockel-Schneider, Yvonne/GQA-6206-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; Jockel-Schneider, Yvonne/0000-0002-5646-3691	German Research Foundation [EH 365/1-1]; IZKF Wuerzburg [Z-2/34]	German Research Foundation(German Research Foundation (DFG)); IZKF Wuerzburg	This study was funded externally by a grant of the German Research Foundation (EH 365/1-1) and by the IZKF Wuerzburg (Z-2/34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINAMO J, 1982, INT DENT J, V32, P281; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Baulmann J, 2010, DEUT MED WOCHENSCHR, V135, pS4, DOI 10.1055/s-0030-1249183; Baulmann J, 2008, J HYPERTENS, V26, P523, DOI 10.1097/HJH.0b013e3282f314f7; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Briggs JE, 2006, J PERIODONTOL, V77, P95, DOI 10.1902/jop.2006.77.1.95; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Elter JR, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.002; Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003; Franek E, 2009, AM J HYPERTENS, V22, P203, DOI 10.1038/ajh.2008.330; Grossi SG, 1996, J PERIODONTAL RES, V31, P330, DOI 10.1111/j.1600-0765.1996.tb00500.x; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hujoel PP, 2000, JAMA-J AM MED ASSOC, V284, P1406, DOI 10.1001/jama.284.11.1406; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; Jimenez M, 2009, ANN NEUROL, V66, P505, DOI 10.1002/ana.21742; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; MARCHAIS SJ, 1993, HYPERTENSION, V22, P876, DOI 10.1161/01.HYP.22.6.876; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Meaume S, 2001, ARTERIOSCL THROM VAS, V21, P2046, DOI 10.1161/hq1201.100226; Mercanoglu F, 2004, J PERIODONTOL, V75, P1694, DOI 10.1902/jop.2004.75.12.1694; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Morrison HI, 1999, J CARDIOVASC RISK, V6, P7; O'Rourke MF, 1999, J HYPERTENS, V17, pS45; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Roman MJ, 2009, J AM COLL CARDIOL, V54, P1730, DOI 10.1016/j.jacc.2009.05.070; Safar H, 2002, ARCH MAL COEUR VAISS, V95, P1215; Seinost G, 2005, AM HEART J, V149, P1050, DOI 10.1016/j.ahj.2004.09.059; Sigurdsson E, 1996, J AM COLL CARDIOL, V27, P1140, DOI 10.1016/0735-1097(95)00614-1; SYRJANEN J, 1989, J INTERN MED, V225, P179, DOI 10.1111/j.1365-2796.1989.tb00060.x; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Tonetti MS, 2009, J CLIN PERIODONTOL, V36, P15, DOI 10.1111/j.1600-051X.2009.01417.x; Van Bortel LM, 2002, AM J HYPERTENS, V15, P445, DOI 10.1016/S0895-7061(01)02326-3; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3	39	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103449	10.1371/journal.pone.0103449	http://dx.doi.org/10.1371/journal.pone.0103449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084111	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800043
J	Roberts, AJ; Druckenmiller, PS; Saetre, GP; Hurum, JH				Roberts, Aubrey Jane; Druckenmiller, Patrick Scott; Saetre, Glenn-Peter; Hurum, Jorn Harald			A New Upper Jurassic Ophthalmosaurid Ichthyosaur from the Slottsmoya Member, Agardhfjellet Formation of Central Spitsbergen	PLOS ONE			English	Article							PLESIOSAURIANS REPTILIA SAUROPTERYGIA; HYDROCARBON SEEP CARBONATES; NEUQUEN BASIN; PLATYPTERYGIUS-AUSTRALIS; CRETACEOUS ICHTHYOSAUR; GENUS; JANUSFJELLET; REDESCRIPTION; SASSENFJORDEN; LAGERSTATTE	Abundant new ichthyosaur material has recently been documented in the Slottsmoya Member of the Agardhfjellet Formation from the Svalbard archipelago of Norway. Here we describe a partial skeleton of a new taxon, Janusaurus lundi, that includes much of the skull and representative portions of the postcranium. The new taxon is diagnosed by a suite of cranial character states including a very gracile stapedial shaft, the presence of a dorsal process on the prearticular and autapomorphic postcranial features such as the presence of an interclavicular trough and a conspicuous anterodorsal process of the ilium. The peculiar morphology of the ilia indicates a previously unrecognized degree of morphological variation in the pelvic girdle of ophthalmosaurids. We also present a large species level phylogenetic analysis of ophthalmosaurids including new and undescribed ichthyosaur material from the Upper Jurassic of Svalbard. Our results recover all Svalbard taxa in a single unresolved polytomy nested within Ophthalmosaurinae, which considerably increases the taxonomic composition of this clade. The paleobiogeographical implications of this result suggest the presence of a single clade of Boreal ophthalmosaurid ichthyosaurs that existed during the latest Jurassic, a pattern also reflected in the high degree of endemicity among some Boreal invertebrates, particularly ammonoids. Recent and ongoing descriptions of marine reptiles from the Slottsmoya Member Lagerstatte provide important new data to test hypotheses of marine amniote faunal turnover at the Jurassic-Cretaceous boundary.	[Roberts, Aubrey Jane; Hurum, Jorn Harald] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Druckenmiller, Patrick Scott] Univ Alaska, Univ Alaska Museum, Fairbanks, AK 99701 USA; [Druckenmiller, Patrick Scott] Univ Alaska, Dept Geol & Geophys, Fairbanks, AK 99775 USA; [Saetre, Glenn-Peter] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, Oslo, Norway	University of Oslo; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Oslo	Roberts, AJ (corresponding author), Univ Southampton, Sch Ocean & Earth Sci, Southampton, Hants, England.	ajr1g13@soton.ac.uk			Spitsbergen Tavel; Fugro; OMV; Exonmobil; CEES at the Department of Biosciences, University of Oslo	Spitsbergen Tavel; Fugro; OMV; Exonmobil; CEES at the Department of Biosciences, University of Oslo	Funding for fieldwork in 2010: Spitsbergen Tavel, Fugro, OMV and Exonmobil. In-kind donations from Powershop, Lividi, Telenor, Simula, Forskning.no, Directconnect, National Geographic, and Livestream.com. AJR's collections visit was funded by CEES at the Department of Biosciences, University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst D, 2010, B SOC GEOL FR, V181, P453, DOI 10.2113/gssgfbull.181.5.453; Arkhangelsky M.S, 1998, PALEONTOL J, V32, P611; Bardet N, 2000, J PALEONTOL, V74, P503, DOI 10.1666/0022-3360(2000)074<0503:ANIFTU>2.0.CO;2; Cecca F, 2005, J BIOGEOGR, V32, P535, DOI 10.1111/j.1365-2699.2005.01176.x; Collignon M, 2012, NORW J GEOL, V92, P89; Druckenmiller PS, 2012, NORW J GEOL, V92, P311; Druckenmiller PS, 2012, NORW J GEOL, V92, P277; Druckenmiller PS, 2010, CAN J EARTH SCI, V47, P1037, DOI 10.1139/E10-028; DYPVIK H, 1991, POLAR RES, V9, P21, DOI 10.1111/j.1751-8369.1991.tb00400.x; Dypvik H, 2012, NORW J GEOL, V92, P65; Efimov, 1999, PALEONTOL J, V33, P174; Fernandez MS, 2012, GEOBIOS-LYON, V45, P535, DOI 10.1016/j.geobios.2012.02.001; Fernandez MS, 1997, J PALEONTOL, V71, P479, DOI 10.1017/S0022336000039494; Fernandez MS, 1999, J PALEONTOL, V73, P677, DOI 10.1017/S0022336000032492; Fernandez MS, 2013, GEOLOGICAL MAGAZINE, V151, P49; Fernandez MS, 2007, J PALEONTOL, V81, P677; Fischer V, 2014, GEOL MAG, V151, P60, DOI 10.1017/S0016756812000994; Fischer V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084709; Fischer V, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0021; Fischer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029234; Fischer V, 2011, J VERTEBR PALEONTOL, V31, P1010, DOI 10.1080/02724634.2011.595464; GILMORE C. W., 1905, MEM CARNEGIE MUS, V2, P77; Godefroit Pascal, 1994, Revue de Paleobiologie Volume Special, V7, P67; Goloboff P, 2010, TNT 1 1 TREE ANAL US; Hammer O, 2011, PALAEOGEOGRAPHY PALA, V306; Hammer O, 2013, ACTA PALAEONTOL POL, V58, P827, DOI 10.4202/app.2012.0020; Herrera Y, 2015, HIST BIOL, V27, P33, DOI 10.1080/08912963.2013.861831; Hjalmarsdottir HR, 2012, NORW J GEOL, V92, P157; Holmer LE, 2012, NORW J GEOL, V92, P167; Hryniewicz K, 2012, NORW J GEOL, V92, P113; Hurum JH, 2012, NORW J GEOL, V92, P55; JOHNSON R, 1977, CAN J EARTH SCI, V14, P1916, DOI 10.1139/e77-162; Kear BP, 2014, GEOL MAG, V151, P71, DOI 10.1017/S0016756813000113; Kear BP, 2005, ZOOL J LINN SOC-LOND, V145, P583, DOI 10.1111/j.1096-3642.2005.00199.x; Kirton A.M., 1983, THESIS U NEWCASTLE U; Knutsen EM, 2012, NORW J GEOL, V92, P235; Knutsen EM, 2012, NORW J GEOL, V92, P213; Knutsen EM, 2012, NORW J GEOL, V92, P175; Knutsen EM, 2012, NORW J GEOL, V92, P187; Kolb C, 2009, PALAEONTOGR ABT A, V288, P151; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Maxwell EE, 2006, PALAEONTOLOGY, V49, P1043, DOI 10.1111/j.1475-4983.2006.00589.x; Maxwell EE, 2012, J VERTEBR PALEONTOL, V32, P1207, DOI 10.1080/02724634.2012.682834; Maxwell EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041692; Maxwell EE, 2011, PALAEONTOL Z, V85, P457, DOI 10.1007/s12542-011-0106-0; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P1059, DOI 10.1080/02724634.2010.483546; Maxwell EE, 2010, J VERTEBR PALEONTOL, V30, P403, DOI 10.1080/02724631003617944; MCGOWAN C, 1976, CAN J EARTH SCI, V13, P668, DOI 10.1139/e76-070; MCGOWAN C., 2003, HDB PALEOHERPETOLOGY; Motani R, 1999, J VERTEBR PALEONTOL, V19, P473, DOI 10.1080/02724634.1999.10011160; Motani R, 1999, J VERTEBR PALEONTOL, V19, P28, DOI 10.1080/02724634.1999.10011120; Mutterlose J, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000625; Nagy J, 2009, POLAR RES, V28, P214, DOI 10.1111/j.1751-8369.2009.00112.x; Nakrem HA, 2012, NORW J GEOL, V92, P149; Novis L.K., 2012, THESIS U OSLO; PARKER JR, 1967, GEOL MAG, V104, P487, DOI 10.1017/S0016756800049220; ROMER ALFRED SHERWOOD, 1968, CONTRIB GEOL, V7, P27; Rousseau J, 2012, NORW J GEOL, V92, P133; Seeley HG, 1874, Q J GEOLOGICAL SOC, V30, P635; Smelror M., 2009, ATLAS GEOLOGICAL HIS; Spalletti LA, 1999, REV GEOL CHILE, V26, P109; Torsvik T., 2002, BATLASMID NORWAY PLA, P18; WADE M, 1984, LETHAIA, V17, P99, DOI 10.1111/j.1502-3931.1984.tb01713.x; Wierzbowski A, 2011, NEUES JAHRB GEOL P-A, V262, P267, DOI 10.1127/0077-7749/2011/0198; Zammit M, 2010, J VERTEBR PALEONTOL, V30, P1726, DOI 10.1080/02724634.2010.521930	65	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103152	10.1371/journal.pone.0103152	http://dx.doi.org/10.1371/journal.pone.0103152			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084533	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800018
J	Ruggeri, A; Gummerum, M; Hanoch, Y				Ruggeri, Azzurra; Gummerum, Michaela; Hanoch, Yaniv			Braving Difficult Choices Alone: Children's and Adolescents' Medical Decision Making	PLOS ONE			English	Article							AUTHORITY; REGRET; FAMILY; PEER	Objective: What role should minors play in making medical decisions? The authors examined children's and adolescents' desire to be involved in serious medical decisions and the emotional consequences associated with them. Methods: Sixty-three children and 76 adolescents were presented with a cover story about a difficult medical choice. Participants were tested in one of four conditions: (1) own informed choice; (2) informed parents' choice to amputate; (3) informed parents' choice to continue a treatment; and (4) uninformed parents' choice to amputate. In a questionnaire, participants were asked about their choices, preference for autonomy, confidence, and emotional reactions when faced with a difficult hypothetical medical choice. Results: Children and adolescents made different choices and participants, especially adolescents, preferred to make the difficult choice themselves, rather than having a parent make it. Children expressed fewer negative emotions than adolescents. Providing information about the alternatives did not affect participants' responses. Conclusions: Minors, especially adolescents, want to be responsible for their own medical decisions, even when the choice is a difficult one. For the adolescents, results suggest that the decision to be made, instead of the agent making the decision, is the main element influencing their emotional responses and decision confidence. For children, results suggest that they might be less able than adolescents to project how they would feel. The results, overall, draw attention to the need to further investigate how we can better involve minors in the medical decision-making process.	[Ruggeri, Azzurra] Max Planck Inst Human Dev, Berlin, Germany; [Gummerum, Michaela; Hanoch, Yaniv] Univ Plymouth, Plymouth PL4 8AA, Devon, England	Max Planck Society; University of Plymouth	Ruggeri, A (corresponding author), Max Planck Inst Human Dev, Berlin, Germany.	ruggeri@mpib-berlin.mpg.de		Hanoch, Yaniv/0000-0001-9453-4588				Albert D, 2011, J RES ADOLESCENCE, V21, P211, DOI 10.1111/j.1532-7795.2010.00724.x; Bodemer N, 2012, HDB RISK THEORY, P621, DOI DOI 10.1007/978-94-007-1433-5; Botti S, 2009, J CONSUM RES, V36, P337, DOI 10.1086/598969; Danne T, 2007, ARCH DIS CHILD, V92, P1015, DOI 10.1136/adc.2006.094904; de Bruin WB, 2007, J ADOLESCENT HEALTH, V41, P208, DOI 10.1016/j.jadohealth.2007.03.014; Edwards A, 2009, SHARED DECISION MAKI; Elkind D, 1970, CHILDREN ADOLESCENTS; Feufel MA, 2012, FINDING RIGHT UNPUB; Fischhoff B, 2010, J ADOLESCENT HEALTH, V46, P265, DOI 10.1016/j.jadohealth.2009.06.026; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gigerenzer G, 2011, BETTER DOCTORS BETTE; Guttentag R, 2004, DEV PSYCHOL, V40, P764, DOI 10.1037/0012-1649.40.5.764; Guttentag R, 2008, COGNITION EMOTION, V22, P815, DOI 10.1080/02699930701541542; Halpern J, 2008, J GEN INTERN MED, V23, P1708, DOI 10.1007/s11606-008-0719-5; Helwig CC, 2003, CHILD DEV, V74, P783, DOI 10.1111/1467-8624.00568; Helwig CC, 1999, CHILD DEV, V70, P502, DOI 10.1111/1467-8624.00036; Henley N, 2003, HEALTH EDUC RES, V18, P1, DOI 10.1093/her/18.1.1; Hickey Kathryn, 2007, JONAS Healthc Law Ethics Regul, V9, P100; Kuther TL, 2003, ADOLESCENCE, V38, P343; Lansdown G., 2005, EVOLVING CAPACITIES; LAUPA M, 1995, SOC DEV, V4, P1, DOI 10.1111/j.1467-9507.1995.tb00047.x; LEWIS CC, 1981, CHILD DEV, V52, P538, DOI 10.2307/1129172; Lyon M.E., 2004, J ADOLESCENT HEALTH, V35, P1, DOI [10.1016/j, DOI 10.1016/J]; McCabe MA, 1996, J PEDIATR PSYCHOL, V21, P505, DOI 10.1093/jpepsy/21.4.505; McNutt RA, 2004, JAMA-J AM MED ASSOC, V292, P2516, DOI 10.1001/jama.292.20.2516; Slater C., 1995, ROAD SAFETY ADVERTIS; SMETANA JG, 1994, CHILD DEV, V65, P1147, DOI 10.1111/j.1467-8624.1994.tb00809.x; Steinberg L, 2010, ADOLESCENCE; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; WADLINGTON W, 1994, U ILLINOIS LAW REV, P311; Zhu LQ, 2006, COGNITION, V98, P287, DOI 10.1016/j.cognition.2004.12.003; Zikmund-Fisher BJ, 2006, J GEN INTERN MED, V21, P618, DOI 10.1111/j.1525-1497.2006.00410.x; Zimmer-Gembeck M.J., 2008, BLACKWELL HDB ADOLES, P175, DOI [10.1002/9780470756607.ch9, DOI 10.1002/9780470756607.CH9]	33	11	11	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103287	10.1371/journal.pone.0103287	http://dx.doi.org/10.1371/journal.pone.0103287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4JL	25084274	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800025
J	Sornette, D; Maillart, T; Ghezzi, G				Sornette, Didier; Maillart, Thomas; Ghezzi, Giacomo			How Much Is the Whole Really More than the Sum of Its Parts? 1 boxed plus 1=2.5: Superlinear Productivity in Collective Group Actions	PLOS ONE			English	Article							POWER-LAW DISTRIBUTIONS; ZIPFS LAW; PERFORMANCE; MODELS; TEAMS; SIZE	In a variety of open source software projects, we document a superlinear growth of production intensity (R similar to c(beta)) as a function of the number of active developers c, with a median value of the exponent beta similar or equal to 4/3, with large dispersions of beta from slightly less than 1 up to 3. For a typical project in this class, doubling of the group size multiplies typically the output by a factor 2(beta)=2.5, explaining the title. This superlinear law is found to hold for group sizes ranging from 5 to a few hundred developers. We propose two classes of mechanisms, interaction-based and large deviation, along with a cascade model of productive activity, which unifies them. In this common framework, superlinear productivity requires that the involved social groups function at or close to criticality, or in a "superradiance" mode, in the sense of the appearance of a cooperative process and order involving a collective mode of developers defined by the build up of correlation between the contributions of developers. In addition, we report the first empirical test of the renormalization of the exponent of the distribution of the sizes of first generation events into the renormalized exponent of the distribution of clusters resulting from the cascade of triggering over all generation in a critical branching process in the non-meanfield regime. Finally, we document a size effect in the strength and variability of the superlinear effect, with smaller groups exhibiting widely distributed superlinear exponents, some of them characterizing highly productive teams. In contrast, large groups tend to have a smaller superlinearity and less variability.	[Sornette, Didier] Swiss Fed Inst Technol, Dept Management Technol & Econ, Zurich, Switzerland; [Maillart, Thomas] Univ Calif Berkeley, Sch Informat, Berkeley, CA USA; [Ghezzi, Giacomo] Univ Zurich, Dept Informat, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Berkeley; University of Zurich	Sornette, D (corresponding author), Swiss Fed Inst Technol, Dept Management Technol & Econ, Zurich, Switzerland.	dsornette@ethz.ch			Swiss National Science Foundation [PA00P2-145368]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	One of the authors (T.M.) acknowledges support from the Swiss National Science Foundation (Grant Nr. PA00P2-145368). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Sahalia Y, 2010, NATL BUREAU EC RES W, V15850; ANDERSON PW, 1963, PHYS REV, V130, P439, DOI 10.1103/PhysRev.130.439; ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; [Anonymous], 2005, 1 MONDAY; Arthur W.Brian., 1994, INCREASING RETURNS P; Baldwin A, 2012, WORKSH EC INF SEC WE; Benedict M. G., 1996, SUPER RADIANCE MULTI; Benkler Y, 2002, YALE LAW J, V112, P369, DOI 10.2307/1562247; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; BOUCHAUD JP, 1990, PHYS REP, V195, P127, DOI 10.1016/0370-1573(90)90099-N; Cardy JL, 1988, CURRENT PHYS SERIES, V2; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Coase RH, 1937, ECONOMICA-NEW SER, V4, P386, DOI 10.1111/j.1468-0335.1937.tb00002.x; Cohen SG, 1997, J MANAGE, V23, P239, DOI 10.1177/014920639702300303; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Daley D., 2003, INTRO THEORY POINT P, V1; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Deschatres F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016112; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Domb C, 1979, PHASE TRANSITIONS CR, V1-20; Ennen E, 2010, J MANAGE, V36, P207, DOI 10.1177/0149206309350083; Filimonov V, 2014, J INT MONEY FINANC, V42, P174, DOI 10.1016/j.jimonfin.2013.08.010; Filimonov V, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056108; Galam S, 2012, WHAT IS SOCIOPHYSICS; Gordon K, 1924, J EXP PSYCHOL, V7, P398, DOI 10.1037/h0074666; Gowers T, 2009, NATURE, V461, P879, DOI 10.1038/461879a; Grimmett GR, 1994, PROBABILITY PHASE TR, V420; GROSS M, 1982, PHYS REP, V93, P301, DOI 10.1016/0370-1573(82)90102-8; Halfaker A, 2013, AM BEHAV SCI, V57, P664, DOI 10.1177/0002764212469365; Harris T. E., 2002, THEORY BRANCHING PRO; HAWKES AG, 1974, J APPL PROBAB, V11, P493, DOI 10.2307/3212693; Helmstetter A, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001580; Helmstetter AS, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017670; Humphrey G, 1924, J EDUC PSYCHOL, V15, P401, DOI 10.1037/h0070207; INGHAM AG, 1974, J EXP SOC PSYCHOL, V10, P371, DOI 10.1016/0022-1031(74)90033-X; JOHN S, 1995, PHYS REV LETT, V74, P3419, DOI 10.1103/PhysRevLett.74.3419; Jorgensen S.E., 2012, INTRO SYSTEMS ECOLOG; Krugman P., 1996, SELF ORG EC; LAUGHLIN PR, 1966, J EXP SOC PSYCHOL, V2, P407, DOI 10.1016/0022-1031(66)90032-1; Liggett, 2005, INTERACTING PARTICLE; Lin Y, 2006, ADV INTERDISCIPLINAR, V12, P53, DOI DOI 10.1016/S1572-0977(06)12003-8; Madey G., 2002, AMCIS 2002 P, P1806; Maillart T, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056101; Maillart T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.218701; Malevergne Y, 2013, J ECON DYN CONTROL, V37, P1195, DOI 10.1016/j.jedc.2013.02.004; Mohler GO, 2011, J AM STAT ASSOC, V106, P100, DOI 10.1198/jasa.2011.ap09546; Neuman GA, 1999, J APPL PSYCHOL, V84, P376, DOI 10.1037/0021-9010.84.3.376; O'Mahony S, 2007, ACAD MANAGE J, V50, P1079; Ostrom E., 1990, GOVERNING COMMONS EV; Raasch C, 2009, R&D MANAGE, V39, P382, DOI 10.1111/j.1467-9310.2009.00567.x; Ramsden JJ, 2000, PHYSICA A, V277, P220, DOI 10.1016/S0378-4371(99)00572-5; Sacramento C. A., 2006, ADV INTERDISCIPLINAR, V12, P81; Saichev A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046123; Saichev A, 2005, PURE APPL GEOPHYS, V162, P1113, DOI 10.1007/s00024-004-2663-6; Saichev A, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012104; Saichev A., 2009, LECT NOTES EC MATH S, VVolume 632; Saichev AI, 2011, EUR PHYS J B, V83, P271, DOI 10.1140/epjb/e2011-20298-3; Saichev AI, 2010, EUR PHYS J B, V75, P343, DOI 10.1140/epjb/e2010-00121-7; Saichev AI, 2013, EUROPEAN PHYS J B, V86, P1; Shaw ME, 1932, AM J PSYCHOL, V44, P491, DOI 10.2307/1415351; Smith Adam, 1976, WEALTH NATIONS; Sornette D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228701; Sornette D., 2006, CRITICAL PHENOMENA N, DOI DOI 10.1007/3-540-33182-4; SUNDSTROM E, 1990, AM PSYCHOL, V45, P120, DOI 10.1037/0003-066X.45.2.120; Toulouse G, 1978, REV FRANCAISE SOCIOL, V19; TZINER A, 1985, J APPL PSYCHOL, V70, P85, DOI 10.1037/0021-9010.70.1.85; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Zhang QZ, 2011, PHYSICA A, V390, P4124, DOI 10.1016/j.physa.2011.06.063; Zhou WX, 2005, P ROY SOC B-BIOL SCI, V272, P439, DOI 10.1098/rspb.2004.2970	73	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103023	10.1371/journal.pone.0103023	http://dx.doi.org/10.1371/journal.pone.0103023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084157	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800014
J	Harastani, HH; Tokajian, ST				Harastani, Houda H.; Tokajian, Sima T.			Community-Associated Methicillin-Resistant Staphylococcus aureus Clonal Complex 80 Type IV (CC80-MRSA-IV) Isolated from the Middle East: A Heterogeneous Expanding Clonal Lineage	PLOS ONE			English	Article							VALENTINE LEUKOCIDIN GENES; TOXIC-SHOCK-SYNDROME; MULTIPLEX PCR ASSAY; MOLECULAR CHARACTERISTICS; LEUCOCIDIN GENES; ST80-IV CLONE; STRAINS; EPIDEMIOLOGY; MRSA; CHROMOSOME	Background: The emergence of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA) has caused a change in MRSA epidemiology worldwide. In the Middle East, the persistent spread of CA-MRSA isolates that were associated with multilocus sequence type (MLST) clonal complex 80 and with staphylococcal cassette chromosome mec (SCCmec) type IV (CC80-MRSA-IV), calls for novel approaches for infection control that would limit its spread. Methodology/Principal Findings: In this study, the epidemiology of CC80-MRSA-IV was investigated in Jordan and Lebanon retrospectively covering the period from 2000 to 2011. Ninety-four S. aureus isolates, 63 (67%) collected from Lebanon and 31 (33%) collected from Jordan were included in this study. More than half of the isolates (56%) were associated with skin and soft tissue infections (SSTIs), and 73 (78%) were Panton-Valentine Leukocidin (PVL) positive. Majority of the isolates (84%) carried the gene for exofoliative toxin d (etd), 19% had the Toxic Shock Syndrome Toxin-1 gene (tst), and seven isolates from Jordan had a rare combination being positive for both tst and PVL genes. spa typing showed the prevalence of type t044 (85%) and pulsed-field gel electrophoresis (PFGE) recognized 21 different patterns. Antimicrobial susceptibility testing showed the prevalence (36%) of a unique resistant profile, which included resistance to streptomycin, kanamycin, and fusidic acid (SKF profile). Conclusions: The genetic diversity among the CC80 isolates observed in this study poses an additional challenge to infection control of CA-MRSA epidemics. CA-MRSA related to ST80 in the Middle East was distinguished in this study from the ones described in other countries. Genetic diversity observed, which may be due to mutations and differences in the antibiotic regimens between countries may have led to the development of heterogeneous strains. Hence, it is difficult to maintain "the European CA-MRSA clone" as a uniform clone and it is better to designate as CC80-MRSA-IV isolates.	[Harastani, Houda H.; Tokajian, Sima T.] Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Byblos, Lebanon	Lebanese American University	Tokajian, ST (corresponding author), Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Byblos, Lebanon.	stokjian@lau.edu.lb	Tokajian, Sima T/G-9644-2018	Tokajian, Sima T/0000-0002-3653-8940; Harastani, Houda/0000-0002-1234-6194	Lebanese American University Research Council	Lebanese American University Research Council	This work was supported by the Lebanese American University Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2010, J CLIN MICROBIOL, V48, P531, DOI 10.1128/JCM.02290-08; Ahmad N, 2009, J MED MICROBIOL, V58, P1213, DOI 10.1099/jmm.0.011353-0; Al-Bakri AG, 2013, EPIDEMIOL INFECT, V141, P2384, DOI 10.1017/S0950268813000010; Antri K, 2011, CLIN MICROBIOL INFEC, V17, P526, DOI 10.1111/j.1469-0691.2010.03273.x; Bekkhoucha SN, 2009, EUR J CLIN MICROBIOL, V28, P553, DOI 10.1007/s10096-008-0660-x; Ben Nejma M, 2013, DIAGN MICR INFEC DIS, V77, P20, DOI 10.1016/j.diagmicrobio.2008.02.010; Boakes E, 2011, J CLIN MICROBIOL, V49, P684, DOI 10.1128/JCM.01917-10; Borg MA, 2007, J ANTIMICROB CHEMOTH, V60, P1310, DOI 10.1093/jac/dkm365; Brady JM, 2007, J CLIN MICROBIOL, V45, P2654, DOI 10.1128/JCM.02579-06; Budimir A, 2010, CLIN MICROBIOL INFEC, V16, P1077, DOI 10.1111/j.1469-0691.2009.03042.x; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; CLSI, 2010, M100S20 CLSI; Cucarella C, 2004, INFECT IMMUN, V72, P2177, DOI 10.1128/IAI.72.4.2177-2185.2004; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P3806, DOI 10.1128/JCM.41.8.3806-3815.2003; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Denis O, 2005, J ANTIMICROB CHEMOTH, V56, P1103, DOI 10.1093/jac/dki379; Denis O, 2004, EUROSURVEILLANCE, V8, P2483; Deresinski S, 2005, CLIN INFECT DIS, V40, P562, DOI 10.1086/427701; Djoudi F, 2013, NEW MICROBIOL, V36, P49; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; El-Mahdy TS, 2014, CLIN MICROBIOL INFEC, V20, P169, DOI 10.1111/1469-0691.12240; Enany S, 2010, MICROBIOL RES, V165, P152, DOI 10.1016/j.micres.2009.03.005; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Goering RV, 2009, CLIN MICROBIOL INFEC, V15, P748, DOI 10.1111/j.1469-0691.2009.02850.x; GOERING RV, 1992, J CLIN MICROBIOL, V30, P577, DOI 10.1128/JCM.30.3.577-580.1992; Hadjihannas L, 2012, DIAGN MICR INFEC DIS, V74, P420, DOI 10.1016/j.diagmicrobio.2012.08.012; Hanssen AM, 2005, J CLIN MICROBIOL, V43, P2118, DOI 10.1128/JCM.43.5.2118-2124.2005; Harastani HH, 2014, INT J INFECT DIS, V19, P33, DOI 10.1016/j.ijid.2013.10.007; Harbarth S, 2005, EMERG INFECT DIS, V11, P962, DOI 10.3201/eid1106.041308; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Hsu LY, 2005, EMERG INFECT DIS, V11, P341, DOI 10.3201/eid1102.040782; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Jekle A, 2013, ANTIMICROB AGENTS CH, V57, P924, DOI 10.1128/AAC.01945-12; JOHNSON WM, 1991, J CLIN MICROBIOL, V29, P426, DOI 10.1128/JCM.29.3.426-430.1991; Khalil W, 2012, DIAGN MICR INFEC DIS, V73, P228, DOI 10.1016/j.diagmicrobio.2012.03.012; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Larsen AR, 2008, J ANTIMICROB CHEMOTH, V61, P589, DOI 10.1093/jac/dkm532; Larsen AR, 2008, J CLIN MICROBIOL, V46, P62, DOI 10.1128/JCM.01381-07; Larsen AR, 2009, J CLIN MICROBIOL, V47, P73, DOI 10.1128/JCM.01557-08; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Maier J, 2005, EUR J CLIN MICROBIOL, V24, P637, DOI 10.1007/s10096-005-0008-8; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; Monday SR, 1999, J CLIN MICROBIOL, V37, P3411, DOI 10.1128/JCM.37.10.3411-3414.1999; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; Ramdani-Bouguessa N, 2006, ANTIMICROB AGENTS CH, V50, P1083, DOI 10.1128/AAC.50.3.1083-1085.2006; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; SHANDS KN, 1980, NEW ENGL J MED, V303, P1436, DOI 10.1056/NEJM198012183032502; Shorr AF, 2007, CLIN INFECT DIS, V45, pS171, DOI 10.1086/519473; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Sonnevend A, 2012, J CLIN PATHOL, V65, P178, DOI 10.1136/jclinpath-2011-200436; Stam-Bolink EM, 2007, EUR J CLIN MICROBIOL, V26, P723, DOI 10.1007/s10096-007-0352-y; Strommenger B, 2008, J CLIN MICROBIOL, V46, P582, DOI 10.1128/JCM.01600-07; STRUELENS MJ, 1992, J CLIN MICROBIOL, V30, P2599, DOI 10.1128/JCM.30.10.2599-2605.1992; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tokajian ST, 2010, EPIDEMIOL INFECT, V138, P707, DOI 10.1017/S0950268810000440; Tristan A, 2007, EMERG INFECT DIS, V13, P594, DOI 10.3201/eid1304.061316; Udo EE, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-31; Urth T, 2005, INFECT CONT HOSP EP, V26, P144, DOI 10.1086/502518; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Witte W, 2004, EUROSURVEILLANCE, V9, P440, DOI DOI 10.2807/ESM.09.01.00440-EN; Yamaguchi T, 2002, INFECT IMMUN, V70, P5835, DOI 10.1128/IAI.70.10.5835-5845.2002; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zhi L, 2010, PLOS ONE, V6	66	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103715	10.1371/journal.pone.0103715	http://dx.doi.org/10.1371/journal.pone.0103715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078407	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800069
J	Rosso, A; Neitlich, P; Smith, RJ				Rosso, Abbey; Neitlich, Peter; Smith, Robert J.			Non-Destructive Lichen Biomass Estimation in Northwestern Alaska: A Comparison of Methods	PLOS ONE			English	Article							MACROLICHEN COMMUNITIES; ABUNDANCE; CARIBOU; BRYOPHYTES; VEGETATION	Terrestrial lichen biomass is an important indicator of forage availability for caribou in northern regions, and can indicate vegetation shifts due to climate change, air pollution or changes in vascular plant community structure. Techniques for estimating lichen biomass have traditionally required destructive harvesting that is painstaking and impractical, so we developed models to estimate biomass from relatively simple cover and height measurements. We measured cover and height of forage lichens (including single-taxon and multi-taxa "community" samples, n = 144) at 73 sites on the Seward Peninsula of northwestern Alaska, and harvested lichen biomass from the same plots. We assessed biomass-to-volume relationships using zero-intercept regressions, and compared differences among two non-destructive cover estimation methods (ocular vs. point count), among four landcover types in two ecoregions, and among single-taxon vs. multi-taxa samples. Additionally, we explored the feasibility of using lichen height (instead of volume) as a predictor of stand-level biomass. Although lichen taxa exhibited unique biomass and bulk density responses that varied significantly by growth form, we found that single-taxon sampling consistently under-estimated true biomass and was constrained by the need for taxonomic experts. We also found that the point count method provided little to no improvement over ocular methods, despite increased effort. Estimated biomass of lichen-dominated communities (mean lichen cover: 84.9 +/- 1.4%) using multi-taxa, ocular methods differed only nominally among landcover types within ecoregions (range: 822 to 1418 g m(-2)). Height alone was a poor predictor of lichen biomass and should always be weighted by cover abundance. We conclude that the multi-taxa (whole-community) approach, when paired with ocular estimates, is the most reasonable and practical method for estimating lichen biomass at landscape scales in northwest Alaska.	[Rosso, Abbey; Neitlich, Peter] Natl Pk Serv, Winthrop, WA 98862 USA; [Smith, Robert J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	United States Department of the Interior; Oregon State University	Neitlich, P (corresponding author), Natl Pk Serv, Winthrop, WA 98862 USA.	peter_neitlich@nps.gov	Smith, Robert J/Q-1408-2017; Smith, Robert/AAT-1994-2021	Smith, Robert J/0000-0001-5085-634X; Smith, Robert/0000-0001-5085-634X	US National Park Service-Western Arctic National Parklands; US National Park Service-Arctic Network; US National Park Service	US National Park Service-Western Arctic National Parklands; US National Park Service-Arctic Network; US National Park Service	This work was funded by the US National Park Service-Western Arctic National Parklands and the US National Park Service-Arctic Network. The corresponding author secured governmental funding for this project via the US National Park Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arseneault D, 1997, J APPL ECOL, V34, P65, DOI 10.2307/2404848; BERGERUD A T, 1971, Canadian Field-Naturalist, V85, P39; BRAKENHIELM S, 1995, WATER AIR SOIL POLL, V79, P75, DOI 10.1007/BF01100431; Chen WJ, 2009, ARCTIC, V62, P281; Daly C, 2009, ANN MEAN AVERAGE TEM; Dunford JS, 2006, ECOSCIENCE, V13, P469, DOI 10.2980/1195-6860(2006)13[469:LAITPO]2.0.CO;2; Engle R. F., 1984, HDB ECONOMETRICS, V2, P775, DOI [DOI 10.1016/S1573-4412(84)02005-5, 10.1016/S1573-4412(84)02005-5]; Epstein HE, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000555; Fancy SG, 2009, ENVIRON MONIT ASSESS, V151, P161, DOI 10.1007/s10661-008-0257-y; Gauslaa Y, 2008, LICHENOLOGIST, V40, P257, DOI 10.1017/S0024282908007664; Geiser LH, 2007, ENVIRON POLLUT, V145, P203, DOI 10.1016/j.envpol.2006.03.024; Godinez-Alvarez H, 2009, ECOL INDIC, V9, P1001, DOI 10.1016/j.ecolind.2008.11.011; Heggberget Thrine Moen, 2002, Rangifer, V22, P13; Higuera PE, 2011, ECOL APPL, V21, P3211, DOI 10.1890/11-0387.1; Holt E., 2010, LICHEN INVENTORY SYN; Holt EA, 2008, BRYOLOGIST, V111, P68, DOI 10.1639/0007-2745(2008)111[68:GAFIOM]2.0.CO;2; Holt EA, 2009, BOTANY, V87, P241, DOI 10.1139/B08-142; Joly K, 2010, ECOSCIENCE, V17, P321, DOI 10.2980/17-3-3337; Jorgenson M. T., 2009, ECOLOGICAL LAND SURV; Kumpula J, 2000, ARCTIC, V53, P152, DOI 10.14430/arctic845; Lang SI, 2012, GLOBAL CHANGE BIOL, V18, P1096, DOI 10.1111/j.1365-2486.2011.02570.x; Li S, 2011, FOREST ECOL MANAG, V261, P1760, DOI 10.1016/j.foreco.2011.01.037; Linder G, 2013, OPEN J AIR POLL, V2, P76, DOI [10.4236/ojap.2013.24010, DOI 10.4236/OJAP.2013.24010]; Macer M.J., 2004, LANDCOVER MAPPING BE; Markon CJ, 1997, 97103 USGS US DEP IN; MCCUNE B, 1992, BRYOLOGIST, V95, P296, DOI 10.2307/3243488; Moen Jon, 2007, Rangifer, V27, P41; Moore KE, 2013, THESIS U ALASKA FAIR; Nelson PR, 2013, REMOTE SENS ENVIRON, V137, P43, DOI 10.1016/j.rse.2013.05.026; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; Porada P, 2013, BIOGEOSCIENCES, V10, P6989, DOI 10.5194/bg-10-6989-2013; Price K, 2001, ECOL APPL, V11, P904, DOI 10.2307/3061124; RHOADES FM, 1981, BRYOLOGIST, V84, P39, DOI 10.2307/3242976; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Swanson D.K, 2013, NPSARCNNRTR2013668; Swanson DK, 2014, TERRESTRIAL VEGETATI; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x	38	8	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103739	10.1371/journal.pone.0103739	http://dx.doi.org/10.1371/journal.pone.0103739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079228	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800075
J	Shi, XY; Wu, YY; Ai, ZY; Du, J; Cao, LX; Guo, ZK; Zhang, Y				Shi, Xiaoyan; YongyanWu; Ai, Zhiying; Du, Juan; Cao, Lixia; Guo, Zekun; Zhang, Yong			MicroRNA Modulation Induced by AICA Ribonucleotide in J1 Mouse ES Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; TRANSCRIPTION FACTOR; SMALL-MOLECULE; DIFFERENTIATION; PLURIPOTENCY; EXPRESSION; NANOG; OCT4; GENE	ES cells can propagate indefinitely, maintain self-renewal, and differentiate into almost any cell type of the body. These properties make them valuable in the research of embryonic development, regenerative medicine, and organ transplantation. MicroRNAs (miRNAs) are considered to have essential functions in the maintenance and differentiation of embryonic stem cells (ES cells). It was reported that, strong external stimuli, such as a transient low-pH and hypoxia stress, were conducive to the formation of induced pluripotent stem cells (iPS cells). AICA ribonucleotide (AICAR) is an AMP-activated protein kinase activator, which can let cells in the state of energy stress. We have demonstrated that AICAR can maintain the pluripotency of J1 mouse ES cells through modulating protein expression in our previous research, but its effects on ES cell miRNA expression remain unknown. In this study, we conducted small RNA high-throughput sequencing to investigate AICAR influence on J1 mouse ES cells by comparing the miRNA expression patterns of the AICAR-treated cells and those without treatment. The result showed that AICAR can significantly modulate the expression of multiple miRNAs, including those have crucial functions in ES cell development. Some differentially expressed miRNAs were selected and confirmed by real-time PCR. For the differently expressed miRNAs identified, further study was conducted regarding the pluripotency and differentiation associated miRNAs with their targets. Moreover, miR-134 was significantly down-regulated after AICAR treatment, and this was suggested to be directly associated with the up-regulated pluripotency markers, Nanog and Sox2. Lastly, Myc was significantly down-regulated after AICAR treatment; therefore, we predicted miRNAs that may target Myc and identified that AICAR induced up-regulation of miR-34a, 34b, and 34c can repress Myc expression in J1 mouse ES cells. Taken together, our study provide a new mechanism for AICAR in ES cells pluripotency maintenance and give insight for its usage in iPS cells generation.	[Shi, Xiaoyan; Ai, Zhiying; Du, Juan; Cao, Lixia] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [YongyanWu; Guo, Zekun; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Shi, Xiaoyan; YongyanWu; Ai, Zhiying; Du, Juan; Cao, Lixia; Guo, Zekun; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Guo, ZK (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	gzk@nwsuaf.edu.cn; zhylab@hotmail.com		Wu, Yongyan/0000-0003-1669-3860	National Natural Science Foundation of China [31172279]; National Major Project for Production of Transgenic Breeding [2013ZX08007-004]; National High Technology Research and Development Program of China (863 Program) [2011AA100303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Project for Production of Transgenic Breeding; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by a grant from the National Natural Science Foundation of China (No. 31172279), the National Major Project for Production of Transgenic Breeding (No. 2013ZX08007-004), and the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Christophersen NS, 2010, J EXP MED, V207, P2287, DOI 10.1084/jem.20101438; Gardner RL, 1998, PATHOL BIOL, V46, P676; Guo Z, 2013, J DERMATOL SCI, V69, P68, DOI 10.1016/j.jdermsci.2012.10.014; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Kang PJ, 2014, BIOMATERIALS, DOI [10.1016/j.biomaterials, DOI 10.1016/J.BIOMATERIALS]; Kim MO, 2012, NAT STRUCT MOL BIOL, V19, P283, DOI 10.1038/nsmb.2217; Koller K, 2013, GENE CHROMOSOME CANC, V52, P709, DOI 10.1002/gcc.22066; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Liu XF, 2013, UNIVERSITAS-TAIWAN, V40, P1; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Merrill BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007971; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Obokata H, 2014, NATURE; Ou X, 2014, STEM CELLS, V32, P1183, DOI 10.1002/stem.1641; Puceat M, 2007, CARDIOVASC RES, V74, P256, DOI 10.1016/j.cardiores.2006.12.012; Rothschild SI, 2012, J THORAC ONCOL, V7, P1069, DOI 10.1097/JTO.0b013e31824fe976; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shi XY, 2013, CELL PHYSIOL BIOCHEM, V32, P459, DOI 10.1159/000354451; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan XC, 2012, P NATL ACAD SCI USA, V109, P15805, DOI 10.1073/pnas.1207787109; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wang YL, 2009, J CELL PHYSIOL, V218, P251, DOI 10.1002/jcp.21607; Wu YY, 2013, EXP CELL RES, V319, P2684, DOI 10.1016/j.yexcr.2013.08.027; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029722; Ye D, 2012, STEM CELLS, V30, P1645, DOI 10.1002/stem.1149; Zhang XY, 2012, IN VITRO CELL DEV-AN, V48, P131, DOI 10.1007/s11626-012-9482-3; Zovoilis A, 2009, DIFFERENTIATION, V78, P69, DOI 10.1016/j.diff.2009.06.003	42	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103724	10.1371/journal.pone.0103724	http://dx.doi.org/10.1371/journal.pone.0103724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078608	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800071
J	Hart, KM; Lamont, MM; Sartain, AR; Fujisaki, I				Hart, Kristen M.; Lamont, Margaret M.; Sartain, Autumn R.; Fujisaki, Ikuko			Migration, Foraging, and Residency Patterns for Northern Gulf Loggerheads: Implications of Local Threats and International Movements	PLOS ONE			English	Article							TURTLES CARETTA-CARETTA; STATE-SPACE MODELS; SEA-TURTLES; OF-MEXICO; SATELLITE-TRACKING; HOME-RANGE; POPULATION-MODEL; GREEN TURTLES; FIDELITY; BEHAVIOR	Northern Gulf of Mexico (NGoM) loggerheads (Caretta caretta) make up one of the smallest subpopulations of this threatened species and have declining nest numbers. We used satellite telemetry and a switching state-space model to identify distinct foraging areas used by 59 NGoM loggerheads tagged during 2010-2013. We tagged turtles after nesting at three sites, 1 in Alabama (Gulf Shores; n = 37) and 2 in Florida (St. Joseph Peninsula; n = 20 and Eglin Air Force Base; n = 2). Peak migration time was 22 July to 9 August during which >40% of turtles were in migration mode; the mean post-nesting migration period was 23.0 d (+/- 13.8 d SD). After displacement from nesting beaches, 44 turtles traveled to foraging sites where they remained resident throughout tracking durations. Selected foraging locations were variable distances from tagging sites, and in 5 geographic regions; no turtles selected foraging sites outside the Gulf of Mexico (GoM). Foraging sites delineated using 50% kernel density estimation were located a mean distance of 47.6 km from land and in water with mean depth of -32.5 m; other foraging sites, delineated using minimum convex polygons, were located a mean distance of 43.0 km from land and in water with a mean depth of -24.9 m. Foraging sites overlapped with known trawling activities, oil and gas extraction activities, and the footprint of surface oiling during the 2010 Deepwater Horizon oil spill (n = 10). Our results highlight the year-round use of habitats in the GoM by loggerheads that nest in the NGoM. Our findings indicate that protection of females in this subpopulation requires both international collaborations and management of threats that spatially overlap with distinct foraging habitats.	[Hart, Kristen M.] US Geol Survey, Southeast Ecol Sci Ctr, Ft Lauderdale, FL 33314 USA; [Lamont, Margaret M.] US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL USA; [Sartain, Autumn R.] Cherokee Nat Technol Solut LLC, Sci R&D, US Geol Survey, Southeast Ecol Sci Ctr, Davie, FL USA; [Fujisaki, Ikuko] Univ Florida, Ft Lauderdale Res & Educ Ctr, Davie, FL USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida	Hart, KM (corresponding author), US Geol Survey, Southeast Ecol Sci Ctr, Ft Lauderdale, FL 33314 USA.	kristen_hart@usgs.gov			KMH by the Natural Resource Damage Assessment (NRDA); U.S. Geological Survey Priority Ecosystem Science (PES) Program	KMH by the Natural Resource Damage Assessment (NRDA); U.S. Geological Survey Priority Ecosystem Science (PES) Program	Funding was provided to KMH by the Natural Resource Damage Assessment (NRDA) and the U.S. Geological Survey Priority Ecosystem Science (PES) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine JW, 1972, TEXAS A M U OCEANOGR, V3; Arendt MD, 2012, MAR BIOL, V159, P113, DOI 10.1007/s00227-011-1826-0; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Bjorndal KA, 2011, SCIENCE, V331, P537, DOI 10.1126/science.1199935; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bogdanova MI, 2014, BIOL CONSERV, V170, P292, DOI 10.1016/j.biocon.2013.12.025; Bograd Steven J., 2010, Endangered Species Research, V10, P1, DOI 10.3354/esr00269; Bolten A.B., 2003, LOGGERHEAD SEA TURTL, P63; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Campagna C, 2011, BIOSCIENCE, V61, P393, DOI 10.1525/bio.2011.61.5.8; CLS, 2011, ARG US MAN WORLDW TR; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Dagg MJ, 2003, J MARINE SYST, V43, P133, DOI 10.1016/j.jmarsys.2003.09.002; Dodd C. Kenneth Jr, 2003, Chelonian Conservation and Biology, V4, P530; Eckert SA, 2008, ECOL APPL, V18, P290, DOI 10.1890/06-2107.1; ESRI, 2007, ARCGIS 9 3 GIS; Fertl D., 2005, Gulf and Caribbean Research, V17, P69; Finkbeiner EM, 2011, BIOL CONSERV, V144, P2719, DOI 10.1016/j.biocon.2011.07.033; Foley AM, 2014, MAR BIOL, V161, P1251, DOI 10.1007/s00227-014-2415-9; Foley AM, 2013, ENDANGER SPECIES RES, V21, P129, DOI 10.3354/esr00512; Fossette S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3065; Girard C, 2009, MAR BIOL, V156, P1827, DOI 10.1007/s00227-009-1216-z; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Griffin DB, 2013, MAR BIOL, V160, P3071, DOI 10.1007/s00227-013-2296-3; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hansson M, 2000, MAR ECOL PROG SER, V198, P191, DOI 10.3354/meps198191; Hart KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066921; Hart KM, 2012, MAR ECOL PROG SER, V457, P193, DOI 10.3354/meps09744; Hart KM, 2012, BIOL CONSERV, V145, P185, DOI 10.1016/j.biocon.2011.10.030; Hatase H, 2004, MAR BIOL, V144, P807, DOI 10.1007/s00227-003-1232-3; Hatase H, 2013, ECOLOGY, V94, P2583, DOI 10.1890/12-1588.1; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; Hawkes LA, 2011, DIVERS DISTRIB, V17, P624, DOI 10.1111/j.1472-4642.2011.00768.x; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hays GC, 2013, FUNCT ECOL, V27, P748, DOI 10.1111/1365-2435.12073; Hays GC, 2010, CONSERV BIOL, V24, P1636, DOI 10.1111/j.1523-1739.2010.01531.x; Hazel Julia, 2007, Endangered Species Research, V3, P105, DOI 10.3354/esr003105; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Hooge P.H. W., 2001, ANIMAL MOVEMENT 2 5; International Maritime Organization (IMO), 2008, COLREG2CIRC60 IMO; International Whaling Commission (IWC), 2008, J CETACEAN RES MAN S, V10, P233; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jones TT, 2013, METHODS ECOL EVOL, V4, P1178, DOI 10.1111/2041-210X.12109; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Lagueux Kerry M., 2011, Endangered Species Research, V14, P69, DOI 10.3354/esr00335; Lamont MM, 2014, J HERPETOL, V48, P98, DOI 10.1670/12-217; Lamont MM, 2012, CHELONIAN CONSERV BI, V11, P190, DOI 10.2744/CCB-1006.1; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; LEATHERWOOD S, 1975, MAR FISH REV, V37, P10; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Malarde J, 2011, IMPROVING ARGOS DOPP; Marcovaldi Maria Angela, 2010, Endangered Species Research, V12, P263, DOI 10.3354/esr00308; Maxwell SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3688; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; McDaniel CJ, 2000, CONSERV ECOL, V4; MEYLAN AB, 1983, BIOL CONSERV, V26, P79, DOI 10.1016/0006-3207(83)90050-2; Mitsch WJ, 2001, BIOSCIENCE, V51, P373, DOI 10.1641/0006-3568(2001)051[0373:RNLTTG]2.0.CO;2; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; National Marine Fisheries Service, 2002, ESA BIOL OP SHRIMP T; National Marine Fisheries Service Southeast Fisheries Science Center (NMFS SEFSC), 2008, NOAA TECHNICAL MEMOR; National Marine Fisheries Service U.S. Fish Wildlife Service, 2008, REC PLAN NW ATL POP; Pajuelo M, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00220.1; Pajuelo M, 2012, MAR BIOL, V159, P1255, DOI 10.1007/s00227-012-1906-9; Parauka FM, 2011, J APPL ICHTHYOL, V27, P343, DOI 10.1111/j.1439-0426.2011.01671.x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Peterson CH, 2012, BIOSCIENCE, V62, P461, DOI 10.1525/bio.2012.62.5.7; Phillips KF, 2014, MAR BIOL, V161, P863, DOI 10.1007/s00227-013-2386-2; Rabalais NN, 2001, COAST EST S, V58, P1; Rees AF, 2010, MAR ECOL PROG SER, V418, P201, DOI 10.3354/meps08767; RENAUD ML, 1994, B MAR SCI, V55, P1; Richards Paul M., 2011, Endangered Species Research, V15, P151, DOI 10.3354/esr00379; Riley GA, 1938, J MAR RES, V1, P60; Rodgers A. R., 2005, HRT HOME RANGE TOOLS; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Schofield G, 2013, DIVERS DISTRIB, V19, P834, DOI 10.1111/ddi.12077; Schofield G, 2013, BIOL CONSERV, V161, P101, DOI 10.1016/j.biocon.2013.03.004; Schofield G, 2010, DIVERS DISTRIB, V16, P840, DOI 10.1111/j.1472-4642.2010.00694.x; Schofield G, 2010, BIOL CONSERV, V143, P722, DOI 10.1016/j.biocon.2009.12.011; Schwinghamer P, 1998, CONSERV BIOL, V12, P1215, DOI 10.1046/j.1523-1739.1998.0120061215.x; Scott R, 2012, GLOBAL ECOL BIOGEOGR, V21, P1053, DOI 10.1111/j.1466-8238.2011.00757.x; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Shamblin BM, 2012, MAR ECOL PROG SER, V469, P145, DOI 10.3354/meps09980; Shamblin BM, 2011, MAR BIOL, V158, P571, DOI 10.1007/s00227-010-1582-6; Shaver DJ, 2005, CHELONIAN CONSERV BI, V4, P817; Shaver DJ, 2013, ECOL EVOL, V3, P2002, DOI 10.1002/ece3.594; Shillinger George L., 2010, Endangered Species Research, V10, P215, DOI 10.3354/esr00251; SONNIER F, 1976, COPEIA, P105; Stewart KR, 2013, J ANIM ECOL, V82, P791, DOI 10.1111/1365-2656.12056; Thomson JA, 2012, MAR ECOL PROG SER, V453, P213, DOI 10.3354/meps09637; Troeng S, 2005, MAR BIOL, V148, P435, DOI 10.1007/s00227-005-0076-4; Tucker AD, 2014, MAR ECOL PROG SER, V502, P267, DOI 10.3354/meps10655; Turtle Expert Working Group, 2009, NMFSSEFSC575 NOAA TU, DOI [10.1007/s00227-005-0076-4, DOI 10.1007/S00227-005-0076-4]; U.S. Coast Guard (USCG), 2010, FED REGISTER, V75, P17562; USFWS NMFS, 2013, FED REGISTER, V78, P18000; Weishampel JF, 2004, GLOBAL CHANGE BIOL, V10, P1424, DOI 10.1111/j.1529-8817.2003.00817.x; White G. C., 1990, ANAL WILDLIFE RADIOT; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022; Work PA, 2010, J EXP MAR BIOL ECOL, V393, P168, DOI 10.1016/j.jembe.2010.07.019; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3; Zanden HBV, 2014, MAR BIOL, V161, P585, DOI 10.1007/s00227-013-2361-y; Zbinden JA, 2008, MAR BIOL, V153, P899, DOI 10.1007/s00227-007-0862-2; Zbinden JA, 2011, MAR ECOL PROG SER, V421, P291, DOI 10.3354/meps08871	116	41	42	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103453	10.1371/journal.pone.0103453	http://dx.doi.org/10.1371/journal.pone.0103453			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076053	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800047
J	Lu, N; Karlsen, TV; Reed, RK; Kusche-Gullberg, M; Gullberg, D				Lu, Ning; Karlsen, Tine V.; Reed, Rolf K.; Kusche-Gullberg, Marion; Gullberg, Donald			Fibroblast alpha 11 beta 1 Integrin Regulates Tensional Homeostasis in Fibroblast/A549 Carcinoma Heterospheroids	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; CELL LUNG-CANCER; IN-VITRO; TUMOR SPHEROIDS; MYOFIBROBLAST DIFFERENTIATION; CXCR2 EXPRESSION; GENE-EXPRESSION; TGF-BETA; MIGRATION; GROWTH	We have previously shown that fibroblast expression of alpha 11 beta 1 integrin stimulates A549 carcinoma cell growth in a xenograft tumor model. To understand the molecular mechanisms whereby a collagen receptor on fibroblast can regulate tumor growth we have used a 3D heterospheroid system composed of A549 tumor cells and fibroblasts without (alpha 11(+/+)) or with a deletion (alpha 11(-/-)) in integrin alpha 11 gene. Our data show that alpha 11(-/-)/A549 spheroids are larger than alpha 11(+/+)/A549 spheroids, and that A549 cell number, cell migration and cell invasion in a collagen I gel are decreased in alpha 11(-/-)/A549 spheroids. Gene expression profiling of differentially expressed genes in fibroblast/A549 spheroids identified CXCL5 as one molecule down-regulated in A549 cells in the absence of alpha 11 on the fibroblasts. Blocking CXCL5 function with the CXCR2 inhibitor SB225002 reduced cell proliferation and cell migration of A549 cells within spheroids, demonstrating that the fibroblast integrin alpha 11 beta 1 in a 3D heterospheroid context affects carcinoma cell growth and invasion by stimulating autocrine secretion of CXCL5. We furthermore suggest that fibroblast alpha 11 beta 1 in fibroblast/A549 spheroids regulates interstitial fluid pressure by compacting the collagen matrix, in turn implying a role for stromal collagen receptors in regulating tensional hemostasis in tumors. In summary, blocking stromal alpha 11 beta 1 integrin function might thus be a stroma-targeted therapeutic strategy to increase the efficacy of chemotherapy.	[Lu, Ning; Karlsen, Tine V.; Reed, Rolf K.; Kusche-Gullberg, Marion; Gullberg, Donald] Univ Bergen, Dept Biomed, Bergen, Norway; [Lu, Ning; Reed, Rolf K.; Kusche-Gullberg, Marion; Gullberg, Donald] Univ Bergen, Norwegian Ctr Excellence, Ctr Canc Biomarkers, Bergen, Norway	University of Bergen; University of Bergen	Gullberg, D (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	donald.gullberg@biomed.uib.no	Reed, Rolf K./B-9422-2017; Gullberg, Donald/H-2495-2016; Kusche-Gullberg, Marion/P-4466-2016	Reed, Rolf K./0000-0002-2633-6595; Gullberg, Donald/0000-0002-7245-4437; Kusche-Gullberg, Marion/0000-0002-5636-1695; Karlsen, Tine Veronica/0000-0002-1512-2479	Research council of Norway [183258, 197066]; Norwegian Centre of Excellence grant [223250]; Norwegian cancer society [536711, 3292722]	Research council of Norway(Research Council of Norway); Norwegian Centre of Excellence grant; Norwegian cancer society(Norwegian Cancer Society)	This research was supported by grants from Research council of Norway (http://www.forskningsradet.no/, grants 183258; 197066 to DG) and Norwegian Centre of Excellence grant (http://www.forskningsradet.no/, grants 223250), and the Norwegian cancer society (https://kreftforeningen.no, id 536711to DG; id 3292722 to MKG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenberg DA, 1998, J CLIN INVEST, V102, P465, DOI 10.1172/JCI3145; Carracedo S, 2010, J BIOL CHEM, V285, P10434, DOI 10.1074/jbc.M109.078766; Eberlein C, 2014, ONCOGENE; Enzerink A, 2009, MOL IMMUNOL, V46, P1787, DOI 10.1016/j.molimm.2009.01.018; Francia G, 2004, MOL CELL BIOL, V24, P6837, DOI 10.1128/mcb.24.15.6837-6849.2004; Green SK, 2004, MOL CANCER THER, V3, P149; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Ivascu A, 2007, INT J ONCOL, V31, P1403; JAIN RK, 1987, CANCER RES, V47, P3039; Kankuri E, 2005, CANCER RES, V65, P9914, DOI 10.1158/0008-5472.CAN-05-1559; Kilarski WW, 2005, LAB INVEST, V85, P643, DOI 10.1038/labinvest.3700255; Kim BJ, 2007, BIOTECHNOL BIOENG, V96, P1167, DOI 10.1002/bit.21205; Kim JB, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b; Kunz-Schughart LA, 1998, INT J EXP PATHOL, V79, P1, DOI 10.1046/j.1365-2613.1998.00051.x; Kunz-Schughart LA, 2003, AM J PHYSIOL-CELL PH, V284, pC209, DOI 10.1152/ajpcell.00557.2001; Kunz-Schughart LA, 2001, EXP CELL RES, V266, P74, DOI 10.1006/excr.2001.5210; Kunz-Schughart LA, 2006, AM J PHYSIOL-CELL PH, V290, pC1385, DOI 10.1152/ajpcell.00248.2005; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Lu N, 2010, MATRIX BIOL, V29, P166, DOI 10.1016/j.matbio.2009.11.003; Luppi F, 2007, LUNG CANCER, V56, P25, DOI 10.1016/j.lungcan.2006.11.014; Marsh T., 2012, BIOCH BIOPHYS ACTA; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; MUELLERKLIESER W, 1983, ADV EXP MED BIOL, V159, P497; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Okabe H, 2012, INT J CANCER, V131, P2234, DOI 10.1002/ijc.27496; Osterholm C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041334; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pettet GJ, 2001, B MATH BIOL, V63, P231, DOI 10.1006/bulm.2000.0217; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Rangarajan R, 2008, CELL ADHES MIGR, V2, P106, DOI 10.4161/cam.2.2.6211; REED RK, 1992, CIRC RES, V71, P978, DOI 10.1161/01.RES.71.4.978; Robinson EE, 2003, J CELL SCI, V116, P377, DOI 10.1242/jcs.00231; Saintigny P, 2013, CANCER RES, V73, P571, DOI 10.1158/0008-5472.CAN-12-0263; Salmenpera P, 2008, EXP CELL RES, V314, P3444, DOI 10.1016/j.yexcr.2008.09.004; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Seidl P, 2002, INT J CANCER, V102, P129, DOI 10.1002/ijc.10675; Silzle T, 2003, EUR J IMMUNOL, V33, P1311, DOI 10.1002/eji.200323057; Stein AM, 2007, BIOPHYS J, V92, P356, DOI 10.1529/biophysj.106.093468; Stuhr LEB, 2003, AM J PHYSIOL-CELL PH, V285, pC1101, DOI 10.1152/ajpcell.00050.2003; Svendsen OS, 2009, ARTERIOSCL THROM VAS, V29, P1864, DOI 10.1161/ATVBAHA.109.194308; Takacova M, 2007, INT J ONCOL, V31, P1103; Talior-Volodarsky I, 2012, CARDIOVASC RES, V96, P265, DOI 10.1093/cvr/cvs259; Tazzyman S, 2011, INT J CANCER, V129, P847, DOI 10.1002/ijc.25987; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; WIIG H, 1981, MICROVASC RES, V21, P308, DOI 10.1016/0026-2862(81)90014-5; Xu ZG, 2012, ANAT REC, V295, P1446, DOI 10.1002/ar.22521; Yanagawa J, 2009, CLIN CANCER RES, V15, P6820, DOI 10.1158/1078-0432.CCR-09-1558; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yip D, 2013, BIOCHEM BIOPH RES CO, V433, P327, DOI 10.1016/j.bbrc.2013.03.008; Zhou SL, 2012, HEPATOLOGY, V56, P2242, DOI 10.1002/hep.25907; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104	56	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103173	10.1371/journal.pone.0103173	http://dx.doi.org/10.1371/journal.pone.0103173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076207	gold, Green Submitted, Green Published			2022-12-27	WOS:000340028800029
J	Nagy, A; Cernikova, L; Jirincova, H; Havlickova, M; Hornickova, J				Nagy, Alexander; Cernikova, Lenka; Jirincova, Helena; Havlickova, Martina; Hornickova, Jitka			Local-Scale Diversity and Between-Year "Frozen Evolution" of Avian Influenza A Viruses in Nature	PLOS ONE			English	Article							RT-PCR; HEMAGGLUTININ; REASSORTMENT; PERSISTENCE; PATTERNS; WATER; NEURAMINIDASE; SURVEILLANCE; ACCUMULATION; INFECTIONS	Influenza A virus (IAV) in wild bird reservoir hosts is characterized by the perpetuation in a plethora of subtype and genotype constellations. Multiyear monitoring studies carried out during the last two decades worldwide have provided a large body of knowledge regarding the ecology of IAV in wild birds. Nevertheless, other issues of avian IAV evolution have not been fully elucidated, such as the complexity and dynamics of genetic interactions between the co-circulating IAV genomes taking place at a local-scale level or the phenomenon of frozen evolution. We investigated the IAV diversity in a mallard population residing in a single pond in the Czech Republic. Despite the relative small number of samples collected, remarkable heterogeneity was revealed with four different IAV subtype combinations, H6N2, H6N9, H11N2, and H11N9, and six genomic constellations in co-circulation. Moreover, the H6, H11, and N2 segments belonged to two distinguishable sub-lineages. A reconstruction of the pattern of genetic reassortment revealed direct parent-progeny relationships between the H6N2, H11N9 and H6N9 viruses. Interestingly the IAV, with the H6N9 subtype, was re-detected a year later in a genetically unchanged form in the close proximity of the original sampling locality. The almost absolute nucleotide sequence identity of all the respective genomic segments between the two H6N9 viruses indicates frozen evolution as a result of prolonged conservation in the environment. The persistence of the H6N9 IAV in various abiotic and biotic environmental components was also discussed.	[Nagy, Alexander; Cernikova, Lenka; Hornickova, Jitka] State Vet Inst Prague, Natl Reference Lab Avian Influenza & Newcastle Di, Lab Mol Methods, Prague, Czech Republic; [Nagy, Alexander; Jirincova, Helena; Havlickova, Martina] Natl Inst Publ Hlth, Ctr Epidemiol & Microbiol, Natl Reference Lab Influenza, Prague, Czech Republic	National Institute of Public Health (SZU) - Czech Republic	Nagy, A (corresponding author), State Vet Inst Prague, Natl Reference Lab Avian Influenza & Newcastle Di, Lab Mol Methods, Prague, Czech Republic.	alexander.nagy@svupraha.cz	Jirincova, Helena/GRJ-0968-2022		Ministry of Health of the Czech Republic [IGA NT 12493-3/2011]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	The work was supported in part by research grant IGA NT 12493-3/2011, Ministry of Health of the Czech Republic. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bountouri M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-350; Chambers TM, 2013, TEXTBOOK OF INFLUENZA, 2ND EDITION, P203; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; Delogu M, 2012, EPIDEMIOL BIOSTAT PU, V9, P29; Delogu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011315; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; ENDO A, 1992, ARCH VIROL, V123, P73, DOI 10.1007/BF01317139; Faust C, 2009, P ROY SOC B-BIOL SCI, V276, P3727, DOI 10.1098/rspb.2009.0572; Fereidouni SR, 2009, VET MICROBIOL, V135, P253, DOI 10.1016/j.vetmic.2008.09.077; Globig A, 2013, TRANSBOUND EMERG DIS, V60, P395, DOI 10.1111/j.1865-1682.2012.01357.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hatchette TF, 2004, J GEN VIROL, V85, P2327, DOI 10.1099/vir.0.79878-0; HAYASHIDA H, 1985, MOL BIOL EVOL, V2, P289; Henaux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031471; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horm VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034160; Huyvaert KP, 2012, VECTOR-BORNE ZOONOT, V12, P904, DOI 10.1089/vbz.2012.0993; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeler SP, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-13; Krasnitz M, 2008, J VIROL, V82, P8947, DOI 10.1128/JVI.00101-08; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Lebarbenchon C, 2012, P ROY SOC B-BIOL SCI, V279, P3967, DOI 10.1098/rspb.2012.1271; Li OTW, 2007, J VIROL METHODS, V142, P218, DOI 10.1016/j.jviromet.2007.01.015; Lindsay LL, 2013, VIRUSES-BASEL, V5, P1964, DOI 10.3390/v5081964; Meixell BW, 2013, APPL ENVIRON MICROB, V79, P7249, DOI 10.1128/AEM.02439-13; Monne I, 2008, J CLIN MICROBIOL, V46, P1769, DOI 10.1128/JCM.02204-07; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nagy A, 2012, VIRUS RES, V165, P126, DOI 10.1016/j.virusres.2012.02.005; Nagy A, 2010, ARCH VIROL, V155, P665, DOI 10.1007/s00705-010-0636-x; Nazir J, 2011, APPL ENVIRON MICROB, V77, P4981, DOI 10.1128/AEM.00415-11; Oesterle PT, 2011, THESIS COLORADO STAT; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Phipps LP, 2004, J VIROL METHODS, V122, P119, DOI 10.1016/j.jviromet.2004.08.008; Qiu BF, 2009, J VIROL METHODS, V155, P193, DOI 10.1016/j.jviromet.2008.10.001; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; Shoham Dany, 2012, Influenza Res Treat, V2012, P912326, DOI 10.1155/2012/912326; Stumpf P, 2010, AVIAN DIS, V54, P1183, DOI 10.1637/9162-111709-Reg.1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tolf C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061201; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Wang RX, 2008, VIROLOGY, V375, P182, DOI 10.1016/j.virol.2008.01.041; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Webster RG, 1998, EMERG INFECT DIS, V4, P436, DOI 10.3201/eid0403.980325; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Wille M, 2013, VIROLOGY, V443, P150, DOI 10.1016/j.virol.2013.05.004; Worobey M, 2008, J VIROL, V82, P3769, DOI 10.1128/JVI.02207-07	48	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103053	10.1371/journal.pone.0103053	http://dx.doi.org/10.1371/journal.pone.0103053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075739	Green Published, gold			2022-12-27	WOS:000340028800024
J	Kobashi, H; Kamiya, K; Hoshi, K; Igarashi, A; Shimizu, K				Kobashi, Hidenaga; Kamiya, Kazutaka; Hoshi, Keika; Igarashi, Akihito; Shimizu, Kimiya			Wavefront-Guided versus Non-Wavefront-Guided Photorefractive Keratectomy for Myopia: Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; HIGHER-ORDER ABERRATIONS; REFRACTIVE-SURGERY SURVEY; MODERATE MYOPIA; CONTRAST SENSITIVITY; CUSTOMIZED ABLATION; CONTRALATERAL EYE; FEMTOSECOND LASER; ASPHERIC PROFILE; CLINICAL-TRIALS	Purpose: To compare the efficacy, predictability, safety, and induced higher-order aberrations (HOAs) between wavefront-guided and non-wavefront-guided photorefractive keratectomy (PRK). Methods: The Cochrane Central Register of Controlled Trials, PubMED, and EMBASE were searched for randomized controlled trials. Trials meeting the selection criteria were quality appraised, and data was extracted by 2 independent authors. Measures of association were pooled quantitatively using meta-analytical methods. Comparisons between wavefront-guided and non-wavefront-guided ablations were made as pooled odds ratios (ORs) or weighted mean differences. The pooled ORs and 95% confidence intervals (CIs) were computed for efficacy, safety, and predictability. The weighted mean differences and 95% CIs were used to compare induced HOAs. Results: The study covered five trials involving 298 eyes. After wavefront-guided PRK, the pooled OR of achieving an uncorrected distance visual acuity of 20/20 (efficacy) was 1.18 (95% CI, 0.53-2.60; p = 0.69), the pooled OR of achieving a result within +/- 0.50 diopter of the intended target (predictability) was 0.86 (95% CI, 0.40-1.84; p = 0.70). No study reported a loss of 2 or more lines of Snellen acuity (safety) with either modality. In eyes with wavefront-guided PRK, the postoperative trefoil aberrations (mean difference -0.02; 95% CI, -0.03 to -0.00; p = 0.03) were significantly lower. There were no significant differences between the two groups in the postoperative total HOAs (mean difference 20.04; 95% CI, 20.23 to 0.14; p = 0.63), spherical (mean difference 0.00; 95% CI, -0.08 to 0.09; p = 0.93), and coma (mean difference -0.06; 95% CI, -0.14 to 0.03; p = 0.20) aberrations. Conclusions: According to the meta-analysis, wavefront-guided PRK offered no advantage in efficacy, predictability, or safety measures over non-wavefront-guided PRK, although it may have induced fewer trefoil aberrations.	[Kobashi, Hidenaga; Kamiya, Kazutaka; Igarashi, Akihito; Shimizu, Kimiya] Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan; [Hoshi, Keika] Kitasato Univ, Sch Med, Dept Prevent Med, Kanagawa, Japan	Kitasato University; Kitasato University	Kobashi, H (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan.	himon@hotmail.co.jp						Bailey MD, 2003, OPHTHALMOLOGY, V110, P1371, DOI 10.1016/S0161-6420(03)00455-X; Calvillo MP, 2004, INVEST OPHTH VIS SCI, V45, P3991, DOI 10.1167/iovs.04-0561; Chen SH, 2012, J REFRACT SURG, V28, P15, DOI 10.3928/1081597X-20111228-02; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Du CX, 2006, J REFRACT SURG, V22, P642, DOI 10.3928/1081-597X-20060901-04; Duffey RJ, 2002, J REFRACT SURG, V18, P185; Dupps WJ, 2011, J CATARACT REFR SURG, V37, P1, DOI 10.1016/j.jcrs.2010.11.010; Falavarjani KG, 2011, J REFRACT SURG, V27, P13, DOI 10.3928/1081597X-20100310-02; Fares U, 2011, J CATARACT REFR SURG, V37, P1465, DOI 10.1016/j.jcrs.2011.02.029; Feng YF, 2011, OPTOMETRY VISION SCI, V88, P1463, DOI 10.1097/OPX.0b013e3182333a50; Ghoreishi SM, 2009, EUR J OPHTHALMOL, V19, P544, DOI 10.1177/112067210901900405; Hashemi H, 2010, J CATARACT REFR SURG, V36, P1732, DOI 10.1016/j.jcrs.2010.04.034; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kamiya K, 2009, CORNEA, V28, P765, DOI 10.1097/ICO.0b013e3181967082; Karimian F, 2010, J CATARACT REFR SURG, V36, P637, DOI 10.1016/j.jcrs.2009.10.050; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Lindstrom RL, 1999, J CATARACT REFR SURG, V25, P1408, DOI 10.1016/S0886-3350(99)00251-5; Marcos S, 2001, J REFRACT SURG, V17, pS596; Mastropasqua L, 2006, EUR J OPHTHALMOL, V16, P219, DOI 10.1177/112067210601600205; Mastropasqua L, 2006, J CATARACT REFR SURG, V32, P109, DOI 10.1016/j.jcrs.2005.11.026; Mastropasqua L, 2004, J REFRACT SURG, V20, P422; Mifflin MD, 2012, J REFRACT SURG, V28, P127, DOI 10.3928/1081597X-20120103-01; Miyai T, 2008, J CATARACT REFR SURG, V34, P1527, DOI 10.1016/j.jcrs.2008.04.038; Montes-Mico R, 2004, J REFRACT SURG, V20, P243, DOI 10.3928/1081-597X-20040501-08; Moreno-Barriuso E, 2001, INVEST OPHTH VIS SCI, V42, P1396; Moshirfar M, 2011, CLIN OPHTHALMOL, V5, P1185, DOI 10.2147/OPTH.S24319; Mrochen M, 2001, J CATARACT REFR SURG, V27, P362, DOI 10.1016/S0886-3350(00)00806-3; Mrochen M, 2001, J CATARACT REFR SURG, V27, P201, DOI 10.1016/S0886-3350(00)00827-0; Nassiri N, 2011, J CATARACT REFR SURG, V37, P1858, DOI 10.1016/j.jcrs.2011.05.023; Netto MV, 2006, AM J OPHTHALMOL, V141, P360, DOI 10.1016/j.ajo.2005.08.034; Oshika T, 1999, AM J OPHTHALMOL, V127, P1, DOI 10.1016/S0002-9394(98)00288-8; Phusitphoykai N, 2003, J REFRACT SURG, V19, pS217; Rajan MS, 2004, OPHTHALMOLOGY, V111, P1813, DOI 10.1016/j.ophtha.2004.05.019; Reinstein DZ, 2009, J REFRACT SURG, V25, P975, DOI 10.3928/1081597X-20091016-01; Solomon KD, 2002, J CATARACT REFR SURG, V28, P346, DOI 10.1016/S0886-3350(01)01318-9; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Sugar A, 2002, OPHTHALMOLOGY, V109, P175, DOI 10.1016/S0161-6420(01)00966-6; Vongthongsri A, 2002, J REFRACT SURG, V18, pS332; Waring GO, 2000, J REFRACT SURG, V16, P459; Williams D, 2000, J REFRACT SURG, V16, pS554; Yeh DL, 2006, AM J OPHTHALMOL, V141, P960, DOI 10.1016/j.ajo.2005.12.001; Zhang ZF, 2011, J CATARACT REFR SURG, V37, P2151, DOI 10.1016/j.jcrs.2011.05.043	43	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103605	10.1371/journal.pone.0103605	http://dx.doi.org/10.1371/journal.pone.0103605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072409	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600070
J	Yoo, JS; Das, RK; Jow, ZY; Chang, YT				Yoo, Jung Sun; Das, Raj Kumar; Jow, Zhi Yen; Chang, Young-Tae			In Vivo Detection of Macrophage Recruitment in Hind-Limb Ischemia Using a Targeted Near-Infrared Fluorophore	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUES; MAGNETIC-RESONANCE; FLUORESCENCE; DISEASE; LIMB; ANGIOGENESIS; INFLAMMATION; HOMEOSTASIS; MONOCYTES; CANCER	Macrophages are an essential component of the immune system and have protective and pathogenic functions in various diseases. Imaging of macrophages in vivo could furnish new tools to advance evaluation of disease and therapies. Critical limb ischemia is a disease in which macrophages have considerable pathogenic roles, and are potential targets for cell-based immunotherapy. We sought to develop a new near-infrared fluorescence (NIRF) imaging probe to target macrophages specifically in vivo in various pathological states, including hind-limb ischemia. We rapidly screened the photostable cyanine-based NIRF library against different blood cell lines. The identified monocyte/macrophage-selective hit was tested in vitro in live-cell labeling assay. Non-invasive NIRF imaging was performed with murine models of paw inflammation by lipopolysaccharide challenge and hind-limb ischemia with femoral artery ligation. in vivo macrophage targeting was further evaluated using intravital microscopy with Csf1r-EGFP transgenic mice and immunofluorescent staining with macrophage-specific markers. We discovered MF800, a Macrophage-specific near-infrared Fluorophore, which showed selective live-cell imaging performance in a panel of cell lines and primary human blood samples. MF800 outperforms the clinically-available NIRF contrast agent ICG for in vivo specificity in paw inflammation and hind-limb ischemia models. We observed a marked overlap of MF800-labeled cells and EGFP-expressing macrophages in intravital imaging of Csf1r-EGFP transgenic mice. In the histologic analysis, MF800-positive cells also expressed the macrophage markers CD68 and CD169. NIRF imaging showcased the potential of using MF800 to understand macrophage behavior in vivo, characterize macrophage-associated diseases, and may help in assessing therapeutic responses in the clinic.	[Yoo, Jung Sun] Seoul Natl Univ, Smart Human Convergence Ctr, Grad Sch Convergence Sci & Technol, Dept Transdisciplinary Studies, Suwon, South Korea; [Yoo, Jung Sun; Das, Raj Kumar; Chang, Young-Tae] Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore; [Jow, Zhi Yen; Chang, Young-Tae] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Bioimaging Probe Dev, Singapore, Singapore	Seoul National University (SNU); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	Chang, YT (corresponding author), Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore.	chmcyt@nus.edu.sg	Chang, Young-Tae/B-2780-2010; Yoo, Jung Sun/I-8760-2017	Chang, Young-Tae/0000-0002-1927-3688; Yoo, Jung Sun/0000-0002-8865-0424	A*STAR (Agency for Science, Technology and Research, Singapore) Biomedical Research Council; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2010-T2-2-030]	A*STAR (Agency for Science, Technology and Research, Singapore) Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore)	This study was supported by intramural funding from A*STAR (Agency for Science, Technology and Research, Singapore) Biomedical Research Council, and by the Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2010-T2-2-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger JS, 2012, CIRCULATION, V126, P491, DOI 10.1161/CIRCULATIONAHA.111.033886; CAMPBELL WB, 1994, ANN ROY COLL SURG, V76, P205; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Das RK, 2011, RSC ADV, V1, P573, DOI 10.1039/c1ra00498k; Deguchi J, 2006, CIRCULATION, V114, P55, DOI 10.1161/CIRCULATIONAHA.106.619056; FDA, 2013, PROD INS IND GREEN I; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Garcia-Allende PB, 2013, J NUCL MED, V54, P664, DOI 10.2967/jnumed.111.099796; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Hirose N, 2008, CELL TRANSPLANT, V17, P211, DOI 10.3727/000000008783906919; Jaffer FA, 2008, CIRCULATION, V118, P1802, DOI 10.1161/CIRCULATIONAHA.108.785881; Kircher MF, 2011, NAT REV CLIN ONCOL, V8, P677, DOI 10.1038/nrclinonc.2011.141; Kooi ME, 2003, CIRCULATION, V107, P2453, DOI 10.1161/01.CIR.0000068315.98705.CC; Lee SC, 2013, MATERIALS, V6, P1779, DOI 10.3390/ma6051779; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Moazzami K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008347.pub2; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nahrendorf M, 2010, P NATL ACAD SCI USA, V107, P7910, DOI 10.1073/pnas.0915163107; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Pande AN, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2186337; Patel AS, 2013, EMBO MOL MED, V5, P858, DOI 10.1002/emmm.201302752; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Samanta A, 2010, CHEM COMMUN, V46, P7406, DOI 10.1039/c0cc02366c; Sanberg PR, 2010, J CELL MOL MED, V14, P553, DOI 10.1111/j.1582-4934.2009.00903.x; Saxena A, 2013, MOL IMAGING BIOL, V15, P282, DOI 10.1007/s11307-012-0599-2; Severino DN, 2009, INFLAMMATION, V32, P57, DOI 10.1007/s10753-008-9102-2; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Tu CQ, 2010, J AM CHEM SOC, V132, P2016, DOI 10.1021/ja909303g; Vahrmeijer AL, 2013, NAT REV CLIN ONCOL, V10, P507, DOI 10.1038/nrclinonc.2013.123; Waldeck J, 2008, J NUCL MED, V49, P1845, DOI 10.2967/jnumed.108.052514; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034	33	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103721	10.1371/journal.pone.0103721	http://dx.doi.org/10.1371/journal.pone.0103721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072508	Green Submitted, gold, Green Published			2022-12-27	WOS:000341307600081
J	Wang, YK; Wang, CY; Jia, YJ; Cheng, XH; Lin, Q; Zhu, MJ; Lu, YS; Ding, LL; Weng, ZY; Wu, KJ				Wang, Yongkun; Wang, Chuanying; Jia, Yijun; Cheng, Xianhua; Lin, Qing; Zhu, Mingjie; Lu, Yunshu; Ding, Longlong; Weng, Ziyi; Wu, Kejin			Oxygen-Carbon Nanotubes as a Chemotherapy Sensitizer for Paclitaxel in Breast Cancer Treatment	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INDUCED APOPTOSIS; DELIVERY; DRUG; RESISTANCE; REOXYGENATION; ENHANCEMENT; EXPRESSION; MECHANISM; SURVIVAL	Objective: To study the in vivo and in vitro effects of adding oxygen carbon nanotubes (CNTs) to chemotherapy for breast cancer. Methods: MCF-7 and SK-BR-3 breast cancer cells were co-cultured with paclitaxel and then exposed to oxygen-CNTs under hypoxic conditions. Cell proliferation, viability, and apoptosis rate were analyzed. Hypoxia-inducible factor-1 alpha (HIF-1 alpha) expression was measured using reverse transcription-polymerase chain reaction (RT-PCR) and western blot. Nude mice were used as a human breast cancer model to explore the impact of oxygen-CNTs on the in vivo chemotherapeutic effect of paclitaxel. Results: Oxygen-CNTs had no significant effects on the growth of breast cancer cells under normoxia and hypoxia. However, in the hypoxic environment, oxygen-CNTs significantly enhanced the inhibitory effect of paclitaxel on cell proliferation, as well as the apoptosis rate. Under hypoxia, downregulation of HIF-1 alpha and upregulation of caspase-3, caspase-8, caspase-9, LC3 and Beclin-1 were observed when paclitaxel was combined with oxygen-CNT. Furthermore, addition of oxygen-CNTs to chemotherapy was found to significantly reduce tumor weight in the tumor-bearing mice model. Conclusions: Oxygen-CNTs can significantly increase the chemotherapeutic effect of paclitaxel on breast cancer cells. Oxygen-CNTs may be a potential chemosensitizer in breast cancer therapy.	[Wang, Yongkun; Jia, Yijun; Lu, Yunshu; Ding, Longlong; Wu, Kejin] Shanghai Jiao Tong Univ, Sch Med, Dept Gen Surg, XinHua Hosp, Shanghai 200030, Peoples R China; [Wang, Chuanying; Cheng, Xianhua] Shanghai Jiao Tong Univ, Sch Mech & Power Engn, Shanghai 200030, Peoples R China; [Lin, Qing] Shanghai Jiao Tong Univ, Sch Med, Dept Oncol, XinHua Hosp, Shanghai 200030, Peoples R China; [Zhu, Mingjie] Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Dept Pathol, Shanghai 200030, Peoples R China; [Weng, Ziyi] Shanghai Jiao Tong Univ, Sch Med, Dept Anorectal Surg, XinHua Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Weng, ZY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Anorectal Surg, XinHua Hosp, Shanghai 200030, Peoples R China.	wzysn88@163.com; kejinwu@163.com			National Natural Science Foundation of China [81102016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (Project No. 81102016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avouris P, 2002, CHEM PHYS, V281, P429, DOI 10.1016/S0301-0104(02)00376-2; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Bhattacharya S, 2012, NANOTECHNOL REV, V1, P235, DOI 10.1515/ntrev-2011-0010; Bonard JM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.197602; Doe MR, 2012, CANCER RES, V72, P949, DOI 10.1158/0008-5472.CAN-11-2371; Durkop T, 2004, NANO LETT, V4, P35, DOI 10.1021/nl034841q; Flamant L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-191; He H, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/578290, 10.1155/2013/798912]; Huang L, 2010, J CANCER RES CLIN, V136, P447, DOI 10.1007/s00432-009-0675-4; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Korkeila EA, 2011, ANTICANCER RES, V31, P4529; Lay CL, 2011, EXPERT REV MED DEVIC, V8, P561, DOI [10.1586/ERD.11.34, 10.1586/erd.11.34]; Liu F, 2009, CHINESE GERMAN J CLI, V8, P199; Madani SY, 2011, INT J NANOMED, V6, P2963, DOI 10.2147/IJN.S16923; McEuen PL, 2002, IEEE T NANOTECHNOL, V1, P78, DOI 10.1109/TNANO.2002.1005429; Merighi S, 2007, MOL PHARMACOL, V72, P162, DOI 10.1124/mol.106.031849; MILAS L, 1995, ACTA ONCOL, V34, P409, DOI 10.3109/02841869509093999; MILAS L, 1995, CANCER RES, V55, P3564; Naruse T, 2011, ANTICANCER RES, V31, P4429; Neves LFF, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/37/375104; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Prylutska S, 2013, J BIOSCI BIOENG, V115, P674, DOI 10.1016/j.jbiosc.2012.12.016; Shannon AM, 2003, CANCER TREAT REV, V29, P297, DOI 10.1016/S0305-7372(03)00003-3; Shao W, 2013, BIOMATERIALS, V34, P10109, DOI 10.1016/j.biomaterials.2013.09.007; Shao ZM, 2011, CHIN J PRACTICAL SUR, V10, P915; Shi YH, 2010, ONCOL LETT, V1, P657, DOI 10.3892/ol_00000115; Song G, 2009, J CELL MOL MED, V13, P1706, DOI 10.1111/j.1582-4934.2008.00540.x; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3525643; Witters L, 2002, ONCOL REP, V9, P1163; Yang ST, 2012, THERANOSTICS, V2, P271, DOI 10.7150/thno.3618; Zhang RG, 2011, CANCER BIOTHER RADIO, V26, P335, DOI 10.1089/cbr.2010.0814; Zhang WX, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-555; Zhang Y, 2010, DRUG DISCOV TODAY, V15, P428, DOI 10.1016/j.drudis.2010.04.005; Zhang ZH, 2006, CLIN CANCER RES, V12, P4933, DOI 10.1158/1078-0432.CCR-05-2831; Zhong H, 1999, CANCER RES, V59, P5830; Zhou YF, 2012, CANCER RES, V72, P304, DOI 10.1158/0008-5472.CAN-11-1674	41	7	7	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104209	10.1371/journal.pone.0104209	http://dx.doi.org/10.1371/journal.pone.0104209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089613	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700111
J	Acharya, S; Kaul, Z; Gocha, AS; Martinez, AR; Harris, J; Parvin, JD; Groden, J				Acharya, Samir; Kaul, Zeenia; Gocha, April Sandy; Martinez, Alaina R.; Harris, Julia; Parvin, Jeffrey D.; Groden, Joanna			Association of BLM and BRCA1 during Telomere Maintenance in ALT Cells	PLOS ONE			English	Article							SYNDROME HELICASE; PROTEIN COMPLEXES; RECQ HELICASES; DNA; RECOMBINATION; SENESCENCE; REPAIR; END; WRN; RECOGNITION	Fifteen percent of tumors utilize recombination-based alternative lengthening of telomeres (ALT) to maintain telomeres. The mechanisms underlying ALT are unclear but involve several proteins involved in homologous recombination including the BLM helicase, mutated in Bloom's syndrome, and the BRCA1 tumor suppressor. Cells deficient in either BLM or BRCA1 have phenotypes consistent with telomere dysfunction. Although BLM associates with numerous DNA damage repair proteins including BRCA1 during DNA repair, the functional consequences of BLM-BRCA1 association in telomere maintenance are not completely understood. Our earlier work showed the involvement of BRCA1 in different mechanisms of ALT, and telomere shortening upon loss of BLM in ALT cells. In order to delineate their roles in telomere maintenance, we studied their association in telomere metabolism in cells using ALT. This work shows that BLM and BRCA1 co-localize with RAD50 at telomeres during S-and G2-phases of the cell cycle in immortalized human cells using ALT but not in cells using telomerase to maintain telomeres. Co-immunoprecipitation of BRCA1 and BLM is enhanced in ALT cells at G2. Furthermore, BRCA1 and BLM interact with RAD50 predominantly in S-and G2-phases, respectively. Biochemical assays demonstrate that full-length BRCA1 increases the unwinding rate of BLM three-fold in assays using a DNA substrate that models a forked structure composed of telomeric repeats. Our results suggest that BRCA1 participates in ALT through its interactions with RAD50 and BLM.	[Acharya, Samir; Kaul, Zeenia; Gocha, April Sandy; Martinez, Alaina R.; Harris, Julia; Parvin, Jeffrey D.; Groden, Joanna] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Ohio State University	Groden, J (corresponding author), Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	joanna.groden@osumc.edu	Parvin, Jeffrey D/C-8955-2009		National Institutes of Health [CA117898]; National Cancer Institute-T32; National Science Foundation Award [GRFP DGE-0822215]; Ohio State University Pelotonia Fellowship Program; National Center For Advancing Translational Sciences [8UL1TR000090-05, 8KL2TR000112-05, 8TL1TR000091-05]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070, TL1TR000091, KL2TR000112, UL1TR000090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute-T32; National Science Foundation Award(National Science Foundation (NSF)); Ohio State University Pelotonia Fellowship Program; National Center For Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by funding from the National Institutes of Health [CA117898 to J.G.]; National Cancer Institute-T32 [Z.K.]; National Science Foundation Award GRFP DGE-0822215 [J.L.H.]; The Ohio State University Pelotonia Fellowship Program (A.S.G; Z.K.]; The project described was supported by Award Number 8UL1TR000090-05, 8KL2TR000112-05, and 8TL1TR000091-05 from the National Center For Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Ballal RD, 2009, J BIOL CHEM, V284, P36083, DOI 10.1074/jbc.M109.025825; Barefield C, 2012, NUCLEIC ACIDS RES, V40, P7358, DOI 10.1093/nar/gks407; Bhattacharyya S, 2010, J CELL BIOCHEM, V109, P7, DOI 10.1002/jcb.22388; Bhattacharyya S, 2009, J BIOL CHEM, V284, P14966, DOI 10.1074/jbc.M900195200; Bryan TM, 1997, EUR J CANCER, V33, P767, DOI 10.1016/S0959-8049(97)00065-8; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cabuy E, 2008, CYTOGENET GENOME RES, V122, P336, DOI 10.1159/000167820; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Chaudhury I, 2013, NUCLEIC ACIDS RES, V41, P6444, DOI 10.1093/nar/gkt348; Cheng WH, 2006, NUCLEIC ACIDS RES, V34, P2751, DOI 10.1093/nar/gkl362; Chiba N, 2001, J BIOL CHEM, V276, P38549, DOI 10.1074/jbc.M105227200; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Davalos AR, 2003, J CELL BIOL, V162, P1197, DOI 10.1083/jcb.200304016; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Dutertre S, 2000, ONCOGENE, V19, P2731, DOI 10.1038/sj.onc.1203595; French JD, 2006, GENE CHROMOSOME CANC, V45, P277, DOI 10.1002/gcc.20290; Gocha ARS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093991; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Grierson PM, 2013, MUTAT RES-FUND MOL M, V743, P89, DOI 10.1016/j.mrfmmm.2012.12.002; Grierson PM, 2012, HUM MOL GENET, V21, P1172, DOI 10.1093/hmg/ddr545; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Grobelny JV, 2000, J CELL SCI, V113, P4577; Hagelstrom RT, 2010, P NATL ACAD SCI USA, V107, P15768, DOI 10.1073/pnas.1006338107; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Lowndes NF, 2010, DNA REPAIR, V9, P1112, DOI 10.1016/j.dnarep.2010.07.012; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; Martinez-Delgado B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002182; McPherson JP, 2006, HUM MOL GENET, V15, P831, DOI 10.1093/hmg/ddl002; Mendez-Bermudez A, 2012, NUCLEIC ACIDS RES, V40, P10809, DOI 10.1093/nar/gks862; Montgomery E, 2004, AM J PATHOL, V164, P1523, DOI 10.1016/S0002-9440(10)63710-8; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nabetani A, 2011, J BIOCHEM, V149, P5, DOI 10.1093/jb/mvq119; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; O'Sullivan RJ, 2014, NAT STRUCT MOL BIOL, V21, P167, DOI 10.1038/nsmb.2754; Ohta T, 2011, FEBS LETT, V585, P2836, DOI 10.1016/j.febslet.2011.05.005; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Reddel RR, 2003, CANCER LETT, V194, P155, DOI 10.1016/S0304-3835(02)00702-4; Schawalder J, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-15; Schulz VP, 1996, HUM GENET, V97, P750; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Simons AM, 2006, CANCER RES, V66, P2012, DOI 10.1158/0008-5472.CAN-05-3296; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Tahara H, 1997, ONCOGENE, V15, P1911, DOI 10.1038/sj.onc.1201377; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Wang Y, 2000, GENE DEV, V14, P927; Wu GK, 2003, CANCER RES, V63, P2589; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Xiong JB, 2003, MOL CELL BIOL, V23, P8668, DOI 10.1128/MCB.23.23.8668-8690.2003; Yeager TR, 1999, CANCER RES, V59, P4175; Zhang JR, 2005, MOL CANCER RES, V3, P531, DOI 10.1158/1541-7786.MCR-05-0192; Zhong Q, 2002, J BIOL CHEM, V277, P28641, DOI 10.1074/jbc.M200748200; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	69	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103819	10.1371/journal.pone.0103819	http://dx.doi.org/10.1371/journal.pone.0103819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084169	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800084
J	Piryankova, IV; Wong, HY; Linkenauger, SA; Stinson, C; Longo, MR; Bulthoff, HH; Mohler, BJ				Piryankova, Ivelina V.; Wong, Hong Yu; Linkenauger, Sally A.; Stinson, Catherine; Longo, Matthew R.; Buelthoff, Heinrich H.; Mohler, Betty J.			Owning an Overweight or Underweight Body: Distinguishing the Physical, Experienced and Virtual Body	PLOS ONE			English	Article							RUBBER HAND; OWNERSHIP; ILLUSION; AGENCY; TOUCH; DISTANCE; REALITY; IMAGE	Our bodies are the most intimately familiar objects we encounter in our perceptual environment. Virtual reality provides a unique method to allow us to experience having a very different body from our own, thereby providing a valuable method to explore the plasticity of body representation. In this paper, we show that women can experience ownership over a whole virtual body that is considerably smaller or larger than their physical body. In order to gain a better understanding of the mechanisms underlying body ownership, we use an embodiment questionnaire, and introduce two new behavioral response measures: an affordance estimation task (indirect measure of body size) and a body size estimation task (direct measure of body size). Interestingly, after viewing the virtual body from first person perspective, both the affordance and the body size estimation tasks indicate a change in the perception of the size of the participant's experienced body. The change is biased by the size of the virtual body (overweight or underweight). Another novel aspect of our study is that we distinguish between the physical, experienced and virtual bodies, by asking participants to provide affordance and body size estimations for each of the three bodies separately. This methodological point is important for virtual reality experiments investigating body ownership of a virtual body, because it offers a better understanding of which cues (e. g. visual, proprioceptive, memory, or a combination thereof) influence body perception, and whether the impact of these cues can vary between different setups.	[Piryankova, Ivelina V.; Stinson, Catherine; Buelthoff, Heinrich H.; Mohler, Betty J.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, D-72076 Tubingen, Germany; [Piryankova, Ivelina V.; Wong, Hong Yu; Stinson, Catherine] Werner Reichardt Ctr Integrat Neurosci, Dept Philosophy Neurosci, Tubingen, Germany; [Linkenauger, Sally A.] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; [Longo, Matthew R.] Univ London, Dept Psychol Sci, London, England; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Eberhard Karls University of Tubingen; Lancaster University; University of London; Korea University	Piryankova, IV (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Spemannstr 38, D-72076 Tubingen, Germany.	ivelina.piryankova@tuebingen.mpg.de; heinrich.buelthoff@tuebingen.mpg.de; betty.mohler@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019; Longo, Matthew R/I-4090-2018	Bülthoff, Heinrich H/0000-0003-2568-0607; Longo, Matthew R/0000-0002-2450-4903; Linkenauger, Sally/0000-0002-6056-0187	Werner Reichardt Centre for Integrative Neuroscience, Tuebingen [CIN2011-16]; EC FP7 project VR-HYPERSPACE [AAT-2011-RTD-1-285681]; Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	Werner Reichardt Centre for Integrative Neuroscience, Tuebingen; EC FP7 project VR-HYPERSPACE; Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	The research leading to these results was funded by the Werner Reichardt Centre for Integrative Neuroscience, Tuebingen (CIN2011-16), and the EC FP7 project VR-HYPERSPACE (AAT-2011-RTD-1-285681). Part of Heinrich H. Bulthoff's research was supported by the Brain Korea 21 PLUS Program through the National Research Foundation of Korea funded by the Ministry of Education (correspondence should be directed to Heinrich H. Bulthoff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKEVOLD F, 1975, PSYCHOTHER PSYCHOSOM, V26, P71, DOI 10.1159/000286913; Bos JE, 2008, DISPLAYS, V29, P47, DOI 10.1016/j.displa.2007.09.002; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; BRODIE DA, 1989, PERCEPT MOTOR SKILL, V69, P723, DOI 10.2466/pms.1989.69.3.723; Croll J, 2002, J ADOLESCENT HEALTH, V31, P166, DOI 10.1016/S1054-139X(02)00368-3; de Vignemont F, 2011, CONSCIOUS COGN, V20, P82, DOI 10.1016/j.concog.2010.09.004; Di Luca M, 2010, PRESENCE-TELEOP VIRT, V19, P569, DOI 10.1162/pres_a_00023; Dobricki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083840; FALLON AE, 1985, J ABNORM PSYCHOL, V94, P102, DOI 10.1037/0021-843X.94.1.102; Farrell C, 2005, EUR EAT DISORD REV, V13, P75, DOI 10.1002/erv.622; Forrest LN, 2012, ROLE PERCEPTION EATI; FREEMAN RJ, 1984, PSYCHOL MED, V14, P411, DOI 10.1017/S0033291700003652; Geuss M., 2010, PROCE 7 S APPL PERCE, P61; Gibson J.J., 1986, ECOLOGICAL APPROACH; Grogan S., 2007, BODY IMAGE UNDERSTAN; Hashimoto T, 2013, EUR J NEUROSCI, V37, P1747, DOI 10.1111/ejn.12187; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2012, CURR DIR PSYCHOL SCI, V21, P140, DOI 10.1177/0963721411434982; Longo MR, 2009, PERCEPTION, V38, P69, DOI 10.1068/p6045; Longo MR, 2008, CONSCIOUS COGN, V17, P1181, DOI 10.1016/j.concog.2008.01.001; Michaels CF, 2003, ECOL PSYCHOL, V15, P135, DOI 10.1207/S15326969ECO1502_3; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Petkova VI, 2011, FRONT PSYCHOL, V2; Preston C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085773; Riva G, 2005, CYBERPSYCHOL BEHAV, V8, P220, DOI 10.1089/cpb.2005.8.220; Riva G, 2008, J CYBERTHERAPY REHAB, V1, P7; Riva G, 2000, NATURE PRECEDINGS, P2; Riva Giuseppe, 2011, J Diabetes Sci Technol, V5, P283; Rizzo AA, 2006, CNS SPECTRUMS, V11, P35, DOI 10.1017/S1092852900024196; Schilder P., 1936, J NERV MENT DIS, V83, P227, DOI [10.1097/00005053-193602000-00051, DOI 10.1097/00005053-193602000-00051]; SLADE PD, 1973, PSYCHOL MED, V3, P188, DOI 10.1017/S0033291700048510; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Stefanucci JK, 2009, PERCEPTION, V38, P1782, DOI 10.1068/p6437; Stunckard Albert J., 1983, GENETICS NEUROLOGICA; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; Willemsen P, 2008, PRESENCE-TELEOP VIRT, V17, P91, DOI 10.1162/pres.17.1.91; Willemsen P, 2009, ACM T APPL PERCEPT, V6, DOI 10.1145/1498700.1498702; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880	51	89	89	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103428	10.1371/journal.pone.0103428	http://dx.doi.org/10.1371/journal.pone.0103428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4JL	25083784	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800040
J	Berdal, JE; Haagensen, R; Ranheim, T; Bjornholt, JV				Berdal, Jan-Erik; Haagensen, Rolf; Ranheim, Trond; Bjornholt, Jorgen V.			Nosocomial Candidemia; Risk Factors and Prognosis Revisited; 11 Years Experience from a Norwegian Secondary Hospital	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; BLOOD-STREAM INFECTIONS; ATTRIBUTABLE MORTALITY; 2009 UPDATE; MANAGEMENT	The aim of the study was to review the epidemiology and prognosis of candidemia in a secondary hospital, and to examine the intra-hospital distribution of candidemia patients. Study design is a retrospective cohort study. Trough 2002-2012, 110 cases of candidemia were diagnosed, giving an incidence of 2, 6/100000 citizens/year. Overall prognosis of candidemia was dismal, with a 30 days case fatality rate of 49% and one year case fatality rate of 64%. Candidemia was a terminal event in 55% of 30 days non-survivors, defined as Candida blood cultures reported positive on the day of death or thereafter (39%), or treatment refrained due to hopeless short-term prognosis (16%). In terminal event candidemias, advanced or incurable cancer was present in 29%. Non-survivors at 30 days were 9 years (median) older than survivors. In 30 days survivors, candidemia was not recognised before discharge in 13% of cases. No treatment were given and no deaths or complications were observed in this group. Candidemia patients were grouped into 8 patient categories: Abdominal surgery (35%), urology (13%), other surgery (11%), pneumonia (13%), haematological malignancy (7%), intravenous drug abuse (4%), other medical (15%), and new-borns (3%). Candidemia was diagnosed while admitted in the ICU in 46% of patients. Urology related cases were all diagnosed in the general ward. Multiple surgical procedures were done in 60% of abdominal surgery patients. Antibiotics were administered prior to candidemia in 87% of patients, with median duration 17 (1-108) days. Neutropenia was less common than expected in patients with candidemia (8/105) and closely associated to haematological malignancy (6/8). Compared with previous national figures the epidemiology of invasive candidiasis seems not to have changed over the last decade.	[Berdal, Jan-Erik] Akershus Univ Hosp, Dept Infect Dis, Nordbyhagen, Norway; [Haagensen, Rolf] Akershus Univ Hosp, Dept Anaesthesiol, Nordbyhagen, Norway; [Ranheim, Trond] Akershus Univ Hosp, Dept Microbiol, Nordbyhagen, Norway; [Bjornholt, Jorgen V.] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Berdal, JE (corresponding author), Akershus Univ Hosp, Dept Infect Dis, Nordbyhagen, Norway.	jan.erik.berdal@ahus.no		Bjornholt, Jorgen Vildershoj/0000-0002-0079-8062				Achkar JM, 2010, CLIN MICROBIOL REV, V23, P253, DOI 10.1128/CMR.00076-09; Arendrup MC, 2011, J CLIN MICROBIOL, V49, P325, DOI 10.1128/JCM.01811-10; DiNubile MJ, 2007, J CRIT CARE, V22, P237, DOI 10.1016/j.jcrc.2006.11.004; Ericsson J, 2013, CLIN MICROBIOLOGY IN; Falagas ME, 2006, EUR J CLIN MICROBIOL, V25, P419, DOI 10.1007/s10096-006-0159-2; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Lundstrom T, 2001, CLIN INFECT DIS, V32, P1602, DOI 10.1086/320531; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Morgan Juliette, 2005, Curr Infect Dis Rep, V7, P429, DOI 10.1007/s11908-005-0044-7; Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0; Pappas PG, 2008, CURR FUNGAL INFECT R, V2, P112, DOI 10.1007/s12281-008-0017-z; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Poikonen E, 2003, EMERG INFECT DIS, V9, P985; Rothman KJ, 1979, EPIDEMIOLOGIC ANAL P; Sandven Per, 2000, Revista Iberoamericana de Micologia, V17, P73; Shorr AF, 2009, CRIT CARE, V13, DOI 10.1186/cc8110; Tortorano A, 2013, INFECTION, P1; Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300; Wenzel RP, 2005, CLIN INFECT DIS, V41, pS389, DOI 10.1086/430923; WENZEL RP, 1995, CLIN INFECT DIS, V20, P1531, DOI 10.1093/clinids/20.6.1531	21	28	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103916	10.1371/journal.pone.0103916	http://dx.doi.org/10.1371/journal.pone.0103916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079361	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800096
J	Cook, GS; Parnell, PE; Levin, LA				Cook, Geoffrey S.; Parnell, P. Ed; Levin, Lisa A.			Population Connectivity Shifts at High Frequency within an Open-Coast Marine Protected Area Network	PLOS ONE			English	Article							CORAL-REEF FISH; LARVAL CONNECTIVITY; SWIMMING ABILITIES; DISPERSAL; PATTERNS; RECRUITMENT; RESERVES; METAPOPULATIONS; REPLENISHMENT; PERSISTENCE	A complete understanding of population connectivity via larval dispersal is of great value to the effective design and management of marine protected areas (MPA). However empirical estimates of larval dispersal distance, self-recruitment, and within season variability of population connectivity patterns and their influence on metapopulation structure remain rare. We used high-resolution otolith microchemistry data from the temperate reef fish Hypsypops rubicundus to explore biweekly, seasonal, and annual connectivity patterns in an open-coast MPA network. The three MPAs, spanning 46 km along the southern California coastline were connected by larval dispersal, but the magnitude and direction of connections reversed between 2008 and 2009. Self-recruitment, i.e. spawning, dispersal, and settlement to the same location, was observed at two locations, one of which is a MPA. Self-recruitment to this MPA ranged from 50-84%; within the entire 60 km study region, self-recruitment accounted for 45% of all individuals settling to study reefs. On biweekly time scales we observed directional variability in alongshore current data and larval dispersal trajectories; if viewed in isolation these data suggest the system behaves as a source-sink metapopulation. However aggregate biweekly data over two years reveal a reef network in which H. rubicundus behaves more like a well-mixed metapopulation. As one of the few empirical studies of population connectivity within a temperate open coast reef network, this work can inform the MPA design process, implementation of ecosystem based management plans, and facilitate conservation decisions.	[Cook, Geoffrey S.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Studies, Miami, FL 33149 USA; [Cook, Geoffrey S.] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; [Parnell, P. Ed; Levin, Lisa A.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of California System; University of California San Diego; Scripps Institution of Oceanography	Cook, GS (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Studies, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	gcook@rsmas.miami.edu		Levin, Lisa/0000-0002-2858-8622	United States Environmental Protection Agency Science; NSF- Marine Biodiversity and Conservation IGERT Fellowship (NSF) [0333444]; University of California Coastal Environmental Quality Initiative Graduate Fellowship; Moore Family Foundation - Center for Marine Biodiversity and Conservation at SIO; PADI Foundation; Mia J. Tegner coastal ecology grant; California Seagrant Traineeship [52-ANS-N]; NSF [OCE 0648656]	United States Environmental Protection Agency Science(United States Environmental Protection Agency); NSF- Marine Biodiversity and Conservation IGERT Fellowship (NSF); University of California Coastal Environmental Quality Initiative Graduate Fellowship; Moore Family Foundation - Center for Marine Biodiversity and Conservation at SIO; PADI Foundation; Mia J. Tegner coastal ecology grant; California Seagrant Traineeship; NSF(National Science Foundation (NSF))	This study was supported in part by the United States Environmental Protection Agency Science to Achieve Results (STAR) Graduate Fellowship Program, an NSF- Marine Biodiversity and Conservation IGERT Fellowship (NSF Award No. 0333444), a University of California Coastal Environmental Quality Initiative Graduate Fellowship, a Moore Family Foundation grant awarded by the Center for Marine Biodiversity and Conservation at SIO, a PADI Foundation grant, a Mia J. Tegner coastal ecology grant, and a California Seagrant Traineeship (52-ANS-N) to GSC. LAL was supported by NSF award OCE 0648656. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Ben-Tzvi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042672; Bernardi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044953; Berumen ML, 2012, ECOL EVOL, V2, P444, DOI 10.1002/ece3.208; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; CADFG, 2012, CAL DEP FISH GAM PUB; Carson HS, 2013, MAR ECOL PROG SER, V473, P133, DOI 10.3354/meps10078; Carson HS, 2010, CURR BIOL, V20, P1926, DOI 10.1016/j.cub.2010.09.057; Chittaro PM, 2013, CORAL REEFS, V32, P341, DOI 10.1007/s00338-012-0990-0; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; CLARKE TA, 1970, ECOL MONOGR, V40, P189, DOI 10.2307/1942295; Cook GS, 2011, MAR ECOL PROG SER, V423, P197, DOI 10.3354/meps08942; Cook GS, 2005, NAT AREA J, V25, P390; Cook GS, 2011, THESIS U CALIFORNIA; Corell H, 2012, MAR ECOL PROG SER, V467, P29, DOI 10.3354/meps09963; Correia AT, 2014, FISH RES, V149, P76, DOI 10.1016/j.fishres.2013.09.016; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crook DA, 2013, CAN J FISH AQUAT SCI, V70, P953, DOI 10.1139/cjfas-2012-0504; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052108; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031681; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Fisher R, 2000, MAR ECOL PROG SER, V202, P163, DOI 10.3354/meps202163; Hamer PA, 2011, J FISH BIOL, V78, P1090, DOI 10.1111/j.1095-8649.2011.02921.x; Hastings A, 2006, P NATL ACAD SCI USA, V103, P6067, DOI 10.1073/pnas.0506651103; Howe EA, 2013, J GREAT LAKES RES, V39, P239, DOI 10.1016/j.jglr.2013.02.006; Kool JT, 2013, LANDSCAPE ECOL, V28, P165, DOI 10.1007/s10980-012-9819-z; Leis JM, 2007, MAR BIOL, V153, P103, DOI 10.1007/s00227-007-0794-x; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; LIMBAUGH CONRAD, 1964, PAC SCI, V18, P41; Lipcius RN, 2008, REV FISH SCI, V16, P101, DOI 10.1080/10641260701812574; Lopez-Duarte PC, 2012, INTEGR COMP BIOL, V52, P511, DOI 10.1093/icb/ics104; Lubchenco J, 2003, ECOL APPL, V13, pS3; MILLAR RB, 1990, CAN J FISH AQUAT SCI, V47, P2235, DOI 10.1139/f90-248; MILLAR RB, 1987, CAN J FISH AQUAT SCI, V44, P583, DOI 10.1139/f87-071; Mitarai S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005166; MOSER HG, 1996, CALCOFI ATLAS, V33; PALUMBI S, 2002, MARINE RESERVES TOOL; PANNELLA G, 1971, SCIENCE, V173, P1124, DOI 10.1126/science.173.4002.1124; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Quinn GP, 2003, EXPT DESIGN DATA ANA; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; SIKKEL PC, 1988, COPEIA, P710; Silva A, 2009, ICES J MAR SCI, V66, P495, DOI 10.1093/icesjms/fsn225; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Watson JR, 2011, ECOLOGY, V92, P1193, DOI 10.1890/10-1436.1; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; White JW, 2007, MAR ECOL PROG SER, V329, P301, DOI 10.3354/meps329301; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zar JH, 1999, BIOSTATISTICAL ANAL	55	13	13	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103654	10.1371/journal.pone.0103654	http://dx.doi.org/10.1371/journal.pone.0103654			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077486	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800063
J	Naidoo, P; du Toit, E; Dunbar, R; Lombard, C; Caldwell, J; Detjen, A; Squire, SB; Enarson, DA; Beyers, N				Naidoo, Pren; du Toit, Elizabeth; Dunbar, Rory; Lombard, Carl; Caldwell, Judy; Detjen, Anne; Squire, S. Bertel; Enarson, Donald A.; Beyers, Nulda			A Comparison of Multidrug-Resistant Tuberculosis Treatment Commencement Times in MDRTBPlus Line Probe Assay and Xpert (R) MTB/RIF-Based Algorithms in a Routine Operational Setting in Cape Town	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; GENOTYPE MTBDRPLUS; RIFAMPIN RESISTANCE; SOUTH-AFRICA; MDR-TB; DIAGNOSIS; IMPLEMENTATION; METAANALYSIS; INITIATION; SPECIMENS	Background: Xpert MTB/RIF was introduced as a screening test for all presumptive tuberculosis cases in primary health services in Cape Town, South Africa. Study Aim: To compare multidrug-resistant tuberculosis (MDR-TB) treatment commencement times in MDRTBPlus Line Probe Assay and Xpert MTB/RIF-based algorithms in a routine operational setting. Methods: The study was undertaken in 10 of 29 high tuberculosis burden primary health facilities, selected through stratified random sampling. An observational study was undertaken as facilities transitioned to the Xpert MTB/RIF-based algorithm. MDR-TB diagnostic data were collected from electronic laboratory records and treatment data from clinical records and registers. Kaplan Meier time-to-event analysis was used to compare treatment commencement time, laboratory turnaround time and action delay between algorithms. A facility-level paired analysis was done: the median time-to-event was estimated per facility in each algorithm and mean differences between algorithms compared using a paired t-test. Cox proportional hazards regression was used to assess the effect of patient-level variables on treatment commencement time. The difference between algorithms was compared using the hazard ratio. Results: The median treatment commencement time in the Xpert MTB/RIF-based algorithm was 17 days (95% CI 13 to 22 days), with a median laboratory turnaround time (to result available in the laboratory) of <1 day (95% CI<1 to 1 day). There was a decrease of 25 days (95% CI 17 to 32 days, p<0.001) in median MDR-TB treatment commencement time in the Xpert MTB/RIF-based algorithm. We found no significant effect on treatment commencement times for the patient-level variables assessed. Conclusion: MDR-TB treatment commencement time was significantly reduced in the Xpert MTB/RIF-based algorithm. Changes in the health system may have contributed. However, an unacceptable level of delay remains. Health system and patient factors contributing to delay need to be evaluated and addressed to optimise test benefits.	[Naidoo, Pren; du Toit, Elizabeth; Dunbar, Rory; Beyers, Nulda] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa; [Lombard, Carl] MRC, Cape Town, South Africa; [Caldwell, Judy] Cape Town Hlth Directorate, Cape Town, South Africa; [Detjen, Anne; Enarson, Donald A.] Int Union TB & Lung Dis, Paris, France; [Squire, S. Bertel] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Stellenbosch University; Liverpool School of Tropical Medicine; University of Liverpool	Naidoo, P (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa.	pnaidoo@icon.co.za		Squire, Stephen/0000-0001-7173-9038; Lombard, Carl/0000-0002-2136-6533	United States Agency for International Development (USAID) [GHN-A-00-08-00004-00]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This research was supported by a United States Agency for International Development (USAID) Cooperative Agreement (TREAT TB - Agreement No. GHN-A-00-08-00004-00). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Ebonwu JI, 2013, INT J TUBERC LUNG D, V17, P1043, DOI 10.5588/ijtld.13.0071; Hanrahan CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065421; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2006, INT J TUBERC LUNG D, V10, P1057; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Hoek KGP, 2011, MOL DIAGN THER, V15, P189, DOI 10.2165/11593780-000000000-00000; Jacobson KR, 2013, CLIN INFECT DIS, V56, P503, DOI 10.1093/cid/cis920; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Mann G, 2010, INT J TUBERC LUNG D, V14, P1518; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Miotto P, 2008, J CLIN MICROBIOL, V46, P393, DOI 10.1128/JCM.01066-07; Narasimooloo R, 2012, SAMJ S AFR MED J, V102, P360, DOI 10.7196/SAMJ.5361; Nathanson E, 2010, NEW ENGL J MED, V363, P1050, DOI 10.1056/NEJMra0908076; Organization WH, 2009, PATHW BETT DIAGN TUB; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Pai M, 2009, CLIN CHEST MED, V30, P701, DOI 10.1016/j.ccm.2009.08.016; Sedgwick P, 2011, BMJ-BRIT MED J, V343, pd4890; South African National AIDS Council, 2012, NAT STRAT PLAN HIV; Steingart KR, 2013, XPERT MTB RIF ASSAY; van Niekerk M, 2013, 44 UN WORLD C LUNG H; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organisation, 2011, XPERT MTB RIF SYSTEM; World Health Organisation, 2008, EXPERT GROUP REPORT; World Health Organisation, 2008, XPERT MTB RIF SYSTEM; Yagui M, 2006, INT J TUBERC LUNG D, V10, P838	29	52	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103328	10.1371/journal.pone.0103328	http://dx.doi.org/10.1371/journal.pone.0103328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079599	Green Published, Green Accepted, gold			2022-12-27	WOS:000339954800037
J	Umana-Pena, R; Franco-Giraldo, A; Diaz, CAD; Ruiz-Cantero, MT; Gil-Gonzalez, D; Hernandez-Aguado, I				Umana-Pena, Roman; Franco-Giraldo, Alvaro; Diaz, Carlos Alvarez-Dardet; Ruiz-Cantero, Maria Teresa; Gil-Gonzalez, Diana; Hernandez-Aguado, Ildefonso			Assessment of the Association of Health with the Liberalisation of Trade in Services under the World Trade Organisation	PLOS ONE			English	Article							GLOBALIZATION; POVERTY	Background: The liberalisation of trade in services which began in 1995 under the General Agreement on Trade in Services (GATS) of the World Trade Organisation (WTO) has generated arguments for and against its potential health effects. Our goal was to explore the relationship between the liberalisation of services under the GATS and three health indicators - life expectancy (LE), under-5 mortality (U5M) and maternal mortality (MM) - since the WTO was established. Methods and Findings: This was a cross-sectional ecological study that explored the association in 2010 and 1995 between liberalisation and health (LE, U5M and MM), and between liberalisation and progress in health in the period 1995-2010, considering variables related to economic and social policies such as per capita income (GDP pc), public expenditure on health (PEH), and income inequality (Gini index). The units of observation and analysis were WTO member countries with data available for 2010 (n = 116), 1995 (n = 114) and 1995-2010 (n = 114). We conducted bivariate and multivariate linear regression analyses adjusted for GDP pc, Gini and PEH. Increased global liberalisation in services under the WTO was associated with better health in 2010 (U5M: -0.358 p<0.001; MM: -0.338 p = 0.001; LE: 0.247 p = 0.008) and in 1995, after adjusting for economic and social policy variables. For the period 1995-2010, progress in health was associated with income equality, PEH and per capita income. No association was found with global liberalisation in services. Conclusions: The favourable association in 2010 between health and liberalisation in services under the WTO seems to reflect a pre-WTO association observed in the 1995 data. However, this liberalisation did not appear as a factor associated with progress in health during 1995-2010. Income equality, health expenditure and per capita income were more powerful determinants of the health of populations.	[Umana-Pena, Roman; Diaz, Carlos Alvarez-Dardet; Ruiz-Cantero, Maria Teresa; Gil-Gonzalez, Diana] Univ Alicante, Observ Publ Policies & Hlth, E-03080 Alicante, Spain; [Franco-Giraldo, Alvaro] Univ Antioquia, Natl Sch Publ Hlth, Medellin, Colombia; [Diaz, Carlos Alvarez-Dardet; Ruiz-Cantero, Maria Teresa; Gil-Gonzalez, Diana] Univ Alicante, Publ Hlth Res Unit, E-03080 Alicante, Spain; [Franco-Giraldo, Alvaro] Univ Antioquia CODI, Res Comm, Res Grp Publ Policy & Hlth, Medellin, Colombia; [Diaz, Carlos Alvarez-Dardet; Ruiz-Cantero, Maria Teresa; Gil-Gonzalez, Diana] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Hernandez-Aguado, Ildefonso] Miguel Hernandez Univ, Dept Publ Hlth Hist Sci & Gynaecol, Alacant, Spain	Universitat d'Alacant; Universidad de Antioquia; Universitat d'Alacant; Universidad de Antioquia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad Miguel Hernandez de Elche	Umana-Pena, R (corresponding author), Univ Alicante, Observ Publ Policies & Hlth, E-03080 Alicante, Spain.	romanumana@hotmail.com	Hernández-Aguado, Ildefonso/I-2634-2015	Hernández-Aguado, Ildefonso/0000-0003-1911-5759; Gil-Gonzalez, Diana/0000-0002-8989-448X; Ruiz-Cantero, Maria Teresa/0000-0001-6724-7866	Carlos III Health Institute; Programme for Promotion of Biomedical and Health Sciences of the Spanish Ministry of Health and Consumer Affairs [PI060295]	Carlos III Health Institute(Instituto de Salud Carlos III); Programme for Promotion of Biomedical and Health Sciences of the Spanish Ministry of Health and Consumer Affairs	This study was funded by the Carlos III Health Institute and the Programme for Promotion of Biomedical and Health Sciences (http://www.isciii.es/) of the Spanish Ministry of Health and Consumer Affairs (Ref. PI060295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cornia GA, 2001, B WORLD HEALTH ORGAN, V79, P834; Dollar D, 2005, WORLD BANK RES OBSER, V20, P145, DOI 10.1093/wbro/lki008; Dollar D, 2004, ECON J, V114, pF22, DOI 10.1111/j.0013-0133.2004.00186.x; Dollar D, 2001, B WORLD HEALTH ORGAN, V79, P827; Hoekman B., 1995, TENTATIVE 1 STEPS AS; Islam Roumeen, 2008, WORLD TRADE INDICATO; Mashayekhi M, 2000, 9 S CTR; Outreville JF, 2007, EUR J HEALTH ECON, V8, P305, DOI 10.1007/s10198-006-0010-9; Pritchett L, 1996, J HUM RESOUR, V31, P841, DOI 10.2307/146149; Rodrik D, 2000, COMMENTS TRADE GROWT; Sebastian MS, 2006, REV PANAM SALUD PUBL, V20, P341; Smith RD, 2009, LANCET, V373, P593, DOI 10.1016/S0140-6736(08)61778-X; United Nations, 2005, HUM DEV REP 2005 INT; United Nations, 2007, METH CLASS PROV CENT; United Nations, 2008, METH CLASS COUNTR AR; United Nations, 2010, HUM DEV REP 2010 REA; United Nations Development Programme, 2003, MAK GLOB TRAD WORK P; Wilkinson RG, 1997, BRIT MED J, V314, P591, DOI 10.1136/bmj.314.7080.591; Woodward D, 2001, B WORLD HEALTH ORGAN, V79, P875; World Bank, 2009, WORLD TRAD IND 2009; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Bank, 2011, COUNTR CLASS DAT; World Bank, 2012, WORLD DEV IND ONL; World Bank Institute, 2008, WORLD TRAD IND US GU; World Health Organization, 2002, WTO AGR PUBL HLTH JO; World Health Organization, 2012, GLOB HLTH OBS DAT RE; World Trade Organization, 1991, MTNGNSW120 WORLD TRA; World Trade Organization, 2012, UND WTO MEMB OBS; World Trade Organization, 2008, MEAS TRAD SERV TRAIN; World Trade Organization, 2008, UND WTO	30	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102385	10.1371/journal.pone.0102385	http://dx.doi.org/10.1371/journal.pone.0102385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6EF	25078783	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800012
J	Cook, MB; Corley, DA; Murray, LJ; Liao, LM; Kamangar, F; Ye, WM; Gammon, MD; Risch, HA; Casson, AG; Freedman, ND; Chow, WH; Wu, AH; Bernstein, L; Nyren, O; Pandeya, N; Whiteman, DC; Vaughan, TL				Cook, Michael B.; Corley, Douglas A.; Murray, Liam J.; Liao, Linda M.; Kamangar, Farin; Ye, Weimin; Gammon, Marilie D.; Risch, Harvey A.; Casson, Alan G.; Freedman, Neal D.; Chow, Wong-Ho; Wu, Anna H.; Bernstein, Leslie; Nyren, Olof; Pandeya, Nirmala; Whiteman, David C.; Vaughan, Thomas L.			Gastroesophageal Reflux in Relation to Adenocarcinomas of the Esophagus: A Pooled Analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON)	PLOS ONE			English	Article							GASTRIC CARDIA; ESOPHAGOGASTRIC JUNCTION; SOCIOECONOMIC-FACTORS; UNITED-STATES; BODY-SIZE; RISK; ALCOHOL; CANCER; SYMPTOMS; SMOKING	Background: Previous studies have evidenced an association between gastroesophageal reflux and esophageal adenocarcinoma (EA). It is unknown to what extent these associations vary by population, age, sex, body mass index, and cigarette smoking, or whether duration and frequency of symptoms interact in predicting risk. The Barrett's and Esophageal Adenocarcinoma Consortium (BEACON) allowed an in-depth assessment of these issues. Methods: Detailed information on heartburn and regurgitation symptoms and covariates were available from five BEACON case-control studies of EA and esophagogastric junction adenocarcinoma (EGJA). We conducted single-study multivariable logistic regressions followed by random-effects meta-analysis. Stratified analyses, meta-regressions, and sensitivity analyses were also conducted. Results: Five studies provided 1,128 EA cases, 1,229 EGJA cases, and 4,057 controls for analysis. All summary estimates indicated positive, significant associations between heartburn/regurgitation symptoms and EA. Increasing heartburn duration was associated with increasing EA risk; odds ratios were 2.80, 3.85, and 6.24 for symptom durations of <10 years, 10 to,20 years, and >= 20 years. Associations with EGJA were slighter weaker, but still statistically significant for those with the highest exposure. Both frequency and duration of heartburn/regurgitation symptoms were independently associated with higher risk. We observed similar strengths of associations when stratified by age, sex, cigarette smoking, and body mass index. Conclusions: This analysis indicates that the association between heartburn/regurgitation symptoms and EA is strong, increases with increased duration and/or frequency, and is consistent across major risk factors. Weaker associations for EGJA suggest that this cancer site has a dissimilar pathogenesis or represents a mixed population of patients.	[Cook, Michael B.; Liao, Linda M.; Kamangar, Farin; Freedman, Neal D.] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Corley, Douglas A.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Corley, Douglas A.] Kaiser Permanente No Calif, Oakland Med Ctr, Oakland, CA USA; [Murray, Liam J.] Queens Univ, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Kamangar, Farin] Morgan State Univ, Sch Community Hlth & Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA; [Ye, Weimin; Nyren, Olof] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Gammon, Marilie D.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Risch, Harvey A.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Casson, Alan G.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Chow, Wong-Ho] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wu, Anna H.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Bernstein, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Bernstein, Leslie] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Pandeya, Nirmala; Whiteman, David C.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Vaughan, Thomas L.] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kaiser Permanente; Kaiser Permanente; Queens University Belfast; Morgan State University; Karolinska Institutet; University of North Carolina; University of North Carolina Chapel Hill; Yale University; University of Saskatchewan; University of Texas System; UTMD Anderson Cancer Center; University of Southern California; City of Hope; Beckman Research Institute of City of Hope; City of Hope; QIMR Berghofer Medical Research Institute; Fred Hutchinson Cancer Center	Cook, MB (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA.	michael.cook@nih.gov	Pandeya, Nirmala/F-8054-2010; Liao, Linda M/B-3960-2011; Freedman, Neal David/B-9741-2015; Whiteman, David C/P-2728-2014; Cook, Michael B/A-5641-2009	Pandeya, Nirmala/0000-0003-1462-4968; Liao, Linda M/0000-0002-1923-5294; Freedman, Neal David/0000-0003-0074-1098; Whiteman, David C/0000-0003-2563-9559; Cook, Michael B/0000-0002-0533-7302; ye, weimin/0000-0002-6859-4648	Intramural Research Program of the National Institutes of Health; Queensland Cancer Fund; National Health and Medical Research Council (NHMRC) of Australia [199600]; California Tobacco Related Research Program [3RT-0122, 10RT-0251]; National Cancer Institute [CA59636]; Northern Ireland Research & Development Office; Health Research Board, Ireland;  [U01-CA57949];  [U01-CA57983];  [U01-CA57923];  [R01 CA57947-03];  [RO1 DK63616- 01];  [R21 DK077742]; MRC [MR/K023241/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA057947, ZIACP010220, U01CA057949, U01CA057923, U01CA057983, R01CA059636, K05CA124911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077742, R01DK063616] Funding Source: NIH RePORTER; Medical Research Council [MR/K023241/1] Funding Source: researchfish	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Queensland Cancer Fund; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); California Tobacco Related Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Northern Ireland Research & Development Office; Health Research Board, Ireland; ; ; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Intramural Research Program of the National Institutes of Health. The US Multi-Center Study was funded by grants U01-CA57949 (awarded to TLV), U01-CA57983 (awarded to MDG), and U01-CA57923 (awarded to HAR). The Australian Cancer Study was supported by the Queensland Cancer Fund and the National Health and Medical Research Council (NHMRC) of Australia (Program no. 199600, awarded to DCW, Adele C. Green, Nicholas K. Hayward, Peter G. Parsons, David M. Purdie, and Penelope M. Webb). The Swedish Esophageal Cancer Study was funded by grant number R01 CA57947-03 (awarded to ON and Hans-Olov Adami). The Los Angeles County Multi-ethnic Case-control Study was funded by grants 3RT-0122 ('Smoking and Risk of Proximal Vs. Distal Gastric Cancer', awarded to AHW) and 10RT-0251 ('Smoking, microsatellite instability & gastric cancers', awarded to AHW) from the California Tobacco Related Research Program and grant CA59636 (awarded to LB) from the National Cancer Institute. The Factors Influencing the Barrett's Adenocarcinoma Relationship (FINBAR) study was funded by an Ireland-Northern Ireland Co-operation Research Project Grant sponsored by the Northern Ireland Research & Development Office, and the Health Research Board, Ireland (All-Ireland case-control study of Oesophageal Adenocarcinoma and Barrett's Oesophagus, awardedto LJM and Harry Comber). DAC was supported by RO1 DK63616- 01, R21 DK077742. The funders of the individual studies had no role in the design, analysis or interpretation of the data, or in writing or publication decisions related to this manuscript.	Anderson LA, 2009, GASTROENTEROLOGY, V136, P799, DOI 10.1053/j.gastro.2008.12.005; BARRETT NR, 1957, SURGERY, V41, P881; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bredenoord AJ, 2006, GUT, V55, P313, DOI 10.1136/gut.2005.074690; BREMNER CG, 1970, SURGERY, V68, P209; BROWN LM, 1994, CANCER CAUSE CONTROL, V5, P333, DOI 10.1007/BF01804984; CHOW WH, 1995, JAMA-J AM MED ASSOC, V274, P474, DOI 10.1001/jama.274.6.474; Cook MB, 2010, JNCI-J NATL CANCER I, V102, P1344, DOI 10.1093/jnci/djq289; Derakhshan MH, 2008, GUT, V57, DOI 10.1136/gut.2007.137364; Farrow DC, 2000, CANCER CAUSE CONTROL, V11, P231, DOI 10.1023/A:1008913828105; Freedman ND, 2011, GUT, V60, P1029, DOI 10.1136/gut.2010.233866; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoyo C, 2012, INT J EPIDEMIOL, V41, P1706, DOI 10.1093/ije/dys176; Jansson C, 2005, CANCER EPIDEM BIOMAR, V14, P1754, DOI 10.1158/1055-9965.EPI-05-0140; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 2000, INT J CANCER, V85, P340; McColl KEL, 2010, GUT, V59, P282, DOI 10.1136/gut.2009.186825; MOERSCH RN, 1959, SURG GYNECOL OBSTET, V108, P476; Rubenstein JH, 2010, ALIMENT PHARM THER, V32, P1222, DOI 10.1111/j.1365-2036.2010.04471.x; Smith-Warner SA, 2006, AM J EPIDEMIOL, V163, P1053, DOI 10.1093/aje/kwj127; TANNER N C, 1954, Postgrad Med J, V30, P577; Whiteman DC, 2008, GUT, V57, P173, DOI 10.1136/gut.2007.131375; Winklestein A, 1935, J AMER MED ASSOC, V104, P906, DOI 10.1001/jama.1935.02760110034008; Woodland P, 2010, BEST PRACT RES CL GA, V24, P861, DOI 10.1016/j.bpg.2010.09.002; Wu AH, 2001, CANCER CAUSE CONTROL, V12, P721, DOI 10.1023/A:1011290704728; Wu AH, 2003, CANCER, V98, P940, DOI 10.1002/cncr.11568	28	74	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103508	10.1371/journal.pone.0103508	http://dx.doi.org/10.1371/journal.pone.0103508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075959	Green Published, gold, Green Submitted			2022-12-27	WOS:000340028800056
J	Allen, EK; Manichaikul, A; Chen, WM; Rich, SS; Daly, KA; Sale, MM				Allen, E. Kaitlynn; Manichaikul, Ani; Chen, Wei-Min; Rich, Stephen S.; Daly, Kathleen A.; Sale, Michele M.			Evaluation of Replication of Variants Associated with Genetic Risk of Otitis Media	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; HERITABILITY; DISEASE; DISEQUILIBRIUM; SCAN; TWIN	The first Genome Wide Association Study (GWAS) of otitis media (OM) found evidence of association in the Western Australian Pregnancy Cohort (Raine) study, but lacked replication in an independent OM population. The aim of this study was to investigate association at these loci in our family-based sample of chronic otitis media with effusion and recurrent otitis media (COME/ROM). Autosomal SNPs were selected from the Raine OM GWAS results. SNPs from the Raine cohort GWAS genotyped in our GWAS of COME/ROM had P-values ranging from P = 0.06-0.80. After removal of SNPs previously genotyped in our GWAS of COME/ROM (N = 21) and those that failed Fluidigm assay design (N = 1), 26 SNPs were successfully genotyped in 716 individuals from our COME/ROM family population. None of the SNP associations replicated in our family-based population (unadjusted P = 0.03-0.93). Replication in an independent sample would confirm that these represent novel OM loci, and that further investigation is warranted.	[Allen, E. Kaitlynn; Manichaikul, Ani; Chen, Wei-Min; Rich, Stephen S.; Sale, Michele M.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA; [Allen, E. Kaitlynn; Sale, Michele M.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Daly, Kathleen A.] Univ Minnesota, Dept Otolaryngol, Minneapolis, MN USA; [Sale, Michele M.] Univ Virginia, Dept Med, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Minnesota System; University of Minnesota Twin Cities; University of Virginia	Sale, MM (corresponding author), Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA.	msale@virginia.edu		Rich, Stephen/0000-0003-3872-7793; Manichaikul, Ani/0000-0002-5998-795X	National Institutes of Health [DC003166]; Hearing Health Foundation Emerging Research Grant; National Institute of General Medical Sciences of the National Institutes of Health [T32GM008715]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hearing Health Foundation Emerging Research Grant; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grant DC003166 (KAD) and the Hearing Health Foundation Emerging Research Grant. Ms. Allen received support from the National Institute of General Medical Sciences of the National Institutes of Health under Award Number T32GM008715. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EK, 2013, JARO-J ASSOC RES OTO, V14, P791, DOI 10.1007/s10162-013-0411-2; Casselbrant ML, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-85; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Chen WM, 2001, GENET EPIDEMIOL, V21, P53, DOI 10.1002/gepi.1018; Daly KA, 2004, AM J HUM GENET, V75, P988, DOI 10.1086/426061; Daly KA, 1996, GENET EPIDEMIOL, V13, P451, DOI 10.1002/(SICI)1098-2272(1996)13:5<451::AID-GEPI2>3.0.CO;2-5; Hafren L, 2012, INT J PEDIATR OTORHI, V76, P41, DOI 10.1016/j.ijporl.2011.09.026; Kvaerner KJ, 1997, ANN OTO RHINOL LARYN, V106, P624, DOI 10.1177/000348949710600802; Kvestad E, 2004, TWIN RES, V7, P239, DOI 10.1375/twin.7.3.239; Kvestad E, 2006, INT J PEDIATR OTORHI, V70, P1561, DOI 10.1016/j.ijporl.2006.04.004; Li Y, 2010, GENET EPIDEMIOL; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Rovers M, 2002, AM J EPIDEMIOL, V155, P958, DOI 10.1093/aje/155.10.958; Rye MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048215; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506	15	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104212	10.1371/journal.pone.0104212	http://dx.doi.org/10.1371/journal.pone.0104212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089819	gold, Green Published, Green Submitted			2022-12-27	WOS:000339812700113
J	Lee, WY; Kim, M; Jablonski, PG; Choe, JC; Lee, SI				Lee, Won Young; Kim, Mincheol; Jablonski, Piotr G.; Choe, Jae Chun; Lee, Sang-im			Effect of Incubation on Bacterial Communities of Eggshells in a Temperate Bird, the Eurasian Magpie (Pica pica)	PLOS ONE			English	Article							REAL-TIME PCR; NEST MATERIAL; PSEUDOMONAS-FLUORESCENS; MICROBIAL-GROWTH; EGG VIABILITY; AVIAN EGG; SP NOV.; QUANTIFICATION; LOADS; SOIL	Inhibitory effect of incubation on microbial growth has extensively been studied in wild bird populations using culture-based methods and conflicting results exist on whether incubation selectively affects the growth of microbes on the egg surface. In this study, we employed culture-independent methods, quantitative PCR and 16S rRNA gene pyrosequencing, to elucidate the effect of incubation on the bacterial abundance and bacterial community composition on the eggshells of the Eurasian Magpie (Pica pica). We found that total bacterial abundance increased and diversity decreased on incubated eggs while there were no changes on non-incubated eggs. Interestingly, Gram-positive Bacillus, which include mostly harmless species, became dominant and genus Pseudomonas, which include opportunistic avian egg pathogens, were significantly reduced after incubation. These results suggest that avian incubation in temperate regions may promote the growth of harmless (or benevolent) bacteria and suppress the growth of pathogenic bacterial taxa and consequently reduce the diversity of microbes on the egg surface. We hypothesize that this may occur due to difference in sensitivity to dehydration on the egg surface among microbes, combined with the introduction of Bacillus from bird feathers and due to the presence of antibiotics that certain bacteria produce.	[Lee, Won Young; Jablonski, Piotr G.; Lee, Sang-im] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Lab Behav Ecol & Evolut, Seoul, South Korea; [Kim, Mincheol] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Lab Prokaryot Biol & Bioinformat, Seoul, South Korea; [Jablonski, Piotr G.] Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland; [Choe, Jae Chun] Ewha Womans Univ, Div EcoSci, Seoul, South Korea; [Lee, Sang-im] Seoul Natl Univ, Inst Adv Machinery & Design, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Ewha Womans University; Seoul National University (SNU)	Lee, SI (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Lab Behav Ecol & Evolut, Seoul, South Korea.	MagpieKorea@gmail.com	Jablonski, Piotr G/A-2753-2015	/0000-0002-8333-0106	Hi Seoul Science/Humanities Fellowship from Seoul Scholarship Foundation; Next Generation Researcher Scholarship of Seoul National University; National Research Foundation [NRF 2013-055323, 2013-005769]; Longterm Ecological Monitoring Project - Ministry of Environment	Hi Seoul Science/Humanities Fellowship from Seoul Scholarship Foundation; Next Generation Researcher Scholarship of Seoul National University; National Research Foundation; Longterm Ecological Monitoring Project - Ministry of Environment	This work was supported by Hi Seoul Science/Humanities Fellowship from Seoul Scholarship Foundation (2010-2011 for WYL), by the Next Generation Researcher Scholarship of Seoul National University (2012-2013 for WYL), research grants from National Research Foundation (NRF 2013-055323 and 2013-005769) and the Longterm Ecological Monitoring Project funded by the Ministry of Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Antunes LCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022674; Awais M, 2007, PAK J BOT, V39, P1303; BAUMANN P, 1968, J BACTERIOL, V96, P39, DOI 10.1002/path.1700960105; Becker J, 2012, ECOL LETT, V15, P468, DOI 10.1111/j.1461-0248.2012.01759.x; Bernardet JF, 1996, INT J SYST BACTERIOL, V46, P128, DOI 10.1099/00207713-46-1-128; Birkhead TR, 1991, MAGPIES; Bruce J., 1994, P63; Burtt EH, 1999, AUK, V116, P364, DOI 10.2307/4089371; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; CLARK L, 1988, OECOLOGIA, V77, P174, DOI 10.1007/BF00379183; CLARK L, 1985, OECOLOGIA, V67, P169, DOI 10.1007/BF00384280; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Cummins S, 2002, BIRD STUDY, V49, P139, DOI 10.1080/00063650209461258; D'Alba L, 2010, NATURWISSENSCHAFTEN, V97, P1089, DOI 10.1007/s00114-010-0735-2; Deeming DC, 2002, OX ORN SER, V13, P1; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fontana A., 2007, WATER ACTIVITY FOODS, P405; Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Goodfellow M., 1987, FRONT APPL MICROBIOL, V2, P97; Gorley C.K., 2006, GETTING STARTED PRIM; Green SJ, 2007, ISME J, V1, P291, DOI 10.1038/ismej.2007.33; Grizard S, 2014, ECOL EVOL, V4, P1140, DOI 10.1002/ece3.1011; Gunderson AR, 2008, AUK, V125, P972, DOI 10.1525/auk.2008.91008; Gwinner H, 2005, J ORNITHOL, V146, P365, DOI 10.1007/s10336-005-0012-x; Haegeman B, 2013, ISME J, V7, P1092, DOI 10.1038/ismej.2013.10; HAGEDORN C, 1975, CAN J MICROBIOL, V21, P353, DOI 10.1139/m75-050; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kampfer P, 2010, INT J SYST EVOL MICR, V60, P824, DOI 10.1099/ijs.0.013540-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Kuta F. A., 2009, Applied Medical Informatics, V24, P42; Ledford H, 2008, NATURE, V455, P847, DOI 10.1038/455847a; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Lee WY, 2013, J FIELD ORNITHOL, V84, P304, DOI 10.1111/jofo.12031; Levitski-Heikkila TV, 2005, AM J KIDNEY DIS, V46, DOI 10.1053/j.ajkd.2005.08.021; LIN XA, 1992, APPL ENVIRON MICROB, V58, P3271, DOI 10.1128/AEM.58.10.3271-3275.1992; Mannanov RN, 2001, CHEM NAT COMPD, V37, P117, DOI 10.1023/A:1012314516354; Martin-Platero AM, 2006, APPL ENVIRON MICROB, V72, P4245, DOI 10.1128/AEM.02940-05; Moller AP, 2009, FUNCT ECOL, V23, P1097, DOI 10.1111/j.1365-2435.2009.01594.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Narushin VG, 1997, J AGR ENG RES, V68, P201, DOI 10.1006/jaer.1997.0188; Nijburg JW, 1998, FEMS MICROBIOL ECOL, V26, P345, DOI 10.1111/j.1574-6941.1998.tb00519.x; Nishimori E, 2000, INT J SYST EVOL MICR, V50, P83, DOI 10.1099/00207713-50-1-83; Peralta-Sanchez JM, 2010, FUNCT ECOL, V24, P426, DOI 10.1111/j.1365-2435.2009.01669.x; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Petit C, 2002, ECOL LETT, V5, P585, DOI 10.1046/j.1461-0248.2002.00361.x; PINOWSKI J, 1994, J BIOSCIENCES, V19, P441, DOI 10.1007/BF02703180; Roberts D.W., 2013, ORDINATION MULTIVARI, V775; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Ruiz-De-Castaneda R, 2011, BEHAV PROCESS, V88, P142, DOI 10.1016/j.beproc.2011.08.012; Ruiz-de-Castaneda R, 2011, CONDOR, V113, P200, DOI 10.1525/cond.2011.100035; Ruiz-de-Castaneda R, 2012, CONDOR, V114, P203, DOI 10.1525/cond.2011.100230; Ruiz-Rodriguez M, 2013, FEMS MICROBIOL ECOL, V85, P495, DOI 10.1111/1574-6941.12138; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Shawkey MD, 2003, J AVIAN BIOL, V34, P345, DOI 10.1111/j.0908-8857.2003.03193.x; Simoes M, 2008, BIOFOULING, V24, P339, DOI 10.1080/08927010802239154; Soler JJ, 2008, FUNCT ECOL, V22, P864, DOI 10.1111/j.1365-2435.2008.01448.x; Soler JJ, 2011, BIOL J LINN SOC, V103, P836, DOI 10.1111/j.1095-8312.2011.01672.x; Soler Juan Jose, 2010, Open Ornithology Journal, V3, P93, DOI 10.2174/1874453201003010093; Steinberg DC, 2009, MICROORGANISMS COSME, P223; STIERITZ DD, 1975, J INFECT DIS, V131, P688, DOI 10.1093/infdis/131.6.688; Tamehiro N, 2002, ANTIMICROB AGENTS CH, V46, P315, DOI 10.1128/AAC.46.2.315-320.2002; TATNER P, 1983, IBIS, V125, P90, DOI 10.1111/j.1474-919X.1983.tb03086.x; Turnbull P., 1990, Topley & Wilson's Principles of bacteriology, virology and immunity. Volume 2. Systematic bacteriology., P187; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Walls JG, 2011, AUK, V128, P663, DOI 10.1525/auk.2011.11124; Wang JM, 2011, ECOLOGY, V92, P1137, DOI 10.1890/i0012-9658-92-5-1137; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; WILLEMS A, 1991, INT J SYST BACTERIOL, V41, P445, DOI 10.1099/00207713-41-3-445; Yu EN, 2002, AM J OPHTHALMOL, V134, P613, DOI 10.1016/S0002-9394(02)01586-6; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999	89	17	17	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103959	10.1371/journal.pone.0103959	http://dx.doi.org/10.1371/journal.pone.0103959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089821	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700069
J	Agmon, M; Armon, G				Agmon, Maayan; Armon, Galit			Increased Insomnia Symptoms Predict the Onset of Back Pain among Employed Adults	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NOXIOUS INHIBITORY CONTROLS; SLEEP LOSS; MUSCULOSKELETAL PAIN; PREVALENCE; SENSITIVITY; DISTURBANCES; EPIDEMIOLOGY; MODULATION; DISORDERS	Background: Back pain is among the most prevalent pain disorders causing chronic disability among adults, and insomnia is a common co-morbidity. However, whether insomnia precedes back pain or vice versa remains unclear. The current study tested the temporal association between insomnia and back pain. Methods: A longitudinal design was used to investigate whether changes in insomnia over time predict the onset of back pain and vice versa. The study was conducted on a cohort of active healthy working adults (N = 2,131, 34% women) at three time points (T1, T2, and T3) over a period of 3.7 years (range = 2.2-5.12) years. Logistic regression analysis was used to test whether increased insomnia symptoms from T1 to T2 predicted the onset of new back pain. Ordinary least squares regression was used to test whether the existence of back pain at T2 predicted an increase in insomnia from T2 to T3. Results: The results indicated that after controlling for socioeconomic variables, self-reported health, lifestyle behaviors, and anthropometrics, a T1-T2 increase in insomnia symptoms was associated with a 1.40-fold increased risk of back pain at T3 (OR = 1.40; 95% CI = 1.10-1.71). No support was found for reverse causation; i.e., that back pain predicts subsequent increase in insomnia. Conclusions: Insomnia appears to be a risk factor in the development of back pain in healthy individuals. However, no evidence of reverse causation was found.	[Agmon, Maayan] Univ Haifa, Sch Nursing, IL-31999 Haifa, Israel; [Armon, Galit] Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel	University of Haifa; University of Haifa	Agmon, M (corresponding author), Univ Haifa, Sch Nursing, IL-31999 Haifa, Israel.	Agmon.mn@gmail.com		Agmon, Maayan/0000-0002-1855-1199				Ahn SH, 2002, SPINE, V27, P911, DOI 10.1097/00007632-200205010-00005; Alsaadi SM, 2011, EUR SPINE J, V20, P737, DOI 10.1007/s00586-010-1661-x; Bahouq H, 2013, RHEUMATOL INT, V33, P1277, DOI 10.1007/s00296-012-2550-x; Bergmann MM, 2004, EUR J EPIDEMIOL, V19, P411, DOI 10.1023/B:EJEP.0000027350.85974.47; Bevan S, 2009, FIT WORK MUSCULOSKEL; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Bongers PM, 2006, J OCCUP REHABIL, V16, P279, DOI 10.1007/s10926-006-9044-1; Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Dormann C, 2001, STRUCT EQU MODELING, V8, P575, DOI 10.1207/S15328007SEM0804_04; Elfering A, 2008, SCAND J WORK ENV HEA, V34, P337, DOI 10.5271/sjweh.1280; Finan PH, 2012, SLEEP MED REV; Froom P, 1999, J CLIN EPIDEMIOL, V52, P731, DOI 10.1016/S0895-4356(99)00070-0; Griffith LE, 2007, J CLIN EPIDEMIOL, V60, P625, DOI 10.1016/j.jclinepi.2006.09.005; Haack M, 2012, EUR J PAIN, V16, P522, DOI 10.1016/j.ejpain.2011.07.007; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Irwin M, 2002, BRAIN BEHAV IMMUN, V16, P503, DOI 10.1016/S0889-1591(02)00003-X; Kaila-Kangas L, 2006, SPINE, V31, P51, DOI 10.1097/01.brs.0000193902.45315.e5; Kelly GA, 2011, CLIN J PAIN, V27, P169, DOI 10.1097/AJP.0b013e3181f3bdd5; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Lavigne GJ, 2011, CURR RHEUMATOL REP, V13, P535, DOI 10.1007/s11926-011-0209-3; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x; Louie GH, 2011, ARTHRIT CARE RES, V63, P247, DOI 10.1002/acr.20362; Manek NJ, 2005, CURR OPIN RHEUMATOL, V17, P134; Marty M, 2008, EUR SPINE J, V17, P839, DOI 10.1007/s00586-008-0660-7; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Pielsticker A, 2005, PAIN, V118, P215, DOI 10.1016/j.pain.2005.08.019; Purushothaman B, 2013, J ORTHOP SURG-HONG K, V21, P68, DOI 10.1177/230949901302100118; Rannou F, 2007, ARTHRIT RHEUM-ARTHR, V57, P1311, DOI 10.1002/art.22985; Richardson CR, 2004, MED SCI SPORT EXER, V36, P1923, DOI 10.1249/01.MSS.0000145443.02568.7A; Rifai N, 1999, CLIN CHEM, V45, P2136; Roehrs T, 2006, SLEEP, V29, P145, DOI 10.1093/sleep/29.2.145; Roizenblatt S, 2011, CURR PAIN HEADACHE R, V15, P347, DOI 10.1007/s11916-011-0213-3; Roth T, 2007, SLEEP MED REV, V11, P71, DOI 10.1016/j.smrv.2006.06.002; Roth T, 2011, BIOL PSYCHIAT, V69, P592, DOI 10.1016/j.biopsych.2010.10.023; Sandrini G, 2006, CEPHALALGIA, V26, P782, DOI 10.1111/j.1468-2982.2006.01130.x; Schneider S, 2006, CLIN J PAIN, V22, P738, DOI 10.1097/01.ajp.0000210920.03289.93; Siivola SM, 2004, SPINE, V29, P1662, DOI 10.1097/01.BRS.0000133644.29390.43; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; Sturmer T, 2005, ANN RHEUM DIS, V64, P921, DOI 10.1136/ard.2004.027045; TEPAS DI, 1989, WORK STRESS, V3, P93, DOI 10.1080/02678378908256883; Treister R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063808; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Twisk JW, 2013, APPL LONGITUDINAL DA; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Zapf D, 1996, J Occup Health Psychol, V1, P145, DOI 10.1037/1076-8998.1.2.145; Zhang JH, 2013, SLEEP, V36, P671, DOI 10.5665/sleep.2624	51	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103591	10.1371/journal.pone.0103591	http://dx.doi.org/10.1371/journal.pone.0103591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084165	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800054
J	Bellmunt, J; Selvarajah, S; Rodig, S; Salido, M; de Muga, S; Costa, I; Bellosillo, B; Werner, L; Mullane, S; Fay, AP; O'Brien, R; Barretina, J; Minoche, AE; Signoretti, S; Montagut, C; Himmelbauer, H; Berman, DM; Kantoff, P; Choueiri, TK; Rosenberg, JE				Bellmunt, Joaquim; Selvarajah, Shamini; Rodig, Scott; Salido, Marta; de Muga, Silvia; Costa, Irmgard; Bellosillo, Beatriz; Werner, Lillian; Mullane, Stephanie; Fay, Andre P.; O'Brien, Robert; Barretina, Jordi; Minoche, Andre E.; Signoretti, Sabina; Montagut, Clara; Himmelbauer, Heinz; Berman, David M.; Kantoff, Philip; Choueiri, Toni K.; Rosenberg, Jonathan E.			Identification of ALK Gene Alterations in Urothelial Carcinoma	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; CELL-LUNG-CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; BLADDER-CANCER; CLINICOPATHOLOGICAL FEATURES; MOLECULAR CHARACTERIZATION; PROGNOSTIC IMPLICATIONS; ACTIVATING MUTATIONS; COPY-NUMBER; RHABDOMYOSARCOMA	Background: Anaplastic lymphoma kinase (ALK) genomic alterations have emerged as a potent predictor of benefit from treatment with ALK inhibitors in several cancers. Currently, there is no information about ALK gene alterations in urothelial carcinoma (UC) and its correlation with clinical or pathologic features and outcome. Methods: Samples from patients with advanced UC and correlative clinical data were collected. Genomic imbalances were investigated by array comparative genomic hybridization (aCGH). ALK gene status was evaluated by fluorescence in situ hybridization (FISH). ALK expression was assessed by immunohistochemistry (IHC) and high-throughput mutation analysis with Oncomap 3 platform. Next generation sequencing was performed using Illumina Genome Analyzer IIx, and Illumina HiSeq 2000 in the FISH positive case. Results: 70 of 96 patients had tissue available for all the tests performed. Arm level copy number gains at chromosome 2 were identified in 17 (24%) patients. Minor copy number alterations (CNAs) in the proximity of ALK locus were found in 3 patients by aCGH. By FISH analysis, one of these samples had a deletion of the 5'ALK. Whole genome next generation sequencing was inconclusive to confirm the deletion at the level of the ALK gene at the coverage level used. We did not observe an association between ALK CNA and overall survival, ECOG PS, or development of visceral disease. Conclusions: ALK genomic alterations are rare and probably without prognostic implications in UC. The potential for testing ALK inhibitors in UC merits further investigation but might be restricted to the identification of an enriched population.	[Bellmunt, Joaquim; Selvarajah, Shamini; Rodig, Scott; Mullane, Stephanie; Fay, Andre P.; O'Brien, Robert; Kantoff, Philip; Choueiri, Toni K.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Bladder Canc Ctr, Boston, MA 02115 USA; [Bellmunt, Joaquim; Montagut, Clara] Hosp Mar Res Inst IMIM, Barcelona, Spain; [Salido, Marta; de Muga, Silvia; Bellosillo, Beatriz] Hosp Mar Res Inst IMIM, Dept Pathol, Barcelona, Spain; [Costa, Irmgard] Hosp Parc Tauli, Sabadell, Spain; [Werner, Lillian] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Barretina, Jordi] Broad Inst, Cambridge, MA USA; [Minoche, Andre E.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Minoche, Andre E.; Himmelbauer, Heinz] CRG, Barcelona, Spain; [Minoche, Andre E.; Himmelbauer, Heinz] Univ Pompeu Fabra, Barcelona, Spain; [Berman, David M.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Rosenberg, Jonathan E.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Max Planck Society; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Johns Hopkins University; Memorial Sloan Kettering Cancer Center	Bellmunt, J (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Bladder Canc Ctr, 44 Binney St, Boston, MA 02115 USA.	joaquim_bellmunt@dfci.harvard.edu	De Muga, Silvia/AAB-9018-2020; Bellmunt, Joaquim/B-8151-2019; Rodig, Scott/Y-3889-2019; Choueiri, Toni/K-5238-2019; berman, david/HIR-4177-2022; Barretina, Jordi/A-7192-2013	De Muga, Silvia/0000-0002-8037-8729; Bellmunt, Joaquim/0000-0003-2328-3421; Choueiri, Toni/0000-0002-9201-3217; Kantoff, Philip/0000-0001-7275-0597; berman, david/0000-0001-5985-3698; Barretina, Jordi/0000-0002-3478-4080; Selvarajah, Shamini/0000-0002-9894-4864; Himmelbauer, Heinz/0000-0001-8897-2928; Rosenberg, Jonathan/0000-0003-2637-4249	Spanish Health Ministry Grant "Fondo de Investigacion Sanitaria" [PI061513]; RTICC [06/0020/19]	Spanish Health Ministry Grant "Fondo de Investigacion Sanitaria"; RTICC(Instituto de Salud Carlos III)	This work has been supported by PI061513 (Spanish Health Ministry Grant "Fondo de Investigacion Sanitaria") and RTICC 06/0020/19 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbas-Martinez C, 2013, NAT GENET, V45, P1464, DOI 10.1038/ng.2799; Barreca A, 2011, J MOL ENDOCRINOL, V47, pR11, DOI 10.1530/JME-11-0004; Bavi P, 2013, BRIT J CANCER, V109, P2735, DOI 10.1038/bjc.2013.641; Bavi P, 2013, BR J CANC; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Bonvini P, 2013, BRIT J CANCER, V109, P3084, DOI 10.1038/bjc.2013.653; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Dai ZY, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-44; Debelenko LV, 2011, MODERN PATHOL, V24, P430, DOI 10.1038/modpathol.2010.213; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hernandez L, 1999, BLOOD, V94, P3265; Hoglund M, 2012, UROL ONCOL-SEMIN ORI, V30, P533, DOI 10.1016/j.urolonc.2012.04.001; Hurst CD, 2012, CLIN CANCER RES, V18, P5865, DOI 10.1158/1078-0432.CCR-12-1807; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Iyer G, 2013, J CLIN ONCOL, V31, P3133, DOI 10.1200/JCO.2012.46.5740; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee JS, 2014, J CLIN PATHOL, V67, P33, DOI 10.1136/jclinpath-2013-201655; Lee JO, 2011, J THORAC ONCOL, V6, P1474, DOI 10.1097/JTO.0b013e3182208fc2; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Lopez V, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-182; Mano H, 2012, CANCER DISCOV, V2, P495, DOI 10.1158/2159-8290.CD-12-0009; Montagut C, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.10537; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Panzeri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024237; Riester M, 2014, CLIN CANCER RES, V20, P1873, DOI 10.1158/1078-0432.CCR-13-0759; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Ross JS, 2014, MODERN PATHOL, V27, P271, DOI 10.1038/modpathol.2013.135; Salido M, 2011, J THORAC ONCOL, V6, P21, DOI 10.1097/JTO.0b013e3181fb7cd6; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sukov WR, 2012, MODERN PATHOL, V25, P1516, DOI 10.1038/modpathol.2012.107; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; van Gaal JC, 2012, J CLIN ONCOL, V30, P308, DOI 10.1200/JCO.2011.37.8588; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Ze TA, 2010, BIOINFORMATICS, V26, P2313, DOI 10.1093/bioinformatics/btq428	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103325	10.1371/journal.pone.0103325	http://dx.doi.org/10.1371/journal.pone.0103325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083769	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800030
J	Ding, XF; Zhu, LM; Ji, T; Zhang, XP; Wang, FM; Gan, SJ; Zhao, M; Yang, HJ				Ding, Xianfeng; Zhu, Limin; Ji, Ting; Zhang, Xiping; Wang, Fengmei; Gan, Shaoju; Zhao, Ming; Yang, Hongjian			Long Intergenic Non-Coding RNAs (LincRNAs) Identified by RNA-Seq in Breast Cancer	PLOS ONE			English	Article							SUSCEPTIBILITY GENE; OVARIAN-CANCER; AMPLIFICATION; 13Q34; CANDIDATE; CARCINOMA; ONCOGENES; SURVIVAL; SEQUENCE; LINKAGE	In an attempt to find the correlation of aberrant expression of long intergenic noncoding RNAs (lincRNAs) with cancer, twenty-five samples of breast cancer tissue and respective adjacent normal tissue were studied for the expression of lincRNAs by RNA-seq. Among the 538 lincRNAs studied, 124 lincRNAs were exclusively expressed in cancer adjacent tissues and 62 lincRNAs were exclusively expressed in the cancer tissues. Furthermore, the expression of 134 lincRNAs was higher while 272 lower in breast cancer tissue compared with adjacent tissue. The expression of four selected lincRNAs (BC2, BC4, BC5, and BC8) was validated by semi-quantitative and real-time PCR. It was revealed that expression of lincRNA-BC5 was positively correlated with patients' age, pathological stage, and progesterone receptor concentration, while lincRNA-BC8 was negatively correlated with progesterone receptor expression. Higher expression of lincRNA-BC4 was seen in advanced breast cancer grade. LincRNA-BC2 showed no specific changes in the pathological features studied. Interactions between selected lincRNAs and breast cancer associated proteins were highly suggested by RPIseq based on the specific secondary structure. The results demonstrated that this group of lincRNAs was aberrantly expressed in breast cancer. They might play important roles in the function of oncogenes or tumor suppressors affecting the development and progression of breast cancer.	[Ding, Xianfeng; Zhu, Limin; Ji, Ting; Gan, Shaoju; Zhao, Ming] Zhejiang Sci Tech Univ, Coll Life Sci, Inst Bioengn, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xiping; Yang, Hongjian] Zhejiang Canc Hosp, Dept Breast Tumor Surg, Zhejiang Canc Res Inst, Hangzhou, Zhejiang, Peoples R China; [Wang, Fengmei] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Sci-Tech University; Zhejiang Cancer Hospital; Zhejiang University	Ding, XF (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Inst Bioengn, Hangzhou, Zhejiang, Peoples R China.	xfding@zstu.edu.cn; yhjzlyy@163.com			Natural Science Foundation of Zhejiang Province, China [LY12H16030]; Foundation of Science and Technology Department of Zhejiang Province; China [2011C23043]; Foundation of Health Department of Zhejiang Province, China [2011BCA015]	Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Foundation of Science and Technology Department of Zhejiang Province; China; Foundation of Health Department of Zhejiang Province, China	This work was supported by Natural Science Foundation of Zhejiang Province, China (No. LY12H16030); Foundation of Science and Technology Department of Zhejiang Province; China (No. 2011C23043) and also by Foundation of Health Department of Zhejiang Province, China (No. 2011BCA015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Bernhart SH, 2011, METHODS MOL BIOL, V760, P307, DOI 10.1007/978-1-61779-176-5_19; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOS JL, 1989, CANCER RES, V49, P4682; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cirillo D, 2012, WILEY INTERDISCIPLIN; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Dhillon VS, 2003, TERATOGEN CARCIN MUT, P35, DOI 10.1002/tcm.10068; Dohna M, 2000, GENE CHROMOSOME CANC, V28, P145, DOI 10.1002/(SICI)1098-2264(200006)28:2<145::AID-GCC3>3.0.CO;2-7; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; He JH, 2014, BIOMED REP, V2, P19, DOI 10.3892/br.2013.191; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu YZ, 2006, HUM GENET, V119, P295, DOI 10.1007/s00439-006-0136-y; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Melchor L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2456; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Michiels EMC, 2002, J PEDIAT HEMATOL ONC, V24, P205, DOI 10.1097/00043426-200203000-00009; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Muppirala UK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-489; Ohman M, 2000, J CLIN ENDOCR METAB, V85, P3183, DOI 10.1210/jc.85.9.3183; Osborne C, 2004, ONCOLOGIST, V9, P361, DOI 10.1634/theoncologist.9-4-361; Osborne CK, 1998, BREAST CANCER RES TR, V51, P227, DOI 10.1023/A:1006132427948; Pastural E, 2000, GENOMICS, V63, P299, DOI 10.1006/geno.1999.6081; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Richard F, 2000, INT J CANCER, V89, P305; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shinomiya T, 1999, GENE CHROMOSOME CANC, V24, P337, DOI 10.1002/(SICI)1098-2264(199904)24:4<337::AID-GCC7>3.0.CO;2-O; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Washietl S, 2010, METHODS MOL BIOL, V609, P285, DOI 10.1007/978-1-60327-241-4_17; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Yoon JH, 2012, MOL CELL	42	30	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103270	10.1371/journal.pone.0103270	http://dx.doi.org/10.1371/journal.pone.0103270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084155	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800024
J	Ku, KM; Jeffery, EH; Juvik, JA				Ku, Kang-Mo; Jeffery, Elizabeth H.; Juvik, John A.			Exogenous Methyl Jasmonate Treatment Increases Glucosinolate Biosynthesis and Quinone Reductase Activity in Kale Leaf Tissue	PLOS ONE			English	Article							BROCCOLI FLORETS; ANTICANCER PROPERTIES; ANTIOXIDANT ACTIVITY; MARKER ENZYME; INDUCTION; CANCER; CELLS; PLANT; ACID; ISOTHIOCYANATES	Methyl jasmonate (MeJA) spray treatments were applied to the kale varieties 'Dwarf Blue Curled Vates' and 'Red Winter' in replicated field plantings in 2010 and 2011 to investigate alteration of glucosinolate (GS) composition in harvested leaf tissue. Aqueous solutions of 250 mu M MeJA were sprayed to saturation on aerial plant tissues four days prior to harvest at commercial maturity. The MeJA treatment significantly increased gluconasturtiin (56%), glucobrassicin (98%), and neoglucobrassicin (150%) concentrations in the apical leaf tissue of these genotypes over two seasons. Induction of quinone reductase (QR) activity, a biomarker for anti-carcinogenesis, was significantly increased by the extracts from the leaf tissue of these two cultivars. Extracts of apical leaf tissues had greater MeJA mediated increases in phenolics, glucosinolate concentrations, GS hydrolysis products, and QR activity than extracts from basal leaf tissue samples. The concentration of the hydrolysis product of glucoraphanin, sulforphane was significantly increased in apical leaf tissue of the cultivar 'Red Winter' in both 2010 and 2011. There was interaction between exogenous MeJA treatment and environmental conditions to induce endogenous JA. Correlation analysis revealed that indole-3-carbanol (I3C) generated from the hydrolysis of glucobrassicin significantly correlated with QR activity (r = 0.800, P<0.001). Concentrations required to double the specific QR activity (CD values) of I3C was calculated at 230 mu M, which is considerably weaker at induction than other isothiocyanates like sulforphane. To confirm relationships between GS hydrolysis products and QR activity, a range of concentrations of MeJA sprays were applied to kale leaf tissues of both cultivars in 2011. Correlation analysis of these results indicated that sulforaphane, NI3C, neoascorbigen, I3C, and diindolylmethane were all significantly correlated with QR activity. Thus, increased QR activity may be due to combined increases in phenolics (quercetin and kaempferol) and GS hydrolysis product concentrations rather than by individual products alone.	[Ku, Kang-Mo; Juvik, John A.] Univ Illinois, Urbana, IL 61801 USA; [Jeffery, Elizabeth H.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Juvik, JA (corresponding author), Univ Illinois, Urbana, IL 61801 USA.	juvik@illinois.edu		Ku, Kang Mo/0000-0002-8588-1163; Jeffery, Elizabeth/0000-0002-8827-9469	Boerner Fellowship in Crop Sciences	Boerner Fellowship in Crop Sciences	The Boerner Fellowship in Crop Sciences partially supported the first author. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbirk N, 1998, J AGR FOOD CHEM, V46, P1563, DOI 10.1021/jf9708498; Agerbirk N, 2009, PHYTOCHEM REV, V8, P101, DOI 10.1007/s11101-008-9098-0; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bradlow HL, 2008, IN VIVO, V22, P441; Brown AF, 2002, J AM SOC HORTIC SCI, V127, P807, DOI 10.21273/JASHS.127.5.807; CARLSON DG, 1987, J AM SOC HORTIC SCI, V112, P173; Clapper ML, 1998, CHEM-BIOL INTERACT, V112, P377, DOI 10.1016/S0009-2797(97)00174-9; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Cuendet M, 2006, J NAT PROD, V69, P460, DOI 10.1021/np050362q; Dai J, 2010, MOLECULES, V15, P7313, DOI 10.3390/molecules15107313; Galati G, 2004, FREE RADICAL BIO MED, V37, P287, DOI 10.1016/j.freeradbiomed.2004.04.034; Harvey JA, 2011, OECOLOGIA, V166, P421, DOI 10.1007/s00442-010-1861-4; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Kang YH, 2004, METHOD ENZYMOL, V382, P380; Keum YS, 2005, DRUG NEWS PERSPECT, V18, P445, DOI 10.1358/dnp.2005.18.7.939350; Kim HS, 2011, J AM SOC HORTIC SCI, V136, P239, DOI 10.21273/JASHS.136.4.239; Ku KM, 2014, J SCI FOOD AGR, V94, P2090, DOI 10.1002/jsfa.6529; Ku KM, 2013, J AGR FOOD CHEM, V61, P9623, DOI 10.1021/jf4027734; Ku KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077127; Ku KM, 2013, HORTSCIENCE, V48, P996, DOI 10.21273/HORTSCI.48.8.996; Ku KM, 2013, PLANT FOOD HUM NUTR, V68, P113, DOI 10.1007/s11130-013-0356-y; Michaud DS, 1999, JNCI-J NATL CANCER I, V91, P605, DOI 10.1093/jnci/91.7.605; Mithen RF, 2000, J SCI FOOD AGR, V80, P967, DOI [10.1002/(SICI)1097-0010(20000515)80:7<967::AID-JSFA597>3.0.CO;2-V, 10.1002/(SICI)1097-0010(20000515)80:7&lt;967::AID-JSFA597&gt;3.0.CO;2-V]; Morton LW, 2000, CLIN EXP PHARMACOL P, V27, P152, DOI 10.1046/j.1440-1681.2000.03214.x; Neave AS, 2005, TOXICOL SCI, V83, P126, DOI 10.1093/toxsci/kfi008; Nestle M, 1998, NUTR REV, V56, P127; PROCHASKA HJ, 1988, ANAL BIOCHEM, V169, P328, DOI 10.1016/0003-2697(88)90292-8; Rose P, 2000, CARCINOGENESIS, V21, P1983, DOI 10.1093/carcin/21.11.1983; Sato C, 2009, BIOSCI BIOTECH BIOCH, V73, P1962, DOI 10.1271/bbb.90119; Segarra G, 2006, PHYTOCHEMISTRY, V67, P395, DOI 10.1016/j.phytochem.2005.11.017; Tian QG, 2005, ANAL BIOCHEM, V343, P93, DOI 10.1016/j.ab.2005.04.045; Tong Y, 2014, FOOD CHEM, V152, P190, DOI 10.1016/j.foodchem.2013.11.099; U. S. Department of Agriculture Agricultural Research Service, 2011, USDA DAT FLAV CONT S; Uda Y, 1997, CANCER LETT, V120, P213, DOI 10.1016/S0304-3835(97)00311-X; Velasco P, 2008, J AM SOC HORTIC SCI, V133, P551, DOI 10.21273/JASHS.133.4.551; Velasco P, 2007, J AGR FOOD CHEM, V55, P955, DOI 10.1021/jf0624897; Velasco P, 2011, PHYTOCHEM ANALYSIS, V22, P144, DOI 10.1002/pca.1259; Wathelet Jean-Paul, 1995, Natural Toxins, V3, P299, DOI 10.1002/nt.2620030425; Williamson G, 1996, CARCINOGENESIS, V17, P2385, DOI 10.1093/carcin/17.11.2385; Wilson EA, 2011, CHROMATOGRAPHIA, V73, pS137, DOI 10.1007/s10337-010-1878-1; Yoshihara T, 1996, PLANT CELL PHYSIOL, V37, P586, DOI 10.1093/oxfordjournals.pcp.a028985; Yudina LN, 2000, CHEM HETEROCYCL COMP, V36, P144; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhu CY, 2003, FOOD CHEM TOXICOL, V41, P455, DOI 10.1016/S0278-6915(02)00278-8	44	26	27	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103407	10.1371/journal.pone.0103407	http://dx.doi.org/10.1371/journal.pone.0103407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084454	gold, Green Submitted, Green Published			2022-12-27	WOS:000339819800037
J	Maguma, HT; De, DD; Bhave, S; Dewey, WL; Akbarali, HI				Maguma, Hercules T.; De, Dipanjana Datta; Bhave, Sukhada; Dewey, William L.; Akbarali, Hamid I.			Specific Localization of beta-Arrestin2 in Myenteric Plexus of Mouse Gastrointestinal Tract	PLOS ONE			English	Article							BETA-ARRESTIN; PHYSICAL-DEPENDENCE; MORPHINE-TOLERANCE; ENTERIC NEURONS; PROTEIN; PROJECTIONS; ACTIVATION; EXPRESSION	beta-arrestin2 is a key molecule involved in signaling and internalization of activated G protein-coupled receptors including mopioid receptors (MOR). Previously we have shown that decreased expression of beta-arrestin2 upon chronic morphine is associated with the development of opioid tolerance in the gastrointestinal tract. However, the localization of beta-arrestin2 within the gastrointestinal wall is not known. In this study we found that beta-arrestin2 is localized in the soma of a select group of neurons in the myenteric ganglia but not in smooth muscle. The density of beta-arestin2 was significantly higher in the ileum than the colon. We identified four variants of beta-arrestin2 in the ileum, with ARRB-005 and ARRB-013 being the most abundant. Further, the current study utilized multiple-labeling immunofluorescence to characterize the chemical coding of neurons expressing beta-arrestin2 in the murine myenteric plexus and the co-localization of MOR1 and beta-arrestin2. beta-arrestin2 co-localized with choline acetyltransferase and calretinin. In contrast, beta-arrestin2 neither co-localized with substance P, nitric oxide synthase nor calbindin. Genetic deletion of beta-arrestin2 did not affect cholinergic neuron activation by nicotine in the isolated ileum (-log M EC50: wild type = 5.8 vs. beta-arrestin2 knockout = 5.9). Our findings suggest specificity in the localization of beta-arrestin2 in the myenteric plexus within MOR1-expressing neurons and provide a relation for direct intracellular crosstalk between MOR1 receptor activation and beta-arrestin2 signaling in the myenteric neurons. beta-arrestin2 deletion does not directly alter basal enteric cholinergic neuronal function.	[Maguma, Hercules T.; De, Dipanjana Datta; Bhave, Sukhada; Dewey, William L.; Akbarali, Hamid I.] Virginia Commonwealth Univ, Program Enter Neuromuscular Sci, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA	Virginia Commonwealth University	Akbarali, HI (corresponding author), Virginia Commonwealth Univ, Program Enter Neuromuscular Sci, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	hiakbarali@vcu.edu	BHAVE, SUKHADA/AAM-3518-2020; Akbarali, Hamid/Q-9344-2019; Bhave, Sukhada/ABC-4954-2020	Akbarali, Hamid/0000-0003-1423-0774	National Institute of Health [NIH DA024009, NIH DK046367]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024009, P30DA033934] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health grants NIH DA024009 and NIH DK046367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREHMER A, 2006, ADV ANAT EMBRYOL CEL, V186, P1; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Fan XL, 2003, NEUROSCIENCE, V117, P383, DOI 10.1016/S0306-4522(02)00930-2; Furness JB, 2000, CELL TISSUE RES, V300, P383, DOI 10.1007/s004410000210; Furness JB, 2002, CURR OPIN PHARMACOL, V2, P612, DOI 10.1016/S1471-4892(02)00219-9; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Kang MH, 2012, J PHARMACOL EXP THER, V340, P567, DOI 10.1124/jpet.111.186320; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maguma HT, 2012, EUR J PHARMACOL, V685, P133, DOI 10.1016/j.ejphar.2012.04.001; MESSENGER JP, 1990, ARCH HISTOL CYTOL, V53, P467, DOI 10.1679/aohc.53.467; Nurgali K, 2004, J COMP NEUROL, V468, P112, DOI 10.1002/cne.10948; PATON WDM, 1968, J PHYSIOL-LONDON, V194, P13, DOI 10.1113/jphysiol.1968.sp008392; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; Raehal KM, 2011, NEUROPHARMACOLOGY, V60, P58, DOI 10.1016/j.neuropharm.2010.08.003; Ross GR, 2008, J PHARMACOL EXP THER, V327, P561, DOI 10.1124/jpet.108.143438; Schulz S, 2004, EMBO J, V23, P3282, DOI 10.1038/sj.emboj.7600334; Smith TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045251; Taylor DA, 2001, J PHARMACOL EXP THER, V297, P11; Van Ginneken C, 1998, ANAT EMBRYOL, V198, P399, DOI 10.1007/s004290050192; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174	22	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103894	10.1371/journal.pone.0103894	http://dx.doi.org/10.1371/journal.pone.0103894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083714	Green Submitted, gold, Green Published			2022-12-27	WOS:000339819800099
J	Korinth, SP; Breznitz, Z				Korinth, Sebastian Peter; Breznitz, Zvia			Fast and Slow Readers of the Hebrew Language Show Divergence in Brain Response similar to 200 ms Post Stimulus: An ERP Study	PLOS ONE			English	Article							WORD RECOGNITION; FACES; IDENTIFICATION	Higher N170 amplitudes to words and to faces were recently reported for faster readers of German. Since the shallow German orthography allows phonological recoding of single letters, the reported speed advantages might have their origin in especially well-developed visual processing skills of faster readers. In contrast to German, adult readers of Hebrew are forced to process letter chunks up to whole words. This dependence on more complex visual processing might have created ceiling effects for this skill. Therefore, the current study examined whether also in the deep Hebrew orthography visual processing skills as reflected by N170 amplitudes explain reading speed differences. Forty university students, native speakers of Hebrew without reading impairments, accomplished a lexical decision task (i.e., deciding whether a visually presented stimulus represents a real or a pseudo word) and a face decision task (i.e., deciding whether a face was presented complete or with missing facial features) while their electroencephalogram was recorded from 64 scalp positions. In both tasks stronger event related potentials (ERPs) were observed for faster readers in time windows at about 200 ms. Unlike in previous studies, ERP waveforms in relevant time windows did not correspond to N170 scalp topographies. The results support the notion of visual processing ability as an orthography independent marker of reading proficiency, which advances our understanding about regular and impaired reading development.	[Korinth, Sebastian Peter] Goethe Univ Frankfurt, Dept Neurocognit Psychol, D-60054 Frankfurt, Germany; [Korinth, Sebastian Peter] Ctr Individual Dev & Adapt Educ Children Risk IDe, Frankfurt, Germany; [Breznitz, Zvia] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel	Goethe University Frankfurt; University of Haifa	Korinth, SP (corresponding author), Goethe Univ Frankfurt, Dept Neurocognit Psychol, D-60054 Frankfurt, Germany.	korinth@korinth.org	Korinth, Sebastian/AAR-6118-2021	Korinth, Sebastian/0000-0002-3657-9857	Edmond J. SAFRA foundation	Edmond J. SAFRA foundation	This study was supported by a grant awarded by the Edmond J. SAFRA foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Brem S, 2009, HUM BRAIN MAPP, V30, P1833, DOI 10.1002/hbm.20751; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Frost R, 1997, J EXP PSYCHOL LEARN, V23, P829, DOI 10.1037/0278-7393.23.4.829; FROST R, 1987, J EXP PSYCHOL HUMAN, V13, P104, DOI 10.1037/0096-1523.13.1.104; Frost R., 2005, WORD FREQUENCY DATAB; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Herzmann G, 2004, PSYCHOPHYSIOLOGY, V41, P688, DOI 10.1111/j.1469-8986.2004.00196.x; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; Kast M, 2010, INT J PSYCHOPHYSIOL, V77, P59, DOI 10.1016/j.ijpsycho.2010.04.003; Korinth SP, 2012, BRAIN LANG, V120, P15, DOI 10.1016/j.bandl.2011.08.003; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Maurer U, 2005, J COGNITIVE NEUROSCI, V17, P1532, DOI 10.1162/089892905774597218; Maurer U, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.018.2008; Mercure E, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00006, 10.3389/fnhum.2011.00062]; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Shimron J, 1999, READ WRIT, V11, P301, DOI 10.1023/A:1008045316692; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; Wechsler D., 1997, WECHSLER ADULT INTEL; Westbury CF, 2007, MENT LEX, V2, P273; Wydell TN, 2003, J COGNITIVE NEUROSCI, V15, P1052, DOI 10.1162/089892903770007434; Ziegler JC, 2001, PSYCHOL SCI, V12, P379, DOI 10.1111/1467-9280.00370	27	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103139	10.1371/journal.pone.0103139	http://dx.doi.org/10.1371/journal.pone.0103139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6EF	25078405	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800029
J	Mucha, J; Majchrzak, K; Taciak, B; Hellmen, E; Krol, M				Mucha, Joanna; Majchrzak, Kinga; Taciak, Bartlomiej; Hellmen, Eva; Krol, Magdalena			MDSCs Mediate Angiogenesis and Predispose Canine Mammary Tumor Cells for Metastasis via IL-28/IL-28RA (IFN-lambda) Signaling	PLOS ONE			English	Article							SUPPRESSOR-CELLS; ANTITUMOR IMMUNITY; GENE-EXPRESSION; CANCER; MICE; PROGRESSION; INHIBITION; EXPANSION; INVASION; GROWTH	Background: Myeloid-derived suppressor cells (MDSCs) function in immunosuppression and tumor development by induction of angiogenesis in a STAT3-dependent manner. Knowledge of MDSC biology is mainly limited to mice studies, and more clinical investigations using spontaneous tumor models are required. Here we performed in vitro experiments and clinical data analysis obtained from canine patients. Methods: Using microarrays we examined changes in gene expression in canine mammary cancer cells due to their co-culture with MDSCs. Further, using Real-time rt-PCR, Western blot, IHC, siRNA, angiogenesis assay and migration/invasion tests we examined a role of the most important signaling pathway. Results: In dogs with mammary cancer, the number of circulating MDSCs increases with tumor clinical stage. Microarray analysis revealed that MDSCs had significantly altered molecular pathways in tumor cells in vitro. Particularly important was the detected increased activation of IL-28/IL-28RA (IFN-lambda) signaling. The highest expression of IL-28 was observed in stage III/IV mammary tumor-bearing dogs. IL-28 secreted by MDSCs stimulates STAT3 in tumor cells, which results in increased expression of angiogenic factors and subsequent induction of angiogenesis by endothelial cells, epithelial-mesenchymal transition (EMT) and increased migration of tumor cells in vitro. Knockdown of IL-28RA decreased angiogenesis, tumor cell invasion and migration. Conclusions: We showed for the first time that MDSCs secrete IL-28 (IFN-lambda), which promotes angiogenesis, EMT, invasion and migration of tumor cells. Thus, IL-28 may constitute an interesting target for further therapies. Moreover, the similarity in circulating MDSC levels at various tumor clinical stages between canine and human patients indicates canines as a good model for clinical trials of drugs targeting MDSCs.	[Mucha, Joanna; Taciak, Bartlomiej; Krol, Magdalena] Warsaw Univ Life Sci, Fac Vet Med, Dept Physiol Sci, Warsaw, Poland; [Majchrzak, Kinga] Warsaw Univ Life Sci, Fac Anim Sci, Dept Anim Environm Biol, Warsaw, Poland; [Hellmen, Eva] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Swedish University of Agricultural Sciences	Krol, M (corresponding author), Warsaw Univ Life Sci, Fac Vet Med, Dept Physiol Sci, Warsaw, Poland.	magdalena_krol@sggw.pl	Krol, Magdalena/A-5554-2019	Krol, Magdalena/0000-0003-0421-5167; Taciak, Bartlomiej/0000-0003-2623-4860; Mucha, Joanna/0000-0001-8322-8155; Majchrzak-Kuligowska, Kinga/0000-0002-9504-4588	Ministry of Science and Higher Education and COST Action [IP 2011027171, CM1106]; 'Mazovia' fellowship	Ministry of Science and Higher Education and COST Action; 'Mazovia' fellowship	This work was supported by grant no. IP 2011027171 from the Ministry of Science and Higher Education and COST Action CM1106. JM was supported by 'Mazovia' fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abastado JP, 2012, MYELOID DERIVED SUPP; Balwit JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-18; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Etschmann B, 2006, VET PATHOL, V43, P934, DOI 10.1354/vp.43-6-934; Gordon I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000161; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Krol M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083995; Krol M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-65; Krol M, 2011, VET RES COMMUN, V35, P409, DOI 10.1007/s11259-011-9489-3; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Kusmartsev S, 2003, CANCER RES, V63, P4441; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086; Owen L.N., 1980, TNM CLASSIFICATION T, pp46; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Petersen OW, 2001, BREAST CANCER RES, V3, P213; Rivat C, 2004, ONCOGENE, V23, P3317, DOI 10.1038/sj.onc.1207437; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104; Shaw AK, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-LB-495; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Tamburini BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005549; Vasquez-Dunddel D, 2013, J CLIN INVEST, V123, P1580, DOI 10.1172/JCI60083; Vidal-Vanaclocha F, 2006, CANCER METAST REV, V25, P417, DOI 10.1007/s10555-006-9013-3; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Wang MJ, 2007, J MOL CELL CARDIOL, V42, P1009, DOI 10.1016/j.yjmcc.2007.04.010; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057114; Zhang YL, 2009, J IMMUNOL, V182, P3801, DOI 10.4049/jimmunol.0801548	38	39	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103249	10.1371/journal.pone.0103249	http://dx.doi.org/10.1371/journal.pone.0103249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075523	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800032
J	Webber, AD; Hill, CM				Webber, Amanda D.; Hill, Catherine M.			Using Participatory Risk Mapping (PRM) to Identify and Understand People's Perceptions of Crop Loss to Animals in Uganda	PLOS ONE			English	Article							HUMAN-WILDLIFE CONFLICT; BUDONGO FOREST RESERVE; KIBALE NATIONAL-PARK; LOCAL PERCEPTIONS; PROTECTED AREAS; RURAL PEOPLE; CONSERVATION; COMMUNITY; ATTITUDES; PATTERNS	Considering how people perceive risks to their livelihoods from local wildlife is central to (i) understanding the impact of crop damage by animals on local people and (ii) recognising how this influences their interactions with, and attitudes towards, wildlife. Participatory risk mapping (PRM) is a simple, analytical tool that can be used to identify and classify risk within communities. Here we use it to explore local people's perceptions of crop damage by wildlife and the animal species involved. Interviews (n = 93, n = 76) and seven focus groups were conducted in four villages around Budongo Forest Reserve, Uganda during 2004 and 2005. Farms (N = 129) were simultaneously monitored for crop loss. Farmers identified damage by wildlife as the most significant risk to their crops; risk maps highlighted its anomalous status compared to other anticipated challenges to agricultural production. PRM was further used to explore farmers' perceptions of animal species causing crop damage and the results of this analysis compared with measured crop losses. Baboons (Papio anubis) were considered the most problematic species locally but measurements of loss indicate this perceived severity was disproportionately high. In contrast goats (Capra hircus) were considered only a moderate risk, yet risk of damage by this species was significant. Surprisingly, for wild pigs (Potamochoerus sp), perceptions of severity were not as high as damage incurred might have predicted, although perceived incidence was greater than recorded frequency of damage events. PRM can assist researchers and practitioners to identify and explore perceptions of the risk of crop damage by wildlife. As this study highlights, simply quantifying crop loss does not determine issues that are important to local people nor the complex relationships between perceived risk factors. Furthermore, as PRM is easily transferable it may contribute to the identification and development of standardised approaches of mitigation across sites of negative human-wildlife interaction.	[Webber, Amanda D.; Hill, Catherine M.] Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev ACCEND, Oxford OX3 0BP, England; [Webber, Amanda D.] Bristol Zool Soc, Bristol, Avon, England	Oxford Brookes University	Webber, AD (corresponding author), Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev ACCEND, Oxford OX3 0BP, England.	awebber@brookes.ac.uk	Hill, Catherine M/D-3634-2009		Oxford Brookes University Scholarship; Wildlife Conservation Society Research Fellowship; Parkes Foundation; Wenner Gren Foundation; Primate Conservation; British Airways/Royal Geographical Society	Oxford Brookes University Scholarship; Wildlife Conservation Society Research Fellowship; Parkes Foundation; Wenner Gren Foundation; Primate Conservation; British Airways/Royal Geographical Society	Funding was provided by an Oxford Brookes University Scholarship, a Wildlife Conservation Society Research Fellowship, grants from the Parkes Foundation, Wenner Gren Foundation, Primate Conservation, Incorporated and a British Airways/Royal Geographical Society (with IBG) Travel Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SE, 2000, ENVIRON CONSERV, V27, P341, DOI 10.1017/S0376892900000394; ASA, 1999, ETH GUID GOOD RES PR; Baird TD, 2009, HUM ECOL, V37, P463, DOI 10.1007/s10745-009-9264-z; Birbili Maria., 2000, SOCIAL RES UPDATE, V31, P1; Bloor M, 2001, FOCUS GROUPS SOCIAL, DOI DOI 10.4135/9781849209175; Brown M., 1992, DESIGNING INTEGRATED; Bryman A, 2000, SOCIAL RES METHODS, P312; Campbell-Smith G, 2010, AM J PRIMATOL, V7, P1; Chalise M. K, 2000, ASIAN PRIMATES, V7, P4; Conforti VA, 2003, BIOL CONSERV, V111, P215, DOI 10.1016/S0006-3207(02)00277-X; De Boer WF, 1998, ENVIRON CONSERV, V25, P208, DOI 10.1017/S0376892998000265; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Gore M. L., 2009, Human Dimensions of Wildlife, V14, P301, DOI 10.1080/10871200903160944; Hill C. M., 2005, PRIMATE COMMENSALISM, P40; Hill CM, 2012, BIODIVERS CONSERV, V21, P2569, DOI 10.1007/s10531-012-0318-y; Hill CM, 1997, INT J PEST MANAGE, V43, P77, DOI 10.1080/096708797229022; Hill CM, 2000, INT J PRIMATOL, V21, P299, DOI 10.1023/A:1005481605637; Hill CM, 2010, AM J PRIMATOL, V71, P1; Hill CM., 2004, HUMAN DIMENSIONS WIL, V9, P279, DOI [10.1080/10871200490505710, DOI 10.1080/10871200490505710]; Inskip C, 2013, HUM ECOL, V41, P169, DOI 10.1007/s10745-012-9556-6; Jackson Rodney M., 2004, Human Dimensions of Wildlife, V9, P307; Jadhav S, 2012, HEALTH PLACE, V18, P1356, DOI 10.1016/j.healthplace.2012.06.019; JHALA YV, 1993, INT J PEST MANAGE, V39, P23, DOI 10.1080/09670879309371754; Kahler JS, 2013, CONSERV BIOL, V27, P177, DOI 10.1111/j.1523-1739.2012.01960.x; Knight J., 2000, NATURAL ENEMIES PEOP, P1; Kreuger R., 2000, FOCUS GROUPS PRACTIC; Lee P. C., 2005, COMMENSALISM CONFLIC, V4, P1, DOI DOI 10.1002/047001539X.CH1; Linkie M, 2007, ANIM CONSERV, V10, P127, DOI 10.1111/j.1469-1795.2006.00083.x; Mackenzie CA, 2012, ECOL ECON, V75, P72, DOI 10.1016/j.ecolecon.2011.12.018; McLennan MR, 2012, J NAT CONSERV, V20, P219, DOI 10.1016/j.jnc.2012.03.002; MITCHELL J, 1991, DISASTERS, V15, P68, DOI 10.1111/j.1467-7717.1991.tb00429.x; Naughton-Treves L, 1997, GEOGR REV, V87, P27, DOI 10.2307/215656; Naughton-Treves L, 1998, CONSERV BIOL, V12, P156, DOI 10.1046/j.1523-1739.1998.96346.x; Naughton-Treves L, 2005, CONSERV BIOL SER, V9, P252; NEWMARK WD, 1993, BIOL CONSERV, V63, P177, DOI 10.1016/0006-3207(93)90507-W; Ogra MV, 2008, GEOFORUM, V39, P1408, DOI 10.1016/j.geoforum.2007.12.004; Okello Moses Makonjio, 2005, Human Dimensions of Wildlife, V10, P19, DOI 10.1080/10871200590904851; PATERSON J, 2005, COMMENSALISM CONFLIC, P76; Priston NEC., 2005, CROP RAIDING MACACA; Quinn CH, 2003, J ENVIRON MANAGE, V68, P111, DOI 10.1016/S0301-4797(03)00013-6; Reynolds V, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P309; Riley E. P., 2010, AM J PRIMATOL, V71, P1; SALAFSKY N, 1993, CONSERV BIOL, V7, P928, DOI 10.1046/j.1523-1739.1993.740928.x; SHEPARD GH, 2002, PRIMATES FACE FACE C, P101, DOI DOI 10.1017/CBO9780511542404.010; Siex KS, 1999, J APPL ECOL, V36, P1009, DOI 10.1046/j.1365-2664.1999.00455.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Smith K, 2000, WORLD DEV, V28, P1945, DOI 10.1016/S0305-750X(00)00053-X; SUKUMAR R, 1990, J TROP ECOL, V6, P33, DOI 10.1017/S0266467400004004; Swetnam RD, 2011, LANDSCAPE URBAN PLAN, V100, P411, DOI 10.1016/j.landurbplan.2011.02.002; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Tweheyo M, 2005, WILDLIFE BIOL, V11, P237, DOI 10.2981/0909-6396(2005)11[237:POCRBP]2.0.CO;2; VanVuren D, 1996, BIOL AGRIC HORTIC, V13, P39, DOI 10.1080/01448765.1996.9754765; Vercammen Paul, 1993, P93; Wallace GE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046636; WARREN Y, 2003, OLIVE BABOONS PAPIO; Warren Y, 2007, INT J PEST MANAGE, V53, P207, DOI 10.1080/09670870701288124; Webber AD, 2007, ORYX, V41, P177, DOI 10.1017/S0030605307001792; Webber AD, 2006, PRIMATE CROP RAIDING; Webber AD, 2010, INT J PEST MANAGE, V56, P9, DOI 10.1080/09670870902980826; Weladji RB, 2003, ORYX, V37, P72, DOI 10.1017/S0030605303000140; Wheaton B., 2002, Power games: a critical sociology of sport, P240	62	24	26	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102912	10.1371/journal.pone.0102912	http://dx.doi.org/10.1371/journal.pone.0102912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25076415	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800020
J	van Bel, N; van der Velden, Y; Bonnard, D; Le Rouzic, E; Das, AT; Benarous, R; Berkhout, B				van Bel, Nikki; van der Velden, Yme; Bonnard, Damien; Le Rouzic, Erwann; Das, Atze T.; Benarous, Richard; Berkhout, Ben			The Allosteric HIV-1 Integrase Inhibitor BI-D Affects Virion Maturation but Does Not Influence Packaging of a Functional RNA Genome	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL-MOLECULE INHIBITORS; REVERSE TRANSCRIPTION; PRIMER TRNA(LYS3); KISSING COMPLEX; DIMERIZATION; REPLICATION; IDENTIFICATION; LEDGF/P75; DIMER	The viral integrase (IN) is an essential protein for HIV-1 replication. IN inserts the viral dsDNA into the host chromosome, thereby aided by the cellular co-factor LEDGF/p75. Recently a new class of integrase inhibitors was described: allosteric IN inhibitors (ALLINIs). Although designed to interfere with the IN-LEDGF/p75 interaction to block HIV DNA integration during the early phase of HIV-1 replication, the major impact was surprisingly found on the process of virus maturation during the late phase, causing a reverse transcription defect upon infection of target cells. Virus particles produced in the presence of an ALLINI are misformed with the ribonucleoprotein located outside the virus core. Virus assembly and maturation are highly orchestrated and regulated processes in which several viral proteins and RNA molecules closely interact. It is therefore of interest to study whether ALLINIs have unpredicted pleiotropic effects on these RNA-related processes. We confirm that the ALLINI BI-D inhibits virus replication and that the produced virus is non-infectious. Furthermore, we show that the wild-type level of HIV-1 genomic RNA is packaged in virions and these genomes are in a dimeric state. The tRNA(lys3) primer for reverse transcription was properly placed on this genomic RNA and could be extended ex vivo. In addition, the packaged reverse transcriptase enzyme was fully active when extracted from virions. As the RNA and enzyme components for reverse transcription are properly present in virions produced in the presence of BI-D, the inhibition of reverse transcription is likely to reflect the mislocalization of the components in the aberrant virus particle.	[van Bel, Nikki; van der Velden, Yme; Das, Atze T.; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Bonnard, Damien; Le Rouzic, Erwann; Benarous, Richard] Biodim Mutabilis, Romainville, France	University of Amsterdam; Academic Medical Center Amsterdam	Berkhout, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	b.berkhout@amc.uva.nl		Bonnard, Damien/0000-0001-9529-5785; van Bel, Nikki/0000-0003-0070-4043	Netherlands Organization for Scientific Research (NWO-CW, Chemical Sciences Division) [700.59.301]; European Union [305137]	Netherlands Organization for Scientific Research (NWO-CW, Chemical Sciences Division)(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission)	This work is supported in part by the Netherlands Organization for Scientific Research (NWO-CW, http://www.nwo.nl/en, Chemical Sciences Division, Top grant 700.59.301 to BB). This work is also supported in part by the European Union Framework Program 7 HIVINNOV (http://www.hivinnov.eu/, Grant 305137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN P, 1995, VIROLOGY, V209, P327, DOI 10.1006/viro.1995.1264; Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Beerens N, 2002, J VIROL, V76, P2329, DOI 10.1128/JVI.76.5.2329-2339.2002; Beerens N, 2001, J BIOL CHEM, V276, P31247, DOI 10.1074/jbc.M102441200; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; Bukovsky A, 1996, J VIROL, V70, P6820, DOI 10.1128/JVI.70.10.6820-6825.1996; Buxton P, 2005, J VIROL, V79, P6338, DOI 10.1128/JVI.79.10.6338-6348.2005; Cen S, 2001, J VIROL, V75, P5043, DOI 10.1128/JVI.75.11.5043-5048.2001; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; DAS AT, 1995, J VIROL, V69, P3090, DOI 10.1128/JVI.69.5.3090-3097.1995; Das AT, 2007, J VIROL, V81, P11159, DOI 10.1128/JVI.01354-07; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Engelman A, 2013, CURR OPIN CHEM BIOL, V17, P339, DOI 10.1016/j.cbpa.2013.04.010; Feng YX, 1999, J VIROL, V73, P4251, DOI 10.1128/JVI.73.5.4251-4256.1999; Fenwick C, 2014, ANTIMICROB AGENTS CH; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; HENDERSON LE, 1992, J VIROL, V66, P1856, DOI 10.1128/JVI.66.4.1856-1865.1992; Hoglund S, 1997, VIROLOGY, V233, P271, DOI 10.1006/viro.1997.8585; HUANG Y, 1994, J VIROL, V68, P7676, DOI 10.1128/JVI.68.12.7676-7683.1994; Jeeninga RE, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-64; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Khorchid A, 2000, J MOL BIOL, V299, P17, DOI 10.1006/jmbi.2000.3709; Kleiman L, 2010, FEBS LETT, V584, P359, DOI 10.1016/j.febslet.2009.11.038; Le Rouzic E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-144; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; MAK J, 1994, J VIROL, V68, P2065, DOI 10.1128/JVI.68.4.2065-2072.1994; Maudru T, 1998, BIOTECHNIQUES, V25, P972, DOI 10.2144/98256bm08; Moore MD, 2008, VIROLOGY, V379, P152, DOI 10.1016/j.virol.2008.06.030; Muriaux D, 1996, J BIOL CHEM, V271, P33686, DOI 10.1074/jbc.271.52.33686; Muriaux D, 1996, BIOCHEMISTRY-US, V35, P5075, DOI 10.1021/bi952822s; Ohishi M, 2011, NUCLEIC ACIDS RES, V39, P3404, DOI 10.1093/nar/gkq1314; Olin JL, 2012, ANN PHARMACOTHER, V46, P1671, DOI 10.1345/aph.1R468; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Saadatmand J, 2012, VIRUS RES, V169, P340, DOI 10.1016/j.virusres.2012.06.001; Shehu-Xhilaga M, 2002, J VIROL, V76, P4331, DOI 10.1128/JVI.76.9.4331-4340.2002; Shehu-Xhilaga M, 2001, J VIROL, V75, P9156, DOI 10.1128/JVI.75.19.9156-9164.2001; SHIN CG, 1994, J VIROL, V68, P1633, DOI 10.1128/JVI.68.3.1633-1642.1994; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Tsantrizos YS, 2009, PREPARATION 2 TERT B; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999	58	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103552	10.1371/journal.pone.0103552	http://dx.doi.org/10.1371/journal.pone.0103552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072705	gold, Green Submitted, Green Published			2022-12-27	WOS:000341307600062
J	Jabourian, A; Lancrenon, S; Delva, C; Perreve-Genet, A; Lablanchy, JP; Jabourian, M				Jabourian, Artin; Lancrenon, Sylvie; Delva, Catherine; Perreve-Genet, Alain; Lablanchy, Jean-Pierre; Jabourian, Maritza			Gait Velocity Is an Indicator of Cognitive Performance in Healthy Middle-Aged Adults	PLOS ONE			English	Article							OSTERRIETH COMPLEX FIGURE; FALL-RELATED FRACTURES; MINI-MENTAL STATE; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; SPATIAL COGNITION; PHYSICAL FUNCTION; OLDER PERSONS; DUAL-TASK; DECLINE	Psychomotor retardation, especially motor and cognitive slowing down, has been described many times in the elderly but to our knowledge, has never been examined in healthy middle-aged adults. The present study explores whether walking time may provide an early signal of cognitive performance, using 266 healthy adults ([18-65] years old, mean age: 45.7 +/- 12.9 years) who were also subdivided in 2 groups: under or over 50. Walking time (50 meters) and cognitive performances (mini-mental state examination, Benton Visual Retention Test and Rey Complex Figure) were assessed; total psychometric score was the sum of individual test scores. Analyses were controlled for age, gender, education level, height and weight. The mean psychometric scores were within the normal range. A substantial proportion of subjects exhibited low performance in some aspects of visuospatial memory, particularly in the older subset. In the total population, walking time was negatively correlated with all cognitive tests, particularly to total psychometric score (R = -0.817, p < 0.0001); the unique contribution of walking time on all cognitive scores was very high (delta R-squared = 0.496). In the older subset, performances on walk and cognition were lower than in the younger subset. Total psychometric score showed the strongest correlation with walking time in the older subset (R = -0.867; p<0.001). In all subsets, walking time was the main explanatory variable of the total psychometric score (delta R-squared: <= 49 = 0.361; >= 50 = 0.613). These findings indicate that i) a significant proportion of adults without cognitive complaints exhibit low cognitive performance including visuospatial memory and longer walking time, ii) cognitive functioning is strongly correlated to walking time in healthy middle-aged adults, iii) gait velocity (GV) could be an indicator of cognitive performance in some important cognitive domains. These results warrant further investigation because such data may represent a marker for the detection of middle-aged adults who are at risk for further cognitive decline.	[Jabourian, Artin; Jabourian, Maritza] Clin Neurophysiol Lab, Paris, France; [Lancrenon, Sylvie; Delva, Catherine] SYLIA STAT, Bourg La Reine, France; [Perreve-Genet, Alain] Ctr Cardiol, Paris, France; [Lablanchy, Jean-Pierre] Ctr Psychiat, Paris, France		Jabourian, M (corresponding author), Clin Neurophysiol Lab, Paris, France.	maritza.jabourian@gmail.com						Abrams L, 2009, NEUROBIOL AGING, V30, P525, DOI 10.1016/j.neurobiolaging.2008.11.012; [Anonymous], GERIATRIC NEUROPSYCH; BENSON DF, 1988, ARCH NEUROL-CHICAGO, V45, P789, DOI 10.1001/archneur.1988.00520310107024; Benton A, 1965, MANUEL APPL TEST RET; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Brooks BL, 2009, CAN PSYCHOL, V50, P196, DOI 10.1037/a0016066; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Clouston SAP, 2013, EPIDEMIOL REV, V35, P33, DOI 10.1093/epirev/mxs004; DEJAEGER C, 1994, J AM GERIATR SOC, V42, P1305, DOI 10.1111/j.1532-5415.1994.tb06519.x; Deshpande N, 2009, AGE AGEING, V38, P509, DOI 10.1093/ageing/afp093; FARBER JF, 1988, J AM GERIATR SOC, V36, P509, DOI 10.1111/j.1532-5415.1988.tb04020.x; Fastenau PS, 1999, CLIN NEUROPSYCHOL, V13, P30, DOI 10.1076/clin.13.1.30.1976; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukuyama H, 1997, NEUROSCI LETT, V228, P183, DOI 10.1016/S0304-3940(97)00381-9; GOLDSTEIN G, 1981, Journal of Clinical Neuropsychology, V3, P65, DOI 10.1080/01688638108403114; Gorelick PB, 1999, NEUROLOGY, V52, P1114, DOI 10.1212/WNL.52.6.1114; HACHINSKI VC, 1993, NEUROLOGY, V43, P2159, DOI 10.1212/WNL.43.10.2159-a; Hausdorff JM, 1999, J AM GERIATR SOC, V47, P1346, DOI 10.1111/j.1532-5415.1999.tb07437.x; HENNERICI MG, 1994, DEMENTIA, V5, P197, DOI 10.1159/000106723; Holtzer R, 2012, MOTOR CONTROL, V16, P64, DOI 10.1123/mcj.16.1.64; Howe TE, 2003, CLIN REHABIL, V17, P363, DOI 10.1191/0269215503cr621oa; Iachini Ina, 2009, Curr Aging Sci, V2, P43; Inzitari M, 2007, NEUROEPIDEMIOLOGY, V29, P156, DOI 10.1159/000111577; JABOURIAN AP, 1995, ANN MED-PSYCHOL, V153, P89; JABOURIAN AP, 1994, BRIT J PSYCHIAT, V165, P122, DOI 10.1192/bjp.165.1.122b; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Johnson DK, 2009, ARCH NEUROL-CHICAGO, V66, P1254, DOI 10.1001/archneurol.2009.158; Klencklen G, 2012, AGEING RES REV, V11, P123, DOI 10.1016/j.arr.2011.10.001; la Fougere C, 2010, NEUROIMAGE, V50, P1589, DOI 10.1016/j.neuroimage.2009.12.060; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Maquet D, 2010, CLIN PHYSIOL FUNCT I, V30, P51, DOI 10.1111/j.1475-097X.2009.00903.x; Marquis S, 2002, ARCH NEUROL-CHICAGO, V59, P601, DOI 10.1001/archneur.59.4.601; Muir SW, 2012, GAIT POSTURE, V35, P96, DOI 10.1016/j.gaitpost.2011.08.014; Nilsson LG, 2009, NEUROBIOL AGING, V30, P521, DOI 10.1016/j.neurobiolaging.2008.11.013; Osterrieth P., 1944, ARCH PSYCHOL-GENEVE, V30, P206; Parkin A. J, 1996, NEUROPSYCHOLOGY, V9, P304, DOI DOI 10.1037/0894-4105.9.3.304; Rey A., 1959, MANUEL TEST COPIE RE; Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3; Ruggiero G, 2008, MEMORY, V16, P821, DOI 10.1080/09658210802307695; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Scherder E, 2007, NEUROSCI BIOBEHAV R, V31, P485, DOI 10.1016/j.neubiorev.2006.11.007; Verghese J, 2008, J AM GERIATR SOC, V56, P1244, DOI 10.1111/j.1532-5415.2008.01758.x; Verlinden VJA, 2013, GAIT POSTURE, V37, P500, DOI 10.1016/j.gaitpost.2012.09.005; Watanabe K, 2005, BRAIN DEV-JPN, V27, P564, DOI 10.1016/j.braindev.2005.02.007; Wiener SI, 2002, COGNITIVE BRAIN RES, V14, P75, DOI 10.1016/S0926-6410(02)00062-9	47	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103211	10.1371/journal.pone.0103211	http://dx.doi.org/10.1371/journal.pone.0103211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25089518	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700022
J	Kondo, Y; Iwao, T; Yoshihashi, S; Mimori, K; Ogihara, R; Nagata, K; Kurose, K; Saito, M; Niwa, T; Suzuki, T; Miyata, N; Ohmori, S; Nakamura, K; Matsunaga, T				Kondo, Yuki; Iwao, Takahiro; Yoshihashi, Sachimi; Mimori, Kayo; Ogihara, Ruri; Nagata, Kiyoshi; Kurose, Kouichi; Saito, Masayoshi; Niwa, Takuro; Suzuki, Takayoshi; Miyata, Naoki; Ohmori, Shigeru; Nakamura, Katsunori; Matsunaga, Tamihide			Histone Deacetylase Inhibitor Valproic Acid Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Hepatocyte-Like Cells	PLOS ONE			English	Article							SMALL MOLECULES; FUNCTIONAL HEPATOCYTES; EFFICIENT GENERATION; LIVER DEVELOPMENT; DEFINED FACTORS; IDENTIFICATION; TRANSDUCTION; INDUCTION; ENDODERM; DRUGS	In this study, we aimed to elucidate the effects and mechanism of action of valproic acid on hepatic differentiation from human induced pluripotent stem cell-derived hepatic progenitor cells. Human induced pluripotent stem cells were differentiated into endodermal cells in the presence of activin A and then into hepatic progenitor cells using dimethyl sulfoxide. Hepatic progenitor cells were matured in the presence of hepatocyte growth factor, oncostatin M, and dexamethasone with valproic acid that was added during the maturation process. After 25 days of differentiation, cells expressed hepatic marker genes and drug-metabolizing enzymes and exhibited drug-metabolizing enzyme activities. These expression levels and activities were increased by treatment with valproic acid, the timing and duration of which were important parameters to promote differentiation from human induced pluripotent stem cell-derived hepatic progenitor cells into hepatocytes. Valproic acid inhibited histone deacetylase activity during differentiation of human induced pluripotent stem cells, and other histone deacetylase inhibitors also enhanced differentiation into hepatocytes. In conclusion, histone deacetylase inhibitors such as valproic acid can be used to promote hepatic differentiation from human induced pluripotent stem cell-derived hepatic progenitor cells.	[Kondo, Yuki; Iwao, Takahiro; Nakamura, Katsunori; Matsunaga, Tamihide] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm, Nagoya, Aichi, Japan; [Iwao, Takahiro; Yoshihashi, Sachimi; Mimori, Kayo; Ogihara, Ruri; Nakamura, Katsunori; Matsunaga, Tamihide] Nagoya City Univ, Fac Pharmaceut Sci, Educ Res Ctr Clin Pharm, Nagoya, Aichi 467, Japan; [Nagata, Kiyoshi] Tohoku Pharmaceut Univ, Environm & Hlth Res Dept, Sendai, Miyagi, Japan; [Kurose, Kouichi] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Dept Food Sci & Technol, Tokyo, Japan; [Saito, Masayoshi; Niwa, Takuro] Mitsubishi Tanabe Pharma Corp, DMPK Res Lab, Toda, Saitama, Japan; [Suzuki, Takayoshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan; [Miyata, Naoki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Organ & Med Chem, Nagoya, Aichi, Japan; [Ohmori, Shigeru] Shinshu Univ, Dept Biochem Pharmacol & Toxicol, Matsumoto, Nagano 390, Japan	Nagoya City University; Nagoya City University; Tohoku Medical & Pharmaceutical University; Tokyo University of Marine Science & Technology; Mitsubishi Tanabe Pharma Corporation; Kyoto Prefectural University of Medicine; Nagoya City University; Shinshu University	Matsunaga, T (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharm, Nagoya, Aichi, Japan.	tmatsu@phar.nagoya-cu.ac.jp	Nakamura, Katsunori/ABA-7439-2021; Kurose, Kouichi/O-1966-2014	Kurose, Kouichi/0000-0002-7042-0153	Japan Society for the Promotion of Science [23390036, 22390028, 25460193]; Japan Health Sciences Foundation [KHB1011, KHB1208]; Japanese Ministry of Health, Labor, and Welfare [H22-003]; Mitsubishi Tanabe Pharma Corporation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Health Sciences Foundation; Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation)	This work was supported, in part, by Grants-in-Aid from the Japan Society for the Promotion of Science (23390036, 22390028 and 25460193), by Research on Publicly Essential Drugs and Medical Devices from Japan Health Sciences Foundation (KHB1011 and KHB1208), and by a National Grant-in-Aid from Japanese Ministry of Health, Labor, and Welfare (H22-003). Mitsubishi Tanabe Pharma Corporation provided support in the form of salaries for authors MS & TN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Chateauvieux S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/479364; Dong XJ, 2009, WORLD J GASTROENTERO, V15, P5165, DOI 10.3748/wjg.15.5165; Dong XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063405; EADIE MJ, 1991, CLIN PHARMACOKINET, V21, P27, DOI 10.2165/00003088-199121010-00003; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Hannoun Z, 2010, CURR STEM CELL RES T, V5, P233, DOI 10.2174/157488810791824403; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Iwao T, 2014, DRUG METAB PHARMACOK, V29, P44, DOI 10.2133/dmpk.DMPK-13-RG-005; Kondo Y, 2014, DRUG METAB PHARMACOK, V29, P237, DOI 10.2133/dmpk.DMPK-13-RG-104; Lewis DFV, 2004, PHARMACOGENOMICS, V5, P305, DOI 10.1517/phgs.5.3.305.29827; Nagamoto Y, 2012, BIOMATERIALS, V33, P4526, DOI 10.1016/j.biomaterials.2012.03.011; Perucca E, 2006, BRIT J CLIN PHARMACO, V61, P246, DOI 10.1111/j.1365-2125.2005.02529.x; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Suzuki T, 2005, CURR MED CHEM, V12, P2867, DOI 10.2174/092986705774454706; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068669; Suzuki T, 2012, J MED CHEM, V55, P9562, DOI 10.1021/jm300837y; Tahamtani Y, 2013, STEM CELLS DEV, V22, P1419, DOI 10.1089/scd.2012.0453; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama K, 2012, J HEPATOL, V57, P628, DOI 10.1016/j.jhep.2012.04.038; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Wen X, 2001, BRIT J CLIN PHARMACO, V52, P547, DOI 10.1046/j.0306-5251.2001.01474.x; Yamashita Y, 2003, INT J CANCER, V103, P572, DOI 10.1002/ijc.10699	30	24	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104010	10.1371/journal.pone.0104010	http://dx.doi.org/10.1371/journal.pone.0104010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084468	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800117
J	Kuroki, H; Hayashi, H; Okabe, H; Hashimoto, D; Takamori, H; Nakahara, O; Nakagawa, S; Fukushima, Y; Chikamoto, A; Beppu, T; Hirota, M; Iyama, K; Baba, H				Kuroki, Hideyuki; Hayashi, Hiromitsu; Okabe, Hirohisa; Hashimoto, Daisuke; Takamori, Hiroshi; Nakahara, Osamu; Nakagawa, Shigeki; Fukushima, Yukiko; Chikamoto, Akira; Beppu, Toru; Hirota, Masahiko; Iyama, Ken-ichi; Baba, Hideo			EZH2 Is Associated with Malignant Behavior in Pancreatic IPMN via p27(Kip1) Downregulation	PLOS ONE			English	Article							PAPILLARY-MUCINOUS TUMORS; K-RAS MUTATION; HISTONE METHYLATION; CARCINOMA-CELLS; CANCER CELLS; NEOPLASMS; 3-DEAZANEPLANOCIN; PROGRESSION; EXPRESSION; INHIBITOR	Background: The epigenetic mechanism of tumorigenesis in pancreatic intraductal papillary mucinous neoplasm (IPMN) remains largely unknown. The aim of this study is to examine the role of enhancer of zeste homologue 2 (EZH2) alteration in pancreatic IPMN progression. Methods: Fifty-four surgically resected pancreatic IPMN specimens, including a total of 181 lesions (normal duct in 48, adenoma in 50, borderline atypia in 53, carcinoma in situ (CIS) in 19, and invasive carcinoma in 11) were analyzed by immunohistochemical staining (EZH2, Ki-67, p27(Kip1)). Using paraffin embedded sections, total RNA was successfully extracted from 20 IPMN lesions (borderline IPMN in 9, CIS in 6, invasive carcinoma in 5) and 7 pancreatic normal ducts, and then levels of EZH2 and p27(Kip1) mRNA were analyzed by real time PCR. Results: In immunohistochemical analysis, cell proliferative activity revealed by Ki-67 positive nuclei was increased during IPMN progression (normal duct<adenoma<borderline atypia<CIS approximate to invasive carcinoma). EZH2 expression displayed a similar pattern (normal duct<adenoma<borderline atypia<CIS approximate to invasive carcinoma) with cell proliferative activity. EZH2 expression in malignant (CIS and invasive carcinoma) IPMNs was significantly higher than that in adenoma and borderline-atypia IPMNs. EZH2 expression level in IPMN lesions was positively correlated with the Ki-67 positive nuclear ratio (p, 0.0001). EZH2-positive cells in malignant IPMN did not express p27(Kip1). EZH2 mRNA expressions in malignant lesions were significantly higher than those in benign lesions (p<0.0001). In contrast, p27(Kip1) mRNA in malignant lesions was significantly decreased compared to those in benign lesion (p<0.05), and there was an inverse correlation between EZH2 and p27(Kip1) mRNA levels (p = 0.0109). Conclusion: EZH2 is associated with the accelerated cell proliferation and malignant step in pancreatic IPMN via the downregulation of p27(Kip1).	[Kuroki, Hideyuki; Hayashi, Hiromitsu; Okabe, Hirohisa; Hashimoto, Daisuke; Takamori, Hiroshi; Nakahara, Osamu; Nakagawa, Shigeki; Fukushima, Yukiko; Chikamoto, Akira; Beppu, Toru; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Hirota, Masahiko] Kumamoto Reg Med Ctr, Dept Surg, Kumamoto, Japan; [Iyama, Ken-ichi] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Pathol, Kumamoto, Japan	Kumamoto University; Kumamoto University	Baba, H (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan.	hdobaba@kumamoto-u.ac.jp	Hashimoto, Daisuke/AAE-7134-2020		Grants-in-Aid for Scientific Research [24592034] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Biankin AV, 2002, GUT, V50, P861, DOI 10.1136/gut.50.6.861; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cheng LL, 2012, CLIN CANCER RES, V18, P4201, DOI 10.1158/1078-0432.CCR-12-0036; Chiba T, 2012, INT J CANCER, V130, P2557, DOI 10.1002/ijc.26264; Fan T, 2011, MOL CANCER RES, V9, P418, DOI 10.1158/1541-7786.MCR-10-0511; Fritz S, 2009, ONCOLOGIST, V14, P125, DOI 10.1634/theoncologist.2008-0200; Izawa T, 2001, CANCER, V92, P1807, DOI 10.1002/1097-0142(20011001)92:7<1807::AID-CNCR1697>3.0.CO;2-0; Kikuchi J, 2012, LUNG CANCER, V78, P138, DOI 10.1016/j.lungcan.2012.08.003; Kimura W, 1995, INT J PANCREATOL, V18, P197; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Lubezky N, 2011, J GASTROINTEST SURG, V15, P503, DOI 10.1007/s11605-010-1411-8; Mallen-St Clair J, 2012, GENE DEV, V26, P439, DOI 10.1101/gad.181800.111; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Miyasaka Y, 2007, CLIN CANCER RES, V13, P4371, DOI 10.1158/1078-0432.CCR-07-0032; Ougolkov AV, 2008, CLIN CANCER RES, V14, P6790, DOI 10.1158/1078-0432.CCR-08-1013; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Raimondo M, 2002, AM J GASTROENTEROL, V97, P2553; Salvia R, 2004, ANN SURG, V239, P678, DOI 10.1097/01.sla.0000124386.54496.15; Sasaki S, 2003, ONCOL REP, V10, P21; Satoh K, 1996, PANCREAS, V12, P362, DOI 10.1097/00006676-199605000-00007; Sohn TA, 2004, ANN SURG, V239, P788, DOI 10.1097/01.sla.0000128306.90650.aa; Sohn TA, 2001, ANN SURG, V234, P313, DOI 10.1097/00000658-200109000-00005; Song WJ, 2010, CANCER SCI, V101, P1754, DOI 10.1111/j.1349-7006.2010.01577.x; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wu J, 2011, J CELL BIOCHEM, V112, P1938, DOI 10.1002/jcb.23114; Yamao K, 2000, HEPATO-GASTROENTEROL, V47, P1129; Yoshizawa K, 2002, VIRCHOWS ARCH, V441, P437, DOI 10.1007/s00428-002-0645-6; Zgraggen K, 1997, ANN SURG, V226, P491, DOI 10.1097/00000658-199710000-00010; Zhang XM, 2002, RADIOLOGY, V223, P547, DOI 10.1148/radiol.2232010815	29	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e100904	10.1371/journal.pone.0100904	http://dx.doi.org/10.1371/journal.pone.0100904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084021	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800003
J	Liu, ZM; Ho, SC; Tang, N; Chan, R; Chen, YM; Woo, J				Liu, Zhao-Min; Ho, Suzanne C.; Tang, Nelson; Chan, Ruth; Chen, Yu-Ming; Woo, Jean			Urinary Sodium Excretion and Dietary Sources of Sodium Intake in Chinese Postmenopausal Women with Prehypertension	PLOS ONE			English	Article							BLOOD-PRESSURE; SALT INTAKE; CARDIOVASCULAR RISK; PUBLIC-HEALTH; POTASSIUM; HYPERTENSION; CALCIUM; QUESTIONNAIRE; METAANALYSIS; POPULATION	Background: Reducing salt intake in communities is one of the most effective and affordable public health strategies to prevent hypertension, stroke and renal disease. The present study aimed to determine the sodium intake in Hong Kong Chinese postmenopausal women and identify the major food sources contributing to sodium intake and urine excretion. Methods: This was a cross-sectional study among 655 Chinese postmenopausal women with prehypertension who were screened for a randomized controlled trial. Data collection included 24 h urine collection for the measurement of sodium, potassium and creatinine, 3-day dietary records, anthropometric measures and questionnaire survey on demographic data and dietary habits. Results: The average salt intake estimated from urinary excretion was 7.8 +/- 3.2 g/d with 82.1% women above WHO recommendation of 5 g/day. Food groups as soup (21.6%), rice and noodles (13.5%), baked cereals (12.3%), salted/preserved foods (10.8%), Chinese dim sum (10.2%) and sea foods (10.1%) were the major contributors of non-discretionary salt. Discretionary salt use in cooking made a modest contribution to overall intake. Vegetable and fruit intake, age, sodium intake from salted foods, sea foods and soup were the independent determinants of urinary sodium excretion. Conclusions: Our data revealed a significant room for reduction of the sodium intake. Efforts to reduce sodium from diets in Hong Kong Chinese postmenopausal women should focus on both processed foods and discretionary salt during cooking. Sodium reduction in soup and increase in fruit intake would be potentially effective strategy for reducing sodium.	[Liu, Zhao-Min; Tang, Nelson; Chan, Ruth; Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Ho, Suzanne C.] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Chen, Yu-Ming] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Sun Yat Sen University	Liu, ZM (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	liuzhaomin@cuhk.edu.hk; jeanwoowong@cuhk.edu.hk	Chen, Yi/HIR-2608-2022; Woo, Jean/K-2625-2014; Chen, Yu/Y-3292-2019; Chan, Ruth/K-4995-2014; Tang, Nelson L/P-5018-2017; LIU, Zhao-min/ABA-4413-2021; Liu, Zhaomin/L-8685-2019	Woo, Jean/0000-0001-7593-3081; Tang, Nelson L/0000-0002-3607-5819; Chan, Ruth/0000-0002-5725-4066	Chinese University of Hong Kong Research Committee [2041783]	Chinese University of Hong Kong Research Committee(Chinese University of Hong Kong)	The study was funded by the Chinese University of Hong Kong Research Committee Direct Grant No. 2041783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 2011, CHIN NCD REP 2011; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Centre for Food Safety, 2012, STUD SOD CONT LOC FO; Charlton KE, 2008, PUBLIC HEALTH NUTR, V11, P83, DOI 10.1017/S1368980007000146; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Du S, 2013, AM J CLIN NUTR; Espeland MA, 2001, AM J EPIDEMIOL, V153, P996, DOI 10.1093/aje/153.10.996; Forman JP, 2012, CIRCULATION, V125, P3108, DOI 10.1161/CIRCULATIONAHA.112.096115; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2011, LANCET, V378, P380, DOI 10.1016/S0140-6736(11)61174-4; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Ho S. C., 1988, Journal of Human Nutrition and Dietetics, V1, P205, DOI 10.1111/j.1365-277X.1988.tb00190.x; Ho SC, 2001, OSTEOPOROSIS INT, V12, P723, DOI 10.1007/s001980170047; JAMES WPT, 1987, LANCET, V1, P426; Joosten MM, 2014, CIRCULATION, V129, P1121, DOI 10.1161/CIRCULATIONAHA.113.004290; Koliaki C, 2013, NUTR REV, V71, P402, DOI 10.1111/nure.12036; Kwok TCY, 2003, EUR J CLIN NUTR, V57, P299, DOI 10.1038/sj.ejcn.1601553; Liu Z-m, 2013, J OBESITY, V2013, P9; LUFT FC, 1982, HYPERTENSION, V4, P805, DOI 10.1161/01.HYP.4.6.805; MASSEY LK, 1995, NUTR REV, V53, P131, DOI 10.1111/j.1753-4887.1995.tb01536.x; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Morris RC, 2006, J AM COLL NUTR, V25, p262S, DOI 10.1080/07315724.2006.10719576; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Ovesen L, 2002, EUR J CLIN NUTR, V56, pS12, DOI 10.1038/sj.ejcn.1601424; Reinivuo H, 2006, EUR J CLIN NUTR, V60, P1160, DOI 10.1038/sj.ejcn.1602431; SANCHEZCASTILLO CP, 1987, CLIN SCI, V72, P95, DOI 10.1042/cs0720095; SIERSBAE.K, 1971, LANCET, V1, P1133; Stamler J, 1997, AM J CLIN NUTR, V65, P626, DOI 10.1093/ajcn/65.2.626S; Weaver CM, 2013, ADV NUTR, V4, p368S, DOI 10.3945/an.112.003533; Webster JL, 2010, AM J CLIN NUTR, V91, P413, DOI 10.3945/ajcn.2009.28688; Woo J., 1998, Hong Kong Medical Journal, V4, P383; Woo J, 1997, NUTR RES, V17, P1633, DOI 10.1016/S0271-5317(97)00170-X; World Health Organization [Internet]. WHO Press, 2010, STRAT MON EV POP SOD; Yuexin Y., 2002, CHINA FOOD COMPOSITI; Zhai FY, 2006, DIET NUTR INTAKE 2; Zhao LC, 2004, HYPERTENSION, V43, P1332, DOI 10.1161/01.HYP.0000128243.06502.bc	41	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104018	10.1371/journal.pone.0104018	http://dx.doi.org/10.1371/journal.pone.0104018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083775	Green Published, Green Submitted			2022-12-27	WOS:000339819800120
J	Vollebergh, MA; Klijn, C; Schouten, PC; Wesseling, J; Israeli, D; Ylstra, B; Wessels, LFA; Jonkers, J; Linn, SC				Vollebergh, Marieke A.; Klijn, Christiaan; Schouten, Philip C.; Wesseling, Jelle; Israeli, Danielle; Ylstra, Bauke; Wessels, Lodewyk F. A.; Jonkers, Jos; Linn, Sabine C.			Lack of Genomic Heterogeneity at High-Resolution aCGH between Primary Breast Cancers and Their Paired Lymph Node Metastases	PLOS ONE			English	Article							PATTERNS; BRCA1; IDENTIFICATION; CHEMOTHERAPY; ASSOCIATION; CARCINOMAS; PROFILES; SENTINEL; TUMORS	Lymph-node metastasis (LNM) predict high recurrence rates in breast cancer patients. Systemic treatment aims to eliminate (micro) metastatic cells. However decisions regarding systemic treatment depend largely on clinical and molecular characteristics of primary tumours. It remains, however, unclear to what extent metastases resemble the cognate primary breast tumours, especially on a genomic level, and as such will be eradicated by the systemic therapy chosen. In this study we used high-resolution aCGH to investigate DNA copy number differences between primary breast cancers and their paired LNMs. To date, no recurrent LNM-specific genomic aberrations have been identified using array comparative genomic hybridization (aCGH) analysis. In our study we employ a high-resolution platform and we stratify on different breast cancer subtypes, both aspects that might have underpowered previously performed studies. To test the possibility that genomic instability in triple-negative breast cancers (TNBCs) might cause increased random and potentially also recurrent copy number aberrations (CNAs) in their LNMs, we studied 10 primary TNBC-LNM pairs and 10 ER-positive (ER+) pairs and verified our findings adding additionally 5 TNBC-LNM and 22 ER+-LNM pairs. We found that all LNMs clustered nearest to their matched tumour except for two cases, of which one was due to the presence of two distinct histological components in one tumour. We found no significantly altered CNAs between tumour and their LNMs in the entire group or in the subgroups. Within the TNBC subgroup, no absolute increase in CNAs was found in the LNMs compared to their primary tumours, suggesting that increased genomic instability does not lead to more CNAs in LNMs. Our findings suggest a high clonal relationship between primary breast tumours and its LNMs, at least prior to treatment, and support the use of primary tumour characteristics to guide adjuvant systemic chemotherapy in breast cancer patients.	[Vollebergh, Marieke A.; Klijn, Christiaan; Schouten, Philip C.; Jonkers, Jos; Linn, Sabine C.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Wesseling, Jelle] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands; [Wessels, Lodewyk F. A.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Bioinformat & Stat, Amsterdam, Netherlands; [Vollebergh, Marieke A.; Linn, Sabine C.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Med Oncol, Amsterdam, Netherlands; [Israeli, Danielle; Ylstra, Bauke] Vrije Univ, Univ Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Wessels, Lodewyk F. A.] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Delft, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Delft University of Technology	Linn, SC (corresponding author), Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands.	s.linn@nki.nl	Jonkers, Jos/AAG-3246-2019; Ylstra, Bauke/D-2906-2012	Jonkers, Jos/0000-0002-9264-9792; Ylstra, Bauke/0000-0001-9479-3010; Wesseling, Jelle/0000-0002-8940-2676; Klijn, Christiaan/0000-0003-0878-4121	A Sister's Hope/Pink Ribbon	A Sister's Hope/Pink Ribbon	This work was supported by A Sister's Hope/Pink Ribbon and a gift of a cancer patient's family (Family name Duijn-Boeree). This study's funders had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The researchers were all independent from these funders.	Buffart TE, 2008, GENE CHROMOSOME CANC, V47, P994, DOI 10.1002/gcc.20605; Cavalli LR, 2003, CANCER GENET CYTOGEN, V146, P33, DOI 10.1016/S0165-4608(03)00123-7; de Ronde Jorma J, 2010, BMC Res Notes, V3, P298, DOI 10.1186/1756-0500-3-298; Desouki MM, 2011, J CANCER RES CLIN, V137, P795, DOI 10.1007/s00432-010-0937-1; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Falck AK, 2010, WORLD J SURG, V34, P1434, DOI 10.1007/s00268-010-0499-z; Friedrich K, 2008, CELL ONCOL, V30, P39; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holstege H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-654; Holstege H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-455; Klijn C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1143; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lips EH, 2011, ANN ONCOL, V22, P870, DOI 10.1093/annonc/mdq468; Melchor L, 2008, ONCOGENE, V27, P3165, DOI 10.1038/sj.onc.1210975; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Nishizaki T, 1997, GENE CHROMOSOME CANC, V19, P267, DOI 10.1002/(SICI)1098-2264(199708)19:4<267::AID-GCC9>3.0.CO;2-V; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rodenhuis S, 2003, NEW ENGL J MED, V349, P7, DOI 10.1056/NEJMoa022794; Schouten PC, 2013, BREAST CANCER RES TR, V139, P317, DOI 10.1007/s10549-013-2558-2; Smeets SJ, 2011, CLIN CANCER RES, V17, P4959, DOI 10.1158/1078-0432.CCR-11-0462; Smid M, 2011, BREAST CANCER RES TR, V128, P23, DOI 10.1007/s10549-010-1026-5; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stefansson OA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2334; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; Vollebergh MA, 2011, ANN ONCOL, V22, P1561, DOI 10.1093/annonc/mdq624; Wang CJ, 2009, GENE CHROMOSOME CANC, V48, P1091, DOI 10.1002/gcc.20711; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100	34	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103177	10.1371/journal.pone.0103177	http://dx.doi.org/10.1371/journal.pone.0103177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083859	Green Submitted, gold, Green Published			2022-12-27	WOS:000339819800021
J	Abdelhamid, RF; Plessy, C; Yamauchi, Y; Taoka, M; de Hoon, M; Gingeras, TR; Isobe, T; Carninci, P				Abdelhamid, Rehab F.; Plessy, Charles; Yamauchi, Yoshio; Taoka, Masato; de Hoon, Michiel; Gingeras, Thomas R.; Isobe, Toshiaki; Carninci, Piero			Multiplicity of 5 ' Cap Structures Present on Short RNAs	PLOS ONE			English	Article							MESSENGER-RNA; SMALL NUCLEAR; NONCODING RNAS; IDENTIFICATION; DATABASE; PROTEIN; U1	Most RNA molecules are co- or post-transcriptionally modified to alter their chemical and functional properties to assist in their ultimate biological function. Among these modifications, the addition of 59 cap structure has been found to regulate turnover and localization. Here we report a study of the cap structure of human short (<200 nt) RNAs (sRNAs), using sequencing of cDNA libraries prepared by enzymatic pretreatment of the sRNAs with cap sensitive-specificity, thin layer chromatographic (TLC) analyses of isolated cap structures and mass spectrometric analyses for validation of TLC analyses. Processed versions of snoRNAs and tRNAs sequences of less than 50 nt were observed in capped sRNA libraries, indicating additional processing and recapping of these annotated sRNAs biotypes. We report for the first time 2,7 dimethylguanosine in human sRNAs cap structures and surprisingly we find multiple type 0 cap structures (mGpppC, 7mGpppG, GpppG, GpppA, and 7mGpppA) in RNA length fractions shorter than 50 nt. Finally, we find the presence of additional uncharacterized cap structures that wait determination by the creation of needed reference compounds to be used in TLC analyses. These studies suggest the existence of novel biochemical pathways leading to the processing of primary and sRNAs and the modifications of their RNA 59 ends with a spectrum of chemical modifications.	[Abdelhamid, Rehab F.; Plessy, Charles; de Hoon, Michiel; Carninci, Piero] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Abdelhamid, Rehab F.; Plessy, Charles; de Hoon, Michiel; Carninci, Piero] RIKEN, Omics Sci Ctr, Yokohama, Kanagawa, Japan; [Yamauchi, Yoshio; Taoka, Masato; Isobe, Toshiaki] Tokyo Metropolitan Univ, Dept Chem, Grad Sch Sci & Technol, Tokyo 158, Japan; [Yamauchi, Yoshio; Taoka, Masato; Isobe, Toshiaki] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan; [Gingeras, Thomas R.] Cold Spring Harbor Lab, Funct Genom Lab, Cold Spring Harbor, NY 11724 USA	RIKEN; RIKEN; Tokyo Metropolitan University; Japan Science & Technology Agency (JST); Cold Spring Harbor Laboratory	Carninci, P (corresponding author), RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan.	carninci@riken.jp	Plessy, Charles/N-5054-2015; Isobe, Toshiaki/Q-9279-2017; de Hoon, Michiel/A-6443-2013; Carninci, Piero/K-1568-2014	Plessy, Charles/0000-0001-7410-6295; Carninci, Piero/0000-0001-7202-7243; Taoka, Masato/0000-0001-5554-4951; de Hoon, Michiel/0000-0003-0489-2352	National Institutes of Health [U54HG004557]; MEXT; Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants from the National Institutes of Health (U54HG004557) to PC, a research grant for RIKEN Omics Science Center from MEXT to Yoshihide Hayashizaki, and a research grant from MEXT to the RIKEN Center for Life Science Technologies. This work was supported by Core Research for Evolutionary Science and Technology (CREST), Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980; Benarroch D, 2010, RNA, V16, P211, DOI 10.1261/rna.1872110; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; CAMPER SA, 1984, MOL CELL BIOL, V4, P538, DOI 10.1128/MCB.4.3.538; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; DIMOCK K, 1979, J BIOL CHEM, V254, P5591; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Girard C, 2008, J BIOL CHEM, V283, P2060, DOI 10.1074/jbc.M704209200; Grosjean H, 2007, METHOD ENZYMOL, V425, P57, DOI 10.1016/S0076-6879(07)25003-7; Hanada T, 2013, NATURE, V495, P474, DOI 10.1038/nature11923; Hartmann RK, 2009, HDB RNA BIOCH STUDEN, P133; Hausmann S, 2005, J BIOL CHEM, V280, P32101, DOI 10.1074/jbc.M506438200; Hausmann S, 2008, J BIOL CHEM, V283, P31706, DOI 10.1074/jbc.M806127200; Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471; Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756; HSUCHEN CC, 1976, NATURE, V264, P190, DOI 10.1038/264190a0; Huang FQ, 1997, BIOCHEMISTRY-US, V36, P6557, DOI 10.1021/bi970475b; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V126, P8, DOI 10.1016/0003-9861(68)90553-5; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kawano M, 2010, BIOTECHNIQUES, V49, P751, DOI 10.2144/000113516; KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1; KRAINER AR, 1988, NUCLEIC ACIDS RES, V16, P9415, DOI 10.1093/nar/16.20.9415; Kuge H, 1998, NUCLEIC ACIDS RES, V26, P3208, DOI 10.1093/nar/26.13.3208; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIMBACH PA, 1995, BIOCHIMIE, V77, P135, DOI 10.1016/0300-9084(96)88116-8; LIPKIN D, 1954, J AM CHEM SOC, V76, P2871, DOI 10.1021/ja01640a004; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mazieres J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060134; McCue AD, 2012, TRENDS GENET, V28, P616, DOI 10.1016/j.tig.2012.09.001; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; O'Mullane L, 1998, MOL CELL BIOL, V18, P7510, DOI 10.1128/MCB.18.12.7510; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; PERRY KL, 1987, P NATL ACAD SCI USA, V84, P8190, DOI 10.1073/pnas.84.23.8190; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Ro-Choi TS, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/369058; Ro-Choi TS, 1999, CRIT REV EUKAR GENE, V9, P107, DOI 10.1615/CritRevEukarGeneExpr.v9.i2.20; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Ruan JP, 2007, MOL BIOCHEM PARASIT, V155, P66, DOI 10.1016/j.molbiopara.2007.05.008; SHIMOTOHNO K, 1977, P NATL ACAD SCI USA, V74, P2734, DOI 10.1073/pnas.74.7.2734; Simoes-Barbosa A, 2008, NUCLEIC ACIDS RES, V36, P6848, DOI 10.1093/nar/gkn706; Simos G, 1999, CURR BIOL, V9, pR238, DOI 10.1016/S0960-9822(99)80152-3; SINGH R, 1989, P NATL ACAD SCI USA, V86, P8280, DOI 10.1073/pnas.86.21.8280; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Takahashi H, 2012, METHODS MOL BIOL, V786, P181, DOI 10.1007/978-1-61779-292-2_11; Zaitseva L, 2006, PLOS BIOL, V4, P1689, DOI 10.1371/journal.pbio.0040332; Zuberek J, 2003, RNA, V9, P52, DOI 10.1261/rna.2133403	52	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102895	10.1371/journal.pone.0102895	http://dx.doi.org/10.1371/journal.pone.0102895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079783	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800018
J	Roriz, AKC; Passos, LCS; de Oliveira, CC; Eickemberg, M; Moreira, PD; Sampaio, LR				Carneiro Roriz, Anna Karla; Santana Passos, Luiz Carlos; de Oliveira, Carolina Cunha; Eickemberg, Michaela; Moreira, Pricilla de Almeida; Sampaio, Lilian Ramos			Evaluation of the Accuracy of Anthropometric Clinical Indicators of Visceral Fat in Adults and Elderly	PLOS ONE			English	Article							LIPID-ACCUMULATION PRODUCT; TO-HEIGHT RATIO; CARDIOMETABOLIC RISK-FACTORS; CARDIOVASCULAR-DISEASE; ADIPOSITY INDEX; METABOLIC SYNDROME; SCREENING TOOL; OBESITY; PREDICTION; PATHOPHYSIOLOGY	Background: Visceral obesity is associated with higher occurrence of cardiovascular events. There are few studies about the accuracy of anthropometric clinical indicators, using Computed Tomography (CT) as the gold standard. We aimed to determine the accuracy of anthropometric clinical indicators for discrimination of visceral obesity. Methods: Cross-sectional study with 191 adults and elderly of both sexes. Variables: area of visceral adipose tissue (VAT) identified by CT, Waist-to-Height Ratio (WHtR), Conicity index (C index), Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI). ROC analyzes. Results: There were a strong correlation between adiposity indicators and VAT area. Higher accuracy of C index and WHtR (AUC >= 0.81) than the LAP and the VAI was observed. The higher AUC of LAP and VAI were observed among elderly with areas of 0.88 (CI: 0.766-0.944) and 0.83 (CI: 0.705-0.955) in men and 0.80 (CI: 0.672-0.930) and 0.71 (CI: 0.566-0.856) in women, respectively. The cutoffs of C index were 1.30 in elderly, in both sexes, with sensitivity >= 92%, the LAP ranged from 26.4 to 37.4 in men and from 40.6 to 44.0 in women and the VAI was 1.24 to 1.45 (sens >= 76.9%) in men and 1.46 to 1.84 in women. Conclusion: Both the anthropometric indicators, C Index and WHtR, as well as LAP and VAI had high accuracy in visceral obesity discrimination. So, they are effective in cardiovascular risk assessment and in the follow-up for individual and collective clinical practice.	[Carneiro Roriz, Anna Karla; Santana Passos, Luiz Carlos; de Oliveira, Carolina Cunha] Univ Fed Bahia, Postgrad Program Med & Hlth, Salvador, BA, Brazil; [Carneiro Roriz, Anna Karla; Moreira, Pricilla de Almeida; Sampaio, Lilian Ramos] Univ Fed Bahia, Sch Nutr, Dept Nutr Sci, Salvador, BA, Brazil; [Santana Passos, Luiz Carlos] Univ Fed Bahia, Fac Med, Dept Med, Salvador, BA, Brazil; [de Oliveira, Carolina Cunha] Univ Fed Sergipe, Dept Nutr, Lagarto, Sergipe, Brazil; [Eickemberg, Michaela] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil; [Eickemberg, Michaela] Bahiana Sch Med & Publ Hlth, Salvador, BA, Brazil; [Sampaio, Lilian Ramos] Univ Fed Bahia, Postgrad Program Food & Nutr, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal de Sergipe; Universidade Federal da Bahia; Universidade Federal da Bahia	Roriz, AKC (corresponding author), Univ Fed Bahia, Postgrad Program Med & Hlth, Salvador, BA, Brazil.	karlaroriz@hotmail.com		C. RORIZ, ANNA KARLA/0000-0002-1768-5646; Oliveira, Carolina Cunha de/0000-0003-1196-0683	Brazilian National Council for Scientific and Technological Development; Foundation Coordination of Improvement of Higher Education Personnel by Ministry of Education	Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation Coordination of Improvement of Higher Education Personnel by Ministry of Education	This study was funded by the Brazilian National Council for Scientific and Technological Development and by Foundation Coordination of Improvement of Higher Education Personnel by Ministry of Education through research scholarship to AKCR. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-183; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Berber A, 2001, INT J OBESITY, V25, P1794, DOI 10.1038/sj.ijo.0801827; Bouza A, 2008, REV ESP OBES, V6, P153; Bozorgmanesh M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-45; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Roriz AKC, 2010, ARQ BRAS CARDIOL, V95, P698, DOI 10.1590/S0066-782X2010005000159; Chiang JK, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-78; de Almeida RT, 2009, ARQ BRAS CARDIOL, V92, P345; Demura S, 2007, EUR J CLIN NUTR, V61, P727, DOI 10.1038/sj.ejcn.1602576; Elisha B, 2013, APPL PHYSIOL NUTR ME, V38, P892, DOI 10.1139/apnm-2012-0307; Guasch-Ferre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043275; Haun DR, 2009, REV ASSOC MED BRAS, V55, P705, DOI 10.1590/S0104-42302009000600015; Hunter G R, 1994, Obes Res, V2, P563; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; Knowles KM, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/931402; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lohman TG, 1988, ANTHROPOMETRIC STAND, P177, DOI DOI 10.1002/AJHB.1310040323; Mohammadreza B, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-20; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pitanga FJG, 2011, REV BRASILEIRA CINEA, V13, P238; Pitanga Francisco José Gondim, 2005, Arq. Bras. Cardiol., V85, P26, DOI 10.1590/S0066-782X2005001400006; Pitanga Francisco José Gondim, 2006, Rev. Assoc. Med. Bras., V52, P157, DOI 10.1590/S0104-42302006000300016; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Sampaio LR, 2007, ARQ BRAS ENDOCRINOL, V51, P980, DOI 10.1590/S0004-27302007000600013; Silva DAS, 2013, EUR J NUTR, V52, P237, DOI 10.1007/s00394-012-0314-8; Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; SEIDELL JC, 1987, AM J CLIN NUTR, V45, P7, DOI 10.1093/ajcn/45.1.7; Taverna MJ, 2011, EUR J ENDOCRINOL, V164, P559, DOI 10.1530/EJE-10-1039; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tellechea Mariana L, 2009, Diabetes Care, V32, pe85, DOI 10.2337/dc08-2284; VALDEZ R, 1993, INT J OBESITY, V17, P77; VALDEZ R, 1991, J CLIN EPIDEMIOL, V44, P955, DOI 10.1016/0895-4356(91)90059-I; Vidigal FD, 2013, NUTR HOSP, V28, P1639, DOI 10.3305/nh.2013.28.5.6743	36	70	76	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103499	10.1371/journal.pone.0103499	http://dx.doi.org/10.1371/journal.pone.0103499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078454	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800050
J	Diekhof, EK; Wittmer, S; Reimers, L				Diekhof, Esther Kristina; Wittmer, Susanne; Reimers, Luise			Does Competition Really Bring Out the Worst? Testosterone, Social Distance and Inter-Male Competition Shape Parochial Altruism in Human Males	PLOS ONE			English	Article							NEURAL RESPONSES; SEX-DIFFERENCES; ULTIMATUM GAME; UNFAIR OFFERS; AGGRESSION; EVOLUTION; BEHAVIOR; PUNISHMENT; CONFLICT; RESPONSIVENESS	Parochial altruism, defined as increased ingroup favoritism and heightened outgroup hostility, is a widespread feature of human societies that affects altruistic cooperation and punishment behavior, particularly in intergroup conflicts. Humans tend to protect fellow group members and fight against outsiders, even at substantial costs for themselves. Testosterone modulates responses to competition and social threat, but its exact role in the context of parochial altruism remains controversial. Here, we investigated how testosterone influences altruistic punishment tendencies in the presence of an intergroup competition. Fifty male soccer fans played an ultimatum game (UG), in which they faced anonymous proposers that could either be a fan of the same soccer team (ingroup) or were fans of other teams (outgroups) that differed in the degree of social distance and enmity to the ingroup. The UG was played in two contexts with varying degrees of intergroup rivalry. Our data show that unfair offers were rejected more frequently than fair proposals and the frequency of altruistic punishment increased with increasing social distance to the outgroups. Adding an intergroup competition led to a further escalation of outgroup hostility and reduced punishment of unfair ingroup members. High testosterone levels were associated with a relatively increased ingroup favoritism and also a change towards enhanced outgroup hostility in the intergroup competition. High testosterone concentrations further predicted increased proposer generosity in interactions with the ingroup. Altogether, a significant relation between testosterone and parochial altruism could be demonstrated, but only in the presence of an intergroup competition. In human males, testosterone may promote group coherence in the face of external threat, even against the urge to selfishly maximize personal reward. In that way, our observation refutes the view that testosterone generally promotes antisocial behaviors and aggressive responses, but underlines its rather specific role in the fine-tuning of male social cognition.	[Diekhof, Esther Kristina] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; Univ Hamburg, Zool Museum, Inst Human Biol, Neuroendocrinol Unit, Hamburg, Germany	University of Hamburg; University of Hamburg	Diekhof, EK (corresponding author), Univ Hamburg, Bioctr Grindel, Hamburg, Germany.	esther.diekhof@uni-hamburg.de	Diekhof, Esther/AAA-1487-2020	Diekhof, Esther/0000-0003-3826-8494	budget resources of the University of Hamburg	budget resources of the University of Hamburg	This work was supported by budget resources of the University of Hamburg. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; ARCHER J, 1991, BRIT J PSYCHOL, V82, P1, DOI 10.1111/j.2044-8295.1991.tb02379.x; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; Book AS, 2001, AGGRESS VIOLENT BEH, V6, P579, DOI 10.1016/S1359-1789(00)00032-X; Bos PA, 2012, NEUROIMAGE, V61, P730, DOI 10.1016/j.neuroimage.2012.04.002; Bos PA, 2010, P NATL ACAD SCI USA, V107, P9991, DOI 10.1073/pnas.0911700107; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Bramen JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033850; Bruneau EG, 2012, PHILOS T R SOC B, V367, P717, DOI 10.1098/rstb.2011.0293; Budickova Marcela, 2007, Biomedical Papers (Olomouc), V151, P69; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; CAMERER C, 1995, J ECON PERSPECT, V9, P209, DOI 10.1257/jep.9.2.209; Campanha C, 2011, J NEUROSCI, V31, P15569, DOI 10.1523/JNEUROSCI.1253-11.2011; Carre JM, 2009, PSYCHONEUROENDOCRINO, V34, P561, DOI 10.1016/j.psyneuen.2008.10.018; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; DABBS JM, 1990, PSYCHOL SCI, V1, P209, DOI 10.1111/j.1467-9280.1990.tb00200.x; Derntl B, 2009, PSYCHONEUROENDOCRINO, V34, P687, DOI 10.1016/j.psyneuen.2008.11.007; Eisenegger C, 2010, NATURE, V463, P356, DOI 10.1038/nature08711; Eisenegger C, 2011, TRENDS COGN SCI, V15, P263, DOI 10.1016/j.tics.2011.04.008; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fershtman C, 2001, Q J ECON, V116, P351, DOI 10.1162/003355301556338; Foddy M, 2009, PSYCHOL SCI, V20, P419, DOI 10.1111/j.1467-9280.2009.02312.x; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gneezy A, 2012, P ROY SOC B-BIOL SCI, V279, P219, DOI 10.1098/rspb.2011.0805; Goette L, 2010, 5189 IZA DP; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Hermans EJ, 2008, BIOL PSYCHIAT, V63, P263, DOI 10.1016/j.biopsych.2007.05.013; Hermans EJ, 2006, PSYCHONEUROENDOCRINO, V31, P859, DOI 10.1016/j.psyneuen.2006.04.002; Hickman T, 2007, ADV CONSUM RES, V34, P314; Mathew S, 2011, P NATL ACAD SCI USA, V108, P11375, DOI 10.1073/pnas.1105604108; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; McDonald MM, 2012, PHILOS T R SOC B, V367, P670, DOI 10.1098/rstb.2011.0301; Mehta PH, 2006, HORM BEHAV, V50, P684, DOI 10.1016/j.yhbeh.2006.07.001; Mehta PH, 2010, J COGNITIVE NEUROSCI, V22, P2357, DOI 10.1162/jocn.2009.21389; Mehta PH, 2009, HORM BEHAV, V56, P158, DOI 10.1016/j.yhbeh.2009.04.001; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Park J. H., 2010, PSYCHOL PROSOCIAL BE, P13; Roselli CE, 1996, NEUROENDOCRINOLOGY, V64, P139, DOI 10.1159/000127111; Saaksvuori L, 2011, P ROY SOC B-BIOL SCI, V278, P3428, DOI 10.1098/rspb.2011.0252; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sellers JG, 2007, J RES PERS, V41, P126, DOI 10.1016/j.jrp.2006.02.004; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Tomaszycki ML, 2005, DEV PSYCHOBIOL, V47, P318, DOI 10.1002/dev.20102; Vallerand RJ, 2008, J SPORT SCI, V26, P1279, DOI 10.1080/02640410802123185; van Honk J, 2012, NATURE, V485, pE4, DOI 10.1038/nature11136; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Van Vugt M, 2009, SOC PERSONAL PSYCHOL, V3, P927, DOI 10.1111/j.1751-9004.2009.00221.x; WANN DL, 1995, BRIT J SOC PSYCHOL, V34, P223, DOI 10.1111/j.2044-8309.1995.tb01060.x; Wann DL, 2007, AM J PSY, V9, P251; WEST CD, 1973, J CLIN ENDOCR METAB, V36, P1230, DOI 10.1210/jcem-36-6-1230; Wirth MM, 2007, PHYSIOL BEHAV, V90, P496, DOI 10.1016/j.physbeh.2006.10.016; Wright ND, 2012, P ROY SOC B-BIOL SCI, V279, P2275, DOI 10.1098/rspb.2011.2523; Yamagishi T, 2008, RATION SOC, V20, P5, DOI 10.1177/1043463107085442; Yamagishi T, 2012, P NATL ACAD SCI USA, V109, P20364, DOI 10.1073/pnas.1212126109; Zak PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008330; Zizzo DJ, 2011, INT REV EC, V58, P91	63	37	38	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e98977	10.1371/journal.pone.0098977	http://dx.doi.org/10.1371/journal.pone.0098977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25075516	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800002
J	Saporiti, F; Bearhop, S; Silva, L; Vales, DG; Zenteno, L; Crespo, EA; Aguilar, A; Cardona, L				Saporiti, Fabiana; Bearhop, Stuart; Silva, Laura; Vales, Damian G.; Zenteno, Lisette; Crespo, Enrique A.; Aguilar, Alex; Cardona, Luis			Longer and Less Overlapping Food Webs in Anthropogenically Disturbed Marine Ecosystems: Confirmations from the Past	PLOS ONE			English	Article							AMERICAN SEA LION; STABLE-ISOTOPE RATIOS; OTARIA-FLAVESCENS; DELTA-N-15 VALUES; TERM CHANGES; NORTH COAST; FUR SEALS; PATAGONIA; PATTERNS; DIET	The human exploitation of marine resources is characterised by the preferential removal of the largest species. Although this is expected to modify the structure of food webs, we have a relatively poor understanding of the potential consequences of such alteration. Here, we take advantage of a collection of ancient consumer tissues, using stable isotope analysis and SIBER to assess changes in the structure of coastal marine food webs in the South-western Atlantic through the second half of the Holocene as a result of the sequential exploitation of marine resources by hunter-gatherers, western sealers and modern fishermen. Samples were collected from shell middens and museums. Shells of both modern and archaeological intertidal herbivorous molluscs were used to reconstruct changes in the stable isotopic baseline, while modern and archaeological bones of the South American sea lion Otaria flavescens, South American fur seal Arctocephalus australis and Magellanic penguin Spheniscus magellanicus were used to analyse changes in the structure of the community of top predators. We found that ancient food webs were shorter, more redundant and more overlapping than current ones, both in northern-central Patagonia and southern Patagonia. These surprising results may be best explained by the huge impact of western sealing on pinnipeds during the fur trade period, rather than the impact of fishing on fish populations. As a consequence, the populations of pinnipeds at the end of the sealing period were likely well below the ecosystem's carrying capacity, which resulted in a release of intraspecific competition and a shift towards larger and higher trophic level prey. This in turn led to longer and less overlapping food webs.	[Saporiti, Fabiana; Zenteno, Lisette; Aguilar, Alex; Cardona, Luis] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; [Saporiti, Fabiana; Zenteno, Lisette; Aguilar, Alex; Cardona, Luis] Univ Barcelona, Fac Biol, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Bearhop, Stuart] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Silva, Laura; Vales, Damian G.; Crespo, Enrique A.] CENPAT CONICET, Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Lab Marine Mammals, Puerto Madryn, Argentina	University of Barcelona; University of Barcelona; University of Exeter; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Saporiti, F (corresponding author), Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain.	fabiana.saporiti@ub.edu	Cardona, Luis/L-1680-2014; Zenteno-Devaud, Lisette/HGB-2633-2022; Aguilar, Alex/L-1283-2014; Bearhop, Stuart/G-3105-2012; Cardona, Luis/AAL-1354-2021	Cardona, Luis/0000-0002-7892-1323; Zenteno-Devaud, Lisette/0000-0002-1619-911X; Aguilar, Alex/0000-0002-5751-2512; Bearhop, Stuart/0000-0002-5864-0129; Cardona, Luis/0000-0002-7892-1323; Vales, Damian G./0000-0002-6252-1616	Fundacion BBVA [BIOCON08-194/092009-2011]; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina); Spanish Ministerio de Educacion, Cultura y Deporte [AP 2009-4573]; University of Barcelona	Fundacion BBVA(BBVA Foundation); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Spanish Ministerio de Educacion, Cultura y Deporte(Spanish Government); University of Barcelona	Fundacion BBVA funded this research as part of the project "Efectos de la explotacion humana sobre depredadores apicales y la estructura de la red trofica del Mar Argentino durante los utimos 6000 anos'' (BIOCON08-194/092009-2011). Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) provided additional funding through the project "Analisis del uso de los recursos troficos y su relacion con cambios en la abundancia en tres predadores tope del Mar Argentino''. FS has been supported by an FPU Fellowship granted by the Spanish Ministerio de Educacion, Cultura y Deporte (AP 2009-4573). Half of the cost of the publication of this article has been funded by the University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Orquera LA, 2011, QUATERN INT, V239, P61, DOI 10.1016/j.quaint.2011.02.032; Alonso MK, 2000, FISH B-NOAA, V98, P250; Anderson A, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P21; Arnould JPY, 2008, ENCY MARINE MAMMALS, P1079; Bailey G, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P215; Balech Enrique, 2009, Revista de Investigacion y Desarrollo Pesquero, V19, P45; Barrett J, 2008, J ARCHAEOL SCI, V35, P850, DOI 10.1016/j.jas.2007.06.004; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Becker BH, 2006, CONSERV BIOL, V20, P470, DOI 10.1111/j.1523-1739.2006.00379.x; Beretta M, 2011, ARQUEOLOGIA, V17, P137; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boersma DP, 1990, PENGUIN BIOL, P15; BUNN SE, 1995, LIMNOL OCEANOGR, V40, P622, DOI 10.4319/lo.1995.40.3.0622; Burton RK, 2001, OECOLOGIA, V128, P107, DOI 10.1007/s004420100631; Caddy J.F., 1998, SCIENCE, V282, p1383a, DOI 10.1126/science.282.5393.1383a; Marina FC, 2011, MAGALLANIA, V39, P207; Casey MM, 2011, EARTH-SCI REV, V106, P131, DOI 10.1016/j.earscirev.2011.02.001; Chamberlain CP, 2005, P NATL ACAD SCI USA, V102, P16707, DOI 10.1073/pnas.0508529102; Christensen JT, 2008, MAR ECOL PROG SER, V368, P1, DOI 10.3354/meps07635; Christensen V, 2003, FISH FISH, V4, P1, DOI 10.1046/j.1467-2979.2003.00103.x; Coll M, 2012, DEEP SEA RES 2, P1; Corbett DG, 2008, HUMAN IMPACTS ON ANCIENT MARINE ECOSYSTEMS: A GLOBAL PERSPECTIVE, P43; Cousseau M. B., 2000, PECES MARINOS ARGENT; Crenshaw M.A., 1980, Topics in Geobiology, V1, P115; CRESPO E. A., 1991, ECOL AUSTRAL, V1, P87; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Dans Silvana L., 2003, P100; Dans SL, 2004, CAN J FISH AQUAT SCI, V61, P1681, DOI 10.1139/F04-105; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Devine JA, 2006, NATURE, V439, P29, DOI 10.1038/439029a; Drago M, 2009, J ZOOL, V279, P251, DOI 10.1111/j.1469-7998.2009.00613.x; Drago M, 2009, MAR ECOL PROG SER, V384, P273, DOI 10.3354/meps08017; Dulvy Nicholas K., 2009, P129; Emslie SD, 2007, P NATL ACAD SCI USA, V104, P11666, DOI 10.1073/pnas.0608477104; Favier Dubois C.M., 2009, ARQUEOLOGIA PATAGONI, P985; Dubois CMF, 2009, MAGALLANIA, V37, P139; Garcia-Rubies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073922; GODOY JC, 1963, FAUNA SILVESTRE; Gomez Otero J, 2007, ARQUEOLOGIA FUEGO PA, P151; Gomez Otero J, 1999, 13 C NAC ARQ ARG, P396; Gomez Otero J., 2006, THESIS U BUENOS AIRE; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hanson NN, 2009, MAR ECOL PROG SER, V388, P263, DOI 10.3354/meps08158; Herling C, 2005, MAR BIOL, V147, P13, DOI 10.1007/s00227-004-1547-8; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jaureguizar AJ, 2008, SCI MAR, V72, P25; Jennings S, 2003, P ROY SOC B-BIOL SCI, V270, P1413, DOI 10.1098/rspb.2003.2392; Jones DS, 1996, PALAIOS, V11, P340, DOI 10.2307/3515244; Koen-Alonso M, 2005, CAN J FISH AQUAT SCI, V62, P1490, DOI 10.1139/F05-087; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; L'Heureux G, 2002, ANALES I PATAGONI CH, V30; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Libralato S, 2010, BIOL CONSERV, V143, P2182, DOI 10.1016/j.biocon.2010.06.002; Lorrain A, 2003, ANAL CHIM ACTA, V491, P125, DOI 10.1016/S0003-2670(03)00815-8; Lotze HK, 2011, ECOSYSTEMS, V14, P198, DOI 10.1007/s10021-010-9404-8; MANGERUD J, 1972, Boreas (Oslo), V1, P143; McClenachan L, 2012, CONSERV LETT, V5, P73, DOI 10.1111/j.1755-263X.2011.00206.x; Milessi AC, 2013, FRENTE MARITIMO, V23, P83; Moreno E, 2008, ARQUEOLOGIA ETNOHIST; Moreno E, 2011, MAGALLANIA, V39, P265, DOI 10.4067/S0718-22442011000100017; Muck P, 1987, PERUVIAN ANCHOVETA I, P351; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Newsome SD, 2006, MAR MAMMAL SCI, V22, P556, DOI 10.1111/j.1748-7692.2006.00043.x; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; O'Donnell TH, 2003, ORG GEOCHEM, V34, P165, DOI 10.1016/S0146-6380(02)00160-2; Obelic Bogomil, 1998, Quaternary of South America and Antarctic Peninsula, V11, P47; Orquera L, 1997, RELACIONES SOC ARGEN, V21, P215; Orquera L, 1987, RELAC SOC ARG ANTR, V17, P201; Padovani LN, 2012, J SEA RES, V67, P85, DOI 10.1016/j.seares.2011.10.007; Paez E., 2006, BASES CONSERVACION M, P577; Page B, 2005, MAR ECOL PROG SER, V293, P283, DOI 10.3354/meps293283; Parnell A. C., 2013, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Piana E, 2007, KAIYAWOTEHA INFORME; Piola AR, 2009, MAR PATAGONICO; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Reyes LM, 1999, MAR MAMMAL SCI, V15, P478, DOI 10.1111/j.1748-7692.1999.tb00814.x; Riet-Sapriza FG, 2013, DEEP-SEA RES PT II, V88-89, P106, DOI 10.1016/j.dsr2.2012.09.005; Rivadeneira MM, 2010, AQUAT CONSERV, V20, P74, DOI 10.1002/aqc.1051; Rivas AL, 2010, CONT SHELF RES, V30, P752, DOI 10.1016/j.csr.2010.01.009; Sala E, 2004, ECOSYSTEMS, V7, P333, DOI 10.1007/s10021-003-0241-x; Saporiti F, 2013, QUATERN INT, V299, P108, DOI 10.1016/j.quaint.2013.03.026; Saporiti F, PALEOINDIAN PI UNPUB; Schiavini A. M., 1993, LAT AM ANTIQ, V4, P346, DOI DOI 10.2307/972072; Schiavini ACM, 2004, MAMM BIOL, V69, P108, DOI 10.1078/1616-5047-00125; Schiavini Adrián, 2005, Hornero, V20, P5; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schweder T, 2006, CONSERV BIOL SER, P310, DOI 10.1017/CBO9780511541964.022; Serran M, 2008, QUATERN INT, V183, P135, DOI 10.1016/j.quaint.2006.12.001; Silva L, 2014, MAR BIOL, V161, P1195, DOI 10.1007/s00227-014-2410-1; Soto KH, 2004, J ZOOL, V264, P419, DOI 10.1017/s0952836904005965; Tivoli AM, 2010, AVES ORG SOCIOECONOM; Tivoli AM, 2011, J ARCHAEOL SCI, V38, P1148, DOI 10.1016/j.jas.2010.12.018; Trites AW, 2006, CONSERV BIOL SER, P11, DOI 10.1017/CBO9780511541964.003; Tunez JI, 2008, HYDROBIOLOGIA, V598, P191, DOI 10.1007/s10750-007-9150-x; Tunez JI, 2008, ICES J MAR SCI, V65, P1733, DOI 10.1093/icesjms/fsn168; Vales DG, 2013, AQUATIC CONSERVATION; Vander Zanden MJ, 2007, OIKOS, V116, P1378, DOI 10.1111/j.2007.0030-1299.16036.x; Vasconcellos M, 2011, 569 FAO, P93; Vaz Ferreira R., 1982, FAO MAMMAL SEAS, VIV, P477; Vaz-Ferreira, 1982, FAO FISHERIES SERIES, V4, P497; Versteegh EAA, 2011, RAPID COMMUN MASS SP, V25, P675, DOI 10.1002/rcm.4905; WAINRIGHT SC, 1993, MAR BIOL, V115, P481, DOI 10.1007/BF00349847; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zangrando AF, 2014, INT J OSTEOARCHAEOL, V24, P231, DOI 10.1002/oa.2352	113	26	27	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103132	10.1371/journal.pone.0103132	http://dx.doi.org/10.1371/journal.pone.0103132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076042	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800027
J	Kovamees, O; Shemyakin, A; Pernow, J				Kovamees, Oskar; Shemyakin, Alexey; Pernow, John			Effect of Arginase Inhibition on Ischemia-Reperfusion Injury in Patients with Coronary Artery Disease with and without Diabetes Mellitus	PLOS ONE			English	Article							INDUCED ENDOTHELIAL DYSFUNCTION; NITRIC-OXIDE; MICROVASCULAR FUNCTION; MYOCARDIAL-INFARCTION; CARDIOPROTECTION; PROTECTS; HEART	Background: Arginase competes with nitric oxide synthase for their common substrate L-arginine. Up-regulation of arginase in coronary artery disease (CAD) and diabetes mellitus may reduce nitric oxide bioavailability contributing to endothelial dysfunction and ischemia-reperfusion injury. Arginase inhibition reduces infarct size in animal models. Therefore the aim of the current study was to investigate if arginase inhibition protects from endothelial dysfunction induced by ischemia-reperfusion in patients with CAD with or without type 2 diabetes (Clinical trial registration number: NCT02009527). Methods: Male patients with CAD (n = 12) or CAD + type 2 diabetes (n = 12), were included in this cross-over study with blinded evaluation. Endothelium-dependent vasodilatation was assessed by flow-mediated dilatation (FMD) of the radial artery before and after 20 min ischemia-reperfusion during intra-arterial infusion of the arginase inhibitor (N-omega-hydroxy-nor-L-arginine, 0.1 mg/min) or saline. Results: The forearm ischemia-reperfusion was well tolerated. Endothelium-independent vasodilatation was assessed by sublingual nitroglycerin. Ischemia-reperfusion decreased FMD in patients with CAD from 12.7 +/- 5.2% to 7.9 +/- 4.0% during saline administration (P<0.05). N-omega-hydroxy-nor-L-arginine administration prevented the decrease in FMD in the CAD group (10.3 +/- 4.3% at baseline vs. 11.5 +/- 3.6% at reperfusion). Ischemia-reperfusion did not significantly reduce FMD in patients with CAD + type 2 diabetes. However, FMD at reperfusion was higher following nor-NOHA than following saline administration in both groups (P<0.01). Endothelium-independent vasodilatation did not differ between the occasions. Conclusions: Inhibition of arginase protects against endothelial dysfunction caused by ischemia-reperfusion in patients with CAD. Arginase inhibition may thereby be a promising therapeutic strategy in the treatment of ischemia-reperfusion injury.	[Kovamees, Oskar; Shemyakin, Alexey; Pernow, John] Karolinska Inst, Dept Med, Stockholm, Sweden	Karolinska Institutet	Kovamees, O (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	oskar.kovamees@ki.se	KÃvamees, Oskar/ABC-3686-2020	Pernow, John/0000-0003-4766-0922	European Foundation for the Study of Diabetes [10857]; Swedish Heart and Lung Foundation; Stockholm County Council (ALF); Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme; Novo Nordisk Foundation; Gustav V and Queen Victoria Foundation; Swedish Research Council Medicine [10857]; Novo Nordisk Fonden [NNF14OC0010417] Funding Source: researchfish	European Foundation for the Study of Diabetes; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council (ALF)(Stockholm County Council); Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Gustav V and Queen Victoria Foundation; Swedish Research Council Medicine(Swedish Research Council); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the European Foundation for the Study of Diabetes, Swedish Research Council Medicine (10857), the Swedish Heart and Lung Foundation, the Stockholm County Council (ALF), Karolinska Institutet/Stockholm County Council Strategic Cardiovascular Programme, Novo Nordisk Foundation and Gustav V and Queen Victoria Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TJ, 1995, J AM COLL CARDIOL, V26, P1235, DOI 10.1016/0735-1097(95)00327-4; Bohm F, 2005, CLIN SCI, V108, P357, DOI 10.1042/CS20040317; Cohen MV, 2006, CARDIOVASC RES, V70, P231, DOI 10.1016/j.cardiores.2005.10.021; Darra E, 2010, THROMB HAEMOSTASIS, V104, P200, DOI 10.1160/TH09-08-0554; Deanfield J, 2005, J HYPERTENS, V23, P7, DOI 10.1097/00004872-200501000-00004; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; Gonon AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042038; Gronros J, 2013, ACTA PHYSIOL, V208, P172, DOI 10.1111/apha.12097; Gronros J, 2011, AM J PHYSIOL-HEART C, V300, pH1174, DOI 10.1152/ajpheart.00560.2010; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hein TW, 2003, FASEB J, V17, P2328, DOI 10.1096/fj.03-0115fje; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Jones SP, 2006, J MOL CELL CARDIOL, V40, P16, DOI 10.1016/j.yjmcc.2005.09.011; Jung C, 2010, CARDIOVASC RES, V85, P147, DOI 10.1093/cvr/cvp303; Kharbanda RK, 2001, CIRCULATION, V103, P1624, DOI 10.1161/01.CIR.103.12.1624; Kim JH, 2009, J APPL PHYSIOL, V107, P1249, DOI 10.1152/japplphysiol.91393.2008; Lee MG, 2012, J CARDIOL, V60, P257, DOI 10.1016/j.jjcc.2012.06.003; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Pernow J, 2003, J APPL PHYSIOL, V95, P2218, DOI 10.1152/japplphysiol.00515.2003; Pernow J, 2013, CARDIOVASC RES, V98, P334, DOI 10.1093/cvr/cvt036; Rafnsson A, 2012, DIABETOLOGIA, V55, P600, DOI 10.1007/s00125-011-2415-y; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Settergren M, 2008, EUR HEART J, V29, P1753, DOI 10.1093/eurheartj/ehn166; Shemyakin A, 2012, CIRCULATION, V126, P2943, DOI 10.1161/CIRCULATIONAHA.112.140335; Wang QD, 2002, CARDIOVASC RES, V55, P25, DOI 10.1016/S0008-6363(02)00261-4; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	29	43	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103260	10.1371/journal.pone.0103260	http://dx.doi.org/10.1371/journal.pone.0103260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072937	gold, Green Submitted, Green Published			2022-12-27	WOS:000341307600036
J	Ren, SL; Kim, JK; Kakiyama, G; Rodriguez-Agudo, D; Pandak, WM; Min, HK; Ning, YX				Ren, Shunlin; Kim, Jin Koung; Kakiyama, Genta; Rodriguez-Agudo, Daniel; Pandak, William M.; Min, Hae-Ki; Ning, Yanxia			Identification of Novel Regulatory Cholesterol Metabolite, 5-Cholesten, 3 beta,25-Diol, Disulfate	PLOS ONE			English	Article							FATTY LIVER-DISEASE; LIPID-METABOLISM; SIGNALING PATHWAY; X-RECEPTOR; INFLAMMATORY RESPONSE; ACID SYNTHESIS; IN-VIVO; OXYSTEROL; PROTEIN; OVEREXPRESSION	Oxysterol sulfation plays an important role in regulation of lipid metabolism and inflammatory responses. In the present study, we report the discovery of a novel regulatory sulfated oxysterol in nuclei of primary rat hepatocytes after overexpression of the gene encoding mitochondrial cholesterol delivery protein (StarD1). Forty-eight hours after infection of the hepatocytes with recombinant StarD1 adenovirus, a water-soluble oxysterol product was isolated and purified by chemical extraction and reverse-phase HPLC. Tandem mass spectrometry analysis identified the oxysterol as 5-cholesten-3 beta, 25-diol, disulfate (25HCDS), and confirmed the structure by comparing with a chemically synthesized compound. Administration of 25HCDS to human THP-1-derived macrophages or HepG2 cells significantly inhibited cholesterol synthesis and markedly decreased lipid levels in vivo in NAFLD mouse models. RT-PCR showed that 25HCDS significantly decreased SREBP-1/2 activities by suppressing expression of their responding genes, including ACC, FAS, and HMG-CoA reductase. Analysis of lipid profiles in the liver tissues showed that administration of 25HCDS significantly decreased cholesterol, free fatty acids, and triglycerides by 30, 25, and 20%, respectively. The results suggest that 25HCDS inhibits lipid biosynthesis via blocking SREBP signaling. We conclude that 25HCDS is a potent regulator of lipid metabolism and propose its biosynthetic pathway.	[Ren, Shunlin] Vet Affairs McGuire Med Center, Dept Med, Richmond, VA 23224 USA; Virginia Commonwealth Univ, Dept Med, Richmond, VA 23298 USA	Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University	Ren, SL (corresponding author), Vet Affairs McGuire Med Center, Dept Med, Richmond, VA 23224 USA.	sren@vcu.edu			Durect Corporation, Cupertino, CA; Department of Veterans Affairs Merit Review Grant; VA Research Career Scientist Award; Veterans Affairs [I01BX000197, I01BX001874] Funding Source: NIH RePORTER	Durect Corporation, Cupertino, CA; Department of Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); VA Research Career Scientist Award; Veterans Affairs(US Department of Veterans Affairs)	The research has been funded by Durect Corporation, Cupertino, CA; Department of Veterans Affairs Merit Review Grant; and VA Research Career Scientist Award; and licensed by Durect Corporation, Cupertino, CA. The funders had no role in study design, data collection and analysis, decision to publish.	Accad M, 1998, CURR BIOL, V8, pR601, DOI 10.1016/S0960-9822(98)70386-0; Bai QM, 2012, METABOLISM, V61, P836, DOI 10.1016/j.metabol.2011.11.014; Bai QM, 2011, ATHEROSCLEROSIS, V214, P350, DOI 10.1016/j.atherosclerosis.2010.11.021; Bai QM, 2010, LIPIDS, V45, P29, DOI 10.1007/s11745-009-3375-6; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Cook IT, 2009, DRUG METAB DISPOS, V37, P2069, DOI 10.1124/dmd.108.025759; Ferber D, 2000, SCIENCE, V289, P1446, DOI 10.1126/science.289.5484.1446; Gill S, 2008, PROG LIPID RES, V47, P391, DOI 10.1016/j.plipres.2008.04.002; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; Ip BC, 2013, NUTRIENTS, V6, P124; James OFW, 1998, J HEPATOL, V29, P495, DOI 10.1016/S0168-8278(98)80073-1; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li XB, 2007, J LIPID RES, V48, P2587, DOI 10.1194/jlr.M700301-JLR200; Li XB, 2006, J LIPID RES, V47, P1507, DOI 10.1194/jlr.M600117-JLR200; Ma Y, 2007, INFLAMM RES, V56, P495, DOI 10.1007/s00011-007-6133-3; Ma YJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1369, DOI 10.1152/ajpendo.90555.2008; Ning YX, 2010, J ZHEJIANG UNIV-SC B, V11, P350, DOI 10.1631/jzus.B0900369; Ning YX, 2009, ATHEROSCLEROSIS, V204, P114, DOI 10.1016/j.atherosclerosis.2008.09.006; Ning YX, 2009, LIPIDS, V44, P511, DOI 10.1007/s11745-009-3299-1; Ning YX, 2006, BIOCHEM BIOPH RES CO, V342, P1249, DOI 10.1016/j.bbrc.2006.02.093; Pandak WM, 2001, AM J PHYSIOL-GASTR L, V281, pG878, DOI 10.1152/ajpgi.2001.281.4.G878; Ren SL, 2007, BIOCHEM BIOPH RES CO, V360, P802, DOI 10.1016/j.bbrc.2007.06.143; Ren SL, 2006, J LIPID RES, V47, P1081, DOI 10.1194/jlr.M600019-JLR200; Ren SL, 2014, AM J PHYSIOL-ENDOC M, V306, pE123, DOI 10.1152/ajpendo.00552.2013; Ren SL, 2004, HEPATOLOGY, V40, P910, DOI 10.1002/hep.20382; Shi XJ, 2014, MOL CELL BIOL, V34, P485, DOI 10.1128/MCB.01094-13; Song C, 2001, STEROIDS, V66, P473, DOI 10.1016/S0039-128X(00)00239-7; Tian D, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-144; van Reyk DM, 2006, REDOX REP, V11, P255, DOI 10.1179/135100006X155003; Willson TM, 1996, ANN NY ACAD SCI, V804, P276, DOI 10.1111/j.1749-6632.1996.tb18622.x; Xu LY, 2013, MOL PHARMACOL, V83, P648, DOI 10.1124/mol.112.081505; Xu LY, 2012, AM J PHYSIOL-ENDOC M, V302, pE788, DOI 10.1152/ajpendo.00337.2011; Xu LY, 2010, LIPIDS, V45, P821, DOI 10.1007/s11745-010-3451-y; Zhang X, 2012, J STEROID BIOCHEM, V132, P262, DOI 10.1016/j.jsbmb.2012.06.001; Zhang X, 2012, AM J PHYSIOL-GASTR L, V303, pG344, DOI 10.1152/ajpgi.00403.2011	40	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103621	10.1371/journal.pone.0103621	http://dx.doi.org/10.1371/journal.pone.0103621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072708	Green Published, Green Submitted, gold			2022-12-27	WOS:000341307600073
J	Xu, XF; Su, B; Xie, CG; Wei, SM; Zhou, YQ; Liu, H; Dai, WQ; Cheng, P; Wang, F; Xu, XR; Guo, CY				Xu, Xuanfu; Su, Bin; Xie, Chuangao; Wei, Shumei; Zhou, Yingqun; Liu, Hua; Dai, Weiqi; Cheng, Ping; Wang, Fan; Xu, Xiaorong; Guo, Chuanyong			Sonic Hedgehog-Gli1 Signaling Pathway Regulates the Epithelial Mesenchymal Transition (EMT) by Mediating a New Target Gene, S100A4, in Pancreatic Cancer Cells	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; IN-VITRO; METASTASIS; EXPRESSION; OVEREXPRESSION; GROWTH; ACTIVATION; SURVIVAL; DISEASE; LINES	Aims: The hedgehog signaling pathway plays an important role in EMT of pancreatic cancer cells, but the precise mechanisms remain elusive. Because S100A4 as a key EMT moleculer marker was found to be upregulated upon Gli1 in pancreatic cancer cells, we focused on the relationship between Shh-Gli1 signals and S100 genes family. Methods: On the base of cDNA microarray data, we investigated regulating mechanism of Gli1 to some members of S100A genes family in pancreatic cancer cell lines firstly. Then, the regulation of Gli1 to S100A4 gene was studied by molecular biology assays and the pro-metastasis effection of Gli1-dependent S100A4 was investigated in vitro. Finally, the expressions of Shh, Gli1, S100A4 and E-cadherin in pancreatic cancer tissues were studied by using immunohistochemistry assays. Results: Five members of the S100 genes family, S100A2, S100A4, S100A6, S100A11, and S100A14 were found to be downregulated significantly upon Gli1 knockdown. Gli1 enhancer prediction combining with in vitro data demonstrated that Gli1 primarily regulates S100A family members via cis-acting elements. Indeed, the data indicate S100A4 and vimentin genes were upregulated significantly by Shh/Gli1-expression increasing and E-cadherin was significantly reduced at the same time. Migration of PC cells was increased significantly in a dose-dependent manner of Gli1 expression (P<0.05) and siS100A4 significantly reversed the response of PC cells induced by L-Shh transduction (P<0.01). Conclusion: Our data establish a novel connection between Shh-Gli1 signaling and S100A4 regulation, which imply that S100A4 might be one of the key factors in EMT mediated by Shh-Gli1 signaling in pancreatic cancer.	[Xu, Xuanfu; Zhou, Yingqun; Liu, Hua; Dai, Weiqi; Cheng, Ping; Wang, Fan; Xu, Xiaorong; Guo, Chuanyong] Tongji Univ, Peoples Hosp Shanghai 10, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Su, Bin] Tongji Univ, Peoples Hosp Shanghai 10, Dept Endocrinol, Shanghai 200092, Peoples R China; [Xie, Chuangao; Wei, Shumei] Zhejiang Univ, Hosp 2, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China	Tongji University; Tongji University; Zhejiang University	Xu, XF (corresponding author), Tongji Univ, Peoples Hosp Shanghai 10, Dept Gastroenterol, Shanghai 200092, Peoples R China.	shuanfusky@aliyun.com; xuxr2000@gmail.com		Guo, Chuanyong/0000-0002-6527-4673	National Natural Science Foundation of China [81072005, 81172312, 81101839]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by grants from the National Natural Science Foundation of China (81072005, 81172312 and 81101839). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai KX, 2008, WORLD J GASTROENTERO, V14, P1931, DOI 10.3748/wjg.14.1931; Ansari D, 2011, BRIT J SURG, V98, P1041, DOI 10.1002/bjs.7574; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Bosetti C, 2012, MOL CARCINOGEN, V51, P3, DOI 10.1002/mc.20785; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Carpenter RL, 2012, DISCOV MED, V13, P105; Danilov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026815; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Hejna M, 2001, ANTICANCER RES, V21, P1183; Henry J, 2012, FRONT BIOSCI-LANDMRK, V17, P1517, DOI 10.2741/4001; Ikenaga N, 2009, J GASTROINTEST SURG, V13, P1852, DOI 10.1007/s11605-009-0978-4; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Lees C, 2005, GASTROENTEROLOGY, V129, P1696, DOI 10.1053/j.gastro.2005.05.010; Li DH, 2003, CLIN CANCER RES, V9, P991; Li XQ, 2012, CANCER LETT, V322, P169, DOI 10.1016/j.canlet.2012.02.035; Li ZK, 2004, CANCER-AM CANCER SOC, V101, P58, DOI 10.1002/cncr.20321; Loos M, 2008, ANN NY ACAD SCI, V1138, P169, DOI 10.1196/annals.1414.024; Loos M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-463; Lukanidin E, 2012, SEMIN CANCER BIOL, V22, P216, DOI 10.1016/j.semcancer.2012.02.006; Matthaios D, 2011, ONCOLOGY-BASEL, V81, P259, DOI 10.1159/000334449; Mencia N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-250; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; Neupane D, 2008, CLIN CANCER RES, V14, P7614, DOI 10.1158/1078-0432.CCR-08-1366; Nipp M, 2012, J MOL MED, V90, P163, DOI 10.1007/s00109-011-0815-6; Oida Y, 2006, ONCOL REP, V16, P457; Onishi H, 2011, CANCER SCI, V102, P1144, DOI 10.1111/j.1349-7006.2011.01912.x; Parkin CA, 2008, AM J PHYSIOL-GASTR L, V294, pG363, DOI 10.1152/ajpgi.00457.2007; Quint K, 2009, PANCREATOLOGY, V9, P116, DOI 10.1159/000178882; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Shang X, 2008, GENET SEL EVOL, V40, P449, DOI 10.1051/gse:2008013; Singh BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027306; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Suemizu H, 2007, INT J ONCOL, V31, P741; Tang SN, 2012, INT J CANCER, V131, P30, DOI 10.1002/ijc.26323; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Xu Xuan-Fu, 2009, J Carcinog, V8, P13, DOI 10.4103/1477-3163.55429; Xu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043119; Yu M, 2009, J BIOL CHEM, V284, P5620, DOI 10.1074/jbc.M809172200; Zhang HY, 2012, MOL BIOL REP, V39, P199, DOI 10.1007/s11033-011-0726-1	42	64	73	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e96441	10.1371/journal.pone.0096441	http://dx.doi.org/10.1371/journal.pone.0096441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072505	Green Published, Green Submitted, gold			2022-12-27	WOS:000341307600001
J	Morita, C; Sumioka, R; Nakata, M; Okahashi, N; Wada, S; Yamashiro, T; Hayashi, M; Hamada, S; Sumitomo, T; Kawabata, S				Morita, Chisato; Sumioka, Ryuichi; Nakata, Masanobu; Okahashi, Nobuo; Wada, Satoshi; Yamashiro, Takashi; Hayashi, Mikako; Hamada, Shigeyuki; Sumitomo, Tomoko; Kawabata, Shigetada			Cell Wall-Anchored Nuclease of Streptococcus sanguinis Contributes to Escape from Neutrophil Extracellular Trap-Mediated Bacteriocidal Activity	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; INFECTIVE ENDOCARDITIS; NUCLEOTIDE-SEQUENCE; EXPRESSION; DNASE; DEOXYRIBONUCLEASE; GENE; MAGNESIUM; PROTEINS; GORDONII	Streptococcus sanguinis, a member of the commensal mitis group of streptococci, is a primary colonizer of the tooth surface, and has been implicated in infectious complications including bacteremia and infective endocarditis. During disease progression, S. sanguinis may utilize various cell surface molecules to evade the host immune system to survive in blood. In the present study, we discovered a novel cell surface nuclease with a cell-wall anchor domain, termed SWAN (streptococcal wall-anchored nuclease), and investigated its contribution to bacterial resistance against the bacteriocidal activity of neutrophil extracellular traps (NETs). Recombinant SWAN protein (rSWAN) digested multiple forms of DNA including NET DNA and human RNA, which required both Mg2+ and Ca2+ for optimum activity. Furthermore, DNase activity of S. sanguinis was detected around growing colonies on agar plates containing DNA. In-frame deletion of the swan gene mostly reduced that activity. These findings indicated that SWAN is a major nuclease displayed on the surface, which was further confirmed by immuno-detection of SWAN in the cell wall fraction. The sensitivity of S. sanguinis to NET killing was reduced by swan gene deletion. Moreover, heterologous expression of the swan gene rendered a Lactococcus lactis strain more resistant to NET killing. Our results suggest that the SWAN nuclease on the bacterial surface contributes to survival in the potential situation of S. sanguinis encountering NETs during the course of disease progression.	[Morita, Chisato; Sumioka, Ryuichi; Nakata, Masanobu; Wada, Satoshi; Sumitomo, Tomoko; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Osaka, Japan; [Morita, Chisato; Yamashiro, Takashi] Osaka Univ, Grad Sch Dent, Dept Orthodont & Dentofacial Orthoped, Osaka, Japan; [Sumioka, Ryuichi; Hayashi, Mikako] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Osaka, Japan; [Okahashi, Nobuo] Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Osaka, Japan; [Hamada, Shigeyuki] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University	Nakata, M (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Osaka, Japan.	nakata@dent.osaka-u.ac.jp	okahashi, nobuo/A-4032-2010; Yamashiro, Takashi/Y-6411-2019; Yamashiro, Takashi/S-6010-2019	okahashi, nobuo/0000-0002-8045-7021; Yamashiro, Takashi/0000-0002-4419-9643; Nakata, Masanobu/0000-0003-1686-5415	Japan Society for the Promotion of Science [24390410, 23390103, 23592700]; Grants-in-Aid for Scientific Research [26463112] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) (#24390410, SK), (B) (#23390103, SH), and (C) (#23592700, MN) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salih G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045695; BALES CW, 1990, AM J CLIN NUTR, V51, P462, DOI 10.1093/ajcn/51.3.462; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Castonguay MC, 2013, CARDIOVASC PATHOL, V22, P19, DOI 10.1016/j.carpath.2012.05.007; Chang A, 2011, MOL MICROBIOL, V79, P1629, DOI 10.1111/j.1365-2958.2011.07550.x; Chiu B, 1999, AM HEART J, V138, pS534, DOI 10.1016/S0002-8703(99)70294-2; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; de Buhr N, 2014, MICROBIOL-SGM, V160, P385, DOI 10.1099/mic.0.072199-0; Dyson C, 1999, J INFECTION, V38, P87, DOI 10.1016/S0163-4453(99)90074-9; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Fan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038059; Fontaine MC, 2004, INFECT IMMUN, V72, P774, DOI 10.1128/IAI.72.2.774-781.2004; Fujihara J, 2012, COMP BIOCHEM PHYS B, V163, P263, DOI 10.1016/j.cbpb.2012.07.002; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HAMADA S, 1989, J GEN MICROBIOL, V135, P335; Hasegawa T, 2010, MICROBIOL-SGM, V156, P184, DOI 10.1099/mic.0.031955-0; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Health Protection Agency, 2012, HLTH PROT REP; Hoshino T, 2004, DIAGN MICR INFEC DIS, V48, P195, DOI 10.1016/j.diagmicrobio.2003.10.002; JABLON JM, 1966, J BACTERIOL, V92, P1590, DOI 10.1128/JB.92.6.1590-1596.1966; Jarvill-Taylor KJ, 1999, J BACTERIOL, V181, P1853, DOI 10.1128/JB.181.6.1853-1860.1999; JEFFRIES CD, 1957, J BACTERIOL, V73, P590, DOI 10.1128/JB.73.4.590-591.1957; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; LACKS S, 1975, J BACTERIOL, V124, P1321, DOI 10.1128/JB.124.3.1321-1329.1975; Lacy P, 2008, FRONT BIOSCI-LANDMRK, V13, P5559; Linares DM, 2010, J BACTERIOL, V192, P5806, DOI 10.1128/JB.00533-10; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; MATSUO S, 1991, ARCH ORAL BIOL, V36, P525, DOI 10.1016/0003-9969(91)90146-L; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; MOORE E W, 1970, Journal of Clinical Investigation, V49, P318, DOI 10.1172/JCI106241; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Nakata M, 2011, J BIOL CHEM, V286, P37566, DOI 10.1074/jbc.M111.239780; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; REINHART RA, 1988, ARCH INTERN MED, V148, P2415, DOI 10.1001/archinte.148.11.2415; RYLE CM, 1989, DIFFERENTIATION, V40, P42, DOI 10.1111/j.1432-0436.1989.tb00812.x; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Strom BL, 1998, ANN INTERN MED, V129, P761, DOI 10.7326/0003-4819-129-10-199811150-00002; Suck Dietrich, 1994, Journal of Molecular Recognition, V7, P65, DOI 10.1002/jmr.300070203; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Turner LS, 2009, INFECT IMMUN, V77, P4966, DOI 10.1128/IAI.00760-09; WHITE JC, 1946, J BACTERIOL, V51, P717, DOI 10.1128/JB.51.6.717-722.1946; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06	56	49	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103125	10.1371/journal.pone.0103125	http://dx.doi.org/10.1371/journal.pone.0103125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084357	gold, Green Submitted, Green Published			2022-12-27	WOS:000339819800016
J	Peng, P; Wang, L; Yang, X; Huang, XY; Ba, YN; Chen, XL; Guo, J; Lian, JF; Zhou, JQ				Peng, Ping; Wang, Lu; Yang, Xi; Huang, Xiaoyan; Ba, Yanna; Chen, Xiaoliang; Guo, Jian; Lian, Jiangfang; Zhou, Jianqing			A Preliminary Study of the Relationship between Promoter Methylation of the ABCG1, GALNT2 and HMGCR Genes and Coronary Heart Disease	PLOS ONE			English	Article							CATALYTIC ACTIVITY CONCENTRATIONS; DNA METHYLATION; ARTERY-DISEASE; ENZYMES; IFCC; ATHEROSCLEROSIS; 37-DEGREES-C; EXPRESSION; CANCER; HDL	Aims: To investigate the association of ABCG1, GALNT2 and HMGCR genes promoter DNA methylation with coronary heart disease (CHD) and explore the interaction between their methylation status and the CHD patients' clinical characteristics in Han Chinese population. Methods and results: Methylation-specific polymerase chain reaction (MSP) technology was used to examine the role of the aberrant gene promoter methylation in CHD in Han Chinese population. A total of 85 CHD patients and 54 participants without CHD confirmed by angiography were recruited. 82.8% of the participants with ABCG1 gene promoter hypermethylation have CHD, while only 17.4% of the participants without hypermethylation have it. The average age of the participants with GALNT2 gene promoter hypermethylation is 62.10 +/- 8.21, while that of the participants without hypermethylation is 57.28 +/- 9.87; in the former group, 75.4% of the participants have CHD, compared to only 50% in the latter group. As for the HMGCR gene, the average age of the participants with promoter hypermethylation is 63.24 +/- 8.10 and that of the participants without hypermethylation is 57.79 +/- 9.55; its promoter hypermethylation is likely to be related to smoking. Our results indicated a significant statistical association of promoter methylation of the ABCG1 gene with increased risk of CHD (OR = 19.966; 95% CI, 7.319-54.468; P*<0.001; P*: adjusted for age, gender, smoking, lipid level, hypertension, and diabetes). Similar results were obtained for that of the GALNT2 gene (OR = 2.978; 95% CI, 1.335-6.646; P* = 0.008), but not of HMGCR gene (OR = 1.388; 95% CI, 0.572-3.371; P* = 0.469). Conclusions: The present work provides evidence to support the association of promoter DNA methylation status with the risk profile of CHD. Our data indicates that promoter DNA hypermethylation of the ABCG1 and GALNT2 genes, but not the HMGCR gene, is associated with an increased risk of CHD. CHD, smoking and aging are likely to be the important factors influencing DNA hypermethylation.	[Peng, Ping; Yang, Xi; Huang, Xiaoyan; Ba, Yanna; Chen, Xiaoliang; Guo, Jian; Lian, Jiangfang; Zhou, Jianqing] Ningbo Univ, Lihuili Hosp, Ningbo Med Ctr, Ningbo 315211, Zhejiang, Peoples R China; [Peng, Ping; Ba, Yanna; Chen, Xiaoliang; Guo, Jian] Ningbo Univ, Sch Med, Affiliated Hosp, Ningbo 315211, Zhejiang, Peoples R China; [Wang, Lu] Univ Cambridge, Sch Clin Med, Cambridge, England	Ningbo University; Ningbo University; University of Cambridge	Lian, JF (corresponding author), Ningbo Univ, Lihuili Hosp, Ningbo Med Ctr, Ningbo 315211, Zhejiang, Peoples R China.	pengpingnb@163.com; hjmpin@163.com	Wang, Lu/AAZ-5097-2021	Wang, Lu/0000-0002-4418-8602	Advanced Key Scientific and Technological Programs of NingBo [2011C51001]; Fund of NingBo Science and Technology Innovation team [2011B82015]; Natural Science Foundation of the Zhejiang Province [LY13H020008]; Ningbo Personnel Training Project; Project of Ningbo Medicine and Science [2009A02]	Advanced Key Scientific and Technological Programs of NingBo; Fund of NingBo Science and Technology Innovation team; Natural Science Foundation of the Zhejiang Province(Natural Science Foundation of Zhejiang Province); Ningbo Personnel Training Project; Project of Ningbo Medicine and Science	The research was supported by the grants from Advanced Key Scientific and Technological Programs of NingBo (2011C51001), Fund of NingBo Science and Technology Innovation team (2011B82015), Natural Science Foundation of the Zhejiang Province (LY13H020008), Ningbo Personnel Training Project (first level), and the Project of Ningbo Medicine and Science (2009A02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, Indian J Med Sci, V58, P405; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Chen CX, 2001, CHINESE MED J-PEKING, V114, P1095; Doumas BT, 1997, CLIN CHIM ACTA, V258, P3, DOI 10.1016/S0009-8981(96)06446-7; Eastwood JA, 2011, HEART LUNG, V40, P147, DOI [10.1016/j.hrtlng.2010.04.002, 10.1016/j.hrtlng.2010.05.056]; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Friso S, 2012, J MED GENET, V49, P192, DOI 10.1136/jmedgenet-2011-100195; Guay SP, 2012, EPIGENETICS-US, V7, P464, DOI 10.4161/epi.19633; Hesson LB, 2007, DIS MARKERS, V23, P73, DOI 10.1155/2007/291538; Hiltunen M, 2002, VASC MED, V7, P5, DOI 10.1191/1358863x02vm418oa; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jeemon P, 2011, WORLD J CARDIOL, V3, P230, DOI 10.4330/wjc.v3.i7.230; Jiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059752; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Peng P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050126; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sadeghi M, 2012, J RES MED SCI, V17, P787; Schumann G, 2002, CLIN CHEM LAB MED, V40, P734, DOI 10.1515/CCLM.2002.126; Schumann G, 2002, CLIN CHEM LAB MED, V40, P718, DOI 10.1515/CCLM.2002.124; Schumann G, 2010, CLIN CHEM LAB MED, V48, P615, DOI 10.1515/CCLM.2010.137; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tietjen I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037437; Viles-Gonzalez JF, 2004, MT SINAI J MED, V71, P197; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang N, 2006, ARTERIOSCL THROM VAS, V26, P1310, DOI 10.1161/01.ATV.0000218998.75963.02; Yin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066924; Zhu SK, 2005, CIRCULATION, V112, P1353, DOI 10.1161/CIRCULATIONAHA.104.519025; Zhuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047193	34	49	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e102265	10.1371/journal.pone.0102265	http://dx.doi.org/10.1371/journal.pone.0102265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084356	gold, Green Submitted, Green Published			2022-12-27	WOS:000339819800007
J	Forg, T; Hafner, M; Lux, A				Foerg, Tassilo; Hafner, Mathias; Lux, Andreas			Investigation of Endoglin Wild-Type and Missense Mutant Protein Heterodimerisation Using Fluorescence Microscopy Based IF, BiFC and FRET Analyses	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HEREDITARY HEMORRHAGIC TELANGIECTASIA; TRANSFORMING GROWTH-FACTOR-BETA-1; EXPRESSION ANALYSIS; ENDOTHELIAL-CELLS; CELLULAR-RESPONSES; MUTATION ANALYSIS; RECEPTOR; GENE; IDENTIFICATION	The homodimeric transmembrane receptor endoglin (CD105) plays an important role in angiogenesis. This is highlighted by mutations in its gene, causing the vascular disorder HHT1. The main role of endoglin function has been assigned to the modulation of transforming growth factor beta and bone morphogenetic protein signalling in endothelial cells. Nevertheless, other functions of endoglin have been revealed to be involved in different cellular functions and in other cell types than endothelial cells. Compared to the exploration of its natural function, little experimental data have been gathered about the mode of action of endoglin HHT mutations at the cellular level, especially missense mutations, and to what degree these might interfere with normal endoglin function. In this paper, we have used fluorescence-based microscopic techniques, such as bimolecular fluorescence complementation (BiFC), immunofluorescence staining with the endoglin specific monoclonal antibody SN6, and protein interaction studies by Forster Resonance Energy Transfer (FRET) to investigate the formation and cellular localisation of possible homo-and heterodimers composed of endoglin wild-type and endoglin missense mutant proteins. The results show that all of the investigated missense mutants dimerise with themselves, as well as with wild-type endoglin, and localise, depending on the position of the affected amino acid, either in the rough endoplasmic reticulum (rER) or in the plasma membrane of the cells. We show that the rER retained mutants reduce the amount of endogenous wild-type endoglin on the plasma membrane through interception in the rER when transiently or stably expressed in HMEC-1 endothelial cells. As a result of this, endoglin modulated TGF-beta 1 signal transduction is also abrogated, which is not due to TGF-beta receptor ER trafficking interference. Protein interaction analyses by FRET show that rER located endoglin missense mutants do not perturb protein processing of other membrane receptors, such as T beta RII, ALK5 or ALK1.	[Foerg, Tassilo; Hafner, Mathias] Univ Appl Sci, Inst Mol & Cell Biol, Mannheim, Germany; [Hafner, Mathias; Lux, Andreas] Heidelberg Univ, Med Fac Mannheim, Heidelberg, Germany; [Hafner, Mathias] Heidelberg Univ, Inst Med Technol, Mannheim, Germany; [Hafner, Mathias] Univ Appl Sci, Mannheim, Germany; [Lux, Andreas] Q Bios GmbH Biotechnol, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Lux, A (corresponding author), Heidelberg Univ, Med Fac Mannheim, Heidelberg, Germany.	a.lux@hs-mannheim.de			Ministerium fur Wissenschaft, Forschung und Kunst (Baden-Wurttemberg); Karl-Volker-Stiftung; Fritz-Thyssen Stiftung [10.04.2.171]	Ministerium fur Wissenschaft, Forschung und Kunst (Baden-Wurttemberg); Karl-Volker-Stiftung; Fritz-Thyssen Stiftung	Financial support by Ministerium fur Wissenschaft, Forschung und Kunst (Baden-Wurttemberg), Karl-Volker-Stiftung, and Fritz-Thyssen Stiftung (Grant 10.04.2.171) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Ali BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026206; Anderie I, 2007, CELL SIGNAL, V19, P582, DOI 10.1016/j.cellsig.2006.08.007; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bourdeau A, 2001, AM J PATHOL, V158, P2011, DOI 10.1016/S0002-9440(10)64673-1; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; Cymerman U, 2000, PEDIATR RES, V47, P24, DOI 10.1203/00006450-200001000-00008; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; DEAGOSTINI AI, 1990, J CELL BIOL, V111, P1293, DOI 10.1083/jcb.111.3.1293; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Fernandez-L Africa, 2006, Hum Mutat, V27, P295; Forg LP T., 2010, MICROSCOPY SCI TECHN, V4, P747; Gallione CJ, 1998, HUM MUTAT, V11, P286, DOI 10.1002/(SICI)1098-1004(1998)11:4<286::AID-HUMU6>3.0.CO;2-B; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Guo BQ, 2004, ANTICANCER RES, V24, P1337; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hume AN, 2013, MOL CELL BIOCHEM, V373, P247, DOI 10.1007/s11010-012-1496-3; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li CG, 2000, FASEB J, V14, P55, DOI 10.1096/fasebj.14.1.55; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; Lux A, 1999, J BIOL CHEM, V274, P9984, DOI 10.1074/jbc.274.15.9984; Lux A, 2000, HUM MOL GENET, V9, P745, DOI 10.1093/hmg/9.5.745; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; MARCUM JA, 1985, BIOCHEM BIOPH RES CO, V126, P365, DOI 10.1016/0006-291X(85)90615-1; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MCALLISTER KA, 1995, HUM MOL GENET, V4, P1983, DOI 10.1093/hmg/4.10.1983; Meng QJ, 2006, J BIOL CHEM, V281, P37069, DOI 10.1074/jbc.M608614200; Nolan-Stevaux O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050920; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Pan CC, 2012, BIOCHEM BIOPH RES CO, V424, P620, DOI 10.1016/j.bbrc.2012.06.163; Paquet ME, 2001, HUM MOL GENET, V10, P1347, DOI 10.1093/hmg/10.13.1347; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Pece N, 1997, J CLIN INVEST, V100, P2568, DOI 10.1172/JCI119800; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Pece-Barbara N, 1999, HUM MOL GENET, V8, P2171, DOI 10.1093/hmg/8.12.2171; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pichuantes S, 1997, TISSUE ANTIGENS, V50, P265, DOI 10.1111/j.1399-0039.1997.tb02870.x; Pyne-Geithman GJ, 2009, NEUROCRIT CARE, V10, P225, DOI 10.1007/s12028-008-9143-2; Raab U, 1999, BIOCHEM J, V339, P579, DOI 10.1042/0264-6021:3390579; Ray BN, 2010, CARCINOGENESIS, V31, P435, DOI 10.1093/carcin/bgp327; Sanz-Rodriguez F, 2004, CLIN CHEM, V50, P2003, DOI 10.1373/clinchem.2004.035287; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Shovlin CL, 1997, AM J HUM GENET, V61, P68, DOI 10.1086/513906; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; YAMASHITA H, 1994, J BIOL CHEM, V269, P1995; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	71	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102998	10.1371/journal.pone.0102998	http://dx.doi.org/10.1371/journal.pone.0102998			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080347	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800022
J	Gladstone, BP; Vach, W				Gladstone, Beryl Primrose; Vach, Werner			Choice of Non-Inferiority (NI) Margins Does Not Protect against Degradation of Treatment Effects on an Average - An Observational Study of Registered and Published NI Trials	PLOS ONE			English	Article							CLINICAL-TRIALS; NONINFERIORITY TRIALS; NOSOCOMIAL PNEUMONIA; EQUIVALENCE; DESIGN; SAMPLE; STATISTICS; ISSUES	Objective: NI margins have to be chosen appropriately to control the risk of degradation of treatment effects in non-inferiority (NI) trials. We aimed to study whether the current choice of NI margins protects sufficiently against a degradation of treatment effect on an average. Study Design and Setting: NI trials reflecting current practice were assembled and for each trial, the NI margin was translated into a likelihood of degradation. The likelihood of degradation was calculated as the conditional probability of a treatment being harmful given that it is declared non-inferior in the trial, using simulation. Its distribution among the NI trials was then studied to assess the potential risk of degradation. Results: The median (lower/upper quartile) NI margin among 112 binary outcome NI trials corresponded to an odds ratio of 0.57(0.45, 0.66), while among 38 NI trials with continuous outcome, to a Cohen's d of -0.42(-0.54, -0.31) and a hazard ratio of 0.82(0.73, 0.86) among 24 survival outcome NI trials. Overall, the median likelihood of degradation was 56% (45%, 62%). Conclusion: Only two fifths of the current NI trials had a likelihood of degradation lower than 50%, suggesting that, in majority of the NI trials, there is no sufficient protection against degradation on an average. We suggest a third hurdle for the choice of NI margins, thus contributing a sufficient degree of protection.	[Gladstone, Beryl Primrose; Vach, Werner] Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, Clin Epidemiol Grp, Freiburg, Germany	University of Freiburg	Gladstone, BP (corresponding author), Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, Clin Epidemiol Grp, Freiburg, Germany.	beryl@imbi.uni-freiburg.de	Vach, Werner/F-2512-2011	Vach, Werner/0000-0003-1865-8399	DFG (the German Research Foundation); Albert Ludwigs University Freiburg	DFG (the German Research Foundation)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The open access publication of this work was supported by the DFG (the German Research Foundation) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crisp A, 2008, PHARM STAT, V7, P236, DOI 10.1002/pst.292; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; EMEA:CHMP, 2008, GUID MED PROD TREATM; EMEA:CHMP, 2010, GUID DEV MED PROD TR; EMEA: CHMP, 2005, GUID CHOIC NON MARG; *EMEA CHMP, 2006, GUID CLIN INV MED PR; Everson-Stewart S, 2010, STAT MED, V29, P2769, DOI 10.1002/sim.4053; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; FDA, 1998, INT C HARM ICH GUID; FDA, 2011, BRIEF DOC ENDP CLIN; FDA, 2001, INT C HARM ICH GUID; Fleming TR, 2011, CLIN TRIALS, V8, P432, DOI 10.1177/1740774511410994; Flerning TR, 2008, STAT MED, V27, P317, DOI 10.1002/sim.2855; Food and Drug Administration Center for Drug Evaluation and Research Center for Biologics Evaluation and Research, 2010, GUID IND NO IN PRESS; Garattini S, 2007, LANCET, V370, P1875, DOI 10.1016/S0140-6736(07)61604-3; Gayet-Ageron A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-93; Gerlinger C, 2008, DRUG INF J, V42, P607, DOI 10.1177/009286150804200608; Gerlinger C, 2011, PHARM STAT, V10, P410, DOI 10.1002/pst.507; Gladstone BP, 2013, J CLIN EPIDEMIOL, V66, P386, DOI 10.1016/j.jclinepi.2012.10.011; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1172, DOI 10.1001/jama.295.10.1172; Greene WL, 2000, ANN INTERN MED, V132, P715, DOI 10.7326/0003-4819-132-9-200005020-00006; Huitfeldt B, 2011, PHARM STAT, V10, P414, DOI 10.1002/pst.508; Lange S, 2005, BIOMETRICAL J, V47, P12, DOI 10.1002/bimj.200410085; Rohmel J, 2013, STAT MED, V32, P2335, DOI 10.1002/sim.5563; Rothmann M, 2003, STAT MED, V22, P239, DOI 10.1002/sim.1400; Rothmann MD, 2011, DESIGN ANAL NONINFER; Siegel JP, 2000, AM HEART J, V139, pS166, DOI 10.1016/S0002-8703(00)90066-8; Soonawala D, 2010, INT J EPIDEMIOL, V39, P1567, DOI 10.1093/ije/dyq136; Sorbello A, 2010, DRUG INF J, V44, P165, DOI 10.1177/009286151004400208; StataCorp, 2011, STAT STAT SOFTW; Suda KJ, 2011, PHARMACOTHERAPY, V31, P833, DOI 10.1592/phco.31.9.833; US Government Accountability Office. New drug approval, 2010, NEW DRUG APPR FDAS C; Wangge G, 2013, CAN MED ASSOC J, V185, P222, DOI 10.1503/cmaj.120142	33	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103616	10.1371/journal.pone.0103616	http://dx.doi.org/10.1371/journal.pone.0103616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080093	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800060
J	Jiao, GZ; Lian, HY; Gao, Y; Sun, MJ; Gong, S; Zheng, LL; Zhang, CX; Tan, JH				Jiao, Guang-Zhong; Lian, Hua-Yu; Gao, Yan; Sun, Ming-Ju; Gong, Shuai; Zheng, Liang-Liang; Zhang, Chuan-Xin; Tan, Jing-He			Carrying-Over Effects of GVBD Blocking on Post-Blocking Meiotic Progression of Oocytes: Species Difference and the Signaling Pathway Leading to MPF Activation	PLOS ONE			English	Article							BOVINE FOLLICULAR OOCYTES; IN-VITRO; BUTYROLACTONE-I; CYTOPLASMIC MATURATION; NUCLEAR MATURATION; EMBRYO DEVELOPMENT; GROWTH; INHIBITION; RESUMPTION; ROSCOVITINE	Efforts to improve the quality of in vitro matured oocytes by blocking germinal vesicle breakdown (GVBD) and allowing more time for ooplasmic maturation have achieved little due to a lack of knowledge on the molecular events during GVBD blocking. Such knowledge is also important for studies aimed at regulating gene expression in maturing oocytes prior to GVBD. We studied species difference and signaling pathways leading to the carrying-over effect of GVBD blocking on post-blocking meiotic progression (PBMP). Overall, GVBD-blocking with roscovitine decelerated PBMP of mouse oocytes but accelerated that of pig oocytes. During blocking culture, whereas cyclin B of pig oocytes increased continuously, that of mouse oocytes declined first and then increased slowly. In both species, (a) whereas active CDC2A showed a dynamics similar to cyclin B, inactive CDC2A decreased continuously; (b) when oocytes were blocked in blocking medium containing cycloheximide, PBMP was decelerated significantly while cyclin B and active CDC2A decreasing to the lowest level; (c) whereas sodium vanadate in blocking medium reduced PBMP, epidermal growth factor (EGF) in blocking medium accelerated PBMP significantly with no effect on cyclin B levels. In conclusion, the EGF signaling cascade accelerated PBMP by promoting the pre-MPF (M-phase-promoting factor) to MPF conversion during GVBD blocking with roscovitine. The significant difference in PBMP observed between mouse and pig oocytes was caused by species difference in cyclin B dynamics during blocking culture as no species difference was observed in either pre-MPF to MPF conversion or the EGF signaling activity.	[Jiao, Guang-Zhong; Lian, Hua-Yu; Gao, Yan; Sun, Ming-Ju; Gong, Shuai; Zheng, Liang-Liang; Zhang, Chuan-Xin; Tan, Jing-He] Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Tan, JH (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China.	tanjh@sdau.edu.cn			National Basic Research Program of China [2012CB944403, 2014CB138503]; China National Natural Science Foundation [31272444, 30972096]	National Basic Research Program of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (Nos. 2012CB944403 and 2014CB138503) and the China National Natural Science Foundation (Nos. 31272444 and 30972096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adona PR, 2008, ANIM REPROD SCI, V104, P389, DOI 10.1016/j.anireprosci.2007.06.013; CARPENTER G, 1985, J CELL SCI, P1; Chen XF, 2008, J ENDOCRINOL, V197, P409, DOI 10.1677/JOE-07-0592; COHEN S, 1983, PROG NUCLEIC ACID RE, V29, P245, DOI 10.1016/S0079-6603(08)60452-3; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; Consiglio AL, 2010, REPROD DOMEST ANIM, V45, pe313, DOI 10.1111/j.1439-0531.2009.01565.x; De Avezedo WF, 1997, EUR J BIOCHEM, V243, P518; De Smedt V, 2002, J BIOL CHEM, V277, P28592, DOI 10.1074/jbc.M202742200; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; DING JC, 1994, MOL REPROD DEV, V39, P30, DOI 10.1002/mrd.1080390106; Fujii W, 2011, BIOL REPROD, V85, P1124, DOI 10.1095/biolreprod.111.091801; Gosden R, 1997, BIOESSAYS, V19, P875, DOI 10.1002/bies.950191007; Han D, 2012, THERIOGENOLOGY, V77, P1900, DOI 10.1016/j.theriogenology.2012.01.008; Hyttel P, 1997, THERIOGENOLOGY, V47, P23, DOI 10.1016/S0093-691X(96)00336-6; Jimenez-Macedo AR, 2006, THERIOGENOLOGY, V65, P1769, DOI 10.1016/j.theriogenology.2005.10.012; Kaldis P, 1998, MOL BIOL CELL, V9, P2545, DOI 10.1091/mbc.9.9.2545; Kikuchi K, 2000, BIOL REPROD, V63, P715, DOI 10.1095/biolreprod63.3.715; Le Beux G, 2003, THERIOGENOLOGY, V60, P1049, DOI 10.1016/S0093-691X(03)00124-9; LEVESQUE JT, 1995, MOL REPROD DEV, V42, P114, DOI 10.1002/mrd.1080420115; Lonergan P, 1997, J REPROD FERTIL, V109, P355, DOI 10.1530/jrf.0.1090355; Marchal R, 2001, MOL REPROD DEV, V60, P65, DOI 10.1002/mrd.1062; Nagahara H, 1999, P NATL ACAD SCI USA, V96, P14961, DOI 10.1073/pnas.96.26.14961; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Oh JS, 2010, J CELL BIOL, V188, P199, DOI 10.1083/jcb.200907161; Ponderato N, 2001, MOL REPROD DEV, V60, P579, DOI 10.1002/mrd.1123; Sakaguchi M, 2002, REPRODUCTION, V123, P135, DOI 10.1530/rep.0.1230135; Sakaguchi M, 2000, THERIOGENOLOGY, V54, P1327, DOI 10.1016/S0093-691X(00)00439-8; Sirard MA, 2007, THERIOGENOLOGY, V68, pS71, DOI 10.1016/j.theriogenology.2007.05.053; Sirard MA, 1996, ANIM REPROD SCI, V42, P417, DOI 10.1016/0378-4320(96)01518-7; Sirard MA, 1998, THERIOGENOLOGY, V49, P483, DOI 10.1016/S0093-691X(97)00420-2; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Stricker SA, 2010, MAR DRUGS, V8, P2417, DOI 10.3390/md8082417; Trounson A, 1998, HUM REPROD, V13, P52, DOI 10.1093/humrep/13.suppl_3.52; Tsuji T, 2012, MOL REPROD DEV, V79, P795, DOI 10.1002/mrd.22114; Vigneron C, 2004, MOL REPROD DEV, V69, P457, DOI 10.1002/mrd.20172; Wang YK, 2013, ENDOCRINOLOGY, V154, P3401, DOI 10.1210/en.2013-1133; Witters LA, 1990, CURR OPIN CELL BIOL, V2, P212, DOI 10.1016/0955-0674(90)90009-4; Zhang DX, 2011, J REPROD DEVELOP, V57, P49, DOI 10.1262/jrd.10-087H	39	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103838	10.1371/journal.pone.0103838	http://dx.doi.org/10.1371/journal.pone.0103838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078078	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800087
J	Normark, J; Nelson, M; Engstrom, P; Andersson, M; Bjork, R; Moritz, T; Fahlgren, A; Bergstrom, S				Normark, Johan; Nelson, Maria; Engstrom, Patrik; Andersson, Marie; Bjork, Rafael; Moritz, Thomas; Fahlgren, Anna; Bergstrom, Sven			Maladjusted Host Immune Responses Induce Experimental Cerebral Malaria-Like Pathology in a Murine Borrelia and Plasmodium Co-Infection Model	PLOS ONE			English	Article							REGULATORY T-CELLS; BORNE RELAPSING FEVER; ANTIGEN PRESENTATION; DENDRITIC CELLS; NITRIC-OXIDE; BLOOD-STAGE; CONCOMITANT INFECTION; UP-REGULATION; IFN-GAMMA; IN-VIVO	In the Plasmodium infected host, a balance between pro- and anti-inflammatory responses is required to clear the parasites without inducing major host pathology. Clinical reports suggest that bacterial infection in conjunction with malaria aggravates disease and raises both mortality and morbidity in these patients. In this study, we investigated the immune responses in BALB/c mice, co-infected with Plasmodium berghei NK65 parasites and the relapsing fever bacterium Borrelia duttonii. In contrast to single infections, we identified in the co-infected mice a reduction of L-Arginine levels in the serum. It indicated diminished bioavailability of NO, which argued for a dysfunctional endothelium. Consistent with this, we observed increased sequestration of CD8+ cells in the brain as well over expression of ICAM-1 and VCAM by brain endothelial cells. Co-infected mice further showed an increased inflammatory response through IL-1 beta and TNF-alpha, as well as inability to down regulate the same through IL-10. In addition we found loss of synchronicity of pro- and anti-inflammatory signals seen in dendritic cells and macrophages, as well as increased numbers of regulatory T-cells. Our study shows that a situation mimicking experimental cerebral malaria (ECM) is induced in co-infected mice due to loss of timing and control over regulatory mechanisms in antigen presenting cells.	[Normark, Johan; Nelson, Maria; Engstrom, Patrik; Andersson, Marie; Fahlgren, Anna; Bergstrom, Sven] Umea Univ, Dept Mol Biol, Umea, Sweden; [Normark, Johan; Engstrom, Patrik; Bergstrom, Sven] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Normark, Johan; Nelson, Maria; Engstrom, Patrik; Fahlgren, Anna; Bergstrom, Sven] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Normark, Johan] Umea Univ, Dept Clin Microbiol, Div Infect Dis, Umea, Sweden; [Engstrom, Patrik] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bjork, Rafael] Umea Univ, Dept Math & Math Stat, Umea, Sweden; [Moritz, Thomas] Swedish Univ Agr Sci SLU, Umea Plant Sci Ctr, Umea, Sweden	Umea University; Umea University; Umea University; Umea University; University of California System; University of California Berkeley; Umea University; Swedish University of Agricultural Sciences; Umea University	Normark, J (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	johan.normark@molbiol.umu.se		Moritz, Thomas/0000-0002-4258-3190	Swedish Research Council [07922]; Jeansson foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Jeansson foundations	This work was supported by Swedish Research Council grants to SB and JN, grant number 07922. JN was also supported by the Jeansson foundations (http://www.jeanssonsstiftelser.se). The authors have no conflicting financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Barbour AG, 2001, INFECT IMMUN, V69, P1009, DOI 10.1128/IAI.69.2.1009-1015.2001; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Berger SA, 2005, AM J TROP MED HYG, V73, P207, DOI 10.4269/ajtmh.2005.73.207; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Carroll RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013124; Coban C, 2007, TRENDS MICROBIOL, V15, P271, DOI 10.1016/j.tim.2007.04.003; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dai QY, 2006, MOL MICROBIOL, V60, P1329, DOI 10.1111/j.1365-2958.2006.05177.x; Dickinson GS, 2010, INFECT IMMUN, V78, P4579, DOI 10.1128/IAI.00438-10; Egima CM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-90; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; Goncalves RM, 2010, INFECT IMMUN, V78, P4763, DOI 10.1128/IAI.00578-10; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Jankovic D, 2001, CURR OPIN IMMUNOL, V13, P403, DOI 10.1016/S0952-7915(00)00234-X; Knowles SCL, 2011, INT J PARASITOL, V41, P1041, DOI 10.1016/j.ijpara.2011.05.009; Koram KA, 2007, AM J TROP MED HYG, V77, P1; Larsson C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000522; Lundie RJ, 2010, EUR J IMMUNOL, V40, P1674, DOI 10.1002/eji.200939265; Lundqvist J, 2010, INFECT IMMUN, V78, P1924, DOI 10.1128/IAI.01082-09; Ma NL, 1996, AM J PATHOL, V149, P1745; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; McCarty MF, 2004, MED HYPOTHESES, V63, P699, DOI 10.1016/j.mehy.2002.11.008; McConnell J, 2003, LANCET INFECT DIS, V3, P604, DOI 10.1016/S1473-3099(03)00787-4; Millington Owain R, 2006, J Biol, V5, P5, DOI 10.1186/jbiol34; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nacher M, 2001, AM J TROP MED HYG, V65, P834, DOI 10.4269/ajtmh.2001.65.834; NEWMAN K, 1984, INFECT IMMUN, V45, P572, DOI 10.1128/IAI.45.3.572-576.1984; Niikura M, 2008, J IMMUNOL, V180, P6877, DOI 10.4049/jimmunol.180.10.6877; Niikura M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/383962; Nordstrand A, 2007, EMERG INFECT DIS, V13, P117, DOI 10.3201/eid1301.060670; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Ramos TN, 2013, J BIOL CHEM, V288, P10962, DOI 10.1074/jbc.C113.457028; Serirom S, 2003, AM J PATHOL, V162, P1651, DOI 10.1016/S0002-9440(10)64299-X; Singh RP, 2002, J IMMUNOL, V168, P4674, DOI 10.4049/jimmunol.168.9.4674; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Spence PJ, 2012, CURR OPIN IMMUNOL, V24, P444, DOI 10.1016/j.coi.2012.05.003; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; TRAPE JF, 1991, LANCET, V337, P473, DOI 10.1016/0140-6736(91)93404-W; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Vial L, 2006, LANCET, V368, P37, DOI 10.1016/S0140-6736(06)68968-X; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; WHO, 2010, GUID TREATM MAL, V2nd; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729	58	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103295	10.1371/journal.pone.0103295	http://dx.doi.org/10.1371/journal.pone.0103295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075973	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800036
J	Ullal-Gupta, S; Hannon, EE; Snyder, JS				Ullal-Gupta, Sangeeta; Hannon, Erin E.; Snyder, Joel S.			Tapping to a Slow Tempo in the Presence of Simple and Complex Meters Reveals Experience-Specific Biases for Processing Music	PLOS ONE			English	Article							OTHER-RACE FACES; SENSORIMOTOR SYNCHRONIZATION; OWN-RACE; RHYTHM PERCEPTION; ADULTS; SEQUENCES; PATTERNS; INFANTS; DISCRIMINATION; ENCULTURATION	Musical meters vary considerably across cultures, yet relatively little is known about how culture-specific experience influences metrical processing. In Experiment 1, we compared American and Indian listeners' synchronous tapping to slow sequences. Inter-tone intervals contained silence or to-be-ignored rhythms that were designed to induce a simple meter (familiar to Americans and Indians) or a complex meter (familiar only to Indians). A subset of trials contained an abrupt switch from one rhythm to another to assess the disruptive effects of contradicting the initially implied meter. In the unfilled condition, both groups tapped earlier than the target and showed large tap-tone asynchronies (measured in relative phase). When inter-tone intervals were filled with simple-meter rhythms, American listeners tapped later than targets, but their asynchronies were smaller and declined more rapidly. Likewise, asynchronies rose sharply following a switch away from simple-meter but not from complex-meter rhythm. By contrast, Indian listeners performed similarly across all rhythm types, with asynchronies rapidly declining over the course of complex-and simple-meter trials. For these listeners, a switch from either simple or complex meter increased asynchronies. Experiment 2 tested American listeners but doubled the duration of the synchronization phase prior to (and after) the switch. Here, compared with simple meters, complex-meter rhythms elicited larger asynchronies that declined at a slower rate, however, asynchronies increased after the switch for all conditions. Our results provide evidence that ease of meter processing depends to a great extent on the amount of experience with specific meters.	[Ullal-Gupta, Sangeeta; Hannon, Erin E.; Snyder, Joel S.] Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Hannon, EE (corresponding author), Univ Nevada, Dept Psychol, Las Vegas, NV 89154 USA.	erin.hannon@unlv.edu	Snyder, Joel S/B-4675-2008	Snyder, Joel S/0000-0002-5565-3063	International Programs Office, University of Nevada, Las Vegas; College of Liberal Arts at the University of Nevada Las Vegas	International Programs Office, University of Nevada, Las Vegas; College of Liberal Arts at the University of Nevada Las Vegas	The research was supported in part by a travel grant from the International Programs Office, University of Nevada, Las Vegas awarded to S.U. and summer research stipends from the College of Liberal Arts at the University of Nevada Las Vegas awarded to E.E.H. and J.S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Batschelet E, 1981, CIRCULAR STAT BIOL; Bird J, 2012, NEWNES ENG SCI POCKE; Clayton M., 2000, TIME INDIAN MUSIC RH; COLLIER GL, 1995, J EXP PSYCHOL HUMAN, V21, P602, DOI 10.1037/0096-1523.21.3.602; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; ESSENS PJ, 1986, PERCEPT PSYCHOPHYS, V40, P69, DOI 10.3758/BF03208185; ESSENS PJ, 1985, PERCEPT PSYCHOPHYS, V37, P1, DOI 10.3758/BF03207132; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fitch WT, 2007, MUSIC PERCEPT, V25, P43, DOI 10.1525/mp.2007.25.1.43; Flege JE, 1997, J PHONETICS, V25, P437, DOI 10.1006/jpho.1997.0052; Fraisse P., 1982, PSYCHOL MUSIC, V1, P149, DOI [DOI 10.1016/B978-0-12-213562-0.50010-3, 10.1016/B978-0-12-213562-0.50010-3]; GETTY DJ, 1976, PERCEPT PSYCHOPHYS, V20, P191, DOI 10.3758/BF03198600; Grondin S, 2004, CAN J EXP PSYCHOL, V58, P1, DOI 10.1037/h0087436; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Grondin S, 1999, J EXP PSYCHOL HUMAN, V25, P993, DOI 10.1037/0096-1523.25.4.993; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Hannon EE, 2007, TRENDS COGN SCI, V11, P466, DOI 10.1016/j.tics.2007.08.008; Hannon EE, 2012, J EXP PSYCHOL HUMAN, V38, P543, DOI 10.1037/a0027225; Hannon EE, 2012, ANN NY ACAD SCI, V1252, P92, DOI 10.1111/j.1749-6632.2012.06466.x; Hannon EE, 2011, DEVELOPMENTAL SCI, V14, P865, DOI 10.1111/j.1467-7687.2011.01036.x; Johnson JJ, 1989, COGNITIVE PSYCHOL, V1, P60, DOI DOI 10.1016/0010-0285(89)90003-0; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Large EW, 2008, PSYCHOLOGY OF TIME, P189, DOI 10.1016/B978-0-08046-977-5.00006-5; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Large EW, 2002, PSYCHOL RES-PSYCH FO, V66, P3, DOI 10.1007/s004260100069; Lerdahl F., 1983, GENERATIVE THEORY TO; LONDON J, 1995, MUSIC PERCEPT, V13, P59; LONGUETHIGGINS HC, 1984, MUSIC PERCEPT, V1, P424; LYNCH MP, 1995, DEV PSYCHOBIOL, V28, P377, DOI 10.1002/dev.420280704; MATES J, 1994, J COGNITIVE NEUROSCI, V6, P332, DOI 10.1162/jocn.1994.6.4.332; McClelland JL, 2002, PHYSIOL BEHAV, V77, P657, DOI 10.1016/S0031-9384(02)00916-2; McNeill W. H., 1995, KEEPING TOGETHER TIM; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Naimpalli S, 2005, THEORY PRACTICE TABL; Nettl B, 2000, ORIGINS OF MUSIC, P463; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Poppel E, 1971, Stud Gen (Berl), V24, P85; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Repp BH, 2005, MUSIC PERCEPT, V23, P61, DOI 10.1525/mp.2005.23.1.61; Repp BH, 2003, J MOTOR BEHAV, V35, P355, DOI 10.1080/00222890309603156; Repp Bruno H, 2010, Adv Cogn Psychol, V5, P114, DOI 10.2478/v10053-008-0071-7; Rhodes G, 2006, PSYCHON B REV, V13, P499, DOI 10.3758/BF03193876; Semjen A, 2001, J EXP PSYCHOL HUMAN, V27, P251, DOI 10.1037//0096-1523.27.2.251; Snyder J, 2001, MUSIC PERCEPT, V18, P455, DOI 10.1525/mp.2001.18.4.455; Snyder JS, 2006, MUSIC PERCEPT, V24, P135, DOI 10.1525/mp.2006.24.2.135; TRAINOR LJ, 1992, J EXP PSYCHOL HUMAN, V18, P394, DOI 10.1037/0096-1523.18.2.394; Walker PM, 2003, PERCEPTION, V32, P1117, DOI 10.1068/p5098	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102962	10.1371/journal.pone.0102962	http://dx.doi.org/10.1371/journal.pone.0102962			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25075514	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800022
J	Bakker, M; Wicherts, JM				Bakker, Marjan; Wicherts, Jelte M.			Outlier Removal and the Relation with Reporting Errors and Quality of Psychological Research	PLOS ONE			English	Article							REPLICABILITY; AVAILABILITY; STANDARDS; SCIENCE	Background: The removal of outliers to acquire a significant result is a questionable research practice that appears to be commonly used in psychology. In this study, we investigated whether the removal of outliers in psychology papers is related to weaker evidence (against the null hypothesis of no effect), a higher prevalence of reporting errors, and smaller sample sizes in these papers compared to papers in the same journals that did not report the exclusion of outliers from the analyses. Methods and Findings: We retrieved a total of 2667 statistical results of null hypothesis significance tests from 153 articles in main psychology journals, and compared results from articles in which outliers were removed (N = 92) with results from articles that reported no exclusion of outliers (N = 61). We preregistered our hypotheses and methods and analyzed the data at the level of articles. Results show no significant difference between the two types of articles in median p value, sample sizes, or prevalence of all reporting errors, large reporting errors, and reporting errors that concerned the statistical significance. However, we did find a discrepancy between the reported degrees of freedom of t tests and the reported sample size in 41% of articles that did not report removal of any data values. This suggests common failure to report data exclusions (or missingness) in psychological articles. Conclusions: We failed to find that the removal of outliers from the analysis in psychological articles was related to weaker evidence (against the null hypothesis of no effect), sample size, or the prevalence of errors. However, our control sample might be contaminated due to nondisclosure of excluded values in articles that did not report exclusion of outliers. Results therefore highlight the importance of more transparent reporting of statistical analyses.	[Bakker, Marjan] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Wicherts, Jelte M.] Tilburg Univ, Tilburg Sch Social & Behav Sci, NL-5000 LE Tilburg, Netherlands	University of Amsterdam; Tilburg University	Bakker, M (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	M.Bakker1@uva.nl	Bakker, Marjan/O-5864-2019; Wicherts, Jelte M./A-2664-2008	Bakker, Marjan/0000-0001-9024-337X; Wicherts, Jelte M./0000-0003-2415-2933	Netherlands Organization for Scientific Research (NWO) [400-08-214, 016-125-385]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The preparation of this article was supported by grant numbers 400-08-214 and 016-125-385 from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA (American Psychological Association), 2010, PUBL MAN AM PSYCH AS; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Bakker M, 2014, PSYCHOL METHODS, V19, P409, DOI 10.1037/met0000014; Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Bakker M, 2011, BEHAV RES METHODS, V43, P666, DOI 10.3758/s13428-011-0089-5; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Eich E, 2013, PSYCHOL SCI; Epskamp S, STATCHECK E IN PRESS; Firebaugh G, 2007, SOCIOL METHOD RES, V36, P200, DOI 10.1177/0049124107306663; Fisher R.A., 1958, STAT METHODS RES WOR; Freese J, 2007, SOCIOL METHOD RES, V36, P153, DOI 10.1177/0049124107306659; Ioannidisa JPA, 2010, RES SYNTH METHODS, V1, P169, DOI 10.1002/jrsm.19; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Lebel EP, 2013, PERSPECT PSYCHOL SCI, V8, P424, DOI 10.1177/1745691613491437; Leggett NC, 2013, Q J EXPT PSYCHOL, P1; Caperos JM, 2013, PSICOTHEMA, V25, P408, DOI 10.7334/psicothema2012.207; McCullough BD, 2003, AM ECON REV, V93, P873, DOI 10.1257/000282803322157133; Molenaar D, 2005, THESIS; Osborne J.W., 2019, PRACT ASSESS RES EVA, V9, P11, DOI [DOI 10.7275/QF69-7K43, 10.7275/ktzq-jq66]; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Petrocelli JV, 2013, BEHAV RES METHODS, V45, P595, DOI 10.3758/s13428-012-0262-5; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Reidpath DD, 2001, BIOETHICS, V15, P125, DOI 10.1111/1467-8519.00220; ROSSI JS, 1987, TEACH PSYCHOL, V14, P98, DOI 10.1207/s15328023top1402_8; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Simmons J. P., 2012, DIALOGUE OFFICIAL NE, V26, P4, DOI [10.2139/ssrn.2160588, DOI 10.2139/SSRN.2160588]; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U., J EXPT PSYC IN PRESS; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078; Wicherts JM, 2006, AM PSYCHOL, V61, P726, DOI 10.1037/0003-066X.61.7.726; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828; Wicherts JM, 2008, 23 IOPS SUMM C JUN 1; Wilcox R.R., 2012, MODERN STAT SOCIAL B; WOLINS L, 1962, AM PSYCHOL, V17, P657, DOI 10.1037/h0038819	36	38	38	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103360	10.1371/journal.pone.0103360	http://dx.doi.org/10.1371/journal.pone.0103360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KU	25072606	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600042
J	Mills, KL; Kemkemer, R; Rudraraju, S; Garikipati, K				Mills, K. L.; Kemkemer, Ralf; Rudraraju, Shiva; Garikipati, Krishna			Elastic Free Energy Drives the Shape of Prevascular Solid Tumors	PLOS ONE			English	Article							ELLIPSOIDAL INCLUSION; CANCER-CELLS; GROWTH; SPHEROIDS; BREAST; SIZE; STABILITY; PHENOTYPE; TISSUE; FIELD	It is well established that the mechanical environment influences cell functions in health and disease. Here, we address how the mechanical environment influences tumor growth, in particular, the shape of solid tumors. In an in vitro tumor model, which isolates mechanical interactions between cancer tumor cells and a hydrogel, we find that tumors grow as ellipsoids, resembling the same, oft-reported observation of in vivo tumors. Specifically, an oblate ellipsoidal tumor shape robustly occurs when the tumors grow in hydrogels that are stiffer than the tumors, but when they grow in more compliant hydrogels they remain closer to spherical in shape. Using large scale, nonlinear elasticity computations we show that the oblate ellipsoidal shape minimizes the elastic free energy of the tumor-hydrogel system. Having eliminated a number of other candidate explanations, we hypothesize that minimization of the elastic free energy is the reason for predominance of the experimentally observed ellipsoidal shape. This result may hold significance for explaining the shape progression of early solid tumors in vivo and is an important step in understanding the processes underlying solid tumor growth.	[Mills, K. L.; Kemkemer, Ralf] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Kemkemer, Ralf] Reutlingen Univ, Reutlingen, Germany; [Rudraraju, Shiva; Garikipati, Krishna] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Garikipati, Krishna] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA	Max Planck Society; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mills, KL (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany.	mills@is.mpg.de; krishna@umich.edu	Mills, Kristen L/D-8864-2011	Mills, Kristen L/0000-0003-0104-4200; Rudraraju, Shiva/0000-0002-8313-0198	Alexander von Humboldt Postdoctoral Research Fellowship; Max Planck Society Postdoctoral Research Fellowship	Alexander von Humboldt Postdoctoral Research Fellowship(Alexander von Humboldt Foundation); Max Planck Society Postdoctoral Research Fellowship	This work was supported by an Alexander von Humboldt Postdoctoral Research Fellowship (KLM) and a Max Planck Society Postdoctoral Research Fellowship (KLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi D, 2011, J MECH PHYS SOLIDS, V59, P863, DOI 10.1016/j.jmps.2010.12.011; Bangerth W, 2007, ACM T MATH SOFTWARE, V33, DOI 10.1145/1268776.1268779; BRENNER MW, 1967, BRIT J CANCER, V21, P1, DOI 10.1038/bjc.1967.1; Bruns T, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.101518; CARLSSON G, 1983, J CANCER RES CLIN, V105, P20, DOI 10.1007/BF00391826; CASCIARI JJ, 1992, J CELL PHYSIOL, V151, P386, DOI 10.1002/jcp.1041510220; CHAPLAIN MAJ, 1993, J MATH BIOL, V31, P431, DOI 10.1007/BF00173886; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Costantini M, 2006, J ULTRAS MED, V25, P649, DOI 10.7863/jum.2006.25.5.649; Dachman AH, 2001, CANCER, V91, P555, DOI 10.1002/1097-0142(20010201)91:3<555::AID-CNCR1034>3.3.CO;2-6; Dassios G, 2012, Q APPL MATH, V70, P1; Demou ZN, 2010, ANN BIOMED ENG, V38, P3509, DOI 10.1007/s10439-010-0097-0; DeWall RJ, 2012, PHYS MED BIOL, V57, P2273, DOI 10.1088/0031-9155/57/8/2273; ESHELBY JD, 1959, PROC R SOC LON SER-A, V252, P561, DOI 10.1098/rspa.1959.0173; ESHELBY JD, 1957, PROC R SOC LON SER-A, V241, P376, DOI 10.1098/rspa.1957.0133; FLORY PJ, 1961, T FARADAY SOC, V57, P829, DOI 10.1039/tf9615700829; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; FORNAGE BD, 1989, RADIOLOGY, V172, P671, DOI 10.1148/radiology.172.3.2549564; Garikipati K, 2004, J MECH PHYS SOLIDS, V52, P1595, DOI 10.1016/j.jmps.2004.01.004; Garikipati K, 2001, J COMPUT PHYS, V174, P138, DOI 10.1006/jcph.2001.6884; GREENSPAN HP, 1976, J THEOR BIOL, V56, P229, DOI 10.1016/S0022-5193(76)80054-9; Guth U, 2009, BREAST CANCER RES TR, V116, P257, DOI 10.1007/s10549-008-0115-1; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Koike C, 2002, BRIT J CANCER, V86, P947, DOI 10.1038/sj.bjc.6600158; Landman KA, 2001, IMA J MATH APPL MED, V18, P131; Mills KL, 2011, INT J MATER RES, V102, P889, DOI 10.3139/146.110532; MUELLERKLIESER W, 1987, J CANCER RES CLIN, V113, P101, DOI 10.1007/BF00391431; Mura T, 1987, MICROMECHANICS DEFEC, DOI [10.1007/978-94-009-3489-4, DOI 10.1007/978-94-009-3489-4]; Narayanan H, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194122; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Rudraraju S., 2013, COMPUTER MODELS BIOM, P293, DOI DOI 10.1007/978-94-007-5464-5_21; Samani A, 2003, PHYS MED BIOL, V48, P2183, DOI 10.1088/0031-9155/48/14/310; Shieh AC, 2011, ANN BIOMED ENG, V39, P1379, DOI 10.1007/s10439-011-0252-2; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Wapnir IL, 1996, BREAST CANCER RES TR, V41, P15, DOI 10.1007/BF01807032; Weinberg RA, 2007, BIOL CANC; Wilhelm Flugge, 1960, STRESSES SHELLS; Yu HM, 2011, TRENDS CELL BIOL, V21, P47, DOI 10.1016/j.tcb.2010.08.015	40	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103245	10.1371/journal.pone.0103245	http://dx.doi.org/10.1371/journal.pone.0103245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072702	Green Published, Green Submitted, gold			2022-12-27	WOS:000341307600033
J	Wranke, A; Heidrich, B; Ernst, S; Serrano, BC; Caruntu, FA; Curescu, MG; Yalcin, K; Gurel, S; Zeuzem, S; Erhardt, A; Luth, S; Papatheodoridis, GV; Bremer, B; Stift, J; Grabowski, J; Kirschner, J; Port, K; Cornberg, M; Falk, CS; Dienes, HP; Hardtke, S; Manns, MP; Yurdaydin, C; Wedemeyer, H				Wranke, Anika; Heidrich, Benjamin; Ernst, Stefanie; Serrano, Beatriz Calle; Caruntu, Florin Alexandru; Curescu, Manuela Gabriela; Yalcin, Kendal; Gurel, Selim; Zeuzem, Stefan; Erhardt, Andreas; Lueth, Stefan; Papatheodoridis, George V.; Bremer, Birgit; Stift, Judith; Grabowski, Jan; Kirschner, Janina; Port, Kerstin; Cornberg, Markus; Falk, Christine S.; Dienes, Hans-Peter; Hardtke, Svenja; Manns, Michael P.; Yurdaydin, Cihan; Wedemeyer, Heiner		HIDIT-2 Study Grp	Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta	PLOS ONE			English	Article							B-VIRUS; LIVER-TRANSPLANTATION; INTERFERON; INFECTION; CHALLENGES; ANTIBODIES; PROFILES; THERAPY; CELLS	Background: Hepatitis delta frequently leads to liver cirrhosis and hepatic decompensation. As treatment options are limited, there is a need for biomarkers to determine disease activity and to predict the risk of disease progression. We hypothesized that anti-HDV IgM could represent such a marker. Methods: Samples of 120 HDV-infected patients recruited in an international multicenter treatment trial (HIDIT-2) were studied. Anti-HDV IgM testing was performed using ETI-DELTA-IGMK-2-assay (DiaSorin). In addition, fifty cytokines, chemokines and angiogenetic factors were measured using multiplex technology (Bio-Plex System). A second independent cohort of 78 patients was studied for the development of liver-related clinical endpoints (decompensation, HCC, liver transplantation or death; median follow up of 3.0 years, range 0.6-12). Results: Anti-HDV IgM serum levels were negative in 18 (15%), low (OD<0.5) in 76 (63%), and high in 26 (22%) patients of the HIDIT-2 cohort. Anti-HDV IgM were significantly associated with histological inflammatory (p<0.01) and biochemical disease activity (ALT, AST p<0.01). HDV replication was independent from anti-HDV IgM, however, low HBV-DNA levels were observed in groups with higher anti-HDV IgM levels (p<0.01). While high IP-10 (CXCL10) levels were seen in greater groups of anti-HDV IgM levels, various other antiviral cytokines were negatively associated with anti-HDV IgM. Associations between anti-HDV IgM and ALT, AST, HBV-DNA were confirmed in the independent cohort. Clinical endpoints occurred in 26 anti-HDV IgM positive patients (39%) but in only one anti-HDV IgM negative individual (9%; p = 0.05). Conclusions: Serum anti-HDV IgM is a robust, easy-to-apply and relatively cheap marker to determine disease activity in hepatitis delta which has prognostic implications. High anti-HDV IgM levels may indicate an activated interferon system but exhausted antiviral immunity.	[Wranke, Anika; Serrano, Beatriz Calle; Bremer, Birgit; Grabowski, Jan; Kirschner, Janina; Port, Kerstin; Cornberg, Markus; Manns, Michael P.; Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Ernst, Stefanie] Hannover Med Sch, Inst Biometry, Hannover, Germany; [Yurdaydin, Cihan] Ankara Univ, Fac Med, TR-06100 Ankara, Turkey; [Caruntu, Florin Alexandru] Inst Boli Infect, Bucharest, Romania; [Curescu, Manuela Gabriela] Spitalul Clin Boli Infect, Timisoara, Romania; [Yalcin, Kendal] Dicle Univ, Fac Med, Diyarbakir, Turkey; [Gurel, Selim] Uludag Univ, Fac Med, Bursa, Turkey; [Zeuzem, Stefan] Goethe Univ Frankfurt, Med Ctr, D-60054 Frankfurt, Germany; [Erhardt, Andreas] Univ Dusseldorf, Dusseldorf, Germany; [Lueth, Stefan] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Papatheodoridis, George V.] Univ Athens, Sch Med, GR-11527 Athens, Greece; [Stift, Judith] Med Univ Vienna, Vienna, Austria; [Falk, Christine S.] Hannover Med Sch, IFB Tx, Inst Transplant Immunol, Hannover, Germany; [Dienes, Hans-Peter; Hardtke, Svenja; Manns, Michael P.; Wedemeyer, Heiner; HIDIT-2 Study Grp] HepNet Study House, Hannover, Germany; [Heidrich, Benjamin; Manns, Michael P.; Wedemeyer, Heiner] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat, Hannover, Germany; [Wedemeyer, Heiner] German Ctr Infect Res DZIF, Partner Side HepNet Study House, Hannover, Germany	Hannover Medical School; Hannover Medical School; Ankara University; Dicle University; Uludag University; Goethe University Frankfurt; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Athens Medical School; National & Kapodistrian University of Athens; Medical University of Vienna; Hannover Medical School; Hannover Medical School; German Center for Infection Research	Wranke, A (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	awranke@freenet.de; Wedemeyer.Heiner@mh-hannover.de	Cornberg, Markus/AAN-6939-2021; Papatheodoridis, George/A-4603-2008; Falk, Christine/Q-4143-2016; Zeuzem, Stefan/AAE-7435-2019	Cornberg, Markus/0000-0002-9141-8001; Papatheodoridis, George/0000-0002-3518-4060; Falk, Christine/0000-0003-1376-7318; Stift, Judith/0000-0001-5334-9343; Caruntu, Florin Alexandru/0000-0001-6103-5336; Luth, Stefan/0000-0001-9946-0960	BMBF; Hannover Medical School, Germany (IFB-Tx) [01E00802]; Roche; Gilead	BMBF(Federal Ministry of Education & Research (BMBF)); Hannover Medical School, Germany (IFB-Tx); Roche(Roche Holding); Gilead(Gilead Sciences)	The study was funded by the BMBF-funded Integrated Research and Treatment Center Transplantation, Hannover Medical School, Germany (IFB-Tx funding number 01E00802, Project 37 (H. Wedemeyer and B. Heidrich)). Roche and Gilead funded the HIDIT-2 study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borghesio E, 1998, HEPATOLOGY, V27, P873, DOI 10.1002/hep.510270334; Colloredo G, 1996, J HEPATOL, V25, P644, DOI 10.1016/S0168-8278(96)80233-9; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; FARCI P, 1986, JAMA-J AM MED ASSOC, V255, P1443, DOI 10.1001/jama.255.11.1443; Grabowski J, 2011, LIVER INT, V31, P1395, DOI 10.1111/j.1478-3231.2011.02593.x; Grabowski J, 2010, DIGEST DIS, V28, P133, DOI 10.1159/000282076; Heidrich B, 2013, CURR INFECT DIS REP, V15, P31, DOI 10.1007/s11908-012-0307-z; Heidrich B, 2012, LIVER INT, V32, P1415, DOI 10.1111/j.1478-3231.2012.02831.x; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jaroszewicz J, 2011, ANTIVIR THER, V16, P915, DOI 10.3851/IMP1866; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mederacke I, 2012, ANTIVIR THER, V17, P305, DOI 10.3851/IMP1926; Mederacke I, 2010, J CLIN MICROBIOL, V48, P2022, DOI 10.1128/JCM.00084-10; Negro F, 1998, J MED VIROL, V56, P224, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;224::AID-JMV8&gt;3.0.CO;2-9; Nisini R, 1997, J VIROL, V71, P2241, DOI 10.1128/JVI.71.3.2241-2251.1997; Pollicino T, 2011, J VIROL, V85, P432, DOI 10.1128/JVI.01609-10; Raimondo G, 2006, HEPATOLOGY, V43, P100, DOI 10.1002/hep.20944; RIZZETTO M, 1979, LANCET, V2, P986; Rizzetto M, 2010, DIGEST DIS, V28, P139, DOI 10.1159/000282077; Sonneveld MJ, 2013, J HEPATOL, V58, P898, DOI 10.1016/j.jhep.2013.01.029; Wedemeyer H, 2011, NEW ENGL J MED, V364, P322, DOI 10.1056/NEJMoa0912696; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205; Zachou K, 2010, LIVER INT, V30, P430, DOI 10.1111/j.1478-3231.2009.02140.x	26	32	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e101002	10.1371/journal.pone.0101002	http://dx.doi.org/10.1371/journal.pone.0101002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072849	Green Published, gold			2022-12-27	WOS:000341307600005
J	Yan, LX; Liu, YH; Luo, DL; Zhang, F; Cheng, Y; Luo, XL; Xu, J; Cheng, J; Zhuang, HG				Yan, Li-Xu; Liu, Yan-Hui; Luo, Dong-Lan; Zhang, Fen; Cheng, Yu; Luo, Xin-Lan; Xu, Jie; Cheng, Jie; Zhuang, Heng-Guo			MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified	PLOS ONE			English	Article							RITUXIMAB PLUS CYCLOPHOSPHAMIDE; CHOP CONSORTIUM PROGRAM; GERMINAL CENTER; TISSUE MICROARRAY; PROGNOSTIC-FACTOR; POOR-PROGNOSIS; PROTEIN; VINCRISTINE; DOXORUBICIN; PREDNISONE	Recent studies provide convincing evidence that a combined immunohistochemical or fluorescence in situ hybridization (FISH) score of MYC, BCL2, BCL6 proteins and MYC translocations predicted outcome in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). However, by far, all these researches are based on Western populations. Therefore, we investigate the prognostic relevance of MYC, BCL2- and BCL6-rearrangements and protein expression by immunohistochemistry and FISH from 336 de novo DLBCL, NOS treated with CHOP or R-CHOP. Breaks in MYC and BCL6, and fusion in IGH/BCL2 were detected in 9.7%, 20.0%, and 11.1% of the cases, respectively, and were not significantly associated with clinical outcomes. Protein overexpression of MYC (>= 40%), BCL2 (>= 70%) and BCL6 (>= 50%) was encountered in 51%, 51% and 36% of the tumors, respectively. On the basis of MYC, BCL2 and BCL6 expression, double-hit scores (DHSs) and triple-hit score (THS) were assigned to all patients with DLBCL. Patients with high MYC/BCL2 DHS, high MYC/BCL6 DHS and high THS had multiple adverse prognostic factors including high LDH level, poor performance status, advanced clinical stage, high International Prognostic Index (IPI) score, and non-germinal center B-cell. In univariate analysis, high MYC/BCL2 DHS, high MYC/BCL6 DHS and high THS were associated with inferior OS and PFS in both CHOP and R-CHOP cohorts (P<0.05). The highly significant correlations with OS and PFS were maintained in multivariate models that controlled for IPI (P<0.05). DLBCLs with high DHSs and high THS share the clinical features and poor prognosis of double-hit lymphoma (P>0.05). These data together suggest that the immunohistochemical DHSs and THS defined a large subset of DLBCLs with double-hit biology and was strongly associated with poor outcome in patients treated with R-CHOP or CHOP.	[Yan, Li-Xu; Liu, Yan-Hui; Luo, Dong-Lan; Zhang, Fen; Cheng, Yu; Luo, Xin-Lan; Xu, Jie; Cheng, Jie; Zhuang, Heng-Guo] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital	Liu, YH (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	yanh_liu@163.com			National Natural Science Foundation of China (NSFC) [81172244]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by a National Natural Science Foundation of China (NSFC, http://www.nsfc.gov.cn/) (Grant No. 81172244). YL, FZ, JX, and HZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek N, 2012, CANCER-AM CANCER SOC, V118, P4173, DOI 10.1002/cncr.27396; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Biagi JJ, 2002, BLOOD, V99, P4265, DOI 10.1182/blood.V99.12.4265; Chen PM, 2002, CANCER, V94, P2635, DOI 10.1002/cncr.10545; Chen Y, 2010, AM J CLIN PATHOL, V133, P305, DOI 10.1309/AJCP4H6ADGYDZMOA; Chen YW, 2006, BLOOD, V108, P2373, DOI 10.1182/blood-2006-05-022517; Chen Z, 2011, MED ONCOL, V28, P241, DOI 10.1007/s12032-010-9433-3; de Jong D, 2007, J CLIN ONCOL, V25, P805, DOI 10.1200/JCO.2006.09.4490; Feugier P, 2005, J CLIN ONCOL, V23, P4117, DOI 10.1200/JCO.2005.09.131; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Green TM, 2012, AM J SURG PATHOL, V36, P612, DOI 10.1097/PAS.0b013e318244e2ba; Gupta M, 2012, BLOOD, V120, P4400, DOI 10.1182/blood-2012-05-428466; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Gutierrez-Garcia G, 2011, BLOOD, V117, P4836, DOI 10.1182/blood-2010-12-322362; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Hu SM, 2013, BLOOD, V121, P4021, DOI 10.1182/blood-2012-10-460063; Huang Y, 2012, SCI WORLD J, DOI 10.1100/2012/897178; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Hussain AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060540; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Klapper W, 2008, LEUKEMIA, V22, P2226, DOI 10.1038/leu.2008.230; Kluk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033813; Krol ADG, 2003, ANN ONCOL, V14, P131, DOI 10.1093/annonc/mdg004; Leucci E, 2008, J PATHOL, V216, P440, DOI 10.1002/path.2410; Li X, 2011, ANN ONCOL, V22, P141; Lu Hong-Yu, 2012, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V20, P315; Mitchell KA, 2008, LEUKEMIA LYMPHOMA, V49, P1717, DOI 10.1080/10428190802238552; Perry AM, 2014, BR J HAEMATOL; Pfreundschuh M, 2012, J CLIN ONCOL, V30, P3433, DOI 10.1200/JCO.2012.44.4729; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Shiozawa E, 2007, LEUKEMIA RES, V31, P1579, DOI 10.1016/j.leukres.2007.03.017; Swerdlow SH, 2008, WHO CLASSIFICATION T; Thompson RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062822; Toda H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057677; Valentino C, 2013, AM J CLIN PATHOL, V139, P242, DOI 10.1309/AJCP2Z0TAGMUYJEB; van Imhoff GW, 2006, J CLIN ONCOL, V24, P4135, DOI 10.1200/JCO.2006.05.5897; Veelken H, 2007, ANN ONCOL, V18, P931, DOI 10.1093/annonc/mdm012; Visco C, 2013, HAEMATOLOGICA, V98, P255, DOI 10.3324/haematol.2012.066209; Xia ZG, 2010, ANN HEMATOL, V89, P171, DOI 10.1007/s00277-009-0799-2; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493	44	36	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104068	10.1371/journal.pone.0104068	http://dx.doi.org/10.1371/journal.pone.0104068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090026	Green Submitted, gold, Green Published			2022-12-27	WOS:000339812700093
J	Barez-Lopez, S; Bosch-Garcia, D; Gomez-Andres, D; Pulido-Valdeolivas, I; Montero-Pedrazuela, A; Obregon, MJ; Guadano-Ferraz, A				Barez-Lopez, Soledad; Bosch-Garcia, Daniel; Gomez-Andres, David; Pulido-Valdeolivas, Irene; Montero-Pedrazuela, Ana; Obregon, Maria Jesus; Guadano-Ferraz, Ana			Abnormal Motor Phenotype at Adult Stages in Mice Lacking Type 2 Deiodinase	PLOS ONE			English	Article							II IODOTHYRONINE DEIODINASE; BROWN ADIPOSE-TISSUE; THYROID-HORMONE; RAT-BRAIN; TARGETED DISRUPTION; INSULIN-RESISTANCE; MENTAL-RETARDATION; MOUSE; GENE; ASSOCIATION	Background: Thyroid hormones have a key role in both the developing and adult central nervous system and skeletal muscle. The thyroid gland produces mainly thyroxine (T4) but the intracellular concentrations of 3,5,3'-triiodothyronine (T3; the transcriptionally active hormone) in the central nervous system and skeletal muscle are modulated by the activity of type 2 deiodinase (D2). To date no neurological syndrome has been associated with mutations in the DIO2 gene and previous studies in young and juvenile D2-knockout mice (D2KO) did not find gross neurological alterations, possibly due to compensatory mechanisms. Aim: This study aims to analyze the motor phenotype of 3-and-6-month-old D2KO mice to evaluate the role of D2 on the motor system at adult stages in which compensatory mechanisms could have failed. Results: Motor abilities were explored by validated tests. In the footprint test, D2KO showed an altered global gait pattern (mice walked slower, with shorter strides and with a hindlimb wider base of support than wild-type mice). No differences were detected in the balance beam test. However, a reduced latency to fall was found in the rotarod, coat-hanger and four limb hanging wire tests indicating impairment on coordination and prehensile reflex and a reduction of muscle strength. In histological analyses of cerebellum and skeletal muscle, D2KO mice did not present gross structural abnormalities. Thyroid hormones levels and deiodinases activities were also determined. In D2KO mice, despite euthyroid T3 and high T4 plasma levels, T3 levels were significantly reduced in cerebral cortex (48% reduction) and skeletal muscle (33% reduction), but not in the cerebellum where other deiodinase (type 1) is expressed. Conclusions: The motor alterations observed in D2KO mice indicate an important role for D2 in T3 availability to maintain motor function and muscle strength. Our results suggest a possible implication of D2 in motor disorders.	[Barez-Lopez, Soledad; Bosch-Garcia, Daniel; Montero-Pedrazuela, Ana; Obregon, Maria Jesus; Guadano-Ferraz, Ana] UAM, CSIC, Inst Invest Biomed Alberto Sols, Dept Endocrine & Nervous Syst Pathophysiol, Madrid, Spain; [Gomez-Andres, David; Pulido-Valdeolivas, Irene] Hosp Univ La Paz, IdiPAZ, Madrid, Spain; [Gomez-Andres, David; Pulido-Valdeolivas, Irene] UAM, Dept Anatomia Histol & Neurociencia, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario La Paz; Autonomous University of Madrid	Guadano-Ferraz, A (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Dept Endocrine & Nervous Syst Pathophysiol, Madrid, Spain.	aguadano@iib.uam.es	Gómez-Andrés, David/AAO-1847-2020; Montero-Pedrazuela, Ana/J-7723-2013; Barez-Lopez, Soledad/L-3356-2017; Montero García, María Pilar/L-2872-2014; Guadaño-Ferraz, Ana/J-7870-2013	Gómez-Andrés, David/0000-0001-5654-7791; Montero-Pedrazuela, Ana/0000-0003-2308-0894; Montero García, María Pilar/0000-0003-3142-4538; Guadaño-Ferraz, Ana/0000-0002-0666-935X; Barez-Lopez, Soledad/0000-0002-2552-0366; PULIDO-VALDEOLIVAS, IRENE/0000-0003-0188-2458	Plan Nacional de I+D: [BFU2007-62979, BFU 2010-16498, SAF2011-25608, SAF2012-32491]; Community of Madrid [S2010-BMD-2423]; FPI program	Plan Nacional de I+D:; Community of Madrid(Comunidad de Madrid); FPI program	This work was supported by grants from Plan Nacional de I+D: BFU2007-62979 and BFU 2010-16498 and SAF2011-25608 (AGF); SAF2012-32491 (MJO), Community of Madrid: S2010-BMD-2423 (MJO). SBL and DBG were recipients of a fellowship from the FPI program and AMP of a contract all from the Ministry of Science and Innovation and Economy and Competitiveness, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola E, 2005, ENDOCRINOLOGY, V146, P5038, DOI 10.1210/en.2005-0882; Arque G, 2009, NEUROBIOL DIS, V36, P312, DOI 10.1016/j.nbd.2009.07.027; Drigo RAE, 2013, BBA-GEN SUBJECTS, V1830, P3956, DOI 10.1016/j.bbagen.2012.08.019; Bassett JHD, 2010, P NATL ACAD SCI USA, V107, P7604, DOI 10.1073/pnas.0911346107; Bates JM, 1999, ENDOCRINOLOGY, V140, P844, DOI 10.1210/en.140.2.844; Bernal J, 2003, THYROID, V13, P1005, DOI 10.1089/105072503770867174; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Canani LH, 2005, J CLIN ENDOCR METAB, V90, P3472, DOI 10.1210/jc.2004-1977; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Croteau W, 1996, J CLIN INVEST, V98, P405, DOI 10.1172/JCI118806; de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25, DOI 10.1530/eje.0.151u025; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; DEESCOBAR GM, 1985, ENDOCRINOLOGY, V117, P1890, DOI 10.1210/endo-117-5-1890; Dentice M, 2010, J CLIN INVEST, V120, P4021, DOI 10.1172/JCI43670; DEONA CR, 1988, PEDIATR RES, V24, P588, DOI 10.1203/00006450-198811000-00010; DEONA CR, 1991, ENDOCRINOLOGY, V128, P422, DOI 10.1210/endo-128-1-422; Dumitrescu AM, 2011, ANN ENDOCRINOL-PARIS, V72, P95, DOI 10.1016/j.ando.2011.03.011; Galton VA, 2007, ENDOCRINOLOGY, V148, P3080, DOI 10.1210/en.2006-1727; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Grozovsky R, 2009, ENDOCRINOLOGY, V150, P1976, DOI 10.1210/en.2008-0938; Guadano-Ferraz A, 1999, J NEUROSCI, V19, P3430; GuadanoFerraz A, 1997, P NATL ACAD SCI USA, V94, P10391, DOI 10.1073/pnas.94.19.10391; Guo TW, 2004, J MED GENET, V41, P585, DOI 10.1136/jmg.2004.019190; He B, 2009, PROG NEURO-PSYCHOPH, V33, P986, DOI 10.1016/j.pnpbp.2009.05.003; Klapdor K, 1997, J NEUROSCI METH, V75, P49, DOI 10.1016/S0165-0270(97)00042-3; Koibuchi N, 2003, CEREBELLUM, V2, P279, DOI 10.1080/14734220310011920; LEONARD JL, 1981, SCIENCE, V214, P571, DOI 10.1126/science.7291997; Maia AL, 2005, J CLIN INVEST, V115, P2524, DOI 10.1172/JCI25083; Marsili A, 2011, AM J PHYSIOL-ENDOC M, V301, pE818, DOI 10.1152/ajpendo.00292.2011; Marsili A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020832; Marsili A, 2010, ENDOCRINOLOGY, V151, P5952, DOI 10.1210/en.2010-0631; Mentuccia D, 2002, DIABETES, V51, P880, DOI 10.2337/diabetes.51.3.880; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; OBREGON MJ, 1989, AM J PHYSIOL, V257, pE625, DOI 10.1152/ajpendo.1989.257.5.E625; Salvatore D, 1996, ENDOCRINOLOGY, V137, P3308, DOI 10.1210/en.137.8.3308; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; SILVA JE, 1984, J CLIN INVEST, V73, P898, DOI 10.1172/JCI111313; StGermain DL, 1997, THYROID, V7, P655; Tu HM, 1997, ENDOCRINOLOGY, V138, P3359, DOI 10.1210/en.138.8.3359; Venero C, 2005, GENE DEV, V19, P2152, DOI 10.1101/gad.346105; Wakeling EN, 2011, J HERED, V102, pS32, DOI 10.1093/jhered/esr031; Wei P, 2011, MOL CELL BIOL, V31, P2838, DOI 10.1128/MCB.05208-11; Zhang KJ, 2012, J HUM GENET, V57, P14, DOI 10.1038/jhg.2011.121	45	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103857	10.1371/journal.pone.0103857	http://dx.doi.org/10.1371/journal.pone.0103857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083788	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800090
J	Carracedo, S; Sacher, F; Brandes, G; Braun, U; Leitges, M				Carracedo, Sergio; Sacher, Frank; Brandes, Gudrun; Braun, Ursula; Leitges, Michael			Redundant Role of Protein Kinase C Delta and Epsilon during Mouse Embryonic Development	PLOS ONE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; PKC-DELTA; N-CADHERIN; VASCULAR MORPHOGENESIS; EXPRESSION PATTERN; MURINE ALLANTOIS; VESSEL FORMATION; VE-CADHERIN; IN-VIVO; VASCULOGENESIS	Protein Kinase C delta and epsilon are mediators of important cellular events, such as cell proliferation, migration or apoptosis. The formation of blood vessels, i.e., vasculo- and angiogenesis, is a process where these isoforms have also been shown to participate. However, mice deficient in either Protein Kinase C delta or epsilon are viable and therefore their individual contribution to the formation of the vasculature appeared so far dispensable. In this study, we show that double null mutation of Protein Kinase C delta and epsilon causes embryonic lethality at approximately E9.5. At this stage, whole mount staining of the endothelial marker CD31 in double null embryos revealed defective blood vessel formation. Moreover, culture of double deficient mouse allantois showed impaired endothelial cell organization, and analyses of double deficient embryo sections showed dilated vessels, decreased endothelial-specific adherent junctions, and decreased contact of endothelial cells with mural cells. Protein kinase C delta and epsilon also appeared essential for vascular smooth muscle cell differentiation, since alpha-smooth muscle actin, a classical marker for vascular smooth muscle cells, was almost undetectable in double deficient embryonic aorta at E9.5. Subsequent qPCR analyses showed decreased VE-cadherin, Vegfr2, Cd31, Cdh2, Ets1, and Fli-1, among other angiogenesis related transcripts in double deficient embryos. Taken together, these data suggest for the first time an in vivo redundant role between members of the novel Protein Kinase C subfamily that allows for mutual compensation during mouse embryonic development, with vasculogenesis/angiogenesis as an obvious common function of these two Protein Kinase Cs. Protein Kinase C delta and epsilon might therefore be useful targets for inhibiting vasculo- and/or angiogenesis.	[Carracedo, Sergio; Braun, Ursula; Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0514 Oslo, Norway; [Sacher, Frank; Braun, Ursula] Max Planck Inst Expt Endocrinol, Hannover, Germany; [Sacher, Frank; Braun, Ursula; Leitges, Michael] Zellbiol Zentrum Anat Gebaude I4, Raum, Germany	University of Oslo; Max Planck Society	Carracedo, S (corresponding author), Univ Oslo, Biotechnol Ctr Oslo, N-0514 Oslo, Norway.	s.c.huroz@biotek.uio.no	Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995	Norwegian Research Council [197261]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was funded by The Norwegian Research Council (http://www.forskningsradet.no; project number:197261). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2010, FASEB J, V24, P5033, DOI 10.1096/fj.10-166934; Arora R, 2012, BLOOD, V120, P2562, DOI 10.1182/blood-2012-03-390070; Asano Y, 2010, AM J PATHOL, V176, P1983, DOI 10.2353/ajpath.2010.090593; Bai X, 2010, ARTERIOSCL THROM VAS, V30, P2467, DOI 10.1161/ATVBAHA.110.215723; Bekhite MM, 2011, J CELL SCI, V124, P1819, DOI 10.1242/jcs.077594; Caprioli A, 2001, DEV BIOL, V238, P64, DOI 10.1006/dbio.2001.0362; Carracedo S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-16; Carracedo S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-2; De Val S, 2004, DEV BIOL, V275, P424, DOI 10.1016/j.ydbio.2004.08.016; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Deuse T, 2010, CIRCULATION, V122, pS170, DOI 10.1161/CIRCULATIONAHA.109.927640; Ding RB, 2004, STEM CELLS DEV, V13, P509, DOI 10.1089/1547328042417336; Downs KM, 1998, DEVELOPMENT, V125, P4507; Duncan GS, 1999, J IMMUNOL, V162, P3022; Duquesnes N, 2011, J MOL CELL CARDIOL, V51, P665, DOI 10.1016/j.yjmcc.2011.07.013; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gambardella L., 2012, TXB ANGIOGENESIS LYM, P189; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Harrington EO, 2005, EXP CELL RES, V308, P407, DOI 10.1016/j.yexcr.2005.05.005; Hashiya N, 2004, CIRCULATION, V109, P3035, DOI 10.1161/01.CIR.0000130643.41587.DB; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Kuriyama M, 2004, BIOCHEM BIOPH RES CO, V325, P843, DOI 10.1016/j.bbrc.2004.10.102; Leitges M, 2001, J CLIN INVEST, V108, P1505; Lessmann E, 2006, INT IMMUNOL, V18, P767, DOI 10.1093/intimm/dxl012; Lizotte F, 2013, DIABETES, V62, P2948, DOI 10.2337/db12-1432; Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241; Luo Y, 2005, J CELL BIOL, V169, P29, DOI 10.1083/jcb.200411127; Meier M, 2007, J AM SOC NEPHROL, V18, P1190, DOI 10.1681/ASN.2005070694; Monti M, 2013, J MOL CELL CARDIOL, V63, P107, DOI 10.1016/j.yjmcc.2013.07.006; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Patel-Hett S, 2011, INT J DEV BIOL, V55, P353, DOI 10.1387/ijdb.103213sp; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P919, DOI 10.1161/ATVBAHA.108.162842; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315, DOI 10.1177/37.3.2918221; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	39	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103686	10.1371/journal.pone.0103686	http://dx.doi.org/10.1371/journal.pone.0103686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084151	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800064
J	Taber, DR; Chriqui, JF; Vuillaume, R; Chaloupka, FJ				Taber, Daniel R.; Chriqui, Jamie F.; Vuillaume, Renee; Chaloupka, Frank J.			How State Taxes and Policies Targeting Soda Consumption Modify the Association between School Vending Machines and Student Dietary Behaviors: A Cross-Sectional Analysis	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; US SECONDARY-SCHOOLS; OBESITY PREVENTION; UNITED-STATES; SOFT DRINKS; COMPETITIVE FOOD; PUBLIC-HEALTH; BODY-WEIGHT; CHILDREN; ADOLESCENTS	Background: Sodas are widely sold in vending machines and other school venues in the United States, particularly in high school. Research suggests that policy changes have reduced soda access, but the impact of reduced access on consumption is unclear. This study was designed to identify student, environmental, or policy characteristics that modify the associations between school vending machines and student dietary behaviors. Methods: Data on school vending machine access and student diet were obtained as part of the National Youth Physical Activity and Nutrition Study (NYPANS) and linked to state-level data on soda taxes, restaurant taxes, and state laws governing the sale of soda in schools. Regression models were used to: 1) estimate associations between vending machine access and soda consumption, fast food consumption, and lunch source, and 2) determine if associations were modified by state soda taxes, restaurant taxes, laws banning in-school soda sales, or student characteristics (race/ethnicity, sex, home food access, weight loss behaviors.) Results: Contrary to the hypothesis, students tended to consume 0.53 fewer servings of soda/week (95% CI: -1.17, 0.11) and consume fast food on 0.24 fewer days/week (95% CI: -0.44, -0.05) if they had in-school access to vending machines. They were also less likely to consume soda daily (23.9% vs. 27.9%, average difference = -4.02, 95% CI: -7.28, -0.76). However, these inverse associations were observed primarily among states with lower soda and restaurant tax rates (relative to general food tax rates) and states that did not ban in-school soda sales. Associations did not vary by any student characteristics except for weight loss behaviors. Conclusion: Isolated changes to the school food environment may have unintended consequences unless policymakers incorporate other initiatives designed to discourage overall soda consumption.	[Taber, Daniel R.; Chriqui, Jamie F.; Chaloupka, Frank J.] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60607 USA; [Vuillaume, Renee] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Chaloupka, Frank J.] Univ Illinois, Dept Econ, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Taber, DR (corresponding author), Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60607 USA.	Daniel.Taber@uth.tmc.edu			Robert Wood Johnson Foundation; National Institute of Child Health and Human Development [4R00HD073271-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD073271] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support for this research was provided by the Robert Wood Johnson Foundation to the Bridging the Gap program located within the Health Policy Center at the University of Illinois at Chicago (PI: Frank Chaloupka), and by grant number 4R00HD073271-02 from the National Institute of Child Health and Human Development (PI: Daniel Taber). The views expressed herein are solely those of the authors and do not reflect the official views or positions of the Robert Wood Johnson Foundation, the National Institute of Child Health and Human Development, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Centers for Disease Control and Prevention, NAT YOUTH PHYS ACT N; Chriqui JF, 2008, J PUBLIC HEALTH POL, V29, P226, DOI 10.1057/jphp.2008.9; Chriqui JF, 2013, JAMA PEDIATR, V167, P714, DOI 10.1001/jamapediatrics.2013.32; Chriqui JF, 2013, J PUBLIC HEALTH POL, V34, P403, DOI 10.1057/jphp.2013.17; Cohen M.L., 1996, LEGAL RES NUTSHELL, V6th ed.; Cradock AL, 2011, PREV CHRONIC DIS, V8; Cullen KW, 2008, AM J PUBLIC HEALTH, V98, P111, DOI 10.2105/AJPH.2007.111765; Cullen KW, 2006, PUBLIC HEALTH NUTR, V9, P814, DOI 10.1079/PHN2005878; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Ellison B, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-21; Finkelstein E, 2004, AM J PREV MED, V27, P163, DOI 10.1016/j.amepre.2004.06.017; Fletcher JM, 2010, HEALTH AFFAIR, V29, P1059, DOI 10.1377/hlthaff.2009.0725; Ghaffarzadegan N, 2011, SYST DYNAM REV, V27, P22, DOI 10.1002/sdr.442; Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016; Hilmers A, 2012, AM J PUBLIC HEALTH, V102, P1644, DOI 10.2105/AJPH.2012.300865; Institute of Medicine, 2007, NUTR STAND FOODS SCH; Levy DT, 2011, ADV NUTR, V2, p182S, DOI 10.3945/an.111.000356; Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318; Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Mersky Roy M., 2002, FUNDAMENTALS LEGAL R; Pomeranz JL, 2012, J PUBLIC HEALTH POL, V33, P75, DOI 10.1057/jphp.2011.46; Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010; Story M, 2009, MILBANK Q, V87, P71, DOI 10.1111/j.1468-0009.2009.00548.x; Sturm R, 2008, PUBLIC HEALTH, V122, P681, DOI 10.1016/j.puhe.2007.09.004; Swinburn B, 2009, CHILD ADOL PSYCH CL, V18, P209, DOI 10.1016/j.chc.2008.07.015; Taber DR, 2012, PEDIATRICS, V130, P437, DOI 10.1542/peds.2011-3353; Taber DR, 2012, ARCH PEDIAT ADOL MED, V166, P452, DOI 10.1001/archpediatrics.2011.1839; Taber DR, 2012, ARCH PEDIAT ADOL MED, V166, P256, DOI 10.1001/archpediatrics.2011.200; Taber DR, 2011, AM J PUBLIC HEALTH, V101, P1769, DOI 10.2105/AJPH.2011.300221; Taras HL, 2004, PEDIATRICS, V113, P152; Terry-McElrath YM, 2013, AM J PREV MED, V44, P573, DOI 10.1016/j.amepre.2013.01.026; Terry-McElrath YM, 2012, ARCH PEDIAT ADOL MED, V166, P776, DOI 10.1001/archpediatrics.2012.716; Terry-McElrath YM, 2012, J SCHOOL HEALTH, V82, P44, DOI 10.1111/j.1746-1561.2011.00666.x; Trust for America's Health The Robert Wood Johnson Foundation, 2010, F FAT OB THREAT AM F; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Woodward-Lopez G, 2010, AM J PUBLIC HEALTH, V100, P2137, DOI 10.2105/AJPH.2010.193490	41	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e98249	10.1371/journal.pone.0098249	http://dx.doi.org/10.1371/journal.pone.0098249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4JL	25083906	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800002
J	Xu, LF; Wu, ZP; Chen, Y; Zhu, QS; Hamidi, S; Navab, R				Xu, Long-feng; Wu, Zhi-ping; Chen, Yan; Zhu, Qi-Shun; Hamidi, Shoeleh; Navab, Roya			MicroRNA-21 (miR-21) Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by Targeting PTEN, RECK and Bcl-2 in Lung Squamous Carcinoma, Gejiu City, China	PLOS ONE			English	Article							CANCER; INHIBITION; CELLS; SENSITIVITY; EXPRESSION; PATHWAY; PROTEIN; GROWTH; GENES; CYCLE	Background: In South China (Gejiu City, Yunnan Province), lung cancer incidence and associated mortality rate is the most prevalent and observed forms of cancer. Lung cancer in this area is called Gejiu squamous cell lung carcinoma (GSQCLC). Research has demonstrated that overexpression of miR-21 occurs in many cancers. However, the unique relationship between miR-21 and its target genes in GSQCLC has never been investigated. The molecular mechanism involved in GSQCLC must be compared to other non-small cell lung cancers in order to establish a relation and identify potential therapeutic targets. Methodology/Principal Findings: In the current study, we initially found overexpression of miR-21 occurring in non-small cell lung cancer (NSCLC) cell lines when compared to the immortalized lung epithelial cell line BEAS-2B. We also demonstrated that high expression of miR-21 could increase tumor cell proliferation, invasion, viability, and migration in GSQCLC cell line (YTMLC-90) and NSCLC cell line (NCI-H157). Additionally, our results revealed that miR-21 could suppress YTMLC-90 and NCI-H157 cell apoptosis through arresting cell-cycle at G(2)/M phase. Furthermore, we demonstrated that PTEN, RECK and Bcl-2 are common target genes of miR-21 in NSCLC. Finally, our studies showed that down-regulation of miR-21 could lead to a significant increase in PTEN and RECK and decrease in Bcl-2 at the mRNA and protein level in YTMLC-90 and NCI-H157 cell lines. However, we have not observed any remarkable difference in the levels of miR-21 and its targets in YTMLC-90 cells when compared with NCI-H157 cells. Conclusions/Significance: miR-21 simultaneously regulates multiple programs that enhance cell proliferation, apoptosis and tumor invasiveness by targeting PTEN, RECK and Bcl-2 in GSQCLC. Our results demonstrated that miR-21 may play a vital role in tumorigenesis and progression of lung squamous cell carcinoma and suppression of miR-21 may be a novel approach for the treatment of lung squamous cell carcinoma.	[Xu, Long-feng; Zhu, Qi-Shun] Yunnan Univ, Key Lab Anim Genet Div & Evolut High Educ Yunnan, Kunming, Yunan, Peoples R China; [Wu, Zhi-ping; Chen, Yan] Kunming Med Univ, Affiliated Hosp 3, Tumor Inst, Kunming, Yunan, Peoples R China; [Hamidi, Shoeleh] Northeast Missouri Hlth Co, Kirksville, MO USA; [Navab, Roya] Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Navab, Roya] Campbell Family Inst Canc Res, Toronto, ON, Canada	Yunnan University; Kunming Medical University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Zhu, QS (corresponding author), Yunnan Univ, Key Lab Anim Genet Div & Evolut High Educ Yunnan, Kunming, Yunan, Peoples R China.	zhuqsfa@aliyun.com	Navab, Roya/AGD-7380-2022		Science and Technology Project of the Yunnan Health Department [2011WS0065]; Research and Talent Training Open Foundation of Life science college, Yunnan University [2013S213]	Science and Technology Project of the Yunnan Health Department; Research and Talent Training Open Foundation of Life science college, Yunnan University	This work was supported by the Science and Technology Project of the Yunnan Health Department (Grant No. 2011WS0065) and the Research and Talent Training Open Foundation of Life science college, Yunnan University (Grant No. 2013S213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babar IA, 2011, CANCER BIOL THER, V12, P908, DOI 10.4161/cbt.12.10.17681; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buscaglia Lindsey E Becker, 2011, Chin J Cancer, V30, P371; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen Jian-Ye, 2003, Ai Zheng, V22, P938; Chu EC, 2004, MED SCI MONITOR, V10, pRA235; Du GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072044; Duan J, 2009, CHINESE J SOCIAL MED, V26, P377; Gao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064704; Gao W, 2012, BIOMED PHARMACOTHER, V66, P21, DOI 10.1016/j.biopha.2011.09.004; Garofalo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067581; Gompelmann D, 2011, RESPIRATION, V82, P111, DOI 10.1159/000329703; Han L, 2012, CNS NEUROSCI THER, V18, P573, DOI 10.1111/j.1755-5949.2012.00344.x; Hiroshi H, 2012, PLOS ONE, V7; Hlobilkova A, 2006, ANTICANCER RES, V26, P1015; Jones N, 2013, INT J CANCER, V133, P323, DOI 10.1002/ijc.28021; Jung HM, 2012, J BIOL CHEM, V287, P29261, DOI 10.1074/jbc.M112.366518; Katlic MR, 2011, CA-CANCER J CLIN, V61, P382, DOI 10.3322/caac.20119; Lan Hai, 2011, Zhonghua Zhong Liu Za Zhi, V33, P742; LAURER GR, 1993, HEALTH PHYS, V64, P253, DOI 10.1097/00004032-199303000-00003; Lei L, 2014, MOL CELL BIOCHEM, V387, P171, DOI 10.1007/s11010-013-1882-5; Li X, 2013, INT J MOL MED, V32, P439, DOI 10.3892/ijmm.2013.1411; Li Y, 2013, ASIAN PAC J CANCER P, V14, P4599, DOI 10.7314/APJCP.2013.14.8.4599; Liu H., 2012, OPTIM METHOD SOFTW, V1, P1, DOI DOI 10.1128/GEN0MEA.00936-13; Liu J, 2004, ONCOGENE, V23, P6316, DOI 10.1038/sj.onc.1207795; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Liu Xiaomei, 2013, Zhongguo Fei Ai Za Zhi, V16, P184, DOI 10.3779/j.issn.1009-3419.2013.04.03; Liu ZL, 2013, MOL CELL BIOCHEM, V372, P35, DOI 10.1007/s11010-012-1443-3; Lubin JH, 1994, RADON LUNG CANC RISK; Mao BL, 1994, YUNXI KEJI, V21, P50; Mao BL, 1982, TUMOR, V2, P337; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Reis ST, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-14; Ruan YH, 2004, ACAD J KUNMING MED C, V4, P6; Ruan YH, 2005, DETECTION RELATED GE, P1; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; Shi L, 2010, BRAIN RES, V1352, P255, DOI 10.1016/j.brainres.2010.07.009; Sun SQ, 1998, CHIN J RADIOL MED PR, V18, P295; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Tao J, 2011, ONCOL REP, V25, P1721, DOI 10.3892/or.2011.1245; Wang N, 2013, DIGEST DIS SCI, V58, P1863, DOI 10.1007/s10620-013-2612-2; Wei B, 2013, ONCOL LETT, V6, P1713, DOI 10.3892/ol.2013.1609; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Xiong Y, 2013, ONCOL LETT, V6, P1789, DOI 10.3892/ol.2013.1613; Xu LF, 2013, CHINESE GERMEN J CLI, V12, P443; Yang F, 2006, MED ONCOL, V23, P191, DOI 10.1385/MO:23:2:191; Yang TS, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-68; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Zeng N, 2013, AGING CELL, V12, P1000, DOI 10.1111/acel.12132; Zhang FM, 1985, IND HLTH OCCUPATIONA, V11, P343; Zhang JG, 2012, CLIN CHIM ACTA, V411, P846; Zhang W., 2013, CLIN TRANSL ONCOL, P1, DOI DOI 10.1007/S00417-013-2267-X; Zhao GF, 1987, RAD PROTECTION, V7, P203; Zhu Y, 2010, J ZHENGZHOU U MED SC, V45, P493; 方国强, 2010, [癌变·畸变·突变, Carcinogenesis, Teratogenesis and Mutagenesis], V22, P65	59	147	163	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103698	10.1371/journal.pone.0103698	http://dx.doi.org/10.1371/journal.pone.0103698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084400	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800067
J	Xu, SH; Yang, Z; Zhang, E; Jiang, Y; Pan, LA; Chen, Q; Xie, ZW; Xu, CW				Xu, Shuhui; Yang, Zefeng; Zhang, Enying; Jiang, Ying; Pan, Liang; Chen, Qing; Xie, Zhengwen; Xu, Chenwu			Nucleotide Diversity of Maize ZmBT1 Gene and Association with Starch Physicochemical Properties	PLOS ONE			English	Article							DNA-SEQUENCE POLYMORPHISM; ADP-GLUCOSE; RICE; GELATINIZATION; CASSAVA; BIOSYNTHESIS; MEMBRANE; SOFTWARE; SAMPLE; WAXY	Cereal Brittle1 protein has been demonstrated to be involved in the ADP-Glc transport into endosperm plastids, and plays vital roles in the biosynthesis of starch. In this study, the genomic sequences of the ZmBT1 gene in 80 elite maize inbred lines were obtained, and the nucleotide polymorphisms and haplotype diversity were detected. A total of 30 variants, including 22 SNPs and 8 indels, were detected from the full sequences of this gene. Among these polymorphic sites, 9 SNPs and 2 indels were found to be located in the coding region. The polymorphisms of CDS sequences classified the maize ZmBT1 gene into 6 haplotypes, which encode 6 different ZmBT1 proteins. Neutrality tests revealed a decrease in population size and/or balancing selection on the maize ZmBT1 locus. To detect the association between sequence variations of this gene and the starch physicochemical properties, 7 pasting and 4 gelatinization traits of starch were measured for the tested inbred lines using rapid visco analyzer (RVA) and differential scanning calorimeter (DSC), respectively. The result of association analysis revealed that an indel in the coding region was significantly associated with the phenotypic variation of starch gelatinization enthalpy.	[Xu, Shuhui; Yang, Zefeng; Zhang, Enying; Jiang, Ying; Pan, Liang; Chen, Qing; Xie, Zhengwen; Xu, Chenwu] Yangzhou Univ, Co Innovat Ctr Modern Prod Technol Grain Crops, Key Lab Plant Funct Gen Minist Educ, Jiangsu Key Lab Crop Genet & Physiology, Yangzhou, Peoples R China; [Zhang, Enying] Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Shandong, Peoples R China	Yangzhou University; Qingdao Agricultural University	Yang, Z (corresponding author), Yangzhou Univ, Co Innovat Ctr Modern Prod Technol Grain Crops, Key Lab Plant Funct Gen Minist Educ, Jiangsu Key Lab Crop Genet & Physiology, Yangzhou, Peoples R China.	zfyang@yzu.edu.cn		Yang, Zefeng/0000-0002-3465-8594	National Training Programs of Innovation and Entrepreneurship for Undergraduates [201311117035Z]	National Training Programs of Innovation and Entrepreneurship for Undergraduates	This work was supported by grants from the National Training Programs of Innovation and Entrepreneurship for Undergraduates (201311117035Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Bahaji A, 2011, PLANT CELL PHYSIOL, V52, P597, DOI 10.1093/pcp/pcr019; Bowsher CG, 2007, J EXP BOT, V58, P1321, DOI 10.1093/jxb/erl297; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; FU YX, 1993, GENETICS, V133, P693; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Hasjim J, 2013, CARBOHYD POLYM, V92, P682, DOI 10.1016/j.carbpol.2012.09.023; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; HUDSON RR, 1985, GENETICS, V111, P147; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kirchberger S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702484200; Laloi M, 1999, CELL MOL LIFE SCI, V56, P918, DOI 10.1007/s000180050484; Leroch M, 2005, J BIOL CHEM, V280, P17992, DOI 10.1074/jbc.M412462200; LI HM, 1992, J BIOL CHEM, V267, P18999; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Patron NJ, 2004, PLANT PHYSIOL, V135, P2088, DOI 10.1104/pp.104.045203; Ratnayake WS, 2006, J AGR FOOD CHEM, V54, P3712, DOI 10.1021/jf0529114; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Saithong T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-75; Sanchez T, 2010, J AGR FOOD CHEM, V58, P5093, DOI 10.1021/jf1001606; Shannon JC, 1998, PLANT PHYSIOL, V117, P1235, DOI 10.1104/pp.117.4.1235; SULLIVAN TD, 1995, PLANTA, V196, P477, DOI 10.1007/BF00203647; TAJIMA F, 1989, GENETICS, V123, P585; Tan YF, 2001, CEREAL CHEM, V78, P666, DOI 10.1094/CCHEM.2001.78.6.666; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Wang GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055469; Xu FF, 2013, J AGR FOOD CHEM, V61, P10110, DOI 10.1021/jf4029688; Yan CJ, 2011, THEOR APPL GENET, V122, P63, DOI 10.1007/s00122-010-1423-5; Yang ZF, 2014, MOL BIOL REP, V41, P1117, DOI 10.1007/s11033-013-2958-8; Yang ZF, 2013, EVOL BIOINFORM, V9, P239, DOI 10.4137/EBO.S11991; Zhang EY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056495	35	8	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103627	10.1371/journal.pone.0103627	http://dx.doi.org/10.1371/journal.pone.0103627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084007	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800062
J	Alonso-Sarduy, L; De Los Rios, P; Benedetti, F; Vobornik, D; Dietler, G; Kasas, S; Longo, G				Alonso-Sarduy, Livan; De Los Rios, Paolo; Benedetti, Fabrizio; Vobornik, Dusan; Dietler, Giovanni; Kasas, Sandor; Longo, Giovanni			Real-Time Monitoring of Protein Conformational Changes Using a Nano-Mechanical Sensor	PLOS ONE			English	Article							LOCAL NANOMECHANICAL MOTION; TOPOISOMERASE-II; REVERSIBLE BINDING; DNA TRANSPORT; DEPENDENCE; CELLS; MICA; ATP	Proteins can switch between different conformations in response to stimuli, such as pH or temperature variations, or to the binding of ligands. Such plasticity and its kinetics can have a crucial functional role, and their characterization has taken center stage in protein research. As an example, Topoisomerases are particularly interesting enzymes capable of managing tangled and supercoiled double-stranded DNA, thus facilitating many physiological processes. In this work, we describe the use of a cantilever-based nanomotion sensor to characterize the dynamics of human topoisomerase II (Topo II) enzymes and their response to different kinds of ligands, such as ATP, which enhance the conformational dynamics. The sensitivity and time resolution of this sensor allow determining quantitatively the correlation between the ATP concentration and the rate of Topo II conformational changes. Furthermore, we show how to rationalize the experimental results in a comprehensive model that takes into account both the physics of the cantilever and the dynamics of the ATPase cycle of the enzyme, shedding light on the kinetics of the process. Finally, we study the effect of aclarubicin, an anticancer drug, demonstrating that it affects directly the Topo II molecule inhibiting its conformational changes. These results pave the way to a new way of studying the intrinsic dynamics of proteins and of protein complexes allowing new applications ranging from fundamental proteomics to drug discovery and development and possibly to clinical practice.	[Alonso-Sarduy, Livan; Benedetti, Fabrizio; Vobornik, Dusan; Dietler, Giovanni; Kasas, Sandor; Longo, Giovanni] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Phys Biol Syst, Lab Phys Living Matter, Lausanne, Switzerland; [De Los Rios, Paolo] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Theoret Phys, Lab Stat Biophys, Lausanne, Switzerland; [Kasas, Sandor] Univ Lausanne, Dept Fundamental Neurosci, Fac Biol & Med, Lausanne, Switzerland; [Longo, Giovanni] Ist Super Sanita, I-00161 Rome, Italy	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Istituto Superiore di Sanita (ISS)	Longo, G (corresponding author), Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Phys Biol Syst, Lab Phys Living Matter, Lausanne, Switzerland.	giovanni.longo@epfl.ch	Longo, G./K-8923-2016; De Los Rios, Paolo/B-2456-2010	Longo, G./0000-0003-2434-2155; De Los Rios, Paolo/0000-0002-5394-5062; Benedetti, Fabrizio/0000-0002-9959-9142	Swiss National Science Foundation [32I3-130676]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation (no.: 32I3-130676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Sarduy L, 2011, FEBS LETT, V585, P3139, DOI 10.1016/j.febslet.2011.08.051; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; BARNES JR, 1994, NATURE, V372, P79, DOI 10.1038/372079a0; Berger R, 1997, SCIENCE, V276, P2021, DOI 10.1126/science.276.5321.2021; Boisen A, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/3/036101; Charbonnier S, 2008, BIOTECHNOL ANN REV, V14, P1, DOI 10.1016/S1387-2656(08)00001-X; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Evans MJ, 2006, CHEM REV, V106, P3279, DOI 10.1021/cr050288g; Fulle S, 2009, METHODS, V49, P181, DOI 10.1016/j.ymeth.2009.04.004; Gakamsky DM, 2007, P NATL ACAD SCI USA, V104, P16639, DOI 10.1073/pnas.0707061104; Godin M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/7/075501; Hammonds TR, 1997, J BIOL CHEM, V272, P32696, DOI 10.1074/jbc.272.51.32696; Ho BK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000343; JENSEN PB, 1993, BIOCHEM PHARMACOL, V45, P2025, DOI 10.1016/0006-2952(93)90013-M; JENSEN PB, 1991, CANCER RES, V51, P5093; Jung S-H, 2012, MOL CELLULAR PROTEOM; Kasas S, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3285262; Kasas S, 2011, NANOSCALE MOTION DET; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Lee HJ, 2005, J PHYSIOL-LONDON, V563, P61, DOI 10.1113/jphysiol.2004.081117; Lindsley JE, 2003, ENZYMES, P371; Longo G, 2013, NAT NANOTECHNOL, V8, P522, DOI [10.1038/nnano.2013.120, 10.1038/NNANO.2013.120]; Longo G, 2014, WIRES NANOMED NANOBI, V6, P230, DOI 10.1002/wnan.1258; MacBeath G, 1999, J AM CHEM SOC, V121, P7967, DOI 10.1021/ja991083q; Mertens J, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/1/015501; Murade CU, 2009, BIOPHYS J, V97, P835, DOI 10.1016/j.bpj.2009.05.024; Nettikadan SR, 1998, J ELECTRON MICROSC, V47, P671, DOI 10.1093/oxfordjournals.jmicro.a023641; OSHEROFF N, 1986, J BIOL CHEM, V261, P9944; Pelling AE, 2004, SCIENCE, V305, P1147, DOI 10.1126/science.1097640; Pelling AE, 2005, NANOMED-NANOTECHNOL, V1, P178, DOI 10.1016/j.nano.2005.04.002; Pietrement O, 2003, LANGMUIR, V19, P2536, DOI 10.1021/la026942u; RADMACHER M, 1994, SCIENCE, V265, P1577, DOI 10.1126/science.8079171; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Rudin M, 2003, NAT REV DRUG DISCOV, V2, P123, DOI 10.1038/nrd1007; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Schneider SW, 1999, P NATL ACAD SCI USA, V96, P12180, DOI 10.1073/pnas.96.21.12180; Thomson NH, 1996, LANGMUIR, V12, P5905, DOI 10.1021/la960497j; Waggoner PS, 2007, LAB CHIP, V7, P1238, DOI 10.1039/b707401h; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Xie P, 2010, EUR BIOPHYS J BIOPHY, V39, P1251, DOI 10.1007/s00249-010-0578-y; Yan YL, 2003, CURR OPIN CHEM BIOL, V7, P635, DOI 10.1016/j.cbpa.2003.08.017; Zhou Shumin, 2012, [Frontiers in Biology, 生物学前沿], V7, P336	42	20	22	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103674	10.1371/journal.pone.0103674	http://dx.doi.org/10.1371/journal.pone.0103674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077809	Green Submitted, gold, Green Published			2022-12-27	WOS:000339954800065
J	Filtness, AJ; MacKenzie, J; Armstrong, K				Filtness, Ashleigh J.; MacKenzie, Janelle; Armstrong, Kerry			Longitudinal Change in Sleep and Daytime Sleepiness in Postpartum Women	PLOS ONE			English	Article							INFANT; PERFORMANCE; QUALITY; NIGHT; MOOD	Sleep disruption strongly influences daytime functioning; resultant sleepiness is recognised as a contributing risk-factor for individuals performing critical and dangerous tasks. While the relationship between sleep and sleepiness has been heavily investigated in the vulnerable sub-populations of shift workers and patients with sleep disorders, postpartum women have been comparatively overlooked. Thirty-three healthy, postpartum women recorded every episode of sleep and wake each day during postpartum weeks 6, 12 and 18. Although repeated measures analysis revealed there was no significant difference in the amount of nocturnal sleep and frequency of night-time wakings, there was a significant reduction in sleep disruption, due to fewer minutes of wake after sleep onset. Subjective sleepiness was measured each day using the Karolinska Sleepiness Scale; at the two earlier time points this was significantly correlated with sleep quality but not to sleep quantity. Epworth Sleepiness Scores significantly reduced over time; however, during week 18 over 50% of participants were still experiencing excessive daytime sleepiness (Epworth Sleepiness Score >= 12). Results have implications for health care providers and policy makers. Health care providers designing interventions to address sleepiness in new mothers should take into account the dynamic changes to sleep and sleepiness during this initial postpartum period. Policy makers developing regulations for parental leave entitlements should take into consideration the high prevalence of excessive daytime sleepiness experienced by new mothers, ensuring enough opportunity for daytime sleepiness to diminish to a manageable level prior to reengagement in the workforce.	[Filtness, Ashleigh J.; MacKenzie, Janelle; Armstrong, Kerry] Queensland Univ Technol, Ctr Accid Res & Rd Safety Queensland, Kelvin Grove, Qld, Australia	Queensland University of Technology (QUT)	Filtness, AJ (corresponding author), Queensland Univ Technol, Ctr Accid Res & Rd Safety Queensland, Kelvin Grove, Qld, Australia.	Ashleigh.filtness@qut.edu.au	Armstrong, Kerry A/I-9861-2012; Filtness, Ashleigh/AAY-7239-2020	Armstrong, Kerry A/0000-0002-3871-7862; Filtness, Ashleigh/0000-0001-7357-0344; MacKenzie, Janelle/0000-0002-6320-9739	Centre for Accident Research and Road Safety - Queensland	Centre for Accident Research and Road Safety - Queensland	This study was funded by the Centre for Accident Research and Road Safety - Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 2003, OCCUP MED-OXFORD, V53, P89, DOI 10.1093/occmed/kqg046; Australian Bureau of Statistcs, 2011, BIRTHS SUMM STAT AUS; Australian Government, 2013, PAR LEAV PAY; Austroads, 2013, ASS FITN DRIV COMM P; Bei B, 2010, SLEEP, V33, P531, DOI 10.1093/sleep/33.4.531; Dennis CL, 2005, BIRTH-ISS PERINAT C, V32, P187, DOI 10.1111/j.0730-7659.2005.00368.x; Doering J, 2011, MCN-AM J MATERN-CHIL, V36, P258, DOI 10.1097/NMC.0b013e31821826e7; Dorheim SK, 2009, SLEEP, V32, P847, DOI 10.1093/sleep/32.7.847; Eurostat, 2011, NUMB LIV BIRTHS; Filtness AJ, 2012, SLEEP BREATH, V16, P865, DOI 10.1007/s11325-011-0588-8; Fitness AJ, 2011, SLEEP MED, V12, P838, DOI 10.1016/j.sleep.2011.07.002; Gay Caryl L, 2004, Biol Res Nurs, V5, P311, DOI 10.1177/1099800403262142; Goyal D, 2009, ARCH WOMEN MENT HLTH, V12, P229, DOI 10.1007/s00737-009-0070-9; Henderson JMT, 2010, PEDIATRICS, V126, pE1081, DOI 10.1542/peds.2010-0976; Horne J, 2012, NEUROSCI BIOBEHAV R, V36, P2226, DOI 10.1016/j.neubiorev.2012.08.005; Insana SP, 2013, DEV PSYCHOBIOL, V55, P361, DOI 10.1002/dev.21040; Insana SP, 2013, SLEEP, V36, P73, DOI 10.5665/sleep.2304; Insana SP, 2011, PHYSIOL BEHAV, V102, P234, DOI 10.1016/j.physbeh.2010.11.017; Insana SP, 2010, J PSYCHOSOM RES, V69, P467, DOI 10.1016/j.jpsychores.2010.07.004; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Kennedy HP, 2007, J PERINAT NEONAT NUR, V21, P114, DOI 10.1097/01.JPN.0000270628.51122.1d; MITLER MM, 1988, SLEEP, V11, P100, DOI 10.1093/sleep/11.1.100; Montgomery-Downs HE, 2010, PEDIATRICS, V126, pE1562, DOI 10.1542/peds.2010-1269; Montgomery-Downs HE, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.057; National Sleep Foundation, 2012, SLEEP AM POLL PLAN T; Nishihara K, 2012, CHRONOBIOL INT, V29, P363, DOI 10.3109/07420528.2012.657762; Philip P, 2005, IND HEALTH, V43, P30, DOI 10.2486/indhealth.43.30; Posmontier B, 2008, JOGNN-J OBST GYN NEO, V37, P722, DOI 10.1111/j.1552-6909.2008.00298.x; Swain AM, 1997, OBSTET GYNECOL, V90, P381, DOI 10.1016/S0029-7844(97)89252-6	31	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103513	10.1371/journal.pone.0103513	http://dx.doi.org/10.1371/journal.pone.0103513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078950	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800053
J	Khabirova, E; Moloney, A; Marciniak, SJ; Williams, J; Lomas, DA; Oliver, SG; Favrin, G; Sattelle, DB; Crowther, DC				Khabirova, Eleonora; Moloney, Aileen; Marciniak, Stefan J.; Williams, Julie; Lomas, David A.; Oliver, Stephen G.; Favrin, Giorgio; Sattelle, David B.; Crowther, Damian C.			The TRiC/CCT Chaperone Is Implicated in Alzheimer's Disease Based on Patient GWAS and an RNAi Screen in A beta-Expressing Caenorhabditis elegans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; STE20-LIKE KINASE; STRESS RESISTANCE; AMYLOID PEPTIDE; PROTEINS; GENES; PROTEOSTASIS; AUTOPHAGY; DEMENTIA	The human Ab peptide causes progressive paralysis when expressed in the muscles of the nematode worm, C. elegans. We have exploited this model of Ab toxicity by carrying out an RNAi screen to identify genes whose reduced expression modifies the severity of this locomotor phenotype. Our initial finding was that none of the human orthologues of these worm genes is identical with the genome-wide significant GWAS genes reported to date (the "white zone''); moreover there was no identity between worm screen hits and the longer list of GWAS genes which included those with borderline levels of significance (the "grey zone''). This indicates that Ab toxicity should not be considered as equivalent to sporadic AD. To increase the sensitivity of our analysis, we then considered the physical interactors (+1 interactome) of the products of the genes in both the worm and the white+grey zone lists. When we consider these worm and GWAS gene lists we find that 4 of the 60 worm genes have a + 1 interactome overlap that is larger than expected by chance. Two of these genes form a chaperonin complex, the third is closely associated with this complex and the fourth gene codes for actin, the major substrate of the same chaperonin.	[Khabirova, Eleonora; Moloney, Aileen; Crowther, Damian C.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Khabirova, Eleonora] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Moloney, Aileen; Marciniak, Stefan J.; Crowther, Damian C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Moloney, Aileen; Sattelle, David B.] Univ Oxford, MRC, Funct Genom Unit, Dept Physiol Anat & Genet, Oxford, England; [Moloney, Aileen] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Oliver, Stephen G.; Favrin, Giorgio] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Marciniak, Stefan J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Williams, Julie] Cardiff Univ, Sch Med, Dept Psychiat & Neurol, MRC,Ctr Neuropsychiat Genet, Cardiff CF10 3AX, S Glam, Wales; [Sattelle, David B.] UCL, Wolfson Inst Biomed Res, London, England; [Lomas, David A.] UCL, Dept Med, London, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Oxford; University of Oxford; University of Cambridge; University of Cambridge; Cardiff University; University of London; University College London; University of London; University College London	Oliver, SG (corresponding author), Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England.	steve.oliver@bioc.cam.ac.uk; dcc26@cam.ac.uk	Oliver, Stephen/AAQ-5992-2021	Oliver, Stephen/0000-0003-3410-6439; Marciniak, Stefan/0000-0001-8472-7183; Favrin, Giorgio/0000-0002-1884-7352; Khabirova, Eleonora/0000-0002-5891-6789; Williams, Julie/0000-0002-4069-0259	Alzheimer's Research UK [ART-SRF2010-2]; MRC; EPSRC, UK [G0700990]; MRC, UK [G0601840, G0300429, G0902227, G0901786]; Wellcome Trust [082604/2/07/Z]; NIHR UCLH BRC; Wellcome Trust/MRC Neurodegenerative Diseases Research Initiative [WT089703AIA]; MRC [MR/K013041/1, G0902227, MC_G1000734, G0601840, G0901786, G0700990, G0300429, G1002610] Funding Source: UKRI; Alzheimers Research UK [ART-SRF2010-2, ARUK-PG2014-1] Funding Source: researchfish; Medical Research Council [G0700990, MR/K013041/1, G0902227, MR/L501517/1, MC_G1000734, G1002610, MR/L010305/1, G0300429, G0901786, G0601840] Funding Source: researchfish	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC, UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR UCLH BRC; Wellcome Trust/MRC Neurodegenerative Diseases Research Initiative(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AM & JW were supported by Alzheimer's Research UK (http://www.alzheimersresearchuk.org). DCC was supported by an Alzheimer's Research UK Senior Research Fellowship (http://www.alzheimersresearchuk.org, grant code: ART-SRF2010-2) and the MRC (http://www.mrc.ac.uk) and EPSRC (http://www.epsrc.ac.uk/), UK (grant code: G0700990). SJM is supported by the MRC, UK (http://www.mrc.ac.uk, grant code: G0601840). JW was supported by the MRC, UK (http://www.mrc.ac.uk, grant codes: G0300429 and G0902227) and the Wellcome Trust (http://www.wellcome.ac.uk, grant code: 082604/2/07/Z). DAL was supported by the MRC, UK (http://www.mrc.ac.uk, grant code: G0901786) and the NIHR UCLH BRC (http://www.uclhospitals.brc.nihr.ac.uk). DCC, DAL, GF, and SGO are all co-investigators on the Wellcome Trust/MRC Neurodegenerative Diseases Research Initiative (http://www.wellcome.ac.uk, grant code: WT089703AIA).	Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; BESAG J, 1991, BIOMETRIKA, V78, P301; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRENNER S, 1974, GENETICS, V77, P71; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Fisher R., 1970, STAT METHODS RES WOR; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Gatz M, 1997, J GERONTOL A-BIOL, V52, pM117, DOI 10.1093/gerona/52A.2.M117; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gerrish A, 2012, J ALZHEIMERS DIS, V28, P377, DOI 10.3233/JAD-2011-110824; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guisbert E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003466; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hillier LW, 2005, GENOME RES, V15, P1651, DOI 10.1101/gr.3729105; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Jensen M, 1999, ANN NEUROL, V45, P504, DOI 10.1002/1531-8249(199904)45:4<504::AID-ANA12>3.0.CO;2-9; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kirstein-Miles J, 2013, CELL CYCLE, V12, P2335, DOI 10.4161/cc.25703; Kraemer BC, 2006, HUM MOL GENET, V15, P1483, DOI 10.1093/hmg/ddl067; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lambourne SL, 2005, MOL CELL BIOL, V25, P278, DOI 10.1128/MCB.25.1.278-293.2005; Lapierre LR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3267; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Lorber B, 2009, NAT NEUROSCI, V12, P1407, DOI 10.1038/nn.2414; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Pryszcz LP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq953; Riedel CG, 2013, NAT CELL BIOL, V15, P491, DOI 10.1038/ncb2720; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Schupf N, 2007, ARCH NEUROL-CHICAGO, V64, P1007, DOI 10.1001/archneur.64.7.1007; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015; Yoo BC, 2001, J NEURAL TRANSM-SUPP, P321; Zhou TH, 2000, J BIOL CHEM, V275, P2513, DOI 10.1074/jbc.275.4.2513	49	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102985	10.1371/journal.pone.0102985	http://dx.doi.org/10.1371/journal.pone.0102985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080104	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000339954800020
J	Loh, SW; Ng, WL; Yeo, KS; Lim, YY; Ea, CK				Loh, Sheng Wei; Ng, Wei Lun; Yeo, Kok Siong; Lim, Yat-Yuen; Ea, Chee-Kwee			Inhibition of Euchromatic Histone Methyltransferase 1 and 2 Sensitizes Chronic Myeloid Leukemia Cells to Interferon Treatment	PLOS ONE			English	Article							G9A; METHYLATION; EXPRESSION; ALPHA; RESISTANCE; THERAPY; FUTURE; GENE	Background: H3K9 methylation is one of the essential histone post-translational modifications for heterochromatin formation and transcriptional repression. Recently, several studies have demonstrated that H3K9 methylation negatively regulates the type I interferon response. Results: We report the application of EHMT1 and EHMT2 specific chemical inhibitors to sensitize CML cell lines to interferon and imatinib treatments. Inhibition of EHMT1 and EHMT2 with BIX01294 enhances the cytotoxicity of IFN alpha 2a in four CML cell lines, K562, KCL22, BV173 and KT1 cells. Chromatin immunoprecipitation assay shows that BIX01294 treatment enhances type I interferon response by reducing H3K9me2 at the promoters of interferon-stimulated genes. Additionally, BIX01294 treatment augments IFN alpha 2a- and imatinib-mediated apoptosis in CML cell lines. Moreover, our data suggest that the expression level of EHMT1 and EHMT2 inversely correlates with the type I interferon responsiveness in CML cell lines. Conclusions: Our study sheds light on the role of EHMT1 and EHMT2 as potential targets in improving the efficacy of standard treatments of CML.	[Loh, Sheng Wei; Ng, Wei Lun; Yeo, Kok Siong; Lim, Yat-Yuen; Ea, Chee-Kwee] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya	Ea, CK (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	eacheekwee@um.edu.my	Ng, Wei Lun/X-3337-2019; YEO, KOK SIONG/D-9910-2010; Yeo, Kok Siong/AAA-8345-2019; Lim, Yat Yuen/I-6495-2013	Yeo, Kok Siong/0000-0003-2430-2487; Lim, Yat Yuen/0000-0001-8617-6063	University of Malaya, HIR [UM.C1625/1/HIR/MOHE/CHAN-02, H-50001-A000022]; UMRG [RG533-13HTM]	University of Malaya, HIR; UMRG	This work was supported by the University of Malaya, HIR Grant (UM.C1625/1/HIR/MOHE/CHAN-02; H-50001-A000022) and UMRG (RG533-13HTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attema JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075517; BORDEN EC, 1981, PROG HEMATOL, V12, P299; COLAMONICI OR, 1992, BLOOD, V80, P744; Ea CK, 2012, J BIOL CHEM, V287, P31207, DOI 10.1074/jbc.M112.365601; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Fausel C, 2007, AM J HEALTH-SYST PH, V64, pS9, DOI 10.2146/ajhp070482; Guilhot F, 2009, BEST PRACT RES CL HA, V22, P315, DOI 10.1016/j.beha.2009.10.005; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Pavlovsky C, 2009, AM J HEMATOL, V84, P287, DOI 10.1002/ajh.21380; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sakai I, 2002, BLOOD, V100, P2926, DOI 10.1182/blood-2002-01-0073; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Talpaz M, 2013, LEUKEMIA, V27, P803, DOI 10.1038/leu.2012.313; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Vial T, 2000, TOXICOLOGY, V142, P161, DOI 10.1016/S0300-483X(99)00141-9; Yanagisawa K, 1998, BLOOD, V91, P641, DOI 10.1182/blood.V91.2.641.641_641_648	22	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103915	10.1371/journal.pone.0103915	http://dx.doi.org/10.1371/journal.pone.0103915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079219	gold, Green Published			2022-12-27	WOS:000339954800095
J	Maximino, C; da Silva, AWB; Araujo, J; Lima, MG; Miranda, V; Puty, B; Benzecry, R; Picanco-Diniz, DLW; Gouveia, A; Oliveira, KRM; Herculano, AM				Maximino, Caio; Batista da Silva, Annanda Waneza; Araujo, Juliana; Lima, Monica Gomes; Miranda, Vanessa; Puty, Bruna; Benzecry, Rances; Wanderley Picanco-Diniz, Domingos Luiz; Gouveia, Amauri, Jr.; Matos Oliveira, Karen Renata; Herculano, Anderson Manoel			Fingerprinting of Psychoactive Drugs in Zebrafish Anxiety-Like Behaviors	PLOS ONE			English	Article							DANIO-RERIO; ANIMAL-MODELS; ADULT ZEBRAFISH; DISCOVERY; SCOTOTAXIS; IDENTIFICATION; MODULATION; LIGHT/DARK; VERTEBRATE; PREFERENCE	A major hindrance for the development of psychiatric drugs is the prediction of how treatments can alter complex behaviors in assays which have good throughput and physiological complexity. Here we report the development of a medium-throughput screen for drugs which alter anxiety-like behavior in adult zebrafish. The observed phenotypes were clustered according to shared behavioral effects. This barcoding procedure revealed conserved functions of anxiolytic, anxiogenic and psychomotor stimulating drugs and predicted effects of poorly characterized compounds on anxiety. Moreover, anxiolytic drugs all decreased, while anxiogenic drugs increased, serotonin turnover. These results underscore the power of behavioral profiling in adult zebrafish as an approach which combines throughput and physiological complexity in the pharmacological dissection of complex behaviors.	[Maximino, Caio; Lima, Monica Gomes] Univ Estado Para, Ctr Ciencias Biol & Saude, Dept Morfol & Ciencias Fisiol, Lab Neurociencias & Comportamento Frederico Graef, Maraba, Para, Brazil; [Batista da Silva, Annanda Waneza; Araujo, Juliana; Miranda, Vanessa; Benzecry, Rances] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Puty, Bruna; Matos Oliveira, Karen Renata; Herculano, Anderson Manoel] Fed Univ Para, Inst Ciencias Biol, Lab Neuroendocrinol, BR-66059 Belem, Para, Brazil; [Wanderley Picanco-Diniz, Domingos Luiz] Univ Fed Oeste Para, Oriximina, Para, Brazil; [Gouveia, Amauri, Jr.] Fed Univ Para, Lab Neurociencias & Comportamento, Nucleo Pesquisa & Teoria Comportamento, BR-66059 Belem, Para, Brazil	Universidade do Estado do Para (UEPA); Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Oeste do Para; Universidade Federal do Para	Maximino, C (corresponding author), Univ Estado Para, Ctr Ciencias Biol & Saude, Dept Morfol & Ciencias Fisiol, Lab Neurociencias & Comportamento Frederico Graef, Maraba, Para, Brazil.	caio.maximino@gmail.com	Maximino, Caio/G-5726-2013; Herculano, Anderson M/M-9016-2017; Puty, Bruna/L-4670-2016; Gouveia, Amauri/AAI-3542-2021; Gouveia, Amauri/D-9296-2012	Maximino, Caio/0000-0002-3261-9196; Puty, Bruna/0000-0001-5570-8530; Gouveia, Amauri/0000-0003-1710-9662; Gouveia, Amauri/0000-0003-1710-9662; Gomes Lima-Maximino, Monica/0000-0002-9816-3443	Conselho Nacional de Pesquisa (CNPq/Brazil) [483336/2009-2, 400039/2009-5]	Conselho Nacional de Pesquisa (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was financed by Conselho Nacional de Pesquisa (CNPq/Brazil, grants 483336/2009-2 and 400039/2009-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2012, BEHAVIOUR, V149, P1241, DOI 10.1163/1568539X-00003020; Araujo J, 2012, ZEBRAFISH PROTOCOLS, DOI [10.1007/978-1-61779-597-8 14, DOI 10.1007/978-1-61779-597-814]; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Baldwin DS, 2011, INT J NEUROPSYCHOPH, V14, P697, DOI 10.1017/S1461145710001434; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Blaser RE, 2012, ANIM BEHAV, V83, P953, DOI 10.1016/j.anbehav.2012.01.014; Brennand KJ, 2012, MOL PSYCHIATR, V17, P1239, DOI 10.1038/mp.2012.20; Cachat J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017597; Cachat J, 2010, BEHAV BRAIN RES, V208, P371, DOI 10.1016/j.bbr.2009.12.004; Cofiel LPV, 2009, BRAZ J MED BIOL RES, V42, P128, DOI 10.1590/S0100-879X2009000100018; Connors KA, 2013, AQUAT TOXICOL; Crabbe JC, 2004, NAT NEUROSCI, V7, P1175, DOI 10.1038/nn1343; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Griebel G, 2013, NAT REV DRUG DISCOV, V12, P667, DOI 10.1038/nrd4075; Herculano AM, 2014, PROG NEURO-PSYCHOPH, V55, P50, DOI 10.1016/j.pnpbp.2014.03.008; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Kalueff AV, 2008, BEHAV BRAIN RES, V188, P243, DOI 10.1016/j.bbr.2007.11.011; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Key Brian, 2003, Methods in Cell Science, V25, P1; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Kokel David, 2008, Briefings in Functional Genomics & Proteomics, V7, P483, DOI 10.1093/bfgp/eln040; Lau BYB, 2011, P NATL ACAD SCI USA, V108, P2581, DOI 10.1073/pnas.1018275108; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Linker A, 2011, NEUROMETHODS, V51, P181, DOI 10.1007/978-1-60761-953-6_15; Maximino C, 2011, PARAMETROS ESCOTOTAX, DOI [10.6084/m9.figshare.928644, DOI 10.6084/M9.FIGSHARE.928644]; Maximino C, 2013, NEUROPHARMACOLOGY, V71, P83, DOI 10.1016/j.neuropharm.2013.03.006; Maximino C, 2012, BEHAVIOUR, V149, P1099, DOI 10.1163/1568539X-00003029; Maximino C, 2011, BASIC CLIN PHARMACOL, V109, P203, DOI 10.1111/j.1742-7843.2011.00710.x; Maximino C, 2011, PROG NEURO-PSYCHOPH, V35, P624, DOI 10.1016/j.pnpbp.2011.01.006; Maximino C, 2010, ZEBRAFISH, V7, P359, DOI 10.1089/zeb.2010.0669; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; Nguyen M, 2013, BRAIN RES BULL, V98, P145, DOI 10.1016/j.brainresbull.2013.08.004; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; Norton WHJ, 2011, J NEUROSCI, V31, P13796, DOI 10.1523/JNEUROSCI.2892-11.2011; Papke RL, 2012, BIOCHEM PHARMACOL, V84, P352, DOI 10.1016/j.bcp.2012.04.022; Peitsaro N, 2003, J NEUROCHEM, V86, P432, DOI 10.1046/j.1471-4159.2003.01850.x; Redfern William S., 2008, Journal of Pharmacological and Toxicological Methods, V58, P110, DOI 10.1016/j.vascn.2008.05.006; Richendrfer H, 2012, BEHAV BRAIN RES, V228, P99, DOI 10.1016/j.bbr.2011.11.041; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Ruhl T, 2014, PSYCHOPHARMACOLOGY, V231, P3829, DOI 10.1007/s00213-014-3522-5; Sackerman James, 2010, Int J Comp Psychol, V23, P43; Schilling Thomas F., 2002, P59; Serra EL, 1999, BRAZ J MED BIOL RES, V32, P1551, DOI 10.1590/S0100-879X1999001200016; Shimada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052549; Steenbergen PJ, 2011, BEHAV BRAIN RES, V222, P15, DOI 10.1016/j.bbr.2011.03.025; Stewart A, 2011, PROG NEURO-PSYCHOPH, V35, P1421, DOI 10.1016/j.pnpbp.2010.11.035; Stewart A, 2011, NEUROMETHODS, V51, P157, DOI 10.1007/978-1-60761-953-6_13; Stewart AM, 2014, BRAIN RES, V1543, P109, DOI 10.1016/j.brainres.2013.11.002; Stewart AM, 2013, NEUROCHEM INT, V62, P893, DOI 10.1016/j.neuint.2013.02.018; Stewart AM, 2013, BEHAV BRAIN RES, V236, P110, DOI 10.1016/j.bbr.2012.08.026; Stewart AM, 2014, BEHAV BRAIN IN PRESS; Stewart AM, 2012, CURR NEUROP IN PRESS; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; van der Staay FJ, 2006, BRAIN RES REV, V52, P131, DOI 10.1016/j.brainresrev.2006.01.006; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	63	68	70	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103943	10.1371/journal.pone.0103943	http://dx.doi.org/10.1371/journal.pone.0103943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079766	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800098
J	Tirodkar, TS; Budiu, RA; Elishaev, E; Zhang, LX; Mony, JT; Brozick, J; Edwards, RP; Vlad, AM				Tirodkar, Tejas S.; Budiu, Raluca A.; Elishaev, Esther; Zhang, Lixin; Mony, Jyothi T.; Brozick, Joan; Edwards, Robert P.; Vlad, Anda M.			MUC1 Positive, Kras and Pten Driven Mouse Gynecologic Tumors Replicate Human Tumors and Vary in Survival and Nuclear Grade Based on Anatomical Location	PLOS ONE			English	Article							SEROUS OVARIAN-CANCER; ENDOMETRIAL CANCER; FALLOPIAN-TUBE; K-RAS; CELL; CARCINOMAS; MUTATIONS; MODEL; EXPRESSION; METAPLASIA	Activating mutations of Kras oncogene and deletions of Pten tumor suppressor gene play important roles in cancers of the female genital tract. We developed here new preclinical models for gynecologic cancers, using conditional (Cre-loxP) mice with floxed genetic alterations in Kras and Pten. The triple transgenic mice, briefly called MUC1KrasPten, express human MUC1 antigen as self and carry a silent oncogenic Kras(G12D) and Pten deletion mutation. Injection of Cre-encoding adenovirus (AdCre) in the ovarian bursa, oviduct or uterus activates the floxed mutations and initiates ovarian, oviductal, and endometrial cancer, respectively. Anatomical site-specific Cre-loxP recombination throughout the genital tract of MUC1KrasPten mice leads to MUC1 positive genital tract tumors, and the development of these tumors is influenced by the anatomical environment. Endometrioid histology was consistently displayed in all tumors of the murine genital tract (ovaries, oviducts, and uterus). Tumors showed increased expression of MUC1 glycoprotein and triggered de novo antibodies in tumor bearing hosts, mimicking the immunobiology seen in patients. In contrast to the ovarian and endometrial tumors, oviductal tumors showed higher nuclear grade. Survival for oviduct tumors was significantly lower than for endometrial tumors (p = 0.0015), yet similar to survival for ovarian cancer. Oviducts seem to favor the development of high grade tumors, providing preclinical evidence in support of the postulated role of fallopian tubes as the originating site for high grade human ovarian tumors.	[Tirodkar, Tejas S.; Budiu, Raluca A.; Elishaev, Esther; Zhang, Lixin; Mony, Jyothi T.; Edwards, Robert P.; Vlad, Anda M.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Tirodkar, Tejas S.; Budiu, Raluca A.; Zhang, Lixin; Mony, Jyothi T.; Brozick, Joan; Edwards, Robert P.; Vlad, Anda M.] Magee Womens Res Inst, Pittsburgh, PA USA; [Elishaev, Esther] Univ Pittsburgh, Magee Womens Hosp, Dept Pathol, Med Ctr, Pittsburgh, PA 15213 USA; [Edwards, Robert P.] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vlad, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	vladam@upmc.edu	/AAC-3404-2019; Brozick, Joan/AAA-5785-2019; Zhang, Li/GWM-7501-2022	/0000-0002-4587-1868; 	Department of Defense Ovarian Cancer Academy Award [W81XWH-10-1-052]; Pennsylvania Department of Health; Scaife Foundation; NIH/NCI [R01 CA163462]; NATIONAL CANCER INSTITUTE [R01CA163462] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	Department of Defense Ovarian Cancer Academy Award; Pennsylvania Department of Health; Scaife Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the Department of Defense Ovarian Cancer Academy Award W81XWH-10-1-052, Pennsylvania Department of Health, Scaife Foundation and NIH/NCI R01 CA163462. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013, P1, DOI DOI 10.1017/CB09781107415324.004; Arango NA, 2008, MOL REPROD DEV, V75, P1154, DOI 10.1002/mrd.20858; Awaya H, 2004, AM J CLIN PATHOL, V121, P644, DOI 10.1039/U4WGE9EBFJN6CM8R; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Bansal N, 2009, CANCER CONTROL, V16, P8, DOI 10.1177/107327480901600102; Barrow E, 2009, CLIN GENET, V75, P141, DOI 10.1111/j.1399-0004.2008.01125.x; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Budiu RA, 2012, ONCOGENE, V10, P397; Cabrera S, 2012, CLIN EXP METASTAS, V29, P217, DOI 10.1007/s10585-011-9444-2; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Deng JL, 2013, CANCER METAST REV, V32, P535, DOI 10.1007/s10555-013-9423-y; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Fan HY, 2009, CANCER RES, V69, P6463, DOI 10.1158/0008-5472.CAN-08-3363; Friel Anne M, 2010, Front Biosci (Elite Ed), V2, P882; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Jones S, 2012, J PATHOL, V226, P413, DOI 10.1002/path.3967; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Joshi A, 2011, EXP CELL RES, V317, P1580, DOI 10.1016/j.yexcr.2011.03.006; Kaira K, 2012, INT J SURG PATHOL, V20, P223, DOI 10.1177/1066896911429296; Katz SC, 2013, ANN SURG ONCOL, V20, P946, DOI 10.1245/s10434-012-2668-9; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Kim R, 1997, CANCER EPIDEM BIOMAR, V6, P369; Kimura T, 2013, EXPERT OPIN BIOL TH, V13, P35, DOI 10.1517/14712598.2012.725719; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; LEUBE RE, 1991, VIRCHOWS ARCH B, V61, P227; MIZUUCHI H, 1995, CANCER, V76, P86, DOI 10.1002/1097-0142(19950701)76:1<86::AID-CNCR2820760112>3.0.CO;2-L; Mullany LK, 2011, ONCOGENE, V30, P3522, DOI 10.1038/onc.2011.70; Musrap N, 2012, MOL CANCER RES, V10, P1254, DOI 10.1158/1541-7786.MCR-12-0353; Pearce CL, 2012, LANCET ONCOL, V13, P385, DOI 10.1016/S1470-2045(11)70404-1; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Przybycin CG, 2010, AM J SURG PATHOL, V34, P1407, DOI 10.1097/PAS.0b013e3181ef7b16; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Roh MH, 2010, MODERN PATHOL, V23, P1316, DOI 10.1038/modpathol.2010.119; RUGHETTI A, 1993, CANCER RES, V53, P2457; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Shen ZB, 2010, J CANCER RES CLIN, V136, P1585, DOI 10.1007/s00432-010-0816-9; *US CANC STAT WORK, 2006, US CANC STAT 2003 IN; van der Zee M, 2013, J PATHOL, V230, P48, DOI 10.1002/path.4160; von Mensdorff-Pouilly S, 1998, TUMOR BIOL, V19, P186, DOI 10.1159/000030006; Von Mensdorff-Pouilly Silvia, 2011, Cancers (Basel), V3, P3073, DOI 10.3390/cancers3033073; Watanabe Y, 2010, ORAL SURG ORAL MED O, V109, P744, DOI 10.1016/j.tripleo.2009.12.015; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433	45	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102409	10.1371/journal.pone.0102409	http://dx.doi.org/10.1371/journal.pone.0102409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078979	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000339954800013
J	Blaho, M; Herczeg, T; Kriska, G; Egri, A; Szaz, D; Farkas, A; Tarjanyi, N; Czinke, L; Barta, A; Horvath, G				Blaho, Miklos; Herczeg, Tamas; Kriska, Gyorgy; Egri, Adam; Szaz, Denes; Farkas, Alexandra; Tarjanyi, Nikolett; Czinke, Laszlo; Barta, Andras; Horvath, Gabor			Unexpected Attraction of Polarotactic Water-Leaving Insects to Matt Black Car Surfaces: Mattness of Paintwork Cannot Eliminate the Polarized Light Pollution of Black Cars	PLOS ONE			English	Article							AQUATIC INSECTS; DIPTERA TABANIDAE; OVIPOSITION SITES; SOLAR PANELS; HORSE FLIES; VISION; EPHEMEROPTERA; ADVANTAGE; TRAPS; RED	The horizontally polarizing surface parts of shiny black cars (the reflection-polarization characteristics of which are similar to those of water surfaces) attract water-leaving polarotactic insects. Thus, shiny black cars are typical sources of polarized light pollution endangering water-leaving insects. A new fashion fad is to make car-bodies matt black or grey. Since rough (matt) surfaces depolarize the reflected light, one of the ways of reducing polarized light pollution is to make matt the concerned surface. Consequently, matt black/grey cars may not induce polarized light pollution, which would be an advantageous feature for environmental protection. To test this idea, we performed field experiments with horizontal shiny and matt black car-body surfaces laid on the ground. Using imaging polarimetry, in multiple-choice field experiments we investigated the attractiveness of these test surfaces to various water-leaving polarotactic insects and obtained the following results: (i) The attractiveness of black car-bodies to polarotactic insects depends in complex manner on the surface roughness (shiny, matt) and species (mayflies, dolichopodids, tabanids). (ii) Non-expectedly, the matt dark grey car finish is much more attractive to mayflies (being endangered and protected in many countries) than matt black finish. (iii) The polarized light pollution of shiny black cars usually cannot be reduced with the use of matt painting. On the basis of these, our two novel findings are that (a) matt car-paints are highly polarization reflecting, and (b) these matt paints are not suitable to repel polarotactic insects. Hence, the recent technology used to make matt the car-bodies cannot eliminate or even can enhance the attractiveness of black/grey cars to water-leaving insects. Thus, changing shiny black car painting to matt one is a disadvantageous fashion fad concerning the reduction of polarized light pollution of black vehicles.	[Blaho, Miklos; Herczeg, Tamas; Egri, Adam; Szaz, Denes; Farkas, Alexandra; Czinke, Laszlo; Barta, Andras; Horvath, Gabor] Eotvos Lorand Univ, Inst Phys, Dept Biol Phys, Environm Opt Lab, Budapest, Hungary; [Kriska, Gyorgy; Czinke, Laszlo] Eotvos Lorand Univ, Inst Biol, Grp Methodol Biol Teaching, Budapest, Hungary; [Kriska, Gyorgy; Tarjanyi, Nikolett] Hungarian Acad Sci, Ctr Ecol Res, Danube Res Inst, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research	Horvath, G (corresponding author), Eotvos Lorand Univ, Inst Phys, Dept Biol Phys, Environm Opt Lab, Budapest, Hungary.	gh@arago.elte.hu	Kriska, György/B-5723-2019	Kriska, Gyorgy/0000-0003-4271-3167	European Commission [TabaNOid 232366]; German Alexander von Humboldt Foundation in Regensburg [3.3-UNG/1073032 STP]	European Commission(European CommissionEuropean Commission Joint Research Centre); German Alexander von Humboldt Foundation in Regensburg	This work was supported by the grant TabaNOid 232366 (Trap for the Novel Control of Horse-flies on Open-air Fields) funded by the European Commission under the 7th Framework Programme received by G. Horvath and G. Kriska. Gabor Horvath thanks the German Alexander von Humboldt Foundation for an equipment donation and a three-month research fellowship (3.3-UNG/1073032 STP, between 1 June and 31 August 2013) in Regensburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernath B, 2004, J EXP BIOL, V207, P755, DOI 10.1242/jeb.00810; Bernath B, 2002, FRESHWATER BIOL, V47, P1707, DOI 10.1046/j.1365-2427.2002.00931.x; Blaho M, 2012, VET PARASITOL, V189, P353, DOI 10.1016/j.vetpar.2012.04.016; Blaho M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041138; Boda P, 2013, HYDROBIOLOGIA, V703, P133, DOI 10.1007/s10750-012-1350-3; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Csabai Z, 2006, FRESHWATER BIOL, V51, P1341, DOI 10.1111/j.1365-2427.2006.01576.x; Csabai Z, 2012, NATURWISSENSCHAFTEN, V99, P751, DOI 10.1007/s00114-012-0957-6; Egri A, 2013, INT J PARASITOL, V43, P555, DOI 10.1016/j.ijpara.2013.02.002; Egri A, 2012, NATURWISSENSCHAFTEN, V99, P407, DOI 10.1007/s00114-012-0916-2; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; Encalada AC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1437, DOI 10.1007/s00265-007-0376-4; Henze MJ, 2007, J EXP BIOL, V210, P3266, DOI 10.1242/jeb.007831; Horvath G., 2008, Aquatic insects: challenges to populations, P204, DOI 10.1079/9781845933968.0204; Horvath G, 1997, J EXP BIOL, V200, P1155; Horvath G., 2004, POLARIZED LIGHT ANIM; Horvath G, 2010, SERIES ENV REMEDIATI, P47; Horvath G, 2008, NATURWISSENSCHAFTEN, V95, P1093, DOI 10.1007/s00114-008-0425-5; Horvath G, 2011, PHYSIOL BEHAV, V104, P1010, DOI 10.1016/j.physbeh.2011.06.022; Horvath G, 2010, CONSERV BIOL, V24, P1644, DOI 10.1111/j.1523-1739.2010.01518.x; Horvath G, 2010, P ROY SOC B-BIOL SCI, V277, P1643, DOI 10.1098/rspb.2009.2202; Horvath G, 2009, FRONT ECOL ENVIRON, V7, P317, DOI 10.1890/080129; Jach M.A., 1997, Latissimus, V9, P10; Krcmar S, 2013, ENTOMOL GEN, V34, P261; Krcmar S, 2011, ENTOMOL GEN, V33, P245; Kriska G, 1998, J EXP BIOL, V201, P2273; Kriska G, 2009, J INSECT PHYSIOL, V55, P1167, DOI 10.1016/j.jinsphys.2009.08.013; Kriska G, 2007, NATURWISSENSCHAFTEN, V94, P148, DOI 10.1007/s00114-006-0180-4; Kriska G, 2006, P ROY SOC B-BIOL SCI, V273, P1667, DOI 10.1098/rspb.2006.3500; Lerner A, 2008, J EXP BIOL, V211, P3536, DOI 10.1242/jeb.022277; Lerner A, 2012, J OPT SOC AM A, V29, P2394, DOI 10.1364/JOSAA.29.002394; Nilsson Anders N., 1997, Latissimus, V9, P12; Russev Boris K., 1992, Lauterbornia, V9, P13; SCHWIND R, 1995, J COMP PHYSIOL A, V177, P439; SCHWIND R, 1991, J COMP PHYSIOL A, V169, P531; Umow N, 1905, PHYS Z, V6, P674; van Vondel Bernhard, 1998, Latissimus, V10, P29; Wildermuth H, 1998, NATURWISSENSCHAFTEN, V85, P297, DOI 10.1007/s001140050504; Wildermuth Hansruedi, 2007, Libellula, V26, P143; Wildermuth Hansruedi, 2005, International Journal of Odonatology, V8, P97; Zar JH., 2010, BIOSTAT ANAL, V5th	41	9	9	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103339	10.1371/journal.pone.0103339	http://dx.doi.org/10.1371/journal.pone.0103339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076137	Green Published, gold, Green Submitted			2022-12-27	WOS:000340028800038
J	Eduardo, E; Lamb, MR; Kandula, S; Howard, A; Mugisha, V; Kimanga, D; Kilama, B; El-Sadr, W; Elul, B				Eduardo, Eduard; Lamb, Matthew R.; Kandula, Sasi; Howard, Andrea; Mugisha, Veronicah; Kimanga, Davies; Kilama, Bonita; El-Sadr, Wafaa; Elul, Batya			Characteristics and Outcomes among Older HIV-Positive Adults Enrolled in HIV Programs in Four Sub-Saharan African Countries	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; FOLLOW-UP; AGE; INFECTION; RESPONSES; SURVIVAL; HIV/AIDS; PEOPLE; LOST	Background: Limited information exists on adults >= 50 years receiving HIV care in sub-Saharan Africa. Methodology: Using routinely-collected longitudinal patient-level data among 391,111 adults >= 15 years enrolling in HIV care from January 2005-December 2010 and 184,689 initiating ART, we compared characteristics and outcomes between older (>= 50 years) and younger adults at 199 clinics in Kenya, Mozambique, Rwanda, and Tanzania. We calculated proportions over time of newly enrolled and active adults receiving HIV care and initiating ART who were >= 50 years; cumulative incidence of loss to follow-up (LTF) and recorded death one year after enrollment and ART initiation, and CD4+ response following ART initiation. Findings: From 2005-2010, the percentage of adults >= 50 years newly enrolled in HIV care remained stable at 10%, while the percentage of adults >= 50 years newly initiating ART (10% [2005]-12% [2010]), active in follow-up (10% [2005]-14% (2010]), and active on ART (10% [2005]-16% [2010]) significantly increased. One year after enrollment, older patients had significantly lower incidence of LTF (33.1% vs. 32.6%[40-49 years], 40.5%[25-39 years], and 56.3%[15-24 years]; p-value<0.0001), but significantly higher incidence of recorded death (6.0% vs. 5.0% [40-49 years], 4.1% [25-39 years], and 2.8% [1524 years]; p-valve<0.0001). LTF was lower after vs. before ART initiation for all ages, with older adults experiencing less LTF than younger adults. Among 85,763 ART patients with baseline and follow-up CD4+ counts, adjusted average 12-month CD4+ response for older adults was 20.6 cells/mm(3) lower than for adults 25-39 years of age (95% CI: 17.1-24.1). Conclusions: The proportion of patients who are >= 50 years has increased over time and been driven by aging of the existing patient population. Older patients experienced less LTF, higher recorded mortality and less robust CD4+ response after ART initiation. Increased programmatic attention on older adults receiving HIV care in sub-Saharan Africa is warranted.	[Eduardo, Eduard; Lamb, Matthew R.; Howard, Andrea; El-Sadr, Wafaa; Elul, Batya] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Lamb, Matthew R.; Kandula, Sasi; Howard, Andrea; Mugisha, Veronicah; El-Sadr, Wafaa; Elul, Batya] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Kimanga, Davies] Minist Hlth, Natl AIDS & STI Control Programme, Nairobi, Kenya; [Kilama, Bonita] Minist Hlth & Social Welf, Natl AIDS Control Program, Dar Es Salaam, Tanzania	Columbia University; Columbia University	Lamb, MR (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	mrl2013@columbia.edu			U.S. Centers for Disease Control and Prevention, Identifying Optimal Models of HIV Care and Treatment [5U2GPS001537-03]	U.S. Centers for Disease Control and Prevention, Identifying Optimal Models of HIV Care and Treatment(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	U.S. Centers for Disease Control and Prevention, Identifying Optimal Models of HIV Care and Treatment, Grant Number 5U2GPS001537-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Centers for Disease Control and Prevention, 2008, HIV AIDS PERS AG 50; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Dorrington R. E., 2006, DEMOGRAPHIC IMPACT H; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; ELSADR W, 1995, ARCH INTERN MED, V155, P184, DOI 10.1001/archinte.155.2.184; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Goodkin K, 2003, JAIDS-J ACQ IMM DEF, V33, pS171, DOI 10.1097/00126334-200306012-00015; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Greig Jane, 2012, AIDS, V26 Suppl 1, pS31; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Kautz T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2841; Manfredi R, 2002, DRUG AGING, V19, P647, DOI 10.2165/00002512-200219090-00003; Manrique L, 2010, JAIDS-J ACQ IMM DEF, V54, P332, DOI 10.1097/QAI.0b013e3181d2eef1; Mayhew S, 1996, HEALTH POLICY PLANN, V11, P339, DOI 10.1093/heapol/11.4.339; Muga GO, 2009, J CROSS-CULT GERONTO, V24, P259, DOI 10.1007/s10823-008-9090-6; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Navarro G, 2008, J INFECTION, V57, P64, DOI 10.1016/j.jinf.2008.05.003; Negin J, 2010, B WHO; Negin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026546; Nguyen N, 2008, CLIN INTERV AGING, V3, P453; Nogueras M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-159; Orlando G, 2006, HIV MED, V7, P549, DOI 10.1111/j.1468-1293.2006.00420.x; Parikh SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076158; Perez JL, 2003, CLIN INFECT DIS, V36, P212, DOI 10.1086/345669; Pontali E, 2003, J HLTH MANAGEMENT, V2003, P315; Remien RH, 2008, AIDS, V22, pS57, DOI 10.1097/01.aids.0000327437.13291.86; Stoff DM, 2004, AIDS, V18, pS3, DOI 10.1097/00002030-200401001-00002; Stoff DM, 2004, AIDS, V18, pS1, DOI 10.1097/00002030-200401001-00001; Tuboi SH, 2010, JAIDS-J ACQ IMM DEF, V53, P70, DOI 10.1097/QAI.0b013e3181c22d19; UNAIDS, 2007, AIDS EP UPD DEC 2007, P1; Valcour V, 2006, CLIN INFECT DIS, V42, P1449, DOI 10.1086/503565; WHO, 2013, GLOB UPD HIV TREATM; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zaba B, 2008, 17 INT AIDS C MEX CI	36	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103864	10.1371/journal.pone.0103864	http://dx.doi.org/10.1371/journal.pone.0103864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075743	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800084
J	Fischer, S; Wiemer, A; Diedrich, L; Moock, J; Rossler, W				Fischer, Sebastian; Wiemer, Anita; Diedrich, Laura; Moock, Joern; Roessler, Wulf			Hell Is Other People? Gender and Interactions with Strangers in the Workplace Influence a Person's Risk of Depression	PLOS ONE			English	Article							EMOTION REGULATION; INTERPERSONAL CONFLICT; WORK STRESS; LABOR; MULTILEVEL; BURNOUT; SERVICE; INAUTHENTICITY; INTELLIGENCE; DISORDERS	We suggest that interactions with strangers at work influence the likelihood of depressive disorders, as they serve as an environmental stressor, which are a necessary condition for the onset of depression according to diathesis-stress models of depression. We examined a large dataset (N = 76,563 in K = 196 occupations) from the German pension insurance program and the Occupational Information Network dataset on occupational characteristics. We used a multilevel framework with individuals and occupations as levels of analysis. We found that occupational environments influence employees' risks of depression. In line with the quotation that 'hell is other people' frequent conflictual contacts were related to greater likelihoods of depression in both males and females (OR = 1.14, p < .05). However, interactions with the public were related to greater likelihoods of depression for males but lower likelihoods of depression for females (ORintercation = 1.21, p < .01). We theorize that some occupations may involve interpersonal experiences with negative emotional tones that make functional coping difficult and increase the risk of depression. In other occupations, these experiences have neutral tones and allow for functional coping strategies. Functional strategies are more often found in women than in men.	[Fischer, Sebastian; Wiemer, Anita; Diedrich, Laura; Moock, Joern; Roessler, Wulf] Leuphana Univ Lueneburg, Luneburg, Germany; [Roessler, Wulf] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland; [Roessler, Wulf] Univ Sao Paulo, Inst Psychiat, Neurosci Lab, Sao Paulo, Brazil	Leuphana University Luneburg; University of Zurich; Universidade de Sao Paulo	Fischer, S (corresponding author), Leuphana Univ Lueneburg, Luneburg, Germany.	sebastian.fsc@gmail.com	Fischer, Sebastian/AAB-2783-2019	Rossler, Wulf/0000-0003-0049-4533	European Union Innovation Incubator	European Union Innovation Incubator	This research was funded by the European Union Innovation Incubator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst J, 2009, J AFFECT DISORDERS, V115, P112, DOI 10.1016/j.jad.2008.09.023; Aron EN, 1997, J PERS SOC PSYCHOL, V73, P345, DOI 10.1037/0022-3514.73.2.345; Bakker AB, 2002, ANXIETY STRESS COPIN, V15, P245, DOI 10.1080/1061580021000020716; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Blakely TA, 2000, J EPIDEMIOL COMMUN H, V54, P367, DOI 10.1136/jech.54.5.367; Burns T, 2007, LANCET, V370, P1146, DOI 10.1016/S0140-6736(07)61516-5; Cooper WH, 2009, PERS SOC PSYCHOL REV, V13, P62, DOI 10.1177/1088868308329378; Costa G, 2003, OCCUP MED-OXFORD, V53, P83, DOI 10.1093/occmed/kqg045; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Erickson RJ, 1997, WORK OCCUPATION, V24, P188, DOI 10.1177/0730888497024002004; Freud S, 2001, INTRO LECT PSYCHOA 3; Frone M R, 2000, J Occup Health Psychol, V5, P246, DOI 10.1037/1076-8998.5.2.246; Garnefski N, 2001, PERS INDIV DIFFER, V30, P1311, DOI 10.1016/S0191-8869(00)00113-6; Geller P A, 2009, INT HDB WORK HLTH PS, V3rd, P353; Grandey AA, 2004, J ORGAN BEHAV, V25, P397, DOI 10.1002/job.252; Grandey AA, 2007, J OCCUP HEALTH PSYCH, V12, P63, DOI 10.1037/1076-8998.12.1.63; GREENGLASS ER, 1991, CAN PSYCHOL, V32, P562, DOI 10.1037/h0079042; Greenglass ER, 2002, GENDER WORK STRESS H, P85, DOI DOI 10.1037/10467-006; GROSS JJ, 1995, CLIN PSYCHOL-SCI PR, V2, P151, DOI 10.1111/j.1468-2850.1995.tb00036.x; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hankin BL, 2001, PSYCHOL BULL, V127, P773, DOI 10.1037//0033-2909.127.6.773; Hobfoll SE, 2011, J OCCUP ORGAN PSYCH, V84, P116, DOI 10.1111/j.2044-8325.2010.02016.x; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Hulsheger UR, 2011, J OCCUP HEALTH PSYCH, V16, P361, DOI 10.1037/a0022876; IBARRA H, 1993, ACAD MANAGE REV, V18, P56, DOI 10.5465/AMR.1993.3997507; Ilies R, 2011, J ORGAN BEHAV, V32, P44, DOI 10.1002/job.677; Johns G, 2006, ACAD MANAGE REV, V31, P386, DOI 10.5465/amr.2006.20208687; Johnson HAM, 2007, J OCCUP HEALTH PSYCH, V12, P319, DOI 10.1037/1076-8998.12.4.319; Jorm AF, 2000, PSYCHOL MED, V30, P11, DOI 10.1017/S0033291799001452; Judd LL, 2000, AM J PSYCHIAT, V157, P1501, DOI 10.1176/appi.ajp.157.9.1501; Judge TA, 2009, PERS PSYCHOL, V62, P57, DOI 10.1111/j.1744-6570.2008.01129.x; Lazarus R.S., 1984, EMOTION ADAPTATION; Le Blanc PM, 2007, J APPL PSYCHOL, V92, P213, DOI 10.1037/0021-9010.92.1.213; MISCHEL W, 1995, PSYCHOL REV, V102, P246, DOI 10.1037/0033-295X.102.2.246; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Muchinsky PM, 2013, J ORGAN BEHAV, V34, P1057, DOI 10.1002/job.1892; MURPHY JM, 1991, ARCH GEN PSYCHIAT, V48, P223; Nolen-Hoeksema S, 2011, PERS INDIV DIFFER, V51, P704, DOI 10.1016/j.paid.2011.06.012; OGUS ED, 1990, J SOC BEHAV PERS, V5, P387; Parker G, 2010, INT REV PSYCHIATR, V22, P429, DOI 10.3109/09540261.2010.492391; Petrides KV, 2004, J SOC PSYCHOL, V144, P149, DOI 10.3200/SOCP.144.2.149-162; Pietrzak RH, 2013, PSYCHOL MED, V43, P1401, DOI 10.1017/S0033291712002309; Rossler Wulf, 2016, Eur Arch Psychiatry Clin Neurosci, V266, P381; Sartre Jean-Paul, 1989, NO EXIT 3 OTHER PLAY; Scott BA, 2011, ACAD MANAGE J, V54, P116, DOI 10.5465/AMJ.2011.59215086; Simpson PA, 2004, J APPL PSYCHOL, V89, P715, DOI 10.1037/0021-9010.89.4.715; Sliter MT, 2011, J OCCUP HEALTH PSYCH, V16, P424, DOI 10.1037/a0023874; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Spector Paul E, 1998, J Occup Health Psychol, V3, P356, DOI 10.1037/1076-8998.3.4.356; Szeto ACH, 2013, J OCCUP HEALTH PSYCH, V18, P191, DOI 10.1037/a0031806; Unger R. K., 1990, MAKING DIFFERENCE PS, P102; van Emmerik IIJH, 2006, SOC NETWORKS, V28, P24, DOI 10.1016/j.socnet.2005.04.002; Vittengl JR, 1998, MOTIV EMOTION, V22, P255, DOI 10.1023/A:1022388123550; Zuckerman M., 1999, VULNERABILITY PSYCHO	55	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103501	10.1371/journal.pone.0103501	http://dx.doi.org/10.1371/journal.pone.0103501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25075855	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800055
J	Guillera-Arroita, G; Lahoz-Monfort, JJ; MacKenzie, DI; Wintle, BA; McCarthy, MA				Guillera-Arroita, Gurutzeta; Lahoz-Monfort, Jose J.; MacKenzie, Darryl I.; Wintle, Brendan A.; McCarthy, Michael A.			Ignoring Imperfect Detection in Biological Surveys Is Dangerous: A Response to 'Fitting and Interpreting Occupancy Models'	PLOS ONE			English	Article							DESIGN; PRECISION; PACKAGE; BIAS	In a recent paper, Welsh, Lindenmayer and Donnelly (WLD) question the usefulness of models that estimate species occupancy while accounting for detectability. WLD claim that these models are difficult to fit and argue that disregarding detectability can be better than trying to adjust for it. We think that this conclusion and subsequent recommendations are not well founded and may negatively impact the quality of statistical inference in ecology and related management decisions. Here we respond to WLD's claims, evaluating in detail their arguments, using simulations and/or theory to support our points. In particular, WLD argue that both disregarding and accounting for imperfect detection lead to the same estimator performance regardless of sample size when detectability is a function of abundance. We show that this, the key result of their paper, only holds for cases of extreme heterogeneity like the single scenario they considered. Our results illustrate the dangers of disregarding imperfect detection. When ignored, occupancy and detection are confounded: the same naive occupancy estimates can be obtained for very different true levels of occupancy so the size of the bias is unknowable. Hierarchical occupancy models separate occupancy and detection, and imprecise estimates simply indicate that more data are required for robust inference about the system in question. As for any statistical method, when underlying assumptions of simple hierarchical models are violated, their reliability is reduced. Resorting in those instances where hierarchical occupancy models do no perform well to the naive occupancy estimator does not provide a satisfactory solution. The aim should instead be to achieve better estimation, by minimizing the effect of these issues during design, data collection and analysis, ensuring that the right amount of data is collected and model assumptions are met, considering model extensions where appropriate.	[Guillera-Arroita, Gurutzeta; Lahoz-Monfort, Jose J.; Wintle, Brendan A.; McCarthy, Michael A.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; [MacKenzie, Darryl I.] Proteus Wildlife Res Consultants, Outram, New Zealand	University of Melbourne	Guillera-Arroita, G (corresponding author), Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia.	gguillera@unimelb.edu.au	McCarthy, Michael A/O-5655-2014; Guillera-Arroita, Gurutzeta/F-7461-2015; Lahoz-Monfort, José J/O-3546-2017	McCarthy, Michael A/0000-0003-1039-7980; Guillera-Arroita, Gurutzeta/0000-0002-8387-5739; Lahoz-Monfort, José J/0000-0002-0845-7035; wintle, brendan/0000-0002-4234-5950	Australian Research Council (ARC) Centre of Excellence for Environmental Decisions; National Environment Research Program (NERP); ARC Future Fellowships	Australian Research Council (ARC) Centre of Excellence for Environmental Decisions(Australian Research Council); National Environment Research Program (NERP); ARC Future Fellowships(Australian Research Council)	This work was supported by the Australian Research Council (ARC) Centre of Excellence for Environmental Decisions (www.ceed.edu.au), the National Environment Research Program (NERP) Decisions Hub (www.nerpdecisions.edu.au), and ARC Future Fellowships to MM and BW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Bailey LL, 2014, METHODS ECOL EVOL, V5, P1269, DOI 10.1111/2041-210X.12100; Borchers D. L., 2003, ESTIMATING ANIMAL AB; Buckland S.T., 2001, pi; Chen GK, 2013, J ECOL, V101, P183, DOI 10.1111/1365-2745.12021; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Garrard GE, 2008, AUSTRAL ECOL, V33, P986, DOI 10.1111/j.1442-9993.2008.01869.x; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guillera-Arroita G, 2014, J AGR BIOL ENVIR ST, V19, P278, DOI 10.1007/s13253-014-0171-4; Guillera-Arroita G, 2012, METHODS ECOL EVOL, V3, P860, DOI 10.1111/j.2041-210X.2012.00225.x; Guillera-Arroita G, 2011, METHODS ECOL EVOL, V2, P401, DOI 10.1111/j.2041-210X.2011.00089.x; Guillera-Arroita G, 2011, J AGR BIOL ENVIR ST, V16, P301, DOI 10.1007/s13253-010-0053-3; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Hines J.E., 2014, PRESENCE SOFTWARE ES; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2013, J BIOGEOGR, V40, P1463, DOI 10.1111/jbi.12087; Kery M, 2011, J BIOGEOGR, V38, P617, DOI 10.1111/j.1365-2699.2011.02487.x; Laake J., 2014, PROGRAM MARK GENTLE; Lahoz-Monfort JJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P504, DOI 10.1111/geb.12138; Link WA, 2003, BIOMETRICS, V59, P1123, DOI 10.1111/j.0006-341X.2003.00129.x; Lunn D., 2012, BUGS BOOK PRACTICAL; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Moilanen A, 2002, OIKOS, V96, P516, DOI 10.1034/j.1600-0706.2002.960313.x; Morgan BJT, 2008, J R STAT SOC C-APPL, V57, P433, DOI 10.1111/j.1467-9876.2008.00620.x; Plummer M., 2003, P 3 INT WORKSH DISTR; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2006, BIOMETRICS, V62, P97, DOI 10.1111/j.1541-0420.2005.00439.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Welsh AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052015; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wintle BA, 2004, ECOL APPL, V14, P703, DOI 10.1890/02-5166; Yee TW, 2010, J STAT SOFTW, V32, P1; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	39	122	123	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e99571	10.1371/journal.pone.0099571	http://dx.doi.org/10.1371/journal.pone.0099571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075615	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800003
J	Roozendaal, R; Tolboom, J; Roos, A; Riahi, S; Theeuwsen, J; Bujny, MV; Klaren, V; Korse, HJWM; Dekking, L; Grootenhuis, A; Weverling, GJ; Koudstaal, W; Goudsmit, J; Radosevic, K				Roozendaal, Ramon; Tolboom, Jeroen; Roos, Anna; Riahi, Sarra; Theeuwsen, Jessica; Bujny, Miriam V.; Klaren, Vincent; Korse, Hans J. W. M.; Dekking, Liesbeth; Grootenhuis, Arijan; Weverling, Gerrit Jan; Koudstaal, Wouter; Goudsmit, Jaap; Radosevic, Katarina			Transient Humoral Protection against H5N1 Challenge after Seasonal Influenza Vaccination of Humans	PLOS ONE			English	Article							NEUTRALIZING MONOCLONAL-ANTIBODIES; HEMAGGLUTININ STALK ANTIBODIES; VIRUS; EPITOPE; RECOGNITION; INFECTION; CELLS; BINDS	Current influenza vaccines are believed to confer protection against a narrow range of virus strains. The identification of broadly influenza neutralizing antibodies (bnAbs) has triggered efforts to develop vaccines providing 'universal' protection against influenza. Several bnAbs were isolated from humans recently vaccinated with conventional influenza vaccines, suggesting that such vaccines could, in principle, be broadly protective. Assessing the breadth-of-protection conferred to humans by influenza vaccines is hampered by the lack of in vitro correlates for broad protection. We designed and employed a novel human-to-mouse serum transfer and challenge model to analyze protective responses in serum samples from clinical trial subjects. One dose of seasonal vaccine induces humoral protection not only against vaccine-homologous H1N1 challenge, but also against H5N1 challenge. This heterosubtypic protection is neither detected, nor accurately predicted by in vitro immunogenicity assays. Moreover, heterosubtypic protection is transient and not boosted by repeated inoculations. Strategies to increase the breadth and duration of the protective response against influenza are required to obtain 'universal' protection against influenza by vaccination. In the absence of known correlates of protection for broadly protective vaccines, the human-to-mouse serum transfer and challenge model described here may aid the development of such vaccines.	[Roozendaal, Ramon; Tolboom, Jeroen; Roos, Anna; Riahi, Sarra; Theeuwsen, Jessica; Bujny, Miriam V.; Klaren, Vincent; Korse, Hans J. W. M.; Dekking, Liesbeth; Weverling, Gerrit Jan; Koudstaal, Wouter; Goudsmit, Jaap; Radosevic, Katarina] Crucell Holland BV, Janssen Ctr Excellence Immunoprophylaxis, Crucell Vaccine Inst, Leiden, Netherlands; [Grootenhuis, Arijan] Crucell Holland BV, Clin Immunol, Leiden, Netherlands	Johnson & Johnson; Johnson & Johnson	Radosevic, K (corresponding author), Crucell Holland BV, Janssen Ctr Excellence Immunoprophylaxis, Crucell Vaccine Inst, Leiden, Netherlands.	KRadosev@its.jnj.com						Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Fleury D, 2000, PROTEINS, V40, P572; Howard MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023791; Hu WB, 2013, VIROLOGY, V435, P320, DOI 10.1016/j.virol.2012.09.034; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Khurana S, 2013, J INFECT DIS, V208, P413, DOI 10.1093/infdis/jit178; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Medina RA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1026; Miller MS, 2013, J INFECT DIS, V207, P98, DOI 10.1093/infdis/jis652; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Sangster MY, 2013, CLIN VACCINE IMMUNOL, V20, P867, DOI 10.1128/CVI.00735-12; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thomson CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00087; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Xie H, 2011, CLIN INFECT DIS, V53, P1179, DOI 10.1093/cid/cir693; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103550	10.1371/journal.pone.0103550	http://dx.doi.org/10.1371/journal.pone.0103550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075622	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800063
J	Song, YJ; Giske, CG; Gille-Johnson, P; Emanuelsson, O; Lundeberg, J; Gyarmati, P				Song, Yajing; Giske, Christian G.; Gille-Johnson, Patrik; Emanuelsson, Olof; Lundeberg, Joakim; Gyarmati, Peter			Nuclease-Assisted Suppression of Human DNA Background in Sepsis	PLOS ONE			English	Article							CULTURE-BASED METHODS; PCR; BLOOD; DIAGNOSIS; GENE; REHYBRIDIZATION; EPIDEMIOLOGY	Sepsis is a severe medical condition characterized by a systemic inflammatory response of the body caused by pathogenic microorganisms in the bloodstream. Blood or plasma is typically used for diagnosis, both containing large amount of human DNA, greatly exceeding the DNA of microbial origin. In order to enrich bacterial DNA, we applied the C(0)t effect to reduce human DNA background: a model system was set up with human and Escherichia coli (E. coli) DNA to mimic the conditions of bloodstream infections; and this system was adapted to plasma and blood samples from septic patients. As a consequence of the C(0)t effect, abundant DNA hybridizes faster than rare DNA. Following denaturation and re-hybridization, the amount of abundant DNA can be decreased with the application of double strand specific nucleases, leaving the non-hybridized rare DNA intact. Our experiments show that human DNA concentration can be reduced approximately 100,000-fold without affecting the E. coli DNA concentration in a model system with similarly sized amplicons. With clinical samples, the human DNA background was decreased 100-fold, as bacterial genomes are approximately 1,000-fold smaller compared to the human genome. According to our results, background suppression can be a valuable tool to enrich rare DNA in clinical samples where a high amount of background DNA can be found.	[Song, Yajing; Emanuelsson, Olof; Lundeberg, Joakim; Gyarmati, Peter] Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Giske, Christian G.; Gyarmati, Peter] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Giske, Christian G.; Gyarmati, Peter] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Gille-Johnson, Patrik] Karolinska Inst, Div Infect Dis, Dept Med, Stockholm, Sweden	Royal Institute of Technology; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Gyarmati, P (corresponding author), Royal Inst Technol, Sci Life Lab, Stockholm, Sweden.	peter.gyarmati@ki.se	Gyarmati, Peter/F-4887-2013	Gyarmati, Peter/0000-0001-7362-316X	Swedish Research Council [2012-3291]; China Scholarship Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); China Scholarship Council(China Scholarship Council)	This work was supported by the Swedish Research Council (Vetenskapsra det, to PG): 2012-3291, and China Scholarship Council, to YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054564; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Gijavanekar C, 2012, ANAL BIOCHEM, V421, P81, DOI 10.1016/j.ab.2011.11.010; Gyarmati P, 2013, J BIOTECHNOL, V168, P95, DOI 10.1016/j.jbiotec.2013.08.020; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Horz HP, 2010, ANAEROBE, V16, P47, DOI 10.1016/j.anaerobe.2009.04.009; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jordan JA, 2005, J MOL DIAGN, V7, P575, DOI 10.1016/S1525-1578(10)60590-9; Jordana-Lluch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062108; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; KREGER BE, 1980, AM J MED, V68, P332, DOI 10.1016/0002-9343(80)90101-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Loonen AJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072349; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; MathieuDaude F, 1996, NUCLEIC ACIDS RES, V24, P2080, DOI 10.1093/nar/24.11.2080; Matvienko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055913; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schreiber J, 2013, MED KLIN-INTENSIVMED, V108, P311, DOI 10.1007/s00063-013-0227-1; Shen W, 2013, CHEM COMMUN, V49, P4959, DOI 10.1039/c3cc41565a; Skvarc M, 2013, EUR J MICROBIOL IMMU, V3, P97, DOI 10.1556/EuJMI.3.2013.2.2; Wu YD, 2008, J CLIN MICROBIOL, V46, P2613, DOI 10.1128/JCM.02237-07; Yi H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr617; Zhou LQ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-164	29	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103610	10.1371/journal.pone.0103610	http://dx.doi.org/10.1371/journal.pone.0103610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076135	Green Published, gold, Green Submitted			2022-12-27	WOS:000340028800068
J	Ascensao, F; Grilo, C; LaPoint, S; Tracey, J; Clevenger, AP; Santos-Reis, M				Ascensao, Fernando; Grilo, Clara; LaPoint, Scott; Tracey, Jeff; Clevenger, Anthony P.; Santos-Reis, Margarida			Inter-Individual Variability of Stone Marten Behavioral Responses to a Highway	PLOS ONE			English	Article							MOVEMENT BEHAVIOR; ANIMAL MOVEMENT; ROAD MORTALITY; LUTRA-LUTRA; HABITAT USE; MITIGATION; CARNIVORES; POPULATIONS; LANDSCAPE; PATTERNS	Efforts to reduce the negative impacts of roads on wildlife may be hindered if individuals within the population vary widely in their responses to roads and mitigation strategies ignore this variability. This knowledge is particularly important for medium-sized carnivores as they are vulnerable to road mortality, while also known to use available road passages (e. g., drainage culverts) for safely crossing highways. Our goal in this study was to assess whether this apparently contradictory pattern of high road-kill numbers associated with a regular use of road passages is attributable to the variation in behavioral responses toward the highway between individuals. We investigated the responses of seven radio-tracked stone martens (Martes foina) to a highway by measuring their utilization distribution, response turning angles and highway crossing patterns. We compared the observed responses to simulated movement parameterized by the observed space use and movement characteristics of each individual, but naive to the presence of the highway. Our results suggested that martens demonstrate a diversity of responses to the highway, including attraction, indifference, or avoidance. Martens also varied in their highway crossing patterns, with some crossing repeatedly at the same location (often coincident with highway passages). We suspect that the response variability derives from the individual's familiarity of the landscape, including their awareness of highway passage locations. Because of these variable yet potentially attributable responses, we support the use of exclusionary fencing to guide transient (e.g., dispersers) individuals to existing passages to reduce the road-kill risk.	[Ascensao, Fernando; Santos-Reis, Margarida] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Ascensao, Fernando; Clevenger, Anthony P.] Montana State Univ, Western Transportat Inst, Bozeman, MT 59717 USA; [Grilo, Clara] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Grilo, Clara] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [LaPoint, Scott] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [LaPoint, Scott] Univ Konstanz, Dept Biol, Constance, Germany; [Tracey, Jeff] US Geol Survey, Western Ecol Res Ctr, San Diego, CA USA	Universidade de Lisboa; Montana State University System; Montana State University Bozeman; Universidade de Aveiro; Universidade de Aveiro; Max Planck Society; University of Konstanz; United States Department of the Interior; United States Geological Survey	Ascensao, F (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal.	fernandoascensao@gmail.com	Santos-Reis, Margarida/H-4064-2011; Ascensão, Fernando/G-1513-2014; Grilo, Clara/H-2002-2012; Ascensão, Fernando/ABF-9787-2021	Ascensão, Fernando/0000-0003-1704-0212; Grilo, Clara/0000-0001-9870-3115; Ascensão, Fernando/0000-0003-1704-0212; LaPoint, Scott/0000-0002-5499-6777; Clevenger, Anthony P/0000-0003-0380-6272; Santos-Reis, Margarida/0000-0002-0337-963X	Fundacaopara a Ciencia e Tecnologia [SFRH/BD/38053/2007, SFRH/BPD/64205/2009]	Fundacaopara a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	FA and CG were funded by Fundacaopara a Ciencia e Tecnologia, respectively with the grants SFRH/BD/38053/2007 and SFRH/BPD/64205/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Ascensao F, 2007, ECOL RES, V22, P57, DOI 10.1007/s11284-006-0004-1; Ascensao F, 2013, ECOL MODEL, V257, P36, DOI 10.1016/j.ecolmodel.2013.02.026; Ascensao F, 2012, BIODIVERS CONSERV, V21, P3681, DOI 10.1007/s10531-012-0390-3; Beckmann J.P., 2010, SAFE PASSAGES HIGHWA; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Beyer HL, 2013, J APPL ECOL, V50, P286, DOI 10.1111/1365-2664.12042; Bissonette JA, 2008, BIOL CONSERV, V141, P482, DOI 10.1016/j.biocon.2007.10.019; Blanco JC, 1992, LIVRO ROJO VERTEBRAD; Calenge C., 2011, HOME RANGE ESTIMATIO; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Clarke GP, 1998, BIOL CONSERV, V86, P117, DOI 10.1016/S0006-3207(98)00018-4; Clevenger A.P., 2009, BANFF WILDLIFE CROSS, P165; Clevenger AP, 2005, BIOL CONSERV, V121, P453, DOI 10.1016/j.biocon.2004.04.025; Clevenger AP, 2001, J APPL ECOL, V38, P1340, DOI 10.1046/j.0021-8901.2001.00678.x; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Dodd NL, 2007, J WILDLIFE MANAGE, V71, P637, DOI 10.2193/2006-340; Eigenbrod F, 2008, LANDSCAPE ECOL, V23, P159, DOI 10.1007/s10980-007-9174-7; Fahrig L, 2009, ECOL SOC, V14; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Gagnon JW, 2011, J WILDLIFE MANAGE, V75, P1477, DOI 10.1002/jwmg.160; Glista DJ, 2009, LANDSCAPE URBAN PLAN, V91, P1, DOI 10.1016/j.landurbplan.2008.11.001; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Gotelli NJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P337, DOI 10.1046/j.1466-822X.2001.00249.x; Grilo C, 2009, BIOL CONSERV, V142, P301, DOI 10.1016/j.biocon.2008.10.026; Grilo C, 2008, BIODIVERS CONSERV, V17, P1685, DOI 10.1007/s10531-008-9374-8; Grilo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043811; Grilo C, 2011, EUR J WILDLIFE RES, V57, P707, DOI 10.1007/s10344-010-0478-6; Hauer S, 2002, J ZOOL, V256, P361, DOI 10.1017/S0952836902000390; Herr J, 2009, J ZOOL, V277, P54, DOI 10.1111/j.1469-7998.2008.00510.x; Herr J, 2009, EUR J WILDLIFE RES, V55, P471, DOI 10.1007/s10344-009-0263-6; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Iuell B, 2003, COST 341 WILDLIFE TR; Jackson ND, 2011, BIOL CONSERV, V144, P3143, DOI 10.1016/j.biocon.2011.09.010; Klar N, 2008, BIOL CONSERV, V141, P308, DOI 10.1016/j.biocon.2007.10.004; Klar N, 2009, J WILDLIFE MANAGE, V73, P631, DOI 10.2193/2007-574; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; Lewis JS, 2011, LANDSCAPE URBAN PLAN, V101, P99, DOI 10.1016/j.landurbplan.2011.01.008; Mangas J, 2009, ENCICLOPEDIA VIRTUAL; Martin J, 2008, ECOL MODEL, V213, P257, DOI 10.1016/j.ecolmodel.2007.12.002; Mateus ARA, 2011, ENVIRON MONIT ASSESS, V181, P101, DOI 10.1007/s10661-010-1816-6; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; MORELLE K, 2013, NAT CONSERV CRACOW, V5, P53, DOI DOI 10.3897/NATUREC0NSERVATI0N.5.4634; Mortelliti A, 2008, LANDSCAPE ECOL, V23, P285, DOI 10.1007/s10980-007-9182-7; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Philcox CK, 1999, J APPL ECOL, V36, P748, DOI 10.1046/j.1365-2664.1999.00441.x; Proulx G, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P21; Quantum GIS Development Team, 2011, QUANT GIS GEOGR INF; Richard E, 2013, ECOGRAPHY, V36, P157, DOI 10.1111/j.1600-0587.2012.07604.x; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rodriguez A, 1996, J APPL ECOL, V33, P1527, DOI 10.2307/2404791; Roedenbeck IA, 2007, ECOL SOC, V12; Rondinini C, 2002, ECOGRAPHY, V25, P257, DOI 10.1034/j.1600-0587.2002.250301.x; Rytwinski T, 2013, OECOLOGIA, V173, P1143, DOI 10.1007/s00442-013-2684-x; Rytwinski T, 2012, BIOL CONSERV, V147, P87, DOI 10.1016/j.biocon.2011.11.023; Santos MJ, 2010, EUR J WILDLIFE RES, V56, P275, DOI 10.1007/s10344-009-0317-9; Santos-Reis M, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P147; Sawaya MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034777; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Serronha AM, 2012, ENV MONITORING ASSES; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Simmons JM, 2010, ECOL SOC, V15; Soanes K, 2013, BIOL CONSERV, V159, P434, DOI 10.1016/j.biocon.2012.10.016; Steiner W, 2014, ACCIDENT ANAL PREV, V66, P168, DOI 10.1016/j.aap.2014.01.020; Stoner D, 1925, Science, V61, P56, DOI 10.1126/science.61.1568.56; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Tracey JA, 2005, J AGR BIOL ENVIR ST, V10, P1, DOI 10.1198/108571105X29056; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; van der Grift EA, 2013, BIODIVERS CONSERV, V22, P425, DOI 10.1007/s10531-012-0421-0; van der Ree R, 2010, ECOLOGY SOC, V15; van der Ree R, 2011, ECOL SOC, V16; Virgos E, 2002, BIODIVERS CONSERV, V11, P1063, DOI 10.1023/A:1015856703786; Whittington J, 2004, ECOL SOC, V9; Wilensky U., 1999, NETLOGO CTR CONNECTE; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; [No title captured], DOI DOI 10.1016/j.jenvman.2010.11.027	86	22	23	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103544	10.1371/journal.pone.0103544	http://dx.doi.org/10.1371/journal.pone.0103544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072639	gold, Green Submitted, Green Published			2022-12-27	WOS:000341307600061
J	Lo Sasso, G; Menzies, KJ; Mottis, A; Piersigilli, A; Perino, A; Yamamoto, H; Schoonjans, K; Auwerx, J				Lo Sasso, Giuseppe; Menzies, Keir Joe; Mottis, Adrienne; Piersigilli, Alessandra; Perino, Alessia; Yamamoto, Hiroyasu; Schoonjans, Kristina; Auwerx, Johan			SIRT2 Deficiency Modulates Macrophage Polarization and Susceptibility to Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL INFLAMMATION; ULCERATIVE-COLITIS; CROHNS-DISEASE; EXPRESSION; DEACETYLASE; ACTIVATION; PERMEABILITY; MONOCYTES; CELLS	Background: SIRT2 belongs to a highly conserved family of NAD(+)-dependent deacylases, consisting of seven members (SIRT1-SIRT7), which vary in subcellular localizations and have substrates ranging from histones to transcription factors and enzymes. Recently SIRT2 was revealed to play an important role in inflammation, directly binding, deacetylating, and inhibiting the p65 subunit of NF-kB. Methods: A Sirt2 deficient mouse line (Sirt2(-/-)) was generated by deleting exons 5-7, encoding part of the SIRT2 deacetylase domain, by homologous recombination. Age-and sex-matched Sirt2(-/-) and Sirt2(+/+) littermate mice were subjected to dextran sulfate sodium (DSS)-induced colitis and analyzed for colitis susceptibility. Results: Sirt2(-/-) mice displayed more severe clinical and histological manifestations after DSS colitis compared to wild type littermates. Notably, under basal condition, Sirt2 deficiency does not affect the basal phenotype and intestinal morphology Sirt2 deficiency, however, affects macrophage polarization, creating a pro-inflammatory milieu in the immune cells compartment. Conclusion: These data confirm a protective role for SIRT2 against the development of inflammatory processes, pointing out a potential role for this sirtuin as a suppressor of colitis. In fact, SIRT2 deletion promotes inflammatory responses by increasing NF-kappa B acetylation and by reducing the M2-associated anti-inflammatory pathway. Finally, we speculate that the activation of SIRT2 may be a potential approach for the treatment of inflammatory bowel disease.	[Lo Sasso, Giuseppe; Menzies, Keir Joe; Mottis, Adrienne; Perino, Alessia; Yamamoto, Hiroyasu; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Piersigilli, Alessandra] Univ Bern, Inst Anim Pathol, Bern, Switzerland; [Piersigilli, Alessandra] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Yamamoto, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Biomed Informat, Div Hlth Sci, Suita, Osaka, Japan	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bern; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Osaka University	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland.	admin.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021	Auwerx, Johan/0000-0002-5065-5393; Menzies, Keir J/0000-0002-1873-8500; Schoonjans, Kristina/0000-0003-1247-4265	Outgoing AIRC/Marie Curie Fellowship; Heart and Stroke Foundation of Canada; EMBO fellowship; Ecole Polytechnique Federale de Lausanne; EU Ideas program [AdG-231138]; Swiss National Science Foundation [31003A-140780, 310030-143748, CSRII3-136201]; NIH [R01AG043930]; NATIONAL INSTITUTE ON AGING [R01AG043930] Funding Source: NIH RePORTER	Outgoing AIRC/Marie Curie Fellowship(Fondazione AIRC per la ricerca sul cancro); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); EMBO fellowship(European Molecular Biology Organization (EMBO)); Ecole Polytechnique Federale de Lausanne; EU Ideas program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	GLS is supported by an Outgoing AIRC/Marie Curie Fellowship. KJM is the recipient of a Heart and Stroke Foundation of Canada research fellowship award. AP is supported by EMBO fellowship. JA is the Nestle Chair in Energy Metabolism and the JA/KS laboratory is supported by grants from the Ecole Polytechnique Federale de Lausanne, the EU Ideas program (AdG-231138), the Swiss National Science Foundation (31003A-140780, 310030-143748, and CSRII3-136201), and NIH (R01AG043930). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Cader MZ, 2013, GUT, V62, P1653, DOI 10.1136/gutjnl-2012-303955; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; COOPER HS, 1993, LAB INVEST, V69, P238; DONNELLY RP, 1993, J IMMUNOL, V151, P5603; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S., 2014, TRENDS CELL BIOL; Kim MJ, 2013, FREE RADICAL BIO MED, V63, P432, DOI 10.1016/j.freeradbiomed.2013.06.005; Ko Y, 2014, WORLD J GASTROENTERO, V20, P1238, DOI 10.3748/wjg.v20.i5.1238; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lin JT, 2013, BIOCHEM BIOPH RES CO, V441, P897, DOI 10.1016/j.bbrc.2013.10.153; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; MALEFYT RD, 1991, J EXP MED, V174, P1209; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Melgar S, 2008, INT IMMUNOPHARMACOL, V8, P836, DOI 10.1016/j.intimp.2008.01.036; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pais TF, 2013, EMBO J, V32, P2603, DOI 10.1038/emboj.2013.200; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; WEISS L, 1989, EUR J IMMUNOL, V19, P1347, DOI 10.1002/eji.1830190731; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001	31	71	71	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103573	10.1371/journal.pone.0103573	http://dx.doi.org/10.1371/journal.pone.0103573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072851	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600064
J	Cannon, WR				Cannon, William R.			Simulating Metabolism with Statistical Thermodynamics	PLOS ONE			English	Article								New methods are needed for large scale modeling of metabolism that predict metabolite levels and characterize the thermodynamics of individual reactions and pathways. Current approaches use either kinetic simulations, which are difficult to extend to large networks of reactions because of the need for rate constants, or flux-based methods, which have a large number of feasible solutions because they are unconstrained by the law of mass action. This report presents an alternative modeling approach based on statistical thermodynamics. The principles of this approach are demonstrated using a simple set of coupled reactions, and then the system is characterized with respect to the changes in energy, entropy, free energy, and entropy production. Finally, the physical and biochemical insights that this approach can provide for metabolism are demonstrated by application to the tricarboxylic acid (TCA) cycle of Escherichia coli. The reaction and pathway thermodynamics are evaluated and predictions are made regarding changes in concentration of TCA cycle intermediates due to 10-and 100-fold changes in the ratio of NAD+: NADH concentrations. Finally, the assumptions and caveats regarding the use of statistical thermodynamics to model non-equilibrium reactions are discussed.	Pacific NW Natl Lab, Computat Biol & Bioinformat Grp, Fundamental & Computat Sci Directorate, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Cannon, WR (corresponding author), Pacific NW Natl Lab, Computat Biol & Bioinformat Grp, Fundamental & Computat Sci Directorate, Richland, WA 99352 USA.	William.cannon@pnnl.gov	Cannon, William R/K-8411-2014	Cannon, William R/0000-0003-3789-7889	Scientific Discovery through Advanced Computing (SciDAC) program, Office of Advanced Scientific Computing Research (OASCR); Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER) through a SciDAC award; U.S. Department of Energy [DE-AC06-76RLO]	Scientific Discovery through Advanced Computing (SciDAC) program, Office of Advanced Scientific Computing Research (OASCR); Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER) through a SciDAC award; U.S. Department of Energy(United States Department of Energy (DOE))	This research was developed under the Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory. Initial concepts were supported through joint funding from the Scientific Discovery through Advanced Computing (SciDAC) program, Office of Advanced Scientific Computing Research (OASCR) and the Genomic Science Program (GSP), Office of Biological and Environmental Research (OBER), through a SciDAC award to W. R. Cannon. PNNL is operated by Battelle for the U.S. Department of Energy under Contract DE-AC06-76RLO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberty R. A., 2003, THERMODYNAMICS BIOCH; Allen M., 2017, COMPUTER SIMULATIONS, V2nd; Annila A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1017; Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bylaska EJ, 2006, THEOR CHEM ACC, V116, P281, DOI 10.1007/s00214-005-0042-8; Cannon WR, 2010, J PHYS CHEM C, V114, P5360, DOI 10.1021/jp905049d; Davidson N., 1962, STAT MECH; De Martino D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002562; Dewar R, 2003, J PHYS A-MATH GEN, V36, P631, DOI 10.1088/0305-4470/36/3/303; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Ge H, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051133; Goldberg RN, 2004, BIOINFORMATICS, V20, P2874, DOI 10.1093/bioinformatics/bth314; Haraldsdottir HS, 2012, BIOPHYS J, V102, P1703, DOI 10.1016/j.bpj.2012.02.032; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; LAIDLER KJ, 1983, J PHYS CHEM-US, V87, P2657, DOI 10.1021/j100238a002; Laughlin RB, 2000, P NATL ACAD SCI USA, V97, P32, DOI 10.1073/pnas.97.1.32; Li Xin, 2011, Database (Oxford), V2011, pbar005, DOI 10.1093/database/bar005; Liu JJ, 2010, J CHEM THEORY COMPUT, V6, P1109, DOI 10.1021/ct100025j; Lotka AJ, 1922, P NATL ACAD SCI USA, V8, P151, DOI 10.1073/pnas.8.6.151; Lotka AJ, 1922, P NATL ACAD SCI USA, V8, P147, DOI 10.1073/pnas.8.6.147; McQuarrie D. A, 2000, STAT MECH; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Nightingale M.P., 1999, QUANTUM MONTE CARLO; Noor E, 2014, PLOS COMPUTATIONAL B, V10; Price MLP, 2000, J AM CHEM SOC, V122, P9455, DOI 10.1021/ja001018c; Qian H, 2003, EUR J BIOCHEM, V270, P415, DOI 10.1046/j.1432-1033.2003.03357.x; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Schrodinger E., 1951, WHAT IS LIFE PHYS AS; Smith E, 2004, P NATL ACAD SCI USA, V101, P13168, DOI 10.1073/pnas.0404922101; Smith MBK, 2000, PROTEIN ENG, V13, P413, DOI 10.1093/protein/13.6.413; van Erp TS, 2014, FRONT PHYS, V1, DOI 10.3389/fphy.2013.00036	34	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103582	10.1371/journal.pone.0103582	http://dx.doi.org/10.1371/journal.pone.0103582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089525	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700033
J	Decelle, J; Romac, S; Sasaki, E; Not, F; Mahe, F				Decelle, Johan; Romac, Sarah; Sasaki, Eriko; Not, Fabrice; Mahe, Frederic			Intracellular Diversity of the V4 and V9 Regions of the 18S rRNA in Marine Protists (Radiolarians) Assessed by High-Throughput Sequencing	PLOS ONE			English	Article							DEEP-SEA; MICROBIAL EUKARYOTES; DNA; PSEUDOGENES; ACANTHARIA; OCEAN	Metabarcoding is a powerful tool for exploring microbial diversity in the environment, but its accurate interpretation is impeded by diverse technical (e. g. PCR and sequencing errors) and biological biases (e. g. intra-individual polymorphism) that remain poorly understood. To help interpret environmental metabarcoding datasets, we investigated the intracellular diversity of the V4 and V9 regions of the 18S rRNA gene from Acantharia and Nassellaria (radiolarians) using 454 pyrosequencing. Individual cells of radiolarians were isolated, and PCRs were performed with generalist primers to amplify the V4 and V9 regions. Different denoising procedures were employed to filter the pyrosequenced raw amplicons (Acacia, AmpliconNoise, Linkage method). For each of the six isolated cells, an average of 541 V4 and 562 V9 amplicons assigned to radiolarians were obtained, from which one numerically dominant sequence and several minor variants were found. At the 97% identity, a diversity metrics commonly used in environmental surveys, up to 5 distinct OTUs were detected in a single cell. However, most amplicons grouped within a single OTU whereas other OTUs contained very few amplicons. Different analytical methods provided evidence that most minor variants forming different OTUs correspond to PCR and sequencing artifacts. Duplicate PCR and sequencing from the same DNA extract of a single cell had only 9 to 16% of unique amplicons in common, and alignment visualization of V4 and V9 amplicons showed that most minor variants contained substitutions in highly-conserved regions. We conclude that intracellular variability of the 18S rRNA in radiolarians is very limited despite its multi-copy nature and the existence of multiple nuclei in these protists. Our study recommends some technical guidelines to conservatively discard artificial amplicons from metabarcoding datasets, and thus properly assess the diversity and richness of protists in the environment.	[Decelle, Johan; Romac, Sarah; Not, Fabrice] UPMC Univ Paris 06, Sorbonne Univ, UMR 7144, Stn Biol Roscoff, Roscoff, France; [Decelle, Johan; Romac, Sarah; Not, Fabrice] CNRS, UMR 7144, Stn Biol Roscoff, Roscoff, France; [Sasaki, Eriko] Gregor Mendel Inst Mol Plant Biol, Vienna, Austria; [Mahe, Frederic] Univ Kaiserslautern, Dept Ecol, D-67663 Kaiserslautern, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); University of Kaiserslautern	Decelle, J (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, UMR 7144, Stn Biol Roscoff, Roscoff, France.	decelle@sb-roscoff.fr	Mahé, Frédéric/AAR-8568-2021	Mahé, Frédéric/0000-0002-2808-0984; Decelle, Johan/0000-0002-4343-8358	PhD fellowship DIPHOPE from the Region Bretagne; BioMarKs project (ERA-net Biodiversa, EU) [2008-6530]; JST-CNRS; Deutsche Forschungsgemeinschaft [DU1319/1-1]; project OCEANOMICS - French government [ANR-11-BTBR-0008]	PhD fellowship DIPHOPE from the Region Bretagne; BioMarKs project (ERA-net Biodiversa, EU); JST-CNRS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); project OCEANOMICS - French government	This work was supported by the PhD fellowship DIPHOPE from the Region Bretagne (J.D.), the BioMarKs project (2008-6530, ERA-net Biodiversa, EU), and a JST-CNRS exchange program (F.N). F. M. was supported by the Deutsche Forschungsgemeinschaft (grant #DU1319/1-1). This study was also supported by the project OCEANOMICS, that has received funding from the French government, managed by the Agence Nationale de la Recherche, under the grant agreement "Investissement d'Avenir" ANR-11-BTBR-0008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander E, 2009, ENVIRON MICROBIOL, V11, P360, DOI 10.1111/j.1462-2920.2008.01777.x; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; CARON DA, 1995, J PLANKTON RES, V17, P103, DOI 10.1093/plankt/17.1.103; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Countway PD, 2007, ENVIRON MICROBIOL, V9, P1219, DOI 10.1111/j.1462-2920.2007.01243.x; Decelle J, 2012, P NATL ACAD SCI USA, V109, P18000, DOI 10.1073/pnas.1212303109; Decelle J, 2012, PROTIST, V163, P435, DOI 10.1016/j.protis.2011.10.002; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gaspar JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060458; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lampitt RS, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003221; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Mackey AJ, 2002, MOL CELL PROTEOMICS, V1, P139, DOI 10.1074/mcp.M100004-MCP200; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Marie D, 2010, FEMS MICROBIOL ECOL, V72, P165, DOI 10.1111/j.1574-6941.2010.00842.x; Marquez LM, 2003, MOL BIOL EVOL, V20, P1077, DOI 10.1093/molbev/msg122; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Nebel M, 2011, ENV MICROBIOL REP, V3, P154, DOI 10.1111/j.1758-2229.2010.00200.x; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Orsi W, 2011, ISME J, V5, P1357, DOI 10.1038/ismej.2011.7; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Pillet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032373; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Santos SR, 2003, J EUKARYOT MICROBIOL, V50, P417, DOI 10.1111/j.1550-7408.2003.tb00264.x; Sasaki E, 2013, MOL BIOL EVOL, V30, P2187, DOI 10.1093/molbev/mst103; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P5656, DOI 10.1128/AEM.69.9.5656-5663.2003; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Stoeck T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000728; Suzuki Noritoshi, 2011, Plankton & Benthos Research, V6, P69; SWANBERG NR, 1991, J PLANKTON RES, V13, P287, DOI 10.1093/plankt/13.2.287; van Berkum P, 2003, J BACTERIOL, V185, P2988, DOI 10.1128/JB.185.10.2988-2998.2003; Weber AAT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056739; Yabuki A, 2014, ISME J, P1; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	48	47	50	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104297	10.1371/journal.pone.0104297	http://dx.doi.org/10.1371/journal.pone.0104297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090095	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700116
J	Madissoon, E; Tohonen, V; Vesterlund, L; Katayama, S; Unneberg, P; Inzunza, J; Hovatta, O; Kere, J				Madissoon, Elo; Tohonen, Virpi; Vesterlund, Liselotte; Katayama, Shintaro; Unneberg, Per; Inzunza, Jose; Hovatta, Outi; Kere, Juha			Differences in Gene Expression between Mouse and Human for Dynamically Regulated Genes in Early Embryo	PLOS ONE			English	Article							HUMAN MATURE OOCYTES; CANCER/TESTIS ANTIGENS; PLURIPOTENT CELLS; EXPANDING FAMILY; COPY NUMBER; PROTEIN; TRANSCRIPTOME; NANOG; IDENTIFICATION; AMPLIFICATION	Infertility is a worldwide concern that can be treated with in vitro fertilization (IVF). Improvements in IVF and infertility treatment depend largely on better understanding of the molecular mechanisms for human preimplantation development. Several large-scale studies have been conducted to identify gene expression patterns for the first five days of human development, and many functional studies utilize mouse as a model system. We have identified genes of possible importance for this time period by analyzing human microarray data and available data from online databases. We selected 70 candidate genes for human preimplantation development and investigated their expression in the early mouse development from oocyte to the 8-cell stage. Maternally loaded genes expectedly decreased in expression during development both in human and mouse. We discovered that 25 significantly upregulated genes after fertilization in human included 13 genes whose orthologs in mouse behaved differently and mimicked the expression profile of maternally expressed genes. Our findings highlight many significant differences in gene expression patterns during mouse and human preimplantation development. We also describe four cancer-testis antigen families that are also highly expressed in human embryos: PRAME, SSX, GAGE and MAGEA.	[Madissoon, Elo; Tohonen, Virpi; Vesterlund, Liselotte; Katayama, Shintaro; Inzunza, Jose; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden; [Tohonen, Virpi] Karolinska Univ Hosp, Dept Obstet & Gynecol, Stockholm, Sweden; [Unneberg, Per] Karolinska Inst, Sci Life Lab, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hovatta, Outi] Karolinska Univ Hosp K57, Dept Clin Sci Intervent & Technol, Karolinska Inst, Stockholm, Sweden; [Kere, Juha] Univ Helsinki, Mol Neurol Program, Res Programs Unit, Helsinki, Finland; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; University of Helsinki	Kere, J (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden.	juha.kere@ki.se	Kere, Juha/AAX-9117-2021; Katayama, Shintaro/F-2958-2010; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Katayama, Shintaro/0000-0001-7581-5157; Kere, Juha/0000-0003-1974-0271; Vesterlund, Liselotte/0000-0003-3547-9288; Unneberg, Per/0000-0001-5735-3315; Inzunza, Jose/0000-0003-0876-6767; Madissoon, Elo/0000-0003-2405-4911	Swedish Research Council; Center for Biosciences; Karolinska Institutet Distinguished Professor Award; Karolinska Institutet funds; Svenska Lakaresallskapet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Center for Biosciences; Karolinska Institutet Distinguished Professor Award; Karolinska Institutet funds; Svenska Lakaresallskapet	This study was supported by the Swedish Research Council, the Center for Biosciences, the Karolinska Institutet Distinguished Professor Award(JK) and by the Karolinska Institutet funds and Svenska Lakaresallskapet (VT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrup K, 2004, CANCER RES, V64, P4736, DOI 10.1158/0008-5472.CAN-04-0679; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Bai Q, 2012, STEM CELL REV REP, V8, P150, DOI 10.1007/s12015-011-9301-3; Bankovic J, 2010, LUNG CANCER, V67, P151, DOI 10.1016/j.lungcan.2009.04.010; Birtle Zoe, 2005, BMC Genomics, V6, P120, DOI 10.1186/1471-2164-6-120; BOUNIOL C, 1995, EXP CELL RES, V218, P57, DOI 10.1006/excr.1995.1130; BRAUDE P, 1979, NATURE, V282, P102, DOI 10.1038/282102a0; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Bruce JW, 2010, J VIROL, V84, P7473, DOI 10.1128/JVI.00299-10; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016867; Chiang WF, 2011, ORAL DIS, V17, P53, DOI 10.1111/j.1601-0825.2010.01702.x; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Dade S, 2003, FEBS LETT, V555, P533, DOI 10.1016/S0014-5793(03)01341-3; Duhoux FP, 2011, LEUKEMIA RES, V35, pE114, DOI 10.1016/j.leukres.2011.02.011; EDWARDS RG, 1981, AM J OBSTET GYNECOL, V141, P408, DOI 10.1016/0002-9378(81)90603-7; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Finger JH, 2011, NUCLEIC ACIDS RES, V39, pD835, DOI 10.1093/nar/gkq1132; Gjerstorff MF, 2008, HUM REPROD, V23, P2194, DOI 10.1093/humrep/den262; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Gure AO, 1997, INT J CANCER, V72, P965, DOI 10.1002/(SICI)1097-0215(19970917)72:6<965::AID-IJC8>3.0.CO;2-N; HARLOW GM, 1982, AUST J BIOL SCI, V35, P187, DOI 10.1071/BI9820187; He K, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-41; Imoto I, 2003, CANCER RES, V63, P5691; Jungbluth Achim A, 2007, Cancer Immun, V7, P15; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Li XL, 2004, INT J ONCOL, V24, P257; Lin SC, 2005, J PATHOL, V206, P417, DOI 10.1002/path.1790; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; Minami N, 2003, BIOL REPROD, V69, P1736, DOI 10.1095/biolreprod.103.018051; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rinaudo P, 2004, REPRODUCTION, V128, P301, DOI 10.1530/rep.1.00297; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sunderam S, 2013, MMWR SURVEILL SUMM, V62, P1; Tanaka M, 2009, AM J SURG PATHOL, V33, P1416, DOI 10.1097/PAS.0b013e3181a9cd6c; Taniwaki M, 2006, INT J ONCOL, V29, P567; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Wadelin F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-226; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Wood JR, 2007, J CLIN ENDOCR METAB, V92, P705, DOI 10.1210/jc.2006-2123; Xie D, 2010, GENOME RES; Xue Z, 2013, NATURE; Yan L, 2013, NAT STRUCT MOL BIOL; Zhang P, 2007, FERTIL STERIL, V87, P677, DOI 10.1016/j.fertnstert.2006.07.1509; Zhang P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007844; Zhang P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002755	56	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102949	10.1371/journal.pone.0102949	http://dx.doi.org/10.1371/journal.pone.0102949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089626	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700012
J	Sponholz, C; Schelenz, C; Reinhart, K; Schirmer, U; Stehr, SN				Sponholz, Christoph; Schelenz, Christoph; Reinhart, Konrad; Schirmer, Uwe; Stehr, Sebastian N.			Catecholamine and Volume Therapy for Cardiac Surgery in Germany - Results from a Postal Survey	PLOS ONE			English	Article							HYDROXYETHYL STARCH; VASOPRESSOR USE; INTENSIVE-CARE; EPINEPHRINE; GUIDELINES; MILRINONE; PERFUSION; OUTCOMES; SOCIETY	Background: Management of cardiac surgery patients is a very standardized procedure in respective local institutions. Yet only very limited evidence exists concerning optimal indication, safety and efficacy of hemodynamic monitoring catecholamine and fluid therapy. Methods: Between April and May 2013, all 81 German anaesthesia departments involved in cardiac surgery care were asked to participate in a questionnaire addressing the institutional specific current practice in hemodynamic monitoring, catecholamine and volume therapy. Results: 51 (63%) questionnaires were completed and returned. All participating centers used basic hemodynamic monitoring (i.e. invasive arterial blood pressure and central venous pressure), supplemented by transesophageal echocardiography. Pulmonary arterial catheter and calibrated trend monitoring devices were also routinely available. In contrast, non-calibrated trend monitoring and esophageal doppler ultrasound devices were not commonly in use. Cerebral oximetry is increasingly emerging, but lacks clear indications. The majority of patients undergoing cardiac surgery, especially in university hospitals, required catecholamines during perioperative care, In case of low cardiac output syndrome, dobutamine (32%), epinephrine (30%) or phosphodiesterase inhibitors (8%) were first choice. In case of hypotension following vasoplegia, norepinephrine (96%) represented the most common catecholamine. 88% of the participating centers reported regular use of colloid fluids, with hydroxyethyl starches (HES) being first choice (64%). Conclusions: Choice of hemodynamic monitoring is homogenous throughout German centers treating cardiac surgery patients. Norepinephrine is the first line catecholamine in cases of decrease in peripheral vascular resistance. However, catecholamine choice for low cardiac output syndrome varies considerably. HES was the primary colloid used for fluid resuscitation. After conduct of this survey, HES use was restricted by European regulatory authorities in critically ill patients and should only be considered as second-line fluid in surgical patients without renal impairment or severe coagulopathy. Large clinical studies addressing catecholamine and fluid therapy in cardiac surgery patients are lacking.	[Sponholz, Christoph; Schelenz, Christoph; Reinhart, Konrad; Stehr, Sebastian N.] Univ Hosp Jena, Dept Anesthesiol & Crit Care Med, Jena, Germany; [Reinhart, Konrad; Stehr, Sebastian N.] Univ Hosp Jena, CSCC, Integrated Res & Treatment Ctr, Jena, Germany; [Schirmer, Uwe] Ruhr Univ Bochum, Inst Anasthesiol, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Ruhr University Bochum	Sponholz, C (corresponding author), Univ Hosp Jena, Dept Anesthesiol & Crit Care Med, Jena, Germany.	christoph.sponholz@med.uni-jena.de	Sponholz, Christoph/I-3585-2019	Sponholz, Christoph/0000-0002-1746-7024	German Federal Ministry of Education and Research (BMBF) [FKZ: 01EO1002]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF), FKZ: 01EO1002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawaf E, 2006, J CARDIOTHOR VASC AN, V20, P353, DOI 10.1053/j.jvca.2006.02.012; Bangert K, 2005, ANASTH INTENSIV NOTF, V40, P291, DOI 10.1055/s-2005-861349; Barron ME, 2004, ARCH SURG-CHICAGO, V139, P552, DOI 10.1001/archsurg.139.5.552; Bastien O, 2005, CRIT CARE, V9, P241, DOI 10.1186/cc3482; Bayer O, 2013, CRIT CARE MED, V41, P2532, DOI 10.1097/CCM.0b013e3182978fb6; Butterworth J F 4th, 1992, J Cardiothorac Vasc Anesth, V6, P535, DOI 10.1016/1053-0770(92)90095-O; Carl M, 2007, THORAC CARDIOV SURG, V55, P130, DOI 10.1055/s-2007-964939; Carl M, 2010, Z HERZ THORAX GEFASS, V24, P294, DOI [DOI 10.1007/S00398-010-0790-1, 10.1007/s00398-010-0790-1.]; De Backer D, 2003, CRIT CARE MED, V31, P1659, DOI 10.1097/01.CCM.0000063045.77339.B6; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Ekbal NJ, 2013, CHEST, V143, P1799, DOI 10.1378/chest.12-1849; Ferguson-Myrthil N, 2012, CARDIOL REV, V20, P153, DOI 10.1097/CRD.0b013e31824e2294; Funkat AK, 2012, THORAC CARDIOV SURG, V60, P371, DOI 10.1055/s-0032-1326724; Gillies M, 2005, CRIT CARE, V9, P266, DOI 10.1186/cc3024; Hamilton MA, 2011, ANESTH ANALG, V112, P1392, DOI 10.1213/ANE.0b013e3181eeaae5; Kastrup M, 2007, ACTA ANAESTH SCAND, V51, P347, DOI 10.1111/j.1399-6576.2006.01190.x; Kastrup M, 2013, ACTA ANAESTH SCAND, V57, P206, DOI 10.1111/aas.12009; Lampard JG, 2013, ANN EMERG MED, V61, P351, DOI 10.1016/j.annemergmed.2012.08.028; Lequeux PY, 2010, EUR J ANAESTH, V27, P295, DOI 10.1097/EJA.0b013e3283315ad0; Levy B, 2011, CRIT CARE MED, V39, P450, DOI 10.1097/CCM.0b013e3181ffe0eb; Lobato EB, 2000, J CARDIOTHOR VASC AN, V14, P374, DOI 10.1053/jcan.2000.7921; Mebazaa A, 2010, CRIT CARE, V14, DOI 10.1186/cc8153; MeierHellmann A, 1997, CRIT CARE MED, V25, P399, DOI 10.1097/00003246-199703000-00005; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; ROYSTER RL, 1993, ANESTH ANALG, V77, P662; Skhirtladze K, 2014, BRIT J ANAESTH, V112, P255, DOI 10.1093/bja/aet348; Weis F, 2006, ANAESTHESIA, V61, P938, DOI 10.1111/j.1365-2044.2006.04779.x; Werner C, 2013, ANASTH INTENSIV NOTF, V48, P437, DOI 10.1055/s-0033-1352487; Williams JB, 2011, J CARDIAC SURG, V26, P572, DOI 10.1111/j.1540-8191.2011.01301.x; Zheng F, 2013, ANESTH ANALG, V116, P663, DOI 10.1213/ANE.0b013e318277a255	31	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103996	10.1371/journal.pone.0103996	http://dx.doi.org/10.1371/journal.pone.0103996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084362	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800116
J	Suo, L; Kang, K; Wang, X; Cao, YG; Zhao, HF; Sun, XY; Tong, LQ; Zhang, F				Suo, Lida; Kang, Kai; Wang, Xun; Cao, Yonggang; Zhao, Haifeng; Sun, Xueying; Tong, Liquan; Zhang, Feng			Carvacrol Alleviates Ischemia Reperfusion Injury by Regulating the PI3K-Akt Pathway in Rats	PLOS ONE			English	Article							ACUTE LIVER-INJURY; HEPATIC ISCHEMIA/REPERFUSION; KINASE-B; APOPTOSIS; ANTIOXIDANT; CELL; PROTECTION; MECHANISMS; SURVIVAL; GROWTH	Background: Liver ischemia reperfusion (I/R) injury is a common pathophysiological process in many clinical settings. Carvacrol, a food additive commonly used in essential oils, has displayed antimicrobials, antitumor and antidepressant-like activities. In the present study, we investigated the protective effects of carvacrol on I/R injury in the Wistar rat livers and an in vitro hypoxia/restoration (H/R) model. Methods: The hepatoportal vein, hepatic arterial and hepatic duct of Wistar rats were isolated and clamped for 30 min, followed by a 2 h reperfusion. Buffalo rat liver (BRL) cells were incubated under hypoxia for 4 h, followed normoxic conditions for 10 h to establish the H/R model in vitro. Liver injury was evaluated by measuring serum levels of alanine aminotransferase (ALT) and aspatate aminotransferase (AST), and hepatic levels of superoxide dismutase (SOD), catalase (CAT), glutathione (GSH) and malondiadehyde (MDA), and hepatic histology and TUNEL staining. MTT assay, flow cytometric analysis and Hoechst 33258 staining were used to evaluate the proliferation and apoptosis of BRL cells in vitro. Protein expression was examined by Western Blot analysis. Results: Carvacrol protected against I/R-induced liver damage, evidenced by significantly reducing the serum levels of ALT and AST, histological alterations and apoptosis of liver cells in I/R rats. Carvacrol exhibited anti-oxidative activity in the I/R rats, reflected by significantly reducing the activity of SOD and the content of MDA, and restoring the activity of CAT and the content of GSH, in I/R rats. In the in vitro assays, carvacrol restored the viability and inhibited the apoptosis of BRL cells, which were subjected to a mimic I/R injury induced by hypoxia. In the investigation on molecular mechanisms, carvacrol downregulated the expression of Bax and upregulated the expression of Bcl-2, thus inhibited the activation of caspase-3. Carvacrol was also shown to enhance the phosphorylation of Akt. Conclusion: The results suggest that carvacrol could alleviate I/R-induced liver injury by its anti-oxidative and anti-apoptotic activities, and warrant a further investigation for using carvacrol to protect I/R injury in clinic.	[Suo, Lida; Kang, Kai; Zhao, Haifeng; Tong, Liquan; Zhang, Feng] Harbin Med Univ, Affiliated Hosp 5, Dept Gen Surg, Daqing, Heilongjiang Pr, Peoples R China; [Wang, Xun] Daqing Oilfield Gen Hosp, Dept Gen Surg, Daqing, Heilongjiang Pr, Peoples R China; [Cao, Yonggang] Harbin Med Univ, Dept Pharmacol, Daqing, Heilongjiang Pr, Peoples R China; [Sun, Xueying] Harbin Med Univ, Affiliated Hosp 1, Hepatosplen Surg Ctr, Dept Gen Surg, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Tong, LQ (corresponding author), Harbin Med Univ, Affiliated Hosp 5, Dept Gen Surg, Daqing, Heilongjiang Pr, Peoples R China.	tlq777666@163.com; zhangfenghyd@gmail.com		Sun, Xueying/0000-0002-8065-8747	Natural Scientific Foundation of Heilongjiang Province in China [D200927]; National Natural Scientific Foundation of China [81172331]	Natural Scientific Foundation of Heilongjiang Province in China; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Scientific Foundation of Heilongjiang Province in China (No.D200927) and the National Natural Scientific Foundation of China (81172331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristatile B, 2009, FUND CLIN PHARMACOL, V23, P757, DOI 10.1111/j.1472-8206.2009.00721.x; Baser KHC, 2008, CURR PHARM DESIGN, V14, P3106, DOI 10.2174/138161208786404227; Borzecka Halina, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P253; Canbek M, 2008, PHYTOMEDICINE, V15, P447, DOI 10.1016/j.phymed.2007.11.022; Melo FHC, 2011, FUND CLIN PHARMACOL, V25, P362, DOI 10.1111/j.1472-8206.2010.00850.x; Daniel PT, 2003, ESSAYS BIOCHEM, V39, P73, DOI 10.1042/bse0390073; Datta G, 2013, WORLD J GASTROENTERO, V19, P1683, DOI 10.3748/wjg.v19.i11.1683; Eguchi M, 2003, MOL CELL BIOCHEM, V252, P17, DOI 10.1023/A:1025567400384; Esposti MD, 2003, BIOCHEM BIOPH RES CO, V304, P455, DOI 10.1016/S0006-291X(03)00617-X; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hattori R, 2001, ANTIOXID REDOX SIGN, V3, P403, DOI 10.1089/15230860152409059; He SQ, 2006, LIVER TRANSPLANT, V12, P1869, DOI 10.1002/lt.21001; JAESCHKE H, 1991, CHEM-BIOL INTERACT, V79, P115, DOI 10.1016/0009-2797(91)90077-K; JAESCHKE H, 1991, FREE RADICAL RES COM, V12-3, P737; Jiang K, 2013, TRANSPL P, V45, P2439, DOI 10.1016/j.transproceed.2013.04.007; Kang KJ, 2002, TRANSPLANT P, V34, P2659, DOI 10.1016/S0041-1345(02)03465-6; Kirimer N., 1995, Chemistry of Natural Compounds, V31, P37, DOI 10.1007/BF01167568; Kohli V, 1999, TRANSPLANTATION, V67, P1099, DOI 10.1097/00007890-199904270-00003; Lehmann TG, 2003, TRANSPLANTATION, V76, P28, DOI 10.1097/01.TP.0000065299.29900.17; Mocanu MM, 2002, J MOL CELL CARDIOL, V34, P661, DOI 10.1006/jmcc.2002.2006; Mullonkal CJ, 2007, J INVEST SURG, V20, P195, DOI 10.1080/08941930701366471; Naqvi S, 2010, INT J NANOMED, V5, P983, DOI 10.2147/IJN.S13244; Park SE, 2009, J ETHNOPHARMACOL, V121, P304, DOI 10.1016/j.jep.2008.10.038; Qi HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065147; Roberts RA, 2000, HEPATOLOGY, V31, P420, DOI 10.1002/hep.510310223; Camara-Lemarroy CR, 2009, EUR J PHARMACOL, V621, P78, DOI 10.1016/j.ejphar.2009.08.038; Romanque P, 2005, REV MED CHILE, V133, P469; Sasaki H, 1998, TRANSPLANT P, V30, P2958, DOI 10.1016/S0041-1345(98)00887-2; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Sokmen M, 2004, J AGR FOOD CHEM, V52, P3309, DOI 10.1021/jf049859g; Song Xudong, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1624; Tang B, 2007, BRAZ J MED BIOL RES, V40, P1637, DOI [10.1590/S0100-879X2006005000173, 10.1590/S0100-879X2007001200007]; Teoh NC, 2003, J GASTROEN HEPATOL, V18, P891, DOI 10.1046/j.1440-1746.2003.03056.x; TOLEDOPEREYRA LH, 1975, AM J SURG, V129, P513, DOI 10.1016/0002-9610(75)90308-6; Xing WJ, 2011, CLIN EXP PHARMACOL P, V38, P605, DOI 10.1111/j.1440-1681.2011.05559.x; Yin QH, 2012, CYTOTECHNOLOGY, V64, P43, DOI 10.1007/s10616-011-9389-y; Yu HL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033584, 10.1371/journal.pone.0051239]; Zhang F, 2011, SURG TODAY, V41, P1075, DOI 10.1007/s00595-010-4423-9; Zhang F, 2010, AMINO ACIDS, V38, P237, DOI 10.1007/s00726-009-0233-z; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zhao ZQ, 2002, CARDIOVASC RES, V55, P438, DOI 10.1016/S0008-6363(02)00442-X	43	30	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104043	10.1371/journal.pone.0104043	http://dx.doi.org/10.1371/journal.pone.0104043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083879	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800121
J	Iwatani, S; Nagashima, H; Reddy, R; Shiota, S; Graham, DY; Yamaoka, Y				Iwatani, Shun; Nagashima, Hiroyuki; Reddy, Rita; Shiota, Seiji; Graham, David Y.; Yamaoka, Yoshio			Identification of the Genes That Contribute to Lactate Utilization in Helicobacter pylori	PLOS ONE			English	Article							SHEWANELLA-ONEIDENSIS MR-1; ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; METABOLISM; GROWTH; CELLS; DEHYDROGENASE; COLONIZATION; PURIFICATION; PYRUVATE	Helicobacter pylori are Gram-negative, spiral-shaped microaerophilic bacteria etiologically related to gastric cancer. Lactate utilization has been implicated although no corresponding genes have been identified in the H. pylori genome. Here, we report that gene products of hp0137-0139 (lldEFG), hp0140-0141 (lctP), and hp1222 (dld) contribute to D-and L-lactate utilization in H. pylori. The three-gene unit hp0137-0139 in H. pylori 26695 encodes L-lactate dehydrogenase (LDH) that catalyzes the conversion of lactate to pyruvate in an NAD-dependent manner. Isogenic mutants of these genes were unable to grow on L-lactate-dependent medium. The hp1222 gene product functions as an NAD-independent D-LDH and also contributes to the oxidation of L-lactate; the isogenic mutant of this gene failed to grow on D-lactate-dependent medium. The parallel genes hp0140-0141 encode two nearly identical lactate permeases (LctP) that promote uptake of both D- and L-lactate. Interestingly an alternate route must also exist for lactate transport as the knockout of genes did not completely prevent growth on D-or L-lactate. Gene expression levels of hp0137-0139 and hp1222 were not enhanced by lactate as the carbon source. Expression of hp0140-0141 was slightly suppressed in the presence of L-lactate but not D-lactate. This study identified the genes contributing to the lactate utilization and demonstrated the ability of H. pylori to utilize both D- and L-lactate.	[Iwatani, Shun; Nagashima, Hiroyuki; Reddy, Rita; Graham, David Y.; Yamaoka, Yoshio] Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA; [Iwatani, Shun; Nagashima, Hiroyuki; Reddy, Rita; Graham, David Y.; Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Iwatani, Shun; Nagashima, Hiroyuki; Shiota, Seiji; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Oita 87011, Japan	Baylor College of Medicine; Baylor College of Medicine; Oita University	Yamaoka, Y (corresponding author), Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA.	yyamaoka@bcm.edu	Graham, David/AAL-2165-2021	Shiota, Seiji/0000-0001-9811-218X; Yamaoka, Yoshio/0000-0002-1222-5819	National Institute of Health [DK62813]; Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [25860544] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062813, P30DK056338] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This report is based on work supported in part by grants from the National Institute of Health (DK62813) (http://www.nih.gov/), and Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST) (http://www.jst.go.jp/EN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera L, 2008, J BACTERIOL, V190, P2997, DOI [10.1128/JB.02013-07, 10.1128/JB.00815-08]; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; BAER W, 1993, ZBL BAKT-INT J MED M, V280, P253; Baldwin DN, 2007, INFECT IMMUN, V75, P1005, DOI 10.1128/IAI.01176-06; Brutinel ED, 2012, APPL ENVIRON MICROB, V78, P8474, DOI 10.1128/AEM.02183-12; Chai YR, 2009, J BACTERIOL, V191, P2423, DOI 10.1128/JB.01464-08; CHALK PA, 1994, MICROBIOL-UK, V140, P2085, DOI 10.1099/13500872-140-8-2085; CHANG HT, 1995, FEMS MICROBIOL LETT, V129, P33, DOI 10.1016/0378-1097(95)00130-W; Clancy CD, 2012, J BACTERIOL, V194, P2402, DOI 10.1128/JB.00230-12; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; DUNCAN JD, 1989, BIOCHEM BIOPH RES CO, V164, P919, DOI 10.1016/0006-291X(89)91546-5; ERWIN AL, 1993, J BACTERIOL, V175, P6382, DOI 10.1128/jb.175.20.6382-6391.1993; Exley RM, 2007, INFECT IMMUN, V75, P1318, DOI 10.1128/IAI.01530-06; Exley RM, 2005, INFECT IMMUN, V73, P5762, DOI 10.1128/IAI.73.9.5762-5766.2005; Exley RM, 2005, J EXP MED, V201, P1637, DOI 10.1084/jem.20041548; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Gill MJ, 1996, INFECT IMMUN, V64, P3374, DOI 10.1128/IAI.64.8.3374-3378.1996; Goffin P, 2004, J BACTERIOL, V186, P6661, DOI 10.1128/JB.186.19.6661-6666.2004; Herbert MA, 2002, MICROB PATHOGENESIS, V33, P211, DOI 10.1006/mpat.2002.0530; Kudo T, 2007, GASTROENTEROLOGY, V132, P1024, DOI 10.1053/j.gastro.2007.01.009; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Marais A, 1999, MICROBIOL MOL BIOL R, V63, P642, DOI 10.1128/MMBR.63.3.642-674.1999; Matsumoto T, 2008, BIOL PHARM BULL, V31, P143, DOI 10.1248/bpb.31.143; MENDZ GL, 1993, J GEN MICROBIOL, V139, P3023, DOI 10.1099/00221287-139-12-3023; MENDZ GL, 1994, ARCH MICROBIOL, V162, P187, DOI 10.1007/s002030050123; Merrell DS, 2003, INFECT IMMUN, V71, P6510, DOI 10.1128/IAI.71.11.6510-6525.2003; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Nakajima N, 1998, J CLIN GASTROENTEROL, V27, pS138, DOI 10.1097/00004836-199800001-00021; Nunez MF, 2002, BIOCHEM BIOPH RES CO, V290, P824, DOI 10.1006/bbrc.2001.6255; Nunez MF, 2001, MICROBIOL-UK, V147, P1069, DOI 10.1099/00221287-147-4-1069; Pinchuk GE, 2011, APPL ENVIRON MICROB, V77, P8234, DOI 10.1128/AEM.05382-11; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; PRATT EA, 1979, BIOCHEMISTRY-US, V18, P312, DOI 10.1021/bi00569a013; Rimbara E, 2011, NAT REV GASTRO HEPAT, V8, P79, DOI 10.1038/nrgastro.2010.210; Sambrook J., 2001, MOL CLONING LAB MANU; Takahashi T, 2007, HELICOBACTER, V12, P532, DOI 10.1111/j.1523-5378.2007.00524.x; Thomas MT, 2011, ENVIRON MICROBIOL, V13, P48, DOI 10.1111/j.1462-2920.2010.02307.x; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; van Amsterdam K, 2004, HELICOBACTER, V9, P614, DOI 10.1111/j.1083-4389.2004.00272.x; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Zhao R, 2013, FEBS OPEN BIO, V3, P379, DOI 10.1016/j.fob.2013.08.005	42	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103506	10.1371/journal.pone.0103506	http://dx.doi.org/10.1371/journal.pone.0103506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078575	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800051
J	Kihara, M; Kiyoshima, T; Nagata, K; Wada, H; Fujiwara, H; Hasegawa, K; Someya, H; Takahashi, I; Sakai, H				Kihara, Makiko; Kiyoshima, Tamotsu; Nagata, Kengo; Wada, Hiroko; Fujiwara, Hiroaki; Hasegawa, Kana; Someya, Hirotaka; Takahashi, Ichiro; Sakai, Hidetaka			Itm2a Expression in the Developing Mouse First Lower Molar, and the Subcellular Localization of Itm2a in Mouse Dental Epithelial Cells	PLOS ONE			English	Article							TOOTH GERM DEVELOPMENT; FUNCTIONAL INVOLVEMENT; LOWER 1ST-MOLAR; GENE; DIFFERENTIATION; PROTEINS; MORPHOGENESIS	Itm2a is a type II transmembrane protein with a BRICHOS domain. We investigated the temporospatial mRNA and protein expression patterns of Itm2a in the developing lower first molar, and examined the subcellular localization of Itm2a in murine dental epithelial (mDE6) cells. From the initiation to the bud stage, the in situ and protein signals of Itm2a were not detected in either the dental epithelial or mesenchymal cells surrounding the tooth bud. However, at the bell stage, these signals of Itm2a were primarily observed in the inner enamel epithelium of the enamel organ. After the initiation of the matrix formation, strong signals were detected in ameloblasts and odontoblasts. Itm2a showed a punctate pattern in the cytoplasm of the mDE6 cells. The perinuclear-localized Itm2a displayed a frequent overlap with the Golgi apparatus marker, GM130. A tiny amount of Itm2a was colocalized with lysosomes and endoplasmic reticulum. Minimal or no overlap between the Itm2a-EGFP signals with the other organelle markers for endoplasmic reticulum, lysosome and mitochondria used in this study noted in the cytoplasm. These findings suggest that Itm2a may play a role in cell differentiation during odontogenesis, rather than during the initiation of tooth germ formation, and may be related to the targeting of proteins associated with enamel and dentin matrices in the secretory pathway.	[Kihara, Makiko; Kiyoshima, Tamotsu; Nagata, Kengo; Wada, Hiroko; Fujiwara, Hiroaki; Hasegawa, Kana; Someya, Hirotaka; Sakai, Hidetaka] Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Lab Oral Pathol, Fukuoka 812, Japan; [Kihara, Makiko; Takahashi, Ichiro] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Orthodont & Dentofacial Orthoped, Fukuoka 812, Japan; [Hasegawa, Kana] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Dept Endodontol & Operat Dent, Fukuoka 812, Japan; [Someya, Hirotaka] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Implant & Rehabil Dent, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University	Sakai, H (corresponding author), Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Lab Oral Pathol, Fukuoka 812, Japan.	hsakaiop@dent.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23659859, 25462862, 23792106]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors disclosed receipt of the following financial support for the research described in this article: Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Nos. 23659859 (to T.K.), 25462862 (to K.N.) and 23792106 (to H.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter M, 2005, HISTOCHEM CELL BIOL, V124, P207, DOI 10.1007/s00418-005-0040-x; Akhter M, 2010, J MOL HISTOL, V41, P185, DOI 10.1007/s10735-010-9277-3; Boeuf S, 2009, DIFFERENTIATION, V78, P108, DOI 10.1016/j.diff.2009.05.007; Buckingham M, 2008, CURR OPIN GENET DEV, V18, P330, DOI 10.1016/j.gde.2008.06.005; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Cobourne MT, 2003, ARCH ORAL BIOL, V48, P1, DOI 10.1016/S0003-9969(02)00208-X; Davidson B, 2013, GYNECOL ONCOL, V128, P349, DOI 10.1016/j.ygyno.2012.11.021; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Honda JY, 2008, HISTOL HISTOPATHOL, V23, P423, DOI 10.14670/HH-23.423; Honda J, 2011, J MOL HISTOL, V42, P83, DOI 10.1007/s10735-010-9309-z; Kirchner J, 1999, J EXP MED, V190, P217, DOI 10.1084/jem.190.2.217; Kobayashi I, 2006, BONE, V38, P836, DOI 10.1016/j.bone.2005.10.026; Lagha M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063143; Matsuda S, 2011, NEUROBIOL AGING, V32, P1400, DOI 10.1016/j.neurobiolaging.2009.08.005; Ookuma YF, 2013, HISTOCHEM CELL BIOL, V139, P355, DOI 10.1007/s00418-012-1033-1; Pittois K, 1998, GENE, V217, P141, DOI 10.1016/S0378-1119(98)00354-0; Pittois K, 1999, MAMM GENOME, V10, P54, DOI 10.1007/s003359900942; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Shiotsuka M, 2013, INT J DEV BIOL, V57, P873, DOI 10.1387/ijdb.120240hs; Takahashi KF, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-115; Tanikawa Y, 1999, ARCH ORAL BIOL, V44, P771, DOI 10.1016/S0003-9969(99)00070-9; Thesleff I, 1995, Adv Dent Res, V9, P12; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Tuckermann JP, 2000, J BONE MINER RES, V15, P1257, DOI 10.1359/jbmr.2000.15.7.1257; Tuomela S, 2012, BLOOD, V119, pE151, DOI 10.1182/blood-2012-01-407528; Van den Plas D, 2004, BIOL CELL, V96, P463, DOI 10.1016/j.biolcel.2004.04.007; Van den Plas D, 2004, CELL BIOL INT, V28, P199, DOI 10.1016/j.cellbi.2003.11.019; Wada H, 2002, HISTOCHEM J, V34, P105, DOI 10.1023/A:1020930228303; Wang HJ, 2005, J BONE MINER RES, V20, P1032, DOI 10.1359/JBMR.050111; Xie M, 2007, J BIOL CHEM, V282, P23275, DOI 10.1074/jbc.M610779200; Xie M, 2009, J MOL HISTOL, V40, P361, DOI 10.1007/s10735-009-9249-7; Yamaza H, 2001, HISTOCHEM J, V33, P437, DOI 10.1023/A:1014491111628; Yamaza H, 2001, INT J DEV BIOL, V45, P675	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103928	10.1371/journal.pone.0103928	http://dx.doi.org/10.1371/journal.pone.0103928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079563	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800097
J	Peng, Y; Yu, G; Tian, SX; Li, H				Peng, Yu; Yu, Ge; Tian, Shaoxiong; Li, Hong			Co-Expression and Co-Purification of Archaeal and Eukaryal Box C/D RNPs	PLOS ONE			English	Article							SMALL NUCLEOLAR RNAS; 18S RIBOSOMAL-RNA; ESCHERICHIA-COLI; PROTEIN COMPLEXES; STRUCTURAL BASIS; RECOMBINANT RNA; SNORNP; BIOGENESIS; METHYLATION; EXPRESSION	Box C/D ribonucleoprotein particles (RNPs) are 2'-O-methylation enzymes required for maturation of ribosomal and small nuclear RNA. Previous biochemical and structural studies of the box C/D RNPs were limited by the unavailability of purified intact RNPs. We developed a bacterial co-expression strategy based on the combined use of a multi-gene expression system and a tRNA-scaffold construct that allowed the expression and purification of homogeneous archaeal and human box C/D RNPs. While the co-expressed and co-purified archaeal box C/D RNP was found to be fully active in a 2'-O-methylation assay, the intact human U14 box C/D RNP showed no detectable catalytic activity, consistent with the earlier findings that assembly of eukaryotic box C/D RNPs is nonspontaneous and requires additional protein factors. Our systems provide a means for further biochemical and structural characterization of box C/D RNPs and their assembly factors.	[Peng, Yu; Li, Hong] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Yu, Ge; Tian, Shaoxiong; Li, Hong] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Li, H (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	hong.li@fsu.edu		Li, Hong/0000-0003-2046-9861; Peng, Yu/0000-0003-2039-9015	National Institutes of Health [R01 GM66958-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066958, R01GM099604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health grant (http://grants.nih.gov/grants/oer.htm) R01 GM66958-01 to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; ARIS JP, 1991, P NATL ACAD SCI USA, V88, P931, DOI 10.1073/pnas.88.3.931; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bleichert F, 2009, SCIENCE, V325, P1384, DOI 10.1126/science.1176099; Boulon S, 2004, MOL CELL, V16, P777, DOI 10.1016/j.molcel.2004.11.013; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Bower-Phipps KR, 2012, RNA, V18, P1527, DOI 10.1261/rna.033134.112; Bratkovic T, 2014, BBA-GENE REGUL MECH, V1839, P438, DOI 10.1016/j.bbagrm.2014.04.009; Cahill NM, 2002, EMBO J, V21, P3816, DOI 10.1093/emboj/cdf376; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Kakihara Y, 2012, BBA-MOL CELL RES, V1823, P101, DOI 10.1016/j.bbamcr.2011.08.016; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Lapinaite A, 2013, NATURE, V502, P519, DOI 10.1038/nature12581; Liang B, 2011, Q REV BIOPHYS, V44, P95, DOI 10.1017/S0033583510000235; LIANG WQ, 1995, GENE DEV, V9, P2433, DOI 10.1101/gad.9.19.2433; Lin JZ, 2011, NATURE, V469, P559, DOI 10.1038/nature09688; McKeegan KS, 2007, MOL CELL BIOL, V27, P6782, DOI 10.1128/MCB.01097-07; McKeegan KS, 2009, MOL CELL BIOL, V29, P4971, DOI 10.1128/MCB.00752-09; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Nano N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0399; Nelissen FHT, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks292; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; PECULIS BA, 1993, CELL, V73, P1233, DOI 10.1016/0092-8674(93)90651-6; Ponchon L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt576; Ponchon L, 2009, NAT PROTOC, V4, P947, DOI 10.1038/nprot.2009.67; Rashid R, 2003, J MOL BIOL, V333, P295, DOI 10.1016/j.jmb.2003.08.012; Robichon C, 2011, APPL ENVIRON MICROB, V77, P4634, DOI 10.1128/AEM.00119-11; Rothe B, 2014, NUCLEIC ACIDS RES, V42, P2015, DOI 10.1093/nar/gkt1091; Rucker P, 1997, PROTEIN ENG, V10, P967, DOI 10.1093/protein/10.8.967; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Snaar S, 2000, J CELL BIOL, V151, P653, DOI 10.1083/jcb.151.3.653; Suryadi J, 2005, BIOCHEMISTRY-US, V44, P9657, DOI 10.1021/bi050568q; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Xue S, 2010, MOL CELL, V39, P939, DOI 10.1016/j.molcel.2010.08.022; Ye KQ, 2009, P NATL ACAD SCI USA, V106, P13808, DOI 10.1073/pnas.0905128106; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061	43	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103096	10.1371/journal.pone.0103096	http://dx.doi.org/10.1371/journal.pone.0103096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078083	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800027
J	Weber, FD; Weinhofer, I; Einwich, A; Forss-Petter, S; Muneer, Z; Maier, H; Weber, WHA; Berger, J				Weber, Franziska D.; Weinhofer, Isabelle; Einwich, Angelika; Forss-Petter, Sonja; Muneer, Zahid; Maier, Harald; Weber, Willi H. A.; Berger, Johannes			Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy	PLOS ONE			English	Article							HEMATOPOIETIC-CELL TRANSPLANTATION; UNION-OF-PHARMACOLOGY; EXPRESSION; THERAPY; ACID; RECEPTORS; ALD; FIBROBLASTS; PROTEIN; TARGET	X-linked adrenoleukodystrophy (X-ALD), the most common peroxisomal disorder, is a clinically heterogeneous disease that can manifest as devastating inflammatory cerebral demyelination (CALD) leading to death of affected males. Currently, the only curative treatment is allogeneic hematopoietic stem cell transplantation (HSCT). However, HSCT is only effective when performed at an early stage because the inflammation may progress for eighteen months after HSCT. Thus, alternative treatment options able to immediately halt the progression are urgently needed. X-ALD is caused by mutations in the ABCD1 gene, encoding the peroxisomal membrane protein ABCD1, resulting in impaired very long-chain fatty acid metabolism. The related ABCD2 protein is able to functionally compensate for ABCD1-deficiency both in vitro and in vivo. Recently, we demonstrated that of the cell types derived from CD34(+) stem cells, predominantly monocytes but not lymphocytes are metabolically impaired in X-ALD. As ABCD2 is virtually not expressed in these cells, we hypothesize that a pharmacological up-regulation of ABCD2 should compensate metabolically and halt the inflammation in CALD. Retinoids are anti-inflammatory compounds known to act on ABCD2. Here, we investigated the capacity of selected retinoids for ABCD2 induction in human monocytes/macrophages. In THP-1 cells, 13-cis-retinoic acid reached the highest, fivefold, increase in ABCD2 expression. To test the efficacy of retinoids in vivo, we analyzed ABCD2 mRNA levels in blood cells isolated from acne patients receiving 13-cis-retinoic acid therapy. In treated acne patients, ABCD2 mRNA levels were comparable to pre-treatment levels in monocytes and lymphocytes. Nevertheless, when primary monocytes were in vitro differentiated into macrophages and treated with 13-cis-retinoic acid, we observed a fourfold induction of ABCD2. However, the level of ABCD2 induction obtained by retinoids alone is probably not of therapeutic relevance for X-ALD. In conclusion, our results suggest a change in promoter accessibility during macrophage differentiation allowing induction of ABCD2 by retinoids.	[Weber, Franziska D.; Weinhofer, Isabelle; Einwich, Angelika; Forss-Petter, Sonja; Muneer, Zahid; Weber, Willi H. A.; Berger, Johannes] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Maier, Harald] Med Univ Vienna, Dept Dermatol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Berger, J (corresponding author), Med Univ Vienna, Ctr Brain Res, Vienna, Austria.	johannes.berger@meduniwien.ac.at	Einwich, Angelika/S-2518-2018; Berger, Johannes/A-9122-2014	Berger, Johannes/0000-0003-0182-2658; Einwich, Angelika/0000-0001-7020-1340; Weinhofer, Isabelle/0000-0002-8455-2069	EU [241622]; Austrian Science Fund (FWF) [P26112-B19]; Hertha Firnberg FWF-fellowship [T562-B13]; Higher Education Commission of Pakistan; Austrian Science Fund (FWF) [P 26112, T 562] Funding Source: researchfish	EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Hertha Firnberg FWF-fellowship; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the EU project "LEUKOTREAT" [241622]; the Austrian Science Fund (FWF) [P26112-B19]; LW. is supported by a Hertha Firnberg FWF-fellowship (T562-B13) and Z.M. by a PhD scholarship from the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asquith DL, 2013, ANN RHEUM DIS, V72, P2024, DOI 10.1136/annrheumdis-2012-202872; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Berger J, 2014, BIOCHIMIE, V98, P135, DOI 10.1016/j.biochi.2013.11.023; Berger J, 2006, BBA-MOL CELL RES, V1763, P1721, DOI 10.1016/j.bbamcr.2006.07.010; Berger J, 2010, BRAIN PATHOL, V20, P845, DOI 10.1111/j.1750-3639.2010.00393.x; Cartier N, 2010, BRAIN PATHOL, V20, P857, DOI 10.1111/j.1750-3639.2010.00394.x; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Fourcade S, 2003, MOL PHARMACOL, V63, P1296, DOI 10.1124/mol.63.6.1296; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Gondcaille C, 2014, BBA-MOL CELL BIOL L, V1841, P259, DOI 10.1016/j.bbalip.2013.11.003; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ito M, 2001, J NEUROPATH EXP NEUR, V60, P1004, DOI 10.1093/jnen/60.10.1004; Kemp S, 1998, NAT MED, V4, P1261, DOI 10.1038/3242; Kemp S, 2012, BBA-MOL BASIS DIS, V1822, P1465, DOI 10.1016/j.bbadis.2012.03.012; Kiss M, 2013, J ALLERGY CLIN IMMUN, V132, P264, DOI 10.1016/j.jaci.2013.05.044; Miller WP, 2011, BLOOD, V118, P1971, DOI 10.1182/blood-2011-01-329235; Montemurro P, 1999, BRIT J HAEMATOL, V107, P294, DOI 10.1046/j.1365-2141.1999.01698.x; Moser H., 2001, METABOLIC MOL BASES, VII, P3257; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Park CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056242; Peters C, 2004, BLOOD, V104, P881, DOI 10.1182/blood-2003-10-3402; Pinheiro J, 2020, R PACKAGE VERSION 31; Pinheiro JC, 2009, MIXED EFFECTS MODELS; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Pujol A, 2000, GENOMICS, V70, P131, DOI 10.1006/geno.2000.6367; R Core Team, 2021, R LANGUAGE ENV STAT; Singh J, 2011, J LIPID RES, V52, P2056, DOI 10.1194/jlr.M017491; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; Venables WN., 2002, MODERN APPL STAT S 4; Weber FD, 2014, HUM MOL GENET, V23, P2542, DOI 10.1093/hmg/ddt645; Weinhofer I, 2005, J BIOL CHEM, V280, P41243, DOI 10.1074/jbc.M509450200; Weinhofer I, 2005, FEBS LETT, V579, P5512, DOI 10.1016/j.febslet.2005.09.014; Weinhofer I, 2002, HUM MOL GENET, V11, P2701, DOI 10.1093/hmg/11.22.2701; Weinhofer I, 2008, EUR J CELL BIOL, V87, P933, DOI 10.1016/j.ejcb.2008.08.002; Wiesinger C, 2013, J BIOL CHEM, V288, P19269, DOI 10.1074/jbc.M112.445445	38	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103742	10.1371/journal.pone.0103742	http://dx.doi.org/10.1371/journal.pone.0103742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079382	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800076
J	Chang, YS; Owen, JP; Desai, SS; Hill, SS; Arnett, AB; Harris, J; Marco, EJ; Mukherjee, P				Chang, Yi-Shin; Owen, Julia P.; Desai, Shivani S.; Hill, Susanna S.; Arnett, Anne B.; Harris, Julia; Marco, Elysa J.; Mukherjee, Pratik			Autism and Sensory Processing Disorders: Shared White Matter Disruption in Sensory Pathways but Divergent Connectivity in Social-Emotional Pathways	PLOS ONE			English	Article							INFERIOR LONGITUDINAL FASCICULUS; DIFFUSION TENSOR TRACKING; HIPPOCAMPO-FUSIFORM; AMYGDALO-FUSIFORM; SPECTRUM DISORDER; CORPUS-CALLOSUM; CHILDREN; SYSTEM; FMRI; ABNORMALITIES	Over 90% of children with Autism Spectrum Disorders (ASD) demonstrate atypical sensory behaviors. In fact, hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment is now included in the DSM-5 diagnostic criteria. However, there are children with sensory processing differences who do not meet an ASD diagnosis but do show atypical sensory behaviors to the same or greater degree as ASD children. We previously demonstrated that children with Sensory Processing Disorders (SPD) have impaired white matter microstructure, and that this white matter microstructural pathology correlates with atypical sensory behavior. In this study, we use diffusion tensor imaging (DTI) fiber tractography to evaluate the structural connectivity of specific white matter tracts in boys with ASD (n = 15) and boys with SPD (n = 16), relative to typically developing children (n = 23). We define white matter tracts using probabilistic streamline tractography and assess the strength of tract connectivity using mean fractional anisotropy. Both the SPD and ASD cohorts demonstrate decreased connectivity relative to controls in parieto-occipital tracts involved in sensory perception and multisensory integration. However, the ASD group alone shows impaired connectivity, relative to controls, in temporal tracts thought to subserve social-emotional processing. In addition to these group difference analyses, we take a dimensional approach to assessing the relationship between white matter connectivity and participant function. These correlational analyses reveal significant associations of white matter connectivity with auditory processing, working memory, social skills, and inattention across our three study groups. These findings help elucidate the roles of specific neural circuits in neurodevelopmental disorders, and begin to explore the dimensional relationship between critical cognitive functions and structural connectivity across affected and unaffected children.	[Chang, Yi-Shin; Owen, Julia P.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Desai, Shivani S.; Hill, Susanna S.; Arnett, Anne B.; Harris, Julia; Marco, Elysa J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marco, EJ (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA.	marcoe@neuropeds.ucsf.edu		Arnett, Anne/0000-0003-1342-0488; Mukherjee, Pratik/0000-0001-7473-7409; Hill, Susanna/0000-0001-5376-1872	Wallace Research Foundation; Gates Family Foundation; Holcombe Kawaja Family Foundation; Simons Foundation; NIH [R01 NS060776, K23 MH083890, KL2 RR024130]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH083890] Funding Source: NIH RePORTER	Wallace Research Foundation; Gates Family Foundation; Holcombe Kawaja Family Foundation; Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by grants from the Wallace Research Foundation, the Gates Family Foundation and the Holcombe Kawaja Family Foundation. EJM, JPO and PM acknowledge support from the Simons Foundation. PM also acknowledges support from NIH R01 NS060776. EJM has received support from NIH K23 MH083890 and KL2 RR024130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn RR, 2004, AM J OCCUP THER, V58, P287, DOI 10.5014/ajot.58.3.287; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; American Psychiatric Association, 1994, DSM 4 DIAGNOSTIC STA; Aoki Y, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-25; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Ben-Sasson A, 2009, J AUTISM DEV DISORD, V39, P1, DOI 10.1007/s10803-008-0593-3; Brett-Green BA, 2008, BRAIN RES, V1242, P283, DOI 10.1016/j.brainres.2008.03.090; Bundy AC, 2007, AM J OCCUP THER, V61, P201, DOI 10.5014/ajot.61.2.201; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Conturo TE, 2008, J INT NEUROPSYCH SOC, V14, P933, DOI 10.1017/S1355617708081381; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; Dunn W, 1997, AM J OCCUP THER, V51, P25, DOI 10.5014/ajot.51.1.25; Dziobek I, 2010, ARCH GEN PSYCHIAT, V67, P397, DOI 10.1001/archgenpsychiatry.2010.31; Eaves LC, 2006, J DEV BEHAV PEDIATR, V27, pS95, DOI 10.1097/00004703-200604002-00007; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Forkel SJ, 2014, CORTEX, V56, P73, DOI 10.1016/j.cortex.2012.09.005; Haas BW, 2012, GENES BRAIN BEHAV, V11, P62, DOI 10.1111/j.1601-183X.2011.00733.x; Jansma H, 2014, NEUROSCIENCE, V256, P230, DOI 10.1016/j.neuroscience.2013.10.047; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Jou RJ, 2011, AUST NZ J PSYCHIAT, V45, P153, DOI 10.3109/00048674.2010.534069; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; Kleinhans NM, 2011, NEUROIMAGE, V54, P697, DOI 10.1016/j.neuroimage.2010.07.037; Koldewyn K, 2014, P NATL ACAD SCI USA, V111, P1981, DOI 10.1073/pnas.1324037111; Kumar A, 2010, CEREB CORTEX, V20, P2103, DOI 10.1093/cercor/bhp278; Lo YC, 2011, PSYCHIAT RES-NEUROIM, V192, P60, DOI 10.1016/j.pscychresns.2010.09.008; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI [10.1203/PDR.0b013e3182130c54, 10.1109/SPL.2011.5782616]; McGrath J, 2013, AUTISM RES, V6, P307, DOI 10.1002/aur.1290; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ortibus E, 2012, DEV MED CHILD NEUROL, V54, P38, DOI 10.1111/j.1469-8749.2011.04147.x; Owen JP, 2013, NEUROIMAGE-CLIN, V2, P844, DOI 10.1016/j.nicl.2013.06.009; Perou R, 2013, MMWR-MORBID MORTAL W, V62, P1; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Shukla DK, 2011, J CHILD PSYCHOL PSYC, V52, P286, DOI 10.1111/j.1469-7610.2010.02342.x; Smith CD, 2009, J MAGN RESON IMAGING, V29, P1248, DOI 10.1002/jmri.21692; Szatmary B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000879; Tang CY, 2010, INTELLIGENCE, V38, P293, DOI 10.1016/j.intell.2010.03.003; Thomas C, 2011, CORTEX, V47, P863, DOI 10.1016/j.cortex.2010.07.006; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wechsler D, 2003, WISC 4 ADM SCORING M	47	116	116	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103038	10.1371/journal.pone.0103038	http://dx.doi.org/10.1371/journal.pone.0103038			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075609	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800023
J	Davis, MS; Bonen, A; Snook, LA; Jain, SS; Bartels, K; Geor, R; Hueffer, K				Davis, Michael S.; Bonen, Arend; Snook, Laelie A.; Jain, Swati S.; Bartels, Kenneth; Geor, Raymond; Hueffer, Karsten			Conditioning Increases the Gain of Contraction-Induced Sarcolemmal Substrate Transport in Ultra-Endurance Racing Sled Dogs	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; MUSCLE GLUCOSE-UPTAKE; RAT SKELETAL-MUSCLE; INTRINSIC ACTIVITY; EXERCISE; GLUT-4; EXPRESSION; TRANSLOCATION; PROTEINS; CAPACITY	Endurance exercise relies on transsarcolemmal flux of substrates in order to avoid depletion of intramuscular reserves. Previous studies of endurance trained sled dogs have shown a remarkable capacity of these dogs to adapt rapidly to endurance exercise by decreasing the utilization of intramuscular reserves. The current study tested the hypothesis that the dogs' glycogen-sparing phenotype is due to increased sarcolemmal transport of glucose and fatty acids. Basal and exercise-induced transport of glucose and fatty acids into sarcolemmal vesicles was evaluated in racing sled dogs prior to and after 7 months of exercise conditioning. Sarcolemmal substrate transport capacity was measured using sarcolemmal vesicles and radiolabelled substrates, and transporter abundance was measured using Western blot quantification in whole muscle homogenates and the sarcolemmal vesicle preparations. Conditioning resulted in increased basal and exercise-induced transport of both glucose and palmitate. Neither acute exercise nor conditioning resulted in changes in muscle content of GLUT4 or FAT/CD36, but conditioning did result in decreased abundance of both transporters in the sarcolemmal vesicles used for the basal transport assays, and this decrease was further amplified in the vesicles used for the exercise-induced transport assays. These results demonstrate conditioning-induced increases in sarcolemmal transport of oxidizable substrates, as well as increased gain of exercise-induced sarcolemmal transport of these substrates. These results further indicate that increased sarcolemmal transport of oxidizable substrates may be due to either an increased intrinsic capacity of the existing transporters or to a different population of transporters from those investigated.	[Davis, Michael S.] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA; [Bonen, Arend; Snook, Laelie A.; Jain, Swati S.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Bartels, Kenneth] Oklahoma State Univ, Dept Vet Clin Sci, Stillwater, OK 74078 USA; [Geor, Raymond] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Hueffer, Karsten] Univ Alaska, Dept Vet Med, Fairbanks, AK 99701 USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of Guelph; Oklahoma State University System; Oklahoma State University - Stillwater; Michigan State University; University of Alaska System; University of Alaska Fairbanks	Davis, MS (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA.	michael.davis@okstate.edu	Geor, Raymond J/P-4631-2017	Geor, Raymond J/0000-0002-6825-6737; Hueffer, Karsten/0000-0001-7154-9066	United States Department of Defense Army Research Office Division of Life Sciences [W911NF-09-1-0549]; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research; Canada Research Chair program; NSERC Canadian Graduate Scholarship	United States Department of Defense Army Research Office Division of Life Sciences; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program(Canada Research Chairs); NSERC Canadian Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	These studies were supported by grants from United States Department of Defense Army Research Office Division of Life Sciences (W911NF-09-1-0549) and by the Natural Sciences and Engineering Research Council of Canada (AB), The Heart and Stroke Foundation of Ontario (AB), the Canadian Institutes of Health Research (AB), and the Canada Research Chair program. A. Bonen, PhD, FRSC, was the Canada Research Chair in Metabolism and Health. Swati S. Jain was the recipient of an NSERC Canadian Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhateeb H, 2007, AM J PHYSIOL-ENDOC M, V293, pE783, DOI 10.1152/ajpendo.00685.2006; BEGUM N, 1993, J BIOL CHEM, V268, P3352; Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501; Bonen A, 2004, P NUTR SOC, V63, P245, DOI 10.1079/PNS2004331; Halseth AE, 1998, J APPL PHYSIOL, V85, P2305, DOI 10.1152/jappl.1998.85.6.2305; HARDIN DS, 1995, J CLIN ENDOCR METAB, V80, P2437, DOI 10.1210/jc.80.8.2437; Hinchcliff KW, 1997, AM J VET RES, V58, P1457; Kitaoka Y, 2012, AM J VET RES, V73, P1813, DOI 10.2460/ajvr.73.11.1813; Klip A, 2009, APPL PHYSIOL NUTR ME, V34, P481, DOI 10.1139/H09-047; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; Kristiansen S, 1997, AM J PHYSIOL-ENDOC M, V272, pE385, DOI 10.1152/ajpendo.1997.272.3.E385; Luiken JJFP, 1999, J LIPID RES, V40, P1007; McCutcheon LJ, 2002, EQUINE VET J, V34, P199; McKenzie E, 2005, MED SCI SPORT EXER, V37, P1307, DOI 10.1249/01.mss.0000175086.41080.01; McKenzie EC, 2008, AM J VET RE IN PRESS; Mohan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014217; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE456, DOI 10.1152/ajpendo.1996.270.3.E456; PLOUG T, 1990, AM J PHYSIOL, V259, pE778, DOI 10.1152/ajpendo.1990.259.6.E778; REN JM, 1994, J BIOL CHEM, V269, P14396; Richter EA, 1998, AM J PHYSIOL-ENDOC M, V274, pE89, DOI 10.1152/ajpendo.1998.274.1.E89; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Talanian JL, 2010, AM J PHYSIOL-ENDOC M, V299, pE180, DOI 10.1152/ajpendo.00073.2010; Tonouchi M, 2002, AM J PHYSIOL-ENDOC M, V282, pE1062, DOI 10.1152/ajpendo.00358.2001; Zaid H, 2009, BIOCHEM J, V419, P475, DOI 10.1042/BJ20081319	26	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103087	10.1371/journal.pone.0103087	http://dx.doi.org/10.1371/journal.pone.0103087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075856	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800025
J	La Merrill, M; Karey, E; Moshier, E; Lindtner, C; La Frano, MR; Newman, JW; Buettner, C				La Merrill, Michele; Karey, Emma; Moshier, Erin; Lindtner, Claudia; La Frano, Michael R.; Newman, John W.; Buettner, Christoph			Perinatal Exposure of Mice to the Pesticide DDT Impairs Energy Expenditure and Metabolism in Adult Female Offspring	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; BODY-MASS INDEX; LIPID-METABOLISM; INSULIN-RESISTANCE; GENE-EXPRESSION; MALARIA CONTROL; BILE-ACIDS; GLUCOSE; FAT; PREVALENCE	Dichlorodiphenyltrichloroethane (DDT) has been used extensively to control malaria, typhus, body lice and bubonic plague worldwide, until countries began restricting its use in the 1970s. Its use in malaria control continues in some countries according to recommendation by the World Health Organization. Individuals exposed to elevated levels of DDT and its metabolite dichlorodiphenyldichloroethylene (DDE) have an increased prevalence of diabetes and insulin resistance. Here we hypothesize that perinatal exposure to DDT disrupts metabolic programming leading to impaired metabolism in adult offspring. To test this, we administered DDT to C57BL/6J mice from gestational day 11.5 to postnatal day 5 and studied their metabolic phenotype at several ages up to nine months. Perinatal DDT exposure reduced core body temperature, impaired cold tolerance, decreased energy expenditure, and produced a transient early-life increase in body fat in female offspring. When challenged with a high fat diet for 12 weeks in adulthood, female offspring perinatally exposed to DDT developed glucose intolerance, hyperinsulinemia, dyslipidemia, and altered bile acid metabolism. Perinatal DDT exposure combined with high fat feeding in adulthood further impaired thermogenesis as evidenced by reductions in core temperature and in the expression of numerous RNA that promote thermogenesis and substrate utilization in the brown adipose tissue of adult female mice. These observations suggest that perinatal DDT exposure impairs thermogenesis and the metabolism of carbohydrates and lipids which may increase susceptibility to the metabolic syndrome in adult female offspring.	[La Merrill, Michele; Karey, Emma] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [La Merrill, Michele; Moshier, Erin] Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA; [La Merrill, Michele; Lindtner, Claudia; Buettner, Christoph] Mt Sinai Sch Med, Metab Inst, New York, NY USA; [Lindtner, Claudia; Buettner, Christoph] Mt Sinai Sch Med, Div Endocrinol Diabet & Bone Dis, New York, NY USA; [La Frano, Michael R.; Newman, John W.] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA; [La Frano, Michael R.; Newman, John W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Newman, John W.] ARS, Obes & Metab Res Unit, USDA, Western Human Nutr Res Ctr, Davis, CA USA	University of California System; University of California Davis; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA)	La Merrill, M (corresponding author), Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA.	mlamerrill@ucdavis.edu	La Frano, Michael/X-7701-2019; karey, Emma/AAT-2649-2020	karey, Emma/0000-0002-5446-5351; Newman, John/0000-0001-9632-6571; La Frano, Michael/0000-0002-2269-1688	National Institute of Health [R00 ES019919, R03 DK082724, U24 DK092993, U24 DK097154, T32 ES007059, P60 DK020541]; American Diabetes Association; United States Department of Agriculture - Agricultural Research Service Intramural Project [5306-51530-019-00D]; ARS [ARS-0426826] Funding Source: Federal RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK082724, P30DK020541, P60DK020541, U24DK092993, U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES019919, R00ES019919, T32ES007059] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); United States Department of Agriculture - Agricultural Research Service Intramural Project; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported through funding by the National Institute of Health (R00 ES019919, R03 DK082724, U24 DK092993, U24 DK097154, T32 ES007059, and P60 DK020541), the American Diabetes Association, and United States Department of Agriculture - Agricultural Research Service Intramural Project 5306-51530-019-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2007, J BIOL CHEM, V283, P4228; Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721; ATTILI AF, 1986, MED HYPOTHESES, V19, P57, DOI 10.1016/0306-9877(86)90137-4; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bastin J, 2011, HUM MOL GENET, V20, P2048, DOI 10.1093/hmg/ddr089; Bazaes RA, 2003, PEDIATRICS, V111, P804, DOI 10.1542/peds.111.4.804; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; BOUWMAN H, 1992, B WORLD HEALTH ORGAN, V70, P241; BOUWMAN H, 1991, J TOXICOL ENV HEALTH, V33, P141, DOI 10.1080/15287399109531514; Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471; Clegg DJ, 2012, MOL ENDOCRINOL, V26, P1957, DOI 10.1210/me.2012-1284; Cox S, 2007, ENVIRON HEALTH PERSP, V115, P1747, DOI 10.1289/ehp.10258; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; ECOBICHON DJ, 1968, CAN J PHYSIOL PHARM, V46, P785, DOI 10.1139/y68-121; Eskenazi B, 2009, ENVIRON HEALTH PERSP, V117, P1359, DOI 10.1289/ehp.11748; Farhang L, 2005, AM J EPIDEMIOL, V162, P717, DOI 10.1093/aje/kwi276; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gallagher EJ, 2010, MT SINAI J MED, V77, P511, DOI 10.1002/msj.20212; Garcia-Canaveras JC, 2012, J LIPID RES, V53, P2231, DOI 10.1194/jlr.D028803; Grapov D, 2012, BIOINFORMATICS, V28, P2288, DOI 10.1093/bioinformatics/bts439; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Guarner-Lans V, 2011, EXP GERONTOL, V46, P517, DOI 10.1016/j.exger.2011.02.007; Hall JA, 2010, ENDOCRINOLOGY, V151, P4573, DOI 10.1210/en.2010-0511; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Herrera-Portugal C, 2005, ENVIRON RES, V99, P158, DOI 10.1016/j.envres.2005.03.010; Hinoi E, 2013, DIABETES; Hondares E, 2013, METABOLISM; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hult M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013582; Jun HJ, 2012, PPAR RES, V2012, DOI 10.1155/2012/320454; KACEW S, 1974, BIOCHEM J, V142, P145, DOI 10.1042/bj1420145; Karmaus W, 2009, OCCUP ENVIRON MED, V66, P143, DOI 10.1136/oem.2008.041921; Kim JY, 2009, J MED FOOD, V12, P629, DOI 10.1089/jmf.2008.1234; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Koves TR, 2013, J LIPID RES, V54, P522, DOI 10.1194/jlr.P028910; KREISS K, 1981, JAMA-J AM MED ASSOC, V245, P1926, DOI 10.1001/jama.245.19.1926; Langenberg C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001230; Lee DH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015977, 10.1371/journal.pone.0026172]; Lee JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-33; Lindtner C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005123; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Merrill ML, 2013, ENVIRON HEALTH PERSP, V121, P594, DOI 10.1289/ehp.1205921; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; NAGAOKA S, 1986, J NUTR, V116, P726, DOI 10.1093/jn/116.5.726; NNODIM JO, 1985, ANAT EMBRYOL, V173, P215, DOI 10.1007/BF00316302; Novo CL, 2013, FASEB J, V27, P3632, DOI 10.1096/fj.12-224204; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Qiao AJ, 2011, HEPATOLOGY, V54, P509, DOI 10.1002/hep.24402; Ramachandran A, 2012, WORLD J DIABETES, V3, P110, DOI 10.4239/wjd.v3.i6.110; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Rolo AP, 2002, TOXICOL LETT, V126, P197, DOI 10.1016/S0378-4274(01)00464-7; Rylander C, 2009, J ENVIRON MONITOR, V11, P370, DOI 10.1039/b811868j; Rylander Lars, 2005, Environ Health, V4, P28, DOI 10.1186/1476-069X-4-28; SANYAL S, 1982, INDIAN J BIOCHEM BIO, V19, P111; Scherer T, 2011, CELL METAB, V13, P183, DOI 10.1016/j.cmet.2011.01.008; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sholtz RI, 2011, ENVIRON INT, V37, P709, DOI 10.1016/j.envint.2011.01.013; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Stefl B, 1998, AM J PHYSIOL-ENDOC M, V274, pE527, DOI 10.1152/ajpendo.1998.274.3.E527; Taylor KW, 2013, ENVIRON HEALTH PERSP, V121, P774, DOI 10.1289/ehp.1205502; TOMATIS L, 1972, INT J CANCER, V10, P489, DOI 10.1002/ijc.2910100308; TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; YAU ET, 1977, TOXICOL APPL PHARM, V39, P81, DOI 10.1016/0041-008X(77)90179-X; You L, 1999, TOXICOL APPL PHARM, V157, P134, DOI 10.1006/taap.1999.8673; Yu XX, 2002, FASEB J, V16, P155, DOI 10.1096/fj.01-0568com; Zaytseva YY, 2012, CANCER RES, V72, P1504, DOI 10.1158/0008-5472.CAN-11-4057; Zhao Y, 2012, ADV EXP MED BIOL, V728, P214, DOI 10.1007/978-1-4614-0887-1_14	77	87	89	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103337	10.1371/journal.pone.0103337	http://dx.doi.org/10.1371/journal.pone.0103337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076055	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800037
J	Shamshirband, S; Petkovic, D; Hashim, R; Motamedi, S				Shamshirband, Shahaboddin; Petkovic, Dalibor; Hashim, Roslan; Motamedi, Shervin			Adaptive Neuro-Fuzzy Methodology for Noise Assessment of Wind Turbine	PLOS ONE			English	Article							PREDICTION; ANFIS	Wind turbine noise is one of the major obstacles for the widespread use of wind energy. Noise tone can greatly increase the annoyance factor and the negative impact on human health. Noise annoyance caused by wind turbines has become an emerging problem in recent years, due to the rapid increase in number of wind turbines, triggered by sustainable energy goals set forward at the national and international level. Up to now, not all aspects of the generation, propagation and perception of wind turbine noise are well understood. For a modern large wind turbine, aerodynamic noise from the blades is generally considered to be the dominant noise source, provided that mechanical noise is adequately eliminated. The sources of aerodynamic noise can be divided into tonal noise, inflow turbulence noise, and airfoil self-noise. Many analytical and experimental acoustical studies performed the wind turbines. Since the wind turbine noise level analyzing by numerical methods or computational fluid dynamics (CFD) could be very challenging and time consuming, soft computing techniques are preferred. To estimate noise level of wind turbine, this paper constructed a process which simulates the wind turbine noise levels in regard to wind speed and sound frequency with adaptive neuro-fuzzy inference system (ANFIS). This intelligent estimator is implemented using Matlab/Simulink and the performances are investigated. The simulation results presented in this paper show the effectiveness of the developed method.	[Petkovic, Dalibor] Univ Nis, Fac Mech Engn, Dept Mechatron & Control, Nish, Serbia; [Shamshirband, Shahaboddin] Islamic Azad Univ, Chalous Branch, Dept Comp Sci, Chalous, Mazandaran, Iran; [Shamshirband, Shahaboddin] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Comp Syst & Technol, Kuala Lumpur, Malaysia; [Hashim, Roslan] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Hashim, Roslan; Motamedi, Shervin] Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia	University of Nis; Islamic Azad University; Universiti Malaya; Universiti Malaya; Universiti Malaya	Shamshirband, S (corresponding author), Islamic Azad Univ, Chalous Branch, Dept Comp Sci, Chalous, Mazandaran, Iran.	shamshirband1396@gmail.com	S.Band, Shahab/AAD-3311-2021; S.Band, Shahab/ABI-7388-2020	S.Band, Shahab/0000-0002-8963-731X; Shamshirband, Shahaboddin/0000-0002-6605-498X	HIR-MOHE University of Malaya [UM.C/HIR/MOHE/ENG/34]; Research and development of new generation wind turbines of high-energy efficiency [TP35005]; Ministry of Education, Science and Technological Development, Republic of Serbia [20112014]	HIR-MOHE University of Malaya(Universiti Malaya); Research and development of new generation wind turbines of high-energy efficiency; Ministry of Education, Science and Technological Development, Republic of Serbia	The authors express their sincere thanks for the funding support they received from HIR-MOHE University of Malaya under Grant No. UM.C/HIR/MOHE/ENG/34. This paper is also supported by Project Grant TP35005 "Research and development of new generation wind turbines of high-energy efficiency'' (20112014) financed by Ministry of Education, Science and Technological Development, Republic of Serbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcayol MA, 2004, ADV ENG SOFTW, V35, P129, DOI 10.1016/j.advengsoft.2004.03.005; Arezes PM, 2014, PROCD SOC BEHV, V109, P390, DOI 10.1016/j.sbspro.2013.12.478; Baath LB, 2013, RENEW ENERG, V57, P512, DOI 10.1016/j.renene.2013.02.007; Ekici BB, 2011, EXPERT SYST APPL, V38, P5352, DOI 10.1016/j.eswa.2010.10.021; Gocmen T, 2012, ENERGY, V46, P62, DOI 10.1016/j.energy.2012.05.036; Grigorie TL, 2009, P I MECH ENG G-J AER, V223, P655, DOI 10.1243/09544100JAERO522; Inal M, 2008, J MATER PROCESS TECH, V195, P34, DOI 10.1016/j.jmatprotec.2007.04.106; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Khajeh A, 2009, EXPERT SYST APPL, V36, P5728, DOI 10.1016/j.eswa.2008.06.051; Kim H, 2012, RENEW ENERG, V42, P46, DOI 10.1016/j.renene.2011.09.019; Laratro A, 2014, J WIND ENG IND AEROD, V127, P1, DOI 10.1016/j.jweia.2014.01.007; Lee GS, 2012, APPL ACOUST, V73, P817, DOI 10.1016/j.apacoust.2012.03.001; Lee S, 2014, RENEW ENERG, V65, P108, DOI 10.1016/j.renene.2013.07.036; Lin B, 2010, MEASUREMENT, V44, P445; Petkovic D, EXPERT SYSTEMS APPL, V39, P13295; Petkovic D, 2012, NEURAL COMPUT APPL, V21, P2065; Petkovic D, 2012, EXPERT SYST APPL, V39, P9477, DOI 10.1016/j.eswa.2012.02.111; Rogers T, 2012, RENEW ENERG, V41, P180, DOI 10.1016/j.renene.2011.10.017; Ryi J, 2014, RENEW ENERG, V65, P257, DOI 10.1016/j.renene.2013.09.032; Son E, 2010, CURR APPL PHYS, V10, pS316, DOI 10.1016/j.cap.2009.11.034; Tadamasa A, 2011, RENEW ENERG, V36, P1902, DOI 10.1016/j.renene.2010.11.036; Taylor J, 2013, RENEW ENERG, V55, P120, DOI 10.1016/j.renene.2012.11.031; Van Renterghem T, 2013, SCI TOTAL ENVIRON, V456, P333, DOI 10.1016/j.scitotenv.2013.03.095; Vick B, 2013, RENEW ENERG, V50, P1044, DOI 10.1016/j.renene.2012.08.057; Wahida B.R.S.D., 2011, INT J MODELING OPTIM, V1, P24, DOI DOI 10.7763/IJM0.2011.V1.5	25	29	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103414	10.1371/journal.pone.0103414	http://dx.doi.org/10.1371/journal.pone.0103414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075621	Green Published, gold, Green Submitted			2022-12-27	WOS:000340028800043
J	Won, JC; Park, CY; Oh, SW; Lee, ES; Youn, BS; Kim, MS				Won, Jong Chul; Park, Cheol-Young; Oh, Sang Woo; Lee, Eon Sook; Youn, Byung-Soo; Kim, Min-Seon			Plasma Clusterin (ApoJ) Levels Are Associated with Adiposity and Systemic Inflammation	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GENOME-WIDE ASSOCIATION; C-REACTIVE PROTEIN; APOLIPOPROTEIN-J; INSULIN-RESISTANCE; ALZHEIMERS-DISEASE; CLUSTERIN/APOLIPOPROTEIN-J; IDENTIFIES VARIANTS; METABOLIC SYNDROME; OXIDATIVE STRESS	Obesity and insulin resistance are hallmarks of the metabolic syndrome, which is associated with low-grade chronic inflammation. Clusterin/apolipoprotein J is an abundant plasma chaperone protein that has recently been suggested as a potential biomarker that reflects the inflammatory process in Alzheimer's disease. In the present study, we investigated anthropometric and clinical factors affecting the plasma levels of clusterin in healthy Korean subjects. We measured fasting plasma clusterin levels in healthy Korean adults (111 men and 93 women) using ELISA kit. We analyzed the relationship between plasma clusterin concentrations and anthropometric and clinical parameters. Fasting plasma clusterin concentrations were higher in overweight and obese subjects than in lean subjects. Correlation analysis revealed that the plasma clusterin levels were positively associated with indices of obesity such as body mass index (BMI), waist circumference and waist-hip ratio and markers of systemic inflammation such as high sensitivity C-reactive protein (hsCRP), uric acid, ferritin and retinol binding protein-4. Multiple linear regression analysis showed that sex, BMI and hsCRP were independent determinants of plasma clusterin levels. Furthermore, plasma clusterin levels showed an upward trend with increasing numbers of metabolic syndrome components. These findings suggest that fasting plasma clusterin levels correlate with the parameters of adiposity and systemic inflammation in healthy adults. Therefore, the circulating clusterin level may be a surrogate marker for obesity-associated systemic inflammation.	[Won, Jong Chul] Inje Univ, Sanggye Paik Hosp, Coll Med, Dept Internal Med,Cardiovasc & Metab Dis Ctr, Seoul, South Korea; [Park, Cheol-Young] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Internal Med, Seoul, South Korea; [Oh, Sang Woo] Dongguk Univ, Ilsan Hosp, Dept Family Med, Ilsan, South Korea; [Lee, Eon Sook] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Family Med,Ctr Hlth Promot, Ilsan, South Korea; [Youn, Byung-Soo] Wonkang Univ, Sch Med, Dept Anat, Iksan, Jeonbuk, South Korea; [Kim, Min-Seon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea	Inje University; Sungkyunkwan University (SKKU); Samsung Medical Center; Dongguk University; NHIS Ilsan Hospital; Inje University; Wonkwang University; University of Ulsan; Asan Medical Center	Youn, BS (corresponding author), Wonkang Univ, Sch Med, Dept Anat, Iksan, Jeonbuk, South Korea.	byung4jc@gmail.com; mskim@amc.seoul.kr	; Park, Cheol-Young/C-6690-2018	Oh, Sang Woo/0000-0002-5623-6720; Lee, Eon Sook/0000-0002-6148-2512; Park, Cheol-Young/0000-0002-9415-9965; Won, Jong Chul/0000-0002-2219-4083	National Research Foundation of Korea [2013M3C7A1056024]; Asan Institute for Life Science [11similar to326]; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0020224]	National Research Foundation of Korea(National Research Foundation of Korea); Asan Institute for Life Science; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by grants from the National Research Foundation of Korea (2013M3C7A1056024), and the Asan Institute for Life Science (11 similar to 326). This study was also supported by a Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0020224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MA, 2003, CIRCULATION, V108, P161, DOI 10.1161/01.CIR.0000080289.72166.CF; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Arnold T, 2011, PEDIATR RES, V69, P237, DOI 10.1203/PDR.0b013e31820930cb; Bhamra MS, 2012, ELECTROPHORESIS, V33, P3598, DOI 10.1002/elps.201200161; BURKEY BF, 1992, J LIPID RES, V33, P1517; CHOIMIURA NH, 1992, J BIOCHEM, V112, P557, DOI 10.1093/oxfordjournals.jbchem.a123938; Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112; Falgarone G, 2009, ADV CANCER RES, V104, P139, DOI 10.1016/S0065-230X(09)04008-1; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.62; Fukushima M, 1999, DIABETES CARE, V22, P1911, DOI 10.2337/diacare.22.11.1911; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; HARDARDOTTIR I, 1994, J CLIN INVEST, V94, P1304, DOI 10.1172/JCI117449; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; International Obesity Task Force (IOTF), 2000, AS PAC PERSP RED OB; Ishii T, 2001, ATHEROSCLEROSIS, V158, P215, DOI 10.1016/S0021-9150(01)00416-6; JENNE DE, 1991, J BIOL CHEM, V266, P11030; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; KELSO GJ, 1994, BIOCHEMISTRY-US, V33, P832, DOI 10.1021/bi00169a026; Kim HJ, 2009, ARTERIOSCL THROM VAS, V29, P1558, DOI 10.1161/ATVBAHA.109.190058; Kujiraoka T, 2006, J ATHEROSCLER THROMB, V13, P314, DOI 10.5551/jat.13.314; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Meisinger C, 2008, ARTERIOSCL THROM VAS, V28, P1186, DOI 10.1161/ATVBAHA.107.160184; Navab M, 1997, J CLIN INVEST, V99, P2005, DOI 10.1172/JCI119369; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; Shapiro H, 2011, THESCIENTIFICWORLDJO, V11, P2509, DOI 10.1100/2011/397971; Shirasawa T, 2009, J ATHEROSCLER THROMB, V16, P772; Tamakoshi K, 2003, INT J OBESITY, V27, P443, DOI 10.1038/sj.ijo.0802260; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Trougakos IP, 2002, EXP GERONTOL, V37, P1175, DOI 10.1016/S0531-5565(02)00139-0; Yao-Borengasser A, 2007, J CLIN ENDOCR METAB, V92, P2590, DOI 10.1210/jc.2006-0816; Yu JT, 2013, NEUROBIOL AGING, V34, p[1921, e1917]	37	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103351	10.1371/journal.pone.0103351	http://dx.doi.org/10.1371/journal.pone.0103351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076422	Green Published, gold, Green Submitted			2022-12-27	WOS:000340028800040
J	Young, SD; Daniels, J; Chiu, CJ; Bolan, RK; Flynn, RP; Kwok, J; Klausner, JD				Young, Sean D.; Daniels, Joseph; Chiu, ChingChe J.; Bolan, Robert K.; Flynn, Risa P.; Kwok, Justin; Klausner, Jeffrey D.			Acceptability of Using Electronic Vending Machines to Deliver Oral Rapid HIV Self-Testing Kits: A Qualitative Study	PLOS ONE			English	Article							STIGMA; MEN; SEX; PREVENTION; PERCEPTIONS; INFECTION; EPIDEMIC; RISK	Introduction: Rates of unrecognized HIV infection are significantly higher among Latino and Black men who have sex with men (MSM). Policy makers have proposed that HIV self-testing kits and new methods for delivering self-testing could improve testing uptake among minority MSM. This study sought to conduct qualitative assessments with MSM of color to determine the acceptability of using electronic vending machines to dispense HIV self-testing kits. Materials and Methods: African American and Latino MSM were recruited using a participant pool from an existing HIV prevention trial on Facebook. If participants expressed interest in using a vending machine to receive an HIV self-testing kit, they were emailed a 4-digit personal identification number (PIN) code to retrieve the test from the machine. We followed up with those who had tested to assess their willingness to participate in an interview about their experience. Results: Twelve kits were dispensed and 8 interviews were conducted. In general, participants expressed that the vending machine was an acceptable HIV test delivery method due to its novelty and convenience. Discussion: Acceptability of this delivery model for HIV testing kits was closely associated with three main factors: credibility, confidentiality, and convenience. Future research is needed to address issues, such as user-induced errors and costs, before scaling up the dispensing method.	[Young, Sean D.; Chiu, ChingChe J.; Kwok, Justin] Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA 90095 USA; [Daniels, Joseph; Klausner, Jeffrey D.] Univ Calif Los Angeles, Program Global Hlth, Los Angeles, CA USA; [Bolan, Robert K.; Flynn, Risa P.] Los Angeles Gay & Lesbian Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Young, SD (corresponding author), Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA 90095 USA.	sdyoung@mednet.ucla.edu	Bolan, Robert/AAD-4716-2020	Young, Sean D./0000-0001-6052-4875	National Institutes of Mental Health (NIMH) [K01 MH090884-02]; UCLA CHIPTS; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, K01MH090884] Funding Source: NIH RePORTER	National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UCLA CHIPTS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study received support from the National Institutes of Mental Health (NIMH; K01 MH090884-02) and from UCLA CHIPTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angotti N, 2009, SOC SCI MED, V68, P2263, DOI 10.1016/j.socscimed.2009.02.041; [Anonymous], 2013, HIV INC; [Anonymous], 2008, SUBP EST HIV INC SUR, P985; Brooks RA, 2005, AIDS PATIENT CARE ST, V19, P737, DOI 10.1089/apc.2005.19.737; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; Centers for Disease Control and Prevention, 2013, HIV US GLANC; Charmaz K., 2003, STRATEGIES QUALITATI, P249, DOI 10.1111/1467-9566.00338; Fullilove MT, 1999, AM BEHAV SCI, V42, P1117, DOI 10.1177/00027649921954796; Hall HI, 2007, AM J PUBLIC HEALTH, V97, P1060, DOI 10.2105/AJPH.2006.087551; HIV Epidemiology Program Los Angeles County Department of Health Services, 2002, SPEC DAT RUN; HIV Epidemiology Program Los Angeles County Department of Health Services, 2008, SPEC DAT RUN; Hoffman ND, 2009, J ADOLESCENT HEALTH, V45, P222, DOI 10.1016/j.jadohealth.2009.01.009; Janssen RS, 2001, AM J PUBLIC HEALTH, V91, P1019, DOI 10.2105/AJPH.91.7.1019; Kirby D, 1999, AM J PUBLIC HEALTH, V89, P182, DOI 10.2105/AJPH.89.2.182; Lyu SY, 2011, AIDS CARE, V23, P508, DOI 10.1080/09540121.2010.516331; MacKellar DA, 2005, JAIDS-J ACQ IMM DEF, V38, P603, DOI 10.1097/01.qai.0000141481.48348.7e; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Marin Barbara VanOss, 2003, J Transcult Nurs, V14, P186, DOI 10.1177/1043659603014003005; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Millett G, 2005, J NATL MED ASSOC, V97, p52S; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Obadia Y, 1999, AM J PUBLIC HEALTH, V89, P1852, DOI 10.2105/AJPH.89.12.1852; Pilcher CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080629; Stekler JD, 2013, J CLIN VIROL, V58, pE119, DOI 10.1016/j.jcv.2013.09.018; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Worthington C, 2003, QUAL HEALTH RES, V13, P636, DOI 10.1177/1049732303013005004; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302; Young SD, 2013, AIDS CARE, P1, DOI DOI 10.1208/SL2249-013-9988-3; Young SD, 2007, PERS SOC PSYCHOL B, V33, P789, DOI 10.1177/0146167207301027; Young SD, 2013, ANN INTERN MED, V159, P318, DOI 10.7326/0003-4819-159-5-201309030-00005; Young SD, 2011, AIDS BEHAV, V15, P643, DOI 10.1007/s10461-009-9653-8; Young SD, 2010, AIDS CARE, V22, P373, DOI 10.1080/09540120903193666	32	49	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103790	10.1371/journal.pone.0103790	http://dx.doi.org/10.1371/journal.pone.0103790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25076208	Green Submitted, gold, Green Published			2022-12-27	WOS:000340028800079
J	Webster, CI; Burrell, M; Olsson, LL; Fowler, SB; Digby, S; Sandercock, A; Snijder, A; Tebbe, J; Haupts, U; Grudzinska, J; Jermutus, L; Andersson, C				Webster, Carl I.; Burrell, Matthew; Olsson, Lise-Lotte; Fowler, Susan B.; Digby, Sarah; Sandercock, Alan; Snijder, Arjan; Tebbe, Jan; Haupts, Ulrich; Grudzinska, Joanna; Jermutus, Lutz; Andersson, Christin			Engineering Neprilysin Activity and Specificity to Create a Novel Therapeutic for Alzheimer's Disease	PLOS ONE			English	Article							BRAIN A-BETA; AMYLOID-BETA; NEUTRAL ENDOPEPTIDASE; NATRIURETIC PEPTIDE; SUBSTRATE; THERMOLYSIN; METABOLISM; INHIBITOR; ENZYME; METALLOENDOPEPTIDASE	Neprilysin is a transmembrane zinc metallopeptidase that degrades a wide range of peptide substrates. It has received attention as a potential therapy for Alzheimer's disease due to its ability to degrade the peptide amyloid beta. However, its broad range of peptide substrates has the potential to limit its therapeutic use due to degradation of additional peptides substrates that tightly regulate many physiological processes. We sought to generate a soluble version of the ectodomain of neprilysin with improved activity and specificity towards amyloid beta as a potential therapeutic for Alzheimer's disease. Extensive amino acid substitutions were performed at positions surrounding the active site and inner surface of the enzyme and variants screened for activity on amyloid beta 1-40, 1-42 and a variety of other physiologically relevant peptides. We identified several mutations that modulated and improved both enzyme selectivity and intrinsic activity. Neprilysin variant G399V/G714K displayed an approximately 20-fold improved activity on amyloid beta 1-40 and up to a 3,200-fold reduction in activity on other peptides. Along with the altered peptide substrate specificity, the mutant enzyme produced a markedly altered series of amyloid beta cleavage products compared to the wild-type enzyme. Crystallisation of the mutant enzyme revealed that the amino acid substitutions result in alteration of the shape and size of the pocket containing the active site compared to the wild-type enzyme. The mutant enzyme offers the potential for the more efficient degradation of amyloid beta in vivo as a therapeutic for the treatment of Alzheimer's disease.	[Webster, Carl I.; Burrell, Matthew; Fowler, Susan B.; Digby, Sarah; Sandercock, Alan; Jermutus, Lutz] MedImmune, Antibody Discovery & Prot Engn, Cambridge, England; [Olsson, Lise-Lotte; Snijder, Arjan] AstraZeneca R&D, Discovery Sci, Molndal, Sweden; [Tebbe, Jan; Haupts, Ulrich; Grudzinska, Joanna] Bayer HealthCare, Global Drug Discovery Global Biol, D-52425 Cologne, Germany; [Andersson, Christin] AstraZeneca R&D, CNS& P iMed, Sodertalje, Sweden	AstraZeneca; Medimmune; AstraZeneca; Bayer AG; Bayer Healthcare Pharmaceuticals; AstraZeneca	Webster, CI (corresponding author), MedImmune, Antibody Discovery & Prot Engn, Cambridge, England.	websterc@medimmune.com	Jermutus, Lutz/AAU-2047-2020	Snijder, Arjan/0000-0003-2829-3098	AstraZeneca; MedImmune; Bayer HealthCare AG	AstraZeneca(AstraZeneca); MedImmune(AstraZenecaMedimmune); Bayer HealthCare AG(Bayer AGBayer Healthcare Pharmaceuticals)	All work was funded by AstraZeneca and MedImmune (a wholly owned subsidiary of AstraZeneca). The funders or Bayer HealthCare AG provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Becker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012793; Bricogne G., 2010, BUSTER; DeLano WL, 2002, PYMOL USERS MANUAL; DEVAULT A, 1987, EMBO J, V6, P1317, DOI 10.1002/j.1460-2075.1987.tb02370.x; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Glossop MS, 2011, BIOORG MED CHEM LETT, V21, P3404, DOI 10.1016/j.bmcl.2011.03.109; Hausrath AC, 2002, ACTA CRYSTALLOGR D, V58, P1002, DOI 10.1107/S090744490200584X; Henderson SJ, 2014, BRAIN, V137, P553, DOI 10.1093/brain/awt308; HOLLAND DR, 1992, BIOCHEMISTRY-US, V31, P11310, DOI 10.1021/bi00161a008; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kadonosono T, 2008, PROTEIN ENG DES SEL, V21, P507, DOI 10.1093/protein/gzn026; KENNY AJ, 1993, BIOCHEM J, V291, P83, DOI 10.1042/bj2910083; KENNY AJ, 1986, BIOMED BIOCHIM ACTA, V45, P1503; KERR MA, 1974, BIOCHEM J, V137, P489, DOI 10.1042/bj1370489; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V27, P30; Li WD, 2010, METAB BRAIN DIS, V25, P277, DOI 10.1007/s11011-010-9207-9; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Marr RA, 2003, J NEUROSCI, V23, P1992; MATSAS R, 1984, BIOCHEM J, V223, P433, DOI 10.1042/bj2230433; MATTHEWS BW, 1974, J BIOL CHEM, V249, P8030; McCord LA, 2013, P NATL ACAD SCI USA, V110, P13827, DOI 10.1073/pnas.1304575110; Medeiros MD, 1996, NEUROCHEM RES, V21, P1125, DOI 10.1007/BF02532423; Mouri A, 2006, BEHAV BRAIN RES, V168, P83, DOI 10.1016/j.bbr.2005.10.014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagatomo Y, 1996, BIOCHEM BIOPH RES CO, V223, P539, DOI 10.1006/bbrc.1996.0930; Newell AJ, 2003, NEUROSCI LETT, V350, P178, DOI 10.1016/S0304-3940(03)00902-9; Oefner C, 2000, J MOL BIOL, V296, P341, DOI 10.1006/jmbi.1999.3492; Oefner C, 2007, ACTA CRYSTALLOGR D, V63, P975, DOI 10.1107/S0907444907036281; Pope D, 2014, J CHEM INF MODEL, V54, P1157, DOI 10.1021/ci500015m; POZSGAY M, 1986, BIOCHEMISTRY-US, V25, P1292, DOI 10.1021/bi00354a015; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rice GI, 2004, BIOCHEM J, V383, P45, DOI 10.1042/BJ20040634; Sexton T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032343; SEYMOUR AA, 1990, J CARDIOVASC PHARM, V16, P163, DOI 10.1097/00005344-199007000-00022; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Spencer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016575; Takaki Y, 2000, J BIOCHEM-TOKYO, V128, P897, DOI 10.1093/oxfordjournals.jbchem.a022839; Tiraboschi G, 1999, PROTEIN ENG, V12, P141, DOI 10.1093/protein/12.2.141; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; Walker JR, 2013, J NEUROSCI, V33, P2457, DOI 10.1523/JNEUROSCI.3407-12.2013; WEBB RL, 1989, J CARDIOVASC PHARM, V14, P285, DOI 10.1097/00005344-198908000-00015	48	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104001	10.1371/journal.pone.0104001	http://dx.doi.org/10.1371/journal.pone.0104001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089527	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700077
J	Braniecka, A; Trzebinska, E; Dowgiert, A; Wytykowska, A				Braniecka, Anna; Trzebinska, Ewa; Dowgiert, Aneta; Wytykowska, Agata			Mixed Emotions and Coping: The Benefits of Secondary Emotions	PLOS ONE			English	Article							POSITIVE EMOTIONS; STRESS; EXPERIENCE; LIFE; RESILIENCE; PSYCHOLOGY; NOSTALGIA; PATTERNS; AMBIVALENCE; INFORMATION	The existing empirical literature suggests that during difficult situations, the concurrent experience of positive and negative affects may be ideal for ensuring successful adaptation and well-being. However, different patterns of mixed emotions may have different adaptive consequences. The present research tested the proposition that experiencing a pattern of secondary mixed emotion (i.e., secondary emotion that embrace both positive and negative affects) more greatly promotes adaptive coping than experiencing two other patterns of mixed emotional experiences: simultaneous (i.e., two emotions of opposing affects taking place at the same time) and sequential (i.e., two emotions of opposing affects switching back and forth). Support for this hypothesis was obtained from two experiments (Studies 1 and 2) and a longitudinal survey (Study 3). The results revealed that secondary mixed emotions predominate over sequential and simultaneous mixed emotional experiences in promoting adaptive coping through fostering the motivational and informative functions of emotions; this is done by providing solution-oriented actions rather than avoidance, faster decisions regarding coping strategies (Study 1), easier access to self-knowledge, and better narrative organization (Study 2). Furthermore, individuals characterized as being prone to feeling secondary mixed emotions were more resilient to stress caused by transitions than those who were characterized as being prone to feeling opposing emotions separately (Study 3). Taken together, the preliminary results indicate that the pattern of secondary mixed emotion provides individuals with a higher capacity to handle adversity than the other two patterns of mixed emotional experience.	[Braniecka, Anna; Trzebinska, Ewa; Dowgiert, Aneta; Wytykowska, Agata] Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland	SWPS University of Social Sciences & Humanities	Braniecka, A (corresponding author), Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland.	aniabraniecka@gmail.com	Wytykowska, Agata/AAJ-1707-2021	Wytykowska, Agata/0000-0003-1541-8699; Dowgiert, Aneta/0000-0003-4920-8446; Braniecka, Anna/0000-0003-1862-3284	Ministry of Science and Higher Education of the Republic of Poland [NN-106-04-00-34]	Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland)	This research was supported by a grant from the Ministry of Science and Higher Education of the Republic of Poland (NN-106-04-00-34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaker J, 2008, J CONSUM RES, V35, P268, DOI 10.1086/588570; Adler JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035633; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Baumeister RF, 2009, THEN MIRACLE OCCURS, P137, DOI [10.1093/acprof:oso/9780195377798.003.0007, DOI 10.1093/ACPROF:OSO/9780195377798.003.0007]; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Bonanno GA, 1997, J ABNORM PSYCHOL, V106, P126, DOI 10.1037/0021-843X.106.1.126; Braniecka A, 2012, PSYCHIATR POL, V46, P1007; Brehm JW, 2006, MOTIV EMOTION, V30, P13, DOI 10.1007/s11031-006-9007-z; Burnett S, 2011, LEARN INDIVID DIFFER, V21, P681, DOI 10.1016/j.lindif.2010.05.007; Carrera P, 2007, COGNITION EMOTION, V21, P422, DOI 10.1080/02699930600557904; Carrera P, 2013, MOTIV EMOTION, V37, P335, DOI 10.1007/s11031-012-9302-9; Chojnacka A, 2006, PSYCHOL JAKOSCI ZYCI, V5, P63; Clore G.L., 2012, OXFORD HDB PERSONALI, P315; Coifman K. G., 2007, J HAPPINESS STUD, V8, P371, DOI [10.1007/s10902-006-9014-5, DOI 10.1007/S10902-006-9014-5]; Davydov DM, 2011, J PSYCHOPHYSIOL, V25, P67, DOI 10.1027/0269-8803/a000031; Ersner-Hershfield H, 2009, MOTIV EMOTION, V33, P333, DOI 10.1007/s11031-009-9140-6; Folkman S, 2000, CURR DIR PSYCHOL SCI, V9, P115, DOI 10.1111/1467-8721.00073; Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3; Folkman S, 2008, ANXIETY STRESS COPIN, V21, P3, DOI 10.1080/10615800701740457; Fong CT, 2006, ACAD MANAGE J, V49, P1016, DOI 10.2307/20159814; Fong CT, 2002, MOTIV EMOTION, V26, P105, DOI 10.1023/A:1015198209285; Fredrickson BL, 2005, AM PSYCHOL, V60, P678, DOI 10.1037/0003-066X.60.7.678; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Fredrickson BL, 2003, J PERS SOC PSYCHOL, V84, P365, DOI 10.1037/0022-3514.84.2.365; Frijda N.H., 2008, HDB EMOTIONS, V3 ed, P68; Frijda N. H., 2006, LAWS EMOTION; Gall TL, 2000, J SOC CLIN PSYCHOL, V19, P544, DOI 10.1521/jscp.2000.19.4.544; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Gruszczynska E, 2009, POL PSYCHOL B, V40, P38, DOI [10.2478/s10059-009-0006-2, DOI 10.2478/S10059-009-0006-2]; Gruszczynska E, 2013, ANXIETY STRESS COPIN, V26, P103, DOI 10.1080/10615806.2011.633601; Hall, 2010, HDB ADULT RESILIENCE, P3; Harber KD, 2005, PERS SOC PSYCHOL B, V31, P276, DOI 10.1177/0146167204271323; Hemenover SH, 2003, PSYCHOL HUMAN STRENG, P211, DOI [DOI 10.1037/10566-015, 10.1037/10566-015]; Isen AM., 2009, OXFORD HDB POSITIVE, P503, DOI DOI 10.1093/OXFORDHB/9780195187243.013.0048; Iyer A, 2011, J PERS SOC PSYCHOL, V101, P94, DOI 10.1037/a0022496; Johnson-Laird P.N., 2000, HDB EMOTIONS, P458; Kalawski JP, 2010, MOTIV EMOTION, V34, P158, DOI 10.1007/s11031-010-9164-y; Keltner D, 2003, COGNITION EMOTION, V17, P297, DOI 10.1080/02699930302297; Kernberg O. F., 2004, HDB PERSONALITY DISO, P92; Kircanski K, 2012, PSYCHOL SCI, V23, P1086, DOI 10.1177/0956797612443830; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; Koster EHW, 2005, EMOTION, V5, P446, DOI 10.1037/1528-3542.5.4.446; Labouvie-Vief G, 2007, PSYCHOL AGING, V22, P738, DOI 10.1037/0882-7974.22.4.738; Larsen JT, 2007, PSYCHOL SCI, V18, P186, DOI 10.1111/j.1467-9280.2007.01870.x; Larsen JT, 2011, J PERS SOC PSYCHOL, V100, P1095, DOI 10.1037/a0021846; Larsen R.J., 2004, HDB SELF REGULATION, P40; Lazarus RS, 2003, PSYCHOL INQ, V14, P93, DOI 10.1207/S15327965PLI1402_02; Lench HC, 2011, PSYCHOL BULL, V137, P834, DOI 10.1037/a0024244; Lieberman MD, 2007, PSYCHOL SCI, V18, P421, DOI 10.1111/j.1467-9280.2007.01916.x; Lieberman MD, 2011, EMOTION, V11, P468, DOI 10.1037/a0023503; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; McAdams DP, 2010, SOCIAL PSYCHOL FDN C; McEwen BS, 2003, MENT RETARD DEV D R, V9, P149, DOI 10.1002/mrdd.10074; Morris PH, 2008, COGNITION EMOTION, V22, P3, DOI 10.1080/02699930701273716; Oatley K., 1996, UNDERSTANDING EMOTIO; Oceja L, 2009, EUR J PSYCHOL ASSESS, V25, P58, DOI 10.1027/1015-5759.25.1.58; Ong AD, 2006, J PERS SOC PSYCHOL, V91, P730, DOI 10.1037/0022-3514.91.4.730; Parnowska D, 2013, PSYCHIATR POL, V47, P945, DOI 10.12740/PP/18177; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Routledge C, 2008, J EXP SOC PSYCHOL, V44, P132, DOI 10.1016/j.jesp.2006.11.001; Sedikides C., 2004, HDB EXPT EXISTENTIAL, P200; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Sorrentino R. M., 2000, UNCERTAIN MIND INDIV; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Wagner AW, 2000, J TRAUMA STRESS, V13, P41, DOI 10.1023/A:1007716813407; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wildschut T, 2006, J PERS SOC PSYCHOL, V91, P975, DOI 10.1037/0022-3514.91.5.975; Wildschut T, 2010, J PERS SOC PSYCHOL, V98, P573, DOI 10.1037/a0017597; Wilson E., 2007, HDB EMOTION ELICITAT, P184; Wytykowska A, 2011, PERS INDIV DIFFER, V50, P944, DOI 10.1016/j.paid.2010.09.003	72	25	28	5	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103940	10.1371/journal.pone.0103940	http://dx.doi.org/10.1371/journal.pone.0103940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4JL	25084461	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800107
J	Bai, E; Li, W; Li, SL; Sun, JF; Peng, B; Dai, WW; Jiang, P; Han, SJ				Bai, Edith; Li, Wei; Li, Shanlong; Sun, Jianfei; Peng, Bo; Dai, Weiwei; Jiang, Ping; Han, Shijie			Pulse Increase of Soil N2O Emission in Response to N Addition in a Temperate Forest on Mt Changbai, Northeast China	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; FIELD MEASUREMENT; ACETYLENE INHIBITION; GENERALIZED-MODEL; CONCEPTUAL-MODEL; CORE INCUBATION; FRESH-WATER; GAS FLUXES; DENITRIFICATION; NITRIFICATION	Nitrogen (N) deposition has increased significantly globally since the industrial revolution. Previous studies on the response of gaseous emissions to N deposition have shown controversial results, pointing to the system-specific effect of N addition. Here we conducted an N addition experiment in a temperate natural forest in northeastern China to test how potential changes in N deposition alter soil N2O emission and its sources from nitrification and denitrification. Soil N2O emission was measured using closed chamber method and a separate incubation experiment using acetylene inhibition method was carried out to determine denitrification fluxes and the contribution of nitrification and denitrification to N2O emissions between Jul. and Oct. 2012. An NH4NO3 addition of 50 kg N/ha/yr significantly increased N2O and N-2 emissions, but their "pulse emission'' induced by N addition only lasted for two weeks. Mean nitrification-derived N2O to denitrification-derived N2O ratio was 0.56 in control plots, indicating higher contribution of denitrification to N2O emissions in the study area, and this ratio was not influenced by N addition. The N2O to (N-2+N2O) ratio was 0.41-0.55 in control plots and was reduced by N addition at one sampling time point. Based on this short term experiment, we propose that N2O and denitrification rate might increase with increasing N deposition at least by the same fold in the future, which would deteriorate global warming problems.	[Bai, Edith; Li, Wei; Li, Shanlong; Sun, Jianfei; Peng, Bo; Dai, Weiwei; Jiang, Ping; Han, Shijie] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Li, Wei; Li, Shanlong; Sun, Jianfei; Peng, Bo] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bai, E (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	baie@iae.ac.cn			Major State Basic Research Development Program of China (973 Program) [2014CB954400, 2011CB403202]; National Science Foundation of China [31100326]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major State Basic Research Development Program of China (973 Program) (2014CB954400 and 2011CB403202) and National Science Foundation of China (31100326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves BJR, 2012, SOIL BIOL BIOCHEM, V46, P129, DOI 10.1016/j.soilbio.2011.11.022; Ambus P, 1998, EUR J SOIL SCI, V49, P495, DOI 10.1046/j.1365-2389.1998.4930495.x; Baggs EM, 2010, BIOL FERT SOILS, V46, P793, DOI 10.1007/s00374-010-0484-6; Bai E, 2012, BIOGEOSCIENCES, V9, P3287, DOI 10.5194/bg-9-3287-2012; Bernal S, 2012, P NATL ACAD SCI USA, V109, P3406, DOI 10.1073/pnas.1121448109; Bollmann A, 1998, GLOBAL CHANGE BIOL, V4, P387, DOI 10.1046/j.1365-2486.1998.00161.x; Bouletreau S, 2012, SCI TOTAL ENVIRON, V416, P323, DOI 10.1016/j.scitotenv.2011.11.066; BOWDEN RD, 1991, J GEOPHYS RES-ATMOS, V96, P9321, DOI 10.1029/91JD00151; Burke W, 1986, SOIL STRUCTURE ASSES; Butterbach-Bahl K, 2002, FOREST ECOL MANAG, V167, P123, DOI 10.1016/S0378-1127(01)00725-3; Butterbach-Bahl K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0122; Cho CM, 1997, CAN J SOIL SCI, V77, P253, DOI 10.4141/S96-056; Ciarlo E, 2007, BIOL FERT SOILS, V43, P675, DOI 10.1007/s00374-006-0147-9; Dannenmann M, 2008, SOIL BIOL BIOCHEM, V40, P2317, DOI 10.1016/j.soilbio.2008.05.009; Davidson EA, 2000, BIOSCIENCE, V50, P667, DOI 10.1641/0006-3568(2000)050[0667:TACMOS]2.0.CO;2; DAVIDSON EA, 1993, ECOLOGY, V74, P130, DOI 10.2307/1939508; DEBOER W, 1992, SOIL BIOL BIOCHEM, V24, P229, DOI 10.1016/0038-0717(92)90223-K; Del Grosso SJ, 2012, NEW PHYTOL, V196, P327, DOI 10.1111/j.1469-8137.2012.04334.x; Ehhalt D, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P239; Felber R, 2012, BIOGEOSCIENCES, V9, P4125, DOI 10.5194/bg-9-4125-2012; Fierer N, 2003, MICROB ECOL, V45, P63, DOI 10.1007/s00248-002-1007-2; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Gillam KM, 2008, CAN J SOIL SCI, V88, P133, DOI 10.4141/CJSS06005; Goebel MO, 2005, GEODERMA, V128, P80, DOI 10.1016/j.geoderma.2004.12.016; GOODROAD LL, 1984, J ENVIRON QUAL, V13, P448, DOI 10.2134/jeq1984.00472425001300030024x; Gregorich EG, 2006, SOIL BIOL BIOCHEM, V38, P2614, DOI 10.1016/j.soilbio.2006.03.017; GROFFMAN PM, 1989, SOIL BIOL BIOCHEM, V21, P613, DOI 10.1016/0038-0717(89)90053-9; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Hall SJ, 2003, ECOL MONOGR, V73, P107, DOI 10.1890/0012-9615(2003)073[0107:NSOTRF]2.0.CO;2; HATCH DJ, 1990, PLANT SOIL, V124, P97, DOI 10.1007/BF00010937; Heinen M, 2006, GEODERMA, V133, P444, DOI 10.1016/j.geoderma.2005.06.010; Henault C, 2005, GLOBAL CHANGE BIOL, V11, P115, DOI 10.1111/j.1365-2486.2004.00879.x; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Kachenchart B, 2012, AGR ECOSYST ENVIRON, V158, P15, DOI 10.1016/j.agee.2012.05.008; Kiese R, 2002, SOIL BIOL BIOCHEM, V34, P975, DOI 10.1016/S0038-0717(02)00031-7; KLEMEDTSSON L, 1987, PLANT SOIL, V99, P303, DOI 10.1007/BF02370877; Li KH, 2012, GLOBAL CHANGE BIOL, V18, P2546, DOI 10.1111/j.1365-2486.2012.02704.x; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lovett GM, 2011, ECOSYSTEMS, V14, P615, DOI 10.1007/s10021-011-9432-z; Lu CQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007990; MARTIKAINEN PJ, 1993, SOIL BIOL BIOCHEM, V25, P343, DOI 10.1016/0038-0717(93)90133-V; Mogge B, 1999, SOIL BIOL BIOCHEM, V31, P1245, DOI 10.1016/S0038-0717(99)00039-5; Morse JL, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001923; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Papen H, 1999, J GEOPHYS RES-ATMOS, V104, P18487, DOI 10.1029/1999JD900293; Parton WJ, 2001, J GEOPHYS RES-ATMOS, V106, P17403, DOI 10.1029/2001JD900101; Parton WJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P401, DOI 10.1029/96GB01455; Petersen SO, 2008, SOIL BIOL BIOCHEM, V40, P967, DOI 10.1016/j.soilbio.2007.11.017; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Ruser R, 2006, SOIL BIOL BIOCHEM, V38, P263, DOI 10.1016/j.soilbio.2005.05.005; RYDEN JC, 1987, SOIL BIOL BIOCHEM, V19, P753, DOI 10.1016/0038-0717(87)90059-9; Scheer C, 2008, SOIL BIOL BIOCHEM, V40, P290, DOI 10.1016/j.soilbio.2007.08.007; Schindlbacher A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004590; Schjonning P, 2003, SOIL SCI SOC AM J, V67, P156, DOI 10.2136/sssaj2003.0156; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; SPSS Inc, SPSS WIND VERS 11 5; Stevens RJ, 1998, SOIL BIOL BIOCHEM, V30, P1119, DOI 10.1016/S0038-0717(97)00227-7; Stief P, 2009, P NATL ACAD SCI USA, V106, P4296, DOI 10.1073/pnas.0808228106; Templer PH, 2012, FRONT ECOL ENVIRON, V10, P547, DOI 10.1890/120055; TIEDJE JM, 1989, PLANT SOIL, V115, P261, DOI 10.1007/BF02202594; Wang CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031042; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Weslien P, 2009, EUR J SOIL SCI, V60, P311, DOI 10.1111/j.1365-2389.2009.01123.x; Wolf I, 2002, SOIL BIOL BIOCHEM, V34, P741, DOI 10.1016/S0038-0717(02)00001-9; Wolf I, 2003, SOIL SCI SOC AM J, V67, P1862, DOI 10.2136/sssaj2003.1862; Xu Hui, 2000, Journal of Forestry Research, V11, P177, DOI 10.1007/BF02855520; Yamamoto A, 2014, BIOL FERT SOILS, V50, P53, DOI 10.1007/s00374-013-0830-6; Zhang LH, 2007, ATMOS ENVIRON, V41, P1080, DOI 10.1016/j.atmosenv.2006.09.029; Zhong L, 2014, SOIL BIOL BIOCHEM, V69, P1, DOI 10.1016/j.soilbio.2013.10.028	71	31	34	11	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e102765	10.1371/journal.pone.0102765	http://dx.doi.org/10.1371/journal.pone.0102765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079363	gold, Green Submitted, Green Published			2022-12-27	WOS:000339954800016
J	Bjorklund, E; Blomqvist, A; Hedlin, J; Persson, E; Fowler, CJ				Bjorklund, Emmelie; Blomqvist, Anders; Hedlin, Joel; Persson, Emma; Fowler, Christopher J.			Involvement of Fatty Acid Amide Hydrolase and Fatty Acid Binding Protein 5 in the Uptake of Anandamide by Cell Lines with Different Levels of Fatty Acid Amide Hydrolase Expression: A Pharmacological Study	PLOS ONE			English	Article							ENDOGENOUS CANNABINOID ANANDAMIDE; TRANSPORT; HYDROLYSIS; INACTIVATION; ACCUMULATION; INHIBITION; MEMBRANES; RECEPTOR; NEURONS; FAAH	Background: The endocannabinoid ligand anandamide (AEA) is removed from the extracellular space by a process of cellular uptake followed by metabolism. In many cells, such as the RBL-2H3 cell line, inhibition of FAAH activity reduces the observed uptake, indicating that the enzyme regulates uptake by controlling the intra-: extracellular AEA concentration gradient. However, in other FAAH-expressing cells, no such effect is seen. It is not clear, however, whether these differences are methodological in nature or due to properties of the cells themselves. In consequence, we have reinvestigated the role of FAAH in gating the uptake of AEA. Methodology/Principal Findings: The effects of FAAH inhibition upon AEA uptake were investigated in four cell lines: AT1 rat prostate cancer, RBL-2H3 rat basophilic leukaemia, rat C6 glioma and mouse P19 embryonic carcinoma cells. Semi-quantitative PCR for the cells and for a rat brain lysate confirmed the expression of FAAH. No obvious expression of a transcript with the expected molecular weight of FLAT was seen. FAAH expression differed between cells, but all four could accumulate AEA in a manner inhibitable by the selective FAAH inhibitor URB597. However, there was a difference in the sensitivities seen in the reduction of uptake for a given degree of FAAH inhibition produced by a reversible FAAH inhibitor, with C6 cells being more sensitive than RBL-2H3 cells, despite rather similar expression levels and activities of FAAH. The four cell lines all expressed FABP5, and AEA uptake was reduced in the presence of the FABP5 inhibitor SB-FI-26, suggesting that the different sensitivities to FAAH inhibition for C6 and RBL2H3 cells is not due to differences at the level of FABP-5. Conclusions/Significance: When assayed using the same methodology, different FAAH-expressing cells display different sensitivities of uptake to FAAH inhibition.	[Bjorklund, Emmelie; Blomqvist, Anders; Hedlin, Joel; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Persson, Emma] Umea Univ, Dept Radiat Sci, Umea, Sweden	Umea University; Umea University	Fowler, CJ (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874	Swedish Science Research Council [12158]; Research Funds of the Medical Faculty	Swedish Science Research Council; Research Funds of the Medical Faculty	This work was supported by the Swedish Science Research Council (Grant no. 12158) and the Research Funds of the Medical Faculty. Umea University is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Berger WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050968; Bjorklund E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087542; Boldrup L, 2004, J BIOCHEM BIOPH METH, V60, P171, DOI 10.1016/j.jbbm.2004.04.020; Chicca A, 2012, J BIOL CHEM, V287, P34660, DOI 10.1074/jbc.M112.373241; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; Di Pasquale E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004989; Fegley D, 2004, P NATL ACAD SCI USA, V101, P8756, DOI 10.1073/pnas.0400997101; Fowler CJ, 2013, FEBS J, V280, P1895, DOI 10.1111/febs.12212; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Hillard CJ, 2005, NEUROPHARMACOLOGY, V48, P1072, DOI 10.1016/j.neuropharm.2004.12.012; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Kaczocha M, 2006, J BIOL CHEM, V281, P9066, DOI 10.1074/jbc.M509721200; Kaczocha M, 2012, ACS CHEM NEUROSCI, V3, P364, DOI 10.1021/cn300001w; Kaczocha M, 2010, J BIOL CHEM, V285, P2796, DOI 10.1074/jbc.M109.058461; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Leung K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079355; Ligresti A, 2004, BIOCHEM J, V380, P265, DOI 10.1042/BJ20031812; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; Oddi S, 2008, CELL MOL LIFE SCI, V65, P840, DOI 10.1007/s00018-008-7494-7; Oddi S, 2009, CHEM BIOL, V16, P624, DOI 10.1016/j.chembiol.2009.05.004; Onnis V, 2010, J MED CHEM, V53, P2286, DOI 10.1021/jm901891p; Ortega-Gutierrez S, 2004, BIOCHEMISTRY-US, V43, P8184, DOI 10.1021/bi049395f; R Core Team, 2012, R LANG ENV STAT COMP; Rakhshan F, 2000, J PHARMACOL EXP THER, V292, P960; Sandberg A, 2005, CHEM PHYS LIPIDS, V134, P131, DOI 10.1016/j.chemphyslip.2004.12.010; Thors L, 2007, BRIT J PHARMACOL, V152, P744, DOI 10.1038/sj.bjp.0707401	30	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103479	10.1371/journal.pone.0103479	http://dx.doi.org/10.1371/journal.pone.0103479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078278	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800048
J	Kiesewetter, B; Lukas, J; Kuchar, A; Mayerhoefer, ME; Streubel, B; Lagler, H; Mullauer, L; Wohrer, S; Fischbach, J; Raderer, M				Kiesewetter, Barbara; Lukas, Julius; Kuchar, Andreas; Mayerhoefer, Marius E.; Streubel, Berthold; Lagler, Heimo; Muellauer, Leonhard; Woehrer, Stefan; Fischbach, Julia; Raderer, Markus			Clinical Features, Treatment and Outcome of Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Ocular Adnexa: Single Center Experience of 60 Patients	PLOS ONE			English	Article							B-CELL LYMPHOMA; PHASE-II TRIAL; MARGINAL ZONE; CHLAMYDIA-PSITTACI; ANTIBIOTIC-THERAPY; 1ST-LINE TREATMENT; FOLLOW-UP; CLASSIFICATION; RADIOTHERAPY; DOXYCYCLINE	Background: Orbital marginal zone B-cell lymphoma (OAML) constitutes for the most frequent diagnosis in orbital lymphoma. Relatively little data, however, have been reported in larger cohorts of patients staged in a uniform way and no therapy standard exists to date. Material and Methods: We have retrospectively analyzed 60 patients diagnosed and treated at our institution 1999-2012. Median age at diagnosis was 64 years (IQR 51-75) and follow-up time 43 months (IQR 16-92). All patients had undergone uniform extensive staging and histological diagnosis was made by a reference pathologist according to the WHO classification. Results: The majority of patients presented with stage IE (n = 40/60, 67%), three had IIE/IIIE and the remaining 17 stage IVE. Seven patients with IVE had bilateral orbital disease whereas the others showed involvement of further organs. Treatment data were available in 58 patients. Local treatment with radiotherapy (14/58, 24%) or surgery (3/58, 5%) resulted in response in 82% of patients. A total of 26 patients (45%) received systemic treatment with a response rate of 85%. Nine patients received antibiotics as initial therapy; response rate was 38%. Watchful-waiting was the initial approach in 6/58 patients. In total 28/58 patients (48%) progressed and were given further therapy. Median time-to-progression in this cohort was 20 months (IQR 9-39). There was no difference in time-to-progression after first-line therapy between the different therapy arms (p = 0.14). Elevated beta-2-microglobulin, plasmacytic differentiation, autoimmune disorder and site of lymphoma were not associated with a higher risk for progress. Conclusion: Our data underscore the excellent prognosis of OAML irrespective of initial therapy, as there was no significant difference in time-to-progression and response between local or systemic therapy. In the absence of randomized trials, the least toxic individual approach should be chosen for OAML.	[Kiesewetter, Barbara; Fischbach, Julia; Raderer, Markus] Med Univ Vienna, Dept Med 1, Div Oncol, Vienna, Austria; [Lukas, Julius; Kuchar, Andreas] Med Univ Vienna, Dept Ophthalmol, Vienna, Austria; [Mayerhoefer, Marius E.] Med Univ Vienna, Dept Radiol, Vienna, Austria; [Streubel, Berthold; Muellauer, Leonhard] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Lagler, Heimo] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Woehrer, Stefan] Med Univ Vienna, Dept Med 1, Div Bone Marrow Transplantat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Raderer, M (corresponding author), Med Univ Vienna, Dept Med 1, Div Oncol, Vienna, Austria.	markus.raderer@meduniwien.ac.at	Kiesewetter, Barbara/AGX-3260-2022; Müllauer, Leonhard/GSN-9884-2022; Mayerhoefer, Marius/AAD-2156-2021	Müllauer, Leonhard/0000-0002-3399-078X; Mayerhoefer, Marius/0000-0001-8786-8686; Lagler, Heimo/0000-0003-3240-7385; Kiesewetter, Barbara/0000-0002-5490-2371				Ben Simon GJ, 2006, OPHTHALMOLOGY, V113, P1209, DOI 10.1016/j.ophtha.2006.01.057; Chadunet E, 2006, J PATHOL, V209, P344; Conconi A, 2003, BLOOD, V102, P2741, DOI 10.1182/blood-2002-11-3496; Couland SE, 1998, OPHTHALMOLOGY, V105, P1430; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Esmaeli B, 2009, ANN ONCOL, V20, P709, DOI 10.1093/annonc/mdn692; Ferreri AJM, 2008, ANN ONCOL, V19, P194, DOI 10.1093/annonc/mdm561; Ferreri AJM, 2004, J NATL CANCER I, V96, P586, DOI 10.1093/jnci/djh102; Ferreri AJM, 2006, JNCI-J NATL CANCER I, V98, P1375, DOI 10.1093/jnci/djj373; Ferreri AJM, 2012, J CLIN ONCOL, V30, P2988, DOI 10.1200/JCO.2011.41.4466; Ferry JA, 2007, AM J SURG PATHOL, V31, P170, DOI 10.1097/01.pas.0000213350.49767.46; Govi S, 2010, BRIT J HAEMATOL, V150, P226, DOI 10.1111/j.1365-2141.2010.08179.x; Hasegawa M, 2003, INT J RADIAT ONCOL, V57, P172, DOI 10.1016/S0360-3016(03)00506-6; Hashimoto N, 2012, INT J RADIAT ONCOL, V82, P1509, DOI 10.1016/j.ijrobp.2011.04.052; Hoffmann M, 2011, LEUKEMIA LYMPHOMA, V52, P42, DOI 10.3109/10428194.2010.534519; HUSSELL T, 1993, LANCET, V342, P571, DOI 10.1016/0140-6736(93)91408-E; Isaacson P.G., 2008, WHO CLASSIFICATION T, V4th, P214; Jenkins C, 2000, BRIT J OPHTHALMOL, V84, P907, DOI 10.1136/bjo.84.8.907; Kiesewetter B, 2013, BLOOD, V122, P1350, DOI 10.1182/blood-2013-02-486522; Kiesewetter B, 2013, HAEMATOLOGICA, V98, P353, DOI 10.3324/haematol.2012.065995; Kim TM, 2010, CANCER SCI, V101, P1199, DOI 10.1111/j.1349-7006.2010.01502.x; Lim SH, 2011, INDIAN J OPHTHALMOL, V59, P273, DOI 10.4103/0301-4738.81993; McKelvie PA, 2001, CLIN EXP OPHTHALMOL, V29, P387, DOI 10.1046/j.1442-9071.2001.00450.x; Nakata M, 1999, LEUKEMIA LYMPHOMA, V32, P533, DOI 10.3109/10428199909058411; Nutting CM, 2006, EYE, V20, P645, DOI 10.1038/sj.eye.6702027; Paik JS, 2012, ANN HEMATOL, V91, P1393, DOI 10.1007/s00277-012-1469-3; Raderer M, 2000, BRIT J CANCER, V83, P454, DOI 10.1054/bjoc.2000.1308; Raderer M, 2005, CLIN CANCER RES, V11, P3349, DOI 10.1158/1078-0432.CCR-04-2282; Rummel MJ, 2013, LANCET, V381, P1203, DOI 10.1016/S0140-6736(12)61763-2; Ruskone -Fourmestraux A, 2011, GUT, V60, P747, DOI 10.1136/gut.2010.224949; Smedby KE, 2006, JNCI-J NATL CANCER I, V98, P51, DOI 10.1093/jnci/djj004; Son SH, 2010, INT J RADIAT ONCOL, V77, P86, DOI 10.1016/j.ijrobp.2009.04.018; Song EK, 2008, ANN ONCOL, V19, P242, DOI 10.1093/annonc/mdm457; Stefanovic A, 2009, BLOOD, V114, P501, DOI 10.1182/blood-2008-12-195453; Tanimoto K, 2006, ANN ONCOL, V17, P135, DOI 10.1093/annonc/mdj025; Thieblemont C, 2000, BLOOD, V95, P802, DOI 10.1182/blood.V95.3.802.003k19_802_806; Troch M, 2013, HAEMATOLOGICA, V98, P264, DOI 10.3324/haematol.2012.072587; Tsang RW, 2003, J CLIN ONCOL, V21, P4157, DOI 10.1200/JCO.2003.06.085; Uno T, 2003, CANCER-AM CANCER SOC, V98, P865, DOI 10.1002/cncr.11539; Wohrer S, 2007, LEUKEMIA, V21, P1812, DOI 10.1038/sj.leu.2404782	40	26	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e104004	10.1371/journal.pone.0104004	http://dx.doi.org/10.1371/journal.pone.0104004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077481	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800103
J	Kunkler, PE; Ballard, CJ; Pellman, JJ; Zhang, LJ; Oxford, GS; Hurley, JH				Kunkler, Phillip Edward; Ballard, Carrie Jo; Pellman, Jessica Joan; Zhang, LuJuan; Oxford, Gerry Stephen; Hurley, Joyce Harts			Intraganglionic Signaling as a Novel Nasal-Meningeal Pathway for TRPA1-Dependent Trigeminovascular Activation by Inhaled Environmental Irritants	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; DORSAL-ROOT GANGLIA; PRIMARY AFFERENT NEURONS; EMERGENCY-DEPARTMENT VISITS; RECEPTOR POTENTIAL A1; ION-CHANNEL TRPA1; BLOOD-FLOW; TRIGEMINAL GANGLION; AIR-POLLUTION; NERVE-FIBERS	Headache is the most common symptom associated with air pollution, but little is understood about the underlying mechanism. Nasal administration of environmental irritants activates the trigeminovascular system by a TRPA1-dependent process. This report addresses questions about the anatomical pathway involved and the function of TRP channels in this pathway. TRPV1 and TRPA1 are frequently co-localized and interact to modulate function in sensory neurons. We demonstrate here that resiniferatoxin ablation of TRPV1 expressing neurons significantly reduces meningeal blood flow responses to nasal administration of both TRPV1 and TRPA1 agonists. Accordingly resiniferatoxin also significantly reduces TRPV1 and CGRP immunostaining and TRPV1 and TRPA1 message levels in trigeminal ganglia. Sensory neurons of the trigeminal ganglia innervate the nasal epithelium and the meninges, but the mechanism and anatomical route by which nasal administration evokes meningeal vasodilatation is unclear. Double retrograde labeling from the nose and meninges reveals no co-localization of fluorescent label, however nasal and meningeal labeled cells are located in close proximity to each other within the trigeminal ganglion. Our data demonstrate that TRPV1 expressing neurons are important for TRPA1 responses in the nasal-meningeal pathway. Our data also suggest that the nasal-meningeal pathway is not primarily by axon reflex, but may instead result from intraganglionic transmission.	[Kunkler, Phillip Edward; Ballard, Carrie Jo; Zhang, LuJuan; Hurley, Joyce Harts] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Pellman, Jessica Joan; Oxford, Gerry Stephen] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Hurley, JH (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	johurley@iupui.edu			National Headache Foundation; Showalter Charitable Trust; NIEHS [ES017430]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017430] Funding Source: NIH RePORTER	National Headache Foundation; Showalter Charitable Trust; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Headache Foundation, the Showalter Charitable Trust and NIEHS (ES017430) to JHH and GSO. The funders had no role in the study design data collection or decision to publish this manuscript.	Akerman S, 2013, CEPHALALGIA, V33, P577, DOI 10.1177/0333102412472071; Akopian AN, 2011, CURR PHARM BIOTECHNO, V12, P89; Amir R, 1996, J NEUROSCI, V16, P4733; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; ANTON F, 1991, NEUROSCIENCE, V41, P617, DOI 10.1016/0306-4522(91)90354-Q; Bae YC, 2004, J COMP NEUROL, V478, P62, DOI 10.1002/cne.20272; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Benemei S, 2010, CEPHALALGIA, V30, P744, DOI 10.1111/j.1468-2982.2009.01988.x; Bigal ME, 2013, HEADACHE, V53, P1230, DOI 10.1111/head.12179; CELANDER O, 1953, ACTA PHYSIOL SCAND, V29, P359, DOI 10.1111/j.1748-1716.1953.tb01031.x; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; CULLEN MR, 1987, OCCUP MED, V2, P655; DEVOR M, 1990, J NEUROPHYSIOL, V64, P1733, DOI 10.1152/jn.1990.64.6.1733; FINGER TE, 1993, J COMP NEUROL, V334, P117, DOI 10.1002/cne.903340110; Frederick J, 2007, BIOCHEM BIOPH RES CO, V358, P1058, DOI 10.1016/j.bbrc.2007.05.029; Friedman DI, 2009, HEADACHE, V49, P941, DOI 10.1111/j.1526-4610.2009.01443.x; Gottselig R, 2004, CEPHALALGIA, V24, P206, DOI 10.1111/j.1468-2982.2004.00649.x; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Ho TW, 2008, NEUROLOGY, V70, P1304, DOI 10.1212/01.WNL.0000286940.29755.61; Hou MY, 2002, NEUROSCI LETT, V330, P223, DOI 10.1016/S0304-3940(02)00741-3; Hsieh YL, 2012, EXP NEUROL, V235, P316, DOI 10.1016/j.expneurol.2012.02.013; Huang DY, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-66; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; Hunter DD, 1998, NEUROSCIENCE, V83, P591, DOI 10.1016/S0306-4522(97)00324-2; Iadarola MJ, 2011, CURR TOP MED CHEM, V11, P2171; Jeffry JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007021; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kissin I, 2011, CURR TOP MED CHEM, V11, P2159, DOI 10.2174/156802611796904924; Klafke JZ, 2012, NEUROSCIENCE, V222, P136, DOI 10.1016/j.neuroscience.2012.07.022; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Kunkler PE, 2011, PAIN, V152, P38, DOI 10.1016/j.pain.2010.08.021; KUROSAWA M, 1995, BRIT J PHARMACOL, V114, P1397, DOI 10.1111/j.1476-5381.1995.tb13361.x; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; MAYBERG M, 1981, SCIENCE, V213, P228, DOI 10.1126/science.6166046; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; MESSLINGER K, 1995, CAN J PHYSIOL PHARM, V73, P1020; Mishra SK, 2010, MOL CELL NEUROSCI, V43, P157, DOI 10.1016/j.mcn.2009.10.006; Nassini R, 2012, BRAIN, V135, P376, DOI 10.1093/brain/awr272; Nattero G, 1996, HEADACHE, V36, P243, DOI 10.1046/j.1526-4610.1996.3604243.x; OCONNOR TP, 1986, J NEUROSCI, V6, P2200; Olah Z, 2001, J BIOL CHEM, V276, P11021, DOI 10.1074/jbc.M008392200; Oxford GS., 2013, OPEN PAIN J, V6, P37, DOI DOI 10.2174/1876386301306010037; Pan HL, 2003, J NEUROSCI, V23, P2911; Pecze L, 2009, CAN J NEUROL SCI, V36, P234, DOI 10.1017/S0317167100006600; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; Plevkova J, 2013, J APPL PHYSIOL, V115, P268, DOI 10.1152/japplphysiol.01144.2012; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Rozanski GM, 2012, EUR J NEUROSCI, V36, P3314, DOI 10.1111/j.1460-9568.2012.08233.x; Schwenger N, 2007, CEPHALALGIA, V27, P481, DOI 10.1111/j.1468-2982.2007.01321.x; Shimizu T, 2007, BRAIN RES, V1173, P84, DOI 10.1016/j.brainres.2007.07.068; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; SUZUKI N, 1989, NEUROSCIENCE, V30, P595, DOI 10.1016/0306-4522(89)90154-1; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; SZALLASI A, 1992, NEUROSCI LETT, V140, P51, DOI 10.1016/0304-3940(92)90679-2; SZALLASI A, 1989, BRAIN RES, V503, P68, DOI 10.1016/0006-8993(89)91705-8; SZOLCSANYI J, 1991, ANN NY ACAD SCI, V632, P473, DOI 10.1111/j.1749-6632.1991.tb33161.x; Szyszkowicz M, 2008, HEADACHE, V48, P1076, DOI 10.1111/j.1526-4610.2007.01039.x; Szyszkowicz M, 2008, HEADACHE, V48, P417, DOI 10.1111/j.1526-4610.2007.00808.x; Szyszkowicz M, 2009, AM J EMERG MED, V27, P391, DOI 10.1016/j.ajem.2008.03.013; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Taylor-Clark TE, 2009, AM J RESP CELL MOL, V40, P756, DOI 10.1165/rcmb.2008-0292OC; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Ulrich-Lai YM, 2001, PAIN, V91, P219, DOI 10.1016/S0304-3959(00)00439-5; Vandewauw I, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-21; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhong J, 2011, PFLUG ARCH EUR J PHY, V462, P861, DOI 10.1007/s00424-011-1043-1; Zhu WG, 2007, J NEUROSCI, V27, P13770, DOI 10.1523/JNEUROSCI.3822-07.2007; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	75	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103086	10.1371/journal.pone.0103086	http://dx.doi.org/10.1371/journal.pone.0103086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077949	gold, Green Submitted, Green Published			2022-12-27	WOS:000339954800026
J	Tax, CMW; Duits, R; Vilanova, A; Romeny, BMT; Hofman, P; Wagner, L; Leemans, A; Ossenblok, P				Tax, Chantal M. W.; Duits, Remco; Vilanova, Anna; Romeny, Bart M. ter Haar; Hofman, Paul; Wagner, Louis; Leemans, Alexander; Ossenblok, Pauly			Evaluating Contextual Processing in Diffusion MRI: Application to Optic Radiation Reconstruction for Epilepsy Surgery	PLOS ONE			English	Article							VISUAL-FIELD DEFECTS; TEMPORAL-LOBE EPILEPSY; TENSOR FIBER TRACTOGRAPHY; ARTERIOVENOUS-MALFORMATIONS; RESECTION; DECONVOLUTION; ARCHITECTURE; ENHANCEMENT; COMPLETION; LOBECTOMY	Diffusion MRI and tractography allow for investigation of the architectural configuration of white matter in vivo, offering new avenues for applications like presurgical planning. Despite the promising outlook, there are many pitfalls that complicate its use for (clinical) application. Amongst these are inaccuracies in the geometry of the diffusion profiles on which tractography is based, and poor alignment with neighboring profiles. Recently developed contextual processing techniques, including enhancement and well-posed geometric sharpening, have shown to result in sharper and better aligned diffusion profiles. However, the research that has been conducted up to now is mainly of theoretical nature, and so far these techniques have only been evaluated by visual inspection of the diffusion profiles. In this work, the method is evaluated in a clinically relevant application: the reconstruction of the optic radiation for epilepsy surgery. For this evaluation we have developed a framework in which we incorporate a novel scoring procedure for individual pathways. We demonstrate that, using enhancement and sharpening, the extraction of an anatomically plausible reconstruction of the optic radiation from a large amount of probabilistic pathways is greatly improved in three healthy controls, where currently used methods fail to do so. Furthermore, challenging reconstructions of the optic radiation in three epilepsy surgery candidates with extensive brain lesions demonstrate that it is beneficial to integrate these methods in surgical planning.	[Tax, Chantal M. W.; Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Tax, Chantal M. W.; Duits, Remco; Vilanova, Anna; Romeny, Bart M. ter Haar; Ossenblok, Pauly] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Duits, Remco] Eindhoven Univ Technol, Dept Math & Comp Sci, NL-5600 MB Eindhoven, Netherlands; [Vilanova, Anna] Delft Univ Technol, Dept Elect Engn, Delft, Netherlands; [Hofman, Paul; Wagner, Louis; Ossenblok, Pauly] Epilepsy Ctr Kempenhaeghe, Dept Funct & Med Technol, Heeze, Netherlands	Utrecht University; Utrecht University Medical Center; Eindhoven University of Technology; Eindhoven University of Technology; Delft University of Technology	Tax, CMW (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	chantal@isi.uu.nl	Leemans, Alexander/A-1784-2011; Romenij, Bart M. ter Haar/A-5323-2013	Leemans, Alexander/0000-0002-9306-6126; 	Physical Sciences division of the Netherlands Organisation for Scientific Research (NWO) [612.001.104]; European Research Council under European Community [335555]	Physical Sciences division of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council under European Community(European Research Council (ERC))	Chantal Tax is supported by a grant (No. 612.001.104) from the Physical Sciences division of the Netherlands Organisation for Scientific Research (NWO). The research leading to the results of this article has received funding from the European Research Council under the European Community's 7th Framework Programme (FP7/2007-2014)/ERC grant agreement No. 335555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.A., 2006, CALCULUS COMPLETE CO; Barbieri D, 2012, J PHYSIOL-PARIS, V106, P183, DOI 10.1016/j.jphysparis.2012.03.001; Barmpoutis A, 2008, LECT NOTES COMPUT SC, V5241, P9, DOI 10.1007/978-3-540-85988-8_2; Bartels RH, 1987, INTRO SPLINES USE CO; Ben-Yosef G, 2012, NEURAL COMPUT, V24, P3277, DOI 10.1162/NECO_a_00365; Boscain U, 2010, P STEKLOV I MATH+, V270, P43, DOI 10.1134/S0081543810030041; Cauley KA, 2010, J NEUROSURG, V112, P814, DOI 10.3171/2009.8.JNS09586; Chen X, 2009, NEUROIMAGE, V45, P286, DOI 10.1016/j.neuroimage.2008.11.038; Chirikjian G., 2011, STOCHASTIC MODELS IN; Chirikjian GS, 2010, ENG APPL NONCOMMUTAT; Citti G, 2006, J MATH IMAGING VIS, V24, P307, DOI 10.1007/s10851-005-3630-2; Creusen E, 2013, NUMER MATH-THEORY ME, V6, P138, DOI 10.4208/nmtma.2013.mssvm08; Dela Haije TCJ, 2014, VISUALIZATI IN PRESS; Dell'Acqua F, 2007, IEEE T BIO-MED ENG, V54, P462, DOI 10.1109/TBME.2006.888830; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Duits R., 2014, LECT NOTES MORPHOGEN, P173; Duits R, 2013, J MATH IMAGING VIS, V46, P326, DOI 10.1007/s10851-012-0387-2; Duits R, 2011, INT J COMPUT VISION, V92, P231, DOI 10.1007/s11263-010-0332-z; EBELING U, 1988, ACTA NEUROCHIR, V92, P29, DOI 10.1007/BF01401969; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; FALCONER MA, 1963, J NEUROL NEUROSUR PS, V26, P154, DOI 10.1136/jnnp.26.2.154; Felsberg M, 2012, COMPUTATIONAL IMAGIN, V41, P31, DOI DOI 10.1007/978-1-4471-2353-8_; Florack Luc, 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4562967; Franken E, 2008, THESIS U TECHNOLOGY; Friston KJ., 1994, FUNCTIONAL NEUROIMAG, P79; Froeling M, 2012, J MAGN RESON IMAGING, V36, P237, DOI 10.1002/jmri.23608; Horton J, 2005, ARCH OPHTHALMOL-CHIC, V109, P1; Hughes TS, 1999, NEUROLOGY, V53, P167, DOI 10.1212/WNL.53.1.167; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2008, IEEE T MED IMAGING, V27, P1268, DOI 10.1109/TMI.2008.922191; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kikuta K, 2006, NEUROSURGERY, V58, P331, DOI 10.1227/01.NEU.0000195017.82776.90; Kim DS, 2005, ANN NY ACAD SCI, V1064, P1, DOI 10.1196/annals.1340.005; Koga T, 2012, INT J RADIAT ONCOL, V82, P799, DOI 10.1016/j.ijrobp.2010.11.046; Krolak-Salmon P, 2000, BRIT J OPHTHALMOL, V84, P884, DOI 10.1136/bjo.84.8.884; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Mashtakov AP, 2013, NUMER MATH-THEORY ME, V6, P95, DOI 10.4208/nmtma.2013.mssvm05; Medioni G., 2000, COMPUTATIONAL FRAMEW; MomayyezSiahkal P, 2013, IEEE T PATTERN ANAL, V35, P983, DOI 10.1109/TPAMI.2012.184; Nilsson D, 2004, ACTA NEUROL SCAND, V110, P301, DOI 10.1111/j.1600-0404.2004.00331.x; Nilsson DT, 2010, EPILEPSIA, V51, P91; Nilsson D, 2007, EPILEPSY RES, V77, P11, DOI 10.1016/j.eplepsyres.2007.07.012; Okada T, 2007, AM J NEURORADIOL, V28, P1107, DOI 10.3174/ajnr.A0493; OSSENBLOK P, 1994, DOC OPHTHALMOL, V88, P77, DOI 10.1007/BF01203704; Pathak-Ray V, 2002, EYE, V16, P744, DOI 10.1038/sj.eye.6700152; Powell HWR, 2005, NEUROLOGY, V65, P596, DOI 10.1212/01.wnl.0000172858.20354.73; Prckovska V, 2010, CDMRI 10 MICCAI 2010, V1, P26; Reisert M, 2012, LEFT INVARIANT DIFFU; Rodrigues P, 2010, EUR WORKSH VIS COMP, P49; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Sachkov Y, 2011, ESAIM CONTORLE OPTIM, V16, P1018; Sachkov YL, 2011, ESAIM CONTR OPTIM CA, V17, P293, DOI 10.1051/cocv/2010005; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; Staempfli P, 2008, NEUROIMAGE, V39, P119, DOI 10.1016/j.neuroimage.2007.08.025; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Tabelow K, 2011, 17 ANN M ORG HUM BRA, P616; Taoka T, 2008, AM J NEURORADIOL, V29, P1329, DOI 10.3174/ajnr.A1101; Tax C, 2012, PROCEEDING OF THE IEEE INTERNATIONAL CONFERENCE ON INFORMATION AND AUTOMATION, P441, DOI 10.1109/ICInfA.2012.6246846; Tax CMW, 2014, NEUROIMAGE, V86, P67, DOI 10.1016/j.neuroimage.2013.07.067; Tax CMW, 2012, THESIS EINDHOVEN U T; Thudium MO, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f7424b; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Uijl SG, 2008, EPILEPSIA, V49, P1317, DOI 10.1111/j.1528-1167.2008.01695.x; van Baarsen KM, 2009, CURR OPIN OPHTHALMOL, V20, P490, DOI 10.1097/ICU.0b013e3283313c02; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Winston GP, 2012, ANN NEUROL, V71, P334, DOI 10.1002/ana.22619; Yamamoto A, 2007, AM J NEURORADIOL, V28, P92; Yamamoto T, 2005, AM J OPHTHALMOL, V140, P781, DOI 10.1016/j.ajo.2005.05.018; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114	71	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101524	10.1371/journal.pone.0101524	http://dx.doi.org/10.1371/journal.pone.0101524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077946	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800006
J	Lorenz, A; Dhingra, R; Chang, HH; Bisanzio, D; Liu, Y; Remais, JV				Lorenz, Alyson; Dhingra, Radhika; Chang, Howard H.; Bisanzio, Donal; Liu, Yang; Remais, Justin V.			Inter-Model Comparison of the Landscape Determinants of Vector-Borne Disease: Implications for Epidemiological and Entomological Risk Modeling	PLOS ONE			English	Article							HEALTH IMPACT ASSESSMENT; EASTERN UNITED-STATES; IXODES-SCAPULARIS; CLIMATE-CHANGE; LYME-DISEASE; INFECTIOUS-DISEASES; EXTRAPOLATION; POLICY; ACARI	Extrapolating landscape regression models for use in assessing vector-borne disease risk and other applications requires thoughtful evaluation of fundamental model choice issues. To examine implications of such choices, an analysis was conducted to explore the extent to which disparate landscape models agree in their epidemiological and entomological risk predictions when extrapolated to new regions. Agreement between six literature-drawn landscape models was examined by comparing predicted county-level distributions of either Lyme disease or Ixodes scapularis vector using Spearman ranked correlation. AUC analyses and multinomial logistic regression were used to assess the ability of these extrapolated landscape models to predict observed national data. Three models based on measures of vegetation, habitat patch characteristics, and herbaceous landcover emerged as effective predictors of observed disease and vector distribution. An ensemble model containing these three models improved precision and predictive ability over individual models. A priori assessment of qualitative model characteristics effectively identified models that subsequently emerged as better predictors in quantitative analysis. Both a methodology for quantitative model comparison and a checklist for qualitative assessment of candidate models for extrapolation are provided; both tools aim to improve collaboration between those producing models and those interested in applying them to new areas and research questions.	[Lorenz, Alyson; Dhingra, Radhika; Liu, Yang; Remais, Justin V.] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Chang, Howard H.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Bisanzio, Donal] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA; [Remais, Justin V.] Emory Univ, Grad Div Biol & Biomed Sci, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University; Emory University	Remais, JV (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	justin.remais@emory.edu	Liu, Yang/AAA-7224-2019; Remais, Justin/V-3207-2019	Liu, Yang/0000-0001-5477-2186; Remais, Justin/0000-0002-0223-4615; Bisanzio, Donal/0000-0002-7832-2291	CDC Climate and Health Program [5 U01 EH000405]; Ecology of Infectious Disease program of the National Science Foundation [0622743]; National Institute for Allergy and Infectious Disease [K01AI091864]; Global Health Institute at Emory University; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U01EH000405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI091864] Funding Source: NIH RePORTER	CDC Climate and Health Program; Ecology of Infectious Disease program of the National Science Foundation; National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Global Health Institute at Emory University; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the CDC Climate and Health Program (award # 5 U01 EH000405), the Ecology of Infectious Disease program of the National Science Foundation under Grant No. 0622743, the National Institute for Allergy and Infectious Disease (K01AI091864) and the Global Health Institute at Emory University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ENV MONITORING ASSES; Bernard SM, 2001, ENVIRON HEALTH PERSP, V109, P199, DOI 10.2307/3435010; BRAY J, 1995, ECON J, V105, P989, DOI 10.2307/2235165; Brownstein JS, 2005, OECOLOGIA, V146, P469, DOI 10.1007/s00442-005-0251-9; Carroll M, 2004, 250 M MODIS NORMALIZ; CDC, 1999, REP TUB US 1998, P1; Dannenberg AL, 2008, AM J PREV MED, V34, P241, DOI 10.1016/j.amepre.2007.11.015; Dennis DT, 1998, J MED ENTOMOL, V35, P629, DOI 10.1093/jmedent/35.5.629; Dhingra R, 2013, ISPRS INT J GEO-INF, V2, P645, DOI 10.3390/ijgi2030645; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; Eisen L, 2007, EMERG INFECT DIS, V13, P1816, DOI 10.3201/eid1312.070211; EPA, 2011, RISK ASS BAS INF; Forbes VE, 2002, BIOSCIENCE, V52, P249, DOI 10.1641/0006-3568(2002)052[0249:EIERAB]2.0.CO;2; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Gagnon AS, 2005, CLIMATIC CHANGE, V69, P269, DOI 10.1007/s10584-005-1815-8; GLASS GE, 1995, AM J PUBLIC HEALTH, V85, P944, DOI 10.2105/AJPH.85.7.944; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; Hollander A, 2008, J ENVIRON MONITOR, V10, P1139, DOI 10.1039/b803760d; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Killilea ME, 2008, ECOHEALTH, V5, P167, DOI 10.1007/s10393-008-0171-3; Kitron U, 1997, AM J EPIDEMIOL, V145, P558, DOI 10.1093/oxfordjournals.aje.a009145; Kuo T, 2009, AM J PUBLIC HEALTH, V99, P1680, DOI 10.2105/AJPH.2008.153023; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; MITCHELL B, 2007, FRAGSTATSBATCH ARCGI; Munns WR, 2002, HUM ECOL RISK ASSESS, V8, P19, DOI 10.1080/20028091056692; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2; Periwal V, 2008, AM J PHYSIOL-REG I, V295, pR1089, DOI 10.1152/ajpregu.90426.2008; Randolph SE, 2009, ECOLOGY, V90, P927, DOI 10.1890/08-0506.1; Rodder D, 2010, NATURWISSENSCHAFTEN, V97, P781, DOI 10.1007/s00114-010-0694-7; Smith KF, 2005, FRONT ECOL ENVIRON, V3, P29, DOI 10.1890/1540-9295(2005)003[0029:ETTEID]2.0.CO;2; Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31, DOI [10.1002/etc.5620150105, 10.1897/1551-5028(1996)015&lt;0031:ERAOAI&gt;2.3.CO;2]; Stromdahl EY, 2012, ZOONOSES PUBLIC HLTH, V59, P48, DOI 10.1111/j.1863-2378.2012.01475.x; U.S. CITIZENSHIP & IMMIGRATION SERVS, 2008, SURV LYM DIS US 1992, P1; United States Department of Agriculture Natural Resource Conservation Service, 2011, SOIL DAT MART; USCB, 2000, AM FACT FIND; USGS, 2001, NLCD 2001 LAND COV V; USGS, 2003, HYDROGP020 US NAT AT; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188	42	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103163	10.1371/journal.pone.0103163	http://dx.doi.org/10.1371/journal.pone.0103163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072884	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600026
J	Luo, J; Walsh, E; Naik, A; Zhuang, WY; Zhang, KQ; Cai, L; Zhang, N				Luo, Jing; Walsh, Emily; Naik, Abhishek; Zhuang, Wenying; Zhang, Keqin; Cai, Lei; Zhang, Ning			Temperate Pine Barrens and Tropical Rain Forests Are Both Rich in Undescribed Fungi	PLOS ONE			English	Article							PHIALOCEPHALA-FORTINII; ENDOPHYTIC MYCOBIOTA; RUST FUNGI; ROOTS; DIVERSITY; MAGNAPORTHACEAE; BIODIVERSITY; MAGNITUDE; COMMUNITIES; EVOLUTION	Most of fungal biodiversity on Earth remains unknown especially in the unexplored habitats. In this study, we compared fungi associated with grass (Poaceae) roots from two ecosystems: the temperate pine barrens in New Jersey, USA and tropical rain forests in Yunnan, China, using the same sampling, isolation and species identification methods. A total of 426 fungal isolates were obtained from 1600 root segments from 80 grass samples. Based on the internal transcribed spacer (ITS) sequences and morphological characteristics, a total of 85 fungal species (OTUs) belonging in 45 genera, 23 families, 16 orders, and 6 classes were identified, among which the pine barrens had 38 and Yunnan had 56 species, with only 9 species in common. The finding that grass roots in the tropical forests harbor higher fungal species diversity supports that tropical forests are fungal biodiversity hotspots. Sordariomycetes was dominant in both places but more Leotiomycetes were found in the pine barrens than Yunnan, which may play a role in the acidic and oligotrophic pine barrens ecosystem. Equal number of undescribed fungal species were discovered from the two sampled ecosystems, although the tropical Yunnan had more known fungal species. Pine barrens is a unique, unexplored ecosystem. Our finding suggests that sampling plants in such unexplored habitats will uncover novel fungi and that grass roots in pine barrens are one of the major reservoirs of novel fungi with about 47% being undescribed species.	[Luo, Jing; Walsh, Emily; Naik, Abhishek; Zhang, Ning] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [Zhuang, Wenying; Cai, Lei] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Zhang, Keqin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Zhang, Keqin] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China; [Zhang, Ning] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Chinese Academy of Sciences; Institute of Microbiology, CAS; Yunnan University; Yunnan University; Rutgers State University New Brunswick	Zhang, N (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	zhang@aesop.rutgers.edu	zhang, ke/AAH-8217-2019; Zhang, Ning/K-3046-2012; Cai, Lei/W-4996-2017; CAI, LEI/K-7226-2014	Zhang, Ning/0000-0002-2680-1354; Cai, Lei/0000-0002-8131-7274; CAI, LEI/0000-0002-8131-7274	National Science Foundation [DEB 1145174]	National Science Foundation(National Science Foundation (NSF))	The research was supported by the National Science Foundation (DEB 1145174, http://www.nsf.gov/) to NZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos C. J., 1996; [Anonymous], 2013, PLANT ROOTS HIDD; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Berndt R, 2012, BIODIVERS CONSERV, V21, P2299, DOI 10.1007/s10531-011-0220-z; Blackwell M, 2000, SCIENCE, V289, P1884, DOI 10.1126/science.289.5486.1884; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Eaton CJ, 2011, PLANT SCI, V180, P190, DOI 10.1016/j.plantsci.2010.10.002; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Forman RTT, 1998, PINE BARRENS ECOSYST; Gazis R, 2010, FUNGAL ECOL, V3, P240, DOI 10.1016/j.funeco.2009.12.001; Gensel PG., 2001, PLANTS INVADE LAND E, P83, DOI DOI 10.7312/GENS11160-006; Ghimire SR, 2011, FUNGAL DIVERS, V47, P19, DOI 10.1007/s13225-010-0085-6; Grunig CR, 2008, BOTANY, V86, P1355, DOI 10.1139/B08-108; Grunig CR, 2004, FUNGAL GENET BIOL, V41, P676, DOI 10.1016/j.fgb.2004.03.004; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hibbett DS, 2013, NAT REV MICROBIOL, V11, P129, DOI 10.1038/nrmicro2963; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Joffe JS, 1933, SOIL SCI, V35, P313, DOI 10.1097/00010694-193304000-00007; Khidir HH, 2010, J ARID ENVIRON, V74, P35, DOI 10.1016/j.jaridenv.2009.07.014; Knapp DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032570; Li XiaoShuang, 2012, Guangxi Zhiwu / Guihaia, V32, P475; Lopez-Pujol J, 2006, BIODIVERS CONSERV, V15, P3983, DOI 10.1007/s10531-005-3015-2; Luo J, 2014, MYCOLOGIA, V106, P580, DOI 10.3852/13-306; Luo J, 2013, MYCOLOGIA, V105, P1019, DOI 10.3852/12-359; Macia-Vicente JG, 2008, FEMS MICROBIOL ECOL, V64, P90, DOI 10.1111/j.1574-6941.2007.00443.x; Mandyam K, 2005, STUD MYCOL, P173; Marquez SS, 2007, FUNGAL DIVERS, V27, P171; Mora C., 2011, PLOS BIOL, V9, DOI 10.1111/j.1600-0587.2013.00291.x.; Mouhamadou B, 2011, FUNGAL DIVERS, V47, P55, DOI 10.1007/s13225-011-0091-3; NYLANDER J.A.A., 2004, MRMODELTEST 2 2 PROG; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Porras-Alfaro A, 2008, APPL ENVIRON MICROB, V74, P2805, DOI 10.1128/AEM.02769-07; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Roberts CA, 2005, NEOTYPHODIUM IN COOL-SEASON GRASSES, pXVII; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Marquez SS, 2010, FUNGAL DIVERS, V41, P115, DOI 10.1007/s13225-009-0015-7; Marquez SS, 2008, FUNGAL DIVERS, V33, P87; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Scholler Markus, 2006, Mycoscience, V47, P159, DOI 10.1007/s10267-006-0286-8; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TEDROW J. C. F., 1952, BARTONIA, V26, P28; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tuininga AR, 2004, CAN J FOREST RES, V34, P1755, DOI [10.1139/x04-037, 10.1139/X04-037]; TURNER RS, 1985, J ENVIRON QUAL, V14, P314, DOI 10.2134/jeq1985.00472425001400030003x; Walsh E, 2014, MYCOLOGIA IN PRESS; Wang Juan, 2006, Scientia Silvae Sinicae, V42, P7; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; Yuan ZL, 2010, FEMS MICROBIOL LETT, V307, P94, DOI 10.1111/j.1574-6968.2010.01963.x; Zhang N, 2011, MYCOLOGIA, V103, P1267, DOI 10.3852/11-022; Zhu H, 2004, BIODIVERS CONSERV, V13, P1355, DOI 10.1023/B:BIOC.0000019397.98407.c3	54	7	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103753	10.1371/journal.pone.0103753	http://dx.doi.org/10.1371/journal.pone.0103753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072783	gold, Green Published, Green Submitted			2022-12-27	WOS:000341307600084
J	Sheng, BB; Zheng, ZJ; Lv, M; Zhang, HW; Qin, T; Gao, C; Ma, CQ; Xu, P				Sheng, Binbin; Zheng, Zhaojuan; Lv, Min; Zhang, Haiwei; Qin, Tong; Gao, Chao; Ma, Cuiqing; Xu, Ping			Efficient Production of (R)-2-Hydroxy-4-Phenylbutyric Acid by Using a Coupled Reconstructed D-Lactate Dehydrogenase and Formate Dehydrogenase System	PLOS ONE			English	Article							ENZYME ACE INHIBITORS; ETHYL 2-OXO-4-PHENYLBUTYRATE; ENANTIOSELECTIVE REDUCTION; ASYMMETRIC REDUCTION; KINETIC RESOLUTION; CARBOXYLIC-ACIDS; INTERMEDIATE; COLI	Background: (R)-2-Hydroxy-4-phenylbutyric acid [(R)-HPBA] is a key precursor for the production of angiotensin-converting enzyme inhibitors. However, the product yield and concentration of reported (R)-HPBA synthetic processes remain unsatisfactory. Methodology/Principal Findings: The Y52L/F299Y mutant of NAD-dependent D-lactate dehydrogenase (D-nLDH) in Lactobacillus bulgaricus ATCC 11842 was found to have high bio-reduction activity toward 2-oxo-4-phenylbutyric acid (OPBA). The mutant D-nLDH Y52L/F299Y was then coexpressed with formate dehydrogenase in Escherichia coli BL21 (DE3) to construct a novel biocatalyst E. coli DF. Thus, a novel bio-reduction process utilizing whole cells of E. coli DF as the biocatalyst and formate as the co-substrate for cofactor regeneration was developed for the production of (R)-HPBA from OPBA. The biocatalysis conditions were then optimized. Conclusions/Significance: Under the optimum conditions, 73.4 mM OPBA was reduced to 71.8 mM (R)-HPBA in 90 min. Given its high product enantiomeric excess (>99%) and productivity (47.9 mM h(-1)), the constructed coupling biocatalysis system is a promising alternative for (R)-HPBA production.	[Sheng, Binbin; Lv, Min; Zhang, Haiwei; Qin, Tong; Gao, Chao; Ma, Cuiqing; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zheng, Zhaojuan] Nanjing Forestry Univ, Coll Chem Engn, Nanjing, Jiangsu, Peoples R China	Shandong University; Nanjing Forestry University	Gao, C (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	jieerbu@sdu.edu.cn		Gao, Chao/0000-0002-5205-0670; Xu, Ping/0000-0002-4418-9680; Ma, Cuiqing/0000-0002-7468-1027	National Natural Science Foundation of China [31270856, 31170052, 31270090, J1103515]; Independent Innovation Foundation of Shandong University [2012GN017]; Excellent Middle-Aged and Youth Scientist Award Foundation of Shandong Province [BS2013SW025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University; Excellent Middle-Aged and Youth Scientist Award Foundation of Shandong Province	This work was supported by the National Natural Science Foundation of China (31270856, 31170052, 31270090 and J1103515), the Independent Innovation Foundation of Shandong University (2012GN017) and the Excellent Middle-Aged and Youth Scientist Award Foundation of Shandong Province (BS2013SW025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YL, 2005, BIOTECHNOL BIOENG, V92, P137, DOI 10.1002/bit.20582; Bai YL, 2007, ENZYME MICROB TECH, V40, P940, DOI 10.1016/j.enzmictec.2006.07.035; de Lacerda PSB, 2006, TETRAHEDRON-ASYMMETR, V17, P1186, DOI 10.1016/j.tetasy.2006.04.008; Chen B, 2010, CHEM COMMUN, V46, P2754, DOI 10.1039/b925402a; Chen Y, 2008, ADV SYNTH CATAL, V350, P426, DOI 10.1002/adsc.200700420; de Lacerda PSB, 2006, BIOCHEM ENG J, V28, P299, DOI 10.1016/j.bej.2006.01.003; Frohlich P, 2011, ORG BIOMOL CHEM, V9, P7941, DOI 10.1039/c1ob06064c; Gao C, 2013, BIORESOURCE TECHNOL, V137, P111, DOI 10.1016/j.biortech.2013.02.115; He CM, 2008, TETRAHEDRON-ASYMMETR, V19, P1347, DOI 10.1016/j.tetasy.2008.05.003; Huang Y, 2010, CURR ORG CHEM, V14, P1447, DOI 10.2174/138527210791616795; IWASAKI G, 1989, CHEM PHARM BULL, V37, P280; KALARITIS P, 1990, J ORG CHEM, V55, P812, DOI 10.1021/jo00290a007; Larissegger-Schnell B, 2006, TETRAHEDRON, V62, P2912, DOI 10.1016/j.tet.2006.01.007; Lin WQ, 2001, TETRAHEDRON-ASYMMETR, V12, P1583, DOI 10.1016/S0957-4166(01)00285-3; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Nakamura K, 2003, TETRAHEDRON-ASYMMETR, V14, P2659, DOI 10.1016/S0957-4166(03)00526-3; Ni Y, 2013, J BIOTECHNOL, V168, P493, DOI 10.1016/j.jbiotec.2013.09.021; SCHMIDT E, 1992, J BIOTECHNOL, V24, P315, DOI 10.1016/0168-1656(92)90040-G; SCHUTTE H, 1976, EUR J BIOCHEM, V62, P151, DOI 10.1111/j.1432-1033.1976.tb10108.x; Shen ND, 2012, ORG LETT, V14, P1982, DOI 10.1021/ol300397d; Shi YG, 2009, BIOCATAL BIOTRANSFOR, V27, P211, DOI 10.1080/10242420902808333; Shi YG, 2009, J CHEM TECHNOL BIOT, V84, P681, DOI 10.1002/jctb.2099; Singhvi M, 2013, BIORESOURCE TECHNOL, V146, P736, DOI 10.1016/j.biortech.2013.07.057; Su YN, 2012, CHINESE J CATAL, V33, P1650, DOI 10.1016/S1872-2067(11)60436-1; Wang Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02643; Yu SH, 2014, BIOTECHNOL LETT, V36, P627, DOI 10.1007/s10529-013-1404-2; Yun H, 2005, BIOTECHNOL PROGR, V21, P366, DOI 10.1021/bp049694w; Zhang W, 2009, PROCESS BIOCHEM, V44, P1270, DOI 10.1016/j.procbio.2009.07.011; Zheng ZJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03401; Zheng ZJ, 2012, APPL ENVIRON MICROB, V78, P3480, DOI 10.1128/AEM.00058-12; Zheng ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019030	31	12	13	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104204	10.1371/journal.pone.0104204	http://dx.doi.org/10.1371/journal.pone.0104204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089519	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700110
J	Hu, Y; Yin, KL; Ma, X; Xia, HF				Hu, Yi; Yin, Kun-Lun; Ma, Xu; Xia, Hong-Fei			Anti-PABPC1 Co-Immunoprecipitation for Examining the miRNAs Directly Targeting the 3 '-UTR of EED mRNA	PLOS ONE			English	Article							TRANSLATIONAL REPRESSION; BINDING PROTEINS; GW182; ARGONAUTE; REQUIRES; DEGRADATION; DEADENYLASE; COMPLEXES; TNRC6C; SITES	MicroRNAs (miRNAs) are small, noncoding RNA molecules that regulate post-transcriptional gene expression by base pairing with partially complementary sequences within target messenger RNAs (mRNAs). Although the target genes and the precise biological functions of individual miRNAs remain largely unknown, miRNAs have been implicated in diverse biological processes, including both normal and pathological states. As a single stranded mRNA can be directly targeted by multiple miRNAs, and as the target sites may exist in the 3'-untranslated region (UTR), 5'-UTR, or the coding regions, it is essential to develop an effective method to identify the full-scale miRNA regulatory pattern of each particular gene. In this study, we employed a biochemical approach to identify the miRNA profiles that regulate the expression of embryonic ectoderm development (EED) protein by using anti-PABPC1 ribonucleoprotein (RNP) co-immunoprecipitation (Co-IP). The full length EED mRNA was subcloned into an expression vector and transiently transfected into a Flag-PABPC1 stable expression cell line. Subsequent to cross-linking and an anti-Hag Co-IP, the miRNAs that directly targeted EED were identified. We found that the best time point to distinguish the positive miRNAs from the background was 18 hours after the plasmid transfection. As expected, the miRNAs that directly target EED were found to interact with EED mRNA through the miRNA-induced silencing complex (miRISC). Meanwhile, the EED mRNA was bound by Flag-PABPC1. This method depends on the integrity of the miRISC complex and achieves greater efficiency when ultraviolet irradiation is used for the process of cross-linking. By using anti-PABPC1 RIP, we identified EED to be a new target gene of miR-16; a finding further confirmed using a dual-luciferase assay. In summary, our data indicate that anti-PABPC1 RIP is a validated and direct biochemical method to provide data about specific miRNA-mRNA interactions, as well as global miRNA patterns regulating the mRNAs.	[Hu, Yi; Yin, Kun-Lun; Ma, Xu; Xia, Hong-Fei] Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing, Peoples R China; [Hu, Yi; Yin, Kun-Lun; Ma, Xu; Xia, Hong-Fei] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Hu, Yi] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	National Research Institute for Family Planning - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Microbiology, CAS	Xia, HF (corresponding author), Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing, Peoples R China.	genetic@263.net.cn; hongfeixia@126.com		Hu, Yi/0000-0002-5432-1438	Natural Science Foundation of China [81370720, 81301446]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by grants from Natural Science Foundation of China (No. 81370720, No. 81301446). http://www.nsfc.gov.cn/Portal0/default166.htm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Brook M, 2009, REPRODUCTION, V137, P595, DOI 10.1530/REP-08-0524; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Huntzinger E, 2010, EMBO J, V29, P4146, DOI 10.1038/emboj.2010.274; ILYIN YV, 1969, J MOL BIOL, V41, P299, DOI 10.1016/0022-2836(69)90395-7; Ivanov PV, 2008, EMBO J, V27, P736, DOI 10.1038/emboj.2008.17; Jinek M, 2010, NAT STRUCT MOL BIOL, V17, P238, DOI 10.1038/nsmb.1768; Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638; Lazzaretti D, 2009, RNA, V15, P1059, DOI 10.1261/rna.1606309; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Lian S, 2007, MOL BIOL CELL, V18, P3375, DOI 10.1091/mbc.E07-01-0070; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Piao XH, 2010, MOL CELL BIOL, V30, P1486, DOI 10.1128/MCB.01481-09; SACHS AB, 1992, CELL, V70, P961, DOI 10.1016/0092-8674(92)90246-9; Song PP, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.045; Takimoto K, 2009, RNA, V15, P1078, DOI 10.1261/rna.1363109; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09; Zhou X, 2009, GENETICA, V137, P159, DOI 10.1007/s10709-009-9378-7; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	34	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103695	10.1371/journal.pone.0103695	http://dx.doi.org/10.1371/journal.pone.0103695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084349	gold, Green Submitted, Green Published			2022-12-27	WOS:000339819800066
J	Skrapits, K; Borsay, BA; Herczeg, L; Ciofi, P; Bloom, SR; Ghatei, MA; Dhillo, WS; Liposits, Z; Hrabovszky, E				Skrapits, Katalin; Borsay, Beata A.; Herczeg, Laszlo; Ciofi, Philippe; Bloom, Stephen R.; Ghatei, Mohammad A.; Dhillo, Waljit S.; Liposits, Zsolt; Hrabovszky, Erik			Colocalization of Cocaine- and Amphetamine-Regulated Transcript with Kisspeptin and Neurokinin B in the Human Infundibular Region	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; MONKEY MACACA-MULATTA; KISS-1 MESSENGER-RNA; ARCUATE NUCLEUS; HUMAN HYPOTHALAMUS; CART PEPTIDES; MALE-MOUSE; MORPHOLOGIC EVIDENCE; RAT HYPOTHALAMUS; MEDIAN-EMINENCE	Kisspeptin (KP)- and neurokinin B (NKB)- synthesizing neurons of the hypothalamic arcuate nucleus play a pivotal role in the regulation of pulsatile gonadotropin-releasing hormone (GnRH) secretion. Unlike in rodents and sheep, the homologous KP and NKB neurons in the human infundibular region rarely express dynorphin-but often exhibit Substance P (SP) immunoreactivity, indicating remarkable species differences in the neurochemical phenotype of these neurons. In search for additional neuropeptides in human KP and NKB neurons, we carried out immunofluorescent studies on hypothalamic sections obtained from five postmenopausal women. Colocalization experiments provided evidence for the presence of cocaine-and amphetamine-regulated transcript (CART) in 47.9 +/- 6.6% of KP-immunoreactive (IR) and 30.0 +/- 4.9% of NKB-IR perikarya and in 17.0 +/- 2.3% of KP-IR and 6.2 +/- 2.0% of NKB-IR axon varicosities. All three neuropeptides were present in 33.3 +/- 4.9% of KP-IR and 28.2 +/- 4.6% of NKB-IR somata, respectively, whereas triple-labeling showed lower incidences in KP-IR (14.3 +/- 1.8%) and NKB-IR (5.9 +/- 2.0%) axon varicosities. CART-IR KP and NKB neurons established contacts with other peptidergic cells, including GnRH-IR neurons and also sent projections to the infundibular stalk. KP and NKB fibers with CART often contained SP as well, while being distinct from CART fibers co-containing the orexigenic peptide agouti-related protein. Presence of CART in human, but not rodent, KP and NKB neurons represents a new example of species differences in the neuropeptide repertoire of mediobasal hypothalamic KP and NKB neurons. Target cells, receptor sites and physiological significance of CART in the efferent communication of KP and NKB neurons in primates require clarification.	[Skrapits, Katalin; Liposits, Zsolt; Hrabovszky, Erik] Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary; [Borsay, Beata A.; Herczeg, Laszlo] Univ Debrecen, Fac Med, Dept Forens Med, H-4012 Debrecen, Hungary; [Ciofi, Philippe] INSERM, Neuroctr Magendie, U862, Bordeaux, France; [Bloom, Stephen R.; Ghatei, Mohammad A.; Dhillo, Waljit S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Invest Med, London, England; [Liposits, Zsolt] Pazmany Peter Catholic Univ, Fac Informat Technol, Dept Neurosci, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Debrecen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Imperial College London	Hrabovszky, E (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Endocrine Neurobiol, Budapest, Hungary.	hrabovszky.erik@koki.hu	Liposits, Zsolt/K-8145-2019; Ciofi, Philippe/N-7009-2017	Ciofi, Philippe/0000-0001-6339-9977; Hrabovszky, Erik/0000-0001-6927-0015; Dhillo, Waljit/0000-0001-5950-4316; Liposits, Zsolt/0000-0002-3508-2750	National Science Foundation of Hungary [OTKA K83710, K100722]; National Development Agency [BONUS HU 08/2-2011-0006]; European Community [245009]; MRC [G1000455] Funding Source: UKRI; Medical Research Council [G1000455] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10080, NF-SI-0507-10337, CDF-2009-02-05] Funding Source: researchfish	National Science Foundation of Hungary; National Development Agency; European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The research leading to these results has received funding from the National Science Foundation of Hungary (OTKA K83710, K100722), the National Development Agency (BONUS HU 08/2-2011-0006) and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 245009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2001, ENDOCRINOLOGY, V142, P3457, DOI 10.1210/en.142.8.3457; Burke MC, 2006, J COMP NEUROL, V498, P712, DOI 10.1002/cne.21086; CUELLO AC, 1979, P NATL ACAD SCI USA, V76, P3532, DOI 10.1073/pnas.76.7.3532; de Croft S, 2013, ENDOCRINOLOGY, V154, P2750, DOI 10.1210/en.2013-1231; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; Donato Jose Jr, 2011, Front Endocrinol (Lausanne), V2, P57, DOI 10.3389/fendo.2011.00057; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Grayson BE, 2006, NEUROSCIENCE, V143, P975, DOI 10.1016/j.neuroscience.2006.08.055; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Hrabovszky E, 2010, EUR J NEUROSCI, V31, P1984, DOI 10.1111/j.1460-9568.2010.07239.x; Hrabovszky E, 2013, NEUROENDOCRINOLOGY; Hrabovszky Erik, 2013, Front Endocrinol (Lausanne), V4, P130, DOI 10.3389/fendo.2013.00130; Hrabovszky E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072369; Hrabovszky E, 2012, ENDOCRINOLOGY, V153, P4978, DOI 10.1210/en.2012-1545; Hrabovszky Erik, 2011, Front Endocrinol (Lausanne), V2, P80, DOI 10.3389/fendo.2011.00080; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Keen KL, 2008, ENDOCRINOLOGY, V149, P4151, DOI 10.1210/en.2008-0231; Kong WM, 2003, FASEB J, V17, P1688, DOI 10.1096/fj.02-0805fje; Koylu EO, 1997, J NEUROENDOCRINOL, V9, P823, DOI 10.1046/j.1365-2826.1997.00651.x; Krajewski SJ, 2005, J COMP NEUROL, V489, P372, DOI 10.1002/cne.20626; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lambert PD, 1998, SYNAPSE, V29, P293, DOI 10.1002/(SICI)1098-2396(199808)29:4<293::AID-SYN1>3.0.CO;2-0; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; Leslie RA, 2001, NEUROSCI LETT, V314, P111, DOI 10.1016/S0304-3940(01)02291-1; Ludwig DS, 1998, AM J PHYSIOL-ENDOC M, V274, pE627, DOI 10.1152/ajpendo.1998.274.4.E627; Menyhert J, 2007, ENDOCRINOLOGY, V148, P4276, DOI 10.1210/en.2007-0390; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Mittelman-Smith MA, 2012, ENDOCRINOLOGY, V153, P2800, DOI 10.1210/en.2012-1045; Molnar CS, 2012, ENDOCRINOLOGY, V153, P5428, DOI 10.1210/en.2012-1739; Navarro VM, 2011, ENDOCRINOLOGY, V152, P4265, DOI 10.1210/en.2011-1143; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Ohkura S, 2009, J NEUROENDOCRINOL, V21, P813, DOI 10.1111/j.1365-2826.2009.01909.x; Ramaswamy S, 2008, ENDOCRINOLOGY, V149, P4387, DOI 10.1210/en.2008-0438; Ramaswamy S, 2010, ENDOCRINOLOGY, V151, P4494, DOI 10.1210/en.2010-0223; Roa J, 2012, ENDOCRINOLOGY, V153, P5587, DOI 10.1210/en.2012-1470; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; Rondini TA, 2004, NEUROSCIENCE, V125, P735, DOI 10.1016/j.neuroscience.2003.12.045; Ruka KA, 2013, ENDOCRINOLOGY, V154, P2761, DOI 10.1210/en.2013-1268; Smith JT, 2007, ENDOCRINOLOGY, V148, P1150, DOI 10.1210/en.2006-1435; Smith JT, 2005, ENDOCRINOLOGY, V146, P2976, DOI 10.1210/en.2005-0323; Smith Y, 1997, SYNAPSE, V27, P90, DOI 10.1002/(SICI)1098-2396(199709)27:1<90::AID-SYN10>3.0.CO;2-V; True C, 2013, ENDOCRINOLOGY, V154, P2821, DOI 10.1210/en.2013-1156; True C, 2011, J NEUROENDOCRINOL, V23, P52, DOI 10.1111/j.1365-2826.2010.02076.x; Vrang N, 1999, J Neurosci, V19, pRC5; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010	47	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103977	10.1371/journal.pone.0103977	http://dx.doi.org/10.1371/journal.pone.0103977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084101	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000339819800113
J	Wu, XJ; Wu, W; Wang, ZZ; Shen, DH; Pan, W; Wang, Y; Wu, LM; Wu, XK; Feng, JC; Liu, KD; Zhu, J; Zhang, HL				Wu, Xiujuan; Wu, Wei; Wang, Zhengzheng; Shen, Donghui; Pan, Wei; Wang, Ying; Wu, Limin; Wu, Xiaokun; Feng, Jiachun; Liu, Kangding; Zhu, Jie; Zhang, Hong-Liang			More Severe Manifestations and Poorer Short-Term Prognosis of Ganglioside-Associated Guillain-Barre Syndrome in Northeast China	PLOS ONE			English	Article							MOTOR AXONAL NEUROPATHY; LOCAL HEALTH DISTRICT; TUMOR-NECROSIS-FACTOR; EXOGENOUS GANGLIOSIDES; MURINE MACROPHAGES; FERRARA; ANTIBODIES; POLYNEUROPATHY; THERAPY; RELEASE	Ganglioside as a neurotrophic drug has been hitherto widely used in China, although Guillain-Barre syndrome (GBS) following intravenous ganglioside treatment was reported in Europe several decades ago. We identified 7 patients who developed GBS after intravenous use of gangliosides (ganglioside+ group) and compared their clinical data with those of 77 non-ganglioside-associated GBS patients (ganglioside- group) in 2013, aiming at gaining the distinct features of ganglioside-associated GBS. Although the mean age, protein levels in cerebrospinal fluid (CSF) and frequency of cranial nerve involvement were similar between the two groups, the Hughes Functional Grading Scale (HFGS) score and the Medical Research Council (MRC) sum score at nadir significantly differed (4.9 +/- 0.4 vs 3.6 +/- 1.0; 7.7 +/- 5.5 vs 36.9 +/- 14.5, both p, 0.001), indicating a higher disease severity of ganglioside-associated GBS. A higher ratio of patients with ganglioside-associated GBS required mechanical ventilation (85.7% vs 15.6%, p<0.01). The short-term prognosis of ganglioside-associated GBS, as measured by the HFGS score and the MRC sum score at discharge, was poorer (4.3 +/- 0.5 vs 2.8 +/- 1.1; 17.3 +/- 12.9 vs 46.0 +/- 13.9, both p<0.001). All the patients in the ganglioside+ group presented an axonal form of GBS, namely acute motor axonal neuropathy (AMAN). When compared with the AMAN patients in the ganglioside- group, more severe functional deficits at nadir and poorer recovery after standard treatment were still prominent in ganglioside-associated GBS. Anti-GM1 and anti-GT1a antibodies were detectable in patients with AMAN while not in patients with the demyelinating subtype of GBS. The concentrations of these antibodies in patients with AMAN were insignificantly different between the ganglioside+ and ganglioside- groups. In sum, ganglioside-associated GBS may be a devastating side effect of intravenous use of gangliosides, which usually manifests a more severe clinical course and poorer outcome.	[Wu, Xiujuan; Wang, Zhengzheng; Shen, Donghui; Wang, Ying; Wu, Limin; Wu, Xiaokun; Feng, Jiachun; Liu, Kangding; Zhu, Jie; Zhang, Hong-Liang] Jilin Univ, Hosp 1, Neurosci Ctr, Dept Neurol, Changchun 130023, Peoples R China; [Wu, Wei] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China; [Pan, Wei] Jilin Univ, Sch Publ Hlth, Changchun 130023, Peoples R China; [Wang, Ying] Jilin Univ, Norman Bethune Hlth Sci Ctr, Changchun 130023, Peoples R China; [Wu, Limin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Neuroprotect Res Lab, Boston, MA USA; [Zhu, Jie; Zhang, Hong-Liang] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	Jilin University; Jilin University; Jilin University; Jilin University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Karolinska Institutet	Zhang, HL (corresponding author), Jilin Univ, Hosp 1, Neurosci Ctr, Dept Neurol, Changchun 130023, Peoples R China.	drzhl@hotmail.com	Zhang, Hongliang/AAN-3077-2020	Zhang, Hongliang/0000-0001-9205-5559	Young Scholars Program of Norman Bethune Health Science Center of Jilin University [2013205035]; Young Scholars Program of the First Hospital of Jilin University [JDYY42013003]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; National Natural Science Foundation of China [81241147]	Young Scholars Program of Norman Bethune Health Science Center of Jilin University; Young Scholars Program of the First Hospital of Jilin University; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Young Scholars Program of Norman Bethune Health Science Center of Jilin University (No. 2013205035), Young Scholars Program of the First Hospital of Jilin University (No. JDYY42013003), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, and the National Natural Science Foundation of China (No. 81241147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; DIEZTEJEDOR E, 1993, NEUROEPIDEMIOLOGY, V12, P251, DOI 10.1159/000110325; FIGUERAS A, 1992, BRIT MED J, V305, P1330, DOI 10.1136/bmj.305.6865.1330; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; GARATTINI S, 1993, LANCET, V342, P1191, DOI 10.1016/0140-6736(93)92181-R; Govoni V, 1997, BRAIN, V120, P1123, DOI 10.1093/brain/120.7.1123; Govoni V, 2003, J NEUROL SCI, V216, P99, DOI 10.1016/S0022-510X(03)00215-6; Govoni V, 1996, J NEUROL SCI, V137, P62, DOI 10.1016/0022-510X(95)00333-W; GRANIERI E, 1991, NEUROEPIDEMIOLOGY, V10, P161, DOI 10.1159/000110265; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; ILLA I, 1995, ANN NEUROL, V38, P218, DOI 10.1002/ana.410380214; Islam Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043976; KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111; Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1; LANDI G, 1993, BRIT MED J, V307, P1463, DOI 10.1136/bmj.307.6917.1463; MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402; NOBILEORAZIO E, 1992, J NEUROL SCI, V109, P200, DOI 10.1016/0022-510X(92)90169-L; Odaka M, 2000, J NEUROL SCI, V175, P96, DOI 10.1016/S0022-510X(00)00287-2; Yuki N, 2005, CURR OPIN NEUROL, V18, P557, DOI 10.1097/01.wco.0000174604.42272.2d; Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012; Zhang HL, 2013, CYTOKINE GROWTH F R, V24, P443, DOI 10.1016/j.cytogfr.2013.05.005; Zhou CK, 2014, NEURAL REGEN RES, V9, P101, DOI 10.4103/1673-5374.125337	25	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e104074	10.1371/journal.pone.0104074	http://dx.doi.org/10.1371/journal.pone.0104074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084153	Green Published, gold			2022-12-27	WOS:000339819800124
J	Arenas-Pinto, A; Winston, A; Stohr, W; Day, J; Wiggins, R; Quah, SP; Ainsworth, J; Fleck, S; Dunn, D; Accoroni, A; Paton, NI				Arenas-Pinto, Alejandro; Winston, Alan; Stoehr, Wolfgang; Day, John; Wiggins, Rebecca; Quah, Say Pheng; Ainsworth, Jonathan; Fleck, Sue; Dunn, David; Accoroni, Alex; Paton, Nicholas I.		PIVOT Trial Team	Neurocognitive Function in HIV-Infected Patients: Comparison of Two Methods to Define Impairment	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DEFICIT SCORES; RISK-FACTORS; DISORDERS; PREVALENCE; PERFORMANCE; ERA	Objective: To compare two definitions of neurocognitive impairment (NCI) in a large clinical trial of effectively-treated HIV-infected adults at baseline. Methods: Hopkins Verbal Learning test-Revised (HVLT-R), Colour Trail (CTT) and Grooved Pegboard (GPT) tests were applied exploring five cognitive domains. Raw scores were transformed into Z-scores and NCI defined as summary NPZ-5 score one standard deviation below the mean of the normative dataset (i.e. <-1SD) or Z-scores <-1SD in at least two individual domains (categorical scale). Principal component analysis (PCA) was performed to explore the contribution of individual tests to the total variance. Results: Mean NPZ-5 score was 20.72 (SD 0.98) and 178/548 (32%) participants had NPZ-5 scores <-1SD. When impairment was defined as <-1SD in at least two individual tests, 283 (52%) patients were impaired. Strong correlations between the two components of the HVLT-R test (learning/recall) (r = 0.73), and the CTT and (attention/executive functioning) (r = 0.66) were observed. PCA showed a clustering with three components accounting for 88% of the total variance. When patients who scored <-1SD only in two correlated tests were considered as not impaired, prevalence of NCI was 43%. When correlated test scores were averaged, 36% of participants had NPZ-3 scores <-1SD and 32% underperformed in at least two individual tests. Conclusion: Controlling for differential contribution of individual test-scores on the overall performance and the level of correlation between components of the test battery used appear to be important when testing cognitive function. These two factors are likely to affect both summary scores and categorical scales in defining cognitive impairment.	[Arenas-Pinto, Alejandro; Stoehr, Wolfgang; Fleck, Sue; Dunn, David; Paton, Nicholas I.] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, London, England; [Arenas-Pinto, Alejandro] UCL, Ctr Sexual Hlth & HIV Res, London, England; [Winston, Alan] Univ London Imperial Coll Sci Technol & Med, Div Med, Infect Dis Sect, London, England; [Winston, Alan] Imperial Coll Healthcare NHS Trust, Dept HIV & GU Med, London, England; [Day, John] Southend Univ Hosp NHS Fdn Trust, Westcliff On Sea, England; [Wiggins, Rebecca] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Quah, Say Pheng] Royal Victoria Hosp, Dept GU Med, Belfast BT12 6BA, Antrim, North Ireland; [Ainsworth, Jonathan] North Middlesex Univ Hosp, London, England; [Accoroni, Alex] Cent & North West London NHS Fdn Trust, Mortimer Market Ctr, Psychol & Psychotherapy Dept, London, England; [Paton, Nicholas I.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	Medical Research Council Clinical Trials Unit; University of London; University College London; University of London; University College London; Imperial College London; Imperial College London; University of York - UK; National University of Singapore	Arenas-Pinto, A (corresponding author), UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, London, England.	A.Arenas-Pinto@ucl.ac.uk	Winston, Alan/AGZ-3015-2022	Winston, Alan/0000-0002-5847-8416; Arenas-Pinto, Alejandro/0000-0002-3368-5005; Stohr, Wolfgang/0000-0002-6533-2888; fox, Julie/0000-0002-0583-8019; Dunn, David/0000-0003-1836-4446; Leen, Clifford/0000-0001-8439-7719	National Institutes for Health Research Health (NIHR) [06/403/90]	National Institutes for Health Research Health (NIHR)	PIVOT is funded by the National Institutes for Health Research Health (NIHR) Technology Assessment programme (project number 06/403/90). The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Health Technology Assessment programme, NIHR, the National Health Service or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Blackstone K, 2012, CLIN NEUROPSYCHOL, V26, P894, DOI 10.1080/13854046.2012.694479; Bonnet F, 2012, COGNITIVE DISORDERS; Bonnet F, 2013, AIDS, V27, P391, DOI 10.1097/QAD.0b013e32835b1019; Brandt J, 2001, HOPKINS VERBAL LEARN; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Chang L, 2004, ANN NEUROL, V56, P259, DOI 10.1002/ana.20190; D'Elia L.F., 1996, COLOR TRAILS TEST; Europe LIC, 2003, GROOVED PEGBOARD USE; Gisslen M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-356; Grant I, 2008, INT REV PSYCHIATR, V20, P33, DOI 10.1080/09540260701877894; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Kanmogne GD, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-60; Meyer ACL, 2013, NEUROEPIDEMIOLOGY, V41, P208, DOI 10.1159/000354629; Moore DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047310; Nakasujja N, 2012, NEUROLOGY; Norman MA, 2011, J CLIN EXP NEUROPSYC, V33, P793, DOI 10.1080/13803395.2011.559157; Roalf DR, 2012, ALZHEIMERS DEMENT; Robertson KR, 2010, NEUROLOGY, V74, P1260, DOI 10.1212/WNL.0b013e3181d9ed09; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Torti C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-138; Tozzi V, 2007, JAIDS-J ACQ IMM DEF, V45, P174, DOI 10.1097/QAI.0b013e318042e1ee; Winston A, 2012, HIV MED, V13, P245, DOI 10.1111/j.1468-1293.2011.00962.x; Winston A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061949; Wright EJ, 2010, NEUROLOGY, V75, P864, DOI 10.1212/WNL.0b013e3181f11bd8	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103498	10.1371/journal.pone.0103498	http://dx.doi.org/10.1371/journal.pone.0103498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078406	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000339954800049
J	Liang, JG; Sun, S; Ji, J; Wu, HY; Meng, F; Zhang, MR; Zheng, XB; Wu, CX; Zhang, ZG				Liang, Jingang; Sun, Shi; Ji, Jun; Wu, Haiying; Meng, Fang; Zhang, Mingrong; Zheng, Xiaobo; Wu, Cunxiang; Zhang, Zhengguang			Comparison of the Rhizosphere Bacterial Communities of Zigongdongdou Soybean and a High-Methionine Transgenic Line of This Cultivar	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; 16S RIBOSOMAL-RNA; MICROBIAL DIVERSITY; PLANT GENOTYPE; TAXONOMIC DIVERSITY; AGRICULTURAL SOIL; SEQUENCE-ANALYSIS; ROOTS; MAIZE; WHEAT	Previous studies have shown that methionine from root exudates affects the rhizosphere bacterial population involved in soil nitrogen fixation. A transgenic line of Zigongdongdou soybean cultivar (ZD91) that expresses Arabidopsis cystathionine c-synthase resulting in an increased methionine production was examined for its influence to the rhizosphere bacterial population. Using 16S rRNA gene-based pyrosequencing analysis of the V4 region and DNA extracted from bacterial consortia collected from the rhizosphere of soybean plants grown in an agricultural field at the pod-setting stage, we characterized the populational structure of the bacterial community involved. In total, 87,267 sequences (approximately 10,908 per sample) were analyzed. We found that Acidobacteria, Proteobacteria, Bacteroidetes, Actinobacteria, Chloroflexi, Planctomycetes, Gemmatimonadetes, Firmicutes, and Verrucomicrobia constitute the dominant taxonomic groups in either the ZD91 transgenic line or parental cultivar ZD, and that there was no statistically significant difference in the rhizosphere bacterial community structure between the two cultivars.	[Zhang, Zhengguang] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Liang, Jingang; Ji, Jun; Meng, Fang; Zheng, Xiaobo] Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Sun, Shi; Wu, Cunxiang] Chinese Acad Agr Sci, Inst Crop Sci, MOA Key Lab Soybean Biol Beijing, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Wu, Haiying; Zhang, Mingrong] Nanchong Acad Agr Sci, Nanchong, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhang, ZG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	wucx@mail.caas.net.cn; zhgzhang@njau.edu.cn			Genetically Modified Organisms Breeding Major Projects of China [2014ZX08011-003]; Jiangsu Provincial Coordination Panel for Recruitment and Selection of Specially-Appointed Professors	Genetically Modified Organisms Breeding Major Projects of China; Jiangsu Provincial Coordination Panel for Recruitment and Selection of Specially-Appointed Professors	This research was supported by Genetically Modified Organisms Breeding Major Projects of China (Grant No. 2014ZX08011-003) and Jiangsu Provincial Coordination Panel for Recruitment and Selection of Specially-Appointed Professors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albareda M, 2006, FEMS MICROBIOL LETT, V259, P67, DOI 10.1111/j.1574-6968.2006.00244.x; Barns SM, 2007, APPL ENVIRON MICROB, V73, P3113, DOI 10.1128/AEM.02012-06; Borneman J, 1996, APPL ENVIRON MICROB, V62, P1935, DOI 10.1128/AEM.62.6.1935-1943.1996; Briones AM, 2002, APPL ENVIRON MICROB, V68, P3067, DOI 10.1128/AEM.68.6.3067-3075.2002; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Chen J, 2007, APPL ENVIRON MICROB, V73, P4407, DOI 10.1128/AEM.02799-06; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; da Silva KRA, 2003, J MICROBIOL METH, V54, P213, DOI 10.1016/S0167-7012(03)00039-3; Demaneche S, 2008, P NATL ACAD SCI USA, V105, P3957, DOI 10.1073/pnas.0800072105; Di Giovanni GD, 1999, MICROBIAL ECOL, V37, P129, DOI 10.1007/s002489900137; Duc C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025014; Duineveld BM, 1998, APPL ENVIRON MICROB, V64, P4950; Duke SO, 2012, J AGR FOOD CHEM, V60, P10375, DOI 10.1021/jf302436u; Dunbar J, 1999, APPL ENVIRON MICROB, V65, P1662; Eichorst SA, 2007, APPL ENVIRON MICROB, V73, P2708, DOI 10.1128/AEM.02140-06; Faragova N, 2005, FOLIA MICROBIOL, V50, P509, DOI 10.1007/BF02931439; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Garbeva P, 2006, ENVIRON MICROBIOL, V8, P233, DOI 10.1111/j.1462-2920.2005.00888.x; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Gelsomino A, 1999, J MICROBIOL METH, V38, P1, DOI 10.1016/S0167-7012(99)00054-8; Gerardi M.H., 2002, NITRIFICATION DENITR, P43, DOI [10.1002/0471216682.ch7, DOI 10.1002/0471216682.CH7]; Germida JJ, 2001, BIOL FERT SOILS, V33, P410, DOI 10.1007/s003740100343; Govaerts B, 2007, APPL SOIL ECOL, V37, P18, DOI 10.1016/j.apsoil.2007.03.006; Hannula SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033819; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Heuer H, 2002, APPL ENVIRON MICROB, V68, P1325, DOI 10.1128/AEM.68.3.1325-1335.2002; Hirsch J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S6; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hsu SF, 2009, ISME J, V3, P124, DOI 10.1038/ismej.2008.82; Hur M, 2011, APPL ENVIRON MICROB, V77, P7611, DOI 10.1128/AEM.06102-11; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; James C, 2012, GLOBAL STATUS COMMER, P44; Jin J, 2009, PEDOSPHERE, V19, P808, DOI 10.1016/S1002-0160(09)60176-4; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Kuske CR, 1997, APPL ENVIRON MICROB, V63, P3614, DOI 10.1128/AEM.63.9.3614-3621.1997; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Li XG, 2013, INT J BIOL SCI, V9, P164, DOI 10.7150/ijbs.5579; Liu B, 2005, PLANT SOIL, V271, P1, DOI 10.1007/s11104-004-1610-8; Liu JJ, 2011, ANN MICROBIOL, V61, P525, DOI 10.1007/s13213-010-0168-3; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lottmann J, 2001, MICROBIOL RES, V156, P75, DOI 10.1078/0944-5013-00086; Lukow T, 2000, FEMS MICROBIOL ECOL, V32, P241, DOI 10.1111/j.1574-6941.2000.tb00717.x; Mao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024750; McCaig AE, 1999, APPL ENVIRON MICROB, V65, P1721; McLaughlin A, 1995, AGR ECOSYST ENVIRON, V55, P201, DOI 10.1016/0167-8809(95)00609-V; Meyer JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053825; MILLER HJ, 1989, CAN J MICROBIOL, V35, P656, DOI 10.1139/m89-106; Milling A, 2004, PLANT SOIL, V266, P23; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nannipieri P., 2008, V15, P339; Philippot L, 2007, ADV AGRON, V96, P249, DOI 10.1016/S0065-2113(07)96003-4; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; [浦传亮 Pu Chuanliang], 2012, [南京农业大学学报, Journal of Nanjing Agricultural University], V35, P8; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rasche F, 2006, FEMS MICROBIOL ECOL, V56, P219, DOI 10.1111/j.1574-6941.2005.00027.x; Rengel Z, 1998, J PLANT NUTR, V21, P99, DOI 10.1080/01904169809365386; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Salles JF, 2006, MICROB ECOL, V52, P267, DOI 10.1007/s00248-006-9048-6; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmalenberger A, 2002, FEMS MICROBIOL ECOL, V40, P29, DOI 10.1111/j.1574-6941.2002.tb00933.x; Shen JP, 2008, ENVIRON MICROBIOL, V10, P1601, DOI 10.1111/j.1462-2920.2008.01578.x; Siciliano SD, 1999, FEMS MICROBIOL ECOL, V29, P263, DOI 10.1111/j.1574-6941.1999.tb00617.x; Smit E, 2001, APPL ENVIRON MICROB, V67, P2284, DOI 10.1128/AEM.67.5.2284-2291.2001; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Song SK, 2013, J EXP BOT, V64, P1917, DOI 10.1093/jxb/ert053; Tan XY, 2003, ENVIRON MICROBIOL, V5, P1009, DOI 10.1046/j.1462-2920.2003.00491.x; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; VASANTHARAJAN VN, 1968, PLANT SOIL, V29, P156, DOI 10.1007/BF01393919; Wang GH, 2007, PEDOSPHERE, V17, P191, DOI 10.1016/S1002-0160(07)60025-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YA, 2009, SYST APPL MICROBIOL, V32, P27, DOI 10.1016/j.syapm.2008.09.007; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Xu YX, 2009, SOIL BIOL BIOCHEM, V41, P919, DOI 10.1016/j.soilbio.2008.10.027; [徐艳霞 XU Yanxia], 2007, [大豆科学, Soybean Science], V26, P907; Yang TY, 2012, BIOL FERT SOILS, V48, P97, DOI 10.1007/s00374-011-0608-7; Yang WK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055470, 10.1371/journal.pone.0076447]; Yashiro E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037131; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160	90	27	32	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103343	10.1371/journal.pone.0103343	http://dx.doi.org/10.1371/journal.pone.0103343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079947	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800039
J	Owusu, M; Annan, A; Corman, VM; Larbi, R; Anti, P; Drexler, JF; Agbenyega, O; Adu-Sarkodie, Y; Drosten, C				Owusu, Michael; Annan, Augustina; Corman, Victor Max; Larbi, Richard; Anti, Priscilla; Drexler, Jan Felix; Agbenyega, Olivia; Adu-Sarkodie, Yaw; Drosten, Christian			Human Coronaviruses Associated with Upper Respiratory Tract Infections in Three Rural Areas of Ghana	PLOS ONE			English	Article							FREQUENT DETECTION; VIRAL ETIOLOGY; CHILDREN; VIRUSES; INFLUENZA; DISEASE; BATS; RHINOVIRUS; BOCAVIRUS; ILLNESSES	Background: Acute respiratory tract infections (ARI) are the leading cause of morbidity and mortality in developing countries, especially in Africa. This study sought to determine whether human coronaviruses (HCoVs) are associated with upper respiratory tract infections among older children and adults in Ghana. Methods: We conducted a case control study among older children and adults in three rural areas of Ghana using asymptomatic subjects as controls. Nasal/Nasopharyngeal swabs were tested for Middle East respiratory syndrome coronavirus (MERS-CoV), HCoV-22E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 using Reverse Transcriptase Real-Time Polymerase Chain Reaction. Results: Out of 1,213 subjects recruited, 150 (12.4%) were positive for one or more viruses. Of these, single virus detections occurred in 146 subjects (12.0%) and multiple detections occurred in 4 (0.3%). Compared with control subjects, infections with HCoV-229E (OR = 5.15, 95% CI = 2.24-11.78), HCoV-OC43 (OR = 6.16, 95% CI = 1.77-21.65) and combine HCoVs (OR = 2.36, 95% CI = 1.5 = 3.72) were associated with upper respiratory tract infections. HCoVs were found to be seasonally dependent with significant detections in the harmattan season (mainly HCoV-229E) and wet season (mainly HCoV-NL63). A comparison of the obtained sequences resulted in no differences to sequences already published in GenBank. Conclusion: HCoVs could play significant role in causing upper respiratory tract infections among adults and older children	[Owusu, Michael; Annan, Augustina; Larbi, Richard] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Corman, Victor Max; Drexler, Jan Felix; Drosten, Christian] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Anti, Priscilla; Agbenyega, Olivia] Kwame Nkrumah Univ Sci & Technol, Inst Renewable & Nat Resources, Kumasi, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Dept Clin Microbiol, Kumasi, Ghana	Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; University of Bonn; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Drosten, C (corresponding author), Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.	drosten@virology-bonn.de	Drexler, Jan Felix/GMW-5098-2022; Corman, Victor M/K-1319-2019; Sylverken, Augustina Angelina/ABE-4664-2020	Corman, Victor M/0000-0002-3605-0136; SYLVERKEN, AUGUSTINA/0000-0002-7691-914X; Drexler, Jan Felix/0000-0002-3509-0232; Owusu, Michael/0000-0001-5066-150X	Deutsche Forschungsgemeinschaft [DR 772/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft under grant No DR 772/3-1, to YAS and CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2012, ARCH VIROL, V157, P1411, DOI 10.1007/s00705-012-1299-6; ADEFOLALU DO, 1984, ARCH METEOR GEOPHY B, V33, P387, DOI 10.1007/BF02274004; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; [Anonymous], 2010, ANN REPORT, V2010, P1; Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Corman V. M., 2012, EURO SURVEILL, V17; Cui LJ, 2011, ADV VIROL, V2011, DOI 10.1155/2011/129134; Dare RK, 2007, J INFECT DIS, V196, P1321, DOI 10.1086/521308; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; DENNY FW, 1986, AM J TROP MED HYG, V35, P1; Dominguez SR, 2012, J GEN VIROL, V93, P2387, DOI 10.1099/vir.0.044628-0; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Falsey AR, 1997, J AM GERIATR SOC, V45, P706, DOI 10.1111/j.1532-5415.1997.tb01474.x; Gessner BD, 2011, EXPERT REV RESP MED, V5, P459, DOI [10.1586/ERS.11.47, 10.1586/ers.11.47]; Ghana Statistical Service, 2000, POP HOUS CENS; Graat JM, 2003, J CLIN EPIDEMIOL, V56, P1218, DOI 10.1016/S0895-4356(03)00171-9; Herberhold S, 2009, J CLIN MICROBIOL, V47, P2682, DOI 10.1128/JCM.00899-09; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Lau SKP, 2013, J VIROL, V87, P8638, DOI 10.1128/JVI.01055-13; Mackay IM, 2012, VIRUSES-BASEL, V4, P637, DOI 10.3390/v4040637; MCINTOSH K, 1974, J INFECT DIS, V130, P502, DOI 10.1093/infdis/130.5.502; McIntosh K, 2012, PEDIATR INFECT DIS J, V31, P241, DOI 10.1097/INF.0b013e31823e081e; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Niang MN, 2010, J MED VIROL, V82, P866, DOI 10.1002/jmv.21665; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Penttinen P. M, 2013, EURO SURVEILL, V18; Perera RA, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.36.20574; Pfefferle S, 2009, DISTANT RELATIVES SE; Prill MM, 2012, PEDIATR INFECT DIS J, DOI [10.1097/INF.1090b1013e31823e31807fe, DOI 10.1097/INF.1090B1013E31823E31807FE]; R Development Core Team, 2008, LANG ENV STAT COMP; Ren LL, 2011, J MED VIROL, V83, P291, DOI 10.1002/jmv.21956; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Sato M, 2009, J CLIN MICROBIOL, V47, P771, DOI 10.1128/JCM.02331-08; Sekyere Central District Assembly, 2010, EURO SURVEILL; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Smuts H, 2008, J MED VIROL, V80, P906, DOI 10.1002/jmv.21135; The Vanuatu National Statistics Office, 2009, NAT POP HOUS CENS AN, V2; The WHO MERS-CoV Research Group, 2013, PLOS CURR, V5; Vabret A, 2003, CLIN INFECT DIS, V36, P985, DOI 10.1086/374222; Vabret A, 2008, J PAEDIATR CHILD H, V44, P176, DOI 10.1111/j.1440-1754.2007.01246.x; van Elden LJR, 2004, J INFECT DIS, V189, P652, DOI 10.1086/381207; Venter M, 2011, J MED VIROL, V83, P1458, DOI 10.1002/jmv.22120; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Xiao Ni-Guang, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P28; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	50	48	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e99782	10.1371/journal.pone.0099782	http://dx.doi.org/10.1371/journal.pone.0099782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080241	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800001
J	Sunny, A; Monroy-Vilchis, O; Reyna-Valencia, C; Zarco-Gonzalez, MM				Sunny, Armando; Monroy-Vilchis, Octavio; Reyna-Valencia, Carlos; Zarco-Gonzalez, Martha M.			Microhabitat Types Promote the Genetic Structure of a Micro-Endemic and Critically Endangered Mole Salamander (Ambystoma leorae) of Central Mexico	PLOS ONE			English	Article							POPULATION-STRUCTURE; HABITAT USE; MIGRATORY ORIENTATION; LIFE-HISTORIES; CLUTCH SIZE; BODY SIZE; EGG SIZE; LANDSCAPE; FOREST; AMPHIBIANS	The reduced immigration and emigration rates resulting from the lack of landscape connectivity of patches and the hospitality of the intervening matrix could favor the loss of alleles through genetic drift and an increased chance of inbreeding. In order for isolated populations to maintain sufficient levels of genetic diversity and adapt to environmental changes, one important conservation goal must be to preserve or reestablish connectivity among patches in a fragmented landscape. We studied the last known population of Ambystoma leorae, an endemic and critically threatened species. The aims of this study were: (1) to assess the demographic parameters of A. leorae and to distinguish and characterize the microhabitats in the river, (2) to determine the number of existing genetic groups or demes of A. leorae and to describe possible relationships between microhabitats types and demes, (3) to determine gene flow between demes, and (4) to search for geographic locations of genetic discontinuities that limit gene flow between demes. We found three types of microhabitats and three genetically differentiated subpopulations with a significant level of genetic structure. In addition, we found slight genetic barriers. Our results suggest that mole salamander's species are very sensitive to microhabitat features and relatively narrow obstacles in their path. The estimates of bidirectional gene flow are consistent with the pattern of a stepping stone model between demes, where migration occurs between adjacent demes, but there is low gene flow between distant demes. We can also conclude that there is a positive correlation between microhabitats and genetic structure in this population.	[Sunny, Armando; Monroy-Vilchis, Octavio; Reyna-Valencia, Carlos; Zarco-Gonzalez, Martha M.] Univ Autonoma Estado Mexico, Fac Ciencias, Estn Biol Sierra Nanchititla, Toluca, Estado De Mexic, Mexico	Universidad Autonoma del Estado de Morelos	Monroy-Vilchis, O (corresponding author), Univ Autonoma Estado Mexico, Fac Ciencias, Estn Biol Sierra Nanchititla, Toluca, Estado De Mexic, Mexico.	omv@uaemex.mx	Sunny, Armando/E-5620-2012; Zarco-González, Martha Mariela/B-3408-2016; Monroy-Vilchis, Octavio/H-8942-2019	Sunny, Armando/0000-0003-4685-5322; Zarco-González, Martha Mariela/0000-0003-4217-8272; Monroy-Vilchis, Octavio/0000-0003-3159-6014	Universidad Autonoma del Estado de Mexico [3527/2013MT]	Universidad Autonoma del Estado de Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by grant number 3527/2013MT (http://www.uaemex.mx/) from the Universidad Autonoma del Estado de Mexico to OMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR-MIGUEL Xóchitl, 2009, Acta Zool. Mex, V25, P443; ANDERSON JD, 1967, AM MIDL NAT, V77, P323, DOI 10.2307/2423346; [Anonymous], 1997, MOL BIOL BIOTECHNOLO; Arens P, 2007, LANDSCAPE ECOL, V22, P1489, DOI 10.1007/s10980-007-9132-4; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Blaustein AR, 2002, ECOL LETT, V5, P597, DOI 10.1046/j.1461-0248.2002.00352.x; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; BRANDON RA, 1970, COPEIA, P385; Casas-Andreu G, 1989, ECOLOGIA URBANA, VEsp, P117; Clobert J, 1998, J EVOLUTION BIOL, V11, P329; CORTWRIGHT SA, 1990, OECOLOGIA, V83, P123, DOI 10.1007/BF00324643; Demaynadier Phillip G., 1995, Environmental Reviews, V3, P230, DOI 10.1139/a95-012; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2009, MOL ECOL RESOUR, V9, P110, DOI 10.1111/j.1755-0998.2008.02384.x; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Egan RS, 2004, WETLANDS, V24, P1, DOI 10.1672/0277-5212(2004)024[0001:WPAOBW]2.0.CO;2; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falush D, 2003, GENETICS, V164, P1567; FORD NB, 1989, HERPETOLOGICA, V45, P75; FORMANOWICZ DR, 1989, AM MIDL NAT, V121, P379, DOI 10.2307/2426042; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Garcia P, 2003, THESIS UMSNH MORELIA; GATES J E, 1981, Journal of the Elisha Mitchell Scientific Society, V97, P209; Gibbs JP, 1998, LANDSCAPE ECOL, V13, P263, DOI 10.1023/A:1008056424692; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Goldstein DB, 1995, GENETICS, V140, P679; Greenwald KR, 2009, CONSERV BIOL, V23, P1232, DOI 10.1111/j.1523-1739.2009.01204.x; Guerry AD, 2002, CONSERV BIOL, V16, P745, DOI 10.1046/j.1523-1739.2002.00557.x; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Herrmann HL, 2005, BIOL CONSERV, V123, P139, DOI 10.1016/j.biocon.2004.05.025; Huacuz D, 2002, PLAN MANEJO ACHOQUE; Huacuz-Elias DC, 2003, BIOLOGICAS, V5, P51; HUACUZELIAS DC, 2001, ESTADO CONSERVACION; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IBM Corp, 2010, IBM SPSS STAT WIND; Jehle R, 2005, CONSERV GENET, V6, P227, DOI 10.1007/s10592-004-7832-8; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kinkead KE, 2007, CONSERV GENET, V8, P281, DOI 10.1007/s10592-006-9168-z; KNUDSEN JENS W., 1960, COPEIA, V1960, P44, DOI 10.2307/1439844; Kraaijeveld-Smit FJL, 2007, OIKOS, V116, P1819, DOI 10.1111/j.0030-1299.2007.16087.x; Langella O, 2002, POPULATIONS 1230 COP; Lemos-Espinal J, 1985, CIENCIA FORESTAL, V10, P44; Lemos-Espinal J, 1999, BRIT HERP SOC B, V68, P1; Lindstrom Jan, 2010, BMC Ecology, V10, P4, DOI 10.1186/1472-6785-10-4; Loredo I, 1996, J HERPETOL, V30, P282, DOI 10.2307/1565527; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Marin-Martinez AI, 2007, THESIS UNAM MEXICO; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; McMenamin Sarah K., 2010, BMC Ecology, V10, P10, DOI 10.1186/1472-6785-10-10; Monroy-Vilchis O, 2014, HERPETOZOA IN PRESS; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Parra-Olea G, 2007, MOL ECOL NOTES, V7, P818, DOI 10.1111/j.1471-8286.2007.01714.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PORTNOY JW, 1990, BIOL CONSERV, V53, P61, DOI 10.1016/0006-3207(90)90063-U; Pritchard JK, 2000, GENETICS, V155, P945; Purrenhage JL, 2009, MOL ECOL, V18, P235, DOI 10.1111/j.1365-294X.2008.04024.x; Rambaut A, 2010, FIGTREE V131; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reyes G, 2003, THESIS UNAM MEXICO; Rittenhouse TAG, 2006, BIOL CONSERV, V131, P14, DOI 10.1016/j.biocon.2006.01.024; Rodriguez Reyes F.R., 2009, THESIS, P80; Rothermel BB, 2002, CONSERV BIOL, V16, P1324, DOI 10.1046/j.1523-1739.2002.01085.x; Sandoval-Comte A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034023; SEALE DB, 1982, COPEIA, P627, DOI 10.2307/1444663; SEMLITSCH RD, 1983, COPEIA, P608; Shaffer B, 2004, IUCN RED LIST THREAT; Shaffer H. B., 2005, AMPHIBIAN DECLINES C, P605; SHOOP CR, 1968, BIOL BULL, V135, P230, DOI 10.2307/1539630; SHOOP CR, 1972, BEHAV BIOL, V7, P131, DOI 10.1016/S0091-6773(72)80195-0; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; Spear SF, 2008, MOL ECOL, V17, P4642, DOI 10.1111/j.1365-294X.2008.03952.x; StatPoint, 2007, STATGRAPHICS CENT 15; StatSoft Inc, 2007, STAT VERS 7 DAT AN S; Stearns S.C., 1992, pi; Stebbins R. C., 2021, NATURAL HIST AMPHIBI; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Sunny A, 2014, CONSERV GENET, V15, P49, DOI 10.1007/s10592-013-0520-9; Taylor Edward H., 1943, UNIV KANSAS SCI BULL, V29, P343; Todd BD, 2009, J APPL ECOL, V46, P554, DOI 10.1111/j.1365-2664.2009.01645.x; Trenham PC, 2005, ECOL APPL, V15, P1158, DOI 10.1890/04-1150; Trenham PC, 2001, J HERPETOL, V35, P343, DOI 10.2307/1566130; Tyler TJ, 1998, J HERPETOL, V32, P345, DOI 10.2307/1565448; Uribe-Pena Z, 1999, I BIOL U NACL AUTONO, V32, P19; Valiere N., 2002, MOL ECOL NOTES, V10, P1046, DOI DOI 10.1046/J.1471-8286.2002.00228.X-I2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vega LA, 1992, ACTA ZOOL MEX, V15, P1; Vega-Lopez A, 1992, ACTA ZOOL MEX, V51, P20; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; WIEBE KL, 1995, J ZOOL, V237, P285, DOI 10.1111/j.1469-7998.1995.tb02763.x; Zamudio KR, 2007, MOL ECOL, V16, P257, DOI 10.1111/j.1365-294X.2006.03139.x	97	17	20	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103595	10.1371/journal.pone.0103595	http://dx.doi.org/10.1371/journal.pone.0103595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076052	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800067
J	Kang, TH; Knoff, J; Yeh, WH; Yang, B; Wang, CG; Kim, YS; Kim, TW; Wu, TC; Hung, CF				Kang, Tae Heung; Knoff, Jayne; Yeh, Wei-Hsi; Yang, Benjamin; Wang, Chenguang; Kim, Young Seob; Kim, Tae Woo; Wu, Tzyy-Choou; Hung, Chien-Fu			Treatment of Tumors with Vitamin E Suppresses Myeloid Derived Suppressor Cells and Enhances CD8+T Cell-Mediated Antitumor Effects	PLOS ONE			English	Article							DNA VACCINE; COLON-CANCER; ANTIGEN; IMMUNITY; IMMUNOTHERAPY; RESPONSES; RISK; GENE	Vitamin E has been shown to have strong anticarcinogenic properties, including antioxidant characteristics, making it an ideal candidate for use in combination with immunotherapies that modify the tumor microenvironment. The tumor microenvironment contains immunosuppressive components, which can be diminished, and immunogenic components, which can be augmented by immunotherapies in order to generate a productive immune response. In the current study, we employ the alpha-tocopherol succinate isomer of vitamin E to reduce immunosuppression by myeloid derived suppressor cells (MDSCs) as well as adoptive transfer of antigen-specific CD8+ T cells to generate potent antitumor effects against the HPV16 E7-expressing TC-1 tumor model. We show that vitamin E alone induces necrosis of TC-1 cells and elicits antitumor effects in TC-1 tumor-bearing mice. We further demonstrate that vitamin E reverses the suppression of T cell activation by MDSCs and that this effect is mediated in part by a nitric oxide-dependent mechanism. Additionally, treatment with vitamin E reduces the percentage of MDSCs in tumor loci, and induces a higher percentage of T cells, following T cell adoptive transfer. Finally, we demonstrate that treatment with vitamin E followed by E7-specific T cell adoptive transfer experience elicits potent antitumor effects in tumor-bearing mice. Our data provide additional evidence that vitamin E has anticancer properties and that it has promise for use as an adjuvant in combination with a variety of cancer therapies.	[Kang, Tae Heung; Kim, Young Seob] Konkuk Univ, Coll Med, Seoul Dept Immunol, Chungju, South Korea; [Knoff, Jayne; Yeh, Wei-Hsi; Yang, Benjamin; Wu, Tzyy-Choou; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Wu, Tzyy-Choou] Johns Hopkins Med Inst, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Wu, Tzyy-Choou] Johns Hopkins Med Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Wu, Tzyy-Choou; Hung, Chien-Fu] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Wang, Chenguang] Johns Hopkins Med Inst, Sidney Kimmel Canc Comprehens Canc Ctr, Dept Biostat & Bioinformat, Baltimore, MD 21205 USA; [Kim, Tae Woo] Korea Univ, Grad Sch Med, Div Infect & Immunol, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Korea University; Korea University Medicine (KU Medicine)	Kang, TH (corresponding author), Konkuk Univ, Coll Med, Seoul Dept Immunol, Chungju, South Korea.	kangiron@kku.ac.kr; chung2@jhmi.edu		Bissonette, Jayne/0000-0001-8376-9242	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [NRF-2013M3A9D3045881]; National Institutes of Health/National Cancer Institute Cervical Cancer SPORE [P50CA098252, 2R01CA114425-06]; NATIONAL CANCER INSTITUTE [P50CA098252, R01CA114425] Funding Source: NIH RePORTER	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; National Institutes of Health/National Cancer Institute Cervical Cancer SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013M3A9D3045881) and by the National Institutes of Health/National Cancer Institute Cervical Cancer SPORE P50CA098252 and 2R01CA114425-06 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSTICK RM, 1993, CANCER RES, V53, P4230; BURTON GW, 1990, ANNU REV NUTR, V10, P357, DOI [10.1146/annurev.nu.10.070190.002041, 10.1146/annurev.nutr.10.1.357]; Casaburi I, 2013, MOL NUTR FOOD RES, V57, P71, DOI 10.1002/mnfr.201200503; Cheng WF, 2001, J CLIN INVEST, V108, P669, DOI 10.1172/JCI200112346; Constantinou C, 2008, INT J CANCER, V123, P739, DOI 10.1002/ijc.23689; Hahn T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-471; Jin M, 2013, INT J BIOL MACROMOL; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kim D, 2007, HUM GENE THER, V18, P575, DOI 10.1089/hum.2007.038; Kim TW, 2004, J BIOMED SCI, V11, P493, DOI 10.1159/000077899; Kim TW, 2004, CANCER RES, V64, P400, DOI 10.1158/0008-5472.CAN-03-1475; Lesokhin AM, 2012, CANCER RES, V72, P876, DOI 10.1158/0008-5472.CAN-11-1792; Lin KY, 1996, CANCER RES, V56, P21; Malmberg KJ, 2002, CLIN CANCER RES, V8, P1772; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; MENKES MS, 1986, NEW ENGL J MED, V315, P1250, DOI 10.1056/NEJM198611133152003; Omer B, 1997, J NATL CANCER I, V89, P972, DOI 10.1093/jnci/89.13.972; Prasad KN, 2003, J AM COLL NUTR, V22, P108, DOI 10.1080/07315724.2003.10719283; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Trimble CL, 2009, CLIN CANCER RES, V15, P361, DOI 10.1158/1078-0432.CCR-08-1725; Tseng CW, 2008, CLIN CANCER RES, V14, P3185, DOI 10.1158/1078-0432.CCR-08-0037; Wang TL, 2000, GENE THER, V7, P726, DOI 10.1038/sj.gt.3301160; White E, 1997, CANCER EPIDEM BIOMAR, V6, P769; Yang CS, 2012, CANCER PREV RES, V5, P701, DOI 10.1158/1940-6207.CAPR-12-0045; YASUNAGA T, 1982, J NUTR, V112, P1075, DOI 10.1093/jn/112.6.1075; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	28	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103562	10.1371/journal.pone.0103562	http://dx.doi.org/10.1371/journal.pone.0103562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072795	Green Published, Green Submitted, gold			2022-12-27	WOS:000341307600063
J	Ramanuj, PP; Granerod, J; Davies, NWS; Conti, S; Brown, DWG; Crowcroft, NS				Ramanuj, Parashar Pravin; Granerod, Julia; Davies, Nicholas W. S.; Conti, Stefano; Brown, David W. G.; Crowcroft, Natasha S.			Quality of Life and Associated Socio-Clinical Factors after Encephalitis in Children and Adults in England: A Population-Based, Prospective Cohort Study	PLOS ONE			English	Article								Objective: We sought to measure HRQoL in all-cause encephalitis survivors and assess the impact of various socio-clinical factors on outcome. Methods: We used a prospective cohort study design, using the short-form 36 (SF-36) to measure the HRQoL in patients 15 years and older, and the short-form 10 (SF-10) for patients less than 15 years old. We posted questionnaires to individuals six months after discharge from hospital. All scores were normalised to the age-and sex-matched general population. We used multivariate statistical analysis to assess the relative association of clinical and socio-demographic variables on HRQoL in adults. Results: Of 109 individuals followed-up, we received 61 SF-36 and twenty SF-10 questionnaires (response rate 74%). Patients scored consistently worse than the general population in all domains of the SF-36 and SF-10, although there was variation in individual scores. Infectious encephalitis was associated with the worst HRQoL in those aged 15 years and over, scoring on average 5.64 points less than immune-mediated encephalitis (95% CI -8.77 - -2.89). In those aged less than 15 years the worst quality of life followed encephalitis of unknown cause. Immuno compromise, unemployment, and the 35-44 age group all had an independent negative association with HRQoL. A poor Glasgow Outcome Score was most strongly associated with a poor HRQoL. Less than half of those who had made a 'good' recovery on the score reported a HRQoL equivalent to the general population. Conclusions: Encephalitis has adverse effects on the majority of survivors' wellbeing and quality of life. Many of these adverse consequences could be minimised by prompt identification and treatment, and with better rehabilitation and support for survivors.	[Ramanuj, Parashar Pravin] Publ Hlth England, Reference Microbiol Serv, London, England; [Ramanuj, Parashar Pravin] Maudsley NHS Fdn Trust, London, England; [Granerod, Julia; Brown, David W. G.] Publ Hlth England, Virus Reference Dept, London, England; [Davies, Nicholas W. S.] Chelsea & Westminster Hosp, Dept Neurol, London, England; [Conti, Stefano] Publ Hlth England, Stat Modelling & Econ Dept, London, England; [Crowcroft, Natasha S.] Publ Hlth Ontario, Toronto, ON, Canada	Public Health England; South London & Maudsley NHS Trust; Public Health England; Imperial College London; Public Health England	Ramanuj, PP (corresponding author), Publ Hlth England, Reference Microbiol Serv, London, England.	p.ramanuj@doctors.org.uk	Ramanuj, Parashar/AAP-4189-2020; Ramanuj, Parashar/M-1330-2019	Ramanuj, Parashar/0000-0002-0488-7070; 	Department of Health, Policy Research Programme in the UK [047/0010]	Department of Health, Policy Research Programme in the UK	Funding was obtained by JG and DWGB. This work was supported by the Department of Health, Policy Research Programme in the UK [Grant number: Prospective Aetiological Study of Encephalitis 047/0010]. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almborg AH, 2009, J REHABIL MED, V41, P48, DOI 10.2340/16501977-0287; [Anonymous], SF 10 HLTH SURVEY CH; Brundage M, 2011, QUAL LIFE RES, V20, P653, DOI 10.1007/s11136-010-9793-3; Davison KL, 2003, EMERG INFECT DIS, V9, P234; Granerod J, 2010, NEUROLOGY, V75, P924, DOI 10.1212/WNL.0b013e3181f11d65; Granerod J, 2013, EMERG INFECT DIS, V19, P1455, DOI 10.3201/eid1909.130064; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Jenkinson C, 1999, J EPIDEMIOL COMMUN H, V53, P46, DOI 10.1136/jech.53.1.46; JENNETT B, 1975, LANCET, V1, P480; King CR, 2012, QUALITY LIFE NURSING, P307; Mailles A, 2012, CLIN INFECT DIS, V54, P1455, DOI 10.1093/cid/cis226; Office for National Statistics, NAT STAT SOC EC CLAS; Plummer M., 2003, P 3 INT WORKSH DISTR, P125, DOI DOI 10.1038/S41598-018-29599-W; R Core Team, 2021, R LANGUAGE ENV STAT; Stansfeld SA, 1997, QUAL LIFE RES, V6, P217; Stapley S., 2008, MAKING SENSE CHRONIC; Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1; Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Ware Jr JE, 2000, SCORE VERSION 2 SF 3, P137	20	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103496	10.1371/journal.pone.0103496	http://dx.doi.org/10.1371/journal.pone.0103496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KU	25072738	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600054
J	Baidya, M; Genovez, M; Torres, M; Chao, MY				Baidya, Melvin; Genovez, Marx; Torres, Marissa; Chao, Michael Y.			Dopamine Modulation of Avoidance Behavior in Caenorhabditis elegans Requires the NMDA Receptor NMR-1	PLOS ONE			English	Article							C-ELEGANS; NERVOUS-SYSTEM; ASH NEURONS; PLASTICITY; RESPONSES; CURRENTS; POTENTIATION; SENSITIVITY; SUBUNIT; PATHWAY	The nematode C. elegans utilizes a relatively simple neural circuit to mediate avoidance responses to noxious stimuli such as the volatile odorant octanol. This avoidance behavior is modulated by dopamine. cat-2 mutant animals that are deficient in dopamine biosynthesis have an increased response latency to octanol compared to wild type animals, and this defect can be fully restored with the application of exogenous dopamine. Because this avoidance behavior is mediated by glutamatergic signaling between sensory neurons and premotor interneurons, we investigated the genetic interactions between dopaminergic signaling and ionotropic glutamate receptors. cat-2 mutant animals lacking either the GLR-1 or GLR-2 AMPA/kainate receptors displayed an increased response latency to octanol, which could be restored via exogenous dopamine. However, whereas cat-2 mutant animals lacking the NMR-1 NMDA receptor had increased response latency to octanol they were insensitive to exogenous dopamine. Mutants that lacked both AMPA/kainate and NMDA receptors were also insensitive to exogenous dopamine. Our results indicate that dopamine modulation of octanol avoidance requires NMR-1, consistent with NMR-1 as a potential downstream signaling target for dopamine.	[Baidya, Melvin; Genovez, Marx; Torres, Marissa; Chao, Michael Y.] Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA	California State University System; California State University San Bernardino	Chao, MY (corresponding author), Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA.	mchao@csusb.edu			National Institute of General Medical Science [1SC3GM089597]; College of Natural Sciences, California State University San Bernardino; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM089597] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); College of Natural Sciences, California State University San Bernardino; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institute of General Medical Science (1SC3GM089597) and the College of Natural Sciences, California State University San Bernardino. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blank T, 1997, P NATL ACAD SCI USA, V94, P14859, DOI 10.1073/pnas.94.26.14859; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Cepeda C, 2009, FRONT NEUROSCI, P41; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chao MY, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-45; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chase Daniel L, 2007, WormBook, P1; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Chergui K, 1999, NEUROPHARMACOLOGY, V38, P223, DOI 10.1016/S0028-3908(98)00187-7; CULOTTI JG, 1978, GENETICS, V90, P243; Ezak MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009487; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Hapiak V, 2013, J NEUROSCI, V33, P14107, DOI 10.1523/JNEUROSCI.1324-13.2013; Harris G, 2010, J NEUROSCI, V30, P7889, DOI 10.1523/JNEUROSCI.0497-10.2010; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hart AC, 1999, J NEUROSCI, V19, P1952; Hart AC, 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.87.1, 10.1895/wormbook.1.87.1]; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hutter H, 2003, DEVELOPMENT, V130, P5307, DOI 10.1242/dev.00727; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kano T, 2008, CURR BIOL, V18, P1010, DOI 10.1016/j.cub.2008.05.051; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Lints R, 1999, DEVELOPMENT, V126, P5819; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Mills H, 2012, EMBO J, V31, P667, DOI 10.1038/emboj.2011.422; Murphy JA, 2014, J NEUROSCI, V34, P869, DOI 10.1523/JNEUROSCI.4538-13.2014; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Ringstad N, 2009, SCIENCE, V325, P96, DOI 10.1126/science.1169243; Rios M, 1999, J NEUROSCI, V19, P3519; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Stiernagle Theresa, 2006, WormBook, P1; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Zhuo M, 2000, Prog Brain Res, V129, P101	50	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e102958	10.1371/journal.pone.0102958	http://dx.doi.org/10.1371/journal.pone.0102958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089710	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700013
J	Hopkins, KL; Laher, F; Otwombe, K; Churchyard, G; Bekker, LG; DeRosa, S; Nchabeleng, M; Mlisana, K; Kublin, J; Gray, G				Hopkins, Kathryn L.; Laher, Fatima; Otwombe, Kennedy; Churchyard, Gavin; Bekker, Linda-Gail; DeRosa, Stephen; Nchabeleng, Maphoshane; Mlisana, Koleka; Kublin, James; Gray, Glenda			Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses	PLOS ONE			English	Article							TEST-OF-CONCEPT; INFLUENZA VACCINATION; ANTIBODY-RESPONSE; SOUTH-AFRICA; DOUBLE-BLIND; ALCOHOL; EFFICACY; SAFETY; IMMUNOGENICITY; HUMANS	Background: Phambili, the Merck (MRK)-Adenovirus Type 5 (Ad5) HIV-1 gag/pol/nef subtype B vaccine study, conducted in South Africa, suspended enrollment and vaccination when companion study, Step, was found non-efficacious. Although the vaccine did not prevent HIV-1 infection or lower viral-load setpoint, immune responses recognized clades B and C HIV-1 subtypes. We investigated predictors of the vaccine-induced antigen-specific immune responses. Methods: Vaccine-induced immunogenicity was ascertained by interferon-c ELISpot assays on the first 186 enrolled participants receiving two vaccinations. Analyses, stratified by study arm/sex, were performed on baseline demographics [ sex, age, Body Mass Index (BMI), site, Adenovirus Type-5 (Ad5) titer, Herpes Simplex Virus Type-2 (HSV2) status, heavy drinking]. Multivariate logistic regression determined predictors. Results: Of the 186 participants, 53.7% (n = 100) were female, median BMI was 22.5 [ IQR: 20.4-27.0], 85.5% (n = 159) were Ad5 seropositive, and 18.8% (n = 35) drank heavily. All vaccine recipients responded to both clade B (n = 87; 47%) and/or C (n = 74; 40%), p = 0.17. In multivariate analysis, female sex [ Adjusted Odds Ratio (AOR): 6.478; p = 0.0159], overweight/obese BMI (AOR: 0.186; p = 0.0452), and heavy drinking (AOR: 0.270; p = 0.048) significantly predicted immune response to clade C for any antigens. A marginally significant predictor of clade C-pol antigen was female sex (AOR: 3.182; p = 0.0500). Conclusions: Sex, BMI, and heavy drinking affected vaccine-induced HIV-1 specific immune responses to clade C antigens. The role of female sex and overweight/obese BMI boosting and suppressing vaccine-induced HIV-1 specific immune responses, respectively, requires elucidation, including any effect on HIV vaccine efficacy, especially in the era of colliding epidemics (HIV and obesity).	[Hopkins, Kathryn L.; Laher, Fatima; Otwombe, Kennedy; Gray, Glenda] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Churchyard, Gavin] Univ Witwatersrand, Sch Publ Hlth, Aurum Inst Hlth Res, Fac Hlth Sci, Johannesburg, South Africa; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [DeRosa, Stephen; Kublin, James] Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, Seattle, WA 98104 USA; [Nchabeleng, Maphoshane] Univ Limpopo, Medunsa HIV Clin Res Unit, Pretoria, South Africa; [Mlisana, Koleka] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Durban, South Africa; [Mlisana, Koleka] Univ KwaZulu Natal, Dept Med Microbiol, Durban, South Africa	University of Witwatersrand; University of Witwatersrand; University of Cape Town; Fred Hutchinson Cancer Center; Sefako Makgatho Health Sciences University; University of Limpopo; University of Kwazulu Natal; University of Kwazulu Natal	Hopkins, KL (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa.	hopkinsk@PHRU.co.za	Bekker, Linda-Gail/AAZ-8929-2020; Mlisana, Koleka/N-6204-2013	Churchyard, Gavin/0000-0002-4269-3699; Mlisana, Koleka/0000-0002-8436-3268; BEKKER, LINDA-GAIL/0000-0002-0755-4386	National Institute of Allergy and Infectious Diseases [5U01 AI068614, 5U01 AI068618, 5U01 AI068635, 5U01 AI069453, 5U01 AI069519, 5U01 AI069469]; Merck and Co Inc.; South African AIDS Vaccine initiative (SAAVI); Canada-Africa Prevention Trials Network (CAPTN); FOGARTY INTERNATIONAL CENTER [U2RTW007373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068618, U01AI069519, UM1AI069519, U01AI068614, U01AI069469, UM1AI069453, UM1AI068614, U01AI069453, U01AI068635] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Merck and Co Inc.(Merck & Company); South African AIDS Vaccine initiative (SAAVI); Canada-Africa Prevention Trials Network (CAPTN); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The original Phambili study was funded by grants from the National Institute of Allergy and Infectious Diseases to the HIV Vaccine Trials Network (5U01 AI068614, 5U01 AI068618, 5U01 AI068635, 5U01 AI069453, 5U01 AI069519, 5U01 AI069469), as well as Merck and Co Inc. The South African AIDS Vaccine initiative (SAAVI) provided support to the clinical trial sites. KCH gratefully acknowledges the support of a publications writing programme funded in part by Canada-Africa Prevention Trials Network (CAPTN). KO received research training from the Fogarty International Center (TW007373/0). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed in this Article are those of the authors and do not represent the official views of the US National Institute of Allergy and Infectious Diseases.	Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c; Bautista AP, 2001, FREE RADICAL BIO MED, V31, P1527, DOI 10.1016/S0891-5849(01)00745-6; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burns VE, 2003, VACCINE, V21, P2523, DOI 10.1016/S0264-410X(03)00041-0; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Caton SJ, 2004, PHYSIOL BEHAV, V81, P51, DOI 10.1016/j.physbeh.2003.12.017; Cooper CJ, 2010, JAMA-J AM MED ASSOC, V304, P275, DOI 10.1001/jama.2010.926; Coplan PM, 2005, J INFECT DIS, V191, P1427, DOI 10.1086/428450; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Gray G, 2010, CURR OPIN HIV AIDS, V5, P357, DOI 10.1097/COH.0b013e32833d2d2b; Gray GE, 2014, LANCET INFECT DIS, V14, P388, DOI 10.1016/S1473-3099(14)70020-9; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; GROSSMAN C, 1989, J STEROID BIOCHEM, V34, P241, DOI 10.1016/0022-4731(89)90088-5; Heikkinen T, 2011, VACCINE, V29, P7529, DOI 10.1016/j.vaccine.2011.08.011; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Kovacs EJ, 2002, ALCOHOL RES HEALTH, V26, P257; MacLachlan E, 2009, JAIDS-J ACQ IMM DEF, V51, P536, DOI 10.1097/QAI.0b013e3181adcbbe; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Messingham KAN, 2002, ALCOHOL, V28, P137, DOI 10.1016/S0741-8329(02)00278-1; MORELL V, 1995, SCIENCE, V269, P773, DOI 10.1126/science.7638587; Morris AG, 2011, S AFR J SCI, V107, P12, DOI 10.4102/sajs.v107i3/4.650; Morris L, 2009, S AFR J SCI, V105, P168; Nelson S, 2002, NAT REV IMMUNOL, V2, P205, DOI 10.1038/nri744; Patterson Steven, 2009, Handb Exp Pharmacol, P275, DOI 10.1007/978-3-540-71029-5_13; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Potter JM, 1999, AGE AGEING, V28, P141, DOI 10.1093/ageing/28.2.141; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Rots NY, 2010, VACCINE, V28, P893, DOI 10.1016/j.vaccine.2009.10.125; Siler SQ, 1999, AM J CLIN NUTR, V70, P928; Van der Wielen M, 2006, VACCINE, V24, P5509, DOI 10.1016/j.vaccine.2006.04.016; WEBER DJ, 1985, JAMA-J AM MED ASSOC, V254, P3187, DOI 10.1001/jama.254.22.3187; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011	37	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103446	10.1371/journal.pone.0103446	http://dx.doi.org/10.1371/journal.pone.0103446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090110	gold, Green Submitted, Green Published			2022-12-27	WOS:000339812700028
J	White, SA; Buscaino, A; Sanchez-Pulido, L; Ponting, CP; Nowicki, MW; Allshire, RC				White, Sharon A.; Buscaino, Alessia; Sanchez-Pulido, Luis; Ponting, Chris P.; Nowicki, Matthew W.; Allshire, Robin C.			The RFTS Domain of Raf2 Is Required for Cul4 Interaction and Heterochromatin Integrity in Fission Yeast	PLOS ONE			English	Article							DNA METHYLTRANSFERASE 1; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME SEGREGATION; HISTONE MODIFICATION; CENTROMERE FUNCTION; RNA INTERFERENCE; UBIQUITIN LIGASE; CHROMATIN; METHYLATION; COMPLEX	Centromeric heterochromatin assembly in fission yeast is critical for faithful chromosome segregation at mitosis. Its assembly requires a concerted pathway of events whereby the RNA interference (RNAi) pathway guides H3K9 methylation to target sequences. H3K9 methylation, a hallmark of heterochromatin structure, is mediated by the single histone methyltransferase Clr4 (equivalent to metazoan Suv3-9), a component of the CLRC complex. Loss of or defects in CLRC components disrupts heterochromatin formation due to loss of H3K9 methylation, thus an intact, fully functional CLRC complex is required for heterochromatin integrity. Despite its importance, little is known about the contribution of the CLRC component Raf2 to H3K9 methylation and heterochromatin assembly. We demonstrate that Raf2 is concentrated at centromeres and contrary to other analyses, we find that loss of Raf2 does not affect CENP-A(Cnp1) localisation or recruitment to centromeres. Our sequence alignments show that Raf2 contains a Replication Foci Targeting Sequence (RFTS) domain homologous to the RFTS domain of the human DNA methyltransferase DNMT1. We show that the Raf2 RFTS domain is required for centromeric heterochromatin formation as its mutation disrupts H3K9 methylation but not the processing of centromeric transcripts into small interfering RNAs (siRNAs) by the RNAi pathway. Analysis of biochemical interactions demonstrates that the RFTS domain mediates an interaction between Raf2 and the CLRC component Cul4. We conclude that the RFTS domain of Raf2 is a protein interaction module that plays an important role in heterochromatin formation at centromeres.	[White, Sharon A.; Nowicki, Matthew W.; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [White, Sharon A.; Nowicki, Matthew W.; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Edinburgh, Midlothian, Scotland; [Buscaino, Alessia] Univ Kent, Kent Fungal Grp, Sch Biosci, Canterbury, Kent, England; [Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford, England	University of Edinburgh; University of Edinburgh; University of Kent; University of Oxford	Allshire, RC (corresponding author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Buscaino, Alessia/AAK-2976-2020; Ponting, Chris/AAV-2621-2021	Buscaino, Alessia/0000-0002-1704-3168; Ponting, Chris/0000-0003-0202-7816; Allshire, Robin/0000-0002-8005-3625; Sanchez Pulido, Luis/0000-0002-2300-8502	Wellcome Trust [065061, 095021, 092076]; European Commission Network of Excellence EpiGeneSys [HEALTH-F4-2010-257082]; MRC; Medical Research Council [MC_UU_12021/1, MC_U137761446] Funding Source: researchfish; MRC [MC_UU_12021/1, MC_U137761446] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission Network of Excellence EpiGeneSys; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Wellcome Trust supported the work of R. C. A. (065061 and 095021) along with funding from the European Commission Network of Excellence EpiGeneSys (HEALTH-F4-2010-257082). The Wellcome Trust Centre for Cell Biology is supported by core funding from the Wellcome Trust (092076). RCA is a Wellcome Trust Principal Research Fellow. LSP and CPP were funded by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buscaino A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002499; Debeauchamp JL, 2008, MOL CELL BIOL; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Djupedal I, 2009, EMBO J, V28, P3832, DOI 10.1038/emboj.2009.351; Ekwall K, 1996, J CELL SCI, V109, P2637; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fellinger K, 2009, J CELL BIOCHEM, V106, P521, DOI 10.1002/jcb.22071; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Gerace EL, 2010, MOL CELL, V39, P360, DOI 10.1016/j.molcel.2010.07.017; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gonzalez M, 2013, P NATL ACAD SCI USA, V110, P606, DOI 10.1073/pnas.1214874110; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hashimoto H, 2009, EPIGENETICS-US, V4, P8, DOI 10.4161/epi.4.1.7370; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kuscu C, 2014, P NATL ACAD SCI USA, V111, P1795, DOI 10.1073/pnas.1313096111; Lando D, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120078; Lejeune E, 2011, CURR OPIN CELL BIOL, V23, P258, DOI 10.1016/j.ceb.2011.03.005; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Margot JB, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-7; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Tullu MS, 2010, EUR J PEDIATR, V169, P629, DOI 10.1007/s00431-009-1083-0; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White SA, 2008, CURR TOP MICROBIOL, V320, P157; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	52	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104161	10.1371/journal.pone.0104161	http://dx.doi.org/10.1371/journal.pone.0104161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25090107	Green Submitted, Green Published, gold			2022-12-27	WOS:000339812700105
J	Afzal, M; Nawaz, R; Ayub, M; Wahab, A				Afzal, Muhammad; Nawaz, Rab; Ayub, Muhammad; Wahab, Abdul			Acoustic Scattering in Flexible Waveguide Involving Step Discontinuity	PLOS ONE			English	Article							ELASTIC PLATE; PROPAGATION; NOISE; DIFFRACTION; SOUND; DUCTS; FLOW	In this paper, the propagation and scattering of acoustic waves in a flexible wave-guide involving step discontinuity at an interface is considered. The emerging boundary value problem is non-Sturm-Liouville and is solved by employing a hybrid mode-matching technique. The physical scattering process and attenuation of duct modes versus frequency regime and change of height is studied. Moreover, the mode-matching solution is validated through a series of numerical experiments by testifying the power conservation identity and matching interface conditions.	[Afzal, Muhammad; Ayub, Muhammad] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Nawaz, Rab; Wahab, Abdul] COMSATS Inst Informat Technol, Dept Math, Wah Cantt, Pakistan	Quaid I Azam University; COMSATS University Islamabad (CUI)	Wahab, A (corresponding author), COMSATS Inst Informat Technol, Dept Math, Wah Cantt, Pakistan.	wahab@ciitwah.edu.pk	Nawaz, Rab/A-3495-2015; Wahab, Abdul/J-3448-2012; Wahab, Abdul/ABG-6042-2021	Nawaz, Rab/0000-0002-9707-0608; Wahab, Abdul/0000-0002-9179-7427; Wahab, Abdul/0000-0002-9179-7427				Alonso R, 2013, COMMUN MATH SCI, V11, P233; Ammari H, 2012, SIAM J APPL MATH, V72, P317, DOI 10.1137/11083191X; ASTLEY RJ, 1991, J SOUND VIB, V150, P119, DOI 10.1016/0022-460X(91)90406-A; Ayub M, 2010, COMPUT MATH APPL, V60, P3123, DOI 10.1016/j.camwa.2010.10.017; Ayub M, 2009, CAN J PHYS, V87, P1139, DOI 10.1139/P09-104; Bhattacharjee J, 2012, J ENG MATH, V75, P29, DOI 10.1007/s10665-011-9511-3; BRAZIERSMITH PR, 1987, P ROY SOC LOND A MAT, V409, P115, DOI 10.1098/rspa.1987.0009; CRIGHTON DG, 1991, PHILOS T ROY SOC A, V335, P557, DOI 10.1098/rsta.1991.0060; Evans DV, 2003, J FLUID MECH, V484, P143, DOI 10.1017/S002211200300435X; Huang LX, 1999, J ACOUST SOC AM, V106, P1801, DOI 10.1121/1.427930; Huang LX, 2004, J SOUND VIB, V269, P467, DOI 10.1016/S0022-460X(02)01642-5; Kang J, 1999, J SOUND VIB, V220, P905, DOI 10.1006/jsvi.1998.1997; Kaplunov YD, 2004, ACOUST PHYS+, V50, P694, DOI 10.1134/1.1825100; Lawrie JB, 2007, IMA J APPL MATH, V72, P376, DOI 10.1093/imamat/hxm004; Lawrie JB, 2006, J ACOUST SOC AM, V120, P780, DOI 10.1121/1.2213571; Lawrie JB, 2012, MECCANICA, V47, P783, DOI 10.1007/s11012-011-9471-8; Lawrie JB, 1999, Q J MECH APPL MATH, V52, P161, DOI 10.1093/qjmam/52.2.161; Lawrie JB, 1997, IMA J APPL MATH, V59, P1, DOI 10.1093/imamat/59.1.1; Manam SR, 2006, P ROY SOC A-MATH PHY, V462, P263, DOI 10.1098/rspa.2005.1562; Nawaz R, 2014, J MOD OPTIC, V61, P1324, DOI 10.1080/09500340.2014.931477; Nawaz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092566; Nawaz R, 2013, J ACOUST SOC AM, V134, P1939, DOI 10.1121/1.4817891; Norris AN, 1995, P R SOC-MATH PHYS SC, V451, P631, DOI 10.1098/rspa.1995.0147; Veitch B, 2008, J FLUID MECH, V613, P275, DOI 10.1017/S0022112008003169; Venkatesham B, 2008, J ACOUST SOC AM, V124, P2952, DOI 10.1121/1.2977671; Warren DP, 2002, WAVE MOTION, V36, P119, DOI 10.1016/S0165-2125(02)00005-7	26	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103807	10.1371/journal.pone.0103807	http://dx.doi.org/10.1371/journal.pone.0103807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084019	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800082
J	Cuskley, CF; Pugliese, M; Castellano, C; Colaiori, F; Loreto, V; Tria, F				Cuskley, Christine F.; Pugliese, Martina; Castellano, Claudio; Colaiori, Francesca; Loreto, Vittorio; Tria, Francesca			Internal and External Dynamics in Language: Evidence from Verb Regularity in a Historical Corpus of English	PLOS ONE			English	Article								Human languages are rule governed, but almost invariably these rules have exceptions in the form of irregularities. Since rules in language are efficient and productive, the persistence of irregularity is an anomaly. How does irregularity linger in the face of internal (endogenous) and external (exogenous) pressures to conform to a rule? Here we address this problem by taking a detailed look at simple past tense verbs in the Corpus of Historical American English. The data show that the language is open, with many new verbs entering. At the same time, existing verbs might tend to regularize or irregularize as a consequence of internal dynamics, but overall, the amount of irregularity sustained by the language stays roughly constant over time. Despite continuous vocabulary growth, and presumably, an attendant increase in expressive power, there is no corresponding growth in irregularity. We analyze the set of irregulars, showing they may adhere to a set of minority rules, allowing for increased stability of irregularity over time. These findings contribute to the debate on how language systems become rule governed, and how and why they sustain exceptions to rules, providing insight into the interplay between the emergence and maintenance of rules and exceptions in language.	[Cuskley, Christine F.; Pugliese, Martina; Castellano, Claudio; Colaiori, Francesca; Loreto, Vittorio] Inst Complex Syst ISC CNR, Rome, Italy; [Pugliese, Martina; Castellano, Claudio; Colaiori, Francesca; Loreto, Vittorio] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Loreto, Vittorio; Tria, Francesca] ISI, Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome	Cuskley, CF (corresponding author), Inst Complex Syst ISC CNR, Rome, Italy.	ccuskley@gmail.com	Cuskley, Christine/GRR-2660-2022; Colaiori, Francesca/K-6533-2015; Cuskley, Christine/J-4175-2019; Castellano, Claudio/B-6946-2008	Cuskley, Christine/0000-0002-5699-4556; Colaiori, Francesca/0000-0001-7165-1941; Cuskley, Christine/0000-0002-5699-4556; Castellano, Claudio/0000-0002-3773-3801	European Science Foundation as part of the DRUST project, a EUROCORES EuroUnderstanding programme	European Science Foundation as part of the DRUST project, a EUROCORES EuroUnderstanding programme	This work was supported by the European Science Foundation as part of the DRUST project, a EUROCORES EuroUnderstanding programme. http://www.esf.org/coordinating-research/eurocores/running-programmes/eurounderstanding.html http://www.eurounderstanding.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright A, 2003, COGNITION, V90, P119, DOI 10.1016/S0010-0277(03)00146-X; Bybee J., 2001, PHONOLOGY LANGUAGE U; Bybee J.L., 1985, TYPOLOGICAL STUDIES, V9; Bybee Joan L., 2007, FREQUENCY USE ORG LA, DOI DOI 10.1093/ACPROF:OSO/9780195301571.001.0001; Carroll R, 2012, J HIST LINGUIST, V2, P153, DOI 10.1075/jhl.2.2.01car; Croft W., 2000, EXPLAINING LANGUAGE; Davies M, 2012, CORPUS HIST AM ENGLI; Emberts Zachary, 2020, EVOLUTION, V74, P897, DOI [10.1111/evo.13948, DOI 10.1111/EVO.13580]; Garside R., 1987, COMPUTATIONAL ANAL E, P30; Gries ST, 2010, ENGL LANG LINGUIST, V14, P293, DOI 10.1017/S1360674310000092; Heaps Harold Stanley, 1978, INFORM RETRIEVAL COM; Hilpert Martin., 2013, CONSTRUCTIONAL CHANG, DOI [10.1017/CBO9781139004206, DOI 10.1017/CBO9781139004206]; JONES MARI C, 2002, LANGUAGE CHANGE INTE; Kirby S, 2008, P NATL ACAD SCI USA, V105, P10681, DOI 10.1073/pnas.0707835105; Labov W, 1972, SOCIOLINGUISTIC PATT, P4; Lieberman E, 2007, NATURE, V449, P713, DOI 10.1038/nature06137; LILJENCRANTS J, 1972, LANGUAGE, V48, P839, DOI 10.2307/411991; Lindblom B., 1986, EXPT PHONOLOGY, P13; Lupyan G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008559; McClelland JL, 2002, TRENDS COGN SCI, V6, P464, DOI 10.1016/S1364-6613(02)02012-0; McMahon AprilM.S., 1994, UNDERSTANDING LANGUA, DOI [10.1017/CBO9781139166591, DOI 10.1017/CBO9781139166591]; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Muhlhausler P, 1996, LINGUISTIC ECOLOGY L, Vxiv; Perc M, 2012, J ROYAL SOC INTERFAC; Petersen AM, 2012, SCI REPORTS, V2, P1, DOI DOI 10.1038/SREP00943; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Pinker S, 2000, LANDFALL, V8, P87; Pinker S., 1999, WORDS RULES INGREDIE; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, DOI DOI 10.7551/MITPRESS/5237.001.0001; Skousen R., 1989, ANALOGICAL MODELING; Whitney WilliamDwight., 1875, LIFE GROWTH LANGUAGE; Yang C. D., 2002, KNOWLEDGE LEARNING N; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	33	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e102882	10.1371/journal.pone.0102882	http://dx.doi.org/10.1371/journal.pone.0102882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AM4JL	25084006	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800012
J	Mohamad, KY; Kaltenboeck, B; Rahman, KS; Magnino, S; Sachse, K; Rodolakis, A				Mohamad, Khalil Yousef; Kaltenboeck, Bernhard; Rahman, Kh. Shamsur; Magnino, Simone; Sachse, Konrad; Rodolakis, Annie			Host Adaptation of Chlamydia pecorum towards Low Virulence Evident in Co-Evolution of the ompA, incA, and ORF663 Loci	PLOS ONE			English	Article							CHLAMYDOPHILA-PECORUM; INFECTIONS; SEQUENCE; DIVERSITY; PSITTACI; SHEEP; IDENTIFICATION; PREVALENCE; STRAINS; CATTLE	Chlamydia (C.) pecorum, an obligate intracellular bacterium, may cause severe diseases in ruminants, swine and koalas, although asymtomatic infections are the norm. Recently, we identified genetic polymorphisms in the ompA, incA and ORF663 genes that potentially differentiate between high-virulence C. pecorum isolates from diseased animals and low-virulence isolates from asymptomatic animals. Here we expand these findings by including additional ruminant, swine, and koala strains. Coding tandem repeats (CTRs) at the tncA locus encoded a variable number of repeats of APA or AGA amino acid motifs. Addition of any non-APA/AGA repeat motif, such as APEVPA, APAVPA, APE, or APAPE, associated with low-virulence (P<10(-4)), as did a high number of amino acids in all incA CTRs (P=0.0028). In ORF663, high numbers of 15-mer CTRs correlated with low virulence (P=0.0001). Correction for ompA phylogram position in ORF663 and incA abolished the correlation between genetic changes and virulence, demonstrating co-evolution of ompA, incA, and ORF663 towards low virulence. Pairwise divergence of ompA,incA, and ORF663 among isolates from healthy animals was significantly higher than among strains isolated from diseased animals (P <= 10(-5)), confirming the longer evolutionary path traversed by low-virulence trains. All three markers combined identified 43 unique strains and 4 pairs of identical strains among all 57 isolates tested, demonstrating the suitability of these markers for epidemiological investigations.	[Mohamad, Khalil Yousef; Rodolakis, Annie] INRA, UR1282, Infectiol Anim & Sante Publ, F-37380 Nouzilly, France; [Kaltenboeck, Bernhard; Rahman, Kh. Shamsur] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA; [Rahman, Kh. Shamsur; Magnino, Simone] Ist Zooprofilat Speriment Lombardia Romagna, Natl Reference Lab Anim Chlamydioses, Sezione Diagnost Pavia, Pavia, Italy; [Sachse, Konrad] Friedrich Loeffler Inst Jena, OIE & Natl Reference Lab Chalmdio, Jena, Germany	INRAE; Auburn University System; Auburn University; Friedrich Loeffler Institute	Mohamad, KY (corresponding author), INRA, UR1282, Infectiol Anim & Sante Publ, F-37380 Nouzilly, France.	khalilyoussef@hotmail.com	Rahman, Kh Shamsur/M-2419-2019; Sachse, Konrad/GWC-4999-2022	Rahman, Kh Shamsur/0000-0001-7243-8501; Sachse, Konrad/0000-0003-1230-1786	French Institut National de la Recherche Agronomique; Auburn University	French Institut National de la Recherche Agronomique; Auburn University	The study was funded by the French Institut National de la Recherche Agronomique, and current funding by Auburn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Coil DA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-218; DENAMUR E, 1991, J GEN MICROBIOL, V137, P2525, DOI 10.1099/00221287-137-11-2525; Di Francesco A, 2013, VET ITAL, V49, P119; Gao X, 2007, J CLIN MICROBIOL, V45, P1185, DOI 10.1128/JCM.02076-06; Godin AC, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-39; Greco G, 2008, THERIOGENOLOGY, V69, P1061, DOI 10.1016/j.theriogenology.2008.01.018; Hood DW, 1996, P NATL ACAD SCI USA, V93, P11121, DOI 10.1073/pnas.93.20.11121; Jackson Michael, 1999, Veterinary Microbiology, V65, P255, DOI 10.1016/S0378-1135(98)00302-2; Jee JB, 2004, J CLIN MICROBIOL, V42, P5664, DOI 10.1128/JCM.42.12.5664-5672.2004; Jelocnik M, 2013, J CLIN MICROBIOL, V51, P2625, DOI 10.1128/JCM.00992-13; KALTENBOECK B, 1992, AM J VET RES, V53, P1482; KALTENBOECK B, 1993, J BACTERIOL, V175, P487, DOI 10.1128/JB.175.2.487-502.1993; Kaltenboeck B, 2009, VET MICROBIOL, V135, P175, DOI 10.1016/j.vetmic.2008.09.036; Kauffold J, 2006, THERIOGENOLOGY, V65, P1750, DOI 10.1016/j.theriogenology.2005.10.010; Kuo CC, 2011, BERGEYS MANUAL SYSTE, V4, P846; Laroucau K, 2008, INFECT GENET EVOL, V8, P171, DOI 10.1016/j.meegid.2007.12.002; Lenzko H, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-29; Marsh J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-77; Mohamad KY, 2010, VET MICROBIOL, V143, P424, DOI 10.1016/j.vetmic.2009.11.017; Mohamad KY, 2010, VET RES, V41, DOI 10.1051/vetres/2009075; Mohamad KY, 2008, INFECT GENET EVOL, V8, P764, DOI 10.1016/j.meegid.2008.06.009; Mohamad KY, 2008, VET RES, V39, DOI 10.1051/vetres:2008032; Mojica S, 2011, J BACTERIOL, V193, P3690, DOI 10.1128/JB.00454-11; NORTON WL, 1967, ARTHRITIS RHEUM, V10, P1, DOI 10.1002/art.1780100102; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Polkinghorne A, 2014, COMMUNICATION; Poudel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044961; Reinhold P, 2008, VET J, V175, P202, DOI 10.1016/j.tvjl.2007.01.004; Reinhold P, 2011, VET J, V189, P257, DOI 10.1016/j.tvjl.2010.09.003; RODOLAKIS A, 1976, Annales de Recherches Veterinaires, V7, P195; RODOLAKIS A, 1989, RES VET SCI, V46, P34, DOI 10.1016/S0034-5288(18)31113-5; Sachse K, 2000, INFECT IMMUN, V68, P680, DOI 10.1128/IAI.68.2.680-687.2000; Sachse K, 2009, VET MICROBIOL, V135, P22, DOI 10.1016/j.vetmic.2008.09.041; Sait M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-23; Salinas J, 1996, COMP IMMUNOL MICROB, V19, P155, DOI 10.1016/0147-9571(95)00029-1; STORZ J, 1971, ANN NY ACAD SCI, V176, P162, DOI 10.1111/j.1749-6632.1971.tb35002.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Duynhoven YTHP, 1998, CLIN INFECT DIS, V26, P314, DOI 10.1086/516291; VANROMPAY D, 1995, VET MICROBIOL, V45, P93, DOI 10.1016/0378-1135(95)00033-7; Wan C, 2011, AUST VET J, V89, P409, DOI 10.1111/j.1751-0813.2011.00827.x; Warren K, 2005, J ZOO WILDLIFE MED, V36, P100, DOI 10.1638/02-067; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	43	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103615	10.1371/journal.pone.0103615	http://dx.doi.org/10.1371/journal.pone.0103615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084532	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800058
J	Vendlinski, MK; Javaras, KN; Van Hulle, CA; Lemery-Chalfant, K; Maier, R; Davidson, RJ; Goldsmith, HH				Vendlinski, Matthew K.; Javaras, Kristin N.; Van Hulle, Carol A.; Lemery-Chalfant, Kathryn; Maier, Rose; Davidson, Richard J.; Goldsmith, H. Hill			Relative Influence of Genetics and Shared Environment on Child Mental Health Symptoms Depends on Comorbidity	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; LATENT CLASS ANALYSIS; ADOLESCENT PSYCHOPATHOLOGY; ACADEMIC DIFFICULTIES; MIDDLE CHILDHOOD; TWIN DATA; BEHAVIOR; QUESTIONNAIRE; ASSOCIATION; CONFLUENCE	Background: Comorbidity among childhood mental health symptoms is common in clinical and community samples and should be accounted for when investigating etiology. We therefore aimed to uncover latent classes of mental health symptoms in middle childhood in a community sample, and to determine the latent genetic and environmental influences on those classes. Methods: The sample comprised representative cohorts of twins. A questionnaire-based assessment of mental health symptoms was used in latent class analyses. Data on 3223 twins (1578 boys and 1645 girls) with a mean age of 7.5 years were analyzed. The sample was predominantly non-Hispanic Caucasian (92.1%). Results: Latent class models delineated groups of children according to symptom profiles-not necessarily clinical groups but groups representing the general population, most with scores in the normative range. The best-fitting models suggested 9 classes for both girls and boys. Eight of the classes were very similar across sexes; these classes ranged from a "Low Symptom'' class to a "Moderately Internalizing & Severely Externalizing'' class. In addition, a "Moderately Anxious'' class was identified for girls but not boys, and a "Severely Impulsive & Inattentive'' class was identified for boys but not girls. Sex-combined analyses implicated moderate genetic influences for all classes. Shared environmental influences were moderate for the "Low Symptom'' and "Moderately Internalizing & Severely Externalizing'' classes, and small to zero for other classes. Conclusions: We conclude that symptom classes are largely similar across sexes in middle childhood. Heritability was moderate for all classes, but shared environment played a greater role for classes in which no one type of symptom predominated.	[Vendlinski, Matthew K.; Javaras, Kristin N.; Van Hulle, Carol A.; Davidson, Richard J.; Goldsmith, H. Hill] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Vendlinski, Matthew K.; Javaras, Kristin N.; Van Hulle, Carol A.; Davidson, Richard J.; Goldsmith, H. Hill] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Lemery-Chalfant, Kathryn] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Maier, Rose] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Arizona State University; Arizona State University-Tempe; University of Oregon	Goldsmith, HH (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	hhgoldsm@wisc.edu		Davidson, Richard/0000-0002-8506-4964; Lemery-Chalfant, Kathryn/0000-0003-4511-6501	National Institute of Mental Health [R01 MH59785, R37 MH50560]; Wisconsin Center for Affective Science [P50 MH069315]; Conte Neuroscience Center [P50 MH084051]; National Institute of Child Health and Human Development [P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100031, R01MH101504, P50MH069315, R37MH050560, R01MH059785, T32MH076694, P50MH084051] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wisconsin Center for Affective Science; Conte Neuroscience Center; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by research grants from the National Institute of Mental Health including R01 MH59785 and R37 MH50560 (to Goldsmith and Lemery-Chalfant), the Wisconsin Center for Affective Science (P50 MH069315), and a Conte Neuroscience Center (P50 MH084051, Center Director, Davidson). Infrastructure support was provided by the Waisman Center via a core grant from the National Institute of Child Health and Human Development (P30 HD03352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MT, 2008, J AM ACAD CHILD PSY, V47, P797, DOI 10.1097/CHI.0b013e318173f70b; Althoff RR, 2006, BIOL PSYCHIAT, V60, P903, DOI 10.1016/j.biopsych.2006.02.025; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1111/1469-7610.00424; Boyce WT, 2002, J AM ACAD CHILD PSY, V41, P580, DOI 10.1097/00004583-200205000-00016; Burt SA, 2009, PSYCHOL BULL, V135, P608, DOI 10.1037/a0015702; Caspi A, 2008, ARCH GEN PSYCHIAT, V65, P203, DOI 10.1001/archgenpsychiatry.2007.24; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Essex MJ, 2002, J AM ACAD CHILD PSY, V41, P588, DOI 10.1097/00004583-200205000-00017; Gjone H, 1997, J ABNORM CHILD PSYCH, V25, P277, DOI 10.1023/A:1025708318528; GOLDSMITH HH, 1991, BEHAV GENET, V21, P257; Gregory AM, 2004, J ABNORM CHILD PSYCH, V32, P111, DOI 10.1023/B:JACP.0000019765.29768.1c; Jaffee SR, 2002, J AM ACAD CHILD PSY, V41, P1095, DOI 10.1097/00004583-200209000-00010; Jensen PS, 2001, J DEV BEHAV PEDIATR, V22, P60, DOI 10.1097/00004703-200102000-00008; Keiley MK, 2003, J ABNORM CHILD PSYCH, V31, P267, DOI 10.1023/A:1023277413027; Kotov R, 2011, ARCH GEN PSYCHIAT, V68, P1003, DOI 10.1001/archgenpsychiatry.2011.107; Krueger RE, 2006, ANNU REV CLIN PSYCHO, V2, P111, DOI 10.1146/annurev.clinpsy.2.022305.095213; Lahey BB, 2004, J ABNORM PSYCHOL, V113, P358, DOI 10.1037/0021-843x.113.3.358; Lemery-Chalfant K, 2006, TWIN RES HUM GENET, V9, P1030, DOI 10.1375/183242706779462363; Magidson J., 2002, CAN J MARKET RES, V20, P37, DOI DOI 10.1017/CBO9780511499531.004; Muthen B, 2006, TWIN RES HUM GENET, V9, P313, DOI 10.1375/183242706777591317; Neale M. C, 2003, MX STAT MODELING, V6th; NEALE MC, 1994, BEHAV GENET, V24, P239, DOI 10.1007/BF01067191; Neale MC, 1992, METHODOLOGY GENETIC; Nigg JT, 2004, J CLIN CHILD ADOLESC, V33, P42, DOI 10.1207/S15374424JCCP3301_5; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Ostrander R, 2008, J CLIN CHILD ADOLESC, V37, P833, DOI 10.1080/15374410802359668; Price T S, 2000, Twin Res, V3, P129, DOI 10.1375/136905200320565391; Schmidt NL, 2013, TWIN RES HUM GENET, V16, P376, DOI 10.1017/thg.2012.105; Schmitz S, 2001, Twin Res, V4, P453; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Spatola CAM, 2007, J AM ACAD CHILD PSY, V46, P619, DOI 10.1097/chi.0b013e3180335b12; Subbarao A, 2008, J ABNORM CHILD PSYCH, V36, P433, DOI 10.1007/s10802-007-9189-1; Sullivan PF, 2002, BEHAV GENET, V32, P221, DOI 10.1023/A:1016025229858; Uebersax JS, 1999, APPL PSYCH MEAS, V23, P283, DOI 10.1177/01466219922031400; Vermunt J.K., 2005, LATENT GOLD 40 USERS; Wood AC, 2010, PSYCHOL BULL, V136, P331, DOI 10.1037/a0019048	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103080	10.1371/journal.pone.0103080	http://dx.doi.org/10.1371/journal.pone.0103080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6EF	25077799	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800025
J	Gaviria-Agudelo, C; Carter, K; Tareen, N; Pascual, V; Copley, LA				Gaviria-Agudelo, Claudia; Carter, Kristen; Tareen, Naureen; Pascual, Virginia; Copley, Lawson A.			Gene Expression Analysis of Children with Acute Hematogenous Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus: Correlation with Clinical Severity of Illness	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; INFLAMMATION; SORTILIN; DISEASE; IDENTIFICATION; LEUKOCYTES; PATTERNS; PROTEIN; SEPSIS; CANCER	Children with acute hematogenous osteomyelitis (AHO) demonstrate a broad spectrum of clinical manifestations, ranging from mild to severe. Several advances have been achieved in the study of host immune response to acute invasive Staphylococcus aureus infections through gene expression analysis. However, previous research has neither attempted to evaluate the response of children with AHO specific to Methicillin-resistant Staphylococcus aureus (MRSA) nor to correlate gene expression with clinical phenotype. Study objective was to correlate gene expression of children with AHO due to MRSA with clinical severity of illness. Whole blood samples were obtained in Tempus tubes from 12 children with osteomyelitis once cultures obtained directly from the site of infection confirmed to be positive for MRSA. Using an Illumina platform and a systems-wide modular analysis, microarray findings from ten of these children were compared to that of nine healthy (age, ethnicity and gender) matched controls and correlated with clinical severity of illness. Children with AHO from MRSA demonstrated over-expression of innate immunity with respect to neutrophil activity, coagulation, inflammatory response, and erythrocyte development. Concurrently, these children demonstrated under-expression of adaptive immunity with respect to lymphocyte activation and activity of T-cell, cytotoxic or NK cell, and B-cell lines. Three over-expressed genes, P2RX1, SORT1, and RETN, and two under-expressed genes, LOC641788 and STAT 4, were significantly correlated with severity of illness. STAT 4 showed the strongest correlation (R2 = -0.83). STAT4 downregulation could potentially explain under-expression of genes related to adaptive immunity in this cohort of patients with AHO. This study identified specific genes which correspond to disease severity during the early hospitalization of children with AHO from MRSA. Pattern recognition of this combination of genes could help to identify in the future severe clinical phenotypes before the disease is fully manifest and direct appropriate attention and resources to those children.	[Gaviria-Agudelo, Claudia] Univ Texas SW Med Ctr Dallas, Dept Pediat Infect Dis, Dallas, TX 75390 USA; [Carter, Kristen] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Gaviria-Agudelo, Claudia; Tareen, Naureen; Copley, Lawson A.] Childrens Med Ctr, Dallas, TX 75235 USA; [Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX USA; [Copley, Lawson A.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Pascual, Virginia; Copley, Lawson A.] Texas Scottish Rite Hosp Crippled Children, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baylor Scott & White Health; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas Scottish Rite Hospital for Children	Gaviria-Agudelo, C (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat Infect Dis, Dallas, TX 75390 USA.	clg14@alumni.utsw.edu	Pascual, Virginia/ABD-3099-2020		National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000451]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000451, UL1TR001105] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study funded by UT-STAR Grant from the Translational Pilot Program 2012 Service Package supported in part by grant UL1TR000451 from the National Center for Advancing Translational Sciences, National Institutes of Health (January 31, 2013 to January 31, 2014). The authors would like to acknowledge and thank for its support in the study to Children's Medical Center Dallas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; Bao Lei, 2013, JAKSTAT, V2, pe24137, DOI 10.4161/jkst.24137; Bi LP, 2013, J LIPID RES, V54, P2754, DOI 10.1194/jlr.M039347; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Bokarewa MI, 2003, J RHEUMATOL, V30, P1719; Bostrom EA, 2009, BBA-MOL CELL RES, V1793, P1894, DOI 10.1016/j.bbamcr.2009.09.008; Bostrom EA, 2008, J RHEUMATOL, V35, P2005; Chaussabel D, 2005, ANN NY ACAD SCI, V1062, P146, DOI 10.1196/annals.1358.017; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chumakov AM, 2004, ONCOGENE, V23, P3414, DOI 10.1038/sj.onc.1207126; Cohen G, 2008, J IMMUNOL, V181, P3761, DOI 10.4049/jimmunol.181.6.3761; Copley LAB, 2014, PEDIATR INFECT DIS J, V33, P35, DOI 10.1097/INF.0000000000000002; Creel AM, 2009, PEDIATR CRIT CARE ME, V10, P323, DOI 10.1097/PCC.0b013e3181988798; Dube JB, 2011, BIOESSAYS, V33, P430, DOI 10.1002/bies.201100003; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Hawkshead JJ, 2009, J PEDIATR ORTHOPED, V29, P85, DOI 10.1097/BPO.0b013e3181901c3a; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hollmig ST, 2007, J BONE JOINT SURG AM, V89A, P1517, DOI 10.2106/JBJS.F.01102; Johansson L, 2009, J IMMUNOL, V183, P4047, DOI 10.4049/jimmunol.0901541; Ju KL, 2011, J BONE JOINT SURG AM, V93A, P1693, DOI [10.2106/JBJSJ.01154, 10.2106/JBJS.J.01154]; Kwon S, 2011, J BIOL CHEM, V286, P21876, DOI 10.1074/jbc.M111.228262; Lecut C, 2012, J THROMB HAEMOST, V10, P453, DOI 10.1111/j.1538-7836.2011.04606.x; Lecut C, 2009, J IMMUNOL, V183, P2801, DOI 10.4049/jimmunol.0804007; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liang SX, 2001, CYTOGENET CELL GENET, V92, P333, DOI 10.1159/000056923; Nagaev I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000031; Nogueiras R, 2003, FEBS LETT, V548, P21, DOI 10.1016/S0014-5793(03)00708-7; Pellme S, 2007, J IMMUNOL METHODS, V325, P88, DOI 10.1016/j.jim.2007.06.001; Peltola H, 2010, PEDIATR INFECT DIS J, V29, P1123, DOI 10.1097/INF.0b013e3181f55a89; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Saavedra-Lozano J, 2008, J PEDIATR ORTHOPED, V28, P569, DOI 10.1097/BPO.0b013e31817bb816; Senolt L, 2007, ANN RHEUM DIS, V66, P458, DOI 10.1136/ard.2006.054734; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sunden-Cullberg J, 2007, CRIT CARE MED, V35, P1536, DOI 10.1097/01.CCM.0000266536.14736.03; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Walcher D, 2010, CARDIOVASC RES, V85, P167, DOI 10.1093/cvr/cvp278; Wang J, 2009, NAT STRUCT MOL BIOL, V16, P987, DOI 10.1038/nsmb.1645; White CW, 2015, NEUROUROL URODYNAM, V34, P292, DOI 10.1002/nau.22519; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	46	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103523	10.1371/journal.pone.0103523	http://dx.doi.org/10.1371/journal.pone.0103523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076205	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800059
J	Kwon, O; Kim, KB; Lee, YI; Byun, SS; Kim, JS; Lee, SE; Hong, SK				Kwon, Ohseong; Kim, Ki Bom; Lee, Young Ik; Byun, Seok-Soo; Kim, Jae-Sung; Lee, Sang Eun; Hong, Sung Kyu			Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes	PLOS ONE			English	Article							ANDROGEN-DEPRIVATION THERAPY; CANCER-SPECIFIC MORTALITY; RADIATION-THERAPY; PROGNOSTIC-FACTORS; NATURAL-HISTORY; IMPACT; RECURRENCE; MEN; PSA	Introduction: A significant proportion of patients undergoing salvage radiotherapy (RT) for biochemical recurrence (BCR) following radical prostatectomy (RP) may again experience BCR after salvage RT. Thus, we evaluated the clinical significances of different parameters on the biochemical outcome of RT in salvage setting. Methods: We reviewed the records of 212 patients who underwent salvage RT between November 2003 and December 2012 for BCR following primary RP. BCR-free survivals after salvage RT were estimated using the Kaplan-Meier method. Cox proportional hazard regression models were used to evaluate the impacts of clinicopathologic parameters on BCR following salvage RT. Results: The overall median follow-up duration was 63.5 months. The BCR-free survival rate after salvage RT was 58.2% at 5 years. Multivariate analysis showed that a pre-RT prostate-specific antigen (PSA) level of <= 0.5 ng/mL, a pre-RT PSA doubling time (PSADT) of >4.5 months, concomitant androgen deprivation therapy (ADT) with salvage RT, and a positive surgical margin were independent predictors of favorable biochemical outcomes after salvage RT (hazard ratios [HR] = 3.012, 1.132, 2.000, and 1.805, respectively, p = less than 0.001, 0.013, 0.005, and 0.036, respectively). In the early (pre-RT PSA <= 0.5 ng/mL) salvage RT setting, concomitant ADT administration was also shown to be significantly associated with higher risk of BCR-free survival following salvage RT (HR = 2.611, p = 0.038). Conclusion: Lower pre-RT PSA value, longer PSADT before salvage RT, concomitant ADT administration, and a positive surgical margin were significant predictors of favorable biochemical outcomes following salvage RT performed for BCR after primary RP.	[Kwon, Ohseong; Lee, Young Ik; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea; [Kim, Jae-Sung] Seoul Natl Univ, Bundang Hosp, Dept Radiat Oncol, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Hong, SK (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea.	hsk823@chol.com	Kwon, Ohseong/W-8318-2019; Kwon, OhSeong/DBV-0709-2022	Kwon, Ohseong/0000-0002-8933-6656; Kim, Jae-Sung/0000-0001-5348-9178				Blute ML, 1997, UROLOGY, V50, P733, DOI 10.1016/S0090-4295(97)00450-0; Boorjian SA, 2012, J UROLOGY, V188, P1761, DOI 10.1016/j.juro.2012.07.037; Boorjian SA, 2012, EUR UROL, V61, P664, DOI 10.1016/j.eururo.2011.11.053; Briganti A, 2013, EUR UROL IN PRESS; Buskirk SJ, 2006, J UROLOGY, V176, P985, DOI 10.1016/j.juro.2006.04.083; Bylow K, 2007, CANCER-AM CANCER SOC, V110, P2604, DOI 10.1002/cncr.23084; D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hayashi S, 2012, J RADIAT RES, V53, P727, DOI 10.1093/jrr/rrs034; Hong SK, 2010, UROLOGY, V76, P723, DOI 10.1016/j.urology.2010.03.081; Karlin JD, 2013, J UROLOGY, V190, P1410, DOI 10.1016/j.juro.2013.04.078; Katz MS, 2003, J CLIN ONCOL, V21, P483, DOI 10.1200/JCO.2003.12.043; King CR, 2012, INT J RADIAT ONCOL, V84, P104, DOI 10.1016/j.ijrobp.2011.10.069; Kinoshita H, 2013, INT J UROL, V20, P806, DOI 10.1111/iju.12049; Lohm G, 2014, STRAHLENTHE IN PRESS; Lohm G, 2013, WORLD J UROL, V31, P423, DOI 10.1007/s00345-012-0860-y; Milecki P, 2011, CENT EUR J UROL, V64, P67, DOI 10.5173/ceju.2011.02.art3; Mottet N, 2011, EUR UROL, V59, P572, DOI 10.1016/j.eururo.2011.01.025; Mullins JK, 2012, J UROLOGY, V188, P2219, DOI 10.1016/j.juro.2012.08.028; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Soto DE, 2012, INT J RADIAT ONCOL, V82, P1227, DOI 10.1016/j.ijrobp.2010.08.030; Stephenson AJ, 2004, JAMA-J AM MED ASSOC, V291, P1325, DOI 10.1001/jama.291.11.1325; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Swanson GP, 2007, J CLIN ONCOL, V25, P2225, DOI 10.1200/JCO.2006.09.6495; Taylor LG, 2009, CANCER-AM CANCER SOC, V115, P2388, DOI 10.1002/cncr.24283; Teeter AE, 2008, J UROLOGY, V180, P1980, DOI 10.1016/j.juro.2008.07.031; Trock BJ, 2008, JAMA-J AM MED ASSOC, V299, P2760, DOI 10.1001/jama.299.23.2760; Umezawa R, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-150; van der Poel HG, 2013, UROLOGY, V82, P834, DOI 10.1016/j.urology.2013.04.057; Zhou P, 2005, J CLIN ONCOL, V23, P6992, DOI 10.1200/JCO.2005.01.2906	30	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103574	10.1371/journal.pone.0103574	http://dx.doi.org/10.1371/journal.pone.0103574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072938	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600065
J	Lin, J; Shigdar, S; Fang, DZ; Xiang, DX; Wei, MQ; Danks, A; Kong, LX; Li, LH; Qiao, L; Duan, W				Lin, Jia; Shigdar, Sarah; Fang, Ding Zhi; Xiang, Dognxi; Wei, Ming Q.; Danks, Andrew; Kong, Lingxue; Li, Lianghong; Qiao, Liang; Duan, Wei			Improved Efficacy and Reduced Toxicity of Doxorubicin Encapsulated in Sulfatide-Containing Nanoliposome in a Glioma Model	PLOS ONE			English	Article							STERICALLY STABILIZED LIPOSOMES; TENASCIN-C; IN-VITRO; ANTITUMOR-ACTIVITY; MULTIDRUG-RESISTANCE; EXTRACELLULAR-MATRIX; DRUG-DELIVERY; CELL-ADHESION; INDUCED CARDIOMYOPATHY; THERAPEUTIC ACTIVITY	As a glycosphingolipid that can bind to several extracellular matrix proteins, sulfatide has the potential to become an effective targeting agent for tumors overexpressing tenasin-C in their microenvironment. To overcome the dose-limiting toxicity of doxorubicin (DOX), a sulfatide-containing nanoliposome (SCN) encapsulation approach was employed to improve treatment efficacy and reduce side effects of free DOX. This study analysed in vitro characteristics of sulfatide-containing nanoliposomal DOX (SCN-DOX) and assessed its cytotoxicity in vitro, as well as biodistribution, therapeutic efficacy, and systemic toxicity in a human glioblastoma U-118MG xenograft model. SCN-DOX was shown to achieve highest drug to lipid ratio (0.5:1) and a remarkable in vitro stability. Moreover, DOX encapsulated in SCN was shown to be delivered into the nuclei and displayed prolonged retention over free DOX in U-118MG cells. This simple two-lipid SCN-DOX nanodrug has favourable pharmacokinetic attributes in terms of prolonged circulation time, reduced volume of distribution and enhanced bioavailability in healthy rats. As a result of the improved biodistribution, an enhanced treatment efficacy of SC-NDOX was found in glioma-bearing mice compared to the free drug. Finally, a reduction in the accumulation of DOX in the drug's principal toxicity organs achieved by SCN-DOX led to the diminished systemic toxicity as evident from the plasma biochemical analyses. Thus, SCN has the potential to be an effective and safer nano-carrier for targeted delivery of therapeutic agents to tumors with elevated expression of tenascin-C in their microenvironment.	[Lin, Jia; Shigdar, Sarah; Xiang, Dognxi; Duan, Wei] Deakin Univ, Fac Hlth, Sch Med, Waurn Ponds, Vic, Australia; [Lin, Jia; Fang, Ding Zhi] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Biochem & Mol Biol, Chengdu 610064, Peoples R China; [Wei, Ming Q.] Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia; [Wei, Ming Q.] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4215, Australia; [Danks, Andrew] Monash Univ, Southern Clin Sch, Dept Surg, Clayton, Vic, Australia; [Kong, Lingxue] Deakin Univ, Inst Frontier Mat, Waurn Ponds, Vic, Australia; [Li, Lianghong] Dalian Med Univ, Liaoning Key Lab Canc Stem Cell Res, Dalian, Peoples R China; [Qiao, Liang] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia	Deakin University; Sichuan University; Griffith University; Griffith University; Menzies Health Institute Queensland; Monash University; Deakin University; Dalian Medical University; University of Sydney; Westmead Institute for Medical Research	Duan, W (corresponding author), Deakin Univ, Fac Hlth, Sch Med, Waurn Ponds, Vic, Australia.	wduan@deakin.edu.au	Shigdar, Sarah/AFR-0438-2022; Duan, Wei/A-5181-2015; Kong, Lingxue/D-8216-2011	Duan, Wei/0000-0001-5782-9184; Kong, Lingxue/0000-0001-6219-3897; Shigdar, Sarah/0000-0001-8084-8447	National Health and Medical Research Council, Australia [479505]; Australia-India Strategic Research Fund Programme-Indo-Australia Science and Technology Fund [ST040007]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia-India Strategic Research Fund Programme-Indo-Australia Science and Technology Fund(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by a grants from National Health and Medical Research Council, Australia (#479505), www.nhmrc.gov.au and Australia-India Strategic Research Fund Programme-Indo-Australia Science and Technology Fund (#ST040007), http://www.innovation.gov.au/Science/InternationalCollaboration/aisrf/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2002, CANCER RES, V62, P3289; Adamsky K, 2001, ONCOGENE, V20, P609, DOI 10.1038/sj.onc.1204119; Alexis F, 2008, UROL ONCOL-SEMIN ORI, V26, P74, DOI 10.1016/j.urolonc.2007.03.017; Allen Theresa M., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P513, DOI 10.2174/187152006778699121; Alvarez-Cedron L, 1999, J CHROMATOGR B, V721, P271, DOI 10.1016/S0378-4347(98)00475-7; Bagchi DB, 2003, MUTAT RES-FUND MOL M, V523, P87, DOI 10.1016/S0027-5107(02)00324-X; Bawarski WE, 2008, NANOMED-NANOTECHNOL, V4, P273, DOI 10.1016/j.nano.2008.06.002; Cabanes A, 1999, CLIN CANCER RES, V5, P687; Campbell Robert B., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P503, DOI 10.2174/187152006778699077; Charrois GJR, 2003, BBA-BIOMEMBRANES, V1609, P102, DOI 10.1016/S0005-2736(02)00661-2; Chen MH, 2010, ANTICANCER RES, V30, P65; Chen ZY, 2012, INT J NANOMED, V7, P3803, DOI 10.2147/IJN.S33541; Cheng Cai, 2009, Interact Cardiovasc Thorac Surg, V8, P635, DOI 10.1510/icvts.2008.194720; Cosan D, 2008, FOLIA HISTOCHEM CYTO, V46, P367, DOI 10.2478/v10042-008-0048-x; Cui J, 2008, J PHARM PHARMACOL, V60, P1651, DOI 10.1211/jpp/60.12.0011; de Menezes DEL, 2000, CLIN CANCER RES, V6, P2891; Drummond DC, 1999, PHARMACOL REV, V51, P691; El Bayoumil T, 2009, CLIN CANCER RES, V15, P1973, DOI 10.1158/1078-0432.CCR-08-2392; Farr KP, 2011, CASE REP ONCOL, V4, P229, DOI 10.1159/000327767; Fernando NT, 2008, CLIN CANCER RES, V14, P1529, DOI 10.1158/1078-0432.CCR-07-4126; Foti C, 2009, MOL CANCER THER, V8, P3140, DOI 10.1158/1535-7163.MCT-09-0431; Fritze A, 2006, BBA-BIOMEMBRANES, V1758, P1633, DOI 10.1016/j.bbamem.2006.05.028; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Goren D, 1996, BRIT J CANCER, V74, P1749, DOI 10.1038/bjc.1996.625; Hancox RA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2251; Herman EH, 1999, J CLIN ONCOL, V17, P2237, DOI 10.1200/JCO.1999.17.7.2237; HERNANDEZ J, 1991, BIOCONJUGATE CHEM, V2, P398, DOI 10.1021/bc00012a003; Huang Y, 2010, AAPS PHARMSCITECH, V11, P752, DOI 10.1208/s12249-010-9430-z; Hussain S, 2007, MOL CANCER THER, V6, P3019, DOI 10.1158/1535-7163.MCT-07-0615; Ishida T, 2002, INT J PHARMACEUT, V232, P59, DOI 10.1016/S0378-5173(01)00896-1; Jung SH, 2009, INT J PHARMACEUT, V382, P254, DOI 10.1016/j.ijpharm.2009.08.002; Koh E, 2004, CIRC J, V68, P163, DOI 10.1253/circj.68.163; Li B, 2012, INT J NANOMED, V7, P187, DOI 10.2147/IJN.S27864; Li XM, 2009, INT J PHARMACEUT, V373, P116, DOI 10.1016/j.ijpharm.2009.01.023; Lim HJ, 1997, J PHARMACOL EXP THER, V281, P566; Lin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049277; Liu F, 2008, NEOPLASIA, V10, P1275, DOI 10.1593/neo.08810; Mackie EJ, 1999, J CELL SCI, V112, P3847; MAYER LD, 1989, CANCER RES, V49, P5922; Mercuro G, 2007, ONCOLOGIST, V12, P1124, DOI 10.1634/theoncologist.12-9-1124; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Quemener C, 2007, CANCER RES, V67, P9, DOI 10.1158/0008-5472.CAN-06-2448; RAHMAN A, 1986, CANCER RES, V46, P2295; Rai S, 2008, J DRUG TARGET, V16, P455, DOI 10.1080/10611860802088481 ; Reardon DA, 2007, EXPERT REV ANTICANC, V7, P675, DOI 10.1586/14737140.7.5.675; Sadzuka Y, 2003, J CONTROL RELEASE, V91, P271, DOI 10.1016/S0168-3659(03)00248-7; Sapra Puja, 2005, Current Drug Delivery, V2, P369, DOI 10.2174/156720105774370159; Shao K, 2006, J CONTROL RELEASE, V115, P150, DOI 10.1016/j.jconrel.2006.07.024; Shmeeda H, 2010, J CONTROL RELEASE, V146, P76, DOI 10.1016/j.jconrel.2010.04.028; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Song HF, 2006, CANCER CHEMOTH PHARM, V57, P591, DOI 10.1007/s00280-005-0076-6; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Sugiyama Ikumi, 2011, Curr Drug Discov Technol, V8, P357; Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931; Tang N, 2007, JNCI-J NATL CANCER I, V99, P1004, DOI 10.1093/jnci/djm027; Tokarska-Schlattner M, 2005, AM J PHYSIOL-HEART C, V289, pH37, DOI 10.1152/ajpheart.01057.2004; Townson K, 2007, GLYCOBIOLOGY, V17, P1156, DOI 10.1093/glycob/cwm095; UNEZAKI S, 1994, PHARMACEUT RES, V11, P1180, DOI 10.1023/A:1018949218380; Wang JC, 2005, BIOL PHARM BULL, V28, P822, DOI 10.1248/bpb.28.822; Wei GL, 2008, BIOMED CHROMATOGR, V22, P1252, DOI 10.1002/bmc.1054; Wu J, 2007, J PHARM PHARM SCI, V10, P350; Wu XF, 1999, BBA-BIOMEMBRANES, V1416, P285, DOI 10.1016/S0005-2736(98)00229-6; Xiong XB, 2005, J CONTROL RELEASE, V107, P262, DOI 10.1016/j.jconrel.2005.03.030; Xiong XB, 2005, PHARM RES-DORDR, V22, P933, DOI 10.1007/s11095-005-4588-x; Xu L, 2011, J PHARM SCI-US, V100, P38, DOI 10.1002/jps.22243; Yokogwa K, 2006, BIOL PHARM BULL, V29, P141, DOI 10.1248/bpb.29.141; Zhang FY, 2009, PHARM RES-DORDR, V26, P914, DOI 10.1007/s11095-008-9793-y; Zhu QQ, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-65	69	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103736	10.1371/journal.pone.0103736	http://dx.doi.org/10.1371/journal.pone.0103736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072631	Green Submitted, Green Published, gold			2022-12-27	WOS:000341307600082
J	Soltysinska, E; Bentzen, BH; Barthmes, M; Hattel, H; Thrush, AB; Harper, ME; Qvortrup, K; Larsen, FJ; Schiffer, TA; Losa-Reyna, J; Straubinger, J; Kniess, A; Thomsen, MB; Bruggemann, A; Fenske, S; Biel, M; Ruth, P; Wahl-Schott, C; Boushel, RC; Olesen, SP; Lukowski, R				Soltysinska, Ewa; Bentzen, Bo Hjorth; Barthmes, Maria; Hattel, Helle; Thrush, A. Brianne; Harper, Mary-Ellen; Qvortrup, Klaus; Larsen, Filip J.; Schiffer, Tomas A.; Losa-Reyna, Jose; Straubinger, Julia; Kniess, Angelina; Thomsen, Morten Baekgaard; Brueggemann, Andrea; Fenske, Stefanie; Biel, Martin; Ruth, Peter; Wahl-Schott, Christian; Boushel, Robert Christopher; Olesen, Soren-Peter; Lukowski, Robert			KCNMA1 Encoded Cardiac BK Channels Afford Protection against Ischemia-Reperfusion Injury	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; INNER MITOCHONDRIAL-MEMBRANE; PERMEABILITY TRANSITION PORE; RAT VENTRICULAR MYOCYTES; CYTOCHROME-C-OXIDASE; PROTEIN-KINASE-A; POTASSIUM CHANNEL; ATP CHANNELS; CARDIOPROTECTION; HEART	Mitochondrial potassium channels have been implicated in myocardial protection mediated through pre-/postconditioning. Compounds that open the Ca2+-and voltage-activated potassium channel of big-conductance (BK) have a pre-conditioninglike effect on survival of cardiomyocytes after ischemia/reperfusion injury. Recently, mitochondrial BK channels (mitoBKs) in cardiomyocytes were implicated as infarct-limiting factors that derive directly from the KCNMA1 gene encoding for canonical BKs usually present at the plasma membrane of cells. However, some studies challenged these cardio-protective roles of mitoBKs. Herein, we present electrophysiological evidence for paxilline- and NS11021-sensitive BK-mediated currents of 190 pS conductance in mitoplasts from wild-type but not BK-/- cardiomyocytes. Transmission electron microscopy of BK-/- ventricular muscles fibres showed normal ultra-structures and matrix dimension, but oxidative phosphorylation capacities at normoxia and upon re-oxygenation after anoxia were significantly attenuated in BK-/- permeabilized cardiomyocytes. In the absence of BK, post-anoxic reactive oxygen species (ROS) production from cardiomyocyte mitochondria was elevated indicating that mitoBK fine-tune the oxidative state at hypoxia and reoxygenation. Because ROS and the capacity of the myocardium for oxidative metabolism are important determinants of cellular survival, we tested BK-/- hearts for their response in an ex-vivo model of ischemia/reperfusion (I/R) injury. Infarct areas, coronary flow and heart rates were not different between wild-type and BK-/- hearts upon I/R injury in the absence of ischemic pre-conditioning (IP), but differed upon IP. While the area of infarction comprised 28 +/- 3% of the area at risk in wild-type, it was increased to 58 +/- 5% in BK-/- hearts suggesting that BK mediates the beneficial effects of IP. These findings suggest that cardiac BK channels are important for proper oxidative energy supply of cardiomyocytes at normoxia and upon re-oxygenation after prolonged anoxia and that IP might indeed favor survival of the myocardium upon I/R injury in a BK-dependent mode stemming from both mitochondrial post-anoxic ROS modulation and non-mitochondrial localizations.	[Soltysinska, Ewa; Bentzen, Bo Hjorth; Thomsen, Morten Baekgaard; Olesen, Soren-Peter] Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, Copenhagen, Denmark; [Soltysinska, Ewa; Hattel, Helle; Thomsen, Morten Baekgaard; Boushel, Robert Christopher; Olesen, Soren-Peter] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Barthmes, Maria; Fenske, Stefanie; Biel, Martin; Wahl-Schott, Christian] Univ Munich, CIPSM, Munich, Germany; [Barthmes, Maria; Fenske, Stefanie; Biel, Martin; Wahl-Schott, Christian] Univ Munich, Ctr Drug Res, Dept Pharm, Munich, Germany; [Barthmes, Maria; Brueggemann, Andrea] Nan Technol GmbH, Munich, Germany; [Thrush, A. Brianne; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Qvortrup, Klaus] Univ Copenhagen, Fac Hlth & Med Sci, Core Facil Integrated Microscopy, Dept Biomed Sci, Copenhagen, Denmark; [Larsen, Filip J.; Schiffer, Tomas A.; Losa-Reyna, Jose] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Straubinger, Julia; Kniess, Angelina; Ruth, Peter; Lukowski, Robert] Univ Tubingen, Inst Pharm, Dept Pharmacol Toxicol & Clin Pharm, Tubingen, Germany	Danmarks Grundforskningsfond; University of Copenhagen; University of Copenhagen; University of Munich; University of Munich; University of Ottawa; University of Copenhagen; Karolinska Institutet; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Olesen, SP (corresponding author), Univ Copenhagen, Danish Natl Res Fdn, Ctr Cardiac Arrhythmia, Copenhagen, Denmark.	spfo@sund.ku.dk; robert.lukowski@uni-tuebingen.de	Biel, Martin/G-1175-2014; Boushel, Robert/ABD-7840-2021; Wahl-Schott, Christian A/J-2623-2015; Losa-Reyna, Jose/L-8341-2014; Schiffer, Tomas/X-1343-2018; Bentzen, Bo/B-9325-2012; Thomsen, Morten B/B-5377-2009; Olesen, Soren-Peter/H-4206-2011	Biel, Martin/0000-0002-9974-3052; Losa-Reyna, Jose/0000-0001-9545-5654; Schiffer, Tomas/0000-0002-9077-2682; Bentzen, Bo/0000-0002-0253-4992; Thomsen, Morten B/0000-0002-2469-6458; Qvortrup, Klaus/0000-0001-8811-0260; Olesen, Soren-Peter/0000-0002-4381-5192; Fenske, Stefanie/0000-0002-6994-8401; Bruggemann, Andrea/0000-0002-7325-6715; Harper, Mary-Ellen/0000-0003-3864-5886	Danish National Research Foundation; Danish Heart Foundation; Danish Agency for Science, Technology and Innovation, Medical Research Council [10-084244]; Aase and Ejnar Danielsens Foundation; Carlsberg Foundation; Bayerische Forschungsstiftung; SME innovation program "ZIM'' of the German Federal Ministry of Economics and Technology (BMWi); Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University; Eliteprogramm of the Baden-Wurttemberg Stiftung	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Heart Foundation; Danish Agency for Science, Technology and Innovation, Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Aase and Ejnar Danielsens Foundation; Carlsberg Foundation(Carlsberg Foundation); Bayerische Forschungsstiftung; SME innovation program "ZIM'' of the German Federal Ministry of Economics and Technology (BMWi); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University; Eliteprogramm of the Baden-Wurttemberg Stiftung	This study was supported by the Danish National Research Foundation to ES, BHB and SPO, by the Danish Heart Foundation to BHB, by the Danish Agency for Science, Technology and Innovation, Medical Research Council (grant 10-084244) to MBT, and by Aase and Ejnar Danielsens Foundation and by Carlsberg Foundation to SPO and ES. CWS and MB received funding from the Bayerische Forschungsstiftung and from the SME innovation program "ZIM'' of the German Federal Ministry of Economics and Technology (BMWi). RL and PR received grants from the Deutsche Forschungsgemeinschaft and acknowledge the support by the Open Access Publishing Fund of Tuebingen University. RL is a fellow of the Eliteprogramm of the Baden-Wurttemberg Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldakkak M, 2010, AM J PHYSIOL-CELL PH, V298, pC530, DOI 10.1152/ajpcell.00468.2009; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P71, DOI 10.1016/j.bbabio.2009.08.002; Baines CP, 1997, J MOL CELL CARDIOL, V29, P207, DOI 10.1006/jmcc.1996.0265; BEAVIS AD, 1992, J BIOENERG BIOMEMBR, V24, P77, DOI 10.1007/BF00769534; Bentzen BH, 2007, MOL PHARMACOL, V72, P1033, DOI 10.1124/mol.107.038331; Bentzen BH, 2009, PFLUG ARCH EUR J PHY, V457, P979, DOI 10.1007/s00424-008-0583-5; Cameron-Smith D, 2003, AM J CLIN NUTR, V77, P313, DOI 10.1093/ajcn/77.2.313; Cancherini DV, 2007, CARDIOVASC RES, V73, P720, DOI 10.1016/j.cardiores.2006.11.035; Cao CM, 2005, BRIT J PHARMACOL, V145, P984, DOI 10.1038/sj.bjp.0706268; CHEN W, 1995, CIRC RES, V77, P424, DOI 10.1161/01.RES.77.2.424; Cheng Y, 2011, CELL PHYSIOL BIOCHEM, V27, P191, DOI 10.1159/000327944; Cheng Y, 2010, FEBS LETT, V584, P2005, DOI 10.1016/j.febslet.2009.12.038; Costa ADT, 2008, AM J PHYSIOL-HEART C, V295, pH874, DOI 10.1152/ajpheart.01189.2007; Costa ADT, 2008, CARDIOVASC RES, V77, P344, DOI 10.1093/cvr/cvm050; Douglas RM, 2006, NEUROSCIENCE, V139, P1249, DOI 10.1016/j.neuroscience.2006.01.061; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Fahanik-Babaei J, 2011, NEUROSCIENCE, V199, P125, DOI 10.1016/j.neuroscience.2011.09.055; Fenske S, 2011, CIRC RES, V109, P1015, DOI 10.1161/CIRCRESAHA.111.246173; Fretwell L, 2011, CAN J PHYSIOL PHARM, V89, P24, DOI [10.1139/Y10-106, 10.1139/y10-106]; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Garlid KD, 2012, J MOL CELL CARDIOL, V52, P578, DOI 10.1016/j.yjmcc.2011.12.011; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39; Gu XQ, 2007, BIOCHEM BIOPH RES CO, V358, P311, DOI 10.1016/j.bbrc.2007.04.110; Guo YR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0288-y; Heinen A, 2007, AM J PHYSIOL-CELL PH, V292, pC148, DOI 10.1152/ajpcell.00215.2006; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Hickey AJR, 2012, J COMP PHYSIOL B, V182, P91, DOI 10.1007/s00360-011-0599-6; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Jin CH, 2012, J PHYSIOL SCI, V62, P325, DOI 10.1007/s12576-012-0206-y; Kang SH, 2007, AM J PHYSIOL-HEART C, V293, pH307, DOI 10.1152/ajpheart.00789.2006; Ko JH, 2009, BIOCHEM BIOPH RES CO, V389, P74, DOI 10.1016/j.bbrc.2009.08.087; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Lukowski R, 2010, P NATL ACAD SCI USA, V107, P5646, DOI 10.1073/pnas.1001360107; Methner C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0337-1; MUKHERJEE A, 1979, AM J PHYSIOL, V237, pH224, DOI 10.1152/ajpheart.1979.237.2.H224; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Ohya S, 2005, AM J PHYSIOL-HEART C, V289, pH1635, DOI 10.1152/ajpheart.00016.2005; Oldenburg O, 2004, AM J PHYSIOL-HEART C, V286, pH468, DOI 10.1152/ajpheart.00360.2003; Oldenburg O, 2003, J MOL CELL CARDIOL, V35, P569, DOI 10.1016/S0022-2828(03)00115-9; Palacios-Callender M, 2004, P NATL ACAD SCI USA, V101, P7630, DOI 10.1073/pnas.0401723101; Park WS, 2007, BIOCHEM BIOPH RES CO, V362, P31, DOI 10.1016/j.bbrc.2007.07.057; Redel A, 2008, ANESTH ANALG, V106, P384, DOI 10.1213/ane.0b013e318160650f; Rochetaing A, 2003, J THORAC CARDIOV SUR, V125, P1516, DOI 10.1016/S0022-5223(03)00024-2; Sato T, 2005, CIRCULATION, V111, P198, DOI 10.1161/01.CIR.0000151099.15706.B1; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Shi Y, 2007, J CARDIOVASC PHARM, V50, P497, DOI 10.1097/FJC.0b013e318137991d; Siemen D, 1999, BIOCHEM BIOPH RES CO, V257, P549, DOI 10.1006/bbrc.1999.0496; Singh H, 2013, P NATL ACAD SCI US; Singh H, 2012, J PHYSIOL-LONDON, V590, P5937, DOI 10.1113/jphysiol.2011.215533; Skyschally A, 2012, EUR HEART J; Sommer N, 2010, EUR RESPIR J, V36, P1056, DOI 10.1183/09031936.00013809; Sprossmann F, 2009, FEBS J, V276, P1680, DOI 10.1111/j.1742-4658.2009.06900.x; Stowe DF, 2006, AM J PHYSIOL-HEART C, V290, pH434, DOI 10.1152/ajpheart.00763.2005; Stumpner J, 2012, BRIT J ANAESTH, V108, P594, DOI 10.1093/bja/aer496; Wang XY, 2008, J MOL CELL CARDIOL, V44, P105, DOI 10.1016/j.yjmcc.2007.10.006; Wang XY, 2004, AM J PHYSIOL-HEART C, V287, pH2070, DOI 10.1152/ajpheart.00431.2004; Wojtovich AP, 2013, PEERJ, V1, DOI 10.7717/peerj.48; Wojtovich AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028287; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Xu ZL, 2004, AM J PHYSIOL-HEART C, V286, pH1433, DOI 10.1152/ajpheart.00882.2003; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003	64	68	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103402	10.1371/journal.pone.0103402	http://dx.doi.org/10.1371/journal.pone.0103402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072914	Green Submitted, Green Published, gold			2022-12-27	WOS:000341307600046
J	Tartu, S; Bustamante, P; Goutte, A; Cherel, Y; Weimerskirch, H; Bustnes, JO; Chastel, O				Tartu, Sabrina; Bustamante, Paco; Goutte, Aurelie; Cherel, Yves; Weimerskirch, Henri; Bustnes, Jan Ove; Chastel, Olivier			Age-Related Mercury Contamination and Relationship with Luteinizing Hormone in a Long-Lived Antarctic Bird	PLOS ONE			English	Article							STABLE-ISOTOPE SIGNATURES; REPRODUCTIVE SUCCESS; HEAVY-METALS; CATHARACTA-SKUA; SURVIVAL RATES; FORAGING AREAS; GIANT PETRELS; ADELIE LAND; BLOOD; SEABIRD	Seabirds, as long-lived top predators, accumulate contaminants such as mercury (Hg), an established endocrine disruptor. In long lived species hormonal secretion varies with age; therefore, Hg-induced endocrine disruption may be exacerbated in some age classes. Here we investigated relationships between blood total Hg and luteinizing hormone (LH, a key pituitary hormone for the onset of breeding), in pre-laying known-age (11-45 years old) snow petrels (Pagodroma nivea) from Adelie Land, Antarctica. We predicted that 1) blood Hg would increase with advancing age as a consequence of bio-accumulation; and that 2) increasing blood Hg would be related to decreased concentrations of LH in the most Hg-contaminated individuals. Hg concentrations were higher in females than in males (p<0.001), and contrary to our prediction, decreased with advancing age in males (p = 0.009) and tended to do so in females (p = 0.06). The analysis of stable isotopes (delta C-13 and delta N-15) suggested that this unexpected pattern could originate from age and sex-related variations in trophic niche, and hence Hg exposure. Regarding LH, our prediction was only supported in young birds (<= 23 years) where baseline LH was inversely correlated with Hg concentrations (p = 0.04). Hg burden did not predict baseline LH or GnRH-induced LH in birds that were more than 23 years old. These results show that age and contaminants may interfere with major endocrine mechanisms and, together with other recent studies, support the view that Hg could be connected to LH secretion and could then impair the fitness of long-lived birds.	[Tartu, Sabrina; Goutte, Aurelie; Cherel, Yves; Weimerskirch, Henri; Chastel, Olivier] Univ La Rochelle, CNRS, CEBC, UMR 7372, Villiers En Bois, France; [Bustamante, Paco] Univ La Rochelle, CNRS, Littoral Environm Soc LIENSs, UMR 7266, La Rochelle, France; [Bustnes, Jan Ove] Norwegian Inst Nat Res, FRAM, High North Res Ctr Climate & Environm, Tromso, Norway	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Norwegian Institute Nature Research	Tartu, S (corresponding author), Univ La Rochelle, CNRS, CEBC, UMR 7372, Villiers En Bois, France.	tartu.sabrina@gmail.com	Goutte, Aurelie/F-7572-2017; Weimerskirch, Henri/K-7306-2019; Bustamante, Paco/G-5833-2011; Tartu, Sabrina/Q-4062-2018; Weimerskirch, Henri/F-5562-2013	Weimerskirch, Henri/0000-0002-0457-586X; Bustamante, Paco/0000-0003-3877-9390; Tartu, Sabrina/0000-0002-4257-7495; Goutte, Aurelie/0000-0001-8322-5843	Agence Nationale de la Recherche (program POLARTOP); Institut Polaire Francais Paul Emile Victor (IPEV) [109]; Terres Australes et Antarctiques Francaises (TAAF)	Agence Nationale de la Recherche (program POLARTOP)(French National Research Agency (ANR)); Institut Polaire Francais Paul Emile Victor (IPEV); Terres Australes et Antarctiques Francaises (TAAF)	Financial support was provided by the Agence Nationale de la Recherche (program POLARTOP, O. Chastel), the Institut Polaire Francais Paul Emile Victor (IPEV, program no. 109, H. Weimerskirch), and the Terres Australes et Antarctiques Francaises (TAAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ORJ, 2009, MAR ECOL PROG SER, V375, P277, DOI 10.3354/meps07784; Angelier F, 2007, J ANIM ECOL, V76, P1181, DOI 10.1111/j.1365-2656.2007.01295.x; Authier M, 2012, METHODS ECOL EVOL, V3, P281, DOI 10.1111/j.2041-210X.2011.00162.x; Bargagli R, 1998, MAR ECOL PROG SER, V169, P65, DOI 10.3354/meps169065; Bearhop S, 2000, ENVIRON TOXICOL CHEM, V19, P1638, DOI [10.1002/etc.5620190622, 10.1897/1551-5028(2000)019&lt;1638:DOMIBA&gt;2.3.CO;2]; Bearhop S, 2000, MAR POLLUT BULL, V40, P181, DOI 10.1016/S0025-326X(99)00205-2; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bentley GE, 2006, HORM BEHAV, V49, P550, DOI 10.1016/j.yhbeh.2005.12.005; Blevin P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054508; Bustamante P, 2006, SCI TOTAL ENVIRON, V368, P585, DOI 10.1016/j.scitotenv.2006.01.038; Carravieri A, 2014, ENVIRON POLLUT, V190, P51, DOI 10.1016/j.envpol.2014.03.017; Champoux L, 2006, HYDROBIOLOGIA, V567, P263, DOI 10.1007/s10750-006-0066-7; CHASTEL O, 1993, OECOLOGIA, V94, P278, DOI 10.1007/BF00341328; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Cherel Y, 2008, MAR BIOL, V154, P813, DOI 10.1007/s00227-008-0974-3; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; Cossa D, 2011, GEOCHIM COSMOCHIM AC, V75, P4037, DOI 10.1016/j.gca.2011.05.001; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Dietz R, 2000, SCI TOTAL ENVIRON, V245, P25, DOI 10.1016/S0048-9697(99)00431-3; Drevnick PE, 2003, ENVIRON SCI TECHNOL, V37, P4390, DOI 10.1021/es034252m; Evers DC, 2008, ECOTOXICOLOGY, V17, P69, DOI 10.1007/s10646-007-0168-7; FOLLETT BK, 1975, GEN COMP ENDOCR, V26, P126, DOI 10.1016/0016-6480(75)90223-3; Frederick P, 2011, P ROY SOC B-BIOL SCI, V278, P1851, DOI 10.1098/rspb.2010.2189; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; FURNESS R, 1979, ENVIRON POLLUT, V19, P261, DOI 10.1016/0013-9327(79)90118-6; Furness R.W., 1993, P86; FURNESS RW, 1990, ENVIRON POLLUT, V63, P33, DOI 10.1016/0269-7491(90)90101-H; Gabrielsen GW, 2009, POLLUTION BARENTS SE; GOCHFELD M, 1980, MAR POLLUT BULL, V11, P362, DOI 10.1016/0025-326X(80)90284-2; Gonzalez-Solis J, 2002, MAR ECOL PROG SER, V244, P257, DOI 10.3354/meps244257; Goutte A., 2013, ECOLOGY; Goutte A, 2014, P R SOC B; Goutte A, 2011, BIOL LETTERS, V7, P790, DOI 10.1098/rsbl.2011.0196; Goutte A, 2010, GEN COMP ENDOCR, V169, P108, DOI 10.1016/j.ygcen.2010.07.016; Goutte A, 2010, FUNCT ECOL, V24, P1007, DOI 10.1111/j.1365-2435.2010.01712.x; Hallinger KK, 2011, ECOTOXICOLOGY, V20, P39, DOI 10.1007/s10646-010-0554-4; Henny CJ, 2002, ECOTOXICOLOGY, V11, P213, DOI 10.1023/A:1016327602656; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; HONDA K, 1986, MAR ENVIRON RES, V20, P143, DOI 10.1016/0141-1136(86)90045-0; HUTTON M, 1981, ENVIRON POLLUT A, V26, P129, DOI 10.1016/0143-1471(81)90043-X; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; KOEMAN J H, 1975, Science of the Total Environment, V3, P279, DOI 10.1016/0048-9697(75)90052-2; Lecomte VJ, 2010, P NATL ACAD SCI USA, V107, P6370, DOI 10.1073/pnas.0911181107; Mitro MG, 2008, J WILDLIFE MANAGE, V72, P665, DOI 10.2193/2006-551; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Norris DO, 2013, VERTEBRATE ENDOCRINOLOGY, FIFTH EDITION, P1; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Ramalingam V, 2003, J ENVIRON BIOL, V24, P401; RIDOUX V, 1989, POLAR BIOL, V9, P137, DOI 10.1007/BF00297168; Robinson SA, 2012, ENVIRON SCI TECHNOL, V46, P7094, DOI 10.1021/es204032m; Rowe CL, 2008, BIOSCIENCE, V58, P623, DOI 10.1641/B580709; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Schoech SJ, 1996, BEHAV ECOL SOCIOBIOL, V39, P77, DOI 10.1007/s002650050269; SHARP PJ, 1975, J ENDOCRINOL, V67, P211, DOI 10.1677/joe.0.0670211; Streets DG, 2009, ENVIRON SCI TECHNOL, V43, P2983, DOI 10.1021/es802474j; Tan SW, 2009, CRIT REV TOXICOL, V39, P228, DOI 10.1080/10408440802233259; Tartu S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0317; Tavares S, 2013, ENVIRON POLLUT, V181, P315, DOI 10.1016/j.envpol.2013.06.032; Thiebot JB, 2014, J ZOOL, V292, P25, DOI 10.1111/jzo.12080; Thiers L, 2014, MAR ECOL PROG SER, V499, P233, DOI 10.3354/meps10620; THOMPSON DR, 1991, J APPL ECOL, V28, P672, DOI 10.2307/2404575; vom Saal F., 1988, PHYSL REPROD, V2nd ed; WAGEMANN R, 1989, CAN J FISH AQUAT SCI, V46, P1558, DOI 10.1139/f89-198; Wayland M, 2001, ENVIRON MONIT ASSESS, V71, P255, DOI 10.1023/A:1011850000360; Wayland M, 2008, ENVIRON TOXICOL CHEM, V27, P698, DOI 10.1897/07-321.1	67	24	24	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103642	10.1371/journal.pone.0103642	http://dx.doi.org/10.1371/journal.pone.0103642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072936	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600076
J	Liu, L; Sun, TY; Liu, ZL; Chen, XR; Zhao, LL; Qu, GQ; Li, QJ				Liu, Liang; Sun, Tingyi; Liu, Zilong; Chen, Xiaorui; Zhao, Lili; Qu, Guoqiang; Li, Qingjie			Traumatic Brain Injury Dysregulates MicroRNAs to Modulate Cell Signaling in Rat Hippocampus	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; AMYLOID PRECURSOR PROTEIN; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; POSTTRANSCRIPTIONAL REGULATION; LEWY BODIES; EXPRESSION; GENDER; CASK	Traumatic brain injury (TBI) is a common cause for cognitive and communication problems, but the molecular and cellular mechanisms are not well understood. Epigenetic modifications, such as microRNA (miRNA) dysregulation, may underlie altered gene expression in the brain, especially hippocampus that plays a major role in spatial learning and memory and is vulnerable to TBI. To advance our understanding of miRNA in pathophysiological processes of TBI, we carried out a time-course microarray analysis of microRNA expression profile in rat ipsilateral hippocampus and examined histological changes, apoptosis and synapse ultrastructure of hippocampus post moderate TBI. We found that 10 out of 156 reliably detected miRNAs were significantly and consistently altered from one hour to seven days after injury. Bioinformatic and gene ontology analyses revealed 107 putative target genes, as well as several biological processes that might be initiated by those dysregulated miRNAs. Among those differentially expressed microRNAs, miR-144, miR-153 and miR-340-5p were confirmed to be elevated at all five time points after TBI by quantitative RT-PCR. Western blots showed three of the predicated target proteins, calcium/calmodulin-dependent serine protein kinase (CASK), nuclear factor erythroid 2-related factor 2 (NRF2) and alpha-synuclein (SNCA), were concurrently down-regulated, suggesting that miR-144, miR-153 and miR-340-5p may play important roles collaboratively in the pathogenesis of TBI-induced cognitive and memory impairments. These microRNAs might serve as potential targets for progress assessment and intervention against TBI to mitigate secondary damage to the brain.	[Liu, Liang; Sun, Tingyi; Liu, Zilong; Chen, Xiaorui; Zhao, Lili; Qu, Guoqiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan 430074, Peoples R China; [Liu, Liang] China Univ Polit Sci & Law, Minist Educ, Key Lab Evidence Sci, Beijing, Peoples R China; [Li, Qingjie] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA	Huazhong University of Science & Technology; China University of Political Science & Law; University of Texas System; University of Texas Medical Branch Galveston	Liu, ZL (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan 430074, Peoples R China.	lzlongfy@gmail.com; quli@utmb.edu		Li, Qingjie/0000-0003-1405-7000	National Natural Science Foundation of China [81102304]; Ministry of Education of China [20090142120054]; Foundation of Huazhong University of Science and Technology [20100573]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Foundation of Huazhong University of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (grant number: 81102304) (http://www.nsfc.gov.cn/), Doctoral Fund of Ministry of Education of China (grant number: 20090142120054) (http://www.cutech.edu.cn/cn/index.htm), and Foundation of Huazhong University of Science and Technology (grant number: 20100573) (http://kfy.hust.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Baba M, 1998, AM J PATHOL, V152, P879; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Cabin DE, 2002, J NEUROSCI, V22, P8797; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Carasatorre Mariana, 2013, Curr Top Behav Neurosci, V15, P73, DOI 10.1007/7854_2012_229; Chao HW, 2008, J CELL BIOL, V182, P141, DOI 10.1083/jcb.200712094; Chen KY, 2011, MOL CELL NEUROSCI, V48, P171, DOI 10.1016/j.mcn.2011.07.009; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cheng C, 2013, J BIOL CHEM, V288, P13748, DOI 10.1074/jbc.M112.381392; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dharap A, 2010, J NEUROCHEM, V113, P1685, DOI 10.1111/j.1471-4159.2010.06735.x; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Hata Y, 1996, J NEUROSCI, V16, P2488; Hsu LJ, 1998, J NEUROCHEM, V71, P338; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Kim TH, 2010, HISTOPATHOLOGY, V57, P734, DOI 10.1111/j.1365-2559.2010.03686.x; Krichevsky Anna M, 2007, ScientificWorldJournal, V7, P155; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li XH, 2012, NEUROSCI LETT, V514, P46, DOI 10.1016/j.neulet.2012.02.054; Liang CL, 2012, BRAIN RES, V1455, P103, DOI 10.1016/j.brainres.2011.10.051; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nistico R, 2012, MOL NEUROBIOL, V46, P572, DOI 10.1007/s12035-012-8324-3; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Patuzzo C, 2012, BALK J MED GENET, V15, P51, DOI 10.2478/v10034-012-0019-6; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rau CS, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-181; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; van Muiswinkel FL, 2005, CNS NEUROL DISORD-DR, V4, P267, DOI 10.2174/1568007054038238; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Xu JZ, 2011, INT J CANCER, V129, P2527, DOI 10.1002/ijc.25917; Xu JZ, 2010, INT J CANCER, V126, P1029, DOI 10.1002/ijc.24823; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015; Zhang Y, 2011, J CELL BIOCHEM, V112, P2435, DOI 10.1002/jcb.23168	66	66	68	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103948	10.1371/journal.pone.0103948	http://dx.doi.org/10.1371/journal.pone.0103948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089700	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700068
J	Zhang, ZJ; Elser, JJ; Cease, AJ; Zhang, XM; Yu, Q; Han, XG; Zhang, GM				Zhang, Zijia; Elser, James J.; Cease, Arianne J.; Zhang, Ximei; Yu, Qiang; Han, Xingguo; Zhang, Guangming			Grasshoppers Regulate N:P Stoichiometric Homeostasis by Changing Phosphorus Contents in Their Frass	PLOS ONE			English	Article							BIOLOGICAL STOICHIOMETRY; NITROGEN; PLANT; HERBIVORE; GROWTH; LIMITATION; TEMPERATE; NUTRIENTS; LOCUSTS; RATIOS	Nitrogen (N) and phosphorus (P) are important limiting nutrients for plant production and consumer performance in a variety of ecosystems. As a result, the N: P stoichiometry of herbivores has received increased attention in ecology. However, the mechanisms by which herbivores maintain N: P stoichiometric homeostasis are poorly understood. Here, using a field manipulation experiment we show that the grasshopper Oedaleus asiaticus maintains strong N: P stoichiometric homeostasis regardless of whether grasshoppers were reared at low or high density. Grasshoppers maintained homeostasis by increasing P excretion when eating plants with higher P contents. However, while grasshoppers also maintained constant body N contents, we found no changes in N excretion in response to changing plant N content over the range measured. These results suggest that O. asiaticus maintains P homeostasis primarily by changing P absorption and excretion rates, but that other mechanisms may be more important for regulating N homeostasis. Our findings improve our understanding of consumer-driven P recycling and may help in understanding the factors affecting plant-herbivore interactions and ecosystem processes in grasslands.	[Zhang, Zijia; Han, Xingguo; Zhang, Guangming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhang, Zijia] Univ Chinese Acad Sci, Beijing, Peoples R China; [Elser, James J.; Cease, Arianne J.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Cease, Arianne J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Zhang, Ximei; Yu, Qiang; Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Yu, Qiang] Colorado State Univ, Grad Degree Program Ecol, Dept Biol, Ft Collins, CO 80523 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Arizona State University; Arizona State University-Tempe; University of Sydney; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Colorado State University	Zhang, GM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	zhanggm@ibcas.ac.cn	Elser, James J/AAL-6199-2020; Elser, James/A-7082-2008; Han, Xingguo/K-7552-2016; zhang, zijia/F-9425-2017; Yu, Qiang/E-2097-2011; Cease, Arianne/F-9954-2014	Elser, James J/0000-0002-1460-2155; Elser, James/0000-0002-1460-2155; Han, Xingguo/0000-0002-1836-975X; zhang, zijia/0000-0002-0812-2171; Yu, Qiang/0000-0002-5480-0623; Cease, Arianne/0000-0002-4778-0775	National Natural Science Foundation of China [30870407, 31270483]; National Science Foundation [DEB-0618193]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF))	Funding for this work came from the National Natural Science Foundation of China (30870407 and 31270483, http://www.nsfc.gov.cn/). JJE and AC were supported by a National Science Foundation grant (DEB-0618193, http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; [Anonymous], 2012, PERSPECT PLANT ECOL, DOI [DOI 10.1038/NCOMMS3934, DOI 10.1016/j.ppees.2011.08.002]; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Belovsky GE, 2000, P NATL ACAD SCI USA, V97, P14412, DOI 10.1073/pnas.250483797; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Branson DH, 2006, BIOSCIENCE, V56, P743, DOI 10.1641/0006-3568(2006)56[743:SMOIHI]2.0.CO;2; Cease AJ, 2012, SCIENCE, V335, P467, DOI 10.1126/science.1214433; Cease AJ, 2010, J INSECT PHYSIOL, V56, P926, DOI 10.1016/j.jinsphys.2010.05.020; Chapman R. F., 1990, BIOL GRASSHOPPERS; Chen YL, 2007, IMPORTANT GRASSHOPPE; Chen YL, 1992, RES GRASSLAND ECOSYS, V4, P141; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Elser JJ, 2000, J EVOLUTION BIOL, V13, P845; Gusewell S, 2003, ECOL APPL, V13, P372, DOI 10.1890/1051-0761(2003)013[0372:BNRAIO]2.0.CO;2; Han X. G., 1999, INTRO BIOGEOCHEMISTR; Harrison J. F., 1995, NITROGEN METABOLISM, P119; Hessen DO, 2002, ECOLOGY, V83, P1886, DOI 10.2307/3071772; [蒋湘 Jiang Xiang], 2003, [草地学报, Acta agrestia sinica], V11, P75; Joern A, 1997, OECOLOGIA, V112, P201, DOI 10.1007/s004420050301; Kagata H, 2011, AGR FOREST ENTOMOL, V13, P143, DOI 10.1111/j.1461-9563.2010.00502.x; Kay AD, 2006, FUNCT ECOL, V20, P1037, DOI 10.1111/j.1365-2435.2006.01187.x; Li Hongchang, 1987, Acta Ecologica Sinica, V7, P331; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Meng ZP, 2006, CHINA PLANT PROTECTI, V26, P35; Persson J, 2010, OIKOS, V119, P741, DOI 10.1111/j.1600-0706.2009.18545.x; PETERS TM, 1977, ANNU REV ENTOMOL, V22, P431, DOI 10.1146/annurev.en.22.010177.002243; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.1890/0012-9658(1998)079[0165:HEOPAN]2.0.CO;2; Simpson SJ, 2001, ECOLOGY, V82, P422; Simpson SJ, 2012, NATURE NUTR UNIFYING; Stearns S.C., 1992, pi; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tao LL, 2012, GLOBAL CHANGE BIOL, V18, P1843, DOI 10.1111/j.1365-2486.2012.02645.x; TRUMPER S, 1993, J INSECT PHYSIOL, V39, P857, DOI 10.1016/0022-1910(93)90118-B; Uvarov B. P., 1977, GRASSHOPPERS LOCUSTS, V2; White T. C. R., 1993, INADEQUATE ENV NITRO; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; ZANOTTO FP, 1993, PHYSIOL ENTOMOL, V18, P425, DOI 10.1111/j.1365-3032.1993.tb00617.x; ZHANG GM, 2007, THESIS CHINESE ACAD; Zhang GM, 2011, OECOLOGIA, V166, P253, DOI 10.1007/s00442-011-1904-5; Zhang LX, 2003, ACTA BOT SIN, V45, P1009	47	24	24	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103697	10.1371/journal.pone.0103697	http://dx.doi.org/10.1371/journal.pone.0103697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089521	Green Published, Green Submitted, gold			2022-12-27	WOS:000339812700044
J	Cabib, C; Llufriu, S; Martinez-Heras, E; Saiz, A; Valls-Sole, J				Cabib, Christopher; Llufriu, Sara; Martinez-Heras, Eloy; Saiz, Albert; Valls-Sole, Josep			Abnormal Control of Orbicularis Oculi Reflex Excitability in Multiple Sclerosis	PLOS ONE			English	Article							PEDUNCULOPONTINE TEGMENTAL NUCLEUS; ELICITED BLINK REFLEX; EVOKED-POTENTIALS; PARKINSONS-DISEASE; PREPULSE INHIBITION; TRIGEMINAL NERVE; HEMIFACIAL SPASM; RECOVERY CURVES; FACIAL MYOKYMIA; LESIONS	Brain lesions in patients with multiple sclerosis may lead to abnormal excitability of brainstem reflex circuits because of impairment of descending control pathways. We hypothesized that such abnormality should show in the analysis of blink reflex responses in the form of asymmetries in response size. The study was done in 20 patients with relapsing-remitting multiple sclerosis and 12 matched healthy subjects. We identified first patients with latency abnormalities (AbLat). Then, we analyzed response size by calculating the R2c/R2 ratio to stimulation of either side and the mean area of the R2 responses obtained in the same side. Patients with significantly larger response size with respect to healthy subjects in at least one side were considered to have abnormal response excitability (AbEx). We also examined the blink reflex excitability recovery (BRER) and prepulse inhibition (BRIP) of either side in search for additional indices of asymmetry in response excitability. Neurophysiological data were correlated with MRI-determined brain lesion-load and volume. Eight patients were identified as AbLat (median Expanded Disability Status Scale-EDSS = 2.75) and 7 of them had ponto-medullary lesions. Nine patients were identified as AbEx (EDSS = 1.5) and only 2 of them, who also were AbLat, had ponto-medullary lesions. In AbEx patients, the abnormalities in response size were confined to one side, with a similar tendency in most variables (significantly asymmetric R1 amplitude, BRER index and BRIP percentage). AbEx patients had asymmetric distribution of hemispheral lesions, in contrast with the symmetric pattern observed in AbLat. The brainstem lesion load was significantly lower in AbEx than in AbLat patients (p = 0.04). Asymmetric abnormalities in blink reflex response excitability in patients with multiple sclerosis are associated with lesser disability and lower tissue loss than abnormalities in response latency. Testing response excitability could provide a reliable neurophysiological index of dysfunction in early stages of multiple sclerosis.	[Cabib, Christopher; Valls-Sole, Josep] Hosp Clin Barcelona, Dept Neurol, EMG Unit, Barcelona, Spain; [Cabib, Christopher; Llufriu, Sara; Martinez-Heras, Eloy; Saiz, Albert; Valls-Sole, Josep] Univ Barcelona, Fac Med, IDIBAPS Inst Invest Augusti Pi & Sunyer, Barcelona 7, Spain; [Llufriu, Sara; Martinez-Heras, Eloy; Saiz, Albert] Hosp Clin Barcelona, Ctr Neuroimmunol, Dept Neurol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona	Valls-Sole, J (corresponding author), Hosp Clin Barcelona, Dept Neurol, EMG Unit, Barcelona, Spain.	jvalls@clinic.ub.es	Martinez-Heras, Eloy/AAN-1849-2020; Cabib, Christopher/AAR-8410-2021; Saiz, Albert/K-8236-2014; Llufriu, Sara/T-6761-2019; Llufriu, Sara/K-2987-2014	Martinez-Heras, Eloy/0000-0001-9937-3162; Cabib, Christopher/0000-0002-1876-6923; Saiz, Albert/0000-0002-5793-8791; Llufriu, Sara/0000-0003-4273-9121	Fundacio TV3 Grant [110930]	Fundacio TV3 Grant	The authors acknowledge the financial support from Fundacio TV3 Grant 110930 to J. V. -S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTINO R, 1987, MOVEMENT DISORD, V2, P227, DOI 10.1002/mds.870020401; ARAMIDEH M, 1995, J NEUROL NEUROSUR PS, V58, P692, DOI 10.1136/jnnp.58.6.692; ARAMIDEH M, 2002, NEUROMUSCULAR FUNCTI, P757; Baker RS, 1997, NEUROLOGY, V49, P223, DOI 10.1212/WNL.49.1.223; Barraza G, 2012, MUSCLE NERVE, V46, P426, DOI 10.1002/mus.23367; Basso MA, 1996, J NEUROSCI, V16, P7318; Basso MA, 1996, J NEUROSCI, V16, P7308, DOI 10.1523/jneurosci.16-22-07308.1996; BERARDELLI A, 1985, BRAIN, V108, P593, DOI 10.1093/brain/108.3.593; Berardelli A, 1988, Adv Neurol, V50, P525; BERARDELLI A, 1983, J NEUROL NEUROSUR PS, V46, P837, DOI 10.1136/jnnp.46.9.837; BOELHOUWER AJW, 1991, PSYCHOPHYSIOLOGY, V28, P133, DOI 10.1111/j.1469-8986.1991.tb00402.x; Caramia AD, 2004, CLIN NEUROPHYSIOL, V115, P956, DOI 10.1016/j.clinph.2003.11.024; COHEN LG, 1989, NEUROLOGY, V39, P572, DOI 10.1212/WNL.39.4.572; Conte A, 2009, J NEUROL, V256, P933, DOI 10.1007/s00415-009-5047-0; Cruccu G, 2005, BRAIN, V128, P386, DOI 10.1093/brain/awh366; Degirmenci E, 2013, ACTA NEUROL BELG, V113, P265, DOI 10.1007/s13760-012-0175-1; Deltenre P, 1982, Adv Neurol, V32, P473; DENGLER R, 1982, ELECTROEN CLIN NEURO, V53, P513, DOI 10.1016/0013-4694(82)90064-5; Eekhof JLA, 1996, MUSCLE NERVE, V19, P10, DOI 10.1002/(SICI)1097-4598(199601)19:1<10::AID-MUS2>3.0.CO;2-B; Erkol G, 2009, NEUROSCI LETT, V460, P201, DOI 10.1016/j.neulet.2009.05.077; FISHER MA, 1979, NEUROLOGY, V29, P45, DOI 10.1212/WNL.29.1.45; Gazioglu S, 2012, CLIN NEUROPHYSIOL, V123, P1872, DOI 10.1016/j.clinph.2012.01.022; GIRLANDA P, 1984, EUR NEUROL, V23, P221, DOI 10.1159/000115706; Gomez-Wong E, 1998, ARCH NEUROL-CHICAGO, V55, P1233, DOI 10.1001/archneur.55.9.1233; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; GUTMANN L, 1993, MUSCLE NERVE, V16, P981; INGLIS WL, 1995, PROG NEUROBIOL, V47, P1, DOI 10.1016/0301-0082(95)00013-L; Iriarte L M, 1988, Funct Neurol, V3, P147; ISON JR, 1990, BEHAV NEUROSCI, V104, P418, DOI 10.1037/0735-7044.104.3.418; JACOBS L, 1994, ARCH NEUROL-CHICAGO, V51, P1115, DOI 10.1001/archneur.1994.00540230053012; KAYAMORI R, 1984, NEUROLOGY, V34, P1318, DOI 10.1212/WNL.34.10.1318; KHOSHBIN S, 1981, NEUROLOGY, V31, P138, DOI 10.1212/WNL.31.2.138; KIMURA J, 1972, J NEUROL NEUROSUR PS, V35, P228, DOI 10.1136/jnnp.35.2.228; KIMURA J, 1973, BRAIN, V96, P87, DOI 10.1093/brain/96.1.87; KIMURA J, 1970, NEUROLOGY, V20, P574, DOI 10.1212/WNL.20.6.574; Kimura J, 1983, Adv Neurol, V39, P773; KIMURA J, 1975, NEUROLOGY, V25, P989, DOI 10.1212/WNL.25.10.989; KIMURA J, 1970, ARCH NEUROL-CHICAGO, V22, P156, DOI 10.1001/archneur.1970.00480200062006; KIMURA J, 1975, BRAIN, V98, P413, DOI 10.1093/brain/98.3.413; Kimura J, 1989, ELECTRODIAGNOSIS DIS, P305; Klissurski M, 2009, Electromyogr Clin Neurophysiol, V49, P59; KOCH M, 1993, EXP BRAIN RES, V97, P71; Kumru H, 2010, J NEUROTRAUM, V27, P721, DOI 10.1089/neu.2009.1089; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Leocani L, 2006, J NEUROL NEUROSUR PS, V77, P1030, DOI 10.1136/jnnp.2005.086280; Leocani L, 2001, NEUROIMAGE, V13, P1186, DOI 10.1006/nimg.2001.0759; Leon L, 2011, MUSCLE NERVE, V43, P196, DOI 10.1002/mus.21810; Llufriu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037167; Manca D, 2001, CLIN NEUROPHYSIOL, V112, P153, DOI 10.1016/S1388-2457(00)00516-2; Margaritella N, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-80; Mikropoulos Efthimios H, 2010, Open Neurol J, V4, P92, DOI 10.2174/1874205X01004010092; MIWA H, 1995, J NEUROL NEUROSUR PS, V58, P95, DOI 10.1136/jnnp.58.1.95; NAMEROW NS, 1970, NEUROLOGY, V20, P1200, DOI 10.1212/WNL.20.12.1200; Nazliel B, 2002, MULT SCLER, V8, P500, DOI 10.1191/1352458502ms813oa; Oge AE, 1996, MUSCLE NERVE, V19, P246; ONGERBOERDEVISSER BW, 1978, BRAIN, V101, P285, DOI 10.1093/brain/101.2.285; PAULETTI G, 1993, MOVEMENT DISORD, V8, P495, DOI 10.1002/mds.870080414; Polak T, 2013, NEUROREPORT, V24, P251, DOI 10.1097/WNR.0b013e32835f00a3; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rasminsky M, 1981, Adv Neurol, V31, P289; REESE NB, 1995, PROG NEUROBIOL, V47, P105, DOI 10.1016/0301-0082(95)00023-O; Rosengren SM, 2011, CLIN NEUROPHYSIOL, V122, P1264, DOI 10.1016/j.clinph.2010.10.040; ROSSI A, 1992, J NEUROL NEUROSUR PS, V55, P774, DOI 10.1136/jnnp.55.9.774; SANDERS EAC, 1985, J NEUROL NEUROSUR PS, V48, P1284, DOI 10.1136/jnnp.48.12.1284; Schicatano EJ, 2002, J NEUROSCI, V22, P569, DOI 10.1523/JNEUROSCI.22-02-00569.2002; SHAHANI BT, 1972, NEUROLOGY, V22, P149, DOI 10.1212/WNL.22.2.149; Syed NA, 1999, NEUROLOGY, V52, P834, DOI 10.1212/WNL.52.4.834; Thickbroom GW, 2008, J NEUROL, V255, P1001, DOI 10.1007/s00415-008-0818-6; TOLOSA E, 1988, MOVEMENT DISORD, V3, P61, DOI 10.1002/mds.870030108; Valls-Sole J, 1999, EXP BRAIN RES, V129, P49, DOI 10.1007/s002210050935; Valls-Sole J, 2004, CLIN NEUROPHYSIOL, V115, P1527, DOI 10.1016/j.clinph.2004.02.014; VALLSSOLE J, 1994, BRAIN RES, V650, P313, DOI 10.1016/0006-8993(94)91797-3; VALLSSOLE J, 1989, NEUROLOGY, V39, P1061, DOI 10.1212/WNL.39.8.1061; Vucic S, 2012, CLIN NEUROPHYSIOL, V123, P221, DOI 10.1016/j.clinph.2011.06.022; Waxman SG, 2001, NEUROLOGY, V56, P1621, DOI 10.1212/WNL.56.12.1621	75	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103897	10.1371/journal.pone.0103897	http://dx.doi.org/10.1371/journal.pone.0103897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083902	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800101
J	da Silva Giehl, NF; Dias-Silva, K; Juen, L; Batista, JD; Cabette, HSR				da Silva Giehl, Nubia Franca; Dias-Silva, Karina; Juen, Leandro; Batista, Joana Darc; Cabette, Helena Soares Ramos			Taxonomic and Numerical Resolutions of Nepomorpha (Insecta: Heteroptera) in Cerrado Streams	PLOS ONE			English	Article							HABITAT INTEGRITY; SPECIES RICHNESS; WATER-QUALITY; PATTERNS; RIVER; TAXA; MACROINVERTEBRATES; BIOASSESSMENTS; COMMUNITIES; ASSEMBLAGES	Transformations of natural landscapes and their biodiversity have become increasingly dramatic and intense, creating a demand for rapid and inexpensive methods to assess and monitor ecosystems, especially the most vulnerable ones, such as aquatic systems. The speed with which surveys can collect, identify, and describe ecological patterns is much slower than that of the loss of biodiversity. Thus, there is a tendency for higher-level taxonomic identification to be used, a practice that is justified by factors such as the cost-benefit ratio, and the lack of taxonomists and reliable information on species distributions and diversity. However, most of these studies do not evaluate the degree of representativeness obtained by different taxonomic resolutions. Given this demand, the present study aims to investigate the congruence between species-level and genus-level data for the infraorder Nepomorpha, based on taxonomic and numerical resolutions. We collected specimens of aquatic Nepomorpha from five streams of first to fourth order of magnitude in the Pindaiba River Basin in the Cerrado of the state of Mato Grosso, Brazil, totaling 20 sites. A principal coordinates analysis (PCoA) applied to the data indicated that species-level and genus-level abundances were relatively similar (>80% similarity), although this similarity was reduced when compared with the presence/absence of genera (R = 0.77). The presence/absence ordinations of species and genera were similar to those recorded for their abundances (R = 0.95 and R = 0.74, respectively). The results indicate that analyses at the genus level may be used instead of species, given a loss of information of 11 to 19%, although congruence is higher when using abundance data instead of presence/absence. This analysis confirms that the use of the genus level data is a safe shortcut for environmental monitoring studies, although this approach must be treated with caution when the objectives include conservation actions, and faunal complementarity and/or inventories.	[da Silva Giehl, Nubia Franca] Univ Estado de Mato Grosso, Prog Postgrad Ecol & Conservacao, Mato Grosso, Brazil; [Dias-Silva, Karina] Univ Fed Goias, Prog Posgrad Ciencias Ambientais, Goiania, Go, Brazil; [Juen, Leandro] Fed Univ Para, Inst Ciencias Biol, Lab Ecol Conservacao, BR-66059 Belem, Para, Brazil; [da Silva Giehl, Nubia Franca; Batista, Joana Darc; Cabette, Helena Soares Ramos] Univ Estado de Mato Grosso, Entomol Lab, Mato Grosso, Brazil; [Cabette, Helena Soares Ramos] Univ Estado de Mato Grosso, Dept Biol, Mato Grosso, Brazil	Universidade do Estado de Mato Grosso; Universidade Federal de Goias; Universidade Federal do Para; Universidade do Estado de Mato Grosso; Universidade do Estado de Mato Grosso	da Silva Giehl, NF (corresponding author), Univ Estado de Mato Grosso, Prog Postgrad Ecol & Conservacao, Mato Grosso, Brazil.	nubiagiehl@gmail.com	Juen, Leandro/I-1338-2012; Giehl, Nubia F.S./K-8952-2015; Juen, Leandro/R-4014-2019; Dias-Silva, Karina KDS/H-3164-2014; Dias-Silva, Karina/AAS-5796-2020	Giehl, Nubia F.S./0000-0001-5733-2100; Juen, Leandro/0000-0002-6188-4386; Dias-Silva, Karina/0000-0001-5548-4995	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); PELD/CNPq; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT) [Proc. 98/04]; Programa de Apoio a Pos-Graduacao (PROAP); Programa de Cooperacao Tecnica (PROCAD) [109/2007]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PELD/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); Programa de Apoio a Pos-Graduacao (PROAP); Programa de Cooperacao Tecnica (PROCAD)	The authors thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for a masters scholarship and PELD/CNPq for a DTI-C Scholarship; KDS thanks the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for a doctoral scholarship; JDB thanks PELD/CNPq for PDJ scholarship; to the Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT) (Proc. 98/04), Programa de Apoio a Pos-Graduacao (PROAP) and Programa de Cooperacao Tecnica (PROCAD #109/2007) for financial support for data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armúa de Reyes C. A., 2006, Braz. J. Biol., V66, P1033, DOI 10.1590/S1519-69842006000600009; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Brown J. H., 1998, BIOGEOGRAPHY; Buss DF, 2010, J N AM BENTHOL SOC, V29, P562, DOI 10.1899/09-095.1; Cabette H. S. R., 2010, GESTAO EDUCACAO AMBI, V2, P113; Carneiro FM, 2013, NAT CONSERVACAO, V11, P43, DOI 10.4322/natcon.2013.006; Carneiro FM, 2010, ECOL INDIC, V10, P249, DOI 10.1016/j.ecolind.2009.05.004; Cortelezzi Agustina, 2011, Acta Limnol. Bras., V23, P412; Couceiro SRM, 2012, ECOL INDIC, V18, P118, DOI 10.1016/j.ecolind.2011.11.001; Couceiro SRM, 2011, AUSTRAL ECOL, V36, P628, DOI 10.1111/j.1442-9993.2010.02198.x; Curry CJ, 2012, FRESHWATER BIOL, V57, P628, DOI 10.1111/j.1365-2427.2011.02724.x; de Souza MAA, 2006, NEOTROP ENTOMOL, V35, P803, DOI 10.1590/S1519-566X2006000600013; Dias-Silva K, 2010, ZOOLOGIA-CURITIBA, V27, P918, DOI 10.1590/S1984-46702010000600013; Dudgeon D, 2012, FRESHWATER BIOL, V57, P1794, DOI 10.1111/j.1365-2427.2012.02839.x; Estevez Ana Lia, 2001, Iheringia Serie Zoologia, V91, P151; Gallego I, 2012, ECOL INDIC, V18, P575, DOI 10.1016/j.ecolind.2012.01.002; GOULART M., 2003, REV FAPAM; Heckman C.W., 2011, ENCY S AM AQUATIC IN; Heino J, 2008, BOREAL ENVIRON RES, V13, P359; Heino J, 2007, BIOL CONSERV, V137, P78, DOI 10.1016/j.biocon.2007.01.017; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Ribeiro JRI, 2007, ZOOTAXA, P1; INMET, 2009, PEC ABS MAPA; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Jiang XM, 2013, ECOL INDIC, V27, P48, DOI 10.1016/j.ecolind.2012.11.015; Jones FC, 2008, ENVIRON REV, V16, P45, DOI 10.1139/A07-010; Kallimanis AS, 2012, ECOL INDIC, V15, P100, DOI 10.1016/j.ecolind.2011.09.024; Karaouzas I, 2006, HYDROBIOLOGIA, V573, P199, DOI 10.1007/s10750-006-0274-1; Kweka EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052084; Landeiro VL, 2012, ECOL INDIC, V23, P366, DOI 10.1016/j.ecolind.2012.04.023; Lock K, 2013, ANN LIMNOL-INT J LIM, V49, P121, DOI 10.1051/limn/2013047; Lovell S, 2007, BIOL CONSERV, V139, P113, DOI 10.1016/j.biocon.2007.06.008; Marshall JC, 2006, HYDROBIOLOGIA, V572, P171, DOI 10.1007/s10750-005-9007-0; Melo AS, 2005, ARCH HYDROBIOL, V164, P309, DOI 10.1127/0003-9136/2005/0164-0309; Metzeling L, 2003, HYDROBIOLOGIA, V510, P39, DOI 10.1023/B:HYDR.0000008500.34301.a0; Nessimian JL, 2008, HYDROBIOLOGIA, V614, P117, DOI 10.1007/s10750-008-9441-x; Nieser N, 1975, STUDIES FAUNA SURINA, V16, P1, DOI DOI 10.1007/978-94-017-7118-4_1; Nieser N, 1997, HETEROPTEROS AQUATIC; Nieser Nico, 2001, Tijdschrift voor Entomologie, V144, P261; Papacek M, 2001, EUR J ENTOMOL, V98, P1, DOI 10.14411/eje.2001.001; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; PETERSEN RC, 1992, FRESHWATER BIOL, V27, P295, DOI 10.1111/j.1365-2427.1992.tb00541.x; Quiroz-Martinez H, 2007, J AM MOSQUITO CONTR, V23, P110, DOI 10.2987/8756-971X(2007)23[110:AIAPOM]2.0.CO;2; R Development Core Team, 2012, R LANG ENV STAT COMP; Resh Vincent H., 1993, P159; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Sanchez-Moyano JE, 2006, HELGOLAND MAR RES, V60, P243, DOI 10.1007/s10152-006-0039-2; Schiesari L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0378; Schmidt-Kloiber A, 2004, HYDROBIOLOGIA, V516, P269, DOI 10.1023/B:HYDR.0000025270.10807.10; Siqueira T, 2012, ECOGRAPHY, V35, P183, DOI 10.1111/j.1600-0587.2011.06875.x; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wagenhoff A, 2012, J APPL ECOL, V49, P892, DOI 10.1111/j.1365-2664.2012.02162.x; Waite IR, 2004, FRESHWATER BIOL, V49, P474, DOI 10.1111/j.1365-2427.2004.01197.x; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Yoshimura M, 2012, ENTOMOL SCI, V15, P145, DOI 10.1111/j.1479-8298.2011.00511.x	57	17	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103623	10.1371/journal.pone.0103623	http://dx.doi.org/10.1371/journal.pone.0103623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083770	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800060
J	Dara, A; Sangamwar, AT				Dara, Ajay; Sangamwar, Abhay T.			Clearing the Fog of Anticancer Patents from 1993-2013: Through an In-Depth Technology Landscape & Target Analysis from Pioneer Research Institutes and Universities Worldwide	PLOS ONE			English	Article							CANCER STATISTICS	Background: In a search for an effective anticancer therapy the R&D units from leading universities and institutes reveal numerous technologies in the form of patent documents. The article addressed comparative anticancer patent landscape and technology assessment of Council of Scientific and Industrial Research (CSIR): India's largest R&D organisation with top twenty international public funded universities and institutes from eight different countries. Methodology/Principal Findings: The methodology include quantitative and qualitative assessment based on the bibliometric parameters and manual technology categorisation to understand the changing patent trends and recent novel technologies. The research finding analysed 25,254 patent documents from the year 1993 to 2013 and reported the insights of latest anticancer technologies and targets through categorisation studies at the level of drug discovery, development and treatment & diagnosis. The article has reported the technology correlation matrix of twelve secondary class technologies with 34 tertiary sub-class research area to identify the leading technologies and scope of future research through whitespaces analysis. In addition, the results have also addressed the target analysis, leading inventor, assignee, collaboration network, geographical distribution, patent trend analysis, citation maps and technology assessment with respect to international patent classification systems such as CPC, IPC and CPI codes. Conclusions/Significance: The result suggested peptide technology as the dominating research area next to gene therapy, vaccine and medical preparation containing organic compounds. The Indian CSIR has ranked itself at seventh position among the top 20 universities. Globally, the anticancer research was focused in the area of genetics and immunology, whereas Indian CSIR reported more patents related to plant extract and organic preparation. The article provided a glimpse of two decade anticancer scenario with respect to top public funded universities worldwide.	[Dara, Ajay; Sangamwar, Abhay T.] NIPER, Dept Pharmacoinformat, Sas Nagar, Punjab, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Sangamwar, AT (corresponding author), NIPER, Dept Pharmacoinformat, Sas Nagar, Punjab, India.	abhays@niper.ac.in	sangamwar, abhay/AAI-2200-2020	DARA, AJAY/0000-0002-8279-3678				Agarwal SP, 2002, NATL CANC CONTROL PR, P41; Aguirre AJ, 2009, The University of Pennsylvania, Patent No. [WO 2005053512 A3, 2005053512]; Ajay D, 2014, EXPERT OPIN THER PAT, DOI [10.1517/13543776.13542014.13926329, DOI 10.1517/13543776.13542014.13926329]; Akers L., 2003, WORLD PAT INF, V25, P303, DOI DOI 10.1016/S0172-2190(03)00086-3; Anand S, 2005, Use of aurora kinase inhibitors for reducing the resistance of cancer cells, Patent No. [WO 2005002571 A1, 2005002571]; Ann CJ, 2002, The University of Queensland, Patent No. [WO 2002092629 A1, 2002092629]; [Anonymous], PATB PATB ONL PAT DA; Antunes AM, 2013, J CANC THER, V4, P56; Arbeit JM, 2003, The Regents Of The University Of California, Patent No. [US 6586655 B2, 6586655]; Bailey P, 2007, Drug delivery system. The University of Manchester, Patent No. [WO 2007012838 A3, 2007012838]; Baker Jr JR, 2010, The Regents Of The University Of Michigan, Patent No. [US 20120259098 A1, 20120259098]; Balaian L, 2011, Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents. The Regents Of The University Of California, Patent No. [US 7977320 B2., 7977320]; Bale S, 2009, 5'-substituted adenosynes, preparation thereof and use as inhibitors of s-adenosylmethionine decarboxylase, Patent No. [WO 2009018541 A1, 2009018541]; Berman DM, 2011, The Johns Hopkins University, Patent No. [US 20110020221 A1, 20110020221]; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Breakefield XO, 2004, University of Boston, Patent No. [EP 0776161 B1, 0776161]; Bundred NJ, 2009, Use of EGFR tyrosine kinase inhibitor for preventing breast cancer, Patent No. [CA 2389411 C, 2389411]; Campbell M, 2009, The Regents Of The University Of California, Patent No. [WO 2009126211 A3, 2009126211]; Campbell RS, 1983, WORLD PAT INF, V5, P137, DOI [DOI 10.1016/0172-2190(83)90134-5, 10.1016/0172-2190(83)90134-5]; Cavalier T., 2001, World Patent Information, V23, P367, DOI 10.1016/S0172-2190(01)00045-X; Chan TA, 1999, The Johns Hopkins University, Patent No. [US 5874235 A, 5874235]; Chaudhary PM, 1999, University of Washington, Patent No. [WO 1999011791 A2, 1999011791]; Civin CI, 2009, The Johns Hopkins University, Patent No. [WO 2009091904 A3, 2009091904]; Clarke MF, 2012, The Regents Of The University Of Michigan, Patent No. [US 8148147 B2, 8148147]; Cooke D, 2012, Neurosurgical devices and associated systems. University Of Washington, Patent No. [WO 2012031275 A3, 2012031275]; Dinesh KL, 2013, Biomarkers useful for detection of types, grades and stages of human breast cancer, Patent No. [WO 2013057567 A1, 2013057567]; Ding J, 2012, National University Of Singapore, Patent No. [WO 2012112125 Al, 2012112125]; Dinshaw K. A., 2005, HLTH ADM, V7, P10; Dong JT, 2005, The Johns Hopkins University, Patent No. [US 20050250102 Al, 20050250102]; Dubinett SM, 2011, The Regents Of The University Of California, Patent No. [US 20120315641 Al, 20120315641]; Eastwood EL, 2007, WO, Patent No. [2007103273, WO 2007103273 A3]; Ernst H., 2003, World Patent Information, V25, P233, DOI 10.1016/S0172-2190(03)00077-2; Fariss M., 2002, Anti-tumor activity of vitamin E, cholesterol, taxol and betulinic acid derivatives, Patent No. [EP1189607, 1189607, EP 1189607 A2]; Ferlay J, 2013, IARC CANCERBASE; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fuller SD, 2007, Process for production of acylated derivative of epigallocatechin gallate, Patent No. [WO 2007105280 A9, 2007105280]; Glick GD, 2013, The Regents Of The University Of Michigan, Patent No. [US 8497307 B2, 8497307]; Gubbay J, 1998, The Regents Of The University Of California, Patent No. [WO 1998022623 A2, 1998022623]; Guglielmi G, 2001, The Regents Of The University Of California, Patent No. [CA 2179863 C, 2179863]; Halmuthur MSK, 2011, Council Of Scientific & Industrial Research, Patent No. [US 20110201661 A1, 20110201661]; Hamilton A, 2008, Compound and Methods For the Treatment of Cancer and Malaria, Patent No. [US 20080312287 A1, 20080312287]; Huang RCC, 2012, The Johns Hopkins University, Patent No. [WO 2012166778 A2, 2012166778]; Imai K, 2013, The University of Tokyo, Patent No. [EP 2165715 A1, 2165715]; Ivkov R, 2012, Formulation and Methods for Enhanced Interventional Image-Guided Therapy of Cancer. The Johns Hopkins University, Patent No. [US 20120277517 A1, 20120277517]; Joe G, 2004, The Regents Of The University Of California, Patent No. [WO 2004018637 A3, 2004018637]; June CH, 2012, The University Of Pennsylvania, Patent No. [WO 2012079000 A4, 2012079000]; Kamal A, 2006, Council Of Scientific & Industrial Research, Patent No. [US 7087641 B2, 7087641]; Kamal A, 2008, Council Of Scientific & Industrial Research, Patent No. [CA 2660799 C, 2660799]; Kamal A, 2006, C8-linked pyrrolo[2,1-c][1,4] benzodiazepine-acridone/acridine hybrids, Patent No. [US 7056913 B2, 7056913]; Karin M, 2007, Gamma subunit of cytokine responsive IkB-alpha kinase complex, Patent No. [US 20070166812 A1, 20070166812]; Katagiri T, 2008, Patent No. [WO 2008018642 A3, 2008018642]; Khanuja SPS, 2011, Council of Scientific & Industrial Research, Patent No. [EP 1951739 B1, 1951739]; Koumenis C, 2011, The University Of Pennsylvania, Patent No. [US 20110190400 A1, 20110190400]; Kwon O, 2012, Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis, Patent No. [WO 2012097371 A3, 2012097371]; Low DA, 2007, University of Washington, Patent No. [US 7283610 B2, 7283610]; Mach R, 2011, Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging, Patent No. [US 20120171119 A1, 20120171119]; Mattmann ME, 2011, EXPERT OPIN THER PAT, V21, P1309, DOI 10.1517/13543776.2011.587959; Maurya R, 2003, Pharmaceutical composition comprising extract from plant Gryptolepis buchanani for treating immunodeficiency, Patent No. [US 6548086 B1, 6548086]; McPhail KL, 2012, The Regents Of The University Of California, Patent No. [US 20120028905 Al, 20120028905]; Meggers E, 2009, The University Of Pennsylvania, Patent No. [US 7488817 B2, 7488817]; MOED HF, 1985, RES POLICY, V14, P131, DOI 10.1016/0048-7333(85)90012-5; Morgan AC, 2010, University of Washington, Patent No. [CA 2187346 C, 2187346]; Mulshine JL, 2001, Epithelial protein and DNA thereof for use in early cancer detection, Patent No. [EP 1426381 Al, 1426381]; Nakamura Y, 2007, The University of Tokyo, Patent No. [WO 2007102526 A1, 2007102526]; Pardoll DM, 2010, The Johns Hopkins University, Patent No. [US 20100196394 Al, 20100196394]; Park J, 2002, TARGETED DELIVERY TH; Park JH, 2010, The Regents Of The University Of California, VUS 20100254914 A1, Patent No. 20100254914; PARKIN DM, 1984, B WORLD HEALTH ORGAN, V62, P163, DOI 10.1139/b84-027; Pasternack GR, 2000, The Johns Hopkins University, Patent No. [US 6040173 A, 6040173]; Penichet ML, 2013, The Regents Of The University Of California, Patent No. [US 20130028891 Al, 20130028891]; Penichet ML, 2011, Unconjugated Anti-TfR Antibodies and Compositions Thereof for the Treatment of Cancer. The Regents Of The University Of California, Patent No. [US 20130028891 A1, 20130028891]; Percec V., 2012, US Patent, Patent No. [20,120,308,640 A1, 20120308640]; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Ralph SJ, 2001, Immune potentiating compositions, Patent No. [WO 2001088097 Al, 2001088097]; Ramnath T, 2011, NATL MED J INDIA, V24, P69; Rao D. N., 1998, Indian Journal of Cancer, V35, P10; Rodgers KE, 2002, The Regents Of The University Of California, Patent No. [US 6455500 Bl, 6455500]; Sangamwar AT, 2014, WORLD PAT INF; Seawright A., 2000, US Patent, Patent No. [US 6057366 A, 6057366, 6,057,366]; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Stewart B.W., 2003, WORLD CANC REPORT; Symonds Q, 2010, QS WORLD U RANKINGS; Tromberg BJ, 2010, The Regents Of The University Of California, Patent No. [US 7729750 B2, 7729750]; Universities QT, 2013, QS WORLD U RANK SUBJ; Varghese C, 2001, CANC PREVENTION CONT, P48; World Health Organization, 2012, IS BRIEF STRUCT PSYC; Wrasidlo W, 2010, The Regents Of The University Of California, Patent No. [US 20100209488 A1, 20100209488]; Yang YY, 2010, WORLD PAT INF, V32, P203, DOI 10.1016/j.wpi.2009.12.006	91	11	12	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103847	10.1371/journal.pone.0103847	http://dx.doi.org/10.1371/journal.pone.0103847			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083710	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800089
J	Lazzari, E; Korczeniewska, J; Gabhann, JN; Smith, S; Barnes, BJ; Jefferies, CA				Lazzari, Elisa; Korczeniewska, Justyna; Gabhann, Joan Ni; Smith, Siobhan; Barnes, Betsy J.; Jefferies, Caroline A.			TRIpartite Motif 21 (TRIM21) Differentially Regulates the Stability of Interferon Regulatory Factor 5 (IRF5) Isoforms	PLOS ONE			English	Article							GENE-EXPRESSION; CRYSTAL-STRUCTURE; FAMILY PROTEINS; RISK HAPLOTYPE; I INTERFERON; BLOOD-CELLS; TRANSACTIVATION; DEGRADATION; UBIQUITIN; VARIANTS	IRF5 is a member of the Interferon Regulatory Factor (IRF) family of transcription factors activated downstream of the Toll-Like receptors (TLRs). Polymorphisms in IRF5 have been shown to be associated with the autoimmune disease Systemic Lupus Erythematosus (SLE) and other autoimmune conditions, suggesting a central role for IRF5 in the regulation of the immune response. Four different IRF5 isoforms originate due to alternative splicing and to the presence or absence of a 30 nucleotide insertion in IRF5 exon 6. Since the polymorphic region disturbs a PEST domain, a region associated with protein degradation, we hypothesized that the isoforms bearing the insertion might have increased stability, thus explaining the association of individual IRF5 isoforms with SLE. As the E3 ubiquitin ligase TRIpartite Motif 21 (TRIM21) has been shown to regulate the stability and hence activity of members of the IRF family, we investigated whether IRF5 is subjected to regulation by TRIM21 and whether dysregulation of this mechanism could explain the association of IRF5 with SLE. Our results show that IRF5 is degraded following TLR7 activation and that TRIM21 is involved in this process. Comparison of the individual IRF5 variants demonstrates that isoforms generated by alternative splicing are resistant to TRIM21-mediated degradation following TLR7 stimulation, thus providing a functional link between isoforms expression and stability/activity which contributes to explain the association of IRF5 with SLE.	[Lazzari, Elisa; Gabhann, Joan Ni; Smith, Siobhan; Jefferies, Caroline A.] Royal Coll Surgeons Ireland, Inst Res, Mol & Cellular Therapeut, Dublin 2, Ireland; [Korczeniewska, Justyna; Barnes, Betsy J.] Rutgers Biomed & Hlth Sci, Dept Biochem & Mol Biol, Newark, NJ USA; [Korczeniewska, Justyna; Barnes, Betsy J.] Rutgers Biomed & Hlth Sci, New Jersey Med School Canc Ctr, Newark, NJ USA	Royal College of Surgeons - Ireland; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Jefferies, CA (corresponding author), Royal Coll Surgeons Ireland, Inst Res, Mol & Cellular Therapeut, Dublin 2, Ireland.	cjefferies@rcsi.ie	Lazzari, Elisa/K-7804-2016; Lazzari, Elisa/AAE-6437-2019; Jefferies, Caroline/AAI-1543-2021; Lazzari, Elisa/O-6394-2019	Lazzari, Elisa/0000-0001-5299-7525; Jefferies, Caroline/0000-0002-8879-6722; Lazzari, Elisa/0000-0001-5299-7525; Ni Gabhann-Dromgoole, Joan/0000-0002-4247-3952	Health Research Board [HRB/RP/2008/234]; Arthritis Foundation; Alliance for Lupus Research	Health Research Board; Arthritis Foundation; Alliance for Lupus Research	This work was supported by Health Research Board grant number HRB/RP/2008/234 (www.hrb.ie), the Arthritis Foundation (www.arthritis.org), and the Alliance for Lupus Research (www.lupusresearch.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold MM, 2013, J VIROLOGY; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Feng D, 2010, ARTHRITIS RHEUM-US, V62, P562, DOI 10.1002/art.27223; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; Hellquist A, 2009, J RHEUMATOL, V36, P1631, DOI 10.3899/jrheum.081160; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Jefferies C, 2011, NAT REV IMMUNOL, V11, P617, DOI 10.1038/nri3043; Kim JY, 2009, J IMMUNOL, V182, P2131, DOI 10.4049/jimmunol.0802755; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Kono DH, 2009, P NATL ACAD SCI USA, V106, P12061, DOI 10.1073/pnas.0905441106; Korczeniewska J, 2013, MOL CELL BIOL, V33, P1124, DOI 10.1128/MCB.00802-12; Kozyrev SV, 2007, ARTHRITIS RHEUM, V56, P1234, DOI 10.1002/art.22497; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Niewold TB, 2012, ANN RHEUMATIC DIS; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Niida M, 2010, MOL IMMUNOL, V47, P2378, DOI 10.1016/j.molimm.2010.05.004; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Santiago-Raber ML, 2009, J AUTOIMMUN, V33, P231, DOI 10.1016/j.jaut.2009.10.001; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Smith S, 2012, ARTHRITIS RHEUM-US, V64, P1601, DOI 10.1002/art.33494; Stacey KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034041; Stone RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054487; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492	48	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103609	10.1371/journal.pone.0103609	http://dx.doi.org/10.1371/journal.pone.0103609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084355	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800056
J	Lin, XC; Li, MG; Wang, M; Zuo, YJ; Zhu, SP; Zheng, YX; Lin, XF; Yu, MB; Lamoureux, EL				Lin, Xianchai; Li, Mingge; Wang, Mei; Zuo, Yajing; Zhu, Siping; Zheng, Yongxin; Lin, Xiaofeng; Yu, Minbin; Lamoureux, Ecosse L.			Validation of Catquest-9SF Questionnaire in a Chinese Cataract Population	PLOS ONE			English	Article							DAILY VISION SCALE; VISUAL FUNCTION; RASCH ANALYSIS; IMPAIRMENT QUESTIONNAIRE; SURGERY CARE; OUTCOMES; RELIABILITY; VALIDITY; IMPACT; VF-14	Purpose: To develop and validate a Chinese version of the Catquest-9SF questionnaire in a cataract population. Methods: The Catquest-9SF Questionnaire was translated and back translated into Chinese. Preoperative patients were recruited at a tertiary eye hospital and their demographic information and visual acuity were documented. Psychometric properties of the Catquest-9SF, including ordered thresholds, the ability to distinguish between different strata of person ability, absence of misfitting items, unidimentionality, differential item functioning (DIF) and construct validity were tested, using Rasch analysis. Results: A total of 102 patients (100% response rate) were enrolled. The participants'mean age was 70.2 year (SD = 12.1) and 46.9% were female. Rasch analysis showed that this version of the questionnaire had ordered response thresholds and was free of DIF. The items fit a single overall construct and unidimensional by principal components analysis of the residuals. Patients with visual impairment had significantly poorer Rasch scores on the Catquest-9SF (mean change, -2.5, p = 0.035, compared with non-visually impaired patients). Conclusion: The Chinese version of Catquest-9SF is a valid and reliable questionnaire for assessing the visual disability outcomes of Chinese patients with cataract, and it may be recommended for routine clinical use.	[Lin, Xianchai; Li, Mingge; Zuo, Yajing; Zhu, Siping; Zheng, Yongxin; Yu, Minbin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Mei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Xiaofeng] Shantou Cent Hosp, Shantou, Peoples R China; [Lamoureux, Ecosse L.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Lamoureux, Ecosse L.] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Lamoureux, Ecosse L.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia	Sun Yat Sen University; Sun Yat Sen University; National University of Singapore; Singapore National Eye Center; National University of Singapore; Centre for Eye Research Australia; University of Melbourne	Yu, MB (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	yuminbin@126.com	Lamoureux, Ecosse/Z-5482-2019		National Natural Science Foundation of China [81200685]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Dr. Lin Xianchai is funded by National Natural Science Foundation of China 81200685. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbell PA, 2005, LANCET, V365, P599; Chiang PPC, 2011, INVEST OPHTH VIS SCI, V52, P8919, DOI 10.1167/iovs.11-7702; Gothwal VK, 2010, J CATARACT REFR SURG, V36, P1181, DOI 10.1016/j.jcrs.2010.01.029; Gothwal VK, 2010, INVEST OPHTH VIS SCI, V51, P694, DOI 10.1167/iovs.09-3448; Gothwal VK, 2009, CLIN EXP OPHTHALMOL, V37, P785, DOI 10.1111/j.1442-9071.2009.02133.x; He LM, 2011, CURR OPIN OPHTHALMOL, V22, P43, DOI 10.1097/ICU.0b013e3283414f76; Holland PW., 1993, DIFFERENTIAL ITEM FU, DOI DOI 10.4324/9780203357811; Johnson GJ, 2000, LANCET, V355, P158, DOI 10.1016/S0140-6736(99)00404-3; Lamoureux EL, 2007, INVEST OPHTH VIS SCI, V48, P1476, DOI 10.1167/iovs.06-0610; Lamoureux EL, 2007, INVEST OPHTH VIS SCI, V48, P1001, DOI 10.1167/iovs.06-0361; Lamoureux EL, 2006, INVEST OPHTH VIS SCI, V47, P4732, DOI 10.1167/iovs.06-0220; Lamoureux EL, 2011, AM J OPHTHALMOL, V151; Linacre JM., 2012, USERS GUIDE WINSTEPS; Lohr K, 2009, QUAL LIFE RES, V18, P99, DOI 10.1007/s11136-008-9413-7; Lundstrom M, 1998, J CATARACT REFR SURG, V24, P968, DOI 10.1016/S0886-3350(98)80053-9; Lundstrom M, 1997, J CATARACT REFR SURG, V23, P1226, DOI 10.1016/S0886-3350(97)80321-5; Lundstrom M, 2000, J CATARACT REFR SURG, V26, P101, DOI 10.1016/S0886-3350(99)00324-7; Lundstrom M, 2011, ACTA OPHTHALMOL, V89, P718, DOI 10.1111/j.1755-3768.2009.01801.x; Lundstrom M, 2009, J CATARACT REFR SURG, V35, P504, DOI 10.1016/j.jcrs.2008.11.038; MANGIONE CM, 1992, MED CARE, V30, P1111, DOI 10.1097/00005650-199212000-00004; Pesudovs K, 2003, INVEST OPHTH VIS SCI, V44, P2892, DOI 10.1167/iovs.02-1075; Pesudovs K, 2010, J CATARACT REFR SURG, V36, P718, DOI 10.1016/j.jcrs.2009.11.019; Revicki DA, 2010, INVEST OPHTH VIS SCI, V51, P712, DOI 10.1167/iovs.09-3766; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Smith RM, 1994, UNIDIMENSIONALITY RA, P316; STEINBERG EP, 1994, ARCH OPHTHALMOL-CHIC, V112, P630, DOI 10.1001/archopht.1994.01090170074026; Swanson MW, 2012, OPTOMETRY VISION SCI, V89, pE23, DOI 10.1097/OPX.0b013e31826a3d85; Wong TY, 2014, BRIT J OPHTHALMOL, V98, P599, DOI 10.1136/bjophthalmol-2013-304047	28	10	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103860	10.1371/journal.pone.0103860	http://dx.doi.org/10.1371/journal.pone.0103860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084020	Green Published, gold			2022-12-27	WOS:000339819800092
J	Reyngold, M; Turcan, S; Giri, D; Kannan, K; Walsh, LA; Viale, A; Drobnjak, M; Vahdat, LT; Lee, W; Chan, TA				Reyngold, Marsha; Turcan, Sevin; Giri, Dilip; Kannan, Kasthuri; Walsh, Logan A.; Viale, Agnes; Drobnjak, Marija; Vahdat, Linda T.; Lee, William; Chan, Timothy A.			Remodeling of the Methylation Landscape in Breast Cancer Metastasis	PLOS ONE			English	Article							LYMPH-NODE METASTASES; CLINICAL-IMPLICATIONS; MOLECULAR PORTRAITS; GENE; EXPRESSION; PATTERNS; SUBTYPES; NUMBER; TUMORS; HYPERMETHYLATION	The development of breast cancer metastasis is accompanied by dynamic transcriptome changes and dramatic alterations in nuclear and chromatin structure. The basis of these changes is incompletely understood. The DNA methylome of primary breast cancers contribute to transcriptomic heterogeneity and different metastatic behavior. Therefore we sought to characterize methylome remodeling during regional metastasis. We profiled the DNA methylome and transcriptome of 44 matched primary breast tumors and regional metastases. Striking subtype-specific patterns of metastasis-associated methylome remodeling were observed, which reflected the molecular heterogeneity of breast cancers. These divergent changes occurred primarily in CpG island (CGI)-poor areas. Regions of methylome reorganization shared by the subtypes were also observed, and we were able to identify a metastasis-specific methylation signature that was present across the breast cancer subclasses. These alterations also occurred outside of CGIs and promoters, including sequences flanking CGIs and intergenic sequences. Integrated analysis of methylation and gene expression identified genes whose expression correlated with metastasis-specific methylation. Together, these findings significantly enhance our understanding of the epigenetic reorganization that occurs during regional breast cancer metastasis across the major breast cancer subtypes and reveal the nature of methylome remodeling during this process.	[Reyngold, Marsha; Turcan, Sevin; Kannan, Kasthuri; Walsh, Logan A.; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Reyngold, Marsha; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Giri, Dilip] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core, New York, NY 10021 USA; [Drobnjak, Marija] Mem Sloan Kettering Canc Ctr, Pathol Core, New York, NY 10021 USA; [Vahdat, Linda T.] Weill Cornell Med Ctr, Dept Med, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Chan, TA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	chant@mskcc.org	Turcan, Sevin/AAF-1095-2019; Chan, Timothy A/ABD-5850-2021	Turcan, Sevin/0000-0002-0885-5607; Vahdat, Linda/0000-0002-3522-7382; Walsh, Logan/0000-0001-8771-2577; Drobnjak, Marija/0000-0003-0676-4709; Kannan, Kasthuri/0000-0002-8479-0657	Louis Gerstner Foundation; Elsa U. Pardee Foundation; AVON Foundation; STARR Cancer Consortium; Metastasis Research Center; Department of Defense Era of Hope Award; NIH [5T32CA160001]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Louis Gerstner Foundation; Elsa U. Pardee Foundation; AVON Foundation; STARR Cancer Consortium; Metastasis Research Center; Department of Defense Era of Hope Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Louis Gerstner Foundation (T.A.C.); the Elsa U. Pardee Foundation (T.A.C.); the AVON Foundation (T.A.C.); the STARR Cancer Consortium (T.A.C., L.T.V.); the Metastasis Research Center (T.A.C.), and the Department of Defense Era of Hope Award (T.A.C.). S.T. was supported by an NIH T32 grant (5T32CA160001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ellsworth RE, 2009, CLIN EXP METASTAS, V26, P205, DOI 10.1007/s10585-008-9232-9; Fackler MJ, 2011, CANCER RES, V71, P6195, DOI 10.1158/0008-5472.CAN-11-1630; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Feng YM, 2007, BREAST CANCER RES TR, V103, P319, DOI 10.1007/s10549-006-9385-7; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hao XS, 2004, CANCER-AM CANCER SOC, V100, P1110, DOI 10.1002/cncr.20095; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Raddatz G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003146; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Suzuki M, 2007, MOL ONCOL, V1, P172, DOI 10.1016/j.molonc.2007.03.005; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Weigman VJ, 2012, BREAST CANCER RES TR, V133, P865, DOI 10.1007/s10549-011-1846-y; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051239	37	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103896	10.1371/journal.pone.0103896	http://dx.doi.org/10.1371/journal.pone.0103896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083786	gold, Green Submitted, Green Published			2022-12-27	WOS:000339819800100
J	Sellier, C; Hwang, VJ; Dandekar, R; Durbin-Johnson, B; Charlet-Berguerand, N; Ander, BP; Sharp, FR; Angkustsiri, K; Simon, TJ; Tassone, F				Sellier, Chantal; Hwang, Vicki J.; Dandekar, Ravi; Durbin-Johnson, Blythe; Charlet-Berguerand, Nicolas; Ander, Bradley P.; Sharp, Frank R.; Angkustsiri, Kathleen; Simon, Tony J.; Tassone, Flora			Decreased DGCR8 Expression and miRNA Dysregulation in Individuals with 22q11.2 Deletion Syndrome	PLOS ONE			English	Article							CARDIO-FACIAL-SYNDROME; SYNDROME CRITICAL REGION; HIPPOCAMPAL VOLUME REDUCTION; DIGEORGE-SYNDROME; CHROMOSOME 22Q11; MONOZYGOTIC TWINS; MOUSE MODEL; NEUROPSYCHIATRIC DISORDERS; VELOCARDIOFACIAL SYNDROME; MYOCARDIAL-INFARCTION	Deletion of the 1.5-3 Mb region of chromosome 22 at locus 11.2 gives rise to the chromosome 22q11.2 deletion syndrome (22q11DS), also known as DiGeorge and Velocardiofacial Syndromes. It is the most common micro-deletion disorder in humans and one of the most common multiple malformation syndromes. The syndrome is characterized by a broad phenotype, whose characterization has expanded considerably within the last decade and includes many associated findings such as craniofacial anomalies (40%), conotruncal defects of the heart (CHD; 70-80%), hypocalcemia (20-60%), and a range of neurocognitive anomalies with high risk of schizophrenia, all with a broad phenotypic variability. These phenotypic features are believed to be the result of a change in the copy number or dosage of the genes located in the deleted region. Despite this relatively clear genetic etiology, very little is known about which genes modulate phenotypic variations in humans or if they are due to combinatorial effects of reduced dosage of multiple genes acting in concert. Here, we report on decreased expression levels of genes within the deletion region of chromosome 22, including DGCR8, in peripheral leukocytes derived from individuals with 22q11DS compared to healthy controls. Furthermore, we found dysregulated miRNA expression in individuals with 22q11DS, including miR-150, miR-194 and miR-185. We postulate this to be related to DGCR8 haploinsufficiency as DGCR8 regulates miRNA biogenesis. Importantly we demonstrate that the level of some miRNAs correlates with brain measures, CHD and thyroid abnormalities, suggesting that the dysregulated miRNAs may contribute to these phenotypes and/or represent relevant blood biomarkers of the disease in individuals with 22q11DS.	[Sellier, Chantal; Charlet-Berguerand, Nicolas] Univ Strasbourg, Inst Genet & Mol & Cellular Biol, Strasbourg, France; [Hwang, Vicki J.; Dandekar, Ravi; Tassone, Flora] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95820 USA; [Durbin-Johnson, Blythe] UC Davis Med Ctr, Dept Publ Hlth Sci, Sacramento, CA USA; [Ander, Bradley P.; Sharp, Frank R.; Angkustsiri, Kathleen; Simon, Tony J.; Tassone, Flora] UC Davis Med Ctr, MIND Inst, Sacramento, CA USA; [Ander, Bradley P.; Sharp, Frank R.] UC Davis Med Ctr, Dept Neurol, Sacramento, CA USA; [Angkustsiri, Kathleen] UC Davis Med Ctr, Dept Pediat, Sacramento, CA USA; [Simon, Tony J.] UC Davis Med Ctr, Dept Psychiat, Sacramento, CA USA	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tassone, F (corresponding author), Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95820 USA.	ftassone@ucdavis.edu	Charlet-Berguerand, Nicolas/I-6727-2016; Charlet-Berguerand, Nicolas/GZM-6636-2022	Charlet-Berguerand, Nicolas/0000-0002-4423-4920; Charlet-Berguerand, Nicolas/0000-0002-4423-4920	National Institutes of Health [R01HD042974, UL1TR000002]; Matteo's Funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042974] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Matteo's Funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Institutes of Health (Grant #R01HD042974 and UL1TR000002) and by Matteo's Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angkustsiri K G-JB, 2014, J AUTISM DE IN PRESS; Antshel KM, 2007, J AUTISM DEV DISORD, V37, P1776, DOI 10.1007/s10803-006-0308-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bassett AS, 1999, BIOL PSYCHIAT, V46, P882, DOI 10.1016/S0006-3223(99)00114-6; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Catalucci D, 2009, CIRC-CARDIOVASC GENE, V2, P402, DOI 10.1161/CIRCGENETICS.109.857425; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Conti E, 2003, EUR J HUM GENET, V11, P349, DOI 10.1038/sj.ejhg.5200956; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; de la Morena MT, 2013, CLIN IMMUNOL, V147, P11, DOI 10.1016/j.clim.2013.01.011; De Smedt B, 2007, J INTELL DISABIL RES, V51, P666, DOI 10.1111/j.1365-2788.2007.00955.x; Debbane M, 2006, NEUROPSYCHOLOGIA, V44, P2360, DOI 10.1016/j.neuropsychologia.2006.05.006; DeBoer T, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-54; Demczuk S, 1996, HUM MOL GENET, V5, P633, DOI 10.1093/hmg/5.5.633; Duijff SN, 2012, BRIT J PSYCHIAT, V200, P462, DOI 10.1192/bjp.bp.111.097139; duMontcel ST, 1996, J MED GENET, V33, P719, DOI 10.1136/jmg.33.8.719; Earls LR, 2012, J NEUROSCI, V32, P14132, DOI 10.1523/JNEUROSCI.1312-12.2012; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Eliez S, 2001, AM J PSYCHIAT, V158, P447, DOI 10.1176/appi.ajp.158.3.447; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Fryer A, 1996, J MED GENET, V33, P173, DOI 10.1136/jmg.33.2.173; Gardiner E, 2012, MOL PSYCHIATR, V17, P827, DOI 10.1038/mp.2011.78; Gong W, 2001, J Med Genet, V38, pE45, DOI 10.1136/jmg.38.12.e45; Goodship J, 1998, ARCH DIS CHILD, V79, P348, DOI 10.1136/adc.79.4.348; GOODSHIP J, 1995, J MED GENET, V32, P746, DOI 10.1136/jmg.32.9.746; Gothelf D, 2007, AM J PSYCHIAT, V164, P663, DOI 10.1176/appi.ajp.164.4.663; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Guo TW, 2011, HUM MUTAT, V32, P1278, DOI 10.1002/humu.21568; Hatchwell E, 1996, J MED GENET, V33, P261, DOI 10.1136/jmg.33.3.261; HEISTERKAMP N, 1995, GENOMICS, V29, P451, DOI 10.1006/geno.1995.9982; Huang ZP, 2010, ARTERIOSCL THROM VAS, V30, P2575, DOI 10.1161/ATVBAHA.110.213306; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kates WR, 2006, J AM ACAD CHILD PSY, V45, P587, DOI 10.1097/01.chi.0000205704.33077.4a; Khella HWZ, 2013, CARCINOGENESIS, V34, P2231, DOI 10.1093/carcin/bgt184; Lai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021635; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lindsay EA, 1997, CYTOGENET CELL GENET, V79, P243, DOI 10.1159/000134736; Lugli G, 2008, J NEUROCHEM, V106, P650, DOI 10.1111/j.1471-4159.2008.05413.x; Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; McQuade L, 1999, AM J MED GENET, V86, P27, DOI 10.1002/(SICI)1096-8628(19990903)86:1<27::AID-AJMG6>3.0.CO;2-7; Meechan DW, 2006, MOL CELL NEUROSCI, V33, P412, DOI 10.1016/j.mcn.2006.09.001; Mellios Nikolaos, 2012, Front Psychiatry, V3, P39, DOI 10.3389/fpsyt.2012.00039; Michaelovsky E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-122; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; ODonnell H, 1997, AM J HUM GENET, V60, P1544; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Oskarsdottir S, 2004, ARCH DIS CHILD, V89, P148, DOI 10.1136/adc.2003.026880; Ouchi Y, 2013, J NEUROSCI, V33, P9408, DOI 10.1523/JNEUROSCI.2700-12.2013; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rutter M., 2003, SOCIAL COMMUNICATION; Schumann CM, 2007, HIPPOCAMPUS, V17, P486, DOI 10.1002/hipo.20282; Shaikh TH, 2001, GENET MED, V3, P6, DOI 10.1097/00125817-200101000-00003; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Sivagnanasundaram S, 2007, BRAIN RES, V1139, P48, DOI 10.1016/j.brainres.2007.01.014; Stappert L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059011, 10.1371/annotation/b03fbc42-8f70-4873-9cce-854e48249a13]; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Swanson JM., 1995, SNAP 4 SCALE; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; van Amelsvoort T, 2004, SCHIZOPHR RES, V70, P223, DOI 10.1016/j.schres.2003.10.004; Van Amelsvoort T, 2001, BRIT J PSYCHIAT, V178, P412; Voelckel MA, 2004, ANN GENET-PARIS, V47, P235, DOI 10.1016/j.anngen.2004.04.002; Vorstman JAS, 2006, J AM ACAD CHILD PSY, V45, P1104, DOI 10.1097/01.chi.0000228131.56956.c1; Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180; Westholm JO, 2011, BIOCHIMIE, V93, P1897, DOI 10.1016/j.biochi.2011.06.017; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852; Woelk CH, 2011, INT REV NEUROBIOL, V101, P41, DOI 10.1016/B978-0-12-387718-5.00003-1; Xu B, 2012, NEUROBIOL DIS, V46, P291, DOI 10.1016/j.nbd.2012.02.016; Yamagishi H, 1998, AM J MED GENET, V78, P319, DOI 10.1002/(SICI)1096-8628(19980724)78:4<319::AID-AJMG3>3.0.CO;2-G; Zhang ZP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-124	80	45	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103884	10.1371/journal.pone.0103884	http://dx.doi.org/10.1371/journal.pone.0103884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084529	gold, Green Published			2022-12-27	WOS:000339819800098
J	Wu, HY; Huang, JJ; Lu, H; Li, GD; Huang, QS				Wu, Hongyu; Huang, Jinjiang; Lu, Hairong; Li, Guodong; Huang, Qingshan			GMEnzy: A Genetically Modified Enzybiotic Database	PLOS ONE			English	Article							BACTERIOPHAGE ENDOLYSINS; ANTI-INFECTIVES; PSI-BLAST; ENZYMES; LYSINS; AGENTS	GMEs are genetically modified enzybiotics created through molecular engineering approaches to deal with the increasing problem of antibiotic resistance prevalence. We present a fully manually curated database, GMEnzy, which focuses on GMEs and their design strategies, production and purification methods, and biological activity data. GMEnzy collects and integrates all available GMEs and their related information into one web based database. Currently GMEnzy holds 186 GMEs from published literature. The GMEnzy interface is easy to use, and allows users to rapidly retrieve data according to desired search criteria. GMEnzy's construction will increase the efficiency and convenience of improving these bioactive proteins for specific requirements, and will expand the arsenal available for researches to control drug-resistant pathogens. This database will prove valuable for researchers interested in genetically modified enzybiotics studies. GMEnzy is freely available on the Web at http://biotechlab.fudan.edu.cn/database/gmenzy/.	[Wu, Hongyu; Huang, Jinjiang; Lu, Hairong; Huang, Qingshan] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai, Peoples R China; [Li, Guodong; Huang, Qingshan] Shanghai Engn Res Ctr, Ind Microorganisms, Shanghai, Peoples R China; [Li, Guodong; Huang, Qingshan] Shanghai High Tech United Bio Technol R&D Co Ltd, Shanghai, Peoples R China	Fudan University	Huang, QS (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai, Peoples R China.	qshuang@fudan.edu.cn			National Major Scientific and Technological Special Project of China for "Significant New Drugs Development" [2013ZX09102057]; China Spark Program [2012GA6900035]; Shanghai Science and Technology Innovation Action Plan of China [12DE1940500]	National Major Scientific and Technological Special Project of China for "Significant New Drugs Development"; China Spark Program; Shanghai Science and Technology Innovation Action Plan of China	This work was supported in part by the National Major Scientific and Technological Special Project of China for "Significant New Drugs Development" (grant 2013ZX09102057, http://www.most.gov.cn/), the China Spark Program (grant 2012GA6900035, http://www.most.gov.cn/) and the Shanghai Science and Technology Innovation Action Plan (2012) of China (Grant 12DE1940500, http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Borysowaski J, 2010, ENZYBIOTICS ANTIBIOT, P199; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; DIAZ E, 1990, P NATL ACAD SCI USA, V87, P8125, DOI 10.1073/pnas.87.20.8125; Diez-Martinez R, 2013, ANTIMICROB AGENTS CH; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Hammami R, 2010, DRUG DISCOV TODAY, V15, P540, DOI 10.1016/j.drudis.2010.05.002; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Hojckova K, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-53; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Moellering RC, 2011, INT J ANTIMICROB AG, V37, P2, DOI 10.1016/j.ijantimicag.2010.08.018; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Pastagia M, 2013, J MED MICROBIOL, V62, P1506, DOI 10.1099/jmm.0.061028-0; Rodriguez-Rubio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064671; Rodriguez-Rubio L, 2013, CRIT REV MICROBIOL, V39, P427, DOI 10.3109/1040841X.2012.723675; Saravanan Sanjeev Rajagopalan, 2013, Bacteriophage, V3, pe26564; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/fmb.12.97, 10.2217/FMB.12.97]; Schmelcher M, 2010, APPL ENVIRON MICROB, V76, P5745, DOI 10.1128/AEM.00801-10; Szweda P, 2012, APPL MICROBIOL BIOT, V96, P1157, DOI 10.1007/s00253-012-4484-3; Thallinger B, 2013, BIOTECHNOL J, V8, P97, DOI 10.1002/biot.201200313; Veiga-Crespo P, 2007, J PHARM SCI-US, V96, P1917, DOI 10.1002/jps.20853; Waghu FH, 2014, NUCLEIC ACIDS RES, V42, pD1154, DOI 10.1093/nar/gkt1157; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Wu HY, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-54; Yang H, 2013, ANTIMICROB AGENTS CH; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557	31	0	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103687	10.1371/journal.pone.0103687	http://dx.doi.org/10.1371/journal.pone.0103687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084271	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800065
J	Yang, S; Wang, X; Cui, L; Ding, X; Niu, LL; Yang, FQ; Wang, C; Wang, CC; Lou, JZ				Yang, Shang; Wang, Xi; Cui, Lei; Ding, Xiang; Niu, Lili; Yang, Fuquan; Wang, Chao; Wang, Chih-chen; Lou, Jizhong			Compact Conformations of Human Protein Disulfide Isomerase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ACTIVE-SITES; BINDING SITE; B DOMAIN; OXIDATION; PATHWAY; REGION; A'	Protein disulfide isomerase (PDI) composed of four thioredoxin-like domains a, b, b', and a', is a key enzyme catalyzing oxidative protein folding in the endoplasmic reticulum. Large scale molecular dynamics simulations starting from the crystal structures of human PDI (hPDI) in the oxidized and reduced states were performed. The results indicate that hPDI adopts more compact conformations in solution than in the crystal structures, which are stabilized primarily by inter-domain interactions, including the salt bridges between domains a and b' observed for the first time. A prominent feature of the compact conformations is that the two catalytic domains a and a' can locate close enough for intra-molecular electron transfer, which was confirmed by the characterization of an intermediate with a disulfide between the two domains. Mutations, which disrupt the inter-domain interactions, lead to decreased reductase activity of hPDI. Our molecular dynamics simulations and biochemical experiments reveal the intrinsic conformational dynamics of hPDI and its biological impact.	[Yang, Shang; Wang, Xi; Cui, Lei; Wang, Chao; Wang, Chih-chen] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Cui, Lei; Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Lab RNA Biol, Beijing 100080, Peoples R China; [Ding, Xiang; Niu, Lili; Yang, Fuquan] Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing 100080, Peoples R China; [Yang, Shang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, CC (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	chihwang@sun5.ibp.ac.cn; jlou@ibp.ac.cn	Wang, Chao/AGP-7000-2022	Yang, Shang/0000-0001-6671-7571; Wang, Chao/0000-0002-3048-8559	National Major Basic Research Program of China [2011CB910303, 2012CB911002]; National Natural Science Foundation of China [31070827, 31222022, 31370758]	National Major Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Major Basic Research Program of China (2011CB910303 and 2012CB911002) http://www.most.gov.cn, and the National Natural Science Foundation of China (31070827, 31222022 and 31370758) http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin NT, 2013, BIOCHEM J, V450, P321, DOI 10.1042/BJ20121635; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chambers JE, 2010, J BIOL CHEM, V285, P29200, DOI 10.1074/jbc.M110.156596; Cheng H, 2010, CELL STRESS CHAPERON, V15, P415, DOI 10.1007/s12192-009-0157-2; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; HAWKINS HC, 1991, BIOCHEM J, V275, P341, DOI 10.1042/bj2750341; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kemmink J, 1996, BIOCHEMISTRY-US, V35, P7684, DOI 10.1021/bi960335m; Kemmink J, 1999, J BIOMOL NMR, V13, P357, DOI 10.1023/A:1008341820489; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTINEZGALISTEO E, 1993, BIOCHIMIE, V75, P803, DOI 10.1016/0300-9084(93)90131-B; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Wang C, 2010, J BIOL CHEM, V285, P26788, DOI 10.1074/jbc.M110.107839; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651	29	17	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103472	10.1371/journal.pone.0103472	http://dx.doi.org/10.1371/journal.pone.0103472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084354	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800046
J	Zheng, N; Yuan, XY; Li, YF; Chi, YY; Gao, HB; Zhao, X; Yu, SB; Sui, HJ; Sharkey, J				Zheng, Nan; Yuan, Xiao-Ying; Li, Yun-Fei; Chi, Yan-Yan; Gao, Hai-Bin; Zhao, Xin; Yu, Sheng-Bo; Sui, Hong-Jin; Sharkey, John			Definition of the To Be Named Ligament and Vertebrodural Ligament and Their Possible Effects on the Circulation of CSF	PLOS ONE			English	Article							SPINAL DURA-MATER; CONNECTIVE-TISSUE; MYODURAL BRIDGE; ANATOMIC RELATION; POSTERIOR MINOR; NUCHAE; MUSCLE; ATTACHMENTS; INTERSPACE; HEADACHE	Few studies have been conducted specifically on the dense connective tissue located in the posterior medial part of the cervical epidural space. This study was undertaken to examine the presence of this connection between the cervical dura mater and the posterior wall of spinal canal at the level of C1-C2. 30 head-neck specimens of Chinese adults were used. Gross dissection was performed on the suboccipital regions of the 20 specimens. Having been treated with the P45 plastination method, 10 specimens were sliced (9 sagittal and 1 horizontal sections). As a result, a dense fibrous band was identified in the nuchal ligament of 29 specimens (except for one horizontal section case). This fascial structure arose from the tissue of the posterior border of the nuchal ligament and then projected anteriorly and superiorly to enter the atlantoaxial interspace. It was termed as to be named ligament (TBNL). In all 30 specimens the existence of a fibrous connection was found between the posterior aspect of the cervical dura mater and the posterior wall of the spinal canal at the level of the atlas to the axis. This fibrous connection was identified as vertebrodural ligament (VDL). The VDL was mainly subdivided into three parts, and five variations of VDL were identified. These two structures, TBNL and VDL, firmly link the posterior aspect of cervical dura mater to the rear of the atlas-axis and the nuchal region. According to these findings, the authors speculated that the movements of the head and neck are likely to affect the shape of the cervical dural sleeve via the TBNL and VDL. It is hypothesized that the muscles directly associated with the cervical dural sleeve, in the suboccipital region, may work as a pump providing an important force required to move the CSF in the spinal canal.	[Zheng, Nan; Yuan, Xiao-Ying; Chi, Yan-Yan; Yu, Sheng-Bo; Sui, Hong-Jin] Dalian Med Univ, Coll Basic Med, Dept Anat, Dalian, Peoples R China; [Li, Yun-Fei] Dalian Med Univ, Zhongshan Coll, Dept Anat, Dalian, Peoples R China; [Gao, Hai-Bin; Sui, Hong-Jin] Dalian Hoffen Biotech Co Ltd, Dalian, Peoples R China; [Zhao, Xin] Dalian Med Univ, Sch Art, Dalian, Peoples R China; [Sharkey, John] Univ Chester, Natl Training Ctr, Dublin, Ireland	Dalian Medical University; Dalian Medical University; Sun Yat Sen University; Dalian Medical University	Yu, SB (corresponding author), Dalian Med Univ, Coll Basic Med, Dept Anat, Dalian, Peoples R China.	ysbdmu@126.com; suihj@hotmail.com			Dalian Hoffen Bio-Technique Co. Ltd	Dalian Hoffen Bio-Technique Co. Ltd	Dalian Hoffen Bio-Technique Co. Ltd freely provided support in making P45 plastination sections (it is a patented technology belonging to this company) and dissecting nuchal specimens. It is confirmed that one or more of the authors employed by this commercial company does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Alix ME, 1999, J MANIP PHYSIOL THER, V22, P534, DOI 10.1016/S0161-4754(99)70006-0; Dean NA, 2002, CLIN ANAT, V15, P182, DOI 10.1002/ca.10001; HACK GD, 1995, SPINE, V20, P2484, DOI 10.1097/00007632-199512000-00003; Hack GD, 2004, HEADACHE, V44, P84, DOI 10.1111/j.1526-4610.2004.04015.x; Hallgren R.C., 1997, AAO J, V7, P30; Hofmann M., 1898, ARCH ANAT PHYSIOL, P403; Humphreys BK, 2003, CLIN ANAT, V16, P152, DOI 10.1002/ca.10109; Johnson GM, 2000, SPINE, V25, P5, DOI 10.1097/00007632-200001010-00003; Kahkeshani K, 2012, CLIN ANAT, V25, P415, DOI 10.1002/ca.21261; KAHN JL, 1992, ACTA ANAT, V144, P65; Lang J, 1987, DIS CRANIO CERVICAL, P27; McPartland J.M., 1999, J BODYW MOV THER, V3, P30, DOI [10.1016/S1360-8592(99)80040-0, DOI 10.1016/S1360-8592(99)80040-0]; Mitchell BS, 1998, J MANIP PHYSIOL THER, V21, P145; Nash L, 2005, SPINE, V30, P1359, DOI 10.1097/01.brs.0000166159.31329.92; Pontell ME, 2013, CLIN ANAT, V26, P450, DOI 10.1002/ca.22134; Rutten HP, 1997, SPINE, V22, P924, DOI 10.1097/00007632-199704150-00018; Scali F, 2013, SPINE J, V13, P558, DOI 10.1016/j.spinee.2013.01.015; Scali F, 2013, CLIN ANAT, V26, P444, DOI 10.1002/ca.22094; Scali F, 2011, SPINE, V36, pE1612, DOI 10.1097/BRS.0b013e31821129df; Sui H.J., 2006, China patent, Patent No. ZL, Patent No. [3 (1), 34109.8, 31341098]; Trolard P., 1888, ARCH PHYSIOL-PARIS, V2, P191; Von Lanz T, 1929, ARCH ENTWICKL MECH O, V118, P252; Zumpano MP, 2006, CLIN ANAT, V19, P522, DOI 10.1002/ca.20220	23	36	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103451	10.1371/journal.pone.0103451	http://dx.doi.org/10.1371/journal.pone.0103451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084162	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800044
J	Figueiredo, CA; Drohomyrecky, PC; McCarthy, SDS; Leontyev, D; Ma, XZ; Branch, DR; Dunn, SE				Figueiredo, Carlyn A.; Drohomyrecky, Paulina C.; McCarthy, Stephen D. S.; Leontyev, Danila; Ma, Xue-Zhong; Branch, Donald R.; Dunn, Shannon E.			Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; REGULATORY T-CELLS; GUILLAIN-BARRE-SYNDROME; FC-GAMMA-RIIB; OFF-LABEL USE; MULTIPLE-SCLEROSIS; KAWASAKI-DISEASE; IMMUNE GLOBULIN; MURINE MODEL; IFN-GAMMA	Background: Intravenous immunoglobulin (IVIg) has been used to treat a variety of autoimmune disorders including multiple sclerosis (MS); however its mechanism of action remains elusive. Recent work has shown that interleukin-11 (IL-11) mRNAs are upregulated by IVIg in MS patient T cells. Both IVIg and IL-11 have been shown to ameliorate experimental autoimmune encephalomyelitis (EAE), an animal model of MS. The objective of this study was to determine whether the protective effects of IVIg in EAE occur through an IL-11 and IL-11 receptor (IL-11R)-dependent mechanism. Methods: We measured IL-11 in the circulation of mice and IL-11 mRNA expression in various organs after IVIg treatment. We then followed with EAE studies to test the efficacy of IVIg in wild-type (WT) mice and in mice deficient for the IL-11 receptor (IL-11R alpha(-/-)). Furthermore, we evaluated myelin-specific Th1 and Th17 responses and assessed spinal cord inflammation and demyelination in WT and IL-11R alpha(-/-) mice, with and without IVIg treatment. We also examined the direct effects of mouse recombinant IL-11 on the production of IL-17 by lymph node mononuclear cells. Results: IVIg treatment induced a dramatic surge (>1000-fold increase) in the levels of IL-11 in the circulation and a prominent increase of IL-11 mRNA expression in the liver. Furthermore, we found that IL-11R alpha(-/-) mice, unlike WT mice, although initially protected, were resistant to full protection by IVIg during EAE and developed disease with a similar incidence and severity as control-treated IL-11R alpha(-/-) mice, despite initially showing protection. We observed that Th17 cytokine production by myelin-reactive T cells in the draining lymph nodes was unaffected by IVIg in IL-11R alpha(-/-) mice, yet was downregulated in WT mice. Finally, IL-11 was shown to directly inhibit IL-17 production of lymph node cells in culture. Conclusion: These results implicate IL-11 as an important immune effector of IVIg in the prevention of Th17-mediated autoimmune inflammation during EAE.	[Figueiredo, Carlyn A.; McCarthy, Stephen D. S.; Leontyev, Danila; Ma, Xue-Zhong; Branch, Donald R.] Canadian Blood Serv, Res & Dev, Toronto, ON, Canada; [Figueiredo, Carlyn A.; McCarthy, Stephen D. S.; Branch, Donald R.] Univ Hlth Network, Dept Lab Med, Toronto, ON, Canada; [Figueiredo, Carlyn A.; McCarthy, Stephen D. S.; Branch, Donald R.] Univ Hlth Network, Dept Pathobiol, Toronto, ON, Canada; [Branch, Donald R.; Dunn, Shannon E.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Drohomyrecky, Paulina C.; Dunn, Shannon E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Drohomyrecky, Paulina C.; Dunn, Shannon E.] Canadian Blood Serv, Ctr Innovat, Toronto, ON, Canada; [Dunn, Shannon E.] Womens Coll Res Inst, Toronto, ON, Canada	Canadian Blood Services; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Canadian Blood Services; University of Toronto; University Toronto Affiliates; Womens College Hospital	Branch, DR (corresponding author), Canadian Blood Serv, Res & Dev, 67 Coll Toronto, Toronto, ON, Canada.	don.branch@utoronto.ca; sdunn@uhnresearch.ca			Canadian Blood Services graduate student fellowship award; Canadian Blood Services/Health Canada Intramural grant [XT00048]; Multiple Sclerosis Society of Canada (MSSC); Canadian Institutes of Health Research (CIHR) Vanier scholarship; MSSC	Canadian Blood Services graduate student fellowship award; Canadian Blood Services/Health Canada Intramural grant; Multiple Sclerosis Society of Canada (MSSC); Canadian Institutes of Health Research (CIHR) Vanier scholarship(Canadian Institutes of Health Research (CIHR)); MSSC	This work was supported by a Canadian Blood Services graduate student fellowship award (C. A. F.) and a Canadian Blood Services/Health Canada Intramural grant, XT00048 (D. R. B.). P. D. was supported by a studentship from the Multiple Sclerosis Society of Canada (MSSC). S. D. S. M. was supported by a Canadian Institutes of Health Research (CIHR) Vanier scholarship. S. E. D. is supported by a Don Paty Award from the MSSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Antonelli A, 1992, Clin Ter, V141, P55; Aslam R, 2012, BLOOD, V120, P2127, DOI 10.1182/blood-2012-02-413526; BERKMAN SA, 1988, SEMIN HEMATOL, V25, P140; Bozza M, 1999, HEPATOLOGY, V30, P1441, DOI 10.1002/hep.510300616; Branch DR, 2013, TRANSFUSION, V53, P242, DOI 10.1111/trf.12053; Busse M, 2012, J IMMUNOL, V189, P1975, DOI 10.4049/jimmunol.1103581; Chi L, 2007, J NEUROIMMUNOL, V192, P206, DOI 10.1016/j.jneuroim.2007.09.034; Chipps E, 1994, J Neurosci Nurs, V26, P8; Cohen JA, 2008, NAT CLIN PRACT NEURO, V4, P588, DOI 10.1038/ncpneuro0923; Crow AR, 2003, BLOOD, V102, P558, DOI 10.1182/blood-2003-01-0023; Curtin F, 2014, EXPERT REV CLIN PHAR, V7, P91, DOI 10.1586/17512433.2014.865517; Dudesek A, 2006, J NEUROL, V253, P50, DOI 10.1007/s00415-006-5007-x; Dunn SE, 2010, J EXP MED, V207, P1599, DOI 10.1084/jem.20091663; Durandy A, 2009, CLIN EXP IMMUNOL, V158, P2, DOI [10.1111/j.1365-2249.2009.04022.X, 10.1111/j.1365-2249.2009.04022.x]; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Foster R, 2010, TRANSFUSION MED, V20, P403, DOI 10.1111/j.1365-3148.2010.01022.x; Gelfand EW, 2012, NEW ENGL J MED, V367, P2015, DOI 10.1056/NEJMra1009433; Guhr T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021246; Gurfein BT, 2009, J IMMUNOL, V183, P4229, DOI 10.4049/jimmunol.0900622; Hirabayashi Y, 2013, EUR J PEDIATR, V172, P833, DOI 10.1007/s00431-013-1937-3; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Ichiyama T, 2005, RHEUMATOLOGY, V44, P314, DOI 10.1093/rheumatology/keh488; IMBACH P, 1981, LANCET, V1, P1228; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jorgensen SH, 2005, J NEUROL SCI, V233, P61, DOI 10.1016/j.jns.2005.03.005; Jorgensen SH, 2005, NEUROL RES, V27, P591, DOI 10.1179/016164105X48798; Katz U, 2011, CURR PHARM DESIGN, V17, P3166, DOI 10.2174/138161211798157540; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kessel A, 2007, J IMMUNOL, V179, P5571, DOI 10.4049/jimmunol.179.8.5571; Leng SX, 1997, INT J BIOCHEM CELL B, V29, P1059, DOI 10.1016/S1357-2725(97)00017-4; Leontyev D, 2012, TRANSFUSION, V52, P1799, DOI 10.1111/j.1537-2995.2011.03517.x; Leontyev D, 2012, BLOOD, V119, P5261, DOI 10.1182/blood-2012-03-415695; Maddur MS, 2011, J ALLERGY CLIN IMMUN, V127, P823, DOI 10.1016/j.jaci.2010.12.1102; Maeshima K, 2004, SHOCK, V21, P134, DOI 10.1097/01.shk.0000103386.98235.f6; Maheshwari A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/685317; Masubachi Y, 2003, BIOCHEM BIOPH RES CO, V304, P207, DOI 10.1016/S0006-291X(03)00572-2; Nishina T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002056; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Oomes PG, 1996, NEUROLOGY, V46, P96, DOI 10.1212/WNL.46.1.96; Othy S, 2013, J IMMUNOL, V190, P4535, DOI 10.4049/jimmunol.1201965; Pashov A, 1997, MULT SCLER, V3, P153, DOI 10.1177/135245859700300218; Pigard N, 2009, J NEUROIMMUNOL, V209, P114, DOI 10.1016/j.jneuroim.2009.01.014; Ramakrishna C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002071; RATKO TA, 1995, JAMA-J AM MED ASSOC, V273, P1865, DOI 10.1001/jama.273.23.1865; Redpath SA, 2013, EUR J IMMUNOL, V43, P705, DOI 10.1002/eji.201242794; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; SCHWARTZ SA, 1990, J CLIN IMMUNOL, V10, P81, DOI 10.1007/BF00918189; SORENSEN PS, 1994, J NEUROL NEUROSUR PS, V57, P62, DOI 10.1136/jnnp.57.Suppl.62; Tjon ASW, 2013, CLIN EXP IMMUNOL, V173, P259, DOI 10.1111/cei.12102; Tran EH, 2000, J IMMUNOL, V164, P2759, DOI 10.4049/jimmunol.164.5.2759; Trepicchio WL, 2001, TOXICOL PATHOL, V29, P242, DOI 10.1080/019262301317052521; Watkatsuki A, 2003, EUR J IMMUNOL, V33, P1859; Zhang MA, 2012, P NATL ACAD SCI USA, V109, P9505, DOI 10.1073/pnas.1118458109; Zhang YT, 2006, J NEUROSCI, V26, P12174, DOI 10.1523/JNEUROSCI.2289-06.2006	57	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e101947	10.1371/journal.pone.0101947	http://dx.doi.org/10.1371/journal.pone.0101947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078447	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800010
J	Hagemann, UB; Gunnarsson, L; Geraudie, S; Scheffler, U; Griep, RA; Reiersen, H; Duncan, AR; Kiprijanov, SM				Hagemann, Urs B.; Gunnarsson, Lavinia; Geraudie, Solene; Scheffler, Ulrike; Griep, Remko A.; Reiersen, Herald; Duncan, Alexander R.; Kiprijanov, Sergej M.			Fully Human Antagonistic Antibodies against CCR4 Potently Inhibit Cell Signaling and Chemotaxis	PLOS ONE			English	Article							REGULATORY T-CELLS; FOSTERS IMMUNE PRIVILEGE; PHAGE DISPLAY TECHNOLOGY; CHEMOKINE RECEPTOR 4; THERAPEUTIC ANTIBODIES; MONOCLONAL-ANTIBODIES; CANCER-IMMUNOTHERAPY; MOLECULAR TARGET; HODGKIN LYMPHOMA; EXPRESSION	Background: CC chemokine receptor 4 (CCR4) represents a potentially important target for cancer immunotherapy due to its expression on tumor infiltrating immune cells including regulatory T cells (Tregs) and on tumor cells in several cancer types and its role in metastasis. Methodology: Using phage display, human antibody library, affinity maturation and a cell-based antibody selection strategy, the antibody variants against human CCR4 were generated. These antibodies effectively competed with ligand binding, were able to block ligand-induced signaling and cell migration, and demonstrated efficient killing of CCR4-positive tumor cells via ADCC and phagocytosis. In a mouse model of human T-cell lymphoma, significant survival benefit was demonstrated for animals treated with the newly selected anti-CCR4 antibodies. Significance: For the first time, successful generation of anti-G-protein coupled chemokine receptor (GPCR) antibodies using human non-immune library and phage display on GPCR-expressing cells was demonstrated. The generated anti-CCR4 antibodies possess a dual mode of action (inhibition of ligand-induced signaling and antibody-directed tumor cell killing). The data demonstrate that the anti-tumor activity in vivo is mediated, at least in part, through Fc-receptor dependent effector mechanisms, such as ADCC and phagocytosis. Anti-CC chemokine receptor 4 antibodies inhibiting receptor signaling have potential as immunomodulatory antibodies for cancer.	[Hagemann, Urs B.; Gunnarsson, Lavinia; Geraudie, Solene; Scheffler, Ulrike; Griep, Remko A.; Reiersen, Herald; Duncan, Alexander R.; Kiprijanov, Sergej M.] Affitech Res AS, Oslo, Norway		Duncan, AR (corresponding author), Actigen Ltd, Cambridge, England.	alex@actigen.com	Reiersen, Herald/ABA-5161-2020	Reiersen, Herald/0000-0002-3288-554X				Abi-Younes S, 2001, THROMB RES, V101, P279, DOI 10.1016/S0049-3848(00)00402-3; Adams GP, 1999, J IMMUNOL METHODS, V231, P249, DOI 10.1016/S0022-1759(99)00161-1; Adams GP, 1998, IN VIVO, V12, P11; Al Mahmoud R, 2012, J PEDIAT HEMATOL ONC, V34, P611, DOI 10.1097/MPH.0b013e3182707592; Argyriou AA, 2009, MOL MED, V15, P183, DOI 10.2119/molmed.2009.00007; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Beck A, 2012, MABS-AUSTIN, V4, P419, DOI 10.4161/mabs.20996; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Byrne WL, 2011, CANCER RES, V71, P6915, DOI 10.1158/0008-5472.CAN-11-1156; Chang DK, 2012, MOL CANCER THER, V11, P2451, DOI 10.1158/1535-7163.MCT-12-0278; Clemetson KJ, 2000, BLOOD, V96, P4046; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Ferenczi K, 2002, J INVEST DERMATOL, V119, P1405, DOI 10.1046/j.1523-1747.2002.19610.x; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198; Hoogenboom HR, 1999, EUR J BIOCHEM, V260, P774, DOI 10.1046/j.1432-1327.1999.00214.x; Huang LL, 2005, J MOL RECOGNIT, V18, P327, DOI 10.1002/jmr.735; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Imai T, 1996, J BIOL CHEM, V271, P21514, DOI 10.1074/jbc.271.35.21514; Imai T, 1998, J BIOL CHEM, V273, P1764, DOI 10.1074/jbc.273.3.1764; Ishida T, 2006, LEUKEMIA, V20, P2162, DOI 10.1038/sj.leu.2404415; Ishida T, 2003, CLIN CANCER RES, V9, P3625; Ishida T, 2006, CANCER SCI, V97, P1139, DOI 10.1111/j.1349-7006.2006.00307.x; Ishida T, 2006, CANCER RES, V66, P5716, DOI 10.1158/0008-5472.CAN-06-0261; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Kipriyanov SM, 2009, METHODS MOL BIOL, V562, P205, DOI 10.1007/978-1-60327-302-2_16; Kipriyanov SM, 1997, J IMMUNOL METHODS, V200, P69, DOI 10.1016/S0022-1759(96)00188-3; Kurosawa G, 2008, P NATL ACAD SCI USA, V105, P7287, DOI 10.1073/pnas.0712202105; Loset GA, 2005, J IMMUNOL METHODS, V299, P47, DOI 10.1016/j.jim.2005.01.014; Menetrier-Caux C, 2009, CANCER RES, V69, P7895, DOI 10.1158/0008-5472.CAN-09-1642; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; Moghaddam A, 2003, J IMMUNOL METHODS, V280, P139, DOI 10.1016/S0022-1759(03)00109-1; Morimoto Y, 2005, J LEUKOCYTE BIOL, V78, P753, DOI 10.1189/jlb.0305139; Murata K, 2007, INT REV IMMUNOL, V26, P249, DOI 10.1080/08830180701709817; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; Norderhaug L, 1997, J IMMUNOL METHODS, V204, P77, DOI 10.1016/S0022-1759(97)00034-3; Overdijk MB, 2012, J IMMUNOL, V189, P3430, DOI 10.4049/jimmunol.1200356; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Ravn P, 2013, J BIOL CHEM, V288, P19760, DOI 10.1074/jbc.M112.426288; Ruter J, 2009, FRONT BIOSCI-LANDMRK, V14, P1761, DOI 10.2741/3338; Subramaniam JM, 2012, DRUGS, V72, P1293, DOI 10.2165/11631090-000000000-00000; Sui JH, 2003, EUR J BIOCHEM, V270, P4497, DOI 10.1046/j.1432-1033.2003.03843.x; Tobinai K, 2012, CURR HEMATOL MALIG R, V7, P235, DOI 10.1007/s11899-012-0124-3; Tohidkia MR, 2013, BIODRUGS, V27, P55, DOI 10.1007/s40259-012-0007-0; van Berkel PHC, 2010, BIOTECHNOL BIOENG, V105, P350, DOI 10.1002/bit.22535; van der Horst E, 2009, NEOPLASIA, V11, P355, DOI 10.1593/neo.81536; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Weiner LM, 2012, CELL, V148, P1081, DOI 10.1016/j.cell.2012.02.034; Whittaker S, 2006, SEMIN ONCOL, V33, pS3, DOI 10.1053/j.seminoncol.2005.12.015; Xu C, 2007, J IMMUNOL, V179, P2408, DOI 10.4049/jimmunol.179.4.2408; Zhang Y, 2004, BIOCHEMISTRY-US, V43, P12575, DOI 10.1021/bi0492152; Zhou Q, 2008, BIOTECHNOL BIOENG, V99, P652, DOI 10.1002/bit.21598; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	60	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103776	10.1371/journal.pone.0103776	http://dx.doi.org/10.1371/journal.pone.0103776			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080123	Green Submitted, gold, Green Published			2022-12-27	WOS:000339954800080
J	Liu, X; Wu, WD; Fang, YF; Zhang, MC; Huang, WH				Liu, Xiong; Wu, Wei-dong; Fang, Ya-feng; Zhang, Mei-chao; Huang, Wen-hua			Biomechanical Comparison of Osteoporotic Distal Radius Fractures Fixed by Distal Locking Screws with Different Length	PLOS ONE			English	Article							DOUBLE-PLATING FIXATION; VOLAR FIXATION; T-PLATES; DORSAL; ANGLE; OUTCOMES; NUMBER; FORCES; GRIP	Objectives: To evaluate the postoperative stability of osteoporotic distal radius fractures fixed with distal locking screws with different length. Methods: A comminuted extra-articular dorsally unstable distal radius fracture, treated with volar locking plate system, was created. The 18 specimens were randomized into 3 groups based on distal locked screws with different length: Group A had unicortical screws with 50% length to the dorsal cortex. Group B had unicortical screws with 75% length to the dorsal cortex. Group C had bicortical screws. Axial compression and bending loads were imposed on the models before and after cycling testing as well as load to clinical and catastrophic failure. Results: Minimum change in stiffness was observed before and after fatigue for all groups. The final stiffness to bending forces was statistically similar in all groups, but stiffness to axial compression was statistically significant different: Group A approached significance with respect to groups B and C (P = 0.017, 0.009), whereas stiffness in group B and C was statistically similar (P = 0.93). Load to clinical failure was significantly less for group A (456.54 +/- 78.59 N) compared with groups B (580.24 +/- 73.85 N) and C (591.07 +/- 38.40 N). Load to catastrophic failure was statistically similar between groups, but mean values for Group A were 18% less than means for Group C. Conclusions: The volar locking plate system fixed with unicortical locking screws with at least 75% length not only produced early stability for osteoporotic distal radius fractures, but also avoided extensor tendon complications due to dorsal screw protrusion.	[Liu, Xiong; Wu, Wei-dong; Fang, Ya-feng; Zhang, Mei-chao; Huang, Wen-hua] Southern Med Univ, Dept Anat, Guangdong Prov Key Lab Med Biomech, Guangzhou, Guangdong, Peoples R China; [Liu, Xiong] Eight Peoples Hosp Dongguan, Shilongboai Hosp, Dept Orthopaed, Dongguan, Guangdong, Peoples R China; [Wu, Wei-dong] Wuzhou Red Cross Hosp, Dept Orthopaed, Wuzhou, Guangxi, Peoples R China	Southern Medical University - China	Zhang, MC (corresponding author), Southern Med Univ, Dept Anat, Guangdong Prov Key Lab Med Biomech, Guangzhou, Guangdong, Peoples R China.	zmc@fimmu.com	huang, wenhua/AAO-5990-2020	huang, wenhua/0000-0003-2382-9180	863 Project of National Ministry of Science and Technology [2012AA02A603]; National Natural Science Foundation of China [31200708]	863 Project of National Ministry of Science and Technology(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by 863 Project of National Ministry of Science and Technology (http://www.most.gov.cn/) grant 2012AA02A603, National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm) grant 31200708. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan Zahab S, 2012, Hand (N Y), V7, P276, DOI 10.1007/s11552-012-9420-6; Armangil M, 2013, EUR J ORTHOP SURG TR; Blythe M, 2006, J HAND SURG-AM, V31A, P1587, DOI 10.1016/j.jhsa.2006.09.011; Burkhart KJ, 2010, CLIN BIOMECH, V25, P771, DOI 10.1016/j.clinbiomech.2010.06.004; CHAO EY, 1976, J BIOMECH, V9, P387, DOI 10.1016/0021-9290(76)90116-0; Chen ACY, 2013, INJURY, V44, P527, DOI 10.1016/j.injury.2012.09.022; Cheng HYK, 2007, CLIN BIOMECH, V22, P510, DOI 10.1016/j.clinbiomech.2006.12.010; Chirpaz-Cerbat JM, 2011, ORTHOP TRAUMATOL-SUR, V97, P465, DOI 10.1016/j.otsr.2011.01.016; Cho CH, 2012, CLIN ORTHOP SURG, V4, P325, DOI 10.4055/cios.2012.4.4.325; Chou YC, 2011, J HAND SURG-AM, V36A, P974, DOI 10.1016/j.jhsa.2011.02.024; COONEY WP, 1977, J BONE JOINT SURG AM, V59, P27, DOI 10.2106/00004623-197759010-00004; Douthit John D, 2005, Am J Orthop (Belle Mead NJ), V34, P140; Drobetz H, 2011, ANZ J SURG, V81, P46, DOI 10.1111/j.1445-2197.2010.05479.x; Duncan Scott F M, 2007, Am J Orthop (Belle Mead NJ), V36, P669; Gondusky JS, 2011, J ORTHOP TRAUMA, V25, P44, DOI 10.1097/BOT.0b013e3181d7a3a6; Haug LCP, 2011, ARCH ORTHOP TRAUM SU, V131, P1279, DOI 10.1007/s00402-011-1300-y; Heidari N, 2012, J HAND SURG-EUR VOL, V37E, P402, DOI 10.1177/1753193411424706; HORII E, 1990, J HAND SURG-AM, V15A, P393, DOI 10.1016/0363-5023(90)90049-W; Jakubietz MG, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-24; Joseph SJ, 2011, J HAND SURG-AM, V36A, P1691, DOI 10.1016/j.jhsa.2011.07.020; Koh S, 2006, J HAND SURG-AM, V31A, P771, DOI 10.1016/j.jhsa.2006.02.015; Konstantinidis L, 2011, ARCH ORTHOP TRAUM SU, V131, P1529, DOI 10.1007/s00402-011-1346-x; Koo SC, 2006, J HAND SURG-ASIAN-PA, V11, P67, DOI 10.1142/S0218810406003048; Kosiyatrakul Arkaphat, 2012, J Med Assoc Thai, V95 Suppl 10, pS213; Lin CL, 2006, MED BIOL ENG COMPUT, V44, P665, DOI 10.1007/s11517-006-0082-9; Martineau PA, 2008, J HAND SURG-AM, V33A, P827, DOI 10.1016/j.jhsa.2008.01.006; Maschke Steven D, 2007, Hand (N Y), V2, P144, DOI 10.1007/s11552-007-9038-2; Mehling I, 2010, J HAND SURG-AM, V35A, P885, DOI 10.1016/j.jhsa.2010.03.027; Mignemi ME, 2013, J HAND SURG-AM, V38A, P40, DOI 10.1016/j.jhsa.2012.10.007; Mudgal CS, 2008, J ORTHOP TRAUMA, V22, pS106, DOI 10.1097/BOT.0b013e31815e9fcd; Nunley JA, 1999, J HAND SURG-AM, V24A, P1279, DOI 10.1053/jhsu.1999.1279; Ozer Kagan, 2011, Hand (N Y), V6, P190, DOI 10.1007/s11552-010-9316-2; Peine R, 2000, J HAND SURG-AM, V25A, P29; Putnam MD, 2000, J HAND SURG-AM, V25A, P469, DOI 10.1053/jhsu.2000.6915; Ring D, 2005, OSTEOPOROSIS INT, V16, pS80, DOI 10.1007/s00198-004-1808-x; Rozental TD, 2006, J HAND SURG-AM, V31A, P359, DOI 10.1016/j.jhsa.2005.10.010; Ruch DS, 2006, J HAND SURG-AM, V31A, P9, DOI 10.1016/j.jhsa.2005.09.011; Swigart CR, 2012, J HAND SURG-AM, V37A, P1868, DOI 10.1016/j.jhsa.2012.06.005; Trease C, 2005, J HAND SURG-AM, V30A, P756, DOI 10.1016/j.jhsa.2005.04.017; Ward JP, 2012, BULL HOSP JT DIS, V70, P273; Wilcke MKT, 2011, ACTA ORTHOP, V82, P76, DOI 10.3109/17453674.2011.552781	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103371	10.1371/journal.pone.0103371	http://dx.doi.org/10.1371/journal.pone.0103371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25080094	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800040
J	Towne, EG; Craine, JM				Towne, E. Gene; Craine, Joseph M.			Ecological Consequences of Shifting the Timing of Burning Tallgrass Prairie	PLOS ONE			English	Article							VEGETATION DYNAMICS; FLINT HILLS; FIRE; VARIABILITY; GRASSLAND; CLIMATE; KANSAS; EMISSIONS; CATTLE; BISON	In the Kansas Flint Hills, grassland burning is conducted during a relatively narrow window because management recommendations for the past 40 years have been to burn only in late spring. Widespread prescribed burning within this restricted time frame frequently creates smoke management issues downwind. A potential remedy for the concentrated smoke production in late spring is to expand burning to times earlier in the year. Yet, previous research suggested that burning in winter or early spring reduces plant productivity and cattle weight gain while increasing the proportion of undesirable plant species. In order to better understand the ecological consequences of burning at different times of the year, plant production and species abundance were measured for 20 years on ungrazed watersheds burned annually in autumn, winter, or spring. We found that there were no significant differences in total grass production among the burns on either upland or lowland topographic positions, although spring burned watersheds had higher grass culm production and lower forb biomass than autumn and winter burned watersheds. Burning in autumn or winter broadened the window of grass productivity response to precipitation, which reduces susceptibility to mid-season drought. Burning in autumn or winter also increased the phenological range of species by promoting cool-season graminoids without a concomitant decrease in warm-season grasses, potentially widening the seasonal window of high-quality forage. Incorporating autumn and winter burns into the overall portfolio of tallgrass prairie management should increase the flexibility in managing grasslands, promote biodiversity, and minimize air quality issues caused by en masse late-spring burning with little negative consequences for cattle production.	[Towne, E. Gene; Craine, Joseph M.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Kansas State University	Towne, EG (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	egtowne@ksu.edu	Craine, Joseph/D-4569-2009	Craine, Joseph/0000-0001-6561-3244	NSF [DEB-0823341]; Kansas State University	NSF(National Science Foundation (NSF)); Kansas State University	This work was supported in part by an NSF grant to the Konza Prairie Long-Term Ecological Research Program (DEB-0823341). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous AE, 1934, KANSAS AGR EXPT STAT, V38; ANDERSON KL, 1970, J RANGE MANAGE, V23, P81, DOI 10.2307/3896105; ANDERSON KLING L., 1965, J RANGE MANAGE, V18, P311, DOI 10.2307/3895421; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Augustine JK, 2011, AVIAN CONSERV ECOL, V6, DOI 10.5751/ACE-00429-060102; AXELROD DI, 1985, BOT REV, V51, P163, DOI 10.1007/BF02861083; BAILEY AW, 1968, ECOLOGY, V49, P1, DOI 10.2307/1933554; BENNING TL, 1993, AM MIDL NAT, V130, P127, DOI 10.2307/2426281; BERNARDO DJ, 1988, J RANGE MANAGE, V41, P178, DOI 10.2307/3898959; Bieber GL, 1961, J SOIL WATER CONSERV, V16, P186; Blocksome C, 2011, PRESCRIBED BURNING N; BRAGG TB, 1982, ECOLOGY, V63, P7, DOI 10.2307/1937024; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; BRIGGS JM, 1995, AM J BOT, V82, P1024, DOI 10.2307/2446232; Coppedge BR, 1998, PLANT ECOL, V139, P235, DOI 10.1023/A:1009728104508; Craine JM, 2012, P NATL ACAD SCI USA, V109, P3401, DOI 10.1073/pnas.1118438109; Craine JM, 2012, NEW PHYTOL, V193, P673, DOI 10.1111/j.1469-8137.2011.03953.x; Craine JM, 2010, ECOLOGY, V91, P2132, DOI 10.1890/09-1242.1; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Engle DM, 2001, J RANGE MANAGE, V54, P2, DOI 10.2307/4003519; ERWIN WJ, 1979, AM MIDL NAT, V101, P247, DOI 10.2307/2424922; Hailey A, 2000, BIOL CONSERV, V92, P321, DOI 10.1016/S0006-3207(99)00099-3; HANKS R. J., 1957, Journal of Soil and Water Conservation, V12, P228; Horowitz LW, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002853; HURST DF, 1994, J GEOPHYS RES-ATMOS, V99, P16441, DOI 10.1029/94JD00670; Kansas Department of Health and Environment, 2010, FLINT HILLS SMOK MAN; KEMP PR, 1980, ECOLOGY, V61, P846, DOI 10.2307/1936755; KOLLMORGEN WM, 1965, ANN ASSOC AM GEOGR, V55, P260, DOI 10.1111/j.1467-8306.1965.tb00518.x; Korontzi S, 2003, J ARID ENVIRON, V54, P395, DOI 10.1006/jare.2002.1098; Main MB, 2002, WETLANDS, V22, P430, DOI 10.1672/0277-5212(2002)022[0430:IOSOFO]2.0.CO;2; Mauzerall DL, 2005, ATMOS ENVIRON, V39, P2851, DOI 10.1016/j.atmosenv.2004.12.041; MCMURPHY W. E., 1963, Transactions of the Kansas Academy of Science, V66, P49, DOI 10.2307/3626834; McMURPHY WILFRED E., 1965, J RANGE MANAGE, V18, P265, DOI 10.2307/3895495; Menard C, 2002, J APPL ECOL, V39, P120, DOI 10.1046/j.1365-2664.2002.00693.x; Mohler Rhett L., 2012, Great Plains Research, V22, P15; Odadi WO, 2013, ECOL APPL, V23, P455, DOI 10.1890/12-0878.1; Ohlenbusch PD, 2000, KSU EXTENSION PUBL L, V815; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Owens MK, 2002, J RANGE MANAGE, V55, P509, DOI 10.2307/4003231; OWENSBY CE, 1967, J RANGE MANAGE, V20, P12, DOI 10.2307/3896282; PLUMB GE, 1993, ECOL APPL, V3, P631, DOI 10.2307/1942096; RAO MR, 1973, J RANGE MANAGE, V26, P419, DOI 10.2307/3896976; Reinking Dan L., 2005, Studies in Avian Biology, V30, P116; Robel RJ, 1998, J RANGE MANAGE, V51, P132, DOI 10.2307/4003197; Simoneit BRT, 2002, APPL GEOCHEM, V17, P129, DOI 10.1016/S0883-2927(01)00061-0; STEUTER AA, 1987, J RANGE MANAGE, V40, P27, DOI 10.2307/3899356; Towne E. Gene, 2002, SIDA Contributions to Botany, V20, P269; Towne EG, 2003, J RANGE MANAGE, V56, P185, DOI 10.2307/4003903	48	24	24	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103423	10.1371/journal.pone.0103423	http://dx.doi.org/10.1371/journal.pone.0103423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077487	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800043
J	Wei, T; Sun, YN; Zhang, B; Wang, RX; Xu, TJ				Wei, Tao; Sun, Yuena; Zhang, Bo; Wang, Rixin; Xu, Tianjun			A Mitogenomic Perspective on the Phylogenetic Position of the Hapalogenys Genus (Acanthopterygii: Perciformes) and the Evolutionary Origin of Perciformes	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; SYSTEMATIC POSITION; TELEOSTEI; FISHES; SEQUENCES; HISTORY	The Hapalogenys genus was the most controversial and problematic in phylogenetic position of Percoidei. In this study, we rechecked the taxonomic status of Hapalogenys in Percoidei using complete mitochondrial genome data. We purposefully added a new complete mitochondrial sequence from chosen species of Hapalogenys and conducted phylogenetic analyses using a large complete mitochondrial data set. The resultant tree topologies were congruent from partitioned Bayesian and Maximum-likelihood methods. The results indicated that Hapalogenys was distantly related to Haemulidae and could be removed from Haemulidae. The results supported the Hapalogeny was upgraded to a family rank titled Hapalogenyidae, and it should be recognized in a separate family of Hapalogenyidae. A relaxed molecular-clock Bayesian analysis indicated that the divergence times of Perciformes groups had a much older than the available old fossil records. The origin of the common ancestral lineage of Perciformes fish was estimated in the late Jurassic about 149 Myr ago.	[Wei, Tao; Sun, Yuena; Zhang, Bo; Wang, Rixin; Xu, Tianjun] Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan, Peoples R China	Zhejiang Ocean University	Sun, YN (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan, Peoples R China.	yuenasun@163.com; tianjunxu@163.com			National Natural Science Foundation of China [31272661]; Zhejiang Provincial Natural Science Foundation [LY13C040001]; Young Academic Leaders in Zhejiang Province [PD2013220]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Young Academic Leaders in Zhejiang Province	This study was supported by National Natural Science Foundation of China (31272661), Zhejiang Provincial Natural Science Foundation (LY13C040001), and grant of Young Academic Leaders in Zhejiang Province (PD2013220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Benton M.J., 1993, FOSSIL RECORD; Benton MJ, 1998, ADEQUACY OF THE FOSSIL RECORD, P269; CANTATORE P, 1994, J MOL EVOL, V39, P589, DOI 10.1007/BF00160404; Carroll RL, 1997, PATTERNS PROCESSES V; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Inoue JG, 2009, MOL PHYLOGENET EVOL, V51, P486, DOI 10.1016/j.ympev.2009.01.020; Iwatsuki Yukio, 2006, Memoirs of Museum Victoria, V63, P29; Johnson GD, 1984, AM SOC ICHTHYOL HERP, V1; KUMAZAWA Y, 1993, J MOL EVOL, V37, P380, DOI 10.1007/BF00178868; Kumazawa Y, 1999, BIOL BIODIVERSITY, P35; Lavoue S, 2010, MOL PHYLOGENET EVOL, V56, P480, DOI 10.1016/j.ympev.2009.11.022; Liang RS, 2012, MITOCHONDR DNA, V23, P264, DOI 10.3109/19401736.2012.690746; MADDISON WP, 2000, MACCLADE 4 0 ANAL PH; McKay RJ, 2001, SPECIES IDENTIFICA 3; Miller TL, 2007, MOL PHYLOGENET EVOL, V44, P450, DOI 10.1016/j.ympev.2006.10.029; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Miya M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-58; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Otero O, 2004, ZOOL J LINN SOC-LOND, V141, P81, DOI 10.1111/j.1096-3642.2004.00111.x; PATTERSON C, 1993, B MAR SCI, V52, P29; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Randall JE, 2000, RAFFLES B ZOOL, P569; Ren Gang, 2007, Acta Zootaxonomica Sinica, V32, P835; Ren Gang, 2007, JOURNAL OF TROPICAL OCEANOGRAPHY, V26, P48; Richardson J, 1844, ANN MAGAZINE NATURAL, V13, P462, DOI DOI 10.1080/03745484409442632; Song CB, 1998, MOL PHYLOGENET EVOL, V10, P343, DOI 10.1006/mpev.1998.0542; Springer VG, 1995, AM TOPICAL ASS HDB, V129, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavera JJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-57; Wei T, 2013, J GENET, V92, P247, DOI 10.1007/s12041-013-0259-6; Xu Tian-Jun, 2010, Acta Zootaxonomica Sinica, V35, P530; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297; Zhu SH, 2006, J TROPICAL OCEANOGRA, V4, P42	40	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103011	10.1371/journal.pone.0103011	http://dx.doi.org/10.1371/journal.pone.0103011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25077480	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800023
J	Zhu, HW; Chen, X; Chen, B; Chen, B; Song, WB; Sun, DY; Zhao, YG				Zhu, Hongwu; Chen, Xiong; Chen, Bin; Chen, Bei; Song, Weibing; Sun, Dayong; Zhao, Yagang			Activating Transcription Factor 4 Promotes Esophageal Squamous Cell Carcinoma Invasion and Metastasis in Mice and Is Associated with Poor Prognosis in Human Patients	PLOS ONE			English	Article							CANCER; RESECTION; SURVIVAL; REINITIATION; TRANSLATION; EXPRESSION; HYPOXIA	Background: Activating transcription factor 4 (ATF4) is a stress response gene that is involved in homeostasis and cellular protection. However, its expression and function in esophageal squamous cell carcinoma (ESCC) remains unknown. In this study, we aimed to determine the clinicopathologic significance of ATF4 in ESCC and its potential role in ESCC invasion and metastasis. Methodology/Principal Findings: We demonstrated that ATF4 overexpression is correlated with multiple malignant characteristics and indicates poor prognosis in ESCC patients. ATF4 expression was an independent factor that affected the overall survival of patients with ESCC after surgical resection. ATF4 promoted cell invasion and metastasis by promoting matrix metalloproteinase (MMP)-2 and MMP-7 expression, while its silencing significantly attenuated these activities both in vitro and in vivo. Conclusions/Significance: We report that ATF4 is a potential biomarker for ESCC prognosis and that its dysregulation may play a key role in the regulation of invasion and metastasis in ESCC cells. The targeting of ATF4 may provide a new strategy for blocking ESCC metastasis.	[Zhu, Hongwu; Sun, Dayong; Zhao, Yagang] Peoples Liberat Army, Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Chen, Xiong] PLA, Nanjing Mil Command, Fuzhou Gen Hosp, Dept Oncol, Fuzhou, Peoples R China; [Chen, Bin; Chen, Bei] Peoples Liberat Army, Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Song, Weibing] Peoples Liberat Army, Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Gerontol, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; Southern Theater Command General Hospital; Southern Theater Command General Hospital	Sun, DY (corresponding author), Peoples Liberat Army, Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China.	sundayong1967@126.com; yagang78@163.com			National Natural Science Foundation of China [81101821, 81101822]; Natural Science Foundation of Guangdong province [10451001002004732]; Ph.D. Start-up Fund of Natural Science Foundation of Guangdong Province [S2011040001277]; Science and Technology Plan Project of Guangdong province [2011B031800317]; Science and Technology Plan Project of Fujian province [2012J05157]; Science and Technology Key Project of Guangzhou, China [11C26090521]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province); Ph.D. Start-up Fund of Natural Science Foundation of Guangdong Province; Science and Technology Plan Project of Guangdong province; Science and Technology Plan Project of Fujian province; Science and Technology Key Project of Guangzhou, China	This study was supported by combined grants from the National Natural Science Foundation of China (No. 81101821, No. 81101822), the Natural Science Foundation of Guangdong province (No. 10451001002004732), the Ph.D. Start-up Fund of Natural Science Foundation of Guangdong Province (No. S2011040001277), the Science and Technology Plan Project of Guangdong province (No. 2011B031800317), the Science and Technology Plan Project of Fujian province (No. 2012J05157), and the Science and Technology Key Project of Guangzhou (No. 11C26090521), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou C, 2006, ANN THORAC SURG, V82, P1073, DOI 10.1016/j.athoracsur.2006.03.012; Ameri K, 2010, BRIT J CANCER, V102, P561, DOI 10.1038/sj.bjc.6605491; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Chen SB, 2013, J THORAC ONCOL, V8, P495, DOI 10.1097/JTO.0b013e3182829e2c; Chen YZ, 2013, APMIS; Crosby T, 2009, ANN ROY COLL SURG, V91, P366; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Guo W, 2013, CLIN EXP METASTASIS; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lee PC, 2009, ANN THORAC SURG, V88, P186, DOI 10.1016/j.athoracsur.2009.03.079; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060027; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Min S, 2013, CANC GENE THER; Mujcic H, 2009, RADIOTHER ONCOL, V92, P450, DOI 10.1016/j.radonc.2009.08.017; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Peyre CG, 2008, ANN SURG, V248, P549, DOI 10.1097/SLA.0b013e318188c474; Rice TW, 1998, ANN THORAC SURG, V65, P787, DOI 10.1016/S0003-4975(97)01387-8; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Torres CM, 1999, MODERN PATHOL, V12, P961; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P85; Wang HH, 2012, FEBS J, V279, P3652, DOI 10.1111/j.1742-4658.2012.08726.x; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063581; Yu Y, 2013, BIOCH BIOPHYS RES CO; Zhang H, 2013, ASIAN PAC J CANCER P, V14, P2851, DOI 10.7314/APJCP.2013.14.5.2851; Zhu HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031431	29	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103882	10.1371/journal.pone.0103882	http://dx.doi.org/10.1371/journal.pone.0103882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078779	Green Submitted, Green Published, gold			2022-12-27	WOS:000339954800092
J	Chou, H; Wu, KG; Yeh, CC; Tai, HY; Tam, MF; Chen, YS; Shen, HD				Chou, Hong; Wu, Keh-Gong; Yeh, Chang-Ching; Tai, Hsiao-Yun; Tam, Ming F.; Chen, Yu-Sen; Shen, Horng-Der			The Transaldolase, a Novel Allergen of Fusarium proliferatum, Demonstrates IgE Cross-Reactivity with Its Human Analogue	PLOS ONE			English	Article							FUNGAL ALLERGENS; MAJOR ALLERGEN; SOLANI; PREVALENCE; ASTHMA; DISEASE; CLONING	Fusarium species are among airborne fungi and recognized as causative agents of human atopic disorders. However, Fusarium allergens have not been well characterized and the lack of information limits clinical diagnosis and treatment of fungal allergy. The purpose of this study is to identify and characterize important allergens of F. proliferatum. IgE-reacting F. proliferatum components were identified by immunoblot using serum samples from patients of respiratory atopic diseases. Characterization of allergens and determination of IgE cross-reactivity were performed by cDNA cloning, then homologous expression and immunoblot inhibition studies. We identified nine different F. proliferatum components that can be recognized by IgE antibodies in 17 (28%) of the 60 atopic sera tested. Components with molecular masses of about 43, 37.5 and 36.5 kDa with IgE-binding frequencies of about 88, 47 and 53%, respectively, were considered as important allergens of F. proliferatum. The 37.5 kDa IgE-binding component was putatively considered as a transaldolase protein of F. proliferatum. The full-length cDNA of F. proliferatum transaldolase was subsequently cloned. It encodes an open reading frame of 312 amino acids and has sequence identifies of 73 and 61%, respectively, with Cladosporium and human transaldolases. The purified recombinant F. proliferatum transaldolase can inhibit the IgE-binding against the 37.5 kDa component of F. proliferatum and the transaldolase allergen from Cladosporium cladosporioides. More importantly, the recombinant F. proliferatum transaldolase can inhibit IgE-binding against human transaldolase in a concentration-dependent manner. Thus, a novel and important F. proliferatum transaldolase allergen was identified. In addition to IgE cross-reactivity between the Fusarium and the Cladosporium transaldolase allergens, IgE cross-reactivity between the Fusarium and the human transaldolases also exists and might contribute to atopic manifestations in the absence of exogenous allergen exposure.	[Chou, Hong; Tai, Hsiao-Yun; Chen, Yu-Sen; Shen, Horng-Der] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Wu, Keh-Gong] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Wu, Keh-Gong] Natl Yang Ming Univ, Taipei 112, Taiwan; [Yeh, Chang-Ching] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Tam, Ming F.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Carnegie Mellon University	Shen, HD (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan.	hdshen@vghtpe.gov.tw		YEH, CHANG-CHING/0000-0003-0690-7503	National Science Council [NSC 101-2320-B-075-005-MY2]; Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China [V102C-066]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China(Taipei Veterans General Hospital)	This work was supported by grants from the National Science Council (Grant NSC 101-2320-B-075-005-MY2) and the Taipei Veterans General Hospital (V102C-066), Taipei, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Dieyeh MH, 2010, AEROBIOLOGIA, V26, P263, DOI 10.1007/s10453-010-9162-2; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Appenzeller U, 1999, INT ARCH ALLERGY IMM, V118, P193, DOI 10.1159/000024064; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; BUSH RK, 1987, CLIN REV ALLERG, V5, P3; Chang HN, 1984, CLIN MED J, V34, P376; Chou H, 2011, CLIN EXP ALLERGY, V41, P739, DOI 10.1111/j.1365-2222.2011.03698.x; Chou H, 2008, INT ARCH ALLERGY IMM, V146, P277, DOI 10.1159/000121462; Crameri R, 2014, ALLERGY, V69, P176, DOI 10.1111/all.12325; Crameri R, 2009, MYCOSES, V52, P99, DOI 10.1111/j.1439-0507.2008.01644.x; Esch RE, 2004, J ALLERGY CLIN IMMUN, V113, P210, DOI 10.1016/j.jaci.2003.11.024; Gonianakis MI, 2006, ALLERGY ASTHMA PROC, V27, P354, DOI 10.2500/aap.2006.27.2918; Hoff M, 2003, MOL IMMUNOL, V39, P965, DOI 10.1016/S0161-5890(03)00026-9; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Khosravi AR, 2012, ARH HIG RADA TOKSIKO, V63, P1, DOI 10.2478/10004-1254-63-2012-2155; LI CS, 1995, ARCH ENVIRON HEALTH, V50, P38, DOI 10.1080/00039896.1995.9955011; Mayer C, 1999, J EXP MED, V189, P1507, DOI 10.1084/jem.189.9.1507; ONEIL CE, 1986, J ALLERGY CLIN IMMUN, V77, P842, DOI 10.1016/0091-6749(86)90382-9; Prasad R, 2009, LUNG INDIA, V26, P70, DOI 10.4103/0970-2113.53228; Shen HD, 1999, INT ARCH ALLERGY IMM, V119, P259, DOI 10.1159/000024202; SPRENGER GA, 1995, J BACTERIOL, V177, P5930, DOI 10.1128/jb.177.20.5930-5936.1995; Stroud RH, 2001, OTOLARYNG HEAD NECK, V125, P491, DOI 10.1067/mhn.2001.119969; Tai HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071269; Thorell S, 2000, FEBS LETT, V475, P205, DOI 10.1016/S0014-5793(00)01658-6; Valenta R, 2009, TRENDS IMMUNOL, V30, P109, DOI 10.1016/j.it.2008.12.004; VERMA J, 1994, INT ARCH ALLERGY IMM, V104, P175, DOI 10.1159/000236727; Verma J, 2003, INT ARCH ALLERGY IMM, V130, P193, DOI 10.1159/000069518; VERMA J, 1994, ALLERGY, V49, P330, DOI 10.1111/j.1398-9995.1994.tb02277.x; Verma J, 1998, ALLERGY, V53, P311, DOI 10.1111/j.1398-9995.1998.tb03893.x; Wahl P. G. von, 1991, Aerobiologia, V7, P111, DOI 10.1007/BF02270679; Zahran Hatice S., 2011, Morbidity and Mortality Weekly Report, V60, P547	31	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103488	10.1371/journal.pone.0103488	http://dx.doi.org/10.1371/journal.pone.0103488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075521	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800052
J	Vallverdu, J; Saladie, P; Rosas, A; Huguet, R; Caceres, I; Mosquera, M; Garcia-Tabernero, A; Estalrrich, A; Lozano-Fernandez, I; Pineda-Alcala, A; Carrancho, A; Villalain, JJ; Bourles, D; Braucher, R; Lebatard, A; Vilalta, J; Esteban-Nadal, M; Bennasar, ML; Bastir, M; Lopez-Polin, L; Olle, A; Verges, JM; Ros-Montoya, S; Martinez-Navarro, B; Garcia, A; Martinell, J; Exposito, I; Burjachs, F; Agusti, J; Carbonell, E				Vallverdu, Josep; Saladie, Palmira; Rosas, Antonio; Huguet, Rosa; Caceres, Isabel; Mosquera, Marina; Garcia-Tabernero, Antonio; Estalrrich, Almudena; Lozano-Fernandez, Ivan; Pineda-Alcala, Antonio; Carrancho, Angel; Jose Villalain, Juan; Bourles, Didier; Braucher, Regis; Lebatard, Anne; Vilalta, Jaume; Esteban-Nadal, Montserrat; Lluc Bennasar, Maria; Bastir, Marcus; Lopez-Polin, Lucia; Olle, Andreu; Maria Verges, Josep; Ros-Montoya, Sergio; Martinez-Navarro, Bienvenido; Garcia, Ana; Martinell, Jordi; Exposito, Isabel; Burjachs, Francesc; Agusti, Jordi; Carbonell, Eudald			Age and Date for Early Arrival of the Acheulian in Europe (Barranc de la Boella, la Canonja, Spain)	PLOS ONE			English	Article							PLEISTOCENE HUMAN-SETTLEMENTS; LOIRE RIVER-BASIN; IBERIAN PENINSULA; FLUVIAL DEPOSITS; CENTER REGION; HALF-LIFE; BE-10; AL-26; RADIONUCLIDES; COLONIZATION	The first arrivals of hominin populations into Eurasia during the Early Pleistocene are currently considered to have occurred as short and poorly dated biological dispersions. Questions as to the tempo and mode of these early prehistoric settlements have given rise to debates concerning the taxonomic significance of the lithic assemblages, as trace fossils, and the geographical distribution of the technological traditions found in the Lower Palaeolithic record. Here, we report on the Barranc de la Boella site which has yielded a lithic assemblage dating to similar to 1 million years ago that includes large cutting tools (LCT). We argue that distinct technological traditions coexisted in the Iberian archaeological repertoires of the late Early Pleistocene age in a similar way to the earliest sub-Saharan African artefact assemblages. These differences between stone tool assemblages may be attributed to the different chronologies of hominin dispersal events. The archaeological record of Barranc de la Boella completes the geographical distribution of LCT assemblages across southern Eurasia during the EMPT (Early-Middle Pleistocene Transition, circa 942 to 641 kyr). Up to now, chronology of the earliest European LCT assemblages is based on the abundant Palaeolithic record found in terrace river sequences which have been dated to the end of the EMPT and later. However, the findings at Barranc de la Boella suggest that early LCT lithic assemblages appeared in the SW of Europe during earlier hominin dispersal episodes before the definitive colonization of temperate Eurasia took place.	[Vallverdu, Josep; Saladie, Palmira; Huguet, Rosa; Caceres, Isabel; Mosquera, Marina; Lozano-Fernandez, Ivan; Pineda-Alcala, Antonio; Vilalta, Jaume; Esteban-Nadal, Montserrat; Lluc Bennasar, Maria; Lopez-Polin, Lucia; Olle, Andreu; Maria Verges, Josep; Martinez-Navarro, Bienvenido; Garcia, Ana; Martinell, Jordi; Exposito, Isabel; Burjachs, Francesc; Agusti, Jordi; Carbonell, Eudald] Inst Catala Paleoecol Humana & Evolucio Social IP, Tarragona, Spain; [Vallverdu, Josep; Saladie, Palmira; Huguet, Rosa; Caceres, Isabel; Mosquera, Marina; Lozano-Fernandez, Ivan; Pineda-Alcala, Antonio; Esteban-Nadal, Montserrat; Lopez-Polin, Lucia; Olle, Andreu; Maria Verges, Josep; Martinez-Navarro, Bienvenido; Exposito, Isabel; Burjachs, Francesc; Agusti, Jordi; Carbonell, Eudald] Univ Rovira & Virgili, Fac Lletres, Area Prehist, Dept Hist & Hist Art, E-43007 Tarragona, Spain; [Saladie, Palmira] Univ Coimbra, Grp Quaternario & Prehist, Fac Ciencias & Tecnol, Ctr Geociencias GQP CG, Coimbra, Portugal; [Vallverdu, Josep; Rosas, Antonio; Huguet, Rosa; Garcia-Tabernero, Antonio; Estalrrich, Almudena; Bastir, Marcus; Carbonell, Eudald] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Carrancho, Angel; Jose Villalain, Juan] Univ Burgos UBU, Escuela Politecn Super, Dept Fis, Lab Paleomagnetismo, Burgos, Spain; [Carrancho, Angel] Univ Burgos UBU, Dept Ciencias Hist & Geog, Area Prehist, Burgos, Spain; [Bourles, Didier; Braucher, Regis; Lebatard, Anne] Univ Aix Marseille, CNRS, Ctr Rech & Enseignement Geosci Environem CEREGE, Lab Natl Nucleides Cosmogen,UM34, Aix En Provence, France; [Ros-Montoya, Sergio] Museo Prehist & Paleontol, Granada, Spain; [Martinez-Navarro, Bienvenido; Burjachs, Francesc; Agusti, Jordi] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain; [Martinell, Jordi] Univ Barcelona, Fac Geol, Dept Estratig Paleontol & Geociencies Marines, Barcelona, Spain	Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Universidade de Coimbra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad de Burgos; Universidad de Burgos; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; ICREA; University of Barcelona	Vallverdu, J (corresponding author), Inst Catala Paleoecol Humana & Evolucio Social IP, Tarragona, Spain.	jvallverdu@iphes.cat; arosas@mncn.csic.es	Rosas, Antonio/D-9742-2016; Huguet, Rosa/H-5713-2015; Ollé, Andreu/D-6837-2013; Burjachs, Francesc/G-2064-2015; López-Polín, Lucía/C-3087-2016; Martinell, Jordi/X-4501-2019; Poch, Josep Vallverdú i/B-7121-2014; Estalrrich, Almudena/ABF-1891-2020; Carrancho, Ángel/R-5077-2018; , Braucher/Q-5971-2017; López-Polín, Lucía/AAC-3482-2019; Mosquera, Marina/B-1140-2014; Martinell, Jordi/K-2981-2014; Martinez-Navarro, Bienvenido/L-5950-2014; García-Tabernero, Antonio/AAQ-8382-2020; Lozano-Fernández, Iván/AAE-1394-2019; Montoya, Sergio Ros/M-6189-2015; Expósito, Isabel/J-2046-2017; Vergès Bosch, Josep Maria/G-4490-2015; Cáceres, Isabel/G-2636-2015; Carbonell, Eudald/G-3003-2015; Saladie, Palmira/AAR-7932-2020; Martínez-Navarro, Bienvenido/ABE-3563-2021; Ros-Montoya, Sergio/AAD-1749-2019; Ros-Montoya, Sergio/L-6105-2014; Saladie, Palmira/G-4019-2015; Bastir, Markus/G-8987-2013	Rosas, Antonio/0000-0002-5829-9952; Ollé, Andreu/0000-0002-8643-5536; Burjachs, Francesc/0000-0002-7200-9552; López-Polín, Lucía/0000-0002-5810-4115; Martinell, Jordi/0000-0003-2638-8106; Poch, Josep Vallverdú i/0000-0002-3177-3263; Estalrrich, Almudena/0000-0003-2295-5396; Carrancho, Ángel/0000-0001-7119-6424; , Braucher/0000-0002-4637-4302; López-Polín, Lucía/0000-0002-5810-4115; Mosquera, Marina/0000-0003-4823-6154; Martinell, Jordi/0000-0003-2638-8106; Martinez-Navarro, Bienvenido/0000-0002-8374-5109; García-Tabernero, Antonio/0000-0001-5400-5630; Montoya, Sergio Ros/0000-0001-6895-807X; Expósito, Isabel/0000-0002-2084-5487; Vergès Bosch, Josep Maria/0000-0003-1807-7463; Cáceres, Isabel/0000-0001-8487-2591; Martínez-Navarro, Bienvenido/0000-0002-8374-5109; Ros-Montoya, Sergio/0000-0001-6895-807X; Ros-Montoya, Sergio/0000-0001-6895-807X; Lozano-Fernandez, Ivan/0000-0003-1036-7634; Bennasar, Maria/0000-0003-3780-7505; Saladie, Palmira/0000-0002-1730-8461; Lebatard, Anne-Elisabeth/0000-0002-9262-9169; Pineda Alcala, Antonio/0000-0002-3767-8590; Bourles, Didier/0000-0001-5991-6126; Bastir, Markus/0000-0002-3141-3401; VILLALAIN, JUAN JOSE/0000-0001-9948-0953	Spanish Ministerio de Economia y Competitividad [CGL2012-36682, CGL2012-38358, CGL2012-38434-C03-03, CGL2010-15326, HAR2009-7223/HIST]; Generalitat de Catalunya; AGAUR agence [2014SGR-901, 2014SGR-899, 2009SGR-324, 2009PBR-0033, 2009SGR-188]; Junta de Castilla y Leon [BU1004A09]; Ajuntament de la Canonja and Departament de Cultura (Servei d'Arqueologia i Paleontologia) de la Generalitat de Catalunya; International Excellence Programme, Reinforcement subprogramme of the Spanish Ministry of Education; Fundacion Atapuerca; ICREA Funding Source: Custom	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); AGAUR agence; Junta de Castilla y Leon(Junta de Castilla y Leon); Ajuntament de la Canonja and Departament de Cultura (Servei d'Arqueologia i Paleontologia) de la Generalitat de Catalunya; International Excellence Programme, Reinforcement subprogramme of the Spanish Ministry of Education; Fundacion Atapuerca; ICREA(ICREA)	The research at Barranc de la Boella has been carried out with the financial support of the Spanish Ministerio de Economia y Competitividad (CGL2012-36682; CGL2012-38358, CGL2012-38434-C03-03 and CGL2010-15326; MICINN project HAR2009-7223/HIST), Generalitat de Catalunya, AGAUR agence ( projects 2014SGR-901; 2014SGR-899; 2009SGR-324, 2009PBR-0033 and 2009SGR-188) and Junta de Castilla y Leon BU1004A09. Financial support for Barranc de la Boella field work and archaeological excavations is provided by the Ajuntament de la Canonja and Departament de Cultura (Servei d'Arqueologia i Paleontologia) de la Generalitat de Catalunya. A. Carrancho's research was funded by the International Excellence Programme, Reinforcement subprogramme of the Spanish Ministry of Education. I. Lozano-Fernandez acknowledges the pre-doctoral grant from the Fundacion Atapuerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIMEN MH, 1975, ANTHROPOLOGIE, V79, P399; Arnold M, 2010, NUCL INSTRUM METH B, V268, P1954, DOI 10.1016/j.nimb.2010.02.107; ASHTON N, 1994, ANTIQUITY, V68, P585, DOI 10.1017/S0003598X00047074; Bar-Yosef O, 1993, LITHIC ASSEMBLAGES U; Biberson PL., 1961, PALEOLITHIQUE INFERI; Binford L.R., 1982, J ANTHROPOL ARCHAEOL, V1, P5, DOI DOI 10.1016/0278-4165(82)90006-X; Bordes F, 1971, MUNIBE, P5; Braucher R, 2011, EARTH PLANET SC LETT, V309, P1, DOI 10.1016/j.epsl.2011.06.036; Bridgland DR, 2006, J QUATERNARY SCI, V21, P437, DOI 10.1002/jqs.1042; BROWN ET, 1991, GEOCHIM COSMOCHIM AC, V55, P2269, DOI 10.1016/0016-7037(91)90103-C; Bunn H T, 1982, Science, V215, P494, DOI 10.1126/science.215.4532.494; Cac hel S., 1998, EARLY HUMAN BEHAV GL, P108; Carbonell E., 1988, COMPLEX PLISTOCE MIT; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carbonell E, 2010, QUATERN INT, V223, P36, DOI 10.1016/j.quaint.2010.02.015; Chevrier B, 2006, GALLIA PREHISTOIRE, V48, P207, DOI DOI 10.3406/GALIP.2006.2451; Chmeleff J, 2010, NUCL INSTRUM METH B, V268, P192, DOI 10.1016/j.nimb.2009.09.012; de la Torre I, 2004, ESTRATEGIAS TECNOLOG; de la Torre I, 2011, J HUM EVOL, V60, P768, DOI 10.1016/j.jhevol.2011.01.009; Dennell R, 2005, NATURE, V438, P1099, DOI 10.1038/nature04259; Dennell R, 2003, J HUM EVOL, V45, P421, DOI 10.1016/j.jhevol.2003.09.006; Despriee J, 2011, QUATERNARY SCI REV, V30, P1474, DOI 10.1016/j.quascirev.2011.02.011; Despriee J, 2010, QUATERN INT, V223, P345, DOI 10.1016/j.quaint.2009.07.019; Garcia Sanchez E, 2006, TRABAJOS PREHIST, V63, P47; Goren-Inbar N., 2004, HUMAN PALEOECOLOGY L; Granger DE, 2006, GEOL SOC AM SPEC PAP, V415, P1, DOI 10.1130/2006.2415(01); Granger DE, 2001, EARTH PLANET SC LETT, V188, P269, DOI 10.1016/S0012-821X(01)00309-0; HAYNES G, 1988, J ARCHAEOL SCI, V15, P131, DOI 10.1016/0305-4403(88)90003-9; Isaac G.L., 1977, OLORGESAILIE ARCHEOL; KOHL CP, 1992, GEOCHIM COSMOCHIM AC, V56, P3583, DOI 10.1016/0016-7037(92)90401-4; Korschinek G, 2010, NUCL INSTRUM METH B, V268, P187, DOI 10.1016/j.nimb.2009.09.020; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; Lozano-Fernandez I, 2013, QUATERNAIRE, V24, P179, DOI 10.4000/quaternaire.6587; Lycett SJ, 2010, WORLD ARCHAEOL, V42, P521, DOI 10.1080/00438243.2010.517667; Madurell-Malapeira J, 2012, J HUM EVOL, V62, P169, DOI 10.1016/j.jhevol.2011.10.005; Jimenez-Arenas JM, 2011, J ARCHAEOL SCI, V38, P3340, DOI 10.1016/j.jas.2011.07.020; Marlowe FW, 2006, FEEDING ECOLOGY APES, P359; Martinez K, 2010, P NATL ACAD SCI USA, V107, P5762, DOI 10.1073/pnas.0913856107; Masana E., 1994, GEOMORFOLOGIA ESPANA, P29; McNabb J, 2005, GEOL SOC SPEC PUBL, V247, P287, DOI 10.1144/GSL.SP.2005.247.01.17; Merchel S, 2004, NUCL INSTRUM METH B, V223, P393, DOI 10.1016/j.nimb.2004.04.076; Merchel S, 1999, RADIOCHIM ACTA, V84, P215; Mgeladze A, 2011, J HUM EVOL, V60, P571, DOI 10.1016/j.jhevol.2010.10.008; Mishra S, 2007, QUATERNARY SCI REV, V26, P2996, DOI 10.1016/j.quascirev.2007.06.035; Moncel MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075529; Moncel MH, 2010, QUATERN INT, V223, P1, DOI 10.1016/j.quaint.2010.02.016; Mosquera M, 2013, QUATERN INT, V295, P130, DOI 10.1016/j.quaint.2012.01.031; Movius HL, 1949, LOWER PALAEOLITHIC C; Nemec W, 1984, SEDIMENTOLOGY GRAVEL, V10, P1; NISHIIZUMI K, 1989, J GEOPHYS RES-SOLID, V94, P17907, DOI 10.1029/JB094iB12p17907; OCONNELL JF, 1988, CURR ANTHROPOL, V29, P356, DOI 10.1086/203648; Pappu S, 2011, SCIENCE, V331, P1596, DOI 10.1126/science.1200183; Parfitt SA, 2010, NATURE, V466, P229, DOI 10.1038/nature09117; Perez Gonzalez A, 1998, B SEMINARIO ESTUDIOS, V64, P9; Perez-Gonzalez A., 2010, CUATERNARIO ARQUEOLO, P45; Petraglia M, 1999, J ANTHROPOL RES, V55, P39, DOI 10.1086/jar.55.1.3630977; Plummer T, 2005, AFRICAN ARCHAEOLOGY, P55; Querol M.A., 1979, EXCAVACIONES ARQUEOL, P181; Rolland Nicolas., 1998, EARLY HUMAN BEHAV GL, P187; Sahnouni M., 2009, CUTTING EDGE NEW APP, P179; SAMWORTH EA, 1972, PHYS REV C, V5, P138, DOI 10.1103/PhysRevC.5.138; Santisteban JI, 2007, QUATERNARY SCI REV, V26, P2738, DOI 10.1016/j.quascirev.2006.12.019; Santonja M., 2006, AXE AGE ACHEULIAN TO, P429; Santonja M, 2000, ZEPHYRUS, V53-54, P27; Santonja M, 2000, ZEPHYRUS, P27; Santonja M, 2010, QUATERN INT, V223, P154, DOI 10.1016/j.quaint.2010.02.010; Schick K., 2003, MULTIPLE APPROACHES, P1; Scott GR, 2009, NATURE, V461, P82, DOI 10.1038/nature08214; Semaw S, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P173, DOI 10.1007/978-0-387-76487-0_10; Sharon G, 2011, J HUM EVOL, V60, P387, DOI 10.1016/j.jhevol.2009.11.012; Sharon G, 2011, AFR ARCHAEOL REV, V28, P125, DOI 10.1007/s10437-011-9087-3; Shea JJ, 2010, VERTEBR PALEOBIOL PA, P47, DOI 10.1007/978-90-481-9036-2_4; Silva PG, 2012, ESTUD GEOL-MADRID, V67, P57, DOI DOI 10.3989/EGE0L.40338.134; Sirakov N, 2010, QUATERN INT, V223, P94, DOI 10.1016/j.quaint.2010.02.023; Stone JO, 2000, J GEOPHYS RES-SOL EA, V105, P23753, DOI 10.1029/2000JB900181; Tauxe L, 1996, J GEOPHYS RES-SOL EA, V101, P571, DOI 10.1029/95JB03041; Toro-Moyano I, 2013, J HUM EVOL, V65, P1, DOI 10.1016/j.jhevol.2013.01.012; Valls Bartolome ML, 1987, NEOTECTONICA RED HID, P885; Vilaseca S., 1973, REUS ENTORNO PREHIST; Villa P, 2001, QUATERN INT, V75, P113, DOI 10.1016/S1040-6182(00)00083-5; Villamarin JA, 1999, GEOGACETA, V25, P211; White MJ, 2000, J WORLD PREHIST, V14, P1, DOI 10.1023/A:1007874901792; Zouak M, 2002, QUATERNAIRE, P65	83	120	121	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103634	10.1371/journal.pone.0103634	http://dx.doi.org/10.1371/journal.pone.0103634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AM7EZ	25076416	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800070
J	Xie, N; Mou, LS; Yuan, JH; Liu, WL; Deng, TT; Li, ZG; Jin, Y; Hu, ZL				Xie, Ni; Mou, Lisha; Yuan, Jianhui; Liu, Wenlan; Deng, Tingting; Li, Zigang; Jin, Yi; Hu, Zhangli			Modulating Drug Resistance by Targeting BCRP/ABCG2 Using Retrovirus-Mediated RNA Interference	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; MULTIDRUG-RESISTANCE; PROTEIN EXPRESSION; BLAST CELLS; IN-VITRO; INHIBITION; TOPOTECAN; MEMBRANE; POTENT	Background: The BCRP/ABCG2 transporter, which mediates drug resistance in many types of cells, depends on energy provided by ATP hydrolysis. Here, a retrovirus encoding a shRNA targeting the ATP-binding domain of this protein was used to screen for highly efficient agents that could reverse drug resistance and improve cell sensitivity to drugs, thus laying the foundation for further studies and applications. Methodology/Principal Findings: To target the ATP-binding domain of BCRP/ABCG2, pLenti6/BCRPsi shRNA recombinant retroviruses, with 20 bp target sequences starting from the 270th, 745th and 939th bps of the 6th exon, were constructed and packaged. The pLenti6/BCRPsi retroviruses (V-BCRPi) that conferred significant knockdown effects were screened using a drug-sensitivity experiment and flow cytometry. The human choriocarcinoma cell line JAR, which highly expresses endogenous BCRP/ABCG2, was injected under the dorsal skin of a hairless mouse to initiate a JAR cytoma. After injecting V-BCRPi-infected JAR tumor cells into the dorsal skin of hairless mice, BCRP/ABCG2 expression in the tumor tissue was determined using immunohistochemistry, fluorescent quantitative RT-PCR and Western blot analyses. After intraperitoneal injection of BCRP/ABCG2-tolerant 5-FU, the tumor volume, weight change, and apoptosis rate of the tumor tissue were determined using in situ hybridization. V-BCRPi increased the sensitivity of the tumor histiocytes to 5-FU and improved the cell apoptosis-promoting effects of 5-FU in the tumor. Conclusions/Significance: The goal of the in vivo and in vitro studies was to screen for an RNA interference recombinant retrovirus capable of stably targeting the ATP-binding domain of BCRP/ABCG2 (V-BCRPi) to inhibit its function. A new method to improve the chemo-sensitivity of breast cancer and other tumor cells was discovered, and this method could be used for gene therapy and functional studies of malignant tumors.	[Xie, Ni; Mou, Lisha; Liu, Wenlan; Jin, Yi] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen, Guangdong, Peoples R China; [Yuan, Jianhui; Deng, Tingting] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China; [Li, Zigang] Peking Univ, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China; [Hu, Zhangli] Shenzhen Univ, Coll Life Sci, Shenzhen, Guangdong, Peoples R China	Shenzhen University; Shenzhen Center for Disease Control & Prevention (SZCDC); Peking University; University Town of Shenzhen; Shenzhen University	Yuan, JH (corresponding author), Shenzhen Ctr Dis Control & Prevent, Shenzhen, Guangdong, Peoples R China.	jianhui_yuan@126.com	Mou, Lisha/I-4739-2012	Mou, Lisha/0000-0001-6232-8341; Xie, Ni/0000-0002-7167-9343	National Natural Science Fund [30500599, 81200465]; Guangdong Natural Science Fund Project [9151503102000019]; Shenzhen Science and Technology Plan [201201028]; Shenzhen Technical Research and Development Fund Project [GJHZ20130412153906740, JCYJ20120615085512920, JCYJ20120613171430264, ZYC201006180477A, SW201110060, SW201110018]; Shenzhen Peacock Plan [KQTD201103]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Fund Project; Shenzhen Science and Technology Plan; Shenzhen Technical Research and Development Fund Project; Shenzhen Peacock Plan	Funding provided by National Natural Science Fund (30500599, 81200465); Guangdong Natural Science Fund Project (9151503102000019); Shenzhen Science and Technology Plan (medical treatment and public health) key project (201201028); Shenzhen Technical Research and Development Fund Project (GJHZ20130412153906740, JCYJ20120615085512920, JCYJ20120613171430264, ZYC201006180477A, SW201110060, SW201110018); Shenzhen Peacock Plan (KQTD201103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BL, 2002, BLOOD, V100, P4594, DOI 10.1182/blood-2002-01-0271; Allen JD, 2002, MOL CANCER THER, V1, P417; Allikmets R, 1998, CANCER RES, V58, P5337; Bailey-Dell KJ, 2001, BBA-GENE STRUCT EXPR, V1520, P234, DOI 10.1016/S0167-4781(01)00270-6; Bera TK, 2001, MOL MED, V7, P509, DOI 10.1007/BF03401856; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Ee PLR, 2004, MOL CANCER THER, V3, P1577; Eisenblatter T, 2003, BRAIN RES, V971, P221, DOI 10.1016/S0006-8993(03)02401-6; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erlichman C, 2001, CANCER RES, V61, P739; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hoffmann U, 2000, PATHOL RES PRACT, V196, P235; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Kanzaki A, 2001, JPN J CANCER RES, V92, P452, DOI 10.1111/j.1349-7006.2001.tb01115.x; Kawabata S, 2001, BIOCHEM BIOPH RES CO, V280, P1216, DOI 10.1006/bbrc.2001.4267; Komatani H, 2001, CANCER RES, V61, P2827; Kowalski P, 2001, CANCER GENE THER, V8, P185, DOI 10.1038/sj.cgt.7700294; KRISHNAMACHARY N, 1993, CANCER RES, V53, P3658; Kubota T, 2001, Breast Cancer, V8, P333, DOI 10.1007/BF02967534; Maliepaard M, 2001, CLIN CANCER RES, V7, P935; Minderman H, 2002, CYTOMETRY, V48, P59, DOI 10.1002/cyto.10111; Miyake K, 1999, CANCER RES, V59, P8; Mohan A, 2006, BRIT J OPHTHALMOL, V90, P889, DOI 10.1136/bjo.2005.089219; Nieth C, 2003, FEBS LETT, V545, P144, DOI 10.1016/S0014-5793(03)00523-4; Rabindran SK, 2000, CANCER RES, V60, P47; Ross DD, 2000, BLOOD, V96, P365, DOI 10.1182/blood.V96.1.365.013k46_365_368; Sargent JM, 2001, BRIT J HAEMATOL, V115, P257, DOI 10.1046/j.1365-2141.2001.03122.x; Scheffer GL, 2000, CANCER RES, V60, P2589; SCHUURHUIS GJ, 1991, BRIT J CANCER, V64, P857, DOI 10.1038/bjc.1991.413; Sheng MY, 2001, CHIN J CANCER, V20, P274; Yasumasa H, 2001, CANCER RES, V61, P6635; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	35	17	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103463	10.1371/journal.pone.0103463	http://dx.doi.org/10.1371/journal.pone.0103463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076217	gold, Green Submitted, Green Published			2022-12-27	WOS:000340028800049
J	Melesse, M; Choi, EY; Hall, H; Walsh, MJ; Geer, MA; Hall, MC				Melesse, Michael; Choi, Eunyoung; Hall, Hana; Walsh, Michael J.; Geer, M. Ariel; Hall, Mark C.			Timely Activation of Budding Yeast APC(Cdh1) Involves Degradation of Its Inhibitor, Acm1, by an Unconventional Proteolytic Mechanism	PLOS ONE			English	Article							UBIQUITIN-INDEPENDENT DEGRADATION; ANAPHASE-PROMOTING COMPLEX; ORNITHINE-DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; PROTEASOMAL DEGRADATION; PSEUDOSUBSTRATE INHIBITION; TUMOR SUPPRESSORS; PROTEINS; SCF; COMPLEX/CYCLOSOME	Regulated proteolysis mediated by the ubiquitin proteasome system is a fundamental and essential feature of the eukaryotic cell division cycle. Most proteins with cell cycle-regulated stability are targeted for degradation by one of two related ubiquitin ligases, the Skp1-cullin-F box protein (SCF) complex or the anaphase-promoting complex (APC). Here we describe an unconventional cell cycle-regulated proteolytic mechanism that acts on the Acm1 protein, an inhibitor of the APC activator Cdh1 in budding yeast. Although Acm1 can be recognized as a substrate by the Cdc20-activated APC (APC(Cdc20)) in anaphase, APC(Cdc20) is neither necessary nor sufficient for complete Acm1 degradation at the end of mitosis. An APC-independent, but 26S proteasome-dependent, mechanism is sufficient for complete Acm1 clearance from late mitotic and G1 cells. Surprisingly, this mechanism appears distinct from the canonical ubiquitin targeting pathway, exhibiting several features of ubiquitin-independent proteasomal degradation. For example, Acm1 degradation in G1 requires neither lysine residues in Acm1 nor assembly of polyubiquitin chains. Acm1 was stabilized though by conditional inactivation of the ubiquitin activating enzyme Uba1, implying some requirement for the ubiquitin pathway, either direct or indirect. We identified an amino terminal predicted disordered region in Acm1 that contributes to its proteolysis in G1. Although ubiquitin-independent proteasome substrates have been described, Acm1 appears unique in that its sensitivity to this mechanism is strictly cell cycle-regulated via cyclin-dependent kinase (Cdk) phosphorylation. As a result, Acm1 expression is limited to the cell cycle window in which Cdk is active. We provide evidence that failure to eliminate Acm1 impairs activation of APC(Cdh1) at mitotic exit, justifying its strict regulation by cell cycle-dependent transcription and proteolytic mechanisms. Importantly, our results reveal that strict cell-cycle expression profiles can be established independent of proteolysis mediated by the APC and SCF enzymes.	[Melesse, Michael; Choi, Eunyoung; Hall, Hana; Walsh, Michael J.; Geer, M. Ariel; Hall, Mark C.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Hall, Mark C.] Purdue Univ, Ctr Canc Res, W Lafayette, IN USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hall, MC (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	mchall@purdue.edu	Hall, Mark C./D-1698-2011; Melesse, Michael/AAA-9425-2019	Hall, Mark/0000-0001-6429-2506; Melesse Vergara, Michael/0000-0002-3474-6981; Hall, Hana/0000-0002-7544-4437	National Science Foundation [MCB0841748]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Science Foundation (www.nsf.gov) grant MCB0841748 to Mark C. Hall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Bremmer SC, 2012, J BIOL CHEM, V287, P1662, DOI 10.1074/jbc.M111.281105; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Choi E, 2008, J BIOL CHEM, V283, P23701, DOI 10.1074/jbc.M803695200; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Dial JM, 2007, J BIOL CHEM, V282, P5237, DOI 10.1074/jbc.M606589200; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; Ferrara P, 2003, ONCOGENE, V22, P1461, DOI 10.1038/sj.onc.1206266; Forster A, 2003, TRENDS CELL BIOL, V13, P550, DOI 10.1016/j.tcb.2003.09.001; Gandre S, 2002, BIOCHEM BIOPH RES CO, V293, P139, DOI 10.1016/S0006-291X(02)00194-8; Ghaboosi N, 2007, MOL BIOL CELL, V18, P1953, DOI 10.1091/mbc.E06-10-0965; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Hall MC, 2008, J BIOL CHEM, V283, P10396, DOI 10.1074/jbc.M710011200; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jaquenoud M, 2002, EMBO J, V21, P6515, DOI 10.1093/emboj/cdf634; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Leggett David S., 2005, V301, P57; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Martinez JS, 2006, MOL CELL BIOL, V26, P9162, DOI 10.1128/MCB.00603-06; Martinez JS, 2012, CELL CYCLE, V11, P384, DOI 10.4161/cc.11.2.18944; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Ostapenko D, 2008, MOL CELL BIOL, V28, P4653, DOI 10.1128/MCB.00055-08; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Robbins JA, 2010, MOL BIOL CELL, V21, P914, DOI 10.1091/mbc.E09-10-0901; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	56	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103517	10.1371/journal.pone.0103517	http://dx.doi.org/10.1371/journal.pone.0103517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072887	gold, Green Submitted, Green Published			2022-12-27	WOS:000341307600056
J	Smieja, M; Orzechowski, J; Stolarski, MS				Smieja, Magdalena; Orzechowski, Jaroslaw; Stolarski, Maciej S.			TIE: An Ability Test of Emotional Intelligence	PLOS ONE			English	Article							TEST MSCEIT; SELF-REPORT; VALIDITY; TRAIT; PERSONALITY; PERFORMANCE; ASSOCIATIONS; RECOGNITION; CONVERGENT; QUALITY	The Test of Emotional Intelligence (TIE) is a new ability scale based on a theoretical model that defines emotional intelligence as a set of skills responsible for the processing of emotion-relevant information. Participants are provided with descriptions of emotional problems, and asked to indicate which emotion is most probable in a given situation, or to suggest the most appropriate action. Scoring is based on the judgments of experts: professional psychotherapists, trainers, and HR specialists. The validation study showed that the TIE is a reliable and valid test, suitable for both scientific research and individual assessment. Its internal consistency measures were as high as.88. In line with theoretical model of emotional intelligence, the results of the TIE shared about 10% of common variance with a general intelligence test, and were independent of major personality dimensions.	[Smieja, Magdalena] Jagiellonian Univ, Inst Psychol, Krakow, Poland; [Orzechowski, Jaroslaw] Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland; [Stolarski, Maciej S.] Univ Warsaw, Fac Psychol, Warsaw, Poland	Jagiellonian University; SWPS University of Social Sciences & Humanities; University of Warsaw	Smieja, M (corresponding author), Jagiellonian Univ, Inst Psychol, Krakow, Poland.	magdalena.smieja-necka@uj.edu.pl		Orzechowski, Jaroslaw/0000-0001-7722-4932	Polish Ministry of Science and Higher Education [N N106 1063 36]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This research was supported by a grant from Polish Ministry of Science and Higher Education (N N106 1063 36). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS S, 1995, SEX ROLES, V33, P309, DOI 10.1007/BF01954572; Austin EJ, 2005, PERS INDIV DIFFER, V39, P1395, DOI 10.1016/j.paid.2005.04.014; Austin EJ, 2010, BRIT J PSYCHOL, V101, P563, DOI 10.1348/000712609X474370; Bar-On R., 1997, BAR ON EMOTIONAL QUO; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Barrett LF, 2000, PERS SOC PSYCHOL B, V26, P1027, DOI 10.1177/01461672002611001; Boyatzis R., 2000, HDB EMOT INTELL, V99, P343; Brackett MA, 2004, PERS INDIV DIFFER, V36, P1387, DOI 10.1016/S0191-8869(03)00236-8; Brackett MA, 2003, PERS SOC PSYCHOL B, V29, P1147, DOI 10.1177/0146167203254596; Brackett MA, 2006, J PERS SOC PSYCHOL, V91, P780, DOI 10.1037/0022-3514.91.4.780; Brannick MT, 2009, MED EDUC, V43, P1062, DOI 10.1111/j.1365-2923.2009.03430.x; Brown RF, 2006, J PSYCHOSOM RES, V60, P585, DOI 10.1016/j.jpsychores.2006.05.001; Burns NR, 2007, SCI EMOTIONAL INTELL, P167, DOI DOI 10.1093/ACPROF:OSO/9780195181890.003.0007; Cabello R, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00037; Caruso DR, 2002, J PERS ASSESS, V79, P306, DOI 10.1207/S15327752JPA7902_12; Ciarrochi J, 2001, PERS INDIV DIFFER, V31, P1105, DOI 10.1016/S0191-8869(00)00207-5; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa PT, 2007, REVISED NEO PERSONAL; Day AL, 2004, PERS INDIV DIFFER, V36, P1443, DOI 10.1016/S0191-8869(03)00240-X; Derksen J, 2002, PERS INDIV DIFFER, V32, P37, DOI 10.1016/S0191-8869(01)00004-6; Di Fabio A, 2013, J CAREER ASSESSMENT, V21, P42, DOI 10.1177/1069072712454698; Dunn EW, 2007, PERS SOC PSYCHOL B, V33, P85, DOI 10.1177/0146167206294201; Farrelly D, 2007, COGNITION EMOTION, V21, P1043, DOI 10.1080/02699930601069404; Fivush R, 2000, SEX ROLES, V42, P233, DOI 10.1023/A:1007091207068; Freudenthaler HH, 2008, PERS INDIV DIFFER, V45, P673, DOI 10.1016/j.paid.2008.07.014; Goleman D, 2020, EMOTIONAL INTELLIGEN, V25th; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; J_oreskog K.G., 1984, LISREL 6 USERS GUIDE, Vthird; Jaworowska A., 2008, KWESTIONARIUSZ INTEL; Joreskog K.G, 2004, LISREL 8 7 WINDOWS; Lopes PN, 2011, J PERS, V79, P429, DOI 10.1111/j.1467-6494.2010.00689.x; Lopes PN, 2004, PERS SOC PSYCHOL B, V30, P1018, DOI 10.1177/0146167204264762; Lopes PN, 2003, PERS INDIV DIFFER, V35, P641, DOI 10.1016/S0191-8869(02)00242-8; MacCann C, 2008, EMOTION, V8, P540, DOI 10.1037/a0012746; Marquez PGO, 2006, PSICOTHEMA, V18, P118; Matczak A., 2005, SKALA INTELIGENCJI E; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Maul A, 2012, EMOT REV, V4, P394, DOI 10.1177/1754073912445811; Maul A, 2011, PERS INDIV DIFFER, V50, P457, DOI 10.1016/j.paid.2010.11.007; Mayer J., 2002, MAYER SALOVEY CARUSO; Mayer J. D., 1997, EMOTIONAL DEV EMOTIO, P3, DOI DOI 10.1177/1066480710387486; Mayer JD, 1999, INTELLIGENCE, V27, P267, DOI 10.1016/S0160-2896(99)00016-1; Mayer JD, 2004, PSYCHOL INQ, V15, P197, DOI 10.1207/s15327965pli1503_02; MAYER JD, 1993, INTELLIGENCE, V17, P433, DOI 10.1016/0160-2896(93)90010-3; Mayer JD, 2008, AM PSYCHOL, V63, P503, DOI 10.1037/0003-066X.63.6.503; Mayer JD, 2012, EMOT REV, V4, P403, DOI 10.1177/1754073912445815; Mayer JD, 2012, AM PSYCHOL, V67, P502, DOI 10.1037/a0029456; Palmer BR, 2005, INTELLIGENCE, V33, P285, DOI 10.1016/j.intell.2004.11.003; Parker JDA, 2005, PERS INDIV DIFFER, V39, P215, DOI 10.1016/j.paid.2005.01.008; Petrides KV, 2007, BRIT J PSYCHOL, V98, P273, DOI 10.1348/000712606X120618; Petrides K. V., 2011, WILEY BLACKWELL HDB, P656, DOI [DOI 10.1002/9781444343120.CH25, 10.1002/9781444343120.ch25]; Petrides KV, 2001, EUR J PERSONALITY, V15, P425, DOI 10.1002/per.416; Petrides KV, 2009, TECHNICAL MANUAL TRA; Ponterotto JG, 2011, J SOC PSYCHOL, V151, P556, DOI 10.1080/00224545.2010.503718; Raven J. C, 1993, MANUAL RAVENS PROGRE; Roberts RD, 2006, EMOTION, V6, P663, DOI 10.1037/1528-3542.6.4.663; Roberts RJ, 2001, J FISH DIS, V24, P1; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI [https://doi.org/10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG, DOI 10.2190/DUGG-P24E-52WK-6CDG]; Schutte NS, 1998, PERS INDIV DIFFER, V25, P167, DOI 10.1016/S0191-8869(98)00001-4; Schutte NS, 2001, J SOC PSYCHOL, V141, P523, DOI 10.1080/00224540109600569; Smieja M, 2007, STUD PSYCHOL, V45, P80; Smieja M, 2008, INTELIGENCJA EMOCJON; Spearman C, 1914, PSYCHOL REV, V21, P101, DOI 10.1037/h0070799; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stolarski M, 2011, TIME SOC, V20, P346, DOI 10.1177/0961463X11414296; Van der Linden D, 2012, PERS INDIV DIFFER, V53, P175, DOI 10.1016/j.paid.2012.03.001; Van Rooy DL, 2004, J VOCAT BEHAV, V65, P71, DOI 10.1016/S0001-8791(03)00076-9; Van Rooy DL, 2005, PERS INDIV DIFFER, V38, P689, DOI 10.1016/j.paid.2004.05.023; Vazire S, 2010, J PERS SOC PSYCHOL, V98, P281, DOI 10.1037/a0017908; WATKINS D, 1989, INT J PSYCHOL, V24, P685; Webb CA, 2013, INTELLIGENCE, V41, P149, DOI 10.1016/j.intell.2013.01.004; Wojciechowski J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092570; Zawadzki B, 1998, INWENTARZ OSOBOWOSCI; Zeidner M, 2005, INTELLIGENCE, V33, P369, DOI 10.1016/j.intell.2005.03.001; Zeidner M, 2013, J FAM PSYCHOL, V27, P795, DOI 10.1037/a0034009	76	31	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103484	10.1371/journal.pone.0103484	http://dx.doi.org/10.1371/journal.pone.0103484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KU	25072656	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600053
J	Zhang, QH; Soderland, D; Steinle, JJ				Zhang, Qiuhua; Soderland, Dylan; Steinle, Jena J.			TNF alpha Inhibits IGFBP-3 through Activation of p38 alpha and Casein Kinase 2 in Human Retinal Endothelial Cells	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; FACTOR-BINDING PROTEIN-3; SIGNALING PATHWAYS; INDUCED APOPTOSIS; PHOSPHORYLATION; SER(307); IRS-1	We recently reported a reciprocal relationship between tumor necrosis factor alpha (TNF alpha) and insulin-like receptor growth factor binding protein 3 (IGFBP-3) in whole retina of normal and IGFBP-3 knockout mice. A similar relationship was also observed in cultured retinal endothelial cells (REC). We found that TNF alpha significantly reduced IGFBP-3 levels and vice-versa, IGFBP-3 can lower TNF alpha and TNF alpha receptor expression. Since IGFBP-3 is protective to the diabetic retina and TNF alpha is causative in the development of diabetic retinopathy, we wanted to better understand the cellular mechanisms by which TNF alpha can reduce IGFBP-3 levels. For these studies, primary human retinal endothelial cells (REC) were used since these cells undergo TNF alpha-mediated apoptosis under conditions of high glucose conditions and contribute to diabetic retinopathy. We first cultured REC in normal or high glucose, treated with exogenous TNF alpha, then measured changes in potential signaling pathways, with a focus on P38 mitogen-activated protein kinase alpha (P38 alpha) and casein kinase 2 (CK2) as these pathways have been linked to both TNF alpha and IGFBP-3. We found that TNF alpha significantly increased phosphorylation of P38 alpha and CK2. Furthermore, specific inhibitors of P38 alpha or CK2 blocked TNF alpha inhibition of IGFBP-3 expression, demonstrating that TNF alpha reduces IGFBP-3 through activation of P38 alpha and CK2. Since TNF alpha and IGFBP-3 are key mediators of retinal damage and protection respectively in diabetic retinopathy, increased understanding of the relationship between these two proteins will offer new therapeutic options for treatment.	[Zhang, Qiuhua; Steinle, Jena J.] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Steinle, Jena J.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Steinle, Jena J.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmaceut Sci, Memphis, TN USA; [Soderland, Dylan] Cell Syst Corp, Washington, DC USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Steinle, JJ (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA.	jsteinl1@uthsc.edu	zhang, qiu/GXG-5600-2022	Steinle, Jena/0000-0002-7539-2892	National Eye Institute [R01-EY022045]; JDRF [2-2011-597]; Oxnard Foundation; HEI Research to Prevent Blindness Award; NEI Vision Core Grant [PHS 3P30 EY013080]; NATIONAL EYE INSTITUTE [R01EY022045, P30EY013080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); JDRF(Juvenile Diabetes Research Foundation); Oxnard Foundation; HEI Research to Prevent Blindness Award; NEI Vision Core Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Eye Institute R01-EY022045 (JJS), JDRF (2-2011-597 to JJS), Oxnard Foundation (JJS), HEI Research to Prevent Blindness Award (PI: James C. Fleming), and NEI Vision Core Grant: PHS 3P30 EY013080 (PI: Dianna Johnson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Baxter RC, 2001, J CLIN PATHOL-MOL PA, V54, P145, DOI 10.1136/mp.54.3.145; Chen XY, 2006, GROWTH HORM IGF RES, V16, P41, DOI 10.1016/j.ghir.2005.09.003; CONOVER CA, 1992, ENDOCRINOLOGY, V130, P3191, DOI 10.1210/en.130.6.3191; Coverley JA, 1997, MOL CELL ENDOCRINOL, V128, P1, DOI 10.1016/S0303-7207(97)04032-X; Coverley JA, 2000, ENDOCRINOLOGY, V141, P564, DOI 10.1210/en.141.2.564; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Jiang YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093788; Jiang YD, 2012, CELL SIGNAL, V24, P1086, DOI 10.1016/j.cellsig.2012.01.003; Jiang YD, 2010, EXP EYE RES, V91, P171, DOI 10.1016/j.exer.2010.04.014; Jiang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065756; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2009, MOL VIS, V15, P1418; Leibowitz BJ, 2009, J CELL PHYSIOL, V220, P182, DOI 10.1002/jcp.21748; Markelic M, 2011, EUR J HISTOCHEM, V55, P187, DOI 10.4081/ejh.2011.e34; Mirzaa GM, 2014, NAT GENET, V46, P510, DOI 10.1038/ng.2948; Panjala SR, 2011, MOL VIS, V17, P1822; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Zhang Q, 2013, INVEST OPHTHALMOL VI; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P5376, DOI 10.1167/iovs.13-12497; Zhang QH, 2013, MOL VIS, V19, P796; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779	23	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103578	10.1371/journal.pone.0103578	http://dx.doi.org/10.1371/journal.pone.0103578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25073020	Green Published, gold, Green Submitted			2022-12-27	WOS:000341307600066
J	Chen, JH; Tarn, WH; Lee, JD				Chen, Jenhui; Tarn, Woei-Hwa; Lee, Jiann-Der			An Extra Power Saving Scheme for Prolonging Lifetime of Mobile Handset in the 4G Mobile Networks	PLOS ONE			English	Article							VISUAL LOCATION RECOGNITION; SYSTEMS; PERFORMANCE; MECHANISM; SERVICES	In the fourth generation or next generation networks, services of non-real-time variable bit rate (NRT-VBR) and best effort (BE) will dominate over 85% of the total traffic in the networks. In this paper, we study the power saving mechanism of NRT-VBR and BE services for mobile handsets (MHs) to prolong their battery lifetime (i.e., the sustained operation duration) in the fourth generation networks. Because the priority of NRT-VBR and BE is lower than that of real-time VBR (RT-VBR) or guaranteed bit rate (GBR) services, we investigate an extended sleep mode for lower priority services (e. g., NRT-VBR and BE) in an MH to conserve the energy. The extended sleep mode is used when the MH wakes up from the sleep mode but it cannot obtain the bandwidth from base station (BS). The proposed mechanism, named extra power saving scheme (EPSS), uses the M/M/k/k Markovian queuing model to estimate the extended sleep duration to let MHs conserve their battery energy when the networks traffic is congested. To study the performance of EPSS, an accurate analysis model of energy is presented and validated by taking a series of simulations. Numerical experiments show that EPSS can achieve 43% extra energy conservation at most when downlink resource is saturated. We conclude that the energy of MHs can be conserved further by applying EPSS when the traffic load is saturated. The effect of energy saving becomes more obvious when the portion of NRT-VBR and BE services is greater than that of RT-VBR and GBR services.	[Chen, Jenhui] Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Taoyuan, Kweishan, Taiwan; [Tarn, Woei-Hwa; Lee, Jiann-Der] Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Elect Engn, Taoyuan, Kweishan, Taiwan	Chang Gung University; Chang Gung University	Chen, JH (corresponding author), Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Taoyuan, Kweishan, Taiwan.	jhchen@mail.cgu.edu.tw	Chen, Jenhui/B-4521-2009; Lee, Jiann-Der/AAE-2442-2022	Chen, Jenhui/0000-0002-8372-9221; Lee, Jiann-Der/0000-0002-8520-2212	National Science Council, Taiwan, R.O.C. [NSC102-2221-E-182-032]; High Speed Intelligent Communication (HSIC) research center, Chang Gung University, Taiwan, R.O.C.	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); High Speed Intelligent Communication (HSIC) research center, Chang Gung University, Taiwan, R.O.C.	This work was supported in part by the National Science Council, Taiwan, R.O.C., under Contract NSC102-2221-E-182-032, and the High Speed Intelligent Communication (HSIC) research center, Chang Gung University, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshamrani A, 2011, IEEE J SEL AREA COMM, V29, P819, DOI 10.1109/JSAC.2011.110413; Americas G, 2013, 3GPP REL 11 UND STAN; Azad AP, 2011, IEEE J SEL AREA COMM, V29, P1605, DOI 10.1109/JSAC.2011.110910; Chen JH, 2014, SCI WORLD J, DOI 10.1155/2014/217973; Choi HH, 2007, IEEE COMMUN LETT, V11, P455, DOI 10.1109/LCOMM.2007.070035; Cicconetti C, 2010, IEEE T MOBILE COMPUT, V9, P1008, DOI 10.1109/TMC.2010.53; Cisco, 2013, CISC VIS NETW IND GL; GPP, 2013, 23203 3GPP TS; GPP, 2013, 36300 3GPP TS; Gross D, 2008, FUNDAMENTALS QUEUEIN, DOI [DOI 10.1002/9781118625651, 10.1002/9781118625651]; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Hsu CH, 2010, IEEE T VEH TECHNOL, V59, P4453, DOI 10.1109/TVT.2010.2070086; Hwang E, 2010, IEEE T VEH TECHNOL, V59, P319, DOI 10.1109/TVT.2009.2032193; Jeong DG, 2006, IEEE T WIREL COMMUN, V5, P3012, DOI 10.1109/TWC.2006.04772; Ji RR, 2011, ACM T MULTIM COMPUT, V7, DOI 10.1145/2037676.2037688; Niyato D, 2008, IEEE T WIREL COMMUN, V7, P5150, DOI 10.1109/T-WC.2008.070609; Palo Alto Networks, 2013, AN APPL US REL THREA; Sanghvi K, 2008, 2008 3RD INTERNATIONAL CONFERENCE ON COMMUNICATION SYSTEM SOFTWARE AND MIDDLEWARE AND WORKSHOPS, VOLS 1 AND 2, P334, DOI 10.1109/COMSWA.2008.4554436; Stevens-Navarro E, 2008, IEEE T VEH TECHNOL, V57, P1243, DOI 10.1109/TVT.2007.907072; Tseng YC, 2011, IEEE T MOBILE COMPUT, V10, P1237, DOI 10.1109/TMC.2010.215; Vu HL, 2010, IEEE T VEH TECHNOL, V59, P460, DOI 10.1109/TVT.2009.2033191; Wang R, 2011, IEEE J SEL AREA COMM, V29, P1618, DOI 10.1109/JSAC.2011.110911; Wu YL, 2012, IEEE T PARALL DISTR, V23, P902, DOI 10.1109/TPDS.2011.198	24	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103429	10.1371/journal.pone.0103429	http://dx.doi.org/10.1371/journal.pone.0103429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089822	gold, Green Submitted, Green Published			2022-12-27	WOS:000339812700025
J	Hussain, T; Shehzad, SA; Hayat, T; Alsaedi, A; Al-Solamy, F; Ramzan, M				Hussain, Tariq; Shehzad, Sabir Ali; Hayat, Tasawar; Alsaedi, Ahmed; Al-Solamy, Falleh; Ramzan, Muhammad			Radiative Hydromagnetic Flow of Jeffrey Nanofluid by an Exponentially Stretching Sheet	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; HEAT-TRANSFER; PERISTALTIC TRANSPORT; STAGNATION POINT; MASS-TRANSFER; FLUID; SLIP; SORET	Two-dimensional hydromagnetic flow of an incompressible Jeffrey nanofluid over an exponentially stretching surface is examined in the present article. Heat and mass transfer analysis is performed in the presence of thermal radiation, viscous dissipation, and Brownian motion and thermophoresis effects. Mathematical modelling of considered flow problem is developed under boundary layer and Rosseland's approximations. The governing nonlinear partial differential equations are converted into ordinary differential equations via transformations. Solution expressions of velocity, temperature and concentration are presented in the series forms. Impacts of physical parameters on the dimensionless temperature and concentration are shown and discussed. Skin-friction coefficients are analyzed numerically. A comparison in a limiting sense is provided to validate the present series solutions.	[Hussain, Tariq; Ramzan, Muhammad] Mohammad Ali Jinnah Univ, Fac Comp, Dept Math, Islamabad, Pakistan; [Shehzad, Sabir Ali; Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed; Al-Solamy, Falleh] King Abdulaziz Univ, Fac Sci, NAAM Res Grp, Jeddah, Saudi Arabia	Mohammad Ali Jinnah University; Quaid I Azam University; King Abdulaziz University	Hussain, T (corresponding author), Mohammad Ali Jinnah Univ, Fac Comp, Dept Math, Islamabad Campus, Islamabad, Pakistan.	zartotariq@yahoo.com	Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/E-9449-2015; Hayat, Tasawar/A-3853-2013; Shehzad, Sabir Ali/J-3885-2014; Alsaedi, Ahmed/A-2094-2013; Hussain, Muhammad/AAD-2380-2022; Ramzan, M./AAH-9959-2020	Alsaedi, Ahmed/0000-0003-3452-8922; Ramzan, M./0000-0002-9523-5800; Hussain, Tariq/0000-0002-1332-2418	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia [37-130-35-HiCi]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia; DSR	This project is funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia under grant no. 37-130-35-HiCi. The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasbandy S, 2013, QUAEST MATH, V36, P93, DOI 10.2989/16073606.2013.780336; Abo-Eldahab E, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/840203; Bidin B., 2009, EUR J SCI RES, V33, P710; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Choi SUS., 1995, ASME PUBLICATIONS FE, P99; El Koumy SR, 2012, TRANSPORT POROUS MED, V94, P643, DOI 10.1007/s11242-012-0016-y; Hamad M. A. A., 2013, J FLUIDS, V2013, P8; Hayat T, 2008, COMMUN NONLINEAR SCI, V13, P1581, DOI 10.1016/j.cnsns.2007.02.008; Hayat T, 2014, J AEROSPACE ENG, V27, DOI 10.1061/(ASCE)AS.1943-5525.0000360; Hayat T, 2014, J MOL LIQ, V194, P93, DOI 10.1016/j.molliq.2014.01.021; Hayat T, 2014, J HYDROL HYDROMECH, V62, P117, DOI 10.2478/johh-2014-0016; Hayat T, 2014, Z NATURFORSCH A, V69, P43, DOI 10.5560/ZNA.2013-0074; Ibrahim W, 2013, COMPUT FLUIDS, V86, P433, DOI 10.1016/j.compfluid.2013.07.029; Jalil M, 2013, INT J NONLIN MECH, V48, P65, DOI 10.1016/j.ijnonlinmec.2012.07.004; Liao S., 2012, HOMOTOPY ANAL METHOD; Liu IC, 2013, CHEM ENG COMMUN, V200, P253, DOI 10.1080/00986445.2012.703148; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mekheimer K., 2014, J EGYPT MATH SOC, V22, P143, DOI [10.1016/j.joems.2013.05.003, DOI 10.1016/J.JOEMS.2013.05.003]; Mekheimer KS, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/12/124702; Mekheimer KhS, 2014, GEN MATH NOTES, V20, P22; Moradi A, 2013, ARAB J SCI ENG, V38, P2845, DOI 10.1007/s13369-012-0472-2; Mukhopadhyay S, 2013, AIN SHAMS ENG J, V4, P485, DOI 10.1016/j.asej.2012.10.007; Nadeem S, 2011, NUMER ALGORITHMS, V57, P187, DOI 10.1007/s11075-010-9423-8; Rashidi MM, 2013, INT J HEAT MASS TRAN, V62, P515, DOI 10.1016/j.ijheatmasstransfer.2013.03.004; Rashidi MM, 2014, ARAB J SCI IN PRESS; Sahoo B, 2011, INT J HEAT MASS TRAN, V54, P5010, DOI 10.1016/j.ijheatmasstransfer.2011.07.015; Shehzad SA, 2013, BRAZ J CHEM ENG, V30, P897, DOI 10.1590/S0104-66322013000400021; Shehzad SA, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13056-6; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078240; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068139; Sheikholeslami M, 2014, J MOL LIQ, V190, P112, DOI 10.1016/j.molliq.2013.11.002; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V59, P167, DOI 10.1016/j.ijheatmasstransfer.2012.12.009; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V57, P82, DOI 10.1016/j.ijheatmasstransfer.2012.10.006; Turkyilmazoglu M, 2012, CHEM ENG SCI, V84, P182, DOI 10.1016/j.ces.2012.08.029; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030	35	56	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103719	10.1371/journal.pone.0103719	http://dx.doi.org/10.1371/journal.pone.0103719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084096	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800073
J	Kwon, H; Bang, K; Cho, S				Kwon, Hyojung; Bang, Kyeongrin; Cho, Saeyoull			Characterization of the Hemocytes in Larvae of Protaetia brevitarsis seulensis: Involvement of Granulocyte-Mediated Phagocytosis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; IMMUNE-RESPONSE; AUTOPHAGY; COLEOPTERA; INSECT; EXPRESSION; APOPTOSIS; PATHWAYS; ATTACIN; TOLL	Hemocytes are key players in the immune response against pathogens in insects. However, the hemocyte types and their functions in the white-spotted flower chafers, Protaetia brevitarsis seulensis (Kolbe), are not known. In this study, we used various microscopes, molecular probes, and flow cytometric analyses to characterize the hemocytes in P. brevitarsis seulensis. The circulating hemocytes were classified based on their size, morphology, and dye-staining properties into six types, including granulocytes, plasmatocytes, oenocytoids, spherulocytes, prohemocytes, and adipohemocytes. The percentages of circulating hemocyte types were as follows: 13% granulocytes, 20% plasmatocytes, 1% oenocytoids, 5% spherulocytes, 17% prohemocytes, and 44% adipohemocytes. Next, we identified the professional phagocytes, granulocytes, which mediate encapsulation and phagocytosis of pathogens. The granulocytes were immunologically or morphologically activated and phagocytosed potentially hazardous substances in vivo. In addition, we showed that the phagocytosis by granulocytes is associated with autophagy, and that the activation of autophagy could be an efficient way to eliminate pathogens in this system. We also observed a high accumulation of autophagic vacuoles in activated granulocytes, which altered their shape and led to autophagic cell death. Finally, the granulocytes underwent mitotic division thus maintaining their number in vivo.	[Kwon, Hyojung; Bang, Kyeongrin; Cho, Saeyoull] Kangwon Natl Univ, Coll Agr & Life Sci, Environm Friendly Agr Ctr, Dept Appl Biol, Chunchon, South Korea	Kangwon National University	Cho, S (corresponding author), Kangwon Natl Univ, Coll Agr & Life Sci, Environm Friendly Agr Ctr, Dept Appl Biol, Chunchon, South Korea.	saeyoullcho@kangwon.ac.kr			National Research Foundation of Korea [NRF-2014R1A1A4A01008545]	National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by National Research Foundation of Korea (Grant Number; NRF-2014R1A1A4A01008545). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, MICROBE; Bang K, 2012, MOL BIOL REP, V39, P5151, DOI 10.1007/s11033-011-1311-3; Caruso R. A., 2012, Experimental Oncology, V34, P306; Castillo JC, 2006, INSECT BIOCHEM MOLEC, V36, P891, DOI 10.1016/j.ibmb.2006.08.010; Colombo MI, 2007, IUBMB LIFE, V59, P238, DOI 10.1080/15216540701230503; Colombo MI, 2005, CELL DEATH DIFFER, V12, P1481, DOI 10.1038/sj.cdd.4401767; Duffin R, 2010, IMMUNOL REV, V236, P28, DOI 10.1111/j.1600-065X.2010.00922.x; Firlej A, 2012, ANN ENTOMOL SOC AM, V105, P328, DOI 10.1603/AN11026; Giglio A, 2008, MICRON, V39, P552, DOI 10.1016/j.micron.2007.07.004; Giulianini PG, 2003, TISSUE CELL, V35, P243, DOI 10.1016/S0040-8166(03)00037-5; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gupta A. P., 1979, INSECT HEMOCYTES DEV; Gupta AP, 1985, COMPREHENSIVE INSECT, P85; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JONES JC, 1962, AM ZOOL, V2, P209; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Kinch G, 2003, J COMP NEUROL, V457, P384, DOI 10.1002/cne.10563; King JG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-55; Kohan R, 2013, SOAJ ENTOMOL STUD, V2, P16; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Kwon Ohseok, 2009, Entomological Research, V39, P152, DOI 10.1111/j.1748-5967.2009.00213.x; Lai Shu-Chin, 2012, Cells, V1, P396, DOI 10.3390/cells1030396; Lee M, 2013, MOL BIOL REP, V40, P3953, DOI 10.1007/s11033-012-2472-4; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Manachini B, 2011, J INVERTEBR PATHOL, V106, P360, DOI 10.1016/j.jip.2010.12.006; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mihalache CC, 2012, EXP CELL RES, V318, P1187, DOI 10.1016/j.yexcr.2011.12.021; Muller F, 2004, EUR J CELL BIOL, V83, P67, DOI 10.1078/0171-9335-00359; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Oczypok EA, 2013, AM J PATHOL, V182, P612, DOI 10.1016/j.ajpath.2012.12.017; Pandey J. P., 2012, American Journal of Biochemistry and Molecular Biology, V2, P82; Pandey J. P., 2010, Research Journal of Immunology, V3, P169, DOI 10.3923/rji.2010.169.177; Romao S, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13198; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Tsakas S, 2010, ISJ-INVERT SURVIV J, V7, P228; Vernon PJ, 2013, ANTIOXID REDOX SIGN, V18, P677, DOI 10.1089/ars.2012.4810; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Yang YQ, 2012, ANAT REC, V295, P372, DOI 10.1002/ar.21537	46	40	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103620	10.1371/journal.pone.0103620	http://dx.doi.org/10.1371/journal.pone.0103620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083702	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800059
J	Laht, M; Karkman, A; Voolaid, V; Ritz, C; Tenson, T; Virta, M; Kisand, V				Laht, Mailis; Karkman, Antti; Voolaid, Veiko; Ritz, Christian; Tenson, Tanel; Virta, Marko; Kisand, Veljo			Abundances of Tetracycline, Sulphonamide and Beta-Lactam Antibiotic Resistance Genes in Conventional Wastewater Treatment Plants (WWTPs) with Different Waste Load	PLOS ONE			English	Article							SEWAGE-TREATMENT PLANTS; ACTIVATED-SLUDGE; SURFACE-WATER; BACTERIA; ENVIRONMENT; FATE; PREVALENCE; DRINKING; EFFLUENT; HOTSPOTS	Antibiotics and antibiotic resistant bacteria enter wastewater treatment plants (WWTPs), an environment where resistance genes can potentially spread and exchange between microbes. Several antibiotic resistance genes (ARGs) were quantified using qPCR in three WWTPs of decreasing capacity located in Helsinki, Tallinn, and Tartu, respectively: sulphonamide resistance genes (sul1 and sul2), tetracycline resistance genes (tetM and tetC), and resistance genes for extended spectrum beta-lactams (bla(oxa-58), bla(shv-34), and bla(ctx-m-32)). To avoid inconsistencies among qPCR assays we normalised the ARG abundances with 16S rRNA gene abundances while assessing if the respective genes increased or decreased during treatment. ARGs were detected in most samples; sul1, sul2, and tetM were detected in all samples. Statistically significant differences (adjusted p<0.01) between the inflow and effluent were detected in only four cases. Effluent values for bla(oxa-58) and tetC decreased in the two larger plants while tetM decreased in the medium-sized plant. Only bla(shv-34) increased in the effluent from the medium-sized plant. In all other cases the purification process caused no significant change in the relative abundance of resistance genes, while the raw abundances fell by several orders of magnitude. Standard water quality variables (biological oxygen demand, total phosphorus and nitrogen, etc.) were weakly related or unrelated to the relative abundance of resistance genes. Based on our results we conclude that there is neither considerable enrichment nor purification of antibiotic resistance genes in studied conventional WWTPs.	[Laht, Mailis; Voolaid, Veiko; Tenson, Tanel; Kisand, Veljo] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Karkman, Antti; Virta, Marko] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Ritz, Christian] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark	University of Tartu; University of Helsinki; University of Copenhagen	Kisand, V (corresponding author), Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia.	kisand@ut.ee	Karkman, Antti/HFZ-8618-2022; Kisand, Veljo/H-2466-2012; Tenson, Tanel/I-6431-2015; Virta, Marko/B-4292-2010; Karkman, Antti/AAW-9096-2021; Ritz, Christian/P-6159-2014	Kisand, Veljo/0000-0002-5535-1639; Tenson, Tanel/0000-0002-0260-3601; Virta, Marko/0000-0001-5981-7566; Karkman, Antti/0000-0003-0983-3319; Ritz, Christian/0000-0002-5095-0624	Academy of Finland; EnSTe graduate school; European Regional Development Fund through the Centre of Excellence in Chemical Biology in Estonia; COST Action [TD0803]	Academy of Finland(Academy of Finland); EnSTe graduate school; European Regional Development Fund through the Centre of Excellence in Chemical Biology in Estonia; COST Action(European Cooperation in Science and Technology (COST))	The research was funded by the Academy of Finland and EnSTe graduate school, and the European Regional Development Fund through the Centre of Excellence in Chemical Biology in Estonia. Additional funding was provided by COST Action TD0803. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Auerbach EA, 2007, WATER RES, V41, P1143, DOI 10.1016/j.watres.2006.11.045; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bates D., 2013, LME4 LINEAR MIXED EF; Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607; Borjesson S, 2010, J WATER HEALTH, V8, P247, DOI 10.2166/wh.2009.159; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brown KD, 2006, SCI TOTAL ENVIRON, V366, P772, DOI 10.1016/j.scitotenv.2005.10.007; Chang XS, 2010, ENVIRON POLLUT, V158, P1444, DOI 10.1016/j.envpol.2009.12.034; Clara M, 2005, WATER RES, V39, P97, DOI 10.1016/j.watres.2004.08.036; COURVALIN P, 1994, ANTIMICROB AGENTS CH, V38, P1447, DOI 10.1128/AAC.38.7.1447; Czekalski N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00106; da Silva MF, 2006, FEMS MICROBIOL ECOL, V55, P322, DOI 10.1111/j.1574-6941.2005.00032.x; Durso LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048325; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Figueira V, 2011, WATER RES, V45, P5599, DOI 10.1016/j.watres.2011.08.021; Gao P, 2012, SCI TOTAL ENVIRON, V421, P173, DOI 10.1016/j.scitotenv.2012.01.061; Graham DW, 2011, ENVIRON SCI TECHNOL, V45, P418, DOI 10.1021/es102473z; Guardabassi L, 2002, WATER RES, V36, P1955, DOI 10.1016/S0043-1354(01)00429-8; Heuer H, 2007, ENVIRON MICROBIOL, V9, P657, DOI 10.1111/j.1462-2920.2006.01185.x; Duong HA, 2008, CHEMOSPHERE, V72, P968, DOI 10.1016/j.chemosphere.2008.03.009; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jury KL, 2011, CRIT REV ENV SCI TEC, V41, P243, DOI 10.1080/10643380902772589; Khachatourians GG, 1998, CAN MED ASSOC J, V159, P1129; Kim S, 2007, J TOXICOL ENV HEAL B, V10, P559, DOI 10.1080/15287390600975137; Koivunen J, 2003, WATER RES, V37, P690, DOI 10.1016/S0043-1354(02)00305-6; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Lachmayr KL, 2009, APPL ENVIRON MICROB, V75, P203, DOI 10.1128/AEM.01254-08; Le-Minh N, 2010, WATER RES, V44, P4295, DOI 10.1016/j.watres.2010.06.020; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; Li D, 2011, WATER RES, V45, P6063, DOI 10.1016/j.watres.2011.09.002; Lillenberg M, 2011, RESIDUES SOME PHARM; Lindberg RH, 2005, ENVIRON SCI TECHNOL, V39, P3421, DOI 10.1021/es048143z; Liu MM, 2012, ENVIRON SCI TECHNOL, V46, P7551, DOI 10.1021/es301145m; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Luczkiewicz A, 2010, WATER RES, V44, P5089, DOI 10.1016/j.watres.2010.08.007; Luo YL, 2014, SCI TOTAL ENVIRON, V473, P619, DOI 10.1016/j.scitotenv.2013.12.065; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Michael I, 2013, WATER RES, V47, P957, DOI 10.1016/j.watres.2012.11.027; Moura A, 2010, RES MICROBIOL, V161, P58, DOI 10.1016/j.resmic.2009.11.004; Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033; Nolvak H, 2013, SCI TOTAL ENVIRON, V461, P636, DOI 10.1016/j.scitotenv.2013.05.052; Novo A, 2013, WATER RES, V47, P1875, DOI 10.1016/j.watres.2013.01.010; Novo A, 2010, APPL MICROBIOL BIOT, V87, P1157, DOI 10.1007/s00253-010-2583-6; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reinthaler FF, 2003, WATER RES, V37, P1685, DOI 10.1016/S0043-1354(02)00569-9; Rizzo L, 2013, SCI TOTAL ENVIRON, V447, P345, DOI 10.1016/j.scitotenv.2013.01.032; Roberts AP, 2009, TRENDS MICROBIOL, V17, P251, DOI 10.1016/j.tim.2009.03.002; Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; Stoll C, 2012, ENVIRON SCI TECHNOL, V46, P9716, DOI 10.1021/es302020s; Szczepanowski R, 2009, MICROBIOL-SGM, V155, P2306, DOI 10.1099/mic.0.028233-0; Tamminen M, 2011, ENVIRON SCI TECHNOL, V45, P386, DOI 10.1021/es102725n; Toleman MA, 2006, J ANTIMICROB CHEMOTH, V58, P1, DOI 10.1093/jac/dkl204; West BM, 2011, WATER AIR SOIL POLL, V217, P473, DOI 10.1007/s11270-010-0602-y; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x	59	113	118	7	163	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103705	10.1371/journal.pone.0103705	http://dx.doi.org/10.1371/journal.pone.0103705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084517	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800068
J	Ling, HH; Beaule, C; Chiang, CK; Tian, RJ; Figeys, D; Cheng, HYM				Ling, Harrod H.; Beaule, Christian; Chiang, Cheng-Kang; Tian, Ruijun; Figeys, Daniel; Cheng, Hai-Ying M.			Time-of-Day- and Light-Dependent Expression of Ubiquitin Protein Ligase E3 Component N-Recognin 4 (UBR4) in the Suprachiasmatic Nucleus Circadian Clock	PLOS ONE			English	Article							GENE-EXPRESSION; DEGRADATION; RHYTHM; VASOPRESSIN; MOUSE; CRYPTOCHROME; OSCILLATION; PROTEASOME; PATHWAYS; REVEALS	Circadian rhythms of behavior and physiology are driven by the biological clock that operates endogenously but can also be entrained to the light-dark cycle of the environment. In mammals, the master circadian pacemaker is located in the suprachiasmatic nucleus (SCN), which is composed of individual cellular oscillators that are driven by a set of core clock genes interacting in transcriptional/translational feedback loops. Light signals can trigger molecular events in the SCN that ultimately impact on the phase of expression of core clock genes to reset the master pacemaker. While transcriptional regulation has received much attention in the field of circadian biology in the past, other mechanisms including targeted protein degradation likely contribute to the clock timing and entrainment process. In the present study, proteome-wide screens of the murine SCN led to the identification of ubiquitin protein ligase E3 component N-recognin 4 (UBR4), a novel E3 ubiquitin ligase component of the N-end rule pathway, as a time-of-day-dependent and light-inducible protein. The spatial and temporal expression pattern of UBR4 in the SCN was subsequently characterized by immunofluorescence microscopy. UBR4 is expressed across the entire rostrocaudal extent of the SCN in a time-of-day-dependent fashion. UBR4 is localized exclusively to arginine vasopressin (AVP)-expressing neurons of the SCN shell. Upon photic stimulation in the early subjective night, the number of UBR4-expressing cells within the SCN increases. This study is the first to identify a novel E3 ubiquitin ligase component, UBR4, in the murine SCN and to implicate the N-end rule degradation pathway as a potential player in regulating core clock mechanisms and photic entrainment.	[Ling, Harrod H.; Cheng, Hai-Ying M.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Beaule, Christian; Chiang, Cheng-Kang; Tian, Ruijun; Figeys, Daniel; Cheng, Hai-Ying M.] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Beaule, Christian; Chiang, Cheng-Kang; Tian, Ruijun; Figeys, Daniel; Cheng, Hai-Ying M.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Toronto; University Toronto Mississauga; University of Ottawa; University of Ottawa	Cheng, HYM (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	haiying.cheng@utoronto.ca	Tian, Ruijun/J-3019-2014; Chiang, Cheng-Kang/AAQ-7472-2021	Figeys, Daniel/0000-0002-5373-7546; Tian, Ruijun/0000-0001-9521-5124; Cheng, Hai-Ying Mary/0000-0002-9292-7406	Natural Sciences and Engineering Research Council (NSERC) of Canada; Canadian Institute of Health Research (CIHR)	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by operating grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada to HYMC and DF, and the Canadian Institute of Health Research (CIHR) to HYMC and DF. HYMC is a Canada Research Chair (CRC) Tier 2 in Molecular Genetics of Biological Clocks. DF is a CRC Tier 1 in Proteomics and Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Arike L, 2014, METHODS MOL BIOL, V1156, P213, DOI 10.1007/978-1-4939-0685-7_14; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Dziema H, 2003, EUR J NEUROSCI, V17, P1617, DOI 10.1046/j.1460-9568.2003.02592.x; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Haas AL, 1997, FASEB J, V11, P1257; Hamada T, 2004, EUR J NEUROSCI, V19, P1741, DOI 10.1111/j.1460-9568.2004.03275.x; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Ishihama Y, 2005, NAT BIOTECHNOL, V23, P617, DOI 10.1038/nbt1086; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; JOHNSON RF, 1988, BRAIN RES, V460, P297, DOI 10.1016/0006-8993(88)90374-5; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Lee YJ, 2011, AM J PHYSIOL-RENAL, V301, pF883, DOI 10.1152/ajprenal.00117.2011; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nakatani Y, 2005, P NATL ACAD SCI USA, V102, P15093, DOI 10.1073/pnas.0507458102; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Ohsaki K, 2008, J BIOCHEM, V144, P609, DOI 10.1093/jb/mvn112; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sancar G, 2011, MOL CELL, V44, P687, DOI 10.1016/j.molcel.2011.10.019; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tian RJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007252; van der Veen Daan R, 2008, J Circadian Rhythms, V6, P5, DOI 10.1186/1740-3391-6-5; Yamaguchi Y, 2013, SCIENCE, V342, P85, DOI 10.1126/science.1238599; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; YOUNG WS, 1993, ENDOCRINOLOGY, V133, P585, DOI 10.1210/en.133.2.585	41	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103103	10.1371/journal.pone.0103103	http://dx.doi.org/10.1371/journal.pone.0103103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084275	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800015
J	Petushkova, NA; Pyatnitskiy, MA; Rudenko, VA; Larina, OV; Trifonova, OP; Kisrieva, JS; Samenkova, NF; Kuznetsova, GP; Karuzina, II; Lisitsa, AV				Petushkova, Natalia A.; Pyatnitskiy, Mikhail A.; Rudenko, Vladislav A.; Larina, Olesya V.; Trifonova, Oxana P.; Kisrieva, Julya S.; Samenkova, Natalia F.; Kuznetsova, Galina P.; Karuzina, Irina I.; Lisitsa, Andrey V.			Applying of Hierarchical Clustering to Analysis of Protein Patterns in the Human Cancer-Associated Liver	PLOS ONE			English	Article							LASER-CAPTURE MICRODISSECTION; SELENIUM-BINDING PROTEIN-1; COLORECTAL-CANCER; PROTEOMIC ANALYSIS; GENE-EXPRESSION; ELECTROPHORESIS; IDENTIFICATION; REPRODUCIBILITY; THERAPIES; BIOMARKER	Background: There are two ways that statistical methods can learn from biomedical data. One way is to learn classifiers to identify diseases and to predict outcomes using the training dataset with established diagnosis for each sample. When the training dataset is not available the task can be to mine for presence of meaningful groups (clusters) of samples and to explore underlying data structure (unsupervised learning). Results: We investigated the proteomic profiles of the cytosolic fraction of human liver samples using two-dimensional electrophoresis (2DE). Samples were resected upon surgical treatment of hepatic metastases in colorectal cancer. Unsupervised hierarchical clustering of 2DE gel images (n = 18) revealed a pair of clusters, containing 11 and 7 samples. Previously we used the same specimens to measure biochemical profiles based on cytochrome P450-dependent enzymatic activities and also found that samples were clearly divided into two well-separated groups by cluster analysis. It turned out that groups by enzyme activity almost perfectly match to the groups identified from proteomic data. Of the 271 reproducible spots on our 2DE gels, we selected 15 to distinguish the human liver cytosolic clusters. Using MALDI-TOF peptide mass fingerprinting, we identified 12 proteins for the selected spots, including known cancer-associated species. Conclusions/Significance: Our results highlight the importance of hierarchical cluster analysis of proteomic data, and showed concordance between results of biochemical and proteomic approaches. Grouping of the human liver samples and/or patients into differing clusters may provide insights into possible molecular mechanism of drug metabolism and creates a rationale for personalized treatment.	[Petushkova, Natalia A.; Pyatnitskiy, Mikhail A.; Larina, Olesya V.; Trifonova, Oxana P.; Kisrieva, Julya S.; Samenkova, Natalia F.; Kuznetsova, Galina P.; Karuzina, Irina I.; Lisitsa, Andrey V.] Russian Acad Med Sci, VN Orekhovich Inst Biomed Chem, Moscow, Russia; [Rudenko, Vladislav A.; Lisitsa, Andrey V.] Postgen Tech LLC, Moscow, Russia	Russian Academy of Medical Sciences; Institute of Biomedical Chemistry	Petushkova, NA (corresponding author), Russian Acad Med Sci, VN Orekhovich Inst Biomed Chem, Moscow, Russia.	natalia.petushkova@ibmc.msk.ru	Petushkova, Natalia/E-9951-2017; Кузнецова, Галина/F-2848-2017; Кисриева, Юлия/F-2823-2017; Лисица, Андрей/ABD-2934-2020; Pyatnitskiy, Mikhail/F-1588-2017; Trifonova, Oxana P/I-9373-2014	Petushkova, Natalia/0000-0002-4101-4607; Pyatnitskiy, Mikhail/0000-0002-4803-8150; Trifonova, Oxana/0000-0002-5803-2529	Ministry of Education and Science of the Russian Federation [16.522.12.2002]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	The work was supported by the Ministry of Education and Science of the Russian Federation, State Contract No. 16.522.12.2002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrethsen J, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-8; Alfonso P, 2008, J PROTEOME RES, V7, P4247, DOI 10.1021/pr800152u; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breikers G, 2006, PROTEOMICS, V6, P2844, DOI 10.1002/pmic.200500067; Cardona DM, 2009, AM J CLIN PATHOL, V132, P877, DOI 10.1309/AJCP74XGRFWTFLJU; Celis JE, 1999, CURR OPIN BIOTECH, V10, P16, DOI 10.1016/S0958-1669(99)80004-4; Chernobrovkin A L, 2011, Bioorg Khim, V37, P132; Cho-Vega JH, 2007, CANCER EPIDEM BIOMAR, V16, P2615, DOI 10.1158/1055-9965.EPI-07-0684; Choe LH, 2003, ELECTROPHORESIS, V24, P3500, DOI 10.1002/elps.200305614; Corona G, 2010, INT J ONCOL, V36, P93, DOI 10.3892/ijo_00000479; Jain R, 2010, J PROTEOME RES, V9, P737, DOI 10.1021/pr9005525; Jimenez CR, 2010, J PROTEOMICS, V73, P1873, DOI 10.1016/j.jprot.2010.06.004; Karp Natasha A, 2007, Proteomics, V7 Suppl 1, P42, DOI 10.1002/pmic.200700683; Kim H, 2006, PROTEOMICS, V6, P3466, DOI 10.1002/pmic.200500629; Kim J, 2002, ELECTROPHORESIS, V23, P4142, DOI 10.1002/elps.200290032; Kulkarni YM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-291; Kwong KY, 2005, GENOMICS, V86, P142, DOI 10.1016/j.ygeno.2005.03.012; Larina OV, 2012, J PROTEOM BIOINFORM, V5, P40; Lentz F, 2005, AM J PHARMACOGENOMIC, V5, P21, DOI 10.2165/00129785-200505010-00002; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; Lise M, 2005, FRONT BIOSCI-LANDMRK, V10, P3042, DOI 10.2741/1761; Lohberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043664; Macgregor PF, 2002, CLIN CHEM, V48, P1170; Mayer-Kuckuk P, 2002, MOL THER, V5, P492, DOI 10.1006/mthe.2002.0596; Melle C, 2007, J PROTEOME RES, V6, P306, DOI 10.1021/pr060439b; Muto T, 2011, J PROTEOMICS, V74, P858, DOI 10.1016/j.jprot.2011.02.030; Ossipova E, 2006, PROTEOMICS, V6, P2079, DOI 10.1002/pmic.200500484; Peng Y, 2012, MOL BIOSYST, V8, P3077, DOI 10.1039/c2mb25286d; Petushkova NA, 2010, EUR J PHARM SCI, V41, P305, DOI 10.1016/j.ejps.2010.06.014; Pohl NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007774; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rochat B, 2005, CLIN PHARMACOKINET, V44, P349, DOI 10.2165/00003088-200544040-00002; Ruan DT, 2005, SEMIN ONCOL, V32, P85, DOI 10.1053/j.seminoncol.2004.09.025; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi HJ, 2013, HUM PATHOL, V44, P1089, DOI 10.1016/j.humpath.2012.09.015; Shi HJ, 2011, J PROTEOMICS, V75, P339, DOI 10.1016/j.jprot.2011.07.025; Slany A, 2010, J PROTEOME RES, V9, P6, DOI 10.1021/pr900057t; Techritz S, 2013, PROTEOMICS, V13, P179, DOI 10.1002/pmic.201100539; Voss T, 2000, ELECTROPHORESIS, V21, P3345, DOI 10.1002/1522-2683(20001001)21:16<3345::AID-ELPS3345>3.0.CO;2-Z; Wimmer H, 2009, ELECTROPHORESIS, V30, P2076, DOI 10.1002/elps.200900072; Wray CJ, 2004, EXPERT OPIN INV DRUG, V13, P631, DOI 10.1517/13543784.13.6.631; Yu B, 2004, WORLD J GASTROENTERO, V10, P2652, DOI 10.3748/wjg.v10.i18.2652	42	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103950	10.1371/journal.pone.0103950	http://dx.doi.org/10.1371/journal.pone.0103950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083712	gold, Green Published, Green Submitted			2022-12-27	WOS:000339819800109
J	Sandrock, C; Tanadini, M; Tanadini, LG; Fauser-Misslin, A; Potts, SG; Neumann, P				Sandrock, Christoph; Tanadini, Matteo; Tanadini, Lorenzo G.; Fauser-Misslin, Aline; Potts, Simon G.; Neumann, Peter			Impact of Chronic Neonicotinoid Exposure on Honeybee Colony Performance and Queen Supersedure	PLOS ONE			English	Article							NOSEMA-CERANAE MICROSPORIDIA; APIS-MELLIFERA; COLLAPSE DISORDER; PESTICIDE EXPOSURE; GENE-EXPRESSION; BEE; INSECTICIDES; TOXICITY; DECLINES; LOSSES	Background: Honeybees provide economically and ecologically vital pollination services to crops and wild plants. During the last decade elevated colony losses have been documented in Europe and North America. Despite growing consensus on the involvement of multiple causal factors, the underlying interactions impacting on honeybee health and colony failure are not fully resolved. Parasites and pathogens are among the main candidates, but sublethal exposure to widespread agricultural pesticides may also affect bees. Methodology/Principal Findings: To investigate effects of sublethal dietary neonicotinoid exposure on honeybee colony performance, a fully crossed experimental design was implemented using 24 colonies, including sister-queens from two different strains, and experimental in-hive pollen feeding with or without environmentally relevant concentrations of thiamethoxam and clothianidin. Honeybee colonies chronically exposed to both neonicotinoids over two brood cycles exhibited decreased performance in the short-term resulting in declining numbers of adult bees (-28%) and brood (-13%), as well as a reduction in honey production (-29%) and pollen collections (-19%), but colonies recovered in the medium-term and overwintered successfully. However, significantly decelerated growth of neonicotinoid-exposed colonies during the following spring was associated with queen failure, revealing previously undocumented long-term impacts of neonicotinoids: queen supersedure was observed for 60% of the neonicotinoid-exposed colonies within a one year period, but not for control colonies. Linked to this, neonicotinoid exposure was significantly associated with a reduced propensity to swarm during the next spring. Both short-term and long-term effects of neonicotinoids on colony performance were significantly influenced by the honeybees' genetic background. Conclusions/Significance: Sublethal neonicotinoid exposure did not provoke increased winter losses. Yet, significant detrimental short and long-term impacts on colony performance and queen fate suggest that neonicotinoids may contribute to colony weakening in a complex manner. Further, we highlight the importance of the genetic basis of neonicotinoid susceptibility in honeybees which can vary substantially.	[Sandrock, Christoph; Fauser-Misslin, Aline; Neumann, Peter] Agroscope, Swiss Bee Res Ctr, Bern, Switzerland; [Tanadini, Matteo] Swiss Fed Inst Technol, Zurich, Switzerland; [Tanadini, Lorenzo G.] Univ Zurich, Inst Social & Prevent Med, Div Biostat, CH-8006 Zurich, Switzerland; [Fauser-Misslin, Aline; Neumann, Peter] Univ Bern, Vetsuisse Fac, Inst Bee Hlth, Bern, Switzerland; [Potts, Simon G.] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England	Swiss Federal Research Station Agroscope; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Bern; University of Reading	Sandrock, C (corresponding author), Agroscope, Swiss Bee Res Ctr, Bern, Switzerland.	ch.sandrock@gmail.com	Neumann, Peter/C-9964-2015; Potts, Simon/ABF-9221-2020; Potts, Simon G/C-7250-2008; Tanadini, Lorenzo/E-7290-2015	Neumann, Peter/0000-0001-5163-5215; Potts, Simon/0000-0002-2045-980X; Potts, Simon G/0000-0002-2045-980X; Tanadini, Lorenzo/0000-0003-4337-0637; Sandrock, Christoph/0000-0002-2054-2216	European Union [244090]	European Union(European Commission)	This research received funding from the European Union Framework 7 under grant agreement no. 244090 (CP-FP) STEP (Status and Trends in European Pollinators, www.STEP-project.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anderson D, 2008, SCIENCE, V319, P724, DOI 10.1126/science.319.5864.724c; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Belzunces LP, 2012, APIDOLOGIE, V43, P348, DOI 10.1007/s13592-012-0134-0; Bendahou N, 1999, ECOTOX ENVIRON SAFE, V44, P147, DOI 10.1006/eesa.1999.1812; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Brodschneider R, 2010, J APICULT RES, V49, P23, DOI 10.3896/IBRA.1.49.1.04; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; BUTLER C. G., 1957, INSECTES SOCIAUX, V4, P211, DOI 10.1007/BF02222154; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chauzat MP, 2010, J APICULT RES, V49, P113, DOI 10.3896/IBRA.1.49.1.22; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; Cressey D, 2013, NATURE, V496, P408, DOI 10.1038/496408a; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; DeGrandi-Hoffman Gloria, 2013, Insects, V4, P71, DOI 10.3390/insects4010071; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Derecka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068191; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Ellis JD, 2010, J APICULT RES, V49, P134, DOI 10.3896/IBRA.1.49.1.30; Elzen PJ, 2003, SOUTHWEST ENTOMOL, V28, P255; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Faucon JP, 2005, PEST MANAG SCI, V61, P111, DOI 10.1002/ps.957; Fauser-Misslin A, 2014, J APPL ECOL, V51, P450, DOI 10.1111/1365-2664.12188; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gregorc A, 2011, PESTIC BIOCHEM PHYS, V99, P200, DOI 10.1016/j.pestbp.2010.12.005; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Han P, 2010, ECOTOXICOLOGY, V19, P1612, DOI 10.1007/s10646-010-0546-4; Hatjina F, 2013, APIDOLOGIE, V44, P467, DOI 10.1007/s13592-013-0199-4; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2008, J INVERTEBR PATHOL, V97, P76, DOI 10.1016/j.jip.2007.06.002; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; IMDORF A, 1987, APIDOLOGIE, V18, P137, DOI 10.1051/apido:19870204; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; James RR, 2012, J INVERTEBR PATHOL, V109, P175, DOI 10.1016/j.jip.2011.12.005; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Larson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066375; Laurino D, 2013, B INSECTOL, V66, P119; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Laycock I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079872; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Lu CS, 2014, B INSECTOL, V67, P125; Lu CS, 2012, B INSECTOL, V65, P99; Maienfisch P, 2001, PEST MANAG SCI, V57, P906, DOI 10.1002/ps.365; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mason R., 2013, J ENV IMMUNOLOGY TOX, V1, P3, DOI DOI 10.7178/JEIT.1; MASSON C, 1993, APIDOLOGIE, V24, P169, DOI 10.1051/apido:19930302; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Garrido PM, 2013, J INSECT PHYSIOL, V59, P113, DOI 10.1016/j.jinsphys.2012.10.019; Moritz R.F.A., 1992, BEES SUPERORGANISMS; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2000, APIDOLOGIE, V31, P67, DOI 10.1051/apido:2000107; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Oliveira RA, 2014, ENVIRON TOXICOL, V29, P1122, DOI 10.1002/tox.21842; Osborne JL, 2012, NATURE, V491, P43, DOI 10.1038/nature11637; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Pettis JS, 1997, INSECT SOC, V44, P311, DOI 10.1007/s000400050053; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Sandrock C, 2014, AGR FOREST ENTOMOL, V16, P119, DOI 10.1111/afe.12041; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Skerl MIS, 2010, APIDOLOGIE, V41, P73, DOI 10.1051/apido/2009051; Stokstad E, 2013, SCIENCE, V340, P674, DOI [10.1126/science.340.6133.674, 10.1126/science.340.6133.675]; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Tennekes H.A., 2011, J ENV ANAL TOXICOL, V01, DOI [10.4172/2161-0525, DOI 10.4172/2161-0525.S4-001, 10.4172/2161-0525.s4-001]; Tennekes HA, 2013, TOXICOLOGY, V309, P39, DOI 10.1016/j.tox.2013.04.007; Thompson HM, 2014, APIDOLOGIE, V45, P545, DOI 10.1007/s13592-014-0273-6; Tremolada P, 2010, B ENVIRON CONTAM TOX, V85, P229, DOI 10.1007/s00128-010-0066-1; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	137	140	145	9	487	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103592	10.1371/journal.pone.0103592	http://dx.doi.org/10.1371/journal.pone.0103592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084279	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000339819800055
J	Moyer, GR; Diaz-Ferguson, E; Hill, JE; Shea, C				Moyer, Gregory R.; Diaz-Ferguson, Edgardo; Hill, Jeffrey E.; Shea, Colin			Assessing Environmental DNA Detection in Controlled Lentic Systems	PLOS ONE			English	Article							SITE OCCUPANCY MODELS; EDNA; CONSERVATION; ABUNDANCE; PREY	Little consideration has been given to environmental DNA (eDNA) sampling strategies for rare species. The certainty of species detection relies on understanding false positive and false negative error rates. We used artificial ponds together with logistic regression models to assess the detection of African jewelfish eDNA at varying fish densities (0, 0.32, 1.75, and 5.25 fish/m(3)). Our objectives were to determine the most effective water stratum for eDNA detection, estimate true and false positive eDNA detection rates, and assess the number of water samples necessary to minimize the risk of false negatives. There were 28 eDNA detections in 324, 1-L, water samples collected from four experimental ponds. The best-approximating model indicated that the per-L-sample probability of eDNA detection was 4.86 times more likely for every 2.53 fish/m(3) (1 SD) increase in fish density and 1.67 times less likely for every 1.02 C (1 SD) increase in water temperature. The best section of the water column to detect eDNA was the surface and to a lesser extent the bottom. Although no false positives were detected, the estimated likely number of false positives in samples from ponds that contained fish averaged 3.62. At high densities of African jewelfish, 3-5 L of water provided a > 95% probability for the presence/absence of its eDNA. Conversely, at moderate and low densities, the number of water samples necessary to achieve a > 95% probability of eDNA detection approximated 42-73 and >100 L, respectively. Potential biases associated with incomplete detection of eDNA could be alleviated via formal estimation of eDNA detection probabilities under an occupancy modeling framework; alternatively, the filtration of hundreds of liters of water may be required to achieve a high (e. g., 95%) level of certainty that African jewelfish eDNA will be detected at low densities (i. e <0.32 fish/m(3) or 1.75 g/m(3)).	[Moyer, Gregory R.; Diaz-Ferguson, Edgardo] US Fish & Wildlife Serv, Conservat Genet Lab, Warm Springs, GA 31830 USA; [Hill, Jeffrey E.] Univ Florida, Trop Aquaculture Lab, Program Fisheries & Aquat Sci, Ruskin, FL USA; [Shea, Colin] Tennessee Technol Univ, Dept Biol, Cookeville, TN 38505 USA; [Diaz-Ferguson, Edgardo] Auburn Univ, Dept Fisheries & Allied Aquacultures, Auburn, AL 36849 USA	United States Department of the Interior; US Fish & Wildlife Service; State University System of Florida; University of Florida; Tennessee Technological University; Auburn University System; Auburn University	Moyer, GR (corresponding author), US Fish & Wildlife Serv, Conservat Genet Lab, Warm Springs, GA 31830 USA.	greg_moyer@fws.gov		Diaz-Ferguson, Edgardo/0000-0002-2314-5021	United States Fish and Wildlife Service Region 4 Aquatic Invasive Species Program	United States Fish and Wildlife Service Region 4 Aquatic Invasive Species Program	This work was funded by the United States Fish and Wildlife Service Region 4 Aquatic Invasive Species Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Britton JR, 2013, ECOLOGY, V94, P2558, DOI 10.1890/13-0527.1; Bryk A. S., 2002, HIERARCHICAL LINEAR; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Congdon P., 2001, BAYESIAN STAT ANAL; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Diaz-Ferguson E, 2014, REV BIOL TR IN PRESS; Diaz-Ferguson E, 2014, MANAG BIOL INVASION, V5, P121, DOI 10.3391/mbi.2014.5.2.05; Dunlop-Hayden KL, 2011, BEHAVIOUR, V148, P795, DOI 10.1163/000579511X577256; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Hutson AM, 2012, J WORLD AQUACULT SOC, V43, P84, DOI 10.1111/j.1749-7345.2011.00537.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Langston JN, 2010, COPEIA, P475, DOI 10.1643/CP-09-069; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Porter-Whitaker AE, 2012, ECOL FRESHW FISH, V21, P375, DOI 10.1111/j.1600-0633.2012.00557.x; Rehage JS, 2013, WETLANDS, P1; RIVAS LUIS R., 1965, QUART J FLORIDA ACAD SCI, V28, P255; Royall R., 1997, STAT EVIDENCE LIKELI; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2006, ECOLOGY, V87, P835, DOI 10.1890/0012-9658(2006)87[835:GSOMAF]2.0.CO;2; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Schofield PJ, 2007, J FISH BIOL, V71, P87, DOI 10.1111/j.1095-8649.2007.01686.x; Snijders TAB, MULTILEVEL ANAL INTR; Sokal R.R., 2012, BIOMETRY; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner C.R., 2014, METHODS ECO IN PRESS; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Woodford DJ, 2013, ECOL APPL, V23, P1926, DOI 10.1890/12-1262.1; Wotton RS, 2001, BIOSCIENCE, V51, P537, DOI 10.1641/0006-3568(2001)051[0537:FIAE]2.0.CO;2; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	52	78	89	4	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103767	10.1371/journal.pone.0103767	http://dx.doi.org/10.1371/journal.pone.0103767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079969	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800079
J	Hessamfar, M; Colin, C; Bruyand, M; Decoin, M; Bonnet, F; Mercie, P; Neau, D; Cazanave, C; Pellegrin, JL; Dabis, F; Morlat, P; Chene, G				Hessamfar, Mojgan; Colin, Celine; Bruyand, Mathias; Decoin, Madeleine; Bonnet, Fabrice; Mercie, Patrick; Neau, Didier; Cazanave, Charles; Pellegrin, Jean-Luc; Dabis, Francois; Morlat, Philippe; Chene, Genevieve		GECSA Study Grp	Severe Morbidity According to Sex in the Era of Combined Antiretroviral Therapy: The ANRS CO3 Aquitaine Cohort	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; IMMUNODEFICIENCY-VIRUS-INFECTION; HEALTH-SERVICES UTILIZATION; LONGITUDINAL DATA-ANALYSIS; IN-HOSPITAL ADMISSIONS; AIDS-DEFINING CANCERS; CD4 CELL COUNT; COLLABORATIVE ANALYSIS; MYOCARDIAL-INFARCTION; GENERAL-POPULATION	Objective: To describe trends and determinants of severe morbidity in HIV-infected women and men. Design: A French prospective cohort of HIV-infected patients of both sexes and all transmission categories. Methods: We used hospital admission data from January 2000 to December 2008. A severe morbid event (SME) was defined as a clinical event requiring hospitalization for >= 48 h, several events could be reported during hospitalization. Yearly incidence rates of SME were estimated and compared using Generalized Estimating Equations. Results: Among 4,987 patients (27% women), followed for a median of 8.7 years, 1,473 (30%) were hospitalized (3,049 hospitalizations for 5,963 SME). The yearly incidence rate of hospitalization decreased in men, from 155 in 2000 to 80/1,000 person-years (PY) in 2008 and in women, from 125 to 71/1,000 PY, (p < 0.001). This trend was observed for all SME except for hepatic events, stable in men (15 to 13/1,000 PY) and increasing in women (2.5 to 11.5), cardiovascular events increasing in men (6 to 10/1,000 PY) and in women (6 to 14) and non-AIDS non-hepatic malignancies increasing in men (4 to 7/1,000 PY) and stable in women (2.5). Intraveneous drug users, age >50 years, HIV RNA >10,000 copies, CD4 <500/mm(3), AIDS stage, hepatitis C co-infection and cardiovascular risk factors (diabetes, high blood pressure, and tobacco use) were associated with SME. Conclusions: HIV-infected individuals in care in France require less and less frequently hospitalization. Women are now presenting with severe hepatic and cardio-vascular events. Disparities in SME between men and women are primarily explained by different exposure patterns to risk factors. Women should be targeted to benefit cardiovascular prevention policies as well as men.	[Hessamfar, Mojgan; Colin, Celine; Bruyand, Mathias; Decoin, Madeleine; Bonnet, Fabrice; Mercie, Patrick; Dabis, Francois; Morlat, Philippe; Chene, Genevieve] Univ Bordeaux, Inst Sante Publ Epidemiol & Dev, INSERM U897, Bordeaux, France; [Hessamfar, Mojgan; Colin, Celine; Bruyand, Mathias; Decoin, Madeleine; Bonnet, Fabrice; Mercie, Patrick; Dabis, Francois; Morlat, Philippe; Chene, Genevieve] Univ Bordeaux, Inst Sante Publ Epidemiol & Dev, CIC EC7, Bordeaux, France; [Hessamfar, Mojgan; Bruyand, Mathias; Bonnet, Fabrice; Mercie, Patrick; Neau, Didier; Cazanave, Charles; Pellegrin, Jean-Luc; Dabis, Francois; Morlat, Philippe; Chene, Genevieve] Ctr Hosp Univ CHU Bordeaux, Coordinat Reg Lutte Infect VIH COREVIH Aquitaine, Bordeaux, France; [Hessamfar, Mojgan; Bonnet, Fabrice; Pellegrin, Jean-Luc; Morlat, Philippe] CHU Bordeaux, Serv Med Interne & Malad Infect, Bordeaux, France; [Mercie, Patrick] CHU Bordeaux, Serv Med Interne & Immunol Clin, Bordeaux, France; [Neau, Didier; Cazanave, Charles] CHU Bordeaux, Federat Malad Infect & Trop, Bordeaux, France; [Neau, Didier; Cazanave, Charles; Pellegrin, Jean-Luc] Univ Bordeaux, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Hessamfar, M (corresponding author), Univ Bordeaux, Inst Sante Publ Epidemiol & Dev, INSERM U897, Bordeaux, France.	mojgan.hessamfar@chu-bordeaux.fr	Bruyand, Mathias/AAP-6177-2020; chene, genevieve/H-8665-2014; Bonnet, Fabrice/T-3254-2019; DABIS, FRANCOIS/S-9298-2019; Cazanave, Charles/AHE-5492-2022	chene, genevieve/0000-0002-8368-6460; DABIS, FRANCOIS/0000-0002-1614-8857; 	French Agency for AIDS and hepatitis research (ANRS)	French Agency for AIDS and hepatitis research (ANRS)(ANRS)	This study was supported by grants from the French Agency for AIDS and hepatitis research (ANRS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglaret X, 2012, CLIN INFECT DIS, V54, P714, DOI 10.1093/cid/cir898; [Anonymous], 2013, PRIS CHARG MED PERS; [Anonymous], 1992, MMWR RECOMM REP, V41, P1; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Benard A, 2007, AIDS PATIENT CARE ST, V21, P458, DOI 10.1089/apc.2006.0142; Benito N, 2001, J ACQ IMMUN DEF SYND, V27, P35, DOI 10.1097/00126334-200105010-00006; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Betz ME, 2005, MED CARE, V43, P3; Blot M, 2012, REV MAL RESPIR, V29, P785, DOI 10.1016/j.rmr.2011.10.974; Bonnet F, 2007, HIV MED, V8, P547, DOI 10.1111/j.1468-1293.2007.00508.x; Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048; Buchacz K, 2008, AIDS, V22, P1345, DOI 10.1097/QAD.0b013e328304b38b; Buchacz K, 2013, ANTIVIR THER, V18, P65, DOI 10.3851/IMP2450; Casau NC, 2005, CLIN INFECT DIS, V41, P855, DOI 10.1086/432797; Crum-Cianflone NF, 2010, JAIDS-J ACQ IMM DEF, V54, P248, DOI 10.1097/QAI.0b013e3181c8ef22; Deeken JF, 2012, CLIN INFECT DIS, V55, P1228, DOI 10.1093/cid/cis613; DREES (Direction de la Recherche dE de l'Evaluation et des Statistiques), 2010, ET SANT POP FRANC SU; Fleishman JA, 2005, MED CARE, V43, P40; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Gebo KA, 2003, JAIDS-J ACQ IMM DEF, V34, P165, DOI 10.1097/00126334-200310010-00006; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V38, P96, DOI 10.1097/00126334-200501010-00017; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Goedert JJ, 2006, BRIT J CANCER, V95, P642, DOI 10.1038/sj.bjc.6603282; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Herida M, 2003, J CLIN ONCOL, V21, P3447, DOI 10.1200/JCO.2003.01.096; Hessamfar-Bonarek M, 2010, INT J EPIDEMIOL, V39, P135, DOI 10.1093/ije/dyp300; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Holmberg SD, 2002, LANCET, V360, P1747, DOI 10.1016/S0140-6736(02)11672-2; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Krentz HB, 2006, HIV MED, V7, P457, DOI 10.1111/j.1468-1293.2006.00408.x; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Levine AM, 2010, J CLIN ONCOL, V28, P1514, DOI 10.1200/JCO.2009.25.6149; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mocroft A, 2004, HIV MED, V5, P437, DOI 10.1111/j.1468-1293.2004.00250.x; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Monforte AD, 2004, AIDS, V18, P1811, DOI 10.1097/00002030-200409030-00010; Pantanowitz L, 2001, JAMA-J AM MED ASSOC, V285, P3090, DOI 10.1001/jama.285.24.3090; Phillips AN, 2007, AIDS, V21, P1717; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; Soriano V, 2001, CLIN INFECT DIS, V33, P1793, DOI 10.1086/323009; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Thiebaut F, 2005, AIDS, V19, P729, DOI 10.1097/01.aids.0000166097.46940.35; Thiebaut R, 2000, AIDS, V14, P971, DOI 10.1097/00002030-200005260-00008; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; UNAIDS, 2012, AIDS EP UPD 2012; Yehia BR, 2010, JAIDS-J ACQ IMM DEF, V53, P397, DOI 10.1097/QAI.0b013e3181bcdc16	48	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102671	10.1371/journal.pone.0102671	http://dx.doi.org/10.1371/journal.pone.0102671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25076050	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800017
J	Mavaddat, N; Parker, RA; Sanderson, S; Mant, J; Kinmonth, AL				Mavaddat, Nahal; Parker, Richard A.; Sanderson, Simon; Mant, Jonathan; Kinmonth, Ann Louise			Relationship of Self-Rated Health with Fatal and Non-Fatal Outcomes in Cardiovascular Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							BIOMEDICAL RISK-FACTORS; ISCHEMIC-HEART-DISEASE; PERCEIVED HEALTH; ALL-CAUSE; MORTALITY; ASSOCIATION; MEN; PREDICTION; MORBIDITY; RATINGS	Background: People who rate their health as poor experience higher all-cause mortality. Study of disease-specific association with self-rated health might increase understanding of why this association exists. Objectives: To estimate the strength of association between self-rated health and fatal and non-fatal cardiovascular disease. Methods: A comprehensive search of PubMed MEDLINE, EMBASE, CINAHL, BIOSIS, PsycINFO, DARE, Cochrane Library, and Web of Science was undertaken during June 2013. Two reviewers independently searched databases and selected studies. Inclusion criteria were prospective cohort studies or cohort analyses of randomised trials with baseline measurement of self-rated health with fatal or non-fatal cardiovascular outcomes. 20 studies were pooled quantitatively in different meta-analyses. Study quality was assessed using Newcastle-Ottawa scales. Results: 'Poor' relative to 'excellent' self-rated health (defined by most extreme categories in each study, most often' poor' or 'very poor' and 'excellent' or 'good') was associated over a follow-up of 2.3-23 years with cardiovascular mortality in studies: where varying degrees of adjustments had been made for cardiovascular disease risk (HR 1.79 (95% CI 1.50 to 2.14); 15 studies, I2 = 71.24%), and in studies reporting outcomes in people with pre-existing cardiovascular disease or ischaemic heart disease symptoms (HR 2.42 (95% CI 1.32 to 4.44); 3 studies; I2 = 71.83%). 'Poor' relative to 'excellent' self rated health was also associated with the combined outcome of fatal and non-fatal cardiovascular events (HR 1.90 (95% CI 1.26 to 2.87); 5 studies; I2 = 68.61%), Self-rated health was not significantly associated with non-fatal cardiovascular disease outcomes (HR 1.66 (95% CI 0.96 to 2.87); 5 studies; I2 = 83.60%). Conclusions: Poor self rated health is associated with cardiovascular mortality in populations with and without prior cardiovascular disease. Those with current poor self-rated health may warrant additional input from health services to identify and address reasons for their low subjective health.	[Mavaddat, Nahal; Mant, Jonathan] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Strangeways Lab, Cambridge, England; [Parker, Richard A.; Sanderson, Simon; Kinmonth, Ann Louise] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England	University of Cambridge; University of Cambridge	Mavaddat, N (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Strangeways Lab, Cambridge, England.	nm212@medschl.cam.ac.uk		Mant, Jonathan/0000-0002-9531-0268	NIHR Walport Clinical Lectureship; National Institute for Health Research [NF-SI-0508-10072, CL-2008-14-006] Funding Source: researchfish	NIHR Walport Clinical Lectureship; National Institute for Health Research(National Institute for Health Research (NIHR))	This report presents independent commissioned research by the National Institute for Health Research (NIHR) through the National School for Primary Care Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NM was funded through an NIHR Walport Clinical Lectureship.	Appels A, 1996, SOC SCI MED, V42, P681, DOI 10.1016/0277-9536(95)00195-6; Bailis DS, 2003, SOC SCI MED, V56, P203, DOI 10.1016/S0277-9536(02)00020-5; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benjamins MR, 2004, SOC SCI MED, V59, P1297, DOI 10.1016/j.socscimed.2003.01.001; Bosworth HB, 1999, MED CARE, V37, P1226, DOI 10.1097/00005650-199912000-00006; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Doganay S, 2012, TURK J GERIATR, V15, P396; Emmelin M, 2003, J HYPERTENS, V21, P887, DOI 10.1097/00004872-200305000-00012; Ernstsen L, 2011, AGE AGEING, V40, P105, DOI 10.1093/ageing/afq141; Fang Xiang-hua, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P184; Fernandez-Ruiz M, 2013, GERONTOLOGY, V59, P368, DOI 10.1159/000348781; Heidrich J, 2002, ANN EPIDEMIOL, V12, P338, DOI 10.1016/S1047-2797(01)00300-3; Heistaro S, 2001, J EPIDEMIOL COMMUN H, V55, P227, DOI 10.1136/jech.55.4.227; Hillen T, 2003, J EPIDEMIOL COMMUN H, V57, P960, DOI 10.1136/jech.57.12.960; Hirdes JP, 1993, J AGING HEALTH, V5, P101, DOI DOI 10.1177/089826439300500105; Howell R., 2007, HEALTH PSYCHOL REV, V1, P83, DOI [DOI 10.1080/17437190701492486, 10.1080/17437190701492486]; Idler E, 2004, J HEALTH SOC BEHAV, V45, P336, DOI 10.1177/002214650404500307; Idler EL, 2000, AM J EPIDEMIOL, V152, P874, DOI 10.1093/aje/152.9.874; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2006, J CLIN EPIDEMIOL, V59, P465, DOI 10.1016/j.jclinepi.2005.12.004; Kamphuis MH, 2009, J AFFECT DISORDERS, V114, P184, DOI 10.1016/j.jad.2008.07.005; Kaplan G, 2003, SOC SCI MED, V56, P1669, DOI 10.1016/S0277-9536(02)00179-X; Kaplan GA, 1996, INT J EPIDEMIOL, V25, P259, DOI 10.1093/ije/25.2.259; Kennedy BS, 2001, AM J EPIDEMIOL, V153, P232, DOI 10.1093/aje/153.3.232; Kirkwood B. R., 2003, ESSENTIAL MEDIAL STA; Kuper H, 2006, AM J EPIDEMIOL, V164, P349, DOI 10.1093/aje/kwj212; LAMB KL, 1990, SOC SCI MED, V31, P963, DOI 10.1016/0277-9536(90)90105-2; Latham K, 2013, J GERONTOL B-PSYCHOL, V68, P107, DOI 10.1093/geronb/gbs104; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; PIJLS LTJ, 1993, AM J EPIDEMIOL, V138, P840, DOI 10.1093/oxfordjournals.aje.a116787; R Core Team, 2021, R LANGUAGE ENV STAT; Rutledge T, 2010, PSYCHOSOM MED, V72, P549, DOI 10.1097/PSY.0b013e3181dc0259; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; SEGOVIA J, 1989, CAN J PUBLIC HEALTH, V80, P32; TSUJI I, 1994, J AM GERIATR SOC, V42, P153, DOI 10.1111/j.1532-5415.1994.tb04944.x; van der Linde RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065290; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; von Bothmer MIK, 2003, SCAND J CARING SCI, V17, P347, DOI 10.1046/j.0283-9318.2003.00234.x; WANNAMETHEE G, 1991, INT J EPIDEMIOL, V20, P239, DOI 10.1093/ije/20.1.239; Weinehall L, 1998, J INTERN MED, V243, P99; Wells G. A., 2007, NEWCASTLE OTTAWA SCA	42	91	93	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103509	10.1371/journal.pone.0103509	http://dx.doi.org/10.1371/journal.pone.0103509			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM7EZ	25076041	Green Submitted, Green Published, gold			2022-12-27	WOS:000340028800057
J	Robison, B; Seibel, B; Drazen, J				Robison, Bruce; Seibel, Brad; Drazen, Jeffrey			Deep-Sea Octopus (Graneledone boreopacifica) Conducts the Longest-Known Egg-Brooding Period of Any Animal	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; CEPHALOPODA; GROWTH; FISH	Octopuses typically have a single reproductive period and then they die (semelparity). Once a clutch of fertilized eggs has been produced, the female protects and tends them until they hatch. In most shallow-water species this period of parental care can last from 1 to 3 months, but very little is known about the brooding of deep-living species. In the cold, dark waters of the deep ocean, metabolic processes are often slower than their counterparts at shallower depths. Extrapolations from data on shallow-water octopus species suggest that lower temperatures would prolong embryonic development periods. Likewise, laboratory studies have linked lower temperatures to longer brooding periods in cephalopods, but direct evidence has not been available. We found an opportunity to directly measure the brooding period of the deep-sea octopus Graneledone boreopacifica, in its natural habitat. At 53 months, it is by far the longest egg-brooding period ever reported for any animal species. These surprising results emphasize the selective value of prolonged embryonic development in order to produce competitive hatchlings. They also extend the known boundaries of physiological adaptations for life in the deep sea.	[Robison, Bruce] Monterey Bay Aquarium Res Inst, Div Res, Moss Landing, CA 95039 USA; [Seibel, Brad] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Drazen, Jeffrey] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA	Monterey Bay Aquarium Research Institute; University of Rhode Island; University of Hawaii System	Robison, B (corresponding author), Monterey Bay Aquarium Res Inst, Div Res, Moss Landing, CA 95039 USA.	robr@mbari.org	Drazen, Jeffrey/C-1197-2013	Drazen, Jeffrey/0000-0001-9613-3833	Monterey Bay Aquarium Research Institute [901220]; David and Lucile Packard Foundation	Monterey Bay Aquarium Research Institute; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This research was funded by the Monterey Bay Aquarium Research Institute (www.mbari.org) as a research project (#901220) led by author BR; MBARI is funded by the David and Lucile Packard Foundation (www.packard.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt IM, 2007, MAR BIOL, V150, P387, DOI 10.1007/s00227-006-0365-6; Boletzky S.v., 1987, P5; BOLETZKY SV, 1994, ANTARCT SCI, V6, P139, DOI 10.1017/S0954102094000210; Bush SL, 2012, J MAR BIOL ASSOC UK, V92, P1629, DOI 10.1017/S0025315411002165; CALOW P, 1987, CEPHALOPOD LIFE CYCL, V2, P351; CHILDRESS JJ, 1978, MAR BIOL, V50, P47, DOI 10.1007/BF00390541; Corse J, 1799, PHILOS T ROY SOC LON, V1799, P31; DANIELS RA, 1979, SCIENCE, V205, P831, DOI 10.1126/science.205.4408.831; Drazen JC, 2003, BIOL BULL-US, V205, P1, DOI 10.2307/1543439; Hanlon RT, 1996, CEPHALOPOD BEHAV; Ibanez CM, 2010, REV FISH BIOL FISHER, V20, P123, DOI 10.1007/s11160-009-9129-y; Kirkwood R, 1997, ECOL MONOGR, V67, P155, DOI 10.1890/0012-9615(1997)067[0155:TFEOFE]2.0.CO;2; Mangold K., 1987, P157; Miaud C, 2001, J ZOOL, V254, P251, DOI 10.1017/S0952836901000760; Nesis KN., 1999, RUSS J MAR BIOL+, V25, P499; Paull CK, 2005, GEOL SOC AM BULL, V117, P1134, DOI 10.1130/B25390.1; Pereyra W.T., 1972, P444; Rocha F, 2001, BIOL REV, V76, P291, DOI 10.1017/S1464793101005681; SAUNDERS WB, 1984, SCIENCE, V224, P990, DOI 10.1126/science.224.4652.990; Seibel BA, 2005, NATURE, V438, P929, DOI 10.1038/438929a; TANAKA S, 1990, JPN J ICHTHYOL, V37, P273; Voight JR, 2008, AM MALACOL BULL, V24, P43, DOI 10.4003/0740-2783-24.1.43; Voight JR, 2004, J MOLLUS STUD, V70, P400, DOI 10.1093/mollus/70.4.400; Voight JR, 2000, BIOL BULL, V198, P94, DOI 10.2307/1542807; VOIGHT JR, 2002, B MAR SCI, V71, P1142; Wood JB, 1998, MALACOLOGIA, V39, P11	26	46	48	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103437	10.1371/journal.pone.0103437	http://dx.doi.org/10.1371/journal.pone.0103437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075745	gold, Green Published, Green Submitted			2022-12-27	WOS:000340028800044
J	Willcox, ML; Dicko, MI; Graz, B; Forster, M; Shinkins, B; Diakite, C; Giani, S; Falquet, J; Diallo, D; Dembele, E				Willcox, Merlin L.; Dicko, Moussa I.; Graz, Bertrand; Forster, Mathieu; Shinkins, Bethany; Diakite, Chiaka; Giani, Sergio; Falquet, Jacques; Diallo, Drissa; Dembele, Eugene			Pre-Hospital Risk Factors for Inpatient Death from Severe Febrile Illness in Malian Children	PLOS ONE			English	Article							LIFE-THREATENING MALARIA; HOME-BASED MANAGEMENT; AFRICAN CHILDREN; TRANSMISSION; MORTALITY; FEATURES; FEVERS; URBAN; AREA	Background: Inpatient case fatality from severe malaria remains high in much of sub-Saharan Africa. The majority of these deaths occur within 24 hours of admission, suggesting that pre-hospital management may have an impact on the risk of case fatality. Methods: Prospective cohort study, including questionnaire about pre-hospital treatment, of all 437 patients admitted with severe febrile illness (presumed to be severe malaria) to the paediatric ward in Sikasso Regional Hospital, Mali, in a two-month period. Findings: The case fatality rate was 17.4%. Coma, hypoglycaemia and respiratory distress at admission were associated with significantly higher mortality. In multiple logistic regression models and in a survival analysis to examine pre-admission risk factors for case fatality, the only consistent and significant risk factor was sex. Girls were twice as likely to die as boys (AOR 2.00, 95% CI 1.08-3.70). There was a wide variety of pre-hospital treatments used, both modern and traditional. None had a consistent impact on the risk of death across different analyses. Reported use of traditional treatments was not associated with post-admission outcome. Interpretation: Aside from well-recognised markers of severity, the main risk factor for death in this study was female sex, but this study cannot determine the reason why. Differences in pre-hospital treatments were not associated with case fatality.	[Willcox, Merlin L.; Shinkins, Bethany] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxon, England; [Dicko, Moussa I.; Diakite, Chiaka; Diallo, Drissa] Inst Natl Rech Sante Publ, Dept Med Traditionnelle, Bamako, Mali; [Graz, Bertrand] Univ Lausanne, Univ Inst Social & Prevent Med, Care Assessment Unit, CAM Group, Lausanne, Switzerland; [Forster, Mathieu] Ungava Tulattavik Hlth Ctr, Kuujjuaq, PQ, Canada; [Giani, Sergio] Aidemet ONG, Bamako, Mali; [Falquet, Jacques] Univ Geneva, Dept Plant Med, Geneva, Switzerland; [Diallo, Drissa] Univ Sci Tech & Technol Bamako, Fac Pharm, Bamako, Mali; [Dembele, Eugene] Sikasso Reg Hosp, Dept Paediat, Sikasso, Mali	University of Oxford; University of Lausanne; University of Geneva; University of Science & Technology of Bamako	Willcox, ML (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxon, England.	merlin.willcox@phc.ox.ac.uk	Willcox, Merlin/I-6255-2019; Shinkins, Bethany/AAX-4045-2020	Willcox, Merlin/0000-0002-5227-3444; Shinkins, Bethany/0000-0001-5350-1018	Swiss Agency for Development and Cooperation (SDC)	Swiss Agency for Development and Cooperation (SDC)	This study was funded by the Swiss Agency for Development and Cooperation (SDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassat Q, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-37; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Biai S, 2007, BRIT MED J, V335, P862, DOI 10.1136/bmj.39345.467813.80; DEFRANCISCO A, 1994, J TROP MED HYG, V97, P69; Diallo D, 2006, T ROY SOC TROP MED H, V100, P515, DOI 10.1016/j.trstmh.2005.08.003; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Ehrhardt S, 2005, MICROBES INFECT, V7, P1204, DOI 10.1016/j.micinf.2005.04.007; Gemperli A, 2004, AM J EPIDEMIOL, V159, P64, DOI 10.1093/aje/kwh001; Graz B, 2010, T ROY SOC TROP MED H, V104, P33, DOI 10.1016/j.trstmh.2009.07.005; Graz B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-242; Issifou S, 2007, AM J TROP MED HYG, V77, P1015, DOI 10.4269/ajtmh.2007.77.1015; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Nonvignon J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-188; Orimadegun AE, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-143; Ranque S, 2008, PEDIATR INFECT DIS J, V27, P130, DOI 10.1097/INF.0b013e31815988ed; Rasoanaivo P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S4; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Willcox ML, 2009, ANN TROP MED PARASIT, V103, P3, DOI 10.1179/136485909X384983; Willcox ML, 2007, T ROY SOC TROP MED H, V101, P1190, DOI 10.1016/j.trstmh.2007.05.017; Willcox ML, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S8; Willcox ML, 2011, T ROY SOC TROP MED H, V105, P23, DOI 10.1016/j.trstmh.2010.10.003; Willcox ML, 2010, TROP MED INT HEALTH, V15, P232, DOI 10.1111/j.1365-3156.2009.02444.x; Zeidan Z., 2006, Eastern Mediterranean Health Journal, V12, P783	23	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e102530	10.1371/journal.pone.0102530	http://dx.doi.org/10.1371/journal.pone.0102530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075623	Green Published, gold, Green Submitted			2022-12-27	WOS:000340028800013
J	Hayat, T; Asad, S; Mustafa, M; Alsaedi, A				Hayat, Tasawar; Asad, Sadia; Mustafa, Meraj; Alsaedi, Ahmed			Radiation Effects on the Flow of Powell-Eyring Fluid Past an Unsteady Inclined Stretching Sheet with Non-Uniform Heat Source/Sink	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; CONVECTION FLOW; MASS-TRANSFER; FILM; GENERATION; NANOFLUID; SURFACE; MHD	This study investigates the unsteady flow of Powell-Eyring fluid past an inclined stretching sheet. Unsteadiness in the flow is due to the time-dependence of the stretching velocity and wall temperature. Mathematical analysis is performed in the presence of thermal radiation and non-uniform heat source/sink. The relevant boundary layer equations are reduced into self-similar forms by suitable transformations. The analytic solutions are constructed in a series form by homotopy analysis method (HAM). The convergence interval of the auxiliary parameter is obtained. Graphical results displaying the influence of interesting parameters are given. Numerical values of skin friction coefficient and local Nusselt number are computed and analyzed.	[Hayat, Tasawar; Asad, Sadia] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Mustafa, Meraj] NUST, SNS, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah, Saudi Arabia	Quaid I Azam University; National University of Sciences & Technology - Pakistan; King Abdulaziz University	Asad, S (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	asadsadia@ymail.com	Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/E-9449-2015; Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/A-3853-2013; Mustafa Hashmi, Meraj/P-1769-2014	Alsaedi, Ahmed/0000-0003-3452-8922; 	Deanship of Scientific Research (DSR), King Abdul-Aziz University, Jeddah [10 - 130/1434HiCi]; DSR	Deanship of Scientific Research (DSR), King Abdul-Aziz University, Jeddah; DSR	This paper was funded by the Deanship of Scientific Research (DSR), King Abdul-Aziz University, Jeddah under grant no. (10 - 130/1434HiCi). The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasbandy S, 2011, COMMUN NONLINEAR SCI, V16, P4268, DOI 10.1016/j.cnsns.2011.03.031; Andersson HI, 1996, J NON-NEWTON FLUID, V62, P1, DOI 10.1016/0377-0257(95)01392-X; Bhattacharyya K., 2013, J THERMODYNAMICS, V2013, P1, DOI [10.1155/2013/169674, DOI 10.1155/2013/169674]; BIRD R.B., 1987, FLUID MECH-SOV RES, V1; Brewster M.Q., 1972, THERMAL RAD TRANSFER; Ei-Aziz MA, 2009, INT COMMUN HEAT MASS, V36, P521, DOI 10.1016/j.icheatmasstransfer.2009.01.016; Elbashbeshy EMA, 2004, HEAT MASS TRANSFER, V41, P1, DOI 10.1007/s00231-004-0520-x; Eldabe NTM, 2003, Z NATURFORSCH A, V58, P204; Harris J., 1977, RHEOLOGY NONNEWTONIA; Hashmi MM, 2012, NONLINEAR ANAL-MODEL, V17, P418, DOI 10.15388/NA.17.4.14048; Hayat T, 2012, INT J HEAT MASS TRAN, V55, P1817, DOI 10.1016/j.ijheatmasstransfer.2011.10.046; Hayat T, 2011, APPL MATH MECH-ENGL, V32, P167, DOI 10.1007/s10483-011-1403-7; Hayat T, 2010, Z NATURFORSCH A, V65, P711, DOI 10.1515/zna-2010-8-913; Ishak A, 2009, MECCANICA, V44, P369, DOI 10.1007/s11012-008-9176-9; Islam S, 2009, Z ANGEW MATH PHYS, V60, P1178, DOI 10.1007/s00033-009-7034-9; Khader MM, 2013, J APPL MECH TECH PH+, V54, P440, DOI 10.1134/S0021894413030139; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P2003, DOI 10.1016/j.cnsns.2009.09.002; Mukhopadhyay S, 2009, INT J HEAT MASS TRAN, V52, P5213, DOI 10.1016/j.ijheatmasstransfer.2009.04.013; Mukhopadhyay S, 2013, MECCANICA, V48, P1717, DOI 10.1007/s11012-013-9704-0; Mushtaq A, 2013, Z NATURFORSCH A, V68, P791, DOI 10.5560/ZNA.2013-0063; Mustafa M, 2013, INFLUENCE INDUCED MA, DOI [10.1007/s11012-013-9809-5, DOI 10.1007/S11012-013-9809-5]; Mustafa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061859; Mustafaa M, 2013, INT J NUMER METHOD H, V23, P945, DOI 10.1108/HFF-09-2011-0179; Nandeppanavar MM, 2011, INT J HEAT MASS TRAN, V54, P4960, DOI 10.1016/j.ijheatmasstransfer.2011.07.009; Patel M, 2009, APPL NUMER MATH, V59, P2584, DOI 10.1016/j.apnum.2009.04.010; Powell R.E., 1944, NATURE; Rahman MM, 2009, INT J THERM SCI, V48, P2331, DOI 10.1016/j.ijthermalsci.2009.05.003; Raptis A, 1998, INT COMMUN HEAT MASS, V25, P289, DOI 10.1016/S0735-1933(98)00016-5; Rashidi MM, 2013, INT J HEAT MASS TRAN, V62, P515, DOI 10.1016/j.ijheatmasstransfer.2013.03.004; Rashidi MM, INT J APPL IN PRESS; Shateyi S, 2009, MATH PROBL ENG, V2009, DOI 10.1155/2009/965603; Sparrow EM., 1978, RAD HEAT TRANSFER; Tsai R, 2008, INT COMMUN HEAT MASS, V35, P1340, DOI 10.1016/j.icheatmasstransfer.2008.07.001; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V59, P167, DOI 10.1016/j.ijheatmasstransfer.2012.12.009; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V57, P82, DOI 10.1016/j.ijheatmasstransfer.2012.10.006; WANG CY, 1990, Q APPL MATH, V48, P601, DOI 10.1090/qam/1079908; Yang Ali-Min, 2014, ADV MECH ENG, V2014, P5; Yang XJ, 2013, THERM SCI, V17, P625, DOI 10.2298/TSCI121124216Y; Zaman H, 2013, AM J COMPUTATIONAL M, V3, P313, DOI DOI 10.4236/ajcm.2013.34041; Zueco J., 2009, INT J APPL MATH MECH, V5, P1	40	48	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103214	10.1371/journal.pone.0103214	http://dx.doi.org/10.1371/journal.pone.0103214			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072515	gold, Green Published, Green Submitted			2022-12-27	WOS:000341307600031
J	Qin, RQ; LeBoldus, JM				Qin, Ruqian; LeBoldus, Jared M.			The Infection Biology of Sphaerulina musiva: Clues to Understanding a Forest Pathogen	PLOS ONE			English	Article							SEPTORIA-MUSIVA; POPULUS CLONES; HYBRID POPLAR; PINE NEEDLES; LEAF-SPOT; RESISTANCE; DISEASE; INOCULATION; CANKERS; TREES	Trees in the genus Populus and their interspecific hybrids are used across North America for fiber production and as a potential source of biofuel. Plantations of these species are severely impacted by a fungal pathogen, Sphaerulina musiva, the cause of leaf spot and stem canker. An inoculation protocol that does not rely on stem wounding to achieve infection was recently developed. Using this protocol two experiments were conducted to examine infection biology and disease development in the S. musiva-Populus interaction. In the first experiment non-wounded stems of one moderately resistant clone (NM6) and one susceptible clone (NC11505) were inoculated and examined by scanning electron microscopy at six different times (6 h, 12 h, 24 h, 72 h, 1 week, and 3 weeks) post-inoculation. The images indicate that the pathogen appears to enter host tissue through small openings and lenticels and that there are no significant differences in the penetration rate between the moderately resistant (NM6) and susceptible (NC11505) clones at 12 h post-inoculation. In a second experiment a histological comparison of stem cankers for resistant clone DN74 and susceptible clone NC11505 were conducted at three time points (3 weeks, 5 weeks, and 7 weeks) post-inoculation. Distinct differences in disease development were apparent between the resistant and susceptible clones at each time point, with the susceptible clone exhibiting a weak and delayed defense response. These results suggest, that following penetration, the pathogen may be able to interfere with the defense response in the susceptible host.	[Qin, Ruqian; LeBoldus, Jared M.] N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA	North Dakota State University Fargo	LeBoldus, JM (corresponding author), N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA.	jared.leboldus@ndsu.edu			United States Department of Agriculture-National Institutes of Food and Agriculture-RIPM from North Dakota State University-AES and the Department of Plant Pathology [2012-34103-19771]	United States Department of Agriculture-National Institutes of Food and Agriculture-RIPM from North Dakota State University-AES and the Department of Plant Pathology	United States Department of Agriculture-National Institutes of Food and Agriculture-RIPM (2012-34103-19771) GRA to RQ from North Dakota State University-AES and the Department of Plant Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomas A, 2007, TREE PHYSIOL, V27, P1441, DOI 10.1093/treephys/27.10.1441; Barakat A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-38; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; BIER J. E., 1939, CANADIAN JOUR RES SECT C BOT SCI, V17, P195; BIGGS AR, 1983, CAN J BOT, V61, P563, DOI 10.1139/b83-064; BIGGS AR, 1986, ANN BOT-LONDON, V57, P463, DOI 10.1093/oxfordjournals.aob.a087128; BIGGS AR, 1984, CAN J FOREST RES, V14, P351, DOI 10.1139/x84-064; BIGGS AR, 1984, CAN J BOT, V62, P2814, DOI 10.1139/b84-375; Deflorio G, 2011, PHYSIOL MOL PLANT P, V75, P180, DOI 10.1016/j.pmpp.2011.02.002; Enebak SA, 1997, EUR J FOREST PATHOL, V27, P337; Eyles A, 2010, NEW PHYTOL, V185, P893, DOI 10.1111/j.1469-8137.2009.03127.x; Feau N, 2010, CAN J PLANT PATHOL, V32, P122, DOI 10.1080/07060661003740009; GRAM K., 1953, Friesia, V4, P262; HEBARD FV, 1984, PHYTOPATHOLOGY, V74, P140, DOI 10.1094/Phyto-74-140; Kovalchuk A, 2013, ANNU REV PHYTOPATHOL, V51, P221, DOI 10.1146/annurev-phyto-082712-102307; KRUPINSKY JM, 1989, PHYTOPATHOLOGY, V79, P413, DOI 10.1094/Phyto-79-413; LeBoldus JM, 2010, PLANT DIS, V94, P1238, DOI 10.1094/PDIS-02-10-0094; LeBoldus JM, 2009, PLANT DIS, V93, P1146, DOI 10.1094/PDIS-93-11-1146; Liang HY, 2014, PLANT SCI, V223, P69, DOI 10.1016/j.plantsci.2014.03.004; LONG R, 1986, CAN J FOREST RES, V16, P405, DOI 10.1139/x86-072; Mullick D.B., 1977, Recent Advances in Phytochemistry, V11, P395; Newcombe G, 2001, PHYTOPATHOLOGY, V91, P1081, DOI 10.1094/PHYTO.2001.91.11.1081; OSTRY ME, 1985, PLANT DIS, V69, P755, DOI 10.1094/PD-69-755; PATTON RF, 1978, PHYTOPATHOLOGY, V68, P1700, DOI 10.1094/Phyto-68-1700; Pegg GS, 2009, PLANT PATHOL, V58, P642, DOI 10.1111/j.1365-3059.2009.02087.x; PETERSON GW, 1969, PHYTOPATHOLOGY, V59, P1044; Qin RQ, 2014, PLANT DIS, V98, P1106, DOI 10.1094/PDIS-11-13-1152-RE; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Sivanesan A, 1990, CMI DESCRIPTIONS PAT, V988; Smith JA, 2006, PHYTOPATHOLOGY, V96, P171, DOI 10.1094/PHYTO-96-0171; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Ward KT, 2005, PLANT DIS, V89, P1077, DOI 10.1094/PD-89-1077; Waterman AM, 1946, 947 USDA; Weiland JE, 2003, PLANT DIS, V87, P1507, DOI 10.1094/PDIS.2003.87.12.1507; Weiland JE, 2007, PLANT DIS, V91, P1524, DOI 10.1094/PDIS-91-12-1524; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; ZALASKY H, 1978, PHYTOPROTECTION, V59, P43	38	14	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103477	10.1371/journal.pone.0103477	http://dx.doi.org/10.1371/journal.pone.0103477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072596	Green Published, Green Submitted, gold			2022-12-27	WOS:000341307600052
J	Spiess, B; Postina, P; Reinwald, M; Cornely, OA; Hamprecht, A; Hoenigl, M; Lass-Florl, C; Rath, PM; Steinmann, J; Miethke, T; Lauten, M; Will, S; Merker, N; Hofmann, WK; Buchheidt, D				Spiess, Birgit; Postina, Patricia; Reinwald, Mark; Cornely, Oliver A.; Hamprecht, Axel; Hoenigl, Martin; Lass-Floerl, Cornelia; Rath, Peter-Michael; Steinmann, Joerg; Miethke, Thomas; Lauten, Melchior; Will, Silke; Merker, Natalia; Hofmann, Wolf-Karsten; Buchheidt, Dieter			Incidence of Cyp51 A Key Mutations in Aspergillus fumigatus-A Study on Primary Clinical Samples of Immunocompromised Patients in the Period of 1995-2013	PLOS ONE			English	Article							AZOLE RESISTANCE; TRIAZOLE RESISTANCE; INVASIVE ASPERGILLOSIS; ANTIFUNGAL RESISTANCE; CROSS-RESISTANCE; TR/L98H MUTATION; FRENCH COHORT; PREVALENCE; GUIDELINES; FREQUENCY	As the incidence of azole resistance in Aspergillus fumigatus is rising and the diagnosis of invasive aspergillosis (IA) in immunocompromised patients is rarely based on positive culture yield, we screened our Aspergillus DNA sample collection for the occurrence of azole resistance mediating cyp51 A key mutations. Using two established, a modified and a novel polymerase chain reaction (PCR) assays followed by DNA sequence analysis to detect the most frequent mutations in the A. fumigatus cyp51 A gene conferring azole resistance (TR34 (tandem repeat), L98H and M220 alterations). We analyzed two itraconazole and voriconazole and two multi-azole resistant clinical isolates and screened 181 DNA aliquots derived from clinical samples (blood, bronchoalveolar lavage (BAL), biopsies, cerebrospinal fluid (CSF)) of 155 immunocompromised patients of our Aspergillus DNA sample collection, previously tested positive for Aspergillus DNA and collected between 1995 and 2013. Using a novel PCR assay for the detection of the cyp51 A 46 bp tandem repeat (TR46) directly from clinical samples, we found the alteration in a TR46/Y121F/T289A positive clinical isolate. Fifty stored DNA aliquots from clinical samples were TR46 negative. DNA sequence analysis revealed a single L98H mutation in 2010, two times the L98H alteration combined with TR34 in 2011 and 2012 and a so far unknown N90K mutation in 1998. In addition, four clinical isolates were tested positive for the TR34/L98H combination in the year 2012. We consider our assay of epidemiological relevance to detect A. fumigatus azole resistance in culture-negative clinical samples of immunocompromised patients; a prospective study is ongoing.	[Spiess, Birgit; Postina, Patricia; Reinwald, Mark; Will, Silke; Merker, Natalia; Hofmann, Wolf-Karsten; Buchheidt, Dieter] Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany; [Cornely, Oliver A.] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Cornely, Oliver A.] ZKS Koln, BMBF 01KN1106, ZKS Koln, Clin Trials Ctr Cologne, Cologne, Germany; [Cornely, Oliver A.] Ctr Integrated Oncol CIO Koln Bonn, Cologne, Germany; [Cornely, Oliver A.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Hamprecht, Axel] Univ Hosp, Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [Hoenigl, Martin] Graz Med Univ, Univ Hosp Internal Med, Sect Infect Dis & Trop Med, Graz, Austria; [Hoenigl, Martin] Graz Med Univ, Univ Hosp Internal Med, Dept Pulmonol, Graz, Austria; [Lass-Floerl, Cornelia] Med Univ Innsbruck, Sect Hyg & Med Microbiol, A-6020 Innsbruck, Austria; [Steinmann, Joerg] Univ Hosp, Inst Med Microbiol, Essen, Germany; [Miethke, Thomas] Univ Hosp, Inst Med Microbiol & Hyg, Mannheim, Germany; [Lauten, Melchior] Univ Hosp Schleswig Holstein, Lubeck, Germany	Ruprecht Karls University Heidelberg; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Medical University of Graz; Medical University of Graz; University of Duisburg Essen; Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital	Spiess, B (corresponding author), Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany.	birgit.spiess@medma.uni-heidelberg.de	Hamprecht, Axel/R-4074-2018; Hoenigl, Martin/E-8802-2010; Lass-Flörl, Cornelia/AAA-8449-2020; Cornely, Oliver A./J-5095-2013	Hamprecht, Axel/0000-0003-1449-5780; Hoenigl, Martin/0000-0002-1653-2824; Cornely, Oliver A./0000-0001-9599-3137; Buchheidt, Dieter/0000-0002-4425-6134; Lass-Florl, Cornelia/0000-0002-2946-7785	German Cancer Aid/Dr. Mildred Scheel Foundation for Cancer Research [109 411]; GILEAD Sciences; Austrian Science Fund (FWF) [I 656, I 661] Funding Source: researchfish	German Cancer Aid/Dr. Mildred Scheel Foundation for Cancer Research; GILEAD Sciences(Gilead Sciences); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The development of the multi-azole resistance PCR assays was supported by a grant of the German Cancer Aid/Dr. Mildred Scheel Foundation for Cancer Research (Project 109 411). An ongoing multicenter prospective clinical study focusing the combined molecular and serologic diagnosis of invasive aspergillosis and multi-azole PCR based detection of cyp51 A alterations in Aspergillus DNA positive clinical samples is supported by a research grant of GILEAD Sciences (ClinicalTrials.gov Identifier: NCT01695512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanio A, 2011, J ANTIMICROB CHEMOTH, V66, P371, DOI 10.1093/jac/dkq450; Bader O, 2013, ANTIMICROB AGENTS CH, V57, P3513, DOI 10.1128/AAC.00167-13; Bueid A, 2010, J ANTIMICROB CHEMOTH, V65, P2116, DOI 10.1093/jac/dkq279; Chowdhary A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052871; Denning DW, 2011, CLIN INFECT DIS, V52, P1123, DOI 10.1093/cid/cir179; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2013, ANT AG BREAKP TABL I; Fischer J, 2014, J ANTIMICROB CH 0131; Garcia-Effron G, 2008, J CLIN MICROBIOL, V46, P1200, DOI 10.1128/JCM.02330-07; Hamprecht A, 2012, EUROSURVEILLANCE, V17, P9; Howard SJ, 2006, INT J ANTIMICROB AG, V28, P450, DOI 10.1016/j.ijantimicag.2006.08.017; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Howard SJ, 2011, MED MYCOL, V49, pS90, DOI 10.3109/13693786.2010.508469; Klaassen CHW, 2010, J ANTIMICROB CHEMOTH, V65, P901, DOI 10.1093/jac/dkq041; Lass-Florl C, 2004, J CLIN MICROBIOL, V42, P4154, DOI 10.1128/JCM.42.9.4154-4157.2004; Lockhart SR, 2011, ANTIMICROB AGENTS CH, V55, P4465, DOI 10.1128/AAC.00185-11; Rodriguez-Tudela JL, 2008, ANTIMICROB AGENTS CH, V52, P2468, DOI 10.1128/AAC.00156-08; Maschmeyer G, 2009, EUR J CANCER, V45, P2462, DOI 10.1016/j.ejca.2009.05.001; Mellado E, 2007, ANTIMICROB AGENTS CH, V51, P1897, DOI 10.1128/AAC.01092-06; Mellado E, 2013, REV IBEROAM MICOL, V30, P64, DOI 10.1016/j.riam.2012.09.002; Morio F, 2012, J ANTIMICROB CHEMOTH, V67, P1870, DOI 10.1093/jac/dks160; Mortensen KL, 2011, J CLIN MICROBIOL, V49, P2243, DOI 10.1128/JCM.00213-11; Rath PM, 2012, ANTIMICROB AGENTS CH, V56, P6060, DOI 10.1128/AAC.01017-12; Reinwald M, 2013, J CLIN MICROBIOL, V51, P4178, DOI 10.1128/JCM.02387-13; Reinwald M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056706; Ruhnke M, 2012, ANN ONCOL, V23, P823, DOI 10.1093/annonc/mdr407; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Skladny H, 1999, J CLIN MICROBIOL, V37, P3865, DOI 10.1128/JCM.37.12.3865-3871.1999; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801; Spiess B, 2012, ANTIMICROB AGENTS CH, V56, P3905, DOI 10.1128/AAC.05902-11; van der Linden JWM, 2013, CLIN INFECT DIS, V57, P513, DOI 10.1093/cid/cit320; van der Linden JWM, 2011, EMERG INFECT DIS, V17, P1846, DOI 10.3201/eid1710.110226; van der Linden JWM, 2010, J CLIN MICROBIOL, V48, P1478, DOI 10.1128/JCM.02221-09; van der Linden JWM, 2009, CLIN INFECT DIS, V48, P1111, DOI 10.1086/597465; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Verweij PE, 2009, DRUG RESIST UPDATE, V12, P141, DOI 10.1016/j.drup.2009.09.002; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258	37	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e103113	10.1371/journal.pone.0103113	http://dx.doi.org/10.1371/journal.pone.0103113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	25072733	Green Published, gold			2022-12-27	WOS:000341307600024
J	Coomans, D; Vandenbossche, J; Homble, K; Van den Bussche, E; Soetens, E; Deroost, N				Coomans, Daphne; Vandenbossche, Jochen; Homble, Koen; Van den Bussche, Eva; Soetens, Eric; Deroost, Natacha			Does Consolidation of Visuospatial Sequence Knowledge Depend on Eye Movements?	PLOS ONE			English	Article							RESPONSE SELECTION; TIME-COURSE; IMPLICIT; SLEEP; DISSOCIATION; MEMORY; STIMULUS	In the current study, we assessed whether visuospatial sequence knowledge is retained over 24 hours and whether this retention is dependent on the occurrence of eye movements. Participants performed two sessions of a serial reaction time (SRT) task in which they had to manually react to the identity of a target letter pair presented in one of four locations around a fixation cross. When the letter pair 'XO' was presented, a left response had to be given, when the letter pair 'OX' was presented, a right response was required. In the Eye Movements (EM) condition, eye movements were necessary to perform the task since the fixation cross and the target were separated by at least 9 degrees visual angle. In the No Eye Movements (NEM) condition, on the other hand, eye movements were minimized by keeping the distance from the fixation cross to the target below 1 degrees visual angle and by limiting the stimulus presentation to 100 ms. Since the target identity changed randomly in both conditions, no manual response sequence was present in the task. However, target location was structured according to a deterministic sequence in both the EM and NEM condition. Learning of the target location sequence was determined at the end of the first session and 24 hours after initial learning. Results indicated that the sequence learning effect in the SRT task diminished, yet remained significant, over the 24 hour interval in both conditions. Importantly, the difference in eye movements had no impact on the transfer of sequence knowledge. These results suggest that the retention of visuospatial sequence knowledge occurs alike, irrespective of whether this knowledge is supported by eye movements or not.	[Coomans, Daphne; Vandenbossche, Jochen; Homble, Koen; Van den Bussche, Eva; Soetens, Eric; Deroost, Natacha] Vrije Univ Brussel, Dept Expt & Appl Psychol, B-1200 Brussels, Belgium	Vrije Universiteit Brussel	Coomans, D (corresponding author), Vrije Univ Brussel, Dept Expt & Appl Psychol, B-1200 Brussels, Belgium.	Daphne.Coomans@vub.ac.be	Van den Bussche, Eva/AFU-0195-2022; Van den Bussche, Eva/E-7977-2010; Deroost, Natacha/E-1738-2013	Van den Bussche, Eva/0000-0003-1894-9380; Deroost, Natacha/0000-0001-8633-9547	Research Foundation - Flanders [FWOTM506]	Research Foundation - Flanders(FWO)	The first author, Daphne Coomans, is a research fellow of the Research Foundation - Flanders (grant FWOTM506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse EL, 2010, PSYCHON B REV, V17, P603, DOI 10.3758/PBR.17.5.603; Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2006, BRAIN RES, V1090, P163, DOI 10.1016/j.brainres.2006.03.076; Albouy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052805; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; Clegg BA, 1998, TRENDS COGN SCI, V2, P275, DOI 10.1016/S1364-6613(98)01202-9; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; Cohen DA, 2007, EXP BRAIN RES, V177, P440, DOI 10.1007/s00221-006-0701-6; Coomans D, 2012, EXP PSYCHOL, V59, P279, DOI 10.1027/1618-3169/a000155; Coomans D, 2011, CONSCIOUS COGN, V20, P1460, DOI 10.1016/j.concog.2011.06.009; Deroost N, 2006, PSYCHOL RES-PSYCH FO, V70, P88, DOI 10.1007/s00426-004-0196-3; Deroost N, 2006, Q J EXP PSYCHOL, V59, P449, DOI 10.1080/17470210500462684; Deroost N, 2006, EXP PSYCHOL, V53, P16, DOI 10.1027/1618-3169.53.1.16; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Fischer S, 2006, J COGNITIVE NEUROSCI, V18, P311, DOI 10.1162/089892906775990598; Genzel L, 2012, PSYCHONEUROENDOCRINO, V37, P987, DOI 10.1016/j.psyneuen.2011.11.006; Hallgato E, 2013, CORTEX, V49, P1073, DOI 10.1016/j.cortex.2012.01.002; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Nattkemper D, 1997, PSYCHOL RES-PSYCH FO, V60, P98, DOI 10.1007/BF00419683; Nemeth D, 2009, NEUROREPORT, V20, P1654, DOI 10.1097/WNR.0b013e328333ba08; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Press DZ, 2005, COGNITIVE BRAIN RES, V25, P375, DOI 10.1016/j.cogbrainres.2005.05.010; Remillard G, 2003, J EXP PSYCHOL LEARN, V29, P581, DOI 10.1037/0278-7393.29.4.581; Remillard G, 2011, PSYCHOL RES-PSYCH FO, V75, P307, DOI 10.1007/s00426-010-0309-0; Remillard G, 2009, J EXP PSYCHOL LEARN, V35, P528, DOI 10.1037/a0014646; Rickard TC, 2008, J EXP PSYCHOL LEARN, V34, P834, DOI 10.1037/0278-7393.34.4.834; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Schneider W., 2002, E PRIME USERS GUIDE; Schwarb H, 2010, MEM COGNITION, V38, P677, DOI 10.3758/MC.38.6.677; Schwarb H, 2009, BRAIN RES, V1247, P114, DOI 10.1016/j.brainres.2008.09.097; Song S, 2008, EXP BRAIN RES, V189, P145, DOI 10.1007/s00221-008-1411-z; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; Willingham DB, 1999, MEM COGNITION, V27, P561, DOI 10.3758/BF03211549; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Witt K, 2010, NEUROSCIENCE, V171, P227, DOI 10.1016/j.neuroscience.2010.07.062; Ziessler M, 2001, J EXP PSYCHOL LEARN, V27, P595, DOI 10.1037/0278-7393.27.3.595; Ziessler M, 1998, J EXP PSYCHOL LEARN, V24, P962, DOI 10.1037/0278-7393.24.4.962	39	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103421	10.1371/journal.pone.0103421	http://dx.doi.org/10.1371/journal.pone.0103421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4GX	25089701	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700024
J	Pustina, D; Doucet, G; Evans, J; Sharan, A; Sperling, M; Skidmore, C; Tracy, J				Pustina, Dorian; Doucet, Gaelle; Evans, James; Sharan, Ashwini; Sperling, Michael; Skidmore, Christopher; Tracy, Joseph			Distinct Types of White Matter Changes Are Observed after Anterior Temporal Lobectomy in Epilepsy	PLOS ONE			English	Article							LOBE EPILEPSY; UNCINATE FASCICULUS; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; LANGUAGE NETWORKS; DIFFUSION; ABNORMALITIES; MEMORY; MRI; ASYMMETRY	Anterior temporal lobectomy (ATL) is commonly adopted to control medically intractable temporal lobe epilepsy (TLE). Depending on the side of resection, the degree to which Wallerian degeneration and adaptive plasticity occur after ATL has important implications for understanding cognitive and clinical outcome. We obtained diffusion tensor imaging from 24 TLE patients (12 left) before and after surgery, and 12 matched controls at comparable time intervals. Voxel-based analyses were performed on fractional anisotropy (FA) before and after surgery. Areas with postoperative FA increase were further investigated to distinguish between genuine plasticity and processes related to the degeneration of crossing fibers. Before surgery, both patient groups showed bilateral reduced FA in numerous tracts, but left TLE patients showed more extensive effects, including language tracts in the contralateral hemisphere (superior longitudinal fasciculus and uncinate). After surgery, FA decreased ipsilaterally in both ATL groups, affecting the fornix, uncinate, stria terminalis, and corpus callosum. FA increased ipsilaterally along the superior corona radiata in both left and right ATL groups, exceeding normal FA values. In these clusters, the mode of anisotropy increased as well, confirming fiber degeneration in an area with crossing fibers. In left ATL patients, pre-existing low FA values in right superior longitudinal and uncinate fasciculi normalized after surgery, while MO values did not change. Preoperative verbal fluency correlated with FA values in all areas that later increased FA in left TLE patients, but postoperative verbal fluency correlated only with FA of the right superior longitudinal fasciculus. Our results demonstrate that genuine reorganization occurs in non-dominant language tracts after dominant hemisphere resection, a process that may help implement the inter-hemispheric shift of language activation found in fMRI studies. The results indicate that left TLE patients, despite showing more initial white matter damage, have the potential for greater adaptive changes postoperatively than right TLE patients.	[Pustina, Dorian; Doucet, Gaelle; Sperling, Michael; Skidmore, Christopher; Tracy, Joseph] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Doucet, Gaelle; Evans, James; Sharan, Ashwini] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Tracy, J (corresponding author), Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA.	joseph.tracy@jefferson.edu	Doucet, Gaelle/H-9367-2019	Doucet, Gaelle/0000-0003-4120-0474; Skidmore, Christopher/0000-0002-9939-4307	National Institute for Neurological Disorders and Stroke (NINDS) [R21 NS056071-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056071] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part, by the National Institute for Neurological Disorders and Stroke (NINDS) [grant number R21 NS056071-01A1] to Dr. Joseph I. Tracy. The remaining funding was provided by other sources of internal organizational support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi ME, 2009, AM J NEURORADIOL, V30, P1740, DOI 10.3174/ajnr.A1650; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Arfanakis K, 2002, MAGN RESON IMAGING, V20, P511, DOI 10.1016/S0730-725X(02)00509-X; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Bonelli SB, 2012, EPILEPSIA, V53, P639, DOI 10.1111/j.1528-1167.2012.03433.x; Cao Y, 2005, IEEE T MED IMAGING, V24, P1216, DOI 10.1109/TMI.2005.853923; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Concha L, 2009, J NEUROL NEUROSUR PS, V80, P312, DOI 10.1136/jnnp.2007.139287; Concha L, 2007, EPILEPSIA, V48, P931, DOI 10.1111/j.1528-1167.2007.01006.x; Diehl B, 2008, EPILEPSIA, V49, P1409, DOI 10.1111/j.1528-1167.2008.01596.x; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Doucet G, 2013, HUM BRAIN MAPP, V34, P2202, DOI 10.1002/hbm.22059; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; Faber J, 2013, EPILEPSIA; Govindan RM, 2008, EPILEPSY RES, V80, P30, DOI 10.1016/j.eplepsyres.2008.03.011; Groeschel S, 2014, NEUROIMAGE, V87, P209, DOI 10.1016/j.neuroimage.2013.10.034; Haberling IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052315; Highley JR, 2002, CEREB CORTEX, V12, P1218, DOI 10.1093/cercor/12.11.1218; Holland SK, 2001, NEUROIMAGE, V14, P837, DOI 10.1006/nimg.2001.0875; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Keller SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046791; Keller SS, 2011, J NEUROIMAGING OFFIC; Kemmotsu N, 2011, EPILEPSIA, V52, P2257, DOI 10.1111/j.1528-1167.2011.03278.x; Kim JH, 2010, J KOREAN NEUROSURG S, V47, P17, DOI 10.3340/jkns.2010.47.1.17; Knake S, 2009, EPILEPTIC DISORD, V11, P244, DOI 10.1684/epd.2009.0272; Liacu D, 2012, J MAGN RESON IMAGING, V36, P561, DOI 10.1002/jmri.23678; Lin JJ, 2008, EPILEPSY RES, V82, P162, DOI 10.1016/j.eplepsyres.2008.07.020; Liu M, 2013, NEUROIMAGE; Liu M, 2012, NEUROIMAGE-CLIN, V1, P99, DOI 10.1016/j.nicl.2012.09.010; Lundgaard I, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001743; Mandl RCW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00817; Mandl RCW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003631; Mao LY, 2011, SEIZURE-EUR J EPILEP, V20, P741, DOI 10.1016/j.seizure.2011.07.002; McDonald CR, 2010, NEUROLOGY, V75, P1631, DOI 10.1212/WNL.0b013e3181fb44db; McDonald CR, 2008, NEUROLOGY, V71, P1869, DOI 10.1212/01.wnl.0000327824.05348.3b; Mori S, 2010, MRI ATLAS HUMAN WHIT; Morrell F, 1999, Adv Neurol, V81, P11; Nguyen D, 2011, EPILEPSY RES; Noppeney U, 2005, BRAIN, V128, P1377, DOI 10.1093/brain/awh414; Nucifora PGP, 2005, NEUROREPORT, V16, P791, DOI 10.1097/00001756-200505310-00002; O'Donnell LJ, 2011, NEUROSURG CLIN N AM, V22, P185, DOI 10.1016/j.nec.2010.12.004; Oguz KK, 2012, AJNR AM J NEURORADIO; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park HJ, 2004, NEUROIMAGE, V23, P213, DOI 10.1016/j.neuroimage.2004.04.036; Powell HWR, 2007, NEUROIMAGE, V36, P209, DOI 10.1016/j.neuroimage.2007.02.028; Reich DS, 2007, NEUROIMAGE, V38, P271, DOI 10.1016/j.neuroimage.2007.07.049; Reijmer YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044074; Rodrigo S, 2007, EUR RADIOL, V17, P1663, DOI 10.1007/s00330-006-0558-x; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Schoene-Bake JC, 2009, NEUROIMAGE, V46, P569, DOI 10.1016/j.neuroimage.2009.03.013; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Shon YM, 2010, EPILEPSIA, V51, P529, DOI 10.1111/j.1528-1167.2009.02327.x; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Spencer S, 2008, LANCET NEUROL, V7, P525, DOI 10.1016/S1474-4422(08)70109-1; SPERLING MR, 1992, NEUROLOGY, V42, P416, DOI 10.1212/WNL.42.2.416; Spreen O., 1977, NEUROSENSORY CTR COM; Tang YY, 2010, P NATL ACAD SCI USA, V107, P15649, DOI 10.1073/pnas.1011043107; Teipel SJ, 2014, J ALZHEIMERS DIS JAD; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Tracy JI, 2007, EPILEPSIA, V48, P2327; Voets NL, 2009, HUM BRAIN MAPP, V30, P4070, DOI 10.1002/hbm.20830; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilke M, 2006, NEUROIMAGE, V33, P522, DOI 10.1016/j.neuroimage.2006.07.010; Winston GP, 2014, NEUROIMAGE-CLIN, V4, P190, DOI 10.1016/j.nicl.2013.12.004; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Wong SWH, 2009, NEUROLOGY, V73, P518, DOI 10.1212/WNL.0b013e3181b2a48e; Yogarajah M, 2010, BRAIN, V133, P2348, DOI 10.1093/brain/awq175	74	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104211	10.1371/journal.pone.0104211	http://dx.doi.org/10.1371/journal.pone.0104211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089698	Green Submitted, gold, Green Published			2022-12-27	WOS:000339812700112
J	Starkhammar, M; Larsson, O; Georen, SK; Leino, M; Dahlen, SE; Adner, M; Cardell, LO				Starkhammar, Magnus; Larsson, Olivia; Georen, Susanna Kumlien; Leino, Marina; Dahlen, Sven-Erik; Adner, Mikael; Cardell, Lars-Olaf			Toll-Like Receptor Ligands LPS and Poly (I:C) Exacerbate Airway Hyperresponsiveness in a Model of Airway Allergy in Mice, Independently of Inflammation	PLOS ONE			English	Article							ASTHMA EXACERBATIONS; SMOOTH-MUSCLE; MOUSE MODEL; BRONCHIAL HYPERRESPONSIVENESS; RESPIRATORY-INFECTIONS; FUNCTIONAL PLASTICITY; INNATE IMMUNITY; RESPONSES; TOLL-LIKE-RECEPTOR-4; RHINOVIRUS	It is well-established that bacterial and viral infections have an exacerbating effect on allergic asthma, particularly aggravating respiratory symptoms, such as airway hyperresponsiveness (AHR). The mechanism by which these infections alter AHR is unclear, but some studies suggest that Toll-like receptors (TLRs) play a role. In this study, we investigated the impact of TLR3 and TLR4 ligands on AHR and airway inflammation in a model of pre-established allergic inflammation. Female BALB/c mice were sensitised and challenged intranasally (i.n.) with either PBS or ovalbumin (OVA) and subsequently i.n. challenged with poly (I:C) (TLR3) or LPS (TLR4) for four consecutive days. The response to methacholine was measured in vivo; cellular and inflammatory mediators were measured in blood, lung tissue and broncheoalveolar lavage fluid (BALF). OVA challenge resulted in an increase in AHR to methacholine, as well as increased airway eosinophilia and TH2 cytokine production. Subsequent challenge with TLR agonists resulted in a significant increase in AHR, but decreased TLR-specific cellular inflammation and production of immune mediators. Particularly evident was a decline in LPS-induced neutrophilia and neutrophil-associated cytokines following LPS and poly (I:C) treatment. The present data indicates that TLRs may play a pivotal role in AHR in response to microbial infection in allergic lung inflammation. These data also demonstrate that aggravated AHR occurs in the absence of an exacerbation in airway inflammation and that allergic inflammation impedes a subsequent inflammatory response to TLRs. These results may parallel clinical signs of microbial asthma exacerbation, including an extended duration of illness and increased respiratory symptoms.	[Starkhammar, Magnus; Larsson, Olivia; Georen, Susanna Kumlien; Leino, Marina; Cardell, Lars-Olaf] Karolinska Inst, CLINTEC, Div ENT Dis, Stockholm, Sweden; [Starkhammar, Magnus; Georen, Susanna Kumlien; Dahlen, Sven-Erik; Adner, Mikael] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Dahlen, Sven-Erik; Adner, Mikael] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Cardell, LO (corresponding author), Karolinska Inst, CLINTEC, Div ENT Dis, Stockholm, Sweden.	lars-olaf.cardell@ki.se		Kumlien Georen, Susanna/0000-0001-7292-9255				Adner M, 2013, EUR J PHARMACOL, V718, P544, DOI 10.1016/j.ejphar.2013.09.004; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bachar O, 2004, EUR J IMMUNOL, V34, P1196, DOI 10.1002/eji.200324569; Bachar O, 2006, AM J PHYSIOL-LUNG C, V291, pL322, DOI 10.1152/ajplung.00141.2006; Balamayooran G, 2010, AM J RESP CELL MOL, V43, P5, DOI 10.1165/rcmb.2009-0047TR; Bjornsson E, 1996, SCAND J INFECT DIS, V28, P63, DOI 10.3109/00365549609027152; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Delayre-Orthez C, 2005, INT ARCH ALLERGY IMM, V138, P298, DOI 10.1159/000088867; Denkers EY, 2003, CHEM IMMUNOL, V83, P95; Duechs MJ, 2011, PULM PHARMACOL THER, V24, P203, DOI 10.1016/j.pupt.2010.12.009; Ekman AK, 2011, EUR J PHARMACOL, V652, P145, DOI 10.1016/j.ejphar.2010.11.009; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fransson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-100; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Habibzay M, 2012, MUCOSAL IMMUNOL, V5, P524, DOI 10.1038/mi.2012.28; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hollingsworth JW, 2005, AM J RESP CRIT CARE, V171, P806, DOI 10.1164/rccm.200407-953OC; Kraft M, 2000, CLIN CHEST MED, V21, P301, DOI 10.1016/S0272-5231(05)70268-9; Krawczyk CM, 2007, J IMMUNOL, V178, P4080, DOI 10.4049/jimmunol.178.7.4080; Kurai D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00293; Kvarnhammar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068701; Luxameechanporn T, 2005, ARCH OTOLARYNGOL, V131, P1001, DOI 10.1001/archotol.131.11.1001; Martin RJ, 2001, AM J RESP CELL MOL, V24, P577, DOI 10.1165/ajrcmb.24.5.4315; Micillo E, 2000, ALLERGY, V55, P42; Morishima H, 2008, INT ARCH ALLERGY IMM, V145, P163, DOI 10.1159/000108141; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Olenec JP, 2010, J ALLERGY CLIN IMMUN, V125, P1001, DOI 10.1016/j.jaci.2010.01.059; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Papadopoulos NG, 2011, ALLERGY, V66, P458, DOI 10.1111/j.1398-9995.2010.02505.x; Rochlitzer S, 2014, CLIN SCI, V126, P55, DOI 10.1042/CS20130174; Rudd BD, 2006, J IMMUNOL, V176, P1937, DOI 10.4049/jimmunol.176.3.1937; Simpson JL, 2008, PAEDIATR RESPIR REV, V9, P263, DOI 10.1016/j.prrv.2008.05.007; Starkhammar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032110; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Sundrud MS, 2003, J IMMUNOL, V171, P3542, DOI 10.4049/jimmunol.171.7.3542; Swedin L, 2009, EUR RESPIR J, V34, P200, DOI 10.1183/09031936.00030908; Swedin L, 2010, INT ARCH ALLERGY IMM, V153, P249, DOI 10.1159/000314365; Wang XR, 2002, J IMMUNOL, V168, P810, DOI 10.4049/jimmunol.168.2.810; Wos M, 2008, AM J RESP CRIT CARE, V177, P1082, DOI 10.1164/rccm.200607-973OC	45	34	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e104114	10.1371/journal.pone.0104114	http://dx.doi.org/10.1371/journal.pone.0104114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25089623	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700100
J	Guerriero, G; Legay, S; Hausman, JF				Guerriero, Gea; Legay, Sylvain; Hausman, Jean-Francois			Alfalfa Cellulose Synthase Gene Expression under Abiotic Stress: A Hitchhiker's Guide to RT-qPCR Normalization	PLOS ONE			English	Article							REAL-TIME PCR; WALL INTEGRITY MAINTENANCE; SUITABLE REFERENCE GENES; PHENOTYPIC PLASTICITY; NORMAL GROWTH; CELL; SELECTION; PLANTS; HEAT; TOLERANCE	Abiotic stress represents a serious threat affecting both plant fitness and productivity. One of the promptest responses that plants trigger following abiotic stress is the differential expression of key genes, which enable to face the adverse conditions. It is accepted and shown that the cell wall senses and broadcasts the stress signal to the interior of the cell, by triggering a cascade of reactions leading to resistance. Therefore the study of wall-related genes is particularly relevant to understand the metabolic remodeling triggered by plants in response to exogenous stresses. Despite the agricultural and economical relevance of alfalfa (Medicago sativa L.), no study, to our knowledge, has addressed specifically the wall-related gene expression changes in response to exogenous stresses in this important crop, by monitoring the dynamics of wall biosynthetic gene expression. We here identify and analyze the expression profiles of nine cellulose synthases, together with other wall-related genes, in stems of alfalfa plants subjected to different abiotic stresses (cold, heat, salt stress) at various time points (e. g. 0, 24, 72 and 96 h). We identify 2 main responses for specific groups of genes, i.e. a salt/heat-induced and a cold/heat-repressed group of genes. Prior to this analysis we identified appropriate reference genes for expression analyses in alfalfa, by evaluating the stability of 10 candidates across different tissues (namely leaves, stems, roots), under the different abiotic stresses and time points chosen. The results obtained confirm an active role played by the cell wall in response to exogenous stimuli and constitute a step forward in delineating the complex pathways regulating the response of plants to abiotic stresses.	[Guerriero, Gea; Legay, Sylvain; Hausman, Jean-Francois] Ctr Rech Publ, Dept Environm & Agrobiotechnol EVA, Gabriel Lippmann, Belvaux, Luxembourg	Luxembourg Institute of Health; Luxembourg Institute of Science & Technology	Guerriero, G (corresponding author), Ctr Rech Publ, Dept Environm & Agrobiotechnol EVA, Gabriel Lippmann, Belvaux, Luxembourg.	guerrier@lippmann.lu	Guerriero, Gea/B-4883-2013; Hausman, Jean-Francois/AAB-6208-2020	Guerriero, Gea/0000-0001-6586-6997; Hausman, Jean-Francois/0000-0001-6103-7817; Legay, Sylvain/0000-0002-2057-7443	Fonds National de la Recherche Luxembourg (FNR) Project [CANCAN C13/SR/5774202]	Fonds National de la Recherche Luxembourg (FNR) Project(Luxembourg National Research Fund)	Financial support was obtained through the Fonds National de la Recherche Luxembourg (FNR) Project CANCAN C13/SR/5774202 and through internal funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Bernal AJ, 2008, PLANT PHYSIOL, V148, P1238, DOI 10.1104/pp.108.121939; Betancur L, 2010, J INTEGR PLANT BIOL, V52, P205, DOI 10.1111/j.1744-7909.2010.00934.x; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carpita NC, 2011, PLANT PHYSIOL, V155, P171, DOI 10.1104/pp.110.163360; Carroll A, 2012, PLANT PHYSIOL, V160, P726, DOI 10.1104/pp.112.199208; Carroll A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00005; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Coello P, 2011, J EXP BOT, V62, P883, DOI 10.1093/jxb/erq331; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Gonzalez-Verdejo CI, 2008, ANAL BIOCHEM, V379, P176, DOI 10.1016/j.ab.2008.05.003; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamann T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00077; Hamann T, 2011, PLANT SIGNAL BEHAV, V6, P1706, DOI 10.4161/psb.6.11.17782; Handakumbura PP, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-131; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Humphrey TV, 2007, NEW PHYTOL, V176, P7, DOI 10.1111/j.1469-8137.2007.02192.x; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Kaushal N, 2013, FUNCT PLANT BIOL, V40, P1334, DOI 10.1071/FP13082; Kumar M, 2009, TRENDS PLANT SCI, V14, P248, DOI 10.1016/j.tplants.2009.02.004; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Li SD, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23179; Lima RB, 2013, CARBOHYD POLYM, V93, P135, DOI 10.1016/j.carbpol.2012.05.015; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Martin RC, 2010, J EXP BOT, V61, P2229, DOI 10.1093/jxb/erq063; Mendu V, 2011, PLANT PHYSIOL, V157, P441, DOI 10.1104/pp.111.179069; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nolan KE, 2006, PLANT CELL REP, V25, P711, DOI 10.1007/s00299-006-0135-4; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Pilling E, 2003, CURR OPIN PLANT BIOL, V6, P611, DOI 10.1016/j.pbi.2003.09.004; Pini F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-78; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; Puijalon S, 2006, AM J BOT, V93, P1090, DOI 10.3732/ajb.93.8.1090; Quiroga M, 2000, PLANT PHYSIOL, V122, P1119, DOI 10.1104/pp.122.4.1119; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sanchez-Aguayo I, 2004, PLANTA, V220, P278, DOI 10.1007/s00425-004-1350-2; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Seifert GJ, 2010, PLANT PHYSIOL, V153, P467, DOI 10.1104/pp.110.153940; Selim M, 2012, PLANT CELL REP, V31, P205, DOI 10.1007/s00299-011-1156-1; Song DL, 2010, NEW PHYTOL, V187, P777, DOI 10.1111/j.1469-8137.2010.03315.x; Sorby LA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-144; Stork J, 2010, PLANT PHYSIOL, V153, P580, DOI 10.1104/pp.110.154062; Sullivan S, 2011, PLANT PHYSIOL, V156, P1725, DOI 10.1104/pp.111.179077; Sultan SE, 2003, EVOL DEV, V5, P25, DOI 10.1046/j.1525-142X.2003.03005.x; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Tesfaye M, 2009, BIOENERG RES, V2, P59, DOI 10.1007/s12155-009-9034-1; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wang W, 2011, J EXP BOT, V62, P5161, DOI 10.1093/jxb/err221; Wolf S, 2012, CURR BIOL, V22, P1732, DOI 10.1016/j.cub.2012.07.036; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yang SS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-323; Yin YB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-99; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhu JH, 2010, PLANT J, V63, P128, DOI 10.1111/j.1365-313X.2010.04227.x	67	37	39	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103808	10.1371/journal.pone.0103808	http://dx.doi.org/10.1371/journal.pone.0103808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084115	gold, Green Submitted, Green Published			2022-12-27	WOS:000339819800083
J	Kirzin, S; Marisa, L; Guimbaud, R; De Reynies, A; Legrain, M; Laurent-Puig, P; Cordelier, P; Pradere, B; Bonnet, D; Meggetto, F; Portier, G; Brousset, P; Selves, J				Kirzin, Sylvain; Marisa, Laetitia; Guimbaud, Rosine; De Reynies, Aurelien; Legrain, Michele; Laurent-Puig, Pierre; Cordelier, Pierre; Pradere, Bernard; Bonnet, Delphine; Meggetto, Fabienne; Portier, Guillaume; Brousset, Pierre; Selves, Janick			Sporadic Early-Onset Colorectal Cancer Is a Specific Sub-Type of Cancer: A Morphological, Molecular and Genetics Study	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; MICROSATELLITE INSTABILITY; OLDER PATIENTS; RECTAL-CANCER; COLON-CANCER; FEATURES; AGE; PATHWAYS; ADENOCARCINOMA; YOUNG	Sporadic early onset colorectal carcinoma (EOCRC) which has by definition no identified hereditary predisposition is a growing problem that remains poorly understood. Molecular analysis could improve identification of distinct sub-types of colorectal cancers (CRC) with therapeutic implications and thus can help establish that sporadic EOCRC is a distinct entity. From 954 patients resected for CRC at our institution, 98 patients were selected. Patients aged 45-60 years were excluded to help define "young" and "old" groups. Thirty-nine cases of sporadic EOCRC (patients <= 45 years with microsatellite stable tumors) were compared to both microsatellite stable tumors from older patients (36 cases, patients>60 years) and to groups of patients with microsatellite instability. Each group was tested for TP53, KRAS, BRAF, PIK3CA mutations and the presence of a methylator phenotype. Gene expression profiles were also used for pathway analysis. Compared to microsatellite stable CRC from old patients, sporadic EOCRC were characterized by distal location, frequent synchronous metastases and infrequent synchronous adenomas but did not have specific morphological characteristics. A familial history of CRC was more common in sporadic EOCRC patients despite a lack of identified hereditary conditions (p = 0.013). Genetic studies also showed the absence of BRAF mutations (p = 0.022) and the methylator phenotype (p = 0.005) in sporadic EOCRC compared to older patients. Gene expression analysis implicated key pathways such as Wnt/beta catenin, MAP Kinase, growth factor signaling (EGFR, HGF, PDGF) and the TNFR1 pathway in sporadic EOCRC. Wnt/beta catenin signaling activation was confirmed by aberrant nuclear beta catenin immunostaining (p = 0.01). This study strongly suggests that sporadic EOCRC is a distinct clinico-molecular entity presenting as a distal and aggressive disease associated with chromosome instability. Furthermore, several signaling pathways including the TNFR1 pathway have been identified as potential biomarkers for both the diagnosis and treatment of this disease.	[Kirzin, Sylvain; Guimbaud, Rosine; Cordelier, Pierre; Meggetto, Fabienne; Brousset, Pierre; Selves, Janick] Univ Toulouse 3, INSERM 1037, Ctr Rech Cancerol Toulouse, Unite Mixte Rech, F-31062 Toulouse, France; [Kirzin, Sylvain; Pradere, Bernard; Portier, Guillaume] Ctr Hosp Univ Toulouse, Dept Surg, Toulouse, France; [Marisa, Laetitia; De Reynies, Aurelien] Ligue Nationale Canc, Cartes Identite Tumeurs Program, Paris, France; [Guimbaud, Rosine; Bonnet, Delphine] Dept Oncol, Toulouse, France; [Legrain, Michele] Hop Univ Hautepierre, Lab Biochim Biol Mol, Strasbourg, France; [Laurent-Puig, Pierre] Univ Paris 05, INSERM, Bases Mol Response Xenobiot, UMR S775, Paris, France; [Brousset, Pierre; Selves, Janick] Ctr Hosp Univ Toulouse, Dept Pathol, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse	Selves, J (corresponding author), Univ Toulouse 3, INSERM 1037, Ctr Rech Cancerol Toulouse, Unite Mixte Rech, F-31062 Toulouse, France.	selves.j@chu-toulouse.fr	Laurent-Puig, Pierre/K-3641-2019; de Reyniès, Aurélien/Q-8640-2017; Cordelier, Pierre/D-1150-2014; Portier, Guillaume/AAI-9411-2021; laurent-puig, pierre/B-2226-2013; Selves, Janick/M-7719-2014; GUIMBAUD, Rosine/M-7503-2014; MEGGETTO, Fabienne/M-1976-2015	Laurent-Puig, Pierre/0000-0001-8475-5459; de Reyniès, Aurélien/0000-0002-1328-5290; Cordelier, Pierre/0000-0003-2096-7967; Portier, Guillaume/0000-0002-1764-8677; laurent-puig, pierre/0000-0001-8475-5459; BONNET, Delphine/0000-0002-8108-0852	Ligue Regionale Contre le Cancer, Comite du Gers; program Carte d'Identite des Tumeurs from Ligue Nationale Contre le Cancer; Institut National Contre le Cancer	Ligue Regionale Contre le Cancer, Comite du Gers; program Carte d'Identite des Tumeurs from Ligue Nationale Contre le Cancer; Institut National Contre le Cancer	This work was supported by a grant from Ligue Regionale Contre le Cancer, Comite du Gers and the program Carte d'Identite des Tumeurs from Ligue Nationale Contre le Cancer. The authors thank the Institut National Contre le Cancer for their support of the clinical and laboratory geneticist. The authors thank Canceropole Grand Sud-Ouest for providing clinical annotations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1994, CANCER RES, V54, P1645; Agesen TH, 2011, GENES IMMUN, V12, P653, DOI 10.1038/gene.2011.43; Alsop K, 2006, EUR J CANCER, V42, P1357, DOI 10.1016/j.ejca.2006.02.023; Antelo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045357; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Benjamini YH, J ROYAL STAT SOC B, V57, P289; Berg M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013978; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Chang DT, 2012, MODERN PATHOL, V25, P1128, DOI 10.1038/modpathol.2012.61; Chiang JM, 2003, DIS COLON RECTUM, V46, P904, DOI 10.1007/s10350-004-6683-1; Cicek MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038175; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Fairley TL, 2006, CANCER, V107, P1153, DOI 10.1002/cncr.22012; Glaab E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-597; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Goel A, 2010, GASTROENTEROLOGY, V138, P1854, DOI 10.1053/j.gastro.2010.01.035; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; HEIMANN TM, 1989, DIS COLON RECTUM, V32, P473, DOI 10.1007/BF02554500; Hill DA, 2007, J CLIN ONCOL, V25, P5808, DOI 10.1200/JCO.2007.12.6102; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Howlader N, 2012, SEER CANC STAT REV 1; INCA, 2011, POL ASS MUT BIALL GE; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 1999, J CLIN PATHOL, V52, P455, DOI 10.1136/jcp.52.6.455; Kim H, 2004, ONCOGENE, V23, P6218, DOI 10.1038/sj.onc.1207853; Kumar K, 2009, CLIN CANCER RES, V15, P1155, DOI 10.1158/1078-0432.CCR-08-1029; Laurent-Puig P, 2012, J CLIN ONCOL, V30, P1550, DOI 10.1200/JCO.2011.40.1190; Liang JT, 2003, BRIT J SURG, V90, P205, DOI 10.1002/bjs.4015; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Maurel J, 1998, GASTROEN CLIN BIOL, V22, pS90; Mitry E, 2001, DIS COLON RECTUM, V44, P380, DOI 10.1007/BF02234737; Nam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031685; O'Connell JB, 2004, DIS COLON RECTUM, V47, P2064, DOI 10.1007/s10350-004-0738-1; Onizawa M, 2009, AM J PHYSIOL-GASTR L, V296, pG850, DOI 10.1152/ajpgi.00071.2008; Parramore JB, 1998, AM SURGEON, V64, P563; Perea J, 2010, WORLD J GASTROENTERO, V16, P3697, DOI 10.3748/wjg.v16.i29.3697; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Samowitz WS, 2001, GASTROENTEROLOGY, V121, P830, DOI 10.1053/gast.2001.27996; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Siegel RL, 2009, CANCER EPIDEM BIOMAR, V18, P1695, DOI 10.1158/1055-9965.EPI-09-0186; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Varma J R, 1990, J Am Board Fam Pract, V3, P54; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b	48	84	84	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103159	10.1371/journal.pone.0103159	http://dx.doi.org/10.1371/journal.pone.0103159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25083765	Green Published, Green Submitted, gold			2022-12-27	WOS:000339819800020
J	Penumutchu, SR; Chou, RH; Yu, C				Penumutchu, Srinivasa R.; Chou, Ruey-Hwang; Yu, Chin			Structural Insights into Calcium-Bound S100P and the V Domain of the RAGE Complex	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; PROTEIN-PROTEIN INTERACTIONS; PANCREATIC-CANCER GROWTH; CELL-SURFACE RECEPTOR; LARGER PROTEINS; SEQUENTIAL ASSIGNMENT; IMPROVED SENSITIVITY; SIGNAL-TRANSDUCTION; CYTOPLASMIC DOMAIN; NEURITE OUTGROWTH	The S100P protein is a member of the S100 family of calcium-binding proteins and possesses both intracellular and extracellular functions. Extracellular S100P binds to the cell surface receptor for advanced glycation end products (RAGE) and activates its downstream signaling cascade to meditate tumor growth, drug resistance and metastasis. Preventing the formation of this S100P-RAGE complex is an effective strategy to treat various disease conditions. Despite its importance, the detailed structural characterization of the S100P-RAGE complex has not yet been reported. In this study, we report that S100P preferentially binds to the V domain of RAGE. Furthermore, we characterized the interactions between the RAGE V domain and Ca2+-bound S100P using various biophysical techniques, including isothermal titration calorimetry (ITC), fluorescence spectroscopy, multidimensional NMR spectroscopy, functional assays and site-directed mutagenesis. The entropy-driven binding between the V domain of RAGE and Ca+2-bound S100P was found to lie in the micromolar range (K-d of similar to 6 mu M). NMR data-driven HADDOCK modeling revealed the putative sites that interact to yield a proposed heterotetrameric model of the S100P-RAGE V domain complex. Our study on the spatial structural information of the proposed protein-protein complex has pharmaceutical relevance and will significantly contribute toward drug development for the prevention of RAGE-related multifarious diseases.	[Penumutchu, Srinivasa R.; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Yu, Chin] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Xiamen University	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan.	cyu.nthu@gmail.com	Chou, Ruey-Hwang/K-8541-2013; Penumutchu, Srinivasa/U-4699-2018	Chou, Ruey-Hwang/0000-0002-2297-2180; Penumutchu, Srinivasa/0000-0002-3608-1442	National Science Council (NSC), Taiwan [NSC 100-2113-M-007-012-MY3]; China Medical University, Taiwan [CMU101-N2-04]	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University)	The authors acknowledge financial support from the National Science Council (NSC), Taiwan (Grant number NSC 100-2113-M-007-012-MY3 to Chin Yu), and from China Medical University, Taiwan (Grant number CMU101-N2-04 to Ruey-Hwang Chou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt Y, 2007, CHEMMEDCHEM, V2, P1648, DOI 10.1002/cmdc.200700096; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Arumugam T, 2006, J NATL CANCER I, V98, P1806, DOI 10.1093/jnci/djj498; Arumugam T, 2013, MOL CANCER THER, V12, P654, DOI 10.1158/1535-7163.MCT-12-0771; Arumugam T, 2012, CLIN CANCER RES, V18, P4356, DOI 10.1158/1078-0432.CCR-12-0221; Arumugam T, 2011, AMINO ACIDS, V41, P893, DOI 10.1007/s00726-010-0496-4; Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Clore GM, 2003, J AM CHEM SOC, V125, P2902, DOI 10.1021/ja028893d; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Fuentes MK, 2007, DIS COLON RECTUM, V50, P1230, DOI 10.1007/s10350-006-0850-5; Gospodarska E, 2011, BBA-PROTEINS PROTEOM, V1814, P592, DOI 10.1016/j.bbapap.2011.02.011; Gribenko AV, 1998, J MOL BIOL, V283, P679, DOI 10.1006/jmbi.1998.2116; Gribenko AV, 2002, PROTEIN SCI, V11, P1367, DOI 10.1110/ps.0202202; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Heil A, 2011, J BIOL CHEM, V286, P7227, DOI 10.1074/jbc.M110.135095; Heizmann C. W., 2007, V45, P93; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hsieh HL, 2004, BIOCHEM BIOPH RES CO, V316, P949, DOI 10.1016/j.bbrc.2004.02.135; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Hung KW, 2012, J BIOMOL NMR, V54, P211, DOI 10.1007/s10858-012-9661-2; Hunter CA, 2003, CHEM BIOL, V10, P1023, DOI 10.1016/j.chembiol.2003.10.009; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KNELLER DG, 1993, J CELL BIOCHEM, P254; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LANE AN, 1994, METHOD ENZYMOL, V239, P596; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Markowitz J, 2004, J MED CHEM, V47, P5085, DOI 10.1021/jm0497038; McInnes C, 2000, PROTEIN ENG, V13, P143, DOI 10.1093/protein/13.3.143; Mohan SK, 2013, BIOCHEM BIOPH RES CO, V434, P328, DOI 10.1016/j.bbrc.2013.03.049; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Penumutchu SR, 2013, BIOMOL NMR ASSIGN, V7, P5, DOI 10.1007/s12104-012-9365-2; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; RAMAN CS, 1995, BIOCHEMISTRY-US, V34, P5831, DOI 10.1021/bi00017a015; Rehbein G, 2008, INT J MOL MED, V22, P69; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Riehl A, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-12; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Shekhtman A, 2001, J MOL BIOL, V314, P129, DOI 10.1006/jmbi.2001.5126; Shishibori T, 1999, BIOCHEM J, V338, P583, DOI 10.1042/0264-6021:3380583; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Tutar Y, 2006, PROTEIN PEPTIDE LETT, V13, P307, DOI 10.2174/092986606775338380; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Wafer LN, 2013, BIOCHEMISTRY-US, V52, P5844, DOI 10.1021/bi400788s; Walters KJ, 1999, P NATL ACAD SCI USA, V96, P7877, DOI 10.1073/pnas.96.14.7877; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xu D, 2013, ACS CHEM BIOL, V8, P1611, DOI 10.1021/cb4001553; Yan SF, 2009, J MOL MED, V87, P235, DOI 10.1007/s00109-009-0439-2; Zhang HM, 2003, J MOL BIOL, V325, P785, DOI 10.1016/S0022-2836(02)01278-0; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297; Zong HL, 2010, J BIOL CHEM, V285, P23135, DOI 10.1074/jbc.M110.133827	88	34	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103947	10.1371/journal.pone.0103947	http://dx.doi.org/10.1371/journal.pone.0103947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084534	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800108
J	Rugelj, D; Gomiscek, G; Sevsek, F				Rugelj, Darja; Gomiscek, Gregor; Sevsek, France			The Influence of Very Low Illumination on the Postural Sway of Young and Elderly Adults	PLOS ONE			English	Article							BODY SWAY; SENSORIMOTOR INTEGRATION; HEALTHY-YOUNG; AGE; STABILITY; STEADINESS; VISION; RELIABILITY; ORIENTATION; ADAPTATION	The purpose of the present study was to evaluate the influence of very low ambient illumination and complete darkness on the postural sway of young and elderly adults. Eighteen healthy young participants aged 23.8 +/- 1.5 years and 26 community-dwelling elderly aged 69.8 +/- 5.6 years were studied. Each participant performed four tests while standing on a force platform in the following conditions: in normal light (215 lx) with open eyes and with closed eyes, in very low illumination (0.25 lx) with open eyes, and in complete darkness with open eyes. The sequences of the tests in the altered visual conditions were determined by random blocs. Postural sway was assessed by means of the force platform measurements. The centre of pressure variables: the medio-lateral and antero-posterior path lengths, mean velocities, sway areas, and fractal dimensions were analysed. Very low illumination resulted in a statistically significant increase in postural sway in both the young and elderly groups compared to normal light, although the increase was significantly smaller than those observed in the eyes closed and complete darkness condition, and no significant effects of illumination on fractal dimensions were detected. The gains of the sways in the very low or no illumination conditions relative to the normal light condition were significantly larger in the group of young participants than in the group of elderly participants (up to 50% and 25%, respectively). However, the response patterns to changes in illumination were similar in the young and elderly participants, with the exception of the short-range fractal dimension of the medio-lateral sway. In conclusion, very low illumination resulted in increased postural sway compared to normal illumination; however, in the closed eye and complete darkness conditions, postural sway was significantly higher than in the very low illumination condition regardless of the age of the participants.	[Rugelj, Darja; Gomiscek, Gregor; Sevsek, France] Univ Ljubljana, Fac Hlth Sci, Biomech Lab, Ljubljana, Slovenia; [Gomiscek, Gregor] Univ Ljubljana, Fac Med, Inst Biophys, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Rugelj, D (corresponding author), Univ Ljubljana, Fac Hlth Sci, Biomech Lab, Ljubljana, Slovenia.	darja.rugelj@zf.uni-lj.si			Faculty of Health Sciences at University of Ljubljana	Faculty of Health Sciences at University of Ljubljana	No external sources of funding were received. The trial was supported by the existing resources of the Faculty of Health Sciences at University of Ljubljana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchard Y, 2007, GAIT POSTURE, V26, P442, DOI 10.1016/j.gaitpost.2006.10.009; Brooke-Wavell K, 2002, GERONTOLOGY, V48, P293, DOI 10.1159/000065252; Brouwer B, 1998, SCAND J REHABIL MED, V30, P131; Doyle Tim L A, 2004, Int J Med Sci, V1, P11; EDWARDS AS, 1946, J EXP PSYCHOL, V36, P526, DOI 10.1037/h0059909; Figueiro MG, 2008, LIGHTING RES TECHNOL, V40, P111, DOI 10.1177/1477153507084198; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P173, DOI 10.1113/jphysiol.1994.sp020240; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Jackson GR, 1999, VISION RES, V39, P3975, DOI 10.1016/S0042-6989(99)00092-9; Johnson EG, 2012, J GERIATR PHYS THER, V35, P15, DOI 10.1519/JPT.0b013e31821cb0ed; Kim J, 2012, INT J PRECIS ENG MAN, V13, P969, DOI 10.1007/s12541-012-0126-z; Kim S, 2008, J BIOMECH, V41, P406, DOI 10.1016/j.jbiomech.2007.08.011; Kinsella-Shaw JM, 2006, J MOTOR BEHAV, V38, P251, DOI 10.3200/JMBR.38.4.251-264; KOLLEGGER H, 1992, EUR NEUROL, V32, P253, DOI 10.1159/000116836; Lanska DJ, 2002, SEMIN NEUROL, V22, P409, DOI 10.1055/s-2002-36763; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Lord SR, 2000, GERONTOLOGY, V46, P306, DOI 10.1159/000022182; LORD SR, 1994, AGE AGEING, V23, P452, DOI 10.1093/ageing/23.6.452; Lord SR, 2001, J AM GERIATR SOC, V49, P508, DOI 10.1046/j.1532-5415.2001.49107.x; Marucchi C, 1987, Agressologie, V28, P947; Massion J, 2004, PROG BRAIN RES, V143, P13, DOI 10.1016/S0079-6123(03)43002-1; Moe-Nilssen R, 2006, J MOTOR BEHAV, V38, P118, DOI 10.3200/JMBR.38.2.118-125; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Poulain I, 2008, GAIT POSTURE, V27, P1, DOI 10.1016/j.gaitpost.2007.02.007; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Rougier P, 2003, NEUROSCI RES, V47, P73, DOI 10.1016/S0168-0102(03)00187-1; Rugelj Darja, 2007, WSEAS Transactions on Signal Processing, V3, P213; Rugelj D, 2011, APPL ERGON, V42, P860, DOI 10.1016/j.apergo.2011.02.002; Santos BR, 2008, GAIT POSTURE, V27, P408, DOI 10.1016/j.gaitpost.2007.05.008; Sevsek F, 2004, COMPUT METH PROG BIO, V73, P189, DOI 10.1016/S0169-2607(03)00065-8; Sevsek F, 2009, STAB V 1 0; Sevsek F, 2011, 23 C INT SOC BIOM BR, P174; SIMONEAU GG, 1992, J GERONTOL, V47, pM151, DOI 10.1093/geronj/47.5.M151; Sozzi S, 2011, HUM MOVEMENT SCI, V30, P172, DOI 10.1016/j.humov.2010.06.002; Springer Barbara A, 2007, J Geriatr Phys Ther, V30, P8; Stambolieva K, 2001, J PHYSIOL SCI, V61, P123; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; TIPTON DA, 1984, AVIAT SPACE ENVIR MD, V55, P145; Wang Z, 2012, EXP BRAIN RES, V222, P333, DOI 10.1007/s00221-012-3212-7	43	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103903	10.1371/journal.pone.0103903	http://dx.doi.org/10.1371/journal.pone.0103903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084015	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800102
J	Sun, C; VanRaden, PM; Cole, JB; O'Connell, JR				Sun, Chuanyu; VanRaden, Paul M.; Cole, John B.; O'Connell, Jeffrey R.			Improvement of Prediction Ability for Genomic Selection of Dairy Cattle by Including Dominance Effects	PLOS ONE			English	Article							BREEDING VALUE PREDICTION; MILK-PRODUCTION TRAITS; VARIANCE; INFORMATION; PEDIGREE; VALUES; YIELD; REGRESSION; HEALTH; PLANT	Dominance may be an important source of non-additive genetic variance for many traits of dairy cattle. However, nearly all prediction models for dairy cattle have included only additive effects because of the limited number of cows with both genotypes and phenotypes. The role of dominance in the Holstein and Jersey breeds was investigated for eight traits: milk, fat, and protein yields; productive life; daughter pregnancy rate; somatic cell score; fat percent and protein percent. Additive and dominance variance components were estimated and then used to estimate additive and dominance effects of single nucleotide polymorphisms (SNPs). The predictive abilities of three models with both additive and dominance effects and a model with additive effects only were assessed using ten-fold cross-validation. One procedure estimated dominance values, and another estimated dominance deviations; calculation of the dominance relationship matrix was different for the two methods. The third approach enlarged the dataset by including cows with genotype probabilities derived using genotyped ancestors. For yield traits, dominance variance accounted for 5 and 7% of total variance for Holsteins and Jerseys, respectively; using dominance deviations resulted in smaller dominance and larger additive variance estimates. For non-yield traits, dominance variances were very small for both breeds. For yield traits, including additive and dominance effects fit the data better than including only additive effects; average correlations between estimated genetic effects and phenotypes showed that prediction accuracy increased when both effects rather than just additive effects were included. No corresponding gains in prediction ability were found for non-yield traits. Including cows with derived genotype probabilities from genotyped ancestors did not improve prediction accuracy. The largest additive effects were located on chromosome 14 near DGAT1 for yield traits for both breeds; those SNPs also showed the largest dominance effects for fat yield (both breeds) as well as for Holstein milk yield.	[Sun, Chuanyu] Natl Assoc Anim Breeders, Columbia, MO USA; [VanRaden, Paul M.; Cole, John B.] USDA, Agr Res Serv, Anim Genom & Improvement Lab, Beltsville, MD USA; [O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland Baltimore	Sun, C (corresponding author), Natl Assoc Anim Breeders, Columbia, MO USA.	Chuanyu.Sun@ars.usda.gov	Cole, John B./J-8571-2014	Cole, John B./0000-0003-1242-4401	National Association of Animal Breeders, United States of America; Animal Improvement Programs Laboratory of Agricultural research service in the United States Department of Agriculture; ARS [ARS-0423282] Funding Source: Federal RePORTER	National Association of Animal Breeders, United States of America; Animal Improvement Programs Laboratory of Agricultural research service in the United States Department of Agriculture; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work was performed in the project funded regularly by National Association of Animal Breeders, United States of America (http://www.naab-css.org/) and Animal Improvement Programs Laboratory of Agricultural research service in the United States Department of Agriculture (http://aipl.arsusda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWELL MS, 2002, P 7 WORLD C GEN APPL, V31, P123; Boysen TJ, 2013, GENETICS, V193, P431, DOI 10.1534/genetics.112.144535; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; *CTR BIOINF COMP B, 2013, BOS TAUR ASS; Da Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087666; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Duangjinda M, 2001, J ANIM SCI, V79, P2997; Forni S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-1; Freyer G, 2003, J DAIRY SCI, V86, P999, DOI 10.3168/jds.S0022-0302(03)73683-2; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; Gengler N, 1998, J ANIM SCI, V76, P2515; Gengler N, 1997, J ANIM SCI, V75, P2885; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; HOESCHELE I, 1991, J DAIRY SCI, V74, P1743, DOI 10.3168/jds.S0022-0302(91)78337-9; *INT CORP, 2013, 630813061 INT CORP; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Misztal I, 1997, J DAIRY SCI, V80, P965, DOI 10.3168/jds.S0022-0302(97)76021-1; O'Connell J., 2013, MMAP USER GUIDE; OCONNELL JR, 2008, 58 ANN M AM SOC HUM; *R COR TEAM, 2012, R 2 15 1 WIND 32 64; Spelman RJ, 1996, GENETICS, V144, P1799; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; Sun C, 2013, J DAIRY SCI, V96, P8014, DOI 10.3168/jds.2013-6969; Van Tassell CP, 2000, J DAIRY SCI, V83, P1873, DOI 10.3168/jds.S0022-0302(00)75059-4; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; VanRaden P.M., 2011, FINDHAP F90; VANRADEN RM, 2006, P 8 WORLD C GEN APPL; Vitezica ZG, 2013, GENETICS, V195, P1223, DOI 10.1534/genetics.113.155176; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolc A, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-5	38	57	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103934	10.1371/journal.pone.0103934	http://dx.doi.org/10.1371/journal.pone.0103934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25084281	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800105
J	Boltong, A; Aranda, S; Keast, R; Wynne, R; Francis, PA; Chirgwin, J; Gough, K				Boltong, Anna; Aranda, Sanchia; Keast, Russell; Wynne, Rochelle; Francis, Prudence A.; Chirgwin, Jacqueline; Gough, Karla			A Prospective Cohort Study of the Effects of Adjuvant Breast Cancer Chemotherapy on Taste Function, Food Liking, Appetite and Associated Nutritional Outcomes	PLOS ONE			English	Article							PERCEPTION; HEDONICS; FLAVOR; NAUSEA	Background: 'Taste' changes are commonly reported during chemotherapy. It is unclear to what extent this relates to actual changes in taste function or to changes in appetite and food liking and how these changes affect dietary intake and nutritional status. Patients and methods: This prospective, repeated measures cohort study recruited participants from three oncology clinics. Women (n = 52) prescribed adjuvant chemotherapy underwent standardised testing of taste perception, appetite and food liking at six time points to measure change from baseline. Associations between taste and hedonic changes and nutritional outcomes were examined. Results: Taste function was significantly reduced early in chemotherapy cycles (p<0.05) but showed recovery by late in the cycle. Ability to correctly identify salty, sour and umami tastants was reduced. Liking of sweet food decreased early and mid-cycle (p<0.01) but not late cycle. Liking of savory food was not significantly affected. Appetite decreased early in the cycle (p<0.001). Reduced taste function was associated with lowest kilojoule intake (r = 0.31; p = 0.008) as was appetite loss with reduced kilojoule (r = 0.34; p = 0.002) and protein intake (r = 0.36; p = 0.001) early in the third chemotherapy cycle. Decreased appetite early in the third and final chemotherapy cycles was associated with a decline in BMI (p = <0.0005) over the study period. Resolution of taste function, food liking and appetite was observed 8 weeks after chemotherapy completion. There was no association between taste change and dry mouth, oral mucositis or nausea. Conclusion: The results reveal, for the first time, the cyclical yet transient effects of adjuvant chemotherapy on taste function and the link between taste and hedonic changes, dietary intake and nutritional outcomes. The results should be used to inform reliable pre-chemotherapy education.	[Boltong, Anna] Canc Council Victoria, Melbourne, Vic, Australia; [Aranda, Sanchia] Canc Inst NSW, Eveleigh, NSW, Australia; [Aranda, Sanchia; Gough, Karla] Peter MacCallum Canc Ctr, Dept Canc Experiences Res, East Melbourne, Vic, Australia; [Aranda, Sanchia; Wynne, Rochelle] Univ Melbourne, Melbourne Sch Hlth Sci, Carlton, Vic 3053, Australia; [Keast, Russell] Deakin Univ, Ctr Phys Act & Nutr Res, Burwood, Vic, Australia; [Francis, Prudence A.] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia; [Chirgwin, Jacqueline] Eastern Hlth, Melbourne, Vic, Australia	Cancer Council Victoria; Peter Maccallum Cancer Center; University of Melbourne; Deakin University; Peter Maccallum Cancer Center	Boltong, A (corresponding author), Canc Council Victoria, Melbourne, Vic, Australia.	anna.boltong@cancervic.org.au	Wynne, Rochelle/AAC-8333-2019; Francis, Prudence A/J-4003-2012; Wynne, Rochelle M/G-6984-2017; Aranda, Sanchia/ABC-3840-2021; Keast, Russell S/P-1899-2017	Wynne, Rochelle/0000-0003-1814-3416; Francis, Prudence A/0000-0002-7207-9286; Wynne, Rochelle M/0000-0003-1814-3416; Keast, Russell S/0000-0003-2147-7687; Gough, Karla/0000-0003-2819-4217; Aranda, Sanchia/0000-0003-4170-9799	Victorian Cancer Agency [SCS08Resub_04_Boltong]	Victorian Cancer Agency	The contribution by first author Dr. Boltong was funded by a Victorian Cancer Agency Supportive Care in Cancer PhD Scholarship (SCS08Resub_04_Boltong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer J, 2002, EUR J CLIN NUTR, V56, P779, DOI 10.1038/sj.ejcn.1601412; Bernhardson BM, 2007, J PAIN SYMPTOM MANAG, V34, P403, DOI 10.1016/j.jpainsymman.2006.12.010; Bernhardson Britt-Marie, 2003, Evid Based Nurs, V6, P62, DOI 10.1136/ebn.6.2.62; Blundell J., 1979, NUTR LIFESTYLES APPL, P21; BOAKES RA, 1993, EUR J CANCER, V29A, P866, DOI 10.1016/S0959-8049(05)80427-7; Boltong A, 2011, CANCER FORUM, V35, P81; Boltong A, 2012, SUPPORT CARE CANCER, V20, P2765, DOI 10.1007/s00520-012-1398-7; Boltong A, 2012, CANCER TREAT REV, V38, P152, DOI 10.1016/j.ctrv.2011.04.008; Breslin PAS, 2008, CURR BIOL, V18, pR148, DOI 10.1016/j.cub.2007.12.017; COHEN J, 1988, APPL PSYCH MEAS, V12, P425, DOI 10.1177/014662168801200410; Doty RL, 2008, DRUG SAFETY, V31, P199, DOI 10.2165/00002018-200831030-00002; Garcia-Granero M, 2011, 2 PROPORTIONS TEST R; HEASMAN KZ, 1985, BREAST CANCER RES TR, V5, P195, DOI 10.1007/BF01805994; International Organization for Standardization, 2011, 39722011 ISO; Knight KRG, 2005, J CLIN ONCOL, V23, P8588, DOI 10.1200/JCO.2004.00.5355; McQuestion M, 2011, EUR J ONCOL NURS, V15, P145, DOI 10.1016/j.ejon.2010.07.006; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ottery F, 2000, CLIN GUIDE ONCOLOGY, P11; PERYAM DR, 1957, FOOD TECHNOL-CHICAGO, V11, P32; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013; Schiffman SS, 2007, J NUTR HEALTH AGING, V11, P439; Schiffman SS, 2000, EUR J CLIN NUTR, V54, pS54, DOI 10.1038/sj.ejcn.1601026; Schiffman SS, 2007, P NUTR SOC, V66, P331, DOI 10.1017/S0029665107005599; Schwartz MD, 1996, PHYSIOL BEHAV, V59, P659, DOI 10.1016/0031-9384(95)02096-9; Steinbach S, 2009, J CLIN ONCOL, V27, P1899, DOI 10.1200/JCO.2008.19.2690; TRANT AS, 1982, AM J CLIN NUTR, V36, P45, DOI 10.1093/ajcn/36.1.45; Zabernigg A, 2010, ONCOLOGIST, V15, P913, DOI 10.1634/theoncologist.2009-0333	29	71	74	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103512	10.1371/journal.pone.0103512	http://dx.doi.org/10.1371/journal.pone.0103512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078776	Green Published, gold, Green Submitted			2022-12-27	WOS:000339954800052
J	Dasgupta, S; Castro, LM; Dulman, R; Yang, CY; Schmidt, M; Ferro, ES; Fricker, LD				Dasgupta, Sayani; Castro, Leandro M.; Dulman, Russell; Yang, Ciyu; Schmidt, Marion; Ferro, Emer S.; Fricker, Lloyd D.			Proteasome Inhibitors Alter Levels of Intracellular Peptides in HEK293T and SH-SY5Y Cells	PLOS ONE			English	Article							THIMET OLIGOPEPTIDASE; NATURAL REGULATORS; DEGRADATION; AMINOPEPTIDASE; GENERATION; PEPTIDOMICS; SPECIFICITY; PROTECTION; PRODUCTS; PROTEINS	The proteasome cleaves intracellular proteins into peptides. Earlier studies found that treatment of human embryonic kidney 293T (HEK293T) cells with epoxomicin (an irreversible proteasome inhibitor) generally caused a decrease in levels of intracellular peptides. However, bortezomib (an antitumor drug and proteasome inhibitor) caused an unexpected increase in the levels of most intracellular peptides in HEK293T and SH-SY5Y cells. To address this apparent paradox, quantitative peptidomics was used to study the effect of a variety of other proteasome inhibitors on peptide levels in HEK293T and SH-SY5Y cells. Inhibitors tested included carfilzomib, MG132, MG262, MLN2238, AM114, and clasto-Lactacystin beta-lactone. Only MG262 caused a substantial elevation in peptide levels that was comparable to the effect of bortezomib, although carfilzomib and MLN2238 elevated the levels of some peptides. To explore off-target effects, the proteosome inhibitors were tested with various cellular peptidases. Bortezomib did not inhibit tripeptidyl peptidase 2 and only weakly inhibited cellular aminopeptidase activity, as did some of the other proteasome inhibitors. However, potent inhibitors of tripeptidyl peptidase 2 (butabindide) and cellular aminopeptidases (bestatin) did not substantially alter the peptidome, indicating that the increase in peptide levels due to proteasome inhibitors is not a result of peptidase inhibition. Although we cannot exclude other possibilities, we presume that the paradoxical increase in peptide levels upon treatment with bortezomib and other inhibitors is the result of allosteric effects of these compounds on the proteasome. Because intracellular peptides are likely to be functional, it is possible that some of the physiologic effects of bortezomib and carfilzomib arise from the perturbation of peptide levels inside the cell.	[Dasgupta, Sayani; Dulman, Russell; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Castro, Leandro M.; Ferro, Emer S.] Univ Sao Paulo, Inst Biomed Sci, Support Ctr Res Proteolysis & Cell Signaling, Dept Pharmacol, Sao Paulo, Brazil; [Yang, Ciyu; Schmidt, Marion] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Universidade de Sao Paulo; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	lloyd.fricker@einstein.yu.edu	Ferro, Emer S/D-3908-2012; Castro, Leandro/ABI-5520-2020; Castro, Leandro/O-6762-2019	Ferro, Emer S/0000-0003-1651-9192; Castro, Leandro/0000-0002-7156-2006; Castro, Leandro/0000-0002-7156-2006; Dasgupta, Sayani/0000-0003-4782-7956; Dulman, Russell/0000-0003-2899-7984	National Institutes of Health [R01-DA-004494, R01-GM-43601]; CNPq; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health R01-DA-004494 (LDF) and National Institutes of Health R01-GM-43601 (MS). ESF is funded by a CNPq research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Beck P, 2012, BIOL CHEM, V393, P1101, DOI 10.1515/hsz-2012-0212; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Berti DA, 2012, PROTEOMICS, V12, P2668, DOI 10.1002/pmic.201200051; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; Dange T, 2011, J BIOL CHEM, V286, P42830, DOI 10.1074/jbc.M111.300178; de Araujo CB, 2014, J BIOL CHEM; Ferro ES, 2004, J NEUROCHEM, V91, P769, DOI 10.1111/j.1471-4159.2004.02757.x; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; Gaedicke S, 2002, CANCER RES, V62, P6901; Garcia-Medel N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011486; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Gelman JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053263; Gelman JS, 2012, METHODS MOL BIOL, V829, P487, DOI 10.1007/978-1-61779-458-2_31; Gelman JS, 2011, J PROTEOME RES, V10, P1583, DOI 10.1021/pr100952f; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Kessler BM, 2002, MOL IMMUNOL, V39, P171, DOI 10.1016/S0161-5890(02)00100-1; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lightcap ES, 2000, CLIN CHEM, V46, P673; Lyons P. J., 2011, CURRENT PROTOCOLS PR; Marcilla M, 2008, EUR J IMMUNOL, V38, P631, DOI 10.1002/eji.200737444; Marcilla M, 2007, MOL CELL PROTEOMICS, V6, P923, DOI 10.1074/mcp.M600302-MCP200; Milner E, 2013, MOL CELL PROTEOMICS, V12, P1853, DOI 10.1074/mcp.M112.026013; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Moravec RA, 2009, ANAL BIOCHEM, V387, P294, DOI 10.1016/j.ab.2009.01.016; Nolte WM, 2009, BIOCHEMISTRY-US, V48, P11971, DOI 10.1021/bi901637c; Nussbaum AK, 1998, P NATL ACAD SCI USA, V95, P12504, DOI 10.1073/pnas.95.21.12504; Ostrowska H, 1997, BIOCHEM BIOPH RES CO, V234, P729, DOI 10.1006/bbrc.1997.6434; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rubinstein M, 2009, BIOPOLYMERS, V91, P505, DOI 10.1002/bip.21164; Russo LC, 2012, PROTEOMICS, V12, P2641, DOI 10.1002/pmic.201200032; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Smulski PA, 2009, STRUCTURE, V17, P1137, DOI 10.1016/j.str.2009.06.011; Tagore DM, 2009, NAT CHEM BIOL, V5, P23, DOI 10.1038/nchembio.126; Towne CF, 2005, J IMMUNOL, V175, P6605, DOI 10.4049/jimmunol.175.10.6605; Towne CF, 2008, J IMMUNOL, V180, P1704, DOI 10.4049/jimmunol.180.3.1704; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x	52	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103604	10.1371/journal.pone.0103604	http://dx.doi.org/10.1371/journal.pone.0103604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079948	Green Submitted, gold, Green Published			2022-12-27	WOS:000339954800059
J	Skowronki, K; Andrews, J; Rodenhiser, DI; Coomber, BL				Skowronki, Karolina; Andrews, Joseph; Rodenhiser, David I.; Coomber, Brenda L.			Genome-Wide Analysis in Human Colorectal Cancer Cells Reveals Ischemia-Mediated Expression of Motility Genes via DNA Hypomethylation	PLOS ONE			English	Article							CPG-BINDING-PROTEIN; PLASMINOGEN-ACTIVATOR; PROSTATE-CANCER; THERAPEUTIC IMPLICATIONS; CHROMOSOMAL INSTABILITY; RECEPTOR EXPRESSION; GASTRIC-CANCER; BREAST-CANCER; TUMOR HYPOXIA; METHYLATION	DNA hypomethylation is an important epigenetic modification found to occur in many different cancer types, leading to the upregulation of previously silenced genes and loss of genomic stability. We previously demonstrated that hypoxia and hypoglycaemia (ischemia), two common micro-environmental changes in solid tumours, decrease DNA methylation through the downregulation of DNMTs in human colorectal cancer cells. Here, we utilized a genome-wide cross-platform approach to identify genes hypomethylated and upregulated by ischemia. Following exposure to hypoxia or hypoglycaemia, methylated DNA from human colorectal cancer cells (HCT116) was immunoprecipitated and analysed with an Affymetrix promoter array. Additionally, RNA was isolated and analysed in parallel with an Affymetrix expression array. Ingenuity pathway analysis software revealed that a significant proportion of the genes hypomethylated and upregulated were involved in cellular movement, including PLAUR and CYR61. A Matrigel invasion assay revealed that indeed HCT116 cells grown in hypoxic or hypoglycaemic conditions have increased mobility capabilities. Confirmation of upregulated expression of cellular movement genes was performed with qPCR. The correlation between ischemia and metastasis is well established in cancer progression, but the molecular mechanisms responsible for this common observation have not been clearly identified. Our novel data suggests that hypoxia and hypoglycaemia may be driving changes in DNA methylation through downregulation of DNMTs. This is the first report to our knowledge that provides an explanation for the increased metastatic potential seen in ischemic cells; i.e. that ischemia could be driving DNA hypomethylation and increasing expression of cellular movement genes.	[Skowronki, Karolina; Coomber, Brenda L.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Andrews, Joseph; Rodenhiser, David I.] Univ Western Ontario, Dept Biochem, London Reg Canc Ctr, London, ON, Canada; [Andrews, Joseph; Rodenhiser, David I.] Univ Western Ontario, Dept Oncol, London Reg Canc Ctr, London, ON, Canada; [Andrews, Joseph; Rodenhiser, David I.] Univ Western Ontario, Dept Paediat, London Reg Canc Ctr, London, ON, Canada; [Andrews, Joseph; Rodenhiser, David I.] Childrens Hlth Res Inst, London, ON, Canada	University of Guelph; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Coomber, BL (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	bcoomber@uoguelph.ca			Canadian Cancer Society Research Institute [020094]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was funded by a Research Grant # 020094 to BLC and DR from the Canadian Cancer Society Research Institute (http://www.cancer.ca/research/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman WM, 2001, P NATL ACAD SCI USA, V98, P2538, DOI 10.1073/pnas.041603298; Andrews J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008665; Avni R, 2011, NMR BIOMED, V24, P569, DOI 10.1002/nbm.1632; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Buechler P, 2009, NEOPLASIA, V11, P196, DOI 10.1593/neo.08734; Cui HM, 2002, CANCER RES, V62, P6442; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Eskandarpour M, 2009, INT J CANCER, V124, P16, DOI 10.1002/ijc.23876; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FEINBERG AP, 1988, CANCER RES, V48, P1159; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; Fromigue O, 2011, J BONE MINER RES, V26, P1533, DOI 10.1002/jbmr.343; Fyles A, 2002, J CLIN ONCOL, V20, P680, DOI 10.1200/JCO.2002.20.3.680; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Graham CH, 1999, INT J CANCER, V80, P617, DOI 10.1002/(SICI)1097-0215(19990209)80:4<617::AID-IJC22>3.0.CO;2-C; Gravina GL, 2013, ONCOL REP, V29, P1189, DOI 10.3892/or.2012.2192; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Guo YJ, 2002, J BIOL CHEM, V277, P41571, DOI 10.1074/jbc.M201864200; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Herath NI, 2010, INT J CANCER, V126, P2003, DOI 10.1002/ijc.25147; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Horiuchi A, 2012, INT J CANC; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jung EJ, 2005, ANTICANCER RES, V25, P2105; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; Kim KH, 2006, WORLD J GASTROENTERO, V12, P5651, DOI 10.3748/wjg.v12.i35.5651; Kita Y, 2009, EJSO-EUR J SURG ONC, V35, P52, DOI 10.1016/j.ejso.2008.01.025; Klein R, 2012, REPROD FERT DEVELOP, V24, P482, DOI 10.1071/RD10335; Krishnamachary B, 2003, CANCER RES, V63, P1138; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Kwon OH, 2011, BIOCHEM BIOPH RES CO, V406, P539, DOI 10.1016/j.bbrc.2011.02.082; Laner T, 2005, ONCOL RES, V15, P257, DOI 10.3727/096504005776404607; Leone G, 2002, HAEMATOLOGICA, V87, P1324; Liu J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-261; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Pakneshan P, 2005, CURR CANCER DRUG TAR, V5, P471, DOI 10.2174/156800905774574011; Phipps KD, 2011, CANCER RES, V71, P6676, DOI 10.1158/0008-5472.CAN-11-1748; PYKE C, 1995, CANCER RES, V55, P4132; Rabbani S A, 2001, Surg Oncol Clin N Am, V10, P393; Raghunand N, 2003, BRIT J RADIOL, V76, pS11, DOI 10.1259/bjr/12913493; Roschke AV, 2002, NEOPLASIA, V4, P19, DOI 10.1038/sj.neo.7900197; Shahrzad S, 2007, EPIGENETICS-US, V2, P119, DOI 10.4161/epi.2.2.4613; Shimozaki K, 2005, J NEUROCHEM, V93, P432, DOI 10.1111/j.1471-4159.2005.03031.x; Skowronski K, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12400; Snyder BN, 2011, EUR J CELL BIOL, V90, P376, DOI 10.1016/j.ejcb.2010.11.016; Subarsky P, 2003, CLIN EXP METASTAS, V20, P237, DOI 10.1023/A:1022939318102; Suzuki S, 1998, GUT, V43, P798, DOI 10.1136/gut.43.6.798; Takeuchi T, 2011, INT J EXP PATHOL, V92, P79, DOI 10.1111/j.1365-2613.2010.00740.x; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Xiao J, 2004, WORLD J GASTROENTERO, V10, P1849; Xie JJ, 2011, INT J MOL MED, V27, P429, DOI 10.3892/ijmm.2011.603; Yanagawa N, 2011, ANTICANCER RES, V31, P171; Yonemura Y, 2000, CLIN CANCER RES, V6, P4234	62	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103243	10.1371/journal.pone.0103243	http://dx.doi.org/10.1371/journal.pone.0103243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079072	gold, Green Published, Green Submitted			2022-12-27	WOS:000339954800034
J	Sohn, H; Kim, B; Kim, KH; Kim, MK; Choi, TK; Lee, SH				Sohn, Hoyoung; Kim, Borah; Kim, Keun Hyang; Kim, Min-Kyoung; Choi, Tai Kiu; Lee, Sang-Hyuk			Effects of VRK2 (rs2312147) on White Matter Connectivity in Patients with Schizophrenia	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COGNITIVE IMPAIRMENT; CONFERRING RISK; COMMON VARIANTS; 1ST-EPISODE; HYPOXIA; SUSCEPTIBILITY; PERFORMANCE; APOPTOSIS	Recent genome-wide association studies of schizophrenia reported a novel risk variant, rs2312147 at vaccinia-related kinase 2 gene (VRK2), in multiple Asian and European samples. However, its effect on the brain structure in schizophrenia is little known. We analyzed the brain structure of 36 schizophrenia patients and 18 healthy subjects with regard to rs2312147 genotype groups. Brain magnetic resonance scans for gray matter (GM) and white matter (WM) analysis, and genotype analysis for VRK2 rs2312147, were conducted. The Positive and Negative Syndrome Scale and the Digit Symbol Test were assessed for schizophrenia patients. There was no significant difference in either GM volume or WM connectivity with regard to rs2312147 genotype in healthy subjects. In contrast, we found significant differences in the WM connectivity between rs2312147 CC and CT/TT genotype groups of schizophrenia patients. The related brain areas included the splenium of corpus callosum, the left occipital lobe WM, the internal capsule (left anterior limb and right retrolenticular part), the bilateral temporal lobe WM, the left fornix/stria terminalis, the left cingulate gyrus WM, and the left parietal lobe WM. Voxelwise correlation analysis revealed that the Digit Symbol Test scores (age corrected) correlated with the fractional anisotropy in WM tracts that previously showed significant group differences between the CT/TT and CC genotypes in the rs2312147 CT/TT genotype group, while no significant correlation was found in the CC genotype group. Our data may provide evidence for the effect of VRK2 on WM connectivity in patients with schizophrenia.	[Sohn, Hoyoung; Kim, Borah; Kim, Keun Hyang; Kim, Min-Kyoung; Choi, Tai Kiu; Lee, Sang-Hyuk] CHA Univ, CHA Bundang Med Ctr, Dept Psychiat, Songnam, Gyeonggi Do, South Korea	Pochon Cha University	Lee, SH (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Psychiat, Songnam, Gyeonggi Do, South Korea.	leesanghyuk@yahoo.com		Sohn, Hoyoung/0000-0002-1856-8636				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Burdick KE, 2010, AM J PSYCHIAT, V167, P436, DOI 10.1176/appi.ajp.2009.09050615; Chabchoub E, 2008, J MED GENET, V45, P189, DOI 10.1136/jmg.2007.056176; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; Dickinson D, 2008, BRIT J PSYCHIAT, V193, P354, DOI 10.1192/bjp.bp.108.049387; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Dong ZH, 2005, MOL BRAIN RES, V134, P282, DOI 10.1016/j.molbrainres.2004.10.039; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; First M. B., 1997, STRUCTURED CLIN INTE; Friedman JI, 2008, AM J PSYCHIAT, V165, P1024, DOI 10.1176/appi.ajp.2008.07101640; Gasso P, 2014, J PSYCHIATR RES, V48, P94, DOI 10.1016/j.jpsychires.2013.09.017; Gibbons LE, 2012, BRAIN IMAGING BEHAV, V6, P517, DOI 10.1007/s11682-012-9176-1; Gonzalez-Blanch C, 2011, ARCH CLIN NEUROPSYCH, V26, P48, DOI 10.1093/arclin/acq086; Han DH, 2008, J PSYCHIATR RES, V42, P399, DOI 10.1016/j.jpsychires.2007.03.002; Hoyer WJ, 2004, PSYCHOL AGING, V19, P211, DOI 10.1037/0882-7974.19.1.211; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Knochel C, 2012, SCHIZOPHR RES, V140, P129, DOI 10.1016/j.schres.2012.06.001; Li LY, 2006, J GEN VIROL, V87, P2869, DOI 10.1099/vir.0.81953-0; Li M, 2012, SCHIZOPHR RES, V142, P200, DOI 10.1016/j.schres.2012.10.008; Rodriguez-Sanchez JM, 2007, BRIT J PSYCHIAT, V191, pS107, DOI 10.1192/bjp.191.51.s107; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Peled S, 2006, MAGN RESON IMAGING, V24, P1263, DOI 10.1016/j.mri.2006.07.009; Price G, 2005, J NEUROL NEUROSUR PS, V76, P585, DOI 10.1136/jnnp.2004.042952; Prontera P, 2011, AM J MED GENET A, V155A, P2473, DOI 10.1002/ajmg.a.33875; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rajcan-Separovic E, 2007, J MED GENET, V44, P269, DOI 10.1136/jmg.2006.045013; Rietschel M, 2012, MOL PSYCHIATR, V17, P906, DOI 10.1038/mp.2011.80; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Schmidt-Kastner R, 2012, MOL PSYCHIATR, V17, P1194, DOI 10.1038/mp.2011.183; Schmidt-Kastner R, 2006, SCHIZOPHR RES, V84, P253, DOI 10.1016/j.schres.2006.02.022; Shirts BH, 2006, SCHIZOPHR RES, V88, P235, DOI 10.1016/j.schres.2006.06.037; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steffens M, 2012, HUM MOL GENET, V21, P5359, DOI 10.1093/hmg/dds373; Steinberg S, 2011, HUM MOL GENET, V20, P4076, DOI 10.1093/hmg/ddr325; Strange A, 2012, BIOL PSYCHIAT, V72, P620, DOI 10.1016/j.biopsych.2012.05.035; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Usui N, 2009, NEUROSCI LETT, V463, P1, DOI 10.1016/j.neulet.2009.07.048; Wechsler D., 1981, WAIS R WECHSLER ADUL; WILLIAMS H, 2011, TLS TIMES LIT S 0114, P16; Yu HJ, 2012, NEUROIMAGE, V59, P3713, DOI 10.1016/j.neuroimage.2011.10.053; Yum TH, 1992, MANUAL KOREAN WECHSL	52	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103519	10.1371/journal.pone.0103519	http://dx.doi.org/10.1371/journal.pone.0103519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25079070	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800054
J	Tomescu, C; Liu, Q; Ross, BN; Yin, XF; Lynn, K; Mounzer, KC; Kostman, JR; Montaner, LJ				Tomescu, Costin; Liu, Qin; Ross, Brian N.; Yin, Xiangfan; Lynn, Kenneth; Mounzer, Karam C.; Kostman, Jay R.; Montaner, Luis J.			A Correlate of HIV-1 Control Consisting of Both Innate and Adaptive Immune Parameters Best Predicts Viral Load by Multivariable Analysis in HIV-1 Infected Viremic Controllers and Chronically-Infected Non-Controllers	PLOS ONE			English	Article							NATURAL-KILLER-CELL; PLASMACYTOID DENDRITIC CELLS; LONG-TERM NONPROGRESSORS; ELITE CONTROLLERS; HLA-B; ACCESSORY CELLS; T-CELLS; REPLICATION CAPACITY; PERFORIN EXPRESSION; TYPE-1 REPLICATION	HIV-1 infected viremic controllers maintain durable viral suppression below 2000 copies viral RNA/ml without anti-retroviral therapy (ART), and the immunological factor(s) associated with host control in presence of low but detectable viral replication are of considerable interest. Here, we utilized a multivariable analysis to identify which innate and adaptive immune parameters best correlated with viral control utilizing a cohort of viremic controllers (median 704 viral RNA/ml) and non-controllers (median 21,932 viral RNA/ml) that were matched for similar CD4(+) T cell counts in the absence of ART. We observed that HIV-1 Gag-specific CD8(+) T cell responses were preferentially targeted over Pol-specific responses in viremic controllers (p = 0.0137), while Pol-specific responses were positively associated with viral load (rho = 0.7753, p = 0.0001, n = 23). Viremic controllers exhibited significantly higher NK and plasmacytoid dendritic cells (pDC) frequency as well as retained expression of the NK CD16 receptor and strong target cell-induced NK cell IFN-gamma production compared to non-controllers (p<0.05). Despite differences in innate and adaptive immune function however, both viremic controllers (p<0.05) and non-controller subjects (p<0.001) exhibited significantly increased CD8(+) T cell activation and spontaneous NK cell degranulation compared to uninfected donors. Overall, we identified that a combination of innate (pDC frequency) and adaptive (Pol-specific CD8(+) T cell responses) immune parameters best predicted viral load (R-2 = 0.5864, p = 0.0021, n = 17) by a multivariable analysis. Together, this data indicates that preferential Gag-specific over Pol-specific CD8(+) T cell responses along with a retention of functional innate subsets best predict host control over viral replication in HIV-1 infected viremic controllers compared to chronically-infected non-controllers.	[Tomescu, Costin; Ross, Brian N.; Montaner, Luis J.] Wistar Inst Anat & Biol, HIV Immunopathogenesis Lab, Philadelphia, PA 19104 USA; [Liu, Qin; Yin, Xiangfan] Wistar Inst Anat & Biol, Biostat Lab, Philadelphia, PA 19104 USA; [Lynn, Kenneth; Kostman, Jay R.] UPENN Presbyterian Med Ctr, Philadelphia, PA USA; [Mounzer, Karam C.] Philadelphia FIGHT, Jonathan Lax Treatment Ctr, Philadelphia, PA USA	The Wistar Institute; The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Presbyterian Medical Center	Montaner, LJ (corresponding author), Wistar Inst Anat & Biol, HIV Immunopathogenesis Lab, 3601 Spruce St, Philadelphia, PA 19104 USA.	Montaner@wistar.org			National Institutes of Health [R21 AI078870, NIDA R01 DA028775, R01 AI073219, RO1 AI065279, P30 CA10815]; Philadelphia Foundation; Pennsylvania Commonwealth Universal Research Enhancement Program; Cancer Center Support Grant (CCSG) [CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078870, R01AI073219, P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philadelphia Foundation; Pennsylvania Commonwealth Universal Research Enhancement Program; Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from the National Institutes of Health (R21 AI078870, NIDA R01 DA028775, R01 AI073219, RO1 AI065279, Core grant P30 CA10815), the Philadelphia Foundation, and funds from the Pennsylvania Commonwealth Universal Research Enhancement Program. Support for Shared Resources utilized in this study was provided by Cancer Center Support Grant (CCSG) CA010815 to The Wistar Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alter G, 2004, J IMMUNOL, V173, P5305, DOI 10.4049/jimmunol.173.8.5305; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2007, J INFECT DIS, V195, P1452, DOI 10.1086/513878; Autran B, 2011, CURR OPIN HIV AIDS, V6, P181, DOI 10.1097/COH.0b013e328345a328; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; BANDYOPADHYAY S, 1986, J EXP MED, V164, P180, DOI 10.1084/jem.164.1.180; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Brown KN, 2007, J IMMUNOL, V178, P6958, DOI 10.4049/jimmunol.178.11.6958; Brown KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000413; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Buzon MJ, 2011, J VIROL, V85, P9646, DOI 10.1128/JVI.05327-11; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Costello C, 1999, AIDS, V13, P1990, DOI 10.1097/00002030-199910010-00031; Dave B, 2012, APPL IMMUNOHISTO M M, V20, P566, DOI 10.1097/PAI.0b013e318251d8a4; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; den Uyl D, 2004, AIDS REV, V6, P89; Eller MA, 2009, JAIDS-J ACQ IMM DEF, V51, P380, DOI 10.1097/QAI.0b013e3181aa256e; Emu B, 2008, J VIROL, V207, P61; FELDMAN M, 1992, J LEUKOCYTE BIOL, V52, P473, DOI 10.1002/jlb.52.5.473; FITZGERALDBOCARSLY P, 1989, J IMMUNOL, V143, P1318; Freeman CM, 2009, AM J RESP CRIT CARE, V180, P1179, DOI 10.1164/rccm.200904-0552OC; Granier C, 2013, J VIROL, V87, P10368, DOI 10.1128/JVI.01313-13; Hatzakis A, 2001, J INTERF CYTOK RES, V21, P861, DOI 10.1089/107999001753238114; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Huff Bob, 2005, GMHC Treat Issues, V19, P12; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Kamya P, 2011, J VIROL, V85, P5949, DOI 10.1128/JVI.02652-10; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Landau A, 2000, AIDS, V14, P96, DOI 10.1097/00002030-200001070-00016; Lehmann C, 2014, J INFECT DIS, V209, P940, DOI 10.1093/infdis/jit612; Long BR, 2008, J VIROL, V82, P4785, DOI 10.1128/JVI.02449-07; Lopez-Vazquez A, 2005, HUM IMMUNOL, V66, P285, DOI 10.1016/j.humimm.2005.01.001; Machmach K, 2012, J VIROL, V86, P4245, DOI 10.1128/JVI.07114-11; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; McNeil AJ, 1996, QJM-INT J MED, V89, P177; Migueles SA, 2003, J VIROL, V77, P6889, DOI 10.1128/JVI.77.12.6889-6898.2003; Miura T, 2009, J VIROL, V83, P3407, DOI 10.1128/JVI.02459-08; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; O'Connell KA, 2009, J VIROL, V83, P5028, DOI 10.1128/JVI.02551-08; OH SH, 1987, J IMMUNOL, V139, P2799; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Papasavvas E, 2004, PLOS MED, V1, P218, DOI 10.1371/journal.pmed.0010064; Papasavvas E, 2010, AIDS RES HUM RETROV, V26, P1047, DOI 10.1089/aid.2010.0020; Payne RP, 2010, J VIROL, V84, P10543, DOI 10.1128/JVI.00793-10; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; PERUSSIA B, 1985, Natural Immunity and Cell Growth Regulation, V4, P120; Portales P, 2003, AIDS, V17, P495, DOI 10.1097/00002030-200303070-00004; Portales P, 2003, AIDS, V17, P505, DOI 10.1097/00002030-200303070-00005; Reeves RK, 2012, J INFECT DIS, V206, P1462, DOI 10.1093/infdis/jis408; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; SIRIANNI MC, 1994, EUR J IMMUNOL, V24, P1874, DOI 10.1002/eji.1830240824; Tomescu C, 2007, J IMMUNOL, V179, P2097, DOI 10.4049/jimmunol.179.4.2097; Tomescu C, 2012, AIDS, V26, P1869, DOI 10.1097/QAD.0b013e32835861b0; Tomescu C, 2010, AIDS, V24, P2151, DOI 10.1097/QAD.0b013e32833dfc20; Tomescu C, 2009, J LEUKOCYTE BIOL, V85, P871, DOI 10.1189/jlb.1008635; Vieillard V, 2010, JAIDS-J ACQ IMM DEF, V53, P564, DOI 10.1097/QAI.0b013e3181d0c5b4; Walker BD, 2007, TOP HIV MED, V15, P134	71	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103209	10.1371/journal.pone.0103209	http://dx.doi.org/10.1371/journal.pone.0103209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	25078947	gold, Green Submitted, Green Published			2022-12-27	WOS:000339954800033
J	Li, JH; Yang, YJ; Li, BW; Li, WJ; Wang, G; Knops, JMH				Li, Jin Hua; Yang, Yu Jie; Li, Bo Wen; Li, Wen Jin; Wang, Gang; Knops, Johannes M. H.			Effects of Nitrogen and Phosphorus Fertilization on Soil Carbon Fractions in Alpine Meadows on the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; ORGANIC-CARBON; GRASSLAND SOILS; STORAGE; MINERALIZATION; SEQUESTRATION; BIODIVERSITY; DEPOSITION; ABUNDANCE; BIOMASS	In grassland ecosystems, N and P fertilization often increase plant productivity, but there is no concensus if fertilization affects soil C fractions. We tested effects of N, P and N+P fertilization at 5, 10, 15 g m(-2) yr(-1) (N-5, N-10, N-15, P-5, P-10, P-15, N5P5, N10P10, and N15P15) compared to unfertilized control on soil C, soil microbial biomass and functional diversity at the 0-20 cm and 20-40 cm depth in an alpine meadow after 5 years of continuous fertilization. Fertilization increased total aboveground biomass of community and grass but decreased legume and forb biomass compared to no fertilization. All fertilization treatments decreased the C:N ratios of legumes and roots compared to control, however fertilization at rates of 5 and 15 g m(-2) yr(-1) decreased the C:N ratios of the grasses. Compared to the control, soil microbial biomass C increased in N-5, N-10, P-5, and P-10 in 0-20 cm, and increased in N-10 and P-5 while decreased in other treatments in 20-40 cm. Most of the fertilization treatments decreased the respiratory quotient (qCO(2)) in 0-20 cm but increased qCO(2) in 20-40 cm. Fertilization increased soil microbial functional diversity (except N-15) but decreased cumulative C mineralization (except in N-15 in 0-20 cm and N-5 in 20-40 cm). Soil organic C (SOC) decreased in P-5 and P-15 in 0-20 cm and for most of the fertilization treatments (except N15P15) in 20-40 cm. Overall, these results suggested that soils will not be a C sink (except N15P15). Nitrogen and phosphorus fertilization may lower the SOC pool by altering the plant biomass composition, especially the C:N ratios of different plant functional groups, and modifying C substrate utilization patterns of soil microbial communities. The N+P fertilization at 15 g m(-2) yr(-1) may be used in increasing plant aboveground biomass and soil C accumulation under these meadows.	[Li, Jin Hua; Yang, Yu Jie; Li, Bo Wen; Li, Wen Jin; Wang, Gang] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China; [Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA	Lanzhou University; University of Nebraska System; University of Nebraska Lincoln	Li, JH (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China.	lijinhuap@sohu.com	Knops, Johannes/AAA-8546-2020		New Century Excellent Talents in University [NCET-11-0210]; Fundamental Research Funds for the Central Universities [LZUJBKY-2013-K12]; National Natural Science Foundation of China [30871823]	New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Program for New Century Excellent Talents in University (NCET-11-0210), the Fundamental Research Funds for the Central Universities (LZUJBKY-2013-K12) and National Natural Science Foundation of China (No. 30871823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2013, ECOLOGY, V94, P714, DOI 10.1890/12-1243.1; ANDERSON TH, 1990, SOIL BIOL BIOCHEM, V22, P251, DOI 10.1016/0038-0717(90)90094-G; [白洁冰 BAI Jiebing], 2011, [生态环境学报, Ecology and Environmental Sciences], V20, P855; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Biudes MS, 2012, SOIL SCI SOC AM J, V76, P2068, DOI 10.2136/sssaj2012.0101n; Bradford MA, 2008, GLOBAL CHANGE BIOL, V14, P1113, DOI 10.1111/j.1365-2486.2008.01564.x; Bradley K, 2006, SOIL BIOL BIOCHEM, V38, P1583, DOI 10.1016/j.soilbio.2005.11.011; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Chen LY, 2010, THESIS LANZHOU U; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Fornara DA, 2013, GLOBAL CHANGE BIOL, V19, P3848, DOI 10.1111/gcb.12323; Fornara DA, 2012, ECOLOGY, V93, P2030, DOI 10.1890/12-0292.1; Garland JL, 1996, SOIL BIOL BIOCHEM, V28, P213, DOI 10.1016/0038-0717(95)00112-3; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Gong Z., 2014, CHINESE SOIL GEOGRAP; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Insam H, 1997, MICROBIAL COMMUNITIES, P259; Isbell F, 2013, ECOL LETT, V16, P454, DOI 10.1111/ele.12066; KALEMBASA SJ, 1973, J SCI FOOD AGR, V24, P1085, DOI 10.1002/jsfa.2740240910; Keeler BL, 2009, ECOSYSTEMS, V12, P1, DOI 10.1007/s10021-008-9199-z; Koyama A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077212; Li JH, 2012, ENVIRON MANAGE, V50, P1193, DOI 10.1007/s00267-012-9958-7; Li LJ, 2010, BIOL FERT SOILS, V46, P653, DOI 10.1007/s00374-010-0463-y; Li Ying-chen, 2010, Shengtaixue Zazhi, V29, P2091; Liu K, 2009, J ENVIRON QUAL, V38, P2267, DOI 10.2134/jeq2008.0387; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; LOVELL RD, 1995, SOIL BIOL BIOCHEM, V27, P969, DOI 10.1016/0038-0717(94)00241-R; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Malhi SS, 2003, NUTR CYCL AGROECOSYS, V66, P33, DOI 10.1023/A:1023376905096; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Qi R, 2013, THESIS LANZHOU U; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ren ZW, 2010, J PLANT ECOL, V3, P25, DOI 10.1093/jpe/rtp034; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Song MH, 2010, EUR J SOIL BIOL, V46, P375, DOI 10.1016/j.ejsobi.2010.09.003; Stapleton LM, 2005, SOIL BIOL BIOCHEM, V37, P2088, DOI 10.1016/j.soilbio.2005.03.016; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vourlitis GL, 2007, BIOL FERT SOILS, V43, P611, DOI 10.1007/s00374-006-0137-y; Vourlitis GL, 2009, ECOSYSTEMS, V12, P473, DOI 10.1007/s10021-009-9236-6; Wang GX, 2002, SCI TOTAL ENVIRON, V291, P207, DOI 10.1016/S0048-9697(01)01100-7; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wedin DA, 1996, SCIENCE, V274, P1720, DOI 10.1126/science.274.5293.1720; Xin XJ, 2011, THESIS LANZHOU U; [杨红飞 YANG Hongfei], 2011, [中国草地学报, Chinese Journal of Grassland], V33, P107; Zhang CB, 2010, ECOL ENG, V36, P62, DOI 10.1016/j.ecoleng.2009.09.010; [张金霞 Zhang Jinxia], 2003, [生态学报, Acta Ecologica Sinica], V23, P627; Zhang RY, 2011, POL J ECOL, V59, P105	52	22	28	19	180	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103266	10.1371/journal.pone.0103266	http://dx.doi.org/10.1371/journal.pone.0103266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075624	gold, Green Published			2022-12-27	WOS:000340028800033
J	Pisano, F; Heine, W; Rosenheinrich, M; Schweer, J; Nuss, AM; Dersch, P				Pisano, Fabio; Heine, Wiebke; Rosenheinrich, Maik; Schweer, Janina; Nuss, Aaron M.; Dersch, Petra			Influence of PhoP and Intra-Species Variations on Virulence of Yersinia pseudotuberculosis during the Natural Oral Infection Route	PLOS ONE			English	Article							RESPONSE REGULATOR PHOP; INVASIN EXPRESSION; IMMUNE-RESPONSE; OUTER PROTEINS; PESTIS; ENTEROCOLITICA; MACROPHAGES; SURVIVAL; SYSTEMS; HOST	The two-component regulatory system PhoP/PhoQ has been shown to (i) control expression of virulence-associated traits, (ii) confer survival and growth within macrophages and (iii) play a role in Yersinia infections. However, the influence of PhoP on virulence varied greatly between different murine models of infection and its role in natural oral infections with frequently used representative isolates of Y. pseudotuberculosis was unknown. To address this issue, we constructed an isogenic set of phoP(+) and phoP-2 variants of strain IP32953 and YPIII and analyzed the impact of PhoP using in vitro functionality experiments and a murine oral infection model, whereby we tested for bacterial dissemination and influence on the host immune response. Our results revealed that PhoP has a low impact on virulence, lymphatic and systemic organ colonization, and on immune response modulation by IP32953 and YPIII, indicating that PhoP is not absolutely essential for oral infections but may be involved in fine-tuning the outcome. Our work further revealed certain strain-specific differences in virulence properties, which do not strongly rely on the function of PhoP, but affect tissue colonization, dissemination and/or persistence of the bacteria. Highlighted intra-species variations may provide a potential means to rapidly adjust to environmental changes inside and outside of the host.	[Pisano, Fabio; Heine, Wiebke; Rosenheinrich, Maik; Schweer, Janina; Nuss, Aaron M.; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Dersch, P (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Germany.	petra.dersch@helmholtz-hzi.de			Deutsche Forschungsgemeinschaft [DE616/4-2 (SPP1316)]; President's Initiative and Network Fund of the Helmholtz Association of German Research Centres (HGF) [VH-GS-202]; DFG [IRTG1273]; Deutsche Zentrum fur Infektionsforschung (DZIF); Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); President's Initiative and Network Fund of the Helmholtz Association of German Research Centres (HGF); DFG(German Research Foundation (DFG)); Deutsche Zentrum fur Infektionsforschung (DZIF); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft Grants DE616/4-2 (SPP1316) for AN, a stipend of the President's Initiative and Network Fund of the Helmholtz Association of German Research Centres (HGF) (VH-GS-202) for WH, a stipend of the DFG funded IRTG1273, the Deutsche Zentrum fur Infektionsforschung (DZIF) for FP and PD, and the Fonds der Chemischen Industrie for PD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RD, 2004, BIOTECHNIQUES, V36, P982, DOI 10.2144/04366ST03; AUTENRIETH IB, 1993, IMMUNOBIOLOGY, V187, P1; AUTENRIETH IB, 1992, INFECT IMMUN, V60, P1140, DOI 10.1128/IAI.60.3.1140-1149.1992; Balada-Llasat JM, 2006, PLOS PATHOG, V2, P816, DOI 10.1371/journal.ppat.0020086; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Bergman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000573; Bliska JB, 2013, CELL MICROBIOL, V15, P1622, DOI 10.1111/cmi.12164; BOLIN I, 1982, INFECT IMMUN, V37, P506; Bozue J, 2011, MICROB PATHOGENESIS, V50, P314, DOI 10.1016/j.micpath.2011.02.005; Brzostek K, 2003, FEMS MICROBIOL LETT, V228, P265, DOI 10.1016/S0378-1097(03)00779-1; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; FINEGOLD MJ, 1969, AM J PATHOL, V54, P167; Fisher ML, 2007, INFECT IMMUN, V75, P429, DOI 10.1128/IAI.01287-06; Flamez C, 2008, INT J MED MICROBIOL, V298, P193, DOI 10.1016/j.ijmm.2007.05.005; Fujimura Yoshinori, 1992, Journal of Clinical Electron Microscopy, V25, P35; Galindo CL, 2011, J PATHOG, V2011, DOI 10.4061/2011/182051; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Grabenstein JP, 2004, INFECT IMMUN, V72, P4973, DOI 10.1128/IAI.72.9.4973-4984.2004; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Groisman EA, 2006, NAT REV MICROBIOL, V4, P705, DOI 10.1038/nrmicro1478; HANSKI C, 1991, INFECT IMMUN, V59, P1106, DOI 10.1128/IAI.59.3.1106-1111.1991; HANSKI C, 1989, INFECT IMMUN, V57, P673, DOI 10.1128/IAI.57.3.673-678.1989; Heise T, 2006, P NATL ACAD SCI USA, V103, P3375, DOI 10.1073/pnas.0507749103; HIGUCHI K, 1957, J BACTERIOL, V73, P122, DOI 10.1128/JB.73.1.122-129.1957; Koornhof HJ, 1999, EUR J CLIN MICROBIOL, V18, P87, DOI 10.1007/s100960050237; Kumar S, 2009, ANTON LEEUW INT J G, V95, P91, DOI 10.1007/s10482-008-9292-5; Laukkanen-Ninios R, 2011, ENVIRON MICROBIOL, V13, P3114, DOI 10.1111/j.1462-2920.2011.02588.x; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; Lockman HA, 2002, INFECT IMMUN, V70, P2708, DOI 10.1128/IAI.70.5.2708-2714.2002; Maldonado-Arocho FJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003415; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; O'Loughlin JL, 2010, INFECT IMMUN, V78, P773, DOI 10.1128/IAI.00718-09; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Paczosa MK, 2013, CELLULAR MICROBIOLOG; Palonen E, 2013, FOODBORNE PATHOG DIS, V10, P21, DOI 10.1089/fpd.2012.1247; Perez JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000428; Pisano F, 2012, INFECT IMMUN, V80, P1050, DOI 10.1128/IAI.05715-11; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Sambrook J., 2001, MOL CLONING LAB MANU; Schaake J, 2013, INFECT IMMUN, V81, P4013, DOI 10.1128/IAI.00572-13; Schweer J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003746; SIMONET M, 1990, INFECT IMMUN, V58, P841, DOI 10.1128/IAI.58.3.841-845.1990; SIMONET M, 1992, INFECT IMMUN, V60, P4414, DOI 10.1128/IAI.60.10.4414-4417.1992; Smego RA, 1999, EUR J CLIN MICROBIOL, V18, P1, DOI 10.1007/s100960050219; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Sun YC, 2009, FEMS MICROBIOL LETT, V290, P85, DOI 10.1111/j.1574-6968.2008.01409.x; Svanborg C, 1999, CURR OPIN MICROBIOL, V2, P99, DOI 10.1016/S1369-5274(99)80017-4; Uliczka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020425; UNE T, 1977, MICROBIOL IMMUNOL, V21, P349, DOI 10.1111/j.1348-0421.1977.tb00300.x; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wershil BK, 2008, J ALLERGY CLIN IMMUN, V121, pS380, DOI 10.1016/j.jaci.2007.10.023; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yamamoto T, 1996, INFECT IMMUN, V64, P2980, DOI 10.1128/IAI.64.8.2980-2987.1996	59	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103541	10.1371/journal.pone.0103541	http://dx.doi.org/10.1371/journal.pone.0103541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075520	Green Published, Green Submitted, gold			2022-12-27	WOS:000340028800062
J	Rakotoarinivo, M; Dransfield, J; Bachman, SP; Moat, J; Baker, WJ				Rakotoarinivo, Mijoro; Dransfield, John; Bachman, Steven P.; Moat, Justin; Baker, William J.			Comprehensive Red List Assessment Reveals Exceptionally High Extinction Risk to Madagascar Palms	PLOS ONE			English	Article							CONSERVATION PRIORITIES; BIODIVERSITY HOTSPOTS; FOREST FRAGMENTATION; PLANT CONSERVATION; DIVERSITY; DEFORESTATION; EASTERN; THREAT; GENUS; AREA	The establishment of baseline IUCN Red List assessments for plants is a crucial step in conservation planning. Nowhere is this more important than in biodiversity hotspots that are subject to significant anthropogenic pressures, such as Madagascar. Here, all Madagascar palm species are assessed using the IUCN Red List categories and criteria, version 3.1. Our results indicate that 83% of the 192 endemic species are threatened, nearly four times the proportion estimated for plants globally and exceeding estimates for all other comprehensively evaluated plant groups in Madagascar. Compared with a previous assessment in 1995, the number of Endangered and Critically Endangered species has substantially increased, due to the discovery of 28 new species since 1995, most of which are highly threatened. The conservation status of most species included in both the 1995 and the current assessments has not changed. Where change occurred, more species have moved to lower threat categories than to higher categories, because of improved knowledge of species and their distributions, rather than a decrease in extinction risk. However, some cases of genuine deterioration in conservation status were also identified. Palms in Madagascar are primarily threatened by habitat loss due to agriculture and biological resource use through direct exploitation or collateral damage. The recent extension of Madagascar's protected area network is highly beneficial for palms, substantially increasing the number of threatened species populations included within reserves. Notably, three of the eight most important protected areas for palms are newly designated. However, 28 threatened and data deficient species are not protected by the expanded network, including some Critically Endangered species. Moreover, many species occurring in protected areas are still threatened, indicating that threatening processes persist even in reserves. Definitive implementation of the new protected areas combined with local community engagement are essential for the survival of Madagascar's palms.	[Rakotoarinivo, Mijoro] Ambodivoanjo Ivandry, Kew Madagascar Conservat Ctr, Antananarivo, Madagascar; [Dransfield, John; Bachman, Steven P.; Moat, Justin; Baker, William J.] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	Royal Botanic Gardens, Kew	Rakotoarinivo, M (corresponding author), Ambodivoanjo Ivandry, Kew Madagascar Conservat Ctr, Antananarivo, Madagascar.	mrakotoarinivo.rbgkew@moov.mg	Rakotoarinivo, Mijoro/AAE-6975-2020; Sambri, Vittorio/H-5372-2019; Baker, William/B-1244-2011	Sambri, Vittorio/0000-0002-5012-7355; rakotoarinivo, mijoro/0000-0001-6644-5107; Moat, Justin/0000-0002-5513-3615; Baker, William/0000-0001-6727-1831; Bachman, Steven/0000-0003-1085-6075	Friends of Kew through the Threatened Plants Appeal; Bentham-Moxon Trust at the Royal Botanic Gardens, Kew	Friends of Kew through the Threatened Plants Appeal; Bentham-Moxon Trust at the Royal Botanic Gardens, Kew	This work was funded by the Friends of Kew through the Threatened Plants Appeal and by the Bentham-Moxon Trust at the Royal Botanic Gardens, Kew. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allnutt TF, 2013, TROP CONSERV SCI, V6, P1, DOI 10.1177/194008291300600101; Allnutt TF, 2008, CONSERV LETT, V1, P173, DOI 10.1111/j.1755-263X.2008.00027.x; Andreone F, 2005, CONSERV BIOL, V19, P1790, DOI 10.1111/j.1523-1739.2005.00249.x; Association Nationale pour la Gestion des Aires Protegees [ANGAP], 2001, MAD PROT AR SYST MAN; Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; Battistini R, 1996, COLLOQ SEMI, P1; Bennett B., 2011, ENCY LIFE SUPPORT SY; Borrini-Feyerabend G., 2005, AIRES PROTEGEES MADA; Brummitt N, 2010, PLANTS PRESSURE GLOB; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Butchart SHM, 2006, CONSERV BIOL, V20, P579, DOI 10.1111/j.1523-1739.2006.00410.x; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Byg A, 2001, BIODIVERS CONSERV, V10, P951, DOI 10.1023/A:1016640713643; Byg Anja, 2003, Palms, V47, P37; Callmander MW, 2007, ORYX, V41, P168, DOI 10.1017/S0030605307001731; Callmander MW, 2005, TAXON, V54, P1047, DOI 10.2307/25065491; Couvreur TLP, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-48; Couvreur TLP, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-44; Davies N., 2013, LEMURS MADAGASCAR ST, P13; Dransfield J, 1999, ACTA HORTIC, P21, DOI 10.17660/ActaHortic.1999.486.1; Dransfield J., 1995, PALMS MADAGASCAR; Dransfield J., 2008, GENERA PALMARUM THE; Dransfield J, 2006, FIELD GUIDE PALMS MA; Dransfield J, 2008, BOT J LINN SOC, V156, P79, DOI 10.1111/j.1095-8339.2007.00742.x; Fattorini S, 2012, ACTA OECOL, V40, P27, DOI 10.1016/j.actao.2012.02.006; Fleischmann K, 2005, AFR J ECOL, V43, P291, DOI 10.1111/j.1365-2028.2005.00567.x; Foibe Taosarintanin'i Madagasikara [FTM], 2006, MAD SES 22 REG; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Good TC, 2006, CONSERV BIOL, V20, P1099, DOI 10.1111/j.1523-1739.2006.00473.x; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Google, 2010, GOOGL EARTH VERS 5 2; Govaerts R, 2012, WORLD CHECKLIST AREC; Groupe des Specialistes des Plantes Malgaches [GSPM], 2011, LIST ROUG PLANT VASC; Hannah L, 2008, BIOL LETTERS, V4, P590, DOI 10.1098/rsbl.2008.0270; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hobbs RJ, 2007, RESTOR ECOL, V15, P354, DOI 10.1111/j.1526-100X.2007.00225.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; International Union for Conservation of Nature [IUCN], 1998, 1997 IUCN RED LIST T; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; IUCN, 2011, GUID US IUCN RED LIS; IUCN, 2013, IUCN RED LIST THREAT; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN, 1994, IUCN RED LIST CAT CR; IUCN, 2012, IUCN RED LIST THREAT; IUCN, 2012, THREATS CLASS SCHEM; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Jury MR., 2003, NATURAL HIST MADAGAS, P75; Kissling WD, 2012, P NATL ACAD SCI USA, V109, P7379, DOI 10.1073/pnas.1120467109; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Marcot BG, 2013, NAT RESOUR MODEL, V26, P194, DOI 10.1111/j.1939-7445.2012.00134.x; Mittermeier RA., 2005, INT J WILDERNESS, V11, P42; Moat J., 2007, ATLAS VEGETATION MAD; Moat J., 2007, CONSERVATION ASSESSM; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nicoll ME, 2003, NATURAL HIST MADAGAS, P1432; Norris S, 2006, BIOSCIENCE, V56, P960, DOI 10.1641/0006-3568(2006)56[960:MD]2.0.CO;2; Rakotoarinivo M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3048; Rakotoarinivo Mijoro, 2010, Palms, V54, P141; Rakotoarinivo Mijoro, 2010, Kew Bulletin, V65, P279, DOI 10.1007/s12225-010-9210-7; Rakotoarinivo Mijoro, 2009, Palms, V53, P125; Ramananjanahary RH, 2010, MADAGASCARS ENDEMIC; Richard D, 2006, TAXONOMY PLANT CONSE, P163; Rivers MC, 2010, BIODIVERS CONSERV, V19, P2071, DOI 10.1007/s10531-010-9826-9; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rojas-Sandoval J, 2012, ACTA OECOL, V41, P30, DOI 10.1016/j.actao.2012.04.004; Scariot A, 1999, J ECOL, V87, P66, DOI 10.1046/j.1365-2745.1999.00332.x; Schatz G. E., 2003, GAZETTEER MALAGASY B; Systeme des Aires Protegees de Madagascar [SAPM], 2011, ATL NUM SAPM; Thiers B., 2012, INDEX HERBARIORUM GL; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Vie J.C., 2008, IUCN RED LIST KEY CO; Willis F, 2003, BIODIVERS CONSERV, V12, P1537, DOI 10.1023/A:1023679329093; WorldBank, 2013, POP DENS	75	20	26	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2014	9	7							e103684	10.1371/journal.pone.0103684	http://dx.doi.org/10.1371/journal.pone.0103684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM7EZ	25075612	Green Published, gold			2022-12-27	WOS:000340028800073
J	Poli, R; Valeriani, D; Cinel, C				Poli, Riccardo; Valeriani, Davide; Cinel, Caterina			Collaborative Brain-Computer Interface for Aiding Decision-Making	PLOS ONE			English	Article							GROUPS PERFORM; INDIVIDUALS; POTENTIALS; PERCEPTION; MOUSE	We look at the possibility of integrating the percepts from multiple non-communicating observers as a means of achieving better joint perception and better group decisions. Our approach involves the combination of a brain-computer interface with human behavioural responses. To test ideas in controlled conditions, we asked observers to perform a simple matching task involving the rapid sequential presentation of pairs of visual patterns and the subsequent decision as whether the two patterns in a pair were the same or different. We recorded the response times of observers as well as a neural feature which predicts incorrect decisions and, thus, indirectly indicates the confidence of the decisions made by the observers. We then built a composite neuro-behavioural feature which optimally combines the two measures. For group decisions, we uses a majority rule and three rules which weigh the decisions of each observer based on response times and our neural and neuro-behavioural features. Results indicate that the integration of behavioural responses and neural features can significantly improve accuracy when compared with the majority rule. An analysis of event-related potentials indicates that substantial differences are present in the proximity of the response for correct and incorrect trials, further corroborating the idea of using hybrids of brain-computer interfaces and traditional strategies for improving decision making.	[Poli, Riccardo; Valeriani, Davide; Cinel, Caterina] Univ Essex, Sch Comp Sci & Elect Engn, Brain Comp Interfaces Lab, Colchester CO4 3SQ, Essex, England	University of Essex	Poli, R (corresponding author), Univ Essex, Sch Comp Sci & Elect Engn, Brain Comp Interfaces Lab, Colchester CO4 3SQ, Essex, England.	rpoli@essex.ac.uk		Poli, Riccardo/0000-0003-4612-0780; Valeriani, Davide/0000-0001-9866-0063	Engineering and Physical Sciences Research Council (EPSRC) [EP/K004638/1]; EPSRC [EP/K004638/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K004638/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research has been partially supported by the Engineering and Physical Sciences Research Council (EPSRC), grant EP/K004638/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Branson L, 2010, J BUSINESS BEHAV SCI, V22, P75; Cinel C, 2002, J EXP PSYCHOL HUMAN, V28, P1243, DOI 10.1037/0096-1523.28.5.1243; Citi L, 2008, IEEE T NEUR SYS REH, V16, P51, DOI 10.1109/TNSRE.2007.913184; DAVIS JH, 1973, PSYCHOL REV, V80, P97, DOI 10.1037/h0033951; DiVita J, 2004, HUM FACTORS, V46, P205, DOI 10.1518/hfes.46.2.205.37340; DONCHIN E, 1966, IEEE T BIO-MED ENG, VBM13, P131, DOI 10.1109/TBME.1966.4502423; Donchin E., 1978, MULTIDISCIPLINARY PE, P555; Eckstein MP, 2012, NEUROIMAGE, V59, P94, DOI 10.1016/j.neuroimage.2011.07.009; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Hagen GF, 2006, INT J PSYCHOPHYSIOL, V59, P8, DOI 10.1016/j.ijpsycho.2005.08.003; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Kahneman D., 2011, THINKING FAST SLOW; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Kerr NL, 1996, PSYCHOL REV, V103, P687, DOI 10.1037/0033-295X.103.4.687; Laughlin PR, 2006, J PERS SOC PSYCHOL, V90, P644, DOI 10.1037/0022-3514.90.4.644; Laughlin PR, 2002, ORGAN BEHAV HUM DEC, V88, P605, DOI 10.1016/S0749-5978(02)00003-1; Luce RD, 1986, RESPONSE TIMES THEIR; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Mack A., 1998, INATTENTIONAL BLINDN; Makeig S, 1999, J NEUROSCI, V19, P2665; Makeig S, 1996, ADV NEUR IN, V8, P145; MCCLELLAN JH, 1973, IEEE T ACOUST SPEECH, VAU21, P506, DOI 10.1109/TAU.1973.1162525; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Padilla ML, 2006, J COGNITIVE NEUROSCI, V18, P1477, DOI 10.1162/jocn.2006.18.9.1477; PALMER J, 1990, J EXP PSYCHOL HUMAN, V16, P332, DOI 10.1037/0096-1523.16.2.332; Peng Yuan, 2013, Universal Access in Human-Computer Interaction. Design Methods, Tools, and Interaction Techniques for eInclusion. 7th International Conference, UAHCI 2013 Held as Part of HCI International 2013. Proceedings. LNCS 8009, P672, DOI 10.1007/978-3-642-39188-0_72; Peters M, 1999, J MOTOR BEHAV, V31, P86, DOI 10.1080/00222899909601894; Poli R, 2013, P INT C INT US INT I; Poli R, 2013, IEEE INT MULT C COGN; Poli R, 2010, IEEE ENG MED BIO, P6011, DOI 10.1109/IEMBS.2010.5627593; Poli R, 2009, IEEE COMPUT INTELL M, V4, P27, DOI 10.1109/MCI.2009.934563; Quilter P. M., 1977, Colloquium on Random Signal Analysis, P93; Salvaris M, 2012, IEEE T NEUR SYS REH, V20, P8, DOI 10.1109/TNSRE.2011.2174463; Selimbeyoglu A, 2012, CLIN NEUROPHYSIOL, V123, P1158, DOI 10.1016/j.clinph.2011.10.037; Sorkin RD, 2001, PSYCHOL REV, V108, P183, DOI 10.1037//0033-295X.108.1.183; Stoica A, 2012, 2012 THIRD INTERNATIONAL CONFERENCE ON EMERGING SECURITY TECHNOLOGIES (EST), P94, DOI 10.1109/EST.2012.47; Streeter D N, 1966, AMRL TR, P1; Tindale R., 2003, SAGE HDB SOCIAL PSYC, P381; Tzovara A, 2012, NEUROIMAGE, V60, P1959, DOI 10.1016/j.neuroimage.2012.01.136; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Yuan P, 2012, P 34 IEEE EMBS C	46	37	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e102693	10.1371/journal.pone.0102693	http://dx.doi.org/10.1371/journal.pone.0102693			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO4KU	25072739	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000341307600014
J	Zhang, B; Chen, SY; He, XY; Liu, WJ; Zhao, Q; Zhao, L; Tian, CJ				Zhang, Bin; Chen, Shengyun; He, Xingyuan; Liu, Wenjie; Zhao, Qian; Zhao, Lin; Tian, Chunjie			Responses of Soil Microbial Communities to Experimental Warming in Alpine Grasslands on the Qinghai-Tibet Plateau	PLOS ONE			English	Article							CLIMATE-CHANGE MANIPULATIONS; CARBON-CYCLE FEEDBACK; DYNAMICS; BACTERIA; FUNGI; MICROORGANISMS; TEMPERATURE; MOISTURE; LITTER; GROWTH	Global surface temperature is predicted to increase by at least 1.5 degrees C by the end of this century. However, the response of soil microbial communities to global warming is still poorly understood, especially in high-elevation grasslands. We therefore conducted an experiment on three types of alpine grasslands on the Qinghai-Tibet Plateau to study the effect of experimental warming on abundance and composition of soil microbial communities at 0-10 and 10-20 cm depths. Plots were passively warmed for 3 years using open-top chambers and compared to adjacent control plots at ambient temperature. Soil microbial communities were assessed using phospholipid fatty acid (PLFA) analysis. We found that 3 years of experimental warming consistently and significantly increased microbial biomass at the 0-10 cm soil depth of alpine swamp meadow (ASM) and alpine steppe (AS) grasslands, and at both the 0-10 and 10-20 cm soil depths of alpine meadow (AM) grasslands, due primarily to the changes in soil temperature, moisture, and plant coverage. Soil microbial community composition was also significantly affected by warming at the 0-10 cm soil depth of ASM and AM and at the 10-20 cm soil depth of AM. Warming significantly decreased the ratio of fungi to bacteria and thus induced a community shift towards bacteria at the 0-10 cm soil depth of ASM and AM. While the ratio of arbuscular mycorrhizal fungi to saprotrophic fungi (AMF/SF) was significantly decreased by warming at the 0-10 cm soil depth of ASM, it was increased at the 0-10 cm soil depth of AM. These results indicate that warming had a strong influence on soil microbial communities in the studied high-elevation grasslands and that the effect was dependent on grassland type.	[Zhang, Bin; He, Xingyuan; Tian, Chunjie] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Chen, Shengyun; Liu, Wenjie; Zhao, Qian; Zhao, Lin] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryospher Sci, Lanzhou, Peoples R China; [Zhao, Lin] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Observat & Res Stn Qinghai Tibet Plateau, Golmud, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Tian, CJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.	tiancj@iga.ac.cn	Zhang, Bangzhou/CAG-9625-2022; Cai, Guanjing/GZK-7070-2022; Zhao, Lin/M-9536-2018	Zhao, Lin/0000-0003-0245-8413	National Basic Research Program of China (973 program) [2013CBA01807]; Science Foundation of Chinese Academy of Sciences [KZZD-EW-TZ-16]; National Natural Science Foundation of China [Y4E1041001, 40901040]; Natural Science Foundation of Jilin Province [20130101080JC]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Science Foundation of Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	This work was financially supported by the National Basic Research Program of China (973 program, 2013CBA01807, http://www.973.gov.cn/Default_3.aspx), the Science Foundation of Chinese Academy of Sciences (KZZD-EW-TZ-16, http://www.cas.cn/), the National Natural Science Foundation of China (Y4E1041001,40901040, http://www.nsfc.gov.cn/) and the Natural Science Foundation of Jilin Province (20130101080JC, http://kjt.jl.gov.cn/kjt/4/tindex.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CLIM CHANG 2013 PHYS; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Berg N, 2008, SOIL BIOL BIOCHEM, V40, P2686, DOI 10.1016/j.soilbio.2008.07.019; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; [陈生云 Chen Shengyun], 2012, [冰川冻土, Journal of Glaciology and Geocryology], V34, P1142; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Crowther TW, 2012, ISME J, V6, P1992, DOI 10.1038/ismej.2012.53; Deslippe JR, 2012, FEMS MICROBIOL ECOL, V82, P303, DOI 10.1111/j.1574-6941.2012.01350.x; Eklof JS, 2012, ECOL LETT, V15, P864, DOI 10.1111/j.1461-0248.2012.01810.x; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Grimm NB, 2013, FRONT ECOL ENVIRON, V11, P474, DOI 10.1890/120282; Guo DL, 2012, INT J CLIMATOL, V32, P1775, DOI 10.1002/joc.2388; Haugwitz MS, 2014, PLANT SOIL, V374, P211, DOI 10.1007/s11104-013-1855-1; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Posada RH, 2012, FUNGAL BIOL-UK, V116, P747, DOI 10.1016/j.funbio.2012.04.003; Institute of Soil Sciences Chinese Academy of Sciences, 1978, PHYS CHEM AN METH SO, P7; IUSS Working Group WRB, 2006, WORLD REFERENCE BASE, V103; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jackson RB, 2007, ECOLOGY, V88, P1343, DOI 10.1890/06-1882; KIEFT TL, 1994, APPL ENVIRON MICROB, V60, P3292, DOI 10.1128/AEM.60.9.3292-3299.1994; Klein JA, 2005, GLOBAL CHANGE BIOL, V11, P1440, DOI 10.1111/j.1365-2486.2005.00994.x; Liang C, 2012, APPL SOIL ECOL, V54, P24, DOI 10.1016/j.apsoil.2011.11.015; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Liu WJ, 2014, ENV RES LET IN PRESS; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Margesin R, 2009, FEMS MICROBIOL ECOL, V67, P208, DOI 10.1111/j.1574-6941.2008.00620.x; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Mille-Lindblom C, 2006, OIKOS, V113, P233, DOI 10.1111/j.2006.0030-1299.14337.x; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; R Core Team, 2013, R LANG ENV STAT COMP; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Rousk J, 2011, FEMS MICROBIOL ECOL, V78, P17, DOI 10.1111/j.1574-6941.2011.01106.x; Sheik CS, 2011, ISME J, V5, P1692, DOI 10.1038/ismej.2011.32; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wen Z, 2014, ENVIRON EARTH SCI, V71, P1195, DOI 10.1007/s12665-013-2523-8; Wixon DL, 2013, SOIL BIOL BIOCHEM, V57, P769, DOI 10.1016/j.soilbio.2012.08.016; Yergeau E, 2012, ISME J, V6, P692, DOI 10.1038/ismej.2011.124; Yuan YL, 2014, FEMS MICROBIOL ECOL, V87, P121, DOI 10.1111/1574-6941.12197; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066184; Zhang B, 2012, SOIL TILL RES, V124, P153, DOI 10.1016/j.still.2012.05.011; Zhang NL, 2013, OECOLOGIA, V173, P1125, DOI 10.1007/s00442-013-2685-9; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078616; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	51	64	80	12	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103859	10.1371/journal.pone.0103859	http://dx.doi.org/10.1371/journal.pone.0103859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	24675867	Green Published, gold, Green Submitted			2022-12-27	WOS:000339819800091
J	Paul, MJ; Dredze, M				Paul, Michael J.; Dredze, Mark			Discovering Health Topics in Social Media Using Topic Models	PLOS ONE			English	Article								By aggregating self-reported health statuses across millions of users, we seek to characterize the variety of health information discussed in Twitter. We describe a topic modeling framework for discovering health topics in Twitter, a social media website. This is an exploratory approach with the goal of understanding what health topics are commonly discussed in social media. This paper describes in detail a statistical topic model created for this purpose, the Ailment Topic Aspect Model (ATAM), as well as our system for filtering general Twitter data based on health keywords and supervised classification. We show how ATAM and other topic models can automatically infer health topics in 144 million Twitter messages from 2011 to 2013. ATAM discovered 13 coherent clusters of Twitter messages, some of which correlate with seasonal influenza (r = 0.689) and allergies (r = 0.810) temporal surveillance data, as well as exercise (r = .534) and obesity (r = -.631) related geographic survey data in the United States. These results demonstrate that it is possible to automatically discover topics that attain statistically significant correlations with ground truth data, despite using minimal human supervision and no historical data to train the model, in contrast to prior work. Additionally, these results demonstrate that a single general-purpose model can identify many different health topics in social media.	[Paul, Michael J.; Dredze, Mark] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Paul, Michael J.; Dredze, Mark] Johns Hopkins Univ, Ctr Language & Speech Proc, Baltimore, MD USA; [Dredze, Mark] Johns Hopkins Univ, Human Language Technol Ctr Excellence, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Paul, MJ (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA.	mpaul@cs.jhu.edu		Dredze, Mark/0000-0002-0422-2474	National Science Foundation [DGE-0707427]; Microsoft Research; Johns Hopkins University Libraries	National Science Foundation(National Science Foundation (NSF)); Microsoft Research(Microsoft); Johns Hopkins University Libraries(Johns Hopkins University)	Mr. Paul was supported in part by a National Science Foundation Graduate Research Fellowship under Grant No. DGE-0707427 and a PhD fellowship from Microsoft Research. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2010, C EMP METH NAT LANG; Asuncion A, 2009, C UNC ART INT; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Barbosa L, 2010, INT C COMP LING; Blei D, 2003, J MACHINE LEARNING R, V3; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Bosley JC, 2013, RESUSCITATION, V84, P206, DOI 10.1016/j.resuscitation.2012.10.017; Callison-Burch C, 2010, WORKSH CREAT SPEECH; Chemudugunta C, 2006, ADV NEURAL INFORM PR; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Cobb NK, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1911; Culotta A, 2012, LANGUAGE RESOURCES E; Culotta A, 2010, KDD WORKSH SOC MED A; De Choudhury M, 2013, INT C WEBL SOC MED; Dredze M, 2013, AAAI WORKSH EXP BOUN; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Gerrish S., 2009, NIPS; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Griffiths T. L., 2004, P NATL ACAD SCI US; Heaivilin N, 2011, J DENT RES, V90, P1047, DOI 10.1177/0022034511415273; Lamb A, 2013, C N AM CHAPT ASS COM; Lampos V, 2010, IAPR 2 WORKSH COGN I; Maskawa S, 2010, C EMP METH NAT LANG; McCallum, 2002, MALLET MACHINE LEARN; Minka T., 2003, TECHNICAL REPORT; Mislove A, 2011, INT C WEBL SOC MED; Morchen F, 2008, ANTICIPATING ANNOTAT; Moreno M, 2011, ARCH PEDIAT ADOLESC; Newman D., 2007, ADV NEURAL INFORM PR; O'Connor B., 2010, TWEETS POLLS LINKING; Paul M, 2010, AAAI C ART INT; Paul M, 2011, INT C WEBL SOC MED; Paul M, 2011, TECHNICAL REPORT; Paul MJ, 2012, C EMP METH NAT LANG; Paul MJ, 2013, C N AM CHAPT ASS COM; Paul MJ, 2009, C EMP METH NAT LANG; Petrovic S, 2010, C N AM CHAPT ASS COM; Sadilek A, 2012, INT C WEBL SOC MED; Sakaki T, 2010, INT WORLD WID WEB C; Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004; Terdiman D, 2012, REPORT TWITTER HITS; Tumasjan A, 2010, INT C WEBL SOC MED; Wang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017243; Yoon S, 2013, AM J PREVENTIVE MED, V45; Zhai C, 2004, CROSS COLLECTION MIX	46	229	232	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103408	10.1371/journal.pone.0103408	http://dx.doi.org/10.1371/journal.pone.0103408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4JL	25642377	Green Submitted, Green Published, gold			2022-12-27	WOS:000339819800038
J	Ward, ME; McMahon, G; St Pourcain, B; Evans, DM; Rietveld, CA; Benjamin, DJ; Koellinger, PD; Cesarini, D; Smith, GD; Timpson, NJ				Ward, Mary E.; McMahon, George; St Pourcain, Beate; Evans, David M.; Rietveld, Cornelius A.; Benjamin, Daniel J.; Koellinger, Philipp D.; Cesarini, David; Smith, George Davey; Timpson, Nicholas J.		Social Sci Genetic Assoc Consortiu	Genetic Variation Associated with Differential Educational Attainment in Adults Has Anticipated Associations with School Performance in Children	PLOS ONE			English	Article							HERITABILITY	Genome-wide association study results have yielded evidence for the association of common genetic variants with crude measures of completed educational attainment in adults. Whilst informative, these results do not inform as to the mechanism of these effects or their presence at earlier ages and where educational performance is more routinely and more precisely assessed. Single nucleotide polymorphisms exhibiting genome-wide significant associations with adult educational attainment were combined to derive an unweighted allele score in 5,979 and 6,145 young participants from the Avon Longitudinal Study of Parents and Children with key stage 3 national curriculum test results (SATS results) available at age 13 to 14 years in English and mathematics respectively. Standardised (z-scored) results for English and mathematics showed an expected relationship with sex, with girls exhibiting an advantage over boys in English (0.433 SD (95%CI 0.395, 0.470), p<10(-10)) with more similar results (though in the opposite direction) in mathematics (0.042 SD (95%CI 0.004, 0.080), p = 0.030). Each additional adult educational attainment increasing allele was associated with 0.041 SD (95%CI 0.020, 0.063), p = 1.79 x 10(-04) and 0.028 SD (95%CI 0.007, 0.050), p = 0.01 increases in standardised SATS score for English and mathematics respectively. Educational attainment is a complex multifactorial behavioural trait which has not had heritable contributions to it fully characterised. We were able to apply the results from a large study of adult educational attainment to a study of child exam performance marking events in the process of learning rather than realised adult end product. Our results support evidence for common, small genetic contributions to educational attainment, but also emphasise the likely lifecourse nature of this genetic effect. Results here also, by an alternative route, suggest that existing methods for child examination are able to recognise early life variation likely to be related to ultimate educational attainment.	[Ward, Mary E.; McMahon, George; St Pourcain, Beate; Evans, David M.; Smith, George Davey; Timpson, Nicholas J.] Univ Bristol, Sch Social & Community Med, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [St Pourcain, Beate] Univ Bristol, Sch Oral & Dent Sci, Bristol, Avon, England; [St Pourcain, Beate] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Evans, David M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Rietveld, Cornelius A.; Koellinger, Philipp D.] Erasmus Univ, Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands; [Rietveld, Cornelius A.; Koellinger, Philipp D.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Benjamin, Daniel J.] Cornell Univ, Dept Econ, Ithaca, NY 14853 USA; [Koellinger, Philipp D.] Univ Amsterdam, Amsterdam Business Sch, Amsterdam, Netherlands; [Cesarini, David] NYU, Dept Econ, Ctr Expt Social Sci, New York, NY 10003 USA; [Cesarini, David] New York Univ Abu Dhabi, Div Social Sci, Abu Dhabi, U Arab Emirates; [Cesarini, David] Res Inst Ind Econ, Stockholm, Sweden	University of Bristol; University of Bristol; University of Bristol; University of Queensland; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Cornell University; University of Amsterdam; New York University; Research Institute of Industrial Economics (IFN)	Timpson, NJ (corresponding author), Univ Bristol, Sch Social & Community Med, MRC, Integrat Epidemiol Unit, Bristol, Avon, England.	n.j.timpson@bris.ac.uk	Evans, David M/H-6325-2013; Fox, Laura J/C-6249-2016; Davey Smith, George/A-7407-2013; Attrill, Lauren/V-1688-2018; St Pourcain, Beate/K-8004-2017; Timpson, Nicholas John/O-7548-2015	Evans, David M/0000-0003-0663-4621; Davey Smith, George/0000-0002-1407-8314; St Pourcain, Beate/0000-0002-4680-3517; Timpson, Nicholas John/0000-0002-7141-9189; Koellinger, Philipp/0000-0001-7413-0412; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Cesarini, David/0000-0002-0043-009X; Munafo, Marcus/0000-0002-4049-993X; s, hema/0000-0002-3440-9475	Wellcome Trust PhD studentship award [099873/Z/12/Z]; Wellcome Trust [092731]; MRC [MC_UU_12013/4, MC_UU_12013/1, MC_UU_12013/3] Funding Source: UKRI; Medical Research Council [MC_UU_12013/4, MC_UU_12013/1, MC_UU_12013/3, MC_PC_15018] Funding Source: researchfish	Wellcome Trust PhD studentship award(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MEW is funded through a Wellcome Trust PhD studentship award (grant ref. 099873/Z/12/Z) (http://www.wellcome.ac.uk/). NJT, DME and GDS work in the UK Medical Research Council and University of Bristol Integrative Epidemiology Unit. The UK Medical Research Council (http://www.mrc.ac.uk/) and the Wellcome Trust (grant ref: 092731) and the University of Bristol (http://www.bristol.ac.uk/) provide core support for ALSPAC. The authors have declared that no competing interests exist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bartels M, 2002, TWIN RES, V5, P544, DOI 10.1375/136905202762342017; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Branigan AR, 2013, SOC FORCES, V92, P109, DOI 10.1093/sf/sot076; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Johnson W, 2011, AM J EPIDEMIOL, V173, P55, DOI 10.1093/aje/kwq333; Levacic R, 2005, RR679 DFES DEP ED SK; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Miller P, 2001, ECON EDUC REV, V20, P211, DOI 10.1016/S0272-7757(00)00018-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Shakeshaft NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080341; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; TAUBMAN P, 1976, AM ECON REV, V66, P858; UNESCO, 2006, INT STAND CLASS ED; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	25	48	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2014	9	7							e100248	10.1371/journal.pone.0100248	http://dx.doi.org/10.1371/journal.pone.0100248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL8VR	25032841	Green Published, Green Submitted, gold			2022-12-27	WOS:000339418300008
J	Wu, JN; Yan, SZ; Zhao, JL; Ye, YY				Wu, Jianing; Yan, Shaoze; Zhao, Jieliang; Ye, Yuying			Barbs Facilitate the Helical Penetration of Honeybee (Apis mellifera ligustica) Stingers	PLOS ONE			English	Article							OVIPOSITOR; HYMENOPTERA; INSECTA; WASPS	The stinger is a very small and efficient device that allows honeybees to perform two main physiological activities: repelling enemies and laying eggs for reproduction. In this study, we explored the specific characteristics of stinger penetration, where we focused on its movements and the effects of it microstructure. The stingers of Italian honeybees (Apis mellifera ligustica) were grouped and fixed onto four types of cubic substrates, before pressing into different substrates. The morphological characteristics of the stinger cross-sections were analyzed before and after penetration by microscopy. Our findings suggest that the honeybee stinger undergoes helical and clockwise rotation during penetration. We also found that the helical penetration of the stinger is associated directly with the spiral distribution of the barbs, thereby confirming that stinger penetration involves an advanced microstructure rather than a simple needle-like apparatus. These results provide new insights into the mechanism of honeybee stinger penetration.	[Wu, Jianing; Yan, Shaoze; Zhao, Jieliang; Ye, Yuying] Tsinghua Univ, Dept Mech Engn, State Key Lab Tribol, Div Intelligent & Biomech Syst, Beijing 100084, Peoples R China	Tsinghua University	Yan, SZ (corresponding author), Tsinghua Univ, Dept Mech Engn, State Key Lab Tribol, Div Intelligent & Biomech Syst, Beijing 100084, Peoples R China.	yansz@mail.tsinghua.edu.cn	Zhao, Jieliang/B-1872-2016; Yan, Shaoze/M-1707-2015; yan, shaoze/X-5768-2019; Yu, GH/H-4968-2013	Zhao, Jieliang/0000-0001-6879-0537; Yan, Shaoze/0000-0003-2578-6831; Yu, GH/0000-0002-5699-779X	Research Project of the State Key Laboratory of Tribology [SKLT11B03]	Research Project of the State Key Laboratory of Tribology	This work was funded by the Research Project of the State Key Laboratory of Tribology under Contract no. SKLT11B03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi S, 2008, SENSOR ACTUAT A-PHYS, V143, P20, DOI 10.1016/j.sna.2007.06.007; Brown PE, 1998, J INSECT PHYSIOL, V44, P1017, DOI 10.1016/S0022-1910(98)00072-9; Cardinal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021086; Choo YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010393; Dade H.A., 1994, ANATOMY DISSECTION H; Duan JJ, 2000, J INSECT BEHAV, V13, P175, DOI 10.1023/A:1007780029320; Frasson L, 2010, P I MECH ENG H, V224, P775, DOI 10.1243/09544119JEIM663; Gao Y, 2007, J SPACECRAFT ROCKETS, V44, P703, DOI 10.2514/1.23025; Izumi H, 2011, SENSOR ACTUAT A-PHYS, V165, P115, DOI 10.1016/j.sna.2010.02.010; Klowden MJ, 2013, PHYSIOLOGICAL SYSTEMS IN INSECTS, 3RD EDITION, P1; Kong XQ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011910; Rahman MH, 1998, ZOOL SCR, V27, P333, DOI 10.1111/j.1463-6409.1998.tb00465.x; Robbins CR., 2002, CHEM PHYS BEHAV HUMA, V4th ed.; Schilthuizen M, 1998, SYST ENTOMOL, V23, P253, DOI 10.1046/j.1365-3113.1998.00049.x; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Tautz J., 2008, BUZZ BEES BIOL SUPER; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; Vilhelmsen L, 2001, ZOOMORPHOLOGY, V121, P63, DOI 10.1007/s004350100046; Visscher PK, 1996, LANCET, V348, P301, DOI 10.1016/S0140-6736(96)01367-0; Winston M. L. L., 1991, BIOL HONEY BEE; WU E, 1994, EXP MECH, V34, P93, DOI 10.1007/BF02325705	22	35	35	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103823	10.1371/journal.pone.0103823	http://dx.doi.org/10.1371/journal.pone.0103823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	25137372	Green Published, gold, Green Submitted			2022-12-27	WOS:000339812700058
J	Zhang, DP; Chen, L; Li, DH; Lv, B; Chen, Y; Chen, JG; Yan, XJ; Liang, JS				Zhang, Dongping; Chen, Li; Li, Dahong; Lv, Bing; Chen, Yun; Chen, Jingui; Yan, Xuejiao; Liang, Jiansheng			OsRACK1 Is Involved in Abscisic Acid- and H2O2-Mediated Signaling to Regulate Seed Germination in Rice (Oryza sativa, L.)	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; PROTEOMIC ANALYSIS; INNATE IMMUNITY; ABA CATABOLISM; RACK1; DORMANCY; PROTEIN; GENE; TRANSCRIPTION; NETWORKS	The receptor for activated C kinase 1 (RACK1) is one member of the most important WD repeat-containing family of proteins found in all eukaryotes and is involved in multiple signaling pathways. However, compared with the progress in the area of mammalian RACK1, our understanding of the functions and molecular mechanisms of RACK1 in the regulation of plant growth and development is still in its infancy. In the present study, we investigated the roles of rice RACK1A gene (OsRACK1A) in controlling seed germination and its molecular mechanisms by generating a series of transgenic rice lines, of which OsRACK1A was either over-expressed or under-expressed. Our results showed that OsRACK1A positively regulated seed germination and negatively regulated the responses of seed germination to both exogenous ABA and H2O2. Inhibition of ABA biosynthesis had no enhancing effect on germination, whereas inhibition of ABA catabolism significantly suppressed germination. ABA inhibition on seed germination was almost fully recovered by exogenous H2O2 treatment. Quantitative analyses showed that endogenous ABA levels were significantly higher and H2O2 levels significantly lower in OsRACK1A-down regulated transgenic lines as compared with those in wildtype or OsRACK1A-up regulated lines. Quantitative real-time PCR analyses showed that the transcript levels of OsRbohs and amylase genes, RAmy1A and RAmy3D, were significantly lower in OsRACK1A-down regulated transgenic lines. It is concluded that OsRACK1A positively regulates seed germination by controlling endogenous levels of ABA and H2O2 and their interaction.	[Zhang, Dongping; Chen, Li; Lv, Bing; Chen, Yun; Yan, Xuejiao; Liang, Jiansheng] Yangzhou Univ, Coll Biosci & Biotechnol, Dept Biotechnol, Yangzhou, Jiangsu, Peoples R China; [Li, Dahong] Huanghuai Univ, Dept Biol Engn, Zhumadian City, Henan Province, Peoples R China; [Chen, Jingui] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	Yangzhou University; Huanghuai University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Liang, JS (corresponding author), Yangzhou Univ, Coll Biosci & Biotechnol, Dept Biotechnol, Yangzhou, Jiangsu, Peoples R China.	jsliang@yzu.edu.cn	Chen, Jin-Gui/AFV-6337-2022; Chen, Jin-Gui/A-4773-2011; Zhang, Dongping/AAD-9164-2019	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; Zhang, Dongping/0000-0001-8564-8348; Yu, Jianming/0000-0001-5326-3099	National Science Foundation of China [31271622]; Hi-Tech Research and Development Program ("863" project) from the Ministry of Science and Technology of China [2008AA10Z120]; College Postgraduate Research and Innovation Project in Jiangsu Province; University Innovation Training Program of Jiangsu Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program ("863" project) from the Ministry of Science and Technology of China; College Postgraduate Research and Innovation Project in Jiangsu Province; University Innovation Training Program of Jiangsu Province	This work was supported by the National Science Foundation of China (grant no: 31271622 to JSL) and the Hi-Tech Research and Development Program ("863" project) from the Ministry of Science and Technology of China (grant no: 2008AA10Z120 to JSL), and by the College Postgraduate Research and Innovation Project in Jiangsu Province (to DPZ) and University Innovation Training Program of Jiangsu Province (to SJY) for research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DR, 2011, CELL COMMUN SIGNAL, V9, P823; Bahin E, 2011, PLANT CELL ENVIRON, V34, P980, DOI 10.1111/j.1365-3040.2011.02298.x; Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Bailly C, 2008, CR BIOL, V331, P806, DOI 10.1016/j.crvi.2008.07.022; Barba-Espin G, 2010, PLANT CELL ENVIRON, V33, P981, DOI 10.1111/j.1365-3040.2010.02120.x; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Chaudhuri A., 2013, J PLANT BIOCH PHYSL, DOI [10.4172/jpbp.1000103, DOI 10.4172/JPBP.1000103]; Chen JG, 2006, J EXP BOT, V57, P2697, DOI 10.1093/jxb/erl035; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Chen Y, 2006, PLANT PHYSIOL, V140, P302, DOI 10.1104/pp.105.069872; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Diaz-Vivancos P, 2013, PLANT CELL REP, V32, P1491, DOI 10.1007/s00299-013-1473-7; El-Maarouf-Bouteau H, 2008, PLANT SIGNAL BEHAV, V3, P175, DOI 10.4161/psb.3.3.5539; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Guo J., 2007, INT J PLANT DEV BIOL, V1, P95; Guo JJ, 2011, PLANT PHYSIOL, V155, P370, DOI 10.1104/pp.110.160663; Guo JJ, 2009, J EXP BOT, V60, P3819, DOI 10.1093/jxb/erp221; He DL, 2011, PROTEOMICS, V11, P2693, DOI 10.1002/pmic.201000598; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Ishibashi Yushi, 2013, Ann Bot, V111, P95, DOI 10.1093/aob/mcs240; Ishibashi Y, 2008, PLANT SIGNAL BEHAV, V3, P183, DOI 10.4161/psb.3.3.5540; Ishida S, 1996, PLANT CELL PHYSIOL, V37, P439, DOI 10.1093/oxfordjournals.pcp.a028965; ISHIDA S, 1993, P NATL ACAD SCI USA, V90, P11152, DOI 10.1073/pnas.90.23.11152; Islas-Flores T, 2012, PLANT SIGNAL BEHAV, V7, P132, DOI 10.4161/psb.7.1.18485; Islas-Flores T, 2009, PHYSIOL PLANTARUM, V137, P264, DOI 10.1111/j.1399-3054.2009.01280.x; IWASAKI Y, 1995, PLANT CELL PHYSIOL, V36, P505, DOI 10.1093/oxfordjournals.pcp.a078786; Kim ST, 2008, PROTEOMICS, V8, P3577, DOI 10.1002/pmic.200800183; Kundu N, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24012; Leymarie J, 2012, PLANT CELL PHYSIOL, V53, P96, DOI 10.1093/pcp/pcr129; Li Da-hong, 2008, Zhongguo Shuidao Kexue, V22, P447; Li DC, 2011, ENZYM RES, V2011, DOI DOI 10.1016/J.CATT0D.2011.04.007; Liu Jian, 2012, PLoS One, V7, pe33817, DOI 10.1371/journal.pone.0033817; Liu YG, 2010, J EXP BOT, V61, P2979, DOI 10.1093/jxb/erq125; Muller K, 2010, PROTEOMICS, V10, P406, DOI 10.1002/pmic.200900548; Muller K, 2009, NEW PHYTOL, V184, P885, DOI 10.1111/j.1469-8137.2009.03005.x; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Nonogaki H, 2010, PLANT SCI, V179, P574, DOI 10.1016/j.plantsci.2010.02.010; Okamoto M, 2010, PLANT J, V62, P39, DOI 10.1111/j.1365-313X.2010.04135.x; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Oracz K, 2009, PLANT PHYSIOL, V150, P494, DOI 10.1104/pp.109.138107; QUARRIE SA, 1988, PLANTA, V173, P330, DOI 10.1007/BF00401020; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Wamaitha MJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-35; Wang PT, 2008, NEW PHYTOL, V178, P703, DOI 10.1111/j.1469-8137.2008.02431.x; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Ye NH, 2012, J EXP BOT, V63, P1809, DOI 10.1093/jxb/err336; Zhu GH, 2009, PLANT CELL PHYSIOL, V50, P644, DOI 10.1093/pcp/pcp022	53	33	37	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97120	10.1371/journal.pone.0097120	http://dx.doi.org/10.1371/journal.pone.0097120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	25072699	Green Published, gold			2022-12-27	WOS:000336914100011
J	Johnson, SN; Lopaticki, G; Hartley, SE				Johnson, Scott N.; Lopaticki, Goran; Hartley, Susan E.			Elevated Atmospheric CO2 Triggers Compensatory Feeding by Root Herbivores on a C-3 but Not a C-4 Grass	PLOS ONE			English	Article							RISING CO2; CARBON; PERFORMANCE; NITROGEN; GROWTH	Predicted increases in atmospheric carbon dioxide (CO2) concentrations often reduce nutritional quality for herbivores by increasing the C:N ratio of plant tissue. This frequently triggers compensatory feeding by aboveground herbivores, whereby they consume more shoot material in an attempt to meet their nutritional needs. Little, however, is known about how root herbivores respond to such changes. Grasslands are particularly vulnerable to root herbivores, which can collectively exceed the mass of mammals grazing aboveground. Here we provide novel evidence for compensatory feeding by a grass root herbivore, Sericesthis nigrolineata, under elevated atmospheric CO2 (600 mmol mol(-1)) on a C-3 (Microlaena stipoides) but not a C-4 (Cymbopogon refractus) grass species. At ambient CO2 (400 mu mol mol(-1)) M. stipoides roots were 44% higher in nitrogen (N) and 7% lower in carbon (C) concentrations than C. refractus, with insects performing better on M. stipoides. Elevated CO2 decreased N and increased C: N in M. stipoides roots, but had no impact on C. refractus roots. Root-feeders displayed compensatory feeding on M. stipoides at elevated CO2, consuming 118% more tissue than at ambient atmospheric CO2. Despite this, root feeder biomass remained depressed by 24%. These results suggest that compensatory feeding under elevated atmospheric CO2 may make some grass species particularly vulnerable to attack, potentially leading to future shifts in the community composition of grasslands.	[Johnson, Scott N.; Lopaticki, Goran] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia; [Hartley, Susan E.] Univ York, Dept Biol, York Environm Sustainabil Inst, York YO10 5DD, N Yorkshire, England	Western Sydney University; University of York - UK	Johnson, SN (corresponding author), Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia.	Scott.Johnson@uws.edu.au	Johnson, Scott/HDN-6310-2022; Johnson, Scott N/B-2268-2012; Gemmell, Neil/C-6774-2009	Johnson, Scott/0000-0002-8388-8345; Rosengrave, Patrice/0000-0001-8421-3094; Gemmell, Neil/0000-0003-0671-3637; Carne, Alan/0000-0003-3665-1940; Hartley, Sue/0000-0002-5117-687X; Kleffmann, Torsten/0000-0001-9305-5980	Hawkesbury Institute for the Environment	Hawkesbury Institute for the Environment	The authors are grateful to the Hawkesbury Institute for the Environment for funding this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Barbehenn RV, 2004, GLOBAL CHANGE BIOL, V10, P1565, DOI 10.1111/j.1365-2486.2004.00833.x; Barbehenn RV, 2004, OECOLOGIA, V140, P86, DOI 10.1007/s00442-004-1572-9; Barbehenn RV, 2004, OECOLOGIA, V140, P96, DOI 10.1007/s00442-004-1555-x; Barnett K, 2013, ADV INSECT PHYSIOL, V45, P1, DOI 10.1016/B978-0-12-417165-7.00001-5; Barton CVM, 2010, AGR FOREST METEOROL, V150, P941, DOI 10.1016/j.agrformet.2010.03.001; Blossey B, 2003, ANNU REV ENTOMOL, V48, P521, DOI 10.1146/annurev.ento.48.091801.112700; BRITTON EB, 1978, AUST J ZOOL, P1; CASWELL H, 1973, AM NAT, V107, P465, DOI 10.1086/282851; Dawson LA, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P3, DOI 10.1079/9781845934613.0003; DeLucia EH, 2012, PLANT PHYSIOL, V160, P1677, DOI 10.1104/pp.112.204750; Frew A, 2013, FOREST ECOL MANAG, V306, P275, DOI 10.1016/j.foreco.2013.06.051; Hovenden MJ, 2010, AUSTRAL ECOL, V35, P665, DOI 10.1111/j.1442-9993.2009.02074.x; Johnson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079479; Johnson SN, 2012, ECOLOGY, V93, P2208, DOI 10.1890/11-2272.1; Johnson SN, 2011, GLOBAL CHANGE BIOL, V17, P688, DOI 10.1111/j.1365-2486.2010.02264.x; Johnson SN, 2010, OECOLOGIA, V162, P209, DOI 10.1007/s00442-009-1428-4; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MURRAY PJ, 1992, ANN APPL BIOL, V121, P715, DOI 10.1111/j.1744-7348.1992.tb03480.x; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Salt DT, 1996, OIKOS, V77, P326, DOI 10.2307/3546072; Scheirs J, 2001, ECOLOGY, V82, P410, DOI 10.1890/0012-9658(2001)082[0410:ATOTCC]2.0.CO;2; Seastedt TR, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P54, DOI 10.1079/9781845934613.0054; Simpson S.J., 1990, P111; Staley JT, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P192, DOI 10.1079/9781845934613.0192; Stiling P, 2007, GLOBAL CHANGE BIOL, V13, P1823, DOI 10.1111/j.1365-2486.2007.01392.x; Trumper K, 2009, UNEP RAPID RESPONSE; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; WILLIAMS RE, 1968, J RANGE MANAGE, V21, P355, DOI 10.2307/3896081	30	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2014	9	3							e90251	10.1371/journal.pone.0090251	http://dx.doi.org/10.1371/journal.pone.0090251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6FV	24651855	Green Published, Green Submitted, gold			2022-12-27	WOS:000333352800012
J	Lin, YF; Nagasawa, H; Little, JB; Kato, TA; Shih, HY; Xie, XJ; Wilson, PF; Brogan, JR; Kurimasa, A; Chen, DJ; Bedford, JS; Chen, BPC				Lin, Yu-Fen; Nagasawa, Hatsumi; Little, John B.; Kato, Takamitsu A.; Shih, Hung-Ying; Xie, Xian-Jin; Wilson, Paul F., Jr.; Brogan, John R.; Kurimasa, Akihiro; Chen, David J.; Bedford, Joel S.; Chen, Benjamin P. C.			Differential Radiosensitivity Phenotypes of DNA-PKcs Mutations Affecting NHEJ and HRR Systems following Irradiation with Gamma-Rays or Very Low Fluences of Alpha Particles	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; SISTER-CHROMATID EXCHANGES; RADIATION-SENSITIVE MUTANT; POTENTIALLY LETHAL DAMAGE; CELL-CYCLE PROGRESSION; DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; CHROMOSOME-ABERRATIONS; CATALYTIC SUBUNIT	We have examined cell-cycle dependence of chromosomal aberration induction and cell killing after high or low dose-rate gamma irradiation in cells bearing DNA-PKcs mutations in the S2056 cluster, the T2609 cluster, or the kinase domain. We also compared sister chromatid exchanges (SCE) production by very low fluences of alpha-particles in DNA-PKcs mutant cells, and in homologous recombination repair (HRR) mutant cells including Rad51C, Rad51D, and Fancg/xrcc9. Generally, chromosomal aberrations and cell killing by gamma-rays were similarly affected by mutations in DNA-PKcs, and these mutant cells were more sensitive in G(1) than in S/G(2) phase. In G(1)-irradiated DNA-PKcs mutant cells, both chromosome- and chromatid-type breaks and exchanges were in excess than wild-type cells. For cells irradiated in late S/G(2) phase, mutant cells showed very high yields of chromatid breaks compared to wild-type cells. Few exchanges were seen in DNA-PKcs-null, Ku80-null, or DNA-PKcs kinase dead mutants, but exchanges in excess were detected in the S2506 or T2609 cluster mutants. SCE induction by very low doses of alpha-particles is resulted from bystander effects in cells not traversed by alpha-particles. SCE seen in wild-type cells was completely abolished in Rad51C- or Rad51D-deficient cells, but near normal in Fancg/xrcc9 cells. In marked contrast, very high levels of SCEs were observed in DNA-PKcs-null, DNA-PKcs kinase-dead and Ku80-null mutants. SCE induction was also abolished in T2609 cluster mutant cells, but was only slightly reduced in the S2056 cluster mutant cells. Since both non-homologous end-joining (NHEJ) and HRR systems utilize initial DNA lesions as a substrate, these results suggest the possibility of a competitive interference phenomenon operating between NHEJ and at least the Rad51C/D components of HRR; the level of interaction between damaged DNA and a particular DNA-PK component may determine the level of interaction of such DNA with a relevant HRR component.	[Lin, Yu-Fen; Shih, Hung-Ying; Chen, David J.; Chen, Benjamin P. C.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Nagasawa, Hatsumi; Kato, Takamitsu A.; Brogan, John R.; Bedford, Joel S.] Colorado State Univ, Dept & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Little, John B.] Harvard Univ, Sch Med, Dept Genet & Complex Dis, Boston, MA USA; [Xie, Xian-Jin] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Wilson, Paul F., Jr.] Brookhaven Natl Lab, Dept Biosci, Upton, NY 11973 USA; [Kurimasa, Akihiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Tottori 680, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; Colorado State University; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Brookhaven National Laboratory	Chen, BPC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	benjamin.chen@utsouthwestern.edu	Kato, Takamitsu A/D-7969-2015; Lin, Yu-Fen/A-2570-2016	Kato, Takamitsu/0000-0002-6263-600X	National Cancer Institute/National Institutes of Health [CA166677]; U.S. Department of Energy Low Dose Radiation Research Program [DE-FG02-07ER64350, DE-FG02-05ER64089]; Cancer Prevention Research Institute of Texas [RP110465-P1]; NATIONAL CANCER INSTITUTE [R01CA162804, R01CA166677] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy Low Dose Radiation Research Program(United States Department of Energy (DOE)); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA166677 from the National Cancer Institute/National Institutes of Health, DE-FG02-07ER64350 and DE-FG02-05ER64089 from the U.S. Department of Energy Low Dose Radiation Research Program, and RP110465-P1 from the Cancer Prevention Research Institute of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLETT CF, 1980, CANCER RES, V40, P926; Bedford JS, 2002, RADIAT RES, V158, P251, DOI 10.1667/0033-7587(2002)158[0251:HACHIR]2.0.CO;2; BEDFORD JS, 1978, RADIAT RES, V76, P573, DOI 10.2307/3574806; CARRANO AV, 1973, MUTAT RES, V17, P341, DOI 10.1016/0027-5107(73)90006-7; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; CORNFORTH MN, 1987, RADIAT RES, V111, P385, DOI 10.2307/3576926; COX R, 1978, ARCH DIS CHILD, V53, P386, DOI 10.1136/adc.53.5.386; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; DEWEY WC, 1971, P NATL ACAD SCI USA, V68, P667, DOI 10.1073/pnas.68.3.667; DEWEY WC, 1962, RADIAT RES, V16, P503, DOI 10.2307/3571085; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; DRITSCHILO A, 1984, RADIAT RES, V100, P387, DOI 10.2307/3576359; FORNACE AJ, 1980, MUTAT RES, V70, P323, DOI 10.1016/0027-5107(80)90022-6; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; HALL EJ, 1964, RADIAT RES, V22, P305, DOI 10.2307/3571661; Hashimoto M, 2001, J BIOL CHEM, V276, P12827, DOI 10.1074/jbc.M010906200; HIGURASHI M, 1973, CANCER-AM CANCER SOC, V32, P380, DOI 10.1002/1097-0142(197308)32:2<380::AID-CNCR2820320214>3.0.CO;2-2; Hinz JM, 2006, NUCLEIC ACIDS RES, V34, P1358, DOI 10.1093/nar/gkl020; Hsu FM, 2012, TRANSL CANCER RES, V1, P22, DOI 10.3978/j.issn.2218-676X.2012.04.01; HSU TC, 1958, J NATL CANCER I, V21, P437; ILIAKIS GE, 1991, INT J RADIAT BIOL, V59, P321, DOI 10.1080/09553009114550311; JEGGO PA, 1982, BIOCHIMIE, V64, P713, DOI 10.1016/S0300-9084(82)80116-8; Jeggo PA, 2006, DNA REPAIR, V5, P1192, DOI 10.1016/j.dnarep.2006.05.011; JONES NJ, 1987, MUTAT RES, V183, P279, DOI 10.1016/0167-8817(87)90011-3; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; Leenhouts HP, 1978, ADV RADIAT BIOL, P55; Lin JYD, 1997, RADIAT RES, V147, P166, DOI 10.2307/3579417; LITTLE JB, 1985, RADIAT RES, V101, P81, DOI 10.2307/3576305; METTING NF, 1995, HEALTH PHYS, V68, P710, DOI 10.1097/00004032-199505000-00012; NAGASAWA H, 1985, MUTAT RES, V148, P71, DOI 10.1016/0027-5107(85)90209-X; Nagasawa H, 2005, RADIAT RES, V164, P141, DOI 10.1667/RR3420; NAGASAWA H, 1981, RADIAT RES, V87, P538, DOI 10.2307/3575519; NAGASAWA H, 1989, RADIAT RES, V118, P559, DOI 10.2307/3577413; NAGASAWA H, 1983, MUTAT RES, V107, P315, DOI 10.1016/0027-5107(83)90173-2; NAGASAWA H, 1994, INT J RADIAT BIOL, V66, P373, DOI 10.1080/09553009414551311; NAGASAWA H, 1992, CANCER RES, V52, P6394; NAGASAWA H, 1992, RADIAT RES, V132, P375, DOI 10.2307/3578247; NAGASAWA H, 1983, MUTAT RES, V109, P297, DOI 10.1016/0027-5107(83)90054-4; Nagasawa H, 2008, DNA REPAIR, V7, P515, DOI 10.1016/j.dnarep.2007.11.014; Nagasawa H, 2011, RADIAT RES, V175, P83, DOI 10.1667/RR2092.1; Nagasawa H, 2010, MUTAT RES-GEN TOX EN, V701, P12, DOI 10.1016/j.mrgentox.2010.03.003; NATARAJAN AT, 1979, HUM GENET, V52, P127; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PARSHAD R, 1983, P NATL ACAD SCI-BIOL, V80, P5612, DOI 10.1073/pnas.80.18.5612; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Perryman LE, 2004, VET PATHOL, V41, P95, DOI 10.1354/vp.41-2-95; Priestley A, 1998, NUCLEIC ACIDS RES, V26, P1965, DOI 10.1093/nar/26.8.1965; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Revell SH., 1983, RAD INDUCED CHROMOSO, P215; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Scott D, 1993, ATAXIA TELANGIECTASI, P101; Shao ZP, 2012, DNA REPAIR, V11, P310, DOI 10.1016/j.dnarep.2011.12.007; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; STACKHOUSE MA, 1993, RADIAT RES, V136, P241, DOI 10.2307/3578617; STACKHOUSE MA, 1994, INT J RADIAT BIOL, V65, P571, DOI 10.1080/09553009414550661; STACKHOUSE MA, 1993, RADIAT RES, V136, P250, DOI 10.2307/3578618; Sun J, 2012, J BIOL CHEM, V287, P4936, DOI 10.1074/jbc.M111.306167; TAYLOR AMR, 1976, NATURE, V260, P441, DOI 10.1038/260441a0; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Tebbs RS, 2005, DNA REPAIR, V4, P11, DOI 10.1016/j.dnarep.2004.06.013; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; THOMPSON LH, 1980, MUTAT RES, V74, P21, DOI 10.1016/0165-1161(80)90188-0; TOBEY RA, 1971, CANCER RES, V31, P46; Wang XS, 2008, CANCER RES, V68, P971, DOI 10.1158/0008-5472.CAN-07-6272; WEICHSELBAUM RR, 1978, NATURE, V271, P261, DOI 10.1038/271261a0; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881; ZAMPETTIBOSSELER F, 1981, INT J RADIAT BIOL, V39, P547, DOI 10.1080/09553008114550651; ZDZIENICKA MZ, 1987, MUTAT RES, V178, P235, DOI 10.1016/0027-5107(87)90274-0; Zhang SC, 2011, J CELL BIOL, V193, P295, DOI 10.1083/jcb.201009074	74	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93579	10.1371/journal.pone.0093579	http://dx.doi.org/10.1371/journal.pone.0093579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714417	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900037
J	Luo, Y; He, FL; Hu, L; Hai, L; Huang, MF; Xu, ZP; Zhang, JJ; Zhou, ZG; Liu, F; Dai, YS				Luo, Yan; He, Fengli; Hu, Li; Hai, Luo; Huang, Meifeng; Xu, Zhipeng; Zhang, Jingjing; Zhou, Zhiguang; Liu, Feng; Dai, Yan-Shan			Transcription Factor Ets1 Regulates Expression of Thioredoxin-Interacting Protein and Inhibits Insulin Secretion in Pancreatic beta-Cells	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; GENE-EXPRESSION; OXIDATIVE STRESS; GLUCOSE; INFLAMMASOME; ACTIVATION; KINASE; TXNIP; LINK; PHOSPHORYLATION	Long-term activation of extracellular-regulated kinase (ERK1/2) pathway has been shown to cause glucotoxicity and inhibit insulin gene expression in beta-cells. Transcription factor Ets1 is activated by ERK1/2-mediated phosphorylation at the Thr38 residue. We hypothesize that Ets1 plays an important role in mediating ERK1/2 induced glucotoxicity in beta-cells. We determined the role of Ets1 in Min6 cells and isolated mouse islets using overexpression and siRNA mediated knockdown of Ets1. The results show that Ets1 was localized in insulin-staining positive cells but not in glucagon-staining positive cells. Overexpression of Ets1 reduced glucose-stimulated insulin secretion in primary mouse islets. Overexpression of Ets1 in Min6 beta-cells and mouse islets increased expression of thioredoxin-interacting protein (TXNIP). Conversely, knockdown of Ets1 by siRNA reduced expression of TXNIP in Min6 cells. Ets1 was associated with the txnip promoter in min6 cells and transfection of 293 cells with Ets1 and p300 synergistically increased txnip promoter reporter activity. Moreover, overexpression of Ets1 inhibited Min6 cell proliferation. Our results suggest that Ets1, by promoting TXNIP expression, negatively regulates beta-cell function. Thus, over-activation of Ets1 may contribute to diet-induced beta-cell dysfunction.	[Luo, Yan; He, Fengli; Hu, Li; Hai, Luo; Huang, Meifeng; Xu, Zhipeng; Zhang, Jingjing; Zhou, Zhiguang; Liu, Feng; Dai, Yan-Shan] Cent S Univ, Xiangya Hosp 2, Minist Educ, Metab Syndrome Res Ctr,Key Lab Diabet Immunol, Changsha, Hunan, Peoples R China; [Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA	Central South University; University of Texas System; University of Texas Health San Antonio	Dai, YS (corresponding author), Cent S Univ, Xiangya Hosp 2, Minist Educ, Metab Syndrome Res Ctr,Key Lab Diabet Immunol, Changsha, Hunan, Peoples R China.	ydai88@csu.edu.cn	Hai, Luo/ABE-5483-2020; Dai, Yanshan/B-8577-2009; Chen, Huai/AAI-1024-2020; Chen, Huai/A-7418-2015; Zhang, Yao/P-2009-2015	Chen, Huai/0000-0001-7650-289X; Zhou, Zhiguang/0000-0002-0374-1838; Dai, Yanshan/0000-0001-5048-7417; Yang, Yanzheng/0000-0002-3299-0403; Chen, Huai/0000-0001-6208-1481; Zhang, Yao/0000-0002-7468-2409	Natural Science Foundation of China [81270905, 81130015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of China grant no. 81270905 (Y.-S. Dai) and 81130015 (F. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MQ, 2011, HUM MOL GENET, V20, P165, DOI 10.1093/hmg/ddq455; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Cha-Molstad H, 2009, J BIOL CHEM, V284, P16898, DOI 10.1074/jbc.M109.010504; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2014, MOL ENDOCRINOL, V28, P674, DOI 10.1210/me.2014-1041; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; Choy WW, 2014, ACTA CRYSTALLOGR F, V70, P44, DOI 10.1107/S2053230X13024795; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Fang SH, 2011, MOL CELL BIOCHEM, V347, P175, DOI 10.1007/s11010-010-0626-z; Fontes G, 2009, DIABETES, V58, P2048, DOI 10.2337/db08-0579; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Goehring I, 2011, DIABETOLOGIA, V54, P2584, DOI 10.1007/s00125-011-2249-7; Hamzaoui H, 2007, MOL CELL ENDOCRINOL, V268, P75, DOI 10.1016/j.mce.2007.01.014; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; Hashiguchi K, 2010, BIOCHEM BIOPH RES CO, V391, P621, DOI 10.1016/j.bbrc.2009.11.109; He XQ, 2012, MOL PHARMACOL, V82, P887, DOI 10.1124/mol.112.081133; Jayaraman G, 1999, J BIOL CHEM, V274, P17342, DOI 10.1074/jbc.274.24.17342; Jin CC, 2010, IMMUNOL CELL BIOL, V88, P510, DOI 10.1038/icb.2010.56; Jing G, 2014, J BIOL CHEM, V289, P11807, DOI 10.1074/jbc.M113.525022; Kanari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059026; Kibbe C, 2013, J BIOL CHEM, V288, P23194, DOI 10.1074/jbc.M113.473082; Kumar P, 2009, HYPERTENSION, V54, P172, DOI 10.1161/HYPERTENSIONAHA.109.133033; Lawrence M, 2008, ACTA PHYSIOL, V192, P11, DOI 10.1111/j.1748-1716.2007.01785.x; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Lombardi A, 2012, DIABETOLOGIA, V55, P141, DOI 10.1007/s00125-011-2315-1; Luo Y, 2013, DIABETES, V62, pA582; Nelson ML, 2010, P NATL ACAD SCI USA, V107, P10026, DOI 10.1073/pnas.0915137107; Oka S, 2009, ENDOCRINOLOGY, V150, P1225, DOI 10.1210/en.2008-0646; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Poungvarin N, 2012, DIABETOLOGIA, V55, P1783, DOI 10.1007/s00125-012-2506-4; Rani S, 2010, CELL PHYSIOL BIOCHEM, V25, P667, DOI 10.1159/000315086; Sarkar A, 2011, FASEB J, V25, P2592, DOI 10.1096/fj.10-173757; Tsao HW, 2013, P NATL ACAD SCI USA, V110, P15776, DOI 10.1073/pnas.1304343110; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; Yoshihara E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1127; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Zhang JJ, 2012, DIABETES, V61, P3189, DOI 10.2337/db12-0249; Zhang XF, 2014, ENDOCRINE, V46, P470, DOI 10.1007/s12020-013-0114-9; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	47	30	32	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2014	9	6							e99049	10.1371/journal.pone.0099049	http://dx.doi.org/10.1371/journal.pone.0099049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK4YO	24897113	Green Submitted, gold, Green Published			2022-12-27	WOS:000338430700109
J	Cousins, SAO; Kaligaric, M; Bakan, B; Lindborg, R				Cousins, Sara A. O.; Kaligaric, Mitja; Bakan, Branko; Lindborg, Regina			Political Systems Affect Mobile and Sessile Species Diversity - A Legacy from the Post-WWII Period	PLOS ONE			English	Article							LAND-USE CHANGE; EXTINCTION DEBT; LANDSCAPE PERSPECTIVES; HABITAT HETEROGENEITY; DRIVING FORCES; USE HISTORY; BIODIVERSITY; CONSERVATION; GRASSLANDS; RICHNESS	Political ideologies, policies and economy affect land use which in turn may affect biodiversity patterns and future conservation targets. However, few studies have investigated biodiversity in landscapes with similar physical properties but governed by different political systems. Here we investigate land use and biodiversity patterns, and number and composition of birds and plants, in the borderland of Austria, Slovenia and Hungary. It is a physically uniform landscape but managed differently during the last 70 years as a consequence of the political "map" of Europe after World War I and II. We used a historical map from 1910 and satellite data to delineate land use within three 10-kilometre transects starting from the point where the three countries meet. There was a clear difference between countries detectable in current biodiversity patterns, which relates to land use history. Mobile species richness was associated with current land use whereas diversity of sessile species was more associated with past land use. Heterogeneous landscapes were positively and forest cover was negatively correlated to bird species richness. Our results provide insights into why landscape history is important to understand present and future biodiversity patterns, which is crucial for designing policies and conservation strategies across the world.	[Cousins, Sara A. O.; Lindborg, Regina] Stockholm Univ, Dept Phys Geog & Quaternary Geol, Landscape Ecol, S-10691 Stockholm, Sweden; [Kaligaric, Mitja; Bakan, Branko] Univ Maribor, Fac Nat Sci & Math, Dept Biol, Maribor, Slovenia; [Kaligaric, Mitja] Univ Maribor, Fac Agr & Life Sci, Hoce, Slovenia	Stockholm University; University of Maribor; University of Maribor	Cousins, SAO (corresponding author), Stockholm Univ, Dept Phys Geog & Quaternary Geol, Landscape Ecol, S-10691 Stockholm, Sweden.	sara.cousins@natgeo.su.se	Cousins, Sara/A-2437-2012; Staab, Jeffrey/B-8792-2015	Cousins, Sara/0000-0003-2656-2645; Seemungal, Barry/0000-0002-6578-0904; Staab, Jeffrey/0000-0002-1516-3131; Kaski, Diego/0000-0002-0591-646X	program group "Biodiversity" [P1-0078]; Slovenian Research Agency; FORMAS; Slovenian Research Agency [P1-0164]	program group "Biodiversity"; Slovenian Research Agency(Slovenian Research Agency - Slovenia); FORMAS(Swedish Research Council Formas); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	Funding was provided by the program group "Biodiversity" (P1-0078) and granted by Slovenian Research Agency to MK and by FORMAS to SC and RL. MK was supported by program group P1-0164, funded by Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggemyr E, 2012, J BIOGEOGR, V39, P1645, DOI 10.1111/j.1365-2699.2012.02733.x; [Anonymous], 2002, PRAVILNIK UVRSTITVI; Bakan B, 2006, SLIKOVNI PREGLAD VIS; Baldi A, 2011, IBIS, V153, P875, DOI 10.1111/j.1474-919X.2011.01169.x; Balmford A, 2005, GLOBAL CHANGE BIOL, V11, P1594, DOI 10.1111/j.1365-2486.2005.001035.x; Batary P, 2011, FRONT ECOL ENVIRON, V9, P152, DOI 10.1890/11.WB.006; Bender O, 2005, LANDSCAPE ECOL, V20, P149, DOI 10.1007/s10980-003-1506-7; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Bommarco R, 2014, DIVERS DISTRIB, V20, P591, DOI 10.1111/ddi.12187; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; Cousins SAO, 2007, LANDSCAPE ECOL, V22, P723, DOI 10.1007/s10980-006-9067-1; Cousins SAO, 2009, BIOL CONSERV, V142, P2752, DOI 10.1016/j.biocon.2009.07.001; Cousins SAO, 2009, J VEG SCI, V20, P3, DOI 10.1111/j.1654-1103.2009.05647.x; Cousins SAO, 2008, APPL VEG SCI, V11, P365, DOI 10.3170/2008-7-18480; Donlan CJ, 2006, AM NAT, V168, P660, DOI 10.1086/508027; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Eriksson O, 2014, LAND-BASEL, V3, P300, DOI 10.3390/land3010300; Ewers RM, 2013, ECOL LETT, V16, P1221, DOI 10.1111/ele.12160; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fischer J, 2008, DIVERS DISTRIB, V14, P38, DOI 10.1111/j.1472-4642.2007.00411.x; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; Geister I., 1995, ORNITOLOSKI ATLAS SL; Gergely K, 2007, VOROS LISTA MAGYAROR; Gobster PH, 2007, LANDSCAPE ECOL, V22, P959, DOI 10.1007/s10980-007-9110-x; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hooftman DAP, 2012, BIOL CONSERV, V145, P30, DOI 10.1016/j.biocon.2011.09.015; Ibbe M, 2011, FOREST ECOL MANAG, V261, P1885, DOI 10.1016/j.foreco.2011.02.011; Katoh K, 2009, BIOL CONSERV, V142, P1930, DOI 10.1016/j.biocon.2009.02.030; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Kuemmerle T, 2008, ECOSYSTEMS, V11, P614, DOI 10.1007/s10021-008-9146-z; Kuemmerle T, 2009, REG ENVIRON CHANGE, V9, P1, DOI 10.1007/s10113-008-0050-z; KULL K, 1991, J VEG SCI, V2, P715, DOI 10.2307/3236182; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Liira J, 2008, J VEG SCI, V19, P3, DOI 10.3170/2007-8-18308; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Lindborg R, 2008, AGR ECOSYST ENVIRON, V125, P213, DOI 10.1016/j.agee.2008.01.006; Martincic A, 2007, MALA FLORA SLOVENIJE; Mikusinski G, 1998, CONSERV BIOL, V12, P200, DOI 10.1046/j.1523-1739.1998.96310.x; Navarro LM, 2012, ECOSYSTEMS, V15, P900, DOI 10.1007/s10021-012-9558-7; Niklfeld H, 1986, ROTE LISTEN GEFAHRDE; Ockinger E, 2012, ECOGRAPHY, V35, P259, DOI 10.1111/j.1600-0587.2011.06870.x; Plieninger T, 2006, ENVIRON SCI POLICY, V9, P317, DOI 10.1016/j.envsci.2006.03.001; Primdahl J., 2010, GLOBALISATION AGR LA; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Serra P, 2008, APPL GEOGR, V28, P189, DOI 10.1016/j.apgeog.2008.02.001; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Sutherland WJ, 2002, TRENDS ECOL EVOL, V17, P148, DOI 10.1016/S0169-5347(01)02421-1; Svensson L., 2009, BIRDS EUROPE; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Vandermeer J, 2007, CONSERV BIOL, V21, P274, DOI 10.1111/j.1523-1739.2006.00582.x; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; Wilson JB, 2012, J VEG SCI, V23, P796, DOI 10.1111/j.1654-1103.2012.01400.x; Zurita GA, 2010, LANDSCAPE ECOL, V25, P147, DOI 10.1007/s10980-009-9410-4; [No title captured]	59	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2014	9	8							e103367	10.1371/journal.pone.0103367	http://dx.doi.org/10.1371/journal.pone.0103367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM4JL	25084154	gold, Green Submitted, Green Published			2022-12-27	WOS:000339819800034
J	Zhang, BZ; Cai, GJ; Wang, HT; Li, D; Yang, XJ; An, XL; Zheng, XW; Tian, Y; Zheng, W; Zheng, TL				Zhang, Bangzhou; Cai, Guanjing; Wang, Haitao; Li, Dong; Yang, Xujun; An, Xinli; Zheng, Xiaowei; Tian, Yun; Zheng, Wei; Zheng, Tianling			Streptomyces alboflavus RPS and Its Novel and High Algicidal Activity against Harmful Algal Bloom Species Phaeocystis globosa	PLOS ONE			English	Article							TOXIC DINOFLAGELLATE; MICROCYSTIS-AERUGINOSA; POPULATION-DYNAMICS; MARINE; BACTERIUM; IDENTIFICATION; CYANOBACTERIA; ACTINOMYCETE; MECHANISMS; COMPOUND	Phaeocystis globosa blooms have frequently occurred along coastal waters and exerted serious impacts on ecological environments by releasing toxic hemolytic substances, forming nuisance foam, and causing oxygen depletion. An actinomycete strain RPS with high algicidal activity against P. globosa was isolated and identified as Streptomyces alboflavus, based on morphology, physiological and biochemical characteristics, and 16S rDNA sequence analysis. RPS lysed 95% of P. globosa within 48 h by releasing an extracellular active substance into the growth medium. The activity of RPS supernatant was sensitive to temperature at and above 50 degrees C and insensitive to pH from 3 to 11. The molecular weight of the active substance was between 100 Da and 1000 Da, and approximately 90% of it was extracted by ethyl acetate. It was presumed that the active component efficiently inhibited the movement of P. globosa, caused the flagella to fall off the algae, and finally lysed the algal cells. RPS showed a wide target range against harmful algae. S. alboflavus RPS with high algicidal activity and such novel features of temperature and pH sensitivity, low molecular weight, algicidal process, and target range possesses great potential in the biological control of P. globosa blooms.	[Zheng, Wei] Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China; Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Zheng, W (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	jedi@xmu.edu.cn; microzh@xmu.edu.cn	Zhang, Bangzhou/CAG-9625-2022; Cai, Guanjing/GZK-7070-2022; Zhao, Lin/M-9536-2018	Zhao, Lin/0000-0003-0245-8413	National Natural Science Foundation of China [40930847, 41376119]; Public Science and Technology Research Funds Projects of Ocean [201305016]; Special Fund for Ph.D. Programs in the University [20120121130001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Science and Technology Research Funds Projects of Ocean; Special Fund for Ph.D. Programs in the University	This work was supported by the National Natural Science Foundation of China (40930847, 41376119) (http://www.nsfc.gov.cn/publish/portal0/default.htm), the Public Science and Technology Research Funds Projects of Ocean (201305016) (http://www.soa.gov.cn/), and the Special Fund for Ph.D. Programs in the University (20120121130001) (http://www.cutech.edu.cn/cn/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actinomycete Classification Group of CAS, 1975, MAN STREPT ID, P13; Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Anderson DM, 2009, OCEAN COAST MANAGE, V52, P342, DOI 10.1016/j.ocecoaman.2009.04.006; Arnoux P, 2009, PLANT CELL, V21, P2036, DOI 10.1105/tpc.109.068007; Bai SJJ, 2011, CURR MICROBIOL, V62, P1774, DOI 10.1007/s00284-011-9927-z; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Baudoux AC, 2005, VIROLOGY, V341, P80, DOI 10.1016/j.virol.2005.07.002; Blauw AN, 2010, J MARINE SYST, V83, P115, DOI 10.1016/j.jmarsys.2010.05.003; Cai WW, 2011, APPL ENVIRON MICROB, V77, P7837, DOI 10.1128/AEM.05783-11; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; Hai DN, 2010, J MARINE SYST, V83, P253, DOI 10.1016/j.jmarsys.2010.04.015; Fei XG, 2004, HYDROBIOLOGIA, V512, P145, DOI 10.1023/B:HYDR.0000020320.68331.ce; Gumbo RJ, 2008, AFR J BIOTECHNOL, V7, P4765; Guo ZY, 2009, J ANTIBIOT, V62, P201, DOI 10.1038/ja.2009.15; Jeong HJ, 2008, HARMFUL ALGAE, V7, P368, DOI 10.1016/j.hal.2007.12.004; Jessup DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004550; Kodama M, 2006, ECOL STU AN, V189, P243, DOI 10.1007/978-3-540-32210-8_19; Kodani S, 2002, J APPL PHYCOL, V14, P109, DOI 10.1023/A:1019533414018; Kong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057654; Lamy D, 2009, AQUAT MICROB ECOL, V58, P95, DOI 10.3354/ame01359; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Lee SW, 2013, J HAZARD MATER, V263, P20, DOI 10.1016/j.jhazmat.2013.08.017; Lee YJ, 2008, HARMFUL ALGAE, V7, P154, DOI 10.1016/j.hal.2007.06.004; Li FM, 2005, APPL ENVIRON MICROB, V71, P6545, DOI 10.1128/AEM.71.11.6545-6553.2005; Li L, 2013, ENVIRON SCI TECHNOL, V47, P4555, DOI 10.1021/es305234d; Li PN, 2011, ENVIRON SCI TECHNOL, V45, P4521, DOI 10.1021/es200057g; LISS PS, 1994, J MARINE SYST, V5, P41, DOI 10.1016/0924-7963(94)90015-9; Manset KJV, 2013, J ENVIRON SCI MANAG, P11; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Mayali X, 2002, HARMFUL ALGAE, V1, P277, DOI 10.1016/S1568-9883(02)00032-X; Meuser D, 1999, FEBS LETT, V462, P447, DOI 10.1016/S0014-5793(99)01579-3; Monchy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039924; Nakashima T, 2006, AQUAT MICROB ECOL, V45, P255, DOI 10.3354/ame045255; Nayak BB, 2000, WORLD J MICROB BIOT, V16, P99, DOI 10.1023/A:1008934406780; Ni LX, 2012, CHEMOSPHERE, V88, P1051, DOI 10.1016/j.chemosphere.2012.05.009; Nishitarumizu S, 2011, FISHERIES SCI, P1; Orton JH, 1923, NATURE, V111, P773, DOI 10.1038/111773a0; Ozaki K, 2008, CHEMOSPHERE, V71, P1531, DOI 10.1016/j.chemosphere.2007.11.052; Paul C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021032; Peng XC, 2005, J INTEGR PLANT BIOL, V47, P165, DOI 10.1111/j.1744-7909.2005.00039.x; Peperzak L, 2008, J SEA RES, V60, P220, DOI 10.1016/j.seares.2008.06.001; Qi YZ, 2004, HYDROBIOLOGIA, V512, P209, DOI 10.1023/B:HYDR.0000020329.06666.8c; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Seong Kyeong Ah, 2011, Ocean Science Journal, V46, P105, DOI 10.1007/s12601-011-0010-2; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Skerratt JH, 2002, MAR ECOL PROG SER, V244, P1, DOI 10.3354/meps244001; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Wang BX, 2010, LETT APPL MICROBIOL, V51, P552, DOI 10.1111/j.1472-765X.2010.02936.x; Wang BX, 2012, HARMFUL ALGAE, V13, P83, DOI 10.1016/j.hal.2011.10.006; Wang XL, 2005, HARMFUL ALGAE, V4, P433, DOI 10.1016/j.hal.2004.06.001; Yamamoto Y, 1998, J APPL PHYCOL, V10, P391, DOI 10.1023/A:1008077414808; Yan Rong-jun, 2011, Huanjing Kexue, V32, P225; Yang CY, 2012, HARMFUL ALGAE, V20, P132, DOI 10.1016/j.hal.2012.09.002; Yoshikawa K, 2000, APPL ENVIRON MICROB, V66, P718, DOI 10.1128/AEM.66.2.718-722.2000; Zhang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063018; Zhang SJ, 2012, ENVIRON SCI TECHNOL, V46, P8764, DOI 10.1021/es301000m; Zheng XW, 2013, APPL MICROBIOL BIOT, V97, P9207, DOI 10.1007/s00253-012-4617-8; Zhou LH, 2007, HARMFUL ALGAE, V6, P354, DOI 10.1016/j.hal.2006.10.002	62	64	80	12	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2014	9	3							e92907	10.1371/journal.pone.0092907	http://dx.doi.org/10.1371/journal.pone.0092907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SW	24675867	gold, Green Submitted, Green Published			2022-12-27	WOS:000333677500054
J	Deng, Y; Sun, MZ; Lin, PH; Ma, JJ; Shaevitz, JW				Deng, Yi; Sun, Mingzhai; Lin, Pei-Hui; Ma, Jianjie; Shaevitz, Joshua W.			Spatial Covariance Reconstructive (SCORE) Super-Resolution Fluorescence Microscopy	PLOS ONE			English	Article							LOCALIZATION; RESOLUTION; BLINKING; PROTEIN; BREAKING; LIMIT	Super-resolution fluorescence microscopy has become a powerful tool to resolve structural information that is not accessible to traditional diffraction-limited imaging techniques such as confocal microscopy. Stochastic optical reconstruction microscopy (STORM) and photoactivation localization microscopy (PALM) are promising super-resolution techniques due to their relative ease of implementation and instrumentation on standard microscopes. However, the application of STORM is critically limited by its long sampling time. Several recent works have been focused on improving the STORM imaging speed by making use of the information from emitters with overlapping point spread functions (PSF). In this work, we present a fast and efficient algorithm that takes into account the blinking statistics of independent fluorescence emitters. We achieve sub-diffraction lateral resolution of 100 nm from 5 to 7 seconds of imaging. Our method is insensitive to background and can be applied to different types of fluorescence sources, including but not limited to the organic dyes and quantum dots that we demonstrate in this work.	[Deng, Yi; Shaevitz, Joshua W.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Sun, Mingzhai; Shaevitz, Joshua W.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Lin, Pei-Hui; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Princeton University; Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Shaevitz, JW (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	shaevitz@princeton.edu	Sun, Mingzhai/B-4945-2012; Deng, Yi/F-9358-2015; Lin, Pei-Hui/I-3011-2015; cui, xiao yong/B-3669-2016	Deng, Yi/0000-0002-6822-6343; Lin, Pei-Hui/0000-0002-3894-5099; Hernandez, Marcela/0000-0002-1041-785X; cui, xiao yong/0000-0001-7592-5866; Dumont, Marc/0000-0002-7347-8668	National Science Foundation [PHY-0844466]; National Institutes of Health [P50GM071508]; Pew Charitable Trusts; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028614] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Science Foundation (PHY-0844466) (www.nsf.gov), the National Institutes of Health (P50GM071508) (www.nih.gov), and The Pew Charitable Trusts (www.pewtrusts.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cordes T, 2009, OPTICAL SOC AM, V7367, p1D; Cox S, 2012, NAT METHODS, V9, P195, DOI [10.1038/NMETH.1812, 10.1038/nmeth.1812]; Dedecker P, 2012, P NATL ACAD SCI USA, V109, P10909, DOI 10.1073/pnas.1204917109; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Dertinger T, 2010, OPT EXPRESS, V18, P18875, DOI 10.1364/OE.18.018875; Geissbuehler S, 2011, BIOMED OPT EXPRESS, V2, P408, DOI 10.1364/BOE.2.000408; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Holden SJ, 2011, NAT METHODS, V8, P279, DOI 10.1038/nmeth0411-279; Hu YS, 2013, NAT METHODS, V10, P96, DOI 10.1038/nmeth.2335; Klar TA, 1999, OPT LETT, V24, P954, DOI 10.1364/OL.24.000954; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; MAUPIN P, 1983, J CELL BIOL, V96, P51, DOI 10.1083/jcb.96.1.51; Mukamel EA, 2012, BIOPHYS J, V102, P2391, DOI 10.1016/j.bpj.2012.03.070; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Rosten E, 2013, NAT METHODS, V10, P97, DOI 10.1038/nmeth.2342; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shimizu KT, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.205316; Stiel AC, 2008, BIOPHYS J, V95, P2989, DOI 10.1529/biophysj.108.130146; Subach FV, 2010, CHEM BIOL, V17, P745, DOI 10.1016/j.chembiol.2010.05.022; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Wang Y, 2013, NANO LETT, V13, P5233, DOI 10.1021/nl4026665; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	34	39	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e94807	10.1371/journal.pone.0094807	http://dx.doi.org/10.1371/journal.pone.0094807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788039	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917300006
J	Yang, YC; Huang, YT; Hsieh, CW; Yang, PM; Wung, BS				Yang, Yan-Chang; Huang, Yu-Ting; Hsieh, Chia-Wen; Yang, Po-Min; Wung, Being-Sun			Carbon Monoxide Induces Heme Oxygenase-1 to Modulate STAT3 Activation in Endothelial Cells via S-Glutathionylation	PLOS ONE			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM-STRESS; CO-RELEASING MOLECULES; THERAPEUTIC APPLICATIONS; GENE-EXPRESSION; UP-REGULATION; JNK PATHWAY; PHOSPHORYLATION; INHIBITION; APOPTOSIS	IL-6/STAT3 pathway is involved in a variety of biological responses, including cell proliferation, differentiation, apoptosis, and inflammation. In our present study, we found that CO releasing molecules (CORMs) suppress IL-6-induced STAT3 phosphorylation, nuclear translocation and transactivity in endothelial cells (ECs). CO is a byproduct of heme degradation mediated by heme oxygenase (HO-1). However, CORMs can induce HO-1 expression and then inhibit STAT3 phosphorylation. CO has been found to increase a low level ROS and which may induce protein glutathionylation. We hypothesized that CORMs increases protein glutathionylation and inhibits STAT3 activation. We found that CORMs increase the intracellular GSSG level and induce the glutathionylation of multiple proteins including STAT3. GSSG can inhibit STAT3 phosphorylation and increase STAT3 glutathionylation whereas the antioxidant enzyme catalase can suppress the glutathionylation. Furthermore, catalase blocks the inhibition of STAT3 phosphorylation by CORMs treatment. The inhibition of glutathione synthesis by BSO was also found to attenuate STAT3 glutathionylation and its inhibition of STAT3 phosphorylation. We further found that HO-1 increases STAT3 glutathionylation and that HO-1 siRNA attenuates CORM-induced STAT3 glutathionylation. Hence, the inhibition of STAT3 activation is likely to occur via a CO-mediated increase in the GSSG level, which augments protein glutathionylation, and CO-induced HO-1 expression, which may enhance and maintain its effects in IL-6-treated ECs.	[Yang, Yan-Chang; Huang, Yu-Ting; Hsieh, Chia-Wen; Wung, Being-Sun] Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Yang, Po-Min] Chiayi Christian Hosp, Dept Ophthalmol, Chiayi, Taiwan	National Chiayi University; Chia-Yi Christian Hospital	Wung, BS (corresponding author), Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan.	bswung@mail.ncyu.edu.tw	; Herrup, Karl/C-5313-2014	Chen, Ji-hua/0000-0002-1151-0693; wung, being sun/0000-0002-9378-2798; Hsieh, Chia-Wen/0000-0003-1188-1934; Herrup, Karl/0000-0001-7786-5844; Li, Jiali/0000-0002-0039-3671	National Science Council, Taiwan [102-2320-B-415-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants (102-2320-B-415-002-MY3) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EMG, 2012, ANTIOXID REDOX SIGN, V17, P1748, DOI 10.1089/ars.2012.4644; Bannenberg GL, 2009, EXPERT OPIN THER PAT, V19, P663, DOI 10.1517/13543770902858824; Brennan JP, 2006, MOL CELL PROTEOMICS, V5, P215, DOI 10.1074/mcp.M500212-MCP200; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Butturini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020174; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Clark JE, 2000, AM J PHYSIOL-HEART C, V278, pH643, DOI 10.1152/ajpheart.2000.278.2.H643; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; GOSPODAROWICZ D, 1976, P NATL ACAD SCI USA, V73, P4120, DOI 10.1073/pnas.73.11.4120; GYLLENHAMMAR H, 1987, J IMMUNOL METHODS, V97, P209, DOI 10.1016/0022-1759(87)90461-3; Kamencic H, 2000, ANAL BIOCHEM, V286, P35, DOI 10.1006/abio.2000.4765; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lian KC, 2010, TOXICOL APPL PHARM, V245, P21, DOI 10.1016/j.taap.2010.01.003; Liao BC, 2010, TOXICOL SCI, V116, P151, DOI 10.1093/toxsci/kfq098; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Morita T, 2005, ARTERIOSCL THROM VAS, V25, P1786, DOI 10.1161/01.ATV.0000178169.95781.49; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Pimentel D, 2012, ANTIOXID REDOX SIGN, V16, P524, DOI 10.1089/ars.2011.4336; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; Schuringa JJ, 2001, J BIOL CHEM, V276, P27709, DOI 10.1074/jbc.M009821200; Schwer CI, 2010, MOL PHARMACOL, V77, P660, DOI 10.1124/mol.109.059519; Shin DY, 2012, BLOOD, V119, P2523, DOI 10.1182/blood-2011-07-366690; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Wu CC, 2006, TOXICOL APPL PHARM, V214, P244, DOI 10.1016/j.taap.2005.12.013; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Wung BS, 2006, LIFE SCI, V78, P3035, DOI 10.1016/j.lfs.2005.12.013; Wung BS, 2005, LIFE SCI, V78, P389, DOI 10.1016/j.lfs.2005.04.052; Wung BS, 2005, J BIOMED SCI, V12, P91, DOI 10.1007/s11373-004-8170-z; Wung BS, 1997, CIRC RES, V81, P1, DOI 10.1161/01.RES.81.1.1; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yeh PY, 2014, FREE RADICAL BIO MED, V70, P1, DOI 10.1016/j.freeradbiomed.2014.01.042; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	40	112	121	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2014	9	7							e100677	10.1371/journal.pone.0100677	http://dx.doi.org/10.1371/journal.pone.0100677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO4KU	24498369	Green Submitted, Green Published, gold			2022-12-27	WOS:000341307600004
J	Chen, XX; Shi, Y; Chai, WM; Feng, HL; Zhuang, JX; Chen, QX				Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Zhuang, Jiang-Xing; Chen, Qing-Xi			Condensed Tannins from Ficus virens as Tyrosinase Inhibitors: Structure, Inhibitory Activity and Molecular Mechanism	PLOS ONE			English	Article							TOF MS ANALYSIS; MUSHROOM TYROSINASE; SKIN; PIGMENTATION; DOPAMINE; KINETICS; LEAVES; IONS; HPLC; NMR	Condensed tannins from Ficus virens leaves, fruit, and stem bark were isolated and their structures characterized by C-13 nuclear magnetic resonance spectrometry, high performance liquid chromatography electrospray ionization mass spectrometry, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The results showed that the leaves, fruit, and stem bark condensed tannins were complex mixtures of homo-and heteropolymers of B-type procyanidins and prodelphinidins with degrees of polymerization up to hexamer, dodecamer, and pentadecamer, respectively. Antityrosinase activities of the condensed tannins were studied. The results indicated that the condensed tannins were potent tyrosinase inhibitors. The concentrations for the leaves, fruit, and stem bark condensed tannins leading to 50% enzyme activity were determined to be 131.67, 99.89, and 106.22 mu g/ml on monophenolase activity, and 128.42, 43.07, and 74.27 mu g/ml on diphenolase activity. The inhibition mechanism, type, and constants of the condensed tannins on the diphenolase activity were further investigated. The results indicated that the condensed tannins were reversible and mixed type inhibitors. Fluorescence quenching, copper interacting, and molecular docking techniques were utilized to unravel the molecular mechanisms of the inhibition. The results showed that the hydroxyl group on the B ring of the condensed tannins could chelate the dicopper irons of the enzyme. Moreover, the condensed tannins could reduce the enzyme product o-quinones into colourless compounds. These results would contribute to the development and design of antityrosinase agents.	[Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Chen, Qing-Xi] Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Zhuang, Jiang-Xing] Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China	Xiamen University; Xiamen University	Zhuang, JX (corresponding author), Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China.	jiangxingzhuang@xmu.edu.cn; chenqx@xmu.edu.cn	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	Natural Science Foundation of China [31071611, 31070522]; National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China [J1310027/J0106]; Science and Technology Foundation of Fujian Province [2010N5013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China; Science and Technology Foundation of Fujian Province(Natural Science Foundation of Fujian Province); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The present investigation was supported by the Natural Science Foundation of China (No. 31071611; No. 31070522), the National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China (Grant No. J1310027/J0106) and by the Science and Technology Foundation of Fujian Province (No. 2010N5013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hameed ESS, 2009, FOOD CHEM, V114, P1271, DOI 10.1016/j.foodchem.2008.11.005; Anandjiwala S, 2008, INDIAN J PHARM SCI, V70, P31, DOI 10.4103/0250-474X.40328; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Baby Joseph, 2010, International Journal of Pharma and Bio Sciences, V1, pP; Bawadi HA, 2005, CANCER LETT, V218, P153, DOI 10.1016/j.canlet.2004.06.021; Chai WM, 2012, J AGR FOOD CHEM, V60, P5013, DOI 10.1021/jf300740d; Chauhan S, 2013, J MED PLANTS STUD, V1, P3846; Chen QX, 2005, FOOD CHEM, V91, P269, DOI 10.1016/j.foodchem.2004.01.078; Chen XX, 2014, FOOD CHEM, V155, P1, DOI 10.1016/j.foodchem.2014.01.011; Chen XX, 2013, INT J BIOL MACROMOL, V62, P726, DOI 10.1016/j.ijbiomac.2013.09.052; Chen XX, 2013, J ZHEJIANG UNIV-SC B, V14, P903, DOI 10.1631/jzus.B1200365; Choi H, 2005, PIGM CELL RES, V18, P439, DOI 10.1111/j.1600-0749.2005.00266.x; Espin JC, 2001, BBA-PROTEIN STRUCT M, V1544, P289, DOI 10.1016/S0167-4838(00)00230-2; Chiari ME, 2011, BIOORGAN MED CHEM, V19, P3474, DOI 10.1016/j.bmc.2011.04.025; Haslam E., 1989, Plant polyphenols: vegetable tannins revisited.; Hummer W, 2008, MOL NUTR FOOD RES, V52, P1381, DOI 10.1002/mnfr.200700463; Jimenez M, 2001, J AGR FOOD CHEM, V49, P4060, DOI 10.1021/jf010194h; Khatib S, 2007, J MED CHEM, V50, P2676, DOI 10.1021/jm061361d; Kim D, 2006, J AGR FOOD CHEM, V54, P935, DOI 10.1021/jf0521855; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Kubo I, 1999, J AGR FOOD CHEM, V47, P4121, DOI 10.1021/jf990201q; Lee N, 2012, ACS CHEM BIOL, V7, P1687, DOI 10.1021/cb300222b; Lim YY, 2007, LWT-FOOD SCI TECHNOL, V40, P1664, DOI 10.1016/j.lwt.2006.12.013; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; McDonald M, 1996, J AGR FOOD CHEM, V44, P599, DOI 10.1021/jf950459q; Niranjan S, 2012, GLOBAL J PHARM RES, V1, P318; Sanjust E, 2003, ARCH BIOCHEM BIOPHYS, V412, P272, DOI 10.1016/S0003-9861(03)00053-5; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Sisti M, 2008, LWT-FOOD SCI TECHNOL, V41, P946, DOI 10.1016/j.lwt.2007.05.012; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Takahashi S, 2010, BIOORGAN MED CHEM, V18, P8112, DOI 10.1016/j.bmc.2010.08.056; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Xiang P, 2006, CHINESE J ANAL CHEM, V34, P1019, DOI 10.1016/S1872-2040(06)60047-9; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Zhang LL, 2008, MOLECULES, V13, P2986, DOI 10.3390/molecules13122986; Zhuang JX, 2010, J AGR FOOD CHEM, V58, P12993, DOI 10.1021/jf103723k	38	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91809	10.1371/journal.pone.0091809	http://dx.doi.org/10.1371/journal.pone.0091809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24622390	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100063
J	Chen, XH; Scholl, TO				Chen, Xinhua; Scholl, Theresa O.			Maternal Biomarkers of Endothelial Dysfunction and Preterm Delivery	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ADHESION MOLECULE-1; RETROSPECTIVE COHORT; HEART-DISEASE; UNITED-STATES; SE-SELECTIN; PREECLAMPSIA; RISK; WOMEN; INFLAMMATION	Background: Endothelial dysfunction is key to the development of atherosclerosis. Preterm delivery foreshadows later maternal cardiovascular disease (CVD), but it is not known if endothelial dysfunction also occurs. We prospectively measured circulating biomarkers of endothelial dysfunction in pregnant women with preterm or term delivery. Methods: We conducted a case-control study nested within a large prospective epidemiological study of young, generally healthy pregnant women. Women who delivered preterm (, 37 completed weeks gestation, n = 240) and controls who delivered at term (n = 439) were included. Pregnancies complicated by preeclampsia were analyzed separately. Circulating endothelial dysfunction biomarkers included soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin). Results: Elevated levels of sICAM-1 and sVCAM-1 were positively associated with preterm delivery independent of usual risk factors. At entry (similar to 16 wks), the adjusted odds ratio (AOR) was 1.73 (95% confidence interval (CI) 1.09-2.74) for the highest quartile of sICAM-1 versus the lowest quartile and for sVCAM-1 the AOR was 2.17 (95% CI 1.36-3.46). When analysis was limited to cases with a spontaneous preterm delivery, the results were unchanged. Similar results were obtained for the 3rd trimester (similar to 30 wks). Elevated sE-selectin was increased only in preterm delivery complicated by preeclampsia; risk was increased at entry (AOR 2.32, 95% CI 1.22-4.40) and in the 3rd trimester (AOR 3.37, 95% CI 1.78-6.39). Conclusions: Impaired endothelial function as indicated by increased levels of soluble molecules commonly secreted by endothelial cells is a pathogenic precursor to CVD that is also present in women with preterm delivery. Our findings underscore the need for follow-up studies to determine if improving endothelial function prevents later CVD risk in women.	[Chen, Xinhua; Scholl, Theresa O.] Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine	Chen, XH (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA.	chenx1@rowan.edu	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	National Institute of Child Health and Human Development [HD061763, HD18269, HD38329]; National Institute on Minority Health and Health Disparities [1R01MD007828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by research grants from the National Institute of Child Health and Human Development (HD061763 to Chen; HD18269 and HD38329 to Scholl) and the National Institute on Minority Health and Health Disparities (1R01MD007828 to Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatisa PK, 2004, AM J PHYSIOL-HEART C, V286, pH1389, DOI 10.1152/ajpheart.00298.2003; [Anonymous], 2006, INCOME EARNINGS POVE; Bartha JL, 2012, J WOMENS HEALTH, V21, P643, DOI 10.1089/jwh.2011.3013; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Bonamy AKE, 2011, CIRCULATION, V124, P2839, DOI 10.1161/CIRCULATIONAHA.111.034884; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V12, P19; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Clapp BR, 2004, CARDIOVASC RES, V64, P172, DOI 10.1016/j.cardiores.2004.06.020; Frieden Thomas R, 2011, MMWR Suppl, V60, P1; Glowinska B, 2005, METABOLISM, V54, P1020, DOI 10.1016/j.metabol.2005.03.004; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gong J, 2012, PAEDIATR PERINAT EP, V26, P45, DOI 10.1111/j.1365-3016.2011.01222.x; Hamilton SJ, 2009, DIABETES CARE, V32, P810, DOI 10.2337/dc08-1736; Hastie CE, 2011, INT J EPIDEMIOL, V40, P914, DOI 10.1093/ije/dyq270; Hediger ML, 1997, ANN EPIDEMIOL, V7, P400, DOI 10.1016/S1047-2797(97)00046-X; Jenny NS, 2006, J THROMB HAEMOST, V4, P107, DOI 10.1111/j.1538-7836.2005.01678.x; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim SY, 2004, J KOREAN MED SCI, V19, P688, DOI 10.3346/jkms.2004.19.5.688; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Martin Joyce A., 2011, Morbidity and Mortality Weekly Report, V60, P78; Marvin KW, 2000, AM J REPROD IMMUNOL, V43, P264, DOI 10.1111/j.8755-8920.2000.430504.x; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Pell JP, 2004, AM J EPIDEMIOL, V159, P336, DOI 10.1093/aje/kwh064; Pina IL, 2011, CARDIOL REV, V19, P71, DOI 10.1097/CRD.0b013e318209c233; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Steinborn A, 2000, OBSTET GYNECOL, V95, P671, DOI 10.1016/S0029-7844(99)00604-3; Stewart FM, 2007, J CLIN ENDOCR METAB, V92, P969, DOI 10.1210/jc.2006-2083; Veas CJ, 2011, J MATERN-FETAL NEO M, V24, P1371, DOI 10.3109/14767058.2011.556204; Velez DR, 2009, AJOG, V200; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548	33	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85716	10.1371/journal.pone.0085716	http://dx.doi.org/10.1371/journal.pone.0085716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24622390	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100065
J	Chen, XK; May, B; Di, YM; Zhang, AL; Lu, CJ; Xue, CC; Lin, L				Chen, Xiankun; May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Lu, Chuanjian; Xue, Charlie Changli; Lin, Lin			Oral Chinese Herbal Medicine Combined with Pharmacotherapy for Stable COPD: A Systematic Review of Effect on BODE Index and Six Minute Walk Test	PLOS ONE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; CORDYCEPS-SINENSIS; ASTRAGALUS-MEMBRANACEUS; DISTANCE; COMPLEMENTARY; MANAGEMENT; PREDICTOR; CAPACITY; OUTCOMES	This systematic review evaluated the effects of Chinese herbal medicine (CHM) plus routine pharmacotherapy (RP) on the objective outcome measures BODE index, 6-minute walk test (6MWT), and 6-minute walk distance (6MWD) in individuals with stable chronic obstructive pulmonary disease (COPD). Searches were conducted of six English and Chinese databases (PubMed, EMBASE, CENTRAL, CINAHL, CNKI and CQVIP) from their inceptions until 18th November 2013 for randomized controlled trials involving oral administration of CHM plus RP compared to the same RP, with BODE Index and/or 6MWT/D as outcomes. Twenty-five studies were identified. BODE Index was used in nine studies and 6MWT/D was used in 22 studies. Methodological quality was assessed using the Cochrane Risk of Bias tool. Weaknesses were identified in most studies. Six studies were judged as 'low' risk of bias for randomisation sequence generation. Twenty-two studies involving 1,834 participants were included in the meta-analyses. The main meta-analysis results showed relative benefits for BODE Index in nine studies (mean difference [MD] -0.71, 95% confidence interval [CI] -0.94, -0.47) and 6MWT/D in 17 studies (MD 54.61 meters, 95% CI 33.30, 75.92) in favour of the CHM plus RP groups. The principal plants used were Astragalus membranaceus, Panax ginseng and Cordyceps sinensis. A. membranaceus was used in combination with other herbs in 18 formulae in 16 studies. Detailed sub-group and sensitivity analyses were conducted. Clinically meaningful benefits for BODE Index and 6MWT were found in multiple studies. These therapeutic effects were promising but need to be interpreted with caution due to variations in the CHMs and RPs used and methodological weakness in the studies. These issues should be addressed in future trials.	[Chen, Xiankun] Guangdong Prov Acad Chinese Med Sci, Evidence Based Med & Clin Res Serv Grp, Guangzhou, Guangdong, Peoples R China; [Chen, Xiankun; Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Xue, Charlie Changli] RMIT Univ, Sch Hlth Sci, Hlth Innovat Res Inst, Tradit & Complementary Med Res Program, Melbourne, Vic, Australia; [Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Acad Chinese Med Sci, Guangzhou, Guangdong, Peoples R China; [Lin, Lin] Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Royal Melbourne Institute of Technology (RMIT); Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Lin, L (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	drlinlin620@163.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China [2012DFA31760]; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study is funded by a project grant from the International Science & Technology Cooperation Project of the Ministry of Science and Technology of China (Project Grant Number: 2012DFA31760, Project Title: Evaluation of Traditional and Scientific Evidence of Chinese Medicine). The project is partially supported by the China-Australia International Research Centre for Chinese Medicine, funded by Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS & GPHCM), Guangdong China, and RMIT University, Australia. The authors also acknowledge the support provided by the GPHCM and the School of Health Sciences, RMIT University to the first author (XKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 1999, AM J RESP CRIT CARE, V159, P1666; An XD, 2012, J ALTERN COMPLEM MED, V18, P731, DOI 10.1089/acm.2011.0389; An XD, 2011, RESP MED, V105, P165, DOI 10.1016/j.rmed.2010.11.007; Brown Cynthia D, 2007, COPD, V4, P217; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen GC, 2012, SHANGHAI J TRADITION, V46, P42; Chen Ning, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P105, DOI 10.3736/jcim20090202; Chen Q, 2009, J FUJIAN U TRAD CHIN, V19, P12; Cote CG, 2008, EUR RESPIR J, V31, P571, DOI 10.1183/09031936.00104507; Cote CG, 2005, EUR RESPIR J, V26, P630, DOI 10.1183/09031936.05.00045505; CSRD, 2007, CHIN J INRERN MED, V46, P254; Cui Peng, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3451; Cui Zhao-bo, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P885; Denzler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012561; Faganello MM, 2010, AM J MED SCI, V339, P10, DOI 10.1097/MAJ.0b013e3181bb8111; Fan BD, 2012, J SICHUAN TRADITIONA, P83; George J, 2004, MED J AUSTRALIA, V181, P248, DOI 10.5694/j.1326-5377.2004.tb06262.x; Glaab T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-79; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Guo WX, 2008, HEBEI J TRADITIONAL, V30, P121; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028696; Hu QG, 2012, J GUIYANG COLLAGE TR, V34, P135; [黄东晖 Huang Donghui], 2005, [第四军医大学学报, Journal of the Fourth Military Medical University], V26, P1611; Imfeld S, 2006, CHEST, V129, P873, DOI 10.1378/chest.129.4.873; Jian XY, 2012, J BEIJING U TRADITIO, V19, P32; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Koh JH, 2002, BIOSCI BIOTECH BIOCH, V66, P407, DOI 10.1271/bbb.66.407; Kumar R, 2011, J ETHNOPHARMACOL, V136, P260, DOI 10.1016/j.jep.2011.04.040; Kuo YH, 2009, J ETHNOPHARMACOL, V122, P28, DOI 10.1016/j.jep.2008.11.025; Kuo YC, 1996, AM J CHINESE MED, V24, P111, DOI 10.1142/S0192415X96000165; Kuo YC, 2001, LIFE SCI, V68, P1067, DOI 10.1016/S0024-3205(00)01011-0; Li CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040824; Li SY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-197; Liang AW, 2013, J EMERGENCY TRADITIO, P1125; Liao Y.L., 2011, HERALD MED, V30, P63; Lin YZ, 2013, CHINESE MANIPULATION, P103; Liu CS, 2009, GUIDING J TRADITIONA, V11, P10; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mansori F, 2010, CLIN RESPIR J, V4, P241, DOI 10.1111/j.1752-699X.2010.00185.x; Marin JM, 2011, RESP MED, V105, P916, DOI 10.1016/j.rmed.2011.01.007; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ong KC, 2005, CHEST, V128, P3810, DOI 10.1378/chest.128.6.3810; Peng ZQ, 2013, THESIS FUJIAN U TRAD; Pinto-Plata V, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-71; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rao YK, 2007, J ETHNOPHARMACOL, V114, P78, DOI 10.1016/j.jep.2007.07.028; Shahed AR, 2001, TRANSPL P, V33, P2986, DOI 10.1016/S0041-1345(01)02282-5; Shan LN, 2011, J GUANGZHOU U TRADIT, V28, P590; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Shergis JL, 2013, PHYTOTHER RES, V27, P949, DOI 10.1002/ptr.4832; Shin IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045734; Spruit MA, 2012, J AM MED DIR ASSOC, V13, P291, DOI 10.1016/j.jamda.2011.06.009; Vickers A, 1999, BRIT MED J, V319, P1050, DOI 10.1136/bmj.319.7216.1050; Wise Robert A, 2005, COPD, V2, P125; Wu L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/705315; Xu JZ, 2012, YUNNAN J TRADITIONAL, V33, P31; Xu TingZhen, 2012, Chinese Archives of Traditional Chinese Medicine, V30, P570; Yang CM, 2013, MODERN J INTEGRATED, P729; Yu JY, 2011, J MED INFORM, P4019; Zeng JQ, 2013, J NEW CHINESE MED, P32; Zhang FY, 2007, SHANXI ZHONGYI J, V28, P1594; Zhang FY, 2007, J EMERGENCY TRADITIO, V19, P198; Zhang R.Z., 2011, CHINA PRACTICAL MED, V6, P118; Zhao YL, 2012, J TRADIT CHIN MED, V32, P203, DOI 10.1016/S0254-6272(13)60012-6; 茅蓉, 2009, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V29, P362	70	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91830	10.1371/journal.pone.0091830	http://dx.doi.org/10.1371/journal.pone.0091830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622390	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300132
J	Chen, XF; Li, LZ; Zhou, T; Li, ZZ				Chen, Xiaofang; Li, Lezhi; Zhou, Tao; Li, Zhanzhan			Prevalence of Hypertension in Rural Areas of China: A Meta-Analysis of Published Studies	PLOS ONE			English	Article							STAGE RENAL-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; MEN; AWARENESS; MORTALITY	Background: Hypertension is one of the leading causes of disease burden across the world. In China, the latest nationwide survey of prevalence of hypertension was ten year ago, and data in rural areas is little known. More information about hypertension prevalence could help to improve overall antihypertensive health care. We aimed to estimate the pooled prevalence of hypertension in rural areas of China. Methods: Comprehensive electronic searches of PubMed, Web of Knowledge, Chinese Web of Knowledge, Wangfang, Weipu and SinoMed databases were conducted to identify any study in each database published from January 1, 2004 to December 31, 2013, reporting the prevalence of hypertension in Chinese rural areas. Prevalence estimates were stratified by age, area, sex, publication year, and sample size. All statistical calculations were made using the Stata Version 11.0 (College Station, Texas) and Statsdirect Version 2.7.9. Results: We identified 124 studies with a total population of 3,735,534 in the present meta-analysis. Among people aged 18 years old in Chinese rural areas, the summarized prevalence is 22.81% (19.41%-26.41%). Subgroup analysis shows the following results: for male 24.46% (21.19%-27.89%, for female 22.17% (18.25%-26.35%). For 2004-2006: 18.94% (14.41%-23.94%), for 2007-2009, 21.24% (15.98%-27.01%) for 2010-2013: 26.68%, (20.79%-33.02%). For Northern region 25.76% (22.36%-29.32%), for Southern region 19.30%, (15.48%-24.08%). Conclusions: The last decade witnessed the growth in prevalence of hypertension in rural areas of China compared with the fourth national investigation, which has climbed the same level as the urban area. Guidelines for screening and treatment of hypertension in rural areas need to be given enough attention.	[Chen, Xiaofang] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Chen, Xiaofang] Southern Med Univ, Affiliated Hostipal 3, Dept Nursing, Guangzhou, Guangdong, Peoples R China; [Li, Lezhi] Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Zhou, Tao] Southern Med Univ, Dept Cardiol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Li, Zhanzhan] Cent South Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China	Central South University; Southern Medical University - China; Central South University; Southern Medical University - China; Central South University	Li, LZ (corresponding author), Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	lilz1988@126.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Chen B, 2008, MOEDERN PREV MED, V35, P2823; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Department of Disease Control and Prevention Ministry of Health, 2006, REP CHRON DIS CHIN; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz AA, 2014, RURAL REMOTE HEALTH, V14; Dong CX, 2013, J INT MED RES, V41, P1291, DOI 10.1177/0300060513488498; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; FLACK JM, 1995, CIRCULATION, V92, P2437, DOI 10.1161/01.CIR.92.9.2437; Gong Jie, 2011, Chinese Preventive Medicine, V12, P227; Han B, 2009, J ZHENGZHOU U MED SC, V44, P337; He F, 2012, CHIN J DIS CONTROL P, V16, P560; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu HH, 2008, PREV TREATMENT CARDI, V8, P195; Hu XJ, 2013, CHIN HLTH SERVICE MA, V5, P391; Hu Y, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P177; Huang JP, 2011, KIDNEY BLOOD PRESS R, V34, P69, DOI 10.1159/000323164; Kannel WB, 1996, JAMA-J AM MED ASSOC, V276, P1269, DOI 10.1001/jama.276.15.1269; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Kokiwar Prashant R, 2012, J Assoc Physicians India, V60, P26; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Li LM, 2008, CHINESE REDIDENTS NU; Li Y, 2011, J SHENYANG MED COLL, V13, P228; Lin Kang, 2014, Wuhan Daxue Xuebao (Yixue Ban), V35, P114; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ma YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058302; Ministry of Health of the People's Republic of China, 2005, CHIN PREV CONTR HYP; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Ni GH, 2013, FOOD NUTR CHIN, V19, P70; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; PRC National Blood Pressure Survey Cooperative Group, 1995, CHIN J HYPERTENS, V3, P1; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Rostom A, 2004, Evid Rep Technol Assess (Summ), P1; Stuart A, 1996, KENDALLS ADV THEORY; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; [王克伟 Wang Kewei], 2011, [中国公共卫生, China Public Health], V27, P1291; Wang YM., 2013, J BENBU MED COLL, V38, P321; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Xia YiYin, 2013, Journal of Tropical Medicine (Guangzhou), V13, P350; Xin RB, 2011, GUANGXI MED, V33, P963; Yang HJ, 2010, CHIN J GEN PRAC, V8, P896; Ye HaoFeng, 2005, China Tropical Medicine, V5, P1114; Ye ZW, 2011, ANHUI J PREV MED, V17, P190; Yin CG, 2009, PREV TREATMENT CARDI, V9, P137; Yu QH, 2011, WORLD HLTH DIG MED P, V8, P13; Yu YX, 2009, MED J CHIN PEOPLE HL, V21, P2364; Zhang AH, 2009, PREV MED TRIB, V15, P720; Zhang G, 2009, GONG GONG WEI SHENG, V20, P24; Zhang LJ, 2010, OCCUP HLTH, V26, P1872; Zhang Y., 2011, NINGXIA MED J, V33, P1222; Zhao JiQing, 2013, Bulletin of Disease Control and Prevention, V28, P27; Zheng YT, 2011, CHIN MED J METALL IN, V28, P573; Zheng ZH, 2010, CHINA CHLIN PRAC MED, V4, P219; Zhong DC, 2009, SICHUAN MED J, V30, P1056; Zhou YX, 2011, PRE MED TRIB, V17, P909	59	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115462	10.1371/journal.pone.0115462	http://dx.doi.org/10.1371/journal.pone.0115462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	24622390	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845600050
J	Chen, XL; Chen, XZ; Lu, ZH; Wang, L; Yang, K; Hu, JK; Zhang, B; Chen, ZX; Chen, JP; Zhou, ZG				Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Wang, Li; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang			Comparison of Ultrasonic Scalpel versus Conventional Techniques in Open Gastrectomy for Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACTIVATED SHEARS; CANCER; LYMPHADENECTOMY	Objectives: To compare surgical efficacy and postoperative recovery of ultrasonic scalpel (USS) with conventional techniques for the resection of gastric carcinoma. Methods: A systematic search of major medical databases (PubMed, Embase, CCRT and CNKI) was conducted. Both randomized and non-randomized controlled trials (RCTs and nRCTs) were considered eligible. Operation time (OT), intraoperative blood loss (BL) and postoperative complications (POC) rates as well as postoperative hospitalization days, number of dissected lymph nodes, abdominal drainage volume and time for recovery of gastrointestinal functions were synthesized and compared. Results: Nineteen studies were included (7 RCTs and 12 nRCTs), in which 1930 patients were enrolled totally (946 in the USS group and 984 in the conventional group). Monopolar electrocautery and ligation were used as the conventional methods. Comparative meta-analysis showed perioperative outcomes were significantly improved using USS compared with conventional surgical instrumentation. OT was reduced from a weighted mean of 185.3 min in the conventional group to 151.0 min in the USS group (MD = -33.30, 95% CI [-41.75, -24.86], p<0.001) and intraoperative BL was decreased from a weighted mean of 217.9 ml in the conventional group to 111.6 ml in the USS group (MD = -113.42, 95% CI [-142.05, -84.79], p<0.001). Results from RCTs subgroup were consistent with those from nRCTs subgroup. The weighted cumulative risk of POC accounted for 8.9% (0%-25%) and 12.9% (5.5%-45%) in the USS and conventional groups, respectively. Pooled estimated results from nRCTs (OR = 0.54, 95% CI [0.27, 1.06], p = 0.07) and RCTs (RR = 0.75, 95% CI [0.44, 1.26], p = 0.27) showed no significant difference between the USS and control groups. Analysis of secondary outcomes showed the improvements of the USS group over control group regarding the number of dissected lymph nodes, postoperative hospitalization days, abdominal drainage volume and time for recovery of gastrointestinal functions. Conclusion: Compared with conventional electrosurgery, the USS is a safe and effective technique with more short-term advantages in open surgery for gastric cancer.	[Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Wang, Li] Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University	Hu, JK (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	hujkwch@126.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China [2011SCU04B19]; Ministry of Education of China [2012SCU-NCET-11-0343]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Ministry of Education of China(Ministry of Education, China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Domestic support from (1) Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China (No. 2011SCU04B19); and (2) New Century Excellent Talents in University support program, Ministry of Education of China (2012SCU-NCET-11-0343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 1998, ONCOLOGY-NY, V12, P44; Ajani JA, 2010, J NATL COMPR CANC NE, V8, P378, DOI 10.6004/jnccn.2010.0030; Chen CP, 2012, GUID CHIN MED, V10, P345; Chen XZ, 2010, J AM COLL SURGEONS, V210, P100, DOI 10.1016/j.jamcollsurg.2009.09.033; Chen Z, 2009, CHIN J MOD OPER SURG, V13, P257; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fu YM, 2011, CONT MED, V17, P104; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hu JK, 2009, SURG TODAY, V39, P207, DOI 10.1007/s00595-008-3856-x; Hu JK, 2008, CHIN J BASES CLIN GE, V15, P718; Inoue K, 2012, J GASTROINTEST SURG, V16, P1840, DOI 10.1007/s11605-012-1970-y; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li G, 2010, J MED POSTGRA, V23, P1050; Li P, 2011, CHIN MED HERALD, V8, P177; Li ZR, 2009, CHIN ARCH GEN SURG E, V3, P510; Lin YH, 2011, CHIN J CLIN ELECT ED, V5, P975; [陆维祺 LU Weiqi], 2008, [中国实用外科杂志, Chinese Journal of Practical Surgery], V28, P203; Mahabaleshwar V, 2012, CAN J SURG, V55, P307, DOI 10.1503/cjs.000411; McCarus SD, 1996, J AM ASSOC GYN LAP, V3, P601, DOI 10.1016/S1074-3804(05)80174-4; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mohri Y, 2007, SURG TODAY, V37, P1060, DOI 10.1007/s00595-007-3551-3; Pons Y, 2009, HEAD NECK ONCOL, V24, P1; Shi YF, 2012, GUID CHIN MED, V10, P154; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Tou S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007886.pub2; Tsimoyiannis EC, 2002, WORLD J SURG, V26, P158; Tu JC, 2010, MED J COMMUN, V24, P60; Tu XH, 2009, CHIN J MOD OPER SURG, V13, P407; Van Cutsem E, 2008, EUR J CANCER, V44, P182, DOI 10.1016/j.ejca.2007.11.001; Wei ZM, 2010, J MINI INVA MED, V5, P445; Wells G, 2009, OTTAWA HOSP RES I NE; Xu L, 2010, PEOPLES MIL SURG, V53, P490; Yang K, 2009, WORLD J GASTROENTERO, V15, P5352, DOI 10.3748/wjg.15.5352; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang ZY, 2012, CHIN J MOD DRUG APPL, V6, P3; Zhong L, 2012, ANN ACAD MED SINGAP, V41, P161; 尹蓓, 2011, [江苏医药, Jiangsu Medical Journal], V37, P2877; 宋小平, 2011, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V31, P590; 刘磊, 2010, [中国癌症杂志, China Oncology], V20, P799	41	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103330	10.1371/journal.pone.0103330	http://dx.doi.org/10.1371/journal.pone.0103330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	24622390	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800038
